PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Vuorenpaa, A; Jorgensen, TN; Newman, AH; Madsen, KL; Scheinin, M; Gether, U				Vuorenpaeaa, Anne; Jorgensen, Trine N.; Newman, Amy H.; Madsen, Kenneth L.; Scheinin, Mika; Gether, Ulrik			Differential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine transporter; monoamine transporter; neurotransmitter transport; protein chimera; trafficking; internalization; norepinephrine transporter; recycling; transporter regulation	PROTEIN-KINASE-C; ENDOCYTIC RECYCLING SIGNAL; GAMMA-AMINOBUTYRIC-ACID; TRANS-GOLGI NETWORK; SURFACE EXPRESSION; CELL-LINES; SUBCELLULAR-LOCALIZATION; MEDIATED INTERNALIZATION; ORTHOSTATIC INTOLERANCE; LYSOSOMAL DEGRADATION	The norepinephrine transporter (NET) mediates reuptake of synaptically released norepinephrine in central and peripheral noradrenergic neurons. The molecular processes governing availability of NET in the plasma membrane are poorly understood. Here we use the fluorescent cocaine analogue JHC 1-64, as well as several other approaches, to investigate the trafficking itinerary of NET in live noradrenergic neurons. Confocal imaging revealed extensive constitutive internalization of JHC 1-64-labeled NET in the neuronal somata, proximal extensions and presynaptic boutons. Phorbol 12-myristate 13-acetate increased intracellular accumulation of JHC 1-64-labeled NET and caused a parallel reduction in uptake capacity. Internalized NET strongly colocalized with the long loop recycling marker Rab11, whereas less overlap was seen with the short loop recycling marker Rab4 and the late endosomal marker Rab7. Moreover, mitigating Rab11 function by overexpression of dominant negative Rab11 impaired NET function. Sorting of NET to the Rab11 recycling compartment was further supported by confocal imaging and reversible biotinylation experiments in transfected differentiated CATH.a cells. In contrast to NET, the dopamine transporter displayed markedly less constitutive internalization and limited sorting to the Rab11 recycling compartment in the differentiated CATH.a cells. Exchange of domains between the two homologous transporters revealed that this difference was determined by non-conserved structural elements in the intracellular N terminus. We conclude that NET displays a distinct trafficking itinerary characterized by continuous shuffling between the plasma membrane and the Rab11 recycling compartment and that the functional integrity of the Rab11 compartment is critical for maintaining proper presynaptic NET function.	[Vuorenpaeaa, Anne; Jorgensen, Trine N.; Madsen, Kenneth L.; Gether, Ulrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Neuropharmacol & Genet Lab,Panum Inst 18 6, DK-2200 Copenhagen N, Denmark; [Vuorenpaeaa, Anne; Scheinin, Mika] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, FI-20014 Turku, Finland; [Vuorenpaeaa, Anne; Scheinin, Mika] Turku Univ Hosp, Clin Pharmacol Unit, FI-20520 Turku, Finland; [Newman, Amy H.] NIDA, Med Chem Sect, Intramural Res Program, NIH, Baltimore, MD 21224 USA	University of Copenhagen; University of Turku; University of Turku; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Gether, U (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Neuropharmacol & Genet Lab,Panum Inst 18 6, DK-2200 Copenhagen N, Denmark.	gether@sund.ku.dk	Madsen, Kenneth/C-7778-2012	Madsen, Kenneth/0000-0001-9274-6691; Scheinin, Mika/0000-0001-7579-9126; Gether, Ulrik/0000-0002-0020-3807	FinPharma Doctoral program; National Institutes of Health [P01 DA 12408]; Danish Council for Independent Research-Medical Sciences; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000610, P01DA012408] Funding Source: NIH RePORTER	FinPharma Doctoral program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation Center for Biomembranes in Nanomedicine; Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the FinPharma Doctoral program (to A. V.), National Institutes of Health Grant P01 DA 12408 (to U. G.), the Danish Council for Independent Research-Medical Sciences (to U. G.), the Lundbeck Foundation Center for Biomembranes in Nanomedicine (to U. G.), and the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health (to A. H. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P733; Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P744; Arapulisamy O, 2013, J BIOL CHEM, V288, P28599, DOI 10.1074/jbc.M113.472878; Axelrod J, 1969, Prog Brain Res, V31, P21; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Biber K, 1997, J NEUROSCI, V17, P4956; Block ER, 2015, J NEUROSCI, V35, P12845, DOI 10.1523/JNEUROSCI.1391-15.2015; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Brown A, 2004, AM J PHYSIOL-CELL PH, V286, pC1071, DOI 10.1152/ajpcell.00291.2003; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; BUCK KJ, 1994, P NATL ACAD SCI USA, V91, P12584, DOI 10.1073/pnas.91.26.12584; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Ding YS, 2010, SYNAPSE, V64, P30, DOI 10.1002/syn.20696; Dipace C, 2007, MOL PHARMACOL, V71, P230, DOI 10.1124/mol.106.026690; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Furman CA, 2009, NEUROSCI LETT, V463, P78, DOI 10.1016/j.neulet.2009.07.049; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; GEFFEN LB, 1971, PHYSIOL REV, V51, P98, DOI 10.1152/physrev.1971.51.1.98; GIROS B, 1994, J BIOL CHEM, V269, P15985; Gonzalez MI, 2007, J NEUROCHEM, V103, P1917, DOI 10.1111/j.1471-4159.2007.04881.x; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gu HH, 2001, MOL BIOL CELL, V12, P3797, DOI 10.1091/mbc.12.12.3797; Hahn MK, 2003, J NEUROSCI, V23, P4470; Holst B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001542; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kim CH, 2006, P NATL ACAD SCI USA, V103, P19164, DOI 10.1073/pnas.0510836103; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; LIVETT BG, 1973, BRIT MED BULL, V29, P93, DOI 10.1093/oxfordjournals.bmb.a071003; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Mannangatti P, 2011, J BIOL CHEM, V286, P20239, DOI 10.1074/jbc.M111.226811; Matthies HJG, 2010, J NEUROSCI, V30, P7863, DOI 10.1523/JNEUROSCI.4574-09.2010; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McCann UD, 1998, J NEUROSCI, V18, P8417; Miner LH, 2003, J COMP NEUROL, V466, P478, DOI 10.1002/cne.10898; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Muth TR, 1998, J BIOL CHEM, V273, P25616, DOI 10.1074/jbc.273.40.25616; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Perego C, 1997, J BIOL CHEM, V272, P6584, DOI 10.1074/jbc.272.10.6584; Qi YP, 1997, J NEUROSCI, V17, P1217; Rahbek-Clemmensen T, 2014, J BIOL CHEM, V289, P23004, DOI 10.1074/jbc.M113.495754; RAITERI M, 1977, EUR J PHARMACOL, V41, P133, DOI 10.1016/0014-2999(77)90202-3; Rajamanickam J, 2015, BIOCHEM J, V468, P177, DOI 10.1042/BJ20140826; Rickhag M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2568; Rumantir MS, 2000, HYPERTENSION, V36, P824, DOI 10.1161/01.HYP.36.5.824; Savchenko V, 2003, MOL CELL NEUROSCI, V24, P1131, DOI 10.1016/S1044-7431(03)00235-5; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sung U, 2003, J NEUROSCI, V23, P1697; SURI C, 1993, J NEUROSCI, V13, P1280; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Vina-Vilaseca A, 2010, J BIOL CHEM, V285, P7645, DOI 10.1074/jbc.M109.058990; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Zhang K, 2013, J NEUROSCI, V33, P7451, DOI 10.1523/JNEUROSCI.4322-12.2013; Zoli M, 1999, TRENDS PHARMACOL SCI, V20, P142, DOI 10.1016/S0165-6147(99)01343-7	78	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5634	5651		10.1074/jbc.M115.702050	http://dx.doi.org/10.1074/jbc.M115.702050			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786096	Green Published, hybrid			2022-12-26	WOS:000372551800016
J	Al-Ta'ii, HMJ; Periasamy, V; Amin, YM				Al-Ta'ii, Hassan Maktuff Jaber; Periasamy, Vengadesh; Amin, Yusoff Mohd			Electronic Characterization of Au/DNA/ITO Metal-Semiconductor-Metal Diode and Its Application as a Radiation Sensor	PLOS ONE			English	Article							VOLTAGE CHARACTERISTICS; DNA-MOLECULES; THIN-FILMS; INTERFACE; HUMIDITY; CONDUCTIVITY; TEMPERATURE; IRRADIATION; EXTRACTION; PARAMETERS	Deoxyribonucleic acid or DNA molecules expressed as double-stranded (DSS) negatively charged polymer plays a significant role in electronic states of metal/silicon semiconductor structures. Electrical parameters of an Au/DNA/ITO device prepared using self-assembly method was studied by using current-voltage (I-V) characteristic measurements under alpha bombardment at room temperature. The results were analyzed using conventional thermionic emission model, Cheung and Cheung's method and Norde's technique to estimate the barrier height, ideality factor, series resistance and Richardson constant of the Au/DNA/ITO structure. Besides demonstrating a strongly rectifying (diode) characteristic, it was also observed that orderly fluctuations occur in various electrical parameters of the Schottky structure. Increasing alpha radiation effectively influences the series resistance, while the barrier height, ideality factor and interface state density parameters respond linearly. Barrier height determined from I-V measurements were calculated at 0.7284 eV for non-radiated, increasing to about 0.7883 eV in 0.036 Gy showing an increase for all doses. We also demonstrate the hypersensitivity phenomena effect by studying the relationship between the series resistance for the three methods, the ideality factor and low-dose radiation. Based on the results, sensitive alpha particle detectors can be realized using Au/DNA/ITO Schottky junction sensor.	[Al-Ta'ii, Hassan Maktuff Jaber; Periasamy, Vengadesh] Univ Malaya, Fac Sci, Dept Phys, LDMRC, Kuala Lumpur 50603, Malaysia; [Amin, Yusoff Mohd] Univ Malaya, Fac Sci, Dept Phys, Kuala Lumpur 50603, Malaysia; [Al-Ta'ii, Hassan Maktuff Jaber] Univ Al Muthana, Dept Phys, Fac Sci, Al Muthana 66001, Iraq	Universiti Malaya; Universiti Malaya	Al-Ta'ii, HMJ; Periasamy, V (corresponding author), Univ Malaya, Fac Sci, Dept Phys, LDMRC, Kuala Lumpur 50603, Malaysia.; Al-Ta'ii, HMJ (corresponding author), Univ Al Muthana, Dept Phys, Fac Sci, Al Muthana 66001, Iraq.	hassankirkukly@gmail.com; vengadeshp@um.edu.my	PERIASAMY, VENGADESH/B-9993-2010; Al-Ta'ii, Hassan/E-7794-2019	PERIASAMY, VENGADESH/0000-0002-0435-4944; Al-Ta'ii, Hassan/0000-0002-5852-868X	Fundamental Research Grant Scheme, FRGS [FP004-2013A]; University of Malaya Postgraduate Research Fund, PPP [PG202-2014B]; University of Malaya Research Grant, UMRG [RG321-15AFR]; Ministry of Higher Education and Scientific Research of Iraq	Fundamental Research Grant Scheme, FRGS; University of Malaya Postgraduate Research Fund, PPP; University of Malaya Research Grant, UMRG; Ministry of Higher Education and Scientific Research of Iraq	This work was supported by Fundamental Research Grant Scheme, FRGS (FP004-2013A), University of Malaya Postgraduate Research Fund, PPP (PG202-2014B) and University of Malaya Research Grant, UMRG (RG321-15AFR).; Financial assistances provided by Fundamental Research Grant Scheme, FRGS (FP004-2013A), University of Malaya Research Grant, UMRG (RG321-15AFR) and University of Malaya Postgraduate Research Fund, PPP (PG202-2014B) grant are greatly appreciated. The first author would also like to thank the Ministry of Higher Education and Scientific Research of Iraq for financial assistance provided for his PhD study.	Al-Ta'ii HMJ, 2015, SENSORS-BASEL, V15, P4810, DOI 10.3390/s150304810; Al-Ta'ii HMJ, 2015, RADIAT MEAS, V72, P85, DOI 10.1016/j.radmeas.2014.11.011; Aydogan S, 2008, MAT SCI SEMICON PROC, V11, P53, DOI 10.1016/j.mssp.2008.11.004; Banihashemian SM, 2013, MOLECULES, V18, P11797, DOI 10.3390/molecules181011797; Batcup S, 2012, INT CONF MICROELECTR, P81, DOI 10.1109/MIEL.2012.6222801; Bazlov NV, 2013, APPL SURF SCI, V267, P224, DOI 10.1016/j.apsusc.2012.11.002; Bellido EP, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175102; Bixon M, 1999, P NATL ACAD SCI USA, V96, P11713, DOI 10.1073/pnas.96.21.11713; Bonea A, 2012, J OPTOELECTRON ADV M, V14, P511; Borhani M, 2007, NUKLEONIKA, V52, P77; CHEUNG SK, 1986, APPL PHYS LETT, V49, P85, DOI 10.1063/1.97359; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Dugasani SR, 2015, RSC ADV, V5, P55839, DOI 10.1039/c5ra07360j; Dugasani SR, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4923377; Dugasani SR, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/27/275604; Gullu O, 2008, APPL SURF SCI, V254, P5175, DOI 10.1016/j.apsusc.2008.02.019; Gullu O, 2012, J APPL PHYS, V111, DOI 10.1063/1.3684989; Gullu O, 2011, J ALLOY COMPD, V509, P571, DOI 10.1016/j.jallcom.2010.09.146; Gullu O, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2936086; Gupta RK, 2012, SOL ENERGY, V86, P1539, DOI 10.1016/j.solener.2012.02.015; Ha DH, 2002, CHEM PHYS LETT, V355, P405, DOI 10.1016/S0009-2614(02)00142-2; Hassan M, 2009, J RAFIDEN SCI, V20, P113; Hassan M.A.-T., 2012, J KERBALA U, V10, P41; Heim T, 2004, J APPL PHYS, V96, P2927, DOI 10.1063/1.1769606; Hibbett D, 2013, FORENSIC DNA MINI PR; Holbert KE, 2012, RAD EFFECTS DAMAGE; Imtiaj A., 2011, Micologia Aplicada International, V23, P1; Jayavel P, 2000, VACUUM, V57, P51, DOI 10.1016/S0042-207X(99)00211-0; Jo YS, 2003, J KOREAN PHYS SOC, V43, P909, DOI 10.3938/jkps.43.909; Karatas S, 2004, VACUUM, V74, P45, DOI 10.1016/j.vacuum.2003.11.006; Khatir NM, 2012, SENSORS-BASEL, V12, P3578, DOI 10.3390/s120303578; Kilicoglu T, 2011, MICROELECTRON ENG, V88, P150, DOI 10.1016/j.mee.2010.10.001; Kulkarni A, 2013, SCI REPORT, P3; Lu JJ, 2009, BIOPHYS CHEM, V145, P91, DOI 10.1016/j.bpc.2009.09.005; Mahmoudi Khatir N, 2013, ELECT CHARACTERIZATI; Martin LM, 2013, CANCER LETT, V338, P209, DOI 10.1016/j.canlet.2013.05.021; Okahata Y, 1998, J AM CHEM SOC, V120, P6165, DOI 10.1021/ja980165w; Okur S, 2009, MICROELECTRON ENG, V86, P2305, DOI 10.1016/j.mee.2009.04.017; Otsuka Y, 2002, JPN J APPL PHYS 1, V41, P891, DOI 10.1143/JJAP.41.891; Reddy MSP, 2014, OPT EXPRESS, V22, P908, DOI 10.1364/OE.22.000908; Reddy VS, 2006, SEMICOND SCI TECH, V21, P1747, DOI 10.1088/0268-1242/21/12/043; Sabet M, 2012, POLYM BULL, V68, P2323, DOI 10.1007/s00289-012-0741-y; Schmitsdorf RF, 1997, J VAC SCI TECHNOL B, V15, P1221, DOI 10.1116/1.589442; Shinde KN, 2012, BASIC MECH PHOTOLUMI, P41; Sonmezoglu S, 2010, J APPL PHYS, V107, DOI 10.1063/1.3447985; Sonmezoglu S, 2011, MAT SCI ENG C-MATER, V31, P1619, DOI 10.1016/j.msec.2011.08.003; Tahir M., 2012, INT C ADV EL EL ENG; Takada T, 2007, P NATL ACAD SCI USA, V104, P11179, DOI 10.1073/pnas.0700795104; Tikhomirov G, 2011, NAT NANOTECHNOL, V6, P485, DOI [10.1038/nnano.2011.100, 10.1038/NNANO.2011.100]; Tsoulou E, 2003, RADIAT RES, V159, P33, DOI 10.1667/0033-7587(2003)159[0033:CIDFAI]2.0.CO;2; Tugluoglu N, 2012, CURR APPL PHYS, V12, P1529, DOI 10.1016/j.cap.2012.04.027	52	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145423	10.1371/journal.pone.0145423	http://dx.doi.org/10.1371/journal.pone.0145423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799703	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300006
J	Bi, XY; Tey, SL; Leong, C; Quek, R; Henry, CJ				Bi, Xinyan; Tey, Siew Ling; Leong, Claudia; Quek, Rina; Henry, Christiani Jeyakumar			Prevalence of Vitamin D Deficiency in Singapore: Its Implications to Cardiovascular Risk Factors	PLOS ONE			English	Article							PLASMA 25-HYDROXYVITAMIN D; BONE-MINERAL DENSITY; INSULIN-RESISTANCE; SERUM 25-HYDROXYVITAMIN-D; FASTING GLUCOSE; HEALTH; ASSOCIATION; PREVENTION; CALCIUM; DISEASE	Objective Vitamin D deficiency is a global health challenge and has been linked to type 2 diabetes and other chronic diseases. However, the relationship between vitamin D status, body composition, and cardiovascular risks has not been well characterized in Asian populations. The objectives of this study were to examine the factors associated with the low vitamin D levels in a sunny tropical region and to assess the role of vitamin D status in cardiovascular risk factors. Design and Methods This was a cross-sectional study. One hundred and fourteen healthy participants (59 males and 55 females) residing in Singapore took part in this study. Plasma 25OH-D-3 concentration was measured by using LC-MS/MS. Body fat (%) was measured by using three different techniques including bioelectrical impedance analysis (BIA), BOD POD, and dual-energy X-ray absorptiometry (DEXA). Basic anthropometric measurements, fasting blood glucose (FBG), fasting serum insulin (FSI), and lipid profiles were obtained using standard protocols. Results Approximately 42% of the participants were vitamin D deficient (< 20 ng/mL). Vitamin D status was inversely associated with body fat (%), homeostasis model assessment of insulin resistance (HOMA-IR), and total cholesterol/high density lipoprotein (TC/HDL) ratio, while positively associated with lean body mass (LBM) and hand grip strength (HGS). Conclusions The high prevalence of vitamin D deficiency in a sunny tropical region reinforces the need to recognize that sunlight alone is not the precursor for optimal vitamin D status. This raises the need to investigate public health measures that will encourage exposure to sunlight without overexposure that is harmful to skin. More importantly, vitamin D deficiency is associated with increased cardiovascular risks, i.e. HOMA-IR, TC/HDL, and LDL/HDL. Future studies should attempt to elucidate the potential mechanisms.	[Bi, Xinyan; Tey, Siew Ling; Leong, Claudia; Quek, Rina; Henry, Christiani Jeyakumar] Clin Nutr Res Ctr, Ctr Translat Med, 14 Med Dr 07-02,MD 6 Bldg, Singapore 117599, Singapore; [Bi, Xinyan; Tey, Siew Ling; Leong, Claudia; Quek, Rina; Henry, Christiani Jeyakumar] ASTAR, Singapore Inst Clin Sci, Brenner Ctr Mol Med, 30 Med Dr, Singapore 117609, Singapore; [Henry, Christiani Jeyakumar] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117599, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Henry, CJ (corresponding author), Clin Nutr Res Ctr, Ctr Translat Med, 14 Med Dr 07-02,MD 6 Bldg, Singapore 117599, Singapore.; Henry, CJ (corresponding author), ASTAR, Singapore Inst Clin Sci, Brenner Ctr Mol Med, 30 Med Dr, Singapore 117609, Singapore.; Henry, CJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117599, Singapore.	jeya_henry@sics.a-star.edu.sg	Tey, Siew Ling/AAV-8115-2021; Henry, Christiani Jeyakumar/AHB-2632-2022	Henry, Christiani Jeyakumar/0000-0002-1602-0140; Tey, Siew Ling/0000-0002-5064-5283; Leong, Claudia/0000-0002-6388-4646				Alsuwaida AO, 2013, SAUDI MED J, V34, P814; Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385; Arsenault BJ, 2011, NAT REV CARDIOL, V8, P197, DOI 10.1038/nrcardio.2010.223; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Brouwer-Brolsma EM, 2013, EUR J NUTR, V52, P917, DOI 10.1007/s00394-012-0399-0; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Choi HS, 2011, J NUTR, V141, P1524, DOI 10.3945/jn.111.139121; CLEMENS TL, 1982, LANCET, V1, P74; Creo AL, 2013, J PEDIATR ENDOCR MET, V26, P97, DOI 10.1515/jpem-2012-0244; Davis CD, 2007, JNCI-J NATL CANCER I, V99, P1563, DOI 10.1093/jnci/djm211; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Gilsanz V, 2010, J CLIN ENDOCR METAB, V95, P1595, DOI 10.1210/jc.2009-2309; Hannan MT, 2008, J CLIN ENDOCR METAB, V93, P40, DOI 10.1210/jc.2007-1217; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; HOLICK MF, 1989, LANCET, V2, P1104; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Joshi L, 2014, SCAND J IMMUNOL, V79, P113, DOI 10.1111/sji.12127; Karhapaa P, 2010, J Intern Med, V268, P604, DOI 10.1111/j.1365-2796.2010.02279.x; Kremer R, 2009, J CLIN ENDOCR METAB, V94, P67, DOI 10.1210/jc.2008-1575; Lim JS, 2012, J CLIN ENDOCR METAB, V97, P1995, DOI 10.1210/jc.2011-3098; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Mathieu C, 2005, TRENDS ENDOCRIN MET, V16, P261, DOI 10.1016/j.tem.2005.06.004; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Nimitphong H, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-60; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Pittas AG, 2012, DIABETES CARE, V35, P565, DOI 10.2337/dc11-1795; Remuzzi A, 2007, KIDNEY INT, V71, P96, DOI 10.1038/sj.ki.5002047; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Seamans KM, 2009, AM J CLIN NUTR, V89, p1997S, DOI 10.3945/ajcn.2009.27230D; Sterling KA, 2012, NAT REV NEPHROL, V8, P403, DOI 10.1038/nrneph.2012.93; Teegarden D, 2009, NUTR RES REV, V22, P82, DOI 10.1017/S0954422409389301; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690	41	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147616	10.1371/journal.pone.0147616	http://dx.doi.org/10.1371/journal.pone.0147616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799569	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300132
J	Hofstede, SN; Marang-van de Mheen, PJ; Vlieland, TPMV; van den Ende, CHM; Nelissen, RGHH; van Bodegom-Vos, L				Hofstede, Stefanie N.; Marang-van de Mheen, Perla J.; Vliet Vlieland, Thea P. M.; van den Ende, Cornelia H. M.; Nelissen, Rob G. H. H.; van Bodegom-Vos, Leti			Barriers and Facilitators Associated with Non Surgical Treatment Use for Osteoarthritis Patients in Orthopaedic Practice	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; HIP-REPLACEMENT; PRIMARY-CARE; MANAGEMENT; RECOMMENDATIONS; IMPLEMENTATION; GUIDELINES; CENTERS; ADULTS; PAIN	Introduction International evidence-based guidelines for the management of patients with hip and knee osteoarthritis (OA) recommend to start with (a combination of) non-surgical treatments, and using surgical intervention only if a patient does not respond sufficiently to non-surgical treatment options. Despite these recommendations, there are strong indications that nonsurgical treatments are not optimally used in orthopaedic practice. To improve the adoption of non-surgical treatments, more insight is needed into barriers and facilitators of these treatments. Therefore, this study assessed which barriers and facilitators are associated with the use and prescription of different non-surgical treatments before hip and knee OA in orthopaedic practice among patients and orthopaedic surgeons in the Netherlands. Materials and Methods We performed two internet-based surveys among 172 orthopaedic surgeons and 174 OA patients. Univariate association and multivariable regression techniques are used to identify barriers and facilitators associated with the use of non-surgical treatments. Results Most barriers and facilitators among patients were associated with the use of physical therapy, lifestyle advice and dietary therapy. Among orthopaedic surgeons, most were associated with prescription of acetaminophen, dietary therapy and physical therapy. Examples of barriers and facilitators among patients included "People in my environment had positive experiences with a surgery" (facilitator for education about OA), and "Advice of people in my environment to keep on moving" (facilitator for lifestyle and dietary advice). For orthopaedic surgeons, examples were "Lack of knowledge about guideline" (barrier for lifestyle advice), "Agreements/deliberations with primary care" and "Easy communication with a dietician" (facilitators for dietary therapy). Also the belief in the efficacy of these treatments was associated with increased prescription. Conclusions Strategies to improve non-surgical treatment use in orthopaedic practice should be targeted at changing the beliefs of orthopedic surgeons, communication with other OA care providers and involving patient's environment in OA treatment.	[Hofstede, Stefanie N.; Marang-van de Mheen, Perla J.; van Bodegom-Vos, Leti] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Vliet Vlieland, Thea P. M.; Nelissen, Rob G. H. H.] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands; [van den Ende, Cornelia H. M.] Sint Maartensklin Nijmegen, Dept Rheumatol, Hengstdal 3, Ubbergen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Sint Maartens Clinic	van Bodegom-Vos, L (corresponding author), Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands.	l.vanbodegom-vos@lumc.nl	de Mheen, Perla J. Marang-van/I-2783-2015; Nelissen, Rob/AAD-8134-2020; van den Ende, Cornelia/G-9559-2011; van den Ende, Cornelia/ABG-7626-2020; van Bodegom-Vos, Leti/J-8087-2015; Vlieland, Thea Vliet/AAJ-8119-2020	de Mheen, Perla J. Marang-van/0000-0003-1439-0989; Nelissen, Rob/0000-0003-1228-4162; van den Ende, Cornelia/0000-0002-4352-2824; van Bodegom-Vos, Leti/0000-0002-8486-6404; Vlieland, Thea Vliet/0000-0001-6322-3859	Netherlands Organisation for Health Research and Development [837004002]; Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research project is supported by a grant from the Netherlands Organisation for Health Research and Development (http://www.zonmw.nl/), grant number 837004002, LV. Funding was obtained from the Netherlands Organisation for Scientific Research (NWO) Incentive fund Open Access publications (http://www.nwo.nl/), LV.	Ackerman IN, 2009, ARTHRIT RHEUM-ARTHR, V61, P166, DOI 10.1002/art.24215; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Beckstead JW, 2012, INT J NURS STUD, V49, P635, DOI 10.1016/j.ijnurstu.2012.04.011; Bennell KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4934; Brand CA, 2014, ARTHRIT CARE RES, V66, P551, DOI 10.1002/acr.22197; Broadbent J, 2008, BRIT J GEN PRACT, V58, P839, DOI 10.3399/bjgp08X376177; Cavazos JM, 2008, ALIMENT PHARM THER, V28, P789, DOI 10.1111/j.1365-2036.2008.03791.x; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; Cuperus N, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-181; Dieppe P, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-19; Dutch Arthroplasty Register (LROI), 2012, MOR INS QUAL ORTH CA; Fernandes L, 2013, ANN RHEUM DIS, V72, P1125, DOI 10.1136/annrheumdis-2012-202745; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hofstede SN, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009117; Hofstede SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094176; Holden MA, 2012, ARTHRIT CARE RES, V64, P1554, DOI 10.1002/acr.21700; Hoogeboom TJ, 2012, OSTEOARTHR CARTILAGE, V20, P525, DOI 10.1016/j.joca.2012.03.003; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Nelson AE, 2013, SEMIN ARTHRITIS RHEU; Netherlands Orthopaedic Association (NOV), 2007, GUID DIAGN TREATM HI; Obremskey W, 2014, J ORTHOP TRAUMA, V28, pE203, DOI 10.1097/BOT.0000000000000034; Otten Renee, 2010, Ned Tijdschr Geneeskd, V154, pA1534; Petursdottir U, 2010, PHYS THER, V90, P1014, DOI 10.2522/ptj.20090217; Poitras S, 2010, JOINT BONE SPINE, V77, P458, DOI 10.1016/j.jbspin.2010.08.001; Prior M, 2008, J EVAL CLIN PRACT, V14, P888, DOI 10.1111/j.1365-2753.2008.01014.x; Sanders C, 2004, RHEUMATOLOGY, V43, P353, DOI 10.1093/rheumatology/keh044; Smink AJ, 2011, CLIN RHEUMATOL, V30, P1623, DOI 10.1007/s10067-011-1835-x; Smink AJ, 2013, ARTHRITIS CARE RES H, V65; Snijders GF, 2011, SCAND J RHEUMATOL, V40, P225, DOI 10.3109/03009742.2010.530611; Ursum J, 2013, COMMON IS OSTEOARTHR; van Beek ELK, 2010, REDUCEREN PRAKTIJKVA; van den Ende CM, 2010, NED TIJDSCHR GENEES, pA1574; Voorn VM, 2014, TRANSFUSION; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	38	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147406	10.1371/journal.pone.0147406	http://dx.doi.org/10.1371/journal.pone.0147406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799974	gold, Green Submitted, Green Published			2022-12-26	WOS:000368655300104
J	Pan, W; Yu, HZ; Huang, SJ; Zhu, PL				Pan, Wei; Yu, Huizhen; Huang, Shujie; Zhu, Pengli			Resveratrol Protects against TNF-alpha-Induced Injury in Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of NF-KB and p38 MAPK	PLOS ONE			English	Article							OXYGEN SPECIES GENERATION; KAPPA-B PATHWAY; OXIDATIVE STRESS; CHLAMYDOPHILA-PNEUMONIAE; SIRT1; CD40; EXPRESSION; ACTIVATION; APOPTOSIS; RELEASE	Inflammation and reactive oxygen species (ROS) play important roles in the pathogenesis of atherosclerosis. Resveratrol has been shown to possess anti-inflammatory and antioxidative stress activities, but the underlying mechanisms are not fully understood. In the present study, we investigated the molecular basis associated with the protective effects of resveratrol on tumor necrosis factor-alpha (TNF-alpha)-induced injury in human umbilical endothelial cells (HUVECs) using a variety of approaches including a cell viability assay, reverse transcription and quantitative polymerase chain reaction, western blot, and immunofluorescence staining. We showed that TNF-alpha induced CD40 expression and ROS production in cultured HUVECs, which were attenuated by resveratrol treatment. Also, resveratrol increased the expression of sirtuin 1 (SIRT1); and repression of SIRT1 by small-interfering RNA (siRNA) and the SIRT1 inhibitor Ex527 reduced the inhibitory effects of resveratrol on CD40 expression and ROS generation. In addition, resveratrol downregulated the levels of p65 and phospho-p38 MAPK, but this inhibitory effect was attenuated by the suppression of SIRT1 activity. Moreover, the p38 MAPK inhibitor SD203580 and the nuclear factor (NF)-kappa B inhibitor pyrrolidine dithiocarbamate (PDTC) achieved similar repressive effects as resveratrol on TNF-alpha-induced ROS generation and CD40 expression. Thus, our study provides a mechanistic link between resveratrol and the activation of SIRT1, the latter of which is involved in resveratrol-mediated repression of the p38 MAPK/NF-kappa B pathway and ROS production in TNF-alpha-treated HUVECs.	[Pan, Wei; Yu, Huizhen; Zhu, Pengli] Fujian Med Univ, Prov Clin Med Coll, Fuzhou, Peoples R China; [Yu, Huizhen] Fujian Med Univ, Fujian Prov Hosp Key Lab Geriatr, Dept Geriatr, Fuzhou, Peoples R China; [Yu, Huizhen; Huang, Shujie; Zhu, Pengli] Fujian Inst Clin Geriatr, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Provincial Hospital	Zhu, PL (corresponding author), Fujian Med Univ, Prov Clin Med Coll, Fuzhou, Peoples R China.; Zhu, PL (corresponding author), Fujian Inst Clin Geriatr, Fuzhou, Peoples R China.	zpl7755@126.com			Natural Science Foundation of China [81373785]; Natural Science Foundation of Fujian Province [2011J01134, 2010J01127]; Projection of Excellent Young Doctor Training Plan in the Fujian Provincial Health System [2013-ZQN-ZD-2]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Projection of Excellent Young Doctor Training Plan in the Fujian Provincial Health System	This study was supported by grants from the Natural Science Foundation of China (grant no. 81373785), the Natural Science Foundation of Fujian Province (no. 2011J01134; no. 2010J01127), and the Projection of Excellent Young Doctor Training Plan in the Fujian Provincial Health System (no. 2013-ZQN-ZD-2).	Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Barbe-Tuana F, 2015, J CELLULAR BIOCH; Basuroy S, 2006, AM J PHYSIOL-CELL PH, V291, pC897, DOI 10.1152/ajpcell.00032.2006; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bosutti A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08093; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chong E, 2015, HEART RHYTHM, V12, P1046, DOI 10.1016/j.hrthm.2015.01.044; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Dong WW, 2015, FREE RADICAL BIOL ME; Dymicka-Piekarska V, 2014, INT J BIOL MARKER, V29, pE261, DOI 10.5301/jbm.5000083; Gao YL, 2016, CARDIOVASC TOXICOL, V16, P130, DOI 10.1007/s12012-015-9321-3; Ghisays F, 2015, CELL REPORTS; Gocmen AY, 2011, APPL PHYSIOL NUTR ME, V36, P323, DOI [10.1139/h11-022, 10.1139/H11-022]; Guo R, 2014, CELL PHYSIOL BIOCHEM, V34, P603, DOI 10.1159/000363026; Harijith A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00352; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Holthoff JH, 2010, BIOCHEM PHARMACOL, V80, P1260, DOI 10.1016/j.bcp.2010.06.027; Ido Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115341; Kutlesa Z, 2015, J BONE MINERAL METAB; Lee JH, 2015, ONCOLOGY REPORTS; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Lin QQ, 2012, CYTOKINE, V60, P447, DOI 10.1016/j.cyto.2012.05.025; Naylor AJD, 2009, LIFE SCI, V84, P637, DOI [10.1016/j.lfs.2009.02.011, 10.1016/j.lfs.2009.02.01]; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Roy SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025166; Sassi N, 2014, BBA-BIOENERGETICS, V1837, P1781, DOI 10.1016/j.bbabio.2014.06.010; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Sun JM, 2007, J BIOL CHEM, V282, P33227, DOI 10.1074/jbc.M703549200; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takizawa Y, 2013, BRIT J NUTR, V110, P2150, DOI 10.1017/S0007114513001670; Thiel G, 2014, MOL NUTR FOOD RES, V58, P1402, DOI 10.1002/mnfr.201300913; Tousoulis D, 2010, TRENDS CARDIOVAS MED, V20, P153, DOI 10.1016/j.tcm.2010.12.004; Tsuruoka S, 2012, KIDNEY INT, V82, P735, DOI 10.1038/ki.2012.182; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; Volz MS, 2015, CLIN VACCINE IMMUNOL, pCVI; Wissel H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-51; Wissel H, 2005, BBA-MOL CELL RES, V1743, P37, DOI 10.1016/j.bbamcr.2004.08.009; Xu H, 2015, INFLAMMATION, V38, P327, DOI 10.1007/s10753-014-0036-6; Yang LN, 2012, CELL PHYSIOL BIOCHEM, V30, P1287, DOI 10.1159/000343318; Yeh CB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079406, 10.1371/journal.pone.0056661]; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang J, 2013, CELL PHYSIOL BIOCHEM, V31, P230, DOI 10.1159/000343364; Zhou L, 1998, THROMB HAEMOSTASIS, V79, P1025	44	98	102	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147034	10.1371/journal.pone.0147034	http://dx.doi.org/10.1371/journal.pone.0147034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799794	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300055
J	van Unen, J; Stumpf, AD; Schmid, B; Reinhard, NR; Hordijk, PL; Hoffmann, C; Gadella, TWJ; Goedhart, J				van Unen, Jakobus; Stumpf, Anette D.; Schmid, Benedikt; Reinhard, Nathalie R.; Hordijk, Peter L.; Hoffmann, Carsten; Gadella, Theodorus W. J.; Goedhart, Joachim			A New Generation of FRET Sensors for Robust Measurement of G alpha(i1), G alpha(i2) and G alpha(i3) Activation Kinetics in Single Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTORS; RESONANCE ENERGY-TRANSFER; LIVING CELLS; SIGNALING PATHWAYS; FLUORESCENT PROTEINS; CROSS-TALK; CHO-CELLS; SUBUNITS; CANCER	G-protein coupled receptors (GPCRs) can activate a heterotrimeric G-protein complex with subsecond kinetics. Genetically encoded biosensors based on Forster resonance energy transfer (FRET) are ideally suited for the study of such fast signaling events in single living cells. Here we report on the construction and characterization of three FRET biosensors for the measurement of G alpha(i1), G alpha(i2) and G alpha(i3) activation. To enable quantitative long-term imaging of FRET biosensors with high dynamic range, fluorescent proteins with enhanced photophysical properties are required. Therefore, we use the currently brightest and most photostable CFP variant, mTurquoise2, as donor fused to G alpha(i) subunit, and cp173Venus fused to the G beta 2 subunit as acceptor. The G alpha(i) FRET biosensors constructs are expressed together with G beta 1 from a single plasmid, providing preferred relative expression levels with reduced variation in mammalian cells. The G alpha(i) FRET sensors showed a robust response to activation of endogenous or over-expressed alpha-2A-adrenergic receptors, which was inhibited by pertussis toxin. Moreover, we observed activation of the G alpha(i) FRET sensor in single cells upon stimulation of several GPCRs, including the LPA(2), M-3 and BK2 receptor. Furthermore, we show that the sensors are well suited to extract kinetic parameters from fast measurements in the millisecond time range. This new generation of FRET biosensors for G alpha(i1), G alpha(i2') and G alpha(i3) activation will be valuable for live-cell measurements that probe G alpha(i) activation.	[van Unen, Jakobus; Reinhard, Nathalie R.; Hordijk, Peter L.; Gadella, Theodorus W. J.; Goedhart, Joachim] Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, van Leeuwenhoek Ctr Adv Microscopy, POB 94215, NL-1090 GE Amsterdam, Netherlands; [Stumpf, Anette D.; Schmid, Benedikt; Hoffmann, Carsten] Univ Wurzburg, Bioimaging Ctr, Rudolf Virchow Zentrum, Versbacher Str 9, D-97078 Wurzburg, Germany; [Stumpf, Anette D.; Schmid, Benedikt; Hoffmann, Carsten] Univ Wurzburg, Dept Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany; [Reinhard, Nathalie R.; Hordijk, Peter L.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Mol Cell Biol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; University of Wurzburg; University of Wurzburg; University of Amsterdam; Academic Medical Center Amsterdam	Goedhart, J (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, van Leeuwenhoek Ctr Adv Microscopy, POB 94215, NL-1090 GE Amsterdam, Netherlands.	j.goedhart@uva.nl		Gadella, Theodorus/0000-0002-7639-219X; van Unen, Jakobus/0000-0002-7931-0989; Goedhart, Joachim/0000-0002-0630-3825; Hordijk, Peter/0000-0002-3348-078X				Adjobo-Hermans MJW, 2008, J CELL SCI, V121, P3770, DOI 10.1242/jcs.029785; Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Akam EC, 2001, BRIT J PHARMACOL, V132, P950, DOI 10.1038/sj.bjp.0703892; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Appleton KM, 2014, BIOORGAN MED CHEM, V22, P3423, DOI 10.1016/j.bmc.2014.04.035; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; BURNS DL, 1988, MICROBIOL SCI, V5, P285; Daaka Y., 2004, SCI STKE, V2004, pre2, DOI [10.1126/stke.2162004re2, DOI 10.1126/STKE.2162004RE2]; Devanathan V, 2015, P NATL ACAD SCI USA, V112, P6491, DOI 10.1073/pnas.1505887112; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Fey D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00355; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Garcia A, 2010, BIOCHEM J, V429, P369, DOI 10.1042/BJ20100166; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; Hamers D, 2014, PROTOPLASMA, V251, P333, DOI 10.1007/s00709-013-0590-z; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hill SJ, 2003, BRIT J PHARMACOL, V138, P1188, DOI 10.1038/sj.bjp.0705192; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2012, MOL PHARMACOL, V82, P236, DOI 10.1124/mol.112.077578; Hornigold DC, 2003, BRIT J PHARMACOL, V138, P1340, DOI 10.1038/sj.bjp.0705178; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Jongsma M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029260; Kimple ME, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.40; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Kue PF, 2000, J UROLOGY, V164, P2162, DOI 10.1016/S0022-5347(05)66990-X; la Sala A, 2005, J IMMUNOL, V175, P2994, DOI 10.4049/jimmunol.175.5.2994; LIAO JK, 1993, J CLIN INVEST, V92, P2168, DOI 10.1172/JCI116818; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; Raymond JR, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-6; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Sparta B, 2015, J BIOL CHEM, V290, P24784, DOI 10.1074/jbc.M115.662247; SUKI WN, 1987, FEBS LETT, V220, P187, DOI 10.1016/0014-5793(87)80900-6; van Unen J, 2015, MOL PHARMACOL, V88, P589, DOI 10.1124/mol.115.098897; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang YT, 2013, ARCH IMMUNOL THER EX, V61, P309, DOI 10.1007/s00005-013-0230-5; Ziegler N, 2011, BIOORGAN MED CHEM, V19, P1048, DOI 10.1016/j.bmc.2010.07.060	48	40	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146789	10.1371/journal.pone.0146789	http://dx.doi.org/10.1371/journal.pone.0146789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799488	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300035
J	Kim, DK; Choi, H; Nishida, H; Oh, JY; Gregory, C; Lee, RH; Yu, JM; Watanabe, J; An, SY; Bartosh, TJ; Prockop, DJ				Kim, Dong-Ki; Choi, Hosoon; Nishida, Hidetaka; Oh, Joo Youn; Gregory, Carl; Lee, Ryang Hwa; Yu, Ji Min; Watanabe, Jun; An, Su Yeon; Bartosh, Thomas J.; Prockop, Darwin J.			Scalable Production of a Multifunctional Protein (TSG-6) That Aggregates with Itself and the CHO Cells That Synthesize It	PLOS ONE			English	Article							INTER-ALPHA-INHIBITOR; FACTOR-STIMULATED GENE-6; COLLAGEN-INDUCED ARTHRITIS; MULTIPOTENT STROMAL CELLS; LINK MODULE; HEAVY-CHAINS; CHROMOSOMAL LOCALIZATION; CONSTITUTIVE EXPRESSION; NEUTROPHIL MIGRATION; ANTIBODY-PRODUCTION	TNF-alpha stimulated gene/protein 6 (TNFAIP6/TSG-6) is a multifunctional protein that has a number of potential therapeutic applications. Experiments and clinical trials with TSG-6, however, have been limited by the technical difficulties of producing the recombinant protein. We prepared stable clones of CHO cells that expressed recombinant human TSG-6 (rhTSG-6) as a secreted glycoprotein. Paradoxically, both cell number and protein production decreased dramatically when the clones were expanded. The decreases occurred because the protein aggregated the synthesizing CHO cells by binding to the brush border of hyaluronan that is found around many cultured cells. In addition, the rhTSG-6 readily self-aggregated. To address these problems, we added to the medium an inhibitor of hyaluronan synthesis and heparin to compete with the binding of TSG-6 to hyaluronan. Also, we optimized the composition of the culture medium, and transferred the CHO cells from a spinner culture system to a bioreactor that controlled pH and thereby decreased pH-dependent binding properties of the protein. With these and other improvements in the culture conditions, we obtained 57.0 mg +/- 9.16 S.D. of rhTSG-6 in 5 or 6 liter of medium. The rhTSG-6 accounted for 18.0% +/- 3.76 S.D. of the total protein in the medium. We then purified the protein with a Ni-chelate column that bound the His tag engineered into the C-terminus of the protein followed by an anion exchange column. The yield of the purified monomeric rhTSG-6 was 4.1 mg to 5.6 mg per liter of culture medium. After intravenous injection into mice, the protein had a longer plasma half-life than commercially available rhTSG-6 isolated from a mammalian cell lysate, apparently because it was recovered as a secreted glycoprotein. The bioactivity of the rhTSG-6 in suppressing inflammation was demonstrated in a murine model.	[Kim, Dong-Ki; Choi, Hosoon; Nishida, Hidetaka; Oh, Joo Youn; Gregory, Carl; Lee, Ryang Hwa; Yu, Ji Min; Watanabe, Jun; An, Su Yeon; Bartosh, Thomas J.; Prockop, Darwin J.] Texas A&M Hlth Sci Ctr, Coll Med Scott & White, Inst Regenerat Med, Temple, TX USA; [Oh, Joo Youn] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea; [Yu, Ji Min] CHA Bio & Diostech Co Ltd, Dept Translat Res, Yeoksam Dong, South Korea; [Watanabe, Jun] Showa Univ, Sch Med, Dept Anat, Shinakawa Ku, Tokyo 142, Japan	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Seoul National University (SNU); Seoul National University Hospital; Showa University	Prockop, DJ (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med Scott & White, Inst Regenerat Med, Temple, TX USA.	Prockop@medicine.tamhsc.edu		Gregory, Carl/0000-0001-6444-5541	TAMU HSC COM	TAMU HSC COM	The work was supported by funds from TAMU HSC COM.	Baranova NS, 2014, J BIOL CHEM, V289, P30481, DOI 10.1074/jbc.M114.568154; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Blundell CD, 2005, THE JOURNAL OF BIOLO, V280, P18182; Blundell CD, 2007, J BIOL CHEM, V282, P12976, DOI 10.1074/jbc.M611713200; Buetler TM, 2011, MOL NUTR FOOD RES, V55, P291, DOI 10.1002/mnfr.201000140; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Chen F, 2012, J BIOSCI BIOENG, V114, P347, DOI 10.1016/j.jbiosc.2012.04.015; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; Jones DC, 2003, J IMMUNOL, V171, P196, DOI 10.4049/jimmunol.171.1.196; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kern J, 2009, BLOOD, V114, P3960, DOI 10.1182/blood-2009-03-209668; Kuznetsova SA, 2005, J BIOL CHEM, V280, P30899, DOI 10.1074/jbc.M500701200; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Leali D, 2012, ARTERIOSCL THROM VAS, V32, P696, DOI 10.1161/ATVBAHA.111.243998; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Li L, 2011, MOL BIOTECHNOL, V47, P9, DOI 10.1007/s12033-010-9306-1; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Malyala P, 2008, J PHARM SCI-US, V97, P2041, DOI 10.1002/jps.21152; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Nagyeri G, 2011, J BIOL CHEM, V286, P23559, DOI 10.1074/jbc.M111.222026; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Okroj M, 2012, J BIOL CHEM, V287, P20100, DOI 10.1074/jbc.M111.324913; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Scavenius C, 2011, BBA-PROTEINS PROTEOM, V1814, P1624, DOI 10.1016/j.bbapap.2011.08.017; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Velez-Suberbie ML, 2013, BIOTECHNOL PROGR, V29, P116, DOI 10.1002/btpr.1647; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873	53	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147553	10.1371/journal.pone.0147553	http://dx.doi.org/10.1371/journal.pone.0147553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26793973	Green Submitted, Green Published, gold			2022-12-26	WOS:000368530300039
J	Chan, KO; Grismer, LL; Zachariah, A; Brown, RM; Abraham, RK				Chan, Kin Onn; Grismer, L. Lee; Zachariah, Anil; Brown, Rafe M.; Abraham, Robin Kurian			Polyphyly of Asian Tree Toads, Genus Pedostibes Gunther, 1876 (Anura: Bufonidae), and the Description of a New Genus from Southeast Asia	PLOS ONE			English	Article							R-PACKAGE; AMPHIBIA; REPRODUCTION; RADIATION; FROGS; SIZE	The Asian Tree Toad genus Pedostibes, as currently understood, exhibits a conspicuously disjunct distribution, posing several immediate questions relating to the biogeography and taxonomy of this poorly known group. The type species, P. tuberculosus and P. kempi, are known only from India, whereas P. hosii, P. rugosus, and P. everetti are restricted to Southeast Asia. Several studies have shown that these allopatric groups are polyphyletic, with the Indian Pedostibes embedded within a primarily South Asian clade of toads, containing the genera Adenomus, Xanthophryne, and Duttaphrynus. Southeast Asian Pedostibes on the other hand, are nested within a Southeast Asian clade, which is the sister lineage to the Southeast Asian river toad genus Phrynoidis. We demonstrate that Indian and Southeast Asian Pedostibes are not only allopatric and polyphyletic, but also exhibit significant differences in morphology and reproductive mode, indicating that the Southeast Asian species' are not congeneric with the true Pedostibes of India. As a taxonomic solution, we describe a new genus, Rentapia gen. nov. to accommodate the Southeast Asian species.	[Chan, Kin Onn; Brown, Rafe M.; Abraham, Robin Kurian] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Chan, Kin Onn; Brown, Rafe M.; Abraham, Robin Kurian] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Grismer, L. Lee] La Sierra Univ, Dept Biol, 4500 Riverwalk Pkwy, Riverside, CA USA; [Zachariah, Anil] Beagle, Wayanad, Kerala, India	University of Kansas; University of Kansas	Chan, KO (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.; Chan, KO (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	chankinonn@gmail.com	Onn, Chan Kin/AAH-1021-2020	Onn, Chan Kin/0000-0001-6270-0983				Altig R, 2007, HERPETOL MONOGR, V21, P1, DOI 10.1655/06-005.1; Barbour T., 1938, Proceedings of the Biological Society of Washington, V51, P191; Biju Sd, 2009, BMC Res Notes, V2, P241, DOI 10.1186/1756-0500-2-241; Boulenger G. A., 1919, Records of the Indian Museum, V16; Boulenger G.A., 1892, P ZOOL SOC LOND, V1892, P505; Boulenger GA, 1896, ANN MAGAZINE NATUR 6, V17, P449; Chan KO, 2014, REAPPRAISAL JAVANESE, V3900, P569; Dinesh K. P., 2013, Journal of Threatened Taxa, V5, P4910; Duellman W. E., 1986, BIOL AMPHIBIANS; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; INGER RF, 1968, COPEIA, P602, DOI 10.2307/1442031; INGER ROBERT F., 1966, FIELDI ANA ZOOL, V52, P1; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Malkmus R., 2002, AMPHIBIANS REPTILES; Manamendra-Arachchi Kelum, 1998, Journal of South Asian Natural History, V3, P213; Manthey U., 1997, AMPHIBIEN REPTILIEN; Matsui M, 2007, ZOOL SCI, V24, P1159, DOI 10.2108/zsj.24.1159; Miller M.A., 2010, P GAT COMP ENV WORKS; Ngo BV, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-12; Peters W.C.H., 1875, MONATSBERICHTE KONIG, V1875, P196; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; R Core Team, 2014, LANG ENV STAT COMP; Rambaut A., 2014, TRACER V1 6; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ron SR, 2015, ZOOTAXA, V3947, P347, DOI 10.11646/zootaxa.3947.3.3; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford D.L., 2002, PHYLOGENETIC ANAL US; TEJEDO M, 1992, J ZOOL, V228, P545, DOI 10.1111/j.1469-7998.1992.tb04454.x; Van Bocxlaer I, 2010, SCIENCE, V327, P679, DOI 10.1126/science.1181707; Van Bocxlaer I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-131	36	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145903	10.1371/journal.pone.0145903	http://dx.doi.org/10.1371/journal.pone.0145903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788854	gold, Green Submitted, Green Published			2022-12-26	WOS:000368529100019
J	Hui, CW; Zhang, Y; Herrup, K				Hui, Chin Wai; Zhang, Yang; Herrup, Karl			Non-Neuronal Cells Are Required to Mediate the Effects of Neuroinflammation: Results from a Neuron-Enriched Culture System	PLOS ONE			English	Article							NF-KAPPA-B; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; A-BETA; PHOSPHORYLATION; ACTIVATION; NEUROTOXICITY; EXCITOTOXICITY; TRANSCRIPTION; INFLAMMATION	Chronic inflammation is associated with activated microglia and reactive astrocytes and plays an important role in the pathogenesis of neurodegenerative diseases such as Alzheimer's. Both in vivo and in vitro studies have demonstrated that inflammatory cytokine responses to immune challenges contribute to neuronal death during neurodegeneration. In order to investigate the role of glial cells in this phenomenon, we developed a modified method to remove the non-neuronal cells in primary cultures of E16.5 mouse cortex. We modified previously reported methods as we found that a brief treatment with the thymidine analog, 5-fluorodeoxyuridine (FdU), is sufficient to substantially deplete dividing non-neuronal cells in primary cultures. Cell cycle and glial markers confirm the loss of similar to 99% of all microglia, astrocytes and oligodendrocyte precursor cells (OPCs). More importantly, under this milder treatment, the neurons suffered neither cell loss nor any morphological defects up to 2.5 weeks later; both pre-and post-synaptic markers were retained. Further, neurons in FdU-treated cultures remained responsive to excitotoxicity induced by glutamate application. The immunobiology of the FdU culture, however, was significantly changed. Compared with mixed culture, the protein levels of NF kappa B p65 and the gene expression of several cytokine receptors were altered. Individual cytokines or conditioned medium from alpha-amyloid-stimulated THP-1 cells that were, potent neurotoxins in normal, mixed cultures, were virtually inactive in the absence of glial cells. The results highlight the importance of our glial-depleted culture system and identifies and offer unexpected insights into the complexity of-brain neuroinflammation.	[Herrup, Karl] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Hui, Chin Wai] Univ Laval, CHU Quebec, Ctr Rech, Axe Neurosci, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Laval University	Herrup, K (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	herrup@ust.hk			National Key Basic Research Program of China [2013CB530900]; Research Grants Council, HKSAR [GRF660813]; Hong Kong University of Science and Technology [R9321]	National Key Basic Research Program of China(National Basic Research Program of China); Research Grants Council, HKSAR(Hong Kong Research Grants Council); Hong Kong University of Science and Technology	Research Grants Council, HKSAR (GRF660813) and the Hong Kong University of Science and Technology (R9321) provided the support for most of the supplies and reagents used in the work described. The National Key Basic Research Program of China (2013CB530900) provided travel money so that the results could be presented at an international meeting. The National Institute of Neurological Diseases and Stroke (US) provided support for the early experiments that formed the foundation for the work described.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ahlemeyer B, 2003, NEUROCHEM INT, V42, P567, DOI 10.1016/S0197-0186(02)00164-X; Bate C, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-7; Bhaskar K, 2014, NEUROBIOL DIS, V62, P273, DOI 10.1016/j.nbd.2013.10.007; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033177; Chiarini Anna, 2006, Italian Journal of Anatomy and Embryology, V111, P221; DUGAN LL, 1995, J NEUROSCI, V15, P4545; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Geller HM, 2001, J NEUROCHEM, V78, P265, DOI 10.1046/j.1471-4159.2001.00395.x; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Henriquez B, 2013, MOL CELL NEUROSCI, V57, P130, DOI 10.1016/j.mcn.2013.07.012; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Hill EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036098; Hui CW, 2015, ENEURO, V2, DOI [10.1523/eneuro.0032-15.2015, DOI 10.1523/ENEUR0.0032-15.2015]; Irobi J, 2010, HUM MOL GENET, V19, P3254, DOI 10.1093/hmg/ddq234; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Lee HS, 2012, INT IMMUNOPHARMACOL, V13, P232, DOI 10.1016/j.intimp.2012.04.013; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; MARTIN DP, 1990, J NEUROSCI, V10, P184; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Millet Larry J., 2012, Yale Journal of Biology and Medicine, V85, P501; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nguyen V, 2010, NEUROBIOL DIS, V37, P195, DOI 10.1016/j.nbd.2009.10.002; Nicole O, 2001, J NEUROSCI, V21, P3024, DOI 10.1523/JNEUROSCI.21-09-03024.2001; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Qiu ZH, 1998, J NEUROSCI, V18, P10445; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; ROSENBERG PA, 1992, J NEUROSCI, V12, P56; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Taylor DL, 2010, J NEUROSCI RES, V88, P1632, DOI 10.1002/jnr.22335; Thirumangalakudi L, 2009, NEUROSCI LETT, V452, P172, DOI 10.1016/j.neulet.2009.01.045; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Varvel NH, 2009, J CLIN INVEST, V119, P3692, DOI 10.1172/JCI39716; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wu Q, 2000, NEUROBIOL AGING, V21, P797, DOI 10.1016/S0197-4580(00)00219-0; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yang YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087749, 10.1371/journal.pone.0100677, 10.1371/journal.pone.0085863, 10.1371/journal.pone.0102942]; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhou C, 2012, CYTOTECHNOLOGY, V64, P173, DOI 10.1007/s10616-011-9405-2; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82	50	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147134	10.1371/journal.pone.0147134	http://dx.doi.org/10.1371/journal.pone.0147134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788729	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100060
J	Pesciarelli, F; Leo, I; Sarlo, M				Pesciarelli, Francesca; Leo, Irene; Sarlo, Michela			Implicit Processing of the Eyes and Mouth: Evidence from Human Electrophysiology	PLOS ONE			English	Article							EARLY FACE; TIME-COURSE; PERCEPTION; INVERSION; N170; SENSITIVITY; ADAPTATION; OBJECTS; ERP	The current study examined the time course of implicit processing of distinct facial features and the associate event-related potential (ERP) components. To this end, we used a masked priming paradigm to investigate implicit processing of the eyes and mouth in upright and inverted faces, using a prime duration of 33 ms. Two types of prime-target pairs were used: 1. congruent (e.g., open eyes only in both prime and target or open mouth only in both prime and target); 2. incongruent (e.g., open mouth only in prime and open eyes only in target or open eyes only in prime and open mouth only in target). The identity of the faces changed between prime and target. Participants pressed a button when the target face had the eyes open and another button when the target face had the mouth open. The behavioral results showed faster RTs for the eyes in upright faces than the eyes in inverted faces, the mouth in upright and inverted faces. Moreover they also revealed a congruent priming effect for the mouth in upright faces. The ERP findings showed a face orientation effect across all ERP components studied (P1, N1, N170, P2, N2, P3) starting at about 80 ms, and a congruency/priming effect on late components (P2, N2, P3), starting at about 150 ms. Crucially, the results showed that the orientation effect was driven by the eye region (N170, P2) and that the congruency effect started earlier (P2) for the eyes than for the mouth (N2). These findings mark the time course of the processing of internal facial features and provide further evidence that the eyes are automatically processed and that they are very salient facial features that strongly affect the amplitude, latency, and distribution of neural responses to faces.	[Pesciarelli, Francesca] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurol Sci, Modena, Italy; [Leo, Irene] Univ Padua, Dept Dev Psychol, Padua, Italy; [Sarlo, Michela] Univ Padua, Dept Gen Psychol, Padua, Italy; [Sarlo, Michela] Univ Padua, Ctr Cognit Neurosci, Padua, Italy	Universita di Modena e Reggio Emilia; University of Padua; University of Padua; University of Padua	Pesciarelli, F (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurol Sci, Modena, Italy.	francesca.pesciarelli@unimore.it	Sarlo, Michela/AAP-4606-2020; Pesciarelli, Francesca/AAK-1692-2020; PESCIARELLI, Francesca/ABE-9870-2021	Sarlo, Michela/0000-0001-6652-7604; Pesciarelli, Francesca/0000-0003-3007-4775; LEO, IRENE/0000-0002-4925-4373				Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; BENTIN S, 1988, J EXP PSYCHOL GEN, V117, P148, DOI 10.1037/0096-3445.117.2.148; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 2002, PSYCHOL SCI, V13, P190, DOI 10.1111/1467-9280.00435; Boutsen L, 2006, NEUROIMAGE, V32, P352, DOI 10.1016/j.neuroimage.2006.03.023; Eimer M, 1998, NEUROREPORT, V9, P2945, DOI 10.1097/00001756-199809140-00005; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Guillaume C, 2009, BRAIN RES, V1248, P149, DOI 10.1016/j.brainres.2008.10.069; Haig ND, 1986, PERCEPTION, V15, P505; Hills PJ, 2011, J EXP PSYCHOL HPP, V37; Hole G, 2011, COGNITION, V119, P216, DOI 10.1016/j.cognition.2011.01.011; Itier RJ, 2006, NEUROIMAGE, V29, P667, DOI 10.1016/j.neuroimage.2005.07.041; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Itier RJ, 2011, NEUROIMAGE, V54, P705, DOI 10.1016/j.neuroimage.2010.07.031; Jacques C, 2007, J VISION, V7, DOI 10.1167/7.8.3; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Liddell BJ, 2004, J COGNITIVE NEUROSCI, V16, P479, DOI 10.1162/089892904322926809; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Nemrodov D, 2014, NEUROIMAGE, V97, P81, DOI 10.1016/j.neuroimage.2014.04.042; Nemrodov D, 2011, BRIT J PSYCHOL, V102, P783, DOI 10.1111/j.2044-8295.2011.02033.x; Pesciarelli F, 2011, NEUROPSYCHOLOGIA, V49, P1154, DOI 10.1016/j.neuropsychologia.2011.02.003; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; Shepherd J, 1981, PERCEIVING REMEMBERI; Shepherd JW., 1981, PERCEIVING REMEMBERI, P55; Taylor MJ, 2001, NEUROREPORT, V12, P1671, DOI 10.1097/00001756-200106130-00031; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; Wallis G, 2008, J VISION, V8, DOI 10.1167/8.3.20; Williams MA, 2004, COGNITION, V91, P155, DOI 10.1016/j.cognition.2003.08.002	37	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147415	10.1371/journal.pone.0147415	http://dx.doi.org/10.1371/journal.pone.0147415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790153	Green Published, Green Submitted, gold			2022-12-26	WOS:000368529100087
J	Cedergreen, N; Norhave, NJ; Svendsen, C; Spurgeon, DJ				Cedergreen, Nina; Norhave, Nils Jakob; Svendsen, Claus; Spurgeon, David J.			Variable Temperature Stress in the Nematode Caenorhabditis elegans (Maupas) and Its Implications for Sensitivity to an Additional Chemical Stressor	PLOS ONE			English	Article							MULTIPLE END-POINTS; ENERGY BUDGET MODEL; MIXTURE TOXICITY; SIZE RULE; COPPER; RESPONSES; GROWTH; TOLERANCE; VIABILITY; GENETICS	A wealth of studies has investigated how chemical sensitivity is affected by temperature, however, almost always under different constant rather than more realistic fluctuating regimes. Here we compared how the nematode Caenorhabditis elegans responds to copper at constant temperatures (8-24 degrees C) and under fluctuation conditions of low (+/- 4 degrees C) and high (+/- 8 degrees C) amplitude (averages of 12, 16, 20 degrees C and 16 degrees C respectively). The DEBkiss model was used to interpret effects on energy budgets. Increasing constant temperature from 12-24 degrees C reduced time to first egg, life-span and population growth rates consistent with temperature driven metabolic rate change. Responses at 8 degrees C did not, however, accord with this pattern (including a deviation from the Temperature Size Rule), identifying a cold stress effect. High amplitude variation and low amplitude variation around a mean temperature of 12 degrees C impacted reproduction and body size compared to nematodes kept at the matching average constant temperatures. Copper exposure affected reproduction, body size and life-span and consequently population growth. Sensitivity to copper (EC50 values), was similar at intermediate temperatures (12, 16, 20 degrees C) and higher at 24 degrees C and especially the innately stressful 8 degrees C condition. Temperature variation did not increase copper sensitivity. Indeed under variable conditions including time at the stressful 8 degrees C condition, sensitivity was reduced. DEBkiss identified increased maintenance costs and increased assimilation as possible mechanisms for cold and higher copper concentration effects. Model analysis of combined variable temperature effects, however, demonstrated no additional joint stressor response. Hence, concerns that exposure to temperature fluctuations may sensitise species to co-stressor effects seem unfounded in this case.	[Cedergreen, Nina; Norhave, Nils Jakob] Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Copenhagen, Denmark; [Svendsen, Claus; Spurgeon, David J.] Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England	University of Copenhagen; UK Centre for Ecology & Hydrology (UKCEH)	Spurgeon, DJ (corresponding author), Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England.	dasp@ceh.ac.uk	Cedergreen, Nina/F-6731-2014; Spurgeon, David J/E-9466-2010; Svendsen, Claus/A-1250-2009	Cedergreen, Nina/0000-0003-4724-9447; Svendsen, Claus/0000-0001-7281-647X; Spurgeon, David/0000-0003-3264-8760	Research School of Environmental Chemistry, Microbiology and Toxicology in Denmark; University of Copenhagen; Centre for Ecology and Hydrology National Capability funding; core NERC national capability funding under the Centre for Ecology and Hydrology Pollution and Ecological Risk science theme; NERC [ceh020007] Funding Source: UKRI; Natural Environment Research Council [ceh020007] Funding Source: researchfish	Research School of Environmental Chemistry, Microbiology and Toxicology in Denmark; University of Copenhagen; Centre for Ecology and Hydrology National Capability funding; core NERC national capability funding under the Centre for Ecology and Hydrology Pollution and Ecological Risk science theme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DJS and CS were supported by core NERC national capability funding under the Centre for Ecology and Hydrology Pollution and Ecological Risk science theme. NJN was supported by the Research School of Environmental Chemistry, Microbiology and Toxicology in Denmark and a PhD grant given jointly by the University of Copenhagen and Centre for Ecology and Hydrology National Capability funding.r DJS and CSV were supported by core NERC national capability funding under the Centre for Ecology and Hydrology Pollution and Ecological Risk science theme. NN was supported by the Research School of Environmental Chemistry, Microbiology and Toxicology in Denmark and a PhD grant given jointly from the University of Copenhagen and Centre for Ecology and Hydrology National Capability funding.	Aguilar-Alberola JA, 2014, J THERM BIOL, V42, P15, DOI 10.1016/j.jtherbio.2014.02.016; Alvarez OA, 2005, FUNCT ECOL, V19, P656, DOI 10.1111/j.1365-2435.2005.01012.x; Alvarez OA, 2006, ENVIRON TOXICOL CHEM, V25, P3230, DOI 10.1897/06-097R.1; Amarasekare P, 2013, J ANIM ECOL, V82, P1240, DOI 10.1111/1365-2656.12112; Angilletta MJ, 2003, AM NAT, V162, P332; Baas J, 2010, SCI TOTAL ENVIRON, V408, P3740, DOI 10.1016/j.scitotenv.2009.09.037; Baas J, 2010, SCI TOTAL ENVIRON, V408, P3735, DOI 10.1016/j.scitotenv.2009.10.066; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; Ben-Horin T, 2013, ECOLOGY, V94, P161, DOI 10.1890/11-2257.1; Bindesbol AM, 2005, ENVIRON TOXICOL CHEM, V24, P1462, DOI 10.1897/04-397R.1; Bindesbol AM, 2009, ENVIRON SCI TECHNOL, V43, P5495, DOI 10.1021/es900898y; Boardman L, 2013, J INSECT PHYSIOL, V59, P781, DOI 10.1016/j.jinsphys.2013.05.005; Boonstra R, 2013, FUNCT ECOL, V27, P7, DOI 10.1111/1365-2435.12048; BRENNER S, 1974, GENETICS, V77, P71; Bundy JG, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-25; Caswell H, 2000, DEMOGRAPHY IN ECOTOX; Cedergreen N, 2012, ENCY ENV MANAGEMENT, P2601; Cedergreen N, 2013, ENVIRON TOXICOL CHEM, V32, P2274, DOI 10.1002/etc.2274; Goranson NC, 2005, EVOL ECOL RES, V7, P325; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Guinnee MA, 2007, J EVOLUTION BIOL, V20, P577, DOI 10.1111/j.1420-9101.2006.01253.x; Gupta RC, 2014, BIOMAKERS TOXICOLOGY; Hayward SAL, 2014, J EXP BIOL, V217, P6, DOI 10.1242/jeb.096537; Heugens EHW, 2001, CRIT REV TOXICOL, V31, P247, DOI 10.1080/20014091111695; Hill RW, 1989, ANIMAL PHYSL, V6; Hoss S, 2011, ENVIRON SCI TECHNOL, V45, P10219, DOI 10.1021/es2027136; Holmstrup M, 1998, ENVIRON TOXICOL CHEM, V17, P897, DOI [10.1002/etc.5620170518, 10.1897/1551-5028(1998)017&lt;0897:CEOCDA&gt;2.3.CO;2]; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Hosseini MJ, 2014, CELL BIOCHEM BIOPHYS, V70, P367, DOI 10.1007/s12013-014-9922-7; Jansch S, 2006, ENVIRON TOXICOL CHEM, V25, P2490, DOI 10.1897/05-439R.1; Jager T, 2004, ENVIRON SCI TECHNOL, V38, P2894, DOI 10.1021/es0352348; Jager T, 2006, ECOTOXICOLOGY, V15, P305, DOI 10.1007/s10646-006-0060-x; Jager T, 2014, ENVIRON SCI TECHNOL, V48, P7026, DOI 10.1021/es501306t; Jager T, 2013, J THEOR BIOL, V328, P9, DOI 10.1016/j.jtbi.2013.03.011; Jager T, 2012, ECOL MODEL, V225, P74, DOI 10.1016/j.ecolmodel.2011.11.012; Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a; Jager T, 2010, ECOTOXICOLOGY, V19, P351, DOI 10.1007/s10646-009-0417-z; JENKINS DE, 1988, J BACTERIOL, V170, P3910, DOI 10.1128/jb.170.9.3910-3914.1988; Kammenga JE, 1996, FUNCT ECOL, V10, P106, DOI 10.2307/2390268; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Kooijman SALM, 1996, WATER RES, V30, P1711, DOI 10.1016/0043-1354(96)00054-1; Kooijman SALM, 2000, DYNAMIC ENERGY BUDGE; Lika K, 2011, J SEA RES, V66, P270, DOI 10.1016/j.seares.2011.07.010; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Norhave NJ, 2014, ENVIRON TOXICOL CHEM, V33, P1363, DOI 10.1002/etc.2563; Norhave NJ, 2012, ENVIRON TOXICOL CHEM, V31, P787, DOI 10.1002/etc.1746; Petersen C, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-4; Philipp E.E.R., 2012, PLOS ONE, V7; Raffel TR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2039; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Ritz C, 2005, J STAT SOFTW, V12, P1; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sivasundar A, 2003, GENETICS, V163, P147; Spurgeon DJ, 2005, ENVIRON POLLUT, V136, P443, DOI 10.1016/j.envpol.2005.01.013; Stelzer CP, 2001, ECOLOGY, V82, P2521; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Swain S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-32; Terrell KA, 2013, J EXP BIOL, V216, P4204, DOI 10.1242/jeb.089896; Van Straalen N, 2003, ENVIRON SCI TECHNOL, V37, p324A; Wren JF, 2011, ECOTOXICOLOGY, V20, P397, DOI 10.1007/s10646-010-0591-z; Xing K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099500	64	16	16	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0140277	10.1371/journal.pone.0140277	http://dx.doi.org/10.1371/journal.pone.0140277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784453	gold, Green Published			2022-12-26	WOS:000368528400001
J	Gupta, G; Song, JX				Gupta, Garvita; Song, Jianxing			C-Terminal Auto-Regulatory Motif of Hepatitis C Virus NS5B Interacts with Human VAPB-MSP to Form a Dynamic Replication Complex	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; VIRAL REPLICATION; STRUCTURAL BASIS; NMR BINDING; PROTEIN; IDENTIFICATION; MOLECULES; MECHANISM; REVEAL	Hepatitis C virus (HCV) is a pathogen of global importance and nearly 200 million people are chronically infected with HCV. HCV is an enveloped single-stranded RNA virus, which is characteristic of the formation of the host membrane associated replication complex. Previous functional studies have already established that the human ER-anchored VAPB protein acts as a host factor to form a complex with HCV NS5A and NS5B, which may be established as a drug target. However, there is lacking of biophysical characterization of the structures and interfaces of the complex, partly due to the dynamic nature of the complex formation and dissociation, which is extensively involved in intrinsically-disordered domains. Here by an integrated use of domain dissection and NMR spectroscopy, for the first time we have successfully deciphered that the HCV NS5B utilizes its auto-regulatory Clinker to bind the VAPB-MSP domain to form a dynamic complex. This finding implies that the NS5B C-linker is capable of playing dual roles by a switch between the folded and disordered states. Interestingly, our previous and present studies together reveal that both HCV NS5A and NS5B bind to the MSP domains of the dimeric VAP with significantly overlapped interfaces and similar affinities. The identification that EphA2 and EphA5 bind to the MSP domain with higher affinity than EphA4 provides a biophysical basis for further exploring whether other than inducing ALS-like syndrome, the HCV infection might also trigger pathogenesis associated with signalling pathways mediated by EphA2 and EphA5.	[Gupta, Garvita; Song, Jianxing] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore	National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore.	dbssjx@nus.edu.sg	Song, Jianxing/H-8026-2012	Song, Jianxing/0000-0003-0224-6322	Ministry of Education of Singapore (MOE) [R-154-002-580-112]	Ministry of Education of Singapore (MOE)	This study was supported by Ministry of Education of Singapore (MOE) Tier 3 R-154-002-580-112 to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2002, BBA-PROTEINS PROTEOM, V1601, P38, DOI 10.1016/S1570-9639(02)00433-8; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Akhvlediani T, 2009, Georgian Med News, P70; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Bastos AF, 2011, NEUROL INT, V3, P12, DOI 10.4081/ni.2011.e4; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Dutta S, 2012, BIOCHEM J, V446, P37, DOI 10.1042/BJ20120001; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Goyal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040341; Gupta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039261; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Harrus D, 2010, J BIOL CHEM, V285, P32906, DOI 10.1074/jbc.M110.151316; Huan XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074040; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Leveque VJP, 2003, J VIROL, V77, P9020, DOI 10.1128/JVI.77.16.9020-9028.2003; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Liu JX, 2008, BIOCHEM BIOPH RES CO, V366, P585, DOI 10.1016/j.bbrc.2007.12.022; Liu JX, 2006, BIOCHEMISTRY-US, V45, P7171, DOI 10.1021/bi060091y; Lohmann V, 2013, CURR TOP MICROBIOL, V369, P167, DOI 10.1007/978-3-642-27340-7_7; Lua SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027072; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Qin HN, 2015, ACS CHEM BIOL, V10, P372, DOI 10.1021/cb500413n; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Reich S, 2010, J BIOL CHEM, V285, P13685, DOI 10.1074/jbc.M109.082206; Schmitt M, 2011, J VIROL, V85, P2565, DOI 10.1128/JVI.02177-10; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Song JX, 2001, J BIOL CHEM, V276, P41205, DOI 10.1074/jbc.M103449200; Tao YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000943; Thiel HJ, 2005, VIRUS TAXONOMY, P979; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Wang W, 2013, BIOCHEM BIOPH RES CO, V438, P169, DOI 10.1016/j.bbrc.2013.07.047; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	54	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147278	10.1371/journal.pone.0147278	http://dx.doi.org/10.1371/journal.pone.0147278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784321	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400132
J	Kaileh, M; Vazquez, E; MacFarlane, AW; Campbell, K; Kurosaki, T; Siebenlist, U; Sen, R				Kaileh, Mary; Vazquez, Estefania; MacFarlane, Alexander W.; Campbell, Kerry; Kurosaki, Tomohiro; Siebenlist, Ulrich; Sen, Ranjan			mTOR-Dependent and Independent Survival Signaling by PI3K in B Lymphocytes	PLOS ONE			English	Article							NF-KAPPA-B; CELL DEVELOPMENT; BAFF-R; IKK-ALPHA; RECEPTOR; ACTIVATION; MICE; INHIBITOR; CD19; PATHWAY	Peripheral B lymphocyte survival requires the B cell receptor (BCR) and B cell activating factor (BAFF) binding to its receptor (BAFF-R). Deletion of the BCR, or its signal transducing chaperone Ig beta, leads to rapid loss of mature B cells, indicating that signals initiated at the BCR are crucial for B cell survival. BAFF or BAFF-R deficiency also significantly reduces the numbers of mature B cells despite normal BCR expression. Together, these observations indicate that continued BCR and BAFF-R signaling are essential for the survival of mature resting B cells in the periphery. Here we demonstrate that tonic BCR signals up-regulate p100 (Nfkb2) as well as Mcl-1 protein expression at a post-transcriptional level via a PI3K-dependent pathway. p100 expression is mTOR-independent, whereas Mcl-1 expression is mTOR-dependent. BAFF treatment further elevated Mcl-1 levels by an mTOR-independent pathway, while consuming p100. Accordingly, Mcl-1 induction by BAFF is abrogated in Nfkb2(-/-) B cells. We propose that the cumulative effects of the BCR and BAFF-R signaling pathways increase Mcl-1 levels beyond the threshold required for B cell survival.	[Kaileh, Mary; Sen, Ranjan] NIA, Gene Regulat Sect, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Vazquez, Estefania; Siebenlist, Ulrich] NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [MacFarlane, Alexander W.; Campbell, Kerry] Fox Chase Canc Ctr, Inst Canc Res, Div Basic Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka, Japan	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fox Chase Cancer Center; Osaka University	Sen, R (corresponding author), NIA, Gene Regulat Sect, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA.	ranjan.sen@nih.gov	Campbell, Kerry S./T-1381-2019	MacFarlane IV, Alexander/0000-0003-1740-4848	Intramural research Program of the NIH, National institute on Aging (Baltimore, MD); NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000376] Funding Source: NIH RePORTER	Intramural research Program of the NIH, National institute on Aging (Baltimore, MD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported entirely by the Intramural research Program of the NIH, National institute on Aging (Baltimore, MD).	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brightbill HD, 2015, J IMMUNOL; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; Cha HS, 2006, J PHARMACOL EXP THER, V317, P571, DOI 10.1124/jpet.105.097436; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Fulcher DA, 1997, IMMUNOL CELL BIOL, V75, P446, DOI 10.1038/icb.1997.69; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Herold MJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.409; Jellusova J, 2013, CELL REP, V5, P1022, DOI 10.1016/j.celrep.2013.10.022; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lin WY, 2007, BLOOD, V110, P3959, DOI 10.1182/blood-2007-04-088088; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; Mills DM, 2007, P NATL ACAD SCI USA, V104, P6359, DOI 10.1073/pnas.0700296104; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Monroe JG, 2004, CURR OPIN IMMUNOL, V16, P288, DOI 10.1016/j.coi.2004.03.010; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Otipoby KL, 2008, P NATL ACAD SCI USA, V105, P12435, DOI 10.1073/pnas.0805460105; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Pelletier M, 2003, J BIOL CHEM, V278, P33127, DOI 10.1074/jbc.M305754200; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shinners NP, 2007, J IMMUNOL, V179, P3872, DOI 10.4049/jimmunol.179.6.3872; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751; Yang QS, 2012, BLOOD, V120, P3491, DOI 10.1182/blood-2012-02-412643; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146955	10.1371/journal.pone.0146955	http://dx.doi.org/10.1371/journal.pone.0146955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785352	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400085
J	Wang, Z; Jin, Y; Shen, CY; Li, TT; Huang, YF; Li, BG				Wang, Zhan; Jin, Yan; Shen, Chongyang; Li, Tiantian; Huang, Yuanfang; Li, Baoguo			Spontaneous Detachment of Colloids from Primary Energy Minima by Brownian Diffusion	PLOS ONE			English	Article							MICROMETER-SCALE PARTICLES; POROUS-MEDIA; SURFACE-ROUGHNESS; SOLUTION CHEMISTRY; DLVO INTERACTION; CARBON NANOTUBES; IONIC-STRENGTH; RELEASE; DEPOSITION; TRANSPORT	The Derjaguin-Landau-Verwey-Overbeek (DLVO) interaction energy profile has been frequently used to interpret the mechanisms controlling colloid attachment/detachment and aggregation/disaggregation behavior. This study highlighted a type of energy profile that is characterized by a shallow primary energy well (i.e., comparable to the average kinetic energy of a colloid) at a small separation distance and a monotonic decrease of interaction energy with separation distance beyond the primary energy well. This energy profile is present due to variations of height, curvature, and density of discrete physical heterogeneities on collector surfaces. The energy profile indicates that colloids can be spontaneously detached from the shallow primary energy well by Brownian diffusion. The spontaneous detachment from primary minima was unambiguously confirmed by conducting laboratory column transport experiments involving flow interruptions for two model colloids (polystyrene latex microspheres) and engineered nanoparticles (fullerene C-60 aggregates). Whereas the spontaneous detachment has been frequently attributed to attachment in secondary minima in the literature, our study indicates that the detached colloids could be initially attached at primary minima. Our study further suggests that the spontaneous disaggregation from primary minima is more significant than spontaneous detachment because the primary minimum depth between colloid themselves is lower than that between a colloid and a collector surface.	[Wang, Zhan; Shen, Chongyang; Li, Tiantian; Huang, Yuanfang; Li, Baoguo] China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China; [Wang, Zhan] Shenyang Agr Univ, Coll Land & Environm, Shenyang 110866, Liaoning, Peoples R China; [Jin, Yan] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA	China Agricultural University; Shenyang Agricultural University; University of Delaware	Shen, CY; Li, BG (corresponding author), China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China.	chongyang.shen@gmail.com; libg@cau.edu.cn	Shen, Chongyang/W-8463-2019		Chinese Universities Scientific Fund [2015QC061]; National Natural Science Foundation of China [41271009]; Program for New Century Excellent Talents in University [NCET-13-0560]; National Key Technology RD Program [2012BAD05B02]	Chinese Universities Scientific Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Key Technology RD Program(National Key Technology R&D Program)	The authors acknowledge the financial support provided by the Chinese Universities Scientific Fund (2015QC061, http://www.moe.edu.cn) (CS), National Natural Science Foundation of China (no. 41271009, http://www.nsfc.gov.cn) (CS), Program for New Century Excellent Talents in University (NCET-13-0560, http://www.moe.edu.cn) (CS), and National Key Technology R&D Program (no. 2012BAD05B02, http://www.most.gov.cn) (BL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna SM, 2008, LANGMUIR, V24, P4881, DOI 10.1021/la703866g; Assemi S, 2006, COLLOID SURFACE A, V286, P70, DOI 10.1016/j.colsurfa.2006.03.024; BALES RC, 1991, ENVIRON SCI TECHNOL, V25, P2088, DOI 10.1021/es00024a016; BALES RC, 1993, WATER RESOUR RES, V29, P957, DOI 10.1029/92WR02986; Batra A, 2001, AICHE J, V47, P2557, DOI 10.1002/aic.690471118; Bergendahl J, 2000, CHEM ENG SCI, V55, P1523, DOI 10.1016/S0009-2509(99)00422-4; Bergendahl JA, 2003, ENVIRON SCI TECHNOL, V37, P2317, DOI 10.1021/es0209316; Bhattacharjee S, 1997, J COLLOID INTERF SCI, V193, P273, DOI 10.1006/jcis.1997.5076; Bhattacharjee S, 1998, LANGMUIR, V14, P3365, DOI 10.1021/la971360b; Bhattacharjee S, 1998, CROAT CHEM ACTA, V71, P883; Bradford SA, 2015, J CONTAM HYDROL, V181, P141, DOI 10.1016/j.jconhyd.2015.04.003; Bradford SA, 2013, LANGMUIR, V29, P6944, DOI 10.1021/la4011357; Brant JA, 2002, ENVIRON ENG SCI, V19, P413, DOI 10.1089/109287502320963409; Burdick GM, 2005, THIN SOLID FILMS, V488, P116, DOI 10.1016/j.tsf.2005.04.112; Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176; CHAN DYC, 1984, J COLLOID INTERF SCI, V102, P400, DOI 10.1016/0021-9797(84)90242-X; Chen KL, 2006, LANGMUIR, V22, P10994, DOI 10.1021/la062072v; Clar JG, 2013, J AM CHEM SOC, V135, P17758, DOI 10.1021/ja4052526; CLAYFIELD EJ, 1970, ENVIRON SCI TECHNOL, V4, P413, DOI 10.1021/es60040a005; Considine RF, 2001, LANGMUIR, V17, P7777, DOI 10.1021/la0017227; DAHNEKE B, 1975, J COLLOID INTERF SCI, V50, P89, DOI 10.1016/0021-9797(75)90257-X; Desset S, 2000, LANGMUIR, V16, P10495, DOI 10.1021/la000734p; DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0; Duffadar RD, 2008, J COLLOID INTERF SCI, V326, P18, DOI 10.1016/j.jcis.2008.07.004; Duffadar RD, 2007, J COLLOID INTERF SCI, V308, P20, DOI 10.1016/j.jcis.2006.12.068; ELIMELECH M, 1990, LANGMUIR, V6, P1153, DOI 10.1021/la00096a023; ELIMELECH M, 1990, ENVIRON SCI TECHNOL, V24, P1528, DOI 10.1021/es00080a012; Fuerstenau DW, 2005, ADV COLLOID INTERFAC, V114, P9, DOI 10.1016/j.cis.2004.08.006; Grolimund D, 2001, WATER RESOUR RES, V37, P559, DOI 10.1029/2000WR900285; Grolimund D, 2001, WATER RESOUR RES, V37, P571, DOI 10.1029/2000WR900286; Hahn MW, 2004, ENVIRON SCI TECHNOL, V38, P5915, DOI 10.1021/es049746d; Hahn MW, 2004, ENVIRON SCI TECHNOL, V38, P210, DOI 10.1021/es030416n; Hamaker HC, 1937, PHYSICA, V4, P1058, DOI 10.1016/S0031-8914(37)80203-7; HAPPEL J, 1958, AICHE J, V4, P197, DOI 10.1002/aic.690040214; Hoek EMV, 2006, J COLLOID INTERF SCI, V298, P50, DOI 10.1016/j.jcis.2005.12.031; Hoek EMV, 2003, LANGMUIR, V19, P4836, DOI 10.1021/la027083c; HOGG R, 1966, T FARADAY SOC, V62, P1638, DOI 10.1039/tf9666201638; Hotze EM, 2010, J ENVIRON QUAL, V39, P1909, DOI 10.2134/jeq2009.0462; Huang XF, 2010, LANGMUIR, V26, P2528, DOI 10.1021/la9028113; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; KALLAY N, 1987, ADV COLLOID INTERFAC, V27, P1, DOI 10.1016/0001-8686(87)85008-X; Kim JU, 2008, MACROMOLECULES, V41, P246, DOI 10.1021/ma071906t; Kovalchuk NM, 2012, ADV COLLOID INTERFAC, V179, P99, DOI 10.1016/j.cis.2011.05.009; Ninham BW, 1999, ADV COLLOID INTERFAC, V83, P1, DOI 10.1016/S0001-8686(99)00008-1; Oliveira R, 1997, EXP THERM FLUID SCI, V14, P316, DOI 10.1016/S0894-1777(96)00134-3; Pazmino E, 2014, ENVIRON SCI TECHNOL, V48, P9227, DOI 10.1021/es502503y; Redman JA, 2004, ENVIRON SCI TECHNOL, V38, P1777, DOI 10.1021/es034887l; Roy SB, 1996, COLLOID SURFACE A, V119, P133, DOI 10.1016/S0927-7757(96)03764-8; RYAN JN, 1994, ENVIRON SCI TECHNOL, V28, P1717, DOI 10.1021/es00058a025; RYAN JN, 1994, J COLLOID INTERF SCI, V164, P21, DOI 10.1006/jcis.1994.1139; Ryan JN, 1996, COLLOID SURFACE A, V107, P1, DOI 10.1016/0927-7757(95)03384-X; Ryde NP, 2000, COLLOID SURFACE A, V165, P59, DOI 10.1016/S0927-7757(99)00447-1; Schijven JF, 2000, CRIT REV ENV SCI TEC, V30, P49, DOI 10.1080/10643380091184174; Schowalter WR, 2001, P NATL ACAD SCI USA, V98, P3644, DOI 10.1073/pnas.061028498; Shay JS, 2001, J RHEOL, V45, P913, DOI 10.1122/1.1378030; Shen C, 2012, COLLOID SURF A, V107, P1; Shen CY, 2007, ENVIRON SCI TECHNOL, V41, P6976, DOI 10.1021/es070210c; Shen CY, 2015, J CONTAM HYDROL, V177, P18, DOI 10.1016/j.jconhyd.2015.03.003; Shen CY, 2015, J HAZARD MATER, V290, P60, DOI 10.1016/j.jhazmat.2015.02.067; Shen CY, 2014, J COLLOID INTERF SCI, V421, P103, DOI 10.1016/j.jcis.2014.01.033; Shen CY, 2013, COLLOID SURFACE A, V433, P14, DOI 10.1016/j.colsurfa.2013.04.048; Shen CY, 2012, LANGMUIR, V28, P14681, DOI 10.1021/la303163c; Shen CY, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0057; Shen CY, 2011, VADOSE ZONE J, V10, P1071, DOI 10.2136/vzj2011.0011; Shen CY, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009218; Suresh L, 1996, J COLLOID INTERF SCI, V183, P199, DOI 10.1006/jcis.1996.0535; Suresh L, 1997, J COLLOID INTERF SCI, V196, P177, DOI 10.1006/jcis.1997.5216; Tian Y, 2012, J HAZARD MATER, V231, P79, DOI 10.1016/j.jhazmat.2012.06.039; Torkzaban S, 2007, LANGMUIR, V23, P9652, DOI 10.1021/la700995e; Torkzaban S, 2016, WATER RES, V88, P274, DOI 10.1016/j.watres.2015.10.022; Torkzaban S, 2013, ENVIRON SCI TECHNOL, V47, P11528, DOI 10.1021/es402075f; Tosco T, 2009, ENVIRON SCI TECHNOL, V43, P4425, DOI 10.1021/es900245d; Tufenkji N, 2005, LANGMUIR, V21, P841, DOI 10.1021/la048102g; Verwey E.J., 1948, THEORY STABILITY LYO; Walz JY, 1998, ADV COLLOID INTERFAC, V74, P119, DOI 10.1016/S0001-8686(97)00042-0; Wu KL, 2005, LANGMUIR, V21, P3238, DOI 10.1021/la0476682; Wu L, 2012, ENVIRON SCI TECHNOL, V46, P8878, DOI 10.1021/es301365f; Yi P, 2013, ENVIRON SCI TECHNOL, V47, P12211, DOI 10.1021/es403133r; Zhuang J, 2005, ENVIRON SCI TECHNOL, V39, P7853, DOI 10.1021/es050265j	79	10	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147368	10.1371/journal.pone.0147368	http://dx.doi.org/10.1371/journal.pone.0147368			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784446	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400144
J	Boraas, LC; Guidry, JB; Pineda, ET; Ahsan, T				Boraas, Liana C.; Guidry, Julia B.; Pineda, Emma T.; Ahsan, Tabassum			Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells	PLOS ONE			English	Article							SHEAR-STRESS; LINEAGE SPECIFICATION; DIFFERENTIATION; GENERATION; ADULT; FIBROBLASTS; TRANSITIONS; INDUCTION; MIGRATION; SYSTEM	Many emerging cell-based therapies are based on pluripotent stem cells, though complete understanding of the properties of these cells is lacking. In these cells, much is still unknown about the cytoskeletal network, which governs the mechanoresponse. The objective of this study was to determine the cytoskeletal state in undifferentiated pluripotent stem cells and remodeling with differentiation. Mouse embryonic stem cells (ESCs) and reprogrammed induced pluripotent stem cells (iPSCs), as well as the original un-reprogrammed embryonic fibroblasts (MEFs), were evaluated for expression of cytoskeletal markers. We found that pluripotent stem cells overall have a less developed cytoskeleton compared to fibroblasts. Gene and protein expression of smooth muscle cell actin, vimentin, lamin A, and nestin were markedly lower for ESCs than MEFs. Whereas, iPSC samples were heterogeneous with most cells expressing patterns of cytoskeletal proteins similar to ESCs with a small subpopulation similar to MEFs. This indicates that dedifferentiation during reprogramming is associated with cytoskeletal remodeling to a less developed state. In differentiation studies, it was found that shear stress-mediated differentiation resulted in an increase in expression of cytoskeletal intermediate filaments in ESCs, but not in iPSC samples. In the embryoid body model of spontaneous differentiation of pluripotent stem cells, however, both ESCs and iPSCs had similar gene expression for cytoskeletal proteins during early differentiation. With further differentiation, however, gene levels were significantly higher for iPSCs compared to ESCs. These results indicate that reprogrammed iPSCs more readily reacquire cytoskeletal proteins compared to the ESCs that need to form the network de novo. The strategic selection of the parental phenotype is thus critical not only in the context of reprogramming but also the ultimate functionality of the iPSC-differentiated cell population. Overall, this increased characterization of the cytoskeleton in pluripotent stem cells will allow for the better understanding and design of stem cell-based therapies.	[Boraas, Liana C.; Guidry, Julia B.; Pineda, Emma T.; Ahsan, Tabassum] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA	Tulane University	Ahsan, T (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.	tahsan@tulane.edu	Ahsan, Tabassum/G-6447-2010		National Institutes of Health [P20 GM103629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Institutes of Health #P20 GM103629 (LCB JBG ETP TA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan T, 2010, TISSUE ENG PT A, V16, P3547, DOI [10.1089/ten.tea.2010.0014, 10.1089/ten.TEA.2010.0014]; Bober BG, 2015, CYTOSKELETON, V72, P193, DOI 10.1002/cm.21219; Chien S, 2005, FRONT BIOSCI-LANDMRK, V10, P1985, DOI 10.2741/1673; Constantinescu D, 2006, STEM CELLS, V24, P177, DOI 10.1634/stemcells.2004-0159; Daniels BR, 2010, BIOPHYS J, V99, P3563, DOI 10.1016/j.bpj.2010.10.007; Discher D, 2009, ANN BIOMED ENG, V37, P847, DOI 10.1007/s10439-009-9661-x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Gopalakrishnan J, 2012, NAT CELL BIOL, V14, P865, DOI 10.1038/ncb2527; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Hammerick KE, 2011, TISSUE ENG PT A, V17, P495, DOI [10.1089/ten.tea.2010.0211, 10.1089/ten.TEA.2010.0211]; Hayes Michael, 2013, Methods Mol Biol, V1029, P77, DOI 10.1007/978-1-62703-478-4_6; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Lai WH, 2010, CELL REPROGRAM, V12, P641, DOI 10.1089/cell.2010.0051; Lee J., 2014, NATURE COMMUNICATION, V5; Li X, 2014, PROTEIN CELL, V5, P580, DOI 10.1007/s13238-014-0064-x; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Luo W, 2011, ACTA BIOCH BIOPH SIN, V43, P210, DOI 10.1093/abbs/gmr004; Madonna R, 2014, BBA-MOL BASIS DIS, V1842, P2266, DOI 10.1016/j.bbadis.2014.07.030; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Mao J, 2014, STEM CELLS DEV, V23, P779, DOI 10.1089/scd.2013.0325; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mulhall H, 2011, J TISSUE ENG REGEN M, V5, P629, DOI 10.1002/term.355; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pineda ET, 2013, CELLS TISSUES ORGANS, V197, P399, DOI 10.1159/000346166; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sakurai K, 2014, CELL STEM CELL, V14, P523, DOI 10.1016/j.stem.2014.03.001; Sanchez-Freire V, 2014, J AM COLL CARDIOL, V64, P436, DOI 10.1016/j.jacc.2014.04.056; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Wolfe RP, 2012, INTEGR BIOL-UK, V4, P1263, DOI 10.1039/c2ib20040f; Yamada M, 2006, ANAL CHEM, V78, P1357, DOI 10.1021/ac0520083; Zhao BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-488	40	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0145084	10.1371/journal.pone.0145084	http://dx.doi.org/10.1371/journal.pone.0145084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771179	gold, Green Submitted, Green Published			2022-12-26	WOS:000368628300004
J	Chung, SJ; Park, E; Ye, BS; Lee, HS; Chang, HJ; Song, D; Kim, YD; Heo, JH; Nam, HS				Chung, Seok Jong; Park, Eunjeong; Ye, Byoung Seok; Lee, Hye Sun; Chang, Hyuk-Jae; Song, Dongbeom; Kim, Young Dae; Heo, Ji Hoe; Nam, Hyo Suk			The Computerized Table Setting Test for Detecting Unilateral Neglect	PLOS ONE			English	Article							HEMISPATIAL NEGLECT; LINE BISECTION; VISUOSPATIAL NEGLECT; SPATIAL NEGLECT; STROKE PATIENTS; BREAST-CANCER; HAND-HELD; SENSITIVITY; METASTASIS; HEMIANOPIA	Background Patients with unilateral neglect fail to respond normally to stimuli on the left side. To facilitate the evaluation of unilateral spatial neglect, we developed a new application that runs on a tablet device and investigated its feasibility in stroke patients. Methods We made the computerized table setting test (CTST) to run on the tablet computer. Forty acute ischemic stroke patients (20 patients with right hemispheric infarction with neglect, 10 patients with right hemispheric infarction without neglect, and 10 patients with left hemispheric infarction) and 10 healthy controls were prospectively enrolled to validate the CTST. The test requires subjects to set a table by dragging 12 dishes located below the table on the tablet screen. The horizontal deviation of the 12 dishes from the midline of the table, the selection tendency measured by the sequence of the dish selection, and the elapsed time for table setting were calculated automatically. Results Parameters measured by the CTST were correlated with the results of conventional neglect tests. The horizontal deviation was significantly higher in patients with right hemispheric infarction with neglect compared with the other groups. The selection tendency and elapsed time also were significantly different in patients with right hemispheric infarction with neglect compared with the left hemispheric infarction and control groups, but were similar to those with right hemispheric infarction without neglect. Conclusions The CTST is feasible to administer and comparable with conventional neglect tests. This new application may be useful for the initial diagnosis and follow-up of neglect patients.	[Chung, Seok Jong; Ye, Byoung Seok; Song, Dongbeom; Kim, Young Dae; Heo, Ji Hoe; Nam, Hyo Suk] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Park, Eunjeong] Univ Calif Los Angeles, Wireless Hlth Inst, Los Angeles, CA USA; [Park, Eunjeong; Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Dept Cardiol, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea	Yonsei University; Yonsei University Health System; University of California System; University of California Los Angeles; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Nam, HS (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	hsnam@yuhs.ac	; Lee, Hye Sun/J-2154-2015	Heo, Ji Hoe/0000-0001-9898-3321; Ye, Byoung Seok/0000-0003-0187-8440; NAM, HYO SUK/0000-0002-4415-3995; Kim, Young Dae/0000-0001-5750-2616; Chung, Seok Jong/0000-0001-6086-3199; Chang, Hyuk-Jae/0000-0002-6139-7545; Lee, Hye Sun/0000-0001-6328-6948	Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [HI08C2149]; Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP) [2012027176]; Yonsei University College of Medicine [6-2014-0181]	Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea; Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP); Yonsei University College of Medicine(General Electric)	This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (HI08C2149); the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (MSIP) (2012027176); and a faculty research grant from Yonsei University College of Medicine for 2014 (6-2014-0181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Azouvi P, 2006, RESTOR NEUROL NEUROS, V24, P273; Bailey MJ, 2000, NEUROREHABILITATION, V14, P139; Bartolomeo P, 1999, NEUROPSYCHOLOGIA, V37, P881, DOI 10.1016/S0028-3932(98)00150-X; Barton JJS, 1998, J NEUROL NEUROSUR PS, V64, P660, DOI 10.1136/jnnp.64.5.660; Brazis PW, 2011, LOCALIZATION CLIN NE; Busis N, 2010, NEUROL CLIN, V28, P395, DOI 10.1016/j.ncl.2009.11.001; Friederichs H, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/s12911-014-0113-7; Graesslin O, 2010, J CLIN ONCOL, V28, P2032, DOI 10.1200/JCO.2009.24.6314; HALLIGAN PW, 1989, LANCET, V2, P908; Nam HS, 2012, THROMB HAEMOSTASIS, V107, P786, DOI 10.1160/TH11-08-0585; Jalas MJ, 2002, J CLIN EXP NEUROPSYC, V24, P479, DOI 10.1076/jcen.24.4.479.1036; Jehkonen M, 2006, RESTOR NEUROL NEUROS, V24, P209; Jehkonen M, 1998, LANCET, V351, P727, DOI 10.1016/S0140-6736(05)78497-X; Kerkhoff G, 2008, CORTEX, V44, P200, DOI 10.1016/j.cortex.2006.07.002; Kim H, 2014, GERIATR GERONTOL INT, V14, P969, DOI 10.1111/ggi.12182; Lee BH, 2004, NEUROPSYCHOLOGIA, V42, P1715, DOI 10.1016/j.neuropsychologia.2004.02.015; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Luukkainen-Markkula R, 2011, NEUROPSYCHOL REHABIL, V21, P103, DOI 10.1080/09602011.2010.531619; Machner B, 2012, J NEUROL NEUROSUR PS, V83, P1032, DOI 10.1136/jnnp-2012-303296; MARSHALL JC, 1975, NEUROPSYCHOLOGIA, V13, P315, DOI 10.1016/0028-3932(75)90008-1; Na DL, 2000, CORTEX, V36, P455, DOI 10.1016/S0010-9452(08)70532-X; Nam HS, 2012, EUR J NEUROL, V19, P426, DOI 10.1111/j.1468-1331.2011.03530.x; Nam HS, 2013, J STROKE, V15, P135, DOI 10.5853/jos.2013.15.3.135; Nam HS, 2014, YONSEI MED J, V55, P25, DOI 10.3349/ymj.2014.55.1.25; Nurmi L, 2010, J INT NEUROPSYCH SOC, V16, P902, DOI 10.1017/S1355617710000792; Parton A, 2004, J NEUROL NEUROSUR PS, V75, P13; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Robertson IH, 2001, NEUROIMAGE, V14, pS85, DOI 10.1006/nimg.2001.0838; Rouzier R, 2005, J CLIN ONCOL, V23, P8331, DOI 10.1200/JCO.2005.01.2898; Shin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041544; Tham K, 1996, NEUROPSYCHOL REHABIL, V6, P19, DOI 10.1080/713755496; Toomey RJ, 2010, AM J ROENTGENOL, V194, P469, DOI 10.2214/AJR.09.3418; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147030	10.1371/journal.pone.0147030	http://dx.doi.org/10.1371/journal.pone.0147030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771512	Green Submitted, gold, Green Published			2022-12-26	WOS:000368628300055
J	Zeale, MRK; Bennitt, E; Newson, SE; Packman, C; Browne, WJ; Harris, S; Jones, G; Stone, E				Zeale, Matt R. K.; Bennitt, Emily; Newson, Stuart E.; Packman, Charlotte; Browne, William J.; Harris, Stephen; Jones, Gareth; Stone, Emma			Mitigating the Impact of Bats in Historic Churches: The Response of Natterer's Bats Myotis nattereri to Artificial Roosts and Deterrence	PLOS ONE			English	Article							PIPISTRELLUS-PIPISTRELLUS; BIODIVERSITY IMPACTS; FORAGING BEHAVIOR; HABITAT SELECTION; CONSERVATION; CHIROPTERA; KUHL	Bats frequently roost in historic churches, and these colonies are of considerable conservation value. Inside churches, bat droppings and urine can cause damage to the historic fabric of the building and to items of cultural significance. In extreme cases, large quantities of droppings can restrict the use of a church for worship and/or other community functions. In the United Kingdom, bats and their roosts are protected by law, and striking a balance between conserving the natural and cultural heritage can be a significant challenge. We investigated mitigation strategies that could be employed in churches and other historic buildings to alleviate problems caused by bats without adversely affecting their welfare or conservation status. We used a combination of artificial roost provision and deterrence at churches in Norfolk, England, where significant maternity colonies of Natterer's bats Myotis nattereri damage church features. Radio-tracking data and population modelling showed that excluding M. nattereri from churches is likely to have a negative impact on their welfare and conservation status, but that judicious use of deterrents, especially high intensity ultrasound, can mitigate problems caused by bats. We show that deterrence can be used to move bats humanely from specific roosting sites within a church and limit the spread of droppings and urine so that problems to congregations and damage to cultural heritage can be much reduced. In addition, construction of bespoke roost spaces within churches can allow bats to continue to roost within the fabric of the building without flying in the church interior. We highlight that deterrence has the potential to cause serious harm to M. nattereri populations if not used judiciously, and so the effects of deterrents will need careful monitoring, and their use needs strict regulation.	[Zeale, Matt R. K.; Bennitt, Emily; Packman, Charlotte; Harris, Stephen; Jones, Gareth; Stone, Emma] Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England; [Newson, Stuart E.] British Trust Ornithol, Thetford IP24 2PU, Norfolk, England; [Browne, William J.] Univ Bristol, Grad Sch Educ, 2 Priory Rd, Bristol BS8 1TX, Avon, England; [Browne, William J.] Univ Bristol, Ctr Multilevel Modelling, 2 Priory Rd, Bristol BS8 1TX, Avon, England	University of Bristol; British Trust for Ornithology; University of Bristol; University of Bristol	Jones, G (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.	gareth.jones@bristol.ac.uk	Bennitt, Emily/AAB-6032-2020; Browne, William J/A-8686-2010	Browne, William J/0000-0002-6659-6885; Jones, Gareth/0000-0002-1904-3735; Zeale, Matt/0000-0002-4997-9577; Stone, Emma/0000-0002-3415-3967	Department for Environment, Food and Rural Affairs (Defra) [WM0322]; English Heritage [6199]; Bat Conservation International	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); English Heritage; Bat Conservation International	The project was funded by the Department for Environment, Food and Rural Affairs (Defra), and by English Heritage. The website for Defra is: https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs, and the grant number is: WM0322. The website for English Heritage is: http://www.english-heritage.org.uk, and the grant number is: 6199. The funding was received by GJ and SH. The funder provided a project brief on which experimental procedures were designed. Members of a Project Advisory Group (PAG) provided advice and support throughout the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the church wardens, members of the clergy, and parishioners for their help and assistance and for their understanding during experimental trials, and we are grateful to the Diocese of Norwich for permitting experiments in some of their churches. We thank the Bats and Wind Energy Cooperative (USA) and Deaton Engineering Inc. for providing acoustic deterrents, and Bat Conservation International for funding the shipping of Deaton devices to the United Kingdom. We thank Concept Research Ltd for developing and building the CR devices. We are grateful to members of the Project Advisory Group (Defra) and the Project Steering Group (English Heritage) for their helpful advice and for valuable comments on an earlier version of the manuscript. Project Advisory Group and Steering Group members included Richard Brand-Hardy (Defra), Alison Elliott (Defra), Stephen Rudd (Natural England), Katherine Walsh (Natural England), Jen Heathcote (English Heritage), Linda Monkton (English Heritage), Dr David Bullock (National Trust), Julia Hanmer (BCT), Dr Karen Haysom (BCT), Philip Parker (Philip Parker Associates Ltd), the Revd Canon Nigel Cooper (Church Buildings Council), the Revd Stephen Thorp (Church of England) and Simon Marks (Coordinator with Ecclesiastical Architects and Surveyors Association). We also thank Henrietta Bellman, David Bennett, Lucy Buckingham, Andrew Carr, Alexandra Cripps, Kara Davies, James Goldsmith, Joanna Haddock, Charles Harris, Joseph Kendrick, Laura Murdoch, Emma Northcote-Smith, Jess O'Doherty, Thomas Pringle, Sonia Reveley, Emma Taylor and John Worthington-Hill who made significant contributions to data collection, and Rob Robinson who advised on population modelling.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Arnett EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065794; Bohnenstengel Thierry, 2012, Bulletin de la Societe Neuchateloise des Sciences Naturelles, V132, P57; BRIGHAM RM, 1986, CAN J ZOOL, V64, P1128, DOI 10.1139/z86-169; Browne W., 2009, MCMC ESTIMATION MLWI; Davidson-Watts I, 2006, J ZOOL, V268, P55, DOI 10.1111/j.1469-7998.2005.00016.x; Davidson-Watts I, 2006, BIOL CONSERV, V133, P118, DOI 10.1016/j.biocon.2006.05.027; Dietz C., 2009, BATS BRITAIN EUROPE; Galimberti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040122; Hales J, 2014, ARCHAEOL INT, V17, P94, DOI 10.5334/ai.1703; Hatton L, 2000, SCOTT BATS, V5, P29; Hillen J, 2010, ACTA CHIROPTEROL, V12, P187, DOI 10.3161/150811010X504680; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Jones G., 1992, P521; Legendre S, 1995, J APPL STAT, V22, P817, DOI 10.1080/02664769524649; Long R., 2006, CALIF AGR, V60, P91; Marnell F., 2010, EUROBATS PUBLICATION, V4; Michaelsen T. C., 2011, BATS, V29, P9; Mitchell-Jones A.J., 2004, BAT WORKERS MANUAL, V3rd; Mortimer G., 2006, THESIS U ST ANDREWS; Packman C, 2015, MANAGEMENT BATS CHUR; Park KJ, 1998, J ZOOL, V244, P379, DOI 10.1017/S0952836998003094; Puechmaille SJ, 2012, MAMM BIOL, V77, P224, DOI 10.1016/j.mambio.2011.11.004; Rasbash J, 2009, MLWIN VERSION 21; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Russ J, 2021, BAT CALLS BRITAIN EU; Salicini I, 2011, MOL PHYLOGENET EVOL, V61, P888, DOI 10.1016/j.ympev.2011.08.010; Salicini I, 2013, J BIOGEOGR, V40, P1182, DOI 10.1111/jbi.12062; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; Siemers BM, 1999, Z SAUGETIERKD, V64, P241; Siemers BM, 2000, BEHAV ECOL SOCIOBIOL, V47, P400, DOI 10.1007/s002650050683; Smith PG, 2008, J ZOOL, V275, P314, DOI 10.1111/j.1469-7998.2008.00445.x; Smith P. G., 2008, MAMMALS BRIT ISLES H, P323; Smith PG, 2005, J ZOOL, V266, P171, DOI 10.1017/S0952836905006758; STEBBINGS R. E., 1993, GREYWELL TUNNEL INT; Stone E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131825; Stone EL, 2012, GLOBAL CHANGE BIOL, V18, P2458, DOI 10.1111/j.1365-2486.2012.02705.x; Stone EL, 2015, MAMM BIOL, V80, P213, DOI 10.1016/j.mambio.2015.02.004; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Tuljapurkar S., 1997, STRUCTURED POPULATIO; White G.C., 1990, ANAL WILDLIFE RADIO; Young JC, 2010, BIODIVERS CONSERV, V19, P3973, DOI 10.1007/s10531-010-9941-7; Zeale MRK, 2012, J MAMMAL, V93, P1110, DOI 10.1644/11-MAMM-A-366.1	43	15	15	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146782	10.1371/journal.pone.0146782	http://dx.doi.org/10.1371/journal.pone.0146782			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771548	Green Published, gold			2022-12-26	WOS:000368628300035
J	Moriwaki, K; Chan, FKM				Moriwaki, Kenta; Chan, Francis Ka-Ming			Regulation of RIPK3-and RHIM-dependent Necroptosis by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; apoptosis; cell death; necrosis (necrotic death); proteasome; ubiquitylation (ubiquitination)	MIXED LINEAGE KINASE; RECEPTOR-INTERACTING PROTEIN; DOMAIN-LIKE PROTEIN; MULTIPLE-MYELOMA CELLS; NF-KAPPA-B; PROGRAMMED NECROSIS; APOPTOSIS; RIP3; DEATH; MLKL	Receptor-interacting protein kinase 3 (RIPK3) is a serine/threonine kinase with essential function in necroptosis. The activity of RIPK3 is controlled by phosphorylation. Once activated, RIPK3 phosphorylates and activates the downstream effector mixed lineage kinase domain-like (MLKL) to induce necroptosis. In certain situations, RIPK3 has also been shown to promote apoptosis or cytokine expression in a necroptosis and kinase-independent manner. The ubiquitin-proteasome system is the major pathway for selective degradation of cellular proteins and thus has a critical role in many cellular processes such as cell survival and cell death. Clinically, proteasome inhibition has shown promise as an anti-cancer agent. Here we show that the proteasome inhibitors MG132 and bortezomib activate the RIPK3-MLKL necroptotic pathway in mouse fibroblasts as well as human leukemia cells. Unlike necroptosis induced by classical TNF-like cytokines, necroptosis induced by proteasome inhibitors does not require caspase inhibition. However, an intact RIP homotypic interaction motif (RHIM) is essential. Surprisingly, when recruitment of MLKL to RIPK3 is restricted, proteasome inhibitors induced RIPK3-dependent apoptosis. Proteasome inhibition led to accumulation of K48-linked ubiquitinated RIPK3, which was partially reduced when Lys-264 was mutated. Taken together, these results reveal the ubiquitin-proteasome system as a novel regulatory mechanism for RIPK3-dependent necroptosis.	[Moriwaki, Kenta; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Immunol & Microbiol Program, 368 Plantat St, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Chan, FKM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, 368 Plantat St, Worcester, MA 01605 USA.	francis.chan@umassmed.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; Moriwaki, Kenta/0000-0002-8724-4715	National Institutes of Health [AI083497]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119030, R01AI083497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI083497. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; Cook WD, 2014, CELL DEATH DIFFER, V21, P1600, DOI 10.1038/cdd.2014.70; de Almagro MC, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.158; Dick LR, 2010, DRUG DISCOV TODAY, V15, P243, DOI 10.1016/j.drudis.2010.01.008; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feng X, 2015, NEOPLASMA, V62, P592, DOI 10.4149/neo_2015_071; Geserick P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.240; Gonzalvez F, 2012, MOL CELL, V48, P888, DOI 10.1016/j.molcel.2012.09.031; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hideshima T, 2001, CANCER RES, V61, P3071; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Koo GB, 2015, CELL RES, V25, P707, DOI 10.1038/cr.2015.56; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Moriwaki K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.16; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Nugues AL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.347; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Palombella VJ, 1998, P NATL ACAD SCI USA, V95, P15671, DOI 10.1073/pnas.95.26.15671; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Weinlich R, 2014, MOL CELL, V56, P469, DOI 10.1016/j.molcel.2014.11.001; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	46	36	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5948	5959		10.1074/jbc.M115.700997	http://dx.doi.org/10.1074/jbc.M115.700997			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786097	Green Published, hybrid			2022-12-26	WOS:000372551800040
J	Christiansen, SC; Eilertsen, TB; Vanky, E; Carlsen, SM				Christiansen, Sverre C.; Eilertsen, Tina B.; Vanky, Eszter; Carlsen, Sven M.			Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; POLYCYSTIC-OVARY-SYNDROME; ANTIMULLERIAN HORMONE; MLLERIAN HORMONE; ANTRAL FOLLICLE; ULTRASOUND; PREVALENCE; EXPRESSION; DIAGNOSIS; EXCESS	Context Increased Anti-Mullerian Hormone in polycystic ovary syndrome, may be due to overactive follicles rather than reflect antral follicle count. Objective Does Anti-Mullerian Hormone reflect antral follicle count similarly in women with or without polycystic ovary syndrome or polycystic ovarian morphology? Design Cross-sectional, case-control. Setting Women who delivered preterm in 1999-2006. For each index woman, a woman with a term delivery was identified. Patients Participation rate was 69%. Between 2006-2008, 262 women were included, and diagnosed to have polycystic ovary syndrome, polycystic ovarian morphology or to be normal controls. Intervention(s) Blood tests, a clinical examination and vaginal ultrasound. Main Outcome Measure(s) Anti-Mullerian Hormone / antral follicle count -ratio, SHBG, androstenedione and insulin, to test potential influence on the Anti-Mullerian Hormone / antral follicle count -ratio. Results Mean Anti-Mullerian Hormone / antral follicle count ratio in women with polycystic ovary syndrome or polycystic ovarian morphology was similar to that of the controls (polycystic ovary syndrome: 1,2 p = 0,10 polycystic ovarian morphology: 1,2, p = 0,27 Controls 1,3). Anti-Mullerian Hormone showed a positive linear correlation to antral follicle count in all groups. Multivariate analysis did not change the results. Conclusions We confirmed the positive correlation between AMH and follicle count. Anti-Mullerian Hormone seems to be a reliable predictor of antral follicle count, independent of polycystic ovary syndrome diagnosis or ovarian morphology.	[Christiansen, Sverre C.; Carlsen, Sven M.] Univ Trondheim Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway; [Christiansen, Sverre C.; Carlsen, Sven M.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Eilertsen, Tina B.] Nord Trondelag Hosp Trust, Hosp Namsos, Dept Obstet & Gynaecol, Namsos, Norway; [Eilertsen, Tina B.; Vanky, Eszter] Norwegian Univ Sci & Technol, Childrens & Womens Hlth, Dept Lab Med, N-7034 Trondheim, Norway; [Vanky, Eszter] Univ Trondheim Hosp, St Olavs Hosp, Dept Obstet & Gynecol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Carlsen, SM (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway.; Carlsen, SM (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	sverre.christiansen@ntnu.no	Carlsen, Sven Magnus/AAI-4635-2020; Christiansen, Sverre/AAD-5214-2020	Christiansen, Sverre Christian/0000-0002-0378-0474	Liaison Committee	Liaison Committee	The study was funded by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) (TBE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CY, 2010, HUM REPROD, V25, P1282, DOI 10.1093/humrep/deq019; Bentzen JG, 2013, J CLIN ENDOCR METAB, V98, P1602, DOI 10.1210/jc.2012-1829; Bhide P, 2015, FERTIL STERIL, V103, P537, DOI 10.1016/j.fertnstert.2014.10.033; Carmina E, 2006, J CLIN ENDOCR METAB, V91, P2, DOI 10.1210/jc.2005-1457; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Cook CL, 2000, FERTIL STERIL, V73, P859, DOI 10.1016/S0015-0282(99)00639-1; Das M, 2008, HUM REPROD, V23, P2122, DOI 10.1093/humrep/den185; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Dewailly D, 2011, HUM REPROD, V26, P3123, DOI 10.1093/humrep/der297; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Eilertsen TB, 2012, BJOG-INT J OBSTET GY, V119, P266, DOI 10.1111/j.1471-0528.2011.03206.x; Eilertsen TB, 2012, HUM REPROD, V27, P2494, DOI 10.1093/humrep/des213; Fanchin R, 2005, HUM REPROD, V20, P923, DOI 10.1093/humrep/deh688; Fenton A, 2013, CLIMACTERIC, V16, P1, DOI 10.3109/13697137.2013.756623; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Homburg R, 2014, HUM REPROD, V29, P1117, DOI 10.1093/humrep/deu076; Jeppesen JV, 2013, MOL HUM REPROD, V19, P519, DOI 10.1093/molehr/gat024; Jonard S, 2003, HUM REPROD, V18, P598, DOI 10.1093/humrep/deg115; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; La Marca A, 2004, HUM REPROD, V19, P2738, DOI 10.1093/humrep/deh508; Naver KV, 2014, BJOG-INT J OBSTET GY, V121, P575, DOI 10.1111/1471-0528.12558; PACHE TD, 1992, RADIOLOGY, V183, P421, DOI 10.1148/radiology.183.2.1561343; Pellatt L, 2007, J CLIN ENDOCR METAB, V92, P240, DOI 10.1210/jc.2006-1582; Pigny P, 2003, J CLIN ENDOCR METAB, V88, P5957, DOI 10.1210/jc.2003-030727; Rosenfield RL, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.059; Singh KL, 2007, BRIT J CANCER, V96, P1808, DOI 10.1038/sj.bjc.6603814; Stubbs SA, 2005, J CLIN ENDOCR METAB, V90, P5536, DOI 10.1210/jc.2005-0907; van Disseldorp J, 2010, HUM REPROD, V25, P221, DOI 10.1093/humrep/dep366; vanSantbrink EJP, 1997, FERTIL STERIL, V67, P452, DOI 10.1016/S0015-0282(97)80068-4; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015	30	19	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146739	10.1371/journal.pone.0146739	http://dx.doi.org/10.1371/journal.pone.0146739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799212	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300032
J	Cui, T; Li, WH; Liu, L; Huang, QY; He, ZG				Cui, Tao; Li, Weihui; Liu, Lei; Huang, Qiaoyun; He, Zheng-Guo			Uncovering New Pathogen-Host Protein-Protein Interactions by Pairwise Structure Similarity	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS H37RV; BACTERIAL PATHOGENS; VIRUS; INFECTION; RESOURCE; NETWORKS; PATHWAYS; SURVIVAL; REVEALS; MANIPULATION	Pathogens usually evade and manipulate host-immune pathways through pathogen-host protein-protein interactions (PPIs) to avoid being killed by the host immune system. Therefore, uncovering pathogen-host PPIs is critical for determining the mechanisms underlying pathogen infection and survival. In this study, we developed a computational method, which we named pairwise structure similarity (PSS)-PPI, to predict pathogen-host PPIs. First, a high-quality and non-redundant structure-structure interaction (SSI) template library was constructed by exhaustively exploring heteromeric protein complex structures in the PDB database. New interactions were then predicted by searching for PSS with complex structures in the SSI template library. A quantitative score named the PSS score, which integrated structure similarity and residue-residue contact-coverage information, was used to describe the overall similarity of each predicted interaction with the corresponding SSI template. Notably, PSS-PPI yielded experimentally confirmed pathogen-host PPIs of human immunodeficiency virus type 1 (HIV-1) with performance close to that of in vitro high-throughput screening approaches. Finally, a pathogen-host PPI network of human pathogen Mycobacterium tuberculosis, the causative agent of tuberculosis, was constructed using PSS-PPI and refined using filtration steps based on cellular localization information. Analysis of the resulting network indicated that secreted proteins of the STPK, ESX-1, and PE/PPE family in M. tuberculosis targeted human proteins involved in immune response and phagocytosis. M. tuberculosis also targeted host factors known to regulate HIV replication. Taken together, our findings provide insights into the survival mechanisms of M. tuberculosis in human hosts, as well as co-infection of tuberculosis and HIV. With the rapid pace of three-dimensional protein structure discovery, the SSI template library we constructed and the PSS-PPI method we devised can be used to uncover new pathogen-host PPIs in the future.	[Cui, Tao; Li, Weihui; Liu, Lei; Huang, Qiaoyun; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Microbiol, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	Huang, Qiaoyun/A-8418-2012; He, Zheng-Guo/P-3647-2014	Huang, Qiaoyun/0000-0002-2733-8066; 	National Natural Science Foundation of China [31300079, 81471996, 31421064]; China Postdoctoral Science Foundation [2013M540586]; Chang Jiang Scholars Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	TC is funded by the National Natural Science Foundation of China (31300079) and the China Postdoctoral Science Foundation (2013M540586). ZGH is funded by the National Natural Science Foundation of China (81471996 and 31421064) and the Chang Jiang Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashida H, 2014, NAT REV MICROBIOL, V12, P399, DOI 10.1038/nrmicro3259; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Blasche S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07531; Calderone A, 2015, NUCLEIC ACIDS RES, V43, pD588, DOI 10.1093/nar/gku830; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cui T, 2014, EXPERT REV PROTEOMIC, V11, P745, DOI 10.1586/14789450.2014.971762; Davis ZH, 2015, MOL CELL, V57, P349, DOI 10.1016/j.molcel.2014.11.026; de Chassey B, 2013, EMBO REP, V14, P938, DOI 10.1038/embor.2013.130; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Doolittle JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000954; Dyer MD, 2007, BIOINFORMATICS, V23, pI159, DOI 10.1093/bioinformatics/btm208; Dyer MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012089; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Kumar R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S16; Liu XW, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0393-z; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; Mehra A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003734; Mei SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08034; Memisevic V, 2013, MOL CELL PROTEOMICS, V12, P3036, DOI 10.1074/mcp.M113.029041; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Nourani E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00094; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Rapanoel HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067472; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Robert CH, 1998, J MOL BIOL, V283, P1037, DOI 10.1006/jmbi.1998.2152; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Srinivasan L, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a022459; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Sun J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003499; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang CS, 2009, J IMMUNOL, V182, P3696, DOI 10.4049/jimmunol.0802217; Yang HY, 2011, INFECT IMMUN, V79, P4413, DOI 10.1128/IAI.05622-11; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	57	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147612	10.1371/journal.pone.0147612	http://dx.doi.org/10.1371/journal.pone.0147612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799490	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300131
J	Roberson, S; Dutton, M; Macdonald, M; Odoi, A				Roberson, Shamarial; Dutton, Matthew; Macdonald, Megan; Odoi, Agricola			Does Place of Residence or Time of Year Affect the Risk of Stroke Hospitalization and Death? A Descriptive Spatial and Temporal Epidemiologic Study	PLOS ONE			English	Article							HEART-DISEASE; GEOGRAPHIC DISPARITIES; UNITED-STATES; CARE; MORTALITY; BURDEN; ATTACK	Background Identifying geographic areas with significantly high risks of stroke is important for informing public health prevention and control efforts. The objective of this study was to investigate geographic and temporal patterns of stroke hospitalization and mortality risks so as to identify areas and seasons with significantly high burden of the disease in Florida. The information obtained will be useful for resource allocation for disease prevention and control. Methods Stroke hospitalization and mortality data from 1992 to 2012 were obtained from the Florida Agency for Health Care Administration. Age-adjusted stroke hospitalization and mortality risks for time periods 1992-94, 1995-97, 1998-2000, 2001-03, 2004-06, 2007-09 and 2010-12 were computed at the county spatial scale. Global Moran's I statistics were computed for each of the time periods to test for evidence of global spatial clustering. Local Moran indicators of spatial association (LISA) were also computed to identify local areas with significantly high risks. Results There were approximately 1.5 million stroke hospitalizations and over 196,000 stroke deaths during the study period. Based on global Moran's I tests, there was evidence of significant (p<0.05) global spatial clustering of stroke mortality risks but no evidence (p>0.05) of significant global clustering of stroke hospitalization risks. However, LISA showed evidence of local spatial clusters of both hospitalization and mortality risks with significantly high risks being observed in the north while the south had significantly low risks of stroke deaths. There were decreasing temporal trends and seasonal patterns of both hospitalization and mortality risks with peaks in the winter. Conclusions Although stroke hospitalization and mortality risks have declined in the past two decades, disparities continue to exist across Florida and it is evident from the results of this study that north Florida may, in fact, be part of the stroke belt despite not being in any of the traditional stroke belt states. These findings are useful for guiding public health efforts to reduce/eliminate inequities in stroke outcomes and inform policy decisions. There is need to continually identify populations with significantly high risks of stroke to better guide the targeting of limited resources to the highest risk populations.	[Roberson, Shamarial; Macdonald, Megan] Bur Chron Dis Prevent, Florida Dept Hlth, Tallahassee, FL USA; [Dutton, Matthew] Florida A&M Univ, Tallahassee, FL USA; [Odoi, Agricola] Univ Tennessee, Knoxville, TN USA	Florida Department of Health; State University System of Florida; Florida A&M University; University of Tennessee System; University of Tennessee Knoxville	Odoi, A (corresponding author), Univ Tennessee, Knoxville, TN USA.	aodoi@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737	CDC through NACDD [5U58DP0002759-04]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP002759] Funding Source: NIH RePORTER	CDC through NACDD(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The authors wish to state that CDC, through partnership with NACDD, only funded mentoring support through CDC Cooperative Agreement Number 5U58DP0002759-04 for the study and was not involved in any way in the conception, design, interpretation of study results, writing of the manuscript, or in the decision to submit the manuscript for publication.	Anselin L, 2003, GEO DA VERSION 0 95I; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Busingye D, 2011, SPAT SPATIO-TEMPORAL, V2, P247, DOI 10.1016/j.sste.2011.07.010; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; ESRI, 2010, ARCGIS VERS 10 1; Ferri CP, 2011, J NEUROL NEUROSUR PS, V82, P1074, DOI 10.1136/jnnp.2010.234153; Gillum RF, 1996, AM J EPIDEMIOL, V144, P665, DOI 10.1093/oxfordjournals.aje.a008979; Glymour MM, 2007, STROKE, V38, P2415, DOI 10.1161/STROKEAHA.107.482059; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Halverson J.A., 2002, ETHNIC DIS, V12, P82; Harris T, 2013, TIBETAN TRADE GLOBAL; Howard G, 2009, PREV MED, V49, P129, DOI 10.1016/j.ypmed.2009.03.004; Khan JA, 2011, PREV CHRONIC DIS, V8; Laditka JN, 2014, DISABIL HEALTH J, V7, P472, DOI 10.1016/j.dhjo.2014.06.005; Leira EC, 2008, ARCH NEUROL-CHICAGO, V65, P887, DOI 10.1001/archneur.65.7.887; Liao YL, 2009, STROKE, V40, P3336, DOI 10.1161/STROKEAHA.109.561688; Lichtman JH, 2009, STROKE, V40, P3574, DOI 10.1161/STROKEAHA.109.561472; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Microsoft, 2010, EXCEL; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Odoi A, 2014, SPAT SPATIO-TEMPORAL, V11, P109, DOI 10.1016/j.sste.2014.10.001; Pandian JD, 2013, J STROKE, V15, P128, DOI 10.5853/jos.2013.15.3.128; Pedigo A, 2011, BMC PUBLIC HEALTH, V11, P1471; Pedigo A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-644; Raj K, 2015, J STROKE CEREBROVASC, V24, P10, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.051; Rich DQ, 2007, STROKE, V38, P2221, DOI 10.1161/STROKEAHA.107.483719; Schieb LJ, 2013, STROKE, V44, P146, DOI 10.1161/STROKEAHA.112.669705; SIEGEL PZ, 1992, PUBLIC HEALTH REP, V107, P540; Tassone EC, 2009, EPIDEMIOLOGY, V20, P234, DOI 10.1097/EDE.0b013e3181935aee; The SAS Institute, 2013, SAS VERS 9 4; Towfighi A, 2011, STROKE, V42, P2740, DOI 10.1161/STROKEAHA.110.612648; United States Census Bureau, 2014, CART BOUND SHAP 2014	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145224	10.1371/journal.pone.0145224	http://dx.doi.org/10.1371/journal.pone.0145224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799559	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300004
J	Bruning, O; Rodenburg, W; Wackers, PFK; van Oostrom, C; Jonker, MJ; Dekker, RJ; Rauwerda, H; Ensink, WA; de Vries, A; Breit, TM				Bruning, Oskar; Rodenburg, Wendy; Wackers, Paul F. K.; van Oostrom, Conny; Jonker, Martijs J.; Dekker, Rob J.; Rauwerda, Han; Ensink, Wim A.; de Vries, Annemieke; Breit, Timo M.			Confounding Factors in the Transcriptome Analysis of an In-Vivo Exposure Experiment	PLOS ONE			English	Article							GENE-EXPRESSION; EXPERIMENTAL-DESIGN; DIFFERENTIAL EXPRESSION; STATISTICAL TESTS; MICROARRAY DATA; RNA-SEQ; DECONVOLUTION; INFORMATION; COMPONENTS; EFFICIENT	Confounding factors In transcriptomics experimentation, confounding factors frequently exist alongside the intended experimental factors and can severely influence the outcome of a transcriptome analysis. Confounding factors are regularly discussed in methodological literature, but their actual, practical impact on the outcome and interpretation of transcriptomics experiments is, to our knowledge, not documented. For instance, in-vivo experimental factors; like Individual, Sample-Composition and Time-of-Day are potentially formidable confounding factors. To study these confounding factors, we designed an extensive in-vivo transcriptome experiment (n = 264) with UVR exposure of murine skin containing six consecutive samples from each individual mouse (n = 64). Analysis Approach Evaluation of the confounding factors: Sample-Composition, Time-of-Day, Handling-Stress, and Individual-Mouse resulted in the identification of many genes that were affected by them. These genes sometimes showed over 30-fold expression differences. The most prominent confounding factor was Sample-Composition caused by mouse-dependent skin composition differences, sampling variation and/or influx/efflux of mobile cells. Although we can only evaluate these effects for known cell type specifically expressed genes in our complex heterogeneous samples, it is clear that the observed variations also affect the cumulative expression levels of many other non-cell-type-specific genes. ANOVA ANOVA analysis can only attempt to neutralize the effects of the well-defined confounding factors, such as Individual-Mouse, on the experimental factors UV-Dose and Recovery-Time. Also, by definition, ANOVA only yields reproducible gene-expression differences, but we found that these differences were very small compared to the fold changes induced by the confounding factors, questioning the biological relevance of these ANOVA-detected differences. Furthermore, it turned out that many of the differentially expressed genes found by ANOVA were also present in the gene clusters associated with the confounding factors. Conclusion Hence our overall conclusion is that confounding factors have a major impact on the outcome of in-vivo transcriptomics experiments. Thus the set-up, analysis, and interpretation of such experiments should be approached with the utmost prudence.	[Bruning, Oskar; Wackers, Paul F. K.; Jonker, Martijs J.; Dekker, Rob J.; Rauwerda, Han; Ensink, Wim A.; Breit, Timo M.] Univ Amsterdam, Fac Sci, RNA Biol & Appl Bioinformat Res Grp, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Rodenburg, Wendy; van Oostrom, Conny; de Vries, Annemieke] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect GZB, Bilthoven, Netherlands	University of Amsterdam; Netherlands National Institute for Public Health & the Environment	Breit, TM (corresponding author), Univ Amsterdam, Fac Sci, RNA Biol & Appl Bioinformat Res Grp, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	t.m.breit@uva.nl		Wackers, Paul/0000-0002-6598-4173; Rauwerda, Han/0000-0003-4360-0797	National Institute of Environmental Health Sciences NIEHS 72-SNP grant [1R01 ES015587-01A2]; University of Amsterdam; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015587] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences NIEHS 72-SNP grant; University of Amsterdam; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partly supported by the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) NIEHS 72-SNP grant 1R01 ES015587-01A2 received by AdV. All additional funding was provided by the University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Altman RB, 2001, CURR OPIN STRUC BIOL, V11, P340, DOI 10.1016/S0959-440X(00)00212-8; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Bruning O, 2010, TRANSCR-AUSTIN, V1, P159, DOI 10.4161/trns.1.3.13487; Bruning O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097089; Bruning Oskar, 2011, BMC Res Notes, V4, P438, DOI 10.1186/1756-0500-4-438; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; de Ridder D, 2005, LEUKEMIA, V19, P618, DOI 10.1038/sj.leu.2403685; Flaherty P, 2005, ADV NEURAL INF PROCE; Hu W, 2013, J LEUKOCYTE BIOL, V94, P409, DOI 10.1189/jlb.0413207; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118; Kagawa Shinichiro, 2009, Legal Medicine, V11, P70, DOI 10.1016/j.legalmed.2008.09.004; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kerr MK, 2007, GENET RES, V89, P509, DOI 10.1017/S0016672308009713; Kerr MK, 2003, BIOMETRICS, V59, P822; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Montagna W., 1974, STRUCTURE FUNCTION S, V3rd, P28; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Pan W, 2002, GENOME BIOL, V3; Pavlidis P, 2003, BIOINFORMATICS, V19, P1620, DOI 10.1093/bioinformatics/btg227; Quackenbush J, 2006, ANIM GENET, V37, P48, DOI 10.1111/j.1365-2052.2006.01476.x; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Quackenbush J, 2007, J EXP BIOL, V210, P1507, DOI 10.1242/jeb.004432; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Rosenfeld S, 2010, GENE REGUL SYST BIO, V4, P61, DOI 10.4137/GRSB.S4657; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Tay SS, 2014, CURR DERMATOL REP, V3, P13, DOI 10.1007/s13671-013-0063-9; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yang MCK, 2003, PHYSIOL GENOMICS, V16, P24, DOI 10.1152/physiolgenomics.00037.2003; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Zhao YD, 2010, GENOME MED, V2, DOI 10.1186/gm214; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646; Zien A, 2003, J COMPUT BIOL, V10, P653, DOI 10.1089/10665270360688246	45	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145252	10.1371/journal.pone.0145252	http://dx.doi.org/10.1371/journal.pone.0145252			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789003	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100007
J	Riley, C; Dellicour, S; Ouma, P; Kioko, U; ter Kuile, FO; Omar, A; Kariuki, S; Buff, AM; Desai, M; Gutman, J				Riley, Christina; Dellicour, Stephanie; Ouma, Peter; Kioko, Urbanus; ter Kuile, Feiko O.; Omar, Ahmeddin; Kariuki, Simon; Buff, Ann M.; Desai, Meghna; Gutman, Julie			Knowledge and Adherence to the National Guidelines for Malaria Case Management in Pregnancy among Healthcare Providers and Drug Outlet Dispensers in Rural, Western Kenya	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CLUSTER RANDOMIZED-TRIAL; TEXT-MESSAGE REMINDERS; ANTIMALARIAL-DRUGS; WOMEN; SURVEILLANCE; UGANDA; LUMEFANTRINE; PREVALENCE; ARTEMETHER	Background Although prompt, effective treatment is a cornerstone of malaria control, information on provider adherence to malaria in pregnancy (MIP) treatment guidelines is limited. Incorrect or sub-optimal treatment can adversely affect the mother and fetus. This study assessed provider knowledge of and adherence to national case management guidelines for uncomplicated MIP. Methods We conducted a cross-sectional study from September to November 2013, in 51 health facilities (HF) and a randomly-selected sample of 39 drug outlets (DO) in the KEMRI/CDC Health and Demographic Surveillance System area in western Kenya. Provider knowledge of national treatment guidelines was assessed with standardized questionnaires. Correct practice required adequate diagnosis, pregnancy assessment, and treatment with correct drug and dosage. In HF, we conducted exit interviews in all women of childbearing age assessed for fever. In DO, simulated clients posing as first trimester pregnant women or as relatives of third trimester pregnant women collected standardized information. Results Correct MIP case management knowledge and practice were observed in 45% and 31% of HF and 0% and 3% of DO encounters, respectively. The correct drug and dosage for pregnancy trimester was prescribed in 62% of HF and 42% of DO encounters; correct prescription occurred less often in first than in second/third trimesters (HF: 24% vs. 65%, p<0.01; DO: 0% vs. 40%, p<0.01). Sulfadoxine-pyrimethamine, which is not recommended for malaria treatment, was prescribed in 3% of HF and 18% of DO encounters. Exposure to artemether-lumefantrine in first trimester, which is contraindicated, occurred in 29% and 49% of HF and DO encounters, respectively. Conclusion This study highlights knowledge inadequacies and incorrect prescribing practices in the treatment of MIP. Particularly concerning is the prescription of contraindicated medications in the first trimester. These issues should be addressed through comprehensive trainings and increased supportive supervision. Additional innovative means to improve care should be explored.	[Riley, Christina] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Dellicour, Stephanie; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Ouma, Peter; Kariuki, Simon] Ctr Global Hlth Res, KEMRI, Kisumu, Kenya; [Kioko, Urbanus; Omar, Ahmeddin] Minist Hlth, Malaria Control Unit, Nairobi, Kenya; [Buff, Ann M.; Desai, Meghna; Gutman, Julie] US Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Buff, Ann M.] US Presidents Malaria Initiat, Nairobi, Kenya; [Desai, Meghna] Ctr Dis Control & Prevent, Kisumu, Kenya	Emory University; Rollins School Public Health; Liverpool School of Tropical Medicine; University of Liverpool; Centers for Disease Control & Prevention - USA	Riley, C (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.; Gutman, J (corresponding author), US Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA.	riley.christinam@gmail.com; jgutman@cdc.gov	Kariuki, Simon/AFT-6596-2022; Kuile, Feiko ter/ABD-6681-2020	Kuile, Feiko ter/0000-0003-3663-5617	United States President's Malaria Initiative; U.S. Agency for International Development; U.S. Centers for Disease Control and Prevention (CDC)	United States President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); U.S. Agency for International Development(United States Agency for International Development (USAID)); U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication was made possible through support provided by the United States President's Malaria Initiative, U.S. Agency for International Development and U.S. Centers for Disease Control and Prevention (CDC), under the terms of an Interagency Agreement with CDC and through a Cooperative Agreement between the CDC and the Kenya Medical Research Institute (KEMRI). The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all of the data in the study and had final responsibility for the decision to submit for publication.	[Anonymous], 2007, ASS SAF ART COMP PRE; AVIV RI, 1993, S AFR MED J, V83, P657; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Brantuo MNA, 2014, TROP MED INT HEALTH, V19, P417, DOI 10.1111/tmi.12270; Bruxvoort K, 2014, AM J TROP MED HYG, V91, P844, DOI 10.4269/ajtmh.14-0126; Cheruiyot J, 2014, ANTIMICROB AGENTS CH, V58, P3737, DOI 10.1128/AAC.02472-14; Dellicour S, 2015, TREATMENT PRAC UNPUB; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2015, CLIN INFECT DIS; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; DOMC, 2010, DIV MAL CONTR NAT GU; Fall B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-310; Hanson C, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-41; Hill J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001688; HUNTINGTON D, 1993, STUD FAMILY PLANN, V24, P187, DOI 10.2307/2939233; Iriemenam NC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-134; Kamuhabwa A, 2011, INDIAN J PHARMACOL, V43, P345, DOI 10.4103/0253-7613.81503; Kebede B, 2009, PHARMACOEPIDEM DR S, V18, P462, DOI 10.1002/pds.1732; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2011, KEN DEM HLTH SURV 20; Kioko U, 2015, AVAILABILITY C UNPUB; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; McCollum AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-77; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Ouma P, 2007, TROP MED INT HEALTH, V12, P1515, DOI 10.1111/j.1365-3156.2007.01960.x; Perlman SE, 2001, J REPROD MED, V46, P163; Perrault SD, 2009, AM J TROP MED HYG, V80, P119, DOI 10.4269/ajtmh.2009.80.119; Pettinelli FO, 2004, AM J TROP MED HYG, V70, P635, DOI 10.4269/ajtmh.2004.70.635; Riley C, 2015, HLTH FACILITY UNPUB; Rohra DK, 2008, BMC PREGNANCY CHILDB, V8, P24, DOI DOI 10.1186/1471-2393-8-24; Sangare LR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-152; Tarning J, 2013, ANTIMICROB AGENTS CH, V57, P5096, DOI 10.1128/AAC.00683-13; Ward SA, 2007, LANCET INFECT DIS, V7, P136, DOI 10.1016/S1473-3099(07)70025-7; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization (WHO), 2003, ASS SAF ART COMP PRE; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x; Zurovac D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092782; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	39	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145616	10.1371/journal.pone.0145616	http://dx.doi.org/10.1371/journal.pone.0145616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789638	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000368529100012
J	Sun, JT; Yang, MX; Ban, YL; Gao, WJ; Song, BF; Wang, Y; Zhang, Y; Shao, QQ; Kong, BH; Qu, X				Sun, Jintang; Yang, Meixiang; Ban, Yanli; Gao, Wenjuan; Song, Bingfeng; Wang, Yang; Zhang, Yun; Shao, Qianqian; Kong, Beihua; Qu, Xun			Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway	PLOS ONE			English	Article							PERIPHERAL-BLOOD; PHENOTYPE; CONVERSION; GAMMA	NK cells accumulate at the maternal-fetal interface (MFI) and play essential roles in maintaining immune tolerance during pregnancy. The mechanisms that facilitate NK cells tolerance to fetal tissue are largely unknown. T cell Ig and mucin domain-containing protein 3 (Tim-3) is a newly defined molecule with essential immunological function in many physiological and pathological processes. Recent study showed that Tim-3 was involved in the regulation of immune tolerance at MFI. However, whether Tim-3 regulates NK cells cytotoxicity toward trophoblasts is unclear. Here, we showed Tim-3 was mainly expressed by decidual NK cells (dNK) and Tim-3 level in dNK was higher than peripheral NK cells (pNK). Tim-3(+) dNK expressed more levels of mature markers CD94 and CD69 than Tim-3(-) dNK cells and blocking Tim-3 significantly inhibited dNK IFN-gamma and TNF-alpha secretion. Furthermore, we found TGF-beta 1 may contribute to such up-regulation of Tim-3 in NK cells. Interestingly, blocking Tim-3 enhanced NK cytotoxicity toward trophoblast cell line HTR-8 but not K562. We found HTR-8 expressed Tim-3 ligand Galectin-9, in contrast K562 did not. Small interfering RNA-mediated silencing of Galectin-9 expression enhanced NK cytotoxicity toward HTR-8. We further showed Tim-3/Galecin-9 inhibited NK cytotoxicity toward trophoblast partially via impairing the degranulation process. In addition, clinical data showed that abnormal Tim-3 level on pNK might be associated with recurrent spontaneous abortion (RSA). Thus, our data demonstrate Tim-3/Galectin-9 pathway maintains local tolerance by suppressing NK cytotoxicity toward trophoblasts which may represent a new immunologic tolerance mechanism at MFI.	[Sun, Jintang; Yang, Meixiang; Gao, Wenjuan; Song, Bingfeng; Wang, Yang; Zhang, Yun; Shao, Qianqian; Qu, Xun] Shandong Univ, Inst Basic Med Sci, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Ban, Yanli; Kong, Beihua] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Qu, X (corresponding author), Shandong Univ, Inst Basic Med Sci, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	quxun@sdu.edu.cn		Ban, Yanli/0000-0002-2299-0362	National Natural Science Foundation of China [31470885, 31300752, 31270971, 81300510, 30901326, 81072406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China: No. 31470885 (XQ), No. 31300752 (JS), No. 31270971 (XQ), No. 81300510 (QS), No. 30901326 (MY), No. 81072406 (XQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbadiaMolina AC, 1996, J REPROD IMMUNOL, V31, P109, DOI 10.1016/0165-0378(96)00965-5; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Cerdeira AS, 2013, J IMMUNOL, V190, P3939, DOI 10.4049/jimmunol.1202582; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; da Silva IP, 2014, CANCER IMMUNOL RES, V2, P410, DOI 10.1158/2326-6066.CIR-13-0171; Eriksson M, 2004, J LEUKOCYTE BIOL, V76, P667, DOI 10.1189/jlb.0204090; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Fu B, P NATL ACAD SCI US; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hou HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110585; Hunt JS, 2006, IMMUNOL REV, V213, P36, DOI 10.1111/j.1600-065X.2006.00436.x; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; KING A, 1990, CELL IMMUNOL, V129, P435, DOI 10.1016/0008-8749(90)90219-H; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kopcow HD, 2005, P NATL ACAD SCI USA, V102, P15563, DOI 10.1073/pnas.0507835102; Lachapelle MH, 1996, J IMMUNOL, V156, P4027; Li YH, CELLULAR MOL IMMUNOL; Male V, 2010, J IMMUNOL, V185, P3913, DOI 10.4049/jimmunol.1001637; Miko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071811; Mold JE, 2012, ADV IMMUNOL, V115, P73, DOI 10.1016/B978-0-12-394299-9.00003-5; Murphy SP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.043; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Santoni A, 2007, AM J REPROD IMMUNOL, V58, P280, DOI 10.1111/j.1600-0897.2007.00513.x; Wu XY, 2006, CELL MOL IMMUNOL, V3, P131; Zhao J, 2009, J IMMUNOL, V182, P6618, DOI 10.4049/jimmunol.0803876; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	31	49	55	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147186	10.1371/journal.pone.0147186	http://dx.doi.org/10.1371/journal.pone.0147186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789128	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100064
J	Wagener, BM; Marjon, NA; Prossnitz, ER				Wagener, Brant M.; Marjon, Nicole A.; Prossnitz, Eric R.			Regulation of N-Formyl Peptide Receptor Signaling and Trafficking by Arrestin-Src Kinase Interaction	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ADRENERGIC-RECEPTOR; ANGIOTENSIN-II RECEPTOR; CLATHRIN ADAPTER AP-2; CARBOXYL-TERMINUS; AGONIST AFFINITY; PHOSPHORYLATION; INTERNALIZATION; DESENSITIZATION; ACTIVATION	Arrestins were originally described as proteins recruited to ligand-activated, phosphorylated G protein-coupled receptors (GPCRs) to attenuate G protein-mediated signaling. It was later revealed that arrestins also mediate GPCR internalization and recruit a number of signaling proteins including, but not limited to, Src family kinases, ERK1/2, and JNK3. GPCR-arrestin binding and trafficking control the spatial and temporal activity of these multi-protein complexes. In previous reports, we concluded that N-formyl peptide receptor (FPR)-mediated apoptosis, which occurs upon receptor stimulation in the absence of arrestins, is associated with FPR accumulation in perinuclear recycling endosomes. Under these conditions, inhibition of Src kinase and ERK1/2 prevented FPR-mediated apoptosis. To better understand the role of Src kinase in this process, in the current study we employed a previously described arrestin-2 (arr2) mutant deficient in Src kinase binding (arr2-P91G/P121E). Unlike wild type arrestin, arr2-P91G/P121E did not inhibit FPR-mediated apoptosis, suggesting that Src binding to arrestin-2 prevents apoptotic signaling. However, in cells expressing this mutant, FPR-mediated apoptosis was still blocked by inhibition of Src kinase activity, suggesting that activation of Src independent of arrestin-2 binding is involved in FPR-mediated apoptosis. Finally, while Src kinase inhibition prevented FPR-mediated-apoptosis in the presence of arr2-P91G/P121E, it did not prevent FPR-arr2-P91G/P121E accumulation in the perinuclear recycling endosome. On the contrary, inhibition of Src kinase activity mediated the accumulation of activated FPR-wild type arrestin-2 in recycling endosomes without initiating FPR-mediated apoptosis. Based on these observations, we conclude that Src kinase has two independent roles following FPR activation that regulate both FPR-arrestin-2 signaling and trafficking.	[Prossnitz, Eric R.] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, UNM Comprehens Canc Ctr, Albuquerque, NM 87131 USA; [Wagener, Brant M.] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Alabama System; University of Alabama Birmingham	Prossnitz, ER (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA.	eprossnitz@salud.unm.edu	Prossnitz, Eric/I-4599-2019; Prossnitz, Eric R./B-4543-2008; Wagener, Brant/AAI-7480-2020	Prossnitz, Eric/0000-0001-9190-8302; 	NIH [GM68901, CA163890]; Department of Defense Breast Cancer Research Program [BC030217]; Foundation for Anesthesia Education and Research; University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL CANCER INSTITUTE [R01CA163890, P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); Foundation for Anesthesia Education and Research; University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grants GM68901 and CA163890 to E.R.P. and BC030217 from the Department of Defense Breast Cancer Research Program and a Research Fellowship Grant from the Foundation for Anesthesia Education and Research to B.M.W. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.; We thank Charlotte Vines for helpful comments during the preparation of this manuscript. Flow cytometry data were generated in the Flow Cytometry Shared Resource Center supported by the University of New Mexico Health Sciences Center and the University of New Mexico Cancer Center. Images in this paper were generated in the University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource, funded as detailed on: http://hsc.unm.edu/crtc/microscopy/Facility.html.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bennett TA, 2001, J BIOL CHEM, V276, P22453, DOI 10.1074/jbc.M009679200; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Dores MR, 2012, MOL BIOL CELL, V23, P3612, DOI 10.1091/mbc.E12-03-0251; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hsu MH, 1997, J BIOL CHEM, V272, P29426, DOI 10.1074/jbc.272.47.29426; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Key TA, 2005, TRAFFIC, V6, P87, DOI 10.1111/j.1600-0854.2004.00248.x; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Key TA, 2001, J BIOL CHEM, V276, P49204, DOI 10.1074/jbc.M109475200; Khoury E, 2014, J BIOL CHEM, V289, P23302, DOI 10.1074/jbc.M114.568147; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kim YM, 2002, J BIOL CHEM, V277, P30760, DOI 10.1074/jbc.M204528200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luttrell DK, 2003, ASSAY DRUG DEV TECHN, V1, P327, DOI 10.1089/15406580360545143; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Luttrell LM, 2013, PROG MOL BIOL TRANSL, V118, P115, DOI 10.1016/B978-0-12-394440-5.00005-X; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Maaty WS, 2013, J BIOL CHEM, V288, P27042, DOI 10.1074/jbc.M113.484113; Maestes DC, 1999, J BIOL CHEM, V274, P29791, DOI 10.1074/jbc.274.42.29791; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Moaven H, 2013, P NATL ACAD SCI USA, V110, P9463, DOI 10.1073/pnas.1301126110; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Potter RM, 2002, J BIOL CHEM, V277, P8970, DOI 10.1074/jbc.M111086200; Potter RM, 2006, J IMMUNOL, V176, P5418, DOI 10.4049/jimmunol.176.9.5418; Prossnitz ER, 1997, J BIOL CHEM, V272, P15213, DOI 10.1074/jbc.272.24.15213; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Strungs Erik G, 2014, Handb Exp Pharmacol, V219, P225, DOI 10.1007/978-3-642-41199-1_12; Tian Xufan, 2014, Handb Exp Pharmacol, V219, P173, DOI 10.1007/978-3-642-41199-1_9; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Wagener BM, 2009, TRAFFIC, V10, P1286, DOI 10.1111/j.1600-0854.2009.00957.x; Walther C, 2013, PROG MOL BIOL TRANSL, V118, P93, DOI 10.1016/B978-0-12-394440-5.00004-8; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Wu XF, 2003, MOL BIOL CELL, V14, P516, DOI 10.1091/mbc.E02-06-0353; Yang XH, 2012, APOPTOSIS, V17, P1019, DOI 10.1007/s10495-012-0741-2; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhan X., 2015, CURR PROTOC PHARM, V68; Zhan Xuanzhi, 2014, Handb Exp Pharmacol, V219, P259, DOI 10.1007/978-3-642-41199-1_13; Zindel D, 2015, MOL PHARMACOL, V87, P349, DOI 10.1124/mol.114.095422	60	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147442	10.1371/journal.pone.0147442	http://dx.doi.org/10.1371/journal.pone.0147442			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788723	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100088
J	Abu-Farha, M; Sriraman, D; Cherian, P; AlKhairi, I; Elkum, N; Behbehani, K; Abubaker, J				Abu-Farha, Mohamed; Sriraman, Devarajan; Cherian, Preethi; AlKhairi, Irina; Elkum, Naser; Behbehani, Kazem; Abubaker, Jehad			Circulating ANGPTL8/Betatrophin Is Increased in Obesity and Reduced after Exercise Training	PLOS ONE			English	Article							ANGIOPOIETIN-LIKE PROTEIN; TYPE-2 DIABETES-MELLITUS; BETA-CELL; BETATROPHIN CONCENTRATIONS; GLUCOSE; LIPASIN; LIFE; PREVENTION; METABOLISM; GENE	Objective ANGPTL8 is a liver and adipose tissue produced protein that regulates the level of triglyceride in plasma as well as glucose homeostasis. This study was designed to evaluate the level of ANGPTL8 in obese and non-obese subjects before and after exercise training. Methods A total of 82 non-obese and 62 adult obese were enrolled in this study. Subjects underwent a three months of exercise training. Both full length and C-terminal 139-198 form of ANGPTL8 were measured by ELISA. Results Our data show that the full length ANGPTL8 level was increased in obese subjects (1150.04 +/- 108.10 pg/mL) compared to non-obese (775.54 +/- 46.12) pg/mL (p-Value = 0.002). C-terminal 139-198 form of ANGPTL8 was also increased in obese subjects 0.28 +/- 0.04 ng/mL vs 0.20 +/- 0.02 ng/mL in non-obese (p-value = 0.058). In obese subjects, the levels of both forms were reduced after three months of exercise training; full length was reduced from 1150.04 +/- 108.10 pg/mL to 852.04 +/- 51.95 pg/mL (p-Values 0.015) and c-terminal form was reduced from 0.28 +/- 0.04 ng/mL to 0.19 +/- 0.03 ng/mL (p-Value = 0.058). Interestingly, full length ANGPTL8 was positively associated with fasting blood glucose (FBG) in non-obese (r = 0.317, p-Value = 0.006) and obese subjects (r = 0.346, p-Value = 0.006) C-terminal 139-198 form of ANGPTL8 on the other hand, did not show any correlation in both groups. Conclusion In conclusion, our data demonstrate that ANGPTL8 was increased in obesity and reduced after exercise training supporting the potential therapeutic benefit of reducing ANGPTL8. The various forms of ANGPTL8 associated differently with FBG suggesting that they have different roles in glucose homeostasis.	[Abu-Farha, Mohamed; Cherian, Preethi; AlKhairi, Irina; Behbehani, Kazem; Abubaker, Jehad] Dasman Diabet Inst, Biochem & Mol Biol Unit, Kuwait, Kuwait; [Sriraman, Devarajan; Behbehani, Kazem] Dasman Diabet Inst, Tissue Banking Unit, Kuwait, Kuwait; [Elkum, Naser] Sidra Med & Res Ctr, Doha, Qatar	Sidra Medical & Research Center	Abu-Farha, M; Abubaker, J (corresponding author), Dasman Diabet Inst, Biochem & Mol Biol Unit, Kuwait, Kuwait.	mohamed.abufarha@dasmaninstitute.org; jehad.abubakr@dasmaninstitute.org	Elkum, Naser/AAU-5555-2020	Elkum, Naser/0000-0002-0457-0444; Abubaker, Jehad/0000-0003-0681-7305; Abu-Farha, Mohamed/0000-0001-8357-1252	Kuwait Foundation for the Advancement of Sciences (KFAS) [RA-2014-021]	Kuwait Foundation for the Advancement of Sciences (KFAS)(Kuwait Foundation for the Advancement of Sciences (KFAS))	The authors are indebted to Kuwait Foundation for the Advancement of Sciences (KFAS) for financial support of this research project (RA-2014-021). The funding agency was not involved in data collection, analysis, or interpretation; trial design; patient recruitment; or any aspect pertinent to the study.	Abu-Farha M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10949; Abu-Farha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075342; Abubaker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069217; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Chen JX, 2015, DIABETOLOGIA, V58, P1036, DOI 10.1007/s00125-015-3521-z; Chen X, 2015, J CLIN ENDOCR METAB, V100, pE96, DOI 10.1210/jc.2014-2300; Espes D., 2013, DIABETOLOGIA; Espes D, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/323407; Fodor JG, 2001, NEW ENGL J MED, V345, P696; Fu Zhiyao, 2014, Diabetologia, V57, P2232, DOI 10.1007/s00125-014-3346-1; Fu ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05013; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Guo KF, 2015, OBESITY, V23, P793, DOI 10.1002/oby.21038; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kugelberg Elisabeth, 2013, Nat Rev Endocrinol, V9, P379, DOI 10.1038/nrendo.2013.98; Lickert H, 2013, CELL METAB, V18, P5, DOI 10.1016/j.cmet.2013.06.006; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Yamada H, 2015, ENDOCR J; Yi P, 2014, CELL, V159, P467, DOI 10.1016/j.cell.2014.09.028; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0133-8; Zhang R, 2013, BIOCHEM BIOPH RES CO, V432, P401, DOI 10.1016/j.bbrc.2013.01.129; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038; Zheng C., 2015, TRENDS ENDOCRINOL ME	34	54	60	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147367	10.1371/journal.pone.0147367	http://dx.doi.org/10.1371/journal.pone.0147367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784326	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400143
J	Matsuyama, M; Ishii, Y; Sakurai, H; Ano, S; Morishima, Y; Yoh, K; Takahashi, S; Ogawa, K; Hizawa, N				Matsuyama, Masashi; Ishii, Yukio; Sakurai, Hirofumi; Ano, Satoshi; Morishima, Yuko; Yoh, Keigyou; Takahashi, Satoru; Ogawa, Kenji; Hizawa, Nobuyuki			Overexpression of ROR gamma t Enhances Pulmonary Inflammation after Infection with Mycobacterium Avium	PLOS ONE			English	Article							HUMAN TH17 CELLS; IFN-GAMMA; INTRACELLULARE INFECTION; BCG VACCINATION; T(H)17 CELLS; TUBERCULOSIS; IL-17; DISEASE; MICE; INTERLEUKIN-17	Mycobacterium avium complex (MAC) is the most common cause of nontuberculous mycobacterial disease in humans. The role of Th17 immunity in the pathogenesis of intracellular bacteria, such as MAC, is not currently understood. Transcription factor RAR-related orphan receptor gamma t (ROR gamma t) is known as the master regulator for Th17 cell development. Here, we investigated the role of ROR gamma t in host responses against MAC infection. Wild-type (WT) mice and ROR gamma t-overexpressing mice were infected with MAC via intratracheal inoculation. Systemic MAC growth was not different between WT mice and ROR gamma t-overexpressing mice. However, neutrophilic pulmonary inflammation following MAC infection was enhanced in ROR gamma t-overexpressing mice compared with that in WT mice. The cytokine expression shifted toward a Th17 phenotype in the lungs of ROR gamma t-overexpressing mice following MAC infection; the levels of IL-6 and IL-17 were significantly higher in the lung of these mice than in WT mice. In addition to the increase in IL-17 single-positive T cells, T cells producing both IL-17 and interferon-. were elevated in the lung of ROR gamma t-overexpressing mice following MAC infection. These findings suggest that ROR gamma t overexpression-mediated Th17 bias contributes to local inflammation rather than systemic responses, by regulating neutrophil recruitment into the sites of infection during MAC infection.	[Matsuyama, Masashi; Ishii, Yukio; Sakurai, Hirofumi; Ano, Satoshi; Morishima, Yuko; Hizawa, Nobuyuki] Univ Tsukuba, Dept Resp Med, Div Clin Med, Tsukuba, Ibaraki, Japan; [Yoh, Keigyou] Univ Tsukuba, Dept Nephrol, Div Clin Med, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Life Sci Ctr, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki, Japan; [Ogawa, Kenji] Higashinagoya Natl Hosp, Natl Hosp Org, Dept Clin Res, Nagoya, Aichi, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba	Ishii, Y (corresponding author), Univ Tsukuba, Dept Resp Med, Div Clin Med, Tsukuba, Ibaraki, Japan.	ishii-y@md.tsukuba.ac.jp			Japan Society for the Promotion of Science [24591152]; Grants-in-Aid for Scientific Research [16K15454] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grants-in-Aid for Scientific Research (C) (KAKENHI) Grant Number 24591152, Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) to YI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Ano S, 2013, J IMMUNOL, V190, P1056, DOI 10.4049/jimmunol.1202386; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gopal R, 2012, EUR J IMMUNOL, V42, P364, DOI 10.1002/eji.201141569; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jung YJ, 2002, INFECT IMMUN, V70, P6436, DOI 10.1128/IAI.70.11.6436-6443.2002; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Linden A, 2001, INT ARCH ALLERGY IMM, V126, P179, DOI 10.1159/000049511; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Matsuyama M, 2014, J IMMUNOL, V192, P1707, DOI 10.4049/jimmunol.1302258; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; North RJ, 1998, CLIN EXP IMMUNOL, V113, P55, DOI 10.1046/j.1365-2249.1998.00636.x; Plotinsky RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077385; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Rook GAW, 2007, CURR MOL MED, V7, P327; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Trinchieri G, 1997, CURR OPIN IMMUNOL, V9, P17, DOI 10.1016/S0952-7915(97)80154-9; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wang YH, 2008, CURR OPIN IMMUNOL, V20, P697, DOI 10.1016/j.coi.2008.09.004; Yamazaki Y, 1999, AM J RESP CRIT CARE, V160, P1851, DOI 10.1164/ajrccm.160.6.9902019; Yamazaki Y, 1998, EUR RESPIR J, V11, P1227, DOI 10.1183/09031936.98.11061227; Yoh K, 2012, EUR J IMMUNOL, V42, P1999, DOI 10.1002/eji.201142250; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147064	10.1371/journal.pone.0147064	http://dx.doi.org/10.1371/journal.pone.0147064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784959	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400103
J	Nelson, MI; Pollett, S; Ghersi, B; Silva, M; Simons, MP; Icochea, E; Gonzalez, AE; Segovia, K; Kasper, MR; Montgomery, JM; Bausch, DG				Nelson, Martha I.; Pollett, Simon; Ghersi, Bruno; Silva, Maria; Simons, Mark P.; Icochea, Eliana; Gonzalez, Armando E.; Segovia, Karen; Kasper, Matthew R.; Montgomery, Joel M.; Bausch, Daniel G.			The Genetic Diversity of Influenza A Viruses in Wild Birds in Peru	PLOS ONE			English	Article							AVIAN INFLUENZA; ARGENTINA; AMERICA	Our understanding of the global ecology of avian influenza A viruses (AIVs) is impeded by historically low levels of viral surveillance in Latin America. Through sampling and whole-genome sequencing of 31 AIVs from wild birds in Peru, we identified 10 HA subtypes (H1H4, H6-H7, H10-H13) and 8 NA subtypes (N1-N3, N5-N9). The majority of Peruvian AIVs were closely related to AIVs found in North America. However, unusual reassortants, including a H13 virus containing a PA segment related to extremely divergent Argentinian viruses, suggest that substantial AIV diversity circulates undetected throughout South America.	[Nelson, Martha I.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Pollett, Simon; Ghersi, Bruno; Silva, Maria; Simons, Mark P.; Segovia, Karen; Kasper, Matthew R.; Montgomery, Joel M.; Bausch, Daniel G.] US Naval Med Res Unit 6, Virol & Emerging Infect Dept, Callao, Peru; [Pollett, Simon] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Pollett, Simon] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Icochea, Eliana; Gonzalez, Armando E.] Univ Nacl Mayor San Marcos, Sch Vet Med, Lima, Peru; [Bausch, Daniel G.] Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); University of Sydney; University of California System; University of California San Francisco; Universidad Nacional Mayor de San Marcos; Tulane University	Pollett, S (corresponding author), US Naval Med Res Unit 6, Virol & Emerging Infect Dept, Callao, Peru.; Pollett, S (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.; Pollett, S (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	spollett@med.usyd.edu.au		Icochea D'Arrigo, Maria Eliana/0000-0001-7102-0584; Ghersi, Bruno/0000-0002-1577-6042; Gonzalez, Armando/0000-0003-1909-1873	Global Emerging Infections Surveillance (GEIS) Work unit [847705 82000 25GB B0016]	Global Emerging Infections Surveillance (GEIS) Work unit	This work was supported by Global Emerging Infections Surveillance (GEIS) Work unit no.: 847705 82000 25GB B0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003570; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ghersi BM, 2011, J WILDLIFE DIS, V47, P792, DOI 10.7589/0090-3558-47.3.792; Ghersi BM, 2009, EMERG INFECT DIS, V15, P935, DOI 10.3201/eid1506.080981; Gonzalez-Reiche AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032873, 10.1371/journal.pone.0046852]; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Huang YY, 2014, VIROLOGY, V456, P353, DOI 10.1016/j.virol.2014.04.009; Jhung MA, 2015, MMWR-MORBID MORTAL W, V64, P111; Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; Lewis NS, 2015, J GEN VIROL, V96, P2050, DOI 10.1099/vir.0.000155; Mathieu C, 2015, VIRUS RES, V199, P42, DOI 10.1016/j.virusres.2015.01.008; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Rimondi A, 2011, J VIROL, V85, P13354, DOI 10.1128/JVI.05946-11; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664	18	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146059	10.1371/journal.pone.0146059	http://dx.doi.org/10.1371/journal.pone.0146059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784331	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400022
J	Ayatollahitafti, V; Ngadi, MA; Sharif, JB; Abdullahi, M				Ayatollahitafti, Vahid; Ngadi, Md Asri; Sharif, Johan bin Mohamad; Abdullahi, Mohammed			An Efficient Next Hop Selection Algorithm for Multi-Hop Body Area Networks	PLOS ONE			English	Article							AWARE ROUTING PROTOCOL; WIRELESS SENSOR	Body Area Networks (BANs) consist of various sensors which gather patient's vital signs and deliver them to doctors. One of the most significant challenges faced, is the design of an energy-efficient next hop selection algorithm to satisfy Quality of Service (QoS) requirements for different healthcare applications. In this paper, a novel efficient next hop selection algorithm is proposed in multi-hop BANs. This algorithm uses the minimum hop count and a link cost function jointly in each node to choose the best next hop node. The link cost function includes the residual energy, free buffer size, and the link reliability of the neighboring nodes, which is used to balance the energy consumption and to satisfy QoS requirements in terms of end to end delay and reliability. Extensive simulation experiments were performed to evaluate the efficiency of the proposed algorithm using the NS-2 simulator. Simulation results show that our proposed algorithm provides significant improvement in terms of energy consumption, number of packets forwarded, end to end delay and packet delivery ratio compared to the existing routing protocol.	[Ayatollahitafti, Vahid] Islamic Azad Univ, Taft Branch, Dept Comp Sci, Taft, Yazd, Iran; [Ngadi, Md Asri; Sharif, Johan bin Mohamad] Univ Teknol Malaysia, Dept Comp Sci, Johor Baharu 81310, Malaysia; [Abdullahi, Mohammed] Ahmadu Bello Univ Zaria, Dept Math, Zaria, Nigeria	Islamic Azad University; Universiti Teknologi Malaysia; Ahmadu Bello University	Abdullahi, M (corresponding author), Ahmadu Bello Univ Zaria, Dept Math, Zaria, Nigeria.	abdullahilwafu@abu.edu.ng	Ayatollahitafti, Vahid/AAO-5918-2021; NGADI, ASRI/G-3174-2011; Abdullahi, Mohammed/Y-3519-2019; Abdullahi, Mohammed/AAN-9860-2020; Abdullahi, Mohammed/GRF-6308-2022	Ayatollahitafti, Vahid/0000-0003-4083-0263; NGADI, ASRI/0000-0003-4907-6359; Abdullahi, Mohammed/0000-0002-0214-6340; Abdullahi, Mohammed/0000-0001-7844-9527; Abdullahi, Mohammed/0000-0001-7844-9527				Acampora G, 2013, P IEEE, V101, P2470, DOI 10.1109/JPROC.2013.2262913; Almashaqbeh G, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0121-2; Alwan H, 2013, MQOSR MULTIOBJECTIVE; Ameen MA, 2008, THIRD 2008 INTERNATIONAL CONFERENCE ON CONVERGENCE AND HYBRID INFORMATION TECHNOLOGY, VOL 1, PROCEEDINGS, P801, DOI 10.1109/ICCIT.2008.130; [Anonymous], 1998, NS 2 NETWORK SIMULAT; Ben Elhadj H, 2012, INT J E-HEALTH MED C, V3, P1, DOI 10.4018/jehmc.2012040101; Braem Bart, 2007, 2007 International Conference on Sensor Technologies and Applications - SensorComm 2007, P566, DOI 10.1109/SENSORCOMM.2007.4394980; Chen J, 2011, J NETW COMPUT APPL, V34, P1225, DOI 10.1016/j.jnca.2011.01.008; Chen M, 2014, IEEE COMMUN SURV TUT, V16, P98, DOI 10.1109/SURV.2013.110113.00249; Djenouri D., 2009, P 2009 6 INT C BROAD, P1, DOI DOI 10.4108/ICST.BROADNETS2009.7188; Elias J., 2012, IEEE International Conference on Communications (ICC 2012), P3409, DOI 10.1109/ICC.2012.6363949; Elias J, 2014, AD HOC NETW, V13, P560, DOI 10.1016/j.adhoc.2013.10.010; Fortino G, 2014, WIREL NETW, V20, P1925, DOI 10.1007/s11276-014-0714-1; Hayajneh T, 2014, WIREL NETW, V20, P2165, DOI 10.1007/s11276-014-0736-8; He DJ, 2012, IEEE T INF TECHNOL B, V16, P1164, DOI 10.1109/TITB.2012.2199996; He DJ, 2012, IEEE T INF TECHNOL B, V16, P623, DOI 10.1109/TITB.2012.2194788; Jun Zhou, 2013, IEEE Wireless Communications, V20, P12, DOI 10.1109/MWC.2013.6590046; Khan Z, 2012, PROCEDIA COMPUT SCI, V10, P188, DOI 10.1016/j.procs.2012.06.027; Khan Z, 2012, 2012 SEVENTH INTERNATIONAL CONFERENCE ON BROADBAND, WIRELESS COMPUTING, COMMUNICATION AND APPLICATIONS (BWCCA 2012), P178, DOI 10.1109/BWCCA.2012.37; Khan ZA, 2013, PROCEDIA COMPUT SCI, V19, P171, DOI 10.1016/j.procs.2013.06.027; Lai XC, 2013, SENSORS-BASEL, V13, P5406, DOI 10.3390/s130505406; Latre B, 2011, WIREL NETW, V17, P1, DOI 10.1007/s11276-010-0252-4; Lee CC, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9973-0; Liang L, 2012, IEEE GLOB COMM CONF, P572, DOI 10.1109/GLOCOM.2012.6503174; Liang X., 2008, P 2008 1 INT S APPL, P1, DOI DOI 10.1109/ISABEL20084712578; Lifei Wei, 2010, Proceedings 2010 30th International Conference on Distributed Computing Systems Workshops (ICDCS 2010 Workshops), P52, DOI 10.1109/ICDCSW.2010.36; Milenkovic A, 2006, COMPUT COMMUN, V29, P2521, DOI 10.1016/j.comcom.2006.02.011; Min Chen, 2011, Mobile Networks and Applications, V16, P171, DOI 10.1007/s11036-010-0260-8; Movassaghi Samaneh, 2013, Journal of Networks, V8, P559, DOI 10.4304/jnw.8.3.559-575; Natarajan A., 2009, P 6 ANN IEEE COMM SO, P1; Ortiz A.M., 2012, P SOFTCOM 2012 20 IN; Patel M, 2010, IEEE WIREL COMMUN, V17, P80, DOI 10.1109/MWC.2010.5416354; RAHIMI MR, 2012, P 2012 IEEE ACM 5 IN, P83, DOI DOI 10.1109/UCC.2012.25; Razzaque MA, 2011, SENSORS-BASEL, V11, P917, DOI 10.3390/s110100917; Ullah S, 2012, J MED SYST, V36, P1065, DOI 10.1007/s10916-010-9571-3; Wan JF, 2013, IEEE NETWORK, V27, P56, DOI 10.1109/MNET.2013.6616116; Wei LF, 2014, INFORM SCIENCES, V258, P371, DOI 10.1016/j.ins.2013.04.028; Xiong NX, 2009, IEEE J SEL AREA COMM, V27, P495, DOI 10.1109/JSAC.2009.090512; Zeng YY, 2013, COMPUT COMMUN, V36, P988, DOI 10.1016/j.comcom.2012.07.016; Zhang ZY, 2012, IEEE T INF TECHNOL B, V16, P1070, DOI 10.1109/TITB.2012.2206115; Zhou J, 2015, INFORM SCIENCES, V314, P255, DOI 10.1016/j.ins.2014.09.003	41	28	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146464	10.1371/journal.pone.0146464	http://dx.doi.org/10.1371/journal.pone.0146464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771586	Green Published, gold			2022-12-26	WOS:000368628300022
J	Myamoto, DT; Pidde-Queiroz, G; Goncalves-de-Andrade, RM; Pedroso, A; van den Berg, CW; Tambourgi, DV				Myamoto, Daniela Tiemi; Pidde-Queiroz, Giselle; Goncalves-de-Andrade, Rute Maria; Pedroso, Aurelio; van den Berg, Carmen W.; Tambourgi, Denise V.			Characterization of a Gene Coding for the Complement System Component FB from Loxosceles laeta Spider Venom Glands	PLOS ONE			English	Article							FACTOR-B; HOMOLOG; EVOLUTION; CLONING; C3	The human complement system is composed of more than 30 proteins and many of these have conserved domains that allow tracing the phylogenetic evolution. The complement system seems to be initiated with the appearance of C3 and factor B (FB), the only components found in some protostomes and cnidarians, suggesting that the alternative pathway is the most ancient. Here, we present the characterization of an arachnid homologue of the human complement component FB from the spider Loxosceles laeta. This homologue, named Lox-FB, was identified from a total RNA L. laeta spider venom gland library and was amplified using RACE-PCR techniques and specific primers. Analysis of the deduced amino acid sequence and the domain structure showed significant similarity to the vertebrate and invertebrate FB/C2 family proteins. Lox-FB has a classical domain organization composed of a control complement protein domain (CCP), a von Willebrand Factor domain (vWFA), and a serine protease domain (SP). The amino acids involved in Mg2+ metal ion dependent adhesion site (MIDAS) found in the vWFA domain in the vertebrate C2/FB proteins are well conserved; however, the classic catalytic triad present in the serine protease domain is not conserved in Lox-FB. Similarity and phylogenetic analyses indicated that Lox-FB shares a major identity (43%) and has a close evolutionary relationship with the third isoform of FB-like protein (FB-3) from the jumping spider Hasarius adansoni belonging to the Family Salcitidae.	[Myamoto, Daniela Tiemi; Pidde-Queiroz, Giselle; Goncalves-de-Andrade, Rute Maria; Pedroso, Aurelio; Tambourgi, Denise V.] Butantan Inst, Immunochem Lab, Sao Paulo, Brazil; [van den Berg, Carmen W.] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Instituto Butantan; Cardiff University	Tambourgi, DV (corresponding author), Butantan Inst, Immunochem Lab, Sao Paulo, Brazil.	denise.tambourgi@butantan.gov.br	Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Tambourgi, Denise/H-7114-2016	Tambourgi, Denise/0000-0003-1896-9074; Pedroso Junior, Aurelio/0000-0002-9170-2088	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq); CeTICS Program FAPESP [2013/07467-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CeTICS Program FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	This work was supported by funds from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP), CeTICS Program FAPESP (2013/07467-1) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; Ausubel FM, 1988, MOL REPROD DEV; BENTLEY DR, 1986, BIOCHEM SOC SYMP, P7; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Fernandes-Pedrosa MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-279; He YN, 2008, FISH SHELLFISH IMMUN, V24, P768, DOI 10.1016/j.fsi.2008.03.004; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Le Saux A, 2008, J MOL BIOL, V377, P902, DOI 10.1016/j.jmb.2008.01.045; Loker E., 2012, FRONTIERS IMMUNOLOGY, V3, P1; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; NONAKA M, 1994, J IMMUNOL, V152, P2263; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Nonaka Masaru, 2014, Subcell Biochem, V80, P31, DOI 10.1007/978-94-017-8881-6_3; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P305, DOI 10.1016/j.fsi.2008.11.015; Sekiguchi R, 2015, DEV COMP IMMUNOL, V50, P58, DOI 10.1016/j.dci.2014.12.008; Smith LC, 1998, J IMMUNOL, V161, P6784; Sunyer JO, 1998, IMMUNOL REV, V27, P549; Tagawa K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036783; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Xiao XP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004848; Xiao XP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004027; Yoshizaki FY, 2005, IMMUNOGENETICS, V56, P930, DOI 10.1007/s00251-004-0752-4; Zarkadis IK, 2001, DEV COMP IMMUNOL, V25, P745, DOI 10.1016/S0145-305X(01)00034-9; Zhong L, 2012, FISH SHELLFISH IMMUN, V33, P504, DOI 10.1016/j.fsi.2012.06.001; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222	32	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146992	10.1371/journal.pone.0146992	http://dx.doi.org/10.1371/journal.pone.0146992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771533	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000368628300049
J	Suzuki, T; Brown, JJ; Swift, LL				Suzuki, Takashi; Brown, Judy J.; Swift, Larry L.			Identification of a Novel Transcript and Regulatory Mechanism for Microsomal Triglyceride Transfer Protein	PLOS ONE			English	Article							OPEN READING FRAMES; ANGIOTENSIN-II RECEPTOR; APOLIPOPROTEIN-B; LIPOPROTEIN SECRETION; GENOMIC ORGANIZATION; GENE-EXPRESSION; TYPE-1 RECEPTOR; MESSENGER-RNAS; CELLS; ABETALIPOPROTEINEMIA	Microsomal triglyceride transfer protein (MTP) is essential for the assembly of triglyceride-rich apolipoprotein B-containing lipoproteins. Previous studies in our laboratory identified a novel splice variant of MTP in mice that we named MTP-B. MTP-B has a unique first exon (1B) located 2.7 kB upstream of the first exon (1A) for canonical MTP (MTP-A). The two mature isoforms, though nearly identical in sequence and function, have different tissue expression patterns. In this study we report the identification of a second MTP splice variant (MTP-C), which contains both exons 1B and 1A. MTP-C is expressed in all the tissues we tested. In cells transfected with MTP-C, protein expression was less than 15% of that found when the cells were transfected with MTP-A or MTP-B. In silico analysis of the 5'-UTR of MTP-C revealed seven ATGs upstream of the start site for MTP-A, which is the only viable start site in frame with the main coding sequence. One of those ATGs was located in the 5'-UTR for MTP-A. We generated reporter constructs in which the 5'-UTRs of MTP-A or MTPC were inserted between an SV40 promoter and the coding sequence of the luciferase gene and transfected these constructs into HEK 293 cells. Luciferase activity was significantly reduced by the MTP-C 5'-UTR, but not by the MTP-A 5'-UTR. We conclude that alternative splicing plays a key role in regulating MTP expression by introducing unique 5'-UTRs, which contain elements that alter translation efficiency, enabling the cell to optimize MTP levels and activity.	[Suzuki, Takashi; Brown, Judy J.; Swift, Larry L.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Swift, Larry L.] Tennessee Valley Hlth Care Syst, Res Serv, Vet Affairs, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Suzuki, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	takashi.suzuki@vanderbilt.edu			VA Merit Award from the Tennessee Valley Health Care System [IBX000735A]; Department of Veterans Affairs	VA Merit Award from the Tennessee Valley Health Care System(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs)	This work was funded by a VA Merit Award (IBX000735A) from the Tennessee Valley Health Care System and Department of Veterans Affairs (LS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Boren J, 1998, J CLIN INVEST, V101, P1197, DOI 10.1172/JCI1785; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Cadar AG, 2014, BIOCHEM BIOPH RES CO, V453, P185, DOI 10.1016/j.bbrc.2014.09.085; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; CURNOW KM, 1992, MOL ENDOCRINOL, V6, P1113, DOI 10.1210/me.6.7.1113; CURNOW KM, 1995, MOL ENDOCRINOL, V9, P1250, DOI 10.1210/me.9.9.1250; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; Elton TS, 2003, TRENDS ENDOCRIN MET, V14, P66, DOI 10.1016/S1043-2760(02)00038-3; GORDON DA, 1995, TRENDS CELL BIOL, V5, P317, DOI 10.1016/S0962-8924(00)89054-6; GUO DF, 1994, BIOCHEM BIOPH RES CO, V200, P313, DOI 10.1006/bbrc.1994.1450; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krzystanek M, 2010, J BIOL CHEM, V285, P10583, DOI 10.1074/jbc.M109.078006; Li CM, 2005, J LIPID RES, V46, P628, DOI 10.1194/jlr.M400428-JLR200; Love JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135598; Madsen EM, 2004, J BIOL CHEM, V279, P55271, DOI 10.1074/jbc.M411404200; Mohler PJ, 2007, J BIOL CHEM, V282, P26981, DOI 10.1074/jbc.M700500200; MORRIS DR, 1995, PROG NUCLEIC ACID RE, V51, P339, DOI 10.1016/S0079-6603(08)60883-1; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nakamuta M, 1996, GENOMICS, V33, P313, DOI 10.1006/geno.1996.0200; Nielsen LB, 1998, CIRCULATION, V98, P13, DOI 10.1161/01.CIR.98.1.13; Nielsen LB, 2002, ARTERIOSCL THROM VAS, V22, P1489, DOI 10.1161/01.ATV.0000030199.06252.26; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Rakhshandehroo M, 2014, J BIOL CHEM, V289, P22128, DOI 10.1074/jbc.M114.551242; Shelton JM, 2000, J LIPID RES, V41, P532; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; SU BG, 1994, BIOCHEM BIOPH RES CO, V204, P1039, DOI 10.1006/bbrc.1994.2567; Swift LL, 2005, FEBS LETT, V579, P3183, DOI 10.1016/j.febslet.2005.05.009; Swift LL, 2003, J LIPID RES, V44, P1841, DOI 10.1194/jlr.M300276-JLR200; Swift LL, 2001, J BIOL CHEM, V276, P22965, DOI 10.1074/jbc.M100172200; Tietge UJF, 1999, J LIPID RES, V40, P2134; Wethmar K, 2014, WIRES RNA, V5, P765, DOI 10.1002/wrna.1245; WETTERAU JR, 1992, SCIENCE, V258, P999; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751	41	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147252	10.1371/journal.pone.0147252	http://dx.doi.org/10.1371/journal.pone.0147252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771188	Green Submitted, Green Published, gold			2022-12-26	WOS:000368628300074
J	Westwell-Roper, C; Denroche, HC; Ehses, JA; Verchere, CB				Westwell-Roper, Clara; Denroche, Heather C.; Ehses, Jan A.; Verchere, C. Bruce			Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELLS; NLRP3 INFLAMMASOME; RECEPTOR 2; DYSFUNCTION; MACROPHAGES; EXPRESSION; TLR2; CYTOTOXICITY; PATHOGENESIS; LANGERHANS	Aggregation of islet amyloid polypeptide (IAPP) contributes to beta cell dysfunction in type 2 diabetes and islet transplantation. Like other amyloidogenic peptides, human IAPP induces macrophage IL-1 beta secretion by stimulating both the synthesis and processing of proIL-1 beta, a pro-inflammatory cytokine that (when chronically elevated) impairs beta cell insulin secretion. We sought to determine the specific mechanism of IAPP-induced proIL-1 beta synthesis. Soluble IAPP species produced early during IAPP aggregation provided a Toll-like-receptor-2-(TLR2-) dependent stimulus for NF-kappa B activation in HEK 293 cells and bone marrow-derived macrophages (BMDMs). Non-amyloidogenic rodent IAPP and thioflavin-T-positive fibrillar amyloid produced by human IAPP aggregation failed to activate TLR2. Blockade of TLR6 but not TLR1 prevented hIAPP-induced TLR2 activation, consistent with stimulation of a TLR2/6 heterodimer. TLR2 and its downstream adaptor protein MyD88 were required for IAPP-induced cytokine production by BMDMs, a process that is partially dependent on autoinduction by IL-1. BMDMs treated with soluble but not fibrillar IAPP provided a TLR2-dependent priming stimulus for ATP-induced IL-1 beta secretion, whereas late IAPP aggregates induced NLRP3-dependent IL-1 beta secretion by LPS-primed macrophages. Moreover, inhibition of TLR2 and depletion of islet macrophages prevented up-regulation of Il1b and Tnf expression in human IAPP-expressing transgenic mouse islets. These data suggest participation by both soluble and fibrillar aggregates in IAPP-induced islet inflammation. IAPP-induced activation of TLR2 and secretion of IL-1 may be important therapeutic targets to prevent amyloid-associated beta cell dysfunction.	[Westwell-Roper, Clara; Verchere, C. Bruce] Univ British Columbia, Child & Family Res Inst, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Denroche, Heather C.; Ehses, Jan A.; Verchere, C. Bruce] Univ British Columbia, Child & Family Res Inst, Dept Surg, Vancouver, BC V5Z 4H4, Canada	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia	Verchere, CB (corresponding author), Child & Family Res Inst, A4-181 950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	bverchere@cfri.ca	Ehses, Jan/AAK-1635-2020	Verchere, Cameron Bruce/0000-0002-9262-0586; Westwell-Roper, Clara/0000-0003-4416-3912; Denroche, Heather/0000-0002-0976-2656; Ehses, Jan/0000-0001-9066-7607	Canadian Institutes of Health Research (CIHR) [MOP-123338]; BC Children's Hospital Foundation; Canucks for Kids Fund Childhood Diabetes Laboratories; Vanier Canada Graduate Studentship; Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship Award; Juvenile Diabetes Research Foundation; Canadian Diabetes Association; CFRI; Irving K. Barber Chair in Diabetes Research at the University of British Columbia	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Children's Hospital Foundation; Canucks for Kids Fund Childhood Diabetes Laboratories; Vanier Canada Graduate Studentship; Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship Award; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Diabetes Association; CFRI; Irving K. Barber Chair in Diabetes Research at the University of British Columbia	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR; MOP-123338) and by core support to the Child & Family Research Institute (CFRI) from the BC Children's Hospital Foundation and Canucks for Kids Fund Childhood Diabetes Laboratories. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Vanier Canada Graduate Studentship and a Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship Award.; Supported by Postdoctoral Fellowships from the Juvenile Diabetes Research Foundation and Canadian Diabetes Association.; Supported by a scholar award from the Canadian Diabetes Association and an investigator award from the CFRI.; Supported by the Irving K. Barber Chair in Diabetes Research at the University of British Columbia and an investigator award from the CFRI.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Chang YC, 2009, FASEB J, V23, P3078, DOI 10.1096/fj.09-129312; Cheng K, 2012, ANGEW CHEM INT EDIT, V51, P12246, DOI 10.1002/anie.201204910; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Fassbender K, 2004, FASEB J, V18, P203, DOI 10.1096/fj.03-0364fje; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Gustot A, 2013, CELL MOL LIFE SCI, V70, P2999, DOI 10.1007/s00018-012-1245-5; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Mahdi T, 2012, CELL METAB, V16, P625, DOI 10.1016/j.cmet.2012.10.009; Masters SL, 2011, TRENDS MOL MED, V17, P276, DOI 10.1016/j.molmed.2011.01.005; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Novotny GW, 2012, ARCH BIOCHEM BIOPHYS, V528, P171, DOI 10.1016/j.abb.2012.09.014; Rapsinski GJ, 2013, J BIOL CHEM, V288, P14178, DOI 10.1074/jbc.M112.447060; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tukel C, 2009, CELL HOST MICROBE, V6, P45, DOI 10.1016/j.chom.2009.05.020; van Bergenhenegouwen J, 2013, J LEUKOCYTE BIOL, V94, P885, DOI 10.1189/jlb.0113003; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; Westwell-Roper Clara, 2013, Methods Mol Biol, V1040, P9, DOI 10.1007/978-1-62703-523-1_2; Westwell-Roper C, 2011, J IMMUNOL, V187, P2755, DOI 10.4049/jimmunol.1002854; Westwell-Roper CY, 2015, DIABETOLOGIA, V58, P575, DOI 10.1007/s00125-014-3447-x; Westwell-Roper CY, 2014, DIABETES, V63, P1698, DOI 10.2337/db13-0863; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	39	28	28	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8908	8917		10.1074/jbc.M115.712455	http://dx.doi.org/10.1074/jbc.M115.712455			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26786104	Green Published, hybrid			2022-12-26	WOS:000374849000005
J	Burana, D; Yoshihara, H; Tanno, H; Yamamoto, A; Saeki, Y; Tanaka, K; Komada, M				Burana, Daocharad; Yoshihara, Hidehito; Tanno, Hidetaka; Yamamoto, Akitsugu; Saeki, Yasushi; Tanaka, Keiji; Komada, Masayuki			The Ankrd13 Family of Ubiquitin-interacting Motif-bearing Proteins Regulates Valosin-containing Protein/p97 Protein-mediated Lysosomal Trafficking of Caveolin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolin; cell surface protein; endocytosis; endosome; membrane trafficking; protein degradation; ubiquitin; ubiquitylation (ubiquitination); VCP; p97; ubiquitin-interacting motif	VCP/P97 AAA-ATPASE; RECEPTOR ENDOCYTOSIS; PLASMA-MEMBRANE; DEGRADATION; P97; PATHWAY; DOMAIN; VCP; QUANTIFICATION; MUTATIONS	Caveolin 1 (Cav-1) is an oligomeric protein that forms flask-shaped, lipid-rich pits, termed caveolae, on the plasma membrane. Cav-1 is targeted for lysosomal degradation in ubiquitination- and valosin-containing protein (VCP)-dependent manners. VCP, an ATPase associated with diverse cellular activities that remodels or segregates ubiquitinated protein complexes, has been proposed to disassemble Cav-1 oligomers on the endosomal membrane, facilitating the trafficking of Cav-1 to the lysosome. Genetic mutations in VCP compromise the lysosomal trafficking of Cav-1, leading to a disease called inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia (IBMPFD). Here we identified the Ankrd13 family of ubiquitin-interacting motif (UIM)-containing proteins as novel VCP-interacting molecules on the endosome. Ankrd13 proteins formed a ternary complex with VCP and Cav-1 and exhibited high binding affinity for ubiquitinated Cav-1 oligomers in an UIM-dependent manner. Mass spectrometric analyses revealed that Cav-1 undergoes Lys-63-linked polyubiquitination, which serves as a lysosomal trafficking signal, and that the UIMs of Ankrd13 proteins bind preferentially to this ubiquitin chain type. The overexpression of Ankrd13 caused enlarged hollow late endosomes, which was reminiscent of the phenotype of the VCP mutations in IBMPFD. Overexpression of Ankrd13 proteins also stabilized ubiquitinated Cav-1 oligomers on the limiting membrane of enlarged endosomes. The interaction with Ankrd13 was abrogated in IMBPFD-associated VCP mutants. Collectively, our results suggest that Ankrd13 proteins cooperate with VCP to regulate the lysosomal trafficking of ubiquitinated Cav-1.	[Burana, Daocharad; Tanno, Hidetaka; Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan; [Yoshihara, Hidehito; Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama 5260829, Japan	Tokyo Institute of Technology; Tokyo Metropolitan Institute of Medical Science	Komada, M (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B16 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	makomada@bio.titech.ac.jp	Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453; Tanno, Hidetaka/0000-0001-6749-0938	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24112003, 24112008, 21000012]; Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants-in-Aid 24112003 (to M. K.), 24112008 (to Y. S.), and 21000012 (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Fujimuro M, 2005, METHOD ENZYMOL, V399, P75, DOI 10.1016/S0076-6879(05)99006-X; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kirchner P, 2013, J BIOL CHEM, V288, P7363, DOI 10.1074/jbc.M112.429076; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Nagahama M, 2009, BIOCHEM BIOPH RES CO, V382, P303, DOI 10.1016/j.bbrc.2009.03.012; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Spina S, 2013, EUR J NEUROL, V20, P251, DOI 10.1111/j.1468-1331.2012.03831.x; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Tanno H, 2013, J BIOCHEM, V153, P497, DOI 10.1093/jb/mvt028; Tanno H, 2012, MOL BIOL CELL, V23, P1343, DOI 10.1091/mbc.E11-09-0817; Tsuchiya H, 2013, BIOCHEM BIOPH RES CO, V436, P223, DOI 10.1016/j.bbrc.2013.05.080; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002	31	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6218	6231		10.1074/jbc.M115.710707	http://dx.doi.org/10.1074/jbc.M115.710707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797118	hybrid, Green Published			2022-12-26	WOS:000372894200014
J	Kim, AJ; Ro, H; Kim, H; Chang, JH; Lee, HH; Chung, W; Jung, JY				Kim, Ae Jin; Ro, Han; Kim, Hyunsook; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong			Klotho and S100A8/A9 as Discriminative Markers between Pre-Renal and Intrinsic Acute Kidney Injury	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; MYELOID-RELATED PROTEIN-14; URINARY BIOMARKER; TISSUE EXPRESSION; CALPROTECTIN; CREATININE; NGAL; GENE; MYELOID-RELATED-PROTEIN-8/14; MORTALITY	Early detection and accurate differentiation of the cause of AKI may improve the prognosis of the patient. However, to date, there are few reliable biomarkers that can discriminate between pre-renal and intrinsic AKI. In this study, we determined whether AKI is associated with altered serum and urinary levels of Klotho, S100A8/A9 (an endogenous ligand of toll-like receptor 4), and neutrophil gelatinase-associated lipocalin (NGAL), which may allow differentiation between pre-renal and intrinsic AKI. A volume-depleted pre-renal AKI model was induced in male Sprague Dawley rats fed a low-salt diet (0.03%) without water 96 h before two intraperitoneal (IP) injections of furosemide (20 mg/kg) at a 24 h interval. In contrast, in the cisplatin-induced intrinsic AKI model, animals were given a single IP injection of cisplatin (5 mg/kg). All of the animals were euthanized 72 h after the first IP injection. Serum and urinary levels of Klotho, S100A8/A9, and NGAL were measured using an enzyme-linked immunosorbent assay. We also performed a proof-of-concept cross-sectional study to measure serum and urinary biomarkers in 61 hospitalized patients with established AKI. Compared to the intrinsic AKI group, the pre-renal AKI group showed a marked depression in urinary Klotho levels (13.21 +/- 17.32 vs. 72.97 +/- 17.96 pg/mL; P = 0.002). In addition, the intrinsic AKI group showed marked elevation of S100A8/A9 levels compared to the pre-renal AKI group (2629.97 +/- 598.05 ng/mL vs. 685.09 +/- 111.65 ng/mL; P = 0.002 in serum; 3361.11 +/- 250.86 ng/mL vs. 741.72 +/- 101.96 ng/mL; P = 0.003 in urine). There was no difference in serum and urinary NGAL levels between the pre-renal and intrinsic AKI groups. The proof-of-concept study with the hospitalized AKI patients also demonstrated decreased urinary Klotho in pre-renal AKI patients and increased urinary S100A8/A9 concentrations in intrinsic AKI patients. The attenuation of urinary Klotho and increase in urinary S100A8/A9 may allow differentiation between pre-renal and intrinsic AKI.	[Kim, Ae Jin; Ro, Han; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Sch Med, Gil Med Ctr, Div Nephrol,Dept Internal Med, Inchon, South Korea; [Kim, Ae Jin; Ro, Han; Kim, Hyunsook; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Gachon Med Res Inst, Gil Med Ctr, Inchon, South Korea	Gachon University; Gachon University	Jung, JY (corresponding author), Gachon Univ, Sch Med, Gil Med Ctr, Div Nephrol,Dept Internal Med, Inchon, South Korea.; Jung, JY (corresponding author), Gachon Univ, Gachon Med Res Inst, Gil Med Ctr, Inchon, South Korea.	jyjung@gachon.ac.kr			Fresenius Medical Care Korea [141008-HRH2-A-59]	Fresenius Medical Care Korea	This work was supported by Fresenius Medical Care Korea (141008-HRH2-A-59, http://www.fmc-korea.co.kr). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; ANDERSSON KB, 1988, SCAND J IMMUNOL, V28, P241, DOI 10.1111/j.1365-3083.1988.tb02437.x; Arai K, 2008, CURR CANCER DRUG TAR, V8, P243, DOI 10.2174/156800908784533445; Bagshaw SM, 2010, INTENS CARE MED, V36, P452, DOI 10.1007/s00134-009-1724-9; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; BORREGAARD N, 1995, BLOOD, V85, P812, DOI 10.1182/blood.V85.3.812.bloodjournal853812; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Constantin JM, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.05.010; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Fagerhol MK, 2005, SCAND J CLIN LAB INV, V65, P211, DOI 10.1080/00365510510013587; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Fukino K, 2002, BIOCHEM BIOPH RES CO, V293, P332, DOI 10.1016/S0006-291X(02)00216-4; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; He Y, 2004, J NEPHROL, V17, P34; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Heller F, 2011, CLIN J AM SOC NEPHRO, V6, P2347, DOI 10.2215/CJN.02490311; Herrera J, 1998, NEPHROL DIAL TRANSPL, V13, P623, DOI 10.1093/ndt/13.3.623; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Jang HR, 2015, NAT REV NEPHROL, V11, P88, DOI 10.1038/nrneph.2014.180; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Montagnana M, 2014, CLIN BIOCHEM, V47, P996, DOI 10.1016/j.clinbiochem.2014.02.021; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Morrow DA, 2008, AM HEART J, V155, P49, DOI 10.1016/j.ahj.2007.08.018; Muller H, 2008, J UROLOGY, V180, P1309, DOI 10.1016/j.juro.2008.06.025; Muramatsu Y, 2002, KIDNEY INT, V62, P1601, DOI 10.1046/j.1523-1755.2002.00633.x; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Panesso MC, 2014, KIDNEY INT, V85, P855, DOI 10.1038/ki.2013.489; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Schrier RW, 2004, J AM SOC NEPHROL, V15, P2756, DOI 10.1097/01.ASN.0000141324.49873.11; Seibert FS, 2013, ACTA PHYSIOL, V207, P700, DOI 10.1111/apha.12064; Singer E, 2011, KIDNEY INT, V80, P405, DOI 10.1038/ki.2011.41; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Tang C, 2011, AM J PHYSIOL-RENAL, V301, pF745, DOI 10.1152/ajprenal.00037.2011; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wadey RM, 2014, TOXICOL PATHOL, V42, P591, DOI 10.1177/0192623313492044; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Wang L, 2008, NEPHRON CLIN PRACT, V108, pC176, DOI 10.1159/000117814; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874	52	19	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147255	10.1371/journal.pone.0147255	http://dx.doi.org/10.1371/journal.pone.0147255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799323	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300081
J	Wu, ZQ; Zhang, Y; Xie, EF; Song, WJ; Yang, RX; Yan, CJ; Zhang, BF; Xu, HG				Wu, Zhi-Qi; Zhang, Yan; Xie, Erfu; Song, Wei-Juan; Yang, Rui-Xia; Yan, Cheng-Jing; Zhang, Bing-Feng; Xu, Hua-Guo			High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; BONE TURNOVER MARKERS; PROSTATE-CANCER; POSTMENOPAUSAL WOMEN; PROGNOSTIC IMPLICATIONS; CLINICAL-SIGNIFICANCE; METABOLIC SYNDROME; CARCINOMA PATIENTS; NATURAL-HISTORY; ISOFORM 5B	Background Bone metastases often occur in the majority of patients with advanced cancer, such as prostate cancer, lung cancer and breast cancer. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b), a novel bone resorption marker, has been used gradually in the clinics as a specific and sensitive marker of bone resorption for the early diagnosis of cancer patients with bone metastasis. Here, we reported that high concentrations of uric acid (UA) lead to decrease of TRACP 5b levels and determined whether TRACP 5b level was associated with UA in interference experiment. Methods A total of 77 patients with high concentrations of UA and 77 healthy subjects were tested to evaluate the differences in their TRACP 5b levels. Serial dilutions of UA were respectively spiked with a known concentration of TRACP 5b standard sample, then Serum TRACP 5b was detected by using bone TRAP (R) Assay. A correction equation was set to eliminate UA-derived TRACP 5b false-decrease. The effect of this correction was evaluated in high-UA individuals. Results The average TRACP level of the high-UA individuals (1.47 +/- 0.62 U/L) was significantly lower than that of the healthy subjects (2.62 +/- 0.63 U/L) (t-test, p<0.0001). The UA correction equation derived: Delta TRACP 5b = -1.9751lg Delta UA + 3.7365 with an R-2 = 0.98899. Application of the UA correction equation resulted in a statistically non-significant difference in TRACP 5b values between the healthy subjects and high-UA individuals (p = 0.24). Conclusions High UA concentrations can falsely decrease TRACP 5b levels due to a method-related systematic error. To avoid misdiagnoses or inappropriate therapeutic decisions, increased attention should be paid to UA interference, when TRACP 5b is used for early diagnosis of cancer patients with bone metastasis, evaluation of the aggressiveness of osteosarcoma or prediction of survival in prostate cancer and breast cancer with bone metastases.	[Wu, Zhi-Qi; Zhang, Yan; Xie, Erfu; Song, Wei-Juan; Yang, Rui-Xia; Yan, Cheng-Jing; Zhang, Bing-Feng; Xu, Hua-Guo] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Xu, HG (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China.	huaguoxu@njmu.edu.cn			National Natural Science Foundation of China [81302531]; Natural Science Foundation of Jiangsu Province of China [BK20131018]; Key laboratory for Laboratory Medicine of Jiangsu Province [XK201114]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Key Clinical Department of Laboratory Medicine of China in Nanjing	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Key laboratory for Laboratory Medicine of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Key Clinical Department of Laboratory Medicine of China in Nanjing	This work was supported by the National Natural Science Foundation of China (81302531), Natural Science Foundation of Jiangsu Province of China (BK20131018), the National Key Clinical Department of Laboratory Medicine of China in Nanjing, Key laboratory for Laboratory Medicine of Jiangsu Province (XK201114) and by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2013, OSTEOPOROSIS INT, V24, P2961, DOI 10.1007/s00198-013-2377-7; Alatalo SL, 2003, J BONE MINER RES, V18, P134, DOI 10.1359/jbmr.2003.18.1.134; Avnet S, 2008, INT J ONCOL, V33, P1231, DOI 10.3892/ijo_00000113; Bonjour JP, 2012, J NUTR, V142, P698, DOI 10.3945/jn.111.153692; Boutroy S, 2008, J BONE MINER RES, V23, P392, DOI 10.1359/JBMR.071108; Chao TY, 2010, CLIN CHIM ACTA, V411, P1553, DOI 10.1016/j.cca.2010.06.027; Chao TY, 2005, CLIN CANCER RES, V11, P544; CHINH NH, 1974, CLIN CHEM, V20, P499; Chung YC, 2006, CANCER EPIDEM BIOMAR, V15, P424, DOI 10.1158/1055-9965.EPI-04-0842; Ebert W, 2004, ANTICANCER RES, V24, P3193; Fini MA, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-16; Ghaemi-Oskouie F, 2011, CURR RHEUMATOL REP, V13, P160, DOI 10.1007/s11926-011-0162-1; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Halleen JM, 2001, CLIN CHEM, V47, P597; Halleen JM, 2000, J BONE MINER RES, V15, P1337, DOI 10.1359/jbmr.2000.15.7.1337; Hammarsten J, 2010, CANCER EPIDEMIOL, V34, P574, DOI 10.1016/j.canep.2010.06.014; Janckila AJ, 2009, CALCIFIED TISSUE INT, V85, P465, DOI 10.1007/s00223-009-9309-8; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Jung K, 2004, INT J CANCER, V111, P783, DOI 10.1002/ijc.20314; Kamiya N, 2010, UROLOGY, V75, P1446, DOI 10.1016/j.urology.2009.11.049; Korpela J, 2006, ANTICANCER RES, V26, P3127; MCNEIL BJ, 1984, SEMIN NUCL MED, V14, P277, DOI 10.1016/S0001-2998(84)80003-3; Recker R, 2004, J BONE MINER RES, V19, P1628, DOI 10.1359/JBMR.040710; Rose DP, 2007, ENDOCR REV, V28, P763, DOI 10.1210/er.2006-0019; Salminen EK, 2006, ANTICANCER RES, V26, P4879; Sarvari BKD, 2015, INDIAN J CLIN BIOCHE, V30, P66, DOI 10.1007/s12291-013-0399-8; Savarino L, 2010, J ORTHOP RES, V28, P887, DOI 10.1002/jor.21082; Tang CH, 2013, CLIN CHIM ACTA, V426, P102, DOI 10.1016/j.cca.2013.09.011; Terpos E, 2003, INT J CANCER, V106, P455, DOI 10.1002/ijc.11247; Terpos E, 2009, ANTICANCER RES, V29, P1651; Wu YY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-158; Zhang L, 2015, CHINESE MED J-PEKING, V128, P1232, DOI 10.4103/0366-6999.156139	32	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147554	10.1371/journal.pone.0147554	http://dx.doi.org/10.1371/journal.pone.0147554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800211	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300122
J	Zhang, SQ; Lindner, HA; Kabtni, S; van den Born, J; Bakker, S; Navis, G; Kramer, B; Yard, B; Hauske, S				Zhang, Shiqi; Lindner, Holger A.; Kabtni, Sarah; van den Born, Jaap; Bakker, Stephan; Navis, Gerjan; Kraemer, Bernard; Yard, Benito; Hauske, Sibylle			Monoclonal Antibody RYSK173 Recognizes the Dinuclear Zn Center of Serum Carnosinase 1 (CN-1): Possible Consequences of Zn Binding for CN-1 Recognition by RYSK173	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; LEUCINE REPEAT; GENE CNDP1; POLYMORPHISM; ZINC; SECRETION; PROTEIN; DISEASE	Background and Aims The proportion of serum carnosinase (CN-1) recognized by RYSK173 monoclonal antibody negatively correlates with CN-1 activity. We thus hypothesized that the epitope recognized by RYSK173 is accessible only in a catalytically incompetent conformation of the zinc dependent enzyme and we mapped its position in the CN-1 structure. Since patients with kidney failure are often deficient in zinc and other trace elements we also assessed the RYSK173 CN-1 proportion in serum of these patients and studied the influence of hemodialysis hereon in relation to Zn2+ and Cu2+ concentration during hemodialysis. Methods and Results Epitope mapping using myc-tagged CN-1 fragments and overlapping peptides revealed that the RYSK173 epitope directly contributes to the formation of the dinuclear Zn center in the catalytic domain of homodimeric CN-1. Binding of RYSK173 to CN-1 was however not influenced by addition of Zn2+ or Cu2+ to serum. In serum of healthy controls the proportion of CN-1 recognized by RYSK173 was significantly lower compared to end-stage renal disease (ESRD) patients (1.12 +/- 0.17 vs. 1.56 +/- 0.40% of total CN-1; p<0.001). During hemodialysis the relative proportion of RYSK173 CN-1 decreased in parallel with increased serum Zn2+ and Cu2+ concentrations after dialysis. Conclusions Our study clearly indicates that RYSK173 recognizes a sequence within the transition metal binding site of CN-1, thus supporting our hypothesis that metal binding to CN-1 masks the epitope. The CN-1 RYSK173 proportion appears overall increased in ESRD patients, yet it decreases during hemodialysis possibly as a consequence of a relative increase in transition metal bound enzyme.	[Zhang, Shiqi; Kabtni, Sarah; Kraemer, Bernard; Yard, Benito; Hauske, Sibylle] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med Nephrol Endocrinol Rheumatol 5, Mannheim, Germany; [Zhang, Shiqi] Anhui Med Univ, Affiliated Hosp 1, Dept Endocrinol, Hefei, Peoples R China; [Lindner, Holger A.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Anesthesiol & Surg Intens Care Med, Mannheim, Germany; [van den Born, Jaap; Bakker, Stephan; Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	Ruprecht Karls University Heidelberg; Anhui Medical University; Ruprecht Karls University Heidelberg; University of Groningen	Yard, B (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med Nephrol Endocrinol Rheumatol 5, Mannheim, Germany.	benito.yard@medma.uni-heidelberg.de	Lindner, Holger A/C-5106-2014	Lindner, Holger A/0000-0002-6679-4355; Krieg, Sarah/0000-0003-0012-0304; Zhang, Shiqi/0000-0002-2120-1544	Deutsche Forschungsgemeinschaft (DFG) [SA 2143/1-1]; Graduiertenkolleg (GRK) [1874/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Graduiertenkolleg (GRK)(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (DFG, URL: http://www.dfg.de/) SA 2143/1-1 to S.H. This author read and revised this manuscript. It was also supported by Graduiertenkolleg (GRK, URL: http://www.umm.uni-heidelberg.de/ag/grk1874/) 1874/1 to B.Y. This author designed, prepared, and decided to publish this manuscript.	Adelmann K, 2012, AMINO ACIDS, V43, P143, DOI 10.1007/s00726-012-1244-8; Aoki A, 2012, MICROB PATHOGENESIS, V52, P17, DOI 10.1016/j.micpath.2011.09.003; Balion CM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-38; Cappiello M, 2006, BIOCHEMISTRY-US, V45, P3226, DOI 10.1021/bi052069v; David A, 1998, HDB PROTEOLYTIC ENZY; Everaert I, 2012, AM J PHYSIOL-RENAL, V302, pF1537, DOI 10.1152/ajprenal.00084.2012; Freedman BI, 2007, NEPHROL DIAL TRANSPL, V22, P1131, DOI 10.1093/ndt/gfl717; HOMSHER R, 1985, CLIN CHEM, V31, P1310; Hu WW, 2012, ACS CHEM NEUROSCI, V3, P238, DOI 10.1021/cn200126p; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; JOHNSEN O, 1987, INT J ANDROL, V10, P435, DOI 10.1111/j.1365-2605.1987.tb00216.x; Kilis-Pstrusinska K, 2010, ARCH MED RES, V41, P356, DOI 10.1016/j.arcmed.2010.07.006; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Peters V, 2011, CLIN CHIM ACTA, V412, P263, DOI 10.1016/j.cca.2010.10.016; Peters V, 2010, AMINO ACIDS, V38, P1607, DOI 10.1007/s00726-009-0367-z; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Riedl E, 2007, DIABETES, V56, P2410, DOI 10.2337/db07-0128; Riedl E, 2010, DIABETES, V59, P1984, DOI 10.2337/db09-0868; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Tonelli M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-25; Wang TY, 2008, FEBS J, V275, P5007, DOI 10.1111/j.1742-4658.2008.06635.x; Yard B, 2004, AM J TRANSPLANT, V4, P22, DOI 10.1046/j.1600-6143.2003.00268.x; Zhu JM, 2013, GENET TEST MOL BIOMA, V17, P289, DOI 10.1089/gtmb.2012.0341	24	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146831	10.1371/journal.pone.0146831	http://dx.doi.org/10.1371/journal.pone.0146831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799971	gold, Green Published			2022-12-26	WOS:000368655300040
J	Rodrigues-da-Silva, RN; da Silva, JHM; Singh, B; Jiang, JL; Meyer, EVS; Santos, F; Banic, DM; Moreno, A; Galinski, MR; Oliveira-Ferreira, J; Lima, JD				Rodrigues-da-Silva, Rodrigo Nunes; Martins da Silva, Joao Herminio; Singh, Balwan; Jiang, Jianlin; Meyer, Esmeralda V. S.; Santos, Fatima; Banic, Dalma Maria; Moreno, Alberto; Galinski, Mary R.; Oliveira-Ferreira, Joseli; Lima-Junior, Josue da Costa			In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9	PLOS ONE			English	Article							BLOOD-STAGE MALARIA; IMMUNE-RESPONSES; WEB SERVER; REDUCED RISK; FALCIPARUM; ANTIGENICITY; ANTIBODIES; RECOMBINANT; REGIONS; SEARCH	Synthetic peptide vaccines provide the advantages of safety, stability and low cost. The success of this approach is highly dependent on efficient epitope identification and synthetic strategies for efficacious delivery. In malaria, the Merozoite Surface Protein-9 of Plasmodium vivax (PvMSP9) has been considered a vaccine candidate based on the evidence that specific antibodies were able to inhibit merozoite invasion and recombinant proteins were highly immunogenic in mice and humans. However the identities of linear B-cell epitopes within PvMSP9 as targets of functional antibodies remain undefined. We used several publicly-available algorithms for in silico analyses and prediction of relevant B-cell epitopes within PMSP9. We show that the tandem repeat sequence EAAPENAEPVHENA (PvMSP9(E795-A808)) present at the C-terminal region is a promising target for antibodies, given its high combined score to be a linear epitope and located in a putative intrinsically unstructured region of the native protein. To confirm the predictive value of the computational approach, plasma samples from 545 naturally exposed individuals were screened for IgG reactivity against the recombinant PvMSP9-RIRII729-972 and a synthetic peptide representing the predicted B-cell epitope PvMSP9(E795-A808). 316 individuals (58%) were responders to the full repetitive region PvMSP9-RIRII, of which 177 (56%) also presented total IgG reactivity against the synthetic peptide, confirming it validity as a B cell epitope. The reactivity indexes of anti-PvMSP9-RIRII and anti-PvMSP9(E795-A808) antibodies were correlated. Interestingly, a potential role in the acquisition of protective immunity was associated with the linear epitope, since the IgG1 subclass against PvMSP9(E795-A808) was the prevalent subclass and this directly correlated with time elapsed since the last malaria episode; however this was not observed in the antibody responses against the full PvMSP9-RIRII. In conclusion, our findings identified and experimentally confirmed the potential of PvMSP9(E795-A808) as an immunogenic linear B cell epitope within the P. vivax malaria vaccine candidate PvMSP9 and support its inclusion in future subunit vaccines.	[Rodrigues-da-Silva, Rodrigo Nunes; Oliveira-Ferreira, Joseli; Lima-Junior, Josue da Costa] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Imunoparasitol, Rio De Janeiro, RJ, Brazil; [Martins da Silva, Joao Herminio] FIOCRUZ CE, Computat Modeling Group, Fortaleza, Ceara, Brazil; [Singh, Balwan; Jiang, Jianlin; Moreno, Alberto; Galinski, Mary R.] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Meyer, Esmeralda V. S.] Emory Univ, Environm Hlth & Safety Off, Atlanta, GA 30322 USA; [Santos, Fatima] Natl Hlth Fdn, Dept Entomol, Cent Lab, Porto Velho, RO, Brazil; [Banic, Dalma Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Simulids & Onchocerciasis Malaria & Onchocerc, Rio De Janeiro, Brazil; [Moreno, Alberto; Galinski, Mary R.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Emory University; Emory University; Fundacao Oswaldo Cruz; Emory University	Oliveira-Ferreira, J; Lima, JD (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Imunoparasitol, Rio De Janeiro, RJ, Brazil.	lila@ioc.fiocruz.br; josue@ioc.fiocruz.br	da Costa Lima-Junior, Josue/AAI-4746-2021; Oliveira-Ferreira, Joseli/E-7942-2014	da Costa Lima-Junior, Josue/0000-0002-5848-404X; Oliveira-Ferreira, Joseli/0000-0002-6063-465X; Rodrigues-da-Silva, Rodrigo Nunes/0000-0002-9772-849X; Moreno, Alberto/0000-0002-3031-7194	Brazilian National Research Council - CNPq/PAPES, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Apoio Pesquisa Estrategica em Saude) Fiocruz; National Institute of Health (NIH) [RO1 1R01AI24710]; Yerkes National Primate Research Center Base Grant - National Center for Research Resources of the National Institutes of Health [ORIP/OD P51OD011132]; FAPERJ-APQ1 [E-26/111.248/2014]; CPNq-Universal research grants [445150/2014-9]; CNPq Productivity Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024710] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Brazilian National Research Council - CNPq/PAPES, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Apoio Pesquisa Estrategica em Saude) Fiocruz(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerkes National Primate Research Center Base Grant - National Center for Research Resources of the National Institutes of Health; FAPERJ-APQ1(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CPNq-Universal research grants; CNPq Productivity Fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Brazilian National Research Council - CNPq/PAPES, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Apoio Pesquisa Estrategica em Saude) Fiocruz, the National Institute of Health (NIH Grant #RO1 1R01AI24710), and the Yerkes National Primate Research Center Base Grant (ORIP/OD P51OD011132) awarded by the National Center for Research Resources of the National Institutes of Health. JCLJ is recipient of a FAPERJ-APQ1 (E-26/111.248/2014) and CPNq-Universal research grants (445150/2014-9), JOF is recipient of CNPq Productivity Fellowship.; We are grateful to all individuals who participated in this study, for their cooperation and generous donation of blood, which made this study possible. We thank the Secretary of Health of Rondonia State and the Laboratorio Central-LACEN of Rondonia for supporting fieldwork. This work was supported by Brazilian National Research Council-CNPq/PAPES, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Apoio Pesquisa Estrategica em Saude) Fiocruz, the National Institute of Health (NIH Grant #RO1 1R01AI24710), and the Yerkes National Primate Research Center Base Grant (ORIP/OD P51OD011132) awarded by the National Center for Research Resources of the National Institutes of Health. JCLJ is recipient of a FAPERJ-APQ1 (E-26/111.248/2014) and CPNq-Universal research grants (445150/2014-9), JOF is recipient of CNPq Productivity Fellowship.	Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amante Fiona H, 2011, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1904s93; ARIAS AE, 1989, TROP MED PARASITOL, V40, P21; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barnwell JW, 1999, EXP PARASITOL, V91, P238, DOI 10.1006/expr.1998.4372; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Bueno LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021289; Caro-Aguilar I, 2005, MICROBES INFECT, V7, P1324, DOI 10.1016/j.micinf.2005.04.020; Cespedes N, 2014, VACCINE, V32, P3179, DOI 10.1016/j.vaccine.2014.04.007; Cespedes N, 2013, VACCINE, V31, P4923, DOI 10.1016/j.vaccine.2013.05.082; Chenet SM, 2013, INFECT GENET EVOL, V20, P239, DOI 10.1016/j.meegid.2013.09.011; Cheng Y, 2014, PARASITOL RES, V113, P2559, DOI 10.1007/s00436-014-3907-8; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; GAUSEPOHL H, 1992, PEPTIDE RES, V5, P315; Gougoutsi A, 2014, VECTOR-BORNE ZOONOT, V14, P378, DOI 10.1089/vbz.2012.1192; GROUX H, 1990, RES IMMUNOL, V141, P529, DOI 10.1016/0923-2494(90)90021-P; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hermsen CC, 2007, VACCINE, V25, P2930, DOI 10.1016/j.vaccine.2006.06.081; Herrera S, 2005, AM J TROP MED HYG, V73, P3, DOI 10.4269/ajtmh.2005.73.3; Herrera S, 2004, INT J PARASITOL, V34, P1535, DOI 10.1016/j.ijpara.2004.10.009; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; Kristensen KL, 2014, SCAND J INFECT DIS, V46, P63, DOI 10.3109/00365548.2013.822093; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Lima JC, 2011, VACCINE, V29, P1801, DOI 10.1016/j.vaccine.2010.12.099; Lima JC, 2010, VACCINE, V28, P3185, DOI 10.1016/j.vaccine.2010.02.046; Lima-Junior JC, 2008, VACCINE, V26, P6645, DOI 10.1016/j.vaccine.2008.09.029; Lima JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036419; Lopera-Mesa TM, 2008, VACCINE, V26, P1335, DOI 10.1016/j.vaccine.2007.12.042; Mahanty S, 2003, J EXP BIOL, V206, P3781, DOI 10.1242/jeb.00646; Nair M, 2002, J MOL BIOL, V322, P741, DOI 10.1016/S0022-2836(02)00806-9; Nayar JK, 1997, J PARASITOL, V83, P739, DOI 10.2307/3284254; Nogueira PA, 2006, INFECT IMMUN, V74, P2726, DOI 10.1128/IAI.74.5.2726-2733.2006; O'Brien AT, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-404; Oliveira-Ferreira J, 2004, VACCINE, V22, P2023, DOI 10.1016/j.vaccine.2003.07.021; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Organization WH, TABL MAL VACC PROJ G; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Polley SD, 2004, TRENDS PARASITOL, V20, P99, DOI 10.1016/j.pt.2003.12.003; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Rahimi BA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-481; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; Schrodinger L., 2020, PYMOL; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Silva-Flannery LM, 2009, MICROBES INFECT, V11, P83, DOI 10.1016/j.micinf.2008.10.009; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Soares LA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/671050; Stanisic DI, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002498; Storti-Melo LM, 2011, AM J TROP MED HYG, V84, P58, DOI 10.4269/ajtmh.2011.10-0044; SVS-SIVEP-Malaria MdS, SIST INF VIG EP NOT; Tan LKK, 2008, LANCET INFECT DIS, V8, P449, DOI 10.1016/S1473-3099(08)70153-1; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vargas-Serrato E, 2002, MOL BIOCHEM PARASIT, V120, P41, DOI 10.1016/S0166-6851(01)00433-9; Vargas-Serrato E, 2003, INFECT GENET EVOL, V3, P67, DOI 10.1016/S1567-1348(03)00007-8; Versiani FG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-294; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039; Zubairi ABS, 2013, EMERG INFECT DIS, V19, P1851, DOI 10.3201/eid1911.130495	75	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146951	10.1371/journal.pone.0146951	http://dx.doi.org/10.1371/journal.pone.0146951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788998	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100049
J	Ben-Dov, IZ; Whalen, VM; Goilav, B; Max, KEA; Tuschl, T				Ben-Dov, Iddo Z.; Whalen, Veronica M.; Goilav, Beatrice; Max, Klaas E. A.; Tuschl, Thomas			Cell and Microvesicle Urine microRNA Deep Sequencing Profiles from Healthy Individuals: Observations with Potential Impact on Biomarker Studies	PLOS ONE			English	Article							EXPRESSION ANALYSIS; BIOCONDUCTOR	Background Urine is a potential source of biomarkers for diseases of the kidneys and urinary tract. RNA, including microRNA, is present in the urine enclosed in detached cells or in extracellular vesicles (EVs) or bound and protected by extracellular proteins. Detection of cell-and disease-specific microRNA in urine may aid early diagnosis of organ-specific pathology. In this study, we applied barcoded deep sequencing to profile microRNAs in urine of healthy volunteers, and characterized the effects of sex, urine fraction (cells vs. EVs) and repeated voids by the same individuals. Results Compared to urine-cell-derived small RNA libraries, urine-EV-derived libraries were relatively enriched with miRNA, and accordingly had lesser content of other small RNA such as rRNA, tRNA and sn/snoRNA. Unsupervised clustering of specimens in relation to miRNA expression levels showed prominent bundling by specimen type (urine cells or EVs) and by sex, as well as a tendency of repeated (first and second void) samples to neighbor closely. Likewise, miRNA profile correlations between void repeats, as well as fraction counterparts (cells and EVs from the same specimen) were distinctly higher than correlations between miRNA profiles overall. Differential miRNA expression by sex was similar in cells and EVs. Conclusions miRNA profiling of both urine EVs and sediment cells can convey biologically important differences between individuals. However, to be useful as urine biomarkers, careful consideration is needed for biofluid fractionation and sex-specific analysis, while the time of voiding appears to be less important.	[Ben-Dov, Iddo Z.] Hadassah Hebrew Univ, Med Ctr, Nephrol & Hypertens, Jerusalem, Israel; [Whalen, Veronica M.] Rockefeller Univ, Rockefeller Univ Hosp, 1230 York Ave, New York, NY 10021 USA; [Goilav, Beatrice] Childrens Hosp Montefiore, Albert Einstein Coll Med, Pediat Nephrol, Bronx, NY USA; [Max, Klaas E. A.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, 1230 York Ave, New York, NY 10021 USA; [Whalen, Veronica M.] Appeals Metro Plus Hlth Plan, New York, NY USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Rockefeller University	Ben-Dov, IZ (corresponding author), Hadassah Hebrew Univ, Med Ctr, Nephrol & Hypertens, Jerusalem, Israel.	iddo@hadassah.org.il	Ben-Dov, Iddo/F-3282-2010; Goilav, Beatrice/AAF-8349-2021	Ben-Dov, Iddo/0000-0002-9180-3604; 	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]; NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH [UH2TR000933]; NATIONAL CANCER INSTITUTE [U19CA179564] Funding Source: NIH RePORTER	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	IZB-D is supported by the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (Grant No. 41/11). The work described in this manuscript was also supported by grant number UH2TR000933 awarded to TT by the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Dov IZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086856; Carey V, MLIINTERFACES UNIFOR; Emerson JW, 2008, BIOMETRICS, V64, P1301, DOI [10.1111/j.1541-0420.2008.01138_4.x, DOI 10.1111/J.1541-0420.2008.01138_]; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goligorsky MS, 2007, J AM SOC NEPHROL, V18, P2233, DOI 10.1681/ASN.2006121399; International Federation of Clinical Chemistry (IFCC), 1984, CLIN CHIMICA ACTA, V139, p205F; Li X, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0039-3; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nissan X, 2011, DEV BIOL, V356, P506, DOI 10.1016/j.ydbio.2011.06.004; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Swayne DF, 2004, COMPSTAT 2004: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P477; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xie MY, 2013, CELL, V155, P1568, DOI 10.1016/j.cell.2013.11.027	15	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147249	10.1371/journal.pone.0147249	http://dx.doi.org/10.1371/journal.pone.0147249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785265	gold, Green Submitted, Green Published			2022-12-26	WOS:000368528400129
J	Irazoki, O; Mayola, A; Campoy, S; Barbe, J				Irazoki, Oihane; Mayola, Albert; Campoy, Susana; Barbe, Jordi			SOS System Induction Inhibits the Assembly of Chemoreceptor Signaling Clusters in Salmonella enterica	PLOS ONE			English	Article							ESCHERICHIA-COLI; SWARMING MOTILITY; PSEUDOMONAS-AERUGINOSA; CELL-DIFFERENTIATION; CHEMOTAXIS SYSTEM; RECA PROTEIN; WILD-TYPE; GENE; DNA; SURFACE	Swarming, a flagellar-driven multicellular form of motility, is associated with bacterial virulence and increased antibiotic resistance. In this work we demonstrate that activation of the SOS response reversibly inhibits swarming motility by preventing the assembly of chemoreceptor-signaling polar arrays. We also show that an increase in the concentration of the RecA protein, generated by SOS system activation, rather than another function of this genetic network impairs chemoreceptor polar cluster formation. Our data provide evidence that the molecular balance between RecA and CheW proteins is crucial to allow polar cluster formation in Salmonella enterica cells. Thus, activation of the SOS response by the presence of a DNA-injuring compound increases the RecA concentration, thereby disturbing the equilibrium between RecA and CheW and resulting in the cessation of swarming. Nevertheless, when the DNA-damage decreases and the SOS response is no longer activated, basal RecA levels and thus polar cluster assembly are reestablished. These results clearly show that bacterial populations moving over surfaces make use of specific mechanisms to avoid contact with DNA-damaging compounds.	[Irazoki, Oihane; Mayola, Albert; Campoy, Susana; Barbe, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, Edifici C, Bellaterra 08193, Barcelona, Spain	Autonomous University of Barcelona	Campoy, S (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Edifici C, Bellaterra 08193, Barcelona, Spain.	Susana.Campoy@uab.cat	campoy, susana/E-4346-2010; Campoy, Susana/C-7335-2008; Irazoki, Oihane/G-8416-2015	campoy, susana/0000-0003-1369-0197; Campoy, Susana/0000-0003-1369-0197; Irazoki, Oihane/0000-0002-8896-7480	Ministerio de Ciencia e Innovacion de Espana [BFU2011-23478]; Generalitat de Catalunya [2014SGR572]	Ministerio de Ciencia e Innovacion de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by grants BFU2011-23478 from the Ministerio de Ciencia e Innovacion de Espana (http://www.idi.mineco.gob.es/) and 2014SGR572 from the Generalitat de Catalunya (http://web.gencat.cat).; This study was supported by grants BFU2011-23478 from the Ministerio de Ciencia e Innovacion de Espana and 2014SGR572 from the Generalitat de Catalunya. The funders had no role in the design of the study, in data collection and analysis, in the decision to publish, or in preparation of the manuscript.	Attmannspacher U, 2008, MOL MICROBIOL, V68, P328, DOI 10.1111/j.1365-2958.2008.06170.x; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Barak JD, 2009, MICROBIOL-SGM, V155, P3701, DOI 10.1099/mic.0.032029-0; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Bi SY, 2015, CELL MOL LIFE SCI, V72, P691, DOI 10.1007/s00018-014-1770-5; Brennan CA, 2013, APPL ENVIRON MICROB, V79, P1889, DOI 10.1128/AEM.03794-12; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; Burkart M, 1998, P NATL ACAD SCI USA, V95, P2568, DOI 10.1073/pnas.95.5.2568; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Campoy S, 2002, MICROBIOL-SGM, V148, P1039, DOI 10.1099/00221287-148-4-1039; Cardozo MJ, 2010, MOL MICROBIOL, V75, P1171, DOI 10.1111/j.1365-2958.2009.07032.x; CAYROL C, 1995, P NATL ACAD SCI USA, V92, P11806, DOI 10.1073/pnas.92.25.11806; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Du HJ, 2012, BIOPHYS J, V103, P601, DOI 10.1016/j.bpj.2012.06.035; Erill I, 2003, BIOINFORMATICS, V19, P2225, DOI 10.1093/bioinformatics/btg303; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Gestwicki JE, 2000, J BACTERIOL, V182, P6499, DOI 10.1128/JB.182.22.6499-6502.2000; GINSBURG H, 1982, MOL GEN GENET, V187, P4, DOI 10.1007/BF00384376; Gomez-Gomez JM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-14; Gotoh H, 2010, Biofouling, V26, P603, DOI 10.1080/08927014.2010.501895; Green M, LAB MANUAL; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Ingham CJ, 2011, P NATL ACAD SCI USA, V108, P19731, DOI 10.1073/pnas.1102097108; Jurica MS, 1998, STRUCT FOLD DES, V6, P809, DOI 10.1016/S0969-2126(98)00082-3; Katribe E, 2009, J BACTERIOL, V191, P2843, DOI 10.1128/JB.01223-08; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Khursigara CM, 2011, EMBO J, V30, P1719, DOI 10.1038/emboj.2011.77; Kim W, 2004, MOL MICROBIOL, V54, P702, DOI 10.1111/j.1365-2958.2004.04295.x; Kim W, 2003, J BACTERIOL, V185, P3111, DOI 10.1128/JB.185.10.3111-3117.2003; Kim Wook, 2003, Biological Procedures Online, V5, P189, DOI 10.1251/bpo61; Latasa C, 2012, J BACTERIOL, V194, P3708, DOI 10.1128/JB.00361-12; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; MADDOCK JR, 1993, SCIENCE, V259, P1717; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mariconda S, 2006, MOL MICROBIOL, V60, P1590, DOI 10.1111/j.1365-2958.2006.05208.x; Martinez I a., 2013, PLOS ONE, V8, P17, DOI [10.1371/journal.pone.0061630, DOI 10.1371/J0URNAL.P0NE.0061630]; Mayola A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105578; MCCARTER L, 1990, MOL MICROBIOL, V4, P1057, DOI 10.1111/j.1365-2958.1990.tb00678.x; Medina-Ruiz L, 2010, INFECT IMMUN, V78, P3217, DOI 10.1128/IAI.01321-09; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Nakajima K, 2008, BIOMED RES-TOKYO, V29, P9, DOI 10.2220/biomedres.29.9; O'May C, 2011, APPL ENVIRON MICROB, V77, P3061, DOI 10.1128/AEM.02677-10; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; Partridge JD, 2013, J BACTERIOL, V195, P919, DOI 10.1128/JB.02064-12; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; POWER EGM, 1992, J MED MICROBIOL, V36, P78, DOI 10.1099/00222615-36-2-78; Raterman EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054133; Rauprich O, 1996, J BACTERIOL, V178, P6525, DOI 10.1128/jb.178.22.6525-6538.1996; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Roth D, 2013, ENVIRON MICROBIOL, V15, P2532, DOI 10.1111/1462-2920.12160; SALLES B, 1987, J BACTERIOL, V169, P5028, DOI 10.1128/jb.169.11.5028-5034.1987; Santos TMA, 2014, MOL MICROBIOL, V92, P985, DOI 10.1111/mmi.12609; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; SCHOEMAKER JM, 1984, J BACTERIOL, V158, P551, DOI 10.1128/JB.158.2.551-561.1984; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; SWENSON PA, 1978, J BACTERIOL, V135, P1167, DOI 10.1128/JB.135.3.1167-1170.1978; WALKER GC, 1985, ENVIRON HEALTH PERSP, V62, P115, DOI 10.2307/3430102; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x	74	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146685	10.1371/journal.pone.0146685	http://dx.doi.org/10.1371/journal.pone.0146685			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784887	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400058
J	Martin-Fernandez, L; Ziyatdinov, A; Carrasco, M; Millon, JA; Martinez-Perez, A; Vilalta, N; Brunel, H; Font, M; Hamsten, A; Souto, JC; Soria, JM				Martin-Fernandez, Laura; Ziyatdinov, Andrey; Carrasco, Marina; Antonio Millon, Juan; Martinez-Perez, Angel; Vilalta, Noelia; Brunel, Helena; Font, Montserrat; Hamsten, Anders; Carlos Souto, Juan; Manuel Soria, Jose			Genetic Determinants of Thrombin Generation and Their Relation to Venous Thrombosis: Results from the GAIT-2 Project	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PLASMA; THROMBOEMBOLISM; SUSCEPTIBILITY; DISEASE; RISK; COAGULATION; HEMOSTASIS; PHENOTYPES; STROKE	Background Venous thromboembolism (VTE) is a common disease where known genetic risk factors explain only a small portion of the genetic variance. Then, the analysis of intermediate phenotypes, such as thrombin generation assay, can be used to identify novel genetic risk factors that contribute to VTE. Objectives To investigate the genetic basis of distinct quantitative phenotypes of thrombin generation and its relationship to the risk of VTE. Patients/Methods Lag time, thrombin peak and endogenous thrombin potential (ETP) were measured in the families of the Genetic Analysis of Idiopathic Thrombophilia 2 (GAIT-2) Project. This sample consisted of 935 individuals in 35 extended families selected through a proband with idiopathic thrombophilia. We performed also genome wide association studies (GWAS) with thrombin generation phenotypes. Results The results showed that 67% of the variation in the risk of VTE is attributable to genetic factors. The heritabilities of lag time, thrombin peak and ETP were 49%, 54% and 52%, respectively. More importantly, we demonstrated also the existence of positive genetic correlations between thrombin peak or ETP and the risk of VTE. Moreover, the major genetic determinant of thrombin generation was the F2 gene. However, other suggestive signals were observed. Conclusions The thrombin generation phenotypes are strongly genetically determined. The thrombin peak and ETP are significantly genetically correlated with the risk of VTE. In addition, F2 was identified as a major determinant of thrombin generation. We reported suggestive signals that might increase our knowledge to explain the variability of this important phenotype. Validation and functional studies are required to confirm GWAS results.	[Martin-Fernandez, Laura; Ziyatdinov, Andrey; Martinez-Perez, Angel; Brunel, Helena; Manuel Soria, Jose] Biomed Res Inst St Pau IIB St Pau, Unit Genom Complex Dis, Barcelona, Spain; [Carrasco, Marina; Antonio Millon, Juan; Vilalta, Noelia; Font, Montserrat; Carlos Souto, Juan] Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Hematol, Unit Hemostasis & Thrombosis, Barcelona, Spain; [Hamsten, Anders] Karolinska Univ Hosp Solna, Karolinska Inst, Cardiovasc Genet & Genom Grp, Atherosclerosis Res Unit,Dept Med, Stockholm, Sweden	Hospital of Santa Creu i Sant Pau; Karolinska Institutet; Karolinska University Hospital	Souto, JC (corresponding author), Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Hematol, Unit Hemostasis & Thrombosis, Barcelona, Spain.	jsouto@santpau.cat	Soria Fernández, José Manuel/AAD-6761-2019; Martinez-Perez, Angel/AAC-4339-2019	Soria Fernández, José Manuel/0000-0002-6226-4293; Martinez-Perez, Angel/0000-0002-5934-1454; Martin-Fernandez, Laura/0000-0002-8909-508X; , Noelia Vilalta/0000-0002-3961-3563	Instituto de Salud Carlos III Fondo de Investigacion Sanitaria [PI 11/0184]; Red Investigacion Cardiovascular [RD12/0042/0032]; Generalitat de Catalunya [AGAUR 2009 SGR 1147]; Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS) [FI12/00322]; Fundacio Josep Carreras contra la leucemia and Institut Josep Carreras (IJC)	Instituto de Salud Carlos III Fondo de Investigacion Sanitaria(Instituto de Salud Carlos IIIEuropean Commission); Red Investigacion Cardiovascular; Generalitat de Catalunya(Generalitat de Catalunya); Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS); Fundacio Josep Carreras contra la leucemia and Institut Josep Carreras (IJC)	This study was supported by funds from the Instituto de Salud Carlos III Fondo de Investigacion Sanitaria PI 11/0184, Red Investigacion Cardiovascular RD12/0042/0032 and AGAUR 2009 SGR 1147 from Generalitat de Catalunya. Laura Martin-Fernandez was supported by Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS) FI12/00322. Juan Antonio Millon was supported by Fundacio Josep Carreras contra la leucemia and Institut Josep Carreras (IJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Baglin T, 2005, BRIT J HAEMATOL, V130, P653, DOI 10.1111/j.1365-2141.2005.05612.x; Besser M, 2008, J THROMB HAEMOST, V6, P1720, DOI 10.1111/j.1538-7836.2008.03117.x; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; Buil A, 2010, BLOOD, V115, P4644, DOI 10.1182/blood-2010-01-263038; Carcaillon L, 2011, ARTERIOSCL THROM VAS, V31, P1445, DOI 10.1161/ATVBAHA.111.223453; Comuzzie AG, 1996, J CLIN ENDOCR METAB, V81, P597, DOI 10.1210/jc.81.2.597; Dargaud Y, 2006, THROMB HAEMOSTASIS, V96, P562, DOI 10.1160/TH06-03-0179; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dielis AWJH, 2008, J THROMB HAEMOST, V6, P125; Faber CG, 2003, PATHOPHYSIOL HAEMO T, V33, P52, DOI 10.1159/000071642; Heit JA, 2004, J THROMB HAEMOST, V2, P731, DOI 10.1111/j.1538-7933.2004.00660.x; Hemker HC, 2000, THROMB HAEMOSTASIS, V84, P747; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HEMKER HC, 1993, THROMB HAEMOSTASIS, V70, P617; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Kyrle PA, 1998, ARTERIOSCL THROM VAS, V18, P1287, DOI 10.1161/01.ATV.18.8.1287; Loeffen R, 2012, J THROMB HAEMOST, V10, P2544, DOI 10.1111/jth.12012; Lutsey PL, 2009, J THROMB HAEMOST, V7, P1639, DOI 10.1111/j.1538-7836.2009.03561.x; Lynch M., 1998, GENETICS ANAL QUANTI; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morange PE, 2010, BRIT J HAEMATOL, V148, P495, DOI 10.1111/j.1365-2141.2009.07975.x; Orbe J, 2008, THROMB HAEMOSTASIS, V99, P382, DOI 10.1160/TH07-07-0443; Rocanin-Arjo A, 2014, BLOOD, V123, P777, DOI 10.1182/blood-2013-10-529628; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosendaal Frits R, 2005, Hematology Am Soc Hematol Educ Program, P1; Segers O, 2010, THROMB HAEMOSTASIS, V103, P114, DOI 10.1160/TH09-06-0356; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Soria JM, 2002, AM J HUM GENET, V70, P567, DOI 10.1086/339259; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2002, PATHOPHYSIOL HAEMO T, V32, P338, DOI 10.1159/000073593; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Souto JC, 2001, THROMB HAEMOSTASIS, V85, P88; Tchaikovski SN, 2007, THROMB HAEMOSTASIS, V98, P1350, DOI 10.1160/TH07-07-0439; Tripodi A, 2008, J THROMB HAEMOST, V6, P1327, DOI 10.1111/j.1538-7836.2008.03018.x; van Veen JJ, 2008, BRIT J HAEMATOL, V142, P889, DOI 10.1111/j.1365-2141.2008.07267.x; Vlieg AV, 2007, BRIT J HAEMATOL, V138, P769, DOI 10.1111/j.1365-2141.2007.06738.x; Wichers IM, 2009, THROMB HAEMOSTASIS, V101, P465, DOI 10.1160/TH08-06-0405	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146922	10.1371/journal.pone.0146922	http://dx.doi.org/10.1371/journal.pone.0146922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784699	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400079
J	Miyashita, A; Kizaki, H; Sekimizu, K; Kaito, C				Miyashita, Atsushi; Kizaki, Hayato; Sekimizu, Kazuhisa; Kaito, Chikara			No Effect of Body Size on the Frequency of Calling and Courtship Song in the Two-Spotted Cricket, Gryllus bimaculatus	PLOS ONE			English	Article							VOCAL-TRACT LENGTH; SOUND PRODUCTION; FIELD CRICKET; SYMMETRY; SIGNALS; GEER	The relationship between body size and vocalization parameters has been studied in many animal species. In insect species, however, the effect of body size on song frequency has remained unclear. Here we analyzed the effect of body size on the frequency spectra of mating songs produced by the two-spotted cricket, Gryllus bimaculatus. We recorded the calling songs and courtship songs of male crickets of different body sizes. The calling songs contained a frequency component that peaked at 5.7 kHz. On the other hand, courtship songs contained two frequency components that peaked at 5.8 and 14.7 kHz. The dominant frequency of each component in both the calling and courtship songs was constant regardless of body size. The size of the harp and mirror regions in the cricket forewings, which are the acoustic sources of the songs, correlated positively with body size. These findings suggest that the frequency contents of both the calling and courtship songs of the cricket are unaffected by whole body, harp, or mirror size.	[Miyashita, Atsushi; Kizaki, Hayato; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Miyashita, Atsushi/0000-0002-9076-0569	Japan Society for the Promotion of Science [26670025, 25-8664]; Mishima Kaiun Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	This study was supported by Grants-in-Aid for Scientific Research 26670025, the Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant 25-8664 (to A.M.), and the Mishima Kaiun Memorial Foundation (to A.M.). The funders had no role in the study design, data collection, or analysis; decision to publish; or preparation of the manuscript.	Bennet-Clark HC, 2002, J EXP BIOL, V205, P613; Cardoso GC, 2008, ETHOLOGY, V114, P1084, DOI 10.1111/j.1439-0310.2008.01552.x; DOHERTY JA, 1985, J EXP BIOL, V114, P17; ELLIOTT CJH, 1985, NATURWISSENSCHAFTEN, V72, P150, DOI 10.1007/BF00490404; Ferreira M, 2002, J ZOOL, V257, P163, DOI 10.1017/S0952836902000766; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Gray DA, 1997, ANIM BEHAV, V54, P1553, DOI 10.1006/anbe.1997.0584; Hall ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056717; KATSUKI Y, 1960, J EXP BIOL, V37, P279; Kostarakos K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-22; LIBERSAT F, 1994, J COMP PHYSIOL A, V174, P485, DOI 10.1007/BF00191714; McClelland BE, 1996, J EXP BIOL, V199, P1907; Montealegre-Z F, 2012, SCIENCE, V338, P968, DOI 10.1126/science.1225271; POPOV AV, 1977, J COMP PHYSIOL, V119, P111, DOI 10.1007/BF00655876; Puechmaille SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103452; Riede T, 1999, J EXP BIOL, V202, P2859; Rodriguez RL, 2015, BEHAV ECOL, V26, P168, DOI 10.1093/beheco/aru174; Sell A, 2010, P ROY SOC B-BIOL SCI, V277, P3509, DOI 10.1098/rspb.2010.0769; Simmons LW, 1996, P ROY SOC B-BIOL SCI, V263, P1305, DOI 10.1098/rspb.1996.0191; Simmons LW, 1995, BEHAV ECOL, V6, P376, DOI 10.1093/beheco/6.4.376; STEPHEN RO, 1995, J EXP BIOL, V198, P2139; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; WEBB KL, 1992, ANIM BEHAV, V44, P823, DOI 10.1016/S0003-3472(05)80578-0; Yamamoto K, 2000, DYN DES C 2000, P333	24	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146999	10.1371/journal.pone.0146999	http://dx.doi.org/10.1371/journal.pone.0146999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785351	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400095
J	Murakami, Y; Hashimoto, S; Kawado, M; Ohta, A; Taniguchi, K; Sunagawa, T; Matsui, T; Nagai, M				Murakami, Yoshitaka; Hashimoto, Shuji; Kawado, Miyuki; Ohta, Akiko; Taniguchi, Kiyosu; Sunagawa, Tomimasa; Matsui, Tamano; Nagai, Masaki			Estimated Number of Patients with Influenza A(H1)pdm09, or Other Viral Types, from 2010 to 2014 in Japan	PLOS ONE			English	Article							SURVEILLANCE DATA; DISEASES; LESSONS	Infectious disease surveillance systems provide information crucial for protecting populations from influenza epidemics. However, few have reported the nationwide number of patients with influenza-like illness (ILI), detailing virological type. Using data from the infectious disease surveillance system in Japan, we estimated the weekly number of ILI cases by virological type, including pandemic influenza (A(H1)pdm09) and seasonal-type influenza (A(H3) and B) over a four-year period (week 36 of 2010 to week 18 of 2014). We used the reported number of influenza cases from nationwide sentinel surveillance and the proportions of virological types from infectious agents surveillance and estimated the number of cases and their 95% confidence intervals. For the 2010/11 season, influenza type A(H1) pdm09 was dominant: 6.48 million (6.33-6.63), followed by types A(H3): 4.05 million (3.90-4.21) and B: 2.84 million (2.71-2.97). In the 2011/12 season, seasonal influenza type A(H3) was dominant: 10.89 million (10.64-11.14), followed by type B: 5.54 million (5.32-5.75). In conclusion, close monitoring of the estimated number of ILI cases by virological type not only highlights the huge impact of previous influenza epidemics in Japan, it may also aid the prediction of future outbreaks, allowing for implementation of control and prevention measures.	[Murakami, Yoshitaka] Toho Univ, Dept Med Stat, Tokyo, Japan; [Hashimoto, Shuji; Kawado, Miyuki] Fujita Hlth Univ, Sch Med, Dept Hyg, Toyoake, Aichi, Japan; [Ohta, Akiko; Nagai, Masaki] Saitama Med Univ, Dept Publ Hlth, Fac Med, Saitama, Japan; [Taniguchi, Kiyosu] Natl Mie Hosp, Dept Pediat, Tsu, Mie, Japan; [Sunagawa, Tomimasa; Matsui, Tamano] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	Toho University; Fujita Health University; Saitama Medical University; National Institute of Infectious Diseases (NIID)	Murakami, Y (corresponding author), Toho Univ, Dept Med Stat, Tokyo, Japan.	yoshitaka.murakami@med.toho-u.ac.jp	Kawado, Miyuki/GPW-9240-2022	Kawado, Miyuki/0000-0002-5824-3289	Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Emerging and Re-emerging Infectious Disease)	Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Emerging and Re-emerging Infectious Disease)	This research was supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Emerging and Re-emerging Infectious Disease). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 2002, STAT METHODS MED RES, P161; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Fleming DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI 10.1017/S0950268807009910; Hashimoto S, 2003, J EPIDEMIOL, V13, P136, DOI 10.2188/jea.13.136; Hashimoto S, 2014, J EPIDEMIOL, V24, P183, DOI 10.2188/jea.JE20130077; Kawado M, 2007, J EPIDEMIOL, V17, pS32, DOI 10.2188/jea.17.S32; Lee JS, 2007, EPIDEMIOL INFECT, V135, P1117, DOI 10.1017/S0950268807007820; Nakamura Y, 2015, JPN J INFECT DIS, V68, P27, DOI 10.7883/yoken.JJID.2014.092; Ohshiro H, 1996, J Epidemiol, V6, pS81; Ohta A, 2014, JPN J INFECT DIS, V67, P368, DOI 10.7883/yoken.67.368; Reed C, 2014, MMWR-MORBID MORTAL W, V63, P1151; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Shimada T, 2009, EUROSURVEILLANCE, V14; Taniguchi K, 2007, J EPIDEMIOL, V17, pS3, DOI 10.2188/jea.17.S3; Tuberculosis and Infectious Diseases Control Division Health Service Bureau the Ministry of Health Labour and Welfare of Japan, 1999, WEEKLY NEWS PUBLIC H, V998, P14; Wang XL, 2010, EMERG INFECT DIS, V16, P1786, DOI 10.3201/eid1611.100323	17	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146520	10.1371/journal.pone.0146520	http://dx.doi.org/10.1371/journal.pone.0146520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784031	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400043
J	Ravva, SV; Sarreal, CZ				Ravva, Subbarao V.; Sarreal, Chester Z.			Persistence of F-Specific RNA Coliphages in Surface Waters from a Produce Production Region along the Central Coast of California	PLOS ONE			English	Article							MICROBIAL SOURCE TRACKING; TROPICAL URBAN CATCHMENT; ESCHERICHIA-COLI; ENTERIC VIRUSES; FECAL CONTAMINATION; RIVER WATER; WASTE-WATER; Q-BETA; SURVIVAL; BACTERIOPHAGES	F+RNA coliphages (FRNA) are used to source-track fecal contamination and as surrogates for enteric pathogen persistence in the environment. However, the environmental persistence of FRNA is not clearly understood and necessitates the evaluation of the survival of prototype and environmental isolates of FRNA representing all four genogroups in surface waters from the central coast of California. Water temperature played a significant role in persistence-all prototype and environmental strains survived significantly longer at 10 degrees C compared to 25 degrees C. Similarly, the availability of host bacterium was found to be critical in FRNA survival. In the absence of E. coli F-amp, all prototypes of FRNA disappeared rapidly with a D-value (days for one log reduction) of < 1.2 d from water samples incubated at 25 degrees C; the longest surviving prototype was SP. However, in the presence of the host, the order of persistence at 25 degrees C was QB>MS2>SP>GA and at 10 degrees C it was QB = MS2> GA> SP. Significant differences in survival were observed between prototypes and environmental isolates of FRNA. While most environmental isolates disappeared rapidly at 25 degrees C and in the absence of the host, members of genogroups GIII and GI persisted longer with the host compared to members of GII and GIV. Consequentially, FRNA based source tracking methods can be used to detect phages from recent fecal contamination along with those that persist longer in the environment as a result of cooler temperatures and increased host presence.	[Ravva, Subbarao V.; Sarreal, Chester Z.] ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA	United States Department of Agriculture (USDA)	Ravva, SV (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA.	subbarao.ravva@ars.usda.gov			U.S. Department of Agricuture (USDA), Agricultural Research Service CRIS project [2030-42000-046]	U.S. Department of Agricuture (USDA), Agricultural Research Service CRIS project	The work was funded by the U.S. Department of Agricuture (USDA), Agricultural Research Service CRIS project 2030-42000-046.	Allwood PB, 2004, J FOOD PROTECT, V67, P2387, DOI 10.4315/0362-028X-67.11.2387; [Anonymous], 2001, 821R01030 USEPA; Ballester Nicola A., 2005, Journal of Water and Health, V3, P59; Benjamin LA, 2015, EPIDEMIOL INFECT, V143, P81, DOI 10.1017/S0950268814000521; Benjamin L, 2013, INT J FOOD MICROBIOL, V165, P65, DOI 10.1016/j.ijfoodmicro.2013.04.003; Blanch AR, 2006, APPL ENVIRON MICROB, V72, P5915, DOI 10.1128/AEM.02453-05; Brion GM, 2002, WATER RES, V36, P2419, DOI 10.1016/S0043-1354(01)00547-4; Cole D, 2003, APPL ENVIRON MICROB, V69, P6507, DOI 10.1128/AEM.69.11.6507-6514.2003; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; FURUSE K, 1979, MICROBIOL IMMUNOL, V23, P867, DOI 10.1111/j.1348-0421.1979.tb02820.x; FURUSE K, 1978, APPL ENVIRON MICROB, V35, P995, DOI 10.1128/AEM.35.6.995-1002.1978; Gordon C, 2003, J APPL MICROBIOL, V95, P536, DOI 10.1046/j.1365-2672.2003.02010.x; Gourmelon M, 2010, WATER RES, V44, P4812, DOI 10.1016/j.watres.2010.07.061; Haramoto E, 2012, LETT APPL MICROBIOL, V54, P367, DOI 10.1111/j.1472-765X.2012.03221.x; Haramoto E, 2011, T ROY SOC TROP MED H, V105, P711, DOI 10.1016/j.trstmh.2011.08.004; HAVELAAR AH, 1993, APPL ENVIRON MICROB, V59, P2956, DOI 10.1128/AEM.59.9.2956-2962.1993; HAVELAAR AH, 1990, J APPL BACTERIOL, V69, P30, DOI 10.1111/j.1365-2672.1990.tb02908.x; Kirs M, 2007, APPL ENVIRON MICROB, V73, P808, DOI 10.1128/AEM.00399-06; Lee JE, 2011, SCI TOTAL ENVIRON, V412, P127, DOI 10.1016/j.scitotenv.2011.09.061; Liang L, 2015, APPL ENVIRON MICROB, V81, P850, DOI 10.1128/AEM.02670-14; Long SC, 2004, J WATER HEALTH, V2, P15, DOI 10.2166/wh.2004.0002; Love DC, 2008, J APPL MICROBIOL, V104, P1203, DOI 10.1111/j.1365-2672.2007.03646.x; Mieszkin S, 2013, J APPL MICROBIOL, V115, P897, DOI 10.1111/jam.12260; Mills S, 2013, GUT MICROBES, V4, P4, DOI 10.4161/gmic.22371; Muniesa M, 2009, WATER RES, V43, P1559, DOI 10.1016/j.watres.2008.12.038; Ogorzaly L, 2010, APPL ENVIRON MICROB, V76, P8019, DOI 10.1128/AEM.00917-10; Ogorzaly L, 2009, WATER RES, V43, P1257, DOI 10.1016/j.watres.2008.12.011; RAO VC, 1984, APPL ENVIRON MICROB, V48, P404, DOI 10.1128/AEM.48.2.404-409.1984; Ravva SV, 2015, ENVIRON SCI-PROC IMP, V17, P1249, DOI [10.1039/c4em00537f, 10.1039/C4EM00537F]; Rezaeinejad S, 2014, WATER RES, V58, P122, DOI 10.1016/j.watres.2014.03.051; Schaper M, 2002, APPL ENVIRON MICROB, V68, P3702, DOI 10.1128/AEM.68.8.3702-3707.2002; Sinton LW, 1999, APPL ENVIRON MICROB, V65, P3605; Skraber S, 2007, WATER SCI TECHNOL, V55, P377, DOI 10.2166/wst.2007.280; Tung-Thompson G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134277; Wilkes G, 2014, APPL ENVIRON MICROB, V80, P3708, DOI 10.1128/AEM.00254-14; Woody MA, 1997, J APPL MICROBIOL, V82, P431, DOI 10.1046/j.1365-2672.1997.00130.x; WOODY MA, 1995, APPL ENVIRON MICROB, V61, P1520, DOI 10.1128/AEM.61.4.1520-1526.1995; Yang YH, 2013, APPL ENVIRON MICROB, V79, P4564, DOI 10.1128/AEM.00612-13; YATES MV, 1985, APPL ENVIRON MICROB, V49, P778, DOI 10.1128/AEM.49.4.778-781.1985	39	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146623	10.1371/journal.pone.0146623	http://dx.doi.org/10.1371/journal.pone.0146623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784030	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400054
J	Li, B; Du, CL; Yuan, XZ; Willison, JHM; Xiao, HY				Li, Bo; Du, Chunlan; Yuan, Xingzhong; Willison, J. H. Martin; Xiao, Hongyan			Suitability of Taxodium distichum for Afforesting the Littoral Zone of the Three Gorges Reservoir	PLOS ONE			English	Article							RIPARIAN VEGETATION; FORESTED WETLANDS; ORGANIC-MATTER; CARBON POOLS; WATER-LEVEL; WINYAH BAY; SEED BANKS; KNEE ROOTS; L. RICH.; GROWTH	The littoral zone ecosystem of the Three Gorges Reservoir (TGR) has become significantly degraded by annual cycles of prolonged winter flooding and summer drought. For purposes of flood control and sediment management, the water level in the reservoir is lowered by 30 m during the summer monsoon season and raised again to 175 m above sea level each year at the end of the monsoon period. To explore an effective way to promote biodiversity and associated ecosystem services, we examined Taxodium distichum as a species for afforesting the littoral zone. Sapling growth variations were measured after two rounds of winter flooding. Dominant influence factors were determined by redundancy analysis. Herb community similarities between the experimental afforested areas and nearby control areas were assessed to detect the ecosystem influence of the experimental afforestation. 94.5% of saplings planted at elevations above 168 m survived. All measured growth indices (tree height, diameter at breast height, crown width and foliage density) decreased as the flood depth increased. Completely submerged saplings had a mean dieback height of -0.65 m. Greater initial foliage density led to increased tree height and stem diameter. Shannon-Wiener indices were not significantly different between plots in experimental and control areas, but the low similarity of herb communities between experimental and control areas (0.242 on average) suggested that afforestation would enrich plant community structure and improve littoral zone ecosystem stability. Because littoral zone afforestation provides several ecosystem services (habitat, carbon sink, water purification and landscaping), it is a promising revegetation model for the TGR.	[Li, Bo; Du, Chunlan] Chongqing Univ, Fac Architecture & Urban Planning, Chongqing 630044, Peoples R China; [Li, Bo] Chongqing Univ, Postdoctoral Stn Urban Rural Planning, Chongqing 630044, Peoples R China; [Yuan, Xingzhong] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 630044, Peoples R China; [Willison, J. H. Martin] Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS, Canada; [Xiao, Hongyan] Yangtze Normal Univ, Sch Chem & Chem Engn, Chongqing, Peoples R China	Chongqing University; Chongqing University; Chongqing University; Dalhousie University; Yangtze Normal University	Du, CL (corresponding author), Chongqing Univ, Fac Architecture & Urban Planning, Chongqing 630044, Peoples R China.; Yuan, XZ (corresponding author), Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 630044, Peoples R China.	cldu@163.com; xzyuan63@aliyun.com		Willison, J.H. Martin/0000-0003-3024-296X	National Natural Science Foundation of China [51278505]; Postdoctoral Foundation of China [2014M550458]; Special Postdoctoral Science Fund of Chongqing [Xm2014098]; Pengxi River Wetland Natural Reserve Management Bureau; Pengxi River Wetland Research Station	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Foundation of China(China Postdoctoral Science Foundation); Special Postdoctoral Science Fund of Chongqing; Pengxi River Wetland Natural Reserve Management Bureau; Pengxi River Wetland Research Station	This work was supported by the National Natural Science Foundation of China (grant number: 51278505 http://www.nsfc.gov.cn/publish/portal1/). This funder will afford the publication fee. It was also supported by the Postdoctoral Foundation of China (grant number: 2014M550458, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx) and Special Postdoctoral Science Fund of Chongqing (grant number: Xm2014098, URL: http://zhuanji.cqhrss.gov.cn/u/zhuanji/). These funders support for the preparation work of this manuscript.; We appreciate support from the Pengxi River Wetland Natural Reserve Management Bureau and the Pengxi River Wetland Research Station. We thank Kang Liu for his excellent picture of the LWE in Hanfeng Lake (Fig 5). The field assistance of Yazhou Huang is gratefully acknowledged.	Ai LiJiao, 2013, Journal of Nanjing Forestry University (Natural Sciences Edition), V37, P23; Awad J, 2015, SCI TOTAL ENVIRON, V529, P72, DOI 10.1016/j.scitotenv.2015.05.037; Berkley J, 2013, ECOL SOC, V18, DOI 10.5751/ES-05988-180469; Bernal B, 2012, GLOBAL CHANGE BIOL, V18, P1636, DOI 10.1111/j.1365-2486.2011.02619.x; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Butt MJ, 2010, WATER RESOUR MANAG, V24, P3701, DOI 10.1007/s11269-010-9627-7; Chen FangQing, 2015, Ecological Processes, V4; Chow AT, 2013, BIOGEOCHEMISTRY, V112, P571, DOI 10.1007/s10533-012-9750-z; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clewell AF, 1999, RESTOR ECOL, V7, P1, DOI 10.1046/j.1526-100X.1999.07101.x; CONNER WH, 1992, AM MIDL NAT, V127, P290, DOI 10.2307/2426535; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Day RH, 2006, ENVIRON EXP BOT, V55, P163, DOI 10.1016/j.envexpbot.2004.10.009; de Lima JA, 2009, REV ARVORE, V33, P685, DOI 10.1590/S0100-67622009000400011; Ernst KA, 2003, FOREST ECOL MANAG, V173, P261, DOI 10.1016/S0378-1127(02)00004-X; Faulkner SP, 2009, WETLANDS, V29, P809, DOI 10.1672/08-211.1; Giese LAB, 2003, FOREST ECOL MANAG, V180, P493, DOI 10.1016/S0378-1127(02)00644-8; Godinho C, 2010, ECOL RES, V25, P283, DOI 10.1007/s11284-009-0655-9; Gois KS, 2012, HYDROBIOLOGIA, V685, P109, DOI 10.1007/s10750-011-0843-9; Goni MA, 2003, ESTUAR COAST SHELF S, V57, P1023, DOI 10.1016/S0272-7714(03)00008-8; Haynes R. J., 2004, Ecological Restoration, V22, P170, DOI 10.3368/er.22.3.170; Hoeppner SS, 2008, FOREST ECOL MANAG, V256, P937, DOI 10.1016/j.foreco.2008.05.040; Holland EP, 2013, AUSTRAL ECOL, V38, P121, DOI 10.1111/j.1442-9993.2012.02384.x; HOSNER JF, 1958, ECOLOGY, V39, P371, DOI 10.2307/1931886; Jimenez MN, 2014, AGROFOREST SYST, V88, P935, DOI 10.1007/s10457-014-9737-y; Keeland BD, 1999, WETLANDS, V19, P149, DOI 10.1007/BF03161743; Keeland BD, 1997, WETLANDS, V17, P559, DOI 10.1007/BF03161522; Lei ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091394; Li B, 2011, ECOL ENG, V37, P1718, DOI 10.1016/j.ecoleng.2011.06.028; Li CX, 2010, WETL ECOL MANAG, V18, P485, DOI 10.1007/s11273-010-9181-3; Li CX, 2010, PLANT SOIL, V329, P481, DOI 10.1007/s11104-009-0174-z; Li ChangXiao, 2008, Scientia Silvae Sinicae, V44, P124; [李昌晓 LI ChangXiao], 2007, [生态学报, Acta Ecologica Sinica], V27, P4394; Li Y, 2014, FOREST ECOL MANAG, V327, P118, DOI 10.1016/j.foreco.2014.04.039; Liu Y, 2013, ENVIRON SCI POLLUT R, V20, P7142, DOI 10.1007/s11356-013-1896-2; Liu ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107636; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Matic V, 2009, ARCH BIOL SCI, V61, P475, DOI 10.2298/ABS0903475M; McKee SE, 2013, BIOMASS BIOENERG, V55, P130, DOI 10.1016/j.biombioe.2013.01.022; Middleton B, 2000, PLANT ECOL, V146, P169; Middleton BA, 2003, J APPL ECOL, V40, P1025, DOI 10.1111/j.1365-2664.2003.00866.x; Middleton BA., 2002, FLOOD PULSING WETLAN, P1; Mitsch WJ, 2013, LANDSCAPE ECOL, V28, P583, DOI 10.1007/s10980-012-9758-8; Mitsch WJ, 2007, WETLANDS, P201; MYERS RS, 1995, WETLANDS, V15, P141, DOI 10.1007/BF03160667; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Newmaster SG, 2006, CAN J FOREST RES, V36, P1218, DOI 10.1139/X06-021; Riggsbee JA, 2012, RIVER RES APPL, V28, P1439, DOI 10.1002/rra.1536; SCHIFF SL, 1990, WATER RESOUR RES, V26, P2949, DOI 10.1029/WR026i012p02949; Senzota R, 2010, AFR J ECOL, V48, P321, DOI 10.1111/j.1365-2028.2009.01110.x; Skeesick DG., 1991, WARMWATER FISHERIES, P149; Su XL, 2010, ACTA ECOLOGICA SINIC, V30, P2582; Sun Rong, 2011, Shengtaixue Zazhi, V30, P208; Susskind L, 2012, J APPL ECOL, V49, P47, DOI 10.1111/j.1365-2664.2011.02070.x; Tabacchi E, 2000, HYDROL PROCESS, V14, P2959, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2959::AID-HYP129&gt;3.0.CO;2-B; [谭淑端 TAN Shu-Duan], 2009, [生态学报, Acta Ecologica Sinica], V29, P3685; Tang Luo-Zhong, 2008, Zhiwu Shengtai Xuebao, V32, P1258, DOI 10.3773/j.issn.1005-264x.2008.06.006; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Waiser MJ, 2004, BIOGEOCHEMISTRY, V69, P263, DOI 10.1023/B:BIOG.0000031048.20050.4e; Wang GB, 2012, S AFR J BOT, V81, P71, DOI 10.1016/j.sajb.2012.05.008; [王海锋 WANG HaiFeng], 2008, [生态学报, Acta Ecologica Sinica], V28, P2571; Wang Q, 2009, J CHONGQING NORMAL U, V26, P48; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100889; [王晓荣 Wang Xiaorong], 2010, [生态学报, Acta Ecologica Sinica], V30, P5821; Wang YH, 2013, J SICHUAN FORESTRY S, V34, P10; [王育松 Wang Yusong], 2010, [山西大学学报. 自然科学版, Journal of Shanxi University], V33, P312; Watson JEM, 2005, BIODIVERS CONSERV, V14, P523, DOI 10.1007/s10531-004-3913-8; Willison JHM, 2013, ENVIRON SCI POLLUT R, V20, P6907, DOI 10.1007/s11356-012-1438-3; Xian XD, 2015, ENVIRON SCI POLLUT R, V22, P12576, DOI 10.1007/s11356-015-4524-5; Xiao Y, 2009, AQUAT BOT, V91, P231, DOI 10.1016/j.aquabot.2009.07.001; Xu Haigen, 2012, NeoBiota, V15, P1; Xu SJ, 2011, ACTA PEDOLOGICA SINI, V48, P161; YAMAMOTO F, 1992, IAWA BULL, V13, P93, DOI 10.1163/22941932-90000560; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108725; Yin YL, 2014, CHINA FORESTRY SCI T, V28, P110; Yuan XZ, 2013, ENVIRON SCI POLLUT R, V20, P7092, DOI 10.1007/s11356-012-1404-0; [No title captured]	78	2	6	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146664	10.1371/journal.pone.0146664	http://dx.doi.org/10.1371/journal.pone.0146664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771509	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300027
J	Dahl, JM; Lieberman, KR; Wang, HY				Dahl, Joseph M.; Lieberman, Kate R.; Wang, Hongyun			Modulation of DNA Polymerase Noncovalent Kinetic Transitions by Divalent Cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA replication; enzyme kinetics; enzyme mechanism; single-molecule biophysics	CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; COMPLEXES; MECHANISM; REPLICATION; TRANSLOCATION; PHI-29; SUBSTRATE; DYNAMICS	Replicative DNA polymerases (DNAPs) require divalent metal cations for phosphodiester bond formation in the polymerase site and for hydrolytic editing in the exonuclease site. Me2+ ions are intimate architectural components of each active site, where they are coordinated by a conserved set of amino acids and functional groups of the reaction substrates. Therefore Me2+ ions can influence the noncovalent transitions that occur during each nucleotide addition cycle. Using a nanopore, transitions in individual phi 29 DNAP complexes are resolved with single-nucleotide spatial precision and sub-millisecond temporal resolution. We studied Mg2+ and Mn2+, which support catalysis, and Ca2+, which supports deoxynucleoside triphosphate (dNTP) binding but not catalysis. We examined their effects on translocation, dNTP binding, and primer strand transfer between the polymerase and exonuclease sites. All three metals cause a concentration-dependent shift in the translocation equilibrium, predominantly by decreasing the forward translocation rate. Me2+ also promotes an increase in the backward translocation rate that is dependent upon the primer terminal 3-OH group. Me2+ modulates the translocation rates but not their response to force, suggesting that Me2+ does not affect the distance to the transition state of translocation. Absent Me2+, the primer strand transfer pathway between the polymerase and exonuclease sites displays additional kinetic states not observed at >1 mm Me2+. Complementary dNTP binding is affected by Me2+ identity, with Ca2+ affording the highest affinity, followed by Mn2+, and then Mg2+. Both Ca2+ and Mn2+ substantially decrease the dNTP dissociation rate relative to Mg2+, while Ca2+ also increases the dNTP association rate.	[Dahl, Joseph M.; Lieberman, Kate R.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Wang, Hongyun] Univ Calif Santa Cruz, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Wang, HY (corresponding author), Univ Calif Santa Cruz, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA.; Lieberman, KR (corresponding author), Baskin Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.	krlieberman@gmail.com; hongwang@soe.ucsc.edu			National Institutes of Health from NIGMS [R01GM087484]; National Science Foundation [DGE 1339067]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R25HG006836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087484] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM087484 from NIGMS (to K. R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an National Science Foundation Graduate Research Fellowship DGE 1339067.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Dahl JM, 2014, BIOCHEMISTRY-US, V53, P8061, DOI 10.1021/bi501216a; Dahl JM, 2014, J BIOL CHEM, V289, P6350, DOI 10.1074/jbc.M113.535666; Dahl JM, 2012, J BIOL CHEM, V287, P13407, DOI 10.1074/jbc.M111.338418; de Vega M, 1999, J MOL BIOL, V292, P39, DOI 10.1006/jmbi.1999.3052; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; ESTEBAN JA, 1992, BIOCHEMISTRY-US, V31, P350, DOI 10.1021/bi00117a006; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; Fersht A., 1985, ENZYME STRUCTURE MEC; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garalde DR, 2011, J BIOL CHEM, V286, P14480, DOI 10.1074/jbc.M111.218750; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; Hogg M, 2014, NAT STRUCT MOL BIOL, V21, P49, DOI 10.1038/nsmb.2712; Johansson E, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012799; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Kirby TW, 2012, NUCLEIC ACIDS RES, V40, P2974, DOI 10.1093/nar/gkr1218; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Lieberman KR, 2014, J AM CHEM SOC, V136, P7117, DOI 10.1021/ja5026408; Lieberman KR, 2013, J AM CHEM SOC, V135, P9149, DOI 10.1021/ja403640b; Lieberman KR, 2012, J AM CHEM SOC, V134, P18816, DOI 10.1021/ja3090302; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Miyabe I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002407; Morin JA, 2012, P NATL ACAD SCI USA, V109, P8115, DOI 10.1073/pnas.1204759109; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Salas M, 2008, IUBMB LIFE, V60, P82, DOI 10.1002/iub.19; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wang MN, 2011, BIOCHEMISTRY-US, V50, P581, DOI 10.1021/bi101192f; Wang M, 2009, BIOCHEMISTRY-US, V48, P2075, DOI 10.1021/bi801627h; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	48	4	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6456	6470		10.1074/jbc.M115.701797	http://dx.doi.org/10.1074/jbc.M115.701797			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797125	hybrid, Green Published			2022-12-26	WOS:000372894200033
J	Dunshee, DR; Bainbridge, TW; Kljavin, NM; Zavala-Solorio, J; Schroeder, AC; Chan, R; Corpuz, R; Wong, M; Zhou, W; Deshmukh, G; Ly, J; Sutherlin, DP; Ernst, JA; Sonoda, J				Dunshee, Diana Ronai; Bainbridge, Travis W.; Kljavin, Noelyn M.; Zavala-Solorio, Jose; Schroeder, Amy C.; Chan, Ruby; Corpuz, Racquel; Wong, Manda; Zhou, Wei; Deshmukh, Gauri; Ly, Justin; Sutherlin, Daniel P.; Ernst, James A.; Sonoda, Junichiro			Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FGF; metabolic disease; protease inhibitor; proteolytic enzyme; serine protease; FGF21; dipeptidyl peptidase IV (DPPIV); fibroblast activation protein (FAP)	DIPEPTIDYL PEPTIDASE-4 INHIBITORS; ENDOPLASMIC-RETICULUM STRESS; SERUM FGF21 LEVELS; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; METABOLIC SYNDROME; HEPATIC STEATOSIS; MICE; OBESITY; EXPRESSION	FGF21 is a stress-induced hormone with potent anti-obesity, insulin-sensitizing, and hepatoprotective properties. Although proteolytic cleavage of recombinant human FGF21 in preclinical species has been observed previously, the regulation of endogenously produced FGF21 is not well understood. Here we identify fibroblast activation protein (FAP) as the enzyme that cleaves and inactivates human FGF21. A selective chemical inhibitor, immunodepletion, or genetic deletion of Fap stabilized recombinant human FGF21 in serum. In addition, administration of a selective FAP inhibitor acutely increased circulating intact FGF21 levels in cynomolgus monkeys. On the basis of our findings, we propose selective FAP inhibition as a potential therapeutic approach to increase endogenous FGF21 activity for the treatment of obesity, type 2 diabetes, non-alcoholic steatohepatitis, and related metabolic disorders.	[Dunshee, Diana Ronai; Zavala-Solorio, Jose; Schroeder, Amy C.; Sonoda, Junichiro] Genentech Inc, Mol Biol, San Francisco, CA 94080 USA; [Bainbridge, Travis W.; Chan, Ruby; Corpuz, Racquel; Wong, Manda; Ernst, James A.] Genentech Inc, Prot Chem, San Francisco, CA 94080 USA; [Kljavin, Noelyn M.] Genentech Inc, Mol Oncol, San Francisco, CA 94080 USA; [Zhou, Wei] Genentech Inc, Translat Oncol, San Francisco, CA 94080 USA; [Deshmukh, Gauri; Ly, Justin] Genentech Inc, Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA; [Sutherlin, Daniel P.] Genentech Inc, Discovery Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Sonoda, J (corresponding author), Genentech Inc, Mol Biol, San Francisco, CA 94080 USA.	junichis@gene.com		Wong, Manda/0000-0001-5830-1517	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was funded by Genentech, Inc. All authors are present or former paid employees of Genentech with no further conflict of interest.	Agusti-Cobos E, 2011, J THROMB HAEMOST, V9, P1266, DOI 10.1111/j.1538-7836.2011.04294.x; Belouski E. J. C., 2014, U. S. Patent, Patent No. [8,835,385, 8835385]; Bobbert T, 2013, DIABETES CARE, V36, P145, DOI 10.2337/dc12-0703; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dong JQ, 2015, BRIT J CLIN PHARMACO, V80, P1051, DOI 10.1111/bcp.12676; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Edosada CY, 2006, FEBS LETT, V580, P1581, DOI 10.1016/j.febslet.2006.01.087; Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Hamson EJ, 2014, PROTEOM CLIN APPL, V8, P454, DOI 10.1002/prca.201300095; Hanssen MJW, 2015, SCI REP-UK, V5, DOI 10.1038/srep10275; Hecht R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049345; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Huang CH, 2011, J BIOCHEM, V149, P685, DOI 10.1093/jb/mvr017; Jansen K, 2014, J MED CHEM, V57, P3053, DOI 10.1021/jm500031w; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Keane FM, 2014, FEBS OPEN BIO, V4, P43, DOI 10.1016/j.fob.2013.12.001; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kim SH, 2015, DIABETOLOGIA, V58, P809, DOI 10.1007/s00125-014-3475-6; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Laverman P, 2015, J NUCL MED, V56, P778, DOI 10.2967/jnumed.114.152959; Lee KN, 2006, BLOOD, V107, P1397, DOI 10.1182/blood-2005-08-3452; Levy MT, 2002, LIVER, V22, P93, DOI 10.1034/j.1600-0676.2002.01503.x; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Liu R, 2012, CANCER BIOL THER, V13, P123, DOI 10.4161/cbt.13.3.18696; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Niedermeyer J, 2000, MOL CELL BIOL, V20, P1089, DOI 10.1128/MCB.20.3.1089-1094.2000; Ong KL, 2012, J CLIN ENDOCR METAB, V97, P4701, DOI 10.1210/jc.2012-2267; Osborne B, 2014, BBA-PROTEINS PROTEOM, V1844, P1248, DOI 10.1016/j.bbapap.2014.03.015; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Patel R, 2015, MOL ENDOCRINOL, V29, P213, DOI 10.1210/me.2014-1259; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Tanaka N, 2015, BBA-MOL BASIS DIS, V1852, P1242, DOI 10.1016/j.bbadis.2015.02.012; Umberger TS, 2014, BIOANALYSIS, V6, P3283, DOI 10.4155/bio.14.241; Waldele S, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0524-6; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yan HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024895; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhen EY, 2016, BIOCHEM J, V473, P605, DOI 10.1042/BJ20151085	52	86	86	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5986	5996		10.1074/jbc.M115.710582	http://dx.doi.org/10.1074/jbc.M115.710582			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26797127	Green Published, hybrid			2022-12-26	WOS:000372551800043
J	Ronan, T; Macdonald-Obermann, JL; Huelsmann, L; Bessman, NJ; Naegle, KM; Pike, LJ				Ronan, Tom; Macdonald-Obermann, Jennifer L.; Huelsmann, Lorel; Bessman, Nicholas J.; Naegle, Kristen M.; Pike, Linda J.			Different Epidermal Growth Factor Receptor (EGFR) Agonists Produce Unique Signatures for the Recruitment of Downstream Signaling Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; epidermal growth factor (EGF); epidermal growth factor receptor (EGFR); growth factor; receptor tyrosine kinase; systems biology	SITE-SPECIFIC PHOSPHORYLATION; POSITIVE FEEDBACK LOOP; TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURE; DOCKING PROTEIN; ACTIVATION; AMPHIREGULIN; LIGANDS; COMPLEX; CANCER	The EGF receptor can bind seven different agonist ligands. Although each agonist appears to stimulate the same suite of downstream signaling proteins, different agonists are capable of inducing distinct responses in the same cell. To determine the basis for these differences, we used luciferase fragment complementation imaging to monitor the recruitment of Cbl, CrkL, Gab1, Grb2, PI3K, p52 Shc, p66 Shc, and Shp2 to the EGF receptor when stimulated by the seven EGF receptor ligands. Recruitment of all eight proteins was rapid, dose-dependent, and inhibited by erlotinib and lapatinib, although to differing extents. Comparison of the time course of recruitment of the eight proteins in response to a fixed concentration of each growth factor revealed differences among the growth factors that could contribute to their differing biological effects. Principal component analysis of the resulting data set confirmed that the recruitment of these proteins differed between agonists and also between different doses of the same agonist. Ensemble clustering of the overall response to the different growth factors suggests that these EGF receptor ligands fall into two major groups as follows: (i) EGF, amphiregulin, and EPR; and (ii) betacellulin, TGF, and epigen. Heparin-binding EGF is distantly related to both clusters. Our data identify differences in network utilization by different EGF receptor agonists and highlight the need to characterize network interactions under conditions other than high dose EGF.	[Ronan, Tom; Naegle, Kristen M.] Washington Univ, Dept Biomed Engn, Sch Med, St Louis, MO 63110 USA; [Ronan, Tom; Naegle, Kristen M.] Washington Univ, Ctr Biol Syst Engn, Sch Med, St Louis, MO 63110 USA; [Macdonald-Obermann, Jennifer L.; Huelsmann, Lorel; Pike, Linda J.] Washington Univ, Dept Biochem & Mol Biophys, Sch Med, St Louis, MO 63110 USA; [Bessman, Nicholas J.] Univ Penn, Dept Biochem & Biophys, Grad Grp Biochem & Mol Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Huelsmann, Lorel] Univ Texas Southwestern, Sch Med, Dallas, TX 75390 USA; [Bessman, Nicholas J.] Cornell Univ, Joan & Sanford I Weill Dept Med, New York, NY 10065 USA; [Bessman, Nicholas J.] Cornell Univ, Joan & Sanford I Weill Dept Microbiol & Immunol, New York, NY 10065 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University; Cornell University	Naegle, KM (corresponding author), Washington Univ, Dept Biomed Engn, Sch Med, St Louis, MO 63110 USA.; Naegle, KM (corresponding author), Washington Univ, Ctr Biol Syst Engn, Sch Med, St Louis, MO 63110 USA.; Pike, LJ (corresponding author), Washington Univ, Dept Biochem & Mol Biophys, Sch Med, St Louis, MO 63110 USA.	knaegle@wustl.edu; pike@biochem.wustl.edu		Naegle, Kristen/0000-0001-7146-9592	National Institutes of Health [RO1GM099695, RO1-CA079992]; Center for Biological Systems Engineering, Washington University, St. Louis, MO; NATIONAL CANCER INSTITUTE [R01CA079992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biological Systems Engineering, Washington University, St. Louis, MO; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant RO1GM099695 ( to L. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Center for Biological Systems Engineering, Washington University, St. Louis, MO.; Supported by National Institutes of Health Grant RO1-CA079992 ( to Mark Lemmon). Present address: Joan and Sanford I. Weill Depts. of Medicine and Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, NY 10065.	BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Curran TG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6924; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gilmore JL, 2008, BREAST CANCER RES TR, V110, P493, DOI 10.1007/s10549-007-9748-8; GRAYSON LS, 1993, BURNS, V19, P401, DOI 10.1016/0305-4179(93)90061-C; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; Hofman EG, 2010, J BIOL CHEM, V285, P39481, DOI 10.1074/jbc.M110.164731; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Ingham RJ, 1998, J BIOL CHEM, V273, P30630, DOI 10.1074/jbc.273.46.30630; Knudsen SLJ, 2014, GROWTH FACTORS, V32, P155, DOI 10.3109/08977194.2014.952410; Kyono WT, 1998, J IMMUNOL, V161, P5555; Lecoq-Lafon C, 1999, BLOOD, V93, P2578, DOI 10.1182/blood.V93.8.2578.408k24_2578_2585; Lemos-Gonzalez Y, 2007, BRIT J CANCER, V96, P1569, DOI 10.1038/sj.bjc.6603770; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; MARTI U, 1989, HEPATOLOGY, V9, P126, DOI 10.1002/hep.1840090122; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; Shin HS, 2003, CIRC RES, V93, P302, DOI 10.1161/01.RES.0000086803.64109.9E; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; Steen H, 2002, J BIOL CHEM, V277, P1031, DOI 10.1074/jbc.M109992200; Streicher KL, 2007, MOL CANCER RES, V5, P847, DOI 10.1158/1541-7786.MCR-06-0427; Wang W., 2015, EUR POLYM J, V1, P1, DOI DOI 10.1016/J.IJCARD.2014.10.148; Wilson KJ, 2012, GROWTH FACTORS, V30, P107, DOI 10.3109/08977194.2011.649918; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	44	29	30	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5528	5540		10.1074/jbc.M115.710087	http://dx.doi.org/10.1074/jbc.M115.710087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786109	Green Published, hybrid			2022-12-26	WOS:000372551800008
J	Farwell, SLN; Kanyi, D; Hamel, M; Slee, JB; Miller, EA; Cipolle, MD; Lowe-Krentz, LJ				Farwell, Sara Lynn N.; Kanyi, Daniela; Hamel, Marianne; Slee, Joshua B.; Miller, Elizabeth A.; Cipolle, Mark D.; Lowe-Krentz, Linda J.			Heparin Decreases in Tumor Necrosis Factor (TNF)-induced Endothelial Stress Responses Require Transmembrane Protein 184A and Induction of Dual Specificity Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; JNK; endothelial cell; heparin-binding protein; inflammation; p38 MAPK	SMOOTH-MUSCLE-CELLS; KAPPA-B ACTIVATION; FLUID SHEAR-STRESS; P38 MAP KINASE; ACTIN POLYMERIZATION; VASCULAR LEAK; CROSS-TALK; EXPRESSION; PERMEABILITY; RECEPTOR	Despite the large number of heparin and heparan sulfate binding proteins, the molecular mechanism(s) by which heparin alters vascular cell physiology is not well understood. Studies with vascular smooth muscle cells (VSMCs) indicate a role for induction of dual specificity phosphatase 1 (DUSP1) that decreases ERK activity and results in decreased cell proliferation, which depends on specific heparin binding. The hypothesis that unfractionated heparin functions to decrease inflammatory signal transduction in endothelial cells (ECs) through heparin-induced expression of DUSP1 was tested. In addition, the expectation that the heparin response includes a decrease in cytokine-induced cytoskeletal changes was examined. Heparin pretreatment of ECs resulted in decreased TNF-induced JNK and p38 activity and downstream target phosphorylation, as identified through Western blotting and immunofluorescence microscopy. Through knockdown strategies, the importance of heparin-induced DUSP1 expression in these effects was confirmed. Quantitative fluorescence microscopy indicated that heparin treatment of ECs reduced TNF-induced increases in stress fibers. Monoclonal antibodies that mimic heparin-induced changes in VSMCs were employed to support the hypothesis that heparin was functioning through interactions with a receptor. Knockdown of transmembrane protein 184A (TMEM184A) confirmed its involvement in heparin-induced signaling as seen in VSMCs. Therefore, TMEM184A functions as a heparin receptor and mediates anti-inflammatory responses of ECs involving decreased JNK and p38 activity.	[Farwell, Sara Lynn N.; Kanyi, Daniela; Hamel, Marianne; Slee, Joshua B.; Miller, Elizabeth A.; Lowe-Krentz, Linda J.] Lehigh Univ, Dept Biol Sci, 111 Res Dr,Rm B217, Bethlehem, PA 18015 USA; [Kanyi, Daniela] Lehigh Univ, Dept Chem, Allentown, PA 18103 USA; [Cipolle, Mark D.] Lehigh Valley Hosp Ctr, Dept Surg, Allentown, PA 18103 USA; [Slee, Joshua B.] DeSales Univ, Dept Nat Sci, Center Valley, PA 18034 USA; [Cipolle, Mark D.] Christiana Care Hlth Syst, Trauma Program, Newark, DE 19718 USA	Lehigh University; Lehigh University; Lehigh Valley Hospital; Christiana Care Health System	Lowe-Krentz, LJ (corresponding author), Lehigh Univ, Dept Biol Sci, 111 Res Dr,Rm B217, Bethlehem, PA 18015 USA.	LJL0@lehigh.edu			National Institutes of Health [HL54269]; Lehigh Valley Hospital Department of Surgery and Division of Surgical Critical Care; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL054269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lehigh Valley Hospital Department of Surgery and Division of Surgical Critical Care; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Contract Grant HL54269 (to L. J. L. K.). It was initiated with funding from Lehigh Valley Hospital Department of Surgery and Division of Surgical Critical Care (to M. D. C. and L. J. L. K.).	Amini N, 2014, ATHEROSCLEROSIS, V235, P613, DOI 10.1016/j.atherosclerosis.2014.05.950; Azuma N, 2001, AM J PHYSIOL-HEART C, V280, pH189, DOI 10.1152/ajpheart.2001.280.1.H189; Baeyens N, 2014, P NATL ACAD SCI USA, V111, P17308, DOI 10.1073/pnas.1413725111; BARZU T, 1985, BIOCHIM BIOPHYS ACTA, V845, P196, DOI 10.1016/0167-4889(85)90177-6; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Blaukovitch CI, 2010, J CELL BIOCHEM, V110, P382, DOI 10.1002/jcb.22543; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; CASTELLOT JJ, 1985, J CELL PHYSIOL, V124, P13, DOI 10.1002/jcp.1041240104; Chang E, 2011, BLOOD, V117, P2527, DOI 10.1182/blood-2010-08-302281; Chaudhury H, 2010, ARTERIOSCL THROM VAS, V30, P546, DOI 10.1161/ATVBAHA.109.201368; Chen KY, 2013, J BIOL CHEM, V288, P13988, DOI 10.1074/jbc.M112.444737; Chiodelli P, 2015, MOLECULES, V20, P6342, DOI 10.3390/molecules20046342; Couchman JR, 2015, INT J EXP PATHOL, V96, P1, DOI 10.1111/iep.12112; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Damarla M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004600; Dougherty CS, 1998, J VASC RES, V35, P437, DOI 10.1159/000025615; Ebong EE, 2014, INTEGR BIOL-UK, V6, P338, DOI 10.1039/c3ib40199e; Engelberg H, 2001, ATHEROSCLEROSIS, V159, P253, DOI 10.1016/S0021-9150(01)00650-5; Ettelaie C, 2011, BBA-MOL BASIS DIS, V1812, P1591, DOI 10.1016/j.bbadis.2011.09.007; Gilotti AC, 2014, J CELL PHYSIOL, V229, P2142, DOI 10.1002/jcp.24677; Gonzales JN, 2014, VASC PHARMACOL, V62, P63, DOI 10.1016/j.vph.2014.01.005; Hamel M, 2006, ENDOTHELIUM-J ENDOTH, V13, P157, DOI 10.1080/10623320600760191; Han JL, 2013, THROMB RES, V132, pE42, DOI 10.1016/j.thromres.2013.03.010; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Li X, 2012, CYTOKINE, V60, P114, DOI 10.1016/j.cyto.2012.06.008; Liu HB, 2013, J CARDIOVASC PHARM, V61, P461, DOI 10.1097/FJC.0b013e31828c0933; Manduteanu I, 2007, PHARMACOLOGY, V79, P154, DOI 10.1159/000098952; Mengistu M, 2012, ACTIN STRUCTURE FUNC, P177; Mengistu M, 2011, J CELL PHYSIOL, V226, P110, DOI 10.1002/jcp.22311; OTTLINGER ME, 1993, J BIOL CHEM, V268, P19173; PATTON WA, 1995, BIOCHEM J, V311, P461, DOI 10.1042/bj3110461; Pugh RJ, 2016, J BIOL CHEM, V291, P5326, DOI 10.1074/jbc.M115.681122; PUKAC LA, 1990, CELL REGUL, V1, P435, DOI 10.1091/mbc.1.5.435; Pukac LA, 1997, J CELL PHYSIOL, V172, P69, DOI 10.1002/(SICI)1097-4652(199707)172:1<69::AID-JCP8>3.0.CO;2-B; Rapraeger AC, 2013, FEBS J, V280, P2194, DOI 10.1111/febs.12134; Rath G, 2009, J PHYSIOL PHARMACOL, V60, P105; REILLY CF, 1989, J BIOL CHEM, V264, P6990; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Savage JM, 2001, J CELL PHYSIOL, V187, P283, DOI 10.1002/jcp.1076; Sen A, 2014, FEBS LETT, V588, P906, DOI 10.1016/j.febslet.2014.01.033; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Thourani VH, 2000, AM J PHYSIOL-HEART C, V278, pH2084, DOI 10.1152/ajpheart.2000.278.6.H2084; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Vlodavsky I, 2013, MATRIX BIOL, V32, P241, DOI 10.1016/j.matbio.2013.03.002; Voyvodic PL, 2014, J BIOL CHEM, V289, P9547, DOI 10.1074/jbc.M113.541573; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yang D, 2010, CARDIOVASC RES, V85, P520, DOI 10.1093/cvr/cvp323; Zakkar M, 2008, CIRC RES, V103, P726, DOI 10.1161/CIRCRESAHA.108.183913; Zeng Z, 2014, INT J MOL SCI, V15, P10185, DOI 10.3390/ijms150610185	57	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5342	5354		10.1074/jbc.M115.681288	http://dx.doi.org/10.1074/jbc.M115.681288			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26769965	Green Published, hybrid			2022-12-26	WOS:000371640600043
J	Ek, A; Sorjonen, K; Eli, K; Lindberg, L; Nyman, J; Marcus, C; Nowicka, P				Ek, Anna; Sorjonen, Kimmo; Eli, Karin; Lindberg, Louise; Nyman, Jonna; Marcus, Claude; Nowicka, Paulina			Associations between Parental Concerns about Preschoolers' Weight and Eating and Parental Feeding Practices: Results from Analyses of the Child Eating Behavior Questionnaire, the Child Feeding Questionnaire, and the Lifestyle Behavior Checklist	PLOS ONE			English	Article							BODY-MASS INDEX; CONFIRMATORY FACTOR-ANALYSIS; MATERNAL SELF-EFFICACY; FACTORIAL VALIDATION; RESTRICTING ACCESS; VEGETABLE INTAKE; RELATIVE WEIGHT; FOOD-INTAKE; LOW-INCOME; OBESITY	Introduction Insight into parents' perceptions of their children's eating behaviors is crucial for the development of successful childhood obesity programs. However, links between children's eating behaviors and parental feeding practices and concerns have yet to be established. This study aims to examine associations between parental perceptions of preschoolers' eating behaviors and parental feeding practices. First, it tests the original 8-factor structure of the Child Eating Behavior Questionnaire (CEBQ). Second, it examines the associations with parental feeding practices, measured with the Child Feeding Questionnaire (CFQ). Materials and Methods Questionnaires were sent to parents from 25 schools/preschools in Stockholm, Sweden and to parents starting a childhood obesity intervention. The CEBQ factor structure was tested with confirmatory factor analysis (CFA). Associations between CEBQ subscales Food approach and Food avoidance and CFQ factors Restriction, Pressure to eat and Monitoring were examined with structural equation modelling (SEM), adjusting for child and parental characteristics, and parental confidence, measured with the Lifestyle Behavior Checklist (LBC). CFQ Concern for child weight and Perceived responsibility for child eating were used as mediators. Results 478 parents completed the questionnaires (children: 52% girls, mean age 5.5 years, 20% overweight/obese). A modified 8-factor structure showed an acceptable fit (TLI = 0.91, CFI = 0.92, RMSEA = 0.05 and SRMR = 0.06) after dropping one item and allowing three pairs of error terms to correlate. The SEM model demonstrated that Food approach had a weak direct effect on Restriction, but a moderate (beta = 0.30) indirect effect via Concern, resulting in a substantial total effect (beta = 0.37). Food avoidance had a strong positive effect on Pressure to eat (beta = 0.71). Discussion The CEBQ is a valid instrument for assessing parental perceptions of preschoolers' eating behaviors. Parental pressure to eat was strongly associated with children's food avoidance. Parental restriction, however, was more strongly associated with parents' concerns about their children's weights than with children's food approach. This suggests that childhood obesity interventions should address parents' perceptions of healthy weight alongside perceptions of healthy eating.	[Ek, Anna; Lindberg, Louise; Nyman, Jonna; Marcus, Claude; Nowicka, Paulina] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Sorjonen, Kimmo] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Solna, Sweden; [Eli, Karin] Univ Oxford, Inst Social & Cultural Anthropol, Unit Biocultural Variat & Obes, Oxford, England; [Nowicka, Paulina] Uppsala Univ, Dept Food Nutr & Dietet, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; University of Oxford; Uppsala University	Nowicka, P (corresponding author), Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	paulina.nowicka@ki.se	Ek, Anna/S-4421-2019; Marcus, Claude/ABE-1177-2020	Ek, Anna/0000-0002-2179-8408; Marcus, Claude/0000-0003-0890-2650; Lindberg, Louise/0000-0002-9517-5000; Eli, Karin/0000-0001-9132-8404; Nowicka, Paulina/0000-0001-9707-8768	Vinnova Marie Curie International Qualification funds [2011-03443]; Swedish Research Council; Karolinska Institutet; Jerring Foundation; Samariten Foundation; Magnus Bergvall Foundation; Fredrik and Ingrid Thurings Foundation; Swedish Society of Medicine; Helge Ax: son Johnsson Foundation; iShizu Matsumurais Donation; Foundation Frimurare Barnhuset in Stockholm; Foundation Barnavard; Crown Princess Lovisa Foundation for Pediatric Care	Vinnova Marie Curie International Qualification funds(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Jerring Foundation; Samariten Foundation; Magnus Bergvall Foundation; Fredrik and Ingrid Thurings Foundation; Swedish Society of Medicine; Helge Ax: son Johnsson Foundation; iShizu Matsumurais Donation; Foundation Frimurare Barnhuset in Stockholm; Foundation Barnavard; Crown Princess Lovisa Foundation for Pediatric Care	Research related to this study was supported by funds to PN by Vinnova Marie Curie International Qualification funds (2011-03443), Swedish Research Council, Karolinska Institutet, Jerring Foundation, Samariten Foundation, Magnus Bergvall Foundation, Fredrik and Ingrid Thurings Foundation, Swedish Society of Medicine, Helge Ax: son Johnsson Foundation, iShizu Matsumurais Donation, Foundation Frimurare Barnhuset in Stockholm, Foundation Barnavard and Crown Princess Lovisa Foundation for Pediatric Care. AE was supported by Jerring Foundation and Crown Princess Lovisa Foundation for Pediatric Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainuki T., 2011, Food and Nutrition Sciences, V2, P228, DOI 10.4236/fns.2011.23032; [Anonymous], 2013, PRIMARY CHILD HLTH C; Ashcroft J, 2008, EUR J CLIN NUTR, V62, P985, DOI 10.1038/sj.ejcn.1602855; Birch LL, 2003, AM J CLIN NUTR, V78, P215, DOI 10.1093/ajcn/78.2.215; Birch LL, 1998, PEDIATRICS, V101, P539; Birch LL, 2001, APPETITE, V36, P201, DOI 10.1006/appe.2001.0398; Blissett J, 2013, EUR J CLIN NUTR, V67, P180, DOI 10.1038/ejcn.2012.198; Blissett J, 2006, APPETITE, V47, P212, DOI 10.1016/j.appet.2006.04.002; Bollen KA, 1989, STRUCTURAL EQUATIONS; Burrows T, 2010, INT J PEDIATR OBES, V5, P43, DOI 10.3109/17477160902957158; Campbell K, 2010, INT J PEDIATR OBES, V5, P501, DOI 10.3109/17477161003777425; Cao YT, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-5; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Carnell S, 2014, INT J EAT DISORDER, V47, P705, DOI 10.1002/eat.22324; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COSTANZO PR, 1985, J SOC CLIN PSYCHOL, V3, P425, DOI 10.1521/jscp.1985.3.4.425; Crouch P, 2007, NUTR DIET, V64, P151, DOI 10.1111/j.1747-0080.2007.00180.x; Daniels LA, 2012, INT J OBESITY, V36, P1292, DOI 10.1038/ijo.2012.96; Daniels LA, 2015, PEDIATRICS, V136, pE40, DOI 10.1542/peds.2014-4108; Daniels LA, 2014, OBESITY, V22, pE104, DOI 10.1002/oby.20693; Daniels LA, 2013, PEDIATRICS, V132, pE109, DOI 10.1542/peds.2012-2882; Danielsson P, 2012, OBESITY FACTS, V5, P34, DOI 10.1159/000336060; de Lauzon-Guillain B, 2013, AM J CLIN NUTR, V98, P804, DOI 10.3945/ajcn.112.057026; de Lauzon-Guillain B, 2012, J ACAD NUTR DIET, V112, P1578, DOI 10.1016/j.jand.2012.06.356; de Vet H.C.W., 2011, MEASUREMENT MED PRAC; Ek A., 2015, International Journal of Behavioral Nutrition and Physical Activity, V12; Ek A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1912-1; Eli K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006609; Faith MS, 2004, OBES RES, V12, P1711, DOI 10.1038/oby.2004.212; Faith MS, 2006, OBESITY, V14, P131, DOI 10.1038/oby.2006.16; Faith MS, 2005, MATERN CHILD NUTR, V1, P164, DOI 10.1111/j.1740-8709.2005.00024.x; Faith MS, 2013, HUM HERED, V75, P80, DOI 10.1159/000353879; Farrow CV, 2009, APPETITE, V52, P307, DOI 10.1016/j.appet.2008.10.009; Farrow C, 2011, INT J PEDIATR OBES, V6, P306, DOI 10.3109/17477166.2011.575160; Fildes A, 2014, AM J CLIN NUTR, V99, P911, DOI 10.3945/ajcn.113.077867; Fisher JO, 2015, APPETITE, V84, P61, DOI 10.1016/j.appet.2014.09.007; Fisher JO, 1999, APPETITE, V32, P405, DOI 10.1006/appe.1999.0231; Fisher JO, 1999, AM J CLIN NUTR, V69, P1264; Fisher JO, 2002, J AM DIET ASSOC, V102, P58, DOI 10.1016/S0002-8223(02)90017-9; Galloway AT, 2006, APPETITE, V46, P318, DOI 10.1016/j.appet.2006.01.019; Gerards SMPL, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-37; Golley RK, 2007, PEDIATRICS, V119, P517, DOI 10.1542/peds.2006-1746; Gregory JE, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-55; Gregory JE, 2010, APPETITE, V54, P550, DOI 10.1016/j.appet.2010.02.013; Harris H, 2014, EAT BEHAV, V15, P519, DOI 10.1016/j.eatbeh.2014.07.003; Haycraft E, 2012, J NUTR EDUC BEHAV, V44, P390, DOI 10.1016/j.jneb.2010.03.001; Hill C, 2008, INT J OBESITY, V32, P1499, DOI 10.1038/ijo.2008.113; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jani R, 2015, APPETITE, V84, P188, DOI 10.1016/j.appet.2014.10.020; Jansen E, 2007, APPETITE, V49, P572, DOI 10.1016/j.appet.2007.03.229; Jansen PW, 2014, AM J CLIN NUTR, V100, P1329, DOI 10.3945/ajcn.114.088922; Jansen PW, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-130; Karlberg J, 2001, ACTA PAEDIATR, V90, P1427, DOI 10.1080/08035250152708851; Keller KL, 2006, INT J OBESITY, V30, P1670, DOI 10.1038/sj.ijo.0803318; Kral TVE, 2007, ACTA PAEDIATR, V96, P29, DOI 10.1111/j.1651-2227.2007.00167.x; Llewellyn CH, 2008, AM J CLIN NUTR, V88, P1560, DOI 10.3945/ajcn.2008.26175; Loh DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082885; Luttikhuis HGMO, 2010, ACTA PAEDIATR, V99, P263, DOI 10.1111/j.1651-2227.2009.01576.x; Mallan KM, 2013, APPETITE, V64, P48, DOI 10.1016/j.appet.2013.01.003; Matheson DM, 2006, J AM DIET ASSOC, V106, P1861, DOI 10.1016/j.jada.2006.08.004; May AL, 2007, J AM DIET ASSOC, V107, P1167, DOI 10.1016/j.jada.2007.04.009; Morrison H, 2013, APPETITE, V63, P77, DOI 10.1016/j.appet.2012.12.017; Norman GR, 2009, BIOSTATISTICS BARE E; Nowicka P, 2014, APPETITE, V81, P232, DOI 10.1016/j.appet.2014.06.027; Payne LO, 2011, INT J PEDIATR OBES, V6, pE540, DOI 10.3109/17477166.2011.575144; Pianta RC, 1997, EARLY CHILD RES Q, V12, P263, DOI 10.1016/S0885-2006(97)90003-X; Powell FC, 2011, APPETITE, V57, P683, DOI 10.1016/j.appet.2011.08.011; Regber S, 2013, PEDIATR OBES, V8, P118, DOI 10.1111/j.2047-6310.2012.00093.x; Reichenbach H., 1956, DIRECTION TIME; Reinehr T, 2010, AM J CLIN NUTR, V91, P1165, DOI 10.3945/ajcn.2009.28705; Rimm-Kaufman SE, 2000, J APPL DEV PSYCHOL, V21, P491, DOI 10.1016/S0193-3973(00)00051-4; Rodgers Rachel F, 2013, Int J Behav Nutr Phys Act, V10, P24, DOI 10.1186/1479-5868-10-24; Rollins BY, 2014, AM J CLIN NUTR, V99, P249, DOI 10.3945/ajcn.113.063545; Rollins BY, 2014, APPETITE, V73, P31, DOI 10.1016/j.appet.2013.10.005; Salari R, 2014, SCAND J PUBLIC HEALT, V42, P547, DOI 10.1177/1403494814541595; Sanders MR, 2005, CHILD CARE HLTH DEV, V31, P65, DOI 10.1111/j.1365-2214.2005.00487.x; Santos JL, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-108; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Sleddens EFC, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-49; Sparks MA, 2012, EAT BEHAV, V13, P267, DOI 10.1016/j.eatbeh.2012.03.002; Spence JC, 2011, INT J PEDIATR OBES, V6, pE501, DOI 10.3109/17477166.2010.512087; Spruijt-Metz D, 2002, AM J CLIN NUTR, V75, P581, DOI 10.1093/ajcn/75.3.581; Spruit-Metz D, 2006, J PEDIATR-US, V148, P314, DOI 10.1016/j.jpeds.2005.10.035; Svensson V, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-134; Tripicchio GL, 2014, PEDIATRICS, V134, pE1399, DOI 10.1542/peds.2013-3828; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Viana V, 2008, BRIT J NUTR, V100, P445, DOI 10.1017/S0007114508894391; WARDLE J, 1992, APPETITE, V18, P167, DOI 10.1016/0195-6663(92)90195-C; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Wardle J, 2005, J AM DIET ASSOC, V105, P227, DOI 10.1016/j.jada.2004.11.006; Webber L, 2009, INT J OBESITY, V33, P21, DOI 10.1038/ijo.2008.219; Webber L, 2010, EUR J CLIN NUTR, V64, P259, DOI 10.1038/ejcn.2009.146; Webber L, 2010, AM J CLIN NUTR, V92, P1423, DOI 10.3945/ajcn.2010.30112; Webber L, 2010, J AM DIET ASSOC, V110, P1718, DOI 10.1016/j.jada.2010.08.007; West F, 2010, CHILD CARE HLTH DEV, V36, P508, DOI 10.1111/j.1365-2214.2010.01074.x; West F, 2010, BEHAV RES THER, V48, P1170, DOI 10.1016/j.brat.2010.08.008; West F, 2009, INT J PEDIATR OBES, V4, P266, DOI 10.3109/17477160902811199	98	79	88	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147257	10.1371/journal.pone.0147257	http://dx.doi.org/10.1371/journal.pone.0147257			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799397	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300082
J	Mei, Y; Zhao, S; Lu, XF; Liu, HX; Li, XY; Ma, R				Mei, Yu; Zhao, Song; Lu, Xiaofei; Liu, Haixia; Li, Xiangyi; Ma, Rong			Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast Cancer	PLOS ONE			English	Article							PREDICTS POOR-PROGNOSIS; METASTASIS; HYPERFIBRINOGENEMIA; ANGIOGENESIS; CARCINOMA; RESECTION; GROWTH	Purpose Elevated plasma fibrinogen levels are associated with tumor progression and poor outcomes in different cancer patients. The objective of this study was to investigate the clinical and prognostic value of preoperative plasma fibrinogen levels in patients with operable breast cancer. Methods Two hundred and twenty-three patients diagnosed with breast cancer were retrospectively evaluated in this study. Plasma fibrinogen levels were examined before treatment and analyzed along with patient clinicopathological parameters, disease-free survival (DFS) and overall survival(OS). Both univariate and multivariate analyses were performed to identify the clinicopathological parameters associated with DFS and OS. Results Elevated preoperative plasma fibrinogen levels were directly associated with age of diagnose (<= 47 vs. > 47, p<0.001), menopause (yes vs. no, p<0.001), tumor size (T1&T2 vs. T3&T4, p = 0.033), tumor stage (Ivs.IIvs.III, p = 0.034) and lymph node involvement (N = 0 vs. 1 <= N >= 3 vs. N >= 4, p<0.001), but not with histological grade, molecular type and other Immunohistochemical parameters(ER, PR, HER2 and Ki-67). In a univariate survival analysis, tumor stage, tumor size, lymph node involvement (p<0.001/p<0.001) and plasma fibrinogen (p<0.001/p<0.001) levels were associated with disease-free and overall survival, but just lymph nodes involvement (p<0.001, hazard ratio [HR] = 2.9, 95% confidence interval [CI] = 1.6-5.3/p = 0.006, HR = 3.2, 95% CI = 1.4-7.3) and plasma fibrinogen levels (p = 0.006, HR = 3.4, 95% CI = 1.4-8.3/p = 0.002, HR = 10.1, 95% CI = 2.3-44.6) were associated with disease-free and overall survival in a multivariate survival analysis, respectively. Conclusions This study demonstrates that elevated preoperative plasma fibrinogen levels are associated with breast cancer progression and are independently associated with a poor prognosis in patients with operable breast cancer.	[Mei, Yu; Zhao, Song; Ma, Rong] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Mei, Yu] Jinan Matern & Child Care Hosp, Dept Breast Surg, Jinan, Shandong, Peoples R China; [Lu, Xiaofei] Shandong Univ, Jinan Cent Hosp, Dept Gen Surg, Jinan 250100, Shandong, Peoples R China; [Liu, Haixia] Jinan Matern & Child Care Hosp, Dept Pathol, Jinan, Shandong, Peoples R China; [Li, Xiangyi] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Ma, R (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	marongw2000@163.com	ma, rong/GVU-3096-2022					Amrani D L, 1990, Blood Coagul Fibrinolysis, V1, P443, DOI 10.1097/00001721-199010000-00013; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; DVORAK HF, 1992, ANN NY ACAD SCI, V667, P101, DOI 10.1111/j.1749-6632.1992.tb51603.x; Goldenberg N, 2003, J CLIN ONCOL, V21, P4194, DOI 10.1200/JCO.2003.05.165; Guo QQ, 2009, PANCREAS, V38, pE75, DOI 10.1097/MPA.0b013e3181987d86; He L, 2014, J CELL MOL MED, V18, P49, DOI 10.1111/jcmm.12158; HUMPHRIES SE, 1995, EUR HEART J, V16, P16, DOI 10.1093/eurheartj/16.suppl_A.16; Humphries SE., 1995, EUROPEAN HEART J SA, V16; Jones JM, 2006, LUNG CANCER, V53, P97, DOI 10.1016/j.lungcan.2006.03.012; Kanz R, 2011, J THROMB HAEMOST, V9, P57, DOI 10.1111/j.1538-7836.2010.04069.x; Kato F, 2016, SURG TODAY, V46, P445, DOI 10.1007/s00595-015-1196-1; Kinoshita A, 2013, ONCOLOGY-BASEL, V85, P269, DOI 10.1159/000355502; Kuderer NM, 2009, J CLIN ONCOL, V27, P4902, DOI 10.1200/JCO.2009.22.4584; Lip GYH, 2002, LANCET ONCOL, V3, P27, DOI 10.1016/S1470-2045(01)00619-2; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Palumbo JS, 2002, CANCER RES, V62, P6966; Polterauer S, 2009, ONCOLOGIST, V14, P979, DOI 10.1634/theoncologist.2009-0079; Polterauer S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.008; Qi Q, 2015, PANCREAS, V44, P977, DOI 10.1097/MPA.0000000000000353; ROKITA H, 1993, CYTOKINE, V5, P454, DOI 10.1016/1043-4666(93)90035-4; Romano S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.109; Sahni A, 2008, J THROMB HAEMOST, V6, P176; Seebacher V, 2010, BRIT J CANCER, V102, P952, DOI 10.1038/sj.bjc.6605547; Shu YJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-566; Sicking I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111306; Simmonds MJ, 2013, J GERIATR CARDIOL, V10, P291, DOI 10.3969/j.issn.1671-5411.2013.03.010; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; Takeuchi H, 2007, J GASTROEN HEPATOL, V22, P2222, DOI 10.1111/j.1440-1746.2006.04736.x; Tang LA, 2010, J SURG ONCOL, V102, P428, DOI 10.1002/jso.21668; Tennent GA, 2007, BLOOD, V109, P1971, DOI 10.1182/blood-2006-08-040956; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang JB, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0543-4; Yamashita H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-147; Zhao KL, 2015, GYNECOL OBSTET INVES, V79, P25, DOI 10.1159/000365477; Zhu LR, 2016, CLIN TRANSL ONCOL, V18, P178, DOI 10.1007/s12094-015-1350-7	37	18	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146233	10.1371/journal.pone.0146233	http://dx.doi.org/10.1371/journal.pone.0146233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799214	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300016
J	Rogacev, KS; Heine, GH; Silbernagel, G; Kleber, ME; Seiler, S; Emrich, I; Lennartz, S; Werner, C; Zawada, AM; Fliser, D; Bohm, M; Marz, W; Scharnagl, H; Laufs, U				Rogacev, Kyrill S.; Heine, Gunnar H.; Silbernagel, Guenther; Kleber, Marcus E.; Seiler, Sarah; Emrich, Insa; Lennartz, Simone; Werner, Christian; Zawada, Adam M.; Fliser, Danilo; Boehm, Michael; Maerz, Winfried; Scharnagl, Hubert; Laufs, Ulrich			PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK; HEART; HEMODIALYSIS; CHOLESTEROL; PROTECTION; MORTALITY; LDL	Background Impaired renal function causes dyslipidemia that contributes to elevated cardiovascular risk in patients with chronic kidney disease (CKD). The proprotein convertase subtilisin/kexin type 9 (PCSK9) is a regulator of the LDL receptor and plasma cholesterol concentrations. Its relationship to kidney function and cardiovascular events in patients with reduced glomerular filtration rate (GFR) has not been explored. Methods Lipid parameters including PCSK9 were measured in two independent cohorts. CARE FOR HOMe (Cardiovascular and Renal Outcome in CKD 2-4 Patients-The Forth Homburg evaluation) enrolled 443 patients with reduced GFR (between 90 and 15ml/min/1.73 m(2)) referred for nephrological care that were prospectively followed for the occurrence of a composite cardiovascular endpoint. As a replication cohort, PCSK9 was quantitated in 1450 patients with GFR between 90 and 15ml/min/1.73m(2) enrolled in the Ludwigshafen Risk and Cardiovascular Health Study (LURIC) that were prospectively followed for cardiovascular deaths. Results PCSK9 concentrations did not correlate with baseline GFR (CARE FOR HOMe: r = -0.034; p = 0.479; LURIC: r = -0.017; p = 0.512). 91 patients in CARE FOR HOMe and 335 patients in LURIC reached an endpoint during a median follow-up of 3.0 [1.8-4.1] years and 10.0 [7.3-10.6] years, respectively. Kaplan-Meier analyses showed that PCSK9 concentrations did not predict cardiovascular events in either cohort [CARE FOR HOMe (p = 0.622); LURIC (p = 0.729)]. Sensitivity analyses according to statin intake yielded similar results. Conclusion In two well characterized independent cohort studies, PCSK9 plasma levels did not correlate with kidney function. Furthermore, PCSK9 plasma concentrations were not associated with cardiovascular events in patients with reduced renal function.	[Rogacev, Kyrill S.; Werner, Christian; Boehm, Michael; Laufs, Ulrich] Univ Saarland, Dept Internal Med 3, Cardiol Angiol & Intens Care Med, Med Ctr, Homburg, Germany; [Rogacev, Kyrill S.; Heine, Gunnar H.; Seiler, Sarah; Emrich, Insa; Lennartz, Simone; Zawada, Adam M.; Fliser, Danilo] Univ Saarland, Dept Internal Med 4, Nephrol & Hypertens, Med Ctr, Homburg, Germany; [Silbernagel, Guenther] Univ Hosp Bern, Swiss Cardiovasc Ctr, Div Angiol, CH-3010 Bern, Switzerland; [Kleber, Marcus E.; Maerz, Winfried] Heidelberg Univ, Dept Med 5, Med Fac Mannheim, Nephrol,Hypertensiol,Endocrinol,Diabetol,Rheumato, Mannheim, Germany; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Mannheim, Germany; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Augsburg, Germany; [Maerz, Winfried; Scharnagl, Hubert] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Saarland University; Saarland University; University of Bern; University Hospital of Bern; Ruprecht Karls University Heidelberg; SYNLAB Group; SYNLAB Group; Medical University of Graz	Rogacev, KS (corresponding author), Univ Saarland, Dept Internal Med 3, Cardiol Angiol & Intens Care Med, Med Ctr, Homburg, Germany.; Rogacev, KS (corresponding author), Univ Saarland, Dept Internal Med 4, Nephrol & Hypertens, Med Ctr, Homburg, Germany.	kyrill.rogacev@uksh.de	Böhm, Michael/C-3638-2011	Silbernagel, Guenther/0000-0001-9323-329X; Kleber, Marcus/0000-0003-0663-7275; Heine, Gunnar/0000-0001-8320-5260	Else Kroner-Fresenius Stiftung; Dr. Marija Orlovic Stiftung; Jubilaumsfond der Oesterreichischen Nationalbank [14219]	Else Kroner-Fresenius Stiftung; Dr. Marija Orlovic Stiftung; Jubilaumsfond der Oesterreichischen Nationalbank	The CARE FOR HOMe study was supported by a grant from the Else Kroner-Fresenius Stiftung. PCSK9 analyses in CARE FOR HOMe were funded by a grant from the Dr. Marija Orlovic Stiftung awarded to Christian Werner. The LURIC study was supported by a grant from the Jubilaumsfond der Oesterreichischen Nationalbank (No. 14219 to H.S.). WM is employed at synlab Services GmbH, Augsburg, Germany, as a board licensed specialist for laboratory medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujrad H, 2014, ATHEROSCLEROSIS, V233, P123, DOI 10.1016/j.atherosclerosis.2013.12.030; Baigent C, 2010, AM HEART J, V160, P785, DOI 10.1016/j.ahj.2010.08.012; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Brandenburg VM, 2014, ATHEROSCLEROSIS, V237, P53, DOI 10.1016/j.atherosclerosis.2014.08.037; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Heine GH, 2013, EUR HEART J, V34, P1112, DOI 10.1093/eurheartj/ehs353; Heine GH, 2012, NAT REV NEPHROL, V8, P362, DOI 10.1038/nrneph.2012.41; Jin K, 2014, AM J KIDNEY DIS, V63, P584, DOI 10.1053/j.ajkd.2013.10.042; Kwakernaak AJ, 2013, ATHEROSCLEROSIS, V226, P459, DOI 10.1016/j.atherosclerosis.2012.11.009; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Landmesser U, 2013, J LIPID RES; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Rogacev KS, 2013, CKD EPI EQUATION INC; Rogacev KS, 2014, ARTERIOSCL THROM VAS, V34, P2120, DOI 10.1161/ATVBAHA.114.304172; Rogacev KS, 2012, CLIN J AM SOC NEPHRO, V7, P943, DOI 10.2215/CJN.05170511; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seiler S, 2014, CLIN J AM SOC NEPHRO; Seiler S, 2014, CLIN J AM SOC NEPHRO, V9, P1049, DOI 10.2215/CJN.07870713; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Thygesen K, 2007, EUR HEART J, V28, P2525; Urban D, 2013, J AM COLL CARDIOL, V62, P1401, DOI 10.1016/j.jacc.2013.07.056; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Werner C, 2014, VASCULAR PHARM; Winkelmann B. R., 2001, PHARMACOGENOMICS S1, V2, P1	27	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146920	10.1371/journal.pone.0146920	http://dx.doi.org/10.1371/journal.pone.0146920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799206	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300048
J	Rune, I; Rolin, B; Larsen, C; Nielsen, DS; Kanter, JE; Bornfeldt, KE; Lykkesfeldt, J; Buschard, K; Kirk, RK; Christoffersen, B; Fels, JJ; Josefsen, K; Kihl, P; Hansen, AK				Rune, Ida; Rolin, Bidda; Larsen, Christian; Nielsen, Dennis Sandris; Kanter, Jenny E.; Bornfeldt, Karin E.; Lykkesfeldt, Jens; Buschard, Karsten; Kirk, Rikke Kaae; Christoffersen, Berit; Fels, Johannes Josef; Josefsen, Knud; Kihl, Pernille; Hansen, Axel Kornerup			Modulating the Gut Microbiota Improves Glucose Tolerance, Lipoprotein Profile and Atherosclerotic Plaque Development in ApoE-Deficient Mice	PLOS ONE			English	Article							GLUTEN-FREE DIET; NOD MICE; METABOLISM; OBESITY; INFLAMMATION; ANTIBIOTICS; DISEASE; PROMOTES; NUMBER	The importance of the gut microbiota (GM) in disease development has recently received increased attention, and numerous approaches have been made to better understand this important interplay. For example, metabolites derived from the GM have been shown to promote atherosclerosis, the underlying cause of cardiovascular disease (CVD), and to increase CVD risk factors. Popular interest in the role of the intestine in a variety of disease states has now resulted in a significant proportion of individuals without coeliac disease switching to gluten-free diets. The effect of gluten-free diets on atherosclerosis and cardiovascular risk factors is largely unknown. We therefore investigated the effect of a gluten-free high-fat cholesterol-rich diet, as compared to the same diet in which the gluten peptide gliadin had been added back, on atherosclerosis and several cardiovascular risk factors in apolipoprotein E-deficient (Apoe(-/-)) mice. The gluten-free diet transiently altered GM composition in these mice, as compared to the gliadin-supplemented diet, but did not alter body weights, glucose tolerance, insulin levels, plasma lipids, or atherosclerosis. In parallel, other Apoe(-/-) mice fed the same diets were treated with ampicillin, a broad-spectrum antibiotic known to affect GM composition. Ampicillin-treatment had a marked and sustained effect on GM composition, as expected. Furthermore, although ampicillin-treated mice were slightly heavier than controls, ampicillin-treatment transiently improved glucose tolerance both in the absence or presence of gliadin, reduced plasma LDL and VLDL cholesterol levels, and reduced aortic atherosclerotic lesion area. These results demonstrate that a gluten-free diet does not seem to have beneficial effects on atherosclerosis or several CVD risk factors in this mouse model, but that sustained alteration of GM composition with a broad-spectrum antibiotic has beneficial effects on CVD risk factors and atherosclerosis. These findings support the concept that altering the microbiota might provide novel treatment strategies for CVD.	[Rune, Ida; Larsen, Christian; Lykkesfeldt, Jens; Kihl, Pernille; Hansen, Axel Kornerup] Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet Dis Biol, Thorvaldsensvej 57, DK-1871 Frederiksberg C, Denmark; [Rolin, Bidda; Kirk, Rikke Kaae; Christoffersen, Berit; Fels, Johannes Josef] Novo Nordisk AS, Global Res, Novo Nordisk Pk 1, DK-2760 Malov, Denmark; [Nielsen, Dennis Sandris] Univ Copenhagen, Dept Food Sci, Fac Sci, Rolighedsvej 26, DK-1958 Frederiksberg C, Denmark; [Kanter, Jenny E.; Bornfeldt, Karin E.] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98109 USA; [Buschard, Karsten; Josefsen, Knud] Bartholin Inst, Rigshosp Dept 3733, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark	University of Copenhagen; Novo Nordisk; University of Copenhagen; University of Washington; University of Washington Seattle; Rigshospitalet	Rune, I (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet Dis Biol, Thorvaldsensvej 57, DK-1871 Frederiksberg C, Denmark.	idarune@hotmail.com	Nielsen, Dennis/A-9769-2015; Bornfeldt, Karin/AAI-2241-2019; Lykkesfeldt, Jens/A-1072-2011	Nielsen, Dennis/0000-0001-8121-1114; Bornfeldt, Karin/0000-0001-9208-6523; Lykkesfeldt, Jens/0000-0002-6514-8407; Buschard, Karsten/0000-0002-0126-7423; Kanter, Jenny/0000-0003-3212-772X	Danish Ministry of Science, Technology and Innovation; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01HL062887, P01HL092969, R01HL097365, R01HL126028, P30DK017047]; American Heart Association [14GRNT20410033]; National Institutes of Health [R01HL062887, P01HL092969, R01HL126028, P30DK017047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097365, R01HL126028, P01HL092969, R01HL062887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	Danish Ministry of Science, Technology and Innovation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was carried out as a part of the 3G research program (Guts, grains and greens; http://www.3g-center.dk/). The 3G program is supported by the Danish Ministry of Science, Technology and Innovation. Ida Rune is part of LIFEPHARM (www.lifepharm.dk). Research reported in this publication was also supported in part by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award numbers R01HL062887, P01HL092969, R01HL097365, R01HL126028 and P30DK017047; and by the American Heart Association, 14GRNT20410033, to KEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Christian Larsen, Lene Winther Takla, Line Rasmussen, Nicolai Hansen, Jane Larsen, Bettina Brandrup, Trine Pagh Ludvigsen, Cecilie Loe Licht and Annie Bjergby Kristensen are kindly thanked for their technical assistance. Karin E. Bornfeldt's laboratory is supported by the National Institutes of Health grants R01HL062887, P01HL092969, R01HL126028, and P30DK017047 and The American Heart Association (14GRNT20410033).	Angelakis E, 2013, LANCET INFECT DIS, V13, P889, DOI 10.1016/S1473-3099(13)70179-8; Antvorskov JC, 2014, DIABETOLOGIA; Bech-Nielsen GV, 2012, RES VET SCI, V92, P501, DOI 10.1016/j.rvsc.2011.04.005; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Carvalho BM, 2012, DIABETOLOGIA, V55, P2823, DOI 10.1007/s00125-012-2648-4; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; de Kort S, 2011, OBES REV, V12, P449, DOI 10.1111/j.1467-789X.2010.00845.x; De Palma G, 2009, BRIT J NUTR, V102, P1154, DOI 10.1017/S0007114509371767; Ejsing-Duun M, 2008, SCAND J IMMUNOL, V67, P553, DOI 10.1111/j.1365-3083.2008.02104.x; Funda DP, 2008, DIABETES-METAB RES, V24, P59, DOI 10.1002/dmrr.748; Hansen AK, 2006, DIABETES-METAB RES, V22, P220, DOI 10.1002/dmrr.609; Hansen CHF, 2014, DIABETES, V63, P2821, DOI 10.2337/db13-1612; Hansen CHF, 2014, DIABETES; Helmerhorst EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013264; Hennessy AA, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0515-2; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; Lima LFO, 2008, APPL BIOCHEM BIOTECH, V151, P283, DOI 10.1007/s12010-008-8187-2; Lykkesfeldt J, 2001, CLIN CHEM, V47, P1725; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Miyata M, 2009, J PHARMACOL EXP THER, V331, P1079, DOI 10.1124/jpet.109.160093; Nash David T, 2014, Proc (Bayl Univ Med Cent), V27, P377; Rune I, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/319321; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Sildorf SM, 2012, BMJ CASE REP; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841	41	31	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146439	10.1371/journal.pone.0146439	http://dx.doi.org/10.1371/journal.pone.0146439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799618	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300021
J	Snodgrass, R; Gardner, A; Jiang, L; Fu, C; Cesarman, E; Erickson, D				Snodgrass, Ryan; Gardner, Andrea; Jiang, Li; Fu, Cheng; Cesarman, Ethel; Erickson, David			KS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy Samples	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; HERPESVIRUS; LYMPHOMA; DNA; OUTCOMES; DISEASE; GENE	Resource-limited settings present unique engineering challenges for medical diagnostics. Diagnosis is often needed for those unable to reach central healthcare systems, making portability and independence from traditional energy infrastructure essential device parameters. In 2014, our group presented a microfluidic device that performed a solar-powered variant of the polymerase chain reaction, which we called solar thermal PCR. In this work, we expand on our previous effort by presenting an integrated, portable, solar thermal PCR system targeted towards the diagnosis of Kaposi's sarcoma. We call this system KS-Detect, and we now report the system's performance as a diagnostic tool using pseudo-biopsy samples made from varying concentrations of human lymphoma cell lines positive for the KS herpesvirus (KSHV). KS-Detect achieved 83% sensitivity and 70% specificity at high (>= 10%) KSHV+ cell concentrations when diagnosing pseudo-biopsy samples by smart-phone image. Using histology, we confirm that our prepared pseudo-biopsies contain similar KSHV+ cell concentrations as human biopsies positive for KS. Through our testing of samples derived from human cell lines, we validate KS-Detect as a viable, portable KS diagnostic tool, and we identify critical engineering considerations for future solar-thermal PCR devices.	[Snodgrass, Ryan; Jiang, Li; Fu, Cheng; Erickson, David] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Gardner, Andrea; Cesarman, Ethel] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Gardner, Andrea] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY USA	Cornell University; Cornell University; Cornell University	Erickson, D (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.; Cesarman, E (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA.	ecesarm@med.cornell.edu; de54@cornell.edu	Erickson, David/A-3319-2009	Erickson, David/0000-0002-1624-9711; Snodgrass, Ryan/0000-0003-0938-0356	US National Institutes of Biomedical Imaging and Bioengineering (NIH-NIBIB) [EB016803]; National Science Foundation [ECCS-15420819]; STC Program of the National Science Foundation [ECS-9876771]; NATIONAL CANCER INSTITUTE [UH3CA202723] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB016803] Funding Source: NIH RePORTER	US National Institutes of Biomedical Imaging and Bioengineering (NIH-NIBIB); National Science Foundation(National Science Foundation (NSF)); STC Program of the National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the US National Institutes of Biomedical Imaging and Bioengineering (NIH-NIBIB) under award EB016803. This work was performed partly at the Cornell NanoScale Facility, a member of the National Nanotechnology Coordinated Infrastructure (NNCI), which is supported by the National Science Foundation (Grant ECCS-15420819). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the US National Institutes of Biomedical Imaging and Bioengineering (NIH-NIBIB) under award EB016803. This work was performed partly at the Cornell NanoScale Facility, a member of the National Nanotechnology Coordinated Infrastructure (NNCI), which is supported by the National Science Foundation (Grant ECCS-15420819) and at the Nanobiotechnology Center (NBTC), a STC Program of the National Science Foundation under Agreement no. ECS-9876771.	Alcendor DJ, 2011, AM J PATHOL, V179, P1443, DOI 10.1016/j.ajpath.2011.05.024; Amerson E, 2012, INFECT AGENTS CANCER, V7, P6; Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Campbell TB, 2003, CLIN INFECT DIS, V36, P1144, DOI 10.1086/374599; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chu KM, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-23; Cox HS, 2015, OPEN FORUM INFECT DI, P2, DOI 10.1093/ofid/ofv014; Dupont C, 2000, AIDS, V14, P987, DOI 10.1097/00002030-200005260-00010; Erickson D, 2014, LAB CHIP, V14, P3159, DOI 10.1039/c4lc00142g; Fan W, 2005, J VIROL, V79, P1244, DOI 10.1128/JVI.79.2.1244-1251.2005; Gingues S, 2006, HIV MED, V7, P369, DOI 10.1111/j.1468-1293.2006.00395.x; Haq IU, 2016, HIV MED, V17, P56, DOI 10.1111/hiv.12273; He J, 1998, J INFECT DIS, V178, P1787, DOI 10.1086/314512; He ML, 2012, CANCER RES, V72, P3582, DOI 10.1158/0008-5472.CAN-11-2876; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Jiang L., 2014, SCI REP, P4, DOI DOI 10.1038/SREP04137; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; Mancuso M, 2013, NANOSCALE, V5, P1678, DOI 10.1039/c3nr33492a; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Mosam A, 2010, CURR OPIN INFECT DIS, V23, P119, DOI 10.1097/QCO.0b013e328335b01a; Nguyen HQ, 2008, AIDS, V22, P937, DOI 10.1097/QAD.0b013e3282ff6275; Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Poddar SK, 2000, MOL CELL PROBE, V14, P25, DOI 10.1006/mcpr.1999.0278; Schulz TF, 2015, CURR OPIN VIROL, V14, P116, DOI 10.1016/j.coviro.2015.08.016; Tam HK, 2002, INT J CANCER, V98, P916, DOI 10.1002/ijc.10274; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Uldrick TS, 2011, CANCER LETT, V305, P150, DOI 10.1016/j.canlet.2011.02.006; World Health Organization, 2013, XPERT MTB RIF FACT S; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Zhang YH, 2009, ANAL CHIM ACTA, V638, P115, DOI 10.1016/j.aca.2009.02.038	31	21	21	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147636	10.1371/journal.pone.0147636	http://dx.doi.org/10.1371/journal.pone.0147636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799834	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300135
J	Hsieh, CC; Huang, YS				Hsieh, Chia-Chien; Huang, Yu-Shan			Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TUMOR PROGRESSION; OBESITY; PREVENTION; INHIBITION; SURVIVAL; FOCUS	Breast cancer is one of the most common cancers in women worldwide. The obesity process is normally accompanied by chronic, low-grade inflammation. Infiltration by inflammatory cytokines and immune cells provides a favorable microenvironment for tumor growth, migration, and metastasis. Epidemiological evidence has shown that aspirin is an effective agent against several types of cancer. The aim of this study is to investigate the anti-inflammatory and anti-cancer effects of aspirin on 3T3-L1 adipocytes, 4T1 murine breast cancer cells, and their crosstalk. The results showed that aspirin treatment inhibited differentiation and lipid accumulation by 3T3-L1 preadipocytes, and decreased the secretion of the inflammatory adipokine MCP-1 after stimulation with tumor necrosis factor (TNF)-alpha or conditioned medium from RAW264.7 cells. In 4T1 cells, treatment with aspirin decreased cell viability and migration, possibly by suppressing MCP-1 and VEGF secretion. Subsequently, culture of 4T1 cells in 3T3-L1 adipocyte-conditioned medium (Ad-CM) and co-culture of 3T3-L1 and 4T1 cells using a transwell plate were performed to clarify the relationship between these two cell lines. Aspirin exerted its inhibitory effects in the transwell co-culture system, as well as the conditioned-medium model. Aspirin treatment significantly inhibited the proliferation of 4T1 cells, and decreased the production of MCP-1 and PAI-1 in both the Ad-CM model and co-culture system. Aspirin inhibited inflammatory MCP-1 adipokine production by 3T3-L1 adipocytes and the cell growth and migration of 4T1 cells. It also broke the crosstalk between these two cell lines, possibly contributing to its chemopreventive properties in breast cancer. This is the first report that aspirin's chemopreventive activity supports the potential application in auxiliary therapy against obesity-related breast cancer development.	[Hsieh, Chia-Chien; Huang, Yu-Shan] Natl Taiwan Normal Univ, Dept Human Dev & Family Studies, Taipei, Taiwan	National Taiwan Normal University	Hsieh, CC (corresponding author), Natl Taiwan Normal Univ, Dept Human Dev & Family Studies, Taipei, Taiwan.	hsieh@ntnu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 103-2320-B-003-003-MY3]; National Taiwan Normal University, Taiwan [T10207000473, T10407000803]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan Normal University, Taiwan	This work was supported by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/en/public) MOST 103-2320-B-003-003-MY3 and the National Taiwan Normal University, Taiwan (http://www2.ntnu.edu.tw/) (#T10207000473, #T10407000803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre MM, 2013, ASIAN PAC J CANCER P, V14, P2207, DOI 10.7314/APJCP.2013.14.4.2207; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; An Y, 2009, INFLAMMATION, V32, P296, DOI 10.1007/s10753-009-9135-1; Ansara AJ, 2010, ANN PHARMACOTHER, V44, P851, DOI 10.1345/aph.1M346; Carter JS, 2009, J SOCIOL RES, V1, P1, DOI [DOI 10.1155/2009/345320, DOI 10.5296/JSR.V1I1.156]; Catalan V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00275; Chattopadhyay M, 2012, BIOCHEM PHARMACOL, V83, P723, DOI 10.1016/j.bcp.2011.12.019; Chen CT, 2012, MOL CANCER THER, V11, P2212, DOI 10.1158/1535-7163.MCT-12-0180; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Dubois V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058541; Ferlay J., 2013, INT AGENCY RES CANC; Ford NA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00209; Hitchcock JR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0573-4; Holmes MD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3336; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Huang XZ, 2015, CANCER CAUSE CONTROL, V26, P589, DOI 10.1007/s10552-015-0539-y; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; Li M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25474; Madera L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133385; Maity G, 2015, LAB INVEST, V95, P702, DOI 10.1038/labinvest.2015.49; Mazid MA, 2006, FEBS LETT, V580, P6885, DOI 10.1016/j.febslet.2006.11.049; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Newman G, 2014, MOL CELL ENDOCRINOL, V382, P570, DOI 10.1016/j.mce.2013.03.025; Ogston NC, 2008, INT J OBESITY, V32, P1807, DOI 10.1038/ijo.2008.190; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Pelucchi C, 2011, ANN ONCOL, V22, P1487, DOI 10.1093/annonc/mdq610; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Saxena NK, 2013, J MAMMARY GLAND BIOL, V18, P309, DOI 10.1007/s10911-013-9308-2; Singh-Ranger G, 2008, BREAST CANCER RES TR, V109, P189, DOI 10.1007/s10549-007-9641-5; Song H, 2015, J NUTR BIOCHEM, V26, P1368, DOI 10.1016/j.jnutbio.2015.07.005; Su YF, 2014, EUR J PHARMACOL, V738, P101, DOI 10.1016/j.ejphar.2014.03.009; Sundaram Sneha, 2013, J Carcinog, V12, P19, DOI 10.4103/1477-3163.119606; Thorat MA, 2013, CURR ONCOL REP, V15, P533, DOI 10.1007/s11912-013-0351-3; Usman MW, 2015, BBA-REV CANCER, V1855, P254, DOI 10.1016/j.bbcan.2015.03.007; Viana CTR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138408; World Cancer Research Fund International (WCRF), 2012, BREAST CANC STAT; World Health Organization (WHO) Media Center Geneva, 2015, OB OV FACTS OV OB; Zarogoulidis P, 2015, J CANCER, V6, P9, DOI 10.7150/jca.10560; Zhong SL, 2015, CANCER EPIDEM BIOMAR, V24, P1645, DOI 10.1158/1055-9965.EPI-15-0452; Zhou Y, 2008, INFLAMMATION, V31, P355, DOI 10.1007/s10753-008-9086-y	43	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147161	10.1371/journal.pone.0147161	http://dx.doi.org/10.1371/journal.pone.0147161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794215	Green Submitted, Green Published, gold			2022-12-26	WOS:000368530300020
J	Le, MH; Weissmiller, AM; Monte, L; Lin, PH; Hexom, TC; Natera, O; Wu, CB; Rissman, RA				Le, Michelle H.; Weissmiller, April M.; Monte, Louise; Lin, Po Han; Hexom, Tia C.; Natera, Orlangie; Wu, Chengbiao; Rissman, Robert A.			Functional Impact of Corticotropin-Releasing Factor Exposure on Tau Phosphorylation and Axon Transport	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PAIRED HELICAL FILAMENTS; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; NEUROFIBRILLARY TANGLES; CRF RECEPTORS; MESSENGER-RNAS; NEURODEGENERATIVE DISEASES; ABNORMAL PHOSPHORYLATION	Stress exposure or increased levels of corticotropin-releasing factor (CRF) induce hippocampal tau phosphorylation (tau-P) in rodent models, a process that is dependent on the type-1 CRF receptor (CRFR1). Although these preclinical studies on stress-induced tau-P provide mechanistic insight for epidemiological work that identifies stress as a risk factor for Alzheimer's disease (AD), the actual impact of stress-induced tau-P on neuronal function remains unclear. To determine the functional consequences of stress-induced tau-P, we developed a novel mouse neuronal cell culture system to explore the impact of acute (0.5hr) and chronic (2hr) CRF treatment on tau-P and integral cell processes such as axon transport. Consistent with in vivo reports, we found that chronic CRF treatment increased tau-P levels and caused globular accumulations of phosphorylated tau in dendritic and axonal processes. Furthermore, while both acute and chronic CRF treatment led to significant reduction in CREB activation and axon transport of brain-derived neurotrophic factor (BDNF), this was not the case with mitochondrial transport. Acute CRF treatment caused increased mitochondrial velocity and distance traveled in neurons, while chronic CRF treatment modestly decreased mitochondrial velocity and greatly increased distance traveled. These results suggest that transport of cellular energetics may take priority over growth factors during stress. Tau-P was required for these changes, as co-treatment of CRF with a GSK kinase inhibitor prevented CRF-induced tau-P and all axon transport changes. Collectively, our results provide mechanistic insight into the consequences of stress peptide-induced tau-P and provide an explanation for how chronic stress via CRF may lead to neuronal vulnerability in AD.	[Le, Michelle H.; Weissmiller, April M.; Monte, Louise; Lin, Po Han; Hexom, Tia C.; Natera, Orlangie; Wu, Chengbiao; Rissman, Robert A.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Rissman, Robert A.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Rissman, RA (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.; Rissman, RA (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.	rrissman@ucsd.edu		Weissmiller, April/0000-0003-4505-0530	NIH [AG032755, AG047484, AG010483, BX003040, AG005131, PN2 EY016525]; Alzheimer's Art Quilt Initiative; Alzheimer's Association; Down syndrome Research and Treatment Foundation; Larry L. Hillblom Foundation; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032755, U01AG010483, R21AG047484, U19AG010483] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Art Quilt Initiative; Alzheimer's Association(Alzheimer's Association); Down syndrome Research and Treatment Foundation; Larry L. Hillblom Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH AG032755, AG047484, AG010483, BX003040 and a pilot grant through AG005131; the Alzheimer's Art Quilt Initiative and the Alzheimer's Association, NIH (PN2 EY016525) and The Down syndrome Research and Treatment Foundation, and the Larry L. Hillblom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2005, NEUROBIOL AGING, V26, P511, DOI 10.1016/j.neurobiolaging.2004.05.006; Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Bremner J. Douglas, 2006, CNS & Neurological Disorders-Drug Targets, V5, P503; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Campbell SN, 2015, J ALZHEIMERS DIS, V43, P967, DOI 10.3233/JAD-141281; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Chadwick D, 1993, CORTICOTROPIN RELEAS, Vx; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Choi JS, 2006, J KOREAN MED SCI, V21, P518, DOI 10.3346/jkms.2006.21.3.518; Cuchillo-Ibanez I, 2008, FASEB J, V22, P3186, DOI 10.1096/fj.08-109181; Davis KL, 1999, ARCH GEN PSYCHIAT, V56, P981, DOI 10.1001/archpsyc.56.11.981; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; DICKSON DW, 1992, ACTA NEUROPATHOL, V84, P596; Dirks A, 2002, EUR J NEUROSCI, V16, P1751, DOI 10.1046/j.1460-9568.2002.02245.x; Dong HX, 2014, PSYCHOPHARMACOLOGY, V231, P4711, DOI 10.1007/s00213-014-3629-8; DUGICHDJORDJEVIC MM, 1995, EUR J NEUROSCI, V7, P1831, DOI 10.1111/j.1460-9568.1995.tb00703.x; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Goebel M, 2010, NEUROSCI LETT, V473, P11, DOI 10.1016/j.neulet.2010.01.068; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; Guo QX, 2012, NEUROBIOL AGING, V33, P2678, DOI 10.1016/j.neurobiolaging.2012.01.002; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; Heinrichs SC, 1996, NEUROSCIENCE, V74, P303, DOI 10.1016/0306-4522(96)00140-6; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Kosik KS, 1990, CURR OPIN CELL BIOL, V2, P101, DOI 10.1016/S0955-0674(05)80038-9; KOSIK KS, 1990, MOL NEUROBIOL, V4, P171, DOI 10.1007/BF02780339; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; LOVENBERG TW, 1995, ENDOCRINOLOGY, V136, P4139, DOI 10.1210/en.136.9.4139; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 1997, MOL PSYCHIATR, V2, P255, DOI 10.1038/sj.mp.4000254; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Oliff HS, 1998, MOL BRAIN RES, V61, P147, DOI 10.1016/S0169-328X(98)00222-8; Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012; Rehman Habib U, 2002, Curr Opin Investig Drugs, V3, P1637; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Rissman RA, 2007, J NEUROSCI, V27, P6552, DOI 10.1523/JNEUROSCI.5173-06.2007; Rissman RA, 2012, P NATL ACAD SCI USA, V109, P6277, DOI 10.1073/pnas.1203140109; Rissman RA, 2009, J ALZHEIMERS DIS, V18, P453, DOI 10.3233/JAD-2009-1153; Roe AD, 2011, EUR J NEUROSCI, V34, P448, DOI 10.1111/j.1460-9568.2011.07764.x; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; SAWCHENKO PE, 2008, NEW ENCY NEUROSCIENC; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Stokin GB, 2006, J PHYSIOL-PARIS, V99, P193, DOI 10.1016/j.jphysparis.2005.12.085; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Touma C, 2004, NEUROBIOL AGING, V25, P893, DOI 10.1016/j.neurobiolaging.2003.09.004; Trinczek B, 1999, J CELL SCI, V112, P2355; Turnbull AV, 1997, P SOC EXP BIOL MED, V215, P1; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Weissmiller AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118379; Wilson RS, 2007, NEUROLOGY, V68, P2085, DOI 10.1212/01.wnl.0000264930.97061.82; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V27, P143, DOI 10.1159/000095761; Wilson RS, 2005, PSYCHONEUROENDOCRINO, V30, P11, DOI 10.1016/j.psyneuen.2004.04.005; Wilson RS, 2003, NEUROLOGY, V61, P1479, DOI 10.1212/01.WNL.0000096167.56734.59; Zhao XB, 2014, JOVE-J VIS EXP, DOI 10.3791/51899; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	82	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147250	10.1371/journal.pone.0147250	http://dx.doi.org/10.1371/journal.pone.0147250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790099	Green Published, gold			2022-12-26	WOS:000368529100072
J	Carneiro, LRD; Lima, AP; Machado, RB; Magnusson, WE				Carneiro, Lorena Ribeiro de A.; Lima, Albertina P.; Machado, Ricardo B.; Magnusson, William E.			Limitations to the Use of Species-Distribution Models for Environmental-Impact Assessments in the Amazon	PLOS ONE			English	Article							SAMPLE-SIZE; PERFORMANCE; RANGE; BIODIVERSITY; COMMUNITIES; PREDICTION; ACCURACY; PATTERNS; BRAZIL; TOOLS	Species-distribution models (SDM) are tools with potential to inform environmental-impact studies (EIA). However, they are not always appropriate and may result in improper and expensive mitigation and compensation if their limitations are not understood by decision makers. Here, we examine the use of SDM for frogs that were used in impact assessment using data obtained from the EIA of a hydroelectric project located in the Amazon Basin in Brazil. The results show that lack of knowledge of species distributions limits the appropriate use of SDM in the Amazon region for most target species. Because most of these targets are newly described and their distributions poorly known, data about their distributions are insufficient to be effectively used in SDM. Surveys that are mandatory for the EIA are often conducted only near the area under assessment, and so models must extrapolate well beyond the sampled area to inform decisions made at much larger spatial scales, such as defining areas to be used to offset the negative effects of the projects. Using distributions of better-known species in simulations, we show that geographical-extrapolations based on limited information of species ranges often lead to spurious results. We conclude that the use of SDM as evidence to support project-licensing decisions in the Amazon requires much greater area sampling for impact studies, or, alternatively, integrated and comparative survey strategies, to improve biodiversity sampling. When more detailed distribution information is unavailable, SDM will produce results that generate uncertain and untestable decisions regarding impact assessment. In many cases, SDM is unlikely to be better than the use of expert opinion.	[Carneiro, Lorena Ribeiro de A.; Lima, Albertina P.; Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Machado, Ricardo B.] Univ Brasilia, Dept Zool, Brasilia, DF, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade de Brasilia	Carneiro, LRD (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.; Carneiro, LRD (corresponding author), Inst Meio Ambiente & Recursos Hidr Dist Fed Brasi, Coordenacao Unidades Conservacao Uso Sustentavel, Brasilia, DF, Brazil.	lribeirocarneiro@gmail.com	Machado, Ricardo Bomfim/J-5894-2012; Machado, Ricardo/GXM-8198-2022	Machado, Ricardo Bomfim/0000-0002-6508-9005; Ribeiro de Almeida Carneiro, Lorena/0000-0002-2861-4085; Lima, Albertina Pimentel/0000-0003-4586-5633	Brazilian National Council for Scientific and Technological Development (CNPq); Amazonas State Research Support Foundation (FAPEAM); CNPq; Wildlife Conservation Program of Santo Antonio Energia	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Amazonas State Research Support Foundation (FAPEAM); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wildlife Conservation Program of Santo Antonio Energia	The Brazilian National Council for Scientific and Technological Development (CNPq) provided a scholarship to LRAC and productivity grant for RBM, APL and WEM. The Wildlife Conservation Program of Santo Antonio Energia financed the construction of plot systems and data collection, but they had no direct involvement in those and other tasks (e.g. analysis, decision to publish, preparation of the manuscript). The Programa de Pesquisa em Biodiversidade (PPBio), the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM) coordinated data management and supported some the field work. The Amazonas State Research Support Foundation (FAPEAM) financed the publication of this manuscript.; We are grateful to CNPq for providing a research fellowship for LRAC and productivity grant for RBM, APL and WEM. The herpetofauna monitoring team of the Santo Antonio Hydroelectric plant provided the data with the support of the Wildlife Conservation Program of Santo Antonio Energia. Coordination was undertaken by the Program for Biodiversity Research (PPBio) and the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM). We thank the Biodiversity Conservation Planning Laboratory/UnB team, for contributions to analyses, and P.I. Simoes, I. Kaffer, V.J.T. Perdigao, J.B. Oliveira, S. Watzel, A. Sousa, D. Norris, D. Cho, and S.H.C. Carvalho for suggestions. V. Landeiro provided the Generic Graphic Script in R software. D. Tonks, L. Robichaud and S. DeAlmeida helped with translations. J.D. Filho, E. Vertincinque, B.W. Nelson, K. Didier, and M. Gordo provided comments on previous drafts. James J. Roper reviewed the English and provided helpful comments. The Amazonas State Research Support Foundation (FAPEAM) provided support for publication of this manuscript.	Acerbi MA, 2014, 34 ANN C INT ASS IMP; Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Araujo MB, 2004, J BIOGEOGR, V31, P1037, DOI 10.1111/j.1365-2699.2004.01051.x; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Barbet-Massin M, 2010, ECOGRAPHY, V33, P878, DOI 10.1111/j.1600-0587.2010.06181.x; Brazil, 2007, 146 IBAMA; Caldwell JP, 2003, HERPETOLOGICA, V59, P219, DOI 10.1655/0018-0831(2003)059[0219:ANASOC]2.0.CO;2; Caro T. M, 2010, CONSERVATION PROXY I; Carroll SS, 1998, ECOGRAPHY, V21, P401, DOI 10.1111/j.1600-0587.1998.tb00405.x; Cayuela L, 2009, TROP CONSERV SCI, V2, P319, DOI 10.1177/194008290900200304; de Fraga R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105453; Dias-Terceiro RG, 2015, BIOTROPICA, V47, P259, DOI 10.1111/btp.12197; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Fearnside PM, 2001, ENVIRON MANAGE, V27, P377, DOI 10.1007/s002670010156; Feeley KJ, 2011, GLOBAL CHANGE BIOL, V17, P626, DOI 10.1111/j.1365-2486.2010.02239.x; Ferreira LV, 2013, AN ACAD BRAS CIENC, V85, P1013, DOI 10.1590/S0001-37652013000300012; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ficetola GF, 2014, GLOBAL ECOL BIOGEOGR, V23, P1303, DOI 10.1111/geb.12201; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; Gascon C, 1998, BIOTROPICA, V30, P104, DOI 10.1111/j.1744-7429.1998.tb00373.x; Godsoe W, 2010, SYST BIOL, V59, P298, DOI 10.1093/sysbio/syq005; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P1; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Jimenez-Valverde A, 2014, BIODIVERS CONSERV, V23, P369, DOI 10.1007/s10531-013-0606-1; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kaefer IL, 2013, EVOL BIOL, V40, P228, DOI 10.1007/s11692-012-9205-4; Kaefer IL, 2012, ACTA ETHOL, V15, P187, DOI 10.1007/s10211-012-0126-0; Lima AP, 2007, COPEIA, P114; Lima Albertina P., 2010, Zootaxa, V2337, P1; Loyola R.D., 2009, MEGADIVERSIDADE, V5, P29; Magnusson W.E., 2005, BIOTA NEOTROP, V5, P1, DOI DOI 10.1590/S0101-81751996000200002; Magnusson WE, 2013, BIODIVERSITY INTEGRA; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ribas CC, 2007, REV BRAS ORNITOL, V15, P245; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Rossetti DD, 2005, QUATERNARY RES, V63, P78, DOI 10.1016/j.yqres.2004.10.001; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Saupe EE, 2012, ECOL MODEL, V237, P11, DOI 10.1016/j.ecolmodel.2012.04.001; Simoes PI, 2010, ZOOTAXA, P1; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Syfert MM, 2014, BIOL CONSERV, V177, P174, DOI 10.1016/j.biocon.2014.06.012; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Torres NM, 2012, NAT CONSERVACAO, V10, P228, DOI 10.4322/natcon.2012.023; Villarroya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107144; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zurell D, 2012, DIVERS DISTRIB, V18, P628, DOI 10.1111/j.1472-4642.2012.00887.x	59	19	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146543	10.1371/journal.pone.0146543	http://dx.doi.org/10.1371/journal.pone.0146543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784891	Green Published, gold			2022-12-26	WOS:000368528400047
J	Dann, LM; Paterson, JS; Newton, K; Oliver, R; Mitchell, JG				Dann, Lisa M.; Paterson, James S.; Newton, Kelly; Oliver, Rod; Mitchell, James G.			Distributions of Virus-Like Particles and Prokaryotes within Microenvironments	PLOS ONE			English	Article							FLOODPLAIN SYSTEM DANUBE; FRESH-WATER; MARINE VIRUSES; FLOW-CYTOMETRY; SPATIAL AUTOCORRELATION; PSEUDOMONAS-AERUGINOSA; HETEROTROPHIC BACTERIA; MICROSCALE PATCHINESS; VIRAL ABUNDANCE; BACTERIOPLANKTON	Microbial interactions are important for ecosystem function, but occur at the microscale and so are difficult to observe. Previous studies in marine systems have shown significant shifts in microbial community abundance and composition over scales of micrometres to centimetres. This study investigates the microscale abundance distributions of virus-like particles (VLPs) and prokaryotes in the lower reaches of a river to determine the extent to which microscale microbial patchiness exists in freshwater systems. Here we report local hotspots surrounded by gradients that reach a maximum 80 and 107 fold change in abundance over 0.9 cm for prokaryotic and VLP subpopulations. Changes in prokaryotic and VLP hotspots were tightly coupled. There were no gradients at tens of centimetres across the boundary layers, which is consistent with strong mixing and turbulence-driven aggregation found in river systems. Quantification of the patchiness shows a marked asymmetry with patches 10 times greater than background common, but depletions being rare or absent in most samples. This consistent asymmetry suggests that coldspots depleted by grazing and lysis are rapidly mixed to background concentrations, while the prevalence of hotspots indicates persistence against disruption. The hotspot to coldspot relative abundance may be useful for understanding microbial river dynamics. The patchiness indicates that the mean-field approach of bulk phase sampling misses the microbially relevant community variation and may underestimate the concentrations of these important microbial groups.	[Dann, Lisa M.; Paterson, James S.; Newton, Kelly; Mitchell, James G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Oliver, Rod] CSIRO, Land & Water Res Div, Adelaide, SA, Australia	Flinders University South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dann, LM (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	lisa.dann@flinders.edu.au	Oliver, Roderick L/D-4195-2011	Oliver, Roderick L/0000-0003-2238-1740; Newton, Kelly/0000-0001-8405-7140; Mitchell, Jim/0000-0002-8445-0935; Paterson, James/0000-0002-1193-5739	Commonwealth Scientific and Industrial Research Organisation; Australian Research Council	Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Research Council(Australian Research Council)	Commonwealth Scientific and Industrial Research Organisation provided a PhD top up scholarship and consumbables for LD. General support was provided by Australian Research Council grants to JGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham ER, 1998, NATURE, V391, P577, DOI 10.1038/35361; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Barbara GM, 2003, FEMS MICROBIOL ECOL, V43, P99, DOI 10.1111/j.1574-6941.2003.tb01049.x; Besemer K, 2005, APPL ENVIRON MICROB, V71, P609, DOI 10.1128/AEM.71.2.609-620.2005; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Bruce C., 2008, CRIMESTAT 3 USER WOR; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Chen F, 2001, APPL ENVIRON MICROB, V67, P539, DOI 10.1128/AEM.67.2.539-545.2001; COCHLAN WP, 1993, MAR ECOL PROG SER, V92, P77, DOI 10.3354/meps092077; Dann LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102805; DUARTE CM, 1992, MAR ECOL PROG SER, V84, P95, DOI 10.3354/meps084095; Durham WM, 2012, ANNU REV MAR SCI, V4, P177, DOI 10.1146/annurev-marine-120710-100957; Durham WM, 2009, SCIENCE, V323, P1067, DOI 10.1126/science.1167334; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Geary R.C., 1954, INC STAT, V5, P115, DOI [DOI 10.2307/2986645, 10.2307/2986645]; Goddard VJ, 2005, AQUAT MICROB ECOL, V39, P211, DOI 10.3354/ame039211; Griffith DA, 1987, RESOURCE PUBLICATION; Griffith PC, 1990, MAR ECOL PROG SER, V108, P1; GROSSART HP, 1993, LIMNOL OCEANOGR, V38, P532, DOI 10.4319/lo.1993.38.3.0532; Grossart HP, 1998, AQUAT MICROB ECOL, V15, P127, DOI 10.3354/ame015127; HENNES KP, 1995, APPL ENVIRON MICROB, V61, P333, DOI 10.1128/AEM.61.1.333-340.1995; HOLM S, 1979, SCAND J STAT, V6, P65; Hondzo M, 1999, FRESHWATER BIOL, V41, P51, DOI 10.1046/j.1365-2427.1999.00389.x; IRIBERRI J, 1987, APPL ENVIRON MICROB, V53, P2308, DOI 10.1128/AEM.53.10.2308-2314.1987; Jacquet S, 2005, FRESHWATER BIOL, V50, P627, DOI 10.1111/j.1365-2427.2005.01349.x; Jacquet S., 2010, ADV OCEANOGR LIMNOL, V1, P97, DOI [10.1080/19475721003743843, DOI 10.1080/19475721003743843]; Jezbera J, 2012, FEMS MICROBIOL ECOL, V81, P467, DOI 10.1111/j.1574-6941.2012.01372.x; KAPUSCINSKI RB, 1980, WATER RES, V14, P363, DOI 10.1016/0043-1354(80)90084-6; KIRCHMAN D, 1982, APPL ENVIRON MICROB, V43, P200, DOI 10.1128/AEM.43.1.200-209.1982; KOKJOHN TA, 1991, J GEN MICROBIOL, V137, P661, DOI 10.1099/00221287-137-3-661; Kolmogoroff AN, 1941, CR ACAD SCI URSS, V32, P16; Larsen A, 2004, LIMNOL OCEANOGR, V49, P180, DOI 10.4319/lo.2004.49.1.0180; Lear G, 2014, ISME J, V8, P1715, DOI 10.1038/ismej.2014.21; Liu Z, 2011, FEMS MICROBIOLOGY EC, V80, P30; Long RA, 2001, AQUAT MICROB ECOL, V26, P103, DOI 10.3354/ame026103; Luef B, 2007, FRESHWATER BIOL, V52, P1043, DOI 10.1111/j.1365-2427.2007.01752.x; Luef B, 2009, APPL ENVIRON MICROB, V75, P5952, DOI 10.1128/AEM.00186-09; MARANGER R, 1995, MAR ECOL PROG SER, V121, P217, DOI 10.3354/meps121217; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Meyer KA, 2014, HARMFUL ALGAE, V38, P110, DOI 10.1016/j.hal.2014.04.015; Mitchell JG, 2008, J MARINE SYST, V69, P247, DOI 10.1016/j.jmarsys.2006.01.019; MITCHELL JG, 1989, MAR ECOL PROG SER, V54, P141, DOI 10.3354/meps054141; MITCHELL JG, 1985, NATURE, V316, P58, DOI 10.1038/316058a0; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Ortmann AC, 2002, MICROB ECOL, V43, P225, DOI 10.1007/s00248-001-1058-9; Palijan G, 2012, MICROB ECOL, V64, P39, DOI 10.1007/s00248-012-0016-z; Parvathi Ammini, 2012, Advances in Oceanography and Limnology, V3, P171, DOI 10.1080/19475721.2012.738157; Paterson JS, 2012, ESTUAR COAST SHELF S, V96, P197, DOI 10.1016/j.ecss.2011.11.009; Patten NL, 2006, J MAR BIOL ASSOC UK, V86, P563, DOI 10.1017/S0025315406013476; Payet JP, 2008, J MARINE SYST, V74, P933, DOI 10.1016/j.jmarsys.2007.11.002; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peduzzi P, 2004, ENVIRON MICROBIOL, V6, P707, DOI 10.1111/j.1462-2920.2004.00602.x; Peduzzi P, 2008, AQUAT SCI, V70, P186, DOI 10.1007/s00027-008-8068-3; Peduzzi P, 2016, BIOL REV, V91, P937, DOI 10.1111/brv.12202; Pollard PC, 2011, LIMNOL OCEANOGR, V56, P1115, DOI 10.4319/lo.2011.56.3.1115; RIPP S, 1995, APPL ENVIRON MICROB, V61, P1214, DOI 10.1128/AEM.61.4.1214-1219.1995; Roudnew B, 2014, GROUNDWATER, V52, P118, DOI 10.1111/gwat.12044; Roudnew B, 2012, GROUND WATER MONIT R, V32, P72, DOI 10.1111/j.1745-6592.2011.01393.x; Schapira M, 2009, AQUAT MICROB ECOL, V54, P171, DOI 10.3354/ame01262; Seymour JR, 2010, AQUAT MICROB ECOL, V59, P161, DOI 10.3354/ame01400; Seymour JR, 2008, ESTUAR COAST SHELF S, V80, P589, DOI 10.1016/j.ecss.2008.09.011; Seymour JR, 2000, AQUAT MICROB ECOL, V22, P143, DOI 10.3354/ame022143; Seymour JR, 2005, MAR ECOL PROG SER, V288, P1, DOI 10.3354/meps288001; Seymour JR, 2006, J MAR BIOL ASSOC UK, V86, P551, DOI 10.1017/S0025315406013464; Seymour JR, 2005, MAR ECOL PROG SER, V300, P21, DOI 10.3354/meps300021; Seymour JR, 2004, AQUAT MICROB ECOL, V35, P1, DOI 10.3354/ame035001; Siegel DA, 1998, LIMNOL OCEANOGR, V43, P1133, DOI 10.4319/lo.1998.43.6.1133; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Smith RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129004; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Stocker R, 2012, MICROBIOL MOL BIOL R, V76, P792, DOI 10.1128/MMBR.00029-12; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; SUTTLE CA, 1992, APPL ENVIRON MICROB, V58, P3721, DOI 10.1128/AEM.58.11.3721-3729.1992; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Taylor JR, 2012, SCIENCE, V338, P675, DOI 10.1126/science.1219417; Thomas R, 2011, ENVIRON MICROBIOL, V13, P616, DOI 10.1111/j.1462-2920.2010.02364.x; WaterConnect Government of South Australia Department of Environment Water and Natural Resources, 2012, RIVER MURRAY DATA; Waters RL, 2003, MAR ECOL PROG SER, V251, P49, DOI 10.3354/meps251049; Weinbauer MG, 1999, AQUAT MICROB ECOL, V18, P217, DOI 10.3354/ame018217; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; WIEBE PH, 1970, LIMNOL OCEANOGR, V15, P205, DOI 10.4319/lo.1970.15.2.0205; Wilhelm SW, 2008, FRESHWATER BIOL, V53, P1076, DOI 10.1111/j.1365-2427.2008.01980.x; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yager PL, 2001, LIMNOL OCEANOGR, V46, P790, DOI 10.4319/lo.2001.46.4.0790; Young WR, 2001, NATURE, V412, P328, DOI 10.1038/35085561; Zhong X, 2014, MICROB ECOL, V67, P66, DOI 10.1007/s00248-013-0320-2; Zimmermann-Timm H, 2002, INT REV HYDROBIOL, V87, P197, DOI 10.1002/1522-2632(200205)87:2/3<197::AID-IROH197>3.0.CO;2-7	95	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146984	10.1371/journal.pone.0146984	http://dx.doi.org/10.1371/journal.pone.0146984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785114	Green Published, gold			2022-12-26	WOS:000368528400093
J	Groves, C; German, T; Dasgupta, R; Mueller, D; Smith, DL				Groves, Carol; German, Thomas; Dasgupta, Ranjit; Mueller, Daren; Smith, Damon L.			Seed Transmission of Soybean vein necrosis virus: The First Tospovirus Implicated in Seed Transmission	PLOS ONE			English	Article							DISCOVERY	Soybean vein necrosis virus (SVNV; genus Tospovirus; Family Bunyaviridae) is a negativesense single-stranded RNA virus that has been detected across the United States and in Ontario, Canada. In 2013, a seed lot of a commercial soybean variety (Glycine max) with a high percentage of discolored, deformed and undersized seed was obtained. A random sample of this seed was planted in a growth room under standard conditions. Germination was greater than 90% and the resulting seedlings looked normal. Four composite samples of six plants each were tested by reverse transcription polymerase chain reaction (RT-PCR) using published primers complimentary to the S genomic segment of SVNV. Two composite leaflet samples retrieved from seedlings yielded amplicons with a size and sequence predictive of SVNV. Additional testing of twelve arbitrarily selected individual plants resulted in the identification of two SVNV positive plants. Experiments were repeated by growing seedlings from the same seed lot in an isolated room inside a thrips-proof cage to further eliminate any external source of infection. Also, increased care was taken to reduce any possible PCR contamination. Three positive plants out of forty-eight were found using these measures. Published and newly designed primers for the L and M RNAs of SVNV were also used to test the extracted RNA and strengthen the diagnosis of viral infection. In experiments, by three scientists, in two different labs all three genomic RNAs of SVNV were amplified in these plant materials. RNA-seq analysis was also conducted using RNA extracted from a composite seedling sample found to be SVNV-positive and a symptomatic sample collected from the field. This analysis revealed both sense and anti-sense reads from all three gene segments in both samples. We have shown that SVNV can be transmitted in seed to seedlings from an infected seed lot at a rate of 6%. To our knowledge this is the first report of seed-transmission of a Tospovirus.	[Groves, Carol; Smith, Damon L.] Univ Wisconsin, Dept Plant Pathol, 1630 Linden Dr, Madison, WI 53706 USA; [German, Thomas; Dasgupta, Ranjit] Univ Wisconsin, Dept Entomol, 1630 Linden Dr, Madison, WI 53706 USA; [Mueller, Daren] Iowa State Univ, Dept Plant Pathol & Microbiol, 351 Bessey Hall, Ames, IA 50011 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Iowa State University	Smith, DL (corresponding author), Univ Wisconsin, Dept Plant Pathol, 1630 Linden Dr, Madison, WI 53706 USA.	damon.smith@wisc.edu		Smith, Damon/0000-0003-3436-3718	Wisconsin Soybean Marketing Board; USDA-ARS Floriculture and Nursery Research Initiative	Wisconsin Soybean Marketing Board; USDA-ARS Floriculture and Nursery Research Initiative(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this work was provided in part by the Wisconsin Soybean Marketing Board and the USDA-ARS Floriculture and Nursery Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Hyun Jin Hwang for assistance in conducting experiments and Anna Whitfield and Medhi Kabbage for thorough review of this manuscript. Funding for this work was provided in part by the Wisconsin Soybean Marketing Board and the USDA-ARS Floriculture and Nursery Research Initiative.	[Anonymous], 2015, SOYB ACR PLANT HARV; de Oliveira AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038634; DEMSKI JW, 1971, PHYTOPATHOLOGY, V61, P308, DOI 10.1094/Phyto-61-308; DEMSKI JW, 1975, PHYTOPATHOLOGY, V65, P1154, DOI 10.1094/Phyto-65-1154; Demski JW, 1999, TOBACCO RINGSPOT COM; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Hajimorad M. R., 2015, Plant Health Progress, pPHP; Hartman GL., 1999, COMPENDIUM SOYBEAN D, V4th ed.; Khatabi B, 2012, EUR J PLANT PATHOL, V133, P783, DOI 10.1007/s10658-012-9969-5; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mitter N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076276; Moyer J. W., 1999, APSNET FEATURES, DOI [10.1094/APSnetFeatures-1999-0499, DOI 10.1094/APSNETFEATURES-1999-0499]; NCSRP-Soybean Research & Information Initiative, 2014, SOYB VIR; Nischwitz C, 2006, PLANT DIS, V90, P524, DOI 10.1094/PD-90-0524B; Pappu S. S., 1999, Peanut Science, V26, P98, DOI 10.3146/i0095-3679-26-2-7; Prabha K, 2013, INDIAN J VIROL, V24, P157, DOI 10.1007/s13337-013-0133-4; Smith DL, 2013, PHYTOPATHOLOGY, V103, P135; Smith DL, 2013, PLANT DIS, V97, P693, DOI 10.1094/PDIS-11-12-1096-PDN; Tolin S.A., 1999, COMPENDIUM SOYBEAN D; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zhou J, 2011, VIRUS GENES, V43, P289, DOI 10.1007/s11262-011-0621-9; Zhou J, 2013, PHYTOPATHOLOGY, V103, P966, DOI 10.1094/PHYTO-12-12-0322-R	25	26	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147342	10.1371/journal.pone.0147342	http://dx.doi.org/10.1371/journal.pone.0147342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784931	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400137
J	Saez-Lopez, E; Guiral, E; Fernandez-Orth, D; Villanueva, S; Gonce, A; Lopez, M; Teixido, I; Pericot, A; Figueras, F; Palacio, M; Cobo, T; Bosch, J; Soto, SM				Saez-Lopez, Emma; Guiral, Elisabet; Fernandez-Orth, Dietmar; Villanueva, Sonia; Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa; Bosch, Jordi; Soto, Sara M.			Vaginal versus Obstetric Infection Escherichia coli Isolates among Pregnant Women: Antimicrobial Resistance and Genetic Virulence Profile	PLOS ONE			English	Article							PATHOGENICITY ISLANDS; NEONATAL SEPSIS; STRAINS; COLONIZATION; PREVALENCE; PHYLOGENY; SUSCEPTIBILITY; EPIDEMIOLOGY; TRACT	Vaginal Escherichia coli colonization is related to obstetric infections and the consequent development of infections in newborns. Ampicillin resistance among E. coli strains is increasing, which is the main choice for treating empirically many obstetric and neonatal infections. Vaginal E. coli strains are very similar to extraintestinal pathogenic E. coli with regards to the virulence factors and the belonging to phylogroup B2. We studied the antimicrobial resistance and the genetic virulence profile of 82 E. coli isolates from 638 vaginal samples and 63 isolated from endometrial aspirate, placental and amniotic fluid samples from pregnant women with obstetric infections. The prevalence of E. coli in the vaginal samples was 13%, which was significant among women with associated risk factors during pregnancy, especially premature preterm rupture of membranes (p<0.0001). Sixty-five percent of the strains were ampicillin-resistant. The E. coli isolates causing obstetric infections showed higher resistance levels than vaginal isolates, particularly for gentamicin (p = 0.001). The most prevalent virulence factor genes were those related to the iron uptake systems revealing clear targets for interventions. More than 50% of the isolates belonged to the virulent B2 group possessing the highest number of virulence factor genes. The ampicillin-resistant isolates had high number of virulence factors primarily related to pathogenicity islands, and the remarkable gentamicin resistance in E. coli isolates from women presenting obstetric infections, the choice of the most appropriate empiric treatment and clinical management of pregnant women and neonates should be carefully made. Taking into account host-susceptibility, the heterogeneity of E. coli due to evolution over time and the geographical area, characterization of E. coli isolates colonizing the vagina and causing obstetric infections in different regions may help to develop interventions and avoid the aetiological link between maternal carriage and obstetric and subsequent puerperal infections.	[Saez-Lopez, Emma; Guiral, Elisabet; Bosch, Jordi; Soto, Sara M.] Univ Barcelona, Dept Microbiol, Hosp Clin, Barcelona, Spain; [Saez-Lopez, Emma; Guiral, Elisabet; Fernandez-Orth, Dietmar; Villanueva, Sonia; Bosch, Jordi; Soto, Sara M.] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa] Hosp Clin Barcelona, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain; [Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa] Hosp St Joan de Deu, Barcelona, Spain; [Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa] Inst Invest Biomed August Pi & Sunyer DIBAPS, Barcelona, Spain; [Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa] Univ Barcelona, Barcelona, Spain; [Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa] Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Soto, SM (corresponding author), Univ Barcelona, Dept Microbiol, Hosp Clin, Barcelona, Spain.; Soto, SM (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.	sara.soto@isglobal.org	Soto, Sara M/J-6297-2012; Orth, Dietmar Fernandez/P-2925-2019; Sáez-López, Emma/AAA-8170-2020; Guiral, Elisabet/K-4241-2017; Fernandez Orth, Dietmar/M-3738-2014; Cobo, Teresa/K-2770-2017	Soto, Sara M/0000-0002-9507-105X; Orth, Dietmar Fernandez/0000-0002-1237-3192; Guiral, Elisabet/0000-0001-5386-8610; Fernandez Orth, Dietmar/0000-0002-1237-3192; Saez-Lopez, Emma/0000-0001-8313-3017; Cobo, Teresa/0000-0003-3130-1829; Bosch, Jordi/0000-0001-9263-3371; Palacio, Montse/0000-0002-5869-4629	Fondo de Investigaciones Sanitarias - ISCIII-Subdireccion General de Evaluacion [PI10/01579, PI13/00137]; Fondo Europeo de Desarrollo Regional (FEDER)	Fondo de Investigaciones Sanitarias - ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	Sara M. Soto has a fellowship from the program I3, of the Instituo de Salud Carlos III (ISCIII, www.isciii.es). This material is based upon work supported by the "Fondo de Investigaciones Sanitarias" (PI10/01579 and PI13/00137) integrated in the "Plan Nacional de I+D+I" and co-funded by the "ISCIII-Subdireccion General de Evaluacion" and the "Fondo Europeo de Desarrollo Regional (FEDER)".	Bauer HW, 2013, VACCINATION AGAINST, V2013, P487; Birosova E, 2004, CLIN MICROBIOL INFEC, V10, P569, DOI 10.1111/j.1469-0691.2004.00922.x; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S24 CLSI, V34; Cook S W, 2001, Infect Dis Obstet Gynecol, V9, P203, DOI 10.1155/S1064744901000333; Villar HE, 2013, J CHEMOTHERAPY, V25, P324, DOI 10.1179/1973947813Y.0000000081; Edwards RK, 2005, OBSTET GYN CLIN N AM, V32, P287, DOI 10.1016/j.ogc.2004.12.002; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Guiral E, 2015, J CLIN MICROBIOL, V53, P1745, DOI 10.1128/JCM.00487-15; Guiral E, 2012, CHEMOTHERAPY, V58, P123, DOI 10.1159/000337062; Guiral E, 2011, FEMS MICROBIOL LETT, V314, P170, DOI 10.1111/j.1574-6968.2010.02160.x; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; Hart A, 2001, J INFECT DIS, V183, P1526, DOI 10.1086/320196; Iranpour D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/846219; Johnson JR, 2005, ANTIMICROB AGENTS CH, V49, P26, DOI 10.1128/AAC.49.1.26-31.2005; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson JR, 2001, INFECT IMMUN; Kaluzna E, 2014, POSTEP HIG MED DOSW, V68, P808; Kankuri E, 2003, ACTA OBSTET GYN SCAN, V82, P730, DOI 10.1034/j.1600-0412.2003.00265.x; Krohn MA, 1997, J INFECT DIS, V175, P606, DOI 10.1093/infdis/175.3.606; Lefort A, 2014, CLIN MICROBIOL INFEC, V20, P01035; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Moreno E, 2006, J ANTIMICROB CHEMOTH, V57, P204, DOI 10.1093/jac/dki468; Obata-Yasuoka M, 2002, MICROBIOL-SGM, V148, P2745, DOI 10.1099/00221287-148-9-2745; Petkovsek Z, 2009, J CLIN MICROBIOL, V47, P1811, DOI 10.1128/JCM.01421-08; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; Rani S, 2014, ASIAN J MED SCI, V5, P58, DOI [10.3126/ajms.v5i4.9889, DOI 10.3126/AJMS.V5I4.9889]; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Saez-Lopez E., 2012, CLIN MICROBIOL OPEN, P02; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Shariff VAAR, 2013, J CLIN DIAGN RES, V7, P1027, DOI 10.7860/JCDR/2013/4917.3038; Soto SM, 2008, J CLIN MICROBIOL, V46, P1123, DOI 10.1128/JCM.01682-07; Soto SM, 2006, ANTIMICROB AGENTS CH, V50, P649, DOI 10.1128/AAC.50.2.649-653.2006; Tameliene R, 2012, MEDICINA-LITHUANIA, V48, P71, DOI 10.3390/medicina48020013; van den Hoogen A, 2010, NEONATOLOGY, V97, P22, DOI 10.1159/000226604; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003	40	27	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146531	10.1371/journal.pone.0146531	http://dx.doi.org/10.1371/journal.pone.0146531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784330	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400044
J	Zhang, H; Zhang, P; Fan, J; Qiu, BH; Pan, J; Zhang, X; Fang, LX; Qi, ST				Zhang, Hui; Zhang, Peng; Fan, Jun; Qiu, Binghui; Pan, Jun; Zhang, Xi'an; Fang, Luxiong; Qi, Songtao			Determining an Optimal Cutoff of Serum beta-Human Chorionic Gonadotropin for Assisting the Diagnosis of Intracranial Germinomas	PLOS ONE			English	Article							GERM-CELL TUMORS; PRIMARY CHEMOTHERAPY; RADIATION-THERAPY; CNS GERMINOMA; BRAIN-TUMORS; RADIOTHERAPY; MANAGEMENT; CHILDREN; MARKERS	Background Beta (beta)-human chorionic gonadotropin (beta-HCG) is used to confirm the diagnosis and plan treatment of intracranial germinomas. However, the cutoff values of serum beta-HCG in diagnosis of intracranial germinomas reported in the literature are inconsistent. To establish an appropriate cutoff value of serum beta-HCG for diagnosis of intracranial germinomas, we retrospectively reviewed the records of intracranial tumor patients who received serum beta-HCG and a-fetoprotein (AFP) tests for diagnostic purposes at our hospital from 2005 to 2014. Methods A total of 93 intracranial germinomas and 289 intracranial non-germ cell tumors were included in this study. Receiver operating characteristic (ROC) analysis was used to evaluate the sensitivity and specificity of 3 cutoffs (0.1, 0.4, and 0.5 mIU/mL) for diagnosing intracranial germinomas. The serum beta-HCG level of intracranial germinoma patients was further analyzed to investigate the effect of metastasis status and tumor location on serum beta-HCG level. Results The area under the ROC curve was 0.81 (P < .001), suggesting beta-HCG is an effective marker. Of the 3 cutoff values, 0.1 mIU/mL possessed a highest sensitivity (66.67%) and good specificity (91%). Although there was no beta-HCG level difference between metastatic and non-metastatic intracranial germinoma patients, the diagnostic rate of metastatic neurohypophyseal germinomas was significantly higher than that of its non-metastatic counterpart (P < .05), implying that the location of the germinoma might need to be considered when beta-HCG is used as a marker to predict metastasis. Conclusions Determining an optimal cutoff of serum beta-HCG is helpful for assisting the diagnosis of intracranial germinoma.	[Zhang, Hui; Fan, Jun; Qiu, Binghui; Pan, Jun; Zhang, Xi'an; Fang, Luxiong; Qi, Songtao] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Peng] Southern Med Univ, Nanfang Hosp, Dept Lab Med, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Qi, ST (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou 510515, Guangdong, Peoples R China.	zhanghuinf@163.com	Pan, Jun/GQQ-7313-2022					Alapetite C, 2010, NEURO-ONCOLOGY, V12, P1318, DOI 10.1093/neuonc/noq093; Allen J, 2012, PEDIATR BLOOD CANCER, V59, P1180, DOI 10.1002/pbc.24097; [Anonymous], 1979, Lancet, V2, P651; Aoyama H, 2002, J CLIN ONCOL, V20, P857, DOI 10.1200/JCO.20.3.857; Bamberg M, 1999, J CLIN ONCOL, V17, P2585, DOI 10.1200/JCO.1999.17.8.2585; Bhatty Usman Najeeb, 2013, Case Rep Urol, V2013, P490638, DOI 10.1155/2013/490638; BLOOM HJG, 1983, CLIN ONCOL, V2, P233; Brandes AA, 2000, CANCER TREAT REV, V26, P233, DOI 10.1053/ctrv.2000.0169; Chen YW, 2012, CANCER-AM CANCER SOC, V118, P2752, DOI 10.1002/cncr.26564; Cho DY, 1997, CHILD NERV SYST, V13, P42, DOI 10.1007/s003810050038; Cho KT, 2002, CHILD NERV SYST, V18, P30, DOI 10.1007/s00381-001-0547-y; Cuccia V, 2006, ACTA NEUROCHIR, V148, P865, DOI 10.1007/s00701-006-0846-x; da Silva NS, 2010, PEDIATR BLOOD CANCER, V54, P377, DOI 10.1002/pbc.22381; Echevarria ME, 2008, ONCOLOGIST, V13, P690, DOI 10.1634/theoncologist.2008-0037; Goodwin TL, 2009, J PEDIAT HEMATOL ONC, V31, P541, DOI 10.1097/MPH.0b013e3181983af5; Loto MG, 2014, CASE REP ENDOCRINOL, V2014, DOI 10.1155/2014/936937; Guzzo MF, 2013, ARQ BRAS ENDOCRINOL, V57, P566, DOI 10.1590/S0004-27302013000700012; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; Jorsal T, 2012, ACTA ONCOL, V51, P3, DOI 10.3109/0284186X.2011.586000; Kawaguchi T, 2011, J NEURO-ONCOL, V104, P779, DOI 10.1007/s11060-011-0544-2; Kellie SJ, 2004, PEDIATR BLOOD CANCER, V43, P126, DOI 10.1002/pbc.20026; Kim JS, 2007, J CLIN NEUROL, V3, P150, DOI 10.3988/jcn.2007.3.3.150; Lee D, 2010, VIRCHOWS ARCH, V457, P347, DOI 10.1007/s00428-010-0951-3; Legault G, 2013, PEDIATR BLOOD CANCER, V60, P1647, DOI 10.1002/pbc.24620; Liu ZY, 2014, ACTA RADIOL, V55, P874, DOI 10.1177/0284185113507824; Lou X, 2009, AM J NEURORADIOL, V30, P1694, DOI 10.3174/ajnr.A1696; Maher CO, 2004, PEDIATR CLIN N AM, V51, P327, DOI 10.1016/S0031-3955(03)00206-2; Malati T, 2007, INDIAN J CLIN BIOCHE, V22, P17, DOI 10.1007/BF02913308; Martens T, 2014, NEUROSURG REV, V37, P445, DOI 10.1007/s10143-014-0544-8; Murray MJ, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.333; Ogawa K, 2004, INT J RADIAT ONCOL, V58, P705, DOI 10.1016/j.ijrobp.2003.07.001; Ogino H, 2005, INT J RADIAT ONCOL, V62, P803, DOI 10.1016/j.ijrobp.2004.10.026; Ozbey Nese, 2006, Hormones (Athens), V5, P67; Packer R J, 2000, Oncologist, V5, P312; Paulino AC, 1999, ONCOLOGY-NY, V13, P513; Pettorini BL, 2013, CHILD NERV SYST, V29, P433, DOI 10.1007/s00381-012-1954-y; Qaddoumi I, 2012, CHILD NERV SYST, V28, P1017, DOI 10.1007/s00381-012-1762-4; Qi ST, 2014, J NEURO-ONCOL, V119, P159, DOI 10.1007/s11060-014-1468-4; Shibamoto Y, 2001, RADIOLOGY, V218, P452, DOI 10.1148/radiology.218.2.r01ja08452; Shibamoto Y, 2009, PROG NEUROL SURG, V23, P119, DOI 10.1159/000210058; Thurnher Majda M, 2009, Cancer Imaging, V9 Spec No A, pS1, DOI 10.1102/1470-7330.2009.9001; TIEN RD, 1990, AM J ROENTGENOL, V155, P143, DOI 10.2214/ajr.155.1.2162137; XIAO Gang, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P429; Yoshida Yoshinobu, 2005, Medical Molecular Morphology, V38, P104, DOI 10.1007/s00795-004-0258-z	44	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147023	10.1371/journal.pone.0147023	http://dx.doi.org/10.1371/journal.pone.0147023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771195	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300053
J	Reale, C; Iervolino, A; Scudiero, I; Ferravante, A; D'Andrea, LE; Mazzone, P; Zotti, T; Leonardi, A; Roberto, L; Zannini, M; de Cristofaro, T; Shanmugakonar, M; Capasso, G; Pasparakis, M; Vito, P; Stilo, R				Reale, Carla; Iervolino, Anna; Scudiero, Ivan; Ferravante, Angela; D'Andrea, Luca Egildo; Mazzone, Pellegrino; Zotti, Tiziana; Leonardi, Antonio; Roberto, Luca; Zannini, Mariastella; de Cristofaro, Tiziana; Shanmugakonar, Muralitharan; Capasso, Giovambattista; Pasparakis, Manolis; Vito, Pasquale; Stilo, Romania			NF-B Essential Modulator (NEMO) Is Critical for Thyroid Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; NF-kappaB; NF-kappaB transcription factor; signal transduction; thyroid; thyroid hormone	HYPOHIDROTIC ECTODERMAL DYSPLASIA; SEVERE LIVER DEGENERATION; ALPHA-INDUCED APOPTOSIS; GAMMA-DEFICIENT MICE; KAPPA-B; EMBRYONIC LETHALITY; GENE-EXPRESSION; CELL-DEATH; C-FLIP; ACTIVATION	The I-B kinase (IKK) subunit NEMO/IKK (NEMO) is an adapter molecule that is critical for canonical activation of NF-B, a pleiotropic transcription factor controlling immunity, differentiation, cell growth, tumorigenesis, and apoptosis. To explore the functional role of canonical NF-B signaling in thyroid gland differentiation and function, we have generated a murine strain bearing a genetic deletion of the NEMO locus in thyroid. Here we show that thyrocyte-specific NEMO knock-out mice gradually develop hypothyroidism after birth, which leads to reduced body weight and shortened life span. Histological and molecular analysis indicate that absence of NEMO in thyrocytes results in a dramatic loss of the thyroid gland cellularity, associated with down-regulation of thyroid differentiation markers and ongoing apoptosis. Thus, NEMO-dependent signaling is essential for normal thyroid physiology.	[Reale, Carla; Iervolino, Anna; Scudiero, Ivan; Ferravante, Angela; D'Andrea, Luca Egildo; Mazzone, Pellegrino; Roberto, Luca; Capasso, Giovambattista; Vito, Pasquale] Biogem Consortium, Via Camporeale, I-83031 Ariano Irpino, Italy; [Zotti, Tiziana; Vito, Pasquale; Stilo, Romania] Univ Sannio, Dipartimento Sci & Tecnol, Via Port Arsa 11, I-82100 Benevento, Italy; [Leonardi, Antonio; Stilo, Romania] Univ Napoli, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [Zannini, Mariastella; de Cristofaro, Tiziana] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Capasso, Giovambattista] Univ Naples 2, Dipartimento Sci Cardiotoraciche & Resp, Naples, Italy; [Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50923 Cologne, Germany; [Shanmugakonar, Muralitharan] Qatar Univ, Anim Lab, Res Ctr, POB 2713, Doha, Qatar	University of Sannio; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Universita della Campania Vanvitelli; University of Cologne; Qatar University	Vito, P (corresponding author), Biogem Consortium, Via Camporeale, I-83031 Ariano Irpino, Italy.; Vito, P (corresponding author), Univ Sannio, Dipartimento Sci & Tecnol, Via Port Arsa 11, I-82100 Benevento, Italy.	vito@unisannio.it	leonardi, antonio/A-2887-2009; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Mazzone, Pellegrino/AAC-6576-2020; De+Cristofaro, Tiziana/AAX-4405-2020; Zotti, Tiziana/AAV-6768-2021; vito, pasquale/ABF-5505-2020; Zannini, Mariastella/I-1735-2012; Reale, Carla/AAB-7939-2020	leonardi, antonio/0000-0001-8636-9623; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Mazzone, Pellegrino/0000-0002-6217-1505; Zotti, Tiziana/0000-0003-4753-116X; Reale, Carla/0000-0001-7682-4784; ZANNINI, MARIASTELLA/0000-0002-5740-9769; Iervolino, Anna/0000-0003-0450-9587; Capasso, Giovambattista/0000-0003-3469-8614; SHANMUGAKONAR, MURALITHARAN/0000-0002-2766-817X; DECRISTOFARO, TIZIANA/0000-0003-0121-0002; scudiero, ivan/0000-0001-5559-5548; ferravante, angela/0000-0002-4932-3877; vito, pasquale/0000-0002-5721-7716				BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bouchard M, 2004, GENESIS, V38, P105, DOI 10.1002/gene.20008; Brahler S, 2012, AM J PHYSIOL-RENAL, V303, pF1473, DOI 10.1152/ajprenal.00031.2012; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; D' Andrea EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116062; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; FRYNS JP, 1989, J MED GENET, V26, P520, DOI 10.1136/jmg.26.8.520; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Iervolino A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119142; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kratsios P, 2010, CIRC RES, V106, P133, DOI 10.1161/CIRCRESAHA.109.202200; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nicola JP, 2010, MOL ENDOCRINOL, V24, P1846, DOI 10.1210/me.2010-0102; PABST HF, 1981, J PEDIATR-US, V98, P223, DOI 10.1016/S0022-3476(81)80639-7; Pacifico F, 2004, J BIOL CHEM, V279, P54610, DOI 10.1074/jbc.M403492200; Pacifico F, 2010, MOL CELL ENDOCRINOL, V321, P29, DOI 10.1016/j.mce.2009.10.010; PIKE MG, 1986, J PEDIATR-US, V108, P109, DOI 10.1016/S0022-3476(86)80782-X; Rudolph D, 2000, GENE DEV, V14, P854; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Shifera AS, 2010, J CELL PHYSIOL, V223, P558, DOI 10.1002/jcp.22105; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Stilo R, 2003, BIOCHEM BIOPH RES CO, V303, P1034, DOI 10.1016/S0006-291X(03)00487-X; Sundaravalli P A, 1980, Indian Pediatr, V17, P566; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Visconti R, 1997, ONCOGENE, V15, P1987, DOI 10.1038/sj.onc.1201373; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382; Zotti T, 2014, MOL IMMUNOL, V58, P27, DOI 10.1016/j.molimm.2013.10.015; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426	41	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5765	5773		10.1074/jbc.M115.711697	http://dx.doi.org/10.1074/jbc.M115.711697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786105	hybrid, Green Published			2022-12-26	WOS:000372551800025
J	Feng, JC; Wang, LH; Zhou, LX; Yang, X; Zhao, X				Feng, Junchang; Wang, Lihong; Zhou, Luoxiong; Yang, Xin; Zhao, Xin			Using In Vitro Immunomodulatory Properties of Lactic Acid Bacteria for Selection of Probiotics against Salmonella Infection in Broiler Chicks	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; LACTOBACILLUS-SALIVARIUS; ANTAGONISTIC ACTIVITY; GENE-EXPRESSION; INNATE IMMUNITY; ENTERITIDIS; CYTOKINES; INVASION; STRAINS; CELLS	Poultry is known to be a major reservoir of Salmonella. The use of lactic acid bacteria has become one of successful strategies to control Salmonella in poultry. The purpose of this study was to select lactic acid bacteria strains by their in vitro immunomodulatory properties for potential use as probiotics against Salmonella infection in broiler chicks. Among 101 isolated lactic acid bacteria strains, 13 strains effectively survived under acidic (pH 2.5) and bile salt (ranging from 0.1% to 1.0%) conditions, effectively inhibited growth of 6 pathogens, and adhered to Caco-2 cells. However, their in vitro immunomodulatory activities differed significantly. Finally, three strains with higher in vitro immunomodulatory properties (Lactobacillus plantarum PZ01, Lactobacillus salivarius JM32 and Pediococcus acidilactici JH231) and three strains with lower in vitro immunomodulatory activities (Enterococcus faecium JS11, Lactobacillus salivarius JK22 and Lactobacillus salivarius JM2A1) were compared for their inhibitory effects on Salmonella adhesion and invasion to Caco-2 cells in vitro and their antimicrobial effects in vivo. The former three strains inhibited Salmonella adhesion and invasion to Caco-2 cells in vitro, reduced the number of Salmonella in intestinal content, spleen and liver, reduced the levels of lipopolysaccharide-induced TNF-alpha factor (LITAF), IL-1 beta, IL-6 and IL-12 in serum and increased the level of IL-10 in serum during a challenge study in vivo more efficiently than the latter three strains. These results suggest that in vitro immunomodulatory activities could be used as additional parameters to select more effective probiotics as feed supplements for poultry.	[Feng, Junchang; Wang, Lihong; Zhou, Luoxiong; Yang, Xin; Zhao, Xin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada	Northwest A&F University - China; McGill University	Zhao, X (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Zhao, X (corresponding author), McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada.	zhaoxin@nwsuaf.edu.cn	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332	innovation project of science and technology plan project of Shaanxi Province, China [2014KTCL02-21]; Ministry of Agriculture [2013-S16]; thousand talent program; Natural Science Foundation of China [31402095]; Northwest A&F University PhD Research Start-up funds [2012BSJJ094]	innovation project of science and technology plan project of Shaanxi Province, China; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); thousand talent program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest A&F University PhD Research Start-up funds	This work was supported by funding from an innovation project of science and technology plan project of Shaanxi Province, China (2014KTCL02-21); the Ministry of Agriculture (No. 2013-S16); the thousand talent program to X.Z.; and Natural Science Foundation of China (No. 31402095) and Northwest A&F University PhD Research Start-up funds (No. 2012BSJJ094) to X.Y.	Al-Madboly LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00347; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Bianchi MA, 2004, LETT APPL MICROBIOL, V39, P301, DOI 10.1111/j.1472-765X.2004.01589.x; Bolcato-Bellemin AL, 2004, J ENDOTOXIN RES, V10, P15, DOI 10.1179/096805104225003780; Botta C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094457; Brisbin JT, 2011, CLIN VACCINE IMMUNOL, V18, P1447, DOI 10.1128/CVI.05100-11; Brisbin JT, 2010, CLIN VACCINE IMMUNOL, V17, P1337, DOI 10.1128/CVI.00143-10; Chen CY, 2012, POULTRY SCI, V91, P2139, DOI 10.3382/ps.2012-02237; Chen CY, 2013, J MED MICROBIOL, V62, P1657, DOI 10.1099/jmm.0.061010-0; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Dawoud TM, 2011, POULTRY SCI, V90, P1134, DOI 10.3382/ps.2010-01182; Ganguly NK, 2011, INDIAN J MED RES, V134, P22; Haghighi HR, 2008, VET MICROBIOL, V126, P225, DOI 10.1016/j.vetmic.2007.06.026; Higgins SE, 2008, POULTRY SCI, V87, P27, DOI 10.3382/ps.2007-00210; Hirose Y, 2010, MICROBIOL IMMUNOL, V54, P143, DOI 10.1111/j.1348-0421.2009.00189.x; Husakova E, 2015, ACTA VET BRNO, V84, P29, DOI 10.2754/avb201585010029; Kang C, 2014, TOXICON, V86, P116, DOI 10.1016/j.toxicon.2014.04.005; Lin WH, 2007, J APPL MICROBIOL, V102, P22, DOI 10.1111/j.1365-2672.2006.03073.x; Liu XM, 2013, FOOD CONTROL, V30, P563, DOI 10.1016/j.foodcont.2012.09.002; Messaoudi S, 2013, FOOD MICROBIOL, V36, P296, DOI 10.1016/j.fm.2013.05.010; Neal-McKinney JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043928; Osmanagaoglu O, 2010, PROBIOTICS ANTIMICRO, V2, P162, DOI 10.1007/s12602-010-9050-7; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Tellez G, 2012, FOOD RES INT, V45, P628, DOI 10.1016/j.foodres.2011.03.047; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Tsai CC, 2011, FEMS IMMUNOL MED MIC, V63, P44, DOI 10.1111/j.1574-695X.2011.00826.x; Waewdee P, 2012, J ANIM VET ADV, V11, P955; Withanage GSK, 2005, INFECT IMMUN, V73, P5173, DOI 10.1128/IAI.73.8.5173-5182.2005; Withanage GSK, 2004, INFECT IMMUN, V72, P2152, DOI 10.1128/IAI.72.4.2152-2159.2004; Yamawaki RA, 2013, POULTRY SCI, V92, P1560, DOI 10.3382/ps.2012-02936	30	39	49	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147630	10.1371/journal.pone.0147630	http://dx.doi.org/10.1371/journal.pone.0147630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799658	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300133
J	Kumase, F; Takeuchi, K; Morizane, Y; Suzuki, J; Matsumoto, H; Kataoka, K; Al-Moujahed, A; Maidana, DE; Miller, JW; Vavvas, DG				Kumase, Fumiaki; Takeuchi, Kimio; Morizane, Yuki; Suzuki, Jun; Matsumoto, Hidetaka; Kataoka, Keiko; Al-Moujahed, Ahmad; Maidana, Daniel E.; Miller, Joan W.; Vavvas, Demetrios G.			AMPK-Activated Protein Kinase Suppresses Ccr2 Expression by Inhibiting the NF-kappa B Pathway in RAW264.7 Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; DEPENDENT TRANSCRIPTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; TNF-ALPHA; C-REL; INFLAMMATION; MECHANISM; POLARIZATION	C-C chemokine receptor 2 (Ccr2) is a key pro-inflammatory marker of classic (M1) macrophage activation. Although Ccr2 is known to be expressed both constitutively and inductively, the full regulatory mechanism of its expression remains unclear. AMP-activated protein kinase (AMPK) is not only a master regulator of energy homeostasis but also a central regulator of inflammation. In this study, we sought to assess AMPK's role in regulating RAW264.7 macrophage Ccr2 protein levels in resting (M0) or LPS-induced M1 states. In both M0 and M1 RAW264.7 macrophages, knockdown of the AMPKa1 subunit by siRNA led to increased Ccr2 levels whereas pharmacologic (A769662) activation of AMPK, attenuated LPS-induced increases in Ccr2 expression in an AMPK dependent fashion. The increases in Ccr2 levels by AMPK downregulation were partially reversed by NF-kappa B inhibition whereas TNF-alpha inhibition had minimal effects. Our results indicate that AMPK is a negative regulator of Ccr2 expression in RAW264.7 macrophages, and that the mechanism of action of AMPK inhibition of Ccr2 is mediated, in part, through the NF-kappa B pathway.	[Kumase, Fumiaki; Takeuchi, Kimio; Morizane, Yuki; Suzuki, Jun; Matsumoto, Hidetaka; Kataoka, Keiko; Al-Moujahed, Ahmad; Maidana, Daniel E.; Miller, Joan W.; Vavvas, Demetrios G.] Harvard Univ, Sch Med, Dept Ophthalmol, Retina Serv,Angiogenesis Lab,Massachusetts Eye &, Boston, MA USA; [Morizane, Yuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Japan; [Suzuki, Jun] Tokyo Med Univ, Dept Ophthalmol, Tokyo 1608402, Japan	Harvard University; Harvard Medical School; Okayama University; Tokyo Medical University	Vavvas, DG (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Retina Serv,Angiogenesis Lab,Massachusetts Eye &, Boston, MA USA.	Demetrios_Vavvas@meei.harvard.edu	Kataoka, Keiko/B-2806-2016	Kataoka, Keiko/0000-0002-8795-6536; /0000-0002-5435-8804; Vavvas, Demetrios/0000-0002-8622-6478	Foundation Lions Eye Research Fund; Yeatts Family Foundation; Macula Society; Bausch & Lomb Vitreoretinal Fellowship; Physician Scientist Award; Research to Prevent Blindness Foundation; NEI [R21EY023079-01A1, EY014104]; NATIONAL EYE INSTITUTE [P30EY014104, R21EY023079, R01EY025362] Funding Source: NIH RePORTER	Foundation Lions Eye Research Fund; Yeatts Family Foundation; Macula Society; Bausch & Lomb Vitreoretinal Fellowship; Physician Scientist Award; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by Foundation Lions Eye Research Fund (DGV); The Yeatts Family Foundation (DGV, JWM); a 2013 Macula Society Research Grant award (DGV); a Bausch & Lomb Vitreoretinal Fellowship (FK); a Physician Scientist Award (DGV), and a unrestricted grant (JWM) from the Research to Prevent Blindness Foundation; NEI R21EY023079-01A1 (DGV); and NEI Grant EY014104 (MEEI Core Grant).	Akbarshahi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042654; Avni D, 2012, BIOCHEM PHARMACOL, V83, P106, DOI 10.1016/j.bcp.2011.09.025; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Chen YB, 2014, INTELL SYST SER, P1, DOI 10.1016/B978-0-12-397199-9.00001-X; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Coward WR, 2002, J IMMUNOL, V169, P5287, DOI 10.4049/jimmunol.169.9.5287; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hickman SE, 2013, J ALZHEIMERS DIS, V33, pS295, DOI 10.3233/JAD-2012-129027; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Kagoya Y, 2014, J CLIN INVEST, V124, P528, DOI 10.1172/JCI68101; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee HY, 2005, BIOCHEM BIOPH RES CO, V336, P716, DOI 10.1016/j.bbrc.2005.08.154; Liu Z, 2013, J IMMUNOL, V191, P857, DOI 10.4049/jimmunol.1300790; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Oeckinghaus A, 2009, COLD SPRING HARB PER, V1, DOI [10.1101/cshperspect.a000034, DOI 10.1101/CSHPERSPECT.A000034]; Pekalski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078887; Pujari R, 2013, IMMUNOL RES, V57, P166, DOI 10.1007/s12026-013-8463-2; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Steinberg GR, 2014, IMMUNOL CELL BIOL, V92, P340, DOI 10.1038/icb.2014.11; Steinberg GR, 2013, TRENDS ENDOCRIN MET, V24, P481, DOI 10.1016/j.tem.2013.06.002; Suzuki J, 2012, INVEST OPHTH VIS SCI, V53, P4158, DOI 10.1167/iovs.11-9323; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Takeuchi K, 2013, J BIOL CHEM, V288, P20581, DOI 10.1074/jbc.M113.460832; Theodoropoulou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052852; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wu X, 2007, AM J PHYSIOL-ENDOC M, V293, pE1836, DOI 10.1152/ajpendo.00115.2007; Xu L, 1997, J LEUKOCYTE BIOL, V62, P653, DOI 10.1002/jlb.62.5.653; Xu L, 1999, EUROPEAN J IMMUNOLOG, V30, P227; Yamasaki R., 2012, CLIN EXP NEUROIMMUNO, V3, P16, DOI [DOI 10.1111/J.1759-1961.2011.00024.X, 10.1111/j.1759-1961.2011.00024.x]; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Zhou YH, 1999, J LEUKOCYTE BIOL, V65, P265, DOI 10.1002/jlb.65.2.265	57	18	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147279	10.1371/journal.pone.0147279	http://dx.doi.org/10.1371/journal.pone.0147279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799633	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300085
J	Yun, S; Donovan, MH; Ross, MN; Richardson, DR; Reister, R; Farnbauch, LA; Fischer, SJ; Riethmacher, D; Gershenfeld, HK; Lagace, DC; Eisch, AJ				Yun, Sanghee; Donovan, Michael H.; Ross, Michele N.; Richardson, Devon R.; Reister, Robin; Farnbauch, Laure A.; Fischer, Stephanie J.; Riethmacher, Dieter; Gershenfeld, Howard K.; Lagace, Diane C.; Eisch, Amelia J.			Stress-Induced Anxiety- and Depressive-Like Phenotype Associated with Transient Reduction in Neurogenesis in Adult Nestin-CreER(T2)/Diphtheria Toxin Fragment A Transgenic Mice	PLOS ONE			English	Article							TAIL-SUSPENSION TEST; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; CELL-PROLIFERATION; PROGENITOR CELLS; ANIMAL-MODELS; NEURAL STEM; SYNAPTIC PLASTICITY; GRANULE CELLS; BEHAVIOR	Depression and anxiety involve hippocampal dysfunction, but the specific relationship between these mood disorders and adult hippocampal dentate gyrus neurogenesis remains unclear. In both humans with MDD and rodent models of depression, administration of antidepressants increases DG progenitor and granule cell number, yet rodents with induced ablation of DG neurogenesis typically do not demonstrate depressive-or anxiety-like behaviors. The conflicting data may be explained by the varied duration and degree to which adult neurogenesis is reduced in different rodent neurogenesis ablation models. In order to test this hypothesis we examined how a transient-rather than permanent-inducible reduction in neurogenesis would alter depressive-and anxiety-like behaviors. Transgenic Nestin-CreER(T2)/floxed diphtheria toxin fragment A (DTA) mice (Cre+DTA+) and littermates (Cre+DTA-; control) were given tamoxifen (TAM) to induce recombination and decrease nestin-expressing stem cells and their progeny. The decreased neurogenesis was transient: 12 days post-TAM Cre+DTA+ mice had fewer DG proliferating Ki67+ cells and fewer DCX+ neuroblasts/immature neurons relative to control, but 30 days post-TAM Cre+DTA+ mice had the same DCX+ cell number as control. This ability of DG neurogenesis to recover after partial ablation also correlated with changes in behavior. Relative to control, Cre+DTA+ mice tested between 12-30 days post-TAM displayed indices of a stress-induced anxiety phenotype-longer latency to consume highly palatable food in the unfamiliar cage in the novelty-induced hypophagia test, and a depression phenotype-longer time of immobility in the tail suspension test, but Cre+DTA+ mice tested after 30 days post-TAM did not. These findings suggest a functional association between adult neurogenesis and stress induced anxiety- and depressive-like behaviors, where induced reduction in DCX+ cells at the time of behavioral testing is coupled with stress-induced anxiety and a depressive phenotype, and recovery of DCX+ cell number corresponds to normalization of these behaviors.	[Yun, Sanghee; Donovan, Michael H.; Ross, Michele N.; Richardson, Devon R.; Reister, Robin; Farnbauch, Laure A.; Fischer, Stephanie J.; Gershenfeld, Howard K.; Lagace, Diane C.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Riethmacher, Dieter] Nazarbayev Univ, Sch Med, Dept Biomed Sci, Astana, Kazakhstan; [Riethmacher, Dieter] Univ Southampton, Southampton Gen Hosp, Sch Med, Human Dev & Hlth, Southampton, Hants, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; Nazarbayev University; University of Southampton	Lagace, DC; Eisch, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	diane.lagace@uottawa.ca; amelia.eisch@utsouthwestern.edu	Riethmacher, Dieter/AAB-8690-2022; Yun, Sanghee/AAL-7543-2020; Riethmacher, Dieter/AAP-2227-2021	Yun, Sanghee/0000-0001-7505-0836; Riethmacher, Dieter/0000-0002-4206-5529; Eisch, Amelia/0000-0001-6476-5385; Donovan, Michael/0000-0001-8235-3851; Gershenfeld, Howard/0000-0002-4107-1513	National Institutes of Health [DA023701, DA023555, MH107945]; National Aeronautics and Space Administration [NNX12AB55G, NNX07AP84G]; Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation; Canadian Institute for Health Research (CIHR) postdoctoral fellowship; CIHR operating grant; Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation; Early Research Award from the Ontario Ministry of Research and Innovation; NIH [F31-DA021045]; NIH, Basic Science Training Program in Drug Abuse Research [T32-DA007290]; NIH, Basic Science Training Program in the Neurobiology of Mental Illness [T32-MH076690];  [F31-MH075457]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH075457, R21MH107945, T32MH076690, R01MH096913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290, K02DA023555, F31DA021045, R01DA016765, R21DA023701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation; Canadian Institute for Health Research (CIHR) postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); CIHR operating grant(Canadian Institutes of Health Research (CIHR)); Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation; Early Research Award from the Ontario Ministry of Research and Innovation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, Basic Science Training Program in Drug Abuse Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, Basic Science Training Program in the Neurobiology of Mental Illness(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants to AJE from the National Institutes of Health (DA023701, DA023555, MH107945), the National Aeronautics and Space Administration (NNX12AB55G, NNX07AP84G), and an Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation. DCL was funded by a Canadian Institute for Health Research (CIHR) postdoctoral fellowship and CIHR operating grant, as well as a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation, and an Early Research Award from the Ontario Ministry of Research and Innovation. MHD was funded by F31-MH075457. MNR was funded by NIH F31-DA021045. MNR and SJF were supported by NIH T32-DA007290, Basic Science Training Program in Drug Abuse Research, PI: Amelia J. Eisch. SY was funded by NIH T32-MH076690, Basic Science Training Program in the Neurobiology of Mental Illness, PI: Carol A. Tamminga.; This work was supported by grants to AJE from the National Institutes of Health (DA023701, DA023555, MH107945), the National Aeronautics and Space Administration (NNX12AB55G, NNX07AP84G), and an Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation. DCL was funded by a Canadian Institute for Health Research (CIHR) postdoctoral fellowship and CIHR operating grant, as well as a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation, and an Early Research Award from the Ontario Ministry of Research and Innovation. MHD was funded by F31-MH075457. MNR was funded by NIH F31-DA021045. MNR and SJF were supported by NIH T32-DA007290, Basic Science Training Program in Drug Abuse Research, PI: Amelia J. Eisch. SY is funded by NIH T32-MH076690, Basic Science Training Program in the Neurobiology of Mental Illness, PI: Carol A. Tamminga. The authors acknowledge David Petrik with interim figure help. Current contact information, MHD: Center for Neurobiology and Psychiatry, University of California, San Francisco, 401 Parnassus Ave., San Francisco, California 94143-0984, U.S.A., michael.donovan@ucsf.edu. LAF: lfarnbau@kent.edu, Department of Psychological Sciences, 144 Kent Hall, 600 Hilltop Drive, Kent State University, Kent, OH 44242. HKG: hkgersh@gmail.com, Unit 7100 Box 1505, DPO, AE 09842-1505. DCL: Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario K1H 8M5, Canada, diane.lagace@uottawa.ca. DR (dual): Department of Biomedical Sciences, Nazarbayev University, School of Medicine, 53 Kabanbay Batyr Ave., Astana, 01000, Kazakhstan, dieter.riethmacher@nu.edu.kz; and Human Development and Health, Southampton University, School of Medicine, Duthie Building (Mail Point 808), Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom. d.riethmacher@southampton.ac.uk.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; ALTMAN J, 1967, NATURE, V214, P1098, DOI 10.1038/2141098a0; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Anacker C, 2011, MOL PSYCHIATR, V16, P738, DOI 10.1038/mp.2011.26; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Boldrini M, 2013, NEUROPSYCHOPHARMACOL, V38, P1068, DOI 10.1038/npp.2013.5; Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; CRAWLEY JN, 1981, PHARMACOL BIOCHEM BE, V15, P695, DOI 10.1016/0091-3057(81)90007-1; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cummings DM, 2014, J NEUROSCI, V34, P13801, DOI 10.1523/JNEUROSCI.2463-14.2014; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; DeCarolis NA, 2013, HIPPOCAMPUS, V23, P708, DOI 10.1002/hipo.22130; Deng W, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00034; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dere E, 2010, BEHAV BRAIN RES, V215, P162, DOI 10.1016/j.bbr.2010.03.017; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Epp JR, 2013, NEUROPSYCHOPHARMACOL, V38, P2297, DOI 10.1038/npp.2013.132; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; FILE SE, 1980, J NEUROSCI METH, V2, P219, DOI 10.1016/0165-0270(80)90012-6; Fuss J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012769; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Gebara E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00145; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Groves JO, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003718; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Hall CS, 1936, J COMP PSYCHOL, V22, P345, DOI 10.1037/h0059253; Hill A.S., 2015, NEUROPSYCHOPHARMACOL; Iascone DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079651; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jayatissa MN, 2009, BRAIN RES, V1290, P133, DOI 10.1016/j.brainres.2009.07.001; Kaidanovich-Beilin O, 2011, JOVE; Karten YJG, 2005, TRENDS NEUROSCI, V28, P171, DOI 10.1016/j.tins.2005.01.009; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kim S, 2009, BIOL PSYCHIAT, V65, P425, DOI 10.1016/j.biopsych.2008.09.015; Kirby ED, 2015, P NATL ACAD SCI USA, V112, P4128, DOI 10.1073/pnas.1422448112; Kodandaramaiah SB, 2012, NAT METHODS, V9, P585, DOI [10.1038/NMETH.1993, 10.1038/nmeth.1993]; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Latchney SE, 2015, FASEB J; Liu XQ, 2001, BIOL PSYCHIAT, V49, P575, DOI 10.1016/S0006-3223(00)01028-3; Lucassen PJ, 2013, MOL PSYCHIATR, V18, P396, DOI 10.1038/mp.2012.39; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Lucassen PJ, 2010, NEUROPHARMACOLOGY, V58, P940, DOI 10.1016/j.neuropharm.2010.01.012; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mamdani F, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.134; Massa F, 2011, P NATL ACAD SCI USA, V108, P6644, DOI 10.1073/pnas.1016928108; Mateus-Pinheiro A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.141; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mouton PR, 2002, J MICROSC-OXFORD, V206, P54, DOI 10.1046/j.1365-2818.2002.01006.x; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Parihar VK, 2011, MOL PSYCHIATR, V16, P171, DOI 10.1038/mp.2009.130; Perera TD, 2008, NEUROSCIENTIST, V14, P326, DOI 10.1177/1073858408317242; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Sahay A, 2007, PROG BRAIN RES, V163, P697, DOI 10.1016/S0079-6123(07)63038-6; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Seri B, 2004, J COMP NEUROL, V480, P427, DOI 10.1002/cne.20395; Sheline YI, 2002, EUR PSYCHIAT, V17, p300S; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Singer BH, 2009, J COMP NEUROL, V514, P567, DOI 10.1002/cne.22052; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Snyder JS, 2012, BEHAV BRAIN RES, V227, P384, DOI 10.1016/j.bbr.2011.06.024; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Sun MY, 2014, J COMP NEUROL, V522, P1191, DOI 10.1002/cne.23497; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Suri D, 2015, REV NEUROSCIENCE, V26, P415, DOI 10.1515/revneuro-2014-0083; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Wager-Smith K, 2011, NEUROSCI BIOBEHAV R, V35, P742, DOI 10.1016/j.neubiorev.2010.09.010; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; WEBSTER DG, 1979, B PSYCHONOMIC SOC, V13, P90, DOI 10.3758/BF03335022; Willner P, 2013, NEUROSCI BIOBEHAV R, V37, P2331, DOI 10.1016/j.neubiorev.2012.12.007; Xiang JX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005175; Zaccaria KJ, 2010, GENES BRAIN BEHAV, V9, P985, DOI 10.1111/j.1601-183X.2010.00638.x; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao Y, 2008, EUR J PHARMACOL, V581, P113, DOI 10.1016/j.ejphar.2007.12.005	110	33	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147256	10.1371/journal.pone.0147256	http://dx.doi.org/10.1371/journal.pone.0147256			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795203	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000368530300025
J	Glaser, K; Fehrholz, M; Curstedt, T; Kunzmann, S; Speer, CP				Glaser, Kirsten; Fehrholz, Markus; Curstedt, Tore; Kunzmann, Steffen; Speer, Christian P.			Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14(+) Monocytes	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NATURAL PORCINE SURFACTANT; NECROSIS-FACTOR-ALPHA; MITOGEN-ACTIVATED PROTEIN; BRONCHOPULMONARY DYSPLASIA; PULMONARY INFLAMMATION; LUNG MORPHOGENESIS; MESSENGER-RNA; PRETERM LUNG; RECEPTOR	Background Surfactant replacement therapy is the standard of care for the prevention and treatment of neonatal respiratory distress syndrome. New generation synthetic surfactants represent a promising alternative to animal-derived surfactants. CHF5633, a new generation reconstituted synthetic surfactant containing SP-B and SP-C analogs and two synthetic phospholipids has demonstrated biophysical effectiveness in vitro and in vivo. While several surfactant preparations have previously been ascribed immunomodulatory capacities, in vitro data on immunomodulation by CHF5633 are limited, so far. Our study aimed to investigate pro- and anti-inflammatory effects of CHF5633 on native and LPS-stimulated human adult monocytes. Methods Highly purified adult CD14(+) cells, either native or simultaneously stimulated with LPS, were exposed to CHF5633, its components, or poractant alfa (Curosurf (R)). Subsequent expression of TNF-alpha, IL-1 beta, IL-8 and IL-10 mRNA was quantified by real-time quantitative PCR, corresponding intracellular cytokine synthesis was analyzed by flow cytometry. Potential effects on TLR2 and TLR4 mRNA and protein expression were monitored by qPCR and flow cytometry. Results Neither CHF5633 nor any of its components induced inflammation or apoptosis in native adult CD14+ monocytes. Moreover, LPS-induced pro-inflammatory responses were not aggravated by simultaneous exposure of monocytes to CHF5633 or its components. In LPS-stimulated monocytes, exposure to CHF5633 led to a significant decrease in TNF-alpha mRNA (0.57 +/- 0.23-fold, p = 0.043 at 4h; 0.56 +/- 0.27- fold, p = 0.042 at 14h). Reduction of LPS-induced IL-1 beta mRNA expression was not significant (0.73 +/- 0.16, p = 0.17 at 4h). LPS-induced IL-8 and IL-10 mRNA and protein expression were unaffected by CHF5633. For all cytokines, the observed CHF5633 effects paralleled a Curosurf (R)-induced modulation of cytokine response. TLR2 and TLR4 mRNA and protein expression were not affected by CHF5633 and Curosurf (R), neither in native nor in LPS- stimulated adult monocytes. Conclusion The new generation reconstituted synthetic surfactant CHF5633 was tested for potential immunomodulation on native and LPS- activated adult human monocytes. Our data confirm that CHF5633 does not exert unintended pro-inflammatory effects in both settings. On the contrary, CHF5633 significantly suppressed TNF-alpha mRNA expression in LPS- stimulated adult monocytes, indicating potential anti-inflammatory effects.	[Glaser, Kirsten; Fehrholz, Markus; Kunzmann, Steffen; Speer, Christian P.] Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany; [Curstedt, Tore] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Karolinska Institutet; Karolinska University Hospital	Glaser, K (corresponding author), Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany.	Glaser_K@ukw.de			Chiesi Farmaceutici S.p.A. [CHF5633]	Chiesi Farmaceutici S.p.A.(Chiesi Pharmaceuticals Inc)	CP Speer has a consultancy agreement with Chiesi Farmaceutici S.p.A. (Parma, Italy). This project was supported by Chiesi Farmaceutici S.p.A., supplying CHF5633, its synthetic components and Poractant alfa (Curosurf (R)). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abate W, 2010, J LIPID RES, V51, P334, DOI 10.1194/jlr.M000513; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; [Anonymous], 2008, PEDIATRICS, V121, P419, DOI 10.1542/peds.2007-3283; Antal JM, 1996, AM J RESP CELL MOL, V14, P374, DOI 10.1165/ajrcmb.14.4.8600942; Baier RJ, 2004, PEDIATR PULM, V37, P137, DOI 10.1002/ppul.10417; Bancalari E, 2001, AM J PERINAT, V18, P1, DOI 10.1055/s-2001-12940; Baur FM, 1998, PEDIATR RES, V44, P32, DOI 10.1203/00006450-199807000-00005; Benjamin JT, 2007, AM J PHYSIOL-LUNG C, V292, pL550, DOI 10.1152/ajplung.00329.2006; Bersani I, 2013, EXPERT REV ANTI-INFE, V11, P99, DOI [10.1586/ERI.12.156, 10.1586/eri.12.156]; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Bry K, 2007, AM J RESP CELL MOL, V36, P32, DOI 10.1165/rcmb.2006-0116OC; Caron JE, 2010, NEONATOLOGY, V97, P266, DOI 10.1159/000255165; Chaudhuri N, 2007, CHEST, V131, P1550, DOI 10.1378/chest.06-2869; Curstedt T, 2015, NEONATOLOGY, V107, P321, DOI 10.1159/000381117; Curstedt T, 2013, NEONATOLOGY, V103, P327, DOI 10.1159/000349942; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467; Glaser K, 2015, IMMUNOL LETT, V166, P19, DOI 10.1016/j.imlet.2015.05.003; Glaser K, 2013, EXPERT REV CLIN IMMU, V9, P1239, DOI 10.1586/1744666X.2013.857275; Glasser JR, 2012, MICROBES INFECT, V14, P17, DOI 10.1016/j.micinf.2011.08.019; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; GRONECK P, 1994, PEDIATRICS, V93, P712; Halliday Henry L, 2005, Biol Neonate, V87, P317, DOI 10.1159/000084879; Hallman M, 2013, NEONATOLOGY, V103, P316, DOI 10.1159/000349948; Hallman M, 2013, NEONATOLOGY, V103, P320, DOI 10.1159/000349994; Hart PH, 1996, J IMMUNOL, V157, P3672; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Hogmalm A, 2014, AM J PHYSIOL-LUNG C, V306, pL23, DOI 10.1152/ajplung.00154.2013; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jobe AH, 2008, NEONATOLOGY, V94, P190, DOI 10.1159/000143721; Jones CA, 1996, PEDIATR RES, V39, P966, DOI 10.1203/00006450-199606000-00007; Kandasamy P, 2011, J BIOL CHEM, V286, P7841, DOI 10.1074/jbc.M110.170241; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerecman J, 2008, INFLAMM RES, V57, P118, DOI 10.1007/s00011-007-7212-1; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kramer BW, 2007, AM J PHYSIOL-LUNG C, V293, pL345, DOI 10.1152/ajplung.00003.2007; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Lavoie PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031351; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; de Guevara YLL, 2014, INT IMMUNOPHARMACOL, V21, P369, DOI 10.1016/j.intimp.2014.05.020; Manimtim WM, 2001, INFECT IMMUN, V69, P3906, DOI 10.1128/IAI.69.6.3906-3915.2001; Martin RJ, 2013, PEDIATR NEONATOL, V54, P228, DOI 10.1016/j.pedneo.2013.03.001; Morris RHK, 2000, CYTOKINE, V12, P1717, DOI 10.1006/cyto.2000.0762; Mosca F, 2011, J MATERN-FETAL NEO M, V24, P80, DOI 10.3109/14767058.2011.607675; Moya F, 2007, CLIN PERINATOL, V34, P145, DOI 10.1016/j.clp.2006.12.005; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Pfister RH, 2007, COCHRANE DATABASE SY; Philip AGS, 2012, NEONATOLOGY, V102, P1, DOI 10.1159/000336030; Polin RA, 2014, PEDIATRICS, V133, P156, DOI 10.1542/peds.2013-3443; Raychaudhuri B, 2004, AM J RESP CELL MOL, V30, P228, DOI 10.1165/rcmb.2003-0263OC; Reyburn B, 2012, NEONATOLOGY, V101, P345, DOI 10.1159/000337355; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sakonidou S, 2015, ARCH DIS CHILD ED PR; Salvesen B, 2014, NEONATOLOGY, V105, P128, DOI 10.1159/000356065; Sarker M, 2007, BIOCHEMISTRY-US, V46, P11047, DOI 10.1021/bi7011756; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039392; Seehase M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047631; Speer CP, 2011, NEONATOLOGY, V99, P316, DOI 10.1159/000326619; Speer Christian P, 2009, Neonatology, V95, P353, DOI 10.1159/000209301; Speer CR, 2013, EARLY HUM DEV, V89, pS22, DOI 10.1016/S0378-3782(13)70008-2; SPEER CP, 1991, PEDIATR RES, V30, P69, DOI 10.1203/00006450-199107000-00015; Speer CP, 2001, BIOL NEONATE, V79, P205; STEINBACH F, 1994, J IMMUNOL METHODS, V174, P109, DOI 10.1016/0022-1759(94)90015-9; Sweet DG, 2013, J MATERN-FETAL NEO M, V26, P27, DOI 10.3109/14767058.2013.829695; Sweet DG, 2013, NEONATOLOGY, V103, P353, DOI 10.1159/000349928; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Thomas W, 2011, NEONATOLOGY, V99, P177, DOI 10.1159/000320170; THOMASSEN MJ, 1994, AM J RESP CELL MOL, V10, P399, DOI 10.1165/ajrcmb.10.4.8136155; Tonks A, 2001, CLIN EXP IMMUNOL, V124, P86, DOI 10.1046/j.1365-2249.2001.01479.x; van Zyl JM, 2013, DRUG DES DEV THER, V7, DOI 10.2147/DDDT.S47270; Walti H, 1997, PEDIATR RES, V41, P114, DOI 10.1203/00006450-199701000-00018; Waring AJ, 2005, J PEPT RES, V66, P364, DOI 10.1111/j.1399-3011.2005.00300.x; Wemhoner A, 2009, METHOD FIND EXP CLIN, V31, P317, DOI [10.1358/mf.2009.31.5.1386592, 10.1358/mf.2009.31.5.1380462]; Willems CHMP, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-17; Wu YZ, 2003, AM J RESP CRIT CARE, V168, P692, DOI 10.1164/rccm.200304-467OC; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X	78	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146898	10.1371/journal.pone.0146898	http://dx.doi.org/10.1371/journal.pone.0146898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790130	Green Published, Green Submitted, gold			2022-12-26	WOS:000368529100044
J	Chen, PW; Fonseca, LL; Hannun, YA; Voit, EO				Chen, Po-Wei; Fonseca, Luis L.; Hannun, Yusuf A.; Voit, Eberhard O.			Analysis of the Involvement of Different Ceramide Variants in the Response to Hydroxyurea Stress in Baker's Yeast	PLOS ONE			English	Article							SPHINGOLIPID METABOLISM; DISEASE	Sphingolipids have been identified as important signaling compounds in stress responses. However, it is not always clear how different sphingolipid profiles are achieved in a particular stress situation. Here we propose a detailed mass action model, containing 42 dependent variables and 137 reactions, that offers explanations of the roles of variant ceramides species, which differ in the lengths of their fatty acyl chains and their saturation state, in the response to hydroxyurea stress. The simulations demonstrate that the cells manage to achieve hydroxyurea tolerance through a well-coordinated, differential usage of the variant ceramide species. Moreover, the results suggest that key enzymes have different affinities toward saturated and unsaturated fatty acyl chains, which implies that the saturation state affords the cells with an additional mode of regulation that had not been recognized so far. These conclusions from our computational analysis are yet to be validated experimentally.	[Chen, Po-Wei; Fonseca, Luis L.; Voit, Eberhard O.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Chen, Po-Wei] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Hlth Sci Ctr, Canc Ctr Stony Brook Med, Stony Brook, NY 11794 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Voit, EO (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	eberhard.voit@bme.gatech.edu	Fonseca, Luis L/B-2265-2009	Fonseca, Luis L/0000-0002-7902-742X	National Institutes of Health [NIH-GM063265]; National Science Foundation [MCB-0946595];  [NSF-MCB-0946595]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118128, R01GM063265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (Project NIH-GM063265; PI: YAH), and the National Science Foundation (Project MCB-0946595; PI: EOV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was in part supported by grant NIH-GM063265, Yusuf Hannun (PI), and by grant NSF-MCB-0946595, Eberhard Voit (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Alvarez-Vasquez F, 2004, J THEOR BIOL, V226, P265, DOI 10.1016/j.jtbi.2003.08.010; Alvarez-Vasquez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028344; Alvarez-Vasquez F, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-42; Chen PC, 2013, J NANOMATER, V2013, P9, DOI DOI 10.1371/J0URNAL.PCBI.1003078; Chen PW, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004373; ELHAZMI MAF, 1992, ACTA HAEMATOL-BASEL, V88, P170; Engstrom KG, 1998, TREATMENT MYELOPROLI; Fonseca LL, 2012, METABOLITES, V2, P221, DOI 10.3390/metabo2010221; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Jessen H, 2014, NEW ENGL J MED, V370, P682, DOI 10.1056/NEJMc1308413; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Lisziewicz J, 2003, DRUG SAFETY, V26, P605, DOI 10.2165/00002018-200326090-00002; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Matmati N, 2013, J BIOL CHEM, V288, P17272, DOI 10.1074/jbc.M112.444802; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200	19	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146839	10.1371/journal.pone.0146839	http://dx.doi.org/10.1371/journal.pone.0146839			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784947	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400071
J	Laughlin, RC; Drake, KL; Morrill, JC; Adams, LG				Laughlin, Richard C.; Drake, Kenneth L.; Morrill, John C.; Adams, L. Garry			Correlative Gene Expression to Protective Seroconversion in Rift Valley Fever Vaccinates	PLOS ONE			English	Article							VIRUS-INFECTION; SYSTEMS BIOLOGY; IMMUNE-RESPONSE; SET ENRICHMENT; MP-12 VACCINE; SHEEP; IMMUNOGENICITY; PROTEIN; NSS; INFLUENZA	Rift Valley fever Virus (RVFV), a negative-stranded RNA virus, is the etiological agent of the vector-borne zoonotic disease, Rift Valley fever (RVF). In both humans and livestock, protective immunity can be achieved through vaccination. Earlier and more recent vaccine trials in cattle and sheep demonstrated a strong neutralizing antibody and total IgG response induced by the RVF vaccine, authentic recombinant MP-12 (arMP-12). From previous work, protective immunity in sheep and cattle vaccinates normally occurs from 7 to 21 days after inoculation with arMP-12. While the serology and protective response induced by arMP-12 has been studied, little attention has been paid to the underlying molecular and genetic events occurring prior to the serologic immune response. To address this, we isolated RNA from whole blood of vaccinated calves over a time course of 21 days before and after vaccination with arMP-12. The time course RNAs were sequenced by RNASeq and bioinformatically analyzed. Our results revealed time-dependent activation or repression of numerous gene ontologies and pathways related to the vaccine induced immune response and its regulation. Additional bioinformatic analyses identified a correlative relationship between specific host immune response genes and protective immunity prior to the detection of protective serum neutralizing antibody responses. These results contribute an important proof of concept for identifying molecular and genetic components underlying the immune response to RVF vaccination and protection prior to serologic detection.	[Laughlin, Richard C.; Adams, L. Garry] Texas A&M Univ, Dept Vet Pathol, College Stn, TX 77843 USA; [Drake, Kenneth L.] Seralogix LLC, 335 Bee Cave Rd,Suite 607, Austin, TX 78746 USA; [Morrill, John C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Laughlin, Richard C.] Texas A&M Univ, Dept Biol & Hlth Sci, Kingsville, TX 78353 USA	Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Medical Branch Galveston; Texas A&M University System; Texas A&M University Kingsville	Adams, LG (corresponding author), Texas A&M Univ, Dept Vet Pathol, College Stn, TX 77843 USA.	lgadams@cvm.tamu.edu		Laughlin, Richard/0000-0002-3321-8642	United States Department of Homeland Security - Foreign Animal & Zoonotic Disease Center [2010-ST-061-AG0002]; National Institutes of Health [NIH-NIAID-DMID-02-24]; Texas AgriLife Research [504064]; Office of the Vice President for Research; Texas A&M University Online Access to Knowledge (OAK) Fund - University Libraries	United States Department of Homeland Security - Foreign Animal & Zoonotic Disease Center(United States Department of Homeland Security (DHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AgriLife Research; Office of the Vice President for Research; Texas A&M University Online Access to Knowledge (OAK) Fund - University Libraries	United States Department of Homeland Security - Foreign Animal & Zoonotic Disease Center http://iiad.tamu.edu 2010-ST-061-AG0002; National Institutes of Health http://www.nih.gov NIH-NIAID-DMID-02-24; Texas AgriLife Research http://agriliferesearch.tamu.edu 504064. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Clay Ashley, Destiny Taylor, and Melissa Walker of the Veterinary Medical Park for their efforts in assuring the welfare and care of the animals for the duration of the experiment. Roberta Pugh (Department of Veterinary Pathobiology, Texas A&M University, College Station, TX) provided technical support and advice during sample collection and RNA processing. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research.	Adams L Garry, 2011, BMC Proc, V5 Suppl 4, pS6, DOI 10.1186/1753-6561-5-S4-S6; Ahmed J, 2009, EURO SURVEILLANCE B, V14; Al-Afaleq AI, 2011, VECTOR-BORNE ZOONOT, V11, P1513, DOI 10.1089/vbz.2010.0245; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bhuju S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003077; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Bolger AM, 2014, BIOINFORMATICS; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Camon Evelyn, 2004, In Silico Biology, V4, P5; Christou L, 2011, CLIN MICROBIOL INFEC, V17, P326, DOI 10.1111/j.1469-0691.2010.03441.x; Colwell DD, 2011, VET PARASITOL, V182, P14, DOI 10.1016/j.vetpar.2011.07.012; Dalrymple BP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r152; Dames P, 2006, P NATL ACAD SCI USA, V103, P3926, DOI 10.1073/pnas.0600011103; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Demasius W, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-93; do Valle TZ, 2010, J IMMUNOL, V185, P6146, DOI 10.4049/jimmunol.1000949; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Guo H, 2011, GENE THER, V18, P106, DOI 10.1038/gt.2010.154; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Illumina I., IGENOME READ TO US R; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Khare S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042127; Kirouac DC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-29; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawhon SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026869; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lihoradova OA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002181; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Marco Di Luca FS, 2011, EUR INFECT DIS, V2, P98; Morrill JC, 1997, AM J VET RES, V58, P1110; MORRILL JC, 1987, AM J VET RES, V48, P1042; MORRILL JC, 1991, VACCINE, V9, P35, DOI 10.1016/0264-410X(91)90314-V; Morrill JC, 1997, AM J VET RES, V58, P1104; MORRILL JC, 1989, REV INFECT DIS, V11, pS815; Morrill JC, 2013, VACCINE, V31, P4988, DOI 10.1016/j.vaccine.2013.08.003; Morrill JC, 2013, VACCINE, V31, P559, DOI 10.1016/j.vaccine.2012.10.118; Morrill JC, 2011, J INFECT DIS, V204, P617, DOI 10.1093/infdis/jir354; Murphy K. P., 2002, THESIS U C BERKELEY; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; NIKLASSON BS, 1984, ACTA PATH MICRO IM C, V92, P197; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Peters C, 2009, RIFT VALLEY FEVER MP; Pittman PR, 1999, VACCINE, V18, P181, DOI 10.1016/S0264-410X(99)00218-2; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ratovonjato J, 2011, VECTOR-BORNE ZOONOT, V11, P753, DOI 10.1089/vbz.2010.0031; Rossetti CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081719; Rossetti CA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-81; Simmons DP, 2012, J IMMUNOL, V188, P3116, DOI 10.4049/jimmunol.1101313; Strimmer K, 2014, FDRTOOL ESTIMATION L; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Weeks JN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-167; Weingartl HM, 2014, VACCINE, V32, P2345, DOI 10.1016/j.vaccine.2013.12.064; Weingartl HM, 2014, VACCINE, V32, P2337, DOI 10.1016/j.vaccine.2014.02.066; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	68	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147027	10.1371/journal.pone.0147027	http://dx.doi.org/10.1371/journal.pone.0147027			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783758	Green Published, gold			2022-12-26	WOS:000368528400097
J	Litwiniuk, A; Pijet, B; Pijet-Kucicka, M; Gajewska, M; Pajak, B; Orzechowski, A				Litwiniuk, Anna; Pijet, Barbara; Pijet-Kucicka, Maja; Gajewska, Malgorzata; Pajak, Beata; Orzechowski, Arkadiusz			FOXO1 and GSK-3 beta Are Main Targets of Insulin-Mediated Myogenesis in C2C12 Muscle Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; IMPAIRED MITOCHONDRIAL ACTIVITY; HUMAN SKELETAL-MUSCLE; GROWTH-FACTOR-I; TRANSCRIPTIONAL COACTIVATOR; SIGNALING PATHWAYS; NUCLEAR CONTROL; GENE; RECEPTOR; RESISTANCE	Myogenesis and muscle hypertrophy account for muscle growth and adaptation to work overload, respectively. In adults, insulin and insulin-like growth factor 1 stimulate muscle growth, although their links with cellular energy homeostasis are not fully explained. Insulin plays critical role in the control of mitochondrial activity in skeletal muscle cells, and mitochondria are essential for insulin action. The aim of this study was to elucidate molecular mechanism(s) involved in mitochondrial control of insulin-dependent myogenesis. The effects of several metabolic inhibitors (LY294002, PD98059, SB216763, LiCl, rotenone, oligomycin) on the differentiation of C2C12 myoblasts in culture were examined in the short-term (hours) and long-term (days) experiments. Muscle cell viability and mitogenicity were monitored and confronted with the activities of selected genes and proteins expression. These indices focus on the roles of insulin, glycogen synthase kinase 3 beta (GSK-3 beta) and forkhead box protein O1 (FOXO1) on myogenesis using a combination of treatments and inhibitors. Long-term insulin (10 nM) treatment in "normoglycemic" conditions led to increased myogenin expression and accelerated myogenesis in C2C12 cells. Insulin-dependent myogenesis was accompanied by the rise of mtTFA, MtSSB, Mfn2, and mitochondrially encoded Cox-1 gene expressions and elevated levels of proteins which control functions of mitochondria (kinase-PKB/AKT, mitofusin 2 protein-Mfn-2). Insulin, via the phosphatidylinositol 3-kinase (PI3-K)/AKT-dependent pathway reduced transcription factor FOXO1 activity and altered GSK-3 beta phosphorylation status. Once FOXO1 and GSK-3 beta activities were inhibited the rise in Cox-1 gene action and nuclear encoded cytochrome c oxidase subunit IV (COX IV) expressions were observed, even though some mRNA and protein results varied. In contrast to SB216763, LiCl markedly elevated Mfn2 and COX IV protein expression levels when given together with insulin. Thus, inhibition of GSK-3 beta activity by insulin alone or together with LiCl raised the expression of genes and some proteins central to the metabolic activity of mitochondria resulting in higher ATP synthesis and accelerated myogenesis. The results of this study indicate that there are at least two main targets in insulin-mediated myogenesis: notably FOXO1 and GSK-3 beta both playing apparent negative role in muscle fiber formation.	[Litwiniuk, Anna] Ctr Postgrad Med Educ, Dept Neuroendocrinol, Marymoncka 99-103, PL-01813 Warsaw, Poland; [Pijet, Barbara] Nencki Inst Expt Biol PAS, Dept Mol & Cellular Neurobiol, Neurobiol Lab, Pasteura 3, PL-02093 Warsaw, Poland; [Pijet-Kucicka, Maja] Med Univ Warsaw, Dept Dermatol, Koszykowa 82A, PL-02008 Warsaw, Poland; [Gajewska, Malgorzata; Pajak, Beata; Orzechowski, Arkadiusz] Warsaw Univ Life Sci SGGW, Dept Physiol Sci, Nowoursynowska 159, PL-02776 Warsaw, Poland; [Pajak, Beata; Orzechowski, Arkadiusz] Mossakowski Med Res Ctr PAS, Electron Microscopy Platform, Pawinskiego 5, PL-02106 Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Medical University of Warsaw; Warsaw University of Life Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Orzechowski, A (corresponding author), Warsaw Univ Life Sci SGGW, Dept Physiol Sci, Nowoursynowska 159, PL-02776 Warsaw, Poland.; Orzechowski, A (corresponding author), Mossakowski Med Res Ctr PAS, Electron Microscopy Platform, Pawinskiego 5, PL-02106 Warsaw, Poland.	orzechowski_arkadiusz@wp.pl	Pijet, Barbara/B-6559-2019; Litwiniuk, Anna/ABG-2099-2020	Pijet, Barbara/0000-0002-9268-5208; Gajewska, Malgorzata/0000-0001-7249-8627; Pijet-Kucicka, Maja/0000-0001-6400-9352; Pajak, Beata/0000-0002-3565-8860; Litwiniuk, Anna/0000-0003-1115-733X	Ministry of Science and Higher Education in Poland [N401 033 32/0759]; National Science Centre in Poland [UMO-2013/11/B/NZ5/03106]	Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland); National Science Centre in Poland(National Science Centre, Poland)	Funded by Ministry of Science and Higher Education in Poland grant No N401 033 32/0759 (BP) and National Science Centre in Poland grant No UMO-2013/11/B/NZ5/03106 (AO).	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chakkalakal JV, 2003, P NATL ACAD SCI USA, V100, P7791, DOI 10.1073/pnas.0932671100; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Cong HL, 2011, HUM GENE THER, V22, P313, DOI 10.1089/hum.2010.057; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; Evenson AR, 2005, INT J BIOCHEM CELL B, V37, P2226, DOI 10.1016/j.biocel.2005.06.002; Fang CH, 2005, ENDOCRINOLOGY, V146, P3141, DOI 10.1210/en.2004-0869; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Henriksen EJ, 2010, CURR DIABETES REV, V6, P285, DOI 10.2174/157339910793360888; Hojlund K, 2006, CURR DIABETES REV, V2, P375, DOI 10.2174/1573399810602040375; Hudson MB, 2013, INT J BIOCHEM CELL B, V45, P2173, DOI 10.1016/j.biocel.2013.06.029; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; Jefferson LS, 1999, INT J BIOCHEM CELL B, V31, P191, DOI 10.1016/S1357-2725(98)00141-1; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Lara-Pezzi E, 1997, J CELL SCI, V179, P1205; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Leger B, 2009, MUSCLE NERVE, V40, P69, DOI 10.1002/mus.21293; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Li BG, 2005, INT J BIOCHEM CELL B, V37, P2207, DOI 10.1016/j.biocel.2005.04.008; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Malinska D, 2012, MITOCHONDRION, V12, P144, DOI 10.1016/j.mito.2011.06.015; MANDEL JL, 1974, NATURE, V251, P618, DOI 10.1038/251618a0; Mikula M., 2005, INT J BIOCHEM CELL B, V37, P127; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Pajak B, 2010, RES VET SCI, V89, P445, DOI 10.1016/j.rvsc.2010.04.013; Pawlikowska P, 2006, CELL PROLIFERAT, V39, P127, DOI 10.1111/j.1365-2184.2006.00376.x; Pawlikowska P, 2007, CELL TISSUE RES, V327, P571, DOI 10.1007/s00441-006-0320-3; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pijet B, 2013, MEDIAT INFLAMM, DOI DOI 10.1155/2013/171437; Pijet M, 2013, CYTOKINE, V61, P445, DOI 10.1016/j.cyto.2012.11.002; Potter RA, 2013, J EXERCISE PHYSL, V16, P32; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sarbassov DD, 1997, MOL ENDOCRINOL, V11, P2038, DOI 10.1210/me.11.13.2038; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 1998, MOL ENDOCRINOL, V12, P1870, DOI 10.1210/me.12.12.1870; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Scarpulla RC, 2011, BIOCHIM BIOPHYS ACTA, V17, P132; Short KR, 2004, NEW ENGL J MED, V350, P2419; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Spangenburg EE, 2004, ENDOCRINOLOGY, V145, P2054, DOI 10.1210/en.2003-1476; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Valdes JA, 2013, J CELL PHYSIOL, V228, P1452, DOI 10.1002/jcp.24298; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; van der Velden JLJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1636, DOI 10.1152/ajpcell.00504.2006; Verhees KJP, 2011, AM J PHYSIOL-CELL PH, V301, pC995, DOI 10.1152/ajpcell.00520.2010; Wang KZQ, 2014, MITOCHONDRION, V17, P132, DOI 10.1016/j.mito.2014.04.008; Welsh GI, 1997, FEBS LETT, V410, P418, DOI 10.1016/S0014-5793(97)00579-6; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu Y-J, 2013, PLOS ONE, V9, DOI [10.1371/journal.pone.0088450, DOI 10.1371/J0URNAL.P0NE.0088450]; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang CJ, 2012, BIOSCIENCE REP, V32, P465, DOI 10.1042/BSR20120034; Zorzano Antonio, 2009, Archives of Physiology and Biochemistry, V115, P1, DOI 10.1080/13813450802676335	72	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146726	10.1371/journal.pone.0146726	http://dx.doi.org/10.1371/journal.pone.0146726			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785133	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400061
J	Sockeel, S; Schwartz, D; Pelegrini-Issac, M; Benali, H				Sockeel, Stephane; Schwartz, Denis; Pelegrini-Issac, Melanie; Benali, Habib			Large-Scale Functional Networks Identified from Resting-State EEG Using Spatial ICA	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; FMRI; DISEASE; MEG	Several methods have been applied to EEG or MEG signals to detect functional networks. In recent works using MEG/EEG and fMRI data, temporal ICA analysis has been used to extract spatial maps of resting-state networks with or without an atlas-based parcellation of the cortex. Since the links between the fMRI signal and the electromagnetic signals are not fully established, and to avoid any bias, we examined whether EEG alone was able to derive the spatial distribution and temporal characteristics of functional networks. To do so, we propose a two-step original method: 1) An individual multi-frequency data analysis including EEG-based source localisation and spatial independent component analysis, which allowed us to characterize the resting-state networks. 2) A group-level analysis involving a hierarchical clustering procedure to identify reproducible large-scale networks across the population. Compared with large-scale resting-state networks obtained with fMRI, the proposed EEG-based analysis revealed smaller independent networks thanks to the high temporal resolution of EEG, hence hierarchical organization of networks. The comparison showed a substantial overlap between EEG and fMRI networks in motor, premotor, sensory, frontal, and parietal areas. However, there were mismatches between EEG-based and fMRI-based networks in temporal areas, presumably resulting from a poor sensitivity of fMRI in these regions or artefacts in the EEG signals. The proposed method opens the way for studying the high temporal dynamics of networks at the source level thanks to the high temporal resolution of EEG. It would then become possible to study detailed measures of the dynamics of connectivity.	[Sockeel, Stephane; Pelegrini-Issac, Melanie; Benali, Habib] Univ Paris 06, Sorbonne Univ, CNRS, INSERM,LIB, Paris, France; [Schwartz, Denis] Univ Paris 06, Sorbonne Univ, CNRS, Inserm U1127,UMR 7225,UMR S 1127,Inst Cerveau & M, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Schwartz, D (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, Inserm U1127,UMR 7225,UMR S 1127,Inst Cerveau & M, Paris, France.	Denis.Schwartz@upmc.fr		Schwartz, Denis/0000-0002-8557-2934; Pelegrini-Issac, Melanie/0000-0003-3260-5795	program "Investissements d'avenir" [ANR-10-IAIHU-06]	program "Investissements d'avenir"(French National Research Agency (ANR))	The research leading to these results has received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06 (http://www.agence-nationale-recherche.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059856; Barnes JJ, 2016, DEVELOPMENTAL SCI, V19, P19, DOI 10.1111/desc.12297; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Bullmore E, 2009, NAT REV NEUROSCI, V10, DOI 10.1038/nrn2618; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Coynel D, 2010, I S BIOMED IMAGING, P652, DOI 10.1109/ISBI.2010.5490092; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; David O., 2003, INT J COMPUT COGN, V1, P53; Deligianni F, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00258; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ducorps A, 2010, FRONT NEUROSCI, DOI [10.3389/conf.fnins.2010.06.00107, DOI 10.10.3389/C0NF.FNINS.2010.06.00107]; Friston KJ, 2011, NEUROIMAGE, V56, P1202, DOI 10.1016/j.neuroimage.2010.12.039; Geffroy D, 2011, PYTH NEUR WORKSH PAR; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Grova C, 2006, NEUROIMAGE, V31, P1475, DOI 10.1016/j.neuroimage.2006.02.049; Hartigan J., 1975, CLUSTERING ALGORITHM; HOLMES CJ, 1998, J COMPUT ASSIST TOMO, V22; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Lei X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024642; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Marzetti L, 2007, NEUROIMAGE, V36, P48, DOI 10.1016/j.neuroimage.2007.02.034; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Perlbarg V, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/218519; Perlbarg V, 2009, NEUROIMAGE, V47, pS80, DOI [10.1016/S1053-8119(09)70568-3, DOI 10.1016/S1053-8119(09)70568-3]; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Regan D., 1989, HUMAN BRAIN ELECTROP; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Shepard D., 1968, P 23 ACM NAT C ACM 6, P517; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Svensen M, 2002, NEUROIMAGE, V16, P551, DOI 10.1006/nimg.2002.1122; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; Wens V, 2015, HUM BRAIN MAPP, V36, P4604, DOI 10.1002/hbm.22943; Yan XD, 2011, J NEUROSCI METH, V199, P108, DOI 10.1016/j.jneumeth.2011.05.001; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	48	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146845	10.1371/journal.pone.0146845	http://dx.doi.org/10.1371/journal.pone.0146845			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785116	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400072
J	Upadhye, DS; Jain, DL; Trivedi, YL; Nadkarni, AH; Ghosh, K; Colah, RB				Upadhye, Dipti S.; Jain, Dipty L.; Trivedi, Yogesh L.; Nadkarni, Anita H.; Ghosh, Kanjaksha; Colah, Roshan B.			Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India	PLOS ONE			English	Article							NATURAL-HISTORY; FETAL HEMOGLOBIN; RISK-FACTORS; ALPHA-THALASSEMIA; ANEMIA; STROKE; COHORT; TRANSFUSIONS; DACTYLITIS; HAPLOTYPE	Background Sickle cell disease (SCD) is a major health burden in India. The objective of the study was to establish a neonatal screening program and to understand the clinical course of children with SCD in central India. Methods and Findings Pregnant mothers were screened for sickle hemoglobin using the solubility test. Babies were screened by high performance liquid chromatography if the mother was positive for sickle hemoglobin. The diagnosis was confirmed by molecular analysis. They received early prophylactic treatment and vaccination. Of 2134 newborns screened, 104 were sickle homozygous (SS), seven had sickle beta-thalassemia (S-beta thal) and 978 were sickle heterozygous (AS). The other hemoglobin abnormalities detected included HbS-delta beta thalassemia-1, HbSD disease-2, HbE traits-5, beta-thalassemia traits-4, alpha chain variants-3 and HbH disease-1. These babies were followed up regularly for hematological and clinical evaluation. Pain, severe anemia requiring blood transfusions and acute febrile illness were the major complications with 59.7, 45.1 and 42.6 cases per 100 person years. Fetal hemoglobin (HbF) levels were inversely associated with vaso-oclussive crisis (VOC) and severe anemia while presence of alpha thalassemia increased the rate of painful events and sepsis. Six early deaths occurred among the SS babies. Conclusion A systematic follow up of this first newborn SCD cohort in central India showed that 47% of babies presented within 1 year of age. In spite of the presence of the Arab-Indian haplotype many babies had severe manifestations.	[Upadhye, Dipti S.; Nadkarni, Anita H.; Ghosh, Kanjaksha; Colah, Roshan B.] Indian Council Med Res, Natl Inst Immunohematol, 13th Floor,New Multistoried Bldg,KEM Hosp Campus, Bombay 400012, Maharashtra, India; [Jain, Dipty L.; Trivedi, Yogesh L.] Govt Med Coll, Nagpur 440003, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Colah, RB (corresponding author), Indian Council Med Res, Natl Inst Immunohematol, 13th Floor,New Multistoried Bldg,KEM Hosp Campus, Bombay 400012, Maharashtra, India.	colahrb@gmail.com	Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565	Department of Biotechnology, Government of India [BT/PR5958/MED/14/721/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was funded by the Department of Biotechnology, Government of India (BT/PR5958/MED/14/721/2005, Dated - 28.08.09). Dr. RC and Dr. DJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY K, 1992, ARCH DIS CHILD, V67, P517, DOI 10.1136/adc.67.4.517; BALKARAN B, 1992, J PEDIATR-US, V120, P360, DOI 10.1016/S0022-3476(05)80897-2; BAUM KF, 1987, ARCH INTERN MED, V147, P1231, DOI 10.1001/archinte.147.7.1231; Colah RB., 1997, INDIAN J HEMATOL BLO, V15, P10; Colah R, 2014, CURR OPIN HEMATOL, V21, P215, DOI 10.1097/MOH.0000000000000029; Dixit S, 2015, J COMMUN GENET, V6, P383, DOI 10.1007/s12687-015-0223-7; Donaldson A, 2001, CLIN LAB HAEMATOL, V23, P285, DOI 10.1046/j.1365-2257.2001.00412.x; EMOND AM, 1985, J PEDIATR-US, V107, P201, DOI 10.1016/S0022-3476(85)80125-6; Foucan L, 2006, PAEDIATR PERINAT EP, V20, P59, DOI 10.1111/j.1365-3016.2006.00692.x; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Gulbis B, 2009, J CLIN PATHOL, V62, P49, DOI 10.1136/jcp.2008.060517; Italia K, 2015, BRIT J HAEMATOL, V168, P156, DOI 10.1111/bjh.13083; Italia Y, 2015, J MED SCREEN, V22, P1, DOI 10.1177/0969141314557372; Jain D, 2012, INDIAN PEDIATR, V49, P911, DOI 10.1007/s13312-012-0217-z; Jain DL, 2012, HEMOGLOBIN, V36, P316, DOI 10.3109/03630269.2012.691434; King L, 2007, J MED SCREEN, V14, P117, DOI 10.1258/096914107782066185; LEIKIN SL, 1989, PEDIATRICS, V84, P500; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; Mukherjee MB, 1997, AM J HEMATOL, V55, P104, DOI 10.1002/(SICI)1096-8652(199706)55:2<104::AID-AJH9>3.0.CO;2-X; Panigrahi S, 2012, INDIAN J PEDIATR, V79, P747, DOI 10.1007/s12098-011-0682-8; PEGELOW CH, 1995, J PEDIATR-US, V126, P896, DOI 10.1016/S0022-3476(95)70204-0; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1978, AM J MED, V65, P461, DOI 10.1016/0002-9343(78)90772-6; POWARS DR, 1975, SEMIN HEMATOL, V12, P267; POWARS DR, 1980, J CLIN INVEST, V65, P732, DOI 10.1172/JCI109720; Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758; SARNAIK S, 1979, AM J DIS CHILD, V133, P1254, DOI 10.1001/archpedi.1979.02130120046009; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; STEVENS MCG, 1981, CLIN PEDIATR, V20, P311, DOI 10.1177/000992288102000501; Tan ASC, 2001, BLOOD, V98, P250, DOI 10.1182/blood.V98.1.250; THOMAS AN, 1982, BRIT MED J, V285, P633, DOI 10.1136/bmj.285.6342.633; VICHINSKY E, 1988, PEDIATRICS, V81, P749	34	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147081	10.1371/journal.pone.0147081	http://dx.doi.org/10.1371/journal.pone.0147081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785407	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400107
J	Biraro, IA; Kimuda, S; Egesa, M; Cose, S; Webb, EL; Joloba, M; Smith, SG; Elliott, AM; Dockrell, HM; Katamba, A				Biraro, Irene Andia; Kimuda, Simon; Egesa, Moses; Cose, Stephen; Webb, Emily L.; Joloba, Moses; Smith, Steven G.; Elliott, Alison M.; Dockrell, Hazel M.; Katamba, Achilles			The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; DELAYED-TYPE HYPERSENSITIVITY; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; WHOLE-BLOOD; BCG VACCINATION; IP-10; ASSAY; RELEASE; CONTACT	Background In the absence of a gold standard for the diagnosis of latent tuberculosis (TB) infection (LTBI), the current tests available for the diagnosis of LTBI are limited by their inability to differentiate between LTBI and active TB disease. We investigated IP-10 as a potential biomarker for LTBI among household contacts exposed to sputum positive active TB cases. Methods Active TB cases and contacts were recruited into a cohort with six months' follow-up. Contacts were tested for LTBI using QuantiFERON (R)-TB Gold In-Tube (QFN) assay and the tuberculin skin test (TST). Baseline supernatants from the QFN assay of 237 contacts and 102 active TB cases were analysed for Mycobacterium tuberculosis (MTB) specific and mitogen specific IP-10 responses. Results Contacts with LTBI (QFN(+)TST(+)) had the highest MTB specific IP-10 responses at baseline, compared to uninfected contacts (QFN(-)TST(-)) p<0.0001; and active cases, p = 0.01. Using a cut-off of 8,239 pg/ml, MTB specific IP-10 was able to diagnose LTBI with a sensitivity of 87.1% (95% CI, 76.2-94.3) and specificity of 90.9%(95% CI, 81.3-96.6). MTB specific to mitogen specific IP-10 ratio was higher in HIV negative active TB cases, compared to HIV negative latently infected contacts, p = 0.0004. Concentrations of MTB specific IP-10 were higher in contacts with TST conversion (negative at baseline, positive at 6-months) than in those that were persistently TST negative, p = 0.001. Conclusion IP-10 performed well in differentiating contacts with either latent or active TB from those who were uninfected but was not able to differentiate LTBI from active disease except when MTB specific to mitogen specific ratios were used in HIV negative adults. In addition, IP-10 had the potential to diagnose 'recent TB infection' in persons classified as having LTBI using the TST. Such individuals with strong IP-10 responses would likely benefit from chemoprophylaxis.	[Biraro, Irene Andia; Kimuda, Simon; Egesa, Moses; Joloba, Moses; Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Biraro, Irene Andia; Kimuda, Simon; Egesa, Moses; Cose, Stephen; Elliott, Alison M.] Uganda Virus Res Inst, Med Res Council, Uganda Res Unit AIDS, Entebbe, Uganda; [Cose, Stephen; Elliott, Alison M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Webb, Emily L.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Smith, Steven G.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England	Makerere University; Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Biraro, IA (corresponding author), Makerere Univ, Coll Hlth Sci, Kampala, Uganda.; Biraro, IA (corresponding author), Uganda Virus Res Inst, Med Res Council, Uganda Res Unit AIDS, Entebbe, Uganda.	andiaodanga@yahoo.com	Cose, Stephen/H-4851-2019	Cose, Stephen/0000-0002-5156-037X; Joloba, Moses/0000-0002-0334-9983; Smith, Steven/0000-0001-5623-7806; Egesa, Moses/0000-0001-5136-868X; Elliott, Alison/0000-0003-2818-9549	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award [084344]; European Community's Seventh Framework Programme (FP7) under EC-GA [241642]; IDEA Consortium; Wellcome Trust Senior Fellowship [095778]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award; European Community's Seventh Framework Programme (FP7) under EC-GA; IDEA Consortium; Wellcome Trust Senior Fellowship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by IAB, funded by a Wellcome Trust Strategic Award, grant number 084344. The work also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under EC-GA number 241642, IDEA Consortium (http://www.idearesearch.eu/). AME is supported by a Wellcome Trust Senior Fellowship, grant number 095778.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; BD Bioscience O, HUM IP 10 ELISA SET; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Biraro IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111517; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Buchwald UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116268; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chen YC, 2011, DIS MARKERS, V31, P101, DOI [10.3233/DMA-2011-0808, 10.1155/2011/938794]; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Diel R, 2006, EUR RESPIR J, V28, P16, DOI 10.1183/09031936.06.00107005; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Eisenhut M, 2009, VACCINE, V27, P6116, DOI 10.1016/j.vaccine.2009.08.031; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Ferrero E, 2003, IMMUNOLOGY, V108, P365, DOI 10.1046/j.1365-2567.2003.01600.x; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Floyd S, 2002, J INFECT DIS, V186, P807, DOI 10.1086/342416; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hoft DF, 2000, CLIN INFECT DIS, V30, pS217, DOI 10.1086/313864; Holm LL, 2014, PEDIATRICS, V134, pE1568, DOI 10.1542/peds.2014-1570; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jeong YH, 2015, J CLIN MICROBIOL, V53, P504, DOI 10.1128/JCM.02758-14; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; KAPLAN G, 1987, J EXP MED, V166, P1098, DOI 10.1084/jem.166.4.1098; Lalvani A, 2003, THORAX, V58, P916, DOI 10.1136/thorax.58.11.916; Lalvani A, 2008, EUR RESPIR J, V32, P1428, DOI 10.1183/09031936.00148308; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lange C, 2010, RESPIROLOGY, V15, P220, DOI 10.1111/j.1440-1843.2009.01692.x; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Mandalakas AM, 2015, AM J RESP CRIT CARE, V191, P820, DOI 10.1164/rccm.201406-1165OC; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Mudido PM, 1999, INT J TUBERC LUNG D, V3, P891; Nkurunungi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047340; Orme IM, 1999, IMMUNOL TODAY, V20, P307, DOI 10.1016/S0167-5699(98)01438-8; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Petrone L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/589471; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Vanini V, 2012, J INFECTION, V65, P49, DOI 10.1016/j.jinf.2012.03.017; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Weinfurter P, 2011, INT J TUBERC LUNG D, V15, P1056, DOI 10.5588/ijtld.10.0650; Wergeland I, 2015, J INFECTION, V70, P381, DOI 10.1016/j.jinf.2014.12.019; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901	65	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146098	10.1371/journal.pone.0146098	http://dx.doi.org/10.1371/journal.pone.0146098			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771653	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000368628300009
J	Chaudhuri, AD; Choi, DC; Kabaria, S; Tran, A; Junn, E				Chaudhuri, Amrita Datta; Choi, Doo Chul; Kabaria, Savan; Tran, Alan; Junn, Eunsung			MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); mitochondrial membrane potential; mitochondrial permeability transition (MPT); Parkinson disease; voltage-dependent anion channel (VDAC); 1-methyl-4-phenylpyridinium	1-METHYL-4-PHENYLPYRIDINIUM-INDUCED CELL-DEATH; ALPHA-SYNUCLEIN EXPRESSION; LARGE GENE LISTS; PARKINSONS-DISEASE; INHIBITS APOPTOSIS; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; OXIDATIVE STRESS; COMPLEX-I; DYSFUNCTION	Mitochondrial dysfunction is one of the major contributors to neurodegenerative disorders including Parkinson disease. The mitochondrial permeability transition pore is a protein complex located on the mitochondrial membrane. Under cellular stress, the pore opens, increasing the release of pro-apoptotic proteins, and ultimately resulting in cell death. MicroRNA-7 (miR-7) is a small non-coding RNA that has been found to exhibit a protective role in the cellular models of Parkinson disease. In the present study, miR-7 was predicted to regulate the function of mitochondria, according to gene ontology analysis of proteins that are down-regulated by miR-7. Indeed, miR-7 overexpression inhibited mitochondrial fragmentation, mitochondrial depolarization, cytochrome c release, reactive oxygen species generation, and release of mitochondrial calcium in response to 1-methyl-4-phenylpyridinium (MPP+) in human neuroblastoma SH-SY5Y cells. In addition, several of these findings were confirmed in mouse primary neurons. Among the mitochondrial proteins identified by gene ontology analysis, the expression of voltage-dependent anion channel 1 (VDAC1), a constituent of the mitochondrial permeability transition pore, was down-regulated by miR-7 through targeting 3-untranslated region of VDAC1 mRNA. Similar to miR-7 overexpression, knockdown of VDAC1 also led to a decrease in intracellular reactive oxygen species generation and subsequent cellular protection against MPP+. Notably, overexpression of VDAC1 without the 3-UTR significantly abolished the protective effects of miR-7 against MPP+-induced cytotoxicity and mitochondrial dysfunction, suggesting that the protective effect of miR-7 is partly exerted through promoting mitochondrial function by targeting VDAC1 expression. These findings point to a novel mechanism by which miR-7 accomplishes neuroprotection by improving mitochondrial health.	[Chaudhuri, Amrita Datta; Choi, Doo Chul; Kabaria, Savan; Tran, Alan; Junn, Eunsung] Rutgers Robert Wood Johnson Med Sch, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Junn, E (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurol, 683 Hoes Lane W,Rm 185, Piscataway, NJ 08854 USA.	junneu@rwjms.rutgers.edu		Junn, Eunsung/0000-0001-5694-2599	National Institutes of Health [NS070898]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS070898 (to E. J.). The following author has disclosed actual or potential conflicts: E. J. (patent). The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Burte F, 2011, J PROTEOME RES, V10, P1974, DOI 10.1021/pr101211k; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Chaudhuri AD, 2015, J BIOL CHEM, V290, P12425, DOI 10.1074/jbc.M114.625962; Choi DC, 2014, J NEUROSCI, V34, P12725, DOI 10.1523/JNEUROSCI.0985-14.2014; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ghosh T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001170; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Hajnoczky G, 2002, CELL CALCIUM, V32, P363, DOI 10.1016/S0143416002001872; Harraz MM, 2011, J CHEM NEUROANAT, V42, P127, DOI 10.1016/j.jchemneu.2011.01.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lessner G, 2010, J PROTEOME RES, V9, P4671, DOI 10.1021/pr100389u; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Manczak M, 2013, J ALZHEIMERS DIS, V37, P679, DOI 10.3233/JAD-130761; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Pazarentzos E, 2014, EMBO J, V33, P2814, DOI 10.15252/embj.201488183; Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004; Sun YN, 2015, J ALZHEIMERS DIS, V45, P269, DOI 10.3233/JAD-142805; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; Xiong YY, 2009, NEUROCHEM RES, V34, P746, DOI 10.1007/s11064-008-9844-0; Yelamanchili SV, 2010, J NEUROIMMUNE PHARM, V5, P63, DOI 10.1007/s11481-009-9172-4; Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46; Zhu M, 2014, CNS NEUROSCI THER, V20, P308, DOI 10.1111/cns.12217	39	80	81	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6483	6493		10.1074/jbc.M115.691352	http://dx.doi.org/10.1074/jbc.M115.691352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26801612	Green Published, hybrid			2022-12-26	WOS:000372894200035
J	Boavida, J; Paulo, D; Aurelle, D; Arnaud-Haond, S; Marschal, C; Reed, J; Goncalves, JMS; Serrao, EA				Boavida, Joana; Paulo, Diogo; Aurelle, Didier; Arnaud-Haond, Sophie; Marschal, Christian; Reed, John; Goncalves, Jorge M. S.; Serrao, Ester A.			A Well-Kept Treasure at Depth: Precious Red Coral Rediscovered in Atlantic Deep Coral Gardens (SW Portugal) after 300 Years	PLOS ONE			English	Article							SHALLOW-WATER; POPULATION-STRUCTURE; RUBRUM POPULATIONS; SUBMARINE-CANYON; BASE-LINE; GROWTH; FAUNA; VARIABILITY; HABITAT; SEA	Background The highly valuable red coral Corallium rubrum is listed in several Mediterranean Conventions for species protection and management since the 1980s. Yet, the lack of data about its Atlantic distribution has hindered its protection there. This culminated in the recent discovery of poaching activities harvesting tens of kg of coral per day from deep rocky reefs off SW Portugal. Red coral was irregularly exploited in Portugal between the 1200s and 1700s, until the fishery collapsed. Its occurrence has not been reported for the last 300 years. Results Here we provide the first description of an Atlantic red coral assemblage, recently rediscovered dwelling at 60-100 m depth in southern Portugal. We report a very slow growth rate (0.23 mm year-1), comparable to Mediterranean specimens. In comparison with most of the Mediterranean reports, the population reaches much larger sizes, estimated to be over one century old, and has a more complex coral branch architecture that promotes a rich assemblage of associated species, with boreal and Mediterranean affinities. Atlantic red coral is genetically distinct, yet mitochondrial analyses suggest that red corals from the Atlantic may have introgressed the Mediterranean ones after migration via the Algeria current. Our underwater surveys, using advanced mixed-gas diving, retrieved lost fishing gear in all coral sites. Besides illegal harvesting, the use and loss of fishing gears, particularly nets, by local fisheries are likely sources of direct impacts on these benthic assemblages. Conclusions We extended the knowledge on the distribution of C. rubrum in the Atlantic, discovered its genetic distinctiveness, and reveal a rich deep-dwelling fauna associated to these coral assemblages. These findings support a barrier role of the Atlantic-Mediterranean transition zone, but reveal also hints of connectivity along its southern margin. The results highlight the genetic and demographic uniqueness of red coral populations from SW Iberia. However, we also report threats to these vulnerable populations by direct and indirect fishing activities and argue that its protection from any mechanically destructive activities is urgent as a precautionary approach. This study advances our understanding of phylogeographic barriers and range edge genetic diversity, and serves as a baseline against which to monitor future human and environmental disturbances to Atlantic C. rubrum.	[Boavida, Joana; Paulo, Diogo; Goncalves, Jorge M. S.; Serrao, Ester A.] Univ Algarve, Ctr Ciencias Mar, CCMAR, Campus Gambelas, P-8005139 Faro, Portugal; [Aurelle, Didier; Marschal, Christian] Avignon Univ, Aix Marseille Univ, CNRS, IRD,IMBE,UMR 7263, F-13007 Marseille, France; [Arnaud-Haond, Sophie] IFREMER, UMR MARBEC Marine Biodivers Exploitat & Conservat, Bd Jean Monnet,BP 171, F-34203 Sete, France; [Reed, John] Florida Atlantic Univ, Harbor Branch Oceanog Inst, Ft Pierce, FL USA	Universidade do Algarve; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Ifremer; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University	Boavida, J (corresponding author), Univ Algarve, Ctr Ciencias Mar, CCMAR, Campus Gambelas, P-8005139 Faro, Portugal.	joanarboavida@gmail.com	Arnaud-Haond, Sophie/B-2479-2008; Aurelle, Didier/F-2592-2010; Serrao, Ester A/C-6686-2012; Gonçalves, Jorge MS/G-5206-2011; Paulo, Diogo/M-7522-2013; boavida, joana/M-5744-2013	Arnaud-Haond, Sophie/0000-0001-5814-8452; Aurelle, Didier/0000-0002-3922-7291; Serrao, Ester A/0000-0003-1316-658X; Gonçalves, Jorge MS/0000-0001-7704-8190; Paulo, Diogo/0000-0001-9061-6850; boavida, joana/0000-0001-5265-2498	Inaqua Conservation Fund by Oceanario de Lisboa; National Geographic Channel through project Deep Reefs, a National Geographic/Waitt grant [W153-11]; MeshAtlantic project [AA ERDF 2009-1/110]; OCEANA (Expedition Portugal)	Inaqua Conservation Fund by Oceanario de Lisboa; National Geographic Channel through project Deep Reefs, a National Geographic/Waitt grant; MeshAtlantic project; OCEANA (Expedition Portugal)	This research was supported with funding from the Inaqua Conservation Fund by Oceanario de Lisboa and National Geographic Channel through project Deep Reefs (http://www.deepreefs.com), a National Geographic/Waitt grant (no. W153-11), MeshAtlantic project 2013 (AA ERDF 2009-1/110), OCEANA (Expedition Portugal 2011), additional support for field expenses by Project Baseline/Global Underwater Expedition 2014. The funders had no role in study design, collection, analysis, interpretation of data, writing and in the decision to publish.	Al-Abdulrazzak D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043386; Allen JT, 2001, J MARINE SYST, V30, P263, DOI 10.1016/S0924-7963(01)00062-8; Alleway HK, 2015, CONSERV BIOL, V29, P795, DOI 10.1111/cobi.12452; Andrada e Silva JB, 1790, MEMORIAS EC ACAD REA, V2, P389; Angiolillo M, 2016, MAR ECOL-EVOL PERSP, V37, P294, DOI 10.1111/maec.12274; Assis J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068646; Aurelle D, 2011, GENETICA, V139, P855, DOI 10.1007/s10709-011-9589-6; Baldaque da Silva AA, 1891, ESTADO ACTUAL PESCAS, P20; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bavestrello G, 2015, MAR ECOL-EVOL PERSP, V36, P1354, DOI 10.1111/maec.12235; Boavida J, 2016, HYDROBIOLOGIA, V766, P247, DOI 10.1007/s10750-015-2459-y; Borges TC, 2001, J APPL ICHTHYOL, V17, P104; Boury-Esnault P. N., 2001, B MUSEU MUNICIPAL FU, V6, P15; Bramanti L, 2014, MAR BIOL, V161, P1015, DOI 10.1007/s00227-013-2383-5; Bramanti L, 2013, GLOBAL CHANGE BIOL, V19, P1897, DOI 10.1111/gcb.12171; BRAZEAU DA, 1988, CORAL REEFS, V7, P139, DOI 10.1007/BF00300973; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Bruckner AW, 2009, MAR ECOL PROG SER, V397, P319, DOI 10.3354/meps08110; Cardenas P, 2013, ZOOL J LINN SOC-LOND, V169, P251, DOI 10.1111/zoj.12056; Carpine C, 1975, B I OCEANOGRAPHIQUE, V71; CastricFey A, 1996, OCEANOL ACTA, V19, P665; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Cerrano C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01457; Costantini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061546; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; da Silva Lopes J, 1841, COROGRAFIA MEMORIA E; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; De Lobo CB L, 1812, MEMORIAS EC ACAD REA, VIV, P241; Doughty CL, 2014, DEEP-SEA RES PT II, V99, P71, DOI 10.1016/j.dsr2.2013.05.023; Drummond A, 2011, GENEIOUS V 8 1 4; Gallmetzer I, 2010, ESTUAR COAST SHELF S, V90, P1, DOI 10.1016/j.ecss.2010.04.018; GARCIA-RODRIGUEZ M, 1986, Boletin Instituto Espanol de Oceanografia, V3, P61; Garrabou J, 2002, J ANIM ECOL, V71, P966, DOI 10.1046/j.1365-2656.2002.00661.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; GFCM General Fisheries Commission for the Mediterranean, 2011, 2 TRANSV WORKSH RED; Goncalves JMS, 2008, FISHERIES MANAG ECOL, V15, P199, DOI 10.1111/j.1365-2400.2008.00607.x; Gori A, 2015, J EXP MAR BIOL ECOL, V466, P92, DOI 10.1016/j.jembe.2015.02.004; GOTELLI NJ, 1991, ECOLOGY, V72, P457, DOI 10.2307/2937187; GOTELLI NJ, 1988, ECOLOGY, V69, P157, DOI 10.2307/1943170; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; HAYNES R, 1993, J GEOPHYS RES-OCEANS, V98, P22681, DOI 10.1029/93JC02016; Henry LA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05589; Henry LA, 2014, ICES J MAR SCI, V71, P895, DOI 10.1093/icesjms/fst175; Costa BHE, 2014, MAR ECOL PROG SER, V504, P241, DOI 10.3354/meps10749; INRH, 2013, ET STOCKS PECH MAR 2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; LASKER HR, 1991, OECOLOGIA, V86, P503, DOI 10.1007/BF00318316; Lasker HR, 1998, MAR ECOL PROG SER, V162, P111, DOI 10.3354/meps162111; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Marschal C, 2004, CORAL REEFS, V23, P423, DOI 10.1007/s00338-004-0398-6; McClenachan L, 2008, P ROY SOC B-BIOL SCI, V275, P1351, DOI 10.1098/rspb.2007.1757; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Montero-Serra I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117250; Morais P, 2007, MAR ECOL-EVOL PERSP, V28, P112, DOI 10.1111/j.1439-0485.2007.00175.x; Movilla J, 2014, CORAL REEFS, V33, P675, DOI 10.1007/s00338-014-1159-9; Nemeth RS, 2005, MAR ECOL PROG SER, V286, P81, DOI 10.3354/meps286081; Oliveira F, 2015, MAR POLLUT BULL, V97, P401, DOI 10.1016/j.marpolbul.2015.05.060; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Peliz A, 2005, DEEP-SEA RES PT I, V52, P621, DOI 10.1016/j.dsr.2004.11.005; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Priori C, 2013, ESTUAR COAST SHELF S, V118, P43, DOI 10.1016/j.ecss.2012.12.011; Rau V, 1972, TEMPO HIST, VV, P143; RAU Virginia, 1971, TEMPO HIST, V4, P97; Reed JK, 2006, B MAR SCI, V78, P343; Reed JK, 2007, B MAR SCI, V81, P481; Relvas P, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000456; Reverdin G, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001020; Robert K, 2014, MAR ECOL PROG SER, V501, P67, DOI 10.3354/meps10677; Rossi S, 2008, MAR BIOL, V154, P533, DOI 10.1007/s00227-008-0947-6; Russ GR, 2015, MAR ECOL PROG SER, V529, P233, DOI 10.3354/meps11246; Saenz-Arroyo A, 2006, FISH FISH, V7, P128, DOI 10.1111/j.1467-2979.2006.00214.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sampaio I, 2012, J MAR BIOL ASSOC UK, V92, P1547, DOI 10.1017/S0025315412000045; Santangelo G, 2015, HYDROBIOLOGIA, V759, P171, DOI 10.1007/s10750-015-2241-1; Santangelo G, 2003, MAR ECOL PROG SER, V248, P99, DOI 10.3354/meps248099; Santangelo G, 2010, MAR ECOL PROG SER, V418, P295, DOI 10.3354/meps08897; Sartoretto S, 2012, SCI MAR, V76, P349, DOI 10.3989/scimar.03262.16B; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Torrents O, 2005, BIOL CONSERV, V121, P391, DOI 10.1016/j.biocon.2004.05.010; Tozzeti AT, 1880, PESCA NEI MARI ITALI, pXV; Tsounis G, 2007, ECOSYSTEMS, V10, P975, DOI 10.1007/s10021-007-9072-5; Tsounis G, 2006, MAR BIOL, V149, P1059, DOI 10.1007/s00227-006-0302-8; Tsounis G, 2013, MAR POLICY, V39, P361, DOI 10.1016/j.marpol.2012.12.010; Tsounis G, 2010, OCEANOGR MAR BIOL, V48, P161, DOI 10.1201/EBK1439821169-c3; Tursi A, 2004, CHEM ECOL, V20, pS107, DOI 10.1080/02757540310001629170; Vazquez-Rodriguez M, 2012, BIOGEOSCIENCES, V9, P5217, DOI 10.5194/bg-9-5217-2012; Vielzeuf D, 2008, AM MINERAL, V93, P1799, DOI 10.2138/am.2008.2923; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Zibrowius H, 2005, ERLANGEN EARTH C SER, P807, DOI 10.1007/3-540-27673-4_42; ZIBROWIUS H, 1984, Tethys, V11, P163	92	25	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147228	10.1371/journal.pone.0147228	http://dx.doi.org/10.1371/journal.pone.0147228			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800449	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300077
J	Wang, YL; Chen, Q; Zhao, HB; Ren, BZ				Wang, Yinliang; Chen, Qi; Zhao, Hanbo; Ren, Bingzhong			Identification and Comparison of Candidate Olfactory Genes in the Olfactory and Non-Olfactory Organs of Elm Pest Ambrostoma quadriimpressum (Coleoptera: Chrysomelidae) Based on Transcriptome Analysis	PLOS ONE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; PHEROMONE-BINDING-PROTEIN; ODORANT RECEPTOR; ANTENNAL TRANSCRIPTOME; BEETLE; MOSQUITO; NEURONS; EXPRESSION; COMPONENTS; FAMILIES	The leaf beetle Ambrostoma quadriimpressum (Coleoptera: Chrysomelidae) is a predominant forest pest that causes substantial damage to the lumber industry and city management. However, no effective and environmentally friendly chemical method has been discovered to control this pest. Until recently, the molecular basis of the olfactory system in A. quadriimpressum was completely unknown. In this study, antennae and leg transcriptomes were analyzed and compared using deep sequencing data to identify the olfactory genes in A. quadriimpressum. Moreover, the expression profiles of both male and female candidate olfactory genes were analyzed and validated by bioinformatics, motif analysis, homology analysis, semi-quantitative RT-PCR and RT-qPCR experiments in antennal and non-olfactory organs to explore the candidate olfactory genes that might play key roles in the life cycle of A. quadriimpressum. As a result, approximately 102.9 million and 97.3 million clean reads were obtained from the libraries created from the antennas and legs, respectively. Annotation led to 34344 Unigenes, which were matched to known proteins. Annotation data revealed that the number of genes in antenna with binding functions and receptor activity was greater than that of legs. Furthermore, many pathway genes were differentially expressed in the two organs. Sixteen candidate odorant binding proteins (OBPs), 10 chemosensory proteins (CSPs), 34 odorant receptors (ORs), 20 inotropic receptors [ 1] and 2 sensory neuron membrane proteins (SNMPs) and their isoforms were identified. Additionally, 15 OBPs, 9 CSPs, 18 ORs, 6 IRs and 2 SNMPs were predicted to be complete ORFs. Using RT-PCR, RT-qPCR and homology analysis, AquaOBP1/2/4/7/C1/C6, AquaCSP3/9, AquaOR8/9/10/14/15/18/20/26/29/33, AquaIR8a/13/25a showed olfactory-specific expression, indicating that these genes might play a key role in olfaction-related behaviors in A. quadriimpressum such as foraging and seeking. AquaOBP4/C5, AquaOBP4/C5, AquaCSP7/9/10, AquaOR17/24/32 and AquaIR4 were highly expressed in the antenna of males, suggesting that these genes were related to sex-specific behaviors, and expression trends that were male specific were observed for most candidate olfactory genes, which supported the existence of a female-produced sex pheromone in A. quadriim-pressum. All of these results could provide valuable information and guidance for future functional studies on these genes and provide better molecular knowledge regarding the olfactory system in A. quadriimpressum.	[Wang, Yinliang; Chen, Qi; Zhao, Hanbo; Ren, Bingzhong] NE Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Peoples R China; [Wang, Yinliang; Chen, Qi; Zhao, Hanbo; Ren, Bingzhong] NE Normal Univ, MOE, Key Lab Vegetat Ecol, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Ren, BZ (corresponding author), NE Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Peoples R China.; Ren, BZ (corresponding author), NE Normal Univ, MOE, Key Lab Vegetat Ecol, Changchun, Peoples R China.	bzren@163.com	zhao, hanbo/AAO-9409-2020	wang, yinliang/0000-0003-2207-3027	Natural Science Foundation of China [31172133, 31501890]; Natural Science Foundation of Jilin province [2412015KJ017, 20150520072JH]; Fundamental Research Funds for the Central Universities [2412015KJ017]; China Postdoctoral Science Foundation [2015M581385]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by Natural Science Foundation of China (No. 31172133, BZR; 31501890, YLW), Natural Science Foundation of Jilin province (No. 2412015KJ017, BZR; 20150520072JH, YLW), Fundamental Research Funds for the Central Universities (No. 2412015KJ017, YLW), and China Postdoctoral Science Foundation (No. 2015M581385, YLW).	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai MR, 2013, J NEUROSCI, V33, P10741, DOI 10.1523/JNEUROSCI.5419-12.2013; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114238; Cheng B., 2010, THESIS NE FORESTRY U; CHRISTENSEN B, 1988, P NATL ACAD SCI USA, V85, P5072, DOI 10.1073/pnas.85.14.5072; Dahanukar A, 2011, FLY, V5, P58, DOI 10.4161/fly.5.1.13794; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Diakite MM, 2015, CAN ENTOMOL; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FURLONG MJ, 1995, B ENTOMOL RES, V85, P331, DOI 10.1017/S0007485300036051; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Hu J., 2012, THESIS NE FORESTRY U; JERMY T, 1991, ENTOMOL EXP APPL, V59, P75, DOI 10.1007/BF00187968; Koh TW, 2014, NEURON, V83, P850, DOI 10.1016/j.neuron.2014.07.012; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li H, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.57; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121504; Liang CJ, 1990, PESITICIDES, V29, P52; Liu S, 2015, COMP BIOCHEM PHYS D, V13, P44, DOI 10.1016/j.cbd.2015.01.004; Liu Y, 2014, HEILONGJIANG AGR SCI, V4, P167; Liu Yang, 2015, Frontiers in Ecology and Evolution, V3, P60; Lodish HF, 2000, MOL CELL BIOL CITESE; Martini N, 2015, J SPECTROSC, V2015, P1, DOI 10.1155/2015/563763; Mitchell RF, 2012, INSECT BIOCHEM MOLEC, V42, P499, DOI 10.1016/j.ibmb.2012.03.007; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nikonov AA, 2002, CHEM SENSES, V27, P495, DOI 10.1093/chemse/27.6.495; Peng GH, 2001, J CHEM ECOL, V27, P2183, DOI 10.1023/A:1012270602288; Raguso RA, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P83, DOI 10.1017/CBO9780511542268.006; Soroka JJ, 2005, J CHEM ECOL, V31, P1829, DOI 10.1007/s10886-005-5929-2; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TODD JL, 1992, PHYSIOL ENTOMOL, V17, P183, DOI 10.1111/j.1365-3032.1992.tb01198.x; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111	46	20	25	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147144	10.1371/journal.pone.0147144	http://dx.doi.org/10.1371/journal.pone.0147144			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800515	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300062
J	Zhang, YX; Moore, DR; Guiraud, J; Molloy, K; Yan, TT; Amitay, S				Zhang, Yu-Xuan; Moore, David R.; Guiraud, Jeanne; Molloy, Katharine; Yan, Ting-Ting; Amitay, Sygal			Auditory Discrimination Learning: Role of Working Memory	PLOS ONE			English	Article							TRAINING JAPANESE LISTENERS; R-VERTICAL-BAR; CONTRAST DISCRIMINATION; INDIVIDUAL-DIFFERENCES; SPECIFICITY; PERCEPTION; INTERFERENCE; INHIBITION; MECHANISMS; PITCH	Perceptual training is generally assumed to improve perception by modifying the encoding or decoding of sensory information. However, this assumption is incompatible with recent demonstrations that transfer of learning can be enhanced by across-trial variation of training stimuli or task. Here we present three lines of evidence from healthy adults in support of the idea that the enhanced transfer of auditory discrimination learning is mediated by working memory (WM). First, the ability to discriminate small differences in tone frequency or duration was correlated with WM measured with a tone n-back task. Second, training frequency discrimination around a variable frequency transferred to and from WM learning, but training around a fixed frequency did not. The transfer of learning in both directions was correlated with a reduction of the influence of stimulus variation in the discrimination task, linking WM and its improvement to across-trial stimulus interaction in auditory discrimination. Third, while WM training transferred broadly to other WM and auditory discrimination tasks, variable -frequency training on duration discrimination did not improve WM, indicating that stimulus variation challenges and trains WM only if the task demands stimulus updating in the varied dimension. The results provide empirical evidence as well as a theoretic framework for interactions between cognitive and sensory plasticity during perceptual experience.	[Zhang, Yu-Xuan; Moore, David R.; Guiraud, Jeanne; Molloy, Katharine; Amitay, Sygal] MRC, Inst Hearing Res, Univ Pk, Nottingham, England; [Zhang, Yu-Xuan; Yan, Ting-Ting] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Yu-Xuan; Yan, Ting-Ting] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Zhang, Yu-Xuan] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Moore, David R.] Cincinnati Childrens Hosp Med Ctr, Commun Sci Res Ctr, Cincinnati, OH 45229 USA; [Guiraud, Jeanne] Univ London, Dept Psychol, Egham, Surrey, England; [Molloy, Katharine] UCL, Inst Cognit Neurosci, London, England	University of Nottingham; Beijing Normal University; Beijing Normal University; Beijing Normal University; Cincinnati Children's Hospital Medical Center; University of London; Royal Holloway University London; University of London; University College London	Zhang, YX (corresponding author), MRC, Inst Hearing Res, Univ Pk, Nottingham, England.; Zhang, YX (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.; Zhang, YX (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China.; Zhang, YX (corresponding author), Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China.	zhangyuxuan@bnu.edu.cn			Medical Research Council (UK) [U135097130]; Medical Research Council [MC_U135097130] Funding Source: researchfish; MRC [MC_U135097130] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by the Medical Research Council (UK) Grant U135097130 as part of core funding to the Institute of Hearing Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini Y, 2004, J VISION, V4, P993, DOI 10.1167/4.12.2; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Amitay S, 2005, PERCEPT PSYCHOPHYS, V67, P691, DOI 10.3758/BF03193525; Amitay S, 2014, VISION RES, V99, P69, DOI 10.1016/j.visres.2013.11.006; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Banai K, 2012, VISION RES, V61, P83, DOI 10.1016/j.visres.2012.01.009; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P977, DOI 10.3758/BF03206911; BRAIDA LD, 1984, J ACOUST SOC AM, V76, P722, DOI 10.1121/1.391258; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Deary LJ, 2004, AM J PSYCHOL, V117, P1, DOI 10.2307/1423593; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Irvine DRF, 2000, J ACOUST SOC AM, V108, P2964, DOI 10.1121/1.1323465; Iverson P, 2005, J ACOUST SOC AM, V118, P3267, DOI 10.1121/1.2062307; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Jeter PE, 2010, VISION RES, V50, P1928, DOI 10.1016/j.visres.2010.06.016; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; KEPPEL G, 1962, J EXP PSYCHOL, V64, P400, DOI 10.1037/h0040424; Kleiner M, 2007, PERCEPTION, V36, P14; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LIVELY SE, 1993, J ACOUST SOC AM, V94, P1242, DOI 10.1121/1.408177; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Lu ZL, 2010, VISION RES, V50, P375, DOI 10.1016/j.visres.2009.08.027; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Mollon JD, 1996, SPATIAL VISION, V10, P51, DOI 10.1163/156856896X00051; Molloy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036929; Moore B., 2003, INTRO PSYCHOL HEARIN; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Oberauer K, 2005, J EXP PSYCHOL GEN, V134, P368, DOI 10.1037/0096-3445.134.3.368; PECHMANN T, 1992, MEM COGNITION, V20, P314, DOI 10.3758/BF03199668; Roberts R, 2002, J PSYCHOLINGUIST RES, V31, P573, DOI 10.1023/A:1021213004302; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Thorndike EL, 1909, AM J PSYCHOL, V20, P364, DOI 10.2307/1413366; Troche SJ, 2014, INTELLIGENCE, V44, P40, DOI 10.1016/j.intell.2014.02.009; WATSON CS, 1980, ANN OTO RHINOL LARYN, V89, P96; Webb BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001323; Wechsler D, 1997, ADM SCORING GUIDE WA, V3; Wechsler D., 2012, WAIS 4 KASIKIRJA; Wright BA, 2010, J NEUROSCI, V30, P12868, DOI 10.1523/JNEUROSCI.0487-10.2010; Wright BA, 2010, J NEUROSCI, V30, P11635, DOI 10.1523/JNEUROSCI.1441-10.2010; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262; Yu C, 2004, J VISION, V4, P169, DOI 10.1167/4.3.4; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010	54	23	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147320	10.1371/journal.pone.0147320	http://dx.doi.org/10.1371/journal.pone.0147320			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799068	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300095
J	Guo, BY; Amano, Y; Nozaki, K				Guo, Boyang; Amano, Yoshihiko; Nozaki, Kouichi			Improvements in Glucose Sensitivity and Stability of Trichoderma reesei beta-Glucosidase Using Site-Directed Mutagenesis	PLOS ONE			English	Article							TERMITE NEOTERMES-KOSHUNENSIS; MICROBIAL METAGENOME; ASPERGILLUS-ORYZAE; TOLERANT; CLONING; PURIFICATION; EXPRESSION; CELLULASE; XYLOSE	Glucose sensitivity and pH and thermal stabilities of Trichoderma reesei Cel1A (Bgl II) were improved by site-directed mutagenesis of only two amino acid residues (L167W or P172L) at the entrance of the active site. The Cel1A mutant showed high glucose tolerance (50% of inhibitory concentration = 650 mM), glucose stimulation (2.0 fold at 50 mM glucose), and enhanced specific activity (2.4-fold) compared with those of the wild-type Cel1A. Furthermore, the mutant enzyme showed stability at a wide pH range of 4.5-9.0 and possessed high thermal stability up to 50 degrees C with 80% of the residual activities compared with the stability seen at the pH range of 6.5-7.0 and temperatures of up to 40 degrees C in the wild-type Cel1A. Kinetic studies for hydrolysis revealed that the Cel1A mutant was competitively inhibited by glucose at similar levels as the wild-type enzyme. Additionally, the mutant enzyme exhibited substrate inhibition, which gradually disappeared with an increasing glucose concentration. These data suggest that the glucose stimulation was caused by relieve the substrate inhibition in the presence of glucose. To conclude, all the properties improved by the mutagenesis would be great advantages in degradation of cellulosic biomass together with cellulases.	[Guo, Boyang; Amano, Yoshihiko; Nozaki, Kouichi] Shinshu Univ, Dept Biosci & Text Technol, Interdisciplinary Grad Sch Sci & Technol, Nagano, Japan	Shinshu University	Nozaki, K (corresponding author), Shinshu Univ, Dept Biosci & Text Technol, Interdisciplinary Grad Sch Sci & Technol, Nagano, Japan.	knoza@shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; New Energy and Industrial Technology Development Organization (NEDO), from the Ministry of Economy, Trade and Industry of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO), from the Ministry of Economy, Trade and Industry of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the Grant-in-Aid for the Global COE Program by the Ministry of Education, Culture, Sports, Science and Technology of Japan and was also sponsored by the New Energy and Industrial Technology Development Organization (NEDO), from the Ministry of Economy, Trade and Industry of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-014-0090-3; BARNETT CC, 1991, BIO-TECHNOL, V9, P562, DOI 10.1038/nbt0691-562; de Giuseppe PO, 2014, ACTA CRYSTALLOGR D, V70, P1631, DOI 10.1107/S1399004714006920; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Fang ZM, 2010, J MICROBIOL BIOTECHN, V20, P1351, DOI 10.4014/jmb.1003.03011; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; KUBICEK CP, 1987, J GEN MICROBIOL, V133, P1481; Lee HL, 2012, PROTEIN ENG DES SEL, V25, P733, DOI 10.1093/protein/gzs073; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu J, 2013, ACTA BIOCH BIOPH SIN, V45, P664, DOI 10.1093/abbs/gmt061; Mai ZM, 2013, APPL BIOCHEM BIOTECH, V169, P1512, DOI 10.1007/s12010-012-0080-3; MANDELS M, 1962, J BACTERIOL, V83, P400, DOI 10.1128/JB.83.2.400-408.1962; Michaelis L, 1913, BIOCHEM Z, V49, P333; Souza FHM, 2013, J MOL CATAL B-ENZYM, V94, P119, DOI 10.1016/j.molcatb.2013.05.012; Souza FHM, 2010, PROCESS BIOCHEM, V45, P272, DOI 10.1016/j.procbio.2009.09.018; Nakazawa H, 2012, BIOTECHNOL BIOENG, V109, P92, DOI 10.1002/bit.23296; Nascimento CV, 2010, J MICROBIOL, V48, P53, DOI 10.1007/s12275-009-0159-x; Pei JJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-31; Rahman Z, 2009, BIOSCI BIOTECH BIOCH, V73, P1083, DOI 10.1271/bbb.80852; Ramani G, 2015, J IND MICROBIOL BIOT, V42, P553, DOI 10.1007/s10295-014-1549-6; Riou C, 1998, APPL ENVIRON MICROB, V64, P3607; Saha BC, 1996, APPL ENVIRON MICROB, V62, P3165, DOI 10.1128/AEM.62.9.3165-3170.1996; Saloheimo M, 2002, APPL ENVIRON MICROB, V68, P4546, DOI 10.1128/AEM.68.9.4546-4553.2002; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-105; Treebupachatsakul T, 2016, J BIOSCI BIOENG, V121, P27, DOI 10.1016/j.jbiosc.2015.05.002; Treebupachatsakul T, 2015, J BIOSCI BIOENG, V120, P657, DOI 10.1016/j.jbiosc.2015.04.015; Uchima CA, 2011, APPL MICROBIOL BIOT, V89, P1761, DOI 10.1007/s00253-010-2963-y; Uchiyama T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00548; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Wang BB, 2011, BIORESOURCE TECHNOL, V102, P4568, DOI 10.1016/j.biortech.2010.12.099; Yang F, 2015, APPL MICROBIOL BIOT, V99, P8903, DOI 10.1007/s00253-015-6619-9; Zanoelo FF, 2004, FEMS MICROBIOL LETT, V240, P137, DOI 10.1016/j.femsle.2004.09.021	33	45	47	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147301	10.1371/journal.pone.0147301	http://dx.doi.org/10.1371/journal.pone.0147301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790148	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100073
J	Kitahara, Y; Ohta, K; Hasuo, H; Shuto, T; Kuroiwa, M; Sotogaku, N; Togo, A; Nakamura, K; Nishi, A				Kitahara, Yosuke; Ohta, Keisuke; Hasuo, Hiroshi; Shuto, Takahide; Kuroiwa, Mahomi; Sotogaku, Naoki; Togo, Akinobu; Nakamura, Kei-ichiro; Nishi, Akinori			Chronic Fluoxetine Induces the Enlargement of Perforant Path-Granule Cell Synapses in the Mouse Dentate Gyrus	PLOS ONE			English	Article							DEPENDENT STRUCTURAL PLASTICITY; SCANNING-ELECTRON-MICROSCOPY; DENDRITIC SPINES; HIPPOCAMPAL NEUROGENESIS; PROTEIN-SYNTHESIS; MATURATION; INCREASES; TRKB; DIFFERENTIATION; RELEASE	A selective serotonin reuptake inhibitor is the most commonly prescribed antidepressant for the treatment of major depression. However, the mechanisms underlying the actions of selective serotonin reuptake inhibitors are not fully understood. In the dentate gyrus, chronic fluoxetine treatment induces increased excitability of mature granule cells (GCs) as well as neurogenesis. The major input to the dentate gyrus is the perforant path axons (boutons) from the entorhinal cortex (layer II). Through voltage-sensitive dye imaging, we found that the excitatory neurotransmission of the perforant path synapse onto the GCs in the middle molecular layer of the mouse dentate gyrus (perforant path-GC synapse) is enhanced after chronic fluoxetine treatment (15 mg/kg/day, 14 days). Therefore, we further examined whether chronic fluoxetine treatment affects the morphology of the perforant path-GC synapse, using FIB/SEM (focused ion beam/scanning electron microscopy). A three-dimensional reconstruction of dendritic spines revealed the appearance of extremely large-sized spines after chronic fluoxetine treatment. The large-sized spines had a postsynaptic density with a large volume. However, chronic fluoxetine treatment did not affect spine density. The presynaptic boutons that were in contact with the large-sized spines were large in volume, and the volumes of the mitochondria and synaptic vesicles inside the boutons were correlated with the size of the boutons. Thus, the large-sized perforant path-GC synapse induced by chronic fluoxetine treatment contains synaptic components that correlate with the synapse size and that may be involved in enhanced glutamatergic neurotransmission.	[Kitahara, Yosuke; Shuto, Takahide; Kuroiwa, Mahomi; Sotogaku, Naoki; Nishi, Akinori] Kurume Univ, Sch Med, Dept Pharmacol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan; [Ohta, Keisuke; Togo, Akinobu; Nakamura, Kei-ichiro] Kurume Univ, Sch Med, Dept Anat, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan; [Hasuo, Hiroshi] Kurume Univ, Sch Med, Dept Physiol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan	Kurume University; Kurume University; Kurume University	Nishi, A (corresponding author), Kurume Univ, Sch Med, Dept Pharmacol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	nishia@med.kurume-u.ac.jp	Ohta, Keisuke/GSD-8525-2022	Ohta, Keisuke/0000-0002-2040-5297	CREST of Japan Science and Technology Agency; JSPS [26293040]	CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a grant from CREST of Japan Science and Technology Agency (to AN) and JSPS Grant-in-Aid for Scientific Research (B) 26293040 (to KN, KO, AT).	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Ampuero E, 2010, NEUROSCIENCE, V169, P98, DOI 10.1016/j.neuroscience.2010.04.035; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Baj G, 2012, NEUROPSYCHOPHARMACOL, V37, P1600, DOI 10.1038/npp.2012.5; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bosch C, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.2015.00060, 10.3389/fnana.7015.00060]; Bourne JN, 2013, J COMP NEUROL, V521, P3898, DOI 10.1002/cne.23384; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; Calabrese F., 2009, PSYCHONEUROENDOCRINO, V34, pS208, DOI DOI 10.1016/J.PSYNEUEN.2009.05.014; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dringenberg HC, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/571285; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; EBNER TJ, 1995, PROG NEUROBIOL, V46, P463, DOI 10.1016/0301-0082(95)00010-S; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Greenwood JSF, 2009, ANN NEUROL, V66, P644, DOI 10.1002/ana.21775; Hajszan T, 2005, EUR J NEUROSCI, V21, P1299, DOI 10.1111/j.1460-9568.2005.03968.x; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HAMA K, 1989, J ELECTRON MICR TECH, V12, P80, DOI 10.1002/jemt.1060120203; Hasuo H, 2013, J KURUME MED ASS, V76, P126; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Holtzheimer PE, 2011, TRENDS NEUROSCI, V34, P1, DOI 10.1016/j.tins.2010.10.004; Huang GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035901; Jiang CG, 2002, TRENDS BIOCHEM SCI, V27, P506, DOI 10.1016/S0968-0004(02)02190-4; Johnson-Venkatesh EM, 2010, EUR J NEUROSCI, V32, P181, DOI 10.1111/j.1460-9568.2010.07338.x; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; KONNERTH A, 1987, J PHYSIOL-LONDON, V393, P681, DOI 10.1113/jphysiol.1987.sp016848; Korkotian E, 2000, HIPPOCAMPUS, V10, P587, DOI 10.1002/1098-1063(2000)10:5<587::AID-HIPO9>3.0.CO;2-C; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lin MY, 2015, EXP CELL RES, V334, P35, DOI 10.1016/j.yexcr.2015.01.004; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McAvoy K, 2015, HIPPOCAMPUS, V25, P1429, DOI 10.1002/hipo.22464; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Ohno N, 2015, MICROSCOPY-JPN, V64, P17, DOI 10.1093/jmicro/dfu112; Ohta K, 2012, MICRON, V43, P612, DOI 10.1016/j.micron.2011.11.001; Pasaoglu T, 2016, HIPPOCAMPUS, V26, P151, DOI 10.1002/hipo.22499; Pilar-Cuellar F, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/537265; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Popov VI, 2009, SYNAPSE, V63, P369, DOI 10.1002/syn.20613; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Ramiro-Cortes Y, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0157; Rantamaki T, 2016, PROG NEURO-PSYCHOPH, V64, P285, DOI 10.1016/j.pnpbp.2015.06.001; Rollenhagen A, 2015, BRAIN STRUCT FUNCT, V220, P3185, DOI 10.1007/s00429-014-0850-5; Rubio FJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00066; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schikorski T, 1997, J NEUROSCI, V17, P5858; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Stahl S, 2009, STAHLS ILLUSTRATED A; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; Takeya Mitsue, 2001, Kurume Medical Journal, V48, P205; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; WALTON J, 1979, J HISTOCHEM CYTOCHEM, V27, P1337, DOI 10.1177/27.10.512319; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	71	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147307	10.1371/journal.pone.0147307	http://dx.doi.org/10.1371/journal.pone.0147307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788851	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100075
J	Liu, XG; Xu, H; Ma, ZJ; Zhang, YJ; Tian, CF; Cheng, GF; Zou, HS; Lu, SM; Liu, SJ; Tang, R				Liu, Xingguo; Xu, Hao; Ma, Zhuojun; Zhang, Yongjun; Tian, Changfeng; Cheng, Guofeng; Zou, Haisheng; Lu, Shimin; Liu, Shijing; Tang, Rong			Design and Application of a Solar Mobile Pond Aquaculture Water Quality-Regulation Machine Based in Bream Pond Aquaculture	PLOS ONE			English	Article							PHOSPHORUS; SEDIMENTS	Bream pond aquaculture plays a very important role in China's aquaculture industry and is the main source of aquatic products. To regulate and control pond water quality and sediment, a movable solar pond aquaculture water quality regulation machine (SMWM) was designed and used. This machine is solar-powered and moves on water, and its primary components are a solar power supply device, a sediment lifting device, a mechanism for walking on the water's surface and a control system. The solar power supply device provides power for the machine, and the water walking mechanism drives the machine's motion on the water. The sediment lifting device orbits the main section of the machine and affects a large area of the pond. Tests of the machine's mechanical properties revealed that the minimum illumination necessary for the SMWM to function is 13,000 Lx and that its stable speed on the water is 0.02-0.03 m/s. For an illumination of 13,000-52,500 Lx, the sediment lifting device runs at 0.13-0.35 m/s, and its water delivery capacity is 110-208 m(3)/h. The sediment lifting device is able to fold away, and the angle of the suction chamber can be adjusted, making the machine work well in ponds at different water depths from 0.5 m to 2 m. The optimal distance from the sediment lifting device to the bottom of the pond is 10-15 cm. In addition, adjusting the length of the connecting rod and the direction of the traction rope allows the SMWM to work in a pond water area greater than 80%. The analysis of water quality in Wuchang bream (Parabramis pekinensis) and silver carp (Hypophthalmichthys molitrix) culture ponds using the SMWM resulted in decreased NH3+-N and available phosphorus concentrations and increased TP concentrations. The TN content and the amount of available phosphorus in the sediment were reduced. In addition, the fish production showed that the SMWM enhanced the yields of Wuchang bream and silver carp by more than 30% and 24%, respectively. These results indicate that the SMWM may be suitable for Wuchang bream pond aquaculture in China and that it can be used in pond aquaculture for regulating and controlling water quality.	[Liu, Xingguo; Xu, Hao; Ma, Zhuojun; Tian, Changfeng; Cheng, Guofeng; Lu, Shimin] Minist Agr, Key Lab Fishery Equipment & Engn, Shanghai 200092, Peoples R China; [Liu, Xingguo; Xu, Hao; Zhang, Yongjun; Tian, Changfeng; Cheng, Guofeng; Zou, Haisheng; Liu, Shijing; Tang, Rong] Chinese Acad Fishery Sci, Fishery Machinery & Instrument Inst, Shanghai 200092, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Fishery Machinery & Instrument Research Institute, CAFS	Liu, XG (corresponding author), Minist Agr, Key Lab Fishery Equipment & Engn, Shanghai 200092, Peoples R China.; Liu, XG (corresponding author), Chinese Acad Fishery Sci, Fishery Machinery & Instrument Inst, Shanghai 200092, Peoples R China.	liuxingguo@fmiri.ac.cn			National \ Science Foundation of China NSFC [31372570]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2012BAD25B01]; National Science Foundation of China NSFC [31372570]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (in China) [2012BAD25B01]	National \ Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program during the Twelfth Five-year Plan Period; National Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (in China)	Dr. XGL received a grant by the National vertical bar Science Foundation of China NSFC(31372570) and Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAD25B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work were supported by the National Science Foundation of China NSFC (31372570) and Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAD25B01) (in China).	[Anonymous], 983788 GB UDC; Boyd CE, 1995, HANDBOOK, P1; [蔡惠凤 CAI Huifeng], 2006, [中国水产科学, Journal of Fishery Sciences of China], V13, P140; Diaz-Espejo A, 1999, HYDROBIOLOGIA, V392, P21, DOI 10.1023/A:1003557408640; Editorial Board of Monitoring and Analytical Method of Water and Wastewater State Environmental Protection Administration of China, 2002, MON AN METH WAT WAST; Ekka SA, 2006, ECOL ENG, V26, P375, DOI 10.1016/j.ecoleng.2006.01.002; Honglu Y, 2010, STUDY ECOLOGY INTEGR, P138; Imai Masae, 1997, Phycological Research, V45, P233, DOI 10.1111/j.1440-1835.1997.tb00082.x; Jiang XL, 2006, AQUACULT ENG, V35, P147, DOI 10.1016/j.aquaeng.2005.10.002; Jin XC, 2006, ENVIRON POLLUT, V139, P288, DOI 10.1016/j.envpol.2005.05.010; Lake BA, 2007, SCI TOTAL ENVIRON, V373, P534, DOI 10.1016/j.scitotenv.2006.12.021; [李柯 Li Ke], 2010, [地理科学进展, Progress in Geography], V29, P1049; Liu XingGuo, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P1; [苗爽 Miao Shuang], 2011, [吉林农业科学, Journal of Jilin Agricultural Sciences], V36, P17; National Bureau of Statistics of China, 2014, CHIN FISH STAT YB, P36; Shidan B, 2000, SOIL AGR CHEM ANAL, P39; Shrestha MK, 1997, J I AGR ANIMAL SCI, V117, P1; Tian ChangFeng, 2013, Journal of Shanghai Ocean University, V22, P616; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; [王春德 Wang Chunde], 2012, [生命科学研究, Life Science Research], V16, P345; Wei L, 2014, J NATURAL SCI HEILON, V31, P646; Wu W, 2000, SCI FISH CULTURE PRO, P136; Xingguo L, 2011, STUDY FRESHWATER PON, P20; Yoo JH, 2006, ECOL ENG, V27, P109, DOI 10.1016/j.ecoleng.2005.12.001; Zhaohui W, 1999, CHINESE J APPL ECOLO, V10, P345	25	3	3	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146637	10.1371/journal.pone.0146637	http://dx.doi.org/10.1371/journal.pone.0146637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789004	gold, Green Submitted, Green Published			2022-12-26	WOS:000368529100035
J	Onouchi, Y; Fukazawa, R; Yamamura, K; Suzuki, H; Kakimoto, N; Suenaga, T; Takeuchi, T; Hamada, H; Honda, T; Yasukawa, K; Terai, M; Ebata, R; Higashi, K; Saji, T; Kemmotsu, Y; Takatsuki, S; Ouchi, K; Kishi, F; Yoshikawa, T; Nagai, T; Hamamoto, K; Sato, Y; Honda, A; Kobayashi, H; Sato, J; Shibuta, S; Miyawaki, M; Oishi, K; Yamaga, H; Aoyagi, N; Yoshiyama, M; Miyashita, R; Murata, Y; Fujino, A; Ozaki, K; Kawasaki, T; Abe, J; Seki, M; Kobayashi, T; Arakawa, H; Ogawa, S; Hara, T; Hata, A; Tanaka, T				Onouchi, Yoshihiro; Fukazawa, Ryuji; Yamamura, Kenichiro; Suzuki, Hiroyuki; Kakimoto, Nobuyuki; Suenaga, Tomohiro; Takeuchi, Takashi; Hamada, Hiromichi; Honda, Takafumi; Yasukawa, Kumi; Terai, Masaru; Ebata, Ryota; Higashi, Kouji; Saji, Tsutomu; Kemmotsu, Yasushi; Takatsuki, Shinichi; Ouchi, Kazunobu; Kishi, Fumio; Yoshikawa, Tetsushi; Nagai, Toshiro; Hamamoto, Kunihiro; Sato, Yoshitake; Honda, Akihito; Kobayashi, Hironobu; Sato, Junichi; Shibuta, Shoichi; Miyawaki, Masakazu; Oishi, Ko; Yamaga, Hironobu; Aoyagi, Noriyuki; Yoshiyama, Megumi; Miyashita, Ritsuko; Murata, Yuji; Fujino, Akihiro; Ozaki, Kouichi; Kawasaki, Tomisaku; Abe, Jun; Seki, Mitsuru; Kobayashi, Tohru; Arakawa, Hirokazu; Ogawa, Shunichi; Hara, Toshiro; Hata, Akira; Tanaka, Toshihiro			Variations in ORAI1 Gene Associated with Kawasaki Disease	PLOS ONE			English	Article							INTERACTION MOLECULE-1 STIM1; CRAC CHANNEL; CALCIUM SENSOR; NUCLEAR-FACTOR; PORE SUBUNIT; STORE; ACTIVATION; RELEASE; CELLS; ENTRY	Kawasaki disease (KD; MIM#61175) is a systemic vasculitis syndrome with unknown etiology which predominantly affects infants and children. Recent findings of susceptibility genes for KD suggest possible involvement of the Ca2+/NFAT pathway in the pathogenesis of KD. ORAI1 is a Ca2+ release activated Ca2+ (CRAC) channel mediating store-operated Ca2+ entry (SOCE) on the plasma membrane. The gene for ORAI1 is located in chromosome 12q24 where a positive linkage signal was observed in our previous affected sib-pair study of KD. A common non-synonymous single nucleotide polymorphism located within exon 2 of ORAI1 (rs3741596) was significantly associated with KD (P = 0.028 in the discovery sample set (729 KD cases and 1,315 controls), P = 0.0056 in the replication sample set (1,813 KD cases vs. 1,097 controls) and P = 0.00041 in a meta-analysis by the Mantel-Haenszel method). Interestingly, frequency of the risk allele of rs3741596 is more than 20 times higher in Japanese compared to Europeans. We also found a rare 6 base-pair in-frame insertion variant associated with KD (rs141919534; 2,544 KD cases vs. 2,414 controls, P = 0.012). These data indicate that ORAI1 gene variations are associated with KD and may suggest the potential importance of the Ca2+'/NFAT pathway in the pathogenesis of this disorder.	[Onouchi, Yoshihiro; Ozaki, Kouichi; Tanaka, Toshihiro] RIKEN, Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Fukazawa, Ryuji; Ogawa, Shunichi] Nippon Med Sch, Dept Pediat, 1-1-5 Sendagi, Tokyo 113, Japan; [Yamamura, Kenichiro; Hara, Toshiro] Kyushu Univ, Dept Pediat, Grad Sch Med Sci, Fukuoka 812, Japan; [Suzuki, Hiroyuki; Kakimoto, Nobuyuki; Suenaga, Tomohiro; Takeuchi, Takashi] Wakayama Med Univ, Dept Pediat, Wakayama, Japan; [Hamada, Hiromichi; Honda, Takafumi; Yasukawa, Kumi; Terai, Masaru] Tokyo Womens Med Univ Yachiyo, Med Ctr, Dept Pediat, Yachiyo, Japan; [Ebata, Ryota] Chiba Univ, Dept Pediat, Grad Sch Med, Chiba, Japan; [Higashi, Kouji] Chiba Childrens Hosp, Dept Cardiol, Chiba, Japan; [Saji, Tsutomu; Kemmotsu, Yasushi; Takatsuki, Shinichi] Toho Univ, Dept Pediat, Med Ctr, Omori Hosp, Tokyo, Japan; [Ouchi, Kazunobu] Kawasaki Med Sch, Dept Pediat, Kurashiki, Okayama, Japan; [Kishi, Fumio] Kawasaki Med Sch, Dept Mol Genet, Kurashiki, Okayama, Japan; [Yoshikawa, Tetsushi] Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi, Japan; [Nagai, Toshiro] Dokkyo Med Univ, Dept Pediat, Koshigaya Hosp, Koshigaya, Japan; [Hamamoto, Kunihiro] Int Univ Hlth & Welf, Dept Occupat Therapy, Okawa, Japan; [Sato, Yoshitake] Fuji Heavy Ind Hlth Insurance Soc Ota Mem Hosp, Dept Pediat, Ota, Japan; [Honda, Akihito; Kobayashi, Hironobu] Asahi Gen Hosp, Dept Pediat, Asahi, Japan; [Sato, Junichi] Funabashi Municipal Med Ctr, Dept Pediat, Funabashi, Chiba, Japan; [Shibuta, Shoichi; Miyawaki, Masakazu] Kinan Hosp, Dept Pediat, Tanabe, Japan; [Oishi, Ko] Hashimoto Municipal Hosp, Dept Pediat, Hashimoto, Japan; [Yamaga, Hironobu] Naga Hosp, Dept Pediat, Kinokawa, Japan; [Aoyagi, Noriyuki] Wakayama Rosai Hosp, Dept Pediat, Wakayama, Japan; [Yoshiyama, Megumi] Hidaka Gen Hosp, Dept Pediat, Gobo, Japan; [Miyashita, Ritsuko] Izumiotsu Municipal Hosp, Dept Pediat, Izumiotsu, Japan; [Murata, Yuji] Sendai City Hosp, Dept Pediat, Sendai, Miyagi, Japan; [Fujino, Akihiro] Keio Univ, Sch Med, Dept Pediat Surg, Tokyo, Japan; [Kawasaki, Tomisaku] Japan Kawasaki Dis Res Ctr, Tokyo, Japan; [Abe, Jun] Natl Ctr Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Seki, Mitsuru; Arakawa, Hirokazu] Gunma Univ, Sch Med, Dept Pediat, Maebashi, Gunma 371, Japan; [Kobayashi, Tohru] Natl Ctr Child Hlth & Dev, Dept Dev Strategy, Ctr Clin Res & Dev, Tokyo, Japan; [Hata, Akira] Chiba Univ, Dept Publ Hlth, Grad Sch Med, Chiba, Japan; [Tanaka, Toshihiro] Tokyo Med & Dent Univ, Dept Human Genet & Dis Div, Tokyo, Japan; [Hara, Toshiro] Fukuoka Childrens Hosp, Fukuoka, Japan; [Hara, Toshiro] Med Ctr Infect Dis, Fukuoka, Japan	RIKEN; Nippon Medical School; Kyushu University; Wakayama Medical University; Chiba University; Chiba Children's Hospital; Toho University; Kawasaki Medical School; Kawasaki Medical School; Fujita Health University; Dokkyo Medical University; International University of Health & Welfare; Keio University; National Center for Child Health & Development - Japan; Gunma University; National Center for Child Health & Development - Japan; Chiba University; Tokyo Medical & Dental University (TMDU)	Onouchi, Y (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan.	onouchy@chiba-u.jp	Ebata, Ryota/AAQ-5832-2021; Fujino, Akihiro/AAH-2243-2019; Sato, Yurie/B-2144-2014	Ebata, Ryota/0000-0001-8471-1042; Fujino, Akihiro/0000-0003-2987-5081; Ozaki, Kouichi/0000-0003-0028-1570	Millennium Project; Japan Kawasaki Disease Research Center; Ministry of Health, Labour and Welfare [0401040]; Japan Society for the Promotion of Science [25293139]; Grants-in-Aid for Scientific Research [26461624] Funding Source: KAKEN	Millennium Project; Japan Kawasaki Disease Research Center; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Millennium Project (http://www.kantei.go.jp/jp/mille/), Japan Kawasaki Disease Research Center (http://www.kawasaki-disease.org/) [2011 to YO], the Ministry of Health, Labour and Welfare [0401040 to A. Hata] and Japan Society for the Promotion of Science (https://www.jsps.go.jp/index.html) [25293139 to YO].	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Baba Y, 2011, TRENDS IMMUNOL, V32, P589, DOI 10.1016/j.it.2011.09.004; Bergmeier W, 2013, CHANNELS, V7, P379, DOI 10.4161/chan.24302; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Burns JC, 2002, PEDIATR INFECT DIS J, V21, P993, DOI 10.1097/00006454-200211000-00002; Chang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029387; Chou YH, 2011, J UROLOGY, V185, P1742, DOI 10.1016/j.juro.2010.12.094; DAVIS RL, 1995, ARCH PEDIAT ADOL MED, V149, P66, DOI 10.1001/archpedi.1995.02170130068016; Deveci M, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-74, 10.1186/1471-2105-15-73]; Felix R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061595; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; FUJITA Y, 1989, PEDIATRICS, V84, P666; FURUSHO K, 1983, LANCET, V2, P1359; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Holman Robert C, 2010, Hawaii Med J, V69, P194; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; Kawasaki T, 1967, Arerugi, V16, P178; Kuo HC, 2011, J CLIN IMMUNOL, V31, P650, DOI 10.1007/s10875-011-9524-8; LEUNG DYM, 1989, J ALLERGY CLIN IMMUN, V84, P588, DOI 10.1016/0091-6749(89)90195-4; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Maul-Pavicic A, 2011, P NATL ACAD SCI USA, V108, P3324, DOI 10.1073/pnas.1013285108; McCarl CA, 2010, J IMMUNOL, V185, P5845, DOI 10.4049/jimmunol.1001796; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2007, J HUM GENET, V52, P179, DOI 10.1007/s10038-006-0092-3; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Sogkas G, 2015, EUR J IMMUNOL, V45, P2143, DOI 10.1002/eji.201445337; Steinckwich N, 2011, J IMMUNOL, V186, P2182, DOI 10.4049/jimmunol.1001338; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Takahashi K, 2005, PEDIATR INT, V47, P305, DOI 10.1111/j.1442-200x.2005.02049.x; Tolhurst G, 2008, PLATELETS, V19, P308, DOI 10.1080/09537100801935710; Uehara R, 2004, ARCH PEDIAT ADOL MED, V158, P1166, DOI 10.1001/archpedi.158.12.1166; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wang JY, 2015, ONCOGENE, V34, P4358, DOI 10.1038/onc.2014.366; Wang JY, 2012, CELL SIGNAL, V24, P162, DOI 10.1016/j.cellsig.2011.08.017; Wei JCC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020426; Wu WF, 2006, J BIOL CHEM, V281, P10682, DOI 10.1074/jbc.M511759200; Yen JH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/834831; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang H, 2014, BLOOD, V123, P2238, DOI 10.1182/blood-2012-08-450403; Zhang L, 2015, ASIAN J ANDROL, V17, P86, DOI 10.4103/1008-682X.138186; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou MH, 2014, J BIOL CHEM, V289, P29446, DOI 10.1074/jbc.M114.578492; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	52	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145486	10.1371/journal.pone.0145486	http://dx.doi.org/10.1371/journal.pone.0145486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789410	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100010
J	Riess, K; Schon, ME; Lutz, M; Butin, H; Oberwinkler, F; Garnica, S				Riess, Kai; Schoen, Max E.; Lutz, Matthias; Butin, Heinz; Oberwinkler, Franz; Garnica, Sigisfredo			On the Evolutionary History of Uleiella chilensis, a Smut Fungus Parasite of Araucaria araucana in South America: Uleiellales ord. nov in Ustilaginomycetes	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; NUCLEAR; MUSHROOMS; SEQUENCES; INFERENCE; RNA; SPECIATION; INOCYBE; SCALE; GENUS	The evolutionary history, divergence times and phylogenetic relationships of Uleiella chilensis (Ustilaginomycotina, smut fungi) associated with Araucaria araucana were analysed. DNA sequences from multiple gene regions and morphology were analysed and compared to other members of the Basidiomycota to determine the phylogenetic placement of smut fungi on gymnosperms. Divergence time estimates indicate that the majority of smut fungal orders diversified during the Triassic-Jurassic period. However, the origin and relationships of several orders remain uncertain. The most recent common ancestor between Uleiella chilensis and Violaceomyces palustris has been dated to the Lower Cretaceous. Comparisons of divergence time estimates between smut fungi and host plants lead to the hypothesis that the early Ustilaginomycotina had a saprobic lifestyle. As there are only two extant species of Araucaria in South America, each hosting a unique Uleiella species, we suggest that either coevolution or a host shift followed by allopatric speciation are the most likely explanations for the current geographic restriction of Uleiella and its low diversity. Phylogenetic and age estimation analyses, ecology, the unusual life-cycle and the peculiar combination of septal and haustorial characteristics support Uleiella chilensis as a distinct lineage among the Ustilaginomycotina. Here, we describe a new ustilaginomycetous order, the Uleiellales to accommodate Uleiella. Within the Ustilaginomycetes, Uleiellales are sister taxon to the Violaceomycetales.	[Riess, Kai; Schoen, Max E.; Lutz, Matthias; Oberwinkler, Franz; Garnica, Sigisfredo] Univ Tubingen, Inst Evolut & Ecol, Plant Evolutionary Ecol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Garnica, S (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Plant Evolutionary Ecol, Morgenstelle 5, D-72076 Tubingen, Germany.	sigisfredo.garnica@uni-tuebingen.de	Riess, Kai/B-5491-2015; Sigisfredo, Garnica/P-6506-2014	Riess, Kai/0000-0002-8804-0175; Schon, Max Emil/0000-0002-4453-4173; Lutz, Matthias/0000-0002-0938-1079	German Research Foundation (DFG) [BA 75/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG), grant BA 75/3-1.	Albu S, 2015, MYCOLOGIA, V107, P1193, DOI 10.3852/14-260; Amend A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004277; [Anonymous], 2002, SE AL SEQUENCE ALIGN; Axsmith BJ, 2008, PALAEONTOL ELECTRON, V11; Bauer R, 2005, MYCOL RES, V109, P1250, DOI 10.1017/S0953756205003783; Bauer R, 1999, MYCOLOGIA, V91, P669, DOI 10.2307/3761254; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; Bauer R, 1999, MYCOLOGIA, V91, P475, DOI 10.2307/3761348; Bauer R, 2001, MYCOL RES, V105, P416, DOI 10.1017/S0953756201003690; Bauer R, 2001, MYCOTA, V7, P57; Bauer R, 2006, MYCOL PROG, V5, P41, DOI 10.1007/s11557-006-0502-0; Begerow D, 2000, MYCOL RES, V104, P53, DOI 10.1017/S0953756299001161; Begerow D, 2001, MYCOL RES, V105, P798, DOI 10.1017/S0953756201004208; Begerow D, 2014, THE MYCOTA A, P295, DOI DOI 10.1007/978-3-642-55318-9_11; Begerow D, 2006, MYCOLOGIA, V98, P906, DOI 10.3852/mycologia.98.6.906; Butin H.L., 1986, BIBLIOTHECA MYCOLOGI, V101, P1; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Garnica S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-1; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hibbett DS, 1997, AM J BOT, V84, P981, DOI 10.2307/2446289; Hopple JS, 1999, MOL PHYLOGENET EVOL, V13, P1, DOI 10.1006/mpev.1999.0634; INGOLD CT, 1987, T BRIT MYCOL SOC, V89, P471, DOI 10.1016/S0007-1536(87)80080-3; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kranitz ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110308; LePage BA, 1997, AM J BOT, V84, P410, DOI 10.2307/2446014; Liu YJJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-74; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Matheny PB, 2005, MOL PHYLOGENET EVOL, V35, P1, DOI 10.1016/j.ympev.2004.11.014; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; MILLER CN, 1977, BOT REV, V43, P217, DOI 10.1007/BF02860718; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; PIEPENBRING M, 1995, MYCOL RES, V99, P853, DOI 10.1016/S0953-7562(09)80741-7; Piepenbring M, 1998, PROTOPLASMA, V204, P155, DOI 10.1007/BF01280322; Rambaut A., 2014, TRACER V1 6; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Riess K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-102; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schroter J., 1894, HEDWIGIA BEIBL, V33, P64; Setoguchi H, 1998, AM J BOT, V85, P1507, DOI 10.2307/2446478; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STOCKEY RA, 1982, REV PALAEOBOT PALYNO, V37, P133, DOI 10.1016/0034-6667(82)90041-0; STOCKEY RA, 1992, REV PALAEOBOT PALYNO, V72, P27, DOI 10.1016/0034-6667(92)90172-D; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Vanky K, 2001, FUNGAL DIVERS, V6, P131; Vanky K, 2002, ILLUSTRATED GENERA S; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang QM, 2015, STUD MYCOL, P55, DOI 10.1016/j.simyco.2015.10.004; Wang QM, 2014, PERSOONIA, V33, P41, DOI 10.3767/003158514X682313; Willis K. J., 2002, EVOLUTION PLANTS	56	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147107	10.1371/journal.pone.0147107	http://dx.doi.org/10.1371/journal.pone.0147107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790149	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100059
J	Verhoeven, H; Simons, D; Van Dyck, D; Van Cauwenberg, J; Clarys, P; De Bourdeaudhuij, I; de Geus, B; Vandelanotte, C; Deforche, B				Verhoeven, Hannah; Simons, Dorien; Van Dyck, Delfien; Van Cauwenberg, Jelle; Clarys, Peter; De Bourdeaudhuij, Ilse; de Geus, Bas; Vandelanotte, Corneel; Deforche, Benedicte			Psychosocial and Environmental Correlates of Walking, Cycling, Public Transport and Passive Transport to Various Destinations in Flemish Older Adolescents	PLOS ONE			English	Article							PHYSICAL-ACTIVITY PATTERNS; ACTIVE SCHOOL TRANSPORT; YOUTH; BENEFITS; VALIDITY; QUESTIONNAIRE; ASSOCIATIONS; RELIABILITY; PREVALENCE; ADULTHOOD	Background Active transport is a convenient way to incorporate physical activity in adolescents' daily life. The present study aimed to investigate which psychosocial and environmental factors are associated with walking, cycling, public transport (train, tram, bus, metro) and passive transport (car, motorcycle, moped) over short distances (maximum eight kilometres) among older adolescents (17-18 years), to school and to other destinations. Methods 562 older adolescents completed an online questionnaire assessing socio-demographic variables, psychosocial variables, environmental variables and transport to school/other destinations. Zero-inflated negative binomial regression models were performed. Results More social modelling and a higher residential density were positively associated with walking to school and walking to other destinations, respectively. Regarding cycling, higher self-efficacy and a higher social norm were positively associated with cycling to school and to other destinations. Regarding public transport, a higher social norm, more social modelling of siblings and/or friends, more social support and a higher land use mix access were positively related to public transport to school and to other destinations, whereas a greater distance to school only related positively to public transport to school. Regarding passive transport, more social support and more perceived benefits were positively associated with passive transport to school and to other destinations. Perceiving less walking and cycling facilities at school was positively related to passive transport to school only, and more social modelling was positively related to passive transport to other destinations. Conclusions Overall, psychosocial variables seemed to be more important than environmental variables across the four transport modes. Social norm, social modelling and social support were the most consistent psychosocial factors which indicates that it is important to target both older adolescents and their social environment in interventions promoting active transport. Walking or cycling together with siblings or friends has the potential to increase social norm, social modelling and social support towards active transport.	[Verhoeven, Hannah; Simons, Dorien; Van Cauwenberg, Jelle; Deforche, Benedicte] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, De Pintelaan 185, B-9000 Ghent, Belgium; [Verhoeven, Hannah; Simons, Dorien; Van Cauwenberg, Jelle; Clarys, Peter; Deforche, Benedicte] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Movement & Sport Sci, Pleinlaan 2, B-1050 Brussels, Belgium; [Verhoeven, Hannah; Simons, Dorien; Van Dyck, Delfien; Van Cauwenberg, Jelle] Fund Sci Res Flanders FWO, Egmontstr 5, B-1000 Brussels, Belgium; [Van Dyck, Delfien; De Bourdeaudhuij, Ilse] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Watersportlaan 2, B-9000 Ghent, Belgium; [de Geus, Bas] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Human Physiol, Pleinlaan 2, B-1050 Brussels, Belgium; [Vandelanotte, Corneel] Cent Queensland Univ, Inst Hlth & Social Sci Res, Phys Act Res Grp, Bruce Highway, Rockhampton, Qld 4702, Australia	Ghent University; Ghent University Hospital; Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Brussel; Central Queensland University	Verhoeven, H (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, De Pintelaan 185, B-9000 Ghent, Belgium.; Verhoeven, H (corresponding author), Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Movement & Sport Sci, Pleinlaan 2, B-1050 Brussels, Belgium.; Verhoeven, H (corresponding author), Fund Sci Res Flanders FWO, Egmontstr 5, B-1000 Brussels, Belgium.	hannah.verhoeven@ugent.be	de Geus, Bas/F-5335-2011; Van Dyck, Delfien/AAO-8981-2020; Vandelanotte, Corneel/ABF-5580-2020; De+Bourdeaudhuij, Ilse/AAC-5528-2019	de Geus, Bas/0000-0001-7447-0230; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Dyck, Delfien/0000-0003-1783-9075; Van Cauwenberg, Jelle/0000-0003-1292-6241	Fund for Scientific Research Flanders (FWO) [GA11111N]; FWO [11U8114N, 11N0313N, FWO12/PDO/158]; Future Leader Fellowship from the National Heart Foundation of Australia [100427]	Fund for Scientific Research Flanders (FWO)(FWO); FWO(FWO); Future Leader Fellowship from the National Heart Foundation of Australia(National Heart Foundation of Australia)	Hannah Verhoeven is supported by Fund for Scientific Research Flanders (FWO, http://www.fwo.be/en) (GA11111N). Dorien Simons is supported by a FWO fellowship (11U8114N). Jelle Van Cauwenberg is supported by a FWO fellowship (11N0313N). Delfien Van Dyck is supported by a FWO post-doctoral research mandate (FWO12/PDO/158). Corneel Vandelanotte is supported by a Future Leader Fellowship from the National Heart Foundation of Australia (ID: 100427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, BELGIAN OFFICIAL J; Armstrong N, 2006, SPORTS MED, V36, P1067, DOI 10.2165/00007256-200636120-00005; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Babey SH, 2009, J PUBLIC HEALTH POL, V30, pS203, DOI 10.1057/jphp.2008.61; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Bere E, 2008, PREV MED, V47, P412, DOI 10.1016/j.ypmed.2008.06.019; Besser LM, 2005, AM J PREV MED, V29, P273, DOI 10.1016/j.amepre.2005.06.010; Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088; Brown WJ, 2003, AM J PREV MED, V25, P140, DOI 10.1016/S0749-3797(03)00119-3; Bungum TJ, 2009, J COMMUN HEALTH, V34, P129, DOI 10.1007/s10900-008-9135-3; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dalton MA, 2011, AM J PREV MED, V40, P312, DOI 10.1016/j.amepre.2010.11.008; de Geus B, 2008, HEALTH EDUC RES, V23, P697, DOI 10.1093/her/cym055; Deforche B, 2010, PREV MED, V50, pS24, DOI 10.1016/j.ypmed.2009.08.017; Emond CR, 2012, J TRANSP GEOGR, V20, P71, DOI 10.1016/j.jtrangeo.2011.07.008; Faulkner GEJ, 2009, PREV MED, V48, P3, DOI 10.1016/j.ypmed.2008.10.017; Frank L, 2007, AM J HEALTH PROMOT, V21, P305, DOI 10.4278/0890-1171-21.4s.305; Ghekiere A, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0216-2; Ghekiere A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106696; Gordon-Larsen P, 2005, OBES RES, V13, P868, DOI 10.1038/oby.2005.100; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Jones A, 2012, HEALTH PLACE, V18, P605, DOI 10.1016/j.healthplace.2012.01.003; Jones L, 2012, CONTEMP CLIN TRIALS, V33, P268, DOI 10.1016/j.cct.2011.10.011; Kerr J, 2006, MED SCI SPORT EXER, V38, P787, DOI 10.1249/01.mss.0000210208.63565.73; Klacicner CA., 2004, 4 INT C TRAFF TRANSP; Moudon AV, 2005, TRANSPORT RES D-TR E, V10, P245, DOI 10.1016/j.trd.2005.04.001; Nelson NM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-1; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Owen CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030932; Panter JR, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-34; Pucher J, 2010, AM J PUBLIC HEALTH, V100, P1986, DOI 10.2105/AJPH.2009.189324; Rissel C, 2012, INT J ENV RES PUB HE, V9, P2454, DOI 10.3390/ijerph9072454; Robertson-Wilson JE, 2008, J ADOLESCENT HEALTH, V42, P486, DOI 10.1016/j.jadohealth.2007.10.006; Ruiz-Canela M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-2; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2002, SCORING PROCEDURES P; Sallis JF, 2008, ECOLOGICAL MODELS HL; Shaw C., 2011, GUIDELINES RES CHILD; Simons D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-323; Spittaels H., 2014, MANUAL ALPHA ENV QUE; Spittaels H, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-48; Van Dyck D, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-87; Vandelanotte C., 2005, J PHYS ACT HEALTH, V2, P63, DOI DOI 10.1123/JPAH.2.1.63; WHO, 2015, GLOB STRAT DIET PHYS, P3; Wong BYM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-618	49	46	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147128	10.1371/journal.pone.0147128	http://dx.doi.org/10.1371/journal.pone.0147128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784933	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400114
J	Bienertova-Vasku, J; Zlamal, F; Necesanek, I; Konecny, D; Vasku, A				Bienertova-Vasku, Julie; Zlamal, Filip; Necesanek, Ivo; Konecny, David; Vasku, Anna			Calculating Stress: From Entropy to a Thermodynamic Concept of Health and Disease	PLOS ONE			English	Article							PRINCIPLE	To date, contemporary science has lacked a satisfactory tool for the objective expression of stress. This text thus introduces a new-thermodynamically derived-approach to stress measurement, based on entropy production in time and independent of the quality or modality of a given stressor or a combination thereof. Hereto, we propose a novel model of stress response based on thermodynamic modelling of entropy production, both in the tissues/organs and in regulatory feedbacks. Stress response is expressed in our model on the basis of stress entropic load (SEL), a variable we introduced previously; the mathematical expression of SEL, provided here for the first time, now allows us to describe the various states of a living system, including differentiating between states of health and disease. The resulting calculation of stress response regardless of the type of stressor(s) in question is thus poised to become an entirely new tool for predicting the development of a living system.	[Bienertova-Vasku, Julie; Zlamal, Filip; Necesanek, Ivo; Konecny, David; Vasku, Anna] Masaryk Univ, Fac Med, Dept Pathol Physiol, Kamenice 5 A18, Brno 62500, Czech Republic	Masaryk University Brno	Bienertova-Vasku, J (corresponding author), Masaryk Univ, Fac Med, Dept Pathol Physiol, Kamenice 5 A18, Brno 62500, Czech Republic.	jbienert@med.muni.cz	Bienertova-Vasku, Julie/G-9763-2017; Vasku, Julie Bienertova/AAV-6821-2020	Bienertova-Vasku, Julie/0000-0001-5327-808X; Vasku, Julie Bienertova/0000-0001-5327-808X				Andersen M, 2013, MATH BIOSCI, V246, P122, DOI 10.1016/j.mbs.2013.08.010; Annamalai K, 2012, ENTROPY-SWITZ, V14, P2550, DOI 10.3390/e14122550; AOKI I, 1991, J THEOR BIOL, V150, P215, DOI 10.1016/S0022-5193(05)80333-9; AOKI I, 1990, J THEOR BIOL, V145, P421, DOI 10.1016/S0022-5193(05)80120-1; AOKI I, 1989, J THEOR BIOL, V141, P11, DOI 10.1016/S0022-5193(89)80004-9; Boonen E, 2014, AM J PHYSIOL-ENDOC M, V306, pE883, DOI 10.1152/ajpendo.00009.2014; Boregowda S.C, 2012, INT SCH RES NOT, V2012, P1, DOI 10.5402/2012/830103; Demetrius LA, 2014, ENTROPY-SWITZ, V16, P5428, DOI 10.3390/e16105428; Gallagher D, 1998, AM J PHYSIOL-ENDOC M, V275, pE249, DOI 10.1152/ajpendo.1998.275.2.E249; Goldstein DS, 2013, COMPR PHYSIOL, V3, P1569, DOI 10.1002/cphy.c130006; Ikegami T, 2008, BIOSYSTEMS, V91, P388, DOI 10.1016/j.biosystems.2007.05.014; Latora V, 1999, PHYS REV LETT, V82, P520, DOI 10.1103/PhysRevLett.82.520; Manke T, 2006, J R SOC INTERFACE, V3, P843, DOI 10.1098/rsif.2006.0140; MASON JW, 1971, J PSYCHIAT RES, V8, P323, DOI 10.1016/0022-3956(71)90028-8; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Pesin YB., 1977, RUSS MATH SURV, V32, P55, DOI [10.1070/RM1977v032n04ABEH001639, DOI 10.1070/RM1977V032N04ABEH001639]; Rahman MA, 2007, THERM SCI, V11, P75, DOI 10.2298/TSCI0701075R; Selye H, 1998, J NEUROPSYCH CLIN N, V10, P230; Silva C., 2009, J THERMODYN, P1, DOI [10.1155/2009/186723, DOI 10.1155/2009/186723]; Sterling P, HDB LIFE STRESS COGN; West J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00802	21	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146667	10.1371/journal.pone.0146667	http://dx.doi.org/10.1371/journal.pone.0146667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771542	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300028
J	da Silva, SG; de Almeida, AA; Fernandes, J; Lopim, GM; Cabral, FR; Scerni, DA; de Oliveira-Pinto, AV; Lent, R; Arida, RM				da Silva, Sergio Gomes; de Almeida, Alexandre Aparecido; Fernandes, Jansen; Lopim, Glauber Menezes; Cabral, Francisco Romero; Scerni, Debora Amado; de Oliveira-Pinto, Ana Virginia; Lent, Roberto; Arida, Ricardo Mario			Maternal Exercise during Pregnancy Increases BDNF Levels and Cell Numbers in the Hippocampal Formation but Not in the Cerebral Cortex of Adult Rat Offspring	PLOS ONE			English	Article							SHORT-TERM-MEMORY; BRAIN-DEVELOPMENT; WATER-MAZE; PUPS; EXPRESSION; NEUROGENESIS; ANXIETY; VEGF	Clinical evidence has shown that physical exercise during pregnancy may alter brain development and improve cognitive function of offspring. However, the mechanisms through which maternal exercise might promote such effects are not well understood. The present study examined levels of brain-derived neurotrophic factor (BDNF) and absolute cell numbers in the hippocampal formation and cerebral cortex of rat pups born from mothers exercised during pregnancy. Additionally, we evaluated the cognitive abilities of adult offspring in different behavioral paradigms (exploratory activity and habituation in open field tests, spatial memory in a water maze test, and aversive memory in a step-down inhibitory avoidance task). Results showed that maternal exercise during pregnancy increased BDNF levels and absolute numbers of neuronal and non-neuronal cells in the hippocampal formation of offspring. No differences in BDNF levels or cell numbers were detected in the cerebral cortex. It was also observed that offspring from exercised mothers exhibited better cognitive performance in nonassociative (habituation) and associative (spatial learning) mnemonic tasks than did offspring from sedentary mothers. Our findings indicate that maternal exercise during pregnancy enhances offspring cognitive function (habituation behavior and spatial learning) and increases BDNF levels and cell numbers in the hippocampal formation of offspring.	[da Silva, Sergio Gomes; de Almeida, Alexandre Aparecido; Fernandes, Jansen; Lopim, Glauber Menezes; Arida, Ricardo Mario] Univ Fed Sao Paulo UNIFESP, Dept Fisiol, Sao Paulo, SP, Brazil; [da Silva, Sergio Gomes; Cabral, Francisco Romero] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil; [da Silva, Sergio Gomes] Univ Mogi das Cruzes, Mogi das Cruzes, SP, Brazil; [Scerni, Debora Amado] Univ Fed Sao Paulo UNIFESP, Disciplina Neurol Expt, Sao Paulo, SP, Brazil; [de Oliveira-Pinto, Ana Virginia; Lent, Roberto] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio de Janeiro, RJ, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Universidade de Mogi das Cruzes; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	da Silva, SG; Arida, RM (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Fisiol, Sao Paulo, SP, Brazil.; da Silva, SG (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.; da Silva, SG (corresponding author), Univ Mogi das Cruzes, Mogi das Cruzes, SP, Brazil.	sgomesilva@hotmail.com; arida.nexp@epm.br	Arida, Ricardo M/E-2667-2013; Arida, Ricardo Mario/P-7408-2016; Fernandes, Jansen/D-1814-2017; da Silva, Sérgio Gomes/F-1847-2013; de Almeida, Alexandre Aparecido/AAB-8101-2020; Lopim, Glauber/W-3166-2019	Arida, Ricardo M/0000-0002-0908-3274; Arida, Ricardo Mario/0000-0002-7771-6133; Fernandes, Jansen/0000-0002-6177-5884; da Silva, Sérgio Gomes/0000-0002-9650-809X; de Almeida, Alexandre Aparecido/0000-0002-9045-7826; Lopim, Glauber/0000-0002-9291-981X; Cabral, Francisco Romero/0000-0003-2582-6960	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/06953-4, 10/11353-3]; Instituto Nacional de Neurociencia Translacional (INNT, Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Neurociencia Translacional (INNT, Brazil)	Research supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; Processes 09/06953-4 and 10/11353-3), and Instituto Nacional de Neurociencia Translacional (INNT, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel JL, 2013, INT J DEV NEUROSCI, V31, P382, DOI 10.1016/j.ijdevneu.2012.11.002; Akhavan MM, 2008, NEUROSCIENCE, V151, P1173, DOI 10.1016/j.neuroscience.2007.10.051; Akhavan MM, 2013, IRAN J BASIC MED SCI, V16, P955; Aksu I, 2012, NEUROSCI LETT, V516, P221, DOI 10.1016/j.neulet.2012.03.091; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Arida RM, 2011, AM J PHYS MED REHAB, V90, P452, DOI 10.1097/PHM.0b013e3182063a9c; Bernd P, 2008, GENE EXPRESSION, V14, P241, DOI 10.3727/105221608786883799; Bick-Sander A, 2006, P NATL ACAD SCI USA, V103, P3852, DOI 10.1073/pnas.0502644103; Clapp JF, 1996, J PEDIATR-US, V129, P856, DOI 10.1016/S0022-3476(96)70029-X; CRUZMORALES SE, 1992, BEHAV NEURAL BIOL, V57, P256, DOI 10.1016/0163-1047(92)90248-3; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; da Silva SG, 2015, EXPERT REV NEUROTHER, V15, P1041, DOI 10.1586/14737175.2015.1077115; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Herring A, 2012, FASEB J, V26, P117, DOI 10.1096/fj.11-193193; Kim H, 2007, INT J DEV NEUROSCI, V25, P243, DOI 10.1016/j.ijdevneu.2007.03.003; Lee HH, 2006, BRAIN DEV-JPN, V28, P147, DOI 10.1016/j.braindev.2005.05.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Parnpiansil P, 2003, NEUROSCI LETT, V352, P45, DOI 10.1016/j.neulet.2003.08.023; Robinson AM, 2014, NEUROSCIENCE, V256, P53, DOI 10.1016/j.neuroscience.2013.10.012; Stafstrom CE, 2002, PROG BRAIN RES, V135, P377; Uysal N, 2011, NEUROSCI LETT, V505, P273, DOI 10.1016/j.neulet.2011.10.039; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Weissgerber TL, 2006, APPL PHYSIOL NUTR ME, V31, P661, DOI [10.1139/H06-060, 10.1139/h06-060]; Wolfe L A, 1994, Exerc Sport Sci Rev, V22, P145	25	53	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147200	10.1371/journal.pone.0147200	http://dx.doi.org/10.1371/journal.pone.0147200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771675	gold, Green Published, Green Submitted			2022-12-26	WOS:000368628300071
J	Kitchen, P; Conner, MT; Bill, RM; Conner, AC				Kitchen, Philip; Conner, Matthew T.; Bill, Roslyn M.; Conner, Alex C.			Structural Determinants of Oligomerization of the Aquaporin-4 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aquaporin; cellular regulation; oligomerization; protein translocation; water channel	MOLECULAR-DYNAMICS SIMULATIONS; WATER PERMEABILITY; MEMBRANE-DIFFUSION; PROTEIN; TETRAMERIZATION; TRAFFICKING; EXPRESSION; MECHANISM; HYDRATION; DOMAINS	The aquaporin (AQP) family of integral membrane protein channels mediate cellular water and solute flow. Although qualitative and quantitative differences in channel permeability, selectivity, subcellular localization, and trafficking responses have been observed for different members of the AQP family, the signature homotetrameric quaternary structure is conserved. Using a variety of biophysical techniques, we show that mutations to an intracellular loop (loop D) of human AQP4 reduce oligomerization. Non-tetrameric AQP4 mutants are unable to relocalize to the plasma membrane in response to changes in extracellular tonicity, despite equivalent constitutive surface expression levels and water permeability to wild-type AQP4. A network of AQP4 loop D hydrogen bonding interactions, identified using molecular dynamics simulations and based on a comparative mutagenic analysis of AQPs 1, 3, and 4, suggest that loop D interactions may provide a general structural framework for tetrameric assembly within the AQP family.	[Kitchen, Philip] Univ Warwick, Mol Assembly & Org Cells Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Conner, Matthew T.] Wolverhampton Univ, Fac Sci & Engn, Sch Biol Chem & Forens Sci, Wolverhampton WV1 1LY, W Midlands, England; [Kitchen, Philip; Bill, Roslyn M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Kitchen, Philip; Bill, Roslyn M.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England; [Conner, Alex C.] Univ Birmingham, Inst Clin Sci, Birmingham B15 2TT, W Midlands, England	University of Warwick; University of Wolverhampton; Aston University; Aston University; University of Birmingham	Bill, RM (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.; Bill, RM (corresponding author), Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England.; Conner, AC (corresponding author), Univ Birmingham, Inst Clin Sci, Birmingham B15 2TT, W Midlands, England.	r.m.bill@aston.ac.uk; a.c.conner@bham.ac.uk	Bill, Roslyn M/D-4554-2012; Kitchen, Philip/J-6936-2019	Bill, Roslyn M/0000-0003-1331-0852; Kitchen, Philip/0000-0002-1558-4673	Science Research Investment Fund; Biotechnology and Biological Sciences Research Council [BB/I019960/1, BB/K013319/1, BB/L502194/1]; Innovative Medicines Joint Undertaking [115583]; BBSRC [BB/I019960/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1091578] Funding Source: researchfish	Science Research Investment Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovative Medicines Joint Undertaking; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The computing facilities were provided by the Centre for Scientific Computing of the University of Warwick with support from the Science Research Investment Fund.; Supported by Biotechnology and Biological Sciences Research Council Grants BB/I019960/1, BB/K013319/1, and BB/L502194/1 and Innovative Medicines Joint Undertaking under Grant Agreement 115583 to the ND4BB ENABLE Consortium. Towhomcorrespondence may be addressed. E-mail: r.m.bill@aston.ac.uk.	Alberga D, 2014, BBA-BIOMEMBRANES, V1838, P3052, DOI 10.1016/j.bbamem.2014.08.015; Atochina-Vasserman EN, 2012, BBA-GEN SUBJECTS, V1820, P763, DOI 10.1016/j.bbagen.2011.12.006; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; Chevalier AS, 2015, PLANT CELL PHYSIOL, V56, P819, DOI 10.1093/pcp/pcu203; Cho G, 2015, BBA-GEN SUBJECTS, V1850, P784, DOI 10.1016/j.bbagen.2015.01.009; Cho MR, 1999, BIOPHYS J, V76, P1136, DOI 10.1016/S0006-3495(99)77278-4; Conner MT, 2012, J BIOL CHEM, V287, P11516, DOI 10.1074/jbc.M111.329219; Duchesne L, 2002, J BIOL CHEM, V277, P20598, DOI 10.1074/jbc.M201179200; Duchesne L, 2001, KIDNEY INT, V60, P422, DOI 10.1046/j.1523-1755.2001.060002422.x; Felber LM, 2004, BIOTECHNIQUES, V36, P878, DOI 10.2144/04365PT04; Fenton RA, 2010, AM J PHYSIOL-RENAL, V298, pF224, DOI 10.1152/ajprenal.00463.2009; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Horner A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400083; Hub Jochen S, 2009, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-540-79885-9_3; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kaldenhoff R, 2014, BBA-GEN SUBJECTS, V1840, P1592, DOI 10.1016/j.bbagen.2013.09.037; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Kaptan S, 2015, STRUCTURE, V23, P2309, DOI 10.1016/j.str.2015.08.020; Kishida K, 2000, J BIOL CHEM, V275, P20896, DOI 10.1074/jbc.M001119200; Kitchen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143027; Kitchen P, 2015, J BIOL CHEM, V290, P16873, DOI 10.1074/jbc.M115.646034; Lagree V, 1998, J BIOL CHEM, V273, P33949, DOI 10.1074/jbc.273.51.33949; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Mazzaferri J, 2013, BIOPHYS J, V105, P328, DOI 10.1016/j.bpj.2013.06.010; Mitsuma T, 2010, J MOL BIOL, V402, P669, DOI 10.1016/j.jmb.2010.07.060; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Potokar M, 2013, GLIA, V61, P917, DOI 10.1002/glia.22485; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roudier N, 2002, J BIOL CHEM, V277, P7664, DOI 10.1074/jbc.M105411200; Sachdeva R, 2014, J BIOMOL STRUCT DYN, V32, P555, DOI 10.1080/07391102.2013.780981; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Schmidt TH, 2012, J CHEM INF MODEL, V52, P2657, DOI [10.1021/ci3000453, 10.1021/ci30006531]; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sjohamn J, 2014, BBA-GEN SUBJECTS, V1840, P1614, DOI 10.1016/j.bbagen.2013.11.012; Tani K, 2009, J MOL BIOL, V389, P694, DOI 10.1016/j.jmb.2009.04.049; Umenishi F, 2000, BIOPHYS J, V78, P1024, DOI 10.1016/S0006-3495(00)76661-6; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Yu J, 2006, STRUCTURE, V14, P1411, DOI 10.1016/j.str.2006.07.006; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001	42	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6858	6871		10.1074/jbc.M115.694729	http://dx.doi.org/10.1074/jbc.M115.694729			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26786101	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000373299700024
J	Becker-Kettern, J; Paczia, N; Conrotte, JF; Kay, DP; Guignard, C; Jung, PP; Linster, CL				Becker-Kettern, Julia; Paczia, Nicole; Conrotte, Jean-Francois; Kay, Daniel P.; Guignard, Cedric; Jung, Paul P.; Linster, Carole L.			Saccharomyces cerevisiae Forms d-2-Hydroxyglutarate and Couples Its Degradation to d-Lactate Formation via a Cytosolic Transhydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dehydrogenase; enzyme kinetics; flavoprotein; inborn error of metabolism; yeast metabolism; 2-hydroxyglutarate; transhydrogenase	ALPHA-HYDROXYGLUTARIC ACID; GRAPHICAL USER-INTERFACE; L-2-HYDROXYGLUTARIC ACIDURIA; HISTONE DEMETHYLASES; MASS ISOTOPOMER; GENE-EXPRESSION; IDH2 MUTATIONS; DEHYDROGENASE; YEAST; 2-HYDROXYGLUTARATE	The d or l form of 2-hydroxyglutarate (2HG) accumulates in certain rare neurometabolic disorders, and high d-2-hydroxyglutarate (d-2HG) levels are also found in several types of cancer. Although 2HG has been detected in Saccharomyces cerevisiae, its metabolism in yeast has remained largely unexplored. Here, we show that S. cerevisiae actively forms the d enantiomer of 2HG. Accordingly, the S. cerevisiae genome encodes two homologs of the human d-2HG dehydrogenase: Dld2, which, as its human homolog, is a mitochondrial protein, and the cytosolic protein Dld3. Intriguingly, we found that a dld3 knock-out strain accumulates millimolar levels of d-2HG, whereas a dld2 knock-out strain displayed only very moderate increases in d-2HG. Recombinant Dld2 and Dld3, both currently annotated as d-lactate dehydrogenases, efficiently oxidized d-2HG to -ketoglutarate. Depletion of d-lactate levels in the dld3, but not in the dld2 mutant, led to the discovery of a new type of enzymatic activity, carried by Dld3, to convert d-2HG to -ketoglutarate, namely an FAD-dependent transhydrogenase activity using pyruvate as a hydrogen acceptor. We also provide evidence that Ser3 and Ser33, which are primarily known for oxidizing 3-phosphoglycerate in the main serine biosynthesis pathway, in addition reduce -ketoglutarate to d-2HG using NADH and represent major intracellular sources of d-2HG in yeast. Based on our observations, we propose that d-2HG is mainly formed and degraded in the cytosol of S. cerevisiae cells in a process that couples d-2HG metabolism to the shuttling of reducing equivalents from cytosolic NADH to the mitochondrial respiratory chain via the d-lactate dehydrogenase Dld1.	[Becker-Kettern, Julia; Paczia, Nicole; Conrotte, Jean-Francois; Kay, Daniel P.; Jung, Paul P.; Linster, Carole L.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, 6 Ave Swing, L-4367 Belvaux, Luxembourg; [Guignard, Cedric] Luxembourg Inst Sci & Technol, 41 Rue Brill, L-4422 Belvaux, Luxembourg	University of Luxembourg; Luxembourg Institute of Science & Technology	Linster, CL (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, 6 Ave Swing, L-4367 Belvaux, Luxembourg.	carole.linster@uni.lu		Linster, Carole/0000-0001-7143-0719; Jung, Paul/0000-0001-5960-1327; Paczia, Nicole/0000-0003-3859-8186; Guignard, Cedric/0000-0001-9925-5932	Fonds National de la Recherche Luxembourg Grant CORE [C13/BM/5773107]; AFR Ph.D. Fellowship [4044610]; Fondation du Pelican de Mie et Pierre Hippert-Faber scholarship	Fonds National de la Recherche Luxembourg Grant CORE(Luxembourg National Research Fund); AFR Ph.D. Fellowship(Luxembourg National Research Fund); Fondation du Pelican de Mie et Pierre Hippert-Faber scholarship	This work was supported by the Fonds National de la Recherche Luxembourg Grant CORE C13/BM/5773107, AFR Ph.D. Fellowship 4044610 (to J. B. K.), and a Fondation du Pelican de Mie et Pierre Hippert-Faber scholarship (to J. B. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Albers E, 2003, J BIOL CHEM, V278, P10264, DOI 10.1074/jbc.M211692200; Albers E, 1998, MICROBIOL-UK, V144, P1683, DOI 10.1099/00221287-144-6-1683; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; ALLEN SHG, 1972, J BIOL CHEM, V247, P909; BLEIWEIS AS, 1967, J BACTERIOL, V94, P1560, DOI 10.1128/JB.94.5.1560-1564.1967; Brachmann CB, 1998, YEAST, V14, P115; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Chalmers R A, 1980, J Inherit Metab Dis, V3, P11, DOI 10.1007/BF02312516; Chelstowska A, 1999, YEAST, V15, P1377, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1377::AID-YEA473>3.0.CO;2-0; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cristescu ME, 2009, J MOL EVOL, V69, P276, DOI 10.1007/s00239-009-9274-x; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; DULEY J, 1975, ANAL BIOCHEM, V69, P164, DOI 10.1016/0003-2697(75)90577-1; Duran M, 1980, J Inherit Metab Dis, V3, P109, DOI 10.1007/BF02312543; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Engqvist M, 2009, J BIOL CHEM, V284, P25026, DOI 10.1074/jbc.M109.021253; Fan J, 2015, ACS CHEM BIOL, V10, P510, DOI 10.1021/cb500683c; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fu XD, 2015, CELL METAB, V22, P508, DOI 10.1016/j.cmet.2015.06.009; GIBSON KM, 1993, PEDIATR RES, V34, P277, DOI 10.1203/00006450-199309000-00007; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GREGERSEN N, 1977, ACTA PAEDIATR SCAND, V66, P85, DOI 10.1111/j.1651-2227.1977.tb07812.x; GREGOLIN C, 1963, BIOCHIM BIOPHYS ACTA, V67, P201; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hudig M, 2015, PLANT CELL PHYSIOL, V56, P1820, DOI 10.1093/pcp/pcv108; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Kardon T, 2006, FEBS LETT, V580, P2347, DOI 10.1016/j.febslet.2006.02.082; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Koh JLY, 2015, G3-GENES GENOM GENET, V5, P1223, DOI 10.1534/g3.115.017830; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kwon DW, 2011, BIOCHEM BIOPH RES CO, V410, P614, DOI 10.1016/j.bbrc.2011.06.039; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JY, 2015, BIOTECHNOL BIOENG, V112, P751, DOI 10.1002/bit.25488; Lin ZG, 2011, MOL BIOL EVOL, V28, P131, DOI 10.1093/molbev/msq184; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; LODI T, 1993, MOL GEN GENET, V238, P315, DOI 10.1007/BF00291989; Lodi T, 1999, MOL GEN GENET, V262, P623, DOI 10.1007/s004380051125; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luo ZL, 2009, MICROBIOL-SGM, V155, P4036, DOI 10.1099/mic.0.030726-0; Luttik MAH, 2000, J BACTERIOL, V182, P7007, DOI 10.1128/JB.182.24.7007-7013.2000; Matsunaga H, 2012, BIOCHEM BIOPH RES CO, V423, P553, DOI 10.1016/j.bbrc.2012.06.002; Muntau AC, 2000, NEUROPEDIATRICS, V31, P137, DOI 10.1055/s-2000-7497; Nota B, 2013, AM J HUM GENET, V92, P627, DOI 10.1016/j.ajhg.2013.03.009; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; Patiny L, 2013, J CHEM INF MODEL, V53, P1223, DOI 10.1021/ci300563h; Petersen S, 2001, METAB ENG, V3, P344, DOI 10.1006/mben.2001.0198; PRONK JT, 1994, MICROBIOL-UK, V140, P717, DOI 10.1099/00221287-140-4-717; Reed DW, 1999, J BACTERIOL, V181, P7580, DOI 10.1128/JB.181.24.7580-7587.1999; REEVES HC, 1962, J BACTERIOL, V84, P186, DOI 10.1128/JB.84.1.186-187.1962; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Rudolph J, 2010, BIOCHEMISTRY-US, V49, P9249, DOI 10.1021/bi101291d; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Rzem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119540; Stewart BJ, 2013, YEAST, V30, P81, DOI 10.1002/yea.2942; Struys EA, 2007, J INHERIT METAB DIS, V30, P690, DOI 10.1007/s10545-007-0697-5; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; Struys EA, 2004, FEBS LETT, V557, P115, DOI 10.1016/S0014-5793(03)01459-5; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; ULANE R, 1972, J BACTERIOL, V109, P34, DOI 10.1128/JB.109.1.34-43.1972; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Vissers LELM, 2011, AM J MED GENET A, V155A, P2609, DOI 10.1002/ajmg.a.34325; Wapinski I, 2010, P NATL ACAD SCI USA, V107, P5505, DOI 10.1073/pnas.0911905107; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; ZACHARIOU M, 1986, J BACTERIOL, V167, P863, DOI 10.1128/jb.167.3.863-869.1986; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	82	34	36	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6036	6058		10.1074/jbc.M115.704494	http://dx.doi.org/10.1074/jbc.M115.704494			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26774271	Green Published, hybrid			2022-12-26	WOS:000372894200001
J	Alonso-Rodriguez, E; Fernandez-Pinar, P; Sacristan-Reviriego, A; Molina, M; Martin, H				Alonso-Rodriguez, Esmeralda; Fernandez-Pinar, Pablo; Sacristan-Reviriego, Almudena; Molina, Maria; Martin, Humberto			An Analog-sensitive Version of the Protein Kinase Slt2 Allows Identification of Novel Targets of the Yeast Cell Wall Integrity Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell wall; mitogen-activated protein kinase (MAPK); phosphorylation; signaling; yeast; ATPS analog; Slt2; cell wall integrity	CAP-DEPENDENT TRANSLATION; SACCHAROMYCES-CEREVISIAE; MAP KINASE; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; SHUTTLE VECTORS; FUSION PROTEINS; PHOSPHORYLATION; SPECIFICITY; MECHANISMS	The yeast cell wall integrity MAPK Slt2 mediates the transcriptional response to cell wall alterations through phosphorylation of transcription factors Rlm1 and SBF. However, the variety of cellular functions regulated by Slt2 suggests the existence of a significant number of still unknown substrates for this kinase. To identify novel Slt2 targets, we generated and characterized an analog-sensitive mutant of Slt2 (Slt2-as) that can be specifically inhibited by bulky kinase inhibitor analogs. We demonstrated that Slt2-as is able to use adenosine 5-[-thio]triphosphate analogs to thiophosphorylate its substrates in yeast cell extracts as well as when produced as recombinant proteins in Escherichia coli. Taking advantage of this chemical-genetic approach, we found that Slt2 phosphorylates the MAPK phosphatase Msg5 both in the N-terminal regulatory and C-terminal catalytic domains. Moreover, we identified the calcineurin regulator Rcn2, the 4E-BP (translation initiation factor eIF4E-binding protein) translation repressor protein Caf20, and the Golgi-associated adaptor Gga1 as novel targets for Slt2. The Slt2 phosphorylation sites on Rcn2 and Caf20 were determined. We also demonstrated that, in the absence of SLT2, the GGA1 paralog GGA2 is essential for cells to survive under cell wall stress and for proper protein sorting through the carboxypeptidase Y pathway. Therefore, Slt2-as provides a powerful tool that can expand our knowledge of the outputs of the cell wall integrity MAPK pathway.	[Molina, Maria] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Plaza Ramon & Cajal S-N, E-28040 Madrid, Spain; IRYCIS, Madrid 28040, Spain	Complutense University of Madrid	Molina, M (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Plaza Ramon & Cajal S-N, E-28040 Madrid, Spain.	molmifa@ucm.es	Brieva, Humberto Martin/E-9254-2016; Molina, Maria/ABE-7186-2021; Martín, Humberto/Z-3423-2019	Brieva, Humberto Martin/0000-0002-6736-3602; Molina, Maria/0000-0003-0074-3309; Martín, Humberto/0000-0002-6736-3602	Ministerio de Ciencia e Innovacion [BIO2010-22369-C02-01]; Ministerio de Economia y Competitividad (Spain) [BIO2013-44112-P]; Comunidad Autonoma de Madrid (Spain) [S2011/BMD-2414]; Formacion de Personal Investigador (FPI) fellowship from Ministerio de Ciencia e Innovacion (Spain)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad (Spain)(Spanish Government); Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); Formacion de Personal Investigador (FPI) fellowship from Ministerio de Ciencia e Innovacion (Spain)	This work was supported by Grants BIO2010-22369-C02-01 and BIO2013-44112-P from Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad (Spain), respectively, and S2011/BMD-2414 from Comunidad Autonoma de Madrid (Spain). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Formacion de Personal Investigador (FPI) fellowship from Ministerio de Ciencia e Innovacion (Spain).	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Arias P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-390; Sanz AB, 2012, MOL BIOL CELL, V23, P2805, DOI 10.1091/mbc.E12-04-0278; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000; Cramer JF, 2010, TRAFFIC, V11, P259, DOI 10.1111/j.1600-0854.2009.01017.x; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Doray B, 2002, P NATL ACAD SCI USA, V99, P8072, DOI 10.1073/pnas.082235699; Emrick MA, 2006, P NATL ACAD SCI USA, V103, P18101, DOI 10.1073/pnas.0608849103; Engelberg D, 2014, CELL SIGNAL, V26, P2865, DOI 10.1016/j.cellsig.2014.09.003; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Garcia R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1879-4; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Ghosh P, 2003, J BIOL CHEM, V278, P14543, DOI 10.1074/jbc.M212543200; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hertz Nicholas T, 2010, Curr Protoc Chem Biol, V2, P15, DOI 10.1002/9780470559277.ch090201; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jin CY, 2014, MOL BIOL CELL, V25, P1396, DOI 10.1091/mbc.E13-09-0550; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Koch A, 2010, EUR J CELL BIOL, V89, P184, DOI 10.1016/j.ejcb.2009.11.024; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Mao K, 2011, AUTOPHAGY, V7, P1564, DOI 10.4161/auto.7.12.17971; Marin MJ, 2009, MOL GENET GENOMICS, V281, P345, DOI 10.1007/s00438-008-0415-5; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MARTIN H, 1993, MOL GEN GENET, V241, P177, DOI 10.1007/BF00280215; Martin H, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145606; Mascaraque V, 2013, MOL CELL PROTEOMICS, V12, P557, DOI 10.1074/mcp.M112.020438; McKay MM, 2004, TRAFFIC, V5, P102, DOI 10.1111/j.1600-0854.2004.00160.x; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Miller GJ, 2003, NAT STRUCT BIOL, V10, P599, DOI 10.1038/nsb953; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Molina M, 2010, YEAST, V27, P503, DOI 10.1002/yea.1791; Paczkowski JE, 2015, TRENDS CELL BIOL, V25, P408, DOI 10.1016/j.tcb.2015.02.005; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Ray A, 2003, NAT GENET, V33, P522, DOI 10.1038/ng1132; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; SIKORSKI RS, 1989, GENETICS, V122, P19; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Thingholm TE, 2009, PROTEOMICS, V9, P1451, DOI 10.1002/pmic.200800454; TORRES L, 1991, MOL MICROBIOL, V5, P2845, DOI 10.1111/j.1365-2958.1991.tb01993.x; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Willett R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2535; Zhang C, 2013, ACS CHEM BIOL, V8, P1931, DOI 10.1021/cb400376p; Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013	65	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5461	5472		10.1074/jbc.M115.683680	http://dx.doi.org/10.1074/jbc.M115.683680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786099	Green Published, hybrid			2022-12-26	WOS:000372551800002
J	Cassady-Cain, RL; Blackburn, EA; Alsarraf, H; Dedic, E; Bease, AG; Bottcher, B; Jorgensen, R; Wear, M; Stevens, MP				Cassady-Cain, Robin L.; Blackburn, Elizabeth A.; Alsarraf, Husam; Dedic, Emil; Bease, Andrew G.; Boettcher, Bettina; Jorgensen, Rene; Wear, Martin; Stevens, Mark P.			Biophysical Characterization and Activity of Lymphostatin, a Multifunctional Virulence Factor of Attaching and Effacing Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; circular dichroism (CD); electron microscopy (EM); Escherichia coli (E; coli); glycosyltransferase; small-angle X-ray scattering (SAXS); structural biology; T-cell; LifA; lymphostatin	CLOSTRIDIUM-DIFFICILE TOXIN; PROTEIN SECONDARY STRUCTURE; COMPLETE GENOME SEQUENCE; X-RAY SOLUTION; STRUCTURE PREDICTION; NEW-GENERATION; UDP-GLUCOSE; WEB; COLONIZATION; EFFECTOR	Attaching and effacing Escherichia coli cause diarrhea and typically produce lymphostatin (LifA), an inhibitor of mitogen-activated proliferation of lymphocytes and pro-inflammatory cytokine synthesis. A near-identical factor (Efa1) has been reported to mediate adherence of E. coli to epithelial cells. An amino-terminal region of LifA shares homology with the catalytic domain of the large clostridial toxins, which are retaining glycosyltransferases with a DXD motif involved in binding of a metal ion. Understanding the mode(s) of action of lymphostatin has been constrained by difficulties obtaining a stably transformed plasmid expression clone. We constructed a tightly inducible clone of enteropathogenic E. coli O127:H6 lifA for affinity purification of lymphostatin. The purified protein inhibited mitogen-activated proliferation of bovine T lymphocytes in the femtomolar range. It is a monomer in solution and the molecular envelope was determined using both transmission electron microscopy and small-angle x-ray scattering. Domain architecture was further studied by limited proteolysis. The largest proteolytic fragment containing the putative glycosyltransferase domain was tested in isolation for activity against T cells, and was not sufficient for activity. Tryptophan fluorescence studies indicated thatlymphostatin binds uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc) but not UDP-glucose (UDP-Glc). Substitution of the predicted DXD glycosyltransferase motif with alanine residues abolished UDP-GlcNAc binding and lymphostatin activity, although other biophysical properties were unchanged. The data indicate that lymphostatin has UDP-sugar binding potential that is critical for activity, and is a major leap toward identifying the nature and consequences of modifications of host cell factors.	[Cassady-Cain, Robin L.; Bease, Andrew G.; Stevens, Mark P.] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Cassady-Cain, Robin L.; Bease, Andrew G.; Stevens, Mark P.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland; [Blackburn, Elizabeth A.; Boettcher, Bettina; Wear, Martin] Univ Edinburgh, CTCB, Michael Swann Bldg,Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland; [Alsarraf, Husam; Dedic, Emil; Jorgensen, Rene] Statens Serum Inst, Dept Microbiol & Infect Control, Artillerivej 5, DK-2300 Copenhagen S, Denmark; [Dedic, Emil] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; Statens Serum Institut; Swiss Federal Institutes of Technology Domain; ETH Zurich	Stevens, MP (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.	Mark.Stevens@roslin.ed.ac.uk	Bottcher, Bettina/E-9397-2010; Jørgensen, René/P-5619-2014; Alsarraf, Husam/G-2918-2017	Bottcher, Bettina/0000-0002-7962-4849; Jørgensen, René/0000-0003-0672-466X; Blackburn, Elizabeth A/0000-0003-1325-9575; Alsarraf, Husam/0000-0001-8147-9647; Stevens, Mark/0000-0003-2174-5039	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004227/1]; Wellcome Trust Multi-User Equipment Grant [101527/Z/13/Z]; Wellcome-UoE ISSF award; DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant [11-104831/FSS]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust Multi-User Equipment Grant(Wellcome Trust); Wellcome-UoE ISSF award; DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant	This work was supported, in whole or in part, by core strategic funding from Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/J004227/1 ( to R. L. C. C. and M. P. S.), Wellcome Trust Multi-User Equipment Grant 101527/Z/13/Z and Wellcome-UoE ISSF award ( to E. A. B., M. W., and B. B.), and the DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant 11-104831/FSS) ( to H. A., E. D., and R. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Median AB, 2006, FEMS MICROBIOL LETT, V258, P43, DOI 10.1111/j.1574-6968.2006.00198.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, MIN 17 STAT SOFTW; Badea L, 2003, MICROB PATHOGENESIS, V34, P205, DOI 10.1016/S0882-4010(03)00026-3; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Bhattacharyya S, 2002, EUR J BIOCHEM, V269, P3425, DOI 10.1046/j.1432-1033.2002.03013.x; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burland V, 1998, NUCLEIC ACIDS RES, V26, P4196, DOI 10.1093/nar/26.18.4196; ChavesOlarte E, 1997, J CLIN INVEST, V100, P1734, DOI 10.1172/JCI119698; Ciesla WP, 1998, J BIOL CHEM, V273, P16021, DOI 10.1074/jbc.273.26.16021; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; D'Urzo N, 2012, FEBS J, V279, P3085, DOI 10.1111/j.1742-4658.2012.08688.x; Deacon V, 2010, MICROBIOL-SGM, V156, P2527, DOI 10.1099/mic.0.039685-0; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Deng WY, 2012, MOL CELL PROTEOMICS, V11, P692, DOI 10.1074/mcp.M111.013672; Egerer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000942; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Grossmann EM, 2000, J SURG RES, V88, P165, DOI 10.1006/jsre.1999.5736; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2015, CELL MICROBIOL, V17, P1752, DOI 10.1111/cmi.12533; Janka A, 2002, INT J MED MICROBIOL, V292, P207, DOI 10.1078/1438-4221-00206; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klapproth JA, 2000, INFECT IMMUN, V68, P2148, DOI 10.1128/IAI.68.4.2148-2155.2000; Klapproth JM, 1996, AM J PHYSIOL-GASTR L, V271, pG841, DOI 10.1152/ajpgi.1996.271.5.G841; Klapproth JMA, 2005, INFECT IMMUN, V73, P1441, DOI 10.1128/IAI.73.3.1441-1451.2005; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Makino K, 1998, DNA Res, V5, P1, DOI 10.1093/dnares/5.1.1; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nicholls L, 2000, MOL MICROBIOL, V35, P275, DOI 10.1046/j.1365-2958.2000.01690.x; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; R Development Core Team, 2014, R LANG ENV STAT COMP; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solomon K, 2005, INFECT IMMUN, V73, P1625, DOI 10.1128/IAI.73.3.1625-1634.2005; Stevens MP, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0007-2013; Stevens MP, 2002, INFECT IMMUN, V70, P5158, DOI 10.1128/IAI.70.9.5158-5166.2002; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	67	7	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5803	5816		10.1074/jbc.M115.709600	http://dx.doi.org/10.1074/jbc.M115.709600			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786100	Green Published, hybrid			2022-12-26	WOS:000372551800028
J	Coughlan, KA; Valentine, RJ; Sudit, BS; Allen, K; Dagon, Y; Kahn, BB; Ruderman, NB; Saha, AK				Coughlan, Kimberly A.; Valentine, Rudy J.; Sudit, Bella S.; Allen, Katherine; Dagon, Yossi; Kahn, Barbara B.; Ruderman, Neil B.; Saha, Asish K.			PKD1 Inhibits AMPK2 through Phosphorylation of Serine 491 and Impairs Insulin Signaling in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; AMP-activated kinase (AMPK); insulin resistance; protein kinase C (PKC); protein kinase D (PKD); skeletal muscle; Serine485; 491	ACTIVATED PROTEIN-KINASE; METABOLISM; EXERCISE; AKT; SER(485/491); RESISTANCE; DISEASE; STRESS; HEALTH; HEART	Background: Diminished activity of the enzyme AMP-activated protein kinase (AMPK) is associated with impaired insulin signaling. Results: Protein Kinase (PK)C/D1 activation inhibits AMPK2 via Ser(491) phosphorylation; PKD1 inhibition prevents this in skeletal muscle cells. Conclusion: PKD1 is a novel upstream AMPK-kinase that phosphorylates AMPK on Ser(491) and regulates insulin signaling. Significance: PKD1 inhibition may be a novel strategy for improving insulin sensitivity. AMP-activated protein kinase (AMPK) is an energy-sensing enzyme whose activity is inhibited in settings of insulin resistance. Exposure to a high glucose concentration has recently been shown to increase phosphorylation of AMPK at Ser(485/491) of its 1/2 subunit; however, the mechanism by which it does so is not known. Diacylglycerol (DAG), which is also increased in muscle exposed to high glucose, activates a number of signaling molecules including protein kinase (PK)C and PKD1. We sought to determine whether PKC or PKD1 is involved in inhibition of AMPK by causing Ser(485/491) phosphorylation in skeletal muscle cells. C2C12 myotubes were treated with the PKC/D1 activator phorbol 12-myristate 13-acetate (PMA), which acts as a DAG mimetic. This caused dose- and time-dependent increases in AMPK Ser(485/491) phosphorylation, which was associated with a approximate to 60% decrease in AMPK2 activity. Expression of a phosphodefective AMPK2 mutant (S491A) prevented the PMA-induced reduction in AMPK activity. Serine phosphorylation and inhibition of AMPK activity were partially prevented by the broad PKC inhibitor Go6983 and fully prevented by the specific PKD1 inhibitor CRT0066101. Genetic knockdown of PKD1 also prevented Ser(485/491) phosphorylation of AMPK. Inhibition of previously identified kinases that phosphorylate AMPK at this site (Akt, S6K, and ERK) did not prevent these events. PMA treatment also caused impairments in insulin-signaling through Akt, which were prevented by PKD1 inhibition. Finally, recombinant PKD1 phosphorylated AMPK2 at Ser(491) in cell-free conditions. These results identify PKD1 as a novel upstream kinase of AMPK2 Ser(491) that plays a negative role in insulin signaling in muscle cells.	[Coughlan, Kimberly A.; Sudit, Bella S.; Allen, Katherine; Ruderman, Neil B.; Saha, Asish K.] Boston Univ, Sch Med, Dept Med, Endocrinol Diabet & Nutr Sect, Boston, MA 02118 USA; [Valentine, Rudy J.] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA; [Dagon, Yossi; Kahn, Barbara B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Boston University; Iowa State University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Saha, AK (corresponding author), 650 Albany St,Room 820, Boston, MA 02118 USA.	aksaha@bu.edu	Dagon, Yossi/AAI-5882-2020		USPHS [RO1DK19514, RO1DK67509]; NIH [NHLBI 2 T32 HL07969-06A1, 5T32HL007224, R01 DK098002]; JPB foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969, T32HL007224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514, R01DK098002, R01DK067509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by USPHS Grants RO1DK19514, RO1DK67509 ( to N. B. R. and A. K. S.), NIH Training Grants NHLBI 2 T32 HL07969-06A1 ( to K. A. C.) and 5T32HL007224 ( to R. J. V.) NIH Grant R01 DK098002 and a Grant from the JPB foundation ( to B. B. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amati F, 2012, OBES REV, V13, P40, DOI 10.1111/j.1467-789X.2012.01036.x; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; BOLLAG GE, 1986, P NATL ACAD SCI USA, V83, P5822, DOI 10.1073/pnas.83.16.5822; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Coughlan KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127388; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Ellwanger K, 2011, BIOCHEM J, V440, P327, DOI 10.1042/BJ20101980; Garcia-Haro L, 2012, FEBS LETT, V586, P4241, DOI 10.1016/j.febslet.2012.10.032; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; IDF, 2014, INT DIAB FED DIAB AT; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim MS, 2008, MOL CELL BIOL, V28, P3600, DOI 10.1128/MCB.00189-08; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; Lopez-Cotarelo P, 2015, J BIOL CHEM, V290, P827, DOI 10.1074/jbc.M114.596551; McGee SL, 2014, FASEB J, V28, P3384, DOI 10.1096/fj.14-249359; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Park DW, 2014, AM J PHYSIOL-LUNG C, V307, pL735, DOI 10.1152/ajplung.00165.2014; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Rhim JH, 2008, REJUV RES, V11, P781, DOI 10.1089/rej.2008.0709; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Tsuchiya Y, 2012, BIOSCIENCE REP, V32, P197, DOI 10.1042/BSR20110076; Valentine RJ, 2014, ARCH BIOCHEM BIOPHYS, V562, P62, DOI 10.1016/j.abb.2014.08.013	29	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5664	5675		10.1074/jbc.M115.696849	http://dx.doi.org/10.1074/jbc.M115.696849			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26797128	Green Published, hybrid			2022-12-26	WOS:000372551800018
J	Backlund, S; Jonsson, M; Strengbom, J; Frisch, A; Thor, G				Backlund, Sofia; Jonsson, Mari; Strengbom, Joachim; Frisch, Andreas; Thor, Goran			A Pine Is a Pine and a Spruce - Is a Spruce The Effect of Tree Species and Stand Age on Epiphytic Lichen Communities	PLOS ONE			English	Article							PICEA-ABIES; FOREST LANDSCAPES; LODGEPOLE PINE; OLD-GROWTH; DIVERSITY; PLANTATIONS; BIODIVERSITY; VEGETATION; PATTERNS; SOUTHERN	With an increasing demand for forest-based products, there is a growing interest in introducing fast-growing non-native tree species in forest management. Such introductions often have unknown consequences for native forest biodiversity. In this study, we examine epiphytic lichen species richness and species composition on the trunks of non-native Pinus contorta and compare these to the native Pinus sylvestris and Picea abies in managed boreal forests in northern Sweden across a chronosequence of age classes. Overall, we recorded a total of 66,209 lichen occurrences belonging to 57 species in the 96 studied forest stands. We found no difference in species richness of lichens between stands of P. contorta and P. sylvestris, but stands of P. abies had higher total species richness. However, species richness of lichens in stands of P. abies decreased with increasing stand age, while no such age effect was detected for P. contorta and P. sylvestris. Lichen species composition progressively diverged with increasing stand age, and in 30-year-old stands all three tree species showed species-specific assemblages. Epiphytic lichen assemblages in stands of 30-year-old P. contorta were influenced by greater basal area, canopy closure, and average diameter at breast height, P. abies stands by higher branch density and canopy closure, and stands of P. sylvestris by greater bark crevice depth. Differences in lichen species richness and composition were mainly explained by canopy closure and habitat availability, and the greater canopy closure in mature P. abies stands promoted the colonization and growth of calicioid lichen species. Our results indicate that the non-native P. contorta have similar species richness as the native P. sylvestris. The main difference in lichen species richness and composition is between P. abies and Pinus spp. in managed forests of boreal Sweden.	[Backlund, Sofia; Strengbom, Joachim; Frisch, Andreas; Thor, Goran] Swedish Univ Agr Sci, Dept Ecol, POB 7044, SE-75007 Uppsala, Sweden; [Jonsson, Mari] Swedish Species Informat Ctr, POB 7007, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences	Backlund, S (corresponding author), Swedish Univ Agr Sci, Dept Ecol, POB 7044, SE-75007 Uppsala, Sweden.	sofia.backlund@slu.se	Strengbom, Joachim/AAE-7645-2022	Strengbom, Joachim/0000-0002-1720-5016	"Stiftelsen Oscar och Lili Lamms minne" [D02008-0003]; "The Royal Swedish Academy of Sciences" [FOA10H-155]	"Stiftelsen Oscar och Lili Lamms minne"; "The Royal Swedish Academy of Sciences"	The work was mainly funded by "Stiftelsen Oscar och Lili Lamms minne", grant number D02008-0003 (http://www.stiftelsenlamm.a.se/). Additional funding for field work was provided by "The Royal Swedish Academy of Sciences", grant number FOA10H-155 (http://www.kva.se/sv/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Carrillo-Gavilan MA, 2010, DIVERS DISTRIB, V16, P203, DOI 10.1111/j.1472-4642.2010.00648.x; ArtDatabanken, 2015, RODL ART SVER 2015, P83; Backlund S, 2015, SILVA FENN, V49; Barton K., 2011, MUMIN MULTIMODEL INF; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2010, MODEL SELECTION MULT; Calvino-Cancela M, 2013, FOREST ECOL MANAG, V291, P386, DOI 10.1016/j.foreco.2012.11.023; Caruso A, 2007, SCAND J FOREST RES, V22, P219, DOI 10.1080/02827580701346031; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Dettki H, 1998, ECOGRAPHY, V21, P613, DOI 10.1111/j.1600-0587.1998.tb00554.x; Dodet M, 2012, BIOL INVASIONS, V14, P1765, DOI 10.1007/s10530-012-0202-4; Elfving B, 2001, FOREST ECOL MANAG, V141, P15, DOI 10.1016/S0378-1127(00)00485-0; Ellis CJ, 2012, PERSPECT PLANT ECOL, V14, P131, DOI 10.1016/j.ppees.2011.10.001; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Eversman S, 2002, BRYOLOGIST, V105, P27, DOI 10.1639/0007-2745(2002)105[0027:POLDIY]2.0.CO;2; EVERSMAN S, 1987, BRYOLOGIST, V90, P212, DOI 10.2307/3242928; Food and Agriculture Organization of the United Nations, 2011, STAT WORLDS FOR 2011; Gauslaa Y, 2007, CAN J FOREST RES, V37, P1832, DOI 10.1139/X07-048; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Gustafsson L, 2012, BIOSCIENCE, V62, P633, DOI 10.1525/bio.2012.62.7.6; Hauck M, 2011, FLORA, V206, P81, DOI 10.1016/j.flora.2010.02.001; Hilmo O, 2009, LICHENOLOGIST, V41, P97, DOI 10.1017/S0024282909007865; HYVARINEN M, 1992, LICHENOLOGIST, V24, P165; Jansson U., 2011, AGR FORESTRY SWEDEN; Johansson P, 2007, ECOSCIENCE, V14, P81, DOI 10.2980/1195-6860(2007)14[81:TARWEL]2.0.CO;2; Kuusinen M, 1996, LICHENOLOGIST, V28, P443, DOI 10.1006/lich.1996.0043; Kuusinen M, 1998, J VEG SCI, V9, P283, DOI 10.2307/3237127; Ledgard N. J., 2008, New Zealand Plant Protection, V61, P98; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lie MH, 2009, BIODIVERS CONSERV, V18, P3579, DOI 10.1007/s10531-009-9661-z; Lieffers VJ, 1999, CAN J FOREST RES, V29, P796, DOI 10.1139/cjfr-29-6-796; Lohmus A, 2011, SILVA FENN, V45, P1015, DOI 10.14214/sf.84; Marmor L, 2011, ECOL INDIC, V11, P1270, DOI 10.1016/j.ecolind.2011.01.009; Marmor L, 2013, LICHENOLOGIST, V45, P51, DOI 10.1017/S0024282912000564; Marmor L, 2012, ANN BOT FENN, V49, P352, DOI 10.5735/085.049.0606; McCune B, 2000, BRYOLOGIST, V103, P417, DOI 10.1639/0007-2745(2000)103[0417:EHIAOC]2.0.CO;2; Nabuurs GJ, 2007, EUR J FOREST RES, V126, P391, DOI 10.1007/s10342-006-0158-y; Nascimbene J, 2010, FOREST ECOL MANAG, V260, P603, DOI 10.1016/j.foreco.2010.05.016; Nascimbene J, 2009, CAN J FOREST RES, V39, P785, DOI 10.1139/X09-013; Nilsson C, 2008, FOREST ECOL MANAG, V255, P1900, DOI 10.1016/j.foreco.2007.12.012; Odor P, 2013, FOREST ECOL MANAG, V306, P256, DOI 10.1016/j.foreco.2013.07.001; Official statistics of Sweden, 2014, OFF STAT SWED FOR ST; Palsson L, 1998, VEGETATIONSTYPER NOR; Peck J. E., 2010, MULTIVARIATE ANAL CO; Quine CP, 2010, BIODIVERS CONSERV, V19, P1503, DOI 10.1007/s10531-009-9771-7; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Roberge JM, 2014, FOREST ECOL MANAG, V318, P239, DOI 10.1016/j.foreco.2014.01.026; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Sanderson LA, 2012, FORESTRY, V85, P329, DOI 10.1093/forestry/cps033; Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL 3, P94; Strengbom J, 2011, FORESTS, V2, P610, DOI 10.3390/f2030610; Taguchi Y, 2005, BIOINFORMATICS, V21, P730, DOI 10.1093/bioinformatics/bti067; Uliczka H, 1999, ECOGRAPHY, V22, P396, DOI 10.1111/j.1600-0587.1999.tb00576.x; [No title captured]	63	21	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147004	10.1371/journal.pone.0147004	http://dx.doi.org/10.1371/journal.pone.0147004			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799558	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300052
J	Hosohama-Saito, K; Kokubu, E; Okamoto-Shibayama, K; Kita, D; Katakura, A; Ishihara, K				Hosohama-Saito, Kyoko; Kokubu, Eitoyo; Okamoto-Shibayama, Kazuko; Kita, Daichi; Katakura, Akira; Ishihara, Kazuyuki			Involvement of luxS in Biofilm Formation by Capnocytophaga ochracea	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; AGGRESSIVE PERIODONTITIS; VIBRIO-HARVEYI; BACTERIA; AUTOINDUCER-2; LUMINESCENCE; EXPRESSION; INDUCTION; PROTEIN; MATRIX	Capnocytophaga ochracea is present in the dental plaque biofilm of patients with periodontitis. Biofilm cells change their phenotype through quorum sensing in response to fluctuations in cell-population density. Quorum sensing is mediated by auto-inducers (AIs). AI-2 is involved in intercellular signaling, and production of its distant precursor is catalyzed by LuxS, an enzyme involved in the activated methyl cycle. Our aim was to clarify the role of LuxS in biofilm formation by C. ochracea. Two luxS-deficient mutants, TmAI2 and LKT7, were constructed from C. ochracea ATCC 27872 by homologous recombination. The mutants produced significantly less AI-2 than the wild type. The growth rates of these mutants were similar to that of the wild-type in both undiluted Tryptic soy broth and 0.5 x Tryptic soy broth. However, according to crystal violet staining, they produced significantly less biofilm than the wild type. Confocal laser scanning microscopy and scanning electron microscopy showed that the biofilm of the TmAI2 strain had a rougher structure than that of the wild type. Complementation of TmAI-2 with extrinsic AI-2 from the culture supernatant of wild-type strain did not restore biofilm formation by the TmAI2 strain, but complementation of LKT7 strain with luxS partially restored biofilm formation. These results indicate that LuxS is involved in biofilm formation by C. ochracea, and that the attenuation of biofilm formation by the mutants is likely caused by a defect in the activated methyl cycle rather than by a loss of AI-2.	[Hosohama-Saito, Kyoko; Katakura, Akira] Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, 5-11-13 Sugano, Chiba, Japan; [Kokubu, Eitoyo; Okamoto-Shibayama, Kazuko; Ishihara, Kazuyuki] Tokyo Dent Coll, Dept Microbiol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo, Japan; [Kita, Daichi] Tokyo Dent Coll, Dept Periodontol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo, Japan; [Katakura, Akira] Tokyo Dent Coll, Dept Oral Pathobiol Sci & Surg, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College; Tokyo Dental College; Tokyo Dental College	Ishihara, K (corresponding author), Tokyo Dent Coll, Dept Microbiol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo, Japan.	ishihara@tdc.ac.jp		Ishihara, Kazuyuki/0000-0002-6567-807X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24592778]; Tokyo Dental College; Grants-in-Aid for Scientific Research [15K11023] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Dental College; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant 24592778 from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Kazuyuki Ishihara, and research funds from Tokyo Dental College.	BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Blehert DS, 2003, J BACTERIOL, V185, P4851, DOI 10.1128/JB.185.16.4851-4860.2003; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Casarin RCV, 2013, J PERIODONTAL RES, V48, P30, DOI 10.1111/j.1600-0765.2012.01498.x; Ciantar M, 2005, J PERIODONTOL, V76, P194, DOI 10.1902/jop.2005.76.2.194; Desai Sima S, 2007, J Infect, V54, pe107, DOI 10.1016/j.jinf.2006.06.014; Dibart S, 1998, ORAL MICROBIOL IMMUN, V13, P30, DOI 10.1111/j.1399-302X.1998.tb00747.x; DYER JK, 1985, CAN J MICROBIOL, V31, P1, DOI 10.1139/m85-001; Filoche S, 2010, J DENT RES, V89, P8, DOI 10.1177/0022034509351812; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Frias J, 2001, INFECT IMMUN, V69, P3431, DOI 10.1128/IAI.69.5.3431-3434.2001; Gajardo M, 2005, J PERIODONTOL, V76, P289, DOI 10.1902/jop.2005.76.2.289; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; HAAPASALO M, 1991, INFECT IMMUN, V59, P4230, DOI 10.1128/IAI.59.11.4230-4237.1991; Heller D, 2012, ARCH ORAL BIOL, V57, P973, DOI 10.1016/j.archoralbio.2012.02.003; Holt SC, 2011, BERGYS MANUAL SYSTEM, P168; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Huyghe A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002453; Kikuchi Y, 2005, MICROBIOL-SGM, V151, P841, DOI 10.1099/mic.0.27589-0; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nakayama K, 2015, J PERIODONTAL RES, V50, P1, DOI 10.1111/jre.12255; Okuda T, 2012, ANAEROBE, V18, P157, DOI 10.1016/j.anaerobe.2012.01.001; Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x; Redanz S, 2012, J BIOL CHEM, V287, P36111, DOI 10.1074/jbc.M112.379230; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Cruz IS, 2013, J PERIODONTAL RES, V48, P443, DOI 10.1111/jre.12024; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shaddox LM, 2012, J DENT RES, V91, P927, DOI 10.1177/0022034512456039; Stanley NR, 2004, MOL MICROBIOL, V52, P917, DOI 10.1111/j.1365-2958.2004.04036.x; Sztajer H, 2008, J BACTERIOL, V190, P401, DOI 10.1128/JB.01086-07; Takahashi N, 2007, J ANTIMICROB CHEMOTH, V59, P59, DOI 10.1093/jac/dkl452; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Wang HK, 2007, J CLIN MICROBIOL, V45, P645, DOI 10.1128/JCM.01815-06; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005	40	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147114	10.1371/journal.pone.0147114	http://dx.doi.org/10.1371/journal.pone.0147114			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800339	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300060
J	Hu, J; Leng, X; Hu, YJ; Atik, A; Song, X; Li, ZX; Liu, YH; Lu, L				Hu, Jie; Leng, Xuan; Hu, Yijun; Atik, Alp; Song, Xin; Li, Zhixi; Liu, Yuhua; Lu, Lin			The Features of Inflammation Factors Concentrations in Aqueous Humor of Polypoidal Choroidal Vasculopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL TRIAMCINOLONE INJECTION; COMBINED PHOTODYNAMIC THERAPY; EPITHELIUM-DERIVED FACTOR; TUMOR-NECROSIS-FACTOR; MACULAR DEGENERATION; NEOVASCULARIZATION SECONDARY; PATHOLOGICAL MYOPIA; RISK-FACTORS; MEMBRANES	Purpose To investigate the cytokine concentrations in the aqueous humor of patients with refractory polypoidal choroidal vasculopathy (PCV). Methods Three separate groups of patients were studied refractory PCV (Group A, 41 eyes), stable PCV (Group B, 39 eyes) and senile cataract (Group C, 44 eyes). Aqueous humor samples were collected at two time points for Groups A and B before the first intravitreal ranibizumab injection and before the last injection. Aqueous humor samples were collected prior to phacoemulsification in Group C. The cytokine concentrations of interleukin 2, 6, and 8 (IL-2, IL-6, and IL-8), tumor necrosis factor a (TNF-a), monocyte chemotactic protein 1 (MCP-1), and vascular endothelial growth factor (VEGF) were measured by cytometric bead array and flow cytometry. Results Before the first treatment, the MCP-1, VEGF, and TNF-a levels in Group A were significantly higher than those in Group C (P < 0.05), and the MCP-1 and VEGF levels in Group A were significantly higher than those in Group B (P < 0.05). Significantly higher MCP-1 and VEGF levels were seen in Group B compared to Group C (P < 0.05). Before the final treatment, the MCP-1, VEGF, and TNF-a concentrations in Group A were significantly higher than those in Group B (P < 0.05) and Group C (P < 0.05). IL-2 levels were significantly lower in Group A compared to Group B (P < 0.05) and Group C (P < 0.05). Conclusion Inflammatory cytokines such as MCP-1, VEGF, and TNF-alpha may be associated with the pathogenesis of both stable and refractory PCV.	[Hu, Jie; Leng, Xuan; Hu, Yijun; Song, Xin; Li, Zhixi; Liu, Yuhua; Lu, Lin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Atik, Alp] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia	Sun Yat Sen University; Royal Victorian Eye & Ear Hospital	Hu, J (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	hehujie@126.com	Hu, Yijun/J-4044-2016	Hu, Yijun/0000-0002-6424-7905	National Natural Science Foundation of China [81271009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81271009), JH. JH conceived and designed the experiments for this manuscript.	Agawa T, 2014, RETINA-J RET VIT DIS, V34, P1811, DOI 10.1097/IAE.0000000000000157; Ahn JK, 2009, AM J OPHTHALMOL, V148, P718, DOI 10.1016/j.ajo.2009.06.012; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chan WM, 2007, BRIT J OPHTHALMOL, V91, P174, DOI 10.1136/bjo.2006.103606; Chen SJ, 2008, INVEST OPHTH VIS SCI, V49, P3126, DOI 10.1167/iovs.08-1803; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fruebis J, 1997, ARTERIOSCL THROM VAS, V17, P1289, DOI 10.1161/01.ATV.17.7.1289; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Kikuchi M, 2007, OPHTHALMOLOGY, V114, P1722, DOI 10.1016/j.ophtha.2006.12.021; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Kuroiwa S, 2004, CLIN EXP OPHTHALMOL, V32, P297, DOI 10.1111/j.1442-9071.2004.00827.x; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lee MY, 2013, AM J OPHTHALMOL, V156, P343, DOI 10.1016/j.ajo.2013.04.001; Lin JT, 2014, CURR PHARM DESIGN, V20, P4580, DOI 10.2174/1381612820666140522115801; Matsuoka M, 2004, BRIT J OPHTHALMOL, V88, P809, DOI 10.1136/bjo.2003.032466; Miao H, 2012, MOL VIS, V18, P574; Montero JA, 2007, BRIT J OPHTHALMOL, V91, P131, DOI 10.1136/bjo.2006.106526; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Sakurada Y, 2015, OPHTHALMIC RES, V53, P2, DOI 10.1159/000365487; Sasaki S, 2012, INVEST OPHTH VIS SCI, V53, P3424, DOI 10.1167/iovs.11-7913; Selzman CH, 2002, AM J PHYSIOL-HEART C, V283, pH1455, DOI 10.1152/ajpheart.00188.2002; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; Tatar O, 2007, RETINA-J RET VIT DIS, V27, P713, DOI 10.1097/IAE.0b013e318042d3b0; Tong JP, 2006, AM J OPHTHALMOL, V141, P456, DOI 10.1016/j.ajo.2005.10.012; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478, DOI 10.1001/archopht.1997.01100150480005	28	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147346	10.1371/journal.pone.0147346	http://dx.doi.org/10.1371/journal.pone.0147346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799405	gold, Green Submitted, Green Published			2022-12-26	WOS:000368655300098
J	Campbell, C; Andersen, L; Mutsikiwa, A; Madanhire, C; Nyamukapa, C; Gregson, S				Campbell, Catherine; Andersen, Louise; Mutsikiwa, Alice; Madanhire, Claudius; Nyamukapa, Constance; Gregson, Simon			Can Schools Support HIV/AIDS-Affected Children? Exploring the 'Ethic of Care' amongst Rural Zimbabwean Teachers	PLOS ONE			English	Article							VULNERABLE CHILDREN; ORPHANS; CONTEXT; STIGMA; HEALTH; HIV	How realistic is the international policy emphasis on schools 'substituting for families' of HIV/AIDS-affected children? We explore the ethic of care in Zimbabwean schools to highlight the poor fit between the western caring schools literature and daily realities of schools in different material and cultural contexts. Interviews and focus groups were conducted with 44 teachers and 55 community members, analysed in light of a companion study of HIV/AIDS-affected pupils' own accounts of their care-related experiences. We conceptualise schools as spaces of engagement between groups with diverse needs and interests (teachers, pupils and surrounding community members), with attention to the pathways through which extreme adversity impacts on those institutional contexts and social identifications central to giving and receiving care. Whilst teachers were aware of how they might support children, they seldom put these ideas into action. Multiple factors undermined caring teacher-pupil relationships in wider contexts of poverty and political uncertainty: loss of morale from low salaries and falling professional status; the inability of teachers to solve HIV/AIDS-related problems in their own lives; the role of stigma in deterring HIV/AIDS-affected children from disclosing their situations to teachers; authoritarian teacher-learner relations and harsh punishments fuelling pupil fear of teachers; and lack of trust in the wider community. These factors undermined: teacher confidence in their skills and capacity to support affected pupils and motivation to help children with complex problems; solidarity and common purpose amongst teachers, and between teachers and affected children; and effective bridging alliances between schools and their surrounding communities-all hallmarks of HIV-competent communities. We caution against ambitious policy expansions of teachers' roles without recognition of the personal and social costs of emotional labour, and the need for significant increases in resources and institutional recognition to enable teachers to adopt support roles. We highlight the need for research into how best to create opportunities for teacher recognition in deprived and disorganised institutional settings, and the development of more culturally appropriate notions of caring.	[Campbell, Catherine; Andersen, Louise] Univ London London Sch Econ & Polit Sci, Dept Social Psychol, Houghton St, London WC2A 2AE, England; [Mutsikiwa, Alice] Biomed Res & Training Inst, Harare, Zimbabwe; [Madanhire, Claudius] Univ KwaZulu Natal, Sch Appl Human Sci, Durban, South Africa; [Nyamukapa, Constance; Gregson, Simon] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England	University of London; London School Economics & Political Science; Biomedical Research Training Institute; University of Kwazulu Natal; Imperial College London	Campbell, C (corresponding author), Univ London London Sch Econ & Polit Sci, Dept Social Psychol, Houghton St, London WC2A 2AE, England.	c.campbell@lse.ac.uk		Gregson, Simon/0000-0003-2707-0714; Nyamukapa, Constance/0000-0001-6779-4069	Economic and Social Research Council - Department for International Development (ESRC-DFID) [RES-167-25-0672]; Wellcome Trust [084401/Z/07/Z]; ESRC [ES/I033459/1] Funding Source: UKRI; Economic and Social Research Council [ES/I033459/1] Funding Source: researchfish	Economic and Social Research Council - Department for International Development (ESRC-DFID)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by: The Economic and Social Research Council - Department for International Development (ESRC-DFID) joint fund (RES-167-25-0672) http://www.esrc.ac.uk/funding-and-guidance/funding-opportunities/international-funding/esrc-dfid/, and The Wellcome Trust (084401/Z/07/Z) http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Joel, 1995, STRUGGLE RECOGNITION; [Anonymous], 2013, ZIMB TEACH WARN STRI; [Anonymous], CHILDRENS REPRESENTA, DOI DOI 10.1186/1471-2458-14-402; Ansell N, 2008, ANTIPODE, V40, P802, DOI 10.1111/j.1467-8330.2008.00638.x; Bialobrzeska M., 2009, CREATING CARING SCH; Campbell C, 2014, CONCEPTUALISING SCH; Campbell C, 2007, J HEALTH PSYCHOL, V12, P403, DOI 10.1177/1359105307076229; Campbell C, 2007, AM J COMMUN PSYCHOL, V39, P347, DOI 10.1007/s10464-007-9116-1; Campbell C, 2015, HEALTH PLACE, V31, P54, DOI 10.1016/j.healthplace.2014.09.008; Campbell C, 2013, AIDS CARE, V25, pS114, DOI 10.1080/09540121.2012.748170; Campbell C, 2012, HEALTH PLACE, V18, P447, DOI 10.1016/j.healthplace.2011.10.006; Campbell C, 2012, HEALTH PLACE, V18, P123, DOI 10.1016/j.healthplace.2011.07.008; Castro A, 2005, AM J PUBLIC HEALTH, V95, P53, DOI 10.2105/AJPH.2003.028563; Chitiyo M, 2008, INT J EDUC DEV, V28, P384, DOI 10.1016/j.ijedudev.2007.05.009; CIA, 2015, WORLD FACTB ZIMB; Ebersohn L, 2011, HEALTH EDUC RES, V26, P596, DOI 10.1093/her/cyr016; FLICK U, 1992, J THEOR SOC BEHAV, V22, P175, DOI 10.1111/j.1468-5914.1992.tb00215.x; Freire, 2005, ED CRITICAL CONSCIOU; Garutsa T., 2013, ROLE NGOS ADDRESSING; Giese S., 2013, STRENGTHENING SCH NO; Hoadley U, 2007, AJAR-AFR J AIDS RES, V6, P251, DOI 10.2989/16085900709490421; LeRoux-Rutledge E, 2015, AIDS CARE, V27, P1367, DOI 10.1080/09540121.2015.1093592; Machawira P, 2009, J EDUC POLICY, V24, P753, DOI 10.1080/02680930903244888; Makaripe T., 2015, ZIM TEACHERS LOWEST; Mangwaya E, 2013, ASIAN SOC SCI, V9; Marist International Solidarity Foundation, 2011, U PER REV REP ZIMB; Massey Doreen., 1999, HUMAN GEOGRAPHY TODA, P279; Mead G. H., 1934, MIND SELF SOC; Morrell R., 2001, S AFR J EDUC, V21, P292; Moscovici S, 2000, SOCIAL REPRESENTATIO, P18; Noddings N., 2003, CARING FEMININE APPR; Nyazema NZ, 2010, J DEV SOC, V26, P233, DOI 10.1177/0169796X1002600204; Ogara C., 2007, COMPARE, V37, P5, DOI DOI 10.1080/03057920601061695; Parsons R., 2012, GROWING HIV ZIMBABWE; Paul-Ebhohimhen VA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-4; Save the Children, 2011, ITS ALL CHILDR; Save the Children, 2010, SPEAK OUT BEING HEAR; Shizha E, 2011, ED DEV ZIMBABWE SOCI; Skovdal M, 2015, INT J EDUC DEV, V41, P175, DOI 10.1016/j.ijedudev.2015.02.005; Skovdal M, 2010, VULNERABLE CHILD YOU, V5, P19, DOI 10.1080/17450120903281173; Smith M., 2009, SOCIAL PEDAGOGY DEV; UNAIDS, 2014, AIDS INF STAT; UNAIDS, 2014, GAP REP; UNAIDS, 2014, GLOB AIDS RESP COUNT; UNESCO, 2008, HIV AIDS SUPP LEARN; UNICEF, 2013, AIDS FREE GEN CHILDR; UNICEF, 2012, STAT WORLDS CHILDR 2; UNICEF, 2010, CHILD FRIENDL SCH; Whitney T., 2010, THESIS U NEBRASKA LI; Zagheni E, 2011, POPUL DEV REV, V37, P761, DOI 10.1111/j.1728-4457.2011.00456.x; Zembylas M., 2008, INT PERSPECTIVES ED, P159	51	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146322	10.1371/journal.pone.0146322	http://dx.doi.org/10.1371/journal.pone.0146322			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BW	26790103	Green Published, Green Accepted, gold			2022-12-26	WOS:000368529100030
J	Yoshida, T; Song, LX; Bai, Y; Kinose, F; Li, JN; Ohaegbulam, KC; Munoz-Antonia, T; Qu, XT; Eschrich, S; Uramoto, H; Tanaka, F; Nasarre, P; Gemmill, RM; Roche, J; Drabkin, HA; Haura, EB				Yoshida, Takeshi; Song, Lanxi; Bai, Yun; Kinose, Fumi; Li, Jiannong; Ohaegbulam, Kim C.; Munoz-Antonia, Teresita; Qu, Xiaotao; Eschrich, Steven; Uramoto, Hidetaka; Tanaka, Fumihiro; Nasarre, Patrick; Gemmill, Robert M.; Roche, Joelle; Drabkin, Harry A.; Haura, Eric B.			ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; E-CADHERIN; MIR-200 FAMILY; TGF-BETA; SIGNALING PATHWAYS; TARGETED THERAPY; REPRESSORS ZEB1; GEFITINIB; MECHANISMS; SENSITIVITY	Epithelial-mesenchymal transition (EMT) is one mechanism of acquired resistance to inhibitors of the epidermal growth factor receptor-tyrosine kinases (EGFR-TKIs) in non-small cell lung cancer (NSCLC). The precise mechanisms of EMT-related acquired resistance to EGFR-TKIs in NSCLC remain unclear. We generated erlotinib-resistant HCC4006 cells (HCC4006ER) by chronic exposure of EGFR-mutant HCC4006 cells to increasing concentrations of erlotinib. HCC4006ER cells acquired an EMT phenotype and activation of the TGF-beta/SMAD pathway, while lacking both T790M secondary EGFR mutation and MET gene amplification. We employed gene expression microarrays in HCC4006 and HCC4006ER cells to better understand the mechanism of acquired EGFR-TKI resistance with EMT. At the mRNA level, ZEB1 (TCF8), a known regulator of EMT, was >20-fold higher in HCC4006ER cells than in HCC4006 cells, and increased ZEB1 protein level was also detected. Furthermore, numerous ZEB1 responsive genes, such as CDH1 (E-cadherin), ST14, and vimentin, were coordinately regulated along with increased ZEB1 in HCC4006ER cells. We also identified ZEB1 overexpression and an EMT phenotype in several NSCLC cells and human NSCLC samples with acquired EGFR-TKI resistance. Short-interfering RNA against ZEB1 reversed the EMT phenotype and, importantly, restored erlotinib sensitivity in HCC4006ER cells. The level of micro-RNA-200c, which can negatively regulate ZEB1, was significantly reduced in HCC4006ER cells. Our results suggest that increased ZEB1 can drive EMT-related acquired resistance to EGFR-TKIs in NSCLC. Attempts should be made to explore targeting ZEB1 to resensitize TKI-resistant tumors.	[Yoshida, Takeshi; Song, Lanxi; Bai, Yun; Kinose, Fumi; Li, Jiannong; Haura, Eric B.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA; [Ohaegbulam, Kim C.; Munoz-Antonia, Teresita] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Qu, Xiaotao; Eschrich, Steven] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL 33612 USA; [Uramoto, Hidetaka; Tanaka, Fumihiro] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 2, Kitakyushu, Fukuoka 807, Japan; [Nasarre, Patrick; Gemmill, Robert M.; Roche, Joelle; Drabkin, Harry A.] Med Univ S Carolina, Dept Med, Div Hematol Oncol, Charleston, SC 29425 USA; [Nasarre, Patrick; Gemmill, Robert M.; Roche, Joelle; Drabkin, Harry A.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Occupational & Environmental Health - Japan; Medical University of South Carolina; Medical University of South Carolina	Haura, EB (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA.	eric.haura@moffitt.org	Eschrich, Steven/K-6848-2013	Eschrich, Steven/0000-0002-9833-2788	Moffitt Cancer Center SPORE in Lung Cancer [P50-CA119997]; NCI [1R01 CA121182]; Colorado Lung Cancer SPORE [NCI-CA58187]; Molecular Biology and Sequencing Core, the Tissue Core, and the Microarray Core at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center [P30-CA076292]; NATIONAL CANCER INSTITUTE [R01CA121182, P50CA119997, P50CA058187, P30CA076292] Funding Source: NIH RePORTER	Moffitt Cancer Center SPORE in Lung Cancer; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Colorado Lung Cancer SPORE; Molecular Biology and Sequencing Core, the Tissue Core, and the Microarray Core at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was partially funded by grants from the Moffitt Cancer Center SPORE in Lung Cancer (P50-CA119997), NCI 1R01 CA121182, and the Colorado Lung Cancer SPORE NCI-CA58187 (HD, PN, RMG). This work has also been supported in part by the Molecular Biology and Sequencing Core, the Tissue Core, and the Microarray Core at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center (P30-CA076292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedi U, 2014, ONCOTARGET, V5, P2016, DOI 10.18632/oncotarget.1875; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Davis FM, 2014, TRENDS PHARMACOL SCI, V35, P479, DOI 10.1016/j.tips.2014.06.006; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Ekins S, 2007, METH MOL B, V356, P319; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hall JG, 2000, P NATL ACAD SCI USA, V97, P8272, DOI 10.1073/pnas.140225597; Haura EB, 2011, J PROTEOME RES, V10, P182, DOI 10.1021/pr100863f; Kakihana M, 2009, J THORAC ONCOL, V4, P1455, DOI 10.1097/JTO.0b013e3181bc9419; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kothari AN, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0035-0; La Monica S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078656; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lei WW, 2010, INT J BIOCHEM CELL B, V42, P1489, DOI 10.1016/j.biocel.2010.05.006; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Machida K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013470; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Mishra VK, 2014, CELL TISSUE RES, V356, P617, DOI 10.1007/s00441-014-1912-y; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Potiron VA, 2007, CANCER RES, V67, P8708, DOI 10.1158/0008-5472.CAN-06-3612; Roche Joelle, 2013, Cancers (Basel), V5, P334, DOI 10.3390/cancers5020334; Schliekelman MJ, 2015, CANCER RES, V75, P1789, DOI 10.1158/0008-5472.CAN-14-2535; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shin SY, 2010, CANCER RES, V70, P6715, DOI 10.1158/0008-5472.CAN-10-1377; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Steinestel K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-17; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Uramoto H, 2011, LUNG CANCER, V30, P2513; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Wu CY, 2012, TRENDS GENET, V28, P454, DOI 10.1016/j.tig.2012.05.005; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	61	57	58	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147344	10.1371/journal.pone.0147344	http://dx.doi.org/10.1371/journal.pone.0147344			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789630	gold, Green Submitted, Green Published			2022-12-26	WOS:000368529100082
J	Behr, JG; Diaz, R				Behr, Joshua G.; Diaz, Rafael			Emergency Department Frequent Utilization for Non-Emergent Presentments: Results from a Regional Urban Trauma Center Study	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; SELF-REPORTED HEALTH; BEHAVIORAL-MODEL; SERVICE UTILIZATION; VULNERABLE POPULATIONS; PATIENT SATISFACTION; NONURGENT EMERGENCY; ETHNIC-MINORITIES; PUBLIC EMERGENCY; HOMELESS ADULTS	Objectives First, to test a model of the drivers of frequent emergency department utilization conceptualized as falling within predisposing, enabling, and need dimensions. Second, to extend the model to include social networks and service quality as predictors of frequent utilization. Third, to illustrate the variation in thresholds that define frequent utilization in terms of the number of emergency department encounters by the predictors within the model. Data Source Primary data collection over an eight week period within a level-1 trauma urban hospital's emergency department. Study Design Representative randomized sample of 1,443 adult patients triaged ESI levels 4-5. Physicians and research staff interviewed patients as they received services. Relationships with the outcome variable, utilization, were tested using logistic regression to establish odds-ratios. Principal Findings 70.6 percent of patients have two or more, 48.3 percent have three or more, 25.3 percent have four or more, and 14.9 percent have five or more emergency department visits within 12 months. Factors associated with frequent utilization include gender, race, poor mental health, mental health drugs, prescription drug abuse, social networks, employment, perceptions of service quality, seriousness of condition, persistence of condition, and previous hospital admittance. Conclusions Interventions targeting associated factors will change global emergency department encounters, although the mutability varies. Policy interventions to address predisposing factors such as substance abuse or access to mental health treatment as well as interventions that speak to enabling factors such as promoting the resiliency of social networks may result in decreased frequency of emergency department utilization.	[Behr, Joshua G.] Old Domin Univ, Virginia Modeling Anal & Simulat Ctr, Suffolk, VA USA; [Diaz, Rafael] MIT, Zaragoza Logist Ctr, Zaragoza, Spain		Behr, JG (corresponding author), Old Domin Univ, Virginia Modeling Anal & Simulat Ctr, Suffolk, VA USA.	jbehr@odu.edu			Sentara Health Foundation [07-08-EX-0198]	Sentara Health Foundation	The project was supported by Sentara Health Foundation, #07-08-EX-0198, http://www.sentara.com/AboutSentara/Foundation/Pages/Foundation.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday L A, 1974, Health Serv Res, V9, P208; ADAY LA, 1981, MED CARE, V19, P4, DOI 10.1097/00005650-198112001-00004; Althaus F, 2011, ANN EMERG MED, V58, P41, DOI 10.1016/j.annemergmed.2011.03.007; Andersen R., 1968, RES SER; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Baker DW, 1996, ANN EMERG MED, V28, P677, DOI 10.1016/S0196-0644(96)70093-8; BAKER DW, 1994, JAMA-J AM MED ASSOC, V271, P1909, DOI 10.1001/jama.271.24.1909; Baker DW, 1997, AM J PUBLIC HEALTH, V87, P1027, DOI 10.2105/AJPH.87.6.1027; BAUM SA, 1987, J AM GERIATR SOC, V35, P398, DOI 10.1111/j.1532-5415.1987.tb04660.x; Behr JG, 2013, J PUBLIC HEALTH MAN, V19, pS55, DOI 10.1097/PHH.0b013e318297226a; Bentley J, 2004, J ADV NURS, V48, P149, DOI 10.1111/j.1365-2648.2004.03182.x; Bertakis KD, 2005, OBES RES, V13, P372, DOI 10.1038/oby.2005.49; Bertakis KD, 2011, J AM BOARD FAM MED, V24, P229, DOI 10.3122/jabfm.2011.03.100170; Bethell Jennifer, 2008, Curr Psychiatry Rep, V10, P53, DOI 10.1007/s11920-008-0010-9; Blank FSJ, 2005, J EMERG NURS, V31, P139, DOI 10.1016/j.jen.2005.02.008; Boudreaux ED, 2004, J EMERG MED, V26, P13, DOI 10.1016/j.jemermed.2003.04.003; Byrne M, 2003, ANN EMERG MED, V41, P309, DOI 10.1067/mem.2003.68; Chan BT, 2002, CAN FAM PHYSICIAN, V48, P1654; Cook LJ, 2004, ACAD EMERG MED, V11, P256, DOI 10.1197/j.aem.2003.10.023; Davidson PL, 2004, INQUIRY-J HEALTH CAR, V41, P21, DOI 10.5034/inquiryjrnl_41.1.21; Dent Andrew Wesley, 2003, Emerg Med (Fremantle), V15, P322, DOI 10.1046/j.1442-2026.2003.00470.x; Dismuke CE, 2011, GEN HOSP PSYCHIAT, V33, P311, DOI 10.1016/j.genhosppsych.2011.03.014; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Fan L, 2011, J RURAL HEALTH, V27, P39, DOI 10.1111/j.1748-0361.2010.00313.x; Fertel BS, 2012, ANN EMERG MED, V60, P693, DOI 10.1016/j.annemergmed.2012.05.009; Folsom DP, 2005, AM J PSYCHIAT, V162, P370, DOI 10.1176/appi.ajp.162.2.370; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gilboy N., 2005, EMERGENCY SEVERITY I, P1; Gill JM, 2000, ARCH FAM MED, V9, P333, DOI 10.1001/archfami.9.4.333; Goetzel RZ, 2010, J OCCUP ENVIRON MED, V52, pS52, DOI 10.1097/JOM.0b013e3181c95b84; Goetzel RZ, 2004, J OCCUP ENVIRON MED, V46, P398, DOI 10.1097/01.jom.0000121151.40413.bd; Grabe HJ, 2009, SOC PSYCH PSYCH EPID, V44, P835, DOI 10.1007/s00127-009-0005-9; GRUMBACH K, 1993, AM J PUBLIC HEALTH, V83, P372, DOI 10.2105/AJPH.83.3.372; Grumbach K., 2010, OUTCOMES IMPLEMENTIN; Hansagi H, 2001, ANN EMERG MED, V37, P561, DOI 10.1067/mem.2001.111762; Harman JS, 2004, PSYCHIAT SERV, V55, P937, DOI 10.1176/appi.ps.55.8.937; Hazlett SB, 2004, ACAD EMERG MED, V11, P193, DOI 10.1197/j.aem.2003.09.014; Heithoff KA, 1997, CLIN THER, V19, P811, DOI 10.1016/S0149-2918(97)80104-X; Honda K, 2004, AM J HEALTH PROMOT, V18, P370, DOI 10.4278/0890-1171-18.5.370; Hunt KA, 2006, ANN EMERG MED, V48, P1, DOI 10.1016/j.annemergmed.2005.12.030; JOHNSON J, 1992, JAMA-J AM MED ASSOC, V267, P1478, DOI 10.1001/jama.267.11.1478; Keene J, 2001, HEALTH SOC CARE COMM, V9, P205, DOI 10.1046/j.1365-2524.2001.00296.x; Kne T, 1998, AM J EMERG MED, V16, P648, DOI 10.1016/S0735-6757(98)90166-8; Knowlton A, 2013, ACAD EMERG MED, V20, P1101, DOI 10.1111/acem.12253; Kushel MB, 2002, AM J PUBLIC HEALTH, V92, P778, DOI 10.2105/AJPH.92.5.778; Lasser KE, 2012, ARCH INTERN MED, V172, P278, DOI 10.1001/archinternmed.2011.709; Lin MT, 2012, SOC PSYCH PSYCH EPID, V47, P939, DOI 10.1007/s00127-011-0401-9; Locker TE, 2007, EMERG MED J, V24, P398, DOI 10.1136/emj.2006.043844; Lucas RH, 1998, ANN EMERG MED, V32, P563, DOI 10.1016/S0196-0644(98)70033-2; MALONE RE, 1995, SOC SCI MED, V40, P469, DOI 10.1016/0277-9536(94)E0116-A; Mandelberg JH, 2000, ACAD EMERG MED, V7, P637, DOI 10.1111/j.1553-2712.2000.tb02037.x; Martinez TE, 2006, PSYCHIAT SERV, V57, P992, DOI 10.1176/appi.ps.57.7.992; McCusker J, 1997, ACAD EMERG MED, V4, P581, DOI 10.1111/j.1553-2712.1997.tb03582.x; Meyer JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042416; Milbrett P, 2009, J EMERG NURS, V35, P191, DOI 10.1016/j.jen.2008.04.032; Miller JE, 2000, AM J PUBLIC HEALTH, V90, P428, DOI 10.2105/AJPH.90.3.428; Neuman B., 2011, NEUMAN SYSTEMS MODEL; NHAMCS National Hospital Ambulatory Medical Care Survey, 2010, EM DEP SUMM TABL; Okin RL, 2000, AM J EMERG MED, V18, P603, DOI 10.1053/ajem.2000.9292; Olsson M, 2001, EMERG MED J, V18, P430, DOI 10.1136/emj.18.6.430; PADGETT DK, 1992, AM J ORTHOPSYCHIAT, V62, P525, DOI 10.1037/h0079369; PADGETT DK, 1995, SOC SCI MED, V41, P547, DOI 10.1016/0277-9536(94)00364-Y; Petersen LA, 1998, MED CARE, V36, P1249, DOI 10.1097/00005650-199808000-00012; Phillips KA, 2000, HEALTH AFFAIR, V19, P65, DOI 10.1377/hlthaff.19.4.65; Phillips KA, 1998, HEALTH SERV RES, V33, P571; Pinkhasov RM, 2010, INT J CLIN PRACT, V64, P475, DOI 10.1111/j.1742-1241.2009.02290.x; Pope D, 2000, CAN MED ASSOC J, V162, P1017; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Rask KJ, 1994, JAMA J AM MED ASS, V1931; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rongey C, 2011, TRANSL BEHAV MED, V1, P644, DOI 10.1007/s13142-011-0098-z; Sachs-Ericsson N, 1999, J HEALTH CARE POOR U, V10, P443; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Sandoval E, 2010, J EMERG MED, V38, P115, DOI 10.1016/j.jemermed.2007.09.042; Sarver JH, 2002, ACAD EMERG MED, V9, P916, DOI 10.1197/aemj.9.9.916; Scheppers E, 2006, FAM PRACT, V23, P325, DOI 10.1093/fampra/cmi113; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Shen C, 2008, DIS MANAGE, V11, P153, DOI 10.1089/dis.2007.0012; Short ME, 2009, J OCCUP ENVIRON MED, V51, P786, DOI 10.1097/JOM.0b013e3181a86671; Spillane LL, 1997, ACAD EMERG MED, V4, P574, DOI 10.1111/j.1553-2712.1997.tb03581.x; Stein JA, 2007, J HEALTH PSYCHOL, V12, P791, DOI 10.1177/1359105307080612; Sun BC, 2000, ANN EMERG MED, V35, P426, DOI 10.1067/mem.2000.104195; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Trasande L, 2009, OBESITY, V17, P1749, DOI 10.1038/oby.2009.67; Vortmann M, 2008, OBESITY, V16, P146, DOI 10.1038/oby.2007.7; Wagner JA, 2008, SOC PSYCH PSYCH EPID, V43, P878, DOI 10.1007/s00127-008-0377-2; Wang FF, 2005, OBES RES, V13, P1450, DOI 10.1038/oby.2005.175; Weber EJ, 2005, ANN EMERG MED, V45, P4, DOI 10.1016/j.annemergmed.2004.06.023; WHITEMEANS SI, 1989, MILBANK Q, V67, P35, DOI 10.2307/3350069; Zuckerman S, 2004, MED CARE, V42, P176, DOI 10.1097/01.mlr.0000108747.51198.41	90	42	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147116	10.1371/journal.pone.0147116	http://dx.doi.org/10.1371/journal.pone.0147116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784515	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400111
J	Matsushita, M; Otsuka, Y; Tsutsumida, N; Tanaka, C; Uchiumi, A; Ozawa, K; Suzuki, T; Ichikawa, D; Aburatani, H; Okamoto, S; Kawakami, Y; Hattori, Y				Matsushita, Maiko; Otsuka, Yohei; Tsutsumida, Naoya; Tanaka, Chiaki; Uchiumi, Akane; Ozawa, Koji; Suzuki, Takuma; Ichikawa, Daiju; Aburatani, Hiroyuki; Okamoto, Shinichiro; Kawakami, Yutaka; Hattori, Yutaka			Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; MYELOID-LEUKEMIA; IMMUNE-RESPONSE; T-LYMPHOCYTES; STEM-CELLS; CANCER; GENE; ANTIGENS; IMMUNOTHERAPY; INDUCTION	The homeobox protein, PEPP2 (RHOXF2), has been suggested as a cancer/testis (CT) antigen based on its expression pattern. However, the peptide epitope of PEPP2 that is recognized by cytotoxic T cells (CTLs) is unknown. In this study, we revealed that PEPP2 gene was highly expressed in myeloid leukemia cells and some other hematological malignancies. This gene was also expressed in leukemic stem-like cells. We next identified the first reported epitope peptide (PEPP2(271-279)). The CTLs induced by PEPP2(271-279) recognized PEPP2-positive target cells in an HLA-A*24:02-restricted manner. We also found that a demethylating agent, 5-aza-2'-deoxycytidine, could enhance PEPP2 expression in leukemia cells but not in blood mononuclear cells from healthy donors. The cytotoxic activity of anti-PEPP2 CTL against leukemic cells treated with 5-aza-2'-deoxycytidine was higher than that directed against untreated cells. These results suggest a clinical rationale that combined treatment with this novel antigen-specific immunotherapy together with demethylating agents might be effective in therapy-resistant myeloid leukemia patients.	[Matsushita, Maiko; Otsuka, Yohei; Tsutsumida, Naoya; Tanaka, Chiaki; Uchiumi, Akane; Ozawa, Koji; Ichikawa, Daiju; Hattori, Yutaka] Keio Univ, Fac Pharm, Div Clin Physiol & Therapeut, Tokyo, Japan; [Suzuki, Takuma] Natl Canc Ctr, Div Pharm, 1-1 Tsukiji 5 chome, Tokyo, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Lab, Tokyo, Japan; [Okamoto, Shinichiro] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan; [Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan	Keio University; National Cancer Center - Japan; University of Tokyo; Keio University; Keio University	Matsushita, M (corresponding author), Keio Univ, Fac Pharm, Div Clin Physiol & Therapeut, Tokyo, Japan.	matsushita-mk@pha.keio.ac.jp		Hattori, Yutaka/0000-0003-1080-9738	Private University Strategic Research Base Development Program of MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan; Friends of Leukemia Research Fund; Keio Gijuku Academic Development Funds	Private University Strategic Research Base Development Program of MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan; Friends of Leukemia Research Fund; Keio Gijuku Academic Development Funds	This work was supported by a Grant-in-Aid for Scientific Research and a grant from the Private University Strategic Research Base Development Program of MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan, Friends of Leukemia Research Fund, and Keio Gijuku Academic Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstedt M, 2010, LEUKEMIA RES, V34, P899, DOI 10.1016/j.leukres.2010.02.004; Anguille S, 2012, LEUKEMIA, V26, P2186, DOI 10.1038/leu.2012.145; Aruga A, 2013, CLIN CANCER RES, V19, P2224, DOI 10.1158/1078-0432.CCR-12-3592; Bae J, 2015, LEUKEMIA, V29, P218, DOI 10.1038/leu.2014.159; Bao L, 2011, CANCER IMMUNOL IMMUN, V60, P1299, DOI 10.1007/s00262-011-1037-z; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Coral S, 2012, BRIT J CANCER, V107, P1116, DOI 10.1038/bjc.2012.361; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Hu Z, 2008, J BIOL CHEM, V283, P3866, DOI 10.1074/jbc.M706717200; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; Jain N, 2009, CANCER-AM CANCER SOC, V115, P3924, DOI 10.1002/cncr.24468; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Li Q, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-63; Li Q, 2009, MOL PHARMACOL, V76, P1072, DOI 10.1124/mol.109.056291; Lin C, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-13; MacLean JA, 2010, REPRODUCTION, V140, P195, DOI 10.1530/REP-10-0100; Pandolfi A, 2013, STEM CELL TRANSL MED, V2, P143, DOI 10.5966/sctm.2012-0109; Pemmaraju N, 2013, CL LYMPH MYELOM LEUK, V13, P485, DOI 10.1016/j.clml.2013.02.023; Rezvani K, 2011, INT J HEMATOL, V93, P274, DOI 10.1007/s12185-011-0781-3; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; She MR, 2012, CANCER LETT, V318, P173, DOI 10.1016/j.canlet.2011.12.017; Shibata-Minoshima F, 2012, INT J ONCOL, V40, P93, DOI 10.3892/ijo.2011.1173; Terwijn M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107587; Toor AA, 2012, BRIT J HAEMATOL, V158, P700, DOI 10.1111/j.1365-2141.2012.09225.x; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Van Tendeloo VF, 2010, P NATL ACAD SCI USA, V107, P13824, DOI 10.1073/pnas.1008051107; Wayne CM, 2002, GENE, V301, P1, DOI 10.1016/S0378-1119(02)01087-9; Wong Rebecca S Y, 2012, Malays J Pathol, V34, P77; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542; Yan MY, 2011, CANCER IMMUNOL IMMUN, V60, P1243, DOI 10.1007/s00262-011-1024-4; Yang H, 2014, LEUKEMIA, V28, P1280, DOI 10.1038/leu.2013.355	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146371	10.1371/journal.pone.0146371	http://dx.doi.org/10.1371/journal.pone.0146371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784514	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400034
J	Nealis, LJ; van Allen, ZM; Zelenski, JM				Nealis, Logan J.; van Allen, Zack M.; Zelenski, John M.			Positive Affect and Cognitive Restoration: Investigating the Role of Valence and Arousal	PLOS ONE			English	Article							SELF-CONTROL FAILURE; EGO DEPLETION; MODEL; EXPERIENCE; EMOTIONS	Positive moods are thought to restore self-control resources following depletion. However, it is not well understood whether this effect is due to affective valence (pleasantness), arousal (activation), or a combination of both. Across four studies, we set out to investigate the role of positive moods on cognitive and behavioral measures of self-regulation in an ego-depletion paradigm. In studies 1 and 2, we independently manipulated affective valence and arousal and assessed self-regulation with a Stroop task. Results did not suggest a restorative effect of either on cognitive resources. In study 3, we employed both behavioral (the 'handgrip task') and cognitive (Stroop) assessments of self-regulation. Again, no significant effect of mood was observed on the Stroop task. Additionally, participants did not persist significantly longer on the handgrip task following a positive mood induction. Finally, in study 4, high vs. low states of arousal were manipulated and self-regulation was assessed via pre- and post-manipulation Stroop performance. In study 4, Stroop performance improved slightly more across time points for those in the high arousal condition than for those in the low arousal condition. Therefore, across four studies, we failed to find a consistent pattern of results suggesting that positive moods restore cognitive resources.	[Nealis, Logan J.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [van Allen, Zack M.; Zelenski, John M.] Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada	Dalhousie University; Carleton University	Zelenski, JM (corresponding author), Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada.	john_zelenski@carleton.ca		Zelenski, John/0000-0002-3668-5764; van Allen, Zack/0000-0002-5778-6441; Nealis, Logan/0000-0002-7176-8098	Social Sciences and Humanities Research Council of Canada [410-2009-1004, 435-2014-1068]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was supported by a Standard Research Grant (#410-2009-1004) and Insight Grant (#435-2014-1068) from the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts HJEM, 2007, BRIT J SOC PSYCHOL, V46, P383, DOI 10.1348/014466606X130111; Barber S, 1998, AM ADAGIOS; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2002, SELF IDENTITY, V1, P129, DOI 10.1080/152988602317319302; Baumgartner T, 2006, INT J PSYCHOPHYSIOL, V60, P34, DOI 10.1016/j.ijpsycho.2005.04.007; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dreisbach G, 2004, J EXP PSYCHOL LEARN, V30, P343, DOI 10.1037/0278-7393.30.2.343; Duckworth AL, 2011, J RES PERS, V45, P259, DOI 10.1016/j.jrp.2011.02.004; Dvorak A, 2007, DVORAK SLAVONIC DANC; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hagger MS, 2014, FRONT PSYCHOL, V5; Holst G, 1987, HOLST PLANETS CD ROM; Inzlicht M, 2015, NEWS EGO DEPLETIONS; Inzlicht M, 2007, PSYCHOL SCI, V18, P933, DOI 10.1111/j.1467-9280.2007.02004.x; Izzard CE, 1977, HUMAN EMOTIONS; Jallais C, 2010, BEHAV RES METHODS, V42, P318, DOI 10.3758/BRM.42.1.318; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Kuppens P, 2008, J RES PERS, V42, P1053, DOI 10.1016/j.jrp.2007.10.007; Kuppens P, 2013, PSYCHOL BULL, V139, P917, DOI 10.1037/a0030811; Lang P.J., 2008, INT AFFECTIVE PICTUR; Lanski HJ, 1920, POLITICAL THOUGHT BR; Larsen R.J., 1992, EMOTION, P25; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; MURAVEN M, 2003, PERS SOC PSYCHOL B, V29, P894, DOI DOI 10.1177/0146167203253209; Nicol Pegi, 2005, SOMETHING DANCING HE; Nisbet EK, 2011, PSYCHOL SCI, V22, P1101, DOI 10.1177/0956797611418527; PALLAK MS, 1975, B PSYCHONOMIC SOC, V6, P248, DOI 10.3758/BF03336652; R Core Team, 2021, R LANGUAGE ENV STAT; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SAKLOFSKE DH, 1992, PERS INDIV DIFFER, V13, P623, DOI 10.1016/0191-8869(92)90204-3; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P770, DOI 10.1037/a0014635; Simonsohn U, 2015, PSYCHOL SCI, P1; Spielberg S, 1982, EXTRA TERRESTRIAL; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tice DM, 2007, J EXP SOC PSYCHOL, V43, P379, DOI 10.1016/j.jesp.2006.05.007; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEGNER DM, 1980, J PERS SOC PSYCHOL, V38, P719, DOI 10.1037/0022-3514.38.5.719; Wenzel M, 2014, COGNITION EMOTION, V28, P747, DOI 10.1080/02699931.2013.851069; Wenzel M, 2013, EUR J SOC PSYCHOL, V43, P175, DOI 10.1002/ejsp.1936; Whelan DC, 2012, SOC PSYCHOL PERS SCI, V3, P430, DOI 10.1177/1948550611425194; Zelenski JM, 2000, J RES PERS, V34, P178, DOI 10.1006/jrpe.1999.2275	43	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147275	10.1371/journal.pone.0147275	http://dx.doi.org/10.1371/journal.pone.0147275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784026	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400131
J	Saroka, KS; Vares, DE; Persinger, MA				Saroka, Kevin S.; Vares, David E.; Persinger, Michael A.			Similar Spectral Power Densities Within the Schumann Resonance and a Large Population of Quantitative Electroencephalographic Profiles: Supportive Evidence for Koenig and Pobachenko	PLOS ONE			English	Article							EARTH-IONOSPHERE CAVITY; GEOMAGNETIC-ACTIVITY; MAGNETIC-FIELDS; BRAIN; EEG; STATES; OSCILLATIONS	In 1954 and 1960 Koenig and his colleagues described the remarkable similarities of spectral power density profiles and patterns between the earth-ionosphere resonance and human brain activity which also share magnitudes for both electric field (mV/m) and magnetic field (pT) components. In 2006 Pobachenko and colleagues reported real time coherence between variations in the Schumann and brain activity spectra within the 6-16 Hz band for a small sample. We examined the ratios of the average potential differences (similar to 3 mu V) obtained by whole brain quantitative electroencephalography (QEEG) between rostral- caudal and left-right (hemispheric) comparisons of 238 measurements from 184 individuals over a 3.5 year period. Spectral densities for the rostral-caudal axis revealed a powerful peak at 10.25 Hz while the left-right peak was 1.95 Hz with beat-differences of similar to 7.5 to 8 Hz. When global cerebral measures were employed, the first (7-8 Hz), second (13-14 Hz) and third (19-20 Hz) harmonics of the Schumann resonances were discernable in averaged QEEG profiles in some but not all participants. The intensity of the endogenous Schumann resonance was related to the 'best-of-fitness' of the traditional 4-class microstate model. Additional measurements demonstrated real-time coherence for durations approximating microstates in spectral power density variations between Schumann frequencies measured in Sudbury, Canada and Cumiana, Italy with the QEEGs of local subjects. Our results confirm the measurements reported by earlier researchers that demonstrated unexpected similarities in the spectral patterns and strengths of electromagnetic fields generated by the human brain and the earth-ionospheric cavity.	[Saroka, Kevin S.; Vares, David E.; Persinger, Michael A.] Laurentian Univ, Behav Neurosci Lab, Sudbury, ON P3E 2C6, Canada; [Saroka, Kevin S.; Vares, David E.; Persinger, Michael A.] Laurentian Univ, Human Studies Program, Sudbury, ON P3E 2C6, Canada; [Persinger, Michael A.] Laurentian Univ, Biomol Sci Programs, Sudbury, ON P3E 2C6, Canada	Laurentian University; Laurentian University; Laurentian University	Persinger, MA (corresponding author), Laurentian Univ, Behav Neurosci Lab, Sudbury, ON P3E 2C6, Canada.; Persinger, MA (corresponding author), Laurentian Univ, Human Studies Program, Sudbury, ON P3E 2C6, Canada.; Persinger, MA (corresponding author), Laurentian Univ, Biomol Sci Programs, Sudbury, ON P3E 2C6, Canada.	mpersinger@laurentian.ca						Abeysuriya RG, 2014, CLIN NEUROPHYSIOL, V125, P2016, DOI 10.1016/j.clinph.2014.01.025; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; ANNINOS PA, 1991, INT J NEUROSCI, V60, P141, DOI 10.3109/00207459109080636; Babayev ES, 2007, ADV SPACE RES, V40, P1941, DOI 10.1016/j.asr.2007.02.099; Balazsi G, 2000, PHYS LETT A, V265, P304, DOI 10.1016/S0375-9601(99)00894-4; BALSER M, 1960, NATURE, V188, P638, DOI 10.1038/188638a0; Blinkov SM., 1968, HUMAN BRAIN FIGURES; Booth JN, 2005, INT J NEUROSCI, V115, P1053, DOI 10.1080/00207450590901521; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Campbell WH, 1967, PHYS GEOMAGNETIC, P821; Corradini PL, 2014, BRAIN INJURY, V28, P1317, DOI 10.3109/02699052.2014.916819; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; FRASERSMITH AC, 1975, J GEOPHYS RES-SPACE, V80, P3141, DOI 10.1029/JA080i022p03141; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; Johnson LC, 1980, TECHNIQUES PSYCHOPHY, P329; Khanna A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114163; Koenig T, 2002, NEUROIMAGE, V16, P41, DOI 10.1006/nimg.2002.1070; Koenig T, 1999, EUR ARCH PSY CLIN N, V249, P205, DOI 10.1007/s004060050088; KONIG H, 1960, NATURWISSENSCHAFTEN, V47, P486; KONIG HL, 1981, BIOL EFFECTS ENV ELE; LEHMANN D, 1995, INT J PSYCHOPHYSIOL, V19, P41, DOI 10.1016/0167-8760(94)00072-M; Lehmann D, 1998, INT J PSYCHOPHYSIOL, V29, P1, DOI 10.1016/S0167-8760(97)00098-6; MADDEN T, 1965, REV GEOPHYS, V3, P211, DOI 10.1029/RG003i002p00211; MINAKOV AA, 1992, IZV VUZ RADIOFIZ+, V35, P488; Mulligan BP, 2012, NEUROSCI LETT, V516, P54, DOI 10.1016/j.neulet.2012.03.054; Mulligan BP, 2010, ADV SPACE RES, V45, P940, DOI 10.1016/j.asr.2009.12.008; Nickolaenko A, 2014, SCHUMAN RESONANCE TY; Nunez Paul L., 1995, P68; NUNEZ PL, 1978, ELECTROEN CLIN NEURO, V44, P344, DOI 10.1016/0013-4694(78)90309-7; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Park TS, 2007, NEUROIMAGE, V35, P531, DOI 10.1016/j.neuroimage.2007.01.001; Pasqual-Marquis RD, 2002, METHOD FIND EXP CLIN, V24, pD5; Persinger M. A., 1974, ELF VLF ELECTROMAGNE; Persinger MA, 2012, J CONSCIOUSNESS STUD, V19, P128; Persinger MA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00019; Phan TD, 2000, NATURE, V404, P848, DOI 10.1038/35009050; Pobachenko S. V., 2006, Biophysics, V51, P480, DOI 10.1134/S0006350906030225; Polk C., 1982, CRC HDB ATMOSPHERICS, P111; ROWLAND VERNON, 1967, COND REFLEX, V2, P3; Ryskin G, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/063015; Sandyk R, 1997, J Altern Complement Med, V3, P365, DOI 10.1089/acm.1997.3.365; SANDYK R, 1995, INT J NEUROSCI, V81, P199, DOI 10.3109/00207459509004887; Saroka KS, 2014, NEUROSCI LETT, V560, P126, DOI 10.1016/j.neulet.2013.11.024; Saroka KS, 2014, INT LETT CHE PHYS AS, V39, P166; Schlegel K, 1999, J GEOPHYS RES-SPACE, V104, P10111, DOI 10.1029/1999JA900056; SCHUMANN WO, 1954, NATURWISSENSCHAFTEN, V41, P183, DOI 10.1007/BF00638174; TANAHASHI S, 1976, J ATMOS TERR PHYS, V38, P135, DOI 10.1016/0021-9169(76)90120-3; Wackermann J, 1999, INT J PSYCHOPHYSIOL, V34, P65, DOI 10.1016/S0167-8760(99)00038-0; Whitman JC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00080	50	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146595	10.1371/journal.pone.0146595	http://dx.doi.org/10.1371/journal.pone.0146595			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785376	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400051
J	Slusser-Nore, A; Larson-Casey, JL; Zhang, RW; Zhou, XD; Somji, S; Garrett, SH; Sens, DA; Dunlevy, JR				Slusser-Nore, Andrea; Larson-Casey, Jennifer L.; Zhang, Ruowen; Zhou, Xu Dong; Somji, Seema; Garrett, Scott H.; Sens, Donald A.; Dunlevy, Jane R.			SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As+3- and Cd+2-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC	PLOS ONE			English	Article							GROWTH-FACTOR; PROMOTER HYPERMETHYLATION; GENE-EXPRESSION; PROTEIN; CANCER; PROGRESSION; CADMIUM; BIOLOGY; SPARC/OSTEONECTIN; OSTEONECTIN	Background This laboratory previously analyzed the expression of SPARC in the parental UROtsa cells, their arsenite (As+3) and cadmium (Cd+2)-transformed cell lines, and tumor transplants generated from the transformed cells. It was demonstrated that SPARC expression was down-regulated to background levels in Cd+2-and As+3-transformed UROtsa cells and tumor transplants compared to parental cells. In the present study, the transformed cell lines were stably transfected with a SPARC expression vector to determine the effect of SPARC expression on the ability of the cells to form tumors in immune-compromised mice. Methods Real time PCR, western blotting, immunohistochemistry, and immunofluorescence were used to define the expression of SPARC in the As+3-and Cd+2-transformed cell lines, and urospheres isolated from these cell lines, following their stable transfection with an expression vector containing the SPARC open reading frame (ORF). Transplantation of the cultured cells into immune-compromised mice by subcutaneous injection was used to assess the effect of SPARC expression on tumors generated from the above cell lines and urospheres. Results It was shown that the As+3-and Cd+2-transformed UROtsa cells could undergo stable transfection with a SPARC expression vector and that the transfected cells expressed both SPARC mRNA and secreted protein. Tumors formed from these SPARC-transfected cells were shown to have no expression of SPARC. Urospheres isolated from cultures of the SPARC-transfected As+3-and Cd+2-transformed cell lines were shown to have only background expression of SPARC. Urospheres from both the non-transfected and SPARC-transfected cell lines were tumorigenic and thus fit the definition for a population of tumor initiating cells. Conclusions Tumor initiating cells isolated from SPARC-transfected As+3-and Cd+2-transformed cell lines have an inherent mechanism to suppress the expression of SPARC mRNA.	[Slusser-Nore, Andrea; Zhang, Ruowen; Zhou, Xu Dong; Somji, Seema; Garrett, Scott H.; Sens, Donald A.] Univ N Dakota, Dept Pathol, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Larson-Casey, Jennifer L.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Med, Birmingham, AL 35294 USA; [Slusser-Nore, Andrea; Dunlevy, Jane R.] Univ N Dakota, Dept Basic Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; University of Alabama System; University of Alabama Birmingham; University of North Dakota Grand Forks	Dunlevy, JR (corresponding author), Univ N Dakota, Dept Basic Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA.	jane.dunlevy@med.und.edu	Casey, Jennifer/N-8385-2019	Casey, Jennifer/0000-0001-7238-7986; Zhang, Ruowen/0000-0003-1403-2356	Department of Pathology; School of Medicine and Health Sciences, University of North Dakota; ND INBRE program from the National Institute of General Medical Sciences, National Institutes of Health [P20 GM103442]; NATIONAL CANCER INSTITUTE [T32CA078586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER	Department of Pathology; School of Medicine and Health Sciences, University of North Dakota; ND INBRE program from the National Institute of General Medical Sciences, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funds were provided by the Department of Pathology and the School of Medicine and Health Sciences, University of North Dakota. Undergraduate research, student mentoring and core facilities for bioinformatics and statistics were supported by the ND INBRE program project P20 GM103442 from the National Institute of General Medical Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff CJ, 2009, CURR OPIN ONCOL, V21, P272, DOI 10.1097/CCO.0b013e328329f184; Cao L, 2010, J APPL TOXICOL, V30, P416, DOI 10.1002/jat.1513; Cheetham S, 2008, BRIT J CANCER, V98, P1810, DOI 10.1038/sj.bjc.6604377; Delostrinos CF, 2006, J CELL PHYSIOL, V206, P211, DOI 10.1002/jcp.20462; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Gilles C, 1998, CANCER RES, V58, P5529; Golembieski WA, 1999, INT J DEV NEUROSCI, V17, P463, DOI 10.1016/S0736-5748(99)00009-X; Hatina J, 2012, NEOPLASMA, V59, P728, DOI 10.4149/neo_2012_089; Hudson AE, 2005, J CELL PHYSIOL, V202, P453, DOI 10.1002/jcp.20140; Johnen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064139; Koukourakis MI, 2003, CANCER RES, V63, P5376; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Larson J, 2010, TOXICOL LETT, V199, P166, DOI 10.1016/j.toxlet.2010.08.020; Ledda F, 1997, J INVEST DERMATOL, V108, P210, DOI 10.1111/1523-1747.ep12334263; Liang JF, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-71; Mok SC, 1996, ONCOGENE, V12, P1895; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Petzoldt JL, 1995, UROL RES, V23, P377, DOI 10.1007/BF00698738; Podhajcer OL, 2008, CANCER METAST REV, V27, P691, DOI 10.1007/s10555-008-9146-7; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Ribeiro N, 2014, J CELL BIOCHEM, V115, P17, DOI 10.1002/jcb.24649; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Said N, 2013, J CLIN INVEST, V123, P4089, DOI 10.1172/JCI71241; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Sens DA, 2004, TOXICOL SCI, V79, P56, DOI 10.1093/toxsci/kfh086; Somji S, 2010, CHEM RES TOXICOL, V23, P348, DOI 10.1021/tx900346q; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Watkins G, 2005, PROSTAG LEUKOTR ESS, V72, P267, DOI 10.1016/j.plefa.2004.12.003; Witkiewicz AK, 2010, CANCER BIOL THER, V10, P391, DOI 10.4161/cbt.10.4.12449; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yang EN, 2007, INT J CANCER, V121, P567, DOI 10.1002/ijc.22706	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147362	10.1371/journal.pone.0147362	http://dx.doi.org/10.1371/journal.pone.0147362			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783756	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400141
J	Krull, CR; Stanley, MC; Burns, BR; Choquenot, D; Etherington, TR				Krull, Cheryl R.; Stanley, Margaret C.; Burns, Bruce R.; Choquenot, David; Etherington, Thomas R.			Reducing Wildlife Damage with Cost-Effective Management Programmes	PLOS ONE			English	Article							PREDATOR-PREY THEORY; FERAL PIG DIGGINGS; SUS-SCROFA; FOREST; BOAR; IMPACTS; CONSERVATION; AUSTRALIA; EMPHASIS	Limiting the impact of wildlife damage in a cost effective manner requires an understanding of how control inputs change the occurrence of damage through their effect on animal density. Despite this, there are few studies linking wildlife management (control), with changes in animal abundance and prevailing levels of wildlife damage. We use the impact and management of wild pigs as a case study to demonstrate this linkage. Ground disturbance by wild pigs has become a conservation issue of global concern because of its potential effects on successional changes in vegetation structure and composition, habitat for other species, and functional soil properties. In this study, we used a 3-year pig control programme (ground hunting) undertaken in a temperate rainforest area of northern New Zealand to evaluate effects on pig abundance, and patterns and rates of ground disturbance and ground disturbance recovery and the cost effectiveness of differing control strategies. Control reduced pig densities by over a third of the estimated carrying capacity, but more than halved average prevailing ground disturbance. Rates of new ground disturbance accelerated with increasing pig density, while rates of ground disturbance recovery were not related to prevailing pig density. Stochastic simulation models based on the measured relationships between control, pig density and rate of ground disturbance and recovery indicated that control could reduce ground disturbance substantially. However, the rate at which prevailing ground disturbance was reduced diminished rapidly as more intense, and hence expensive, pig control regimes were simulated. The model produced in this study provides a framework that links conservation of indigenous ecological communities to control inputs through the reduction of wildlife damage and suggests that managers should consider carefully the marginal cost of higher investment in wildlife damage control, relative to its marginal conservation return.	[Krull, Cheryl R.] AUT Univ, Inst Appl Ecol New Zealand, Auckland, New Zealand; [Stanley, Margaret C.; Burns, Bruce R.] Univ Auckland, Ctr Biodivers & Biosecur, Auckland 1, New Zealand; [Choquenot, David] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Etherington, Thomas R.] Royal Bot Gardens Kew, Wakehurst Pl, Ardingly, England; [Etherington, Thomas R.] Univ Auckland, Sch Environm, Auckland 1, New Zealand	Auckland University of Technology; University of Auckland; University of Canberra; Royal Botanic Gardens, Kew; University of Auckland	Krull, CR (corresponding author), AUT Univ, Inst Appl Ecol New Zealand, Auckland, New Zealand.	ckrull@aut.ac.nz	Burns, B R/A-1974-2014	Etherington, Thomas/0000-0002-3187-075X; Burns, Bruce/0000-0002-5002-4823	University of Auckland; Auckland Council; Manaaki Whenua Landcare Research	University of Auckland; Auckland Council; Manaaki Whenua Landcare Research	This study was funded by the University of Auckland (CK), Auckland Council (CK) and Manaaki Whenua Landcare Research (CK). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. However, council staff members were involved in the collection of data.	Alexiou P. N., 1983, Proceedings of the Ecological Society of Australia, V12, P135; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 1996, MANAGING VERTEBRATE; Barrios-Garcia MN, 2013, AUSTRAL ECOL, V38, P884, DOI 10.1111/aec.12027; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; BOWMAN DMJS, 1991, WILDLIFE RES, V18, P761, DOI 10.1071/WR9910761; BRATTON SP, 1975, ECOLOGY, V56, P1356, DOI 10.2307/1934702; Bueno CG, 2009, J ZOOL, V279, P195, DOI 10.1111/j.1469-7998.2009.00607.x; CALEY P, 1995, WILDLIFE RES, V22, P147, DOI 10.1071/WR9950147; Campbell TA, 2009, FOREST ECOL MANAG, V257, P2319, DOI 10.1016/j.foreco.2009.03.036; Caughley G., 1977, Analysis of vertebrate populations.; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Chavarria Pedro M., 2007, Human-Wildlife Conflicts, V1, P199; Choquenot D, 1998, J ANIM ECOL, V67, P887, DOI 10.1046/j.1365-2656.1998.6760887.x; Choquenot D, 1999, WILDLIFE RES, V26, P251, DOI 10.1071/WR98006; Choquenot D, 2001, BIOL CONSERV, V99, P29, DOI 10.1016/S0006-3207(00)00186-5; Choquenot D, 2005, P 13 AUSTR VERT PEST, P275; Conover MR, 2001, RESOLVING HUMAN WILD; Conway GR, 1981, THEORETICAL ECOLOGY, P356; Cushman JH, 2004, ECOL APPL, V14, P1746, DOI 10.1890/03-5142; Cuthbert R, 2002, BIOL CONSERV, V108, P69, DOI 10.1016/S0006-3207(02)00091-5; Dexter N, 1990, R1190 BUR RUR RES; Diong CH., 1982, T INT UNION GAME BIO, V14, P381; Engeman RM, 2007, BIOL CONSERV, V134, P440, DOI 10.1016/j.biocon.2006.08.033; Esler A.E, 1983, TANE, V29, P109, DOI DOI 10.1093/ANALYS/ANY035; Fordham D, 2006, BIOL CONSERV, V133, P379, DOI 10.1016/j.biocon.2006.07.001; GARROTT RA, 1993, CONSERV BIOL, V7, P946, DOI 10.1046/j.1523-1739.1993.740946.x; Giles J., 1980, DISSERTATION; Holling C. S., 1959, Canadian Entomologist, V91, P385; HONE J, 1990, AUST WILDLIFE RES, V17, P123, DOI 10.1071/WR9900123; HONE J, 1983, AUST WILDLIFE RES, V10, P269; HONE J, 1990, AUST WILDLIFE RES, V17, P131; HONE J, 1988, AUST J ECOL, V13, P393, DOI 10.1111/j.1442-9993.1988.tb00987.x; Hone J, 2002, BIOL CONSERV, V105, P231, DOI 10.1016/S0006-3207(01)00185-9; HONE J, 1989, WILDLIFE SOC B, V17, P419; HONE J, 1995, J APPL ECOL, V32, P311, DOI 10.2307/2405098; Hone J., 1994, ANAL VERTEBRATE PEST; Hone J., 2012, APPL POPULATION COMM; Hone J., 2007, WILDLIFE DAMAGE CONT; HOWE TD, 1981, J WILDLIFE MANAGE, V45, P748, DOI 10.2307/3808713; Ickes K, 2003, J ECOL, V91, P222, DOI 10.1046/j.1365-2745.2003.00767.x; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Krull CR, 2016, NEW ZEAL J ECOL, V40, P191; Krull CR, 2013, BIOL INVASIONS, V15, P2193, DOI 10.1007/s10530-013-0444-9; Krull CR, 2013, AUSTRAL ECOL, V38, P534, DOI 10.1111/j.1442-9993.2012.02444.x; Laurance WF, 1997, WILDLIFE RES, V24, P579, DOI 10.1071/WR96029; Leslie PH, 1939, J ANIM ECOL, V8, P94, DOI 10.2307/1255; Li A, 2010, 5 IUFRO PHYT DIS FOR; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mitchell J, 2007, WILDLIFE RES, V34, P597, DOI 10.1071/WR06064; Mitchell J, 2007, WILDLIFE RES, V34, P603, DOI 10.1071/WR06065; Mohr D, 2005, SOIL BIOL BIOCHEM, V37, P693, DOI 10.1016/j.soilbio.2004.10.002; Peters HA, 2001, BIOTROPICA, V33, P60, DOI 10.1111/j.1744-7429.2001.tb00157.x; RALPH CJ, 1984, BIOL CONSERV, V30, P291, DOI 10.1016/0006-3207(84)90048-X; Rollins D, 2001, WILDLIFE SOC B, V29, P39; SAUNDERS G, 1988, AUST WILDLIFE RES, V15, P73, DOI 10.1071/WR9880073; SINGER FJ, 1984, J WILDLIFE MANAGE, V48, P464, DOI 10.2307/3801179; SPATZ G, 1975, Phytocoenologia, V3, P346; Sweitzer R. A., 2002, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P219; THOMSON C, 1988, NEW ZEAL J ECOL, V11, P73	61	12	12	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146765	10.1371/journal.pone.0146765	http://dx.doi.org/10.1371/journal.pone.0146765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771384	Green Submitted, Green Published, gold			2022-12-26	WOS:000368628300033
J	Qiu, ZX; Sun, RF; Mo, XM; Li, WM				Qiu, Zhi-Xin; Sun, Rong-Fei; Mo, Xian-Ming; Li, Wei-Min			The p70S6K Specific Inhibitor PF-4708671 Impedes Non-Small Cell Lung Cancer Growth	PLOS ONE			English	Article							S6 KINASE; PHOSPHORYLATION; OVEREXPRESSION; AMPLIFICATION; TRANSLATION; EXPRESSION; PREDICTS; TARGET; MTOR	Background As a serine/threonine protein kinase, p70S6K plays an important role in tumor cells. Evidence has revealed overexpression of p70S6K and phosphorylated p70S6K (p-p70S6K) in various tumor tissues, with these proteins identified as independent prognostic markers in non-small cell lung cancer (NSCLC). In this study, we explored the role of the p70S6K specific inhibitor PF-4708671 in NSCLC. Methods Three NSCLC cell lines (A549, SK-MES-1, and NCI-H460) were treated with PF-4708671 at five different concentrations, including 0.1 mu M, 0.3 mu M, 1 mu M, 3 mu M and 10 mu M, and protein levels were determined by Western-blot. Then, PF-4708671's effects were assessed both in vitro (cell proliferation, apoptosis, cell cycle distribution, and invasion) and in vivo. Results The expression levels of p-p70S6K and the downstream effector S6 were significantly reduced by PF-4708671. Diametrically opposite, the downstream protein levels of BAD, Caspase3 and ERK had increased after treatment with PF-4708671. In addition, PF-4708671 drastically inhibited cell proliferation and invasion ability in A549, SK-MES-1 and NCI-H460 cells in vitro, causing cell cycle arrest in G0-G1 phase. Limited effects of PF-4708671 were observed on apoptosis in the three NSCLC cell lines assessed. Importantly, PF-4708671 could inhibit tumorigenesis in nude mice in vivo. Conclusion These findings demonstrated that the p70S6K specific inhibitor PF-4708671 has inhibitory effects on NSCLC tumorigenesis in vitro and in vivo. Therefore, P70S6K should be considered a new potential therapeutic target, and PF-470867 may be used as targeted drug for cancer treatment.	[Qiu, Zhi-Xin; Li, Wei-Min] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610041, Peoples R China; [Sun, Rong-Fei] Tianjin First Cent Hosp, Dept Resp Med, Tianjin 300192, Peoples R China; [Mo, Xian-Ming] Sichuan Univ, Lab Stem Cell Biol, State Key Lab Biotherapy, West China Hosp, Chengdu 610041, Peoples R China	Sichuan University; Tianjin Medical University; Sichuan University	Li, WM (corresponding author), Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610041, Peoples R China.	weimi003@yahoo.com	qiu, zhixin/HHC-0554-2022	qiu, zhixin/0000-0003-0256-4419	National Natural Science Foundation of China [81372504]; Science and Technology Support Program of Science and Technology Department of Sichuan Province [2014SZ-0148]; International Cooperation Program of Science and Technology Department of Sichuan Province [2014AA022202-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program of Science and Technology Department of Sichuan Province; International Cooperation Program of Science and Technology Department of Sichuan Province	This work was supported by the National Natural Science Foundation of China (No. 81372504), the Science and Technology Support Program of Science and Technology Department of Sichuan Province (2014SZ-0148), and the International Cooperation Program of Science and Technology Department of Sichuan Province (2014AA022202-2).	Baba HA, 2009, LIVER INT, V29, P399, DOI 10.1111/j.1478-3231.2008.01798.x; Barlund M, 2000, CANCER RES, V60, P5340; Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; Bian CX, 2010, BIOCHEM BIOPH RES CO, V398, P395, DOI 10.1016/j.bbrc.2010.06.080; Bussenius J, 2012, BIOORG MED CHEM LETT, V22, P2283, DOI 10.1016/j.bmcl.2012.01.105; Du W, 2013, LAB INVEST, V93, P1115, DOI 10.1038/labinvest.2013.98; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Filonenko VV, 2004, EXP ONCOL, V26, P294; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Ip CKM, 2012, EXPERT OPIN THER TAR, V16, P619, DOI 10.1517/14728222.2012.684680; Kim EK, 2013, ANTICANCER RES, V33, P4073; Kohler BA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv048; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Li PD, 2012, MED ONCOL, V29, P3070, DOI 10.1007/s12032-012-0268-y; Liu D, 2011, CANCER-AM CANCER SOC, V117, P3763, DOI 10.1002/cncr.25959; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Nakamura JL, 2008, CANCER RES, V68, P6516, DOI 10.1158/0008-5472.CAN-07-6188; Nozawa H, 2007, CANCER LETT, V251, P105, DOI 10.1016/j.canlet.2006.11.008; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Perez-Tenorio G, 2011, BREAST CANCER RES TR, V128, P713, DOI 10.1007/s10549-010-1058-x; Sahin F, 2004, CLIN CANCER RES, V10, P8421, DOI 10.1158/1078-0432.CCR-04-0941; Tolcher A, 2014, EUR J CANCER, V50, P867, DOI 10.1016/j.ejca.2013.11.039; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Yoshida S, 2013, ANTICANCER RES, V33, P469; Zhang Y, 2013, ASIAN PAC J CANCER P, V14, P3725, DOI 10.7314/APJCP.2013.14.6.3725	29	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147185	10.1371/journal.pone.0147185	http://dx.doi.org/10.1371/journal.pone.0147185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771549	gold, Green Submitted, Green Published			2022-12-26	WOS:000368628300070
J	Bilova, T; Lukasheva, E; Brauch, D; Greifenhagen, U; Paudel, G; Tarakhovskaya, E; Frolova, N; Mittasch, J; Balcke, GU; Tissier, A; Osmolovskaya, N; Vogt, T; Wessjohann, LA; Birkemeyer, C; Milkowski, C; Frolov, A				Bilova, Tatiana; Lukasheva, Elena; Brauch, Dominic; Greifenhagen, Uta; Paudel, Gagan; Tarakhovskaya, Elena; Frolova, Nadezhda; Mittasch, Juliane; Balcke, Gerd Ulrich; Tissier, Alain; Osmolovskaya, Natalia; Vogt, Thomas; Wessjohann, Ludger A.; Birkemeyer, Claudia; Milkowski, Carsten; Frolov, Andrej			A Snapshot of the Plant Glycated Proteome STRUCTURAL, FUNCTIONAL, AND MECHANISTIC ASPECTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; END-PRODUCTS; HUMAN PLASMA; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; AUTOXIDATIVE GLYCOSYLATION; ARGININE RESIDUES; SKELETAL-MUSCLE; IN-VITRO; PROTEINS; IDENTIFICATION	Glycation is the reaction of carbonyl compounds (reducing sugars and alpha-dicarbonyls) with amino acids, lipids, and proteins, yielding early and advanced glycation end products (AGEs). The AGEs can be formed via degradation of early glycation intermediates (glycoxidation) and by interaction with the products of monosaccharide autoxidation (autoxidative glycosylation). Although formation of these potentially deleterious compounds is well characterized in animal systems and thermally treated foods, only a little information about advanced glycation in plants is available. Thus, the knowledge of the plant AGE patterns and the underlying pathways of their formation are completely missing. To fill this gap, we describe the AGE-modified proteome of Brassica napus and characterize individual sites of advanced glycation by the methods of liquid chromatography-based bottom-up proteomics. The modification patterns were complex but reproducible: 789 AGE-modified peptides in 772 proteins were detected in two independent experiments. In contrast, only 168 polypeptides contained early glycated lysines, which did not resemble the sites of advanced glycation. Similar observations were made with Arabidopsis thaliana. The absence of the early glycated precursors of the AGE-modified protein residues indicated autoxidative glycosylation, but not glycoxidation, as the major pathway of AGE formation. To prove this assumption and to identify the potential modifying agents, we estimated the reactivity and glycative potential of plant-derived sugars using a model peptide approach and liquid chromatography-mass spectrometry-based techniques. Evaluation of these data sets together with the assessed tissue carbohydrate contents revealed dihydroxyacetone phosphate, glyceraldehyde 3-phosphate, ribulose, erythrose, and sucrose as potential precursors of plant AGEs.	[Bilova, Tatiana; Paudel, Gagan; Wessjohann, Ludger A.; Frolov, Andrej] Leibniz Inst Plant Biochem IPB, Dept Bioorgan Chem, D-06120 Halle, Saale, Germany; [Balcke, Gerd Ulrich; Tissier, Alain; Vogt, Thomas] Leibniz Inst Plant Biochem IPB, Dept Cell & Metab Biol, D-06120 Halle, Saale, Germany; [Bilova, Tatiana; Brauch, Dominic; Greifenhagen, Uta; Paudel, Gagan; Birkemeyer, Claudia; Frolov, Andrej] Univ Leipzig, Fac Chem & Mineral, D-04103 Leipzig, Germany; [Lukasheva, Elena] St Petersburg State Univ, Fac Biol, Dept Biochem, St Petersburg 199034, Russia; [Lukasheva, Elena; Tarakhovskaya, Elena; Osmolovskaya, Natalia] St Petersburg State Univ, Fac Biol, Dept Plant Physiol & Biochem, St Petersburg 199034, Russia; [Brauch, Dominic] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Stadt Seeland, Germany; [Frolova, Nadezhda; Mittasch, Juliane; Milkowski, Carsten] Univ Halle Wittenberg, Interdisciplinary Ctr Crop Plant Res IZN, D-06120 Halle, Saale, Germany	Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie; Leipzig University; Saint Petersburg State University; Saint Petersburg State University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Martin Luther University Halle Wittenberg	Frolov, A (corresponding author), Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Weinberg 3, D-06120 Halle, Saale, Germany.	afrolov@ipb-halle.de	Osmolovskaya, Natalia G./G-2226-2015; Lukasheva, Elena/V-1195-2019; Tissier, Alain F/B-2108-2017; Frolova, Nadezhda/AAT-5791-2020; Wessjohann, Ludger/AAZ-3838-2021; Tarakhovskaya, Elena/Y-8165-2019; Frolov, Andrej A/V-5550-2018; Lukasheva, Elena/U-4334-2017; Tarakhovskaya, Elena R./I-7458-2013; Bilova, Tatiana E./M-2405-2015; Birkemeyer, Claudia/L-8687-2015	Osmolovskaya, Natalia G./0000-0001-8764-8552; Lukasheva, Elena/0000-0002-0889-2395; Tissier, Alain F/0000-0002-9406-4245; Tarakhovskaya, Elena/0000-0002-5341-2813; Lukasheva, Elena/0000-0002-0889-2395; Tarakhovskaya, Elena R./0000-0002-5341-2813; Bilova, Tatiana E./0000-0002-6024-3667; Herfurth, Uta/0000-0002-3883-3230; Frolova, Nadezhda/0000-0002-1895-1133; Birkemeyer, Claudia/0000-0002-8538-8838; Wessjohann, Ludger A./0000-0003-2060-8235; Milkowski, Carsten/0000-0001-9758-6789	Deutsche Forschungsgemeinschaft [FR-3117/2-1]; Ernst-Schering Foundation; Deutscher Akademischer Austauschdienst DAAD; St. Petersburg University [1.38.233.2014]; Leibniz Association	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst-Schering Foundation; Deutscher Akademischer Austauschdienst DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); St. Petersburg University; Leibniz Association	This work was supported by Deutsche Forschungsgemeinschaft Grant FR-3117/2-1 (to A. F., G. P., and T. B.), the Ernst-Schering Foundation (to U. G.), the Deutscher Akademischer Austauschdienst DAAD Program "Dmitry Mendeleev" (to E. T. and E. L.), and St. Petersburg University Grant 1.38.233.2014 (to E. L.). The publication of this article was funded by the Open Access fund of the Leibniz Association. The authors declare that they have no conflicts of interest with the contents of this article.	Abordo EA, 1999, BIOCHEM PHARMACOL, V58, P641, DOI 10.1016/S0006-2952(99)00132-X; Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; AHMED MU, 1986, J BIOL CHEM, V261, P4889; Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Ahmed N, 2005, DIABETES CARE, V28, P2465, DOI 10.2337/diacare.28.10.2465; Baraka-Vidot J, 2012, BIOCHIMIE, V94, P1960, DOI 10.1016/j.biochi.2012.05.017; Bechtold U, 2009, PLANT J, V59, P661, DOI 10.1111/j.1365-313X.2009.03898.x; Bollineni RC, 2014, J PROTEOME RES, V13, P5081, DOI 10.1021/pr500324y; Bou R, 2008, ANAL BIOCHEM, V377, P1, DOI 10.1016/j.ab.2008.02.029; Cellar NA, 2008, J CHROMATOGR B, V861, P29, DOI 10.1016/j.jchromb.2007.11.024; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Fortpied J, 2005, BIOCHEM J, V388, P795, DOI 10.1042/BJ20041976; Frolov A, 2008, ANN NY ACAD SCI, V1126, P253, DOI 10.1196/annals.1433.060; Frolov A, 2014, ANAL BIOANAL CHEM, V406, P5755, DOI 10.1007/s00216-014-8018-y; Frolov A, 2014, J AGR FOOD CHEM, V62, P3626, DOI 10.1021/jf4050183; Frolov A, 2010, ANAL BIOANAL CHEM, V397, P2349, DOI 10.1007/s00216-010-3810-9; Greifenhagen U, 2015, AMINO ACIDS, V47, P1065, DOI 10.1007/s00726-015-1940-2; Greifenhagen U, 2015, J PROTEOME RES, V14, P768, DOI 10.1021/pr500799m; Griffiths G, 2000, J EXP BOT, V51, P1363, DOI 10.1093/jexbot/51.349.1363; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; Hamada Y, 1996, BIOCHEM BIOPH RES CO, V228, P539, DOI 10.1006/bbrc.1996.1695; HAYASHI T, 1980, AGR BIOL CHEM TOKYO, V44, P2575, DOI 10.1080/00021369.1980.10864377; HENLE T, 1994, Z LEBENSM UNTERS FOR, V199, P55, DOI 10.1007/BF01192954; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; HEYNS K, 1962, CHEM BER-RECL, V95, P720, DOI 10.1002/cber.19620950323; HODGE JE, 1955, ADV CARBOHYD CHEM, V10, P169, DOI 10.1016/S0096-5332(08)60392-6; Hori M, 2012, ANTIAGING MED, V9, P125; Huang CH, 2005, J EXP BOT, V56, P3041, DOI 10.1093/jxb/eri301; Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247; Manini P, 2006, CARBOHYD RES, V341, P1828, DOI 10.1016/j.carres.2006.03.027; Miele C, 2003, J BIOL CHEM, V278, P47376, DOI 10.1074/jbc.M301088200; Milkovska-Stamenova S, 2015, J AGR FOOD CHEM, V63, P5911, DOI 10.1021/jf505757m; Morgan F, 1999, INT J FOOD SCI TECH, V34, P429, DOI 10.1046/j.1365-2621.1999.00318.x; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Rabbani N, 2008, ANN NY ACAD SCI, V1126, P124, DOI 10.1196/annals.1433.043; Rich D.H., 1979, PEPTIDES ANAL SYNTHE, V1, P241, DOI [10.1016/B978-0-12-304201-9.50011-4, DOI 10.1016/B978-0-12-304201-9.50011-4]; Schmidt R, 2015, J MASS SPECTROM, V50, P613, DOI 10.1002/jms.3569; Schwarzenbolz U, 1997, Z LEBENSM UNTERS F A, V205, P121, DOI 10.1007/s002170050137; Sebekova K, 1998, CELL MOL BIOL, V44, P1051; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Singer D, 2010, ANAL CHEM, V82, P6409, DOI 10.1021/ac100473k; Singla-Pareek SL, 2008, TRANSGENIC RES, V17, P171, DOI 10.1007/s11248-007-9082-2; Snow LM, 2007, J GERONTOL A-BIOL, V62, P1204, DOI 10.1093/gerona/62.11.1204; SYROVY I, 1994, J BIOCHEM BIOPH METH, V28, P115, DOI 10.1016/0165-022X(94)90025-6; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; Weiss MF, 2000, KIDNEY INT, V57, P2571, DOI 10.1046/j.1523-1755.2000.00117.x; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; WOLFF SP, 1988, BIOCHEM J, V249, P618, DOI 10.1042/bj2490618; Yamauchi Y, 2003, J BIOCHEM, V134, P251, DOI 10.1093/jb/mvg138; Yamauchi Y, 2002, PLANT CELL PHYSIOL, V43, P1334, DOI 10.1093/pcp/pcf162; Yan H, 1997, BIOCHEM J, V328, P599, DOI 10.1042/bj3280599; Zhang QB, 2008, J PROTEOME RES, V7, P2025, DOI 10.1021/pr700763r; Zhang QB, 2011, J PROTEOME RES, V10, P3076, DOI 10.1021/pr200040j; Zoccali C, 2000, NEPHROL DIAL TRANSPL, V15, P7, DOI 10.1093/ndt/15.suppl_1.7	55	32	37	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7621	7636		10.1074/jbc.M115.678581	http://dx.doi.org/10.1074/jbc.M115.678581			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26786108	Green Published, hybrid			2022-12-26	WOS:000383447600034
J	Lum, MA; Barger, CJ; Hsu, AH; Leontieva, OV; Black, AR; Black, JD				Lum, Michelle A.; Barger, Carter J.; Hsu, Alice H.; Leontieva, Olga V.; Black, Adrian R.; Black, Jennifer D.			Protein Kinase C (PKC) Is Resistant to Long Term Desensitization/Down-regulation by Prolonged Diacylglycerol Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); diacylglycerol; heat shock protein 90 (Hsp90); lipid raft; protein degradation; protein kinase C (PKC); protein phosphorylation; signal transduction; PKC; desensitization	INTESTINAL EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; DOWN-REGULATION; PLASMA-MEMBRANE; LIPID RAFTS; PHOSPHOLIPASE-D; DIFFERENTIAL REGULATION; TUMOR-FORMATION; LIVING CELLS; CYCLE ARREST	Sustained activation of PKC is required for long term physiological responses, such as growth arrest and differentiation. However, studies with pharmacological agonists (e.g. phorbol 12-myristate 13-acetate (PMA)) indicate that prolonged stimulation leads to PKC desensitization via dephosphorylation and/or degradation. The current study analyzed effects of chronic stimulation with the physiological agonist diacylglycerol. Repeated addition of 1,2-dioctanoyl-sn-glycerol (DiC(8)) resulted in sustained plasma membrane association of PKC in a pattern comparable with that induced by PMA. However, although PMA potently down-regulated PKC, prolonged activation by DiC(8) failed to engage known desensitization mechanisms, with the enzyme remaining membrane-associated and able to support sustained downstream signaling. DiC(8)-activated PKC did not undergo dephosphorylation, ubiquitination, or internalization, early events in PKC desensitization. Although DiC(8) efficiently down-regulated novel PKCs PKC and PKCE, differences in Ca2+ sensitivity and diacylglycerol affinity were excluded as mediators of the selective resistance of PKC. Roles for Hsp/Hsc70 and Hsp90 were also excluded. PMA, but not DiC(8), targeted PKC to detergent-resistant membranes, and disruption of these domains with cholesterol-binding agents demonstrated a role for differential membrane compartmentalization in selective agonist-induced degradation. Chronic DiC(8) treatment failed to desensitize PKC in several cell types and did not affect PKCI; thus, conventional PKCs appear generally insensitive to desensitization by sustained diacylglycerol stimulation. Consistent with this conclusion, prolonged (several-day) membrane association/activation of PKC is seen in self-renewing epithelium of the intestine, cervix, and skin. PKC deficiency affects gene expression, differentiation, and tumorigenesis in these tissues, highlighting the importance of mechanisms that protect PKC from desensitization in vivo.	[Lum, Michelle A.; Barger, Carter J.; Hsu, Alice H.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Lum, Michelle A.; Barger, Carter J.; Hsu, Alice H.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska, Med Ctr, Fred & Pamela Buffet Canc Ctr, Omaha, NE 68198 USA; [Lum, Michelle A.; Leontieva, Olga V.; Black, Adrian R.; Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Roswell Park Cancer Institute	Black, JD (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	jennifer.black@unmc.edu		Barger, Carter/0000-0002-1508-0504	National Institutes of Health [DK060632, DK054909, CA191894, CA016056, CA036727, CA009476]; NATIONAL CANCER INSTITUTE [R21CA191894, T32CA009476, P30CA016056, P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060632, R56DK060632, R01DK054909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants DK060632, DK054909, CA191894, CA016056, and CA036727 and T32 Award CA009476 (to C. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrahamsen H, 2012, J BIOL CHEM, V287, P13262, DOI 10.1074/jbc.M112.349753; Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Antal CE, 2014, BIOCHEM SOC T, V42, P1477, DOI 10.1042/BST20140172; Antal CE, 2014, CHEM BIOL, V21, P459, DOI 10.1016/j.chembiol.2014.02.008; ASAOKA Y, 1991, P NATL ACAD SCI USA, V88, P8681, DOI 10.1073/pnas.88.19.8681; Assender JW, 1996, ACTA PHYSIOL SCAND, V157, P451, DOI 10.1046/j.1365-201X.1996.511285000.x; Becker KP, 2005, CELL MOL LIFE SCI, V62, P1448, DOI 10.1007/s00018-005-4531-7; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; BERRY N, 1990, P NATL ACAD SCI USA, V87, P2294, DOI 10.1073/pnas.87.6.2294; BISHOP WR, 1986, J BIOL CHEM, V261, P2513; Black AR, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00423; Black JD, 2001, GASTROENTEROLOGY, V120, P1868, DOI 10.1053/gast.2001.25287; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Black JD, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P155, DOI 10.1007/978-1-60761-543-9_8; Botto L, 2007, J NEUROSCI RES, V85, P443, DOI 10.1002/jnr.21111; Cheng W, 2012, J BIOL CHEM, V287, P26126, DOI 10.1074/jbc.M112.342170; Chiosis G, 2003, MOL CANCER THER, V2, P123; Chiu T, 2003, AM J PHYSIOL-GASTR L, V285, pG1, DOI 10.1152/ajpgi.00419.2002; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; Diaz O, 2005, J IMMUNOL, V175, P8077, DOI 10.4049/jimmunol.175.12.8077; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; EBELING JG, 1985, P NATL ACAD SCI USA, V82, P815, DOI 10.1073/pnas.82.3.815; Egea-Jimenez AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069041; Eichmann TO, 2015, CELL MOL LIFE SCI, V72, P3931, DOI 10.1007/s00018-015-1982-3; Farah CA, 2012, ADV EXP MED BIOL, V740, P663, DOI 10.1007/978-94-007-2888-2_29; Feng X, 2000, J BIOL CHEM, V275, P17024, DOI 10.1074/jbc.275.22.17024; FLORINCHRISTENSEN J, 1992, J BIOL CHEM, V267, P14783; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Frey MR, 2000, J CELL BIOL, V151, P763, DOI 10.1083/jcb.151.4.763; Frey MR, 1997, J BIOL CHEM, V272, P9424; Gao TY, 2006, J BIOL CHEM, V281, P32461, DOI 10.1074/jbc.M604076200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Goodell AL, 1996, J INVEST DERMATOL, V107, P354, DOI 10.1111/1523-1747.ep12363325; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hao F, 2011, J BIOL CHEM, V286, P18104, DOI 10.1074/jbc.M110.208488; Hara T, 2005, CANCER RES, V65, P7356, DOI 10.1158/0008-5472.CAN-04-4241; Hizli AA, 2006, J BIOL CHEM, V281, P14596, DOI 10.1074/jbc.M601959200; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Hu TH, 2005, BIOCHEM BIOPH RES CO, V327, P1047, DOI 10.1016/j.bbrc.2004.12.117; Igumenova TI, 2015, BIOCHEMISTRY-US, V54, P4953, DOI 10.1021/acs.biochem.5b00565; Jerome-Morais A, 2009, J INVEST DERMATOL, V129, P2365, DOI 10.1038/jid.2009.74; Kazanietz MG, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P1, DOI 10.1007/978-1-60761-543-9; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; KHALIL RA, 1994, AM J PHYSIOL, V266, pC1544, DOI 10.1152/ajpcell.1994.266.6.C1544; Kozak SL, 2002, J VIROL, V76, P1802, DOI 10.1128/JVI.76.4.1802-1815.2002; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Lenz JC, 2002, J CELL BIOL, V159, P291, DOI 10.1083/jcb.200203048; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li JN, 2014, J AM CHEM SOC, V136, P11757, DOI 10.1021/ja505369r; Lum MA, 2013, J BIOL CHEM, V288, P27112, DOI 10.1074/jbc.M112.437095; Lum MA, 2013, J BIOL CHEM, V288, P13093, DOI 10.1074/jbc.M112.437061; Magee AI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-234; Manzow S, 2000, INT J CANCER, V85, P503, DOI 10.1002/(SICI)1097-0215(20000215)85:4<503::AID-IJC10>3.0.CO;2-L; Mateos MV, 2010, BBA-BIOMEMBRANES, V1798, P624, DOI 10.1016/j.bbamem.2009.12.008; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Neill GW, 2003, CANCER RES, V63, P4692; Newton AC, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P9, DOI 10.1007/978-1-60761-543-9_2; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Nowicki S, 2000, AM J PHYSIOL-CELL PH, V279, pC1812, DOI 10.1152/ajpcell.2000.279.6.C1812; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Parolini I, 1999, J BIOL CHEM, V274, P14176, DOI 10.1074/jbc.274.20.14176; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; PRESTA M, 1991, CELL REGUL, V2, P719, DOI 10.1091/mbc.2.9.719; Pysz MA, 2014, J BIOL CHEM, V289, P22268, DOI 10.1074/jbc.M114.571554; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Rybin VO, 1999, CIRC RES, V84, P980, DOI 10.1161/01.RES.84.9.980; Santiskulvong C, 2007, CELL SIGNAL, V19, P1348, DOI 10.1016/j.cellsig.2007.01.006; SEVERSON DL, 1989, AM J PHYSIOL, V256, pC11, DOI 10.1152/ajpcell.1989.256.1.C11; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Stahelin RV, 2005, J BIOL CHEM, V280, P36452, DOI 10.1074/jbc.M506224200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; STENSON WF, 1993, AM J PHYSIOL, V265, pG955, DOI 10.1152/ajpgi.1993.265.5.G955; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; Wang XQ, 2006, J INVEST DERMATOL, V126, P951, DOI 10.1038/sj.jid.5700282; Yen CLE, 2015, J LIPID RES, V56, P489, DOI 10.1194/jlr.R052902; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	88	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6331	6346		10.1074/jbc.M115.696211	http://dx.doi.org/10.1074/jbc.M115.696211			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26769967	Green Published, hybrid			2022-12-26	WOS:000372894200023
J	Pan, DX; Barber, MA; Hornigold, K; Baker, MJ; Toth, JM; Oxley, D; Welch, HCE				Pan, Dingxin; Barber, Mark A.; Hornigold, Kirsti; Baker, Martin J.; Toth, Judit M.; Oxley, David; Welch, Heidi C. E.			Norbin Stimulates the Catalytic Activity and Plasma Membrane Localization of the Guanine-Nucleotide Exchange Factor P-Rex1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; G protein-coupled receptor (GPCR); guanine nucleotide exchange factor (GEF); protein complex; Rac (Rac GTPase); Rho (Rho GTPase); small GTPase; Neurochondrin (NCDN); PREX1; PREX2	BETA-GAMMA-SUBUNITS; OUTGROWTH-RELATED PROTEIN; BREAST-CANCER CELLS; NEURITE-OUTGROWTH; NEUTROPHIL FUNCTION; RHO GTPASES; RAC; NEUROCHONDRIN; ACTIVATION; MIGRATION	P-Rex1 is a guanine-nucleotide exchange factor (GEF) that activates the small G protein (GTPase) Rac1 to control Rac1-dependent cytoskeletal dynamics, and thus cell morphology. Three mechanisms of P-Rex1 regulation are currently known: (i) binding of the phosphoinositide second messenger PIP3, (ii) binding of the G subunits of heterotrimeric G proteins, and (iii) phosphorylation of various serine residues. Using recombinant P-Rex1 protein to search for new binding partners, we isolated the G-protein-coupled receptor (GPCR)-adaptor protein Norbin (Neurochondrin, NCDN) from mouse brain fractions. Coimmunoprecipitation confirmed the interaction between overexpressed P-Rex1 and Norbin in COS-7 cells, as well as between endogenous P-Rex1 and Norbin in HEK-293 cells. Binding assays with purified recombinant proteins showed that their interaction is direct, and mutational analysis revealed that the pleckstrin homology domain of P-Rex1 is required. Rac-GEF activity assays with purified recombinant proteins showed that direct interaction with Norbin increases the basal, PIP3- and G-stimulated Rac-GEF activity of P-Rex1. Pak-CRIB pulldown assays demonstrated that Norbin promotes the P-Rex1-mediated activation of endogenous Rac1 upon stimulation of HEK-293 cells with lysophosphatidic acid. Finally, immunofluorescence microscopy and subcellular fractionation showed that coexpression of P-Rex1 and Norbin induces a robust translocation of both proteins from the cytosol to the plasma membrane, as well as promoting cell spreading, lamellipodia formation, and membrane ruffling, cell morphologies generated by active Rac1. In summary, we have identified a novel mechanism of P-Rex1 regulation through the GPCR-adaptor protein Norbin, a direct P-Rex1 interacting protein that promotes the Rac-GEF activity and membrane localization of P-Rex1.	[Pan, Dingxin; Barber, Mark A.; Hornigold, Kirsti; Baker, Martin J.; Toth, Judit M.; Welch, Heidi C. E.] Babraham Inst, Signalling Programme, Babraham Res Campus, Cambridge CB22 3AT, England; [Oxley, David] Babraham Inst, Mass Spectrometry Facil, Babraham Res Campus, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Welch, HCE (corresponding author), Babraham Inst, Signalling Programme, Babraham Res Campus, Cambridge CB22 3AT, England.	heidi.welch@babraham.ac.uk	Baker, Martin James/AAO-1650-2020; Baker, Martin/AAM-8426-2020; Pan, Dingxin/AAE-1205-2021	Baker, Martin/0000-0002-9743-6294; 	Cambridge Overseas Trust; Cambridge Commonwealth Trust; Biotechnology and Biological Sciences Research Council; United Kindom Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/I02154X/1, 1104302, BBS/E/B/000C0411] Funding Source: researchfish; BBSRC [BB/I02154X/1, BBS/E/B/000C0411] Funding Source: UKRI	Cambridge Overseas Trust; Cambridge Commonwealth Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kindom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by graduate studentships from the Cambridge Overseas Trust (to D. P.), the Cambridge Commonwealth Trust (to M. A. B.), and the Biotechnology and Biological Sciences Research Council (to M. J. B.), as well as by a Strategic Core grant from the United Kindom Biotechnology and Biological Sciences Research Council to the Babraham Institute Signaling Programme. The authors declare that they have no conflicts of interest with the contents of this article.	Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Barber MA, 2012, BIOCHEM J, V443, P173, DOI 10.1042/BJ20112078; Campbell AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053982; Montero JC, 2013, CELL SIGNAL, V25, P2281, DOI 10.1016/j.cellsig.2013.07.018; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Damoulakis G, 2014, J CELL SCI, V127, P2589, DOI 10.1242/jcs.153049; Dateki M, 2005, J BIOL CHEM, V280, P20503, DOI 10.1074/jbc.M414033200; Donald S, 2008, P NATL ACAD SCI USA, V105, P4483, DOI 10.1073/pnas.0712324105; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Francke F, 2006, J BIOL CHEM, V281, P32496, DOI 10.1074/jbc.M602889200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Herter JM, 2013, BLOOD, V121, P2301, DOI 10.1182/blood-2012-09-457085; Hill K, 2006, METHOD ENZYMOL, V406, P26, DOI 10.1016/S0076-6879(06)06003-4; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Hodakoski C, 2014, P NATL ACAD SCI USA, V111, P155, DOI 10.1073/pnas.1213773111; Ishizuka Y, 1999, BBA-MOL CELL RES, V1450, P92, DOI 10.1016/S0167-4889(99)00039-7; Istvanffy R, 2004, DEV GENES EVOL, V214, P206, DOI 10.1007/s00427-004-0396-2; Jackson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011962; Ktistakis NT, 2003, BIOCHEM SOC T, V31, P94, DOI 10.1042/bst0310094; Lawson CD, 2011, J IMMUNOL, V186, P1467, DOI 10.4049/jimmunol.1002738; Li J, 2015, P NATL ACAD SCI USA, V112, pE6964, DOI 10.1073/pnas.1512913112; Lindsay CR, 2015, J INVEST DERMATOL, V135, P314, DOI 10.1038/jid.2014.323; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Lucato CM, 2015, J BIOL CHEM, V290, P20827, DOI 10.1074/jbc.M115.660456; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1913, DOI 10.1074/jbc.M506034200; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; Mense SM, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005840; Mochizuki R, 2003, BIOCHEM BIOPH RES CO, V310, P1219, DOI 10.1016/j.bbrc.2003.09.153; Mochizuki R, 1999, BBA-GENE STRUCT EXPR, V1446, P397, DOI 10.1016/S0167-4781(99)00120-7; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Ohoka Y, 2001, BIOCHEM BIOPH RES CO, V280, P237, DOI 10.1006/bbrc.2000.4080; Oku S, 2013, J BIOL CHEM, V288, P19816, DOI 10.1074/jbc.M112.431676; Pan DX, 2015, BLOOD, V125, P1146, DOI 10.1182/blood-2014-07-591040; Qian F, 2012, ARTERIOSCL THROM VAS, V32, P768, DOI 10.1161/ATVBAHA.111.243675; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schwaibold EMC, 2008, BIOCHEM BIOPH RES CO, V373, P366, DOI 10.1016/j.bbrc.2008.06.042; Shinozaki K, 1999, MOL BRAIN RES, V71, P364, DOI 10.1016/S0169-328X(99)00181-3; Shinozaki K, 1997, BIOCHEM BIOPH RES CO, V240, P766, DOI 10.1006/bbrc.1997.7660; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Urano D, 2008, CELL SIGNAL, V20, P1545, DOI 10.1016/j.cellsig.2008.04.009; Wang H, 2015, P NATL ACAD SCI USA, V112, P9745, DOI 10.1073/pnas.1510291112; Wang Hong, 2010, Commun Integr Biol, V3, P487, DOI 10.4161/cib.3.6.12844; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496; Ward RJ, 2009, J NEUROCHEM, V109, P182, DOI 10.1111/j.1471-4159.2009.05918.x; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Zhao TM, 2007, J LEUKOCYTE BIOL, V81, P1127, DOI 10.1189/jlb.0406251	55	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6359	6375		10.1074/jbc.M115.686592	http://dx.doi.org/10.1074/jbc.M115.686592			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26792863	Green Published, hybrid			2022-12-26	WOS:000372894200025
J	Choi, YJ; Baek, GY; Park, HR; Jo, SK; Jung, U				Choi, Yeo-Jin; Baek, Ga-Young; Park, Hae-Ran; Jo, Sung-Kee; Jung, Uhee			Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines	PLOS ONE			English	Article							HOMEOBOX GENE-EXPRESSION; STEM-CELLS; GROWTH-FACTOR; TUMOR PROGRESSION; RADIOTHERAPY; IDENTIFICATION; METASTASIS; MIGRATION; BIOMARKER; INVASION	The control of radioresistance and metastatic potential of surviving cancer cells is important for improving cancer eradication by radiotheraphy. The distal-less homeobox2 (DLX2) gene encodes for a homeobox transcription factor involved in morphogenesis and its deregulation was found in human solid tumors and hematologic malignancies. Here we investigated the role of DLX2 in association with radiation-induced epithelial to mesenchymal transition (EMT) and stem cell-like properties and its regulation by Smad2/3 signaling in irradiated A549 and MDA-MB-231 human cancer cell lines. In irradiated A549 and MDA-MB-231 cells, EMT was induced as demonstrated by EMT marker expression, phosphorylation of Smad2/3, and migratory and invasive ability. Also, irradiated A549 and MDA-MB-231 cells showed increased cancer stem cells (CSCs) marker. Interestingly, DLX2 was overexpressed upon irradiation. Therefore, we examined the role of DLX2 in radiation-induced EMT and radioresistance. The overexpression of DLX2 alone induced EMT, migration and invasion, and CSC marker expression. The reduced colony-forming ability in irradiated cells was partially restored by DLX2 overexpression. On the other hand, the depletion of DLX2 using si-RNA abolished radiation-induced EMT, CSC marker expression, and phosphorylation of Smad2/3 in irradiated A549 and MDA-MB-231 cells. Also, depletion of DLX2 increased the radiation sensitivity in both cell lines. Moreover, knockdown of Smad2/3, a key activator of TGF-131 pathway, abrogated the radiation-induced DLX2 expression, indicating that radiation-induced DLX2 expression is dependent on Smad2/3 signaling. These results demonstrated that DLX2 plays a crucial role in radioresistance, radiation-induced EMT and CSC marker expression, and the expression of DLX2 is regulated by Smad2/3 signaling in A549 and MDA-MB-231 cell lines.	[Choi, Yeo-Jin; Baek, Ga-Young; Park, Hae-Ran; Jo, Sung-Kee; Jung, Uhee] KAERI, Radiat Biotechnol Res Div, Adv Radiat Technol Inst, Jeongeup, South Korea; [Park, Hae-Ran; Jo, Sung-Kee; Jung, Uhee] Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope, Daejeon, South Korea	Korea Atomic Energy Research Institute (KAERI); University of Science & Technology (UST)	Jung, U (corresponding author), KAERI, Radiat Biotechnol Res Div, Adv Radiat Technol Inst, Jeongeup, South Korea.; Jung, U (corresponding author), Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope, Daejeon, South Korea.	uhjung@kaeri.re.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2013M2A2A7043663]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by National Research Foundation of Korea (NRF) grant funded by Korea government (MSIP) (No. 2013M2A2A7043663).	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; Baumann M, 2010, CLIN CANCER RES, V16, P5091, DOI 10.1158/1078-0432.CCR-10-2244; Bentzen SM, 2010, INT J RADIAT ONCOL, V76, pS145, DOI 10.1016/j.ijrobp.2009.08.076; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brunner TB, 2012, SEMIN RADIAT ONCOL, V22, P151, DOI 10.1016/j.semradonc.2011.12.003; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Ding ZY, 2013, CELL SIGNAL, V25, P1981, DOI 10.1016/j.cellsig.2013.05.027; Du S, 2013, SEMIN RADIAT ONCOL, V23, P242, DOI 10.1016/j.semradonc.2013.05.001; Dubrovska A, 2014, INT J RADIAT BIOL, V90, P607, DOI 10.3109/09553002.2014.920968; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Ferrari N, 2003, J LEUKOCYTE BIOL, V74, P302, DOI 10.1189/jlb.1102581; Gomez-Casal R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-94; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Itoh Y, 2002, ESSAYS BIOCHEM, V38, P21, DOI 10.1042/bse0380021; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kuonen F, 2012, CLIN CANCER RES, V18, P5196, DOI 10.1158/1078-0432.CCR-11-1758; Lee SY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-113; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marie-Egyptienne DT, 2013, CANCER LETT, V341, P63, DOI 10.1016/j.canlet.2012.11.019; Merlo GR, 2000, INT J DEV BIOL, V44, P619; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Mizutani H, 2010, ONCOL LETT, V1, P1011, DOI 10.3892/ol.2010.190; Morini M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-649; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; O'Connor JW, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-23; Ogawa K, 2013, ANTICANCER RES, V33, P747; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prud'homme GJ, 2012, CURR PHARM DESIGN, V18, P2838; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Starkova J, 2011, HAEMATOL-HEMATOL J, V96, P820, DOI 10.3324/haematol.2010.031179; Tang P, 2013, WORLD J GASTROENTERO, V19, P2697, DOI 10.3748/wjg.v19.i17.2697; Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x; Yilmaz M, 2011, EMBO J, V30, P4489, DOI 10.1038/emboj.2011.319; Zhao B, 2014, SCI CAIRO, V2014; Zielske SP, 2011, TRANSL ONCOL, V4, P217, DOI 10.1593/tlo.10247	45	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147343	10.1371/journal.pone.0147343	http://dx.doi.org/10.1371/journal.pone.0147343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799321	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300097
J	Madani, N; Kimball, JS; Nazeri, M; Kumar, L; Affleck, DLR				Madani, Nima; Kimball, John S.; Nazeri, Mona; Kumar, Lalit; Affleck, David L. R.			Remote Sensing Derived Fire Frequency, Soil Moisture and Ecosystem Productivity Explain Regional Movements in Emu over Australia	PLOS ONE			English	Article							PATTERNS; BIRDS; DISTRIBUTIONS; DISPERSAL; EMISSIONS; HABITAT; AREA	Species distribution modeling has been widely used in studying habitat relationships and for conservation purposes. However, neglecting ecological knowledge about species, e.g. their seasonal movements, and ignoring the proper environmental factors that can explain key elements for species survival (shelter, food and water) increase model uncertainty. This study exemplifies how these ecological gaps in species distribution modeling can be addressed by modeling the distribution of the emu (Dromaius novaehollandiae) in Australia. Emus cover a large area during the austral winter. However, their habitat shrinks during the summer months. We show evidence of emu summer habitat shrinkage due to higher fire frequency, and low water and food availability in northern regions. Our findings indicate that emus prefer areas with higher vegetation productivity and low fire recurrence, while their distribution is linked to an optimal intermediate (similar to 0.12 m(3) m(-3)) soil moisture range. We propose that the application of three geospatial data products derived from satellite remote sensing, namely fire frequency, ecosystem productivity, and soil water content, provides an effective representation of emu general habitat requirements, and substantially improves species distribution modeling and representation of the species' ecological habitat niche across Australia.	[Madani, Nima; Kimball, John S.] Univ Montana, Numer Terradynam Simulat Grp, Coll Forestry & Conservat, 32 Campus Dr, Missoula, MT 59812 USA; [Nazeri, Mona] Univ Montana, Sch Journalism, Dept Environm Journalism, 32 Campus Dr, Missoula, MT 59812 USA; [Kumar, Lalit] Univ New England, Sch Environm & Rural Sci, Ecosyst Management, Ring Rd, Armidale, NSW 2351, Australia; [Affleck, David L. R.] Univ Montana, Coll Forestry & Conservat, 32 Campus Dr, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of New England; University of Montana System; University of Montana	Madani, N (corresponding author), Univ Montana, Numer Terradynam Simulat Grp, Coll Forestry & Conservat, 32 Campus Dr, Missoula, MT 59812 USA.	nima.madani@ntsg.umt.edu	Madani, Nima/A-2840-2016; Kumar, Lalit/A-6397-2011; Kimball, John S/B-9234-2011	Madani, Nima/0000-0003-2853-7611; Kumar, Lalit/0000-0002-9205-756X; 	NASA [NX14AI50G, NNX15AB59G]	NASA(National Aeronautics & Space Administration (NASA))	This study was conducted with funding provided by NASA Earth Science Program (NNX14AI50G, NNX15AB59G).	Agee J. K., 1993, FIRE ECOLOGY PACIFIC; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Barrett G., NEW ATLAS AUSTR BIRD; Bastos A, 2013, J GEOPHYS RES-BIOGEO, V118, P1247, DOI 10.1002/jgrg.20100; BirdLife International, 2012, DROM NOV IUCN RED LI; Bond-Lamberty B, 2007, NATURE, V450, P89, DOI 10.1038/nature06272; Bradstock RA., 2002, FLAMMABLE AUSTR FIRE; Calvino-Cancela M, 2006, ECOGRAPHY, V29, P632, DOI 10.1111/j.0906-7590.2006.04677.x; Chuang TW, 2012, REMOTE SENS ENVIRON, V125, P147, DOI 10.1016/j.rse.2012.07.018; DAWSON TJ, 1984, EMU, V84, P93, DOI 10.1071/MU9840093; Diaz-Delgado R, 2002, ECOLOGY, V83, P2293, DOI 10.1890/0012-9658(2002)083[2293:SEODRI]2.0.CO;2; Dingle D. H., 1996, MIGRATION BIOL LIFE; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Dunstan H, 2013, EMU, V113, P168, DOI 10.1071/MU12061; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Giglio L, 2013, J GEOPHYS RES-BIOGEO, V118, P317, DOI 10.1002/jgrg.20042; Google Earth Engine Team, 2015, GOOGL EARTH ENG PLAN; Griffioen PA, 2002, EMU, V102, P99, DOI 10.1071/MU01024; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kozhoridze G, 2015, ECOGRAPHY, V38, P1141, DOI 10.1111/ecog.01496; Kumar M., 1981, Plants and the daylight spectrum. [Smith, H. (Editor)]., P133; Leavesley AJ, 2010, INT J WILDLAND FIRE, V19, P949, DOI 10.1071/WF09028; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Liu YY, 2011, HYDROL EARTH SYST SC, V15, P425, DOI 10.5194/hess-15-425-2011; Madani N, 2014, J GEOPHYS RES-BIOGEO, V119, P1755, DOI 10.1002/2014JG002709; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; Morin X, 2013, ECOGRAPHY, V36, P300, DOI 10.1111/j.1600-0587.2012.07340.x; Myneni RB, 1999, NASA GODDARD SP FLIG, V121, P126; Nazeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048104; Nield AP, 2015, EMU, V115, P29, DOI 10.1071/MU13113; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; R Core Team, 2013, R LANG ENV STAT COMP; Ramon S., 2010, MODIS VEGETATION IND; Reside AE, 2012, ECOL EVOL, V2, P705, DOI 10.1002/ece3.197; Reside AE, 2012, DIVERS DISTRIB, V18, P213, DOI 10.1111/j.1472-4642.2011.00818.x; Reside AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013569; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Ryan SJ, 2012, J WILDLIFE MANAGE, V76, P1499, DOI 10.1002/jwmg.407; SCHWARTZ CC, 1991, WILDLIFE MONOGR, P1; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Szabo JK, 2007, EMU, V107, P89, DOI 10.1071/MU06020; Wagner W., 2012, ISPRS ANN PHOTOGRAMM, V17, P315, DOI [10.5194/isprsannals-I-7-315-2012, DOI 10.5194/ISPRSANNALS-I-7-315-2012]; Whetton P, 2012, CLIMATIC CHANGE, V115, P433, DOI 10.1007/s10584-012-0471-z; Wiedinmyer C, 2006, ATMOS ENVIRON, V40, P3419, DOI 10.1016/j.atmosenv.2006.02.010; Wood S.N, 2006, GEN ADDITIVE MODELS, DOI DOI 10.1201/9781315370279; World Resources Institute, 2005, MILL EC ASS EC HUM W; Zager P.E., 1983, INT C BEAR RES MANAG, V5, P124, DOI DOI 10.2307/3872529; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	54	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147285	10.1371/journal.pone.0147285	http://dx.doi.org/10.1371/journal.pone.0147285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799732	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300086
J	Meyer, CB; Meyer, JS; Francisco, AB; Holder, J; Verdonck, F				Meyer, Carolyn B.; Meyer, Joseph S.; Francisco, Alex B.; Holder, Jennifer; Verdonck, Frederik			Can Ingestion of Lead Shot and Poisons Change Population Trends of Three European Birds: Grey Partridge, Common Buzzard, and Red Kite?	PLOS ONE			English	Article							PERDIX-PERDIX; MILVUS-MILVUS; DENSITY-DEPENDENCE; BUTEO-BUTEO; SURVIVAL; RAPTOR; EXPOSURE; REPRODUCTION; DECLINE; KESTREL	Little is known about the magnitude of the effects of lead shot ingestion alone or combined with poisons (e.g., in bait or seeds/granules containing pesticides) on population size, growth, and extinction of non-waterbird avian species that ingest these substances. We used population models to create example scenarios demonstrating how changes in these parameters might affect three susceptible species: grey partridge (Perdix perdix), common buzzard (Buteo buteo), and red kite (Milvus milvus). We added or subtracted estimates of mortality due to lead shot ingestion (4-16% of mortality, depending on species) and poisons (4-46% of mortality) reported in the UK or France to observed mortality of studied populations after models were calibrated to observed population trends. Observed trends were decreasing for partridge (in continental Europe), stable for buzzard (in Germany), and increasing for red kite (in Wales). Although lead shot ingestion and poison at modeled levels did not change the trend direction for the three species, they reduced population size and slowed population growth. Lead shot ingestion at modeled rates reduced population size of partridges by 10%, and when combined with bait and pesticide poisons, by 18%. For buzzards, decrease in mean population size by lead shot and poisons combined was much smaller (<= 1%). The red kite population has been recovering; however, modeled lead shot ingestion reduced its annual growth rate from 6.5% to 4%, slowing recovery. If mortality from poisoned baits could be removed, the kite population could potentially increase at a rapid annual rate of 12%. The effects are somewhat higher if ingestion of these substances additionally causes sublethal reproductive impairment. These results have uncertainty but suggest that declining or recovering populations are most sensitive to lead shot or poison ingestion, and removal of poisoned baits can have a positive impact on recovering raptor populations that frequently feed on carrion.	[Meyer, Carolyn B.; Meyer, Joseph S.] Arcadis, Lakewood, CO USA; [Meyer, Joseph S.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Francisco, Alex B.] Arcadis, Walnut Creek, CA USA; [Holder, Jennifer] ERM, Carpinteria, CA USA; [Verdonck, Frederik] ARCHE, Ghent, Belgium	Colorado School of Mines	Meyer, CB (corresponding author), Arcadis, Lakewood, CO USA.	Carolyn.meyer@arcadis.com			"ARCADIS"; "ERM"; "ARCHE"; Association of European Manufacturers of Sporting Ammunition (AFEMS)	"ARCADIS"; "ERM"; "ARCHE"; Association of European Manufacturers of Sporting Ammunition (AFEMS)	"ARCADIS", "ERM" and "ARCHE" provided support in the form of salaries for authors CBM, JSM, ABF (ARCADIS), JH (ERM) & FV (ARCHE), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section. Support was also provided by Association of European Manufacturers of Sporting Ammunition (AFEMS at www.afems.org).	Akcakaya HR, 2005, RAMAS METAPOP VIABIL; BEISSINGER SR, 1995, ECOL APPL, V5, P618, DOI 10.2307/1941971; Bennett R, 2011, EPA600R11023; Berny P, 2008, J WILDLIFE DIS, V44, P417, DOI 10.7589/0090-3558-44.2.417; Bird Life International, 2015, RED LIST OF BRIDS; BirdLife International, 2015, SPEC FACT SHEET RED; BirdLife International, 2004, BIRDS EUR UN STAT AS; Boele A, 2011, 201301 SOV VOG; Bro E, 2001, IBIS, V143, P120, DOI 10.1111/j.1474-919X.2001.tb04176.x; Bro E, 2005, WILDLIFE BIOL, V11, P287; Bro E, 2012, BIRD STUDY, V59, P320, DOI 10.1080/00063657.2012.674099; Browne SJ, 2006, GAMEBIRD 2006 QUAIL, P380; BUERGER TT, 1986, J WILDLIFE MANAGE, V50, P1, DOI 10.2307/3801479; Butler DA, 2005, WILDLIFE SOC B, V33, P583, DOI 10.2193/0091-7648(2005)33[583:LEIRPO]2.0.CO;2; Caswell H, 1989, MATRIX POPULATION MO; Clausen B, 1979, COMMUNICATION; Cross T., THREATS TO KITES; DAVIS PE, 1981, J ANIM ECOL, V50, P759, DOI 10.2307/4135; De Leo GA, 2004, ECOL MODEL, V177, P313, DOI 10.1016/j.ecolmodel.2003.11.017; Donazar JA, 2002, BIOL CONSERV, V107, P89, DOI 10.1016/S0006-3207(02)00049-6; Elliott KH, 2011, J WILDLIFE MANAGE, V75, P1688, DOI 10.1002/jwmg.233; Ewald J, 2006, GAMEBIRD 2006 QUAIL, P27; Gangoso L, 2009, ENVIRON POLLUT, V157, P569, DOI 10.1016/j.envpol.2008.09.015; Garcia-Ferandez AJ, 2005, B ENVIRON CONTAM TOX, V74, P314, DOI 10.1007/s00128-004-0586-7; Green RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004022; Grell MD, 2007, BIRD CENSUS NEWS, p20/1; HEITMEYER ME, 1993, J WILDLIFE MANAGE, V57, P733, DOI 10.2307/3809073; HENNY CJ, 2003, HDB ECOTOXICOLOGY, P755; Hernandez M, 2009, EUR J WILDLIFE RES, V55, P415, DOI 10.1007/s10344-009-0255-6; HIRAI M, 1991, BIOL TRACE ELEM RES, V30, P291, DOI 10.1007/BF02991424; Hood G. M., 2011, POPTOOLS VERSION 3 2; JORGENSEN SS, 1987, AMBIO, V16, P11; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015350; Kendall RJ, 1996, ENVIRON TOXICOL CHEM, V15, P4, DOI 10.1002/etc.5620150103; Kenward RE, 2000, OIKOS, V91, P271, DOI 10.1034/j.1600-0706.2000.910207.x; Kruger O, 2004, BIRD STUDY, V51, P125; Kruger O, 2001, OIKOS, V93, P260, DOI 10.1034/j.1600-0706.2001.930209.x; Kruger O., 2000, THESIS U BIELEFELD; Kuijper DPJ, 2009, EUR J WILDLIFE RES, V55, P455, DOI 10.1007/s10344-009-0311-2; Landis W.G., 2011, INTRO ENV TOXICOLOGY, V4th edn.; Lensick R., 1997, J ANIM ECOL, V66, P811; Lieske DJ, 2000, AUK, V117, P184, DOI 10.1642/0004-8038(2000)117[0184:EOPDOS]2.0.CO;2; Lopez-Antia A, 2015, ENVIRON RES, V136, P97, DOI 10.1016/j.envres.2014.10.023; Madry MM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034003; Mallory M.L., 2014, COMMON BIRDS NUNAVUT; Mateo R, 2009, INGESTION LEAD SPENT, P1; Mcconnell CA, 1968, P ANN C SE ASS GAM F, V21, P208; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Morris W. F., 2002, QUANTITATIVE CONSERV; Murn C, 2012, ECOLOGY CONSERVATION, P351; Newman MC., 2013, QUANTITATIVE ECOTOXI; NEWTON I, 1994, P ROY SOC B-BIOL SCI, V257, P317, DOI 10.1098/rspb.1994.0132; Newton I., 1979, Raptor Research, V13, P65; Nicoll MAC, 2003, J ANIM ECOL, V72, P917, DOI 10.1046/j.1365-2656.2003.00768.x; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Pain DJ, 2007, SCI TOTAL ENVIRON, V376, P116, DOI 10.1016/j.scitotenv.2007.01.062; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; PAIN DJ, 1995, ENVIRON POLLUT, V87, P173, DOI 10.1016/0269-7491(94)P2604-8; Parish DMB, 2007, WILDLIFE BIOL, V13, P140, DOI 10.2981/0909-6396(2007)13[140:TFORCG]2.0.CO;2; Potts G.R., 2012, PARTRIDGES COUNTRYSI, P480; Potts GR, 2005, EUR J WILDLIFE RES, V51, P31, DOI 10.1007/s10344-004-0071-y; Potts GR, 1986, PARTRIDGE PESTICIDES; Reif V, 2004, ANN ZOOL FENN, V41, P599; Rodriguez B, 2010, J RAPTOR RES, V44, P30, DOI 10.3356/JRR-09-40.1; Rooney CP, 2007, ENVIRON POLLUT, V149, P149, DOI 10.1016/j.envpol.2007.01.009; SAMUEL MD, 1992, T N AM WILDL NAT RES, P486; Sanderson GC, 1986, SPEC PUBL, V4; SCHMUTZ J K, 1989, Journal of Raptor Research, V23, P147; Schreiber A, 2001, J ORNITHOL, V142, P34, DOI 10.1007/BF01651737; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Smart J, 2010, BIOL CONSERV, V143, P1278, DOI 10.1016/j.biocon.2010.03.002; Stephens RM, 2005, SECONDARY LEAD POI; Tannenbaum L, 2014, HUM ECOL RISK ASSESS, V20, P479, DOI 10.1080/10807039.2012.746143; Tavecchia G, 2001, J APPL ECOL, V38, P1197, DOI 10.1046/j.0021-8901.2001.00684.x; Tavecchia G, 2012, J APPL ECOL, V49, P297, DOI 10.1111/j.1365-2664.2011.02074.x; Tenan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049187; Thomas VG, 2009, SCI TOTAL ENVIRON, V407, P3494, DOI 10.1016/j.scitotenv.2009.02.003; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Welsh Kite Trust Producer, RED KIT DAT; Wotton SR, 2002, BIRD STUDY, V49, P278	80	9	10	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147189	10.1371/journal.pone.0147189	http://dx.doi.org/10.1371/journal.pone.0147189			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799815	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300071
J	Ohde, D; Moeller, M; Brenmoehl, J; Walz, C; Ponsuksili, S; Schwerin, M; Fuellen, G; Hoeflich, A				Ohde, Daniela; Moeller, Mark; Brenmoehl, Julia; Walz, Christina; Ponsuksili, Siriluck; Schwerin, Manfred; Fuellen, Georg; Hoeflich, Andreas			Advanced Running Performance by Genetic Predisposition in Male Dummerstorf Marathon Mice (DUhTP) Reveals Higher Sterol Regulatory Element-Binding Protein (SREBP) Related mRNA Expression in the Liver and Higher Serum Levels of Progesterone	PLOS ONE			English	Article							MASS-SPECTROMETRY ASSAY; ARTIFICIAL SELECTION; EXERCISE; GLUCOKINASE; QUANTIFICATION; ADAPTATIONS; METABOLISM; CAPACITY; MUSCLE; BORN	Long-term-selected DUhTP mice represent a non-inbred model for inborn physical high-performance without previous training. Abundance of hepatic mRNA in 70-day male DUhTP and control mice was analyzed using the Affymetrix mouse array 430A 2.0. Differential expression analysis with PLIER corrected data was performed using AltAnalyze. Searching for over-representation in biochemical pathways revealed cholesterol metabolism being most prominently affected in DUhTP compared to unselected control mice. Furthermore, pathway analysis by AltAnalyze plus PathVisio indicated significant induction of glycolysis, fatty acid synthesis and cholesterol biosynthesis in the liver of DUhTP mice versus unselected control mice. In contrast, gluconeogenesis was partially inactivated as judged from the analysis of hepatic mRNA transcript abundance in DUhTP mice. Analysis of mRNA transcripts related to steroid hormone metabolism inferred elevated synthesis of progesterone and reduced levels of sex steroids. Abundance of steroid delta isomerase-5 mRNA (Hsd3b5, FC 4.97) was increased and steroid 17-alpha-monooxygenase mRNA (Cyp17a1, FC -11.6) was massively diminished in the liver of DUhTP mice. Assessment of steroid profiles by LC-MS revealed increased levels of progesterone and decreased levels of sex steroids in serum from DUhTP mice versus controls. Analysis of hepatic mRNA transcript abundance indicates that sterol regulatory element-binding protein-1 (SREBP-1) may play a major role in metabolic pathway activation in the marathon mouse model DUhTP. Thus, results from bioinformatics modeling of hepatic mRNA transcript abundance correlated with direct steroid analysis by mass spectrometry and further indicated functions of SREBP-1 and steroid hormones for endurance performance in DUhTP mice.	[Ohde, Daniela; Brenmoehl, Julia; Walz, Christina; Ponsuksili, Siriluck; Schwerin, Manfred; Hoeflich, Andreas] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany; [Moeller, Mark; Fuellen, Georg] Univ Rostock, Med Ctr, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); University of Rostock	Hoeflich, A (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany.; Fuellen, G (corresponding author), Univ Rostock, Med Ctr, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany.	fuellen@uni-rostock.de; hoeflich@fbn-dummerstorf.de		Ohde, Daniela/0000-0002-0669-8409	H. Wilhelm Schaumann Stiftung; BMBF as part of the GerontoSys initiative (ROSAge project) [FKZ 0315892]; Deutsche Forschungsgemeinschaft [DFG HO 2003/6-1]; BMBF Verbundprojekt ROSAge [FKZ 0315892A]; EU [633589]	H. Wilhelm Schaumann Stiftung; BMBF as part of the GerontoSys initiative (ROSAge project)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF Verbundprojekt ROSAge(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	D.O. received a stipend from the H. Wilhelm Schaumann Stiftung. G.F. and A. H. were supported by grants from the BMBF as part of the GerontoSys initiative (ROSAge project), FKZ 0315892 and from the Deutsche Forschungsgemeinschaft (DFG HO 2003/6-1), respectively. M.M. and G.F. were supported by the BMBF Verbundprojekt ROSAge, FKZ 0315892A and the EU's Horizon 2020 research and innovation program under grant agreement No. 633589. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becard D, 2001, DIABETES, V50, P2425, DOI 10.2337/diabetes.50.11.2425; Ben-Zaken S, 2015, GROWTH HORM IGF RES, V25, P196, DOI 10.1016/j.ghir.2015.04.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; BONEN A, 1979, EUR J APPL PHYSIOL O, V42, P15, DOI 10.1007/BF00421100; Brenmoehl J, 2013, MED SCI SPORT EXER, V45, P841, DOI 10.1249/MSS.0b013e31827e0fca; Cai HL, 2010, ANAL BIOCHEM, V396, P103, DOI 10.1016/j.ab.2009.09.015; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Coggan AR, 2000, METABOLISM, V49, P122, DOI 10.1016/S0026-0495(00)90963-6; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Falkenberg H, 2000, ARCH TIERZUCHT, V43, P513, DOI 10.5194/aab-43-513-2000; Fitts R H, 1996, Exerc Sport Sci Rev, V24, P427; Gomes M, 2015, OMICS, V19, P499, DOI 10.1089/omi.2015.0065; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Hawley JA, 2014, CLIN EXP PHARMACOL P, V41, P608, DOI 10.1111/1440-1681.12246; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; JENSEN CE, 1995, FERTIL STERIL, V64, P1189, DOI 10.1016/S0015-0282(16)57983-7; JEZOVA D, 1985, EUR J APPL PHYSIOL, V54, P62, DOI 10.1007/BF00426300; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Keski-Rahkonen P, 2011, J STEROID BIOCHEM, V127, P396, DOI 10.1016/j.jsbmb.2011.06.006; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kunze M, 2015, J CHROMATOGR B, V1007, P132, DOI 10.1016/j.jchromb.2015.10.010; Kushnir MM, 2008, AM J CLIN PATHOL, V129, P530, DOI 10.1309/LC03BHQ5XJPJYEKG; Latasa MJ, 2003, MOL CELL BIOL, V23, P5896, DOI 10.1128/MCB.23.16.5896-5907.2003; Lazovic B, 2015, EUR REV MED PHARMACO, V19, P2269; Lira FS, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/809576; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Marwah A, 2001, J CHROMATOGR B, V757, P333, DOI 10.1016/S0378-4347(01)00171-2; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Miles JL, 2009, ENDOCRINOLOGY, V150, P179, DOI 10.1210/en.2008-1035; Murray A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-76; Nirogi R, 2013, J CHROMATOGR B, V913, P41, DOI 10.1016/j.jchromb.2012.09.034; O'Shaughnessy PJ, 2013, MOL HUM REPROD, V19, P177, DOI 10.1093/molehr/gas059; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; Seifert T, 2009, AM J PHYSIOL-REG I, V297, pR867, DOI 10.1152/ajpregu.00277.2009; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; Templeman NM, 2012, AM J PHYSIOL-REG I, V303, pR101, DOI 10.1152/ajpregu.00511.2011; THORENS B, 1992, INT REV CYTOL, V137A, P209; Vaanholt LM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P148, DOI 10.1086/525289; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Vesterinen V, 2016, INT J SPORT PHYSIOL, V11, P393, DOI 10.1123/ijspp.2015-0366; Wasfy MM, 2015, JOURNAL OF THE AMERI, DOI [10.1016/j.echo.2015.08.002, DOI 10.1016/J.ECH0.2015.08.002]; Yeo WK, 2011, APPL PHYSIOL NUTR ME, V36, P12, DOI 10.1139/H10-089; ZAWALICH W, 1982, AM J PHYSIOL, V243, pE464, DOI 10.1152/ajpendo.1982.243.6.E464; Zhan WZ, 1999, J APPL PHYSIOL, V87, P2326, DOI 10.1152/jappl.1999.87.6.2326; Zhang SM, 2008, J PHARMACEUT BIOMED, V48, P1174, DOI 10.1016/j.jpba.2008.08.024; Znazen H, 2015, THE JOURNAL OF SPORT	56	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146748	10.1371/journal.pone.0146748	http://dx.doi.org/10.1371/journal.pone.0146748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799318	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300033
J	Kubo, T; Kubo, MO				Kubo, Tai; Kubo, Mugino O.			Nonplantigrade Foot Posture: A Constraint on Dinosaur Body Size	PLOS ONE			English	Article							BASAL METABOLIC-RATE; ORNITHISCHIAN DINOSAURS; RANDOM-WALKS; EVOLUTION; MAMMALS; MASS; DIVERSITY; SELECTIVITY; EXTINCTION; RADIATION	Dinosaurs had functionally digitigrade or sub-unguligrade foot postures. With their immediate ancestors, dinosaurs were the only terrestrial nonplantigrades during the Mesozoic. Extant terrestrial mammals have different optimal body sizes according to their foot posture (plantigrade, digitigrade, and unguligrade), yet the relationship of nonplantigrade foot posture with dinosaur body size has never been investigated, even though the body size of dinosaurs has been studied intensively. According to a large dataset presented in this study, the body sizes of all nonplantigrades (including nonvolant dinosaurs, nonvolant terrestrial birds, extant mammals, and extinct Nearctic mammals) are above 500 g, except for macroscelid mammals (i.e., elephant shrew), a few alvarezsauroid dinosaurs, and nondinosaur ornithodirans (i.e., the immediate ancestors of dinosaurs). When nonplantigrade tetrapods evolved from plantigrade ancestors, lineages with nonplantigrade foot posture exhibited a steady increase in body size following Cope's rule. In contrast, contemporaneous plantigrade lineages exhibited no trend in body size evolution and were largely constrained to small body sizes. This evolutionary pattern of body size specific to foot posture occurred repeatedly during both the Mesozoic and the Cenozoic eras. Although disturbed by the end-Cretaceous extinction, species of mid to large body size have predominantly been nonplantigrade animals from the Jurassic until the present; conversely, species with small body size have been exclusively composed of plantigrades in the nonvolant terrestrial tetrapod fauna.	[Kubo, Tai] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo, Japan; [Kubo, Mugino O.] Univ Tokyo, Dept Nat Environm Studies, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo, Japan.	taikubo@um.u-tokyo.ac.jp		Kubo, Mugino/0000-0002-7748-7377; Kubo, Tai/0000-0003-3207-0399	Japan Society for the Promotion of Science (JSPS KAKENHI) [26800267]	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 26800267) to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Bates KT, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0215; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Brassey CA, 2015, BIOL LETT, V11, P3; Brown CM, 2013, J VERTEBR PALEONTOL, V33, P495, DOI 10.1080/02724634.2013.746229; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Butler RJ, 2010, P ROY SOC B-BIOL SCI, V277, P375, DOI 10.1098/rspb.2009.1494; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Carrano MT, 1997, ZOOL J LINN SOC-LOND, V121, P77; Codron D, 2012, BIOL LETTERS, V8, P620, DOI 10.1098/rsbl.2012.0240; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Damuth J., 1990, BODY SIZE MAMMALIAN, P412; Dunning J. B., 2008, CRC HDB AVIAN BODY M, P672; Evans DC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2749; Fara E, 2000, GEOBIOS-LYON, V33, P387, DOI 10.1016/S0016-6995(00)80166-7; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Hunt G., 2010, QUANTITATIVE METHODS, P245; Hunt G, 2008, EVOLUTION GEOBIOLOGY, P578; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Hunt G, 2006, PALEOBIOLOGY, V32, P578, DOI 10.1666/05070.1; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Lovegrove BG, 2013, J EVOLUTION BIOL, V26, P1317, DOI 10.1111/jeb.12138; Lovegrove BG, 2014, J EXP BIOL, V217, P1316, DOI 10.1242/jeb.095737; Lovegrove BG, 2004, PHYSIOL BIOCHEM ZOOL, V77, P916, DOI 10.1086/425189; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; Lovegrove BG, 2004, OECOLOGIA, V138, P13, DOI 10.1007/s00442-003-1376-3; Lovegrove BG, 2001, EVOLUTION, V55, P1464; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Macdonald DW, 2006, PRINCETON ENCY MAMMA, P936; Maidment SCR, 2014, NATURWISSENSCHAFTEN, V101, P989, DOI 10.1007/s00114-014-1239-2; Moreno K, 2007, J MORPHOL, V268, P50, DOI 10.1002/jmor.10498; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Parrish MJ, 1986, HUNTERIA, V1, P1; PECZKIS J, 1994, J VERTEBR PALEONTOL, V14, P520; Polly P. David, 2010, P374; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reilly SM, 2007, ZOOLOGY, V110, P271, DOI 10.1016/j.zool.2007.01.003; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Tanaka I, 2015, LETHAIA, V48, P188, DOI 10.1111/let.12098; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2013, GEOL SOC SPEC PUBL, V379, P573, DOI 10.1144/SP379.15; Van der Geer A., 2010, EVOLUTION ISLAND MAM, DOI [10.1002/9781444323986, DOI 10.1002/9781444323986]; Wilson GP, 2013, PALEOBIOLOGY, V39, P429, DOI 10.1666/12041	49	7	7	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145716	10.1371/journal.pone.0145716	http://dx.doi.org/10.1371/journal.pone.0145716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790003	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100015
J	Lakshminarayanan, V; Supekar, NT; Wei, J; McCurry, DB; Dueck, AC; Kosiorek, HE; Trivedi, PP; Bradley, JM; Madsen, CS; Pathangey, LB; Hoelzinger, DB; Wolfert, MA; Boons, GJ; Cohen, PA; Gendler, SJ				Lakshminarayanan, Vani; Supekar, Nitin T.; Wei, Jie; McCurry, Dustin B.; Dueck, Amylou C.; Kosiorek, Heidi E.; Trivedi, Priyanka P.; Bradley, Judy M.; Madsen, Cathy S.; Pathangey, Latha B.; Hoelzinger, Dominique B.; Wolfert, Margreet A.; Boons, Geert-Jan; Cohen, Peter A.; Gendler, Sandra J.			MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice	PLOS ONE			English	Article							POLYMORPHIC EPITHELIAL MUCIN; CELL LUNG-CANCER; BREAST-CANCER; DENDRITIC CELLS; T-CELLS; PANCREATIC-CANCER; ERADICATE TUMORS; SELF-TOLERANCE; IN-VIVO; ANTIGEN	It remains challenging to produce decisive vaccines against MUC1, a tumor-associated antigen widely expressed by pancreas, breast and other tumors. Employing clinically relevant mouse models, we ruled out such causes as irreversible T-cell tolerance, inadequate avidity, and failure of T-cells to recognize aberrantly glycosylated tumor MUC1. Instead, every tested MUC1 preparation, even non-glycosylated synthetic 9mer peptides, induced interferon gamma-producing CD4(+) and CD8(+) T-cells that recognized glycosylated variants including tumor-associated MUC1. Vaccination with synthetic peptides conferred protection as long as vaccination was repeated post tumor challenge. Failure to revaccinate post challenge was associated with down-regulated tumor MUC1 and MHC molecules. Surprisingly, direct admixture of MUC1-expressing tumor with MUC1-hyperimmune T-cells could not prevent tumor outgrowth or MUC1 immunoediting, whereas ex vivo activation of the hyperimmune T-cells prior to tumor admixture rendered them curative. Therefore, surrogate T-cell preactivation outside the tumor bed, either in culture or by repetitive vaccination, can over-come tumor escape.	[Lakshminarayanan, Vani; Wei, Jie; Trivedi, Priyanka P.; Bradley, Judy M.; Madsen, Cathy S.; Pathangey, Latha B.; Hoelzinger, Dominique B.; Cohen, Peter A.; Gendler, Sandra J.] Mayo Clin Arizona, Dept Immunol, Scottsdale, AZ USA; [Gendler, Sandra J.] Mayo Clin Arizona, Dept Biochem Mol Biol, Scottsdale, AZ USA; [McCurry, Dustin B.; Cohen, Peter A.; Gendler, Sandra J.] Mayo Clin Arizona, Hematol Oncol, Scottsdale, AZ USA; [Dueck, Amylou C.; Kosiorek, Heidi E.] Mayo Clin Arizona, Biostat, Scottsdale, AZ USA; [Supekar, Nitin T.; Wolfert, Margreet A.; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; University System of Georgia; University of Georgia	Cohen, PA; Gendler, SJ (corresponding author), Mayo Clin Arizona, Dept Immunol, Scottsdale, AZ USA.; Gendler, SJ (corresponding author), Mayo Clin Arizona, Dept Biochem Mol Biol, Scottsdale, AZ USA.; Cohen, PA; Gendler, SJ (corresponding author), Mayo Clin Arizona, Hematol Oncol, Scottsdale, AZ USA.; Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu; cohen.peter@mayo.edu; gendler.sandra@mayo.edu	Boons, Geert-Jan P H/J-3211-2016; Supekar, Nitin/K-5737-2019; Wolfert, Margreet A/J-1726-2016	Boons, Geert-Jan P H/0000-0003-3111-5954; Supekar, Nitin/0000-0002-7006-7177; Wolfert, Margreet A/0000-0003-4864-0026; Lakshminarayanan, Vani/0000-0002-1750-7858; McCurry, Dustin/0000-0003-0585-3259	National Cancer Institute of the US National Institutes of Health Mayo Breast Specialized Programs of Research Excellence (SPORE) Grant [P50 CA116201]; Mayo Pancreas SPORE Grant [P50 CA102701, RO1 CA64389, RO1 CA88986]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R01CA088986, P50CA116201, P30CA015083, P50CA102701, R01CA064389] Funding Source: NIH RePORTER	National Cancer Institute of the US National Institutes of Health Mayo Breast Specialized Programs of Research Excellence (SPORE) Grant; Mayo Pancreas SPORE Grant; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Cancer Institute of the US National Institutes of Health Mayo Breast Specialized Programs of Research Excellence (SPORE) Grant P50 CA116201 (to S.J.G.), Mayo Pancreas SPORE Grant P50 CA102701 (to P.A.C. and S.J.G.), RO1 CA64389 (to S.J.G.), RO1 CA88986 (to G.-J.B.) and the Mayo Foundation.	Apostolopoulos V, 1998, J IMMUNOL, V161, P767; Beatty P, 2012, ONCOIMMUNOLOGY, V1, P263, DOI 10.4161/onci.18950; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Butterfield LH, 2003, CLIN CANCER RES, V9, P998; Butts C, 2014, LANCET ONCOL, V15, P59, DOI 10.1016/S1470-2045(13)70510-2; Carmon L, 2015, BRIT J HAEMATOL, V169, P44, DOI 10.1111/bjh.13245; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Chawla A, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28325; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Cloosen S, 2007, CANCER RES, V67, P3919, DOI 10.1158/0008-5472.CAN-06-2112; Cohen PA, 2008, BLOOD, V112, P1832, DOI 10.1182/blood-2007-12-130138; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Fu J, 2014, CANCER RES, V74, P4042, DOI 10.1158/0008-5472.CAN-13-2685; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; Gong JL, 1998, P NATL ACAD SCI USA, V95, P6279, DOI 10.1073/pnas.95.11.6279; Grinstead JS, 2003, BIOCHEMISTRY-US, V42, P14293, DOI 10.1021/bi0301237; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Hanisch FG, 2003, EUR J IMMUNOL, V33, P3242, DOI 10.1002/eji.200324189; Hattrup CL, 2008, BREAST CANCER-BASIC, V1, P57; Hemmer B, 2000, INT IMMUNOL, V12, P375, DOI 10.1093/intimm/12.3.375; Inderberg-Suso EM, 2012, ONCOIMMUNOLOGY, V1, P670, DOI 10.4161/onci.20426; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kimura T, 2013, CANCER PREV RES, V6, P18, DOI 10.1158/1940-6207.CAPR-12-0275; Kimura T, 2013, EXPERT OPIN BIOL TH, V13, P35, DOI 10.1517/14712598.2012.725719; Kmieciak M, 2007, EUR J IMMUNOL, V37, P675, DOI 10.1002/eji.200636639; Knutson KL, 2006, J IMMUNOL, V177, P1526, DOI 10.4049/jimmunol.177.3.1526; Kohlgraf KG, 2004, CANCER IMMUNOL IMMUN, V53, P1068, DOI 10.1007/s00262-004-0557-1; Koido S, 2014, ANTICANCER RES, V34, P3917; Kondo H, 2008, ANTICANCER RES, V28, P379; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lakshminarayanan V, 2012, P NATL ACAD SCI USA, V109, P261, DOI 10.1073/pnas.1115166109; Lutz M, 2015, BLOOD, V125, P261, DOI 10.1182/blood-2014-09-601302; Madan RA, 2012, SEMIN ONCOL, V39, P296, DOI 10.1053/j.seminoncol.2012.02.010; Matsuzaki J, 2014, CANCER IMMUNOL RES, V2, P341, DOI 10.1158/2326-6066.CIR-13-0138; Mittendorf EA, 2006, SURGERY, V139, P407, DOI 10.1016/j.surg.2005.06.059; Morikane K, 2001, INT IMMUNOL, V13, P233, DOI 10.1093/intimm/13.2.233; Mukherjee P, 2007, VACCINE, V25, P1607, DOI 10.1016/j.vaccine.2006.11.007; Mukherjee P, 2003, J IMMUNOTHER, V26, P47, DOI 10.1097/00002371-200301000-00006; Mukherjee P, 2001, CLIN CANCER RES, V7, p848S; Mukherjee P, 2000, J IMMUNOL, V165, P3451, DOI 10.4049/jimmunol.165.6.3451; Mukherjee P, 2009, J IMMUNOL, V182, P216, DOI 10.4049/jimmunol.182.1.216; Nemunaitis B, 2013, J IMMUNOTHERAPY CANC, V240; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pestano C, 2011, CANCER RES, V71, P762; Picco G, 2014, EUR J IMMUNOL, V44, P1947, DOI 10.1002/eji.201344076; Quoix E, 2011, LANCET ONCOL, V12, P1125, DOI 10.1016/S1470-2045(11)70259-5; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Romagnoli P, 2012, J IMMUNOL, V189, P3831, DOI 10.4049/jimmunol.1201564; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Roulois D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/871936; Rowse GJ, 1998, CANCER RES, V58, P315; Ryan SO, 2010, CANCER RES, V70, P5788, DOI 10.1158/0008-5472.CAN-09-4519; Ryan SO, 2009, BIOL CHEM, V390, P611, DOI 10.1515/BC.2009.070; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Sugiura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044770; Tempero RM, 1998, J IMMUNOL, V161, P5500; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Turner MS, 2007, J IMMUNOL, V178, P2787, DOI 10.4049/jimmunol.178.5.2787; Vassilaros S, 2013, IMMUNOTHERAPY-UK, V5, P1177, DOI [10.2217/IMT.13.126, 10.2217/imt.13.126]; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; WANG KC, 1980, INT J CANCER, V25, P487, DOI 10.1002/ijc.2910250410; Xu SW, 2003, J IMMUNOL, V171, P2251, DOI 10.4049/jimmunol.171.5.2251; Xu YF, 2004, J EXP MED, V199, P707, DOI 10.1084/jem.20031865	67	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145920	10.1371/journal.pone.0145920	http://dx.doi.org/10.1371/journal.pone.0145920			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788922	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100020
J	Liu, Y; Chen, LL; Zhi, CC; Shen, M; Sun, WW; Miao, DS; Yuan, XQ				Liu, Yun; Chen, Lulu; Zhi, Chunchun; Shen, Ming; Sun, Weiwei; Miao, Dengshun; Yuan, Xiaoqin			1,25(OH)(2)D-3 Deficiency Induces Colon Inflammation via Secretion of Senescence-Associated Inflammatory Cytokines	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; CARCINOMA-CELLS; CANCER CELLS; ENDOCRINE; RISK; PHENOTYPE; PROMOTES; KLOTHO; DIFFERENTIATION; CHEMOPREVENTION	Epidemiological studies showed that 1,25-Dihydroxyvitamin D[1,25(OH)(2)D-3] insufficiency appears to be associated with aging and colon cancer while underlying biological mechanisms remain largely unknown. Inflammatory bowel disease is one of the risk factors for colon cancer. In this study, we investigated whether 1,25(OH)(2)D-3 deficiency has an impact on the colon of 25-hydroxyvitamin D 1 alpha-hydroxylase knockout [Cyp27b1(-/-]) mice fed on a rescue diet (high calcium, phosphate, and lactose) from weaning to 10 months of age. We found that 1,25(OH)(2)D-3 deficient mice displayed significant colon inflammation phenotypes including shortened colon length, thinned and disordered mucosal structure, and inflammatory cell infiltration. DNA damage, cellular senescence and the production of senescence-associated inflammatory cytokines were also increased significantly in the colon of Cyp27b1(-/-) mice. Furthermore, the levels of ROS in the colon were increased significantly, whereas the expression levels of antioxidative genes were down-regulated dramatically in the colon of Cyp27b1(-/-) mice. Taken together, our results demonstrated that 1,25(OH)(2)D-3 deficiency could induce colon inflammation, which may result from increased oxidative stress and DNA damage, subsequently, induced cell senescence and overproduction of senescence-associated secretory factors. Therefore, our findings suggest that 1,25(OH)(2)D-3 may play an important role in preventing the development and progression of colon inflammation and colon cancer.	[Liu, Yun; Chen, Lulu; Zhi, Chunchun; Sun, Weiwei; Miao, Dengshun; Yuan, Xiaoqin] Nanjing Med Univ, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China; [Shen, Ming] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yuan, XQ (corresponding author), Nanjing Med Univ, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China.	yuanxq@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502	National Natural Science Foundation of China [81201529, 81200431, 81230009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (81201529 to X Yuan, 81200431 to W Sun and 81230009 to D Miao) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2012, GASTROENTEROLOGY, V142, P482, DOI 10.1053/j.gastro.2011.11.040; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; Cross HS, 2011, MOL CELL ENDOCRINOL, V347, P70, DOI 10.1016/j.mce.2011.07.022; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DELUCA HF, 1973, NEW ENGL J MED, V289, P359, DOI 10.1056/NEJM197308162890710; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Forster RE, 2011, BIOCHEM BIOPH RES CO, V414, P557, DOI 10.1016/j.bbrc.2011.09.117; Froicu M, 2003, MOL ENDOCRINOL, V17, P2386, DOI 10.1210/me.2003-0281; Halicka HD, 2012, AGING-US, V4, P270, DOI 10.18632/aging.100450; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Holick MF, 1996, J NUTR, V126, pS1159, DOI 10.1093/jn/126.suppl_4.1159S; Holick MF, 2011, J INVEST MED, V59, P872, DOI 10.2310/JIM.0b013e318214ea2d; Hopkins MH, 2011, CANCER PREV RES, V4, P1645, DOI 10.1158/1940-6207.CAPR-11-0105; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Huerta S, 2002, CANCER RES, V62, P741; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; Lin R, 2002, MOL ENDOCRINOL, V16, P1243, DOI 10.1210/me.16.6.1243; Liu N, 2008, ENDOCRINOLOGY, V149, P4799, DOI 10.1210/en.2008-0060; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lofano Katia, 2013, J Gastrointest Cancer, V44, P1, DOI 10.1007/s12029-012-9425-y; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meeker S, 2014, CANCER RES, V74, P4398, DOI 10.1158/0008-5472.CAN-13-2820; Murillo G, 2005, J STEROID BIOCHEM, V97, P129, DOI 10.1016/j.jsbmb.2005.06.008; Nagai Taku, 2003, FASEB Journal, V17, P50; Nakai K, 2014, AM J HYPERTENS, V27, P586, DOI 10.1093/ajh/hpt160; Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schutze N, 1999, BIOFACTORS, V10, P329, DOI 10.1002/biof.5520100403; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Shen M, 2013, BONE, V55, P400, DOI 10.1016/j.bone.2013.04.015; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith SM, 2005, J NUTR, V135, P437, DOI 10.1093/jn/135.3.437; Tamez H, 2012, CURR OPIN NEPHROL HY, V21, P492, DOI 10.1097/MNH.0b013e3283557bf0; Ting HJ, 2012, CANCER RES, V72, P958, DOI 10.1158/0008-5472.CAN-11-0042; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; van den Bergh Joop P W, 2011, Curr Osteoporos Rep, V9, P36, DOI 10.1007/s11914-010-0041-0; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321	55	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146426	10.1371/journal.pone.0146426	http://dx.doi.org/10.1371/journal.pone.0146426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790152	gold, Green Submitted, Green Published			2022-12-26	WOS:000368529100031
J	Venot, Q; Delaunay, JL; Fouassier, L; Delautier, D; Falguieres, T; Housset, C; Maurice, M; Ait-Slimane, T				Venot, Quitterie; Delaunay, Jean-Louis; Fouassier, Laura; Delautier, Daniele; Falguieres, Thomas; Housset, Chantal; Maurice, Michele; Ait-Slimane, Tounsia			A PDZ-Like Motif in the Biliary Transporter ABCB4 Interacts with the Scaffold Protein EBP50 and Regulates ABCB4 Cell Surface Expression	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DOMAIN INTERACTION CONTROLS; BINDING; PHOSPHOPROTEIN; PHOSPHORYLATION; RECOGNITION; CHOLESTASIS; MEMBRANE; SPECTRUM; RECEPTOR	ABCB4/MDR3, a member of the ABC superfamily, is an ATP-dependent phosphatidylcholine translocator expressed at the canalicular membrane of hepatocytes. Defects in the ABCB4 gene are associated with rare biliary diseases. It is essential to understand the mechanisms of its canalicular membrane expression in particular for the development of new therapies. The stability of several ABC transporters is regulated through their binding to PDZ (PSD95/DglA/ZO-1) domain-containing proteins. ABCB4 protein ends by the sequence glutamineasparagine-leucine (QNL), which shows some similarity to PDZ-binding motifs. The aim of our study was to assess the potential role of the QNL motif on the surface expression of ABCB4 and to determine if PDZ domain-containing proteins are involved. We found that truncation of the QNL motif decreased the stability of ABCB4 in HepG2-transfected cells. The deleted mutant ABCB4-Delta QNL also displayed accelerated endocytosis. EBP50, a PDZ protein highly expressed in the liver, strongly colocalized and coimmunoprecipitated with ABCB4, and this interaction required the QNL motif. Down-regulation of EBP50 by siRNA or by expression of an EBP50 dominant-negative mutant caused a significant decrease in the level of ABCB4 protein expression, and in the amount of ABCB4 localized at the canalicular membrane. Interaction of ABCB4 with EBP50 through its PDZ-like motif plays a critical role in the regulation of ABCB4 expression and stability at the canalicular plasma membrane.	[Venot, Quitterie; Delaunay, Jean-Louis; Fouassier, Laura; Delautier, Daniele; Falguieres, Thomas; Housset, Chantal; Maurice, Michele; Ait-Slimane, Tounsia] Univ Paris 06, Sorbonne Univ, INSERM, UMR S 938,Ctr Rech St Antoine, Paris, France; [Housset, Chantal] Hop St Antoine, Assistance Publ Hop Paris, Ctr Reference Malad Rares Malad Inflammatoires Vo, F-75571 Paris, France; [Housset, Chantal] Serv Hepatol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Ait-Slimane, T (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, UMR S 938,Ctr Rech St Antoine, Paris, France.	tounsia.ait-slimane@inserm.fr	Fouassier, Laura/M-7556-2017	Fouassier, Laura/0000-0001-6377-5610; Delaunay, jean-louis/0000-0002-6512-5483; Falguieres, Thomas/0000-0003-2867-0500; Housset, Chantal/0000-0001-6469-0651; AIT SLIMANE, Tounsia/0000-0002-7459-859X; Venot, Quitterie/0000-0001-5964-5370	French association for the study of the liver (AFEF); Association Mucoviscidose - ABCF2; "Ministere de l'Enseignement Superieur et de la Recherche"; "Association pour la lutte contre les maladies inflammatoires du foie et des voies biliaires (Albi)"; INSERM; Fondation pour la Recherche Medicale (FRM)	French association for the study of the liver (AFEF); Association Mucoviscidose - ABCF2; "Ministere de l'Enseignement Superieur et de la Recherche"(Estonian Research CouncilEuropean Commission); "Association pour la lutte contre les maladies inflammatoires du foie et des voies biliaires (Albi)"; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by grants from the French association for the study of the liver (AFEF), and the Association Mucoviscidose - ABCF2. QV received a fellowship from the "Ministere de l'Enseignement Superieur et de la Recherche" and "Association pour la lutte contre les maladies inflammatoires du foie et des voies biliaires (Albi)". TF was supported by fellowships from INSERM and Fondation pour la Recherche Medicale (FRM).	Bezprozvanny I, 2001, P NATL ACAD SCI USA, V98, P787, DOI 10.1073/pnas.98.3.787; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Davit-Spraul A, 2010, SEMIN LIVER DIS, V30, P134, DOI 10.1055/s-0030-1253223; Delaunay JL, 2009, HEPATOLOGY, V49, P1218, DOI 10.1002/hep.22775; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elferink RPJO, 2006, GASTROENTEROLOGY, V130, P908, DOI 10.1053/j.gastro.2005.08.052; Emi Y, 2011, J BIOCHEM, V149, P177, DOI 10.1093/jb/mvq131; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Fouassier L, 2009, AM J PATHOL, V174, P869, DOI 10.2353/ajpath.2009.080079; Galmes R, 2013, J CELL SCI, V126, P3409, DOI 10.1242/jcs.126250; Gautherot J, 2014, HEPATOLOGY, V60, P610, DOI 10.1002/hep.27170; Gautherot J, 2012, J BIOL CHEM, V287, P5070, DOI 10.1074/jbc.M111.275438; Giral H, 2011, J BIOL CHEM, V286, P15032, DOI 10.1074/jbc.M110.199752; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hayashi H, 2012, HEPATOLOGY, V55, P1889, DOI 10.1002/hep.25591; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jacquemin E, 2001, GASTROENTEROLOGY, V120, P1448, DOI 10.1053/gast.2001.23984; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Lam P, 2012, HEPATOLOGY, V55, P1901, DOI 10.1002/hep.25523; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Li M, 2010, J BIOL CHEM, V285, P19299, DOI 10.1074/jbc.M109.096081; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; RUETZ S, 1994, CELL, V77, P1071, DOI 10.1016/0092-8674(94)90446-4; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Villa-Bellosta R, 2008, KIDNEY INT, V73, P456, DOI 10.1038/sj.ki.5002703; Wang DQH, 2009, J LIPID RES, V50, pS406, DOI 10.1194/jlr.R800075-JLR200; Xue P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097360	38	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146962	10.1371/journal.pone.0146962	http://dx.doi.org/10.1371/journal.pone.0146962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789121	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100050
J	Abhimanyu; Bose, M; Varma-Basil, M; Jain, A; Sethi, T; Tiwari, PK; Agrawal, A; Banavaliker, JN; Bhowmick, KT				Abhimanyu; Bose, Mridula; Varma-Basil, Mandira; Jain, Ashima; Sethi, Tavpritesh; Tiwari, Pradeep Kumar; Agrawal, Anurag; Banavaliker, Jayant Nagesh; Bhowmick, Kumar Tapas			Establishment of Elevated Serum Levels of IL-10, IL-8 and TNF-beta as Potential Peripheral Blood Biomarkers in Tubercular Lymphadenitis: A Prospective Observational Cohort Study	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; ACTIVE TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; DIAGNOSIS; INFECTION; PULMONARY	Background Tubercular lymphadenitis (TL) is the most common form of extra-pulmonary tuberculosis (TB) consisting about 15-20% of all TB cases. The currently available diagnostic modalities for (TL), are invasive and involve a high index of suspicion, having limited accuracy. We hypothesized that TL would have a distinct cytokine signature that would distinguish it from pulmonary TB (PTB), peripheral tubercular lymphadenopathy (LNTB), healthy controls (HC), other lymphadenopathies (LAP) and cancerous LAP. To assess this twelve cytokines (Tumor Necrosis Factor (TNF)-alpha, Interferon (IFN) -gamma, Interleukin (IL)-2, IL-12, IL-18, IL-1 beta, IL-10, IL-6, IL-4, IL-1Receptor antagonist (IL-1Ra), IL-8 and TNF-beta, which have a role in pathogenesis of tuberculosis, were tested as potential peripheral blood biomarkers to aid the diagnosis of TL when routine investigations prove to be of limited value. Methods and Findings A prospective observational cohort study carried out during 2010-2013. This was a multicenter study with three participating hospitals in Delhi, India where through random sampling cohorts were established. The subjects were above 15 years of age, HIV-negative with no predisposing ailments to TB (n = 338). The discovery cohort (n = 218) had LNTB (n = 50), PTB (n = 84) and HC (n = 84). The independent validation cohort (n = 120) composed of patients with cancerous LAP (n = 35), other LAP (n = 20) as well as with independent PTB (n = 30), LNTB (n = 15) and HC (n = 20). Eight out of twelve cytokines achieved statistical relevance upon evaluation by pairwise and ROC analysis. Further, variable selection using random forest backward elimination revealed six serum biosignatures including IL-12, IL-4, IL-6, IL-10, IL-8 and TNF-beta as optimal for classifying the LNTB status of an individual. For the sake of clinical applicability we further selected a three analyte panel (IL-8, IL-10 and TNF-beta) which was subjected to multinomial modeling in the independent validation cohort which was randomised into training and test cohorts, achieving an overwhelming 95.9% overall classifying accuracy for correctly classifying LNTB cases with a minimal (7%) misclassification error rate in the test cohort. Conclusions In our study, a three analyte serum biosignatures and probability equations were established which can guide the physician in their clinical decision making and step wise management of LNTB patients. This set of biomarkers has the potential to be a valuable adjunct to the diagnosis of TL in cases where AFB positivity and granulomatous findings elude the clinician.	[Abhimanyu; Bose, Mridula; Varma-Basil, Mandira; Jain, Ashima] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Microbiol, New Delhi, India; [Sethi, Tavpritesh; Tiwari, Pradeep Kumar; Agrawal, Anurag] CSIR Inst Genom & Integrat Biol, New Delhi, India; [Banavaliker, Jayant Nagesh] RajanBabu Inst Pulm Med & TB, New Delhi, India; [Bhowmick, Kumar Tapas] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Radiotherapy, New Delhi, India; [Abhimanyu] Univ Johannesburg, Dept Biochem, Auckland Pk Campus, Johannesburg, Gauteng, South Africa	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Vardhman Mahavir Medical College & Safdarjung Hospital; University of Johannesburg	Bose, M (corresponding author), Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Microbiol, New Delhi, India.	bosemridula@yahoo.co.in	Abhimanyu, Abhimanyu/P-4463-2019; Agrawal, Anurag/GZL-5821-2022; Tiwari, Dr. Pradeep/V-8314-2018	Abhimanyu, Abhimanyu/0000-0001-7888-8722; Agrawal, Anurag/0000-0002-0340-5252; Tiwari, Dr. Pradeep/0000-0003-0387-9236; Sethi, Tavpritesh/0000-0002-4776-7941	Council for Scientific and Industrial Research, Government of India [60/80 EMR-II]; CSIR	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Council for Scientific and Industrial Research, Government of India funded the Research and Fellowship for Dr. Abhimanyu via Grant Number: 60/80 EMR-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the results were submitted to the funders as a part of the final project report.; The Authors thank CSIR for providing Junior Research Fellowship to Dr. Abhimanyu. We are indebted to the patients and volunteers who served as control and to the clinicians Dr Anuj Bhatnagar, Dr. Anil Choudhry and Dr Nilang Tale at Rajan Babu Institute of Pulmonary Medicine and Tuberculosis, Kingsway Camp, New Delhi and Lok Nayak Jai Prakash Hospital, New Delhi. We wish to acknowledge the help of Dr. Ashwani Khanna, of the Chest Clinic, LNJP to facilitate in patient recruitment and Dr. Shyama Jain, Department of Pathology, Maulana Azad Medical College for the help with histological findings for LNTB cases. We are also thankful to Drs Rupa Das, Pooja Mate and Neha of Department of Radiotherapy, Vardhman Mahavir Medical College and Safdarjung Hospital for their help in patient recruitment. Help in statistics from Dr. Koundinya Desiraju and Mr. Rintu Kutum from CSIR-IGIB is also acknowledged.	April MM, 1996, ARCH OTOLARYNGOL, V122, P1214; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Borgia JA, 2009, J THORAC ONCOL, V4, P338, DOI 10.1097/JTO.0b013e3181982abf; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Fitzgerald D, PRINCIPLES PRACTICE, V2, P3158; Fortun J, 2014, INFECTION, V42, P649, DOI 10.1007/s15010-014-0602-8; Hasan Z, 2009, SCAND J IMMUNOL, V69, P259, DOI 10.1111/j.1365-3083.2008.02217.x; Juffermans NP, 1998, AM J RESP CRIT CARE, V157, P1328, DOI 10.1164/ajrccm.157.4.9709126; Kim HO, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-113; Kim YK, 2011, TOHOKU J EXP MED, V224, P189, DOI 10.1620/tjem.224.189; Kohane IS, 2012, NEW ENGL J MED, V367, P2538, DOI 10.1056/NEJMe1213371; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Manitchotpisit Boonchu, 1999, Journal of the Medical Association of Thailand, V82, P363; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mohapatra Prasanta Raghab, 2009, J Assoc Physicians India, V57, P585; Polesky A, 2005, MEDICINE, V84, P350, DOI 10.1097/01.md.0000189090.52626.7a; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Song KH, 2009, DIAGN MICR INFEC DIS, V63, P182, DOI 10.1016/j.diagmicrobio.2008.10.013; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang Y, 2009, ZHONGHUA JIE HE HE H, V25, P535; WHO, GLOB TUB REP 2014	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145576	10.1371/journal.pone.0145576	http://dx.doi.org/10.1371/journal.pone.0145576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784906	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400015
J	Dwyer, JB; Leslie, FM				Dwyer, Jennifer B.; Leslie, Frances M.			Adolescent Maturation of Dopamine D1 and D2 Receptor Function and Interactions in Rodents	PLOS ONE			English	Article							EARLY GENE-EXPRESSION; STRIA TERMINALIS; BED NUCLEUS; PREFRONTAL CORTEX; C-FOS; POSTNATAL-DEVELOPMENT; D1/D2 SYNERGISM; METABOLIC-RATES; BRAIN-REGIONS; COCAINE	Adolescence is a developmental period characterized by heightened vulnerability to illicit drug use and the onset of neuropsychiatric disorders. These clinical phenomena likely share common neurobiological substrates, as mesocorticolimbic dopamine systems actively mature during this period. Whereas prior studies have examined age-dependent changes in dopamine receptor binding, there have been fewer functional analyses. The aim of the present study was therefore to determine whether the functional consequences of D1 and D2-like activation are age-dependent. Adolescent and adult rats were given direct D1 and D2 agonists, alone and in combination. Locomotor and stereotypic behaviors were measured, and brains were collected for analysis of mRNA expression for the immediate early genes (IEGs), cfos and arc. Adolescents showed enhanced D2-like receptor control of locomotor and repetitive behaviors, which transitioned to dominant D1-like mechanisms in adulthood. When low doses of agonists were co-administered, adults showed supra-additive behavioral responses to D1/D2 combinations, whereas adolescents did not, which may suggest age differences in D1/D2 synergy. D1/D2-stimulated IEG expression was particularly prominent in the bed nucleus of the stria terminalis (BNST). Given the BNST's function as an integrator of corticostriatal, hippocampal, and stress-related circuitry, and the importance of neural network dynamics in producing behavior, an exploratory functional network analysis of regional IEG expression was performed. This data-driven analysis demonstrated similar developmental trajectories as those described in humans and suggested that dopaminergic drugs alter forebrain coordinated gene expression age dependently. D1/D2 recruitment of stress nuclei into functional networks was associated with low behavioral output in adolescents. Network analysis presents a novel tool to assess pharmacological action, and highlights critical developmental changes in functional neural circuitry. Immature D1/D2 interactions in adolescents may underlie their unique responses to drugs of abuse and vulnerability to psychopathology. These data highlight the need for age-specific pharmacotherapy design and clinical application in adolescence.	[Dwyer, Jennifer B.; Leslie, Frances M.] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Dwyer, JB (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	Jennifer.dwyer@yale.edu	Dwyer, Jennifer/AAW-8701-2021		National Institute of Drug Abuse [DA19138]; PhRMA Foundation Paul Calabresi Medical Student Fellowship; NIH [DA19138]; PhRMA Foundation fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019138] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PhRMA Foundation Paul Calabresi Medical Student Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by (1) National Institute of Drug Abuse, Grant number DA19138, funding to FML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (2) The PhRMA Foundation Paul Calabresi Medical Student Fellowship (http://www.phrmafoundation.org/2015-awards/other-awards/clinical-pharmacology/paul-calabresi-medical-student-fellowship/) to JBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by NIH grant DA19138. Stipend support for JBD was provided in part from a PhRMA Foundation fellowship. A special thanks to the NIMH for generously providing SKF83822.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ANDERSEN PH, 1990, EUR J PHARM-MOLEC PH, V188, P335, DOI 10.1016/0922-4106(90)90194-3; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2002, BEHAV BRAIN RES, V130, P197, DOI 10.1016/S0166-4328(01)00417-X; Bahi A, 2008, PSYCHOPHARMACOLOGY, V199, P169, DOI 10.1007/s00213-008-1164-1; Benes FM, 2000, CEREB CORTEX, V10, P1014, DOI 10.1093/cercor/10.10.1014; Bolanos CA, 1998, DEV BRAIN RES, V111, P25, DOI 10.1016/S0165-3806(98)00116-3; Bowman BP, 1997, PSYCHOPHARMACOLOGY, V129, P121, DOI 10.1007/s002130050171; BRAUN AR, 1986, EUR J PHARMACOL, V131, P301, DOI 10.1016/0014-2999(86)90588-1; Brenhouse HC, 2008, J NEUROSCI, V28, P2375, DOI 10.1523/JNEUROSCI.5064-07.2008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao J, 2007, NEUROPSYCHOPHARMACOL, V32, P2279, DOI 10.1038/sj.npp.1301349; Caster JM, 2009, NEUROSCIENCE, V160, P13, DOI 10.1016/j.neuroscience.2009.01.001; Chen YI, 2010, DEV NEUROSCI-BASEL, V32, P125, DOI 10.1159/000286215; Choi DC, 2007, J NEUROSCI, V27, P2025, DOI 10.1523/JNEUROSCI.4301-06.2007; Correll CU, 2008, J CLIN PSYCHIAT, V69, P26; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Dao JM, 2011, NEUROPSYCHOPHARMACOL, V36, P1319, DOI 10.1038/npp.2011.8; DELFS JM, 1990, NEUROSCIENCE, V39, P59, DOI 10.1016/0306-4522(90)90221-O; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frantz KJ, 1999, PHARMACOL BIOCHEM BE, V64, P821, DOI 10.1016/S0091-3057(99)00162-8; Frantz KJ, 2007, NEUROPSYCHOPHARMACOL, V32, P625, DOI 10.1038/sj.npp.1301130; Fuhrmann D, 2015, TRENDS COGN SCI, V19, P558, DOI 10.1016/j.tics.2015.07.008; Gali RA, 2015, NEUROPSYCHOPHARMACOL, V40, pS109; Gardner EL, 2002, SYNAPSE, V46, P240, DOI 10.1002/syn.10138; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; HORWITZ B, 1984, J CEREBR BLOOD F MET, V4, P484, DOI 10.1038/jcbfm.1984.73; HORWITZ B, 1995, BEHAV BRAIN RES, V66, P187, DOI 10.1016/0166-4328(94)00139-7; HORWITZ B, 1986, ANN NEUROL, V19, P60, DOI 10.1002/ana.410190111; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; Johnston LD OMP, 2005, NIH PUBLICATION, V06-5884:278; Johnstone TB, 2011, J PHARMACOL EXP THER, V336, P908, DOI 10.1124/jpet.110.176255; LAHOSTE GJ, 1992, SYNAPSE, V12, P14, DOI 10.1002/syn.890120103; LAHOSTE GJ, 1993, BRAIN RES, V611, P108, DOI 10.1016/0006-8993(93)91782-N; LaHoste GJ, 1996, BRAIN RES, V728, P97; LAVIOLA G, 1995, J PHARMACOL EXP THER, V275, P345; Lewis DA, 2004, ANN NY ACAD SCI, V1021, P64, DOI 10.1196/annals.1308.008; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Macey DJ, 2003, J NEUROSCI, V23, P12; MAHAN LC, 1990, P NATL ACAD SCI USA, V87, P2196, DOI 10.1073/pnas.87.6.2196; Mathews IZ, 2011, INT J DEV NEUROSCI, V29, P501, DOI 10.1016/j.ijdevneu.2011.05.003; McElligott ZA, 2009, PROG NEURO-PSYCHOPH, V33, P1329, DOI 10.1016/j.pnpbp.2009.05.022; McQuown SC, 2009, PSYCHOPHARMACOLOGY, V207, P143, DOI 10.1007/s00213-009-1642-0; Mojica CY, 2014, NEUROPHARMACOLOGY, V77, P285, DOI 10.1016/j.neuropharm.2013.10.012; MOODY CA, 1992, PSYCHOPHARMACOLOGY, V106, P161, DOI 10.1007/BF02801967; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; O'Sullivan GJ, 2004, EUR J PHARMACOL, V486, P273, DOI 10.1016/j.ejphar.2004.01.004; Pollack Alexia, 2004, Sci STKE, V2004, ppe50, DOI 10.1126/stke.2552004pe50; RAPOPORT JL, 1980, ARCH GEN PSYCHIAT, V37, P933; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Robinson TE, 2001, SYNAPSE, V39, P257; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rodrigues AJ, 2011, PSYCHOPHARMACOLOGY, V214, P107, DOI 10.1007/s00213-010-2085-3; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Schwarz AJ, 2008, MAGN RESON IMAGING, V26, P914, DOI 10.1016/j.mri.2008.01.048; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Sporns Olaf, 2002, Complexity, V8, P56, DOI 10.1002/cplx.10047; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Svenningsson P, 2000, NEUROSCIENCE, V98, P749, DOI 10.1016/S0306-4522(00)00155-X; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tarazi FI, 1999, DEV NEUROSCI-BASEL, V21, P43, DOI 10.1159/000017365; Teicher MH, 2003, NEUROSCI LETT, V339, P169, DOI 10.1016/S0304-3940(02)01475-1; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Wei L, 2015, DEV NEUROSCI-BASEL, V37, P476, DOI 10.1159/000430861; Winzer-Serhan UH, 1999, BRAIN RES PROTOC, V3, P229, DOI 10.1016/S1385-299X(98)00043-9; Xu HY, 2012, NEUROSCIENCE, V221, P21, DOI 10.1016/j.neuroscience.2012.06.056; Yuan ML, 2015, J PHYSIOL-LONDON, V593, P3397, DOI 10.1113/JP270492; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	82	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146966	10.1371/journal.pone.0146966	http://dx.doi.org/10.1371/journal.pone.0146966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784516	Green Published, gold			2022-12-26	WOS:000368528400089
J	Helmer, M; Kozyrev, V; Stephan, V; Treue, S; Geisel, T; Battaglia, D				Helmer, Markus; Kozyrev, Vladislav; Stephan, Valeska; Treue, Stefan; Geisel, Theo; Battaglia, Demian			Model-Free Estimation of Tuning Curves and Their Attentional Modulation, Based on Sparse and Noisy Data	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; AREA MT; NEURONAL POPULATIONS; CORTICAL-CELLS; MACAQUE; DIRECTION; VARIABILITY; DIVERSITY; INFERENCE	Tuning curves are the functions that relate the responses of sensory neurons to various values within one continuous stimulus dimension (such as the orientation of a bar in the visual domain or the frequency of a tone in the auditory domain). They are commonly determined by fitting a model e.g. a Gaussian or other bell-shaped curves to the measured responses to a small subset of discrete stimuli in the relevant dimension. However, as neuronal responses are irregular and experimental measurements noisy, it is often difficult to determine reliably the appropriate model from the data. We illustrate this general problem by fitting diverse models to representative recordings from area MT in rhesus monkey visual cortex during multiple attentional tasks involving complex composite stimuli. We find that all models can be well-fitted, that the best model generally varies between neurons and that statistical comparisons between neuronal responses across different experimental conditions are affected quantitatively and qualitatively by specific model choices. As a robust alternative to an often arbitrary model selection, we introduce a model-free approach, in which features of interest are extracted directly from the measured response data without the need of fitting any model. In our attentional datasets, we demonstrate that data-driven methods provide descriptions of tuning curve features such as preferred stimulus direction or attentional gain modulations which are in agreement with fit-based approaches when a good fit exists. Furthermore, these methods naturally extend to the frequent cases of uncertain model selection. We show that model-free approaches can identify attentional modulation patterns, such as general alterations of the irregular shape of tuning curves, which cannot be captured by fitting stereotyped conventional models. Finally, by comparing datasets across different conditions, we demonstrate effects of attention that are cell-and even stimulus-specific. Based on these proofs-of-concept, we conclude that our data-driven methods can reliably extract relevant tuning information from neuronal recordings, including cells whose seemingly haphazard response curves defy conventional fitting approaches.	[Helmer, Markus; Geisel, Theo] Max Planck Inst Dynam & Self Org, Dept Nonlinear Dynam, Gottingen, Germany; [Helmer, Markus; Stephan, Valeska; Treue, Stefan; Geisel, Theo; Battaglia, Demian] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Kozyrev, Vladislav] Ruhr Univ Bochum, Inst Neuroinformat, Univ Str 150, Bochum, Germany; [Kozyrev, Vladislav; Stephan, Valeska; Treue, Stefan] German Primate Ctr, Cognit Neurosci Lab, Gottingen, Germany; [Battaglia, Demian] Aix Marseille Univ, Inst Neurosci Syst, Marseille, France	Max Planck Society; Ruhr University Bochum; Deutsches Primatenzentrum (DPZ); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Helmer, M (corresponding author), Max Planck Inst Dynam & Self Org, Dept Nonlinear Dynam, Gottingen, Germany.; Helmer, M (corresponding author), Bernstein Ctr Computat Neurosci, Gottingen, Germany.	markus@nld.ds.mpg.de	Battaglia, Demian/C-1281-2017; 889, CRC/L-1607-2018	Battaglia, Demian/0000-0003-2021-7920; 889, CRC/0000-0002-6678-3138; Helmer, Markus/0000-0001-9680-0595	Volkswagen Foundation [I/79868]; Bernstein Center of Computational Neuroscience Goettingen; Bundesministerium fuer Bildung und Forschung (BMBF) [01GQ0433, 01GQ1005C]; German Research Foundation (DFG) Collaborative Research Center "Cellular Mechanisms of Sensory Processing" [889]; Marie Curie career development fellowship ("DynViB") [FP7-IEF 330792]	Volkswagen Foundation(Volkswagen); Bernstein Center of Computational Neuroscience Goettingen; Bundesministerium fuer Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) Collaborative Research Center "Cellular Mechanisms of Sensory Processing"; Marie Curie career development fellowship ("DynViB")	This research was supported by Volkswagen Foundation (www.volkswagenstiftung.de), grant I/79868, by the Bernstein Center of Computational Neuroscience Goettingen (www.bccngoettingen.de), grants 01GQ0433 and 01GQ1005C of the Bundesministerium fuer Bildung und Forschung (BMBF, www.bmbf.de) and the German Research Foundation (DFG, www.dfg.de) Collaborative Research Center 889 "Cellular Mechanisms of Sensory Processing". DB was supported by the Marie Curie career development fellowship (http://ec.europa.eu/research/mariecurieactions/) FP7-IEF 330792 ("DynViB").	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Anderson JC, 2011, J NEUROSCI, V31, P10872, DOI 10.1523/JNEUROSCI.0622-11.2011; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Battaglia D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002176; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Charalambides CA, 2000, PROBABILITY AND STAT; Chelaru MI, 2008, P NATL ACAD SCI USA, V105, P16344, DOI 10.1073/pnas.0807744105; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cronin B, 2010, J NEUROPHYSIOL, V103, P591, DOI 10.1152/jn.00379.2009; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DeBello WM, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00112; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Etzold A, 2004, J NEUROSCI METH, V134, P109, DOI 10.1016/j.jneumeth.2003.11.009; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Jupp PE, 1999, WILEY SERIES PROBABI; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kozyrev V, 2009, SOC NEUROSCIENCE; Lochte A, 2009, SOC NEUROSCIENCE; Maldonado PE, 1996, VISUAL NEUROSCI, V13, P509, DOI 10.1017/S095252380000818X; Maynard EM, 1999, J NEUROSCI, V19, P8083; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Poort J, 2009, CEREB CORTEX, V19, P543, DOI 10.1093/cercor/bhn103; Pouget A, 1999, NEURAL COMPUT, V11, P85, DOI 10.1162/089976699300016818; Press WH, 2007, ART SCI COMPUTING, Vthird; Ringach DL, 2002, J NEUROSCI, V22, P5639; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Saproo S, 2010, J NEUROPHYSIOL, V104, P885, DOI 10.1152/jn.00369.2010; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; Sejnowski TJ, 2014, NAT NEUROSCI, V17, P1440, DOI 10.1038/nn.3839; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Smith GD, 2002, BMJ-BRIT MED J, V325, P1437; Stevenson IH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002775; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Tkacik G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003408; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Ubeyli ED, 2009, J MED SYST, V33, P353, DOI 10.1007/s10916-008-9197-x; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980	52	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146500	10.1371/journal.pone.0146500	http://dx.doi.org/10.1371/journal.pone.0146500			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785378	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400041
J	Liu, BP; Yue, Y; Yang, Y; Jin, YF				Liu, Baoping; Yue, Yuan; Yang, Yun; Jin, Yongfeng			Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; REGULATORY T-CELLS; NOD MICE; FUSION PROTEIN; TOLERANCE INDUCTION; IMMUNE TOLERANCE; SUBUNIT; VACCINE; PLANTS; CHAIN	Induction of mucosal tolerance by oral administration of protein antigens is a potential therapeutic strategy for preventing and treating type 1 diabetes (T1D); however, the requirement for a large dosage of protein limits clinical applications because of the low efficacy. In this study, we generated a fusion protein CTB-Ins-GAD composed of CTB (cholera toxin B subunit), insulin, and three copies of GAD65 peptide 531-545, which were efficiently produced in silkworm pupae, to evaluate its protective effect against T1D. We demonstrate that oral administration of CTB-Ins-GAD suppressed T1D by up to 78%, which is much more effective than GAD65 single-antigen treatment. Strikingly, CTB-Ins-GAD enhance insulin-and GAD65-specific Th2-like immune responses, which repairs the Th1/Th2 imbalance and increases the number of CD4(+) CD25(+) Foxp3(+) T cell and suppresses insulin-and GAD65-reactive spleen T lymphocyte proliferation and migration. Our results strongly suggest that the combined dual antigens promote the induction of oral tolerance, thus providing an effective and economic immunotherapy against T1D in combination with a silkworm bioreactor.	[Liu, Baoping; Yue, Yuan; Yang, Yun; Jin, Yongfeng] Zhejiang Univ, Coll Life Sci, Inst Biochem, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Jin, YF (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	jinyf@zju.edu.cn	Lang, Ming/HIK-0758-2022; yang, yang/GWB-9426-2022		National Science and Technology Project [2012ZX09102301-009]; National Natural Science Foundation of China [31125011]	National Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by research grants from the National Science and Technology Project (2012ZX09102301-009) and the National Natural Science Foundation of China (31125011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 1998, NAT BIOTECHNOL, V16, P934, DOI 10.1038/nbt1098-934; Aspord C, 2002, CLIN EXP IMMUNOL, V130, P204, DOI 10.1046/j.1365-2249.2002.01988.x; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Boettler T, 2013, J AUTOIMMUN, V44, P40, DOI 10.1016/j.jaut.2013.05.002; Bregenholt S, 2003, SCAND J IMMUNOL, V57, P432, DOI 10.1046/j.1365-3083.2003.01248.x; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Chaillous L, 2000, LANCET, V356, P545, DOI 10.1016/S0140-6736(00)02579-4; Clemente-Casares X, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007773; Denes B, 2005, J IMMUNOTHER, V28, P438, DOI 10.1097/01.cji.0000171315.82997.9a; Diabetes Prevention Trial Type Stu, 2005, DIABETES CARE, V28, P1068; DiLorenzo TP, 2002, CLIN IMMUNOL, V105, P332, DOI 10.1006/clim.2002.5298; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Gong ZH, 2005, J BIOTECHNOL, V119, P93, DOI 10.1016/j.jbiotec.2005.05.027; Gong ZH, 2007, VACCINE, V25, P1444, DOI 10.1016/j.vaccine.2006.10.039; Gong ZH, 2010, VACCINE, V28, P4052, DOI 10.1016/j.vaccine.2010.04.005; Herold KC, 2013, NAT REV IMMUNOL, V13, P243, DOI 10.1038/nri3422; Herold KC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002981; Jaeckel E, 2003, J EXP MED, V197, P1635, DOI 10.1084/jem.20030215; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kim HJ, 2014, LETT APPL MICROBIOL, V58, P285, DOI 10.1111/lam.12188; Li D, 2006, PLANT CELL REP, V25, P417, DOI 10.1007/s00299-005-0069-2; Lin MS, 2011, IMMUNOL RES, V50, P213, DOI 10.1007/s12026-011-8215-0; Ma SW, 2004, P NATL ACAD SCI USA, V101, P5680, DOI 10.1073/pnas.0307420101; Ma SW, 1997, NAT MED, V3, P793, DOI 10.1038/nm0797-793; Ma SW, 1999, ADV EXP MED BIOL, V464, P179; Mamchak AA, 2012, DIABETES, V61, P1490, DOI 10.2337/db11-1304; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Meng QH, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/831704; Mundkur L, 2014, INT J CARDIOL, V175, P340, DOI 10.1016/j.ijcard.2014.06.001; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Ploix C, 1999, DIABETES, V48, P2150, DOI 10.2337/diabetes.48.11.2150; Pozzilli P, 2000, DIABETOLOGIA, V43, P1000, DOI 10.1007/s001250051482; Ramiya VK, 1997, AUTOIMMUNITY, V26, P139, DOI 10.3109/08916939708994736; Robert S, 2014, DIABETES, V63, P2876, DOI 10.2337/db13-1236; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Skyler JS, 2008, ANN NY ACAD SCI, V1150, P14, DOI 10.1196/annals.1447.054; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Tisch R, 1998, DIABETES, V47, P894, DOI 10.2337/diabetes.47.6.894; Tong JC, 2002, J BIOTECHNOL, V97, P183, DOI 10.1016/S0168-1656(02)00060-3; Wang XM, 2013, ADV DRUG DELIVER REV, V65, P759, DOI 10.1016/j.addr.2012.10.013; Wang YL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/580463; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Xu HF, 2014, TRANSGENIC RES, V23, P697, DOI 10.1007/s11248-014-9826-8; Zhang WP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005353; Zhou J, 2006, FOOD CHEM TOXICOL, V44, P1123, DOI 10.1016/j.fct.2006.01.009	50	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147260	10.1371/journal.pone.0147260	http://dx.doi.org/10.1371/journal.pone.0147260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783749	gold, Green Submitted, Green Published			2022-12-26	WOS:000368528400130
J	Munari, E; Chaux, A; Vaghasia, AM; Taheri, D; Karram, S; Bezerra, SM; Roibon, NG; Nelson, WG; Yegnasubramanian, S; Netto, GJ; Haffner, MC				Munari, Enrico; Chaux, Alcides; Vaghasia, Ajay M.; Taheri, Diana; Karram, Sarah; Bezerra, Stephania M.; Roibon, Nilda Gonzalez; Nelson, William G.; Yegnasubramanian, Srinivasan; Netto, George J.; Haffner, Michael C.			Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies	PLOS ONE			English	Article							DEOXYRIBONUCLEIC-ACID; DNA DEMETHYLATION; MAMMALIAN DNA; HUMAN CANCERS; HYDROXYMETHYLATION; 5-METHYLCYTOSINE; METHYLATION; DYNAMICS; MARKS; IDH1	Solid tumors are characterized by a plethora of epigenetic changes. In particular, patterns methylation of cytosines at the 5-position (5mC) in the context of CpGs are frequently altered in tumors. Recent evidence suggests that 5mC can get converted to 5-hydroxylmethylcytosine (5hmC) in an enzymatic process involving ten eleven translocation (TET) protein family members, and this process appears to be important in facilitating plasticity of cytosine methylation. Here we evaluated the global levels of 5hmC using a validated immunohistochemical staining method in a large series of clear cell renal cell carcinoma (n = 111), urothelial cell carcinoma (n = 55) and testicular germcell tumors (n = 84) and matched adjacent benign tissues. Whereas tumor-adjacent benign tissues were mostly characterized by high levels of 5hmC, renal cell carcinoma and urothelial cell carcinoma showed dramatically reduced staining for 5hmC. 5hmC levels were low in both primary tumors and metastases of clear cell renal cell carcinoma and showed no association with disease outcomes. In normal testis, robust 5hmC staining was only observed in stroma and Sertoli cells. Seminoma showed greatly reduced 5hmC immunolabeling, whereas differentiated teratoma, embryonal and yolk sack tumors exhibited high 5hmC levels. The substantial tumor specific loss of 5hmC, particularly in clear cell renal cell carcinoma and urothelial cell carcinoma, suggests that alterations in pathways involved in establishing and maintaining 5hmC levels might be very common in cancer and could potentially be exploited for diagnosis and treatment.	[Munari, Enrico; Chaux, Alcides; Taheri, Diana; Karram, Sarah; Bezerra, Stephania M.; Roibon, Nilda Gonzalez; Nelson, William G.; Netto, George J.; Haffner, Michael C.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA; [Vaghasia, Ajay M.; Nelson, William G.; Yegnasubramanian, Srinivasan; Netto, George J.; Haffner, Michael C.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Nelson, William G.; Netto, George J.] Johns Hopkins Univ, Brady Urol Inst, Baltimore, MD 21231 USA; [Chaux, Alcides] Norte Univ, Dept Sci Res, Asuncion, Paraguay; [Chaux, Alcides] Ctr Desarrollo Invest Cient CEDIC Asuncion, Asuncion, Paraguay; [Taheri, Diana] Isfahan Univ Med Sci, Dept Pathol, Isfahan Kidney Dis Res Ctr, Esfahan, Iran	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Universidad del Norte; Isfahan University Medical Science	Netto, GJ; Haffner, MC (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA.; Netto, GJ; Haffner, MC (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.; Netto, GJ (corresponding author), Johns Hopkins Univ, Brady Urol Inst, Baltimore, MD 21231 USA.	gnetto1@jhmi.edu; michael.c.haffner@gmail.com	taheri, diana/V-6369-2017; Bezerra, Stephania M/X-9260-2018; Chaux, Alcides/H-4656-2019; Munari, Enrico/J-7516-2016	Chaux, Alcides/0000-0002-5824-9867; Munari, Enrico/0000-0002-3867-6685; Netto, George/0000-0003-3915-9134	PATANA Brady Research Fund; Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Award; NIH/NCI grant [P30CA006973, P50CA58236, R01CA070196]; NATIONAL CANCER INSTITUTE [P50CA058236, R01CA070196, P30CA006973] Funding Source: NIH RePORTER	PATANA Brady Research Fund; Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Award; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the PATANA Brady Research Fund; Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Award; NIH/NCI grants P30CA006973, P50CA58236 and R01CA070196.	Aryee MJ, 2013, AMERICAN ASSOCIATION, V5, DOI [10.1126/scitranslmed.3005211, DOI 10.1126/SCITRANSLMED.3005211]; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fedor HL, 2005, METH MOLEC MED, V103, P89; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guibert S, 2013, CURR TOP DEV BIOL, V104, P47, DOI 10.1016/B978-0-12-416027-9.00002-4; Haffner MC, 2013, CELL CYCLE, V12, P1835, DOI 10.4161/cc.25010; Haffner MC, 2011, ONCOTARGET, V2, P627; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Johnstone SE, 2010, NAT REV GENET, V11, P806, DOI 10.1038/nrg2881; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kristensen DG, 2013, NATURE          1128, P1; Kroeze LI, 2014, BLOOD, V124, P1110, DOI 10.1182/blood-2013-08-518514; Larsson AO, 2016, NEW MEDIA SOC, V18, P274, DOI 10.1177/1461444814538798; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Liu Chunhua, 2013, P 2013 IEEE INT S IN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0062828; Muller T, 2012, AM J PATHOL, V181, P675, DOI 10.1016/j.ajpath.2012.04.017; Nelson WG, 2009, ENDOCRINOLOGY, V150, P3991, DOI 10.1210/en.2009-0573; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Nettersheim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082881; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; Orr BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041036; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Pfeifer GP, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-10; Plongthongkum N, 2014, NAT REV GENET, V15, P647, DOI 10.1038/nrg3772; Robinson CM, 2014, FEBS LETT, V588, P2704, DOI 10.1016/j.febslet.2014.02.026; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schultz L, 2011, AM J SURG PATHOL, V35, P1549, DOI 10.1097/PAS.0b013e31822895e5; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Shen L, 2013, CURR OPIN CELL BIOL, V25, P289, DOI 10.1016/j.ceb.2013.02.017; Shim E-H, 2014, CANC DISCOVERY; Smith ZD, 2013, EMBO J, V32, P318, DOI 10.1038/emboj.2012.349; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	45	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146302	10.1371/journal.pone.0146302	http://dx.doi.org/10.1371/journal.pone.0146302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785262	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400030
J	Rebbapragada, I; Birkus, G; Perry, J; Xing, WM; Kwon, H; Pflanz, S				Rebbapragada, Indrani; Birkus, Gabriel; Perry, Jason; Xing, Weimei; Kwon, HyockJoo; Pflanz, Stefan			Molecular Determinants of GS-9620-Dependent TLR7 Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; SINGLE-STRANDED RNA; TLR4-MD-2 COMPLEX; RECOGNITION; AGONISTS; INNATE; SENSITIVITY; LYSOSOMES; INDUCTION	GS-9620 is an orally administered agonist of Toll-like receptor (TLR) 7 currently being evaluated in clinical studies for the treatment of chronic HBV and HIV patients. GS-9620 has shown antiviral efficacy in preclinical models of chronic hepadnavirus infection in woodchuck as well as chimpanzee. However, the molecular determinants of GS-9620-dependent activation of TLR7 are not well defined. The studies presented here elucidate GS-9620 subcellular distribution and characterize its molecular interactions with human TLR7 using structure-guided mutational analysis. Based on our results we present a molecular model of TLR7 bound to GS-9620. We also determine that several coding SNPs had no effect on GS-9620-dependent TLR7 activation. In addition, our studies provide evidence that TLR7 exists in a ligand-independent oligomeric state and that, TLR7 activation by GS-9620 is likely associated with compound-induced conformational changes. Finally, we demonstrate that activation of NF-kappa B and Akt pathways in primary plasmacytoid dendritic cells occur as immediate downstream cellular responses to GS-9620 stimulation. The data presented here further our understanding of the molecular parameters governing TLR7 activation by GS-9620, and more generally by nucleos/tide-related ligands.	[Rebbapragada, Indrani; Birkus, Gabriel; Xing, Weimei; Kwon, HyockJoo; Pflanz, Stefan] Gilead Sci Inc, Dept Biol, 353 Lakeside Dr, Foster City, CA 94404 USA; [Perry, Jason] Gilead Sci Inc, Dept Struct Chem, 353 Lakeside Dr, Foster City, CA 94404 USA	Gilead Sciences; Gilead Sciences	Pflanz, S (corresponding author), Gilead Sci Inc, Dept Biol, 353 Lakeside Dr, Foster City, CA 94404 USA.	Stefan.Pflanz@gilead.com	Birkus, Gabriel/GNW-3123-2022; Birkus, Gabriel/G-7765-2016	Birkus, Gabriel/0000-0002-5537-9447	Gilead Sciences Inc	Gilead Sciences Inc(Gilead Sciences)	The funder of this study, Gilead Sciences Inc, provided support in the form of salaries, employee benefits, and company stock for authors IR, GB, JP, WX, HK, and SP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Birkus G, 2011, ANTIMICROB AGENTS CH, V55, P2166, DOI 10.1128/AAC.01603-10; Birmachu W, 2007, BMC IMMUNOL, V8, P1, DOI 10.1186/1471-2172-8-26; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Colak E, 2014, J IMMUNOL, V192, P5963, DOI 10.4049/jimmunol.1303058; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fosdick A, 2014, J PHARMACOL EXP THER, V348, P96, DOI 10.1124/jpet.113.207878; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Hanten JA, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-39; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Holtzman E., 1989, LYSOSOMES; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kazmi F, 2013, DRUG METAB DISPOS, V41, P897, DOI 10.1124/dmd.112.050054; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lanford RE, 2013, GASTROENTEROLOGY, V144, P1508, DOI 10.1053/j.gastro.2013.02.003; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lawitz E, 2015, ANTIVIR THER, V20, P699, DOI 10.3851/IMP2845; Lopatin U, 2013, ANTIVIR THER, V18, P409, DOI 10.3851/IMP2548; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Menne S, 2015, J HEPATOL, V62, P1237, DOI 10.1016/j.jhep.2014.12.026; MERION M, 1983, J CELL BIOL, V96, P644, DOI 10.1083/jcb.96.3.644; Ouar Z, 2003, BIOCHEM J, V370, P185, DOI 10.1042/BJ20021411; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PENNINGTON R, 1961, BIOCHEM J, V80, P649, DOI 10.1042/bj0800649; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Roethle PA, 2013, J MED CHEM, V56, P7324, DOI 10.1021/jm400815m; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159	43	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146835	10.1371/journal.pone.0146835	http://dx.doi.org/10.1371/journal.pone.0146835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784926	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400070
J	Southey, BR; Zhu, P; Carr-Markell, MK; Liang, ZZS; Zayed, A; Li, RQ; Robinson, GE; Rodriguez-Zas, SL				Southey, Bruce R.; Zhu, Ping; Carr-Markell, Morgan K.; Liang, Zhengzheng S.; Zayed, Amro; Li, Ruiqiang; Robinson, Gene E.; Rodriguez-Zas, Sandra L.			Characterization of Genomic Variants Associated with Scout and Recruit Behavioral Castes in Honey Bees Using Whole-Genome Sequencing	PLOS ONE			English	Article							DIACYLGLYCEROL KINASE THETA; DIVISION-OF-LABOR; APIS-MELLIFERA; SOCIAL INSECTS; GENE-EXPRESSION; BOMBYX-MORI; DROSOPHILA; CERANA; RECOMBINATION; TRANSCRIPTION	Among forager honey bees, scouts seek new resources and return to the colony, enlisting recruits to collect these resources. Differentially expressed genes between these behaviors and genetic variability in scouting phenotypes have been reported. Whole-genome sequencing of 44 Apis mellifera scouts and recruits was undertaken to detect variants and further understand the genetic architecture underlying the behavioral differences between scouts and recruits. The median coverage depth in recruits and scouts was 10.01 and 10.7 X, respectively. Representation of bacterial species among the unmapped reads reflected a more diverse microbiome in scouts than recruits. Overall, 1,412,705 polymorphic positions were analyzed for associations with scouting behavior, and 212 significant (p-value < 0.0001) associations with scouting corresponding to 137 positions were detected. Most frequent putative transcription factor binding sites proximal to significant variants included Broad-complex 4, Broad-complex 1, Hunchback, and CF2-II. Three variants associated with scouting were located within coding regions of ncRNAs including one codon change (LOC102653644) and 2 frameshift indels (LOC102654879 and LOC102655256). Significant variants were also identified on the 5'UTR of membrin, and 3'UTRs of laccase 2 and diacylglycerol kinase theta. The 60 significant variants located within introns corresponded to 39 genes and most of these positions were > 1000 bp apart from each other. A number of these variants were mapped to ncRNA LOC100578102, solute carrier family 12 member 6-like gene, and LOC100576965 (meprin and TRAF-C homology domain containing gene). Functional categories represented among the genes corresponding to significant variants included: neuronal function, exoskeleton, immune response, salivary gland development, and enzymatic food processing. These categories offer a glimpse into the molecular support to the behaviors of scouts and recruits. The level of association between genomic variants and scouting behavior observed in this study may be linked to the honey bee's genomic plasticity and fluidity of transition between castes.	[Southey, Bruce R.] Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA; [Zhu, Ping] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Zhu, Ping] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Carr-Markell, Morgan K.] Univ Illinois, Sch Integrat Biol, Ecol Evolut & Conservat Biol Program, Urbana, IL 61801 USA; [Liang, Zhengzheng S.] Univ Illinois, Sch Mol & Cell Biol, Urbana, IL 61801 USA; [Liang, Zhengzheng S.; Robinson, Gene E.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Zayed, Amro] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Li, Ruiqiang] Novogene Bioinformat Inst, Beijing, Peoples R China; [Li, Ruiqiang] Peking Univ, Peking Tsinghua Ctr Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Li, Ruiqiang] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Robinson, Gene E.] Univ Illinois, Dept Entomol, Carle Woese Inst Genom Biol, 320 Morrill Hall, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Neurosci Program, Dept Stat, Dept Anim Sci, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Peking University; Peking University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; York University - Canada; Peking University; Peking University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Neurosci Program, Dept Stat, Dept Anim Sci, Urbana, IL 61801 USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL 61801 USA.	rodrgzzs@illinois.edu	Zayed, Amro/G-6405-2011	Zayed, Amro/0000-0003-3233-4585; Zhu, Ping/0000-0002-4521-7524; Liang, Zhengzheng/0000-0002-3969-4199; Southey, Bruce/0000-0002-8959-7709; Carr-Markell, Morgan/0000-0002-7787-9194; Rodriguez-Zas, Sandra/0000-0003-1122-4758	NIH [R21 DA027548, P30 DA018310]; USDA NIFA [ILLU-538-909, ILLU-538-632]; NSF [EF 0425852]; Discovery grant from the Natural Sciences and Engineering Council of Canada; Early Researcher Award from the Ontario Ministry of Research and Innovation;  [1DP10D006416]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310, R21DA027548] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA NIFA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Discovery grant from the Natural Sciences and Engineering Council of Canada(CGIAR); Early Researcher Award from the Ontario Ministry of Research and Innovation; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R21 DA027548 and P30 DA018310 (SRZ, BRS), USDA NIFA grants ILLU-538-909 and ILLU-538-632 (SRZ), 1DP10D006416 and NSF grant EF 0425852 (GER), a Discovery grant from the Natural Sciences and Engineering Council of Canada, and an Early Researcher Award from the Ontario Ministry of Research and Innovation (AZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-503; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arnold G, 2002, ETHOLOGY, V108, P751, DOI 10.1046/j.1439-0310.2002.00809.x; Beekman M, 2007, BEHAV ECOL SOCIOBIOL, V61, P985, DOI 10.1007/s00265-006-0331-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Biesmeijer J, 2005, BEHAV ECOL SOCIOBIOL, V59, P133, DOI 10.1007/s00265-005-0019-6; Brockmann A, 2009, P NATL ACAD SCI USA, V106, P2383, DOI 10.1073/pnas.0813021106; Calabria LK, 2011, J INSECT PHYSIOL, V57, P1300, DOI 10.1016/j.jinsphys.2011.06.005; Carr-Markell MK, 2014, J INSECT BEHAV, V27, P736, DOI 10.1007/s10905-014-9465-1; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Denis GV, 2010, DISCOV MED, V10, P489; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Dreller C, 1998, BEHAV ECOL SOCIOBIOL, V43, P191, DOI 10.1007/s002650050480; Elias-Neto M, 2010, INSECT BIOCHEM MOLEC, V40, P241, DOI 10.1016/j.ibmb.2010.02.004; Gajewski KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010713; Ganesh K, 2014, FEBS LETT, V588, P21, DOI 10.1016/j.febslet.2013.11.013; Grusche FA, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-14; Guan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073628; Guo FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041877; Guo J, 2015, J INVERTEBR PATHOL, V127, P110, DOI 10.1016/j.jip.2015.03.010; Han Z, 2004, P NATL ACAD SCI USA, V101, P12567, DOI 10.1073/pnas.0405085101; Higginson AD, 2011, EXPT WING DAMAGE AFF; Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055; Kapheim KM, 2015, SCIENCE, V348, P1139, DOI 10.1126/science.aaa4788; Kapheim KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123911; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Kraus FB, 2011, BEHAV GENET, V41, P323, DOI 10.1007/s10519-010-9382-9; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Leiserson WM, 2011, GLIA, V59, P320, DOI 10.1002/glia.21103; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liang ZZS, 2012, SCIENCE, V335, P1225, DOI 10.1126/science.1213962; Liu HX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0566-0; Lusk RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110808; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Mattila HR, 2014, APIDOLOGIE, V45, P347, DOI 10.1007/s13592-013-0252-3; Mattila HR, 2011, BEHAV ECOL SOCIOBIOL, V65, P799, DOI 10.1007/s00265-010-1083-0; Meznar ER, 2010, J HERED, V101, pS118, DOI 10.1093/jhered/esq002; Mondet F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10454; Moran NA, 2015, CURR OPIN INSECT SCI, V10, P22, DOI 10.1016/j.cois.2015.04.003; Page RE, 2012, ANNU REV GENET, V46, P97, DOI 10.1146/annurev-genet-110711-155610; Pan CY, 2009, PESTIC BIOCHEM PHYS, V93, P105, DOI 10.1016/j.pestbp.2008.12.003; Park D, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-1; Percudani R, 2013, BIOINFORM BIOL INSIG, V7, P55, DOI 10.4137/BBI.S11064; Robinson G, 1988, THE GENETICS OF SOCI, P61; Rodriguez-Zas SL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-233; Rodriguez-Zas SL, 2012, J BIOL RHYTHM, V27, P12, DOI 10.1177/0748730411431404; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Seehuus SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069870; SEELEY TD, 1983, BEHAV ECOL SOCIOBIOL, V12, P253, DOI 10.1007/BF00290778; Shiomi K, 2007, MOL CELL NEUROSCI, V34, P209, DOI 10.1016/j.mcn.2006.10.015; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Spokony RF, 2007, DEV GENES EVOL, V217, P499, DOI 10.1007/s00427-007-0159-y; Tarpy DR, 2015, APPL ENVIRON MICROB, V81, P3182, DOI 10.1128/AEM.00307-15; Tsuruda JM, 2009, BEHAV BRAIN RES, V205, P132, DOI 10.1016/j.bbr.2009.07.022; Tu-Sekine Becky, 2013, Advances in Biological Regulation, V53, P118, DOI 10.1016/j.jbior.2012.09.007; Tyvand PA, 2010, J THEOR BIOL, V266, P470, DOI 10.1016/j.jtbi.2010.07.005; Ueda S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-35; Vance JT, 2014, J INSECT PHYSIOL, V65, P27, DOI 10.1016/j.jinsphys.2014.04.003; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilson MJ, 2011, DEVELOPMENT, V138, P3497, DOI 10.1242/dev.067926; Yan H, 2015, ANNU REV ENTOMOL, V60, P435, DOI 10.1146/annurev-ento-010814-020803; Yang CW, 2014, BBA-GEN SUBJECTS, V1840, P2674, DOI 10.1016/j.bbagen.2014.05.013; Yu XL, 2011, ARCH INSECT BIOCHEM, V77, P163, DOI 10.1002/arch.20432	69	7	8	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146430	10.1371/journal.pone.0146430	http://dx.doi.org/10.1371/journal.pone.0146430			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784945	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400037
J	Yang, K; Wu, WM; Chen, YC; Lo, SH; Liao, YC				Yang, Kuan; Wu, Wei-Ming; Chen, Ya-Chi; Lo, Su Hao; Liao, Yi-Chun			Delta Np63 alpha Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion	PLOS ONE			English	Article							P53 HOMOLOG P63; KERATINOCYTE PROLIFERATION; EPIDERMAL DIFFERENTIATION; GENOTOXIC STRESS; STEM-CELLS; CANCER; ISOFORMS; GENE; METASTASIS; TARGET	p63 is a member of the p53 transcription factor family and a linchpin of epithelial development and homeostasis. p63 drives the expression of many target genes involved in cell survival, adhesion, migration and cancer. In this study, we identify C-terminal tensin-like (CTEN) molecule as a downstream target of Delta Np63 alpha, the predominant p63 isoform expressed in epithelium. CTEN belongs to the tensin family and is mainly localized to focal adhesions, which mediate many biological events such as cell adhesion, migration, proliferation and gene expression. Our study demonstrate that Delta Np63 and CTEN are both highly expressed in normal prostate epithelial cells and are down-regulated in prostate cancer. In addition, reduced expression of CTEN and Delta Np63 is correlated with prostate cancer progression from primary tumors to metastatic lesions. Silencing of Delta Np63 leads to decreased mRNA and protein levels of CTEN Delta Np63 alpha induces transcriptional activity of the CTEN promoter and a 140-bp fragment upstream of the transcription initiation site is the minimal promoter region required for activation. A putative binding site for p63 is located between -61 and -36 within the CTEN promoter and mutations of the critical nucleotides in this region abolish Delta Np63 alpha-induced promoter activity. The direct interaction of Delta Np63 alpha-mediated with the CTEN promoter was demonstrated using a chromatin immunoprecipitation (ChIP) assay. Moreover, impaired cell adhesion caused by Delta Np63 alpha depletion is rescued by over-expression of CTEN, suggesting that CTEN is a downstream effector of Delta Np63 alpha-mediated cell adhesion. In summary, our findings demonstrate that Delta Np63 alpha functions as a trans-activation factor of CTEN promoter and regulates cell adhesion through modulating CTEN. Our study further contributes to the potential regulatory mechanisms of CTEN in prostate cancer progression.	[Yang, Kuan; Wu, Wei-Ming; Chen, Ya-Chi; Liao, Yi-Chun] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Lo, Su Hao] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	National Taiwan University; University of California System; University of California Davis	Liao, YC (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	yliao@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	Wu, Wei-Ming/0000-0001-5998-0478; Liao, Yi-Chun/0000-0002-0399-0201; Lo, Su Hao/0000-0002-2675-9387	Ministry of Science and Technology, Taiwan [NSC-102-2628-B-002-028-MY3]; National Taiwan University [NTU-CESRP-104R76262]; NATIONAL CANCER INSTITUTE [R01CA102537] Funding Source: NIH RePORTER	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded from the Ministry of Science and Technology, Taiwan, grant NSC-102-2628-B-002-028-MY3 (http://www.most.gov.tw/) and National Taiwan University grant NTU-CESRP-104R76262 (http://www.ntu.edu.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Chia-Chung Chang for providing the pGL-923 plasmid. This study was supported by grants from the Ministry of Science and Technology, Taiwan (NSC-102-2628-B-002-028-MY3) and National Taiwan University (NTU-CESRP-104R76262).	Bamberger C, 2001, FEBS LETT, V501, P121, DOI 10.1016/S0014-5793(01)02643-6; Barbieri CE, 2006, EXP CELL RES, V312, P695, DOI 10.1016/j.yexcr.2005.11.028; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Bergholz J, 2014, ONCOGENE, V33, P212, DOI 10.1038/onc.2012.564; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Celardo I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.175; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chen NT, 2013, GENE, V520, P90, DOI 10.1016/j.gene.2013.02.041; Coppola V, 2013, ONCOGENE, V32, P1843, DOI 10.1038/onc.2012.194; Dellavalle RP, 2001, J DERMATOL SCI, V27, P82, DOI 10.1016/S0923-1811(01)00105-0; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Duijf PHG, 2002, HUM MOL GENET, V11, P799, DOI 10.1093/hmg/11.7.799; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Grisanzio C, 2008, J CELL BIOCHEM, V103, P1354, DOI 10.1002/jcb.21555; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Higashikawa K, 2007, CANCER RES, V67, P9207, DOI 10.1158/0008-5472.CAN-07-0932; Hong SY, 2013, CANCER RES, V73, P5266, DOI 10.1158/0008-5472.CAN-12-4441; Hu H, 2002, INT J CANCER, V102, P580, DOI 10.1002/ijc.10739; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Kommagani R, 2009, J CELL SCI, V122, P2828, DOI 10.1242/jcs.049619; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Koster MI, 2004, DIFFERENTIATION, V72, P364, DOI 10.1111/j.1432-0436.2004.07208002.x; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Kouwenhoven EN, 2015, EMBO REP, V16, P863, DOI 10.15252/embr.201439941; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Kumar RMR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-559; Kurata S, 2004, J BIOL CHEM, V279, P50069, DOI 10.1074/jbc.M406322200; Li YQ, 2010, PROSTATE, V70, P48, DOI 10.1002/pros.21037; Lo SH, 2002, CANCER RES, V62, P4217; Lo SH, 2014, INT J BIOCHEM CELL B, V51, P150, DOI 10.1016/j.biocel.2014.04.003; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; Martynova E, 2012, ONCOTARGET, V3, P132; Massion PP, 2003, CANCER RES, V63, P7113; McDade SS, 2014, NUCLEIC ACIDS RES, V42, P6270, DOI 10.1093/nar/gku299; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Olsen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062547; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Parsons JK, 2009, PROSTATE, V69, P559, DOI 10.1002/pros.20904; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Rinne T, 2006, AM J MED GENET A, V140A, P1396, DOI 10.1002/ajmg.a.31271; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Seo EY, 2012, BRIT J DERMATOL, V166, P337, DOI 10.1111/j.1365-2133.2011.10665.x; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Wang TY, 2001, HUM PATHOL, V32, P479, DOI 10.1053/hupa.2001.24324; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2005, CANCER RES, V65, P758; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	68	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147542	10.1371/journal.pone.0147542	http://dx.doi.org/10.1371/journal.pone.0147542			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784942	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400148
J	Zhang, JT; Yi, M; Zha, LY; Chen, SQ; Li, ZJ; Li, C; Gong, MX; Deng, H; Chu, XW; Chen, JH; Zhang, ZQ; Mao, LM; Sun, SX				Zhang, Jintao; Yi, Man; Zha, Longying; Chen, Siqiang; Li, Zhijia; Li, Cheng; Gong, Mingxing; Deng, Hong; Chu, Xinwei; Chen, Jiehua; Zhang, Zheqing; Mao, Limei; Sun, Suxia			Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; CYCLE ARREST; CANCER; DEATH; PATHWAYS; PROLIFERATION; INFLAMMATION; INHIBITOR; MECHANISM; TARGET	Purpose Butyrate, a short-chain fatty acid derived from dietary fiber, inhibits proliferation and induces cell death in colorectal cancer cells. However, clinical trials have shown mixed results regarding the anti-tumor activities of butyrate. We have previously shown that sodium butyrate increases endoplasmic reticulum stress by altering intracellular calcium levels, a well-known autophagy trigger. Here, we investigated whether sodium butyrate-induced endoplasmic reticulum stress mediated autophagy, and whether there was crosstalk between autophagy and the sodium butyrate-induced apoptotic response in human colorectal cancer cells. Methods Human colorectal cancer cell lines (HCT-116 and HT-29) were treated with sodium butyrate at concentrations ranging from 0.5-5mM. Cell proliferation was assessed using MTT tetrazolium salt formation. Autophagy induction was confirmed through a combination of Western blotting for associated proteins, acridine orange staining for acidic vesicles, detection of autolysosomes (MDC staining), and electron microscopy. Apoptosis was quantified by flow cytometry using standard annexinV/propidium iodide staining and by assessing PARP-1 cleavage by Western blot. Results Sodium butyrate suppressed colorectal cancer cell proliferation, induced autophagy, and resulted in apoptotic cell death. The induction of autophagy was supported by the accumulation of acidic vesicular organelles and autolysosomes, and the expression of autophagya-ssociated proteins, including microtubule-associated protein II light chain 3 (LC3-II), beclin-1, and autophagocytosis-associated protein (Atg)3. The autophagy inhibitors 3-methyladenine (3-MA) and chloroquine inhibited sodium butyrate induced autophagy. Furthermore, sodium butyrate treatment markedly enhanced the expression of endoplasmic reticulum stress-associated proteins, including BIP, CHOP, PDI, and IRE-1a. When endoplasmic reticulum stress was inhibited by pharmacological (cycloheximide and mithramycin) and genetic (siRNA targeting BIP and CHOP) methods, the induction of BIP, PDI, IRE1a, and LC3-II was blocked, but PARP cleavage was markedly enhanced. Discussion Taken together, these results suggested that sodium butyrate-induced autophagy was mediated by endoplasmic reticulum stress, and that preventing autophagy by blocking the endoplasmic reticulum stress response enhanced sodium butyrate-induced apoptosis. These results provide novel insights into the anti-tumor mechanisms of butyric acid.	[Zhang, Jintao; Yi, Man; Zha, Longying; Li, Zhijia; Li, Cheng; Gong, Mingxing; Deng, Hong; Chu, Xinwei; Chen, Jiehua; Zhang, Zheqing; Mao, Limei; Sun, Suxia] Southern Med Univ, Guangdong Prov Key Lab Trop Dis Res, Dept Nutr & Food Hyg, Sch Publ Hlth, 1023 South Sha Tai Rd, Guangzhou 510515, Guangdong, Peoples R China; [Chen, Siqiang] Guangdong Entry Exit Inspect & Quarantine Bur, Dept Certificat Supervis, Guojian Bldg,66,Huacheng Ave, Guangzhou 510623, Guangdong, Peoples R China	Southern Medical University - China	Sun, SX (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Trop Dis Res, Dept Nutr & Food Hyg, Sch Publ Hlth, 1023 South Sha Tai Rd, Guangzhou 510515, Guangdong, Peoples R China.	suxiasun@hotmail.com		Sun, Suxia/0000-0002-1159-6191	National Natural Science Foundation of China [81202204]; Guangdong National Natural Science Foundation [S2012010009467]; Project for Excellent Young University Teacher	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong National Natural Science Foundation; Project for Excellent Young University Teacher	Financial support for this study was provided by National Natural Science Foundation of China (No. 81202204), Guangdong National Natural Science Foundation (No. S2012010009467), Project for Excellent Young University Teacher awarded to Southern Medical University.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; [Anonymous], 1993, HLTH CLAIMS FIBER CO; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; Bultman SJ, 2014, CLIN CANCER RES, V20, P799, DOI 10.1158/1078-0432.CCR-13-2483; Chen ML, 2013, AUTOPHAGY, V9, P2033, DOI 10.4161/auto.26336; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; CUMMINGS JH, 1984, SCAND J GASTROENTERO, V19, P89; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Fauser JK, 2014, CANCER BIOL THER, V11, P724; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gurusamy N, 2009, ACTA PHYSIOL HUNG, V96, P267, DOI 10.1556/APhysiol.96.2009.3.2; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kawakami T, 2009, NEPHROL DIAL TRANSPL, V24, P2665, DOI 10.1093/ndt/gfp215; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152; Lee S, 2014, EMBO MOL MED, V6, P732, DOI 10.15252/emmm.201302561; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liu EY, 2012, J CELL SCI, V125, P2349, DOI 10.1242/jcs.093708; Louis M, 2004, INT J ONCOL, V25, P1701; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Nelson RS, 2009, CURR ONCOL REP, V11, P482, DOI 10.1007/s11912-009-0065-8; Nemchenko A, 2011, J MOL CELL CARDIOL, V51, P584, DOI 10.1016/j.yjmcc.2011.06.010; Paglin S, 2001, CANCER RES, V61, P439; Park M, 2015, J CELL PHYSIOL, V230, P630, DOI 10.1002/jcp.24781; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Stankiewicz M, 1996, INT J PARASITOL, V26, P445, DOI 10.1016/0020-7519(96)00003-3; Su CC, 2015, MOL MED REP, V11, P3160, DOI 10.3892/mmr.2014.3090; Sun SX, 2012, BIOSCIENCE REP, V32, P83, DOI 10.1042/BSR20110062; Tang Y, 2011, CELL DEATH DIFFER, V18, P602, DOI 10.1038/cdd.2010.117; Tang Y, 2011, AUTOPHAGY, V7, P235, DOI 10.4161/auto.7.2.14277; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang GH, 2010, AM J TRANSL RES, V2, P65; Wang YJ, 2014, TOXICOLOGY, V326, P9, DOI 10.1016/j.tox.2014.09.010; Wang YF, 2006, MOL CELL BIOCHEM, V285, P51, DOI 10.1007/s11010-005-9054-x; Wang Z, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.503; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yang PM, 2010, CANCER RES, V70, P7699, DOI 10.1158/0008-5472.CAN-10-1626; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653	50	58	63	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147218	10.1371/journal.pone.0147218	http://dx.doi.org/10.1371/journal.pone.0147218			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784903	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400125
J	Sumie, M; Shiokawa, H; Yamaura, K; Karashima, Y; Hoka, S; Yoshimura, M				Sumie, Makoto; Shiokawa, Hiroaki; Yamaura, Ken; Karashima, Yuji; Hoka, Sumio; Yoshimura, Megumu			Direct Effect of Remifentanil and Glycine Contained in Ultiva (R) on Nociceptive Transmission in the Spinal Cord: In Vivo and Slice Patch Clamp Analyses	PLOS ONE			English	Article							SUBSTANTIA-GELATINOSA NEURONS; OPIOID-INDUCED HYPERALGESIA; D-ASPARTATE RECEPTOR; ANTINOCICEPTIVE TOLERANCE; DORSAL-HORN; NO EVIDENCE; RAT; HUMANS; PAIN; FACILITATION	Background Ultiva (R) is commonly administered intravenously for analgesia during general anaesthesia and its main constituent remifentanil is an ultra-short-acting mu-opioid receptor agonist. Ultiva (R) is not approved for epidural or intrathecal use in clinical practice. Previous studies have reported that Ultiva (R) provokes opioid-induced hyperalgesia by interacting with spinal dorsal horn neurons. Ultiva (R) contains glycine, an inhibitory neurotransmitter but also an N-methyl-D-aspartate receptor co-activator. The presence of glycine in the formulation of Ultiva (R) potentially complicates its effects. We examined how Ultiva (R) directly affects nociceptive transmission in the spinal cord. Methods We made patch-clamp recordings from substantia gelatinosa (SG) neurons in the adult rat spinal dorsal horn in vivo and in spinal cord slices. We perfused Ultiva (R) onto the SG neurons and analysed its effects on the membrane potentials and synaptic responses activated by noxious mechanical stimuli. Results Bath application of Ultiva (R) hyperpolarized membrane potentials under current-clamp conditions and produced an outward current under voltage-clamp conditions. A barrage of excitatory postsynaptic currents (EPSCs) evoked by the stimuli was suppressed by Ultiva (R). Miniature EPSCs (mEPSCs) were depressed in frequency but not amplitude. Ultiva (R)-induced outward currents and suppression of mEPSCs were not inhibited by the mu-opioid receptor antagonist naloxone, but were inhibited by the glycine receptor antagonist strychnine. The Ultiva (R)-induced currents demonstrated a specific equilibrium potential similar to glycine. Conclusions We found that intrathecal administration of Ultiva (R) to SG neurons hyperpolarized membrane potentials and depressed presynaptic glutamate release predominantly through the activation of glycine receptors. No Ultiva (R)-induced excitatory effects were observed in SG neurons. Our results suggest different analgesic mechanisms of Ultiva (R) between intrathecal and intravenous administrations.	[Sumie, Makoto; Karashima, Yuji; Hoka, Sumio] Kyushu Univ, Grad Sch Med Sci, Dept Anesthesiol & Crit Care Med, Fukuoka 812, Japan; [Shiokawa, Hiroaki] Kyushu Univ, Dept Anesthesiol & Crit Care Med, Fukuoka 812, Japan; [Yamaura, Ken] Fukuoka Univ, Sch Med, Dept Anesthesiol, Fukuoka 81401, Japan; [Yoshimura, Megumu] Kumamoto Hlth Sci Univ, Div Hlth Sci, Grad Sch Hlth Sci, Kumamoto, Japan	Kyushu University; Kyushu University; Fukuoka University; Kumamoto Health Science University	Shiokawa, H (corresponding author), Kyushu Univ, Dept Anesthesiol & Crit Care Med, Fukuoka 812, Japan.	salt@kuaccm.med.kyushu-u.ac.jp	Karashima, Yuji/AGY-5391-2022	Karashima, Yuji/0000-0002-2866-8999	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology https://www.jsps.go.jp/j-grantsinaid/.	Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Albertin A, 2005, ANESTH ANALG, V101, P125, DOI 10.1213/01.ANE.0000153012.35120.FE; Angst MS, 2009, PAIN, V142, P17, DOI 10.1016/j.pain.2008.11.001; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Angst MS, 2003, PAIN, V106, P49, DOI 10.1016/S0304-3959(03)00276-8; Bonnet MP, 2007, INTENS CARE MED, V33, P1179, DOI 10.1007/s00134-007-0574-6; Buerkle H, 1996, ANESTHESIOLOGY, V84, P926, DOI 10.1097/00000542-199604000-00021; Buerkle H, 1996, ANESTHESIOLOGY, V84, P94; DERSHWITZ M, 1995, ANESTH ANALG, V81, P619, DOI 10.1097/00000539-199509000-00035; Fujita T, 2006, NEUROSCIENCE, V139, P1095, DOI 10.1016/j.neuroscience.2006.01.010; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; Guignard B, 2000, ANESTHESIOLOGY, V93, P409, DOI 10.1097/00000542-200008000-00019; Guntz E, 2005, ANESTHESIOLOGY, V102, P1235, DOI 10.1097/00000542-200506000-00025; Hahnenkamp K, 2004, ANESTHESIOLOGY, V100, P1531, DOI 10.1097/00000542-200406000-00028; Hood DD, 2003, ANESTH ANALG, V97, P810, DOI 10.1213/01.ANE.0000078811.80093.88; Ikoma M, 2007, ANESTHESIOLOGY, V107, P807, DOI 10.1097/01.anes.0000286985.80301.5e; Ishii H, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-11; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Kawamata M, 2006, ANESTHESIOLOGY, V104, P432, DOI 10.1097/00000542-200603000-00009; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Kohno T, 2000, ANESTHESIOLOGY, V92, P507, DOI 10.1097/00000542-200002000-00034; Koppert W, 2003, ANESTHESIOLOGY, V99, P152, DOI 10.1097/00000542-200307000-00025; Kostera-Pruszczyk A, 2002, ACTA NEUROL SCAND, V106, P34, DOI 10.1034/j.1600-0404.2002.00149.x; Lee LHY, 2005, ANESTHESIOLOGY, V102, P398, DOI 10.1097/00000542-200502000-00024; Maxwell DJ, 1999, EUR J NEUROSCI, V11, P2151, DOI 10.1046/j.1460-9568.1999.00632.x; MITCHELL K, 1993, J NEUROSCI, V13, P2371, DOI 10.1523/JNEUROSCI.13-06-02371.1993; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Petersen KL, 2001, ANESTHESIOLOGY, V94, P15, DOI 10.1097/00000542-200101000-00008; Sonohata M, 2004, J PHYSIOL-LONDON, V555, P515, DOI 10.1113/jphysiol.2003.054932; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Terashima Y, 2011, PAIN, V152, P1024, DOI 10.1016/j.pain.2010.12.039; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Xie JY, 2005, J NEUROSCI, V25, P409, DOI 10.1523/JNEUROSCI.4054-04.2005; Xu XB, 2007, ANESTH ANALG, V104, P1004, DOI 10.1213/01.ane.0000258822.21787.db; Yajiri Y, 1997, NEUROSCIENCE, V76, P673, DOI 10.1016/S0306-4522(96)00291-6; Zhao M, 2008, ANESTHESIOLOGY, V109, P308, DOI 10.1097/ALN.0b013e31817f4c5d	37	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147339	10.1371/journal.pone.0147339	http://dx.doi.org/10.1371/journal.pone.0147339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771515	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000368628300076
J	Xu, M; Mu, XD; Dick, JTA; Fang, M; Gu, DG; Luo, D; Zhang, JE; Luo, JR; Hu, YC				Xu, Meng; Mu, Xidong; Dick, Jaimie T. A.; Fang, Miao; Gu, Dangen; Luo, Du; Zhang, Jiaen; Luo, Jianren; Hu, Yinchang			Comparative Functional Responses Predict the Invasiveness and Ecological Impacts of Alien Herbivorous Snails	PLOS ONE			English	Article							POMACEA-CANALICULATA; APPLE SNAILS; BODY-MASS; PREDATOR; TEMPERATURE; MACROPHYTES; SURVIVAL; INVASION; MODEL	Understanding determinants of the invasiveness and ecological impacts of alien species is amongst the most sought-after and urgent research questions in ecology. Several studies have shown the value of comparing the functional responses (FRs) of alien and native predators towards native prey, however, the technique is under-explored with herbivorous alien species and as a predictor of invasiveness as distinct from ecological impact. Here, in China, we conducted a mesocosm experiment to compare the FRs among three herbivorous snail species: the golden apple snail, Pomacea canaliculata, a highly invasive and high impact alien listed in "100 of the World's Worst Invasive Alien Species"; Planorbarius corneus, a non-invasive, low impact alien; and the Chinese native snail, Bellamya aeruginosa, when feeding on four locally occurring plant species. Further, by using a numerical response equation, we modelled the population dynamics of the snail consumers. For standard FR parameters, we found that the invasive and damaging alien snail had the highest "attack rates" a, shortest "handling times" h and also the highest estimated maximum feeding rates, 1/hT, whereas the native species had the lowest attack rates, longest handling times and lowest maximum feeding rates. The non-invasive, low impact alien species had consistently intermediate FR parameters. The invasive alien species had higher population growth potential than the native snail species, whilst that of the non-invasive alien species was intermediate. Thus, while the comparative FR approach has been proposed as a reliable method for predicting the ecological impacts of invasive predators, our results further suggest that comparative FRs could extend to predict the invasiveness and ecological impacts of alien herbivores and should be explored in other taxa and trophic groups to determine the general utility of the approach.	[Xu, Meng; Mu, Xidong; Fang, Miao; Gu, Dangen; Luo, Du; Luo, Jianren; Hu, Yinchang] Chinese Acad Fishery Sci, Pearl River Fisheries Res Inst, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Guangzhou, Guangdong, Peoples R China; [Dick, Jaimie T. A.] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, MBC, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Fang, Miao] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Zhang, Jiaen] South China Agr Univ, Dept Ecol, Key Lab Agroenvironm Trop, Coll Agr,Minist Agr, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Fishery Sciences; Pearl River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Queens University Belfast; Shanghai Ocean University; Ministry of Agriculture & Rural Affairs; South China Agricultural University	Hu, YC (corresponding author), Chinese Acad Fishery Sci, Pearl River Fisheries Res Inst, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Guangzhou, Guangdong, Peoples R China.	huyc22@163.com		Xu, Meng/0000-0002-2906-6471; Mu, Xidong/0000-0003-4091-7430	National Natural Science Foundation of China [31400487, 31300468, U1131006]; Agricultural Biological Resources Protection and Utilization Project of China [2130108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Biological Resources Protection and Utilization Project of China	This work was funded by the National Natural Science Foundation of China (grant number 31400487, 31300468 and U1131006), and Agricultural Biological Resources Protection and Utilization Project of China (2130108).	Alexander ME, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0946; Alexander ME, 2012, MAR ECOL PROG SER, V468, P191, DOI 10.3354/meps09978; Barrios-O'Neill D, 2015, FUNCT ECOL, V29, P377, DOI 10.1111/1365-2435.12347; Barrios-O'Neill D, 2014, J ANIM ECOL, V83, P693, DOI 10.1111/1365-2656.12155; Bolker B., 2011, EMDBOOK ECOLOGICAL M; Bollache L, 2008, BIOL LETTERS, V4, P166, DOI 10.1098/rsbl.2007.0554; Carlsson NOL, 2006, FRESHWATER BIOL, V51, P695, DOI 10.1111/j.1365-2427.2006.01523.x; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Chen Q., 1987, Acta Hydrobiologica Sinica, V11, P117; Chen Q.Y., 1975, ACTA HYDROBIOL SIN, V5, P371; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Costil K, 1997, J MOLLUS STUD, V63, P293, DOI 10.1093/mollus/63.2.293; Cowie R. H., 2002, Molluscs as crop pests, P145, DOI 10.1079/9780851993201.0145; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Crawley MJ, 2004, SOAY SHEEP: DYNAMICS AND SELECTION IN AN ISLAND POPULATION, P89; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dick JTA, 2014, BIOL INVASIONS, V16, P735, DOI 10.1007/s10530-013-0550-8; Dick JTA, 2013, BIOL INVASIONS, V15, P837, DOI 10.1007/s10530-012-0332-8; Dodd JA, 2014, FRESHWATER BIOL, V59, P337, DOI 10.1111/fwb.12268; Durant D, 2003, J ANIM ECOL, V72, P220, DOI 10.1046/j.1365-2656.2003.00689.x; Englund G, 2008, ECOL LETT, V11, P440, DOI 10.1111/j.1461-0248.2008.01159.x; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Fang L, 2010, FRESHWATER BIOL, V55, P1191, DOI 10.1111/j.1365-2427.2009.02343.x; Farnsworth KD, 1996, FUNCT ECOL, V10, P678; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Haddaway NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032229; HALWART M, 1994, INT J PEST MANAGE, V40, P199, DOI 10.1080/09670879409371882; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hobbs NT, 2003, ECOLOGY, V84, P666; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hu YC, 2014, BIOCHEM SYST ECOL, V57, P203, DOI 10.1016/j.bse.2014.08.016; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Jopp F, 2006, LIMNOLOGICA, V36, P17, DOI 10.1016/j.limno.2005.10.003; Juliano S.A., 2001, DESIGN ANAL ECOLOGIC, P178; Kalinkat G, 2013, ECOL LETT, V16, P1126, DOI 10.1111/ele.12147; Kestrup AM, 2011, BIOL INVASIONS, V13, P769, DOI 10.1007/s10530-010-9867-8; Kriska G., 2013, FRESHWATER INVERTEBR; Kulhanek SA, 2011, ECOL APPL, V21, P189, DOI 10.1890/09-1452.1; Lin Jin-xiang, 2005, Chinese Journal of Zoonoses, V21, P24; Liu Jun, 2012, Yingyong Shengtai Xuebao, V23, P559; Liu YY., 1993, MED MALACOLOGY; Lowe S., 2000, ENCY BIOL INVASIONS; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000368; Mccoy MW, 2012, ECOL LETT, V15, P1449, DOI 10.1111/ele.12005; Morrison WE, 2011, BIOL INVASIONS, V13, P945, DOI 10.1007/s10530-010-9881-x; MURDOCH W W, 1975, P1; Paterson RA, 2015, J ANIM ECOL, V84, P453, DOI 10.1111/1365-2656.12292; Poznanska M, 2015, HYDROBIOLOGIA, V747, P177, DOI 10.1007/s10750-014-2130-z; R Development Core Team, 2014, R LANG ENV STAT COMP; Ricciardi A, 2007, BIOL INVASIONS, V9, P309, DOI 10.1007/s10530-006-9034-4; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; ROGERS D, 1972, J ANIM ECOL, V41, P369, DOI 10.2307/3474; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; ROSENZWEIG ML, 1969, AM NAT, V103, P81, DOI 10.1086/282584; Schneider FD, 2012, ECOL LETT, V15, P436, DOI 10.1111/j.1461-0248.2012.01750.x; Smout S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010761; Toscano BJ, 2014, J ANIM ECOL, V83, P1469, DOI 10.1111/1365-2656.12236; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Leeuwen E, 2007, ECOLOGY, V88, P1571, DOI 10.1890/06-1335; Yearsley J, 2001, P NUTR SOC, V60, P145, DOI 10.1079/PNS200062; Zhao W, 2013, AQUARIUM, P128	61	24	27	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147017	10.1371/journal.pone.0147017	http://dx.doi.org/10.1371/journal.pone.0147017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771658	Green Submitted, Green Published, gold			2022-12-26	WOS:000368628300051
J	Rossi, P; Sterlini, B; Castroflorio, E; Marte, A; Onofri, F; Valtorta, F; Maragliano, L; Corradi, A; Benfenati, F				Rossi, Pia; Sterlini, Bruno; Castroflorio, Enrico; Marte, Antonella; Onofri, Franco; Valtorta, Flavia; Maragliano, Luca; Corradi, Anna; Benfenati, Fabio			A Novel Topology of Proline-rich Transmembrane Protein 2 (PRRT2): HINTS FOR AN INTRACELLULAR FUNCTION AT THE SYNAPSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; molecular dynamics; neurological disease; SNARE proteins; synapse	PAROXYSMAL DYSKINESIA; INFANTILE CONVULSIONS; MOLECULAR-DYNAMICS; MUTATIONS; GENE; SIMULATION; DISORDERS; SRC	Proline-rich transmembrane protein 2 (PRRT2) has been identified as the single causative gene for a group of paroxysmal syndromes of infancy, including epilepsy, paroxysmal movement disorders, and migraine. On the basis of topology predictions, PRRT2 has been assigned to the recently characterized family of Dispanins, whose members share the two-transmembrane domain topology with a large N terminus and short C terminus oriented toward the outside of the cell. Because PRRT2 plays a role at the synapse, it is important to confirm the exact orientation of its N and C termini with respect to the plasma membrane to get clues regarding its possible function. Using a combination of different experimental approaches, including live immunolabeling, immunogold electron microscopy, surface biotinylation and computational modeling, we demonstrate a novel topology for this protein. PRRT2 is a type II transmembrane protein in which only the second hydrophobic segment spans the plasma membrane, whereas the first one is associated with the internal surface of the membrane and forms a helix-loop-helix structure without crossing it. Most importantly, the large proline-rich N-terminal domain is not exposed to the extracellular space but is localized intracellularly, and only the short C terminus is extracellular (N-cyt/C-exo topology). Accordingly, we show that PRRT2 interacts with the Src homology 3 domain-bearing protein Intersectin 1, an intracellular protein involved in synaptic vesicle cycling. These findings will contribute to the clarification of the role of PRRT2 at the synapse and the understanding of pathogenic mechanisms on the basis of PRRT2-related neurological disorders.	[Corradi, Anna; Benfenati, Fabio] Univ Genoa, Dept Expt Med, Viale Benedetto 15,3, I-16132 Genoa, Italy; [Sterlini, Bruno; Castroflorio, Enrico; Maragliano, Luca; Benfenati, Fabio] Fdn Ist Italiano Tecnol, Ctr Synapt Neurosci & Technol, Largo Rosanna Benzi 10, I-16132 Genoa, Italy; [Valtorta, Flavia] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Via Olgettina 58, I-20132 Milan, Italy	University of Genoa; Istituto Italiano di Tecnologia - IIT; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Benfenati, F (corresponding author), Fdn Ist Italiano Tecnol, Ctr Synapt Neurosci & Technol, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.	fabio.benfenati@iit.it	Maragliano, Luca/A-8294-2010; Flavia, Valtorta/F-3450-2012; CASTROFLORIO, ENRICO/I-6767-2019; Corradi, Anna/AAC-5209-2022; Marte, Antonella/AAA-8072-2019	Maragliano, Luca/0000-0002-5705-6967; Flavia, Valtorta/0000-0001-9556-4746; CASTROFLORIO, ENRICO/0000-0002-6953-5420; Marte, Antonella/0000-0001-9842-2663; Sterlini, Bruno/0000-0001-8247-4709	Italian Ministry of University and Research; EU [602531]; EU ITN "ECMED" Grant [642881]; Telethon-Italy Grant [GGP13033]; CARIPLO Foundation [2013 0879]; Italian Ministry of Health Ricerca Finalizzata	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); EU(European Commission); EU ITN "ECMED" Grant; Telethon-Italy Grant(Fondazione Telethon); CARIPLO Foundation(Fondazione Cariplo); Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy)	This study was supported by Italian Ministry of University and Research Grants PRIN 2009 (to A. C.) and PRIN 2010/11 (to F. B. and F. O.), EU FP7 Integrating Project "Desire" Grant Agreement 602531 (to F. B.), EU ITN "ECMED" Grant Agreement 642881 (to F. B.), Telethon-Italy Grant GGP13033 (to F. B. and F. V.), CARIPLO Foundation Grant 2013 0879 (to F. V. and F. B.), and Italian Ministry of Health Ricerca Finalizzata 2013 (to F. V. and F. B.). The authors declare that they have no conflict of interest with the contents of this article.	Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Becker F, 2013, J NEUROL, V260, P1234, DOI 10.1007/s00415-012-6777-y; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Cloarec R, 2012, NEUROLOGY, V79, P2097, DOI 10.1212/WNL.0b013e3182752c46; Corradi A, 2014, HUM MOL GENET, V23, P90, DOI 10.1093/hmg/ddt401; Cowell JK, 2014, PROG BRAIN RES, V213, P159, DOI 10.1016/B978-0-444-63326-2.00009-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Vries B, 2012, NEUROLOGY, V79, P2154, DOI 10.1212/WNL.0b013e3182752c30; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gardiner AR, 2012, NEUROLOGY, V79, P2115, DOI 10.1212/WNL.0b013e3182752c5a; Guerrini R, 2012, NEUROLOGY, V79, P2086, DOI 10.1212/WNL.0b013e3182752edd; Heron SE, 2013, J MED GENET, V50, P133, DOI 10.1136/jmedgenet-2012-101406; Heron SE, 2012, AM J HUM GENET, V90, P152, DOI 10.1016/j.ajhg.2011.12.003; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jacob J, 1999, BIOPHYS J, V76, P1367, DOI 10.1016/S0006-3495(99)77298-X; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Li M, 2015, INT J MOL SCI, V16, P9134, DOI 10.3390/ijms16059134; Marini C, 2012, NEUROLOGY, V79, P2109, DOI 10.1212/WNL.0b013e3182752ca2; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; Meneret A, 2013, EUR J NEUROL, V20, P872, DOI 10.1111/ene.12104; Onofri F, 2000, J BIOL CHEM, V275, P29857, DOI 10.1074/jbc.M006018200; Onofri F, 1997, P NATL ACAD SCI USA, V94, P12168, DOI 10.1073/pnas.94.22.12168; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Riant F, 2012, NEUROLOGY, V79, P2122, DOI 10.1212/WNL.0b013e3182752cb8; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Scheffer IE, 2012, NEUROLOGY, V79, P2104, DOI 10.1212/WNL.0b013e3182752c6c; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341; Wood Heather, 2012, Nat Rev Neurol, V8, P657, DOI 10.1038/nrneurol.2012.240; Wu L, 2014, PARKINSONISM RELAT D, V20, P1399, DOI 10.1016/j.parkreldis.2014.10.012	44	43	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6111	6123		10.1074/jbc.M115.683888	http://dx.doi.org/10.1074/jbc.M115.683888			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797119	Green Published, hybrid			2022-12-26	WOS:000372894200006
J	Corona, A; Meleddu, R; Esposito, F; Distinto, S; Bianco, G; Masaoka, T; Maccioni, E; Menendez-Arias, L; Alcaro, S; Le Grice, SFJ; Tramontano, E				Corona, Angela; Meleddu, Rita; Esposito, Francesca; Distinto, Simona; Bianco, Giulia; Masaoka, Takashi; Maccioni, Elias; Menendez-Arias, Luis; Alcaro, Stefano; Le Grice, Stuart F. J.; Tramontano, Enzo			Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6	PLOS ONE			English	Article							HIGH-RESOLUTION STRUCTURES; RNASE-H ACTIVITIES; DNA-SYNTHESIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FORCE-FIELD; PRIMER GRIP; RESISTANCE; MUTATIONS; SITE	The DNA polymerase and ribonuclease H (RNase H) activities of human immunodeficiency virus type 1 (HIV-1) are needed for the replication of the viral genome and are validated drug targets. However, there are no approved drugs inhibiting RNase H and the efficiency of DNA polymerase inhibitors can be diminished by the presence of drug resistance mutations. In this context, drugs inhibiting both activities could represent a significant advance towards better anti-HIV therapies. We report on the mechanisms of allosteric inhibition of a newly synthesized isatin-based compound designated as RMNC6 that showed IC50 values of 1.4 and 9.8 mu M on HIV-1 RT-associated RNase H and polymerase activities, respectively. Blind docking studies predict that RMNC6 could bind two different pockets in the RT: one in the DNA polymerase domain (partially overlapping the non-nucleoside RT inhibitor [NNRTI] binding pocket), and a second one close to the RNase H active site. Enzymatic studies showed that RMNC6 interferes with efavirenz (an approved NNRTI) in its binding to the RT polymerase domain, although NNRTI resistance-associated mutations such as K103N, Y181C and Y188L had a minor impact on RT susceptibility to RMNC6. In addition, despite being naturally resistant to NNRTIs, the polymerase activity of HIV-1 group O RT was efficiently inhibited by RMNC6. The compound was also an inhibitor of the RNase H activity of wild-type HIV-1 group O RT, although we observed a 6.5-fold increase in the IC50 in comparison with the prototypic HIV-1 group M subtype B enzyme. Mutagenesis studies showed that RT RNase H domain residues Asn474 and Tyr501, and in a lesser extent Ala502 and Ala508, are critical for RMNC6 inhibition of the endonuclease activity of the RT, without affecting its DNA polymerization activity. Our results show that RMNC6 acts as a dual inhibitor with allosteric sites in the DNA polymerase and the RNase H domains of HIV-1 RT.	[Corona, Angela; Meleddu, Rita; Esposito, Francesca; Distinto, Simona; Bianco, Giulia; Maccioni, Elias; Tramontano, Enzo] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Masaoka, Takashi; Le Grice, Stuart F. J.] NCI, Frederick, MD 21701 USA; [Menendez-Arias, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Menendez-Arias, Luis] Univ Autonoma Madrid, Madrid, Spain; [Alcaro, Stefano] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Campus S Venuta,Viale Europa, I-88100 Catanzaro, Italy; [Tramontano, Enzo] CNR, Ist Ric Genet & Biomed, Cagliari, Italy	University of Cagliari; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Tramontano, E (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.	tramon@unica.it	Corona, Angela/G-7327-2014; Esposito, Francesca/I-8879-2012; Tramontano, Enzo/B-4919-2012; Arias, Luis Menendez/N-7447-2016; Menendez Arias, Luis/G-2436-2016; Distinto, Simona/P-9803-2016	Corona, Angela/0000-0002-6630-8636; Esposito, Francesca/0000-0001-9725-7977; Tramontano, Enzo/0000-0002-4849-0980; Arias, Luis Menendez/0000-0002-1251-6640; Distinto, Simona/0000-0003-1620-6225; Meleddu, Rita/0000-0003-1629-7454; Maccioni, Elias/0000-0003-2175-2802; ALCARO, Stefano/0000-0002-0437-358X	RAS [LR 7/2007CRP-24915]; Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services; Spanish Ministry of Economy and Competitiveness [BIO2013-48788-C2-1-R]; Fundacion Ramon Areces	RAS(Russian Academy of SciencesRegione Sardegna); Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services; Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Ramon Areces	This work was supported by RAS grant LR 7/2007CRP-24915. T.M. and S.L.G. are supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. Work in Madrid was supported by grant BIO2013-48788-C2-1-R (Spanish Ministry of Economy and Competitiveness) and an institutional grant of Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2013, NUCLEIC ACIDS RES, V41, P4601, DOI 10.1093/nar/gkt109; Alvarez M, 2009, J MOL BIOL, V392, P872, DOI 10.1016/j.jmb.2009.07.081; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betancor G, 2015, NUCLEIC ACIDS RES, V43, P2259, DOI 10.1093/nar/gkv077; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; BRODER S, 1984, NEW ENGL J MED, V311, P1292, DOI 10.1056/NEJM198411153112006; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Cho AE, 2005, J COMPUT CHEM, V26, P915, DOI 10.1002/jcc.20222; Christen MT, 2012, CHEM BIOL DRUG DES, V80, P706, DOI 10.1111/cbdd.12010; Chung SM, 2012, J BIOL CHEM, V287, P4066, DOI 10.1074/jbc.M111.314781; Corona A, 2014, ANTIMICROB AGENTS CH, V58, P6101, DOI 10.1128/AAC.03605-14; Corona A, 2014, FUTURE VIROL, V9, P445, DOI 10.2217/fvl.14.24; Corona A, 2013, FUTURE MED CHEM, V5, P2127, DOI 10.4155/fmc.13.178; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Das K, 2008, P NATL ACAD SCI USA, V105, P1466, DOI 10.1073/pnas.0711209105; Das K, 2011, J MED CHEM, V54, P2727, DOI 10.1021/jm101536x; Distinto S, 2013, CURR PHARM DESIGN, V19, P1850, DOI 10.2174/1381612811319100009; Distinto S, 2012, EUR J MED CHEM, V50, P216, DOI 10.1016/j.ejmech.2012.01.056; Esposito Francesca, 2012, Mol Biol Int, V2012, P586401, DOI 10.1155/2012/586401; Esposito F, 2011, FEBS J, V278, P1444, DOI 10.1111/j.1742-4658.2011.08057.x; Felts AK, 2011, J CHEM INF MODEL, V51, P1986, DOI 10.1021/ci200194w; Frentz D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-407; Gong QG, 2011, CHEM BIOL DRUG DES, V77, P39, DOI 10.1111/j.1747-0285.2010.01052.x; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Hasel W., 1988, TETRAHEDRON COMPUT M, V1, P103, DOI DOI 10.1016/0898-5529(88)90015-2; Herman BD, 2013, BIOCHEM J, V455, P179, DOI 10.1042/BJ20130850; Himmel DM, 2006, ACS CHEM BIOL, V1, P702, DOI 10.1021/cb600303y; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Julias JG, 2002, P NATL ACAD SCI USA, V99, P9515, DOI 10.1073/pnas.142123199; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; Masaoka T, 2013, J MED CHEM, V56, P5436, DOI 10.1021/jm400405z; Meleddu R, 2015, EUR J MED CHEM, V93, P452, DOI 10.1016/j.ejmech.2015.02.032; Meleddu R, 2014, CHEMMEDCHEM, V9, P1869, DOI 10.1002/cmdc.201402015; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Paris KA, 2009, J MED CHEM, V52, P6413, DOI 10.1021/jm900854h; Pata JD, 2004, P NATL ACAD SCI USA, V101, P10548, DOI 10.1073/pnas.0404151101; QuinonesMateu ME, 1997, VIROLOGY, V236, P364, DOI 10.1006/viro.1997.8748; Rausch JW, 2002, BIOCHEMISTRY-US, V41, P4856, DOI 10.1021/bi015970t; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; Ren JS, 2000, J BIOL CHEM, V275, P14316, DOI 10.1074/jbc.275.19.14316; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V61, P973, DOI 10.1093/jac/dkn060; SCHATZ O, 1990, ADV AP BIOT, V7, P293; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; Su HP, 2010, J VIROL, V84, P7625, DOI 10.1128/JVI.00353-10; Tramontano E, 2005, ANTIVIR RES, V65, P117, DOI 10.1016/j.antiviral.2004.11.002; Vernekar SKV, 2015, J MED CHEM, V58, P651, DOI 10.1021/jm501132s; Xu L, 2015, J MICROBIOL; YONETANI T, 1982, METHOD ENZYMOL, V87, P500	56	38	38	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147225	10.1371/journal.pone.0147225	http://dx.doi.org/10.1371/journal.pone.0147225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800261	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300075
J	Koronowicz, AA; Kopec, A; Master, A; Smolen, S; Piatkowska, E; Biezanowska-Kopec, R; Ledwozyw-Smolen, I; Skoczylas, L; Rakoczy, R; Leszczynska, T; Kapusta-Duch, J; Pysz, M				Koronowicz, Aneta A.; Kopec, Aneta; Master, Adam; Smolen, Sylwester; Piatkowska, Ewa; Biezanowska-Kopec, Renata; Ledwozyw-Smolen, Iwona; Skoczylas, Lukasz; Rakoczy, Roksana; Leszczynska, Teresa; Kapusta-Duch, Joanna; Pysz, Miroslaw			Transcriptome Profiling of Caco-2 Cancer Cell Line following Treatment with Extracts from Iodine-Biofortified Lettuce (Lactuca sativa L.)	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; THYROID-HORMONE; C-MYC; VAPOR GENERATION; DIFFERENTIATION; PROTEINS; APOPTOSIS; E2F1; 6-IODOLACTONE; EXPRESSION	Although iodization of salt is the most common method used to obtain iodine-enriched food, iodine deficiency disorders are still a global health problem and profoundly affect the quality of human life. Iodine is required for the synthesis of thyroid hormones, which are crucial regulators of human metabolism, cell growth, proliferation, apoptosis and have been reported to be involved in carcinogenesis. In this study, for the first time, we evaluated the effect of iodine-biofortified lettuce on transcriptomic profile of Caco-2 cancer cell line by applying the Whole Human Genome Microarray assay. We showed 1326 differentially expressed Caco2 transcripts after treatment with iodine-biofortified (BFL) and non-fortified (NFL) lettuce extracts. We analysed pathways, molecular functions, biological processes and protein classes based on comparison between BFL and NFL specific genes. Iodine, which was expected to act as a free ion (KI-NFL) or at least in part to be incorporated into lettuce macromolecules (BFL), differently regulated pathways of numerous transcription factors leading to different cellular effects. In this study we showed the inhibition of Caco-2 cells proliferation after treatment with BFL, but not potassium iodide (KI), and BFL-mediated induction of mitochondrial apoptosis and/or cell differentiation. Our results showed that iodine-biofortified plants can be effectively used by cells as an alternative source of this trace element. Moreover, the observed differences in action of both iodine sources may suggest a potential of BFL in cancer treatment.	[Koronowicz, Aneta A.; Kopec, Aneta; Piatkowska, Ewa; Biezanowska-Kopec, Renata; Leszczynska, Teresa; Kapusta-Duch, Joanna; Pysz, Miroslaw] Univ Agr, Fac Food Technol, Dept Human Nutr, Krakow, Poland; [Master, Adam] Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Smolen, Sylwester; Rakoczy, Roksana] Univ Agr, Unit Plant Nutr, Inst Plant Biol & Biotechnol, Fac Hort, Krakow, Poland; [Ledwozyw-Smolen, Iwona] Univ Agr, Biochem Unit, Inst Plant Biol & Biotechnol, Fac Biotechnol & Hort, Krakow, Poland; [Skoczylas, Lukasz] Univ Agr, Fac Food Technol, Dept Fruit Vegetable & Mushroom Proc, Krakow, Poland	Agricultural University Krakow; Centre of Postgraduate Medical Education - Poland; Agricultural University Krakow; Agricultural University Krakow; Agricultural University Krakow	Koronowicz, AA (corresponding author), Univ Agr, Fac Food Technol, Dept Human Nutr, Krakow, Poland.	aneta.koronowicz@gmail.com	Smoleń, Sylwester/S-4081-2019; Kapusta-Duch, Joanna/AAF-9894-2019	Rakoczy-Lelek, Roksana/0000-0002-9782-3200; Kapusta-Duch, Joanna/0000-0003-3882-2483; Piatkowska, Ewa/0000-0003-3699-314X; Skoczylas, Lukasz/0000-0002-8349-4477; Smolen, Sylwester/0000-0001-8093-3801	Polish National Science Center [DEC-2011/03/D/NZ9/05560]	Polish National Science Center	This work was financed by the 2012-2015 Polish National Science Center, grant no. DEC-2011/03/D/NZ9/05560, "I and Se biofortification of selected vegetables, including the influence of these microelements on yield quality as well as evaluation of iodine absorption and selected biochemical parameters in rats fed with vegetables biofortified with iodine."	Aceves C, 2013, THYROID, V23, P938, DOI 10.1089/thy.2012.0579; Aceves C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-33; [Anonymous], 2011, PHIE; Arroyo-Helguera O, 2006, ENDOCR-RELAT CANCER, V13, P1147, DOI 10.1677/erc.1.01250; Asadpour E, 2014, ACTA POL PHARM, V71, P409; Avram M, 2014, J MED AR, VXVII, P64; BELFIORE A, 1987, CANCER, V60, P3096, DOI 10.1002/1097-0142(19871215)60:12<3096::AID-CNCR2820601240>3.0.CO;2-V; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Dai JL, 2004, BIOL TRACE ELEM RES, V101, P265, DOI 10.1385/BTER:101:3:265; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Enechi O. C., 2014, African Journal of Biotechnology, V13, P4215, DOI 10.5897/AJB2013.13128; Eskin B A, 1977, Adv Exp Med Biol, V91, P293; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Haldimann M, 2005, J FOOD COMPOS ANAL, V18, P461, DOI 10.1016/j.jfca.2004.06.003; Henson DE, 2013, CANCER CAUSE CONTROL, V24, P609, DOI 10.1007/s10552-012-0135-3; Kawa S, 2002, PANCREAS, V24, P1, DOI 10.1097/00006676-200201000-00001; Knudsen N, 2001, J CLIN ENDOCR METAB, V86, P3599, DOI 10.1210/jc.86.8.3599; Kopec A, 2015, J FUNCT FOODS, V14, P479, DOI 10.1016/j.jff.2015.02.027; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Master A., 2014, ATLAS GENET CYTOGENE, V18, P400, DOI 10.4267/2042/53769; Master A, 2010, BBA-MOL BASIS DIS, V1802, P995, DOI 10.1016/j.bbadis.2010.07.025; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; MILLARD MM, 1988, PLANT CELL PHYSIOL, V29, P901; Nava-Villalba M, 2014, PROSTAG OTH LIPID M, V112, P27, DOI 10.1016/j.prostaglandins.2014.07.001; Olvera-Caltzontzin P, 2013, MOL MED, V19, P409, DOI 10.2119/molmed.2013.00093; Perez-Juste G, 2000, J BIOL CHEM, V275, P1307, DOI 10.1074/jbc.275.2.1307; Romaris-Hortas V, 2014, TALANTA, V127, P175, DOI 10.1016/j.talanta.2014.04.003; Romaris-Hortas V, 2013, J CHROMATOGR A, V1309, P33, DOI 10.1016/j.chroma.2013.08.022; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Rusanescu G, 2014, J CELL MOL MED, V18, P2103, DOI 10.1111/jcmm.12362; Sainmont J., 2014, STRATEGIES SUCCESS C; Simile MM, 2004, CARCINOGENESIS, V25, P333, DOI 10.1093/carcin/bgh014; Smolen S, 2014, SCI HORTIC-AMSTERDAM, V166, P9, DOI 10.1016/j.scienta.2013.11.011; Soriguer F, 2011, NUTR ENDOCRINOLOGY, V105, P1783, DOI DOI 10.1017/S0007114510005568; Swanson CA, 2012, J NUTR, V142, p1175S, DOI 10.3945/jn.111.156448; Thomasz L, 2013, PROSTAG LEUKOTR ESS, V88, P273, DOI 10.1016/j.plefa.2013.01.002; Tonacchera M, 2013, J CLIN ENDOCR METAB, V98, pE694, DOI 10.1210/jc.2012-3509; Turowska O, 2007, THYROID, V17, P1039, DOI 10.1089/thy.2007.0075; Vejbjerg P, 2009, EUR J ENDOCRINOL, V161, P475, DOI 10.1530/EJE-09-0262; Venturi S, 2000, Adv Clin Path, V4, P11; Vtorushina EA, 2008, J ANAL CHEM+, V63, P643, DOI 10.1134/S1061934808070071; Vtorushina EA, 2009, J ANAL CHEM+, V64, P129, DOI 10.1134/S1061934809020063; Wang B, 2014, HEPATOLOGY, V59, P555, DOI 10.1002/hep.26712; Weng HX, 2008, BIOL TRACE ELEM RES, V125, P59, DOI 10.1007/s12011-008-8155-2; Weng HX, 2009, ENVIRON GEOCHEM HLTH, V31, P401, DOI 10.1007/s10653-008-9193-6; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; World Health Organization, 2008, 2008 2013 ACT PLAN G; Zanirato V, 2009, Patent No. [PCT/EP2009/ 050142, 2009050142, PCT/EP2009/050142]; Zhang WX, 2015, MOL MED REP, V11, P3148, DOI 10.3892/mmr.2014.3096; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	50	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147336	10.1371/journal.pone.0147336	http://dx.doi.org/10.1371/journal.pone.0147336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799209	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300096
J	Lee, SA; Holly, KS; Voziyanov, V; Villalba, SL; Tong, R; Grigsby, HE; Glasscock, E; Szele, FG; Vlachos, I; Murray, TA				Lee, Seon A.; Holly, Kevin S.; Voziyanov, Vladislav; Villalba, Stephanie L.; Tong, Rudi; Grigsby, Holly E.; Glasscock, Edward; Szele, Francis G.; Vlachos, Ioannis; Murray, Teresa A.			Gradient Index Microlens Implanted in Prefrontal Cortex of Mouse Does Not Affect Behavioral Test Performance over Time	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; CEREBRAL-CORTEX; ACETYLCHOLINE-RECEPTORS; CELLULAR RESOLUTION; FLUORESCENT PROTEIN; MICE; ORGANIZATION; MODELS; EXPRESSION; SUBUNITS	Implanted gradient index lenses have extended the reach of standard multiphoton microscopy from the upper layers of the mouse cortex to the lower cortical layers and even subcortical regions. These lenses have the clarity to visualize dynamic activities, such as calcium transients, with subcellular and millisecond resolution and the stability to facilitate repeated imaging over weeks and months. In addition, behavioral tests can be used to correlate performance with observed changes in network function and structure that occur over time. Yet, this raises the questions, does an implanted microlens have an effect on behavioral tests, and if so, what is the extent of the effect? To answer these questions, we compared the performance of three groups of mice in three common behavioral tests. A gradient index lens was implanted in the prefrontal cortex of experimental mice. We compared their performance with mice that had either a cranial window or a sham surgery. Three presurgical and five postsurgical sets of behavioral tests were performed over seven weeks. Behavioral tests included rotarod, foot fault, and Morris water maze. No significant differences were found between the three groups, suggesting that microlens implantation did not affect performance. The results for the current study clear the way for combining behavioral studies with gradient index lens imaging in the prefrontal cortex, and potentially other regions of the mouse brain, to study structural, functional, and behavioral relationships in the brain.	[Lee, Seon A.; Holly, Kevin S.; Voziyanov, Vladislav; Grigsby, Holly E.; Vlachos, Ioannis; Murray, Teresa A.] Louisiana Tech Univ, Ctr Biomed Res & Rehabil Sci, Ruston, LA 71270 USA; [Villalba, Stephanie L.; Glasscock, Edward] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Tong, Rudi; Szele, Francis G.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Louisiana System; Louisiana Technical University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Oxford	Murray, TA (corresponding author), Louisiana Tech Univ, Ctr Biomed Res & Rehabil Sci, Ruston, LA 71270 USA.	bioengineer1@hotmail.com	Murray, Teresa/AAG-3531-2019; Murray, Teresa/AAV-3011-2020	Murray, Teresa/0000-0002-8857-154X; Lee, Seona/0000-0002-0124-6964	National Institutes of Health [R21 HD075376]; Louisiana Board of Regents Research Competitiveness Subprogram grant [12-180]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD075376] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL107641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents Research Competitiveness Subprogram grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided by the National Institutes of Health grant R21 HD075376 (https://grants.nih.gov) to TM, and the Louisiana Board of Regents Research Competitiveness Subprogram grant 12-180 (https://web.laregents.org/programs/borsf-programs) to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Birngruber T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090221; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Comte I, 2011, J CELL SCI, V124, P2438, DOI 10.1242/jcs.079954; Dazai J, 2011, JOVE-J VIS EXP, DOI 10.3791/2497; Deacon RM, 2013, JOVE-J VIS EXP, DOI [10.3791/2609(75):e2609, DOI 10.3791/2609(75):E2609]; DECOSTER MA, 1992, NEUROREPORT, V3, P773, DOI 10.1097/00001756-199209000-00013; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Deng HX, 2000, ARCH NEUROL-CHICAGO, V57, P1695, DOI 10.1001/archneur.57.12.1695; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Glasscock E, 2010, J NEUROSCI, V30, P5167, DOI 10.1523/JNEUROSCI.5591-09.2010; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Gonzalez-Islas C, 2001, J NEUROPHYSIOL, V86, P2911, DOI 10.1152/jn.2001.86.6.2911; Green ECJ, 2005, BIOINFORMATICS, V21, P2930, DOI 10.1093/bioinformatics/bti441; James R, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00030; James RE, 2016, GLIA, V64, P105, DOI 10.1002/glia.22906; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Li T, 2008, NEUROSCI LETT, V448, P99, DOI 10.1016/j.neulet.2008.10.033; Low RJ, 2014, P NATL ACAD SCI USA, V111, P18739, DOI 10.1073/pnas.1421753111; Lu XH, 2009, INT REV NEUROBIOL, V89, P37, DOI 10.1016/S0074-7742(09)89002-8; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Magnusson KR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-43; Massot P, 2012, CONTRAST MEDIA MOL I, V7, P45, DOI 10.1002/cmmi.464; Muhammad A, 2013, NEUROSCIENCE, V252, P178, DOI 10.1016/j.neuroscience.2013.08.016; Murray TA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021106; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; Murray TA, 2009, ACTA PHARMACOL SIN, V30, P828, DOI 10.1038/aps.2009.78; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Paxinos G, 2002, MOUSE BRAIN STEREOTA, V1st; Picciotto MR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012112; Picciotto MR, 2002, J NEUROSCI, V22, P3338; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Song CZ, 2005, NEUROPHARMACOLOGY, V48, P869, DOI 10.1016/j.neuropharm.2005.01.003; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; SZELE FG, 1995, J NEUROSCI, V15, P4429; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; Takano H, 2012, J NEUROSCI, V32, P4743, DOI 10.1523/JNEUROSCI.4277-11.2012; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Valentim AM, 2008, J AM ASSOC LAB ANIM, V47, P16; Valvassori SS, 2013, REV BRAS PSIQUIATR, V35, pS121, DOI 10.1590/1516-4446-2013-1168; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Young CC, 2014, NEUROBIOL DIS, V63, P155, DOI 10.1016/j.nbd.2013.11.003; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	59	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146533	10.1371/journal.pone.0146533	http://dx.doi.org/10.1371/journal.pone.0146533			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799938	gold, Green Submitted, Green Published			2022-12-26	WOS:000368655300024
J	Lee, SW; Yu, MY; Baek, SH; Ahn, SY; Kim, S; Na, KY; Chae, DW; Chin, HJ				Lee, Sung Woo; Yu, Mi-Yeon; Baek, Seon Ha; Ahn, Shin-Young; Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun			Glomerular Immune Deposits Are Predictive of Poor Long-Term Outcome in Patients with Adult Biopsy-Proven Minimal Change Disease: A Cohort Study in Korea	PLOS ONE			English	Article							C1Q NEPHROPATHY; IGM NEPHROPATHY; NEPHROTIC SYNDROME; PRIMARY GLOMERULONEPHRITIS; SINGLE-CENTER; CHILDREN; PATHOLOGY	Background and Objectives There has been little published information on risk factors for poor long-term outcome in adult biopsy-proven minimal change disease (MCD). Methods Data from sixty-three adult, biopsy-proven primary MCD patients treated at a tertiary university hospital between 2003 and 2013 were analyzed. Baseline clinical and pathologic factors were assessed for the associations with composite outcome of creatinine doubling, end stage renal disease, or all-cause mortality. Results During a median (interquartile) 5.0 (2.8-5.0) years, the composite outcome occurred in 11.1% (7/63) of patients. The rate of glomerular immune deposits was 23.8% (15/63). Patients with glomerular immune deposits showed a significantly lower urine protein creatinine ratio than those without deposits (P = 0.033). The rate of non-responders was significantly higher in patients with glomerular immune deposits than in those without deposits (P = 0.033). In patients with deposits, 26.7% (4/15) developed the composite outcome, while only 6.3% (3/48) developed the composite outcome among those without deposits (P = 0.049). In multivariate Cox proportional hazards regression analysis, the presence of glomerular immune deposits was the only factor associated with development of the composite outcome (hazard ratio: 2.310, 95% confidence interval: 1.031-98.579, P = 0.047). Conclusion Glomerular immune deposits were associated with increased risk of a composite outcome in adult MCD patients. The higher rate of non-responders in patients with deposits might be related to the poor outcome. Future study is needed.	[Lee, Sung Woo; Ahn, Shin-Young; Chin, Ho Jun] Seoul Natl Univ, Postgrad Sch, Dept Immunol, Seoul, South Korea; [Lee, Sung Woo; Yu, Mi-Yeon; Baek, Seon Ha; Ahn, Shin-Young; Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Nephrol, Songnam, South Korea; [Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ, Postgrad Sch, Dept Immunol, Seoul, South Korea.; Chin, HJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Nephrol, Songnam, South Korea.; Chin, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	mednep@snubh.org	Kim, Sejoong/J-5356-2015; Yu, Mi-Yeon/ABB-7937-2021	Kim, Sejoong/0000-0002-7238-9962; 				Arias LF, 2013, NEFROLOGIA, V33, P532, DOI 10.3265/Nefrologia.pre2013.Mar.11962; BHASIN HK, 1978, LAB INVEST, V39, P21; Chembo CL, 2015, NEPHROLOGY, V20, P899, DOI 10.1111/nep.12538; Chou YH, 2012, CLIN J AM SOC NEPHRO, V7, P1401, DOI 10.2215/CJN.04500511; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; COHEN AH, 1978, LAB INVEST, V38, P610; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fukuma Y, 2006, AM J KIDNEY DIS, V47, P412, DOI 10.1053/j.ajkd.2005.11.013; Garin EH, 2009, J AM SOC NEPHROL, V20, P260, DOI 10.1681/ASN.2007080836; Gunasekara VN, 2014, PEDIATR NEPHROL, V29, P407, DOI 10.1007/s00467-013-2692-4; JENNETTE JC, 1985, AM J KIDNEY DIS, V6, P103, DOI 10.1016/S0272-6386(85)80150-5; Lai KW, 2007, J AM SOC NEPHROL, V18, P1476, DOI 10.1681/ASN.2006070710; Lau KK, 2005, PEDIATR NEPHROL, V20, P744, DOI 10.1007/s00467-004-1810-8; Lee H, 2013, AM J NEPHROL, V37, P74, DOI 10.1159/000345960; Levart TK, 2005, PEDIATR NEPHROL, V20, P1756, DOI 10.1007/s00467-005-2040-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Malafronte P, 2006, NEPHROL DIAL TRANSPL, V21, P3098, DOI 10.1093/ndt/gfl237; Mubarak M, 2011, APMIS, V119, P180, DOI 10.1111/j.1600-0463.2010.02708.x; Myllymaki J, 2003, AM J KIDNEY DIS, V41, P343, DOI 10.1053/ajkd.2003.50042; Oh SW, 2012, DIABETES RES CLIN PR, V97, P418, DOI 10.1016/j.diabres.2012.03.016; Shakeel S, 2012, J CLIN PATHOL, V65, P1072, DOI 10.1136/jclinpath-2012-200933; SHALHOUB RJ, 1974, LANCET, V2, P556; SHARPSTONE P, 1969, BMJ-BRIT MED J, V2, P533, DOI 10.1136/bmj.2.5656.533; Szeto CC, 2015, AM J KIDNEY DIS, V65, P710, DOI 10.1053/j.ajkd.2014.09.022; Vanikar Aruna, 2013, J Nephropathol, V2, P98, DOI 10.12860/JNP.2013.16; Vanikar AV, 2012, INDIAN J PEDIATR, V79, P1025, DOI 10.1007/s12098-012-0693-0; Vizjak A, 2008, J AM SOC NEPHROL, V19, P2237, DOI 10.1681/ASN.2007080929; Wenderfer SE, 2010, PEDIATR NEPHROL, V25, P1385, DOI 10.1007/s00467-009-1429-x; Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147387	10.1371/journal.pone.0147387	http://dx.doi.org/10.1371/journal.pone.0147387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799663	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300101
J	Mehta, K; Appleman, L; Wang, H; Tarhini, AA; Parikh, RA				Mehta, Kathan; Appleman, Leonard; Wang, Hong; Tarhini, Ahmad A.; Parikh, Rahul A.			Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients	PLOS ONE			English	Article							METASTATIC MELANOMA; BRAF; VEMURAFENIB; SURVIVAL; THERAPY	Background Immunotherapy using high dose interleukin-2 (HD IL2) in patients with renal cell carcinoma (RCC) and melanoma is associated with severe toxicities. The association between annual hospital volume of HD IL2 and inpatient mortality is not well studied. In this study we aim to quantify the impact of annual hospital volume of HD IL2 on inpatient mortality using National Inpatient Sample (NIS) data. Methods We did a cross-sectional study using NIS, one of the largest inpatient datasets in United States, from 2003 to 2011. Patients with melanoma and RCC receiving HD IL2 were identified by ICD9 procedure code 00.15. The primary outcome was inpatient mortality. Using Joinpoint regression, which detects change in trend of inpatient mortality with change in annual volume, the hospitals were classified in three volume categories (low: 1-40, medium: 41-120, high: >120). Multivariate logistic regression was used to identify predictors of inpatient mortality controlling for confounders. Results From 2003 to 2011, 29,532 patients with RCC or melanoma who received HD IL2 were identified, and 124 died during the hospitalization (0.4%). The hospitals with low, medium and high annual volume had significant difference in inpatient mortality (0.83%, 0.29% and 0.13% respectively, p = 0.0003). On multivariate analysis, low volume hospitals were associated with significantly higher odds of inpatient mortality (OR 6.1, 95% CI 1.6-23.2, p = 0.003) as compared to high volume hospitals. Additionally, the hospitals with annual volume of 1-20 had even higher rates (1.31% vs. 0.13%, p<0.0001) and multivariate odds (OR 8.9, 95% CI 2.4-33.2, p = 0.0006) of inpatient mortality as compared to high volume hospitals. Conclusions Lower annual hospital volume of HD IL2 is associated with worse outcomes. Annual hospital volume of 1-40 and 1-20 treatments per year is associated with 6 and 9 times higher odds of inpatient mortality respectively as compared to high volume hospitals. Our findings provide preliminary evidence for a volume-outcome relationship for RCC and melanoma patients undergoing HD IL2 treatment. They support future volume-outcome analyses in relation to other anti-cancer therapies that require special training and expertise.	[Mehta, Kathan] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Appleman, Leonard; Wang, Hong; Tarhini, Ahmad A.; Parikh, Rahul A.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Parikh, RA (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA.	parikhr@upmc.edu		Parikh, Rahul/0000-0002-3372-7914; Wang, Hong/0000-0003-0477-2908	NCI NIH HHS [P50 CA121973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA121973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Atkins MB, 2000, CANCER J SCI AM, V6, pS11; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dutcher J, 2002, ONCOLOGY-NY, V16, P4; Dutcher JP, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/s40425-014-0026-0; FDA, 2013, APPR DRUGS SOR NEXAV; FDA, 2006, 2006 FDA APPR NEW TR; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; HCUP, 2015, APP A CLIN CLASS SOF; Hewitt M PD, 2001, INT VOL OUTC REL CON; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOROWITZ MM, 1992, BLOOD, V79, P2771; Hospital cost and utilization project (HCUP), 2012, HCUP NAT INP SAMPL N; HOWS J, 1993, BONE MARROW TRANSPL, V12, P371; Kim HJ, 2014, STAT MED, V33, P4087, DOI 10.1002/sim.6221; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; McDermott DF, 2015, CLIN CANCER RES, V21, P561, DOI 10.1158/1078-0432.CCR-14-1520; ROSENBERG SA, 1994, JAMA-J AM MED ASSOC, V271, P907, DOI 10.1001/jama.271.12.907; Steiner Claudia, 2002, Eff Clin Pract, V5, P143	25	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147153	10.1371/journal.pone.0147153	http://dx.doi.org/10.1371/journal.pone.0147153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799322	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000368655300065
J	Rauwerda, H; Wackers, P; Pagano, JFB; de Jong, M; Ensink, W; Dekker, R; Nehrdich, U; Spaink, HP; Jonker, M; Breit, TM				Rauwerda, Han; Wackers, Paul; Pagano, Johanna F. B.; de Jong, Mark; Ensink, Wim; Dekker, Rob; Nehrdich, Ulrike; Spaink, Herman P.; Jonker, Martijs; Breit, Timo M.			Mother-Specific Signature in the Maternal Transcriptome Composition of Mature, Unfertilized Zebrafish Eggs	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; GENE-EXPRESSION; BIOINFORMATICS; IDENTIFICATION; LOCALIZATION; TRANSITION; DYNAMICS; PATTERNS	Maternal mRNA present in mature oocytes plays an important role in the proper development of the early embryo. As the composition of the maternal transcriptome in general has been studied with pooled mature eggs, potential differences between individual eggs are unknown. Here we present a transcriptome study on individual zebrafish eggs from clutches of five mothers in which we focus on the differences in maternal mRNA abundance per gene between and within clutches. To minimize technical interference, we used mature, unfertilized eggs from siblings. About half of the number of analyzed genes was found to be expressed as maternal RNA. The expressed and non-expressed genes showed that maternal mRNA accumulation is a non-random process, as it is related to specific biological pathways and processes relevant in early embryogenesis. Moreover, it turned out that overall the composition of the maternal transcriptome is tightly regulated as about half of the expressed genes display a less than twofold expression range between the observed minimum and maximum expression values of a gene in the experiment. Even more, the maximum gene-expression difference within clutches is for 88% of the expressed genes lower than twofold. This means that expression differences observed in maternally expressed genes are primarily caused by differences between mothers, with only limited variability between eggs from the same mother. This was underlined by the fact that 99% of the expressed genes were found to be differentially expressed between any of the mothers in an ANOVA test. Furthermore, linking chromosome location, transcription factor binding sites, and miRNA target sites of the genes in clusters of distinct and unique mother-specific gene-expression, suggest biological relevance of the mother-specific signatures in the maternal transcriptome composition. Altogether, the maternal transcriptome composition of mature zebrafish oocytes seems to be tightly regulated with a distinct mother-specific signature.	[Rauwerda, Han; Wackers, Paul; Pagano, Johanna F. B.; de Jong, Mark; Ensink, Wim; Dekker, Rob; Jonker, Martijs; Breit, Timo M.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, RNA Biol & Appl Bioinformat Res Grp, Amsterdam, Netherlands; [Nehrdich, Ulrike; Spaink, Herman P.] Leiden Univ, Inst Biol Leiden, Fac Sci, Leiden, Netherlands	University of Amsterdam; Leiden University; Leiden University - Excl LUMC	Breit, TM (corresponding author), Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, RNA Biol & Appl Bioinformat Res Grp, Amsterdam, Netherlands.	t.m.breit@uva.nl	Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; Wackers, Paul/0000-0002-6598-4173; Rauwerda, Han/0000-0003-4360-0797	University of Amsterdam	University of Amsterdam	The University of Amsterdam has provided the funding for this work but had no role as such in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-331; Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Abramov R, 2013, GEN COMP ENDOCR, V188, P309, DOI 10.1016/j.ygcen.2013.02.012; Abrams EW, 2009, CURR OPIN GENET DEV, V19, P396, DOI 10.1016/j.gde.2009.06.002; Amaral IPG, 2012, J EXP BIOL, V215, P3895, DOI 10.1242/jeb.068908; Assou S, 2011, HUM REPROD UPDATE, V17, P272, DOI 10.1093/humupd/dmq036; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bouleau A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119925; Brooks S, 1997, REV FISH BIOL FISHER, P416; Celeghin A, 2011, GEN COMP ENDOCR, V172, P120, DOI 10.1016/j.ygcen.2010.12.020; de Jong Mark, 2010, BMC Res Notes, V3, P73, DOI 10.1186/1756-0500-3-73; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Ho E, 2012, COMP BIOCHEM PHYS C, V155, P26, DOI 10.1016/j.cbpc.2011.05.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HYLLNER SJ, 1994, MOL REPROD DEV, V39, P166, DOI 10.1002/mrd.1080390208; Juanchich A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105361; Kosaka K, 2007, MECH DEVELOP, V124, P279, DOI 10.1016/j.mod.2007.01.003; Li SF, 1997, CANCER RES, V57, P4356; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Liebers R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004296; Lindeman RE, 2010, MOL REPROD DEV, V77, P299, DOI 10.1002/mrd.21128; Marlow F.L., 2010, MATERNAL CONTROL DEV; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; OLSZANSKA B, 1993, J EXP ZOOL, V265, P317, DOI 10.1002/jez.1402650313; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Preuss KM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-671; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Rauwerda Han, 2010, BMC Res Notes, V3, P192, DOI 10.1186/1756-0500-3-192; Reich A, 2011, J BIOL CHEM, V286, P40743, DOI 10.1074/jbc.M111.289868; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SIMON R, 1992, GENE DEV, V6, P2580, DOI 10.1101/gad.6.12b.2580; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Sullivan CV, 2015, GEN COMP ENDOCR, V221, P23, DOI 10.1016/j.ygcen.2015.02.012; TATA JR, 1986, BIOESSAYS, V4, P197, DOI 10.1002/bies.950040503; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Wei CY, 2012, RNA, V18, P915, DOI 10.1261/rna.029090.111; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yao YG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-117; Yartseva V, 2015, CURR TOP DEV BIOL; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zhang Y, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-7	58	20	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147151	10.1371/journal.pone.0147151	http://dx.doi.org/10.1371/journal.pone.0147151			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799215	gold, Green Submitted, Green Published			2022-12-26	WOS:000368655300064
J	Wang, SB; Niu, CC				Wang, Shibo; Niu, Chengchao			Torsional Tribological Behavior and Torsional Friction Model of Polytetrafluoroethylene against 1045 Steel	PLOS ONE			English	Article							FRETTING WEAR BEHAVIOR; CONTACT; BODIES	In this work, the plane-on-plane torsional fretting tribological behavior of polytetrafluoroethylene ( PTFE) was studied. A model of a rigid, flat-ended punch acting on an elastic half-space was built according to the experimental conditions. The results indicate that the shape of T-theta curves was influenced by both the torsional angle and the normal load. The torsion friction torque and wear rate of PTFE exponentially decreased when the torsion angle rose. The torsional torque increased from 0.025 N.m under a normal load of 43 N to 0.082 N.m under a normal load of 123 N. With sequentially increasing normal load, the value of torque was maintained. With rising normal load, the wear mass loss of PTFE disks was increased and the wear rate was decreased. Good agreement was found with the calculated torque according to the model and the experimental torque except for that under a normal load of 163 N. The difference under a normal load of 163 N was caused by the coefficient of friction. Usually the coefficient of friction of a polymer decreases with increasing normal load, whereas a constant coefficient of friction was applied in the model.	[Wang, Shibo; Niu, Chengchao] China Univ Min & Technol, Sch Mech & Elect Engn, Xuzhou 221116, Jiangsu, Peoples R China; [Wang, Shibo] Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China	China University of Mining & Technology; Tsinghua University	Wang, SB (corresponding author), China Univ Min & Technol, Sch Mech & Elect Engn, Xuzhou 221116, Jiangsu, Peoples R China.; Wang, SB (corresponding author), Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China.	wangshb@cumt.edu.cn			Fundamental Research Funds for the Central University - Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [2012QA29]	Fundamental Research Funds for the Central University - Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The research was financially supported by the Fundamental Research Funds for the Central University (2012QA29), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Briscoe BJ, 1998, TRIBOL INT, V31, P701, DOI 10.1016/S0301-679X(98)00093-0; Briscoe BJ, 2000, WEAR, V240, P27, DOI 10.1016/S0043-1648(99)00366-X; Cai ZB, 2011, WEAR, V270, P230, DOI 10.1016/j.wear.2010.10.063; Cai ZB, 2009, TRIBOL INT, V42, P1676, DOI 10.1016/j.triboint.2009.04.031; Cai ZB, 2010, TRIBOL INT, V43, P361, DOI 10.1016/j.triboint.2009.06.016; [蔡振兵 CAI Zhenbing], 2008, [摩擦学学报, Tribology], V28, P18; Chateauminois A, 2003, SURF COAT TECH, V163, P435, DOI 10.1016/S0257-8972(02)00640-0; [陈聚文 Chen Juwen], 2004, [高分子材料科学与工程, Polymer Materials Science & Engineering], V20, P114; Dorin G, 2011, FASCICLE MANAGEMENT, V5, P46; Gallego L, 2007, J TRIBOL-T ASME, V129, P528, DOI 10.1115/1.2736436; Gallego L, 2010, WEAR, V268, P208, DOI 10.1016/j.wear.2009.07.019; Hetenyi M., 1958, T ASME J APPL MECH, V25, P396; Hills DA, 1986, J APPL MECH-T ASME, V54, P8; JAGER J, 1995, ARCH APPL MECH, V65, P478, DOI 10.1007/BF00835661; Jeong SH, 2007, TRIBOL T, V50, P564, DOI 10.1080/10402000701691076; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; Kim JS, 2012, TRIBOL T, V55, P730, DOI 10.1080/10402004.2012.700764; Kumar SA, 2012, TRIBOL T, V55, P615, DOI 10.1080/10402004.2012.686087; Lu Y, 2000, INT J PROD ECON, V67, P17, DOI 10.1016/S0925-5273(00)00006-2; LUBKIN JL, 1951, J APPL MECH-T ASME, V18, P183; Qiu H, 2008, J MECH PHYS SOLIDS, V56, P3352, DOI 10.1016/j.jmps.2008.09.008; Rae PJ, 2004, POLYMER, V45, P7615, DOI 10.1016/j.polymer.2004.08.064; Timothy TL, 2010, PHYS REV LETT, V104, P39; VINGSBO O, 1988, WEAR, V126, P131, DOI 10.1016/0043-1648(88)90134-2; Wang SB, 2012, TRIBOL LETT, V45, P445, DOI 10.1007/s11249-011-9904-5; Wang SB, 2013, TRIBOL T, V56, P178, DOI 10.1080/10402004.2012.734548; Wang SB, 2013, MATER DESIGN, V43, P507, DOI 10.1016/j.matdes.2012.07.048; Yu J, 2008, THESIS SW JIAOTONG U; Yu J, 2008, APPL SURF SCI, V255, P616, DOI 10.1016/j.apsusc.2008.06.179; Zhou ZR, 2006, TRIBOL INT, V39, P1068, DOI 10.1016/j.triboint.2006.02.001	30	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147598	10.1371/journal.pone.0147598	http://dx.doi.org/10.1371/journal.pone.0147598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799324	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300129
J	Yabas, M; Jing, WD; Shafik, S; Broer, S; Enders, A				Yabas, Mehmet; Jing, Weidong; Shafik, Sarah; Broeer, Stefan; Enders, Anselm			ATP11C Facilitates Phospholipid Translocation across the Plasma Membrane of All Leukocytes	PLOS ONE			English	Article							P-TYPE ATPASES; ANNEXIN-V BINDS; B-CELLS; PHOSPHATIDYLSERINE; FLIPPASES; EXPRESSION; LYMPHOCYTES; DEFICIENCY; ASYMMETRY; EXPOSURE	Organization of the plasma membrane into specialized substructures in different blood lineages facilitates important biological functions including proper localization of receptors at the plasma membrane as well as the initiation of crucial intracellular signaling cascades. The eukaryotic plasma membrane is a lipid bilayer that consists of asymmetrically distributed phospholipids. This asymmetry is actively maintained by membrane-embedded lipid transporters, but there is only limited data available about the molecular identity of the predominantly active transporters and their substrate specificity in different leukocyte subsets. We demonstrate here that the P4-type ATPase ATP11C mediates significant flippase activity in all murine leukocyte subsets. Loss of ATP11C resulted in a defective internalization of phosphatidylserine (PS) and phosphatidylethanolamine (PE) in comparison to control cells. The diminished flippase activity caused increased PS exposure on 7-aminoactinomycin D- (7-AAD(-)) viable pro-B cells freshly isolated from the bone marrow of ATP11C-deficient mice, which was corrected upon a 2-hour resting period in vitro. Despite the impaired flippase activity in all immune cell subsets, the only other blood cell type with an accumulation of PS on the surface were viable 7-AAD(-) developing T cells but this did not result in any discernable effect on their development in the thymus. These findings show that all leukocyte lineages exhibit flippase activity, and identify ATP11C as an aminophospholipid translocase in immune cells.	[Yabas, Mehmet; Enders, Anselm] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia; [Yabas, Mehmet] Trakya Univ, Dept Genet & Bioengn, Fac Engn, Edirne, Turkey; [Jing, Weidong; Shafik, Sarah; Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research; Trakya University; Australian National University	Enders, A (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia.; Broer, S (corresponding author), Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT, Australia.	stefan.broeer@anu.edu.au; anselm.enders@anu.edu.au	Broer, Stefan/A-1286-2008; Jing, Weidong/D-7145-2019; Yabas, Mehmet/D-9513-2012; Shafik, Sarah/AAW-5156-2020; Enders, Anselm/B-1165-2011	Broer, Stefan/0000-0002-8040-1634; Jing, Weidong/0000-0002-6747-6076; Yabas, Mehmet/0000-0002-3462-5389; Enders, Anselm/0000-0001-5933-6463; Shafik, Sarah/0000-0001-6503-3565	National Health and Medical Research Council [GNT1061288]; Ministry of National Education, Republic of Turkey; National Health and Medical Research Council Career Development Fellowship [GNT1035858]; Ramaciotti Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ministry of National Education, Republic of Turkey(Ministry of National Education - Turkey); National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Ramaciotti Foundation	This work was supported by National Health and Medical Research Council Grant GNT1061288. MY was supported by a postgraduate award from the Ministry of National Education, Republic of Turkey, and AE was supported by a National Health and Medical Research Council Career Development Fellowship GNT1035858 and by the Ramaciotti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Cai SY, 2009, GASTROENTEROLOGY, V136, P1060, DOI 10.1053/j.gastro.2008.10.025; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Dillon SR, 2001, J IMMUNOL, V166, P58, DOI 10.4049/jimmunol.166.1.58; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gomes E, 2000, PLANT CELL, V12, P2441, DOI 10.1105/tpc.12.12.2441; Gorter E, 1925, J EXP MED, V41, P439, DOI 10.1084/jem.41.4.439; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Kok JW, 1999, FLUORESCENT LUMINESC, P136; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Nagao K, 2010, FEBS LETT, V584, P2717, DOI 10.1016/j.febslet.2010.04.036; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; Panatala R, 2015, J CELL SCI, V128, P2021, DOI 10.1242/jcs.102715; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Pozarowski Piotr, 2004, Curr Protoc Cell Biol, VChapter 18, DOI [10.1002/0471142956.cy0719s25, 10.1002/0471143030.cb1808s21]; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; VAN GENDEREN I, 1995, J CELL BIOL, V131, P645, DOI 10.1083/jcb.131.3.645; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Yabas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026440; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	34	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146774	10.1371/journal.pone.0146774	http://dx.doi.org/10.1371/journal.pone.0146774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799398	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300034
J	Martill, DM; Vidovic, SU; Howells, C; Nudds, JR				Martill, David M.; Vidovic, Steven U.; Howells, Cindy; Nudds, John R.			The Oldest Jurassic Dinosaur: A Basal Neotheropod from the Hettangian of Great Britain	PLOS ONE			English	Article							THEROPOD DINOSAUR; SOUTH-WALES; NORTH-AMERICA; BOUNDARY; SECTION; SYSTEM; EXTINCTION; MOUNTAINS; EVOLUTION; AUSTRIA	Approximately 40% of a skeleton including cranial and postcranial remains representing a new genus and species of basal neotheropod dinosaur is described. It was collected from fallen blocks from a sea cliff that exposes Late Triassic and Early Jurassic marine and quasi marine strata on the south Wales coast near the city of Cardiff. Matrix comparisons indicate that the specimen is from the lithological Jurassic part of the sequence, below the first occurrence of the index ammonite Psiloceras planorbis and above the last occurrence of the Rhaetian conodont Chirodella verecunda. Associated fauna of echinoderms and bivalves indicate that the specimen had drifted out to sea, presumably from the nearby Welsh Massif and associated islands (St David's Archipelago). Its occurrence close to the base of the Blue Lias Formation (Lower Jurassic, Hettangian) makes it the oldest known Jurassic dinosaur and it represents the first dinosaur skeleton from the Jurassic of Wales. A cladistic analysis indicates basal neotheropodan affinities, but the specimen retains plesio-morphic characters which it shares with Tawa and Daemonosaurus.	[Martill, David M.; Vidovic, Steven U.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England; [Howells, Cindy] Amgueddfa Cymru Natl Museum Wales, Dept Nat Sci, Cardiff, S Glam, Wales; [Nudds, John R.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	University of Portsmouth; University of Manchester	Martill, DM (corresponding author), Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England.	david.martill@port.ac.uk	Vidovic, Steven Uros/I-1141-2019	Vidovic, Steven Uros/0000-0002-4726-8018; Martill, David/0000-0002-3208-5702				Allain R, 2007, J VERTEBR PALEONTOL, V27, P610, DOI 10.1671/0272-4634(2007)27[610:AADTFT]2.0.CO;2; Andrews C. W., 1921, Annals & Magazine of Natural History Series 9, V8, P570; [Anonymous], 1974, CASOPIS PRO MINERALO; Arkell W. J., 1933, JURASSIC SYSTEM GREA; Bakker RT., 1986, DINOSAUR HERESIES; Barrett PM, 2009, PALAEONTOLOGY, V52, P681, DOI 10.1111/j.1475-4983.2009.00887.x; BENTON MJ, 1995, SCOT J GEOL, V31, P177, DOI 10.1144/sjg31020177; Brazeau MD, 2011, BIOL J LINN SOC, V104, P489, DOI 10.1111/j.1095-8312.2011.01755.x; Bristowe Anthea, 2004, Palaeontologia Africana, V40, P31; Carrano MT, 2005, J VERTEBR PALEONTOL, V25, P835, DOI 10.1671/0272-4634(2005)025[0835:NIOSHA]2.0.CO;2; Cope JCW, 1980, CORRELATION JURASSIC, V14, P1; Cuny Gilles, 1993, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V187, P261; Dean WT, 1961, GEOLOGY, V4, P438; Delsate D, 2014, GEOL BELG, V17, P175; Ezcurra MD, 2007, J VERTEBR PALEONTOL, V27, P73, DOI 10.1671/0272-4634(2007)27[73:TCLAGN]2.0.CO;2; Ezcurra MD, 2011, PALAEONTOLOGY, V54, P763, DOI 10.1111/j.1475-4983.2011.01069.x; Galton PM, 2007, NEUES JAHRB GEOL P-A, V243, P119, DOI 10.1127/0077-7749/2007/0243-0119; Galton Peter M., 2005, Revue de Paleobiologie, V24, P51; Guerin-Franiatte S, 1979, CR SOMM SOC GEOL FR, V3, P125; Guex J, 2004, EARTH PLANET SC LETT, V225, P29, DOI 10.1016/j.epsl.2004.06.006; HAMMER WR, 1994, SCIENCE, V264, P828, DOI 10.1126/science.264.5160.828; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hillebrandt AV, 2013, EPISODES, V36, P162, DOI 10.18814/epiiugs/2013/v36i3/001; HODGES P, 1994, GEOL MAG, V131, P841, DOI 10.1017/S0016756800012905; Huene F, 1932, MONOGRAPHIEN GEOLOGI, V1, P1; IvimeyCook H.C., 1974, UPPER PALEOZOIC POST, P295; KERMACK D, 1984, ZOOL J LINN SOC-LOND, V82, P101, DOI 10.1111/j.1096-3642.1984.tb00538.x; Long R.A., 1995, NEW MEXICO MUSEUM NA, V4, P1; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; McRoberts C. A., 2007, INT SUBCOMMISSION JU, V34, P43; McRoberts CA, 1997, PALAEOGEOGR PALAEOCL, V136, P79, DOI 10.1016/S0031-0182(97)00074-6; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Newton E.T., 1899, Q J GEOLOGICAL SOC L, V55, P89; Orbell G, 1973, GEOLOGICAL SURVEY GR, V44, P1; Owen R, 1842, 11 M BRIT ASS ADV SC, P60; Owen R, 1863, PALAEONTOGRAPHICAL S, V14, P1, DOI DOI 10.1080/02693445.1863.12027933; Page KN, 1995, GEOSCIENCE S W ENGLA, V9, P231; Palfy J, 2001, GEOLOGY, V29, P1047, DOI 10.1130/0091-7613(2001)029<1047:CIAAOG>2.0.CO;2; POLUBOTKO IV, 1981, DOKL AKAD NAUK SSSR+, V261, P1394; Raath M.A., 1990, P91, DOI 10.1017/CBO9780511608377.010; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Rowe T., 1989, Journal of Vertebrate Paleontology, V9, P125; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Simms M.J., 2004, GEOLOGICAL CONSERVAT, V30, P458; SOWERBY JD, 1823, MINERAL CONCHOLOGY G; Storrs Glenn W., 1999, Palaeontological Association Field Guides to Fossils, V9, P223; Suan G, 2012, J GEOL SOC LONDON, V169, P191, DOI 10.1144/0016-76492011-045; Sues HD, 2011, P ROY SOC B-BIOL SCI, V278, P3459, DOI 10.1098/rspb.2011.0410; SWEET WC, 1971, GEOL SOC AM MEM, V127, P441; SWIFT A, 1989, PALAEONTOLOGY, V32, P325; Swift A, 1995, MONOGRAPH PALAEONTOG, V147, P1; Talbot M, 1911, AM J SCI, V31, P469; TUCKER ME, 1977, PALAEOGEOGR PALAEOCL, V22, P195, DOI 10.1016/0031-0182(77)90028-1; Tykoski RS, 2002, J VERTEBR PALEONTOL, V22, P728, DOI 10.1671/0272-4634(2002)022[0728:AFITCT]2.0.CO;2; von Hillebrandt A.V., 2007, INT SUBCOM JURASSIC, V34, P2; Ward PD, 2007, PALAEOGEOGR PALAEOCL, V244, P281, DOI 10.1016/j.palaeo.2006.06.042; Waters RA, 1987, MEMOIRE BRIT GEOLOGI; WELLES SP, 1954, GEOL SOC AM BULL, V65, P591, DOI 10.1130/0016-7606(1954)65[591:NJDFTK]2.0.CO;2; Woodward A. Smith, 1908, Annals & Magazine of Natural History, V1; Woollam R., 1983, 83 I GEOL SCI, V2, P1; Xu X, 2001, J VERTEBR PALEONTOL, V21, P477, DOI 10.1671/0272-4634(2001)021[0477:ANTFTL]2.0.CO;2; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; You HL, 2014, ZOOTAXA, V3873, P233, DOI 10.11646/zootaxa.3873.3.3	63	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145713	10.1371/journal.pone.0145713	http://dx.doi.org/10.1371/journal.pone.0145713			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789843	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000368529100014
J	Salomons, EM; Lohman, WJA; Zhou, H				Salomons, Erik M.; Lohman, Walter J. A.; Zhou, Han			Simulation of Sound Waves Using the Lattice Boltzmann Method for Fluid Flow: Benchmark Cases for Outdoor Sound Propagation	PLOS ONE			English	Article							MODEL; SITUATIONS; FDTD	Propagation of sound waves in air can be considered as a special case of fluid dynamics. Consequently, the lattice Boltzmann method (LBM) for fluid flow can be used for simulating sound propagation. In this article application of the LBM to sound propagation is illustrated for various cases: free-field propagation, propagation over porous and non-porous ground, propagation over a noise barrier, and propagation in an atmosphere with wind. LBM results are compared with solutions of the equations of acoustics. It is found that the LBM works well for sound waves, but dissipation of sound waves with the LBM is generally much larger than real dissipation of sound waves in air. To circumvent this problem it is proposed here to use the LBM for assessing the excess sound level, i.e. the difference between the sound level and the free-field sound level. The effect of dissipation on the excess sound level is much smaller than the effect on the sound level, so the LBM can be used to estimate the excess sound level for a non-dissipative atmosphere, which is a useful quantity in atmospheric acoustics. To reduce dissipation in an LBM simulation two approaches are considered: i) reduction of the kinematic viscosity and ii) reduction of the lattice spacing.	[Salomons, Erik M.; Lohman, Walter J. A.; Zhou, Han] TNO, Netherlands Org Appl Sci Res, Delft, Netherlands	Netherlands Organization Applied Science Research	Salomons, EM (corresponding author), TNO, Netherlands Org Appl Sci Res, Delft, Netherlands.	erik.salomons@tno.nl			National Public Authority "Rijksdienst voor Ondernemend Nederland" in The Netherlands	National Public Authority "Rijksdienst voor Ondernemend Nederland" in The Netherlands	This work was performed within the framework of the ITEA2 project MACH. The Dutch partner TNO of the MACH project has received funding from the National Public Authority "Rijksdienst voor Ondernemend Nederland" in The Netherlands within the framework of the ITEA2 PROGRAMME. URL: http://www.rvo.nl/. URL Mach: http://www.mach-project.org.	[Anonymous], 2008, CHOICE UNITS LATTICE; Buick JM, 1998, EUROPHYS LETT, V43, P235, DOI 10.1209/epl/i1998-00346-7; Crespo AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020685; d'Humieres D, 2002, PHILOS T ROY SOC A, V360, P437, DOI 10.1098/rsta.2001.0955; Dellar PJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.031203; Feichtinger C, 2012, THESIS ERLANGEN NUMB; Guo ZL, 2002, INT J NUMER METH FL, V39, P325, DOI 10.1002/fld.337; HADDEN WJ, 1981, J ACOUST SOC AM, V69, P1266, DOI 10.1121/1.385809; Hecht M, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/02/E02001; Hecht M, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/01/P01018; Hornikx M, 2010, J ACOUST SOC AM, V128, P1632, DOI 10.1121/1.3474234; Hughes WF, 1967, FLUID DYNAMICS SCHAU, P1; Kinsler, 1999, FUNDAMENTALS ACOUSTI; Latt J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056703; Mohamad AA, 2011, LATTICE BOLTZMANN METHOD: FUNDAMENTALS AND ENGINEERING APPLICATIONS WITH COMPUTER CODES, P1, DOI 10.1007/978-0-85729-455-5; Pierce A. D., 1991, ACOUSTICS INTRO ITS; Reichl LE, 1980, MODERN COURSE STAT P, P468; Salomons EM, 1999, J ACOUST SOC AM, V105, P2287, DOI 10.1121/1.426835; Salomons EM, 1997, ACUSTICA, V83, P436; Salomons EM, 2002, ACTA ACUST UNITED AC, V88, P483; Salomons EM, 2001, COMPUTATIONAL ATMOSP; Salomons EM, 2015, P 4 INT C PART BAS M; Sukop M.C., 2007, LATTICE BOLTZMANN MO; Tolke J, 2008, INT J COMPUT FLUID D, V22, P443, DOI 10.1080/10618560802238275; Ul Islam S, 2012, J MECH SCI TECHNOL, V26, P1027, DOI 10.1007/s12206-012-0328-4; Van Renterghem T, 2007, APPL ACOUST, V68, P201, DOI 10.1016/j.apacoust.2005.10.003; Van Renterghem T, 2005, ACTA ACUST UNITED AC, V91, P671; Viggen E. M., 2009, THESIS NTNU NORWAY; Viggen EM, 2014, THESIS NTNU NORWAY; Viggen EM, 2013, COMMUN COMPUT PHYS, V13, P671, DOI 10.4208/cicp.271011.020212s; Viggen EM, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.023306; Viggen EM, 2011, PHILOS T R SOC A, V369, P2246, DOI 10.1098/rsta.2011.0040; Zou QS, 1997, PHYS FLUIDS, V9, P1591, DOI 10.1063/1.869307; Zwikker C, 1949, SOUND ABSORBING MAT	34	18	20	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147206	10.1371/journal.pone.0147206	http://dx.doi.org/10.1371/journal.pone.0147206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789631	Green Submitted, gold, Green Published			2022-12-26	WOS:000368529100068
J	Betancourt, AB; Emery, JL; Recino, A; Wong, FS; Cooke, A; Okkenhaug, K; Wallberg, M				Betancourt, Ariana Barbera; Emery, Juliet L.; Recino, Asha; Wong, F. Susan; Cooke, Anne; Okkenhaug, Klaus; Wallberg, Maja			Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DENDRITIC CELLS; NOD MICE; P110-DELTA; PI3K; INFLAMMATION; ACTIVATION; RESPONSES; GENERATION	Type 1 diabetes is caused by the destruction of insulin producing beta cells by the immune system. The p110d isoform of PI3K is expressed primarily in cells of haematopoietic origin and the catalytic activity of p110d is important for the activation of these cells. Targeting of this pathway offers an opportunity to reduce immune cell activity without unwanted side effects. We have explored the effects of a specific p110d isoform inhibitor, IC87114, on diabetogenic T cells both in vitro and in vivo, and find that although pharmacological inhibition of p110d has a considerable impact on the production of pro-inflammatory cytokines, it does not delay the onset of diabetes after adoptive transfer of diabetogenic cells. Further, we demonstrate that combination treatment with CTLA4-Ig does not improve the efficacy of treatment, but instead attenuates the protective effects seen with CTLA4-Ig treatment alone. Our results suggest that decreased IL-10 production by Foxp3(+) CD4(+) T cells in the presence of IC87114 negates individual anti-inflammatory effects of IC8114 and CTLA4-Ig.	[Betancourt, Ariana Barbera; Recino, Asha; Cooke, Anne; Wallberg, Maja] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Emery, Juliet L.; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Wong, F. Susan] Cardiff Univ, Inst Mol & Expt Med, Cardiff Sch Med, Diabet Res Grp, Cardiff CF14 4XN, S Glam, Wales	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cardiff University	Wallberg, M (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mw394@cam.ac.uk	Okkenhaug, Klaus/H-3154-2019; Cooke, Anne/S-4763-2019	Okkenhaug, Klaus/0000-0002-9432-4051; Cooke, Anne/0000-0003-3327-6081; Wong, F. Susan/0000-0002-2812-8845	Diabetes UK [09/0003840]; Juvenile Diabetes Research Foundation [5-2006-229]; European Research Council 7th Frame Programme [health-f5-2009-241883]; Britain Israel Research and Academic Exchange Partnership (BIRAX) [02BX12ACYD]; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C236]; BBSRC [BBS/E/B/0000C236] Funding Source: UKRI; The British Council [02BX12ACYD] Funding Source: researchfish	Diabetes UK(Diabetes UK); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Research Council 7th Frame Programme; Britain Israel Research and Academic Exchange Partnership (BIRAX); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The British Council	This work was supported by Grant number 09/0003840, Diabetes UK https://www.diabetes.org.uk/ (MW); Grant number 5-2006-229, Juvenile Diabetes Research Foundation https://www.jdrf.org.uk/ (KO); Grant number BBS/E/B/0000C236 Biotechnology and Biological Sciences Research Council (KO); Grant number health-f5-2009-241883 European Research Council 7th Frame Programme http://ec.europa.eu/research/fp7/index_en.cfm (AC); and Grant number 02BX12ACYD, the Britain Israel Research and Academic Exchange Partnership (BIRAX) http://www.britishcouncil.org.il/en/programmes/science/birax. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Ambery P, 2014, DIABETIC MED, V31, P399, DOI 10.1111/dme.12361; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Arif S, 2011, DIABETES, V60, P2112, DOI 10.2337/db10-1643; Banting FG, 1922, CAN MED ASSOC J, V7, P141; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Delong T, 2012, DIABETES, V61, P3239, DOI 10.2337/db12-0112; Durand CA, 2013, AUTOIMMUNITY, V46, P62, DOI 10.3109/08916934.2012.732130; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Phillips Jenny M, 2009, Rev Diabet Stud, V6, P97, DOI 10.1900/RDS.2009.6.97; Raine T, 2006, J IMMUNOL, V177, P2224, DOI 10.4049/jimmunol.177.4.2224; Randis TM, 2008, EUR J IMMUNOL, V38, P1215, DOI 10.1002/eji.200838266; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221; Szot Gregory L, 2007, J Vis Exp, P404, DOI 10.3791/404; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Tai NW, 2011, CLIN IMMUNOL, V139, P336, DOI 10.1016/j.clim.2011.03.003; Thomas DC, 2013, DIABETES, V62, P3132, DOI 10.2337/db12-1740; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; von Herrath MG, 2016, CLIN EXP IMMUNOL, V183, P1, DOI 10.1111/cei.12656; Wallberg M, 2013, TRENDS IMMUNOL, V34, P583, DOI 10.1016/j.it.2013.08.005; Wallberg M, 2011, J IMMUNOL, V186, P2543, DOI 10.4049/jimmunol.1002098; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Wong FS, 2009, DIABETES, V58, P1156, DOI 10.2337/db08-0800; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146516	10.1371/journal.pone.0146516	http://dx.doi.org/10.1371/journal.pone.0146516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783747	Green Published, gold			2022-12-26	WOS:000368528400042
J	Bowen, HJ; Spaniol, J; Patel, R; Voss, A				Bowen, Holly J.; Spaniol, Julia; Patel, Ronak; Voss, Andreas			A Diffusion Model Analysis of Decision Biases Affecting Delayed Recognition of Emotional Stimuli	PLOS ONE			English	Article							COGNITIVE-PROCESSES; RESPONSE BIAS; MEMORY; VALENCE; WORDS; NEUROSCIENCE; AMYGDALA; AROUSAL; DISTINCTIVENESS; CONSOLIDATION	Previous empirical work suggests that emotion can influence accuracy and cognitive biases underlying recognition memory, depending on the experimental conditions. The current study examines the effects of arousal and valence on delayed recognition memory using the diffusion model, which allows the separation of two decision biases thought to underlie memory: response bias and memory bias. Memory bias has not been given much attention in the literature but can provide insight into the retrieval dynamics of emotion modulated memory. Participants viewed emotional pictorial stimuli; half were given a recognition test 1-day later and the other half 7-days later. Analyses revealed that emotional valence generally evokes liberal responding, whereas high arousal evokes liberal responding only at a short retention interval. The memory bias analyses indicated that participants experienced greater familiarity with high-arousal compared to low-arousal items and this pattern became more pronounced as study-test lag increased; positive items evoke greater familiarity compared to negative and this pattern remained stable across retention interval. The findings provide insight into the separate contributions of valence and arousal to the cognitive mechanisms underlying delayed emotion modulated memory.	[Bowen, Holly J.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA; [Spaniol, Julia] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Patel, Ronak] Univ Manitoba, Dept Clin Hlth Psychol, Coll Med, Winnipeg, MB, Canada; [Voss, Andreas] Heidelberg Univ, Psychol Inst, Heidelberg, Germany	Boston College; Toronto Metropolitan University; University of Manitoba; Ruprecht Karls University Heidelberg	Bowen, HJ (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	holly.bowen@bc.edu	Voss, Andreas/F-5087-2011	Voss, Andreas/0000-0002-4499-3660; Bowen, Holly/0000-0002-3855-8961	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [358797]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant # 358797 (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp). It was awarded to JS, who was involved in study design, data analysis, decision to publish and preparation of the manuscript.	Anderson AK, 2006, LEARN MEMORY, V13, P711, DOI 10.1101/lm.388906; Bowen HJ, 2011, APPL COGNITIVE PSYCH, V25, P906, DOI 10.1002/acp.1767; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Dewhurst SA, 2000, EUR J COGN PSYCHOL, V12, P541, DOI 10.1080/095414400750050222; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Dougal S, 2007, PSYCHON B REV, V14, P423, DOI 10.3758/BF03194083; Greder RC, 2008, MEM COGNITION, V36, P933, DOI 10.3758/MC.36.5.933; Green DM, 1966, SIGNAL DETECTION THE; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; HEALY AF, 1978, MEM COGNITION, V6, P544, DOI 10.3758/BF03198243; Kapucu A, 2008, J EXP PSYCHOL LEARN, V34, P703, DOI 10.1037/0278-7393.34.3.703; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kensinger EA, 2004, REV NEUROSCIENCE, V15, P241, DOI 10.1515/REVNEURO.2004.15.4.241; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Kensinger EA, 2006, PSYCHON B REV, V13, P757, DOI 10.3758/BF03193993; Kensinger EA, 2007, J MEM LANG, V56, P575, DOI 10.1016/j.jml.2006.05.004; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; LaBar KS, 2000, NEUROPSYCHOLOGIA, V38, P1734, DOI 10.1016/S0028-3932(00)00077-4; Lang PJ, 2008, TECH REP A 8; Leite FP, 2011, JUDGM DECIS MAK, V6, P651; LOFTUS EF, 1974, J VERB LEARN VERB BE, V13, P585, DOI 10.1016/S0022-5371(74)80011-3; Luce R. D., 1963, HDB MATH PSYCHOL, V1, P103; Macmillan NA, 2005, DETECTION THEORY USE; Maratos EJ, 2000, NEUROPSYCHOLOGIA, V38, P1452, DOI 10.1016/S0028-3932(00)00061-0; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McGaugh JL, 1989, INVOLVEMENT OF HORMO; Oates JM, 2011, MEMORY PICTURES SOME, P1; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Payne JD, 2010, CURR DIR PSYCHOL SCI, V19, P290, DOI 10.1177/0963721410383978; Pierce BH, 2011, EMOTION, V11, P139, DOI 10.1037/a0021287; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Ratcliff R, 2003, PERCEPT PSYCHOPHYS, V65, P523, DOI 10.3758/BF03194580; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ritchey M, 2008, CEREB CORTEX, V18, P2494, DOI 10.1093/cercor/bhm262; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sharot T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001068; Sharot T, 2008, COGNITION, V106, P538, DOI 10.1016/j.cognition.2007.03.002; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Spaniol J, 2011, PSYCHOL AGING, V26, P932, DOI 10.1037/a0023297; Spaniol J, 2008, PSYCHOL AGING, V23, P859, DOI 10.1037/a0014218; Talmi D, 2007, J MEM LANG, V56, P555, DOI 10.1016/j.jml.2007.01.002; Thapar A, 2009, PSYCHON B REV, V16, P699, DOI 10.3758/PBR.16.4.699; Tukey JW, 1977, EXPLORATORY DATA ANA; Voss A, 2004, MEM COGNITION, V32, P1206, DOI 10.3758/BF03196893; Voss A, 2008, J EXP SOC PSYCHOL, V44, P1048, DOI 10.1016/j.jesp.2007.10.009; Voss A, 2007, BEHAV RES METHODS, V39, P767, DOI 10.3758/BF03192967; Voss A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00336; Voss A, 2013, EXP PSYCHOL, V60, P385, DOI 10.1027/1618-3169/a000218; Wagenmakers EJ, 2009, EUR J COGN PSYCHOL, V21, P641, DOI 10.1080/09541440802205067; Weymar M, 2011, HUM BRAIN MAPP, V32, P632, DOI 10.1002/hbm.21051; Weymar M, 2009, PSYCHOPHYSIOLOGY, V46, P1200, DOI 10.1111/j.1469-8986.2009.00869.x; White C, 2009, COGNITION EMOTION, V23, P181, DOI 10.1080/02699930801976770; White CN, 2014, J EXP PSYCHOL LEARN, V40, P385, DOI 10.1037/a0034851; White CN, 2010, J MATH PSYCHOL, V54, P39, DOI 10.1016/j.jmp.2010.01.004; Windmann S, 2001, J COGNITIVE NEUROSCI, V13, P577, DOI 10.1162/089892901750363172; YONELINAS AP, 1994, J EXP PSYCHOL LEARN, V20, P1341, DOI 10.1037/0278-7393.20.6.1341	63	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146769	10.1371/journal.pone.0146769	http://dx.doi.org/10.1371/journal.pone.0146769			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784108	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400065
J	Marinello, J; Bertoncini, S; Aloisi, I; Cristini, A; Tagliazucchi, GM; Forcato, M; Sordet, O; Capranico, G				Marinello, Jessica; Bertoncini, Stefania; Aloisi, Iris; Cristini, Agnese; Tagliazucchi, Guidantonio Malagoli; Forcato, Mattia; Sordet, Olivier; Capranico, Giovanni			Dynamic Effects of Topoisomerase I Inhibition on R-Loops and Short Transcripts at Active Promoters	PLOS ONE			English	Article							RNA-POLYMERASE-II; CPG-ISLAND PROMOTERS; DOUBLE-STRAND BREAKS; ANTISENSE TRANSCRIPTION; DNA TOPOISOMERASES; HUMAN-CELLS; CAMPTOTHECIN; REPLICATION; ACTIVATION; SITES	Topoisomerase I-DNA-cleavage complexes (Top1cc) stabilized by camptothecin (CPT) have specific effects at transcriptional levels. We recently reported that Top1cc increase antisense transcript (aRNAs) levels at divergent CpG-island promoters and, transiently, DNA/RNA hybrids (R-loop) in nuclear and mitochondrial genomes of colon cancer HCT116 cells. However, the relationship between R-loops and aRNAs was not established. Here, we show that aRNAs can form R-loops in N-TERA-2 cells under physiological conditions, and that promoter-associated R-loops are somewhat increased and extended in length immediately upon cell exposure to CPT. In contrast, persistent Top1ccs reduce the majority of R-loops suggesting that CPT-accumulated aRNAs are not commonly involved in R-loops. The enhancement of aRNAs by Top1ccs is present both in human colon cancer HCT116 cells and WI38 fibroblasts suggesting a common response of cancer and normal cells. Although Top1ccs lead to DSB and DDR kinases activation, we do not detect a dependence of aRNA accumulation on ATM or DNA-PK activation. However, we showed that the cell response to persistent Top1ccs can involve an impairment of aRNA turnover rather than a higher synthesis rate. Finally, a genome-wide analysis shows that persistent Top1ccs also determine an accumulation of sense transcripts at 5'-end gene regions suggesting an increased occurrence of truncated transcripts. Taken together, the results indicate that Top1 may regulate transcription initiation by modulating RNA polymerase-generated negative supercoils, which can in turn favor R-loop formation at promoters, and that transcript accumulation at TSS is a response to persistent transcriptional stress by Top1 poisoning.	[Marinello, Jessica; Bertoncini, Stefania; Aloisi, Iris; Capranico, Giovanni] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Cristini, Agnese; Sordet, Olivier] Canc Res Ctr Toulouse, INSERM UMR1037, Toulouse, France; [Tagliazucchi, Guidantonio Malagoli; Forcato, Mattia] Univ Modena & Reggio Emilia, Dept Life Sci, Ctr Genome Res, Modena, Italy; [Aloisi, Iris] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Tagliazucchi, Guidantonio Malagoli] IRCCS Osped Maggiore Policlin, Ist Nazl Genet Mol, Milan, Italy	University of Bologna; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universita di Modena e Reggio Emilia; University of Bologna; IRCCS Ca Granda Ospedale Maggiore Policlinico	Capranico, G (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	giovanni.capranico@unibo.it	Sordet, Olivier/M-3271-2014; Tagliazucch, Guidantonio Malagoli/E-5026-2018; Capranico, Giovanni/K-1678-2014; Forcato, Mattia/B-7733-2015	Sordet, Olivier/0000-0001-6027-4925; Tagliazucch, Guidantonio Malagoli/0000-0001-5581-4851; Capranico, Giovanni/0000-0002-8708-6454; Forcato, Mattia/0000-0002-7383-6576; Cristini, Agnese/0000-0003-0235-8770; Aloisi, Iris/0000-0001-5053-4818; Marinello, Jessica/0000-0002-2356-869X	"Associazione Italiana per la Ricerca sul Cancro" (AIRC), Milan, Italy [IG15886, IG-15886]; Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale [FDT20140931166]; CIB (Consorzio Interuniversitario per le Biotecnologie)	"Associazione Italiana per la Ricerca sul Cancro" (AIRC), Milan, Italy(Fondazione AIRC per la ricerca sul cancro); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); CIB (Consorzio Interuniversitario per le Biotecnologie)	This work was supported by a grant from the "Associazione Italiana per la Ricerca sul Cancro" (AIRC), Milan, Italy [IG15886 grant to GC]. AC is supported by a grant from the Ministere de l'Enseignement Superieur et de la Recherche and from the Fondation pour la Recherche Medicale [FDT20140931166]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the "Associazione Italiana per la Ricerca sul Cancro" (AIRC), Milan, Italy [IG-15886 grant to G. Capranico]. A.C. was supported by grant from the Ministere de l'Enseignement Superieur et de la Recherche and from the Fondation pour la Recherche Medicale [FDT20140931166]. S.B. was partially supported by CIB (Consorzio Interuniversitario per le Biotecnologie).	Baranello L, 2010, NUCLEIC ACIDS RES, V38, P159, DOI 10.1093/nar/gkp817; Bertozzi D, 2014, MOL CANCER THER, V13, P239, DOI 10.1158/1535-7163.MCT-13-0729; Bertozzi D, 2011, CELL CYCLE, V10, P3189, DOI 10.4161/cc.10.18.17183; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boque-Sastre R, 2015, P NATL ACAD SCI USA, V112, P5785, DOI 10.1073/pnas.1421197112; Capranico G, 2007, BIOCHIMIE, V89, P482, DOI 10.1016/j.biochi.2007.01.001; Capranico G, 2010, BBA-REV CANCER, V1806, P240, DOI 10.1016/j.bbcan.2010.06.003; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen PB, 2015, NAT STRUCT MOL BIOL, V22, P999, DOI 10.1038/nsmb.3122; Costantino L, 2015, CURR OPIN CELL BIOL, V34, P39, DOI 10.1016/j.ceb.2015.04.008; Cristini A, 2015, NUCL ACIDS RES; Dalla Rosa I, 2014, J BIOL CHEM, V289, P18595, DOI 10.1074/jbc.M114.555367; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004630; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Jeanblanc M, 2012, ONCOGENE, V31, P3072, DOI 10.1038/onc.2011.481; Khobta A, 2006, J MOL BIOL, V357, P127, DOI 10.1016/j.jmb.2005.12.069; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lim YW, 2015, ELIFE, V4, DOI 10.7554/eLife.08007; Lombrana R, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00158; Marinello J, 2013, NUCLEIC ACIDS RES, V41, P10110, DOI 10.1093/nar/gkt778; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Powell WT, 2013, P NATL ACAD SCI USA, V110, P13938, DOI 10.1073/pnas.1305426110; Preker P, 2011, NUCLEIC ACIDS RES, V39, P7179, DOI 10.1093/nar/gkr370; Roy D, 2008, MOL CELL BIOL, V28, P50, DOI 10.1128/MCB.01251-07; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Sollier J, 2015, TRENDS CELL BIOL; Sordet O, 2008, J MOL BIOL, V381, P540, DOI 10.1016/j.jmb.2008.06.028; Sordet O, 2010, CELL CYCLE, V9, P274, DOI 10.4161/cc.9.2.10506; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Stuckey R, 2015, P NATL ACAD SCI USA, V112, P5779, DOI 10.1073/pnas.1501769112; Sun QW, 2013, SCIENCE, V340, P619, DOI 10.1126/science.1234848; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Veloso A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078190; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	47	31	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147053	10.1371/journal.pone.0147053	http://dx.doi.org/10.1371/journal.pone.0147053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784695	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400101
J	Polosa, A; Liu, WW; Lachapelle, P				Polosa, Anna; Liu, Wenwen; Lachapelle, Pierre			Retinotopic Distribution of Structural and Functional Damages following Bright Light Exposure of Juvenile Rats	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; CELL INTRAOCULAR IMPLANTS; PHOTORECEPTOR DEGENERATION; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; INDUCED RETINOPATHY; RETINAL-DEGENERATION; ALBINO-RATS; AGE; CNTF	In the present study, we aimed at better understanding the short (acute) and long term (chronic) degenerative processes characterizing the juvenile rat model of light-induced retinopathy. Electroretinograms, visual evoked potentials (VEP), retinal histology and western blots were obtained from juvenile albino Sprague-Dawley rats at preselected postnatal ages (from P30 to P400) following exposure to 10,000 lux from P14 to P28. Our results show that while immediately following the cessation of exposure, photoreceptor degeneration was concentrated within a well delineated area of the superior retina (i.e. the photoreceptor hole), with time, this hole continued to expand to form an almost photoreceptor-free region covering most of superior-inferior axis. By the end of the first year of life, only few photoreceptors remained in the far periphery of the superior hemiretina. Interestingly, despite a significant impairment of the outer retinal function, the retinal output (VEP) was maintained in the early phase of this retinopathy. Our findings thus suggest that postnatal exposure to a bright luminous environment triggers a degenerative process that continues to impair the retinal structure and function (mostly at the photoreceptor level) long after the cessation of the exposure regimen (more than 1 year documented herein). Given the slow degenerative process triggered following postnatal bright light exposure, we believe that our model represents an attractive alternative (to other more genetic models) to study the pathophysiology of photoreceptor-induced retinal degeneration as well as therapeutic strategies to counteract it.	[Polosa, Anna; Liu, Wenwen; Lachapelle, Pierre] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Polosa, Anna; Liu, Wenwen; Lachapelle, Pierre] McGill Univ, Dept Ophthalmol, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Lachapelle, P (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.; Lachapelle, P (corresponding author), McGill Univ, Dept Ophthalmol, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada.	pierre.lachapelle@mcgill.ca		Lachapelle, Pierre/0000-0002-7792-1102	Natural Sciences and Engineering Research Council of Canada [Rgpin 138448-09]; Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council of Canada. Grant number: Rgpin 138448-09. Receipient: PL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a research grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada. Thanks are due to Dr. Allison L. Dorfman for reviewing earlier versions of this manuscript.	Cayouette M, 1998, J NEUROSCI, V18, P9282; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246; Gordon WC, 2002, INVEST OPHTH VIS SCI, V43, P3511; Green WR, 1999, MOL VIS, V5, P1; Joly S, 2007, INVEST OPHTH VIS SCI, V48, P2311, DOI 10.1167/iovs.06-1205; Joly S, 2006, INVEST OPHTH VIS SCI, V47, P3202, DOI 10.1167/iovs.05-1515; Joly S, 2006, DOC OPHTHALMOL, V113, P93, DOI 10.1007/s10633-006-9018-9; Jones BW, 2006, ADV EXP MED BIOL, V572, P405; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; KUWABARA T, 1976, ARCH OPHTHALMOL-CHIC, V94, P1369; LACHAPELLE P, 1987, CAN J OPHTHALMOL, V22, P354; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; LI ZY, 1994, EXP EYE RES, V58, P397, DOI 10.1006/exer.1994.1032; MALIK S, 1986, INVEST OPHTH VIS SCI, V27, P164; Marc RE, 2008, MOL VIS, V14, P782; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Noell W K, 1966, Invest Ophthalmol, V5, P450; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; OSTEEN WK, 1974, INVEST OPHTH VISUAL, V13, P334; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; PENN JS, 1986, EXP EYE RES, V43, P915, DOI 10.1016/0014-4835(86)90070-9; Pilli S, 2014, RETINA-J RET VIT DIS, V34, P1384, DOI 10.1097/IAE.0000000000000064; Rapp L, 1985, RETINAL DEGENERATION, P421; RAPP LM, 1992, INVEST OPHTH VIS SCI, V33, P3367; RAPP LM, 1990, INVEST OPHTH VIS SCI, V31, P1186; RAPP LM, 1980, EFFECTS CONSTANT LIG, P135; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; Shao Z, 2011, INVEST OPHTH VIS SCI, V52, P6238, DOI 10.1167/iovs.10-6742; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; SIMONS K, 1993, ARCH OPHTHALMOL-CHIC, V111, P297, DOI 10.1001/archopht.1993.01090030015002; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Tanito M, 2008, EXP EYE RES, V87, P292, DOI 10.1016/j.exer.2008.06.002; Taylor H R, 1990, Trans Am Ophthalmol Soc, V88, P163; Valter K, 2003, BRAIN RES, V985, P169, DOI 10.1016/S0006-8993(03)03130-5; Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146979	10.1371/journal.pone.0146979	http://dx.doi.org/10.1371/journal.pone.0146979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784954	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400092
J	Rueda, P; Harley, E; Lu, Y; Stewart, GD; Fabb, S; Diepenhorst, N; Cremers, B; Rouillon, MH; Wehrle, I; Geant, A; Lamarche, G; Leach, K; Charman, WN; Christopoulos, A; Summers, RJ; Sexton, PM; Langmead, CJ				Rueda, Patricia; Harley, Elizabeth; Lu, Yao; Stewart, Gregory D.; Fabb, Stewart; Diepenhorst, Natalie; Cremers, Beatrice; Rouillon, Marie-Helene; Wehrle, Isabelle; Geant, Anne; Lamarche, Gwladys; Leach, Katie; Charman, William N.; Christopoulos, Arthur; Summers, Roger J.; Sexton, Patrick M.; Langmead, Christopher J.			Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; KNOCKOUT MICE; GLA PROTEIN; L-ARGININE; IN-VITRO; BONE; EXPRESSION; SECRETION; PATHWAY; ISLETS	Phenotyping of Gprc6a KO mice has shown that this promiscuous class C G protein coupled receptor is variously involved in regulation of metabolism, inflammation and endocrine function. Such effects are described as mediated by extracellular calcium, L-amino acids, the bone-derived peptide osteocalcin (OCN) and the male hormone testosterone, introducing the concept of a bone-energy-metabolism-reproduction functional crosstalk mediated by GPRC6A. However, whilst the calcium and L-amino acid-sensing properties of GPRC6A are well established, verification of activity of osteocalcin at both human and mouse GPRC6A in vitro has proven somewhat elusive. This study characterises the in vitro pharmacology of mouse GPRC6A in response to its putative ligands in both recombinant and endogenous GPRC6A-expressing cells. Using cell signalling, and glucagon-like peptide (GLP)-1 and insulin release assays, our results confirm that basic L-amino acids act as agonists of the murine GPRC6A receptor in both recombinant cells and immortalised enteroendocrine and pancreatic beta-cells. In contrast, our studies do not support a role for OCN as a direct ligand for mouse GPRC6A, suggesting that the reported in vivo effects of OCN that require GPRC6A may be indirect, rather than via direct activation of the receptor.	[Rueda, Patricia; Lu, Yao; Stewart, Gregory D.; Fabb, Stewart; Diepenhorst, Natalie; Leach, Katie; Charman, William N.; Christopoulos, Arthur; Summers, Roger J.; Sexton, Patrick M.; Langmead, Christopher J.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Harley, Elizabeth; Cremers, Beatrice; Rouillon, Marie-Helene; Wehrle, Isabelle; Geant, Anne; Lamarche, Gwladys] Inst Rech Servier, Suresnes, France	Monash University; Servier; Institut de Recherches Internationales Servier	Langmead, CJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia.	chris.langmead@monash.edu	Diepenhorst, Natalie/HHS-2496-2022; Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Summers, Roger J/F-6351-2011	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Summers, Roger J/0000-0002-8367-4056; Leach, Katherine/0000-0002-9280-1803; Rueda, Patricia/0000-0003-1553-0840; Stewart, Gregory David/0000-0002-9748-4990; Charman, William/0000-0002-7051-2023; Fabb, Stewart/0000-0002-8887-7661; Langmead, Christopher/0000-0003-3483-1120	Servier	Servier(Servier)	Servier provided support in the form of salaries for EH, BC, M-HR, IW, AG, GL and provided research support to Monash University to fund salaries for PR, YL, GDS, SF, ND and CJL. However, Servier did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. AC and PMS are NHMRC Principal Research Fellows.	BENTON ME, 1995, BIOCHEMISTRY-US, V34, P9541, DOI 10.1021/bi00029a031; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Clemmensen C, 2013, PHYSIOL BEHAV, V118, P144, DOI 10.1016/j.physbeh.2013.05.015; Clemmensen C, 2013, J ENDOCRINOL, V217, P151, DOI 10.1530/JOE-12-0550; De Toni L, 2014, ENDOCRINOLOGY, V155, P4266, DOI 10.1210/en.2014-1283; Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004; Gloriam DE, 2011, CHEM BIOL, V18, P1489, DOI 10.1016/j.chembiol.2011.09.012; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Kim JH, 2007, BIOTECHNOL LETT, V29, P1631, DOI 10.1007/s10529-007-9437-z; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Mizokami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057375; Otani T, 2015, CELL SIGNAL, V27, P532, DOI 10.1016/j.cellsig.2014.12.018; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Oya M, 2013, J BIOL CHEM, V288, P4513, DOI 10.1074/jbc.M112.402677; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Smajilovic S, 2013, AMINO ACIDS, V44, P383, DOI 10.1007/s00726-012-1341-8; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Wellendorph P, 2009, J MOL ENDOCRINOL, V42, P215, DOI 10.1677/JME-08-0149; Wellendorph Petrine, 2014, ASCEPT MGPCR JOINT S	32	36	37	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146846	10.1371/journal.pone.0146846	http://dx.doi.org/10.1371/journal.pone.0146846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785252	gold, Green Submitted, Green Published			2022-12-26	WOS:000368528400073
J	Smieja, M; Warszycki, D				Smieja, Marek; Warszycki, Dawid			Average Information Content Maximization-A New Approach for Fingerprint Hybridization and Reduction	PLOS ONE			English	Article							MACHINE LEARNING-METHODS; DERIVATIVES; DESIGN; CHEMISTRY; ANTIDEPRESSANT; PROTOCOL; LIGANDS; SEARCH; 5-HT7	Fingerprints, bit representations of compound chemical structure, have been widely used in cheminformatics for many years. Although fingerprints with the highest resolution display satisfactory performance in virtual screening campaigns, the presence of a relatively high number of irrelevant bits introduces noise into data and makes their application more time-consuming. In this study, we present a new method of hybrid reduced fingerprint construction, the Average Information Content Maximization algorithm (AIC-MAX ALGORITHM), which selects the most informative bits from a collection of fingerprints. This methodology, applied to the ligands of five cognate serotonin receptors (5-HT2A, 5-HT2B, 5-HT2C, 5-HT5A, 5-HT6), proved that 100 bits selected from four non-hashed fingerprints reflect almost all structural information required for a successful in silico discrimination test. A classification experiment indicated that a reduced representation is able to achieve even slightly better performance than the state-of-the-art 10-times-longer fingerprints and in a significantly shorter time.	[Smieja, Marek] Jagiellonian Univ, Fac Math & Comp Sci, 6 Lojasiewicza St, PL-30348 Krakow, Poland; [Warszycki, Dawid] Polish Acad Sci, Inst Pharmacol, 12 Smetna St, PL-31343 Krakow, Poland	Jagiellonian University; Polish Academy of Sciences	Smieja, M (corresponding author), Jagiellonian Univ, Fac Math & Comp Sci, 6 Lojasiewicza St, PL-30348 Krakow, Poland.	marek.smieja@ii.uj.edu.pl	Warszycki, Dawid/T-9712-2017	Warszycki, Dawid/0000-0002-2393-4709	National Centre of Science (Poland) [2014/13/N/ST6/01832]	National Centre of Science (Poland)(National Science Centre, Poland)	This study was fully supported by the National Centre of Science (Poland) grant no. 2014/13/N/ST6/01832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Centre of Science (Poland) grant no. 2014/13/N/ST6/01832.	Alpaydin E., 2009, INTRO MACHINE LEARNI; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Bojarski AJ, 2006, CURR TOP MED CHEM, V6, P2005, DOI 10.2174/156802606778522186; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Canale V, 2015, EUR J MED CHEM, V92, P202, DOI 10.1016/j.ejmech.2014.12.041; Chlon-Rzepa G, 2015, ARCH PHARM, V348, P242, DOI 10.1002/ardp.201500015; Cover T. M., 1991, Elements of information theory, DOI 10.1002/0471200611; Czarnecki WM, 2015, EXPERT SYST APPL, V42, P5591, DOI 10.1016/j.eswa.2015.03.007; Ewing T, 2006, J CHEM INF MODEL, V46, P2423, DOI 10.1021/ci060155b; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gabrielsen M, 2014, J CHEM INF MODEL, V54, P933, DOI 10.1021/ci400742s; HALL LH, 1995, J CHEM INF COMP SCI, V35, P1039, DOI 10.1021/ci00028a014; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Klekota J, 2008, BIOINFORMATICS, V24, P2518, DOI 10.1093/bioinformatics/btn479; Kurczab R, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-32; Kurczab R, 2010, BIOORG MED CHEM LETT, V20, P2465, DOI 10.1016/j.bmcl.2010.03.012; MacKay D. J. C., 2003, INFORM THEORY INFERE; McCorvy JD, 2015, PHARMACOL THERAPEUT, V150, P129, DOI 10.1016/j.pharmthera.2015.01.009; Nisius B, 2010, CHEM BIOL DRUG DES, V75, P152, DOI 10.1111/j.1747-0285.2009.00930.x; Nisius B, 2009, J CHEM INF MODEL, V49, P1347, DOI 10.1021/ci900087y; Partyka A, 2015, BIOORGAN MED CHEM, V23, P212, DOI 10.1016/j.bmc.2014.11.008; Raevsky OA, 1999, RUSS CHEM REV, V68, P505, DOI [10.1070/RC1999v068n06ABEH000425, DOI 10.1070/RC1999V068N06ABEH000425]; Shemetulskis NE, 1996, J CHEM INF COMP SCI, V36, P862, DOI 10.1021/ci950169+; Smieja M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102069; Smusz S, 2015, J CHEM INF MODEL, V55, P823, DOI 10.1021/ci500564b; Smusz S, 2015, BIOORG MED CHEM LETT, V25, P1827, DOI 10.1016/j.bmcl.2015.03.049; Spurek P, 2013, INFORM SCIENCES, V252, P132, DOI 10.1016/j.ins.2013.06.030; Staron J, 2015, RSC ADV, V5, P25806, DOI 10.1039/c5ra00054h; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Wang Y, 2008, J CHEM INF MODEL, V48, P1754, DOI 10.1021/ci8002045; Williams C, 2006, MOL DIVERS, V10, P311, DOI 10.1007/s11030-006-9039-z; Witek J, 2014, BIOORG MED CHEM LETT, V24, P580, DOI 10.1016/j.bmcl.2013.12.017; Xue L, 2004, J CHEM INF COMP SCI, V44, P2032, DOI 10.1021/ci0400819; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zajdel P, 2009, COMB CHEM HIGH T SCR, V12, P723, DOI 10.2174/138620709788923719; Zajdel P, 2012, EUR J MED CHEM, V56, P348, DOI 10.1016/j.ejmech.2012.07.043; Zajdel P, 2012, BIOORGAN MED CHEM, V20, P1545, DOI 10.1016/j.bmc.2011.12.039	37	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146666	10.1371/journal.pone.0146666	http://dx.doi.org/10.1371/journal.pone.0146666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784447	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400056
J	Oda, S; Nozawa, T; Nozawa-Minowa, A; Tanaka, M; Aikawa, C; Harada, H; Nakagawa, I				Oda, Seiichiro; Nozawa, Takashi; Nozawa-Minowa, Atsuko; Tanaka, Misako; Aikawa, Chihiro; Harada, Hiroyuki; Nakagawa, Ichiro			Golgi-Resident GTPase Rab30 Promotes the Biogenesis of Pathogen-Containing Autophagosomes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; G-PROTEINS; CELLS; MATURATION; INVASION; NETWORK; FAMILY	Autophagy acts as a host-defense system against pathogenic microorganisms such as Group A Streptococcus (GAS). Autophagy is a membrane-mediated degradation system that is regulated by intracellular membrane trafficking regulators, including small GTPase Rab proteins. Here, we identified Rab30 as a novel regulator of GAS-containing autophago-some-like vacuoles (GcAVs). We found that Rab30, a Golgi-resident Rab, was recruited to GcAVs in response to autophagy induction by GAS infection in epithelial cells. Rab30 recruitment was dependent upon its GTPase activity. In addition, the knockdown of Rab30 expression significantly reduced GcAV formation efficiency and impaired intracellular GAS degradation. Rab30 normally functions to maintain the structural integrity of the Golgi complex, but GcAV formation occurred even when the Golgi apparatus was disrupted. Although Rab30 also colocalized with a starvation-induced autophagosome, Rab30 was not required for autophagosome formation during starvation. These results suggest that Rab30 mediates autophagy against GAS independently of its normal cellular role in the structural maintenance of the Golgi apparatus, and autophagosome biogenesis during bacterial infection involves specific Rab GTPases.	[Oda, Seiichiro; Nozawa, Takashi; Nozawa-Minowa, Atsuko; Tanaka, Misako; Aikawa, Chihiro; Nakagawa, Ichiro] Tokyo Med & Dent Univ, Dept Bacterial Pathogenesis, Grad Sch Med & Dent Sci, Tokyo 1138549, Japan; [Oda, Seiichiro; Harada, Hiroyuki] Tokyo Med & Dent Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med & Dent Sci, Tokyo 1138549, Japan; [Nozawa, Takashi; Nozawa-Minowa, Atsuko; Aikawa, Chihiro; Nakagawa, Ichiro] Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Kyoto 6068501, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University	Nozawa, T (corresponding author), Tokyo Med & Dent Univ, Dept Bacterial Pathogenesis, Grad Sch Med & Dent Sci, Tokyo 1138549, Japan.; Nozawa, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Kyoto 6068501, Japan.	nozawa.takashi.4r@kyoto-u.ac.jp		Nozawa, Takashi/0000-0002-1822-5553	Funding Programs for Next Generation World-Leading Researchers [LS041]; JSPS KAKENHI [25293370, 70294113, 10598858]	Funding Programs for Next Generation World-Leading Researchers; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Funding Programs for Next Generation World-Leading Researchers (LS041) and JSPS KAKENHI Grant Numbers 25293370, 70294113 (to I.N.) and 10598858 (to T.N.).	Ao X, 2014, CELL DEATH DIFFER; Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003; Bento CF, 2013, J CELL SCI, V126, P1059, DOI 10.1242/jcs.123075; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Chen D, 1996, GENE, V174, P129, DOI 10.1016/0378-1119(96)00509-4; Chua CEL, 2011, CELL MOL LIFE SCI, V68, P3349, DOI 10.1007/s00018-011-0748-9; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Gillingham AK, 2014, DEV CELL, V31, P358, DOI 10.1016/j.devcel.2014.10.007; Guo YJ, 2012, J CELL SCI, V125, P1706, DOI 10.1242/jcs.093203; Haobam B, 2014, CELL MICROBIOL, V16, P1806, DOI 10.1111/cmi.12329; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Kelly EE, 2012, BIOL CELL, V104, P84, DOI 10.1111/boc.201100080; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nozawa T, 2012, CELL MICROBIOL, V14, P1149, DOI 10.1111/j.1462-5822.2012.01792.x; O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394; Sakurai A, 2010, J BIOL CHEM, V285, P22666, DOI 10.1074/jbc.M109.100131; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Szatmari Z, 2014, AUTOPHAGY, V10, P1154, DOI 10.4161/auto.29395; Thomas C, 2009, DEV BIOL, V331, P250, DOI 10.1016/j.ydbio.2009.05.001; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Tsatsaronis JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004266; Yamaguchi H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000670	32	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147061	10.1371/journal.pone.0147061	http://dx.doi.org/10.1371/journal.pone.0147061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771875	Green Submitted, gold, Green Published			2022-12-26	WOS:000368628300059
J	Spetale, FE; Tapia, E; Krsticevic, F; Roda, F; Bulacio, P				Spetale, Flavio E.; Tapia, Elizabeth; Krsticevic, Flavia; Roda, Fernando; Bulacio, Pilar			A Factor Graph Approach to Automated GO Annotation	PLOS ONE			English	Article							GENE-FUNCTION; MOLECULAR CHAPERONES; FUNCTION PREDICTION; PROTEIN FUNCTION; ENSEMBLE	As volume of genomic data grows, computational methods become essential for providing a first glimpse onto gene annotations. Automated Gene Ontology (GO) annotation methods based on hierarchical ensemble classification techniques are particularly interesting when interpretability of annotation results is a main concern. In these methods, raw GO-term predictions computed by base binary classifiers are leveraged by checking the consistency of predefined GO relationships. Both formal leveraging strategies, with main focus on annotation precision, and heuristic alternatives, with main focus on scalability issues, have been described in literature. In this contribution, a factor graph approach to the hierarchical ensemble formulation of the automated GO annotation problem is presented. In this formal framework, a core factor graph is first built based on the GO structure and then enriched to take into account the noisy nature of GO-term predictions. Hence, starting from raw GO-term predictions, an iterative message passing algorithm between nodes of the factor graph is used to compute marginal probabilities of target GO-terms. Evaluations on Saccharomyces cerevisiae, Arabidopsis thaliana and Drosophila melanogaster protein sequences from the GO Molecular Function domain showed significant improvements over competing approaches, even when protein sequences were naively characterized by their physicochemical and secondary structure properties or when loose noisy annotation datasets were considered. Based on these promising results and using Arabidopsis thaliana annotation data, we extend our approach to the identification of most promising molecular function annotations for a set of proteins of unknown function in Solanum lycopersicum.	[Spetale, Flavio E.; Tapia, Elizabeth; Krsticevic, Flavia; Roda, Fernando; Bulacio, Pilar] CIFASIS Conicet Inst, Rosario, Santa Fe, Argentina; [Spetale, Flavio E.; Tapia, Elizabeth; Bulacio, Pilar] Natl Univ Rosario, Fac Cs Exactas Ingn & Agrimensura, Rosario, Santa Fe, Argentina; [Krsticevic, Flavia; Bulacio, Pilar] Natl Technol Univ, Fac Reg San Nicolas, San Nicolas, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Spetale, FE (corresponding author), CIFASIS Conicet Inst, Rosario, Santa Fe, Argentina.; Spetale, FE (corresponding author), Natl Univ Rosario, Fac Cs Exactas Ingn & Agrimensura, Rosario, Santa Fe, Argentina.	spetale@cifasis-conicet.gov.ar	Spetale, Flavio Ezequiel/AAT-6556-2021; Tapia, Elizabeth/AAS-4263-2021	Spetale, Flavio Ezequiel/0000-0002-0226-8372; Tapia, Elizabeth/0000-0002-9363-4824; Roda, Fernando/0000-0002-9878-5947	project PICT, "Multiplex systems for targeted microfluidic amplification and NGS sequencing" [2012-2513]; National Agency for Science and Technology Promotion; Argentina. Institution: National Scientific and Technical Research Council (CONICET); project PID INI, "GO functional annotation based on supervised hierarchical classification" [3600]	project PICT, "Multiplex systems for targeted microfluidic amplification and NGS sequencing"; National Agency for Science and Technology Promotion; Argentina. Institution: National Scientific and Technical Research Council (CONICET); project PID INI, "GO functional annotation based on supervised hierarchical classification"	This work was supported by project PICT 2012-2513, "Multiplex systems for targeted microfluidic amplification and NGS sequencing," National Agency for Science and Technology Promotion, Argentina. Institution: National Scientific and Technical Research Council (CONICET). Researcher: Elizabeth Tapia; and project PID INI 3600, "GO functional annotation based on supervised hierarchical classification", National Technological University, Argentina. Institution: National Scientific and Technical Research Council (CONICET). Researcher: Pilar Bulacio.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2001, GENOME RES, V11, P1425; Bartlett PL, 1997, ADV NEUR IN, V9, P134; Barutcuoglu Z, 2006, BIOINFORMATICS, V22, P830, DOI 10.1093/bioinformatics/btk048; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baxevanis AD, 2006, PRACTICAL ASPECTS MU, P172; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Bradford JR, 2010, PLANT J, V61, P713, DOI 10.1111/j.1365-313X.2009.04097.x; Burger A, 2004, BIOINFORMATICS, V20, P259, DOI 10.1093/bioinformatics/btg400; Carlson M., 2014, GENOME WIDE ANNOTATI; Cheng Liangxi, 2014, PLoS One, V9, pe107187, DOI 10.1371/journal.pone.0107187; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; DAGUM P, 1993, ARTIF INTELL, V60, P141, DOI 10.1016/0004-3702(93)90036-B; DECHTER R, 1985, J ACM, V32, P505, DOI 10.1145/3828.3830; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Eisner R, 2005, PROCEEDINGS OF THE 2005 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P354; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernandez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045899; Fragkostefanakis S, 2015, PLANT CELL ENVIRON, V38, P693, DOI 10.1111/pce.12426; Goyal RK, 2012, PLANTA, V235, P453, DOI 10.1007/s00425-011-1518-5; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Kappen HJ, 2012, MACH LEARN, V87, P159, DOI 10.1007/s10994-012-5278-7; Kohler Sebastian, 2014, Nucleic Acids Res, V42, pD966, DOI 10.1093/nar/gkt1026; Kourmpetis YAI, 2011, PLANT PHYSIOL, V155, P271, DOI 10.1104/pp.110.162164; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Lee BJ, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-27; Loeliger HA, 2004, IEEE SIGNAL PROC MAG, V21, P28, DOI 10.1109/MSP.2004.1267047; MacKay DJC, 1999, IEEE T INFORM THEORY, V45, P399, DOI 10.1109/18.748992; Meyer D, 2014, MISC FUNCTIONS DEP S; Mitsakakis N, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-8; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nawrocki EP, 2014, METHODS MOL BIOL, V1097, P163, DOI 10.1007/978-1-62703-709-9_9; Novak C, 2013, IEEE T SIGNAL PROCES, V61, P4051, DOI 10.1109/TSP.2013.2261989; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; Park JH, 2011, NEW PHYTOL, V191, P692, DOI 10.1111/j.1469-8137.2011.03734.x; Platt JC, 2000, ADV NEUR IN, P61; Riley MC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-112; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Robinson PN, 2015, LECT NOTES COMPUT SC, V9132, P15, DOI 10.1007/978-3-319-20248-8_2; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schapire R.E., 1997, P 14 INT C MACHINE L, P322; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; Schuler GD, 2006, SEQUENCE ALIGNMENT D, P145; Sicheritz-Ponten T, 2002, PACKAGE SEQUTILS; Soti C, 2005, CURR OPIN CELL BIOL, V17, P210, DOI 10.1016/j.ceb.2005.02.012; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sykacek P, 2012, BIOINFORMATICS, V28, pI603, DOI 10.1093/bioinformatics/bts405; Tanoue J, 2002, BIOINFORMATICS, V18, P1705, DOI 10.1093/bioinformatics/18.12.1705; Tapia E, 2010, PATTERN RECOGN LETT, V31, P210, DOI 10.1016/j.patrec.2009.09.031; Teichmann SA, 2001, CURR OPIN STRUC BIOL, V11, P354, DOI 10.1016/S0959-440X(00)00215-3; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Verspoor K, 2006, PROTEIN SCI, V15, P1544, DOI 10.1110/ps.062184006; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Weeks A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00409; Wei Qiong, 2013, PLoS One, V8, pe67863, DOI 10.1371/journal.pone.0067863	63	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146986	10.1371/journal.pone.0146986	http://dx.doi.org/10.1371/journal.pone.0146986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771463	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300048
J	Wu, YQ; Cheng, TC; Liu, C; Liu, DL; Zhang, Q; Long, RW; Zhao, P; Xia, QY				Wu, Yuqian; Cheng, Tingcai; Liu, Chun; Liu, Duolian; Zhang, Quan; Long, Renwen; Zhao, Ping; Xia, Qingyou			Systematic Identification and Characterization of Long Non-Coding RNAs in the Silkworm, Bombyx mori	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; EMBRYONIC-DEVELOPMENT; EXPRESSION PATTERNS; FUNCTIONAL-ANALYSIS; MULTIPLE TISSUES; REVEALS; PROTEIN; ANNOTATION; EVOLUTION; HONEYBEE	Long noncoding RNAs (lncRNAs) are emerging as important regulators in various biological processes. However, to date, no systematic characterization of lncRNAs has been reported in the silkworm Bombyx mori. In the present study, we generated eighteen RNA-seq data-sets with relatively high depth. Using an in-house designed lncRNA identification pipeline, 11,810 lncRNAs were identified for 5,556 loci. Among these lncRNAs, 474 transcripts were intronic lncRNAs (ilncRNAs), 6,250 transcripts were intergenic lncRNAs (lincRNAs), and 5,086 were natural antisense lncRNAs (lncNATs). Compared with protein-coding mRNAs, silkworm lncRNAs are shorter in terms of full length but longer in terms of exon and intron length. In addition, lncRNAs exhibit a lower level of sequence conservation, more repeat sequences overlapped and higher tissue specificity than protein-coding mRNAs in the silkworm. We found that 69 lncRNA transcripts from 33 gene loci may function as miRNA precursors, and 104 lncRNA transcripts from 72 gene loci may act as competing endogenous RNAs (ceRNAs). In total, 49.47% of all gene loci (2,749/5,556) for which lncRNAs were identified showed sex-biased expression. Co-expression network analysis resulted in 19 modules, 12 of which revealed relatively high tissue specificity. The highlighted darkgoldenrod module was specifically associated with middle and posterior silk glands, and the hub lncRNAs within this module were co-expressed with proteins involved in translation, translocation, and secretory processes, suggesting that these hub lncRNAs may function as regulators of the biosynthesis, translocation, and secretion of silk proteins. This study presents the first comprehensive genome-wide analysis of silkworm lncRNAs and provides an invaluable resource for genetic, evolutionary, and genomic studies of B. mori.	[Wu, Yuqian] Chongqing Univ, Sch Life Sci, Chongqing 400044, Peoples R China; [Wu, Yuqian; Cheng, Tingcai; Liu, Chun; Liu, Duolian; Zhang, Quan; Long, Renwen; Zhao, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China	Chongqing University; Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	xiaqy@swu.edu.cn		Xia, Qingyou/0000-0002-9263-2886; cheng, tingcai/0000-0002-3862-0817	National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31372380, 31530071]; Chongqing Fundamental and Advanced Research Projects [CSTC2014JCYJA80004]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Fundamental and Advanced Research Projects	The work was supported by National Basic Research Program of China (2012CB114600), National Natural Science Foundation of China (31372380), key program of the National Natural Science Foundation of China (31530071) and Chongqing Fundamental and Advanced Research Projects (CSTC2014JCYJA80004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonasio R, 2014, ANNU REV GENET, V48, P433, DOI 10.1146/annurev-genet-120213-092323; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018853; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098965; Deng XX, 2006, TRENDS BIOCHEM SCI, V31, P526, DOI 10.1016/j.tibs.2006.07.007; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Ferguson LC, 2011, MOL BIOL EVOL, V28, P257, DOI 10.1093/molbev/msq192; Gong J, 2015, NUCLEIC ACIDS RES, V43, pD181, DOI 10.1093/nar/gku1000; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hao ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121800; Humann FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078915; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jayakodi M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1868-7; Jenkins AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1507-3; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Kiya T, 2008, INSECT MOL BIOL, V17, P531, DOI 10.1111/j.1365-2583.2008.00821.x; Kiya T, 2012, INT J MOL SCI, V13, P15496, DOI 10.3390/ijms131215496; Kolde R., 2015, PHEATMAP PRETTY HEAT, DOI DOI 10.1093/nar/gkv007; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lakhotia SC, 2012, CHROMOSOMA, V121, P49, DOI 10.1007/s00412-011-0341-x; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li DD, 2011, NUCLEIC ACIDS RES, V39, P3792, DOI 10.1093/nar/gkq1317; Li JY, 2015, J PROTEOMICS, V126, P109, DOI 10.1016/j.jprot.2015.06.001; Li JS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-410; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li MX, 2012, NUCLEIC ACIDS RES, V40, P11714, DOI 10.1093/nar/gks943; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu K, 2013, BIOINFORMATICS, V29, P2221, DOI 10.1093/bioinformatics/btt361; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-85; Mohammadin S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0603-5; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Nie HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094185; Noh MY, 2015, DEV BIOL, V399, P315, DOI 10.1016/j.ydbio.2015.01.009; Padron A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-636; Parker BJ, 2011, GENOME RES, V21, P1929, DOI 10.1101/gr.112516.110; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Peng JJ, 2015, INT J DEV NEUROSCI, V46, P100, DOI 10.1016/j.ijdevneu.2015.07.006; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Royer C, 2011, INSECT BIOCHEM MOLEC, V41, P118, DOI 10.1016/j.ibmb.2010.11.003; Sawata M, 2004, RNA, V10, P1047, DOI 10.1261/rna.5231504; Sawata M, 2002, RNA, V8, P772, DOI 10.1017/S1355838202028790; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Soshnev AA, 2011, GENETICS, V189, P455, DOI 10.1534/genetics.111.131706; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075750; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tadano H, 2009, INSECT MOL BIOL, V18, P715, DOI 10.1111/j.1365-2583.2009.00911.x; Taguchi S, 2011, NEUROSCI LETT, V496, P176, DOI 10.1016/j.neulet.2011.04.011; TASHIRO Y, 1968, J CELL BIOL, V38, P574, DOI 10.1083/jcb.38.3.574; Tattikota SG, 2015, J BIOL CHEM, V290, P20284, DOI 10.1074/jbc.M115.658625; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang MJ, 2015, NEW PHYTOL, V207, P1181, DOI 10.1111/nph.13429; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020; Zhang KS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-845; Zhang YC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0512-1; Zhao XM, 2015, J BIOL CHEM, V290, P972, DOI 10.1074/jbc.M114.606921; Zhou ZY, 2014, GENOME BIOL EVOL, V6, P1387, DOI 10.1093/gbe/evu113	88	76	86	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147147	10.1371/journal.pone.0147147	http://dx.doi.org/10.1371/journal.pone.0147147			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771876	Green Submitted, Green Published, gold			2022-12-26	WOS:000368628300066
J	Melo, CA; Leveille, N; Rooijers, K; Wijchers, PJ; Geeven, G; Tal, A; Melo, SA; de Laat, W; Agami, R				Melo, C. A.; Leveille, N.; Rooijers, K.; Wijchers, P. J.; Geeven, G.; Tal, A.; Melo, S. A.; de Laat, W.; Agami, R.			A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response	ONCOGENE			English	Article							CHROMATIN INTERACTIONS; GENE-EXPRESSION; HUMAN-CELLS; GENOME; TRANSCRIPTION; CANCER; CONFORMATION; REPRESSION; OCCUPANCY; LNCRNA	Genome-wide chromatin studies identified the tumor suppressor p53 as both a promoter and an enhancer-binding transcription factor. As an enhancer factor, p53 can induce local production of enhancer RNAs, as well as transcriptional activation of distal neighboring genes. Beyond the regulation of protein-coding genes, p53 has the capacity to regulate long intergenic noncoding RNA molecules (lincRNAs); however, their importance to the p53 tumor suppressive function remains poorly characterized. Here, we identified and characterized a novel p53-bound intronic enhancer that controls the expression of its host, the lincRNA00475 (linc-475). We demonstrate the requirement of linc-475 for the proper induction of a p53-dependent cell cycle inhibitory response. We further confirm the functional importance of linc-475 in the maintenance of CDKN1A/p21 levels, a cell cycle inhibitor and a major p53 target gene, following p53 activation. Interestingly, loss of linc-475 reduced the binding of both p53 and RNA polymerase II (RNAPII) to the promoter of p21, attenuating its transcription rate following p53 activation. Altogether, our data suggest a direct role of p53-bound enhancer domains in the activation of lincRNAs required for an efficient p53 transcriptional response.	[Melo, C. A.; Leveille, N.; Rooijers, K.; Tal, A.; Agami, R.] Netherlands Canc Inst, Div Biol Stress Response, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Wijchers, P. J.; Geeven, G.; de Laat, W.] Hubrecht Inst KNAW, Utrecht, Netherlands; [Wijchers, P. J.; Geeven, G.; de Laat, W.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Melo, S. A.] Univ Porto IPATIMUP, Inst Invest & Inovacao Saude, Inst Pathol & Mol Immunol, Univ Porto, Oporto, Portugal; [Agami, R.] Rotterdam Univ, Dept Genet, Erasmus MC, Rotterdam, Netherlands	Netherlands Cancer Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Erasmus University Rotterdam; Erasmus MC	Leveille, N; Agami, R (corresponding author), Netherlands Canc Inst, Div Biol Stress Response, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	n.leveille@nki.nl; r.agami@nki.nl	agami, reuven/GOG-8289-2022; MELO, SONIA/H-8972-2013	Guedes, Carlos/0000-0001-9648-0560; Geeven, Geert/0000-0002-5603-0095; Rooijers, Koos/0000-0002-0412-468X; MELO, SONIA/0000-0002-2291-4263; de Laat, Wouter/0000-0002-6393-595X; Leveille, Nicolas/0000-0002-6086-5984; Agami, Reuven/0000-0002-2848-2473				Abdelmohsen K, 2013, AGING CELL, V12, P890, DOI 10.1111/acel.12115; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; de Leeuw J, 2009, J STAT SOFTW, V32, P1; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Grossi E, 2016, BBA-GENE REGUL MECH, V1859, P200, DOI 10.1016/j.bbagrm.2015.07.011; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kumar PP, 2014, ELIFE, V3, DOI 10.7554/eLife.02805; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lazorthes S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6971; Leveille N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7520; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Marin-Bejar O, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r104; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Sanchez Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6812; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Splinter E, 2011, EMBO J, V30, P4345, DOI 10.1038/emboj.2011.344; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Zhou X, 2013, NAT METHODS, V10, P375, DOI 10.1038/nmeth.2440; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	38	18	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	33					4399	4406		10.1038/onc.2015.502	http://dx.doi.org/10.1038/onc.2015.502			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3ZU	26776159				2022-12-26	WOS:000382152100011
J	Leu, ST; Bull, CM				Leu, Stephan T.; Bull, C. Michael			Artificial Water Point for Livestock Influences Spatial Ecology of a Native Lizard Species	PLOS ONE			English	Article							SLEEPY LIZARD; TILIQUA-RUGOSA; BEHAVIORAL THERMOREGULATION; BODY TEMPERATURES; AUSTRALIAN LIZARD; MICROHABITAT USE; SOCIAL NETWORK; GILA MONSTERS; PATTERNS; REFUGE	Pastoralism is a major agricultural activity in drier environments, and can directly and indirectly impact native species in those areas. We investigated how the supply of an artificial watering point to support grazing livestock affected movement and activity patterns of the Australian sleepy lizard (Tiliqua rugosa) during a drought year. We observed 23 adult lizards; six had access to a dam, whereas 17 lizards did not. Lizards with access to the dam had larger home ranges, were substantially active on more days (days with >100 steps), and moved more steps per day compared to lizards that did not have access to the dam, both during the early and late period of our observation. Furthermore, while the two groups of lizards had similar body condition early in the season, they differed later in the season. Lizards with dam access retained, whereas lizards without access lost body condition. Local heterogeneity in access to an artificial water resource resulted in spatially dependent behavioural variation among sleepy lizard individuals. This suggests that sleepy lizards have flexible responses to changing climatic conditions, depending on the availability of water. Furthermore, while reducing activity appears a suitable short term strategy, if harsh conditions persist, then access to dams could be of substantial benefit and could support sustained lizard activity and movement and allow maintenance of body condition. Hence, artificial watering points, such as the dams constructed by pastoralists, may provide local higher quality refugia for sleepy lizards and other species during drought conditions.	[Leu, Stephan T.; Bull, C. Michael] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	Flinders University South Australia	Leu, ST (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	stephan.leu@flinders.edu.au		Leu, Stephan T./0000-0003-2547-5056; Bull, Michael/0000-0002-9350-5950	Australian Research Council	Australian Research Council(Australian Research Council)	This research was supported by a Discovery Grant to CMB from the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; [Australian Bureau of Meteorology CSIRO], 2007, CLIM CHANG AUSTR TEC; BENNETT AF, 1977, ECOLOGY, V58, P697, DOI 10.2307/1939022; Bonnet X, 2008, AUSTRAL ECOL, V33, P911, DOI 10.1111/j.1442-9993.2008.01917.x; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Bull CM, 1998, BEHAV ECOL SOCIOBIOL, V42, P357, DOI 10.1007/s002650050448; BULL CM, 1987, COPEIA, P749; Bull CM, 1999, AUST J ZOOL, V47, P125, DOI 10.1071/ZO99021; BULL CM, 1995, AUST J ECOL, V20, P393, DOI 10.1111/j.1442-9993.1995.tb00555.x; Christian K, 1999, AUST J ECOL, V24, P171, DOI 10.1046/j.1442-9993.1999.241960.x; Davis JR, 2010, J HERPETOL, V44, P83, DOI 10.1670/08-263.1; Dawson TJ, 2006, J COMP PHYSIOL B, V176, P45, DOI 10.1007/s00360-005-0030-2; DUBAS G, 1991, WILDLIFE RES, V18, P147, DOI 10.1071/WR9910147; Firth BT, 1998, PHYSIOL ZOOL, V71, P303, DOI 10.1086/515919; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gienger CM, 2014, COPEIA, P279, DOI 10.1643/CP-13-086; Godfrey SS, 2014, ANIM BEHAV, V97, P35, DOI 10.1016/j.anbehav.2014.08.019; Godfrey SS, 2013, ANIM BEHAV, V86, P763, DOI 10.1016/j.anbehav.2013.07.016; Gomez M, 2015, 2ND ACM INTERNATIONAL CONFERENCE ON MOBILE SOFTWARE ENGINEERING AND SYSTEMS MOBILESOFT 2015, P1, DOI 10.1109/MobileSoft.2015.8; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kenward R. E., 2008, RANGES 8 ANAL TRACKI; Kerr GD, 2006, J ZOOL, V269, P137, DOI 10.1111/j.1469-7998.2006.00091.x; Kerr GD, 2006, BEHAV ECOL, V17, P380, DOI 10.1093/beheco/arj041; Kerr GD, 2004, J HERPETOL, V38, P519, DOI 10.1670/13-04A; Kerr GD, 2004, J ZOOL, V264, P179, DOI 10.1017/S0952836904005734; Kerr GD, 2004, WILDLIFE RES, V31, P171, DOI 10.1071/WR03048; Kerr GD, 2003, AUSTRAL ECOL, V28, P152, DOI 10.1046/j.1442-9993.2003.01268.x; Kerr GD, 2008, J ZOOL; Kerr Gregory D., 2002, Herpetological Review, V33, P24; Letnic M, 2015, BIODIVERS CONSERV, V24, P1, DOI 10.1007/s10531-014-0770-y; Letnic M, 2014, J APPL ECOL, V51, P795, DOI 10.1111/1365-2664.12232; Leu ST, 2016, ANIM BEHAV, V111, P23, DOI 10.1016/j.anbehav.2015.10.001; Leu ST, 2015, ETHOLOGY, V121, P760, DOI 10.1111/eth.12390; Leu ST, 2011, BEHAV ECOL SOCIOBIOL, V65, P837, DOI 10.1007/s00265-010-1087-9; Leu ST, 2010, BEHAV ECOL SOCIOBIOL, V64, P1495, DOI 10.1007/s00265-010-0964-6; Leu ST, 2010, ANIM BEHAV, V79, P217, DOI 10.1016/j.anbehav.2009.11.002; Lillywhite HB, 2012, INTEGR COMP BIOL, V52, P227, DOI 10.1093/icb/ics039; Lorenzon P, 1999, OECOLOGIA, V118, P423, DOI 10.1007/s004420050744; Murray Kris, 2004, Acta Ethologica, V7, P19; Prowse Thomas A. A., 2011, Pacific Conservation Biology, V17, P168; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Wright CD, 2013, J EXP BIOL, V216, P1439, DOI 10.1242/jeb.080895	47	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147433	10.1371/journal.pone.0147433	http://dx.doi.org/10.1371/journal.pone.0147433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800274	Green Published, gold			2022-12-26	WOS:000368655300107
J	Hoeller, AA; Costa, APR; Bicca, MA; Matheus, FC; Lach, G; Spiga, F; Lightman, SL; Walz, R; Collingridge, GL; Bortolotto, ZA; de Lima, TCM				Hoeller, Alexandre A.; Costa, Ana Paula R.; Bicca, Maira A.; Matheus, Filipe C.; Lach, Gilliard; Spiga, Francesca; Lightman, Stafford L.; Walz, Roger; Collingridge, Graham L.; Bortolotto, Zuner A.; de Lima, Thereza C. M.			The Role of Hippocampal NMDA Receptors in Long-Term Emotional Responses following Muscarinic Receptor Activation	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; PITUITARY-ADRENAL AXIS; NUCLEUS-ACCUMBENS; PILOCARPINE MODEL; DEPENDENT MODULATION; DOPAMINE RELEASE; PROLONGED STRESS; SINGLE EXPOSURE; CEREBRAL-CORTEX; WORKING-MEMORY	Extensive evidence indicates the influence of the cholinergic system on emotional processing. Previous findings provided new insights into the underlying mechanisms of long-term anxiety, showing that rats injected with a single systemic dose of pilocarpine-a muscarinic receptor (mAChR) agonist-displayed persistent anxiogenic-like responses when evaluated in different behavioral tests and time-points (24 h up to 3 months later). Herein, we investigated whether the pilocarpine-induced long-term anxiogenesis modulates the HPA axis function and the putative involvement of NMDA receptors (NMDARs) following mAChRs activation. Accordingly, adult male Wistar rats presented anxiogenic-like behavior in the elevated plus-maze (EPM) after 24 h or 1 month of pilocarpine injection (150 mg/kg, i.p.). In these animals, mAChR activation disrupted HPA axis function inducing a long-term increase of corticosterone release associated with a reduced expression of hippocampal GRs, as well as consistently decreased NMDAR subunits expression. Furthermore, in another group of rats injected with memantine-an NMDARs antagonist (4 mg/kg, i.p.)-prior to pilocarpine, we found inhibition of anxiogenic-like behaviors in the EPM but no further alterations in the pilocarpine-induced NMDARs downregulation. Our data provide evidence that behavioral anxiogenesis induced by mAChR activation effectively yields short-and long-term alterations in hippocampal NMDARs expression associated with impairment of hippocampal inhibitory regulation of HPA axis activity. This is a novel mechanism associated with anxiety-like responses in rats, which comprise a putative target to future translational studies.	[Hoeller, Alexandre A.; Walz, Roger] Univ Fed Santa Catarina, Univ Hosp, Ctr Hlth Sci, Postgrad Program Med Sci, BR-88040970 Florianopolis, SC, Brazil; [Hoeller, Alexandre A.; Costa, Ana Paula R.; Bicca, Maira A.; Matheus, Filipe C.; Lach, Gilliard; de Lima, Thereza C. M.] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Pharmacol, BR-88040970 Florianopolis, SC, Brazil; [Lach, Gilliard] Univ Innsbruck, Inst Pharmacol, A-6020 Innsbruck, Austria; [Spiga, Francesca; Lightman, Stafford L.] Univ Bristol, Sch Clin Sci, Henry Wellcome Labs Integrat Neurosci & Endocrino, Dorothy Hodgkin Bldg, Bristol BS1 3NY, Avon, England; [Walz, Roger] Univ Fed Santa Catarina, Univ Hosp, Ctr Hlth Sci, Dept Clin Med, BR-88040970 Florianopolis, SC, Brazil; [Hoeller, Alexandre A.; Collingridge, Graham L.; Bortolotto, Zuner A.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Ctr Synapt Plast, Dorothy Hodgkin Bldg, Bristol BS1 3NY, Avon, England	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); University of Innsbruck; University of Bristol; Universidade Federal de Santa Catarina (UFSC); University of Bristol	Hoeller, AA (corresponding author), Univ Fed Santa Catarina, Univ Hosp, Ctr Hlth Sci, Postgrad Program Med Sci, BR-88040970 Florianopolis, SC, Brazil.; Hoeller, AA; de Lima, TCM (corresponding author), Univ Fed Santa Catarina, Ctr Biol Sci, Dept Pharmacol, BR-88040970 Florianopolis, SC, Brazil.; Hoeller, AA (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Ctr Synapt Plast, Dorothy Hodgkin Bldg, Bristol BS1 3NY, Avon, England.	alexandrehoeller@gmail.com; thereza.lima@ufsc.br	collingridge, graham/AAI-8362-2020; Lach, Gilliard/P-7136-2019; Hoeller, Alexandre Ademar/F-2823-2013; Matheus, Filipe Carvalho/AAB-9747-2020; de Lima, Thereza Christina Monteiro/AAH-9402-2019; Lima, Thereza CM/C-6812-2015; Bicca, Maíra Assunção/AAG-7560-2020; Collingridge, Graham L/C-4605-2015; Lach, Gilliard/O-9824-2014; Walz, Roger/K-9096-2013	Hoeller, Alexandre Ademar/0000-0001-7526-1502; Lima, Thereza CM/0000-0002-3253-7350; Bicca, Maíra Assunção/0000-0002-3648-8824; Collingridge, Graham L/0000-0002-9572-5359; Lach, Gilliard/0000-0003-3750-7764; Lightman, Stafford/0000-0002-8546-9646; Ramos Costa, Ana Paula/0000-0002-4632-038X; Spiga, Francesca/0000-0002-6904-2247; Walz, Roger/0000-0002-9875-6687	Conselho Nacional de Desenvolvimento Cientfico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PNPD); Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional (INNT); Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC); BBSRC [BB/H015779/01]; MRC [90601813, MR/K023098/1]; CNPq; CAPES/PNPD; National Institute of Translational Neuroscience (INNT); NENASC project (PRONEX Program CNPq/FAPESC); BBSRC [BB/H015779/1] Funding Source: UKRI; MRC [MR/J008893/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H015779/1] Funding Source: researchfish; Medical Research Council [MR/J008893/1, MR/K023098/1] Funding Source: researchfish	Conselho Nacional de Desenvolvimento Cientfico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional (INNT); Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institute of Translational Neuroscience (INNT); NENASC project (PRONEX Program CNPq/FAPESC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientfico (CNPq, www.cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PNPD, www.capes.gov.br), Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional (INNT, inct.cnpq.br), and Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC), Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC) which provided research grants to AAH, APRC, GL, MAB, RW and TCML; by the BBSRC (BB/H015779/01) to FS and SLL; and by the MRC (90601813, MR/K023098/1) to GLC and ZAB. The authors have no financial or personal conflicts of interest related to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by CNPq, CAPES/PNPD, National Institute of Translational Neuroscience (INNT) and NENASC project (PRONEX Program CNPq/FAPESC) which provided research grants to AA Hoeller, APR Costa, MA Bicca, FC Matheus, G Lach, R Walz and TCM de Lima; by the BBSRC (BB/H015779/01) to F Spiga and SL Lightman; by the MRC (90601813, MR/K023098/1) to GL Collingridge and ZA Bortolotto. We would like to acknowledge Zidong Zhao and Dr. Joao Batista Calixto for their technical support.	Acquas E, 1996, J NEUROSCI, V16, P3089; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Armario Antonio, 2006, CNS & Neurological Disorders-Drug Targets, V5, P485, DOI 10.2174/187152706778559336; Aslan N, 1997, EUR J PHARMACOL, V333, P63, DOI 10.1016/S0014-2999(97)01106-0; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Belda X, 2004, BEHAV BRAIN RES, V154, P399, DOI 10.1016/j.bbr.2004.03.011; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Bertoglio LJ, 2003, PSYCHOPHARMACOLOGY, V170, P335, DOI 10.1007/s00213-003-1558-z; Bhatnagar S, 1997, BRAIN RES, V766, P244, DOI 10.1016/S0006-8993(97)00684-7; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; BUBSER M, 1992, EUR J PHARMACOL, V229, P75, DOI 10.1016/0014-2999(92)90288-F; Butcher AJ, 2009, J BIOL CHEM, V284, P17147, DOI 10.1074/jbc.M901031200; Calabrese F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037916; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909; COLE JC, 1994, PSYCHOPHARMACOLOGY, V114, P288, DOI 10.1007/BF02244851; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; Degroot A, 2005, NEUROPSYCHOPHARMACOL, V30, P391, DOI 10.1038/sj.npp.1300624; Demontis F, 2015, EUR J PHARMACOL, V752, P49, DOI 10.1016/j.ejphar.2015.01.041; Di Maio R, 2011, NEUROBIOL DIS, V42, P482, DOI 10.1016/j.nbd.2011.02.012; Duarte FS, 2013, PSYCHOPHARMACOLOGY, V227, P209, DOI 10.1007/s00213-012-2951-2; Duarte FS, 2010, PSYCHOPHARMACOLOGY, V212, P653, DOI 10.1007/s00213-010-1985-6; DUNN JD, 1984, EXP BRAIN RES, V54, P1; Dutra RC, 2012, BIOCHEM PHARMACOL, V83, P531, DOI 10.1016/j.bcp.2011.11.026; Ghasemi M, 2014, NEUROSCI BIOBEHAV R, V47, P336, DOI 10.1016/j.neubiorev.2014.08.017; Graef S, 2011, PSYCHOPHARMACOLOGY, V215, P205, DOI 10.1007/s00213-010-2153-8; Grishin AA, 2004, J NEUROSCI, V24, P350, DOI 10.1523/JNEUROSCI.4933-03.2004; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Higley MJ, 2014, CURR OPIN NEUROBIOL, V29, P88, DOI 10.1016/j.conb.2014.06.004; Hoeller AA, 2013, BRAIN RES, V1532, P21, DOI 10.1016/j.brainres.2013.07.045; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; IMPERATO A, 1990, EUR J PHARMACOL, V187, P555, DOI 10.1016/0014-2999(90)90387-L; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; JASPER MS, 1994, NEUROENDOCRINOLOGY, V59, P97, DOI 10.1159/000126645; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; LEDOUX JE, 1994, SCI AM, V270, P50, DOI 10.1038/scientificamerican0694-50; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lopes MW, 2013, EXP BRAIN RES, V226, P153, DOI 10.1007/s00221-013-3421-8; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Marti O, 2001, EUR J NEUROSCI, V13, P129, DOI 10.1046/j.1460-9568.2001.01355.x; Martinez G, 2002, PHYSIOL BEHAV, V76, P219, DOI 10.1016/S0031-9384(02)00704-7; Mesulam MM, 1995, PSYCHOPHARMACOLOGY T; Micheau J, 2011, BEHAV BRAIN RES, V221, P424, DOI 10.1016/j.bbr.2010.11.052; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; OBrien JT, 1997, BRIT J PSYCHIAT, V170, P199, DOI 10.1192/S0007125000146513; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Park HJ, 2015, ARCH PHARM RES, V38, P1204, DOI 10.1007/s12272-015-0548-0; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Figueredo LZP, 2008, BRAIN RES BULL, V77, P71, DOI 10.1016/j.brainresbull.2008.05.008; Power JM, 2008, J NEUROSCI, V28, P3209, DOI 10.1523/JNEUROSCI.4310-07.2008; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Rogawski MA, 2003, CNS DRUG REV, V9, P275, DOI 10.1111/j.1527-3458.2003.tb00254.x; RUBIN RT, 1966, SCIENCE, V153, P767, DOI 10.1126/science.153.3737.767; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Scarr E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00055; Spiga F, 2011, ENDOCRINOLOGY, V152, P1448, DOI 10.1210/en.2010-1209; Steimer Thierry, 2002, Dialogues Clin Neurosci, V4, P231; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Varatharajan R, 2015, NEUROCHEM INT, V90, P255, DOI 10.1016/j.neuint.2015.10.002; Volianskis A, 2015, BRAIN RES, V1621, P5, DOI 10.1016/j.brainres.2015.01.016; Volpicelli LA, 2004, PROG BRAIN RES, V145, P59, DOI 10.1016/S0079-6123(03)45003-6; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wall PM, 2001, PSYCHOPHARMACOLOGY, V155, P58, DOI 10.1007/s002130000671; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yoshida M, 1998, BRAIN RES, V786, P226, DOI 10.1016/S0006-8993(97)00694-X; Zhang LM, 2015, PSYCHOPHARMACOLOGY, V232, P663, DOI 10.1007/s00213-014-3697-9; Zhang LM, 2002, J NEUROPHYSIOL, V88, P3315, DOI 10.1152/jn.01025.2001; Zhe D, 2008, ACTA HISTOCHEM CYTOC, V41, P89, DOI 10.1267/ahc.08013	79	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147293	10.1371/journal.pone.0147293	http://dx.doi.org/10.1371/journal.pone.0147293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795565	Green Published, Green Submitted, gold			2022-12-26	WOS:000368530300027
J	Hua, L; Song, Y; Kim, N; Laing, C; Wang, JTL; Schlick, T				Hua, Lei; Song, Yang; Kim, Namhee; Laing, Christian; Wang, Jason T. L.; Schlick, Tamar			CHSalign: A Web Server That Builds upon Junction-Explorer and RNAJAG for Pairwise Alignment of RNA Secondary Structures with Coaxial Helical Stacking	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; 3D MOTIFS; TERTIARY STRUCTURES; 3-WAY JUNCTIONS; EDIT DISTANCE; FOLDED RNAS; TREE EDIT; CLASSIFICATION; SEQUENCES; IDENTIFICATION	RNA junctions are important structural elements of RNA molecules. They are formed when three or more helices come together in three-dimensional space. Recent studies have focused on the annotation and prediction of coaxial helical stacking (CHS) motifs within junctions. Here we exploit such predictions to develop an efficient alignment tool to handle RNA secondary structures with CHS motifs. Specifically, we build upon our Junction-Explorer software for predicting coaxial stacking and RNAJAG for modelling junction topologies as tree graphs to incorporate constrained tree matching and dynamic programming algorithms into a new method, called CHSalign, for aligning the secondary structures of RNA molecules containing CHS motifs. Thus, CHSalign is intended to be an efficient alignment tool for RNAs containing similar junctions. Experimental results based on thousands of alignments demonstrate that CHSalign can align two RNA secondary structures containing CHS motifs more accurately than other RNA secondary structure alignment tools. CHSalign yields a high score when aligning two RNA secondary structures with similar CHS motifs or helical arrangement patterns, and a low score otherwise. This new method has been implemented in a web server, and the program is also made freely available, at http://bioinformatics.njit.edu/CHSalign/.	[Hua, Lei; Song, Yang; Laing, Christian; Wang, Jason T. L.] New Jersey Inst Technol, Dept Comp Sci, Bioinformat Lab, Newark, NJ 07102 USA; [Kim, Namhee; Schlick, Tamar] NYU, Dept Chem, New York, NY USA; [Schlick, Tamar] NYU, Courant Inst Math Sci, New York, NY USA	New Jersey Institute of Technology; New York University; New York University	Wang, JTL (corresponding author), New Jersey Inst Technol, Dept Comp Sci, Bioinformat Lab, Newark, NJ 07102 USA.; Schlick, T (corresponding author), NYU, Dept Chem, New York, NY USA.; Schlick, T (corresponding author), NYU, Courant Inst Math Sci, New York, NY USA.	wangj@njit.edu; schlick@nyu.edu		Schlick, Tamar/0000-0002-2392-2062	National Science Foundation [IIS-0707571]; National Institute of General Medical Sciences [GM100469, GM081410]; Empire State Development's Division of Science, Technology and Innovation [through National Science Foundation (NSF) Group] [TG-MCB080036N]; Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100469, R01GM081410] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Empire State Development's Division of Science, Technology and Innovation [through National Science Foundation (NSF) Group]; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation [grant IIS-0707571 to J.W.], and National Institute of General Medical Sciences [grants GM100469 and GM081410 to T.S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Drs. Bruce Shapiro and Kaizhong Zhang for helpful conversations. We also thank Dongrong Wen and Akhila Nagula for their contributions in the early stage of this work. J.W. acknowledges support of this work by the National Science Foundation Grant IIS-0707571. T.S. acknowledges support of this work by the National Institute of General Medical Sciences Grants GM100469 and GM081410. Computing resources, utilized by the NYU team, of the Computational Center for Nanotechnology Innovations and Empire State Development's Division of Science, Technology and Innovation [through National Science Foundation (NSF) Group Award TG-MCB080036N] and the New York Center for Computational Sciences at Stony Brook University/Brookhaven National Laboratory (supported by Department of Energy Grant DE-AC02-98CH10886 and the State of New York) are gratefully acknowledged.	Aalberts DP, 2010, RNA, V16, P1350, DOI 10.1261/rna.1831710; Abraham M, 2008, RNA, V14, P2274, DOI 10.1261/rna.853208; Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bindewald E, 2008, NUCLEIC ACIDS RES, V36, pD392, DOI 10.1093/nar/gkm842; Bindewald E, 2011, RNA, V17, P1688, DOI 10.1261/rna.2640111; BRIMACOMBE R, 1985, BIOCHEM J, V229, P1; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Butcher SE, 2011, ACCOUNTS CHEM RES, V44, P1302, DOI 10.1021/ar200098t; Byron Kevin, 2013, Recent Pat DNA Gene Seq, V7, P115; Capriotti E, 2009, NUCLEIC ACIDS RES, V37, pW260, DOI 10.1093/nar/gkp433; Chang YF, 2008, NUCLEIC ACIDS RES, V36, pW19, DOI 10.1093/nar/gkn327; Chen SH, 2014, J COMB OPTIM, V27, P778, DOI 10.1007/s10878-012-9552-1; Cohen Adaya, 2008, In Silico Biology, V8, P105; Dror O, 2005, BIOINFORMATICS, V21, P47, DOI 10.1093/bioinformatics/bti1108; Ferre F, 2007, NUCLEIC ACIDS RES, V35, pW659, DOI 10.1093/nar/gkm334; Gardner PP, 2005, NUCLEIC ACIDS RES, V33, P2433, DOI 10.1093/nar/gki541; Goody TA, 2004, J AM CHEM SOC, V126, P4126, DOI 10.1021/ja0319240; Hamada M, 2009, BIOINFORMATICS, V25, P3236, DOI 10.1093/bioinformatics/btp580; Havgaard JH, 2007, PLOS COMPUT BIOL, V3, P1896, DOI 10.1371/journal.pcbi.0030193; He GW, 2014, NUCLEIC ACIDS RES, V42, pW377, DOI 10.1093/nar/gku429; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hochsmann M, 2004, IEEE ACM T COMPUT BI, V1, P53, DOI 10.1109/TCBB.2004.11; Hoksza D, 2012, BIOINFORMATICS, V28, P1858, DOI 10.1093/bioinformatics/bts301; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; JIANG T, 1995, THEOR COMPUT SCI, V143, P137, DOI 10.1016/0304-3975(95)80015-8; Jiang T, 2002, J COMPUT BIOL, V9, P371, DOI 10.1089/10665270252935511; Kieft JS, 2002, NAT STRUCT BIOL, V9, P370, DOI 10.1038/nsb781; Kim J, 1996, BIOCHEMISTRY-US, V35, P13753, DOI 10.1021/bi960913z; Kim N, 2015, METHOD ENZYMOL, V553, P115, DOI 10.1016/bs.mie.2014.10.054; Kim N, 2014, P NATL ACAD SCI USA, V111, P4079, DOI 10.1073/pnas.1318893111; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; Klein RJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-44; Lafontaine DA, 2001, EMBO J, V20, P1415, DOI 10.1093/emboj/20.6.1415; Laing C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071947; Laing C, 2012, NUCLEIC ACIDS RES, V40, P487, DOI 10.1093/nar/gkr629; Laing C, 2009, J MOL BIOL, V393, P67, DOI 10.1016/j.jmb.2009.07.089; Laing C, 2009, J MOL BIOL, V390, P547, DOI 10.1016/j.jmb.2009.04.084; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; LILLEY DMJ, 1995, NUCLEIC ACIDS RES, V23, P3363, DOI 10.1093/nar/23.17.3363; Liu JH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-89; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048460; Mathews DH, 2002, J MOL BIOL, V317, P191, DOI 10.1006/jmbi.2001.5351; McGinnis JL, 2012, J AM CHEM SOC, V134, P6617, DOI 10.1021/ja2104075; Meyer IM, 2007, PLOS COMPUT BIOL, V3, P1441, DOI 10.1371/journal.pcbi.0030149; Ouellet J, 2010, RNA, V16, P1597, DOI 10.1261/rna.2158410; Petrov AI, 2013, RNA, V19, P1327, DOI 10.1261/rna.039438.113; Petrov AI, 2011, NUCLEIC ACIDS RES, V39, pW50, DOI 10.1093/nar/gkr249; Popovic M, 2012, RNA, V18, P2093, DOI 10.1261/rna.035782.112; Rahrig RR, 2010, BIOINFORMATICS, V26, P2689, DOI 10.1093/bioinformatics/btq506; Sarver M, 2008, J MATH BIOL, V56, P215, DOI 10.1007/s00285-007-0110-x; Sato K, 2012, BIOINFORMATICS, V28, P3218, DOI 10.1093/bioinformatics/bts612; Scott WG, 1996, SCIENCE, V274, P2065, DOI 10.1126/science.274.5295.2065; Shang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039383; SHAPIRO BA, 1990, COMPUT APPL BIOSCI, V6, P309; Smit S, 2008, RNA, V14, P410, DOI 10.1261/rna.881308; Tabei Y, 2006, BIOINFORMATICS, V22, P1723, DOI 10.1093/bioinformatics/btl177; Walter F, 1998, RNA, V4, P719, DOI 10.1017/S135583829898030X; Wang CW, 2010, NUCLEIC ACIDS RES, V38, pW340, DOI 10.1093/nar/gkq483; Wang LS, 2003, BIOINFORMATICS, V19, P2237, DOI 10.1093/bioinformatics/btg305; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Xin YR, 2008, RNA, V14, P2465, DOI 10.1261/rna.1249208; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; Yang SC, 2010, J PHYS CHEM B, V114, P10039, DOI 10.1021/jp1057308; Yuan FQ, 2007, NUCLEIC ACIDS RES, V35, P2833, DOI 10.1093/nar/gkm134; Zhong XH, 2007, EMBO J, V26, P3836, DOI 10.1038/sj.emboj.7601812; Zirbel CL, 2015, NUCLEIC ACIDS RES, V43, P7504, DOI 10.1093/nar/gkv651; Zirbel CL, 2009, NUCLEIC ACIDS RES, V37, P4898, DOI 10.1093/nar/gkp468	69	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147097	10.1371/journal.pone.0147097	http://dx.doi.org/10.1371/journal.pone.0147097			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789998	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100057
J	Unnerstale, S; Nowakowski, M; Baraznenok, V; Stenberg, G; Lindberg, J; Mayzel, M; Orekhov, V; Agback, T				Unnerstale, Sofia; Nowakowski, Michal; Baraznenok, Vera; Stenberg, Gun; Lindberg, Jimmy; Mayzel, Maxim; Orekhov, Vladislav; Agback, Tatiana			Backbone Assignment of the MALT1 Paracaspase by Solution NMR	PLOS ONE			English	Article							TRIPLE-RESONANCE EXPERIMENTS; B-CELL LYMPHOMA; PROTEASE ACTIVITY; LARGE PROTEINS; TROSY; SPECTROSCOPY; RELAXATION; ACTIVATION; KEY	Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) is a unique paracaspase protein whose protease activity mediates oncogenic NF-kappa B signalling in activated B cell-like diffuse large B cell lymphomas (ABC-DLBCLs). ABC-DLBCLs are aggressive lymphomas with high resistance to current chemotherapies. Low survival rate among patients emphasizes the urgent need for alternative treatment options. The characterization of the MALT1 will be an essential tool for developing new target-directed drugs against MALT1 dependent disorders. As the first step in the atomic-level NMR studies of the system, here we report, the N-15/C-13/H-1 backbone assignment of the apo form of the MALT1 paracaspase region together with the third immunoglobulin-like (Ig3) domain, 44 kDa, by high resolution NMR. In addition, the non-uniform sampling (NUS) based targeted acquisition procedure is evaluated as a mean of decreasing acquisition and analysis time for larger proteins.	[Unnerstale, Sofia; Baraznenok, Vera; Stenberg, Gun; Lindberg, Jimmy; Agback, Tatiana] Medivir AB, POB 1086, SE-14122 Huddinge, Sweden; [Nowakowski, Michal; Mayzel, Maxim; Orekhov, Vladislav] Univ Gothenburg, Swedish NMR Ctr, POB 465, SE-40530 Gothenburg, Sweden; [Nowakowski, Michal] Univ Warsaw, Ctr New Technol, PL-02097 Warsaw, Poland	Medivir; University of Gothenburg; University of Warsaw	Agback, T (corresponding author), Medivir AB, POB 1086, SE-14122 Huddinge, Sweden.	Tatiana.Agback@medivir.com	Orekhov, Vladislav/AAD-8464-2019; Mayzel, Maksim/AAM-1393-2020; Nowakowski, Michał/G-8973-2012; Orekhov, Vladislav/AAC-8357-2022; Nowakowski, Michal/P-7632-2019	Orekhov, Vladislav/0000-0002-7892-6896; Nowakowski, Michał/0000-0002-1356-0301; Nowakowski, Michal/0000-0002-1356-0301; Agback, Tatiana/0000-0003-1325-6024	National Centre of Science [DEC-2012/07/E/ST4/01386]; Medivir AB	National Centre of Science; Medivir AB	M.N would like to thank the National Centre of Science for support with Sonata Bis 2 Grant No. DEC-2012/07/E/ST4/01386. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medivir AB provided support in the form of salaries for authors SU, VB, GS, JL and TA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Dunleavy K, 2014, ONCOLOGY-NY, V28, P326; Eitelhuber AC, 2015, CHEM BIOL, V22, P129, DOI 10.1016/j.chembiol.2014.10.021; Eletsky A, 2001, J BIOMOL NMR, V20, P177, DOI 10.1023/A:1011265430149; Goddard T, 2004, SPARKY 3, V14, P15; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Isaksson L, 2013, HIGHLY EFFICIENT NMR, DOI [10.1371/journal.pone.0062947, DOI 10.1371/JOURNAL.PONE.0062947]; Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o; Jaravine VA, 2006, J AM CHEM SOC, V128, P13421, DOI 10.1021/ja062146p; Jong WY, 2011, P NATL ACAD SCI USA, V108, P21004; Lenz G, 2015, CANCERS, V7, P811, DOI 10.3390/cancers7020812; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Niklasson M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004022; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Pelzer C, 2013, NAT IMMUNOL, V14, P337, DOI 10.1038/ni.2540; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schlauderer F, 2013, ANGEW CHEM INT EDIT, V52, P10384, DOI 10.1002/anie.201304290; Schulte-Herbruggen T, 2000, J MAGN RESON, V144, P123, DOI 10.1006/jmre.2000.2020; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wiesmann C, 2012, J MOL BIOL, V419, P4, DOI 10.1016/j.jmb.2012.02.018; Wishart DS, 2011, PROG NUCL MAG RES SP, V58, P62, DOI 10.1016/j.pnmrs.2010.07.004	27	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146496	10.1371/journal.pone.0146496	http://dx.doi.org/10.1371/journal.pone.0146496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788853	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100033
J	Merilahti, P; Karelehto, E; Susi, P				Merilahti, Pirjo; Karelehto, Eveliina; Susi, Petri			Role of Heparan Sulfate in Cellular Infection of Integrin-Binding Coxsackievirus A9 and Human Parechovirus 1 Isolates	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SEQUENCE ALIGNMENT; ALPHA(V)BETA(3); ATTACHMENT; PROTEIN; CELLS; EFFICIENT; RECEPTOR; CULTURE; ENTRY	Heparan sulfate/heparin class of proteoglycans (HSPG) have been shown to function in cellular attachment and infection of numerous viruses including picornaviruses. Coxsackievirus A9 (CV-A9) and human parechovirus 1 (HPeV-1) are integrin-binding members in the family Picornaviridae. CV-A9 Griggs and HPeV-1 Harris (prototype) strains have been reported not to bind to heparin, but it was recently shown that some CV-A9 isolates interact with heparin in vitro via VP1 protein with a specific T132R/K mutation. We found that the infectivity of both CV-A9 Griggs and HPeV-1 Harris was reduced by sodium chlorate and heparinase suggestive of HSPG interactions. We analyzed the T132 site in fifty-four (54) CV-A9 clinical isolates and found that only one of them possessed T132/R mutation while the other nine (9) had T132K. We then treated CV-A9 Griggs and HPeV-1 Harris and eight CV-A9 and six HPeV-1 clinical isolates with heparin and protamine. Although infectivity of Griggs strain was slightly reduced (by 25%), heparin treatment did not affect the infectivity of the CV-A9 isolates that do not possess the T132R/K mutation, which is in line with the previous findings. Some of the HPeV-1 isolates were also affected by heparin treatment, which suggested that there may be a specific heparin binding site in HPeV-1. In contrast, protamine (a specific inhibitor of heparin) completely inhibited the infection of both prototypes and clinical CV-A9 and HPeV-1 isolates. We conclude that T132R/K mutation has a role in heparin binding of CV-A9, but we also show data, which suggest that there are other HSPG binding sites in CV-A9. In all, we suggest that HSPGs play a general role in both CV-A9 and HPeV-1 infections.	[Merilahti, Pirjo; Karelehto, Eveliina; Susi, Petri] Univ Turku, Dept Virol, Turku, Finland; [Karelehto, Eveliina] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Susi, Petri] Turku Univ Appl Sci, Biomat & Diagnost Grp, Turku, Finland	University of Turku; University of Amsterdam; Academic Medical Center Amsterdam; University of Turku	Susi, P (corresponding author), Univ Turku, Dept Virol, Turku, Finland.; Susi, P (corresponding author), Turku Univ Appl Sci, Biomat & Diagnost Grp, Turku, Finland.	pesusi@utu.fi	Susi, Petri/AAL-8194-2020	Susi, Petri/0000-0002-9245-3271	Academy of Finland [128539, 263255]; European Union [612308]; Turku Graduate School of Biomedical Sciences; Turku Doctoral Programme of Molecular Medicine; Finnish Culture Foundation; Jane and Aatos Erkko Foundation; Turku University of Applied Sciences [601129]	Academy of Finland(Academy of Finland); European Union(European Commission); Turku Graduate School of Biomedical Sciences; Turku Doctoral Programme of Molecular Medicine; Finnish Culture Foundation(Finnish Cultural Foundation); Jane and Aatos Erkko Foundation; Turku University of Applied Sciences	This work was supported by Academy of Finland (128539, 263255 to P.S.), European Union (AIROPico, FP7-PEOPLE-2013-IAPP Grant no. 612308), Turku Graduate School of Biomedical Sciences, Turku Doctoral Programme of Molecular Medicine, Finnish Culture Foundation, Jane and Aatos Erkko Foundation and Turku University of Applied Sciences (601129 to P.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Katja Wolthers (Academic Medical Center, Amsterdam, the Netherlands) and Dr. Sisko Tauriainen (Department of Virology, University of Turku, Finland) for parechovirus strains. Dr. Juha Himanen (Sloan-Kettering Institute for Cancer Research, New York, USA) is thanked for modelling and fruitful discussions. Dr. Robert M. Badeau (Turku University Language Centre) is gratefully acknowledged for the English proofreading and linguistic editing of this manuscript. We thank Ms. Ritva Kajander for technical assistance. This work was supported by Academy of Finland (128539, 263255 to P.S.), European Union (AIROPico, FP7-PEOPLE-2013-IAPP Grant no. 612308), Turku Graduate School of Biomedical Sciences, Turku Doctoral Programme of Molecular Medicine, Finnish Culture Foundation, Jane and Aatos Erkko Foundation and Turku University of Applied Sciences (601129 to P.S.).	ABRAHAM G, 1984, J VIROL, V51, P340, DOI 10.1128/JVI.51.2.340-345.1984; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Boonyakiat Y, 2001, J VIROL, V75, P10000, DOI 10.1128/JVI.75.20.10000-10004.2001; Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998; CHANG KH, 1989, J GEN VIROL, V70, P3269, DOI 10.1099/0022-1317-70-12-3269; Ehrenfeld E, 2010, PICORNAVIRUSES; Escribano-Romero E, 2004, J GEN VIROL, V85, P653, DOI 10.1099/vir.0.19603-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Goodfellow IG, 2001, J VIROL, V75, P4918, DOI 10.1128/JVI.75.10.4918-4921.2001; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Heikkila O, 2010, J VIROL, V84, P3666, DOI 10.1128/JVI.01340-09; Jackson T, 1996, J VIROL, V70, P5282, DOI 10.1128/JVI.70.8.5282-5287.1996; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Joki-Korpela P, 2001, ANN MED, V33, P466, DOI 10.3109/07853890109002095; Joki-Korpela P, 1998, CLIN INFECT DIS, V27, P129, DOI 10.1086/514615; Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Khan AG, 2007, J VIROL, V81, P4625, DOI 10.1128/JVI.02160-06; Knowles NJ, 2012, PICORNAVIRIDAE, P855; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; McLeish NJ, 2012, J VIROL, V86, P11163, DOI 10.1128/JVI.00640-12; Merilahti P, 2012, ADV VIROL, V2012, DOI 10.1155/2012/547530; Nicholas K.B., 1997, EMBNET NEWS, V4, P4; Pulli T, 1998, VIROLOGY, V240, P202, DOI 10.1006/viro.1997.8908; Reddi HV, 2002, J VIROL, V76, P8400, DOI 10.1128/JVI.76.16.8400-8407.2002; ROIVAINEN M, 1991, J VIROL, V65, P4735, DOI 10.1128/JVI.65.9.4735-4740.1991; SaCarvalho D, 1997, J VIROL, V71, P5115, DOI 10.1128/JVI.71.7.5115-5123.1997; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Seitsonen J, 2010, J VIROL, V84, P8509, DOI 10.1128/JVI.02176-09; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiwari V, 2011, J BIOL CHEM, V286, P25406, DOI 10.1074/jbc.M110.201103; Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000; Triantafilou M, 1999, J GEN VIROL, V80, P2591, DOI 10.1099/0022-1317-80-10-2591; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Williams CH, 2004, J VIROL, V78, P6967, DOI 10.1128/JVI.78.13.6967-6973.2004; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989	38	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147168	10.1371/journal.pone.0147168	http://dx.doi.org/10.1371/journal.pone.0147168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785353	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400118
J	Mullerova, J; Pejcha, V; Altman, J; Plener, T; Dorner, P; Dolezal, J				Muellerova, Jana; Pejcha, Vit; Altman, Jan; Plener, Tomas; Doerner, Petr; Dolezal, Jiri			Detecting Coppice Legacies from Tree Growth	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; FOREST DISTURBANCE; RADIAL-GROWTH; RING SERIES; EUROPE; DENDROCHRONOLOGY; RECONSTRUCTION; MANAGEMENT; RESPONSES; CRITERIA	In coppice-with-standards, once a common type of management in Central European lowland forests, selected trees (standards) were left to grow mature among the regularly harvested coppice stools to obtain construction wood. After the underwood was harvested, the forest canopy opened rapidly, giving standard trees an opportunity to benefit from reduced competition. Although this silvicultural system virtually disappeared after WWII, historical management cycles can still be traced in the tree-rings of remaining standards. Our research aims at answering the question whether tree-ring series of standard trees can be used to reconstruct past management practices. The study was carried out on 117 oak standard trees from five sites situated in formerly coppiced calcareous oak-hornbeam and acidophilous oak forests in the Bohemian Karst Protected Landscape Area, Czech Republic. The evaluation was based on the analysis of growth releases representing the response of the standards to coppicing events, and comparison to the archival records of coppice events. Our results showed that coppicing events can be successfully detected by tree-ring analysis, although there are some limitations. Altogether 241 releases were identified (49% of major releases). Large number of releases could be related to historical records, with the major ones giving better results. The overall probability of correct detection (positive predictive power) was 58%, ranging from 50 to 67%, probability for major releases was 78%, ranging from 63 to 100% for different sites. The ability of individual trees to mirror past coppice events was significantly affected by competition from neighboring trees (their number and the sum of distance-weighted basal areas). A dendro-ecological approach to the study of forest management history can serve as an input for current attempts of coppice reintroduction and for conservation purposes.	[Muellerova, Jana; Pejcha, Vit; Altman, Jan; Plener, Tomas; Doerner, Petr; Dolezal, Jiri] Acad Sci Czech Republic, Inst Bot, Trebon, Czech Republic; [Muellerova, Jana] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Mullerova, J (corresponding author), Acad Sci Czech Republic, Inst Bot, Trebon, Czech Republic.	jana.mullerova@ibot.cas.cz	Altman, Jan/B-4305-2015; Mullerova, Jana/A-7915-2012	Mullerova, Jana/0000-0001-7331-3479	ERC [278065]; European Research Council; Czech Academy of Sciences [RVO 67985939]; Ministry of Education of the Czech Republic [CZ.1.07/2.3.00/20.0267]; Grant Agency of the Czech Republic [P504/12/1952, 14-12262S]	ERC(European Research Council (ERC)European Commission); European Research Council(European Research Council (ERC)European Commission); Czech Academy of Sciences(Czech Academy of Sciences); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The research leading to these results has received funding from: ERC Grant agreement no 278065, the European Research Council (http://erc.europa.eu; recipient-JM, PD); long-term research development project no. RVO 67985939, The Czech Academy of Sciences (http://www.cas.cz/; recipients-JA, JD, JM, VP, TP, PD); CZ.1.07/2.3.00/20.0267 of the Ministry of Education of the Czech Republic (http://www.msmt.cz/; recipients-JM, VP, TP, PD); P504/12/1952 and 14-12262S of the Grant Agency of the Czech Republic (https://gacr.cz/; recipients-JA, JD, VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Altman J, 2014, DENDROCHRONOLOGIA, V32, P107, DOI 10.1016/j.dendro.2014.01.004; Altman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055770; Altman J, 2013, GLOBAL CHANGE BIOL, V19, P498, DOI 10.1111/gcb.12067; Billamboz A, 2008, DENDROCHRONOLOGIA, V26, P145, DOI 10.1016/j.dendro.2008.07.001; Black BA, 2003, ECOL APPL, V13, P1733, DOI 10.1890/02-5122; Black Bryan A., 2004, Dendrochronologia, V22, P31, DOI 10.1016/j.dendro.2004.09.004; Black BA, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008087; Bleicher N, 2014, VEG HIST ARCHAEOBOT, V23, P615, DOI 10.1007/s00334-013-0410-6; BRIDGE MC, 1986, J ECOL, V74, P1095, DOI 10.2307/2260236; Bridge MC, 2000, BOT J LINN SOC, V134, P61, DOI [10.1006/bojl.2000.0364, 10.1111/j.1095-8339.2000.tb02345.x]; Buckley G.P., 1992, ECOLOGY MANAGEMENT C; Congalton R.G., 2008, ASSESSING ACCURACY R, V2nd, DOI [10.1201/9781420055139, DOI 10.1201/9781420055139]; Corcuera L, 2006, TREES-STRUCT FUNCT, V20, P91, DOI 10.1007/s00468-005-0016-4; Deforce K, 2014, QUATERN INT, P1, DOI 10.1016/j.quaint.2014.05.056; Druckenbrod DL, 2005, CAN J FOREST RES, V35, P868, DOI [10.1139/x05-020, 10.1139/X05-020]; ESRI, 2012, ARCGIS DESKT 10 1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fonti P, 2006, J VEG SCI, V17, P103, DOI 10.1658/1100-9233(2006)017[0103:TRSCDI]2.0.CO;2; Fraver S, 2005, CAN J FOREST RES, V35, P1648, DOI 10.1139/X05-092; Frelich L.E., 2002, FOREST DYNAMICS DIST, Vfirst; Gartner H, 2010, DENDROCHRONOLOGIA, V28, P85, DOI 10.1016/j.dendro.2009.09.002; Haneca K, 2005, ANN FOREST SCI, V62, P797, DOI 10.1051/forest:2005085; Haneca K, 2009, J ARCHAEOL SCI, V36, P1, DOI 10.1016/j.jas.2008.07.005; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Keenan Rodney J., 1993, Environmental Reviews, V1, P121, DOI 10.1139/a93-010; Knibbe B., 2008, PAST4 PERSONAL ANAL; LORIMER CG, 1989, CAN J FOREST RES, V19, P651, DOI 10.1139/x89-102; Mullerova J, 2015, FOREST ECOL MANAG, V343, P88, DOI 10.1016/j.foreco.2015.02.003; Mullerova J, 2014, FOREST ECOL MANAG, V331, P104, DOI 10.1016/j.foreco.2014.07.032; Nagel TA, 2007, ANN FOREST SCI, V64, P891, DOI 10.1051/forest:2007067; Nowacki GJ, 1997, ECOL MONOGR, V67, P225, DOI 10.1890/0012-9615(1997)067[0225:RGACFR]2.0.CO;2; Peterken G.F., 1996, NATURAL WOODLAND ECO; Peterken G. F, 1993, WOODLAND CONSERVATIO; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rackham O, 2003, ANCIENT WOODLAND ITS; Rackham O, 2008, NEW PHYTOL, V180, P571, DOI 10.1111/j.1469-8137.2008.02579.x; Rubino Darrin L., 2004, Dendrochronologia, V21, P97, DOI 10.1078/1125.7865.00047; Samonil P, 2009, FOREST ECOL MANAG, V257, P1148, DOI 10.1016/j.foreco.2008.11.024; Sjolund MJ, 2013, FORESTRY, V86, P503, DOI 10.1093/forestry/cpt030; Szabo P, 2010, FOREST ECOL MANAG, V259, P650, DOI 10.1016/j.foreco.2009.11.026; Thompson RD, 2007, CAN J FOREST RES, V37, P1034, DOI 10.1139/X06-300; Venables WN., 2002, MODERN APPL STAT S 4; WEINER J, 1984, J ECOL, V72, P183, DOI 10.2307/2260012; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053; Ziaco E, 2012, FOREST ECOL MANAG, V286, P28, DOI 10.1016/j.foreco.2012.09.005; Zielonka T, 2010, J VEG SCI, V21, P31, DOI 10.1111/j.1654-1103.2009.01121.x	47	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147205	10.1371/journal.pone.0147205	http://dx.doi.org/10.1371/journal.pone.0147205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784583	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400123
J	Goldberg, A; Kusunose, K; Qamruddin, S; Rodriguez, LL; Mazgalev, TN; Griffin, BP; Van Wagoner, DR; Zhang, YH; Popovic, ZB				Goldberg, Adam; Kusunose, Kenya; Qamruddin, Salima; Rodriguez, L. Leonardo; Mazgalev, Todor N.; Griffin, Brian P.; Van Wagoner, David R.; Zhang, Youhua; Popovic, Zoran B.			Left Atrial Size and Function in a Canine Model of Chronic Atrial Fibrillation and Heart Failure	PLOS ONE			English	Article							VAGAL NERVE-STIMULATION; VENTRICULAR PERFORMANCE; ASSOCIATION; RESTITUTION; TRACKING; STRAIN	Background Our aim was to assess how atrial fibrillation (AF) induction, chronicity, and RR interval irregularity affect left atrial (LA) function and size in the setting of underlying heart failure (HF), and to determine whether AF effects can be mitigated by vagal nerve stimulation (VNS). Methods HF was induced by 4-weeks of rapid ventricular pacing in 24 dogs. Subsequently, AF was induced and maintained by atrial pacing at 600 bpm. Dogs were randomized into control (n = 9) and VNS (n = 15) groups. In the VNS group, atrioventricular node fat pad stimulation (310 mu s, 20 Hz, 3-7 mA) was delivered continuously for 6 months. LA volume and LA strain data were calculated from bi-weekly echocardiograms. Results RR intervals decreased with HF in both groups (p = 0.001), and decreased further during AF in control group (p = 0.014), with a non-significant increase in the VNS group during AF. LA size increased with HF (p<0.0001), with no additional increase during AF. LA strain decreased with HF (p = 0.025) and further decreased after induction of AF (p = 0.0001). LA strain decreased less (p = 0.001) in the VNS than in the control group. Beat-by-beat analysis showed a curvilinear increase of LA strain with longer preceding RR interval, (r = 0.45, p<0.0001) with LA strain 1.1% higher (p = 0.02) in the VNS-treated animals, independent of preceding RR interval duration. The curvilinear relationship between ratio of preceding and pre-preceding RR intervals, and subsequent LA strain was weaker, (r = 0.28, p = 0.001). However, VNS-treated animals again had higher LA strain (by 2.2%, p = 0.002) independently of the ratio of preceding and pre-preceding RR intervals. Conclusions In the underlying presence of pacing-induced HF, AF decreased LA strain, with little impact on LA size. LA strain depends on the preceding RR interval duration.	[Goldberg, Adam; Kusunose, Kenya; Qamruddin, Salima; Rodriguez, L. Leonardo; Griffin, Brian P.; Popovic, Zoran B.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Mazgalev, Todor N.; Van Wagoner, David R.; Zhang, Youhua] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Popovic, ZB (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA.	popoviz@ccf.org	Kusunose, Kenya/AAC-9978-2021; Van Wagoner, David R/C-6783-2008	Kusunose, Kenya/0000-0002-4909-754X; Van Wagoner, David R/0000-0001-8250-9828; Goldberg, Adam/0000-0003-1547-2695; popovic, zoran/0000-0001-5692-2299	Atrial Fibrillation Innovation Center (AFIC), a State of Ohio Wright Center of Innovation, at the Cleveland Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111314] Funding Source: NIH RePORTER	Atrial Fibrillation Innovation Center (AFIC), a State of Ohio Wright Center of Innovation, at the Cleveland Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Atrial Fibrillation Innovation Center (AFIC), a State of Ohio Wright Center of Innovation, at the Cleveland Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2004, APPL LONGITUDINAL AN; Burstein B, 2009, CIRC RES, V105, P1213, DOI 10.1161/CIRCRESAHA.108.183400; Chao TS, 2000, CHEST, V117, P1546, DOI 10.1378/chest.117.6.1546; Committee on Pain and Distress in Laboratory Animal: Institute of Laboratory Animal Resources CoLS National Research Council, 1992, REC ASS PAIN STRESS, P32; Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618; GOSSELINK ATM, 1995, J AM COLL CARDIOL, V26, P1516, DOI 10.1016/0735-1097(95)00340-1; Imai M, 2014, RADIOLOGY, V273, P703, DOI 10.1148/radiol.14131971; Jayachandran JV, 2000, CIRCULATION, V101, P1185, DOI 10.1161/01.CIR.101.10.1185; Kuppahally SS, 2010, CIRC-CARDIOVASC IMAG, V3, P231, DOI 10.1161/CIRCIMAGING.109.865683; Kusunose K, 2014, JACC-CARDIOVASC IMAG, V7, P1085; Kusunose K, 2014, CIRC-HEART FAIL, V7, P320, DOI 10.1161/CIRCHEARTFAILURE.113.000937; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; MARTIN P, 1982, AM J PHYSIOL, V243, pH219, DOI 10.1152/ajpheart.1982.243.2.H219; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; Miyauchi Y, 2003, CIRCULATION, V108, P360, DOI 10.1161/01.CIR.0000080327.32573.7C; Nguyen BL, 2009, HEART RHYTHM, V6, P454, DOI 10.1016/j.hrthm.2009.01.010; Popovic ZB, 2002, AM J PHYSIOL-HEART C, V283, pH2706, DOI 10.1152/ajpheart.00571.2002; Saraiva RM, 2010, J AM SOC ECHOCARDIOG, V23, P172, DOI 10.1016/j.echo.2009.11.003; Schauerte P, 2000, CIRCULATION, V102, P2774, DOI 10.1161/01.CIR.102.22.2774; SCHNEIDER J, 1983, AM J CARDIOL, V51, P1189, DOI 10.1016/0002-9149(83)90367-3; Siniaia MS, 2000, J PHYSIOL-LONDON, V523, P479, DOI 10.1111/j.1469-7793.2000.t01-1-00479.x; Stavrakis S, 2015, J AM COLL CARDIOL, V65, P867, DOI 10.1016/j.jacc.2014.12.026; Suzuki S, 1998, AM J PHYSIOL-HEART C, V275, pH1513, DOI 10.1152/ajpheart.1998.275.5.H1513; Tabata T, 2004, AM J PHYSIOL-HEART C, V286, pH145, DOI 10.1152/ajpheart.00588.2003; Tabata T, 2001, AM J PHYSIOL-HEART C, V281, pH573, DOI 10.1152/ajpheart.2001.281.2.H573; Wallick DW, 2001, AM J PHYSIOL-HEART C, V281, pH1490, DOI 10.1152/ajpheart.2001.281.4.H1490; Yuan Y, 2015, CARDIOVASC PATHOL; Zhang YH, 2013, J CARDIOVASC ELECTR, V24, P86, DOI 10.1111/j.1540-8167.2012.02405.x; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968	29	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147015	10.1371/journal.pone.0147015	http://dx.doi.org/10.1371/journal.pone.0147015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771573	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300050
J	Leung, MYM; Groes, F; Santaeulalia-Llopis, R				Leung, Man Yee Mallory; Groes, Fane; Santaeulalia-Llopis, Raul			The Relationship between Age at First Birth and Mother's Lifetime Earnings: Evidence from Danish Data	PLOS ONE			English	Article							WAGE PENALTY; FAMILY GAP; WORK; INTERRUPTIONS; EXPERIENCE; CHILDREN; CAREER; MARKET	Background Having children creates career interruptions and reductions in labor income for women. This study documents the relation between the age at first birth (AFB) and women's labor income. We study these dynamics in the short run (i.e. ratio between labor income at AFB and two years prior to AFB) and long run (i.e., positive/negative differences in total lifetime labor income). Methods Using unique Danish administrative register data for the entire Danish population, we estimate the age-income profiles separately for college and non-college women conditional on marital status, and mothers' age at first birth (AFB). We compute the lifetime labor income differentials by taking the differences between the labor income of women with and without children at each AFB. Results The short-run loss in labor income, defined as the difference in percentages between the income earned two years prior to AFB and income earned at AFB, ranges from 37% to 65% for college women and from 40% to 53% for non-college women. These losses decrease monotonically with respect to AFB for both education groups. Our results on the lifetime labor income differentials between mothers and women without children also show a net effect that is monotonic (from negative to positive) in AFB. With AFB<25, the lifetime labor income loss for college women is -204% of their average annual labor income and this figure is -252% for non-college women. There are lifetime labor income gains with AFB>31. The largest gains for college women are 13% of their average annual income and this figure is 50% for non-college women. Conclusion Women have a large and unambiguous short-run reduction in labor income at their AFB. In terms of lifetime labor income, both college and non-college women, compared to childless women, are associated with lower income of more than twice their respective average annual income when bearing a child at AFB<25. In other words, women with AFB<25 are associated with a lower lifetime income of more than two years of annual labor income. The lifetime labor incomes for college and non-college women associated with AFB>31 are relatively higher.	[Leung, Man Yee Mallory] Washington Univ, Dept Surg, Div Publ Hlth, St Louis, MO USA; [Groes, Fane] Copenhagen Business Sch, Dept Econ, Copenhagen, Denmark; [Santaeulalia-Llopis, Raul] Washington Univ, Dept Econ, St Louis, MO 63130 USA	Washington University (WUSTL); Copenhagen Business School; Washington University (WUSTL)	Leung, MYM (corresponding author), Washington Univ, Dept Surg, Div Publ Hlth, St Louis, MO USA.	leungm@wudosis.wustl.edu		Groes, Fane/0000-0001-8683-3449				Anderson DJ, 2003, IND LABOR RELAT REV, V56, P273, DOI 10.2307/3590938; Blatter M, 2012, IZA DISCUSSION PAPER; Budig MJ, 2001, AM SOCIOL REV, V66, P204, DOI 10.2307/2657415; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Ejrnaes M, 2013, SCAND J ECON, V115, P856, DOI 10.1111/sjoe.12025; Fuller S, 2008, AM SOCIOL REV, V73, P158, DOI 10.1177/000312240807300108; Glauber R, 2008, GENDER SOC, V22, P8, DOI 10.1177/0891243207311593; Gupta ND, 2002, ECONOMICA, V69, P609, DOI 10.1111/1468-0335.00303; Karimi A., 2014, 201417 I EV LAB MARK; Katz L.F., 1999, HDB LABOR EC, V3, P1463, DOI DOI 10.1016/S1573-4463(99)03007-2; KORENMAN S, 1992, J HUM RESOUR, V27, P233, DOI 10.2307/145734; Lundberg S, 2002, REV ECON STAT, V84, P251, DOI 10.1162/003465302317411514; Miller AR, 2011, J POPUL ECON, V24, P1071, DOI 10.1007/s00148-009-0296-x; Nielsen HS, 2004, SCAND J ECON, V106, P721, DOI 10.1111/j.0347-0520.2004.00385.x; Olivetti C, 2006, REV ECON DYNAM, V9, P557, DOI 10.1016/j.red.2006.06.001; Phipps S, 2001, CAN J ECON, V34, P411, DOI 10.1111/0008-4085.00081; Simonsen M, 2006, J APPL ECONOMET, V21, P919, DOI 10.1002/jae.893; Staff J, 2012, DEMOGRAPHY, V49, P1, DOI 10.1007/s13524-011-0068-6; Statistics Denmark, 2014, DAN SYST ACC MICR; Waldfogel J, 1997, AM SOCIOL REV, V62, P209, DOI 10.2307/2657300	20	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146989	10.1371/journal.pone.0146989	http://dx.doi.org/10.1371/journal.pone.0146989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799481	Green Published, gold			2022-12-26	WOS:000368655300051
J	Langford-Smith, A; Tilakaratna, V; Lythgoe, PR; Clark, SJ; Bishop, PN; Day, AJ				Langford-Smith, Alex; Tilakaratna, Viranga; Lythgoe, Paul R.; Clark, Simon J.; Bishop, Paul N.; Day, Anthony J.			Age and Smoking Related Changes in Metal Ion Levels in Human Lens: Implications for Cataract Formation	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; HEPARAN-SULFATE; TRACE-ELEMENTS; CADMIUM ACCUMULATION; OXIDATIVE DAMAGE; COPPER; ZINC; SELENIUM; LEAD; TOXICITY	Age-related cataract formation is the primary cause of blindness worldwide and although treatable by surgical removal of the lens the majority of sufferers have neither the finances nor access to the medical facilities required. Therefore, a better understanding of the pathogenesis of cataract may identify new therapeutic targets to prevent or slow its progression. Cataract incidence is strongly correlated with age and cigarette smoking, factors that are often associated with accumulation of metal ions in other tissues. Therefore this study evaluated the age-related changes in 14 metal ions in 32 post mortem human lenses without known cataract from donors of 11 to 82 years of age by inductively coupled plasma mass spectrometry; smoking-related changes in 10 smokers verses 14 non-smokers were also analysed. A significant age-related increase in selenium and decrease in copper ions was observed for the first time in the lens tissue, where cadmium ion levels were also increased as has been seen previously. Aluminium and vanadium ions were found to be increased in smokers compared to non-smokers (an analysis that has only been carried out before in lenses with cataract). These changes in metal ions, i.e. that occur as a consequence of normal ageing and of smoking, could contribute to cataract formation via induction of oxidative stress pathways, modulation of extracellular matrix structure/function and cellular toxicity. Thus, this study has identified novel changes in metal ions in human lens that could potentially drive the pathology of cataract formation.	[Langford-Smith, Alex; Tilakaratna, Viranga; Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Lythgoe, Paul R.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Lythgoe, Paul R.] Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester, Lancs, England; [Clark, Simon J.; Bishop, Paul N.] Univ Manchester, Inst Human Dev, Ctr Ophthalmol & Vis Sci, Manchester, Lancs, England; [Clark, Simon J.; Bishop, Paul N.] Univ Manchester, Ctr Adv Discovery & Expt Therapeut, Manchester, Lancs, England; [Clark, Simon J.; Bishop, Paul N.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Bishop, Paul N.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester; Manchester Royal Eye Hospital; University of Manchester	Langford-Smith, A; Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	alexander.langford-smith@manchester.ac.uk; anthony.day@manchester.ac.uk	Day, Anthony/O-1658-2015; Langford-Smith, Alex/K-7624-2017	Day, Anthony/0000-0002-1415-3134; Langford-Smith, Alex/0000-0001-7006-0592; Bishop, Paul/0000-0001-7937-7932; Clark, Simon/0000-0001-8394-8355	Medical Research Council UK [K004441]; MRC [MR/K004441/1, MR/K024418/1] Funding Source: UKRI; Medical Research Council [MR/K004441/1, MR/K024418/1] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge funding from the Medical Research Council UK (http://www.mrc.ac.uk/), grant number K004441 (SJC, PNB, and AJD). The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	[Anonymous], 2013, CHEM COMPONENTS TOBA, P1067; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Bernhard D, 2006, ARTERIOSCL THROM VAS, V26, P833, DOI 10.1161/01.ATV.0000205616.70614.e5; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Brian G, 2001, B WORLD HEALTH ORGAN, V79, P249; BROWN NAP, 1987, EYE-T OPHTH SOC UK, V1, P234, DOI 10.1038/eye.1987.43; Buratti M, 1986, Med Lav, V77, P208; Cardoso BR, 2015, METALLOMICS, V7, P1213, DOI 10.1039/c5mt00075k; Cekic O, 1998, BRIT J OPHTHALMOL, V82, P186, DOI 10.1136/bjo.82.2.186; Cekic O, 1998, OPHTHALMIC RES, V30, P49, DOI 10.1159/000055454; Cekic O, 1999, OPHTHALMIC RES, V31, P332, DOI 10.1159/000055555; Chang JR, 2011, OPHTHALMOLOGY, V118, P2113, DOI 10.1016/j.ophtha.2011.03.032; Choudhury S, 2015, ENVIRON SCI TECHNOL, V49, P2255, DOI 10.1021/es503848s; Christen WG, 2015, JAMA OPHTHALMOL, V133, P17, DOI 10.1001/jamaophthalmol.2014.3478; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Dadoukis P, 2013, GRAEF ARCH CLIN EXP, V251, P1929, DOI 10.1007/s00417-013-2349-9; Erie JC, 2009, AM J OPHTHALMOL, V147, P276, DOI 10.1016/j.ajo.2008.08.014; Erie JC, 2005, AM J OPHTHALMOL, V139, P888, DOI 10.1016/j.ajo.2004.12.007; Fuchs B, 2014, ANTIOXID REDOX SIGN, V21, P1044, DOI 10.1089/ars.2013.5634; Fujiwara Y, 2002, TOXICOLOGY, V170, P89, DOI 10.1016/S0300-483X(01)00538-8; Haddad HH, 2012, J ANAL CHEM+, V03, P4, DOI [10.4236/ajac.2012.310094, DOI 10.4236/AJAC.2012.310094]; Haddad NS, 2012, J ANAL CHEM+, V03, P4, DOI [10.4236/ajac.2012.37065, DOI 10.4236/AJAC.2012.37065]; Hosseini MJ, 2013, METALLOMICS, V5, P152, DOI 10.1039/c2mt20198d; Hou XL, 1996, BIOL TRACE ELEM RES, V55, P89, DOI 10.1007/BF02784171; Imtiaz Ahmad AA, 2014, JOURNAL OF ENVIRONME, V05, DOI [10.4172/2161-0525.1000252, DOI 10.4172/2161-0525.1000252]; Junemann AGM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056734; KAJI T, 1994, TOXICOLOGY, V94, P161; Kalariya NM, 2010, TOXICOL LETT, V198, P56, DOI 10.1016/j.toxlet.2010.04.021; Kanthan GL, 2008, OPHTHALMOLOGY, V115, P808, DOI 10.1016/j.ophtha.2007.07.008; KARAKUCUK S, 1995, ACTA OPHTHALMOL SCAN, V73, P329; Kasaikina MV, 2011, J BIOL CHEM, V286, P33203, DOI 10.1074/jbc.M111.259218; Keenan TDL, 2014, INVEST OPHTH VIS SCI, V55, P5370, DOI 10.1167/iovs.14-14126; Kennett EC, 2011, BIOCHEM SOC T, V39, P1279, DOI 10.1042/BST0391279; Kim MH, 2016, J EXPO SCI ENV EPID, V26, P214, DOI 10.1038/jes.2014.75; Kim YJ, 2010, ORAL DIS, V16, P823, DOI 10.1111/j.1601-0825.2010.01698.x; Klein BEK, 2008, OPHTHALMOLOGY, V115, P477, DOI 10.1016/j.ophtha.2007.11.024; Kliment CR, 2008, ANTIOXID REDOX SIGN, V10, P261, DOI 10.1089/ars.2007.1906; Kocyigit A, 2001, CLIN BIOCHEM, V34, P629, DOI 10.1016/S0009-9120(01)00271-5; Konz I, 2014, ANAL BIOANAL CHEM, V406, P2343, DOI 10.1007/s00216-014-7617-y; Langford-Smith A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00025; Langford-Smith A, 2014, J INNATE IMMUN, V6, P407, DOI 10.1159/000356513; Lim JC, 2013, EXP EYE RES, V116, P219, DOI 10.1016/j.exer.2013.09.002; Lim JC, 2011, EXP EYE RES, V92, P162, DOI 10.1016/j.exer.2010.05.007; LYDAHL E, 1984, ACTA OPHTHALMOL, P1; Manikandan R, 2009, CHEM-BIOL INTERACT, V181, P202, DOI 10.1016/j.cbi.2009.05.011; McCarty CA, 1999, BRIT J OPHTHALMOL, V83, P62, DOI 10.1136/bjo.83.1.62; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Misra S, 2010, METALLOMICS, V2, P710, DOI 10.1039/c0mt00008f; Mosad SM, 2010, CURR EYE RES, V35, P23, DOI 10.3109/02713680903362880; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nair AR, 2013, INT J MOL SCI, V14, P6116, DOI 10.3390/ijms14036116; Padmaja S., 2004, Indian Journal of Experimental Biology, V42, P601; Park DU, 2014, ENVIRON MONIT ASSESS, V186, P5209, DOI 10.1007/s10661-014-3770-1; Park SS, 2011, ANAL BIOCHEM, V409, P81, DOI 10.1016/j.ab.2010.10.003; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Rajkumar S, 2013, INVEST OPHTH VIS SCI, V54, P6224, DOI 10.1167/iovs.13-11935; RAMAKRISHNAN S, 1995, BRIT J OPHTHALMOL, V79, P202, DOI 10.1136/bjo.79.3.202; Ramos P, 2014, BIOL TRACE ELEM RES, V161, P190, DOI 10.1007/s12011-014-0093-6; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Rembach A., 2013, INT J ALZHEIMERS DIS, V2013; Remko M, 2013, RSC ADV, V3, P9843, DOI 10.1039/c3ra40566d; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Ruiperez F, 2012, J INORG BIOCHEM, V117, P118, DOI 10.1016/j.jinorgbio.2012.09.008; Sabrina K, 2011, 2 NAT HLTH PROM C NH; Saffari A, 2014, ENVIRON SCI-PROC IMP, V16, P2259, DOI 10.1039/c4em00415a; Seo YJ, 2011, INT J MASS SPECTROM, V303, P191, DOI 10.1016/j.ijms.2011.02.003; Shukla N, 1996, SCI TOTAL ENVIRON, V181, P161, DOI 10.1016/0048-9697(95)05006-X; Simmons Steven O, 2011, Curr Chem Genomics, V5, P1, DOI 10.2174/1875397301105010001; Song NH, 2012, MOL VIS, V18, P983; SRIVASTAVA VK, 1992, ACTA OPHTHALMOL, V70, P839; Sulochana K. N., 2002, Indian Journal of Pharmacology, V34, P428; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; Tyler G., 1995, ICP OPT EMISS SPECTR, V5; Ugarte M, 2013, SURV OPHTHALMOL, V58, P585, DOI 10.1016/j.survophthal.2012.12.002; Ugarte M, 2012, METALLOMICS, V4, P1245, DOI 10.1039/c2mt20157g; Umapathy A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/207250; Unkiewicz-Winiarczyk A, 2009, BIOL TRACE ELEM RES, V132, P41, DOI 10.1007/s12011-009-8390-1; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Watts DL, 1994, J ORTHOMOLECULAR MED, V9, P111; Wederell ED, 2006, SEMIN CELL DEV BIOL, V17, P759, DOI 10.1016/j.semcdb.2006.10.006; Wills NK, 2008, EXP EYE RES, V87, P80, DOI 10.1016/j.exer.2008.04.013; Ye J, 2012, INVEST OPHTH VIS SCI, V53, P3885, DOI 10.1167/iovs.12-9820; Zhang M, 2011, J TOXICOL ENV HEAL A, V74, P380, DOI 10.1080/15287394.2011.538835; Zhang SP, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-100; Zhao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083060	85	28	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147576	10.1371/journal.pone.0147576	http://dx.doi.org/10.1371/journal.pone.0147576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794210	Green Published, gold, Green Submitted			2022-12-26	WOS:000368530300040
J	Wu, YY; Yang, XH; Yang, YF				Wu, Yingying; Yang, Xiaohong; Yang, Yufang			Eye Movement Evidence for Hierarchy Effects on Memory Representation of Discourses	PLOS ONE			English	Article							RHETORICAL STRUCTURE; LINGUISTIC FOCUS; INFORMATION; FIXATIONS; ATTENTION; SENTENCES; CHINESE; SCENES; DEPTH	In this study, we applied the text-change paradigm to investigate whether and how discourse hierarchy affected the memory representation of a discourse. Three kinds of three-sentence discourses were constructed. In the hierarchy-high condition and the hierarchy-low condition, the three sentences of the discourses were hierarchically organized and the last sentence of each discourse was located at the high level and the low level of the discourse hierarchy, respectively. In the linear condition, the three sentences of the discourses were linearly organized. Critical words were always located at the last sentence of the discourses. These discourses were successively presented twice and the critical words were changed to semantically related words in the second presentation. The results showed that during the early processing stage, the critical words were read for longer times when they were changed in the hierarchy-high and the linear conditions, but not in the hierarchy-low condition. During the late processing stage, the changed-critical words were again found to induce longer reading times only when they were in the hierarchy-high condition. These results suggest that words in a discourse have better memory representation when they are located at the higher rather than at the lower level of the discourse hierarchy. Global discourse hierarchy is established as an important factor in constructing the mental representation of a discourse.	[Wu, Yingying; Yang, Xiaohong; Yang, Yufang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Wu, Yingying] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, XH; Yang, YF (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	yangxh@psych.ac.cn; yangyf@psych.ac.cn			National Natural Science Foundation of China [61433018, 31400968]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to YY (61433018) and XY (31400968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER L, 1987, MEM COGNITION, V15, P247, DOI 10.3758/BF03197723; Birch S, 2010, MEM COGNITION, V38, P740, DOI 10.3758/MC.38.6.740; Chomsky N., 1957, SYNTACTIC STRUCTURES; Cooreman A., 1996, FOCUS SYNTACTIC SUBO; de Villiers PA, 1974, J EXP PSYCHOL, V103, P263; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; GIVON T, 1992, LINGUISTICS, V30, P5, DOI 10.1515/ling.1992.30.1.5; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; INHOFF AW, 1984, J VERB LEARN VERB BE, V23, P612, DOI 10.1016/S0022-5371(84)90382-7; Jiang XM, 2009, NEUROPSYCHOLOGIA, V47, P1282, DOI 10.1016/j.neuropsychologia.2009.01.013; Johnson RL, 2009, J EXP PSYCHOL LEARN, V35, P943, DOI 10.1037/a0015572; KINTSCH W, 1973, COGNITIVE PSYCHOL, V5, P257, DOI 10.1016/0010-0285(73)90036-4; Kintsch W., 1992, LEARNING PROCESSES C, V2, P261; Klin CM, 2004, MEM COGNITION, V32, P511, DOI 10.3758/BF03195843; LIMA SD, 1985, J EXP PSYCHOL HUMAN, V11, P272, DOI 10.1037/0096-1523.11.3.272; Magliano JP, 2000, DISCOURSE PROCESS, V29, P83, DOI 10.1207/S15326950dp2902_1; Mann W., 1988, TEXT, V8, P243; MORROW DG, 1985, J MEM LANG, V24, P304, DOI 10.1016/0749-596X(85)90030-0; Munte TF, 1997, NEUROSCI LETT, V235, P105, DOI 10.1016/S0304-3940(97)00719-2; Ouden Hd, 2009, SPEECH COMMUN, V51, P116; RANEY GE, 1995, CAN J EXP PSYCHOL, V49, P151, DOI 10.1037/1196-1961.49.2.151; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rensink RA, 2000, VIS COGN, V7, P17, DOI 10.1080/135062800394667; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Sanford AJ, 2002, MIND LANG, V17, P188, DOI 10.1111/1468-0017.00195; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Sturt P, 2004, PSYCHON B REV, V11, P882, DOI 10.3758/BF03196716; Taboada M, 2006, DISCOURSE STUD, V8, P423, DOI 10.1177/1461445606061881; TOWNSEND DJ, 1978, J VERB LEARN VERB BE, V17, P509, DOI 10.1016/S0022-5371(78)90304-3; Ward P, 2007, MEM COGNITION, V35, P73, DOI 10.3758/BF03195944; Yang XH, 2014, MEM COGNITION, V42, P325, DOI 10.3758/s13421-013-0363-0; Yang XH, 2012, IEEE T AUDIO SPEECH, V20, P1196, DOI 10.1109/TASL.2011.2173676	32	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147313	10.1371/journal.pone.0147313	http://dx.doi.org/10.1371/journal.pone.0147313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BW	26789002	Green Published, Green Submitted, gold			2022-12-26	WOS:000368529100077
J	Zhang, YM; Pan, Y; Bian, ZX; Chen, PH; Zhu, SJ; Gu, HY; Guo, LP; Hu, C				Zhang, Yumei; Pan, Yu; Bian, Zhixiang; Chen, Peihua; Zhu, Shijian; Gu, Huiyi; Guo, Liping; Hu, Chun			Ceramide Production Mediates Aldosterone-Induced Human Umbilical Vein Endothelial Cell (HUVEC) Damages	PLOS ONE			English	Article							DAUNORUBICIN-INDUCED APOPTOSIS; TUBULAR EPITHELIAL-CELLS; NEUROBLASTOMA-CELLS; IN-VIVO; ANGIOTENSIN; DEATH; SPHINGOLIPIDS; METABOLISM; RECEPTOR; DISEASE	Here, we studied the underlying mechanism of aldosterone (Aldo)-induced vascular endothelial cell damages by focusing on ceramide. We confirmed that Aldo (at nmol/L) inhibited human umbilical vein endothelial cells (HUVEC) survival, and induced considerable cell apoptosis. We propose that ceramide (mainly C18) production might be responsible for Aldo-mediated damages in HUVECs. Sphingosine-1-phosphate (S1P), an anti-ceramide lipid, attenuated Aldo-induced ceramide production and following HUVEC damages. On the other hand, the glucosylceramide synthase (GCS) inhibitor PDMP or the ceramide (C6) potentiated Aldo-induced HUVEC apoptosis. Eplerenone, a mineralocorticoid receptor (MR) antagonist, almost completely blocked Aldo-induced C18 ceramide production and HUVEC damages. Molecularly, ceramide synthase 1 (CerS-1) is required for C18 ceramide production by Aldo. Knockdown of CerS-1 by targeted-shRNA inhibited Aldo-induced C18 ceramide production, and protected HUVECs from Aldo. Reversely, CerS-1 overexpression facilitated Aldo-induced C18 ceramide production, and potentiated HUVEC damages. Together, these results suggest that C18 ceramide production mediates Aldo-mediated HUVEC damages. MR and CerS-1 could be the two signaling molecule regulating C18 ceramide production by Aldo.	[Zhang, Yumei; Pan, Yu; Bian, Zhixiang; Chen, Peihua; Zhu, Shijian; Gu, Huiyi; Guo, Liping; Hu, Chun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Div Nephrol, Shanghai 201999, Peoples R China	Shanghai Jiao Tong University	Hu, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Div Nephrol, Shanghai 201999, Peoples R China.	huchunjiuyuan@163.com			Science Fund Project of Shanghai Jiaotong University School of Medicine [13XJ10056]; Science Research Tasks of Shanghai Municipal Commission of Health and Family Planning [201440331]	Science Fund Project of Shanghai Jiaotong University School of Medicine; Science Research Tasks of Shanghai Municipal Commission of Health and Family Planning	This study was funded by Science Fund Project of Shanghai Jiaotong University School of Medicine (no. 13XJ10056, to CH) and Science Research Tasks of Shanghai Municipal Commission of Health and Family Planning (201440331, to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babia T, 1998, EUR J BIOCHEM, V258, P233, DOI 10.1046/j.1432-1327.1998.2580233.x; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Calhoun DA, 2006, CIRCULATION, V114, P2572, DOI 10.1161/CIRCULATIONAHA.106.668715; Chun TY, 2004, TRENDS ENDOCRIN MET, V15, P353, DOI 10.1016/j.tem.2004.08.002; Di Raimondo D, 2012, CURR PHARM DESIGN, V18, P4385, DOI 10.2174/138161212802481282; Dijkhuis AJ, 2006, MOL CANCER THER, V5, P593, DOI 10.1158/1535-7163.MCT-05-0457; Ding W, 2012, BIOCHEM BIOPH RES CO, V418, P451, DOI 10.1016/j.bbrc.2012.01.037; Edmonds Y, 2011, PHARMACOL THERAPEUT, V132, P352, DOI 10.1016/j.pharmthera.2011.08.004; Epstein M, 2001, AM J KIDNEY DIS, V37, P677, DOI 10.1016/S0272-6386(01)80115-3; Farquharson CAJ, 2002, CLIN SCI, V103, P425, DOI 10.1042/cs1030425; Gong L, 2014, CANCER CHEMOTH PHARM, V73, P69, DOI 10.1007/s00280-013-2318-3; Hashikabe Y, 2006, J CARDIOVASC PHARM, V47, P609, DOI 10.1097/01.fjc.0000211738.63207.c3; Hillaert MA, 2011, AM HEART J, V162, P585, DOI 10.1016/j.ahj.2011.06.015; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Huo HZ, 2014, BIOCHEM BIOPH RES CO, V443, P406, DOI 10.1016/j.bbrc.2013.11.099; Jaffrezou JP, 1996, EMBO J, V15, P2417, DOI 10.1002/j.1460-2075.1996.tb00599.x; Keidar S, 2004, CIRCULATION, V109, P2213, DOI 10.1161/01.CIR.0000127949.05756.9D; Kraveka JM, 2003, ARCH BIOCHEM BIOPHYS, V419, P110, DOI 10.1016/j.abb.2003.08.034; Lai LY, 2007, LIFE SCI, V81, P570, DOI 10.1016/j.lfs.2007.06.025; LARAGH JH, 1972, AM J MED, V52, P633, DOI 10.1016/0002-9343(72)90054-X; Lin CF, 2006, CURR MED CHEM, V13, P1609, DOI 10.2174/092986706777441986; Lu JP, 2014, J HUAZHONG U SCI-MED, V34, P821, DOI 10.1007/s11596-014-1359-0; Luo Yang, 2006, Zhonghua Yi Xue Za Zhi, V86, P3133; Maron BA, 2012, CIRCULATION, V126, P963, DOI 10.1161/CIRCULATIONAHA.112.094722; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Myrick D, 1999, LEUKEMIA RES, V23, P569, DOI 10.1016/S0145-2126(99)00048-X; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2001, DRUG RESIST UPDATE, V4, P368, DOI 10.1054/drup.2001.0225; Palmer BR, 2008, EUR HEART J, V29, P2489, DOI 10.1093/eurheartj/ehn383; Patel BM, 2012, EUR J PHARMACOL, V697, P1, DOI 10.1016/j.ejphar.2012.09.034; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Qiao WW, 2015, MOL MED REP, V12, P1631, DOI 10.3892/mmr.2015.3596; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Sietsma H, 2000, CLIN CANCER RES, V6, P942; Terada Y, 2012, CLIN EXP NEPHROL, V16, P81, DOI 10.1007/s10157-011-0498-x; Toda N, 2013, BRIT J PHARMACOL, V168, P519, DOI 10.1111/j.1476-5381.2012.02194.x; Tomaschitz A, 2010, EUR HEART J, V31, P1237, DOI 10.1093/eurheartj/ehq019; Vantrimpont P, 1998, EUR HEART J, V19, P1552, DOI 10.1053/euhj.1998.1093; Veldman RJ, 1998, BIOCHEM J, V331, P563, DOI 10.1042/bj3310563; Wu CH, 2012, NANO LETT, V12, P5475, DOI 10.1021/nl301865c; Yao C, 2012, CELL BIOCH BIOPHYS; Yao C, 2012, MOL ONCOL, V6, P392, DOI 10.1016/j.molonc.2012.04.002; Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278; Yu T, 2012, MOL CELL BIOCHEM, V361, P47, DOI 10.1007/s11010-011-1086-9; Yuan YG, 2012, FREE RADICAL BIO MED, V53, P30, DOI 10.1016/j.freeradbiomed.2012.03.015; Zecevic A, 2009, CELL CYCLE, V8, P2769, DOI 10.4161/cc.8.17.9410	48	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146944	10.1371/journal.pone.0146944	http://dx.doi.org/10.1371/journal.pone.0146944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788916	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100048
J	Zhang, Z; Liu, SY; Wei, JF; Xu, JL; Guo, WQ; Bao, WJ; Jiang, ZL				Zhang, Zhen; Liu, Shiyin; Wei, Junfeng; Xu, Junli; Guo, Wanqin; Bao, Weijia; Jiang, Zongli			Mass Change of Glaciers in Muztag Ata-Kongur Tagh, Eastern Pamir, China from 1971/76 to 2013/14 as Derived from Remote Sensing Data	PLOS ONE			English	Article							TIBETAN PLATEAU; ASTER GDEM; SRTM; MOUNTAINS; VOLUME; STEREO; INVENTORY; ACCURACY; BASIN; SHAN	The assessment of glacier mass budget is crucial for assessing water reserves stored in glaciers. Derived glacier mass changes in the Muztag Ata and Kongur Tagh (MAKT) region in the eastern Pamir, northwestern China, is helpful in improving our knowledge of the dynamics of glaciers under a changing climate in High Mountain Asia. Here, glacier area and mass changes derived from remote sensing data are investigated for the period 1971/76-2013/14 for glaciers in MAKT. We have used ASTER images (2013/14), Cartosat-1 (2014) and Landsat, SRTM (Shuttle Radar Terrain Mission) digital elevation model (DEM) (2000), topographic maps (1971/76) and the first and second Chinese glacier inventories (CGIs). Our results indicated that the glacier area of MAKT decreased from 1018.3 +/- 12.99 km(2) in 1971/76 to 999.2 +/- 31.22 km(2) in 2014 (-1.9 +/- 0.2%). Weak area shrinkage of glaciers by 2.5 +/- 0.5 km(2) (0.2 +/- 0.1%) happened after 2000 and the period 2009-2014 even saw a slight expansion by 0.5 +/- 0.1 km(2) (0.1 +/- 0.0%). The glaciers in this region have experienced an overall loss of -6.99 +/- 0.80 km(3) in ice volume or -0.15 +/- 0.12 m water equivalent (w.e.) a(-1) from 1971/76 to 2013/14. The mass budget of MAKT was -0.19 +/- 0.19 m w.e. a(-1) for the period similar to 1971/76-1999 and -0.14 +/- 0.24 m w.e. a(-1) during 1999-2013/2014. Similar to previous studies, there has been little mass change in the Pamir over recent decades despite such uncertainties. Glacier mass change showed spatial and temporal heterogeneity, with strong mass loss on debris-covered glaciers with an average of -0.32 +/- 0.12 m w.e. a(-1) from the 1970s to 2013/14.	[Zhang, Zhen; Liu, Shiyin; Xu, Junli; Guo, Wanqin; Bao, Weijia; Jiang, Zongli] Chinese Acad Sci, State Key Lab Cryospher Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China; [Zhang, Zhen; Xu, Junli; Bao, Weijia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wei, Junfeng] Hunan Univ Sci & Technol, Sch Architecture & Urban Planning, Xiangtan, Hunan, Peoples R China; [Jiang, Zongli] Hunan Univ Sci & Technol, Hunan Prov Key Lab Coal Resources Clean Utilizat, Xiangtan, Hunan, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hunan University of Science & Technology; Hunan University of Science & Technology	Liu, SY (corresponding author), Chinese Acad Sci, State Key Lab Cryospher Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China.	liusy@lzb.ac.cn	Liu, Shiyin/AAT-4278-2020; Wei, Junfeng/G-5694-2014; Guo, Wanqin/E-7553-2015	Guo, Wanqin/0000-0002-3211-9300; zhang, zhen/0000-0002-2160-8619	fundamental program from the Ministry of Science and Technology of China (MOST) [2013FY111400]; Key Research Program of Chinese Academy of Sciences [KZZD-EW-12-1]; National Natural Science Foundation of China [41190084, 41471067]; MOST [2006FY110200]; Chinese Academy of Sciences [kzcx2-yw-301]	fundamental program from the Ministry of Science and Technology of China (MOST); Key Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the fundamental program from the Ministry of Science and Technology of China (MOST) (Grant No. 2013FY111400), the Key Research Program of Chinese Academy of Sciences (KZZD-EW-12-1), and the National Natural Science Foundation of China (Grant No. 41190084 and 41471067).; The authors thank the anonymous reviewers for their constructive comments. The glacier inventory data was provided by "Investigation on glacier resources and their change in China" of the MOST (Grant No. 2006FY110200) and "Glacier change monitoring and its impact assessment research in west China" of Chinese Academy of Sciences (Grant No. kzcx2-yw-301) (http://westdc.westgis.ac.cn/glacier, accessed on 7.21.2015). We also thank USGS and NASA for satellite images.	[Anonymous], 2008, GBT1235312008; Bao WJ, 2015, J MT SCI-ENGL, V12, P344, DOI 10.1007/s11629-014-3220-0; Berthier E, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025862; Berthier E, 2005, REMOTE SENS ENVIRON, V95, P14, DOI 10.1016/j.rse.2004.11.005; Berthier E, 2010, NAT GEOSCI, V3, P92, DOI 10.1038/NGEO737; Bhambri R, 2013, CRYOSPHERE, V7, P1385, DOI 10.5194/tc-7-1385-2013; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Bolch T, 2011, CRYOSPHERE, V5, P349, DOI 10.5194/tc-5-349-2011; Bolch T, 2010, REMOTE SENS ENVIRON, V114, P127, DOI 10.1016/j.rse.2009.08.015; Brahmbhatt R.M., 2015, CRYOSPHERE DISCUSS, V9, P1555, DOI DOI 10.5194/TCD-9-1555-2015; Braithwaite RJ, 2009, ANN GLACIOL, V50, P127, DOI 10.3189/172756410790595930; [蔡迪花 CAI Dihua], 2006, [兰州大学学报. 自然科学版, Journal of Lanzhou University. Natural Science], V42, P13; Duan KQ, 2015, J HYDROL, V531, P912, DOI 10.1016/j.jhydrol.2015.10.013; [段克勤 DUAN Keqin], 2007, [冰川冻土, Journal of Glaciology and Geocryology], V29, P680; Farajzadeh M, 2014, J MT SCI-ENGL, V11, P215, DOI 10.1007/s11629-013-2714-5; Gardelle J, 2013, CRYOSPHERE, V7, P1263, DOI 10.5194/tc-7-1263-2013; Gardelle J, 2012, J GLACIOL, V58, P419, DOI 10.3189/2012JoG11J175; Gardelle J, 2012, NAT GEOSCI, V5, P322, DOI [10.1038/ngeo1450, 10.1038/NGEO1450]; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Ghosh S, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083579; Gianinetto M, 2009, SENSORS-BASEL, V9, P3269, DOI 10.3390/s90503269; Guo WQ, 2015, J GLACIOL, V61, P357, DOI 10.3189/2015JoG14J209; Guo WQ, 2013, ANN GLACIOL, V54, P299, DOI 10.3189/2013AoG63A495; Hirano A, 2003, ISPRS J PHOTOGRAMM, V57, P356, DOI 10.1016/S0924-2716(02)00164-8; Holzer N, 2015, CRYOSPHERE, V9, P2071, DOI 10.5194/tc-9-2071-2015; Huss M, 2013, CRYOSPHERE, V7, P877, DOI 10.5194/tc-7-877-2013; Immerzeel WW, 2012, NAT GEOSCI, V5, P841, DOI 10.1038/ngeo1643; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jacobsen K., 2005, P ASPRS 2005 ANN C M; Jarvis A, 2008, HOLE FILLED SEAMLESS; Kaab A, 2015, CRYOSPHERE, V9, P557, DOI 10.5194/tc-9-557-2015; Kaab A, 2008, IEEE T GEOSCI REMOTE, V46, P2823, DOI 10.1109/TGRS.2008.2000627; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Kamp U, 2003, ASPRS 2003 ANN C P A; Ke LH, 2015, REMOTE SENS ENVIRON, V168, P13, DOI 10.1016/j.rse.2015.06.019; Khromova TE, 2006, REMOTE SENS ENVIRON, V102, P24, DOI 10.1016/j.rse.2006.01.019; Koblet T, 2010, CRYOSPHERE, V4, P333, DOI 10.5194/tc-4-333-2010; Kumar S, 2009, J INDIAN SOC REMOTE, V36, P159; Lambrecht A, 2014, J GLACIOL, V60, P233, DOI 10.3189/2014JoG13J110; Langley K, 2008, IEEE T GEOSCI REMOTE, V46, P2506, DOI 10.1109/TGRS.2008.918648; Lehner M, 2008, ISPRS J PHOTOGRAMMET; [刘时银 Liu Shiyin], 2015, [地理学报, Acta Geographica Sinica], V70, P3; Martha TR, 2010, IEEE GEOSCI REMOTE S, V7, P582, DOI 10.1109/LGRS.2010.2041895; Maussion F, 2014, J CLIMATE, V27, P1910, DOI 10.1175/JCLI-D-13-00282.1; Miehe G., 2001, ERDKUNDE, V55, P94, DOI [10.3112/erdkunde.2001.01.06, DOI 10.3112/ERDKUNDE.2001.01.06]; Miliaresis GC, 2011, REMOTE SENS LETT, V2, P127, DOI 10.1080/01431161.2010.503667; Miller P, GEOSCIENCE REMOTE SE, P1971; Minora U., 2013, CRYOSPHERE DISCUSS, V7, P2891, DOI [10.5194/tcd-7-2891-2013, DOI 10.5194/TCD-7-2891-2013]; Neckel N, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014009; Nuth C, 2011, CRYOSPHERE, V5, P271, DOI 10.5194/tc-5-271-2011; Osipov EY, 2015, ENVIRON EARTH SCI, V74, P1969, DOI 10.1007/s12665-015-4352-4; Osmonov A, 2013, REMOTE SENS LETT, V4, P725, DOI 10.1080/2150704X.2013.789146; Paul F, 2013, ANN GLACIOL, V54, P171, DOI 10.3189/2013AoG63A296; Pellicciotti F, 2015, J GLACIOL, V61, P373, DOI 10.3189/2015JoG13J237; Pieczonka T, 2015, GLOBAL PLANETARY CHA, P128; Pieczonka T, 2013, REMOTE SENS ENVIRON, V130, P233, DOI 10.1016/j.rse.2012.11.020; [蒲健辰 Pu Jianchen], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P680; Rodriguez E, 2006, PHOTOGRAMM ENG REM S, V72, P249, DOI 10.14358/PERS.72.3.249; Seong YB, 2009, GEOL SOC AM BULL, V121, P348, DOI 10.1130/B26339.1; Seong YB, 2009, GEOMORPHOLOGY, V103, P227, DOI 10.1016/j.geomorph.2008.04.025; Shangguan DH, 2015, CRYOSPHERE, V9, P703, DOI 10.5194/tc-9-703-2015; Shangguan DH, 2006, ANN GLACIOL-SER, V43, P79, DOI 10.3189/172756406781812393; Shangguan D, 2009, PROG NAT SCI-MATER, V19, P727, DOI 10.1016/j.pnsc.2008.11.002; Shen Y., 1997, J GLACIOL GEOCRYOL, V19, P302; Shih Y, 1980, IAHS-AISH PUBL, P111; Tian LD, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006249; Tiwari PS, 2008, INT J GEOINFORMATICS, V4, P51; Toutin T, 2008, INT J REMOTE SENS, V29, P1855, DOI 10.1080/01431160701408477; van Zyl JJ, 2001, ACTA ASTRONAUT, V48, P559, DOI 10.1016/S0094-5765(01)00020-0; [王解先 Wang Jiexian], 2003, [大地测量与地球动力学, Journal of Geodesy and Geodynamics], V23, P70; Wang WC, 2012, HYDROL PROCESS, V26, P213, DOI 10.1002/hyp.8127; Wang Z., 2001, GLACIER INVENTORY CH; Wei JF, 2015, J MT SCI-ENGL, V12, P330, DOI 10.1007/s11629-014-3175-1; Wei JF, 2015, ARCT ANTARCT ALP RES, V47, P301, DOI 10.1657/AAAR00C-13-129; Wei JF, 2014, ANN GLACIOL, V55, P213, DOI 10.3189/2014AoG66A038; Xu J, J GLACIOLOG IN PRESS; Xu J, 2015, ADV METEOROL, P1; Xu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070574; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; [曾磊 Zeng Lei], 2013, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V27, P144; Zhang QB, 2014, MT RES DEV, V34, P56, DOI 10.1659/MRD-JOURNAL-D-12-00074.1; Zhang Z, 1960, J MT SCI EN IN PRESS	82	31	34	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147327	10.1371/journal.pone.0147327	http://dx.doi.org/10.1371/journal.pone.0147327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789404	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100080
J	Circu, ML; Dykes, SS; Carroll, J; Kelly, K; Galiano, F; Greer, A; Cardelli, J; El-Osta, H				Circu, Magdalena L.; Dykes, Samantha S.; Carroll, Jennifer; Kelly, Kinsey; Galiano, Floyd; Greer, Adam; Cardelli, James; El-Osta, Hazem			A Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invasion	PLOS ONE			English	Article							CATHEPSIN-B; QUALITY-CONTROL; HIT SELECTION; LUNG-CANCER; TUMOR-CELLS; ACIDIFICATION; AUTOPHAGY; PROGRESSION; TRANSPORT; PATHWAYS	Lysosome trafficking plays a significant role in tumor invasion, a key event for the development of metastasis. Previous studies from our laboratory have demonstrated that the anterograde (outward) movement of lysosomes to the cell surface in response to certain tumor microenvironment stimulus, such as hepatocyte growth factor (HGF) or acidic extracellular pH (pHe), increases cathepsin B secretion and tumor cell invasion. Anterograde lysosome trafficking depends on sodium-proton exchanger activity and can be reversed by blocking these ion pumps with Troglitazone or EIPA. Since these drugs cannot be advanced into the clinic due to toxicity, we have designed a high-content assay to discover drugs that block peripheral lysosome trafficking with the goal of identifying novel drugs that inhibit tumor cell invasion. An automated high-content imaging system (Cellomics) was used to measure the position of lysosomes relative to the nucleus. Among a total of 2210 repurposed and natural product drugs screened, 18 "hits" were identified. One of the compounds identified as an anterograde lysosome trafficking inhibitor was niclosamide, a marketed human anti-helminthic drug. Further studies revealed that niclosamide blocked acidic pHe, HGF, and epidermal growth factor (EGF)-induced anterograde lysosome redistribution, protease secretion, motility, and invasion of DU145 castrate resistant prostate cancer cells at clinically relevant concentrations. In an effort to identify the mechanism by which niclosamide prevented anterograde lysosome movement, we found that this drug exhibited no significant effect on the level of ATP, microtubules or actin filaments, and had minimal effect on the PI3K and MAPK pathways. Niclosamide collapsed intralysosomal pH without disruption of the lysosome membrane, while bafilomycin, an agent that impairs lysosome acidification, was also found to induce JLA in our model. Taken together, these data suggest that niclosamide promotes juxtanuclear lysosome aggregation (JLA) via modulation of pathways involved in lysosome acidification. In conclusion, we have designed a validated reproducible high-content assay to screen for drugs that inhibit lysosome trafficking and reduce tumor invasion and we summarize the action of one of these drugs.	[Circu, Magdalena L.; Dykes, Samantha S.; Carroll, Jennifer; Kelly, Kinsey; Galiano, Floyd; Greer, Adam; Cardelli, James; El-Osta, Hazem] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; [Dykes, Samantha S.; Cardelli, James] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	El-Osta, H (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA.	helost@lsuhsc.edu			Pfizer; Feist-Weiller Cancer Center	Pfizer(Pfizer); Feist-Weiller Cancer Center	This research was funded, in part, by grant from Pfizer, and funding from the Feist-Weiller Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Deng D, 2009, BBA-BIOMEMBRANES, V1788, P470, DOI 10.1016/j.bbamem.2008.11.018; DiCiccio JE, 2011, J GEN PHYSIOL, V137, P385, DOI 10.1085/jgp.201110596; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HOLLENBECK PJ, 1990, NATURE, V346, P864, DOI 10.1038/346864a0; Hosogi S, 2014, J CELL MOL MED, V18, P1124, DOI 10.1111/jcmm.12257; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Jedeszko C., 2008, CURR PROTOC CELL BIO; Jiang PD, 2015, METHODS, V75, P13, DOI 10.1016/j.ymeth.2014.11.021; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Jordens I, 2006, PIGM CELL RES, V19, P412, DOI 10.1111/j.1600-0749.2006.00329.x; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Khanim FL, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.38; Korolchuk VI, 2011, AUTOPHAGY, V7, P927, DOI 10.4161/auto.7.8.15862; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Li H, 2000, J DIABETES COMPLICAT, V14, P175, DOI 10.1016/S1056-8727(00)00076-3; Li R, 2013, MOL CANCER THER, V12, P2200, DOI 10.1158/1535-7163.MCT-13-0095; Liu CF, 2014, CLIN CANCER RES, V20, P3198, DOI 10.1158/1078-0432.CCR-13-3296; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045910; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MACH L, 1994, J BIOL CHEM, V269, P13030; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; Muller S, 2012, BBA-PROTEINS PROTEOM, V1824, P34, DOI 10.1016/j.bbapap.2011.07.003; Nishimura Y, 2000, CELL TISSUE RES, V301, P341, DOI 10.1007/s004410000243; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Sack U, 2011, JNCI-J NATL CANCER I, V103, P1018, DOI 10.1093/jnci/djr190; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Shun TY, 2011, J BIOMOL SCREEN, V16, P1, DOI 10.1177/1087057110389039; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Steffan JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087882; Steffan JJ, 2011, CURR PROTEIN PEPT SC, V12, P12; Steffan JJ, 2010, J CELL SCI, V123, P1151, DOI 10.1242/jcs.063644; Steffan JJ, 2010, TRAFFIC, V11, P274, DOI 10.1111/j.1600-0854.2009.01012.x; Steffan JJ, 2009, TRAFFIC, V10, P737, DOI 10.1111/j.1600-0854.2009.00904.x; Sukhai MA, 2013, J CLIN INVEST, V123, P315, DOI 10.1172/JCI64180; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074538; WEINBACH EC, 1969, NATURE, V221, P1016, DOI 10.1038/2211016a0; Wieland A, 2013, CLIN CANCER RES, V19, P4124, DOI 10.1158/1078-0432.CCR-12-2895; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623; Yo YT, 2012, MOL CANCER THER, V11, P1703, DOI 10.1158/1535-7163.MCT-12-0002; You S, 2014, MOL CANCER THER, V13, P606, DOI 10.1158/1535-7163.MCT-13-0608; Zhang XD, 2007, GENOMICS, V89, P552, DOI 10.1016/j.ygeno.2006.12.014; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851	56	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146931	10.1371/journal.pone.0146931	http://dx.doi.org/10.1371/journal.pone.0146931			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784896	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400080
J	Libro, S; Vollmer, SV				Libro, Silvia; Vollmer, Steven V.			Genetic Signature of Resistance to White Band Disease in the Caribbean Staghorn Coral Acropora cervicornis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CLIMATE-CHANGE; HOST-DEFENSE; IMMUNITY; NLRC5; ARABIDOPSIS; RESILIENCE; RESPONSES; SYSTEM; REEFS	Coral reefs are declining worldwide due to multiple factors including rising sea surface temperature, ocean acidification, and disease outbreaks. Over the last 30 years, White Band Disease (WBD) alone has killed up to 95% of the Caribbean's dominant shallow-water corals-the staghorn coral Acropora cervicornis and the elkhorn coral A. palmata. Both corals are now listed on the US Endangered Species Act, and while their recovery has been slow, recent transmission surveys indicate that more than 5% of staghorn corals are disease resistant. Here we compared transcriptome-wide gene expression between resistant and susceptible staghorn corals exposed to WBD using in situ transmission assays. We identified constitutive gene expression differences underlying disease resistance that are independent from the immune response associated with disease exposure. Genes involved in RNA interference-mediated gene silencing, including Argonaute were up-regulated in resistant corals, whereas heat shock proteins (HSPs) were down-regulated. Up-regulation of Argonaute proteins indicates that post-transcriptional gene silencing plays a key, but previously unsuspected role in coral immunity and disease resistance. Constitutive expression of HSPs has been linked to thermal resilience in other Acropora corals, suggesting that the down-regulation of HSPs in disease resistant staghorn corals may confer a dual benefit of thermal resilience.	[Libro, Silvia; Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, 430 Nahant Rd, Nahant, MA 01908 USA	Northeastern University	Libro, S (corresponding author), Northeastern Univ, Ctr Marine Sci, 430 Nahant Rd, Nahant, MA 01908 USA.; Libro, S (corresponding author), New England Biolabs Inc, Genome Biol Div, Mol Parasitol, 240 Cty Rd, Ipswich, MA USA.	libro.silv@gmail.com	libro, silvia/AAM-7256-2021	libro, silvia/0000-0003-0230-3876	National Science Foundation as part of the Academic Research Infrastructure Recovery and Reinvestment Program [0963010]; NSF Biological Oceanography program [OCE 0751666]	National Science Foundation as part of the Academic Research Infrastructure Recovery and Reinvestment Program; NSF Biological Oceanography program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation (http://www.nsf.gov) Grant 0963010, as part of the Academic Research Infrastructure Recovery and Reinvestment Program and by the NSF Biological Oceanography program to SVV (OCE 0751666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio A, 2007, PLANT CELL, V19, P3778, DOI 10.1105/tpc.107.054494; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2012, REORGANIZING PROTEIN; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Casas V, 2004, ENVIRON MICROBIOL, V6, P1137, DOI 10.1111/j.1462-2920.2004.00647.x; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gignoux-Wolfsohn SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00804; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Gould J, 2013, GENE E INTERACT GENE; Hamada M, 2013, MOL BIOL EVOL, V30, P167, DOI 10.1093/molbev/mss213; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hogarth WT, 2005, FED REGISTER, V70, P24359; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kline DI, 2011, SCI REP-UK, V1, DOI 10.1038/srep00007; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Libro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081821; Love MI, MODERATED ESTIMATION; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Moran Y, 2014, GENOME RES, V24, P651, DOI 10.1101/gr.162503.113; Moran Y, 2013, MOL BIOL EVOL, V30, P2541, DOI 10.1093/molbev/mst159; Nakamura M, 2012, BIOL OPEN, V1, P75, DOI 10.1242/bio.2011036; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; Ritchie KB, 1998, REV BIOL TROP, V46, P199; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Sweet MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0094; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010	40	23	23	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146636	10.1371/journal.pone.0146636	http://dx.doi.org/10.1371/journal.pone.0146636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784329	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400055
J	Wu, LH; Leung, H; Jiang, H; Zheng, H; Ma, L				Wu, Lihua; Leung, Henry; Jiang, Hao; Zheng, Hong; Ma, Li			Incorporating Human Movement Behavior into the Analysis of Spatially Distributed Infrastructure	PLOS ONE			English	Article							MIGRATION	For the first time in human history, the majority of the world's population resides in urban areas. Therefore, city managers are faced with new challenges related to the efficiency, equity and quality of the supply of resources, such as water, food and energy. Infrastructure in a city can be viewed as service points providing resources. These service points function together as a spatially collaborative system to serve an increasing population. To study the spatial collaboration among service points, we propose a shared network according to human's collective movement and resource usage based on data usage detail records (UDRs) from the cellular network in a city in western China. This network is shown to be not scale-free, but exhibits an interesting triangular property governed by two types of nodes with very different link patterns. Surprisingly, this feature is consistent with the urban-rural dualistic context of the city. Another feature of the shared network is that it consists of several spatially separated communities that characterize local people's active zones but do not completely overlap with administrative areas. According to these features, we propose the incorporation of human movement into infrastructure classification. The presence of well-defined spatially separated clusters confirms the effectiveness of this approach. In this paper, our findings reveal the spatial structure inside a city, and the proposed approach provides a new perspective on integrating human movement into the study of a spatially distributed system.	[Wu, Lihua; Jiang, Hao; Zheng, Hong; Ma, Li] Wuhan Univ, Dept Commun Engn, Wuhan 430072, Peoples R China; [Leung, Henry] Univ Calgary, Dept Elect & Comp Engn, Calgary, AB T2N 1N4, Canada; [Jiang, Hao] Wuhan Univ, Geospatial Informat Technol Cooperat Innovat Ctr, Wuhan 430072, Peoples R China	Wuhan University; University of Calgary; Wuhan University	Jiang, H (corresponding author), Wuhan Univ, Dept Commun Engn, Wuhan 430072, Peoples R China.; Jiang, H (corresponding author), Wuhan Univ, Geospatial Informat Technol Cooperat Innovat Ctr, Wuhan 430072, Peoples R China.	jh@whu.edu.cn			National Natural Science Foundation of China (NSFC) [61371126]; National High Technology Research and Development Program of China (863 Program) [2014AA01A707]; National key Basic Research Program of China (973 Program) [2011CB707106]; Independent Research Program of Central Universities [2042014kf0256]; Natural Science Foundation of Hubei province [2011CDA042]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National key Basic Research Program of China (973 Program)(National Basic Research Program of China); Independent Research Program of Central Universities; Natural Science Foundation of Hubei province(Natural Science Foundation of Hubei Province)	This work was funded by the National Natural Science Foundation of China (NSFC, grant number: 61371126, http://www.nsfc.gov.cn/), the National High Technology Research and Development Program of China (863 Program, grant number: 2014AA01A707, http://www.863.gov.cn/), the National key Basic Research Program of China (973 Program, grant number: 2011CB707106, http://www.973.gov.cn/), the Independent Research Program of Central Universities (grant number: 2042014kf0256), and the Natural Science Foundation of Hubei province (grant number: 2011CDA042, http://www.hbstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X., 2014, P WORKSHOP DATA SCI, P1; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Clements M, 2011, PERSONALISED TRAVEL, P1; De Montis A, 2007, ENVIRON PLANN B, V34, P905, DOI 10.1068/b32128; Gao S, 2013, T GIS, V17, P463, DOI 10.1111/tgis.12042; Gao S, 2013, ENVIRON PLANN B, V40, P135, DOI 10.1068/b38141; Glaeser EL, 2011, TRIUMPH CITY OUR GRE; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; IBM Global Business Services, 2010, SMART CIT ASS; Jarv O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049171; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086026; Louail T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7007; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ng AY, 2002, ADV NEUR IN, V14, P849; Ni SJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016111; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Paul U, 2012, IEEE CONF COMPUT, P244, DOI 10.1109/INFCOMW.2012.6193499; Pei T, 2014, INT J GEOGR INF SCI, V28, P1988, DOI 10.1080/13658816.2014.913794; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Shelton T, 2015, CAMB J REG ECON SOC, V8, P13, DOI 10.1093/cjres/rsu026; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Townsend A.M., 2013, SMART CITIES BIG DAT; Vang J, 2015, EUR PLAN STUD, V23, P638, DOI 10.1080/09654313.2014.990607; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021197; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713; Yook SH, 2001, PHYS REV LETT, V86, P5835, DOI 10.1103/PhysRevLett.86.5835	36	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147216	10.1371/journal.pone.0147216	http://dx.doi.org/10.1371/journal.pone.0147216			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784749	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400124
J	Zhang, JQ; Gao, BW; Wang, J; Wang, XW; Ren, QL; Chen, JF; Ma, Q; Xing, BS				Zhang, Jia-Qing; Gao, Bin-Wen; Wang, Jing; Wang, Xian-Wei; Ren, Qiao-Ling; Chen, Jun-Feng; Ma, Qiang; Xing, Bao-song			Chronic Exposure to Diquat Causes Reproductive Toxicity in Female Mice	PLOS ONE			English	Article							GRANULOSA-CELL APOPTOSIS; OXIDATIVE STRESS; HEPATIC-NECROSIS; OXYGEN; METHOXYCHLOR; GROWTH; LIVER; SUPEROXIDE; INHIBITION; MECHANISMS	Diquat is a bipyridyl herbicide that has been widely used as a model chemical for in vivo studies of oxidative stress due to its generation of superoxide anions, and cytotoxic effects. There is little information regarding the toxic effects of diquat on the female reproductive system, particularly ovarian function. Thus, we investigated the reproductive toxic effects of diquat on female mice. Chronic exposure to diquat reduced ovary weights, induced ovarian oxidative stress, resulted in granulosa cell apoptosis, and disrupted oocyte developmental competence, as shown by reactive oxygen species (ROS) accumulation, decreased polar body extrusion rates and increased apoptosis-related genes expression. Additionally, after diquat treatment, the numbers of fetal mice and litter sizes were significantly reduced compared to those of control mice. Thus, our results indicated that chronic exposure to diquat induced reproductive toxicity in female mice by promoting the ROS production of gruanousa cells and ooctyes, impairing follicle development, inducing apoptosis, and reducing oocyte quality. In conclusion, our findings indicate that diquat can be used as a potent and efficient chemical for in vivo studies of female reproductive toxicity induced by oxidative stress. Moreover, the findings from this study will further enlarge imitative research investigating the effect of ovarian damage induced by oxidative stress on reproductive performance and possible mechanisms of action in large domestic animals.	[Zhang, Jia-Qing; Gao, Bin-Wen; Wang, Jing; Ren, Qiao-Ling; Chen, Jun-Feng; Ma, Qiang; Xing, Bao-song] Henan Acad Agr Sci, Inst Anim Husb & Vet Sci, Zhengzhou, Peoples R China; [Wang, Xian-Wei] Henan Prov Anim Husb Gen Stn, Zhengzhou, Peoples R China	Henan Academy of Agricultural Sciences	Xing, BS (corresponding author), Henan Acad Agr Sci, Inst Anim Husb & Vet Sci, Zhengzhou, Peoples R China.	xingbaosong502@163.com			Key Program for Science and Technology Development of Henan [152102110126]; Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences [2016YQ19]	Key Program for Science and Technology Development of Henan; Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences	This work was supported by Key Program for Science and Technology Development of Henan (152102110126) and the Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences (2016YQ19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, ANTIOXID REDOX SIGN, V10, P1375, DOI 10.1089/ars.2007.1964; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Alavanja MCR, 2004, ANNU REV PUBL HEALTH, V25, P155, DOI 10.1146/annurev.publhealth.25.101802.123020; Ardestani A, 2007, FOOD CHEM, V104, P21, DOI 10.1016/j.foodchem.2006.10.066; Devine PJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095224; Droge W, 2008, ANTIOXID REDOX SIGN, V10, P661, DOI 10.1089/ars.2007.1953; Duan X, 2015, SCI REP-UK, V5, DOI 10.1038/srep11562; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; FARRINGTON JA, 1973, BIOCHIM BIOPHYS ACTA, V314, P372, DOI 10.1016/0005-2728(73)90121-7; Fu YX, 1999, FREE RADICAL BIO MED, V27, P605, DOI 10.1016/S0891-5849(99)00104-5; Fussell KC, 2011, FREE RADICAL BIO MED, V50, P874, DOI 10.1016/j.freeradbiomed.2010.12.035; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Gupta RK, 2006, TOXICOL APPL PHARM, V216, P436, DOI 10.1016/j.taap.2006.06.013; Gupta RK, 2007, TOXICOL PATHOL, V35, P649, DOI 10.1080/01926230701459960; Gupta RK, 2006, TOXICOL SCI, V93, P382, DOI 10.1093/toxsci/kfl052; Gupta S, 2000, TOXICOL SCI, V54, P203, DOI 10.1093/toxsci/54.1.203; Hamm ML, 2004, BIOL REPROD, V71, P66, DOI 10.1095/biolreprod.104.027292; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; Lu T, 2010, FOOD CHEM TOXICOL, V48, P764, DOI 10.1016/j.fct.2009.12.018; Lv M, 2012, ANIMAL, V6, P928, DOI 10.1017/S1751731111002382; Mao XB, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-49; Murdoch WJ, 1998, J REPROD FERTIL, V114, P127, DOI 10.1530/jrf.0.1140127; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; RAWLINGS JM, 1994, BIOCHEM PHARMACOL, V47, P1271, DOI 10.1016/0006-2952(94)90401-4; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Seino T, 2002, FERTIL STERIL, V77, P1184, DOI 10.1016/S0015-0282(02)03103-5; Sen N, 2015, REPROD TOXICOL, V53, P15, DOI 10.1016/j.reprotox.2015.02.012; Sewalk CJ, 2000, J TOXICOL ENV HEAL A, V62, P33, DOI 10.1080/00984100050201659; Shen M, 2012, J BIOL CHEM, V287, P25727, DOI 10.1074/jbc.M112.349902; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; SMITH CV, 1985, J PHARMACOL EXP THER, V235, P172; Sugino Norihiro, 2005, Reprod Med Biol, V4, P31, DOI 10.1111/j.1447-0578.2005.00086.x; TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242; TSOKOSKUHN JO, 1988, MOL PHARMACOL, V34, P209; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wu KC, 2012, FREE RADICAL RES, V46, P1220, DOI 10.3109/10715762.2012.700709; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yumino K, 2002, J BIOCHEM, V131, P565, DOI 10.1093/oxfordjournals.jbchem.a003135; Zhang JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086589; Zheng P, 2013, BRIT J NUTR, V109, P2253, DOI 10.1017/S0007114512004321	40	9	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147075	10.1371/journal.pone.0147075	http://dx.doi.org/10.1371/journal.pone.0147075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785375	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400106
J	Andruszkow, H; Schweigkofler, U; Lefering, R; Frey, M; Horst, K; Pfeifer, R; Beckers, SK; Pape, HC; Hildebrand, F				Andruszkow, Hagen; Schweigkofler, Uwe; Lefering, Rolf; Frey, Magnus; Horst, Klemens; Pfeifer, Roman; Beckers, Stefan Kurt; Pape, Hans-Christoph; Hildebrand, Frank			Impact of Helicopter Emergency Medical Service in Traumatized Patients: Which Patient Benefits Most?	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; INJURY SEVERITY SCORE; MAJOR TRAUMA; TRANSPORT; SURVIVAL; LEVEL; HEMS; ASSOCIATION; OUTCOMES; ADULTS	Introduction The Helicopter Emergency Medical Service (HEMS) was established for the prehospital trauma care of patients. Improved rescue times and increased coverage areas are discussed as specific advantages of HEMS. We recently found evidence that HEMS exerts beneficial effects on outcomes for severely injured patients. However, it still remains unknown which group of trauma patients might benefit most from HEMS rescue. Consequently, the unique aim of this study was to reveal which patients might benefit most from HEMS rescue. Methods Trauma patients (ISS >= 9) primarily treated by HEMS or ground emergency medical services (GEMS) between 2002 and 2012 were analysed using the TraumaRegister DGU. A multivariate regression analysis was used to reveal the survival benefit between different trauma populations. Results The study included 52 281 trauma patients. Of these, 68.8% (35 974) were rescued by GEMS and 31.2% (16 307) by HEMS. HEMS patients were more severely injured compared to GEMS patients (ISS: HEMS 24.8+/-13.5 vs. GEMS 21.7+/-18.0) and more frequently suffered traumatic shock (SBP sys <90mmHg: HEMS 18.3% vs. GEMS 14.8%). However, logistic regression analysis revealed that HEMS rescues resulted in an overall survival benefit compared to GEMS (OR 0.81, 95% CI [0.75-0.87], p<0.001, Nagelkerke's R squared 0.526, area under the ROC curve 0.922, 95% CI [0.919-0.925]). Analysis of specific subgroups demonstrated that patients aged older than 55 years (OR 0.62, 95% CI [0.50-0.77]) had the highest survival benefit after HEMS treatment. Furthermore, HEMS rescue had the most significant impact after 'low falls' (OR 0.68, 95% CI [0.55-0.84]) and in the case of minor severity injuries (ISS 9-15) (OR 0.66, 95% CI [0.49-0.88]). Conclusions In general, trauma patients benefit from HEMS rescue with in-hospital survival as the main outcome parameter. Focusing on special subgroups, middle aged and older patients, low-energy trauma, and minor severity injuries had the highest survival benefit when rescued by HEMS. Further studies are required to determine the potential reasons of this benefit.	[Andruszkow, Hagen; Frey, Magnus; Horst, Klemens; Pfeifer, Roman; Pape, Hans-Christoph; Hildebrand, Frank] Univ Aachen, Dept Orthoped Trauma, Pauwelsstr 30, D-52074 Aachen, Germany; [Andruszkow, Hagen; Frey, Magnus; Horst, Klemens; Pfeifer, Roman; Pape, Hans-Christoph; Hildebrand, Frank] Univ Hosp Aachen, Harald Tscherne Lab, Pauwelsstr 30, D-52074 Aachen, Germany; [Schweigkofler, Uwe] Berufsgenossenschaftliche Unfallklin Frankfurt, Dept Trauma & Orthoped Surg, Friedberger Landstr 430, D-60389 Frankfurt, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Beckers, Stefan Kurt] Rhein Westfal TH Aachen, Univ Hosp Aachen, Emergency Med Serv Aachen, Dept Anaesthesiol, Pauwelsstr 30, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; Witten Herdecke University; RWTH Aachen University; RWTH Aachen University Hospital	Andruszkow, H (corresponding author), Univ Aachen, Dept Orthoped Trauma, Pauwelsstr 30, D-52074 Aachen, Germany.; Andruszkow, H (corresponding author), Univ Hosp Aachen, Harald Tscherne Lab, Pauwelsstr 30, D-52074 Aachen, Germany.	handruszkow@ukaachen.de	Beckers, Stefan K./O-2943-2019; Beckers, Stefan K/C-6776-2011; Hildebrand, Frank/J-3176-2017	Beckers, Stefan K./0000-0002-2896-7948; Beckers, Stefan K/0000-0002-2896-7948; Pape, Hans-Christoph/0000-0002-2059-4980				Abe T, 2014, CRIT CARE, V18, DOI 10.1186/cc13981; Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Andruszkow H, 2014, INJURY, V45, pS53, DOI 10.1016/j.injury.2014.08.018; Andruszkow H, 2013, CRIT CARE, V17, DOI 10.1186/cc12796; Andruszkow H, 2012, TECHNOL HEALTH CARE, V20, P435, DOI 10.3233/THC-2012-0691; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bala M, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-91; Biewener A, 2004, J TRAUMA, V56, P94, DOI 10.1097/01.TA.0000061883.92194.50; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brathwaite CEM, 1998, J TRAUMA, V45, P140, DOI 10.1097/00005373-199807000-00029; Brown JB, 2010, J TRAUMA, V69, P1030, DOI 10.1097/TA.0b013e3181f6f450; Bulger EM, 2012, J TRAUMA ACUTE CARE, V72, P567, DOI 10.1097/TA.0b013e31824baddf; Butler DP, 2010, EMERG MED J, V27, P692, DOI 10.1136/emj.2009.087486; de Jongh MAC, 2012, INJURY, V43, P1362, DOI 10.1016/j.injury.2012.01.009; Galvagno SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009228.pub2; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Hannan EL, 2004, J TRAUMA, V56, P1297, DOI 10.1097/01.TA.0000075350.66739.53; Hranjec T, 2012, AM SURGEON, V78, P1369; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Pandya SR, 2011, J TRAUMA, V70, P1326, DOI 10.1097/TA.0b013e31820e327c; Peschman J, 2011, J TRAUMA, V70, P1331, DOI 10.1097/TA.0b013e31821693e2; Plevin RE, 2011, HELICOPTER TRANSPORT; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Salottolo KM, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-7; Sampalis JS, 2009, ANN SURG, V249, P488, DOI 10.1097/SLA.0b013e31819a8b4f; Schweigkofler U, 2014, UNFALLCHIRURG; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stewart KE, 2011, ACAD EMERG MED, V18, P1208, DOI 10.1111/j.1553-2712.2011.01207.x; Sturm JA, 2013, CLIN ORTHOP RELAT R, V471, P2912, DOI 10.1007/s11999-013-2967-x; Sullivent EE, 2011, PREHOSP EMERG CARE, V15, P295, DOI 10.3109/10903127.2011.569849; Talving P, 2009, WORLD J SURG, V33, P2469, DOI 10.1007/s00268-009-0185-1; Taylor C, 2012, INJURY, V43, P1843, DOI 10.1016/j.injury.2012.07.184; Taylor CB, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-11; TEASDALE G, 1974, LANCET, V2, P81; Thomas Stephen H, 2002, Prehosp Emerg Care, V6, P359, DOI 10.1080/10903120290938508; Thomas SH, 2014, PREHOSP EMERG CARE, V18, P35, DOI 10.3109/10903127.2013.844872; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Westhoff J, 2003, INJURY, V34, P674, DOI 10.1016/S0020-1383(03)00147-5	40	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146897	10.1371/journal.pone.0146897	http://dx.doi.org/10.1371/journal.pone.0146897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771462	gold, Green Published, Green Submitted			2022-12-26	WOS:000368628300041
J	Crouch, LI; Labourel, A; Walton, PH; Davies, GJ; Gilbert, HJ				Crouch, Lucy I.; Labourel, Aurore; Walton, Paul H.; Davies, Gideon J.; Gilbert, Harry J.			The Contribution of Non-catalytic Carbohydrate Binding Modules to the Activity of Lytic Polysaccharide Monooxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL WALL DEGRADATION; CELLULOSE-BINDING; SUBSTRATE-SPECIFICITY; FUNCTIONAL-CHARACTERIZATION; SERRATIA-MARCESCENS; LIMITED PROTEOLYSIS; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; PROTEIN CBP21; FAMILY	Lignocellulosic biomass is a sustainable industrial substrate. Copper-dependent lytic polysaccharide monooxygenases (LPMOs) contribute to the degradation of lignocellulose and increase the efficiency of biofuel production. LPMOs can contain non-catalytic carbohydrate binding modules (CBMs), but their role in the activity of these enzymes is poorly understood. Here we explored the importance of CBMs in LPMO function. The family 2a CBMs of two monooxygenases, CfLPMO10 and TbLPMO10 from Cellulomonas fimi and Thermobispora bispora, respectively, were deleted and/or replaced with CBMs from other proteins. The data showed that the CBMs could potentiate and, surprisingly, inhibit LPMO activity, and that these effects were both enzyme-specific and substrate-specific. Removing the natural CBM or introducing CtCBM3a, from the Clostridium thermocellum cellulosome scaffoldin CipA, almost abolished the catalytic activity of the LPMOs against the cellulosic substrates. The deleterious effect of CBM removal likely reflects the importance of prolonged presentation of the enzyme on the surface of the substrate for efficient catalytic activity, as only LPMOs appended to CBMs bound tightly to cellulose. The negative impact of CtCBM3a is in sharp contrast with the capacity of this binding module to potentiate the activity of a range of glycoside hydrolases including cellulases. The deletion of the endogenous CBM from CfLPMO10 or the introduction of a family 10 CBM from Cellvibrio japonicus LPMO10B into TbLPMO10 influenced the quantity of non-oxidized products generated, demonstrating that CBMs can modulate the mode of action of LPMOs. This study demonstrates that engineered LPMO-CBM hybrids can display enhanced industrially relevant oxygenations.	[Crouch, Lucy I.; Labourel, Aurore; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Walton, Paul H.; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England	Newcastle University - UK; University of York - UK	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	harry.gilbert@ncl.ac.uk	Davies, Gideon J/A-9042-2011	Davies, Gideon J/0000-0002-7343-776X; Labourel, Aurore/0000-0002-4762-5804; Walton, Paul/0000-0002-1152-1480	Biotechnology and Biological Sciences Research Council [BB/K020358/1, BB/L021633/1, BB/K001949/1]; BBSRC [BB/K020358/1, BB/L021633/1, BB/K001949/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (Grants BB/K020358/1, BB/L021633/1, and BB/K001949/1). The authors declare that they have no conflicts of interest with the contents of this article.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Andersen N, 2008, ENZYME MICROB TECH, V42, P362, DOI 10.1016/j.enzmictec.2007.11.018; Arfi Y, 2014, P NATL ACAD SCI USA, V111, P9109, DOI 10.1073/pnas.1404148111; ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283; Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Book AJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-109; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gardner JG, 2014, MOL MICROBIOL, V94, P1121, DOI 10.1111/mmi.12821; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Urbanowicz BR, 2012, P NATL ACAD SCI USA, V109, P14253, DOI 10.1073/pnas.1208097109; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; VANTILBEURGH H, 1986, FEBS LETT, V204, P223, DOI 10.1016/0014-5793(86)80816-X; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Zhang XY, 2014, J BIOL CHEM, V289, P2002, DOI 10.1074/jbc.M113.527770	49	74	77	2	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7439	7449		10.1074/jbc.M115.702365	http://dx.doi.org/10.1074/jbc.M115.702365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26801613	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000383447600020
J	Salvo, E; Alabi, S; Liu, B; Schlessinger, A; Bechhofer, DH				Salvo, Elizabeth; Alabi, Shanique; Liu, Bo; Schlessinger, Avner; Bechhofer, David H.			Interaction of Bacillus subtilis Polynucleotide Phosphorylase and RNase Y: STRUCTURAL MAPPING AND EFFECT ON mRNA TURNOVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial genetics; endonuclease; mRNA decay; phosphorylase; RNA turnover; Bacillus subtilis; PNPase; RNase Y	BACTERIAL 2-HYBRID SYSTEM; ESCHERICHIA-COLI; DECAY; EXORIBONUCLEASES; ENDORIBONUCLEASE; IDENTIFICATION; DEGRADATION; DEGRADOSOME; INITIATION; SEQUENCE	Polynucleotide phosphorylase (PNPase), a 3-to-5 phosphorolytic exoribonuclease, is thought to be the primary enzyme responsible for turnover of Bacillus subtilis mRNA. The role of PNPase in B. subtilis mRNA decay has been analyzed previously by comparison of mRNA profiles in a wild-type strain versus a strain that is deleted for pnpA, the gene encoding PNPase. Recent studies have provided evidence for a degradosome-like complex in B. subtilis that is built around the major decay-initiating endonuclease, RNase Y, and there is ample evidence for a strong interaction between PNPase and RNase Y. The role of the PNPase-RNase Y interaction in the exonucleolytic function of PNPase needs to be clarified. We sought to construct a B. subtilis strain containing a catalytically active PNPase that could not interact with RNase Y. Mapping studies of the PNPase-RNase Y interaction were guided by a homology model of B. subtilis PNPase based on the known structure of the Escherichia coli PNPase in complex with an RNase E peptide. Mutations in B. subtilis residues predicted to be involved in RNase Y binding showed a loss of PNPase-RNase Y interaction. Two mRNAs whose decay is dependent on RNase Y and PNPase were examined in strains containing full-length PNPase that was either catalytically active but unable to interact with RNase Y, or catalytically inactive but able to interact with RNase Y. At least for these two mRNAs, disruption of the PNPase-RNase Y interaction did not appear to affect mRNA turnover.	[Salvo, Elizabeth; Alabi, Shanique; Liu, Bo; Schlessinger, Avner; Bechhofer, David H.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Alabi, Shanique] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Icahn School of Medicine at Mount Sinai; Yale University	Bechhofer, DH (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	david.bechhofer@mssm.edu	Liu, Bo/G-5317-2015	Liu, Bo/0000-0002-4511-6926	National Institutes of Health [R01 GM100137, R01 GM108911]; United States Department of Defense [W81XWH-15-1-0539]; Post-baccalaureate Research Education Program [R25 GM06118]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100137, R01GM108911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Post-baccalaureate Research Education Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM100137 (to D. H. B.) and R01 GM108911 (to A. S.) and United States Department of Defense Grant W81XWH-15-1-0539 (to A. S.) This work was also supported by Post-baccalaureate Research Education Program Grant R25 GM06118 (to S. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bechhofer DH, 2008, METHOD ENZYMOL, V447, P259, DOI 10.1016/S0076-6879(08)02214-3; Bechhofer DH, 1998, J BACTERIOL, V180, P5968, DOI 10.1128/JB.180.22.5968-5977.1998; BROSIUS J, 1992, METHOD ENZYMOL, V216, P469; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; DEUTSCHER MP, 1991, P NATL ACAD SCI USA, V88, P3277, DOI 10.1073/pnas.88.8.3277; DUFFY JJ, 1972, J MOL BIOL, V64, P565, DOI 10.1016/0022-2836(72)90083-6; Gerwig J, 2014, MOL MICROBIOL, V94, P5, DOI 10.1111/mmi.12769; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Jarrige AC, 2002, J MOL BIOL, V321, P397, DOI 10.1016/S0022-2836(02)00645-9; Kang SO, 2010, INFECT IMMUN, V78, P2754, DOI 10.1128/IAI.01370-09; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Laalami S, 2014, CELL MOL LIFE SCI, V71, P1799, DOI 10.1007/s00018-013-1472-4; Lehnik-Habrink M, 2012, MOL MICROBIOL, V84, P1005, DOI 10.1111/j.1365-2958.2012.08072.x; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Liu B, 2014, MOL MICROBIOL, V94, P41, DOI 10.1111/mmi.12748; Luttinger A, 1996, MOL MICROBIOL, V19, P343, DOI 10.1046/j.1365-2958.1996.380907.x; Newman JA, 2012, J MOL BIOL, V416, P121, DOI 10.1016/j.jmb.2011.12.024; Nurmohamed S, 2009, J MOL BIOL, V389, P17, DOI 10.1016/j.jmb.2009.03.051; Oussenko IA, 2005, J BACTERIOL, V187, P2758, DOI 10.1128/JB.187.8.2758-2767.2005; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Sharp JS, 2003, J BACTERIOL, V185, P5372, DOI 10.1128/JB.185.18.5372-5379.2003; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Wang W, 1996, J BACTERIOL, V178, P2375, DOI 10.1128/jb.178.8.2375-2382.1996; Wu YH, 2012, ANAL BIOCHEM, V423, P15, DOI 10.1016/j.ab.2012.01.012; Yao SY, 2010, J BACTERIOL, V192, P3279, DOI 10.1128/JB.00230-10	37	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6655	6663		10.1074/jbc.M115.711044	http://dx.doi.org/10.1074/jbc.M115.711044			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26797123	Green Published, hybrid			2022-12-26	WOS:000373299700004
J	Tanaka, H; Muto, A; Shima, H; Katoh, Y; Sax, N; Tajima, S; Brydun, A; Ikura, T; Yoshizawa, N; Masai, H; Hoshikawa, Y; Noda, T; Nio, M; Ochiai, K; Igarashi, K				Tanaka, Hiromu; Muto, Akihiko; Shima, Hiroki; Katoh, Yasutake; Sax, Nicolas; Tajima, Shinya; Brydun, Andrey; Ikura, Tsuyoshi; Yoshizawa, Naoko; Masai, Hisao; Hoshikawa, Yutaka; Noda, Tetsuo; Nio, Masaki; Ochiai, Kyoko; Igarashi, Kazuhiko			Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; epigenetics; gene regulation; histone; transcription factor; B cells; methylation; plasma cells	TRANSCRIPTION FACTOR BLIMP-1; SECRETING PLASMA-CELLS; T-CELLS; PROTEIN COMPLEXES; REPRESSOR BACH2; IN-VIVO; NETWORK; DIFFERENTIATION; HOMEOSTASIS; SMRT	B lymphocyte-induced maturation protein 1 (Blimp-1) encoded by Prdm1 is a master regulator of plasma cell differentiation. The transcription factor Bach2 represses Blimp-1 expression in B cells to stall terminal differentiation, by which it supports reactions such as class switch recombination of the antibody genes. We found that histones H3 and H4 around the Prdm1 intron 5 Maf recognition element were acetylated at higher levels in X63/0 plasma cells expressing Blimp-1 than in BAL17 mature B cells lacking its expression. Conversely, methylation of H3-K9 was lower in X63/0 cells than BAL17 cells. Purification of the Bach2 complex in BAL17 cells revealed its interaction with histone deacetylase 3 (HDAC3), nuclear co-repressors NCoR1 and NCoR2, transducin -like 1X-linked (Tbl1x), and RAP1-interacting factor homolog (Rif1). Chromatin immunoprecipitation confirmed the binding of HDAC3 and Rif1 to the Prdm1 locus. Reduction of HDAC3 or NCoR1 expression by RNA interference in B cells resulted in an increased Prdm1 mRNA expression. Bach2 is suggested to cooperate with HDAC3-containing co-repressor complexes in B cells to regulate the stage-specific expression of Prdm1 by writing epigenetic modifications at the Prdm1 locus.	[Tanaka, Hiromu; Muto, Akihiko; Shima, Hiroki; Katoh, Yasutake; Sax, Nicolas; Tajima, Shinya; Brydun, Andrey; Ochiai, Kyoko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Katoh, Yasutake; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Tanaka, Hiromu; Nio, Masaki] Tohoku Univ, Grad Sch Med, Dept Pediat Surg, Seiryo Machi 1-1, Sendai, Miyagi 9800874, Japan; [Muto, Akihiko; Shima, Hiroki; Sax, Nicolas; Ochiai, Kyoko; Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Ikura, Tsuyoshi] Kyoto Univ, Ctr Radiat Biol, Kyoto 6068501, Japan; [Yoshizawa, Naoko; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Kamikitazawa 1-6, Tokyo 1568506, Japan; [Hoshikawa, Yutaka; Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Ariake 3-10-6, Tokyo 1358550, Japan	Tohoku University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); Kyoto University; Tokyo Metropolitan Institute of Medical Science; Japanese Foundation for Cancer Research	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	igarashi@med.tohoku.ac.jp	Nio, Masaki/AAF-4406-2019	Yoshizawa-Sugata, Naoko/0000-0001-8792-8669; Igarashi, Kazuhiko/0000-0002-2470-2475	Japan Society for the Promotion of Science [15H02506, 24390066, 21249014, 17054028, 25460352, 24790271]; Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan; Takeda Foundation and Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [26251004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan; Takeda Foundation and Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 15H02506, 24390066, 21249014, 17054028, 25460352, and 24790271 from Japan Society for the Promotion of Science and the Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan and The Takeda Foundation and Astellas Foundation for Research on Metabolic Disorders. Restoration of the laboratory from the damage due to the 2011 Tohoku earthquake was provided in part by the Astellas Foundation for Research on Metabolic Disorders, the Banyu Foundation, the Naito Foundation, A. Miyazaki, and A. Iida. The authors declare that they have no conflicts of interest with the contents of this article.	Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Dan JM, 2014, DEV CELL, V29, P7, DOI 10.1016/j.devcel.2014.03.004; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hoshino H, 2007, J BIOCHEM, V141, P719, DOI 10.1093/jb/mvm073; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Igarashi K, 2014, IMMUNOL REV, V261, P116, DOI 10.1111/imr.12201; Igarashi K, 2014, TOHOKU J EXP MED, V232, P229, DOI 10.1620/tjem.232.229; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kim EH, 2014, J IMMUNOL, V192, P985, DOI 10.4049/jimmunol.1302378; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Law IKM, 2009, PROTEOMICS, V9, P2444, DOI 10.1002/pmic.200800738; Lawrence Ann-Marie, 2009, J Vis Exp, DOI 10.3791/1350; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Minami J, 2014, LEUKEMIA, V28, P680, DOI 10.1038/leu.2013.231; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Osakabe A, 2010, J BIOL CHEM, V285, P11913, DOI 10.1074/jbc.M109.083238; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Yamasaki C, 2005, J BIOCHEM, V137, P287, DOI 10.1093/jb/mvi031; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	51	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6316	6330		10.1074/jbc.M116.713842	http://dx.doi.org/10.1074/jbc.M116.713842			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26786103	Green Published, hybrid			2022-12-26	WOS:000372894200022
J	Casadebaig, P; Zheng, BY; Chapman, S; Huth, N; Faivre, R; Chenu, K				Casadebaig, Pierre; Zheng, Bangyou; Chapman, Scott; Huth, Neil; Faivre, Robert; Chenu, Karine			Assessment of the Potential Impacts of Wheat Plant Traits across Environments by Combining Crop Modeling and Global Sensitivity Analysis	PLOS ONE			English	Article							GENETIC-VARIATION; USE EFFICIENCY; WATER-DEFICIT; YIELD GAINS; BREAD WHEAT; GENOTYPE; ADAPTATION; DROUGHT; SELECTION; IMPROVEMENT	A crop can be viewed as a complex system with outputs (e.g. yield) that are affected by inputs of genetic, physiology, pedo-climatic and management information. Application of numerical methods for model exploration assist in evaluating the major most influential inputs, providing the simulation model is a credible description of the biological system. A sensitivity analysis was used to assess the simulated impact on yield of a suite of traits involved in major processes of crop growth and development, and to evaluate how the simulated value of such traits varies across environments and in relation to other traits (which can be interpreted as a virtual change in genetic background). The study focused on wheat in Australia, with an emphasis on adaptation to low rainfall conditions. A large set of traits (90) was evaluated in a wide target population of environments (4 sites x 125 years), management practices (3 sowing dates x 3 nitrogen fertilization levels) and CO2 (2 levels). The Morris sensitivity analysis method was used to sample the parameter space and reduce computational requirements, while maintaining a realistic representation of the targeted trait x environment x management landscape (similar to 82 million individual simulations in total). The patterns of parameter x environment x management interactions were investigated for the most influential parameters, considering a potential genetic range of +/- 20% compared to a reference cultivar. Main (i.e. linear) and interaction (i.e. non-linear and interaction) sensitivity indices calculated for most of APSIM-Wheat parameters allowed the identification of 42 parameters substantially impacting yield in most target environments. Among these, a subset of parameters related to phenology, resource acquisition, resource use efficiency and biomass allocation were identified as potential candidates for crop (and model) improvement.	[Casadebaig, Pierre] INRA, AGIR UMR1248, F-31326 Castanet Tolosan, France; [Zheng, Bangyou] CSIRO Agr, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld 4067, Australia; [Chapman, Scott] Univ Queensland, QAAFI, St Lucia, Qld 4350, Australia; [Huth, Neil] CSIRO Agr, 203 Tor St, Toowoomba, Qld 4350, Australia; [Faivre, Robert] INRA, MIAT UR875, F-31326 Castanet Tolosan, France; [Chenu, Karine] Univ Queensland, QAAFI, 203 Tor St, Toowoomba, Qld 4350, Australia	INRAE; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); INRAE; University of Queensland	Casadebaig, P (corresponding author), INRA, AGIR UMR1248, F-31326 Castanet Tolosan, France.	pierre.casadebaig@toulouse.inra.fr	Casadebaig, Pierre/AAL-3307-2020; Casadebaig, Pierre/AAL-6998-2020; Chapman, Scott C/B-9673-2008; Huth, Neil I/F-7882-2010; Huth, Neil/U-3271-2019; Chenu, Karine/A-8967-2009	Casadebaig, Pierre/0000-0001-7225-936X; Chapman, Scott C/0000-0003-4732-8452; Huth, Neil I/0000-0002-4197-830X; Zheng, Bangyou/0000-0003-1551-0970; Chenu, Karine/0000-0001-7273-2057	INRA-Environment and Agronomy Division; Queensland Alliance for Agriculture and Food Innovation (QAAFI); Grains Research & Development Corporation (GRDC); ARC Centre of Excellence for Translational Photosynthesis	INRA-Environment and Agronomy Division; Queensland Alliance for Agriculture and Food Innovation (QAAFI); Grains Research & Development Corporation (GRDC)(Grains R&D Corp); ARC Centre of Excellence for Translational Photosynthesis(Australian Research Council)	This study was partly funded by INRA-Environment and Agronomy Division, the Queensland Alliance for Agriculture and Food Innovation (QAAFI), the Grains Research & Development Corporation (GRDC) and the ARC Centre of Excellence for Translational Photosynthesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbad H, 2004, AGRONOMIE, V24, P19, DOI 10.1051/agro:2003056; Alwala S, 2010, FIELD CROP RES, V119, P225, DOI 10.1016/j.fcr.2010.07.010; [Anonymous], 2014, R LANG ENV STAT COMP; Babar MA, 2006, CROP SCI, V46, P1046, DOI 10.2135/cropsci2005.0211; Bertin N, 2010, J EXP BOT, V61, P955, DOI 10.1093/jxb/erp377; Bogard M, 2014, J EXP BOT, V65, P5849, DOI 10.1093/jxb/eru328; Cabrera-Bosquet L, 2007, ANN APPL BIOL, V151, P277, DOI 10.1111/j.1744-7348.2007.00195.x; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Chan K., 2000, SENSITIVITY ANAL; Chapman S, 2003, AGRON J, V95, P99, DOI 10.2134/agronj2003.0099; Chapman S. C., 2002, P167, DOI 10.1079/9780851996011.0167; Chapman SC, 2002, AUST J AGR RES, V53, P379, DOI 10.1071/AR01070; Chapman SC, 2000, AUST J AGR RES, V51, P197, DOI 10.1071/AR99020; Chapman SC, 1997, EUPHYTICA, V95, P1, DOI 10.1023/A:1002918008679; Chapman SC, 2008, EUPHYTICA, V161, P195, DOI 10.1007/s10681-007-9623-z; Chapman SC, 2012, CROP PASTURE SCI, V63, P251, DOI 10.1071/CP11303; Chenu K, 2011, J EXP BOT, V62, P1743, DOI 10.1093/jxb/erq459; Chenu K, 2015, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, 2ND EDITION, P321, DOI 10.1016/B978-0-12-417104-6.00013-3; Chenu K, 2013, NEW PHYTOL, V198, P801, DOI 10.1111/nph.12192; Chenu K, 2009, GENETICS, V183, P1507, DOI 10.1534/genetics.109.105429; Christopher JT, 2008, AUST J AGR RES, V59, P354, DOI 10.1071/AR07193; Christopher JT, 2014, FUNCT PLANT BIOL, V41, P1035, DOI 10.1071/FP14052; Cooper M, 1997, CROP SCI, V37, P1168, DOI 10.2135/cropsci1997.0011183X003700040024x; COOPER M, 1995, THEOR APPL GENET, V90, P492, DOI 10.1007/BF00221995; Da Silva D, 2014, ANN BOT-LONDON, V114, P739, DOI 10.1093/aob/mcu034; de la Vega AJ, 2007, FIELD CROP RES, V100, P73, DOI 10.1016/j.fcr.2006.05.007; Dreccer MF, 2009, FIELD CROP RES, V112, P43, DOI 10.1016/j.fcr.2009.02.006; Dumont B, 2014, ENVIRON MODELL SOFTW, V52, P121, DOI 10.1016/j.envsoft.2013.10.022; Fischer R, 1996, WORKSH P CD OBR MEX, P150; Hammer G, 2006, TRENDS PLANT SCI, V11, P587, DOI 10.1016/j.tplants.2006.10.006; Hammer GL, 2014, CROP PASTURE SCI, V65, P614, DOI 10.1071/CP14088; Holzworth DP, 2014, ENVIRON MODELL SOFTW, V62, P327, DOI 10.1016/j.envsoft.2014.07.009; Iooss B, UNCERTAINTY MANAGEME, P101, DOI [10.1007/978-1-4899-7547-8, DOI 10.1007/978-1-4899-7547-8]; Jeuffroy MH, 2014, AGRON SUSTAIN DEV, V34, P121, DOI 10.1007/s13593-013-0170-9; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Lopes MS, 2012, CROP SCI, V52, P1123, DOI 10.2135/cropsci2011.09.0467; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Martre P, 2015, J EXPT BOT SOC EXPT; Mathews KL, 2007, THEOR APPL GENET, V115, P819, DOI 10.1007/s00122-007-0611-4; Messina CD, 2011, J EXP BOT, V62, P855, DOI 10.1093/jxb/erq329; Monod H., 2006, WORKING DYNAM CROP M, V4, P55; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; NYQUIST WE, 1991, CRIT REV PLANT SCI, V10, P235, DOI 10.1080/07352689109382313; OrtizMonasterio JI, 1997, CROP SCI, V37, P898, DOI 10.2135/cropsci1997.0011183X003700030033x; Parry MAJ, 2011, J EXP BOT, V62, P453, DOI 10.1093/jxb/erq304; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Poorter H, 1999, HANDBOOK OF FUNCTIONAL PLANT ECOLOGY, P81; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Potgieter AB, 2002, AUST J AGR RES, V53, P77, DOI 10.1071/AR01002; Pujol G., 2014, SENSITIVITY SENSITIV; Rebetzke G, 2008, THEOR APPL GENET, V118, P123, DOI 10.1007/s00122-008-0882-4; Rebetzke GJ, 2014, FUNCT PLANT BIOL, V41, P107, DOI 10.1071/FP13177; Rebetzke GJ, 2013, FUNCT PLANT BIOL, V40, P1, DOI 10.1071/FP12180; Reynolds M, 2009, J EXPT BOT SOC EXPT, V60, P1899, DOI [10.1093/jxb/erp016, DOI 10.1093/JXB/ERP016PMID:19363203]; Reynolds M, 2012, PLANT CELL ENVIRON, V35, P1799, DOI 10.1111/j.1365-3040.2012.02588.x; Richards RA, 2014, CROP PASTURE SCI, V65, P676, DOI 10.1071/CP13426; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; Sadras VO, 2014, J EXP BOT, V65, P1981, DOI 10.1093/jxb/eru061; Sadras VO, 2010, FIELD CROP RES, V118, P297, DOI 10.1016/j.fcr.2010.06.010; Sadras VO, 2015, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, 2ND EDITION, P1; Sinclair TR, 2004, TRENDS PLANT SCI, V9, P70, DOI 10.1016/j.tplants.2003.12.008; Snape JW, 2001, EUPHYTICA, V119, P185, DOI 10.1023/A:1017594422176; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tambussi EA, 2007, CRIT REV PLANT SCI, V26, P1, DOI 10.1080/07352680601147901; Valade A, 2014, GEOSCI MODEL DEV, V7, P1225, DOI 10.5194/gmd-7-1225-2014; Veyradier M., 2013, P 7 INT C FUNCT STRU, P317; Wallach D, 2011, ENVIRON MODELL SOFTW, V26, P386, DOI 10.1016/j.envsoft.2010.09.004; Wang E, 2002, EUR J AGRON, V18, P121, DOI 10.1016/S1161-0301(02)00100-4; Wang J, 2009, CLIMATIC CHANGE, V96, P79, DOI 10.1007/s10584-009-9599-x; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams J., 2002, CSIRO LAND; Yang DQ, 2014, CROP J, V2, P144, DOI 10.1016/j.cj.2014.02.004; Yang RC, 2005, CROP SCI, V45, P106; Yin XY, 2010, J EXP BOT, V61, P2171, DOI 10.1093/jxb/erp375; Zhao G, 2014, ECOL MODEL, V279, P1, DOI 10.1016/j.ecolmodel.2014.02.003; Zheng B., 2014, APSIM WHEAT MODULE 7; Zheng B, 2013, WHEAT MODELLING CASE; Zheng BY, 2013, J EXP BOT, V64, P3747, DOI 10.1093/jxb/ert209; Zheng BY, 2012, GLOBAL CHANGE BIOL, V18, P2899, DOI 10.1111/j.1365-2486.2012.02724.x; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	82	51	51	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146385	10.1371/journal.pone.0146385	http://dx.doi.org/10.1371/journal.pone.0146385			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799483	gold, Green Submitted, Green Published			2022-12-26	WOS:000368655300019
J	Lezyk, M; Jers, C; Kjaerulff, L; Gotfredsen, CH; Mikkelsen, MD; Mikkelsen, JD				Lezyk, Mateusz; Jers, Carsten; Kjaerulff, Louise; Gotfredsen, Charlotte H.; Mikkelsen, Maria D.; Mikkelsen, Jorn D.			Novel alpha-L-Fucosidases from a Soil Metagenome for Production of Fucosylated Human Milk Oligosaccharides	PLOS ONE			English	Article							THERMOTOGA-MARITIMA; CATALYTIC NUCLEOPHILE; NMR-SPECTROSCOPY; IDENTIFICATION; FUCOSE	This paper describes the discovery of novel alpha-L-fucosidases and evaluation of their potential to catalyse the transglycosylation reaction leading to production of fucosylated human milk oligosaccharides. Seven novel alpha-L-fucosidase-encoding genes were identified by functional screening of a soil -derived metagenome library and expressed in E. coli as recombinant 6xHis-tagged proteins. All seven fucosidases belong to glycosyl hydrolase family 29 (GH 29). Six of the seven alpha-L-fucosidases were substrate -inhibited, moderately thermostable and most hydrolytically active in the pH range 6-7, when tested with para-nitrophenyl-aL-fucopyranoside (pNP-Fuc) as the substrate. In contrast, one fucosidase (Mfuc6) exhibited a high pH optimum and an unusual sigmoidal kinetics towards pNP-Fuc substrate. When tested for trans-fucosylation activity using pNP-Fuc as donor, most of the enzymes were able to transfer fucose to pNP-Fuc (self -condensation) or to lactose. With the alpha-L-fucosidase from Thermotoga maritima and the metagenome-derived Mfuc5, different fucosyllactose variants including the principal fucosylated HMO 2'-fucosyllactose were synthesised in yields of up to -6.4%. Mfuc5 was able to release fucose from xyloglucan and could also use it as a fucosyl-donor for synthesis of fucosyllactose. This is the first study describing the use of glycosyl hydrolases for the synthesis of genuine fucosylated human milk oligosaccharides.	[Lezyk, Mateusz; Jers, Carsten; Mikkelsen, Jorn D.] Tech Univ Denmark, Ctr BioProc Engn, Dept Chem & Biochem Engn, DK-2800 Lyngby, Denmark; [Kjaerulff, Louise; Gotfredsen, Charlotte H.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Mikkelsen, Maria D.] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen	Jers, C (corresponding author), Tech Univ Denmark, Ctr BioProc Engn, Dept Chem & Biochem Engn, DK-2800 Lyngby, Denmark.	cjer@dtu.dk	Gotfredsen, Charlotte Held/ABC-8211-2021; Łężyk, Mateusz/O-9639-2019; Łężyk, Mateusz/W-1015-2018; Mikkelsen, Maria Dalgaard/AAP-3139-2021; Mikkelsen, Maria/R-1243-2016	Łężyk, Mateusz/0000-0003-4130-3561; Łężyk, Mateusz/0000-0003-4130-3561; Mikkelsen, Maria Dalgaard/0000-0003-4297-6119; Gotfredsen, Charlotte Held/0000-0002-7386-119X; Kjaerulff, Louise/0000-0001-6274-4265	Hempel (Barcelona, Spain); National Science Foundations' Plant Genome Program [DBI-0421683]	Hempel (Barcelona, Spain); National Science Foundations' Plant Genome Program	This work was supported by the funding from Hempel (Barcelona, Spain). Generation of the CCRC-M1 monoclonal antibody used in this work was supported by a grant from the National Science Foundations' Plant Genome Program (DBI-0421683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL PK, 1992, PHYTOCHEMISTRY, V31, P3307, DOI 10.1016/0031-9422(92)83678-R; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Benesova E, 2013, GLYCOBIOLOGY, V23, P1052, DOI 10.1093/glycob/cwt041; Bienenstock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076236; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Cao HN, 2014, J BIOL CHEM, V289, P25624, DOI 10.1074/jbc.M114.583286; Cobucci-Ponzano B, 2003, BIOCHEMISTRY-US, V42, P9525, DOI 10.1021/bi035036t; Copeland RA, 2000, ENZYMES PRACTICAL IN, P109; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gavlighi HA, 2013, J AGR FOOD CHEM, V61, P1272, DOI 10.1021/jf304795f; Han NS, 2012, BIOTECHNOL ADV, V30, P1268, DOI 10.1016/j.biotechadv.2011.11.003; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Ishimizu T, 2007, J BIOCHEM, V142, P721, DOI 10.1093/jb/mvm186; Lee Myung Hwan, 2013, Genomics & Informatics, V11, P114, DOI 10.5808/GI.2013.11.3.114; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Michalak M, 2014, PROCESS BIOCHEM, V49, P265, DOI 10.1016/j.procbio.2013.10.023; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Murata T, 1999, CARBOHYD RES, V320, P192, DOI 10.1016/S0008-6215(99)00156-1; Osanjo G, 2007, BIOCHEMISTRY-US, V46, P1022, DOI 10.1021/bi061444w; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pauly M, 2001, PLANTA, V214, P67, DOI 10.1007/s004250100585; Rodriguez-Diaz J, 2013, APPL ENVIRON MICROB, V79, P3847, DOI 10.1128/AEM.00229-13; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakurama H, 2012, BIOSCI BIOTECH BIOCH, V76, P1022, DOI 10.1271/bbb.111004; Schomburg I., 2000, GENE FUNCT DIS, V1, P109, DOI DOI 10.1002/1438-826X(200010)1:3/43.0.CO;2-O; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarling CA, 2003, J BIOL CHEM, V278, P47394, DOI 10.1074/jbc.M306610200; Tuffin Marla, 2009, Biotechnology Journal, V4, P1671, DOI 10.1002/biot.200900235; Vanhooren PT, 1999, J CHEM TECHNOL BIOT, V74, P479, DOI 10.1002/(SICI)1097-4660(199906)74:6<479::AID-JCTB76>3.0.CO;2-E; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138; Zeuner B, 2014, J AGR FOOD CHEM, V62, P9615, DOI 10.1021/jf502619p	38	46	47	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147438	10.1371/journal.pone.0147438	http://dx.doi.org/10.1371/journal.pone.0147438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800369	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300108
J	Manaskova, SH; Nazmi, K; van't Hof, W; van Belkum, A; Martin, NI; Bikker, FJ; van Wamel, WJB; Veerman, ECI				Manaskova, Silvie Hansenova; Nazmi, Kamran; van't Hof, Wim; van Belkum, Alex; Martin, Nathaniel I.; Bikker, Floris J.; van Wamel, Willem J. B.; Veerman, Enno C. I.			Staphylococcus aureus Sortase A-Mediated Incorporation of Peptides: Effect of Peptide Modification on Incorporation	PLOS ONE			English	Article							SURFACE-PROTEINS; CELL-WALL; LIPID-II; ANCHOR; SUBSTRATE; SEQUENCE; GENE	The endogenous Staphylococcus aureus sortase A (SrtA) transpeptidase covalently anchors cell wall-anchored (CWA) proteins equipped with a specific recognition motif (LPXTG) into the peptidoglycan layer of the staphylococcal cell wall. Previous in situ experiments have shown that SrtA is also able to incorporate exogenous, fluorescently labelled, synthetic substrates equipped with the LPXTG motif (K(FITC)LPETG-amide) into the bacterial cell wall, albeit at high concentrations of 500 pM to 1 mM. In the present study, we have evaluated the effect of substrate modification on the incorporation efficiency. This revealed that (i) by elongation of LPETG-amide with a sequence of positively charged amino acids, derived from the C-terminal domain of physiological SrtA substrates, the incorporation efficiency was increased by 20-fold at 10 pM, 100 pM and 250 pM; (ii) Substituting aspartic acid (E) for methionine increased the incorporation of the resulting K(FITC)LPMTG-amide approximately three times at all concentrations tested; (iii) conjugation of the lipid II binding antibiotic vancomycin to K(FITC)LPMTG-amide resulted in the same incorporation levels as K(FITC)LPETG-amide, but much more efficient at an impressive 500-fold lower substrate concentration. These newly developed synthetic substrates can potentially find broad applications in for example the in situ imaging of bacteria; the incorporation of antibody recruiting moieties; the targeted delivery and covalent incorporation of antimicrobial compounds into the bacterial cell wall.	[Manaskova, Silvie Hansenova; Nazmi, Kamran; van't Hof, Wim; Bikker, Floris J.; Veerman, Enno C. I.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Periodontol & Oral Biochem, Amsterdam, Netherlands; [Manaskova, Silvie Hansenova; Nazmi, Kamran; van't Hof, Wim; Bikker, Floris J.; Veerman, Enno C. I.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Manaskova, Silvie Hansenova; van Belkum, Alex; van Wamel, Willem J. B.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Martin, Nathaniel I.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Med Chem & Chem Biol, Utrecht, Netherlands; [van Belkum, Alex] BioMerieux, Microbiol Res & Dev Unit, La Balme Les Grottes, France	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Utrecht University; bioMerieux	Manaskova, SH (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Periodontol & Oral Biochem, Amsterdam, Netherlands.; Manaskova, SH (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.; Manaskova, SH (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	s.hansenovamanaskova@erasmusmc.nl	Bikker, Floris/B-1187-2012; Bikker, Floris/R-1941-2019	Bikker, Floris/0000-0002-9453-4630; van Wamel, Willem/0000-0001-9145-9121	ZonMW [50-51700-98-055]	ZonMW(Netherlands Organization for Health Research and Development)	This work was supported by ZonMW; grant title: Exploiting Staphylococcus aureus sortase for anti-infective purposes with the project number: 50-51700-98-055. The funding organisation was involved in financial support for conducting the research only.	Arnusch CJ, 2008, BIOCHEMISTRY-US, V47, P12661, DOI 10.1021/bi801597b; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Fischetti V. A., 2006, Gram-positive pathogens; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Jonsson IM, 2002, J INFECT DIS, V185, P1417, DOI 10.1086/340503; Jonsson IM, 2003, MICROBES INFECT, V5, P775, DOI 10.1016/S1286-4579(03)00143-6; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manaskova SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089260; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nelson JW, 2010, ACS CHEM BIOL, V5, P1147, DOI 10.1021/cb100195d; Pera NP, 2010, ORG BIOMOL CHEM, V8, P2425, DOI 10.1039/c000819b; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Punna S, 2005, BIOCONJUGATE CHEM, V16, P1536, DOI 10.1021/bc0501496; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316; Turner RD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1025; Wallace BA, 1999, ADV EXP MED BIOL, V467, P789; Weiss WJ, 2004, J ANTIMICROB CHEMOTH, V53, P480, DOI 10.1093/jac/dkh078; Zhang L, 2007, ANGEW CHEM INT EDIT, V46, P1798, DOI 10.1002/anie.200604222; Zhou XX, 2012, BIOCHEMISTRY-US, V51, P8143, DOI 10.1021/bi3012115	33	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147401	10.1371/journal.pone.0147401	http://dx.doi.org/10.1371/journal.pone.0147401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799839	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300103
J	Shen, YH; Yang, F; Wang, H; Cai, ZJ; Xu, YP; Zhao, A; Su, Y; Zhang, G; Zhu, SX				Shen, Yue-Hong; Yang, Fei; Wang, Hua; Cai, Zhi-Jian; Xu, Yi-Peng; Zhao, An; Su, Ying; Zhang, Gu; Zhu, Shao-Xing			Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice	PLOS ONE			English	Article							DOUBLE-RESTRICTED ADENOVIRUS; GENE-THERAPY; ONCOLYTIC ADENOVIRUS; INCREASED SURVIVAL; E1A; EXPRESSION; CARCINOMA; INTEGRIN; RECEPTOR; CAR	CAR is a transmembrane protein that is expressed in various epithelial and endothelial cells. CAR mediates adenoviral infection, as well as adenovirus-mediated oncolysis of AxdAdB-3, an E1A/E1B double-restricted oncolytic adenovirus, in prostate cancer cells. This study further assessed the therapeutic efficacy of AxdAdB-3 with Arg-Gly-Asp (RGD)-fiber modification (AxdAdB3-F/RGD), which enables integrin-dependent infection, in prostate cancer. Susceptibility of prostate cancer cells LNCaP, PC3, and DU145 to adenovirus infection was associated with CAR expression. All of the prostate cancer cell lines expressed integrin alpha(v)beta(3) and alpha(v)beta(5). AxdAdB-3 was more cytopathic in CAR-positive prostate cancer cells than in CAR-negative cells, whereas AxdAdB3-F/RGD caused potent oncolysis in both CAR-positive and CAR-negative prostate cancer cells. In contrast, AxdAdB3-F/RGD was not cytopathic against normal prostate epithelial cells, RWPE-1. Intratumoral injection of AxdAdB3-F/RGD into CAR-negative prostate cancer cell xenografts in nude mice inhibited tumor growth. The current study demonstrates that E1A/E1B double-restricted oncolytic adenovirus with an RGD-fiber modification enhances infection efficiency and anti-tumor activity in CAR-deficient prostate cancer cells, while sparing normal cells. Future studies will evaluate the therapeutic potential of AxdAdB3-F/RGD in prostate cancer.	[Shen, Yue-Hong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Fei] Zhejiang Univ, Sch Publ Hlth, Sch Med, Chron Dis Res Inst,Dept Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hua; Xu, Yi-Peng; Zhao, An; Zhu, Shao-Xing] Zhejiang Canc Hosp, Dept Urol, Hangzhou, Zhejiang, Peoples R China; [Cai, Zhi-Jian] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Ying; Zhang, Gu] Zhejiang Canc Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital; Zhejiang University; Zhejiang Cancer Hospital	Wang, H (corresponding author), Zhejiang Canc Hosp, Dept Urol, Hangzhou, Zhejiang, Peoples R China.	hwangua@aliyun.com	ZHAO, AN/O-1547-2014; Xu, Yipeng/GZG-2237-2022	Xu, Yipeng/0000-0003-4775-4160; ZHAO, An/0000-0002-2716-9733	Natural Science Foundation of Zhejiang Province, China [LY12H16031]; Health Bureau of Zhejiang Province, China [2012KYA025]	Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Health Bureau of Zhejiang Province, China	This study was supported in part by a grant from Natural Science Foundation of Zhejiang Province, China (#LY12H16031) and from the Health Bureau of Zhejiang Province, China (#2012KYA025).	Adam V, 2012, HUM GENE THER, V23, P1003, DOI 10.1089/hum.2012.046; CARROLL AG, 1993, PROSTATE, V23, P123, DOI 10.1002/pros.2990230206; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehari H, 2003, CANCER GENE THER, V10, P75, DOI 10.1038/sj.cgt.7700529; Dong WL, 2014, HUM GENE THER, V25, P897, DOI 10.1089/hum.2013.229; Douglas JT, 2001, CANCER RES, V61, P813; Freytag SO, 2014, INT J RADIAT ONCOL, V89, P268, DOI 10.1016/j.ijrobp.2014.02.034; Fukuda K, 2003, CANCER RES, V63, P4434; Gomez-Manzano C, 2004, ONCOGENE, V23, P1821, DOI 10.1038/sj.onc.1207321; Harada JN, 1999, J VIROL, V73, P5333, DOI 10.1128/JVI.73.7.5333-5344.1999; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Hess K, 2014, ANN DIAGN PATHOL, V18, P343, DOI 10.1016/j.anndiagpath.2014.09.001; Jarrard DF, 1997, GENE CHROMOSOME CANC, V19, P90, DOI 10.1002/(SICI)1098-2264(199706)19:2<90::AID-GCC4>3.0.CO;2-V; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Lee JT, 2008, CELL CYCLE, V7, P1745, DOI 10.4161/cc.7.12.6166; Pesonen S, 2012, INT J CANCER, V130, P1937, DOI 10.1002/ijc.26216; Rauen KA, 2002, CANCER RES, V62, P3812; Reeh M, 2013, BRIT J CANCER, V109, P1848, DOI 10.1038/bjc.2013.509; Amaral TMS, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/327253; Satoh M, 2007, UROLOGY, V70, DOI 10.1016/j.urology.2007.09.031; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Taki M, 2005, ONCOGENE, V24, P3130, DOI 10.1038/sj.onc.1208460; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Wakayama M, 2007, CLIN CANCER RES, V13, P3043, DOI 10.1158/1078-0432.CCR-06-2103; Yang YF, 2014, GENE THER, V21, P723, DOI 10.1038/gt.2014.46; Zhang L, 2009, ASIAN J ANDROL, V11, P9, DOI 10.1038/aja.2008.21; Zheng DQ, 1999, CANCER RES, V59, P1655	28	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147173	10.1371/journal.pone.0147173	http://dx.doi.org/10.1371/journal.pone.0147173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799485	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300067
J	Wang, SS; Zhang, HY; Scharadin, TM; Zimmermann, M; Hu, B; Pan, AW; Vinall, R; Lin, TY; Cimino, G; Chain, P; Vuyisich, M; Gleasner, C; Mcmurry, K; Malfatti, M; Turteltaub, K; White, RD; Pan, CX; Henderson, PT				Wang, Sisi; Zhang, Hongyong; Scharadin, Tiffany M.; Zimmermann, Maike; Hu, Bin; Pan, Amy Wang; Vinall, Ruth; Lin, Tzu-Yin; Cimino, George; Chain, Patrick; Vuyisich, Momchilo; Gleasner, Cheryl; Mcmurry, Kim; Malfatti, Michael; Turteltaub, Kenneth; White, Ralph de Vere; Pan, Chong-Xian; Henderson, Paul T.			Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; KETO REDUCTASES AKR1C1; ENHANCED DNA-REPAIR; CISPLATIN RESISTANCE; CARRIER LIGAND; PHASE-II; OXALIPLATIN; CHEMOTHERAPY; LUNG; PHARMACOKINETICS	We report herein the development, functional and molecular characterization of an isogenic, paired bladder cancer cell culture model system for studying platinum drug resistance. The 5637 human bladder cancer cell line was cultured over ten months with stepwise increases in oxaliplatin concentration to generate a drug resistant 5637R sub cell line. The MTT assay was used to measure the cytotoxicity of several bladder cancer drugs. Liquid scintillation counting allowed quantification of cellular drug uptake and efflux of radiolabeled oxaliplatin and carboplatin. The impact of intracellular drug inactivation was assessed by chemical modulation of glutathione levels. Oxaliplatin-and carboplatin-DNA adduct formation and repair was measured using accelerator mass spectrometry. Resistance factors including apoptosis, growth factor signaling and others were assessed with RNAseq of both cell lines and included confirmation of selected transcripts by RT-PCR. Oxaliplatin, carboplatin, cisplatin and gemcitabine were significantly less cytotoxic to 5637R cells compared to the 5637 cells. In contrast, doxorubicin, methotrexate and vinblastine had no cell line dependent difference in cytotoxicity. Upon exposure to therapeutically relevant doses of oxaliplatin, 5637R cells had lower drug-DNA adduct levels than 5637 cells. This difference was partially accounted for by pre-DNA damage mechanisms such as drug uptake and intracellular inactivation by glutathione, as well as faster oxaliplatin-DNA adduct repair. In contrast, both cell lines had no significant differences in carboplatin cell uptake, efflux and drug-DNA adduct formation and repair, suggesting distinct resistance mechanisms for these two closely related drugs. The functional studies were augmented by RNAseq analysis, which demonstrated a significant change in expression of 83 transcripts, including 50 known genes and 22 novel transcripts. Most of the transcripts were not previously associated with bladder cancer chemoresistance. This model system and the associated phenotypic and genotypic data has the potential to identify some novel details of resistance mechanisms of clinical importance to bladder cancer.	[Wang, Sisi; Zhang, Hongyong; Scharadin, Tiffany M.; Zimmermann, Maike; Pan, Amy Wang; Lin, Tzu-Yin; Pan, Chong-Xian; Henderson, Paul T.] Univ Calif Davis, Div Hematol & Oncol, Dept Internal Med, Sacramento, CA 95817 USA; [Vinall, Ruth; White, Ralph de Vere; Pan, Chong-Xian] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA; [Malfatti, Michael; Turteltaub, Kenneth] Lawrence Livermore Natl Lab, Livermore, CA USA; [Pan, Chong-Xian] VA Northern Calif Hlth Care Syst, Mather, CA USA; [Hu, Bin; Chain, Patrick; Vuyisich, Momchilo; Gleasner, Cheryl; Mcmurry, Kim] Los Alamos Natl Lab, Los Alamos, NM USA; [Zimmermann, Maike; Cimino, George; Henderson, Paul T.] Accelerated Med Diagnostics Inc, Dublin, CA USA; [Wang, Sisi] Jilin Univ, Hosp 1, Translat Med Res Inst, Changchun 130023, Jilin, Peoples R China; [Pan, Amy Wang] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Vinall, Ruth] Calif Northstate Univ, Coll Pharm, Rancho Cordova, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Jilin University; University of California System; University of California San Diego	Pan, CX; Henderson, PT (corresponding author), Univ Calif Davis, Div Hematol & Oncol, Dept Internal Med, Sacramento, CA 95817 USA.; Pan, CX (corresponding author), Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA.; Pan, CX (corresponding author), VA Northern Calif Hlth Care Syst, Mather, CA USA.; Henderson, PT (corresponding author), Accelerated Med Diagnostics Inc, Dublin, CA USA.	cxpan@ucdavis.edu; paul.henderson@ucdmc.ucdavis.edu	Chain, Patrick/O-4140-2019; Vinall, Ruth/L-7026-2019	Chain, Patrick/0000-0003-3949-3634; Hu, Bin/0000-0002-0278-8466; Zimmermann, Maike/0000-0001-9005-3795	DOE [DE-AC52-07NA27344]; NIH/NCRR Resource for Biomedical Accelerator Mass Spectrometry [P41 RR013461]; DOE LDRD [08-LW-100]; American Cancer Society Institutional Research Grant; VA Career Development Award-2; NCI Cancer Center Support Grant a Cancer Clinical Investigator Team Leadership Award; NIH [HHSN261201200048C, HHSN261201200084C, R01CA155642, T32 CA108459-08]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NATIONAL CANCER INSTITUTE [R01CA155642, T32CA108459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001784] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); NIH/NCRR Resource for Biomedical Accelerator Mass Spectrometry; DOE LDRD(United States Department of Energy (DOE)); American Cancer Society Institutional Research Grant(American Cancer Society); VA Career Development Award-2; NCI Cancer Center Support Grant a Cancer Clinical Investigator Team Leadership Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	AMS samples were analyzed at Lawrence Livermore National Laboratory under the auspices of the DOE contract DE-AC52-07NA27344 and supported by NIH/NCRR Resource for Biomedical Accelerator Mass Spectrometry P41 RR013461 and DOE LDRD grant 08-LW-100 (PTH and KT), and by the American Cancer Society Institutional Research Grant (CXP). This study was also supported by the VA Career Development Award-2 (CXP), an NCI Cancer Center Support Grant (RDW) a Cancer Clinical Investigator Team Leadership Award (CXP), and NIH awards HHSN261201200048C, HHSN261201200084C, R01CA155642 (PTH) and T32 CA108459-08 (TS). The authors gratefully acknowledge the Susan and Gerry Knapp Family Fund. This work was performed, in part, under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. The work reported here does not represent the views or opinions of the Department of Veterans Affairs or the United States Government.	ALIOSMAN F, 1994, J CELL BIOCHEM, V54, P11, DOI 10.1002/jcb.240540103; Brown K, 2005, METHOD ENZYMOL, V402, P423, DOI 10.1016/S0076-6879(05)02014-8; Catalano V, 2011, HISTOPATHOLOGY, V58, P669, DOI 10.1111/j.1365-2559.2011.03818.x; Chaney SG, 2004, J INORG BIOCHEM, V98, P1551, DOI 10.1016/j.jinorgbio.2004.04.024; CHAO CCK, 1991, CANCER RES, V51, P601; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Chen YJ, 2005, GYNECOL ONCOL, V97, P110, DOI 10.1016/j.ygyno.2004.12.031; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Cimino GD, 2013, BIOANALYSIS, V5, P369, DOI [10.4155/bio.12.325, 10.4155/BIO.12.325]; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Di Francesco AM, 2002, CELL MOL LIFE SCI, V59, P1914, DOI 10.1007/PL00012514; Ehrsson H, 2002, MED ONCOL, V19, P261, DOI 10.1385/MO:19:4:261; Ferry KV, 2000, BIOCHEM PHARMACOL, V60, P1305, DOI 10.1016/S0006-2952(00)00441-X; Fujiwara K, 2001, CANCER CHEMOTH PHARM, V47, P22, DOI 10.1007/s002800000212; GIBBONS GR, 1990, CANCER RES, V50, P6497; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Graham MA, 2000, CLIN CANCER RES, V6, P1205; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; He XP, 2012, INT J CANCER, V130, P1029, DOI 10.1002/ijc.26044; Hector S, 2007, CANCER LETT, V245, P195, DOI 10.1016/j.canlet.2006.01.007; Henderson PT, 2011, INT J CANCER, V129, P1425, DOI 10.1002/ijc.25814; HILL BT, 1990, INT J RADIAT ONCOL, V19, P75, DOI 10.1016/0360-3016(90)90137-9; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; JJ R, 1986, DNA TARGET CYTOTOXIC; JOHNSON SW, 1994, CANCER RES, V54, P5911; Johnson SW, 1997, CANCER RES, V57, P850; KELLAND LR, 1993, CRIT REV ONCOL HEMAT, V15, P191, DOI 10.1016/1040-8428(93)90042-3; Kool M, 1997, CANCER RES, V57, P3537; Kuhnl A, 2010, BLOOD, V115, P3737, DOI 10.1182/blood-2009-09-241943; LAI GM, 1988, BIOCHEM PHARMACOL, V37, P4597, DOI 10.1016/0006-2952(88)90325-5; Leung CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6092; Lin XJ, 2002, MOL PHARMACOL, V62, P1154, DOI 10.1124/mol.62.5.1154; Ma XY, 2011, J JIANGSU U MED EDIT, V21, P308; Matsunaga T, 2014, ANTI-CANCER DRUG, V25, P868, DOI 10.1097/CAD.0000000000000112; Matsunaga T, 2013, CHEM-BIOL INTERACT, V202, P234, DOI 10.1016/j.cbi.2012.09.024; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MAULDIN SK, 1988, CANCER RES, V48, P5136; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Menon T, 2010, MOL ENDOCRINOL, V24, P1165, DOI 10.1210/me.2009-0421; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ognibene TJ, 2003, ANAL CHEM, V75, P2192, DOI 10.1021/ac026334j; Plasencia C, 2006, INT J ONCOL, V29, P225; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; Samimi G, 2004, MOL PHARMACOL, V66, P25, DOI 10.1124/mol.66.1.25; Saris CP, 1996, CARCINOGENESIS, V17, P2763, DOI 10.1093/carcin/17.12.2763; SHARMA H, 1983, CANCER CHEMOTH PHARM, V11, P5; Shirato A, 2014, ONCOL LETT, V7, P674, DOI 10.3892/ol.2013.1768; Silva MJ, 2005, ENVIRON MOL MUTAGEN, V46, P104, DOI 10.1002/em.20138; Sweeney CJ, 2006, J CLIN ONCOL, V24, P3451, DOI 10.1200/JCO.2005.03.6699; Tamashiro DAA, 2012, DIFFERENTIATION, V83, P282, DOI 10.1016/j.diff.2012.02.010; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trigueros-Motos L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-434; Vaisman A, 1998, CANCER RES, V58, P3579; Vaughn DJ, 2002, J CLIN ONCOL, V20, P937, DOI 10.1200/JCO.20.4.937; Virag P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-480; Virag P, 2012, ANTI-CANCER DRUG, V23, P1032, DOI 10.1097/CAD.0b013e328355076f; Virag P, 2011, CELL BIOCHEM FUNCT, V29, P351, DOI 10.1002/cbf.1754; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang HW, 2007, INT J CANCER, V120, P2019, DOI 10.1002/ijc.22402; Weaver DA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-18; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; WOOD DP, 1993, MODERN PATHOL, V6, P33; Woynarowski JM, 2000, MOL PHARMACOL, V58, P920, DOI 10.1124/mol.58.5.920; Xu YQ, 2014, J CELL BIOCHEM, V115, P1112, DOI 10.1002/jcb.24751; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Yu HM, 2012, FOOD CHEM TOXICOL, V50, P1226, DOI 10.1016/j.fct.2012.01.040; Zdraveski ZZ, 2002, J BIOL CHEM, V277, P1255, DOI 10.1074/jbc.M105382200	70	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146256	10.1371/journal.pone.0146256	http://dx.doi.org/10.1371/journal.pone.0146256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799320	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300017
J	Bajwa, NM; Halavi, S; Hamer, M; Semple, BD; Noble-Haeusslein, LJ; Baghchechi, M; Hiroto, A; Hartman, RE; Obenaus, A				Bajwa, Nikita M.; Halavi, Shina; Hamer, Mary; Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Baghchechi, Mohsen; Hiroto, Alex; Hartman, Richard E.; Obenaus, Andre			Mild Concussion, but Not Moderate Traumatic Brain Injury, Is Associated with Long-Term Depression-Like Phenotype in Mice	PLOS ONE			English	Article							BEHAVIORAL DEFICITS; MOUSE MODEL; MOOD DISORDERS; ANIMAL-MODEL; IMPACT; BLAST; MOTOR; MAZE; RATS; NEUROINFLAMMATION	Mild traumatic brain injuries can lead to long-lasting cognitive and motor deficits, increasing the risk of future behavioral, neurological, and affective disorders. Our study focused on long-term behavioral deficits after repeated injury in which mice received either a single mild CHI (mCHI), a repeated mild CHI (rmCHI) consisting of one impact to each hemisphere separated by 3 days, or a moderate controlled cortical impact injury (CCI). Shams received only anesthesia. Behavioral tests were administered at 1, 3, 5, 7, and 90 days post-injury (dpi). CCI animals showed significant motor and sensory deficits in the early (1-7 dpi) and long-term (90 dpi) stages of testing. Interestingly, sensory and subtle motor deficits in rmCHI animals were found at 90 dpi. Most importantly, depression-like behaviors and social passiveness were observed in rmCHI animals at 90 dpi. These data suggest that mild concussive injuries lead to motor and sensory deficits and affective disorders that are not observed after moderate TBI.	[Bajwa, Nikita M.; Halavi, Shina; Hartman, Richard E.] Loma Linda Univ, Sch Behav Hlth, Dept Psychol, Loma Linda, CA 92350 USA; [Hamer, Mary; Baghchechi, Mohsen; Hiroto, Alex; Obenaus, Andre] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA; [Semple, Bridgette D.] Univ Melbourne, Melbourne Brain Ctr, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3052, Australia; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Sch Med, Dept Neurol Surg, San Francisco, CA USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Sch Med, Dept Phys Therapy & Rehabil Sci, San Francisco, CA USA; [Obenaus, Andre] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Obenaus, Andre] Loma Linda Univ, Sch Behav Hlth, Div Interdisciplinary Studies, Loma Linda, CA 92350 USA	Loma Linda University; Loma Linda University; Royal Melbourne Hospital; University of Melbourne; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Riverside; Loma Linda University	Hartman, RE (corresponding author), Loma Linda Univ, Sch Behav Hlth, Dept Psychol, Loma Linda, CA 92350 USA.; Obenaus, A (corresponding author), Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA.; Obenaus, A (corresponding author), Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA.; Obenaus, A (corresponding author), Loma Linda Univ, Sch Behav Hlth, Div Interdisciplinary Studies, Loma Linda, CA 92350 USA.	behavioralneuroscience@gmail.com; aobenaus@llu.edu		Semple, Bridgette/0000-0002-2535-0491	School of Behavioral Health seed grant at Loma Linda University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077767] Funding Source: NIH RePORTER	School of Behavioral Health seed grant at Loma Linda University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this study was provided by the School of Behavioral Health seed grant at Loma Linda University.; This work was supported by School of Behavioral Health seed grant at Loma Linda University. We are thankful to Chris Nishioka for his assistance in behavioral testing and CHI surgeries. Lastly, we would like to thank the Biomedical Undergraduate Research Program at University of California, Riverside for providing research students to assist in MRI analysis.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Arakawa H, 2008, NEUROSCI BIOBEHAV R, V32, P1236, DOI 10.1016/j.neubiorev.2008.05.012; Arakawa H, 2009, BEHAV BRAIN RES, V205, P138, DOI 10.1016/j.bbr.2009.07.007; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Costa TL, 2015, NEUROPSYCHOLOGIA, V78, P142, DOI 10.1016/j.neuropsychologia.2015.10.008; Craft TKS, 2006, BIOL PSYCHIAT, V60, P812, DOI 10.1016/j.biopsych.2006.03.011; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Dantzer R, 2006, NEUROL CLIN, V24, P441, DOI 10.1016/j.ncl.2006.03.003; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Dulcich MS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/940830; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fenn AM, 2013, BIOL PSYCHIAT, P1; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gerberding JL, 2003, REPORT TO CONGRESS O; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guley NH, 2015, J NEUROTRAUM, P1; Hall C., 1932, U CALIF PUBL PSYCHOL, V6, P1; Hartman RE, 2006, NEUROBIOL DIS, V24, P506, DOI 10.1016/j.nbd.2006.08.006; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hua Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/272976; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laskowski RA., 2015, BRAIN NEUROTRAUMA MO; Lekic T, 2011, EXP NEUROL, V227, P96, DOI 10.1016/j.expneurol.2010.09.017; Luo Jian, 2014, Front Neurol, V5, P12, DOI 10.3389/fneur.2014.00012; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Obenaus A, 2012, MILD TRAUMATIC BRAIN, P53; Obenaus A, 2015, ENCYCLOPEDIA OF MENT; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	76	36	36	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146886	10.1371/journal.pone.0146886	http://dx.doi.org/10.1371/journal.pone.0146886			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796696	Green Published, gold			2022-12-26	WOS:000368530300014
J	Danner, SM; Krenn, M; Hofstoetter, US; Toth, A; Mayr, W; Minassian, K				Danner, Simon M.; Krenn, Matthias; Hofstoetter, Ursula S.; Toth, Andrea; Mayr, Winfried; Minassian, Karen			Body Position Influences Which Neural Structures Are Recruited by Lumbar Transcutaneous Spinal Cord Stimulation	PLOS ONE			English	Article							SOLEUS-H-REFLEX; TRANSCRANIAL MAGNETIC STIMULATION; POSTERIOR ROOT STIMULATION; POST-ACTIVATION DEPRESSION; HUMAN LUMBOSACRAL CORD; ELECTRICAL-STIMULATION; LEG MUSCLES; EPIDURAL STIMULATION; HUMANS; MODULATION	Transcutaneous stimulation of the human lumbosacral spinal cord is used to evoke spinal reflexes and to neuromodulate altered sensorimotor function following spinal cord injury. Both applications require the reliable stimulation of afferent posterior root fibers. Yet under certain circumstances, efferent anterior root fibers can be co-activated. We hypothesized that body position influences the preferential stimulation of sensory or motor fibers. Stimulus-triggered responses to transcutaneous spinal cord stimulation were recorded using surface-electromyography from quadriceps, hamstrings, tibialis anterior, and triceps surae muscles in 10 individuals with intact nervous systems in the supine, standing and prone positions. Single and paired (30-ms inter-stimulus intervals) biphasic stimulation pulses were applied through surface electrodes placed on the skin between the T11 and T12 interspinous processes referenced to electrodes on the abdomen. The paired stimulation was applied to evaluate the origin of the evoked electromyographic response; trans-synaptic responses would be suppressed whereas direct efferent responses would almost retain their amplitude. We found that responses to the second stimulus were decreased to 14% +/- 5% of the amplitude of the response to the initial pulse in the supine position across muscles, to 30%+/- 5% in the standing, and to only 80%+/- 5% in the prone position. Response thresholds were lowest during standing and highest in the prone position and response amplitudes were largest in the supine and smallest in the prone position. The responses obtained in the supine and standing positions likely resulted from selective stimulation of sensory fibers while concomitant motor-fiber stimulation occurred in the prone position. We assume that changes of root-fiber paths within the generated electric field when in the prone position increase the stimulation thresholds of posterior above those of anterior root fibers. Thus, we recommend conducting spinal reflex or neuromodulation studies with subjects lying supine or in an upright position, as in standing or stepping.	[Danner, Simon M.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Danner, Simon M.] Vienna Univ Technol, Inst Anal & Sci Comp, A-1040 Vienna, Austria; [Danner, Simon M.; Krenn, Matthias; Hofstoetter, Ursula S.; Toth, Andrea; Mayr, Winfried; Minassian, Karen] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria	Drexel University; Technische Universitat Wien; Medical University of Vienna	Mayr, W (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.	winfried.mayr@meduniwien.ac.at	Danner, Simon M./I-7944-2012	Danner, Simon M./0000-0002-4642-7064; Minassian, Karen/0000-0003-4197-6141; Krenn, Matthias J./0000-0002-3398-3627; Hofstoetter, Ursula S./0000-0002-3156-6483	Vienna Science and Technology Fund (WWTF) [LS11-057]; Wings for Life Spinal Cord Research Foundation [WFL-AT-007/11]	Vienna Science and Technology Fund (WWTF); Wings for Life Spinal Cord Research Foundation	This work was supported by the Vienna Science and Technology Fund (WWTF; Grant LS11-057; www.wwtf.at) and the Wings for Life Spinal Cord Research Foundation (Grant WFL-AT-007/11, http://www.wingsforlife.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese M, 1996, ELECTROMYOGR MOTOR C, V101, P339, DOI 10.1016/0924-980X(96)95682-9; Alrowayeh HN, 2005, J NEUROSCI METH, V144, P215, DOI 10.1016/j.jneumeth.2004.11.011; Andrews JC, 2015, J NEUROPHYSIOL, V114, P485, DOI 10.1152/jn.01007.2014; Andrews JC, 2015, NEUROSCI LETT, V589, P144, DOI 10.1016/j.neulet.2015.01.041; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; BROOKE JD, 1995, J NEUROPHYSIOL, V73, P102, DOI 10.1152/jn.1995.73.1.102; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; Courtine GG, 2007, J PHYSIOL-LONDON, V582, P1125, DOI 10.1113/jphysiol.2007.128447; CRONE C, 1990, EXP BRAIN RES, V81, P35; CRONE C, 1989, EXP BRAIN RES, V78, P28, DOI 10.1007/bf00230683; Danner SM, 2015, BRAIN, V138, P577, DOI 10.1093/brain/awu372; Danner SM, 2011, ARTIF ORGANS, V35, P257, DOI 10.1111/j.1525-1594.2011.01213.x; Danner SM, 2014, ENCY COMPUTATIONAL N, P1, DOI DOI 10.1007/978-1-4614-7320-6; Dietz V, 2000, GAIT POSTURE, V11, P102, DOI 10.1016/S0966-6362(99)00052-1; DIMITRIJEVIC MR, 1983, SPINAL CORD RECONSTR, P465; Dy CJ, 2010, J NEUROPHYSIOL, V103, P2808, DOI 10.1152/jn.00316.2009; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; HAYASHI R, 1992, NEUROSCI RES, V13, P227, DOI 10.1016/0168-0102(92)90062-H; Hofstoetter U. S., 2013, Biomedical Engineering-Biomedizinische Technik, V58, DOI 10.1515/bmt-2013-4014; Hofstoetter U.S., 2014, ENCY COMPUTATIONAL N, P1, DOI DOI 10.1007/978-1-4614-7320-6; Hofstoetter US, 2008, ARTIF ORGANS, V32, P644, DOI 10.1111/j.1525-1594.2008.00616.x; Hofstoetter US, 2015, ARTIF ORGANS, V39, pE176, DOI 10.1111/aor.12615; Hofstoetter US, 2014, J SPINAL CORD MED, V37, P202, DOI 10.1179/2045772313Y.0000000149; Holsheimer J, 1998, NEUROMODULATION, V1, P57, DOI 10.1111/j.1525-1403.1998.tb00018.x; HOLSHEIMER J, 1994, AM J NEURORADIOL, V15, P951; Huang H, 2006, IEEE T NEUR SYS REH, V14, P14, DOI 10.1109/TNSRE.2005.862694; Kagamihara Y, 1998, MUSCLE NERVE, V21, P352, DOI 10.1002/(SICI)1097-4598(199803)21:3<352::AID-MUS9>3.0.CO;2-9; KATZ R, 1988, BRAIN, V111, P417, DOI 10.1093/brain/111.2.417; Kitano K, 2009, J NEUROSCI METH, V180, P111, DOI 10.1016/j.jneumeth.2009.03.006; Knikou M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102313; Knikou M, 2013, BIOELECTROMAGNETICS, V34, P630, DOI 10.1002/bem.21808; Knikou M, 2009, INT J NEUROSCI, V119, P2056, DOI 10.1080/00207450903139747; Krenn M., 2013, Biomedical Engineering-Biomedizinische Technik, V58, DOI 10.1515/bmt-2013-4010; Krenn M, 2015, ARTIF ORGANS, V39, P834, DOI 10.1111/aor.12616; Ladenbauer J, 2010, IEEE T NEUR SYS REH, V18, P637, DOI 10.1109/TNSRE.2010.2054112; LLOYD DPC, 1957, J GEN PHYSIOL, V40, P409, DOI 10.1085/jgp.40.3.409; MERLETTI R, 1992, CRIT REV BIOMED ENG, V19, P293; Minassian K, 2007, HUM MOVEMENT SCI, V26, P275, DOI 10.1016/j.humov.2007.01.005; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Minassian K, 2016, NEUROREHAB NEURAL RE, V30, P233, DOI 10.1177/1545968315591706; Pierrot-Deseilligny E, 2012, THE CIRCUITRY OF THE; Pinter MM, 2000, SPINAL CORD, V38, P524, DOI 10.1038/sj.sc.3101040; Ranger MRB, 2008, BRIT J ANAESTH, V101, P804, DOI 10.1093/bja/aen295; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; Rattay F, 1990, ELECT NERVE STIMULAT; Rattay F., 2014, ENCY COMPUTATIONAL N, P1, DOI DOI 10.1007/978-1-4614-7320-6; Roy FD, 2014, EXP BRAIN RES, V232, P1717, DOI 10.1007/s00221-014-3864-6; Roy FD, 2012, EXP BRAIN RES, V223, P281, DOI 10.1007/s00221-012-3258-6; Sayenko DG, 2015, J APPL PHYSIOL, V118, P1364, DOI 10.1152/japplphysiol.01128.2014; Sherwood AM, 1996, MUSCLE NERVE, V19, P966, DOI 10.1002/(SICI)1097-4598(199608)19:8<966::AID-MUS5>3.3.CO;2-N; Troni W, 1996, MUSCLE NERVE, V19, P595, DOI 10.1002/(SICI)1097-4598(199605)19:5<595::AID-MUS7>3.3.CO;2-4; Tucker KJ, 2005, HUM MOVEMENT SCI, V24, P667, DOI 10.1016/j.humov.2005.09.010; UGAWA Y, 1989, J NEUROL NEUROSUR PS, V52, P1025, DOI 10.1136/jnnp.52.9.1025; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053	56	43	50	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147479	10.1371/journal.pone.0147479	http://dx.doi.org/10.1371/journal.pone.0147479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26797502	Green Submitted, gold, Green Published			2022-12-26	WOS:000368530300038
J	Pittman, HT; Krementz, DG				Pittman, H. Tyler; Krementz, David G.			Impacts of Short-Rotation Early-Growing Season Prescribed Fire on a Ground Nesting Bird in the Central Hardwoods Region of North America	PLOS ONE			English	Article							WILD TURKEY HENS; MELEAGRIS-GALLOPAVO SILVESTRIS; SITE SELECTION; REPRODUCTIVE ECOLOGY; FOREST STRUCTURE; SURVIVAL; POPULATION; DYNAMICS; ARKANSAS; SUCCESS	Landscape-scale short-rotation early-growing season prescribed fire, hereafter prescribed fire, in upland hardwood forests represents a recent shift in management strategies across eastern upland forests. Not only does this strategy depart from dormant season to growing season prescriptions, but the strategy also moves from stand-scale to landscape-scale implementation (>1,000 ha). This being so, agencies are making considerable commitments in terms of time and resources to this management strategy, but the effects on wildlife in upland forests, especially those dominated by hardwood canopy species, are relatively unknown. We initiated our study to assess whether this management strategy affects eastern wild turkey reproductive ecology on the Ozark-St. Francis National Forest. We marked 67 wild turkey hens with Global Positioning System (GPS) Platform Transmitting Terminals in 2012 and 2013 to document exposure to prescribed fire, and estimate daily nest survival, nest success, and nest-site selection. We estimated these reproductive parameters in forest units managed with prescribed fire (treated) and units absent of prescribed fire (untreated). Of 60 initial nest attempts monitored, none were destroyed or exposed to prescribed fire because a majority of fires occurred early than a majority of the nesting activity. We found nest success was greater in untreated units than treated units (36.4% versus 14.6%). We did not find any habitat characteristic differences between successful and unsuccessful nest-sites. We found that nest-site selection criteria differed between treated and untreated units. Visual concealment and woody ground cover were common selection criteria in both treated and untreated units. However, in treated units wild turkey selected nest-sites with fewer small shrubs (<5 cm ground diameter) and large trees (>20 cm DBH) but not in untreated units. In untreated units wild turkey selected nest-sites with more large shrubs (>= 5cm ground diameter) but did not select for small shrubs or large trees. Our findings suggest that wild turkey have not benefited from the reintroduction of prescribed fire to the WRERA.	[Pittman, H. Tyler] Univ Arkansas, Dept Biol Sci, Arkansas Cooperat Fish & Wildlife Res Unit, Fayetteville, AR 72701 USA; [Krementz, David G.] Univ Arkansas, Dept Biol Sci, Cooperat Fish & Wildlife Res Unit, US Geol Survey, Fayetteville, AR 72701 USA; [Pittman, H. Tyler] Florida Fish & Wildlife Commiss, Florida Fish & Wildlife Res Inst, 1105 SW Williston Rd, Gainesville, FL 32601 USA	University of Arkansas System; University of Arkansas Fayetteville; United States Department of the Interior; United States Geological Survey; University of Arkansas System; University of Arkansas Fayetteville; Florida Fish & Wildlife Conservation Commission	Pittman, HT (corresponding author), Univ Arkansas, Dept Biol Sci, Arkansas Cooperat Fish & Wildlife Res Unit, Fayetteville, AR 72701 USA.; Pittman, HT (corresponding author), Florida Fish & Wildlife Commiss, Florida Fish & Wildlife Res Inst, 1105 SW Williston Rd, Gainesville, FL 32601 USA.	H.T.Pittman@gmail.com			Arkansas Game and Fish Commission; USDA Forest Service Boson Mountain Ranger District; University of Arkansas; U.S. Geological Survey Arkansas Cooperative Fish and Wildlife Research Unit; United States Department of Agriculture U.S. Forest Service; National Wild Turkey Federation	Arkansas Game and Fish Commission; USDA Forest Service Boson Mountain Ranger District; University of Arkansas; U.S. Geological Survey Arkansas Cooperative Fish and Wildlife Research Unit; United States Department of Agriculture U.S. Forest Service; National Wild Turkey Federation	The authors received financial support from the Arkansas Game and Fish Commission for project implementation and logistics. The authors received support from the USDA Forest Service Boson Mountain Ranger District and the University of Arkansas, and the U.S. Geological Survey Arkansas Cooperative Fish and Wildlife Research Unit to complete the project.; We received support from the United States Department of Agriculture U.S. Forest Service, Arkansas Game and Fish Commission, National Wild Turkey Federation, U.S. Geological Survey Arkansas Cooperative Fish and Wildlife Research Unit, and the University of Arkansas. We thank R. Whalen, B. Bowers, K. Lynch, J. Lindsay, J. Honey, J. Cothern, D. Magoulick, M. Douglas, and D. Moler for financial and logistical support. We thank C. Moorman, B. Collier, J. Cothern, D. Magoulick, M. Douglas, and two anonymous reviewers for comments to an early version of our manuscript. We also thank the Florida Fish and Wildlife Research Institute for allowing the work to be complete at the institute. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. All research was conducted under the approval of the Animal Care and Use Committee at the University of Arkansas (#11012).	Artman Vanessa L., 2005, Studies in Avian Biology, V30, P127; Artman VL, 2001, CONSERV BIOL, V15, P1423, DOI 10.1046/j.1523-1739.2001.00181.x; BADYAEV AV, 1995, CONDOR, V97, P221, DOI 10.2307/1368998; Badyaev AV, 1996, CONDOR, V98, P589, DOI 10.2307/1369571; Badyaev AV, 1994, THESIS U ARKANSAS; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Byrne ME, 2013, AM MIDL NAT, V170, P95, DOI 10.1674/0003-0031-170.1.95; Chapman RA, 2006, FOREST ECOL MANAG, V236, P85, DOI 10.1016/j.foreco.2006.08.341; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Elliott KJ, 1999, FOREST ECOL MANAG, V114, P199, DOI 10.1016/S0378-1127(98)00351-X; Foti T. L., 2004, General Technical Report - Southern Research Station, USDA Forest Service, P21; Frank III., 2012, GEN TECH REP NRS P 1, P159; Franklin SB, 2003, FOREST ECOL MANAG, V184, P315, DOI 10.1016/S0378-1127(03)00153-1; Fryar RD, 2012, P 4 FIR E OAK FOR C, P292; Fuller AK, 2013, WILDLIFE BIOL, V19, P138, DOI 10.2981/11-121; Greenberg CH, 2007, J WILDLIFE MANAGE, V71, P1906, DOI 10.2193/2006-070; Greenberg CH, 2013, FOREST ECOL MANAG, V304, P80, DOI 10.1016/j.foreco.2013.04.035; Grubb TG, 1991, RM502 USDA FOR SERV; Guyette RP, 2006, FOREST ECOL MANAG, V234, P293, DOI 10.1016/j.foreco.2006.07.016; Kilburg EL, 2014, J WILDLIFE MANAGE, V78, P1033, DOI 10.1002/jwmg.751; Kiss BW, 2015, THESIS U MANITOBA; KURZEJESKI EW, 1987, J WILDLIFE MANAGE, V51, P188, DOI 10.2307/3801653; Lanham JD, 2006, FIRE E OAK FORESTS D, P303; Lehman CP, 2003, AM MIDL NAT, V149, P192, DOI 10.1674/0003-0031(2003)149[0192:COMCAN]2.0.CO;2; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Little AR, 2014, FOREST ECOL MANAG, V331, P180, DOI 10.1016/j.foreco.2014.07.030; Ludwig E, 2012, THESIS U DELAWARE; MARTIN TE, 1988, CONDOR, V90, P51, DOI 10.2307/1368432; Miller DA, 1998, J WILDLIFE MANAGE, V62, P903, DOI 10.2307/3802541; Moore William F., 2010, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V64, P24; Nguyen LP, 2003, WILSON BULL, V115, P131, DOI 10.1676/02-123; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; Paisley RN, 1998, J WILDLIFE MANAGE, V62, P911, DOI 10.2307/3802542; PALMER WE, 1993, J WILDLIFE MANAGE, V57, P783, DOI 10.2307/3809080; Peterson DW, 2001, ECOL APPL, V11, P914, DOI 10.1890/1051-0761(2001)011[0914:PFIOSF]2.0.CO;2; Pollentier CD, 2014, J WILDLIFE MANAGE, V78, P985, DOI 10.1002/jwmg.749; Reidy JL, 2014, FOREST ECOL MANAG, V313, P34, DOI 10.1016/j.foreco.2013.10.042; Thogmartin WE, 1999, AUK, V116, P912, DOI 10.2307/4089671; Thogmartin WE, 1998, THESIS U ARKANSAS; United States Department of Agriculture (USDA), 2005, US FOR SERV MAN B; VANGILDER LD, 1987, J WILDLIFE MANAGE, V51, P535, DOI 10.2307/3801265; Williams M, 2012, THESIS U GEORGIA; Wilson Walker B., 2005, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V59, P126	43	5	5	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147317	10.1371/journal.pone.0147317	http://dx.doi.org/10.1371/journal.pone.0147317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795913	gold, Green Published, Green Submitted			2022-12-26	WOS:000368530300029
J	Rebolj, M; Bonde, J; Preisler, S; Ejegod, D; Rygaard, C; Lynge, E				Rebolj, Matejka; Bonde, Jesper; Preisler, Sarah; Ejegod, Ditte; Rygaard, Carsten; Lynge, Elsebeth			Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; MESSENGER-RNA ASSAY; INTRAEPITHELIAL NEOPLASIA; DNA TESTS; FOLLOW-UP; HPV TEST; CANCER; POPULATION; PERFORMANCE; PREVENTION	In women aged >= 30 years, Human Papillomavirus testing will replace cytology for primary cervical screening. We compared Hybrid Capture 2 (HC2), cobas, CLART, and APTIMA HPV assays with cytology on 2869 SurePath samples from women undergoing routine screening at 30-65 years in Copenhagen, Denmark. Women with cytological abnormalities were managed according to routine recommendations, with 92% completeness. Those with cytology-normal/HPV-positive samples (on any of the four assays) were invited for repeated cytology and HPV testing in 1.5 year, and 58% had additional testing. HPV testing detected more >= CIN3 than cytology (HC2: 35, cobas, CLART: 37, APTIMA: 34, cytology: 31), although statistically the differences were not significant. Cobas and CLART detected significantly more >= CIN2 than cytology (cobas, CLART: 49, cytology: 39). The proportion of women with false-positive test results (positive test results without >= CIN3) varied between 3.3% with cytology and 14.9% with cobas. All HPV assays led to significantly more false-positive tests, whereas compared to HC2 cobas and CLART were associated with a significantly higher and APTIMA with a significantly lower proportion. Detection of CIN1 was particularly increased for the three DNA assays. With APTIMA combined with cytological triage, about 20% more women were referred for colposcopy than with cytology screening. With the three DNA assays, the increase was >= 50%. The number of women with repeated testing was twice as high with APTIMA and almost five times as high with cobas compared to cytology. To our knowledge, Horizon was the only study set in routine practice that compared more than two HPV assays in the same women while also ascertaining the histological status of women with normal cytology/HPV-positive test results. HPV-based screening of Danish women aged 30-65 detected more high-grade CIN but decreased the screening specificity, and increased the demand for additional testing.	[Rebolj, Matejka; Lynge, Elsebeth] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Bonde, Jesper; Preisler, Sarah; Ejegod, Ditte; Rygaard, Carsten] Copenhagen Univ Hosp, Dept Pathol, Hvidovre, Denmark; [Rebolj, Matejka; Bonde, Jesper; Preisler, Sarah] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Rebolj, M (corresponding author), Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.; Rebolj, M (corresponding author), Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark.	matejkarebolj@gmail.com	Bonde, Jesper/AAN-5930-2020; Bonde, Jesper H/F-1478-2013	Lynge, Elsebeth/0000-0003-4785-5236; Rebolj, Matejka/0000-0001-9597-645X; Bonde, Jesper/0000-0003-4853-6747	Danish Strategic Research Council [10092793]; Genomica; Hologic; Roche; QIAGEN	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Genomica; Hologic; Roche(Roche Holding); QIAGEN	Genomica, the manufacturer of the CLART HPV2 Assay; Hologic, the manufacturer of the APTIMA HPV Assay; Roche, the manufacturer of the cobas HPV Test; and QIAGEN, the manufacturer of the Hybrid Capture 2 Assay, provided tests, instrumentation, and limited co-funding for laboratory material. MR and SP were funded by the Danish Strategic Research Council (grant number: 10092793). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The researchers worked independently of the funders.	Bjerregaard B, 2011, SCAND J PUBLIC HEALT, V39, P72, DOI 10.1177/1403494810393563; Bonde J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-413; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Castle PE, 2010, LANCET ONCOL, V11, P214, DOI 10.1016/S1470-2045(09)70385-7; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Goldman B, 2013, VACCINE, V31, P1604, DOI 10.1016/j.vaccine.2012.12.084; Heideman DAM, 2011, J CLIN MICROBIOL, V49, P3983, DOI 10.1128/JCM.05552-11; Ingemann-Hansen O, 2008, BRIT J CANCER, V98, P1292, DOI 10.1038/sj.bjc.6604293; Kirschner B, 2011, GYNECOL ONCOL, V120, P68, DOI 10.1016/j.ygyno.2010.09.021; Lloveras B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058153; Lynge E, 2009, NAT REV CLIN ONCOL, V6, P699, DOI 10.1038/nrclinonc.2009.167; Monsonego J, 2011, INT J CANCER, V129, P691, DOI 10.1002/ijc.25726; Nieves L, 2013, INT J GYNECOL CANCER, V23, P513, DOI 10.1097/IGC.0b013e318280f3bc; Pista A, 2011, J MED VIROL, V83, P272, DOI 10.1002/jmv.21952; Poljak M, 2012, VACCINE, V30, pF100, DOI 10.1016/j.vaccine.2012.04.105; Preisler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059765; Ratnam S, 2011, J CLIN MICROBIOL, V49, P557, DOI 10.1128/JCM.02147-10; Rebolj M, 2010, BRIT J CANCER, V103, P310, DOI 10.1038/sj.bjc.6605771; Rebolj M, 2007, INT J CANCER, V120, P806, DOI 10.1002/ijc.22167; Rebolj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086835; Rebolj M, 2013, J MOL DIAGN, V15, P670, DOI 10.1016/j.jmoldx.2013.04.002; Rebolj M, 2013, CURR PHARM DESIGN, V19, P1439; Rebolj M, 2012, EUR J CANCER PREV, V21, P73, DOI 10.1097/CEJ.0b013e3283498dbe; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Wright TC, 2015, GYNECOL ONCOL, V136, P189, DOI 10.1016/j.ygyno.2014.11.076; Wu RF, 2010, INT J GYNECOL CANCER, V20, P1411, DOI 10.1111/IGC.0b013e3181f29547	31	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147326	10.1371/journal.pone.0147326	http://dx.doi.org/10.1371/journal.pone.0147326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789267	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100079
J	Chandrasekaran, S; Bonchev, D				Chandrasekaran, Sreedevi; Bonchev, Danail			Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer's Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; OXIDATIVE STRESS; NEUROFIBRILLARY TANGLES; GAMMA-SECRETASE; BETA; EXPRESSION; DYSFUNCTION; MECHANISMS; NEURODEGENERATION	Network-based approaches are powerful and beneficial tools to study complex systems in their entirety, elucidating the essential factors that turn the multitude of individual elements into a functional system. In this study we used critical network topology descriptors and guilt-by-association rule to explore and understand the significant molecular players, drug targets and underlying biological mechanisms of Alzheimer's disease. Analyzing two post-mortem brain gene microarrays (GSE4757 and GSE28146) with Pathway Studio software package we constructed and analyzed a set of protein-protein interaction, as well as miRNA-target networks. In a 4-step procedure the expression datasets were normalized using Robust Multi-array Average approach, while the modulation of gene expression by the disease was statistically evaluated by the empirical Bayes method from the limma Bioconductor package. Representative set of 214 seed-genes (p<0.01) common for the three brain sections of the two microarrays was thus created. The Pathway Studio analysis of the networks built identified 15 new potential AD-related genes and 17 novel AD-involved microRNAs. Using KEGG pathways relevant in Alzheimer's disease we built an integrated mechanistic network from the interactions between the overlapping genes in these pathways. Routes of possible disease initiation process were thus revealed through the CD4, DCN, and IL8 extracellular ligands. DAVID and IPA enrichment analysis uncovered a number of deregulated biological processes and pathways including neuron projection/differentiation, aging, oxidative stress, chemokine/neurotrophin signaling, long-term potentiation and others. The findings in this study offer information of interest for subsequent experimental studies.	[Chandrasekaran, Sreedevi; Bonchev, Danail] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	Virginia Commonwealth University	Chandrasekaran, S (corresponding author), Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA.	sreedevi.c@gmail.com						Agadjanyan MG, 2005, J IMMUNOL, V174, P1580, DOI 10.4049/jimmunol.174.3.1580; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Arrazola MS, 2009, J CELL PHYSIOL, V221, P658, DOI 10.1002/jcp.21902; Auffret A, 2010, J ALZHEIMERS DIS, V19, P1021, DOI 10.3233/JAD-2010-1302; Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/871313; Batagelj V., 1998, CONNECTIONS, V21, P1; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Cecarini V, 2012, BBA-MOL BASIS DIS, V1822, P1741, DOI 10.1016/j.bbadis.2012.07.015; Chandrasekaran S, 2013, COMPUT STRUCT BIOTEC, V7, DOI 10.5936/csbj.201304004; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Das P, 2006, J CLIN INVEST, V116, P2855, DOI 10.1172/JCI30284; Delay C, 2012, NEUROBIOL DIS, V46, P285, DOI 10.1016/j.nbd.2012.01.003; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; Dhawan G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-117; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Dunckley T, 2006, NEUROBIOL AGING, V27, P1359, DOI 10.1016/j.neurobiolaging.2005.08.013; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Estrada E, 2011, STRUCTURE COMPLEX NE; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; GITTER BD, 1995, P NATL ACAD SCI USA, V92, P10738, DOI 10.1073/pnas.92.23.10738; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414; Hertel M, 2002, EUR J NEUROSCI, V15, P1707, DOI 10.1046/j.1460-9568.2002.01992.x; Hippius Hanns, 2003, Dialogues Clin Neurosci, V5, P101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobs HIL, 2013, NEUROSCI BIOBEHAV R, V37, P753, DOI 10.1016/j.neubiorev.2013.03.009; Jellinger KA, 2010, J CELL MOL MED, V14, P457, DOI 10.1111/j.1582-4934.2010.01010.x; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Jordan-Sciutto KL, 2002, J NEUROPATH EXP NEUR, V61, P358, DOI 10.1093/jnen/61.4.358; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Klein C, 2006, NAT CLIN PRACT NEURO, V2, P136, DOI 10.1038/ncpneuro0126; Larbi A, 2009, J ALZHEIMERS DIS, V17, P91, DOI 10.3233/JAD-2009-1015; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Leuba G, 2004, NEUROPATH APPL NEURO, V30, P57, DOI 10.1046/j.0305-1846.2003.00511.x; Liang CL, 2012, BRAIN RES, V1455, P103, DOI 10.1016/j.brainres.2011.10.051; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Manczak M, 2013, J ALZHEIMERS DIS, V36, P285, DOI 10.3233/JAD-130275; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; Mateo I, 2009, ACTA NEUROL SCAND, V120, P130, DOI 10.1111/j.1600-0404.2008.01128.x; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; NCBI, NCHI GEO DAT GSE4757; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Pollak D, 2003, J NEURAL TRANSM-SUPP, P149; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Proctor CJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-7; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Qin QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009999; Qin S, 2004, ACTA NEUROPATHOL, V107, P209, DOI 10.1007/s00401-003-0800-4; Raux G, 2005, J MED GENET, V42, P793, DOI 10.1136/jmg.2005.033456; Reddy PH, 2014, J ALZHEIMERS DIS, V40, P245, DOI 10.3233/JAD-132060; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P139, DOI 10.4137/GRSB.S13204; Satoh J, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-17; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serretti A, 2005, J ALZHEIMERS DIS, V7, P331; Smith MZ, 1999, NEUROSCI LETT, V271, P45, DOI 10.1016/S0304-3940(99)00509-1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SNOW AD, 1992, J HISTOCHEM CYTOCHEM, V40, P105, DOI 10.1177/40.1.1370306; Solerte SB, 1998, NEUROBIOL AGING, V19, P191, DOI 10.1016/S0197-4580(98)00050-5; Sonoda Y, 2010, NEUROSCI LETT, V471, P20, DOI 10.1016/j.neulet.2009.12.078; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199; Tichauer JE, 2012, J NEUROSCI RES, V90, P1970, DOI 10.1002/jnr.23082; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tsang SWY, 2008, NEUROBIOL AGING, V29, P1524, DOI 10.1016/j.neurobiolaging.2007.03.014; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Witten TM, 2007, CHEM BIODIVERS, V4, P2639, DOI 10.1002/cbdv.200790216; Wolfe MS, 2013, NAT MED, V19, P22, DOI 10.1038/nm.3053; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia Jing, 2014, Int J Alzheimers Dis, V2014, P721453, DOI 10.1155/2014/721453; Xia MQ, 1999, J NEUROVIROL, V5, P32, DOI 10.3109/13550289909029743; Zambrano N, 2004, J BIOL CHEM, V279, P16161, DOI 10.1074/jbc.M311027200; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523; Zhu HC, 2012, BRAIN RES BULL, V88, P596, DOI 10.1016/j.brainresbull.2012.05.018	98	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0144052	10.1371/journal.pone.0144052	http://dx.doi.org/10.1371/journal.pone.0144052			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784894	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400003
J	Kajubi, P; Whyte, SR; Kyaddondo, D; Katahoire, AR				Kajubi, Phoebe; Whyte, Susan Reynolds; Kyaddondo, David; Katahoire, Anne Ruhweza			Tensions in Communication between Children on Antiretroviral Therapy and Their Caregivers: A Qualitative Study in Jinja District, Uganda	PLOS ONE			English	Article							HIV STATUS; DISCLOSURE MODEL; DIAGNOSIS; ADOLESCENTS; CHILDHOODS; HIV/AIDS; ANTHROPOLOGY; DISTRESS; HEALTH	Introduction HIV treatment and disclosure guidelines emphasize the importance of communicating diagnosis and treatment to infected children in ways that are appropriate to children's developmental stage and age. Minimal attention, however, has been given to communication challenges confronted by HIV-infected children and their caregivers. This study examined the tensions between children and their caregivers arising from differing perspectives regarding when and what to communicate about antiretroviral therapy (ART). Methods This qualitative study was conducted between November 2011 and December 2012 and involved 29 HIV-infected children aged 8-17 years on ART and their caregivers. Data were collected through observations and in-depth interviews, which took place in homes, treatment centres and post-test clubs. Children and caregivers were sampled from among the 394 HIV-infected children and (their) 393 caregivers who participated in the cross-sectional survey that preceded the qualitative study. ATLAS.ti. Version 7 was used in the management of the qualitative data and in the coding of the emerging themes. The data were then analyzed using content thematic analysis. Results While the children felt that they were mature enough to know what they were suffering and what the medications were for, the caregivers wanted to delay discussions relating to the children's HIV diagnosis and medication until they felt that the children were mature enough to deal with the information and keep it a secret and this caused a lot of tension. The children employed different tactics including refusing to take the medicines, to find out what they were suffering from and what the medications were for. Children also had their own ideas about when, where and with whom to discuss their HIV condition, ideas that did not necessarily coincide with those of their caregivers, resulting in tensions. Conclusions Guidelines should take into consideration differing perceptions of maturity when recommending ages at which caregivers should communicate with their children about diagnosis and ART. Health care providers should also encourage caregivers to recognize and respect children's efforts to learn about and manage their condition. Children's questions and expressions of feelings should be treated as openings for communication on these issues.	[Kajubi, Phoebe; Kyaddondo, David; Katahoire, Anne Ruhweza] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Whyte, Susan Reynolds] Univ Copenhagen, Dept Anthropol, Copenhagen, Denmark	Makerere University; University of Copenhagen	Kajubi, P (corresponding author), Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda.	phoebekajubi@yahoo.com		Whyte, Susan/0000-0001-7253-6478	Danish Ministry of Foreign Affairs, Uganda, through a project called "Quality Medicine Use for Children in Uganda (ChildMed)" [09-100KU]; ChildMed coordination team	Danish Ministry of Foreign Affairs, Uganda, through a project called "Quality Medicine Use for Children in Uganda (ChildMed)"; ChildMed coordination team	The study was funded by the Danish Ministry of Foreign Affairs, Uganda, through a project called "Quality Medicine Use for Children in Uganda (ChildMed)" project number: 09-100KU; website: http://childmed.ku.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the children and their caregivers who participated in the study and the health workers in all the study sites for their support. We acknowledge the support of the ChildMed coordination team.	Abadia-Barrero CE, 2006, AIDS PATIENT CARE ST, V20, P36, DOI 10.1089/apc.2006.20.36; Abebe W, 2012, AIDS CARE, V24, P1097, DOI 10.1080/09540121.2012.656565; [Anonymous], 2009, HIGH LOC GOV STAT AB; Aries P., 1962, CENTURIES CHILDHOOD; Arun S, 2009, INDIAN J PEDIATR, V76, P805, DOI 10.1007/s12098-009-0177-z; Baaroy JO, 1999, THESIS U OSLO NORWAY; Bernard H. R., 2017, RES METHODS ANTHR; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Blasini I, 2004, J DEV BEHAV PEDIATR, V25, P181, DOI 10.1097/00004703-200406000-00007; Bluebond-Langner M, 2007, AM ANTHROPOL, V109, P241, DOI 10.1525/AA.2007.109.2.241; Boyden J., 2003, CHILDREN YOUTH ENV, V13, P1; Brannen J, 2004, CHILDHOOD, V11, P409, DOI 10.1177/0907568204047104; Buhler-Niederberger D, 2008, CHILDHOOD, V15, P147, DOI 10.1177/0907568207088419; Campbell C, 2015, HEALTH PLACE, V31, P54, DOI 10.1016/j.healthplace.2014.09.008; Gerson A C, 2001, J Pediatr Health Care, V15, P161, DOI 10.1067/mph.2001.114835; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Hardman C, 2001, CHILDHOOD, V8, P501, DOI 10.1177/0907568201008004006; HARDY MS, 1994, J DEV BEHAV PEDIATR, V15, pS49; Heeren GA, 2011, INNOVATION-ABINGDON, V24, P199, DOI 10.1080/13511610.2011.553506; Instone S L, 2000, J Pediatr Health Care, V14, P235, DOI 10.1067/mph.2000.107338; Jenks C, 2004, CHILDHOOD, V11, P5, DOI 10.1177/0907568204040179; Kajubi P, 2014, CHILD YOUTH SERV REV, V45, P38, DOI 10.1016/j.childyouth.2014.03.036; Kajubi P, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19012; Kalibala S, 2010, SITUATION ANAL VULNE, P2; Kidia KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087322; Kiwanuka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093276; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Kyaddondo D, 2013, SAHARA J-J SOC ASP H, V10, pS37, DOI 10.1080/02664763.2012.755323; Lancy D. F., 2008, ANTHR CHILDHOOD CHER; Ledlie SW, 1999, NURS RES, V48, P141, DOI 10.1097/00006199-199905000-00004; Lee CL, 1999, AIDS PATIENT CARE ST, V13, P41, DOI 10.1089/apc.1999.13.41; LEE M, 1999, AIDS BEHAV, V3, P33, DOI DOI 10.1023/A:1025415418759; Lester P, 2002, JAIDS-J ACQ IMM DEF, V31, P309, DOI 10.1097/00126334-200211010-00006; LeVine RA, 2007, AM ANTHROPOL, V109, P247, DOI 10.1525/AA.2007.109.2.247; Mburu G, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18866; Meinert L., 2009, HOPES FRICTION SCH H; Ministry of Health (MOH) [Uganda] and ICF International, 2011, UG AIDS IND SURV 201; MOH, 2009, UG NAT ANT TREATM GU; MOH, 2005, UG NAT POL HIV COUNS; Moodley K, 2008, S AFR MED J, V96, P201; Mupambireyi Z, 2014, CHILDREN YOUTH SERVI; Murphy DA, 2000, J ADOLESCENT HEALTH, V27, P391, DOI 10.1016/S1054-139X(00)00158-0; Myer L, 2006, J TROP PEDIATRICS, V52, P293, DOI 10.1093/tropej/fml004; Oberdorfer P, 2006, J PAEDIATR CHILD H, V42, P283, DOI 10.1111/j.1440-1754.2006.00855.x; Onyango-Ouma W, 2001, CHILDREN HLTH COMMUN; Punch S, 2003, SOCIOLOGY, V37, P277, DOI 10.1177/0038038503037002004; Rushforth H, 1999, J CHILD PSYCHOL PSYC, V40, P683, DOI 10.1017/S0021963099003996; Rwemisisi J, 2008, HEALTH POLICY PLANN, V23, P36, DOI 10.1093/heapol/czm040; Siu GE, 2012, AIDS CARE, V24, P606, DOI 10.1080/09540121.2011.630346; Skovdal M, 2012, AJAR-AFR J AIDS RES, V11, P153, DOI 10.2989/16085906.2012.734975; Suris JC, 2004, ARCH DIS CHILD, V89, P938, DOI 10.1136/adc.2003.045369; The Government of the Republic of Uganda, 2010, NAT POL DIS PREP MAN; UAC, 2013, UG HIV AIDS COUNTR P; Vaz L, 2011, J DEV BEHAV PEDIAT J; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; Vreeman RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086616; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; WHO, 2013, GLOB UPD HIV TREATM; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wilfert C, 1999, PEDIATRICS, V103, P164; World Health Organization, 2011, GUID HIV DISCL COUNS; World Health Organization, 2013, GUID HIV TEST COUNS	64	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147119	10.1371/journal.pone.0147119	http://dx.doi.org/10.1371/journal.pone.0147119			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784904	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400113
J	Kang, L; Zhang, S				Kang, Ling; Zhang, Song			Application of the Elitist-Mutated PSO and an Improved GSA to Estimate Parameters of Linear and Nonlinear Muskingum Flood Routing Models	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION	Heuristic search algorithms, which are characterized by faster convergence rates and can obtain better solutions than the traditional mathematical methods, are extensively used in engineering optimizations. In this paper, a newly developed elitist-mutated particle swarm optimization (EMPSO) technique and an improved gravitational search algorithm (IGSA) are successively applied to parameter estimation problems of Muskingum flood routing models. First, the global optimization performance of the EMPSO and IGSA are validated by nine standard benchmark functions. Then, to further analyse the applicability of the EMPSO and IGSA for various forms of Muskingum models, three typical structures are considered: the basic two-parameter linear Muskingum model (LMM), a three-parameter nonlinear Muskingum model (NLMM) and a four-parameter nonlinear Muskingum model which incorporates the lateral flow (NLMM-L). The problems are formulated as optimization procedures to minimize the sum of the squared deviations (SSQ) or the sum of the absolute deviations (SAD) between the observed and the estimated outflows. Comparative results of the selected numerical cases (Case 1-3) show that the EMPSO and IGSA not only rapidly converge but also obtain the same best optimal parameter vector in every run. The EMPSO and IGSA exhibit superior robustness and provide two efficient alternative approaches that can be confidently employed to estimate the parameters of both linear and nonlinear Muskingum models in engineering applications.	[Kang, Ling; Zhang, Song] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zhang, S (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan 430074, Peoples R China.	zhangs@hust.edu.cn		Zhang, Song/0000-0002-6516-3965	Hubei Support Plan of Science and Technology of China [2015BCA291]; Wuhan Planning Project of Science and Technology of China [2014060101010062]	Hubei Support Plan of Science and Technology of China; Wuhan Planning Project of Science and Technology of China	This study was partly supported by the Hubei Support Plan of Science and Technology of China (No. 2015BCA291), and the Wuhan Planning Project of Science and Technology of China (No. 2014060101010062).	Al-Humoud JM, 2006, WATER RESOUR MANAG, V20, P979, DOI 10.1007/s11269-006-9018-2; [Anonymous], 1983, ENG HYDROLOGY; Barati R, 2011, J HYDROL ENG, V16, P946, DOI 10.1061/(ASCE)HE.1943-5584.0000379; Chen JJ, 2007, COMMUN NONLINEAR SCI, V12, P849, DOI 10.1016/j.cnsns.2005.06.005; Chow V. T., 1988, APPL HYDROLOGY; Chu HJ, 2009, J HYDROL ENG, V14, P1024, DOI 10.1061/(ASCE)HE.1943-5584.0000070; Clerc M., 1999, P C EV COMP, P1951, DOI DOI 10.1109/CEC.1999.785513; Das A, 2004, J IRRIG DRAIN ENG, V130, P140, DOI 10.1061/(ASCE)0733-9437(2004)130:2(140); Deb K, 2000, COMPUT METHOD APPL M, V186, P311, DOI 10.1016/S0045-7825(99)00389-8; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Geem ZW, 2006, J IRRIG DRAIN ENG, V132, P474, DOI 10.1061/(ASCE)0733-9437(2006)132:5(474); Geem ZW, 2014, ENG OPTIMIZ, V46, P328, DOI 10.1080/0305215X.2013.768242; GILL MA, 1978, J HYDROL, V36, P353, DOI 10.1016/0022-1694(78)90153-1; Jamil Momin, 2013, International Journal of Mathematical Modelling and Numerical Optimisation, V4, P150; Karahan H, 2015, ENG OPTIMIZ, V47, P737, DOI 10.1080/0305215X.2014.918115; Kennedy J, 2002, IEEE C EVOL COMPUTAT, P1671, DOI 10.1109/CEC.2002.1004493; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kim JH, 2001, J AM WATER RESOUR AS, V37, P1131, DOI 10.1111/j.1752-1688.2001.tb03627.x; Kumar DN, 2007, J WATER RES PLAN MAN, V133, P192, DOI 10.1061/(ASCE)0733-9496(2007)133:3(192); Li CH, 2009, IEEE C EVOL COMPUTAT, P381, DOI 10.1109/CEC.2009.4982972; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Luo JG, 2010, J HYDROL ENG, V15, P844, DOI 10.1061/(ASCE)HE.1943-5584.0000244; [马细霞 MA Xixia], 2007, [郑州大学学报. 工学版, Journal of Zhengzhou University. Engineering Science], V28, P122; McCarthy GT., 1938, C N ATL DIV; Mendes R, 2004, IEEE T EVOLUT COMPUT, V8, P204, DOI [10.1109/TEVC.2004.826074, 10.1109/tevc.2004.826074]; Mirjalili S., 2010, Proceedings of the 2010 International Conference on Computer and Information Application (ICCIA 2010), P374, DOI 10.1109/ICCIA.2010.6141614; ODONNELL T, 1985, HYDROLOG SCI J, V30, P479, DOI 10.1080/02626668509491013; Ouyang AJ, 2014, NEURAL COMPUT APPL, V25, P1785, DOI 10.1007/s00521-014-1669-y; Qu GJ, 1977, J HYDROL, V36, P40; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; TUNG YK, 1985, J HYDRAUL ENG-ASCE, V111, P1447, DOI 10.1061/(ASCE)0733-9429(1985)111:12(1447); Vesterstrom J, 2004, IEEE C EVOL COMPUTAT, P1980; Wang GG, 2014, ENG COMPUTATION, V31, P1198, DOI 10.1108/EC-10-2012-0232; Xu DM, 2012, J HYDROL ENG, V17, P348, DOI 10.1061/(ASCE)HE.1943-5584.0000432; Yang ZX, 2010, 2010 2ND IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND FINANCIAL ENGINEERING (ICIFE), P910, DOI 10.1109/ICIFE.2010.5609501; YOON JW, 1993, J WATER RES PL-ASCE, V119, P600, DOI 10.1061/(ASCE)0733-9496(1993)119:5(600)	38	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147338	10.1371/journal.pone.0147338	http://dx.doi.org/10.1371/journal.pone.0147338			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784900	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400136
J	Khoory, J; Estanislau, J; Elkhal, A; Lazaar, A; Melhorn, MI; Brodsky, A; Illigens, B; Hamachi, I; Kurishita, Y; Ivanov, AR; Shevkoplyas, S; Shapiro, NI; Ghiran, IC				Khoory, Joseph; Estanislau, Jessica; Elkhal, Abdallah; Lazaar, Asmae; Melhorn, Mark I.; Brodsky, Abigail; Illigens, Ben; Hamachi, Itaru; Kurishita, Yasutaka; Ivanov, Alexander R.; Shevkoplyas, Sergey; Shapiro, Nathan I.; Ghiran, Ionita C.			Ligation of Glycophorin A Generates Reactive Oxygen Species Leading to Decreased Red Blood Cell Function	PLOS ONE			English	Article							INDUCED ATP RELEASE; HUMAN ERYTHROCYTES; LUNG INJURY; RECEPTORS; PROTEIN; SEPSIS; DEFORMABILITY; PATHOGENESIS; DYSFUNCTION; APOPTOSIS	Acute, inflammatory conditions associated with dysregulated complement activation are characterized by significant increases in blood concentration of reactive oxygen species (ROS) and ATP. The mechanisms by which these molecules arise are not fully understood. In this study, using luminometric- and fluorescence-based methods, we show that ligation of glycophorin A (GPA) on human red blood cells (RBCs) results in a 2.1-fold, NADPH-oxidase-dependent increase in intracellular ROS that, in turn, trigger multiple downstream cascades leading to caspase-3 activation, ATP release, and increased band 3 phosphorylation. Functionally, using 2D microchannels to assess membrane deformability, GPS-ligated RBCs travel 33% slower than control RBCs, and lipid mobility was hindered by 10% using fluorescence recovery after photobleaching (FRAP). These outcomes were preventable by pretreating RBCs with cell-permeable ROS scavenger glutathione monoethyl ester (GSH-ME). Our results obtained in vitro using anti-GPA antibodies were validated using complement-altered RBCs isolated from control and septic patients. Our results suggest that during inflammatory conditions, circulating RBCs significantly contribute to capillary flow dysfunctions, and constitute an important but overlooked source of intravascular ROS and ATP, both critical mediators responsible for endothelial cell activation, microcirculation impairment, platelet activation, as well as long-term dysregulated adaptive and innate immune responses.	[Khoory, Joseph; Estanislau, Jessica; Lazaar, Asmae; Melhorn, Mark I.; Brodsky, Abigail; Ghiran, Ionita C.] Beth Israel Deaconess Med Ctr, Div Allergy & Inflammat, Boston, MA 02215 USA; [Khoory, Joseph; Estanislau, Jessica; Elkhal, Abdallah; Lazaar, Asmae; Melhorn, Mark I.; Brodsky, Abigail; Illigens, Ben; Shapiro, Nathan I.; Ghiran, Ionita C.] Harvard Univ, Sch Med, Boston, MA USA; [Elkhal, Abdallah] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Illigens, Ben] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Hamachi, Itaru; Kurishita, Yasutaka] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan; [Ivanov, Alexander R.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Shevkoplyas, Sergey] Univ Houston, Cullen Coll Engn, Dept Biomed Engn, Houston, TX USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Ctr Vasc Biol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Kyoto University; Northeastern University; University of Houston System; University of Houston; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Ghiran, IC (corresponding author), Beth Israel Deaconess Med Ctr, Div Allergy & Inflammat, Boston, MA 02215 USA.; Ghiran, IC (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	ighiran@bidmc.harvard.edu	Shapiro, Nathan/F-1718-2016	Shevkoplyas, Sergey/0000-0002-8203-8365	National Institutes of Health [R01 HL096795]; Bill and Melinda Gates Foundation [OPP1032683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health R01 HL096795 (ICG), and Bill and Melinda Gates Foundation award OPP1032683 (ICG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EH, 2001, BLOOD CELL MOL DIS, V27, P165, DOI 10.1006/bcmd.2000.0357; ABRAMSON SB, 1991, ANN INTERN MED, V114, P941, DOI 10.7326/0003-4819-114-11-941; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; [Anonymous], 2009, CHEST; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; Bakhtiari N, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-9; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905; Betz T, 2009, P NATL ACAD SCI USA, V106, P15320, DOI 10.1073/pnas.0904614106; Bloomfield C D, 1976, Semin Oncol, V3, P297; Bohm R, 1996, BBA-BIOMEMBRANES, V1280, P238, DOI 10.1016/0005-2736(95)00303-7; Borschukova O, 2012, LUPUS, V21, P1294, DOI 10.1177/0961203312454342; Brain MC, 2002, BRIT J HAEMATOL, V118, P899, DOI 10.1046/j.1365-2141.2002.03657.x; Brandao-Burch Andrea, 2012, Front Endocrinol (Lausanne), V3, P41, DOI 10.3389/fendo.2012.00041; CHAPLIN H, 1983, BLOOD, V62, P965; CHASIS JA, 1985, J CLIN INVEST, V75, P1919, DOI 10.1172/JCI111907; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; COOPER NR, 1969, SCIENCE, V165, P396, DOI 10.1126/science.165.3891.396; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; De Backer D, 2014, VIRULENCE, V5, P73, DOI 10.4161/viru.26482; Fan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038059; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Ghiran IC, 2010, ARTHRITIS RHEUMATISM; Ghiran I, 2008, BLOOD, V112, P3465, DOI 10.1182/blood-2008-04-151845; Ghiran IC, 2011, ARTHRITIS RHEUM-US, V63, P503, DOI 10.1002/art.30143; Glodek AM, 2010, BLOOD, V116, P6063, DOI 10.1182/blood-2010-04-273904; HARRISON ML, 1994, J BIOL CHEM, V269, P955; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Higuchi M, 1998, ONCOGENE, V17, P2753, DOI 10.1038/sj.onc.1202211; Howell MD, 2007, CRIT CARE MED, V35, P1422, DOI 10.1097/01.CCM.0000262933.08673.0C; HURD TC, 1988, ARCH SURG-CHICAGO, V123, P217; Inoue Y, 2008, CRIT CARE MED, V36, P2569, DOI 10.1097/CCM.0b013e3181841a91; Karnchanaphanurach P, 2009, J CLIN INVEST, V119, P788, DOI 10.1172/JCI36088; Kolachala VL, 2008, AM J PHYSIOL-GASTR L, V294, pG401, DOI 10.1152/ajpgi.00454.2007; MACFARLANE GD, 1994, ORAL MICROBIOL IMMUN, V9, P180, DOI 10.1111/j.1399-302X.1994.tb00056.x; Martin C, 2000, CRIT CARE MED, V28, P3198, DOI 10.1097/00003246-200009000-00014; Matsuyama H, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-79; McMullin MF, 1999, J CLIN PATHOL, V52, P245, DOI 10.1136/jcp.52.4.245; Melhorn MI, 2013, J BIOL CHEM, V288, P31139, DOI 10.1074/jbc.M113.486035; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; Moutzouri AG, 2007, CLIN HEMORHEOL MICRO, V36, P291; Muroya T, 2014, CRIT CARE MED, V42, pE364, DOI 10.1097/CCM.0000000000000231; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Nencioni A, 2009, INTERN EMERG MED; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; PIERCE KR, 1972, J AM VET MED ASSOC, V160, P323; PISANO A, 1993, GLYCOBIOLOGY, V3, P429, DOI 10.1093/glycob/3.5.429; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Sinha A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09768; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Vicas AE, 2005, AM J MED SCI, V329, P6, DOI 10.1097/00000441-200501000-00002; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Zhou G, 2012, AM J PHYSIOL-REG I, V302, pR409, DOI 10.1152/ajpregu.00153.2011	58	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0141206	10.1371/journal.pone.0141206	http://dx.doi.org/10.1371/journal.pone.0141206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784696	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400002
J	Vallianou, I; Hadzopoulou-Cladaras, M				Vallianou, Ioanna; Hadzopoulou-Cladaras, Margarita			Camphene, a Plant Derived Monoterpene, Exerts Its Hypolipidemic Action by Affecting SREBP-1 and MTP Expression	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; TRIGLYCERIDE TRANSFER PROTEIN; HMG-COA REDUCTASE; ELEMENT-BINDING PROTEINS; CORONARY-HEART-DISEASE; FATTY-ACID SYNTHESIS; CHOLESTEROL-METABOLISM; CHEMICAL-COMPOSITION; STEROL REGULATION	The control of hyperlipidemia plays a central role in cardiovascular disease. Previously, we have shown that camphene, a constituent of mastic gum oil, lowers cholesterol and triglycerides (TG) in the plasma of hyperlipidemic rats without affecting HMG-CoA reductase activity, suggesting that its hypocholesterolemic and hypotriglyceridemic effects are associated with a mechanism of action different than that of statins. In the present study, we examine the mechanism by which camphene exerts its hypolipidemic action. We evaluated the effect of camphene on the de novo synthesis of cholesterol and TG from [C-14]-acetate in HepG2 cells, along with the statin mevinolin. Camphene inhibited the biosynthesis of cholesterol in a concentration-dependent manner, and a maximal inhibition of 39% was observed at 100 mu M while mevinolin nearly abolished cholesterol biosynthesis. Moreover, treatment with camphene reduced TG by 34% and increased apolipoprotein AI expression. In contrast, mevinolin increased TG by 26% and had a modest effect on apolipoprotein AI expression. To evaluate the mode of action of camphene, we examined its effects on the expression of SREBP-1, which affects TG biosynthesis and SREBP-2, which mostly affects sterol synthesis. Interestingly, camphene increased the nuclear translocation of the mature form of SREBP-1 while mevinolin was found to increase the amount of the mature form of SREBP-2. The effect of camphene is most likely regulated through SREBP-1 by affecting MTP levels in response to a decrease in the intracellular cholesterol. We propose that camphene upregulates SREBP-1 expression and MTP inhibition is likely to be a probable mechanism whereby camphene exerts its hypolipidemic effect.	[Vallianou, Ioanna; Hadzopoulou-Cladaras, Margarita] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki 54124, Greece	Aristotle University of Thessaloniki	Hadzopoulou-Cladaras, M (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki 54124, Greece.	cladaras@bio.auth.gr						Aggarwal Dimple, 2005, BMC Cardiovasc Disord, V5, P30, DOI 10.1186/1471-2261-5-30; ALBERTS AW, 1988, AM J CARDIOL, V62, pJ10, DOI 10.1016/0002-9149(88)90002-1; Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; ANDERSON KM, 1987, ATHEROSCLEROSIS, V68, P59, DOI 10.1016/0021-9150(87)90094-3; Ansell BJ, 1999, JAMA-J AM MED ASSOC, V282, P2051, DOI 10.1001/jama.282.21.2051; ASSMANN G, 1993, CIRCULATION, V87, P28; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; BADIMON JJ, 1992, CIRCULATION, V86, P86; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Bergstrom JD, 1998, BBA-LIPID LIPID MET, V1389, P213, DOI 10.1016/S0005-2760(97)00182-3; BLANKENHORN DH, 1987, CONTROL CLIN TRIALS, V8, P354, DOI 10.1016/0197-2456(87)90156-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonn V, 2002, ATHEROSCLEROSIS, V163, P59; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Costet P, 2010, PHARMACOL THERAPEUT, V126, P263, DOI 10.1016/j.pharmthera.2010.02.006; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; DASHTI N, 1987, J LIPID RES, V28, P423; ENDO A, 1992, J LIPID RES, V33, P1569; Forte Trudy M., 1994, Current Opinion in Lipidology, V5, P354, DOI 10.1097/00041433-199410000-00007; Garcia-Pelayo MC, 2000, ANALYST, V125, P1583, DOI 10.1039/b004481o; GORDON T, 1972, J AMER MED ASSOC, V221, P661, DOI 10.1001/jama.221.7.661; Gotto AM, 2004, J AM COLL CARDIOL, V43, P717, DOI 10.1016/j.jacc.2003.08.061; Grassmann J, 2003, J AGR FOOD CHEM, V51, P7576, DOI 10.1021/jf030496e; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 1998, CIRCULATION, V97, P1436; GRUNDY SM, 1977, AM J CLIN NUTR, V30, P985, DOI 10.1093/ajcn/30.6.985; HAGAN DL, 1994, J BIOL CHEM, V269, P28737; Hajhosseiny R, 2014, CLIN PHARMACOL THER, V96, P64, DOI 10.1038/clpt.2014.76; Harper CR, 2007, CURR OPIN LIPIDOL, V18, P401, DOI 10.1097/MOL.0b013e32825a6773; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hussain MM, 2003, FRONT BIOSCI, V8, pS500, DOI 10.2741/1071; Jactel H, 1996, J CHEM ECOL, V22, P1037, DOI 10.1007/BF02029953; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Jin FY, 1999, ARTERIOSCL THROM VAS, V19, P1051, DOI 10.1161/01.ATV.19.4.1051; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Kim S, OBESITY SILVER SPRIN, V22, P408; KORNBRUST DJ, 1989, J PHARMACOL EXP THER, V248, P498; Koutsoudaki C, 2005, J AGR FOOD CHEM, V53, P7681, DOI 10.1021/jf050639s; KRAUSE BR, 1995, ATHEROSCLEROSIS, V117, P237, DOI 10.1016/0021-9150(95)05576-I; Lakusic D, 2013, NAT PROD COMMUN, V8, P131; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Maejima T, 2004, BIOCHEM BIOPH RES CO, V324, P835, DOI 10.1016/j.bbrc.2004.09.122; Magiatis P, 1999, PLANTA MED, V65, P749, DOI 10.1055/s-2006-960856; Maki KC, 2012, J CLIN LIPIDOL, V6, P413, DOI 10.1016/j.jacl.2012.04.003; Marz W, 2001, CIRCULATION, V103, P1942; MASTERS BA, 1995, TOXICOL APPL PHARM, V131, P163, DOI 10.1006/taap.1995.1058; Maxia A, 2009, FITOTERAPIA, V80, P57, DOI 10.1016/j.fitote.2008.09.008; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; QIN W, 1992, BIOCHIM BIOPHYS ACTA, V1127, P57, DOI 10.1016/0005-2760(92)90201-6; Rached FH, 2014, CLIN PHARMACOL THER, V96, P57, DOI 10.1038/clpt.2014.85; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Sawada M, 2001, EUR J PHARMACOL, V431, P11, DOI 10.1016/S0014-2999(01)01411-X; Scharnagl H, 2001, BIOCHEM PHARMACOL, V62, P1545, DOI 10.1016/S0006-2952(01)00790-0; Sebai H, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-189; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Stein EA, 1998, AM J CARDIOL, V81, p66B, DOI 10.1016/S0002-9149(98)00041-1; TAM SP, 1985, J BIOL CHEM, V260, P1670; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tiwari M, 2009, TOXICOL IN VITRO, V23, P295, DOI 10.1016/j.tiv.2008.12.014; Toth PP, 2004, CIRCULATION, V109, P1809, DOI 10.1161/01.CIR.0000126889.97626.B8; Trapani L, 2011, IUBMB LIFE, V63, P964, DOI 10.1002/iub.522; Vallianou I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020516; Venteclef N, 2005, BIOCHEM PHARMACOL, V69, P1041, DOI 10.1016/j.bcp.2005.01.005; Verdier C, 2013, ARCH CARDIOVASC DIS, V106, P601, DOI 10.1016/j.acvd.2013.06.052; Wierzbicki AS, 2012, INT J CLIN PRACT, V66, P270, DOI 10.1111/j.1742-1241.2011.02867.x; Wierzbicki Anthony S, 2003, Expert Opin Emerg Drugs, V8, P365, DOI 10.1517/14728214.8.2.365; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200	82	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147117	10.1371/journal.pone.0147117	http://dx.doi.org/10.1371/journal.pone.0147117			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784701	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400112
J	Wang, F; Wang, ZH; Kou, CL; Ma, ZH; Zhao, D				Wang, Fan; Wang, Zhaohui; Kou, Changlin; Ma, Zhenghua; Zhao, Dong			Responses of Wheat Yield, Macro- and Micro-Nutrients, and Heavy Metals in Soil and Wheat following the Application of Manure Compost on the North China Plain	PLOS ONE			English	Article							MICRONUTRIENT AVAILABILITY; NITROGEN-FERTILIZER; CROPPING SYSTEMS; WASTE-WATER; FOOD CROPS; IMPACT; MANAGEMENT; RESIDUES; CARBON; RISKS	The recycling of livestock manure in cropping systems is considered to enhance soil fertility and crop productivity. However, there have been no systematic long-term studies of the effects of manure application on soil and cropmacro- and micro-nutrients, heavy metals, and crop yields in China, despite their great importance for sustainable crop production and food safety. Thus, we conducted field experiments in a typical cereal crop production area of the North China Plain to investigate the effects of compost manure application rates on wheat yield, as well as on the macro-/micro-nutrients and heavy metals contents of soil and wheat. We found that compost application increased the soil total N and the available K, Fe, Zn, and Mn concentrations, whereas the available P in soil was not affected, and the available Cu decreased. In general, compost application had no significant effects on the grain yield, biomass, and harvest index of winter wheat. However, during 2012 and 2013, the N concentration decreased by 9% and 18% in straw, and by 16% and 12% in grain, respectively. With compost application, the straw P concentration only increased in 2012 but the grain P generally increased, while the straw K concentration tended to decrease and the grain K concentration increased in 2013. Compost application generally increased the Fe and Zn concentrations in straw and grain, whereas the Cu and Mn concentrations decreased significantly compared with the control. The heavy metal concentrations increased at some compost application rates, but they were still within the safe range. The balances of the macro-and micro-nutrients indicated that the removal of nutrients by wheat was compensated for by the addition of compost, whereas the level of N decreased without the application of compost. The daily intake levels of micronutrients via the consumption of wheat grain were still lower than the recommended levels when sheep manure compost was applied, except for that of Mn.	[Wang, Fan; Wang, Zhaohui] Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Wang, Fan; Wang, Zhaohui] Northwest Agr & Forestry Univ, Key Lab Plant Nutr & Agri Environm Northwest Chin, Minist Agr, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [Wang, Fan; Kou, Changlin; Ma, Zhenghua] Henan Acad Agr Sci, Inst Plant Nutr & Resource Environm, Zhengzhou, Peoples R China; [Zhao, Dong] Minist Agr, Henan Acad Agr Sci, Key Lab Anim Immunol, Henan Prov Key Lab Anim Immunol, Zhengzhou, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Henan Academy of Agricultural Sciences; Henan Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Wang, ZH (corresponding author), Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Wang, ZH (corresponding author), Northwest Agr & Forestry Univ, Key Lab Plant Nutr & Agri Environm Northwest Chin, Minist Agr, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.; Kou, CL (corresponding author), Henan Acad Agr Sci, Inst Plant Nutr & Resource Environm, Zhengzhou, Peoples R China.	w-zhaohui@263.net; koucl@126.com			National Key Basic Research Special Funds [2015CB150404]; Special Fund for Agro-scientific Research in the Public Interest [201103003]; China Agricultural Research System [CARS-3-1]	National Key Basic Research Special Funds(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; China Agricultural Research System	This study was supported by the National Key Basic Research Special Funds under grant 2015CB150404, the Special Fund for Agro-scientific Research in the Public Interest under grant 201103003, and the China Agricultural Research System (CARS-3-1).	Abbasi MK, 2012, AGRON J, V104, P169, DOI 10.2134/agronj2011.0264; Ahmad R, 2008, RENEW AGR FOOD SYST, V23, P243, DOI 10.1017/S1742170508002299; Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; Bao S.D., 2015, SOIL AGR CHEM ANAL, V3; Bastida F, 2008, MICROB ECOL, V55, P651, DOI 10.1007/s00248-007-9308-0; Berry PM, 2003, SOIL USE MANAGE, V19, P112, DOI 10.1079/SUM2003176; Bhattacharyya R, 2008, EUR J AGRON, V28, P33, DOI 10.1016/j.eja.2007.04.006; Campbell CR, 2009, SOUTHERN COOPERATIVE, V394; Chinese National Ministry of Health, 2012, 27622012 GB CHIN NAT; [崔崧 CUI Song], 2006, [华北农学报, Acta Agriculturae Boreali-Sinica], V21, P125; Dai XQ, 2013, FIELD CROP RES, V149, P141, DOI 10.1016/j.fcr.2013.04.027; Dong TongXi, 2014, Journal of Agricultural Resources and Environment, V31, P355; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; George S, 2013, SOIL TILL RES, V132, P47, DOI 10.1016/j.still.2013.05.004; Goni MA, 2014, B ENVIRON CONTAM TOX, V92, P726, DOI 10.1007/s00128-014-1264-z; Health and Human Services, 2010, DIET GUID AM; Jiang D, 2006, PEDOSPHERE, V16, P25, DOI 10.1016/S1002-0160(06)60022-2; Ju XT, 2007, ENVIRON POLLUT, V145, P497, DOI 10.1016/j.envpol.2006.04.017; Keshavarzi B, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4113-y; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; Li BY, 2007, SOIL TILL RES, V96, P166, DOI 10.1016/j.still.2007.05.005; Li PJ, 2009, J HAZARD MATER, V161, P516, DOI 10.1016/j.jhazmat.2008.03.130; Li ShuTian, 2011, Scientia Agricultura Sinica, V44, P4207; Limon-Ortega A, 2009, AGRON J, V101, P600, DOI 10.2134/agronj2008.0036x; Ma W-Q, 1999, CHINESE J SOIL SCI, V30, P217; MacRae RJ., 1985, ADV SOIL SCI, V3, P71, DOI [10.1007/978-1-4612-5090-6_2, DOI 10.1007/978-1-4612-5090-6_2]; Majumdar B, 2005, INDIAN J AGR SCI, V75, P809; Marcussen H, 2009, ENVIRON SCI TECHNOL, V43, P1122, DOI 10.1021/es801970z; Ministry of Agriculture PRC, 2012, CHIN AGR STAT REP; NEPA (National Environmental Protection Agency), 1995, 156181995 NEPA GB; Ning Z.X., 2014, TIANJIN AGR SCI, V20, P30; Panwar NR, 2010, COMMUN SOIL SCI PLAN, V41, P1073, DOI 10.1080/00103621003687166; Paul GC, 2006, P INT S TECHN IMPR S, P108; Portch S., 1995, Fertiliser News, V40, P83; Qiu Huan-guang, 2013, Huanjing Kexue, V34, P2766; Rengel Z, 1999, FIELD CROP RES, V60, P27, DOI 10.1016/S0378-4290(98)00131-2; Rezig FAM, 2013, ARCH AGRON SOIL SCI, V59, P1245, DOI 10.1080/03650340.2012.709623; Rutkowska B, 2014, PLANT SOIL ENVIRON, V60, P198, DOI 10.17221/914/2013-PSE; Rutkowska B, 2009, J ELEM, V14, P349, DOI 10.5601/jelem.2009.14.2.15; Shah SA, 2009, INT J PLANT PROD, V3; Shen P, 2014, CATENA, V118, P20, DOI 10.1016/j.catena.2014.01.020; Singh A, 2010, ECOL ENG, V36, P1733, DOI 10.1016/j.ecoleng.2010.07.021; Wang JW, 2013, FIELD CROP RES, V150, P83, DOI 10.1016/j.fcr.2013.06.010; Yang HS, 1997, EUR J AGRON, V7, P211, DOI 10.1016/S1161-0301(97)00047-6; Ye YL, 2006, THEORY PRACTICE INTE, P180; Zhang F.S., 2003, PHOSPHATE COMPOUND F, V18, P1; Zhang SL, 2015, J PLANT NUTR, V38, P742, DOI 10.1080/01904167.2014.957390; Zhou LL, 2014, ENVIRON SCI POLLUT R, V21, P1360, DOI 10.1007/s11356-013-2023-0	48	90	95	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146453	10.1371/journal.pone.0146453	http://dx.doi.org/10.1371/journal.pone.0146453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771517	gold, Green Submitted, Green Published			2022-12-26	WOS:000368628300020
J	Wang, HR; Wang, XH; Xu, XP; Kyba, M; Cooney, AJ				Wang, Hongran; Wang, Xiaohong; Xu, Xueping; Kyba, Michael; Cooney, Austin J.			Germ Cell Nuclear Factor (GCNF) Represses Oct4 Expression and Globally Modulates Gene Expression in Human Embryonic Stem (hES) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; embryonic stem cell; gene expression; gene regulation; pluripotency; Germ cell nuclear factor; Oct4	TRANSCRIPTION FACTOR; MOUSE EMBRYOS; SELF-RENEWAL; DIFFERENTIATION; ESTABLISHMENT; PLURIPOTENCY; OCT-3/4; KNOCKDOWN; ENDODERM; LINEAGES	Oct4 is considered a key transcription factor for pluripotent stem cell self-renewal. It binds to specific regions within target genes to regulate their expression and is downregulated upon induction of differentiation of pluripotent stem cells; however, the mechanisms that regulate the levels of human Oct4 expression remain poorly understood. Here we show that expression of human Oct4 is directly repressed by germ cell nuclear factor (GCNF), an orphan nuclear receptor, in hES cells. Knockdown of GCNF by siRNA resulted in maintenance of Oct4 expression during RA-induced hES cell differentiation. While overexpression of GCNF promoted repression of Oct4 expression in both undifferentiated and differentiated hES cells. The level of Oct4 repression was dependent on the level of GCNF expression in a dose-dependent manner. mRNA microarray analysis demonstrated that overexpression of GCNF globally regulates gene expression in undifferentiated and differentiated hES cells. Within the group of altered genes, GCNF down-regulated 36% of the genes, and up-regulated 64% in undifferentiated hES cells. In addition, GCNF also showed a regulatory gene pattern that is different from RA treatment during hES cell differentiation. These findings increase our understanding of the mechanisms that maintain hES cell pluripotency and regulate gene expression during the differentiation process.	[Wang, Hongran; Cooney, Austin J.] Univ Texas Austin, Dept Pediat, Dell Pediat Res Inst, Dell Med Sch, 1400 Barbara Jordan Blvd, Austin, TX 78723 USA; [Wang, Xiaohong] Texas Heart Inst, Stem Cell Ctr, Houston, TX 77030 USA; [Wang, Xiaohong; Xu, Xueping] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kyba, Michael] Univ Minnesota, Dept Pediat, Lillehei Heart Inst, Minneapolis, MN 55454 USA	University of Texas System; University of Texas Austin; Texas Heart Institute; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Cooney, AJ (corresponding author), Univ Texas Austin, Dept Pediat, Dell Pediat Res Inst, Dell Med Sch, 1400 Barbara Jordan Blvd, Austin, TX 78723 USA.	austin.cooney@austin.utexas.edu		Kyba, Michael/0000-0002-5579-7534	National Institutes of Health [P01 GM081627]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant P01 GM081627 (to A. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agoulnik IY, 1998, FEBS LETT, V424, P73, DOI 10.1016/S0014-5793(98)00142-2; Akamatsu W, 2009, J NEUROSCI, V29, P2113, DOI 10.1523/JNEUROSCI.4527-08.2009; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chung ACK, 2006, DEV BIOL, V293, P13, DOI 10.1016/j.ydbio.2005.12.017; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; HIROSE T, 1995, GENE, V152, P247, DOI 10.1016/0378-1119(94)00656-D; Kapelle M, 1997, BBA-GENE STRUCT EXPR, V1352, P13, DOI 10.1016/S0167-4781(97)00043-2; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kim MH, 2002, BIOCHEM BIOPH RES CO, V296, P1372, DOI 10.1016/S0006-291X(02)02070-3; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Lan ZJ, 2002, J BIOL CHEM, V277, P50660, DOI 10.1074/jbc.M209586200; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma YH, 2010, RNA, V16, P2564, DOI 10.1261/rna.2350710; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oka M, 2013, J BIOL CHEM, V288, P15085, DOI 10.1074/jbc.M112.448837; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; PIKARSKY E, 1994, MOL CELL BIOL, V14, P1026, DOI 10.1128/MCB.14.2.1026; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Shufaro Y, 2004, BEST PRACT RES CL OB, V18, P909, DOI 10.1016/j.bpobgyn.2004.07.002; Susens U, 1996, BBA-GENE STRUCT EXPR, V1309, P179, DOI 10.1016/S0167-4781(96)00157-1; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang HR, 2013, STEM CELLS, V31, P2659, DOI 10.1002/stem.1367; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zafarana G, 2009, STEM CELLS, V27, P776, DOI 10.1002/stem.5	31	10	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8644	8652		10.1074/jbc.M115.694208	http://dx.doi.org/10.1074/jbc.M115.694208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26769970	hybrid, Green Published			2022-12-26	WOS:000374773200027
J	Gorelik, A; Illes, K; Superti-Furga, G; Nagar, B				Gorelik, Alexei; Illes, Katalin; Superti-Furga, Giulio; Nagar, Bhushan			Structural Basis for Nucleotide Hydrolysis by the Acid Sphingomyelinase-like Phosphodiesterase SMPDL3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme catalysis; nucleoside; nucleotide metabolism; sphingomyelinase; zinc; SMPDL3A	LYSOSOMAL PROTEINS; PROTEOMIC ANALYSIS; INDUCTION; GENE; CALCINEURIN; MECHANISM; SYSTEM; SERUM; MODEL	Sphingomyelin phosphodiesterase, acid-like 3A (SMPDL3A) is a member of a small family of proteins founded by the well characterized lysosomal enzyme, acid sphingomyelinase (ASMase). ASMase converts sphingomyelin into the signaling lipid, ceramide. It was recently discovered that, in contrast to ASMase, SMPDL3A is inactive against sphingomyelin and, surprisingly, can instead hydrolyze nucleoside diphosphates and triphosphates, which may play a role in purinergic signaling. As none of the ASMase-like proteins has been structurally characterized to date, the molecular basis for their substrate preferences is unknown. Here we report crystal structures of murine SMPDL3A, which represent the first structures of an ASMase-like protein. The catalytic domain consists of a central mixed -sandwich surrounded by -helices. Additionally, SMPDL3A possesses a unique C-terminal domain formed from a cluster of four -helices that appears to distinguish this protein family from other phosphoesterases. We show that SMDPL3A is a di-zinc-dependent enzyme with an active site configuration that suggests a mechanism of phosphodiester hydrolysis by a metal-activated water molecule and protonation of the leaving group by a histidine residue. Co-crystal structures of SMPDL3A with AMP and ,-methylene ADP (AMPCP) reveal that the substrate binding site accommodates nucleotides by establishing interactions with their base, sugar, and phosphate moieties, with the latter the major contributor to binding affinity. Our study provides the structural basis for SMPDL3A substrate specificity and sheds new light on the function of ASMase-like proteins.	[Gorelik, Alexei; Illes, Katalin; Nagar, Bhushan] McGill Univ, Fac Med, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Gorelik, Alexei; Illes, Katalin; Nagar, Bhushan] McGill Univ, Fac Med, Grp Rech Axe Struct Proteines, Montreal, PQ H3G 0B1, Canada; [Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria	McGill University; McGill University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Nagar, B (corresponding author), Rm 464,3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	bhushan.nagar@mcgill.ca	Superti-Furga, Giulio/AAE-5681-2019	Gorelik, Alexei/0000-0001-6236-4633	National Science Foundation; NIGMS, National Institutes of Health under National Science Foundation [DMR-1332208]; National Institutes of Health [GM-103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIGMS, National Institutes of Health under National Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and the NIGMS, National Institutes of Health under National Science Foundation Grant DMR-1332208 using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by National Institutes of Health Grant GM-103485 (NIGMS). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ago H, 2006, J BIOL CHEM, V281, P16157, DOI 10.1074/jbc.M601089200; Airola MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105830; Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Antherieu S, 2011, HEPATOLOGY, V53, P1895, DOI 10.1002/hep.24290; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Cheng JJ, 2013, J BIOL CHEM, V288, P14863, DOI 10.1074/jbc.M113.466532; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kornhuber J, 2015, BIOL CHEM, V396, P707, DOI 10.1515/hsz-2015-0109; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Lim JM, 2008, J PROTEOME RES, V7, P1251, DOI 10.1021/pr7006945; Masuishi Y, 2013, J PROTEOME RES, V12, P4617, DOI 10.1021/pr4004807; Noto PB, 2012, MOL PHARMACOL, V82, P719, DOI 10.1124/mol.112.078865; Ong WY, 2015, EXPERT OPIN THER TAR, V19, P1725, DOI 10.1517/14728222.2015.1071794; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padilla J, 2013, PHYSIOL GENOMICS, V45, P434, DOI 10.1152/physiolgenomics.00038.2013; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Perisic L, 2013, ARTERIOSCL THROM VAS, V33, P2432, DOI 10.1161/ATVBAHA.113.301743; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sawada H, 2005, TOXICOL SCI, V83, P282, DOI 10.1093/toxsci/kfh264; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sleat DE, 2007, PROTEOM CLIN APPL, V1, P1134, DOI 10.1002/prca.200700250; Sleat DE, 2012, PROTEOMICS, V12, P3499, DOI 10.1002/pmic.201200205; Traini M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.612341; Veenstra TD, 2005, MOL CELL PROTEOMICS, V4, P409, DOI 10.1074/mcp.M500006-MCP200; Zampieri S, 2016, HUM MUTAT, V37, P139, DOI 10.1002/humu.22923; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	36	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6376	6385		10.1074/jbc.M115.711085	http://dx.doi.org/10.1074/jbc.M115.711085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26792860	Green Published, hybrid			2022-12-26	WOS:000372894200026
J	Lefoulon, C; Boeglin, M; Moreau, B; Very, AA; Szponarski, W; Dauzat, M; Michard, E; Gaillard, I; Cherel, I				Lefoulon, Cecile; Boeglin, Martin; Moreau, Bertrand; Very, Anne-Alienor; Szponarski, Wojciech; Dauzat, Myriam; Michard, Erwan; Gaillard, Isabelle; Cherel, Isabelle			The Arabidopsis AtPP2CA Protein Phosphatase Inhibits the GORK K+ Efflux Channel and Exerts a Dominant Suppressive Effect on Phosphomimetic-activating Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						abscisic acid (ABA); Arabidopsis thaliana; mutagenesis; phosphatase; plant molecular biology; plant physiology; potassium channel; potassium transport; protein-protein interaction; Xenopus	ACID SIGNAL-TRANSDUCTION; PLANT POTASSIUM CHANNEL; ABSCISIC-ACID; GUARD-CELL; PLASMA-MEMBRANE; XENOPUS OOCYTES; ANION CHANNEL; NEGATIVE REGULATOR; PP2C PHOSPHATASES; CRYSTAL-STRUCTURE	The regulation of the GORK (Guard Cell Outward Rectifying) Shaker channel mediating a massive K+ efflux in Arabidopsis guard cells by the phosphatase AtPP2CA was investigated. Unlike the gork mutant, the atpp2ca mutants displayed a phenotype of reduced transpiration. We found that AtPP2CA interacts physically with GORK and inhibits GORK activity in Xenopus oocytes. Several amino acid substitutions in the AtPP2CA active site, including the dominant interfering G145D mutation, disrupted the GORK-AtPP2CA interaction, meaning that the native conformation of the AtPP2CA active site is required for the GORK-AtPP2CA interaction. Furthermore, two serines in the GORK ankyrin domain that mimic phosphorylation (Ser to Glu) or dephosphorylation (Ser to Ala) were mutated. Mutations mimicking phosphorylation led to a significant increase in GORK activity, whereas mutations mimicking dephosphorylation had no effect on GORK. In Xenopus oocytes, the interaction of AtPP2CA with phosphorylated or dephosphorylated GORK systematically led to inhibition of the channel to the same baseline level. Single-channel recordings indicated that the GORK S722E mutation increases the open probability of the channel in the absence, but not in the presence, of AtPP2CA. The dephosphorylation-independent inactivation mechanism of GORK by AtPP2CA is discussed in relation with well known conformational changes in animal Shaker-like channels that lead to channel opening and closing. In plants, PP2C activity would control the stomatal aperture by regulating both GORK and SLAC1, the two main channels required for stomatal closure.	[Lefoulon, Cecile; Boeglin, Martin; Moreau, Bertrand; Very, Anne-Alienor; Szponarski, Wojciech; Michard, Erwan; Gaillard, Isabelle; Cherel, Isabelle] CNRS, INRA, SupAgro, Lab Biochim & Physiol Mol Plantes,UM2,UMR 5004, 2 Pl Viala, F-34060 Montpellier, France; [Dauzat, Myriam] INRA, SupAgro, UMR 759, Lab Ecophysiol Plantes Stress Environnementaux, 2 Pl Viala, F-34060 Montpellier, France; [Lefoulon, Cecile] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cellular & Syst Biol, Bower Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Michard, Erwan] Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Institut Agro; Montpellier SupAgro; University of Glasgow; Instituto Gulbenkian de Ciencia	Cherel, I (corresponding author), Univ Montpellier, CNRS, INRA, Biochim & Physiol Mol Plantes,SupAgro, 2 Pl Viala, F-34060 Montpellier, France.	cherel@supagro.inra.fr	michard, erwan/GXH-1685-2022	Cecile, Lefoulon/0000-0002-1131-3710; Cherel, Isabelle/0000-0001-8007-7099; VERY, Anne-Alienor/0000-0003-1961-5243; Gaillard, Isabelle/0000-0002-7993-4046	Agence Nationale pour la Recherche [PUMPKin ANR-08-BLAN-01 312133, ANR-14-CE20-0002]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale pour la Recherche contracts PUMPKin ANR-08-BLAN-01 312133 and Sweetkaligrape ANR-14-CE20-0002. The authors declare that they have no conflicts of interest with the contents of this article.	Ache P, 2000, FEBS LETT, V486, P93, DOI 10.1016/S0014-5793(00)02248-1; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anschutz U, 2014, J PLANT PHYSIOL, V171, P670, DOI 10.1016/j.jplph.2014.01.009; ARMSTRONG F, 1995, P NATL ACAD SCI USA, V92, P9520, DOI 10.1073/pnas.92.21.9520; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Cherel I, 2002, PLANT CELL, V14, P1133, DOI 10.1105/tpc.000943; Cohen A, 2006, J NEUROSCI METH, V153, P62, DOI 10.1016/j.jneumeth.2005.10.005; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Curran A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00036; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Demidchik V, 2014, J PLANT PHYSIOL, V171, P696, DOI 10.1016/j.jplph.2014.01.015; Dreyer I, 2009, TRENDS PLANT SCI, V14, P383, DOI 10.1016/j.tplants.2009.04.001; Eisenach C, 2014, PLANT J, V78, P203, DOI 10.1111/tpj.12471; Garcia-Mata C, 2010, J BIOL CHEM, V285, P29286, DOI 10.1074/jbc.M110.141176; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Geiger D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001346; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hill WG, 2005, AM J PHYSIOL-RENAL, V289, pF217, DOI 10.1152/ajprenal.00022.2005; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Ivashikina N, 2005, J GEN PHYSIOL, V125, P483, DOI 10.1085/jgp.200409211; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Johansson I, 2006, PLANT J, V46, P269, DOI [10.1111/j.1365-313X.2006.02690.x, 10.1111/j.1365-313X.2006.02690.X]; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Joshi-Saha A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002164; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Lacombe B, 2000, FEBS LETT, V466, P351, DOI 10.1016/S0014-5793(00)01093-0; Lacombe B, 2000, PLANT CELL, V12, P837, DOI 10.1105/tpc.12.6.837; Lan WZ, 2011, MOL PLANT, V4, P527, DOI 10.1093/mp/ssr031; Lebaudy A, 2008, P NATL ACAD SCI USA, V105, P5271, DOI 10.1073/pnas.0709732105; Lee SC, 2007, P NATL ACAD SCI USA, V104, P15959, DOI 10.1073/pnas.0707912104; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Maierhofer T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005703; Marten I, 1997, P NATL ACAD SCI USA, V94, P3448, DOI 10.1073/pnas.94.7.3448; MAUREL C, 1995, EMBO J, V14, P3028, DOI 10.1002/j.1460-2075.1995.tb07305.x; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Merilo E, 2013, PLANT PHYSIOL, V162, P1652, DOI 10.1104/pp.113.220608; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Michard E, 2005, PLANT J, V44, P783, DOI 10.1111/j.1365-313X.2005.02566.x; Miller AJ, 2000, BBA-BIOMEMBRANES, V1465, P343, DOI 10.1016/S0005-2736(00)00148-6; Nieves-Cordones M, 2014, PLANT PHYSIOL, V164, P1415, DOI 10.1104/pp.113.229757; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pilot G, 2003, J MOL EVOL, V56, P418, DOI 10.1007/s00239-002-2413-2; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Robert N, 2006, FEBS LETT, V580, P4691, DOI 10.1016/j.febslet.2006.07.047; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Sharma T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00224; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Szyroki A, 2001, P NATL ACAD SCI USA, V98, P2917, DOI 10.1073/pnas.051616698; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; VERY AA, 1995, PLANT J, V7, P321, DOI 10.1046/j.1365-313X.1995.7020321.x; Vlad F, 2008, PLANT J, V55, P104, DOI 10.1111/j.1365-313X.2008.03488.x; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Vranova E, 2001, J EXP BOT, V52, P181, DOI 10.1093/jexbot/52.354.181; YOSHIDA N, 1995, ZOOL SCI, V12, P599, DOI 10.2108/zsj.12.599; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou XE, 2012, PLANT SIGNAL BEHAV, V7, P581, DOI 10.4161/psb.19694	74	31	33	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6521	6533		10.1074/jbc.M115.711309	http://dx.doi.org/10.1074/jbc.M115.711309			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26801610	Green Published, hybrid			2022-12-26	WOS:000372894200038
J	Dogba, MJ; Dahan-Oliel, N; Snider, L; Glorieux, FH; Durigova, M; Palomo, T; Cordey, M; Bedard, MH; Bedos, C; Rauch, F				Dogba, Maman Joyce; Dahan-Oliel, Noemi; Snider, Laurie; Glorieux, Francis H.; Durigova, Michaela; Palomo, Telma; Cordey, Michel; Bedard, Marie-Helene; Bedos, Christophe; Rauch, Frank			Involving Families with Osteogenesis Imperfecta in Health Service Research: Joint Development of the OI/ECE Questionnaire	PLOS ONE			English	Article							CHILDREN; IMPACT; DISEASE; EXPERIENCES; TRANSLATION; INSTRUMENT; QUALITY; SCALE; LIFE	Background Despite the growing interest in understanding the psycho-social impact of rare genetic diseases, few studies examine this concept and even fewer seek to obtain feedback from families who have lived the experience. The aim of this project was to involve families of children living with osteogenesis imperfecta (OI) in the development of a tool to assess the impact of OI on the lives of patients and their families. Methods This project used an integrated knowledge translation approach in which knowledge users (clinicians and people living with OI and their families) were consulted throughout the four steps of development, that is: content mapping, item generation, tool appraisal and pre-testing of the questionnaires. The International Classification of Functioning and Health was used as a framework for content mapping. Based on a scoping review we selected two validated tools to use as a basis for developing the questionnaire. The final parent self-report version measured six domains: experience of diagnosis; use of health services; use of social and psychological support services; expectations about tertiary specialized centers; and socio-demographic information. Results A total of 27 out of 40 families receiving care at the Shriners Hospital for Children-Canada and invited to participate in the pre-test returned the completed questionnaires. In more than two-thirds of families (69%; n = 18) OI was suspected either at or within the first 3 months after birth. Up to 46% of families consulted between 3 and 5 doctors (46%; n = 12) prior to final diagnosis. The use of services by families varied from 0 to 16 consultations, 0 to 9 exploratory examinations and 1 to 10 types of allied health services. In the 12 months prior to the study, fewer than a quarter of children had been admitted, for treatment, for hospital stays of longer than 8 hours or to an emergency department (24% and 9% respectively). Only 29% of parents received psychological support. Conclusion This joint development process generated a tool, with good psychometric properties, that provides unique insight into the experiences of patients and families with OI, the psychosocial impact of the illness, and their service needs and expectations.	[Dogba, Maman Joyce] Univ Laval, Fac Med, Dept Family & Emergency Med, Quebec City, PQ G1K 7P4, Canada; [Dahan-Oliel, Noemi] Shriners Hosp Children, Off Clin Res, Montreal, PQ, Canada; [Snider, Laurie] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Glorieux, Francis H.; Durigova, Michaela; Palomo, Telma; Cordey, Michel; Bedard, Marie-Helene; Rauch, Frank] Shriners Hosp Children, Genet Unit, Montreal, PQ, Canada; [Bedos, Christophe] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Bedos, Christophe] Univ Montreal, Fac Med, Dept Social & Prevent Med, Montreal, PQ H3C 3J7, Canada	Laval University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal	Dogba, MJ (corresponding author), Univ Laval, Fac Med, Dept Family & Emergency Med, Quebec City, PQ G1K 7P4, Canada.	joyce-maman.dogba@fmed.ulaval.ca; mdurigova@shriners.mcgill.ca	Rauch, Frank/D-1554-2009	Bedos, Christophe/0000-0003-0141-0928; Palomo, Telma/0000-0002-1655-7319; Rauch, Frank/0000-0002-6261-0360	Richard and Edith Strauss Foundation in Rehabilitation Research	Richard and Edith Strauss Foundation in Rehabilitation Research	This work was supported by the Richard and Edith Strauss Foundation in Rehabilitation Research.	Anderson M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-22; Battista RN, 2012, PUBLIC HEALTH GENOM, V15, P34, DOI 10.1159/000328846; Boote J, 2010, HEALTH POLICY, V95, P10, DOI 10.1016/j.healthpol.2009.11.007; Cheung MS, 2008, REV ENDOCR METAB DIS, V9, P153, DOI 10.1007/s11154-008-9074-4; Cho TJ, 2007, J BONE JOINT SURG AM, V89A, P1028, DOI 10.2106/JBJS.F.00814; Claesson IB, 2002, CHILD CARE HLTH DEV, V28, P309, DOI 10.1046/j.1365-2214.2002.00282.x; Daykin N, 2007, EVID POLICY, V3, P47, DOI [10.1332/174426407779702201, DOI 10.1332/174426407779702201]; Dogba MJ, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0151-y; Dogba MJ, 2014, DISABIL HEALTH J, V7, P343, DOI 10.1016/j.dhjo.2014.03.002; Dogba MJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-153; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Dye DE, 2011, PUBLIC HEALTH GENOM, V14, P153, DOI 10.1159/000321767; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Hatzmann J, 2008, PEDIATRICS, V122, pE1030, DOI 10.1542/peds.2008-0582; Kole A, 2009, VOICE 12000 PATIENTS; Maneesriwongul W, 2004, J ADV NURS, V48, P175, DOI 10.1111/j.1365-2648.2004.03185.x; Menon D, 2015, PATIENT, V8, P29, DOI 10.1007/s40271-014-0106-8; Parry D SJ, 2009, CONNAISSANCES PRATIQ; Perneger TV, 1999, J CLIN EPIDEMIOL, V52, P1037, DOI 10.1016/S0895-4356(99)00088-8; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Stein REK, 2003, J DEV BEHAV PEDIATR, V24, P9, DOI 10.1097/00004703-200302000-00004; STEIN REK, 1980, MED CARE, V18, P465, DOI 10.1097/00005650-198004000-00010; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; van den Tweel XW, 2008, HAEMATOLOGICA, V93, P588, DOI 10.3324/haematol.11610; WHO, 2001, WHO INT CLASS FUNCT; Zeitlin L, 2003, J PEDIATR ORTHOP B, V12, P77, DOI 10.1097/01.bpb.0000049567.52224.fa	27	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147654	10.1371/journal.pone.0147654	http://dx.doi.org/10.1371/journal.pone.0147654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799959	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300136
J	Lazaro-Diez, M; Remuzgo-Martinez, S; Rodriguez-Mirones, C; Acosta, F; Icardo, JM; Martinez-Martinez, L; Ramos-Vivas, J				Lazaro-Diez, Maria; Remuzgo-Martinez, Sara; Rodriguez-Mirones, Cristina; Acosta, Felix; Icardo, Jose M.; Martinez-Martinez, Luis; Ramos-Vivas, Jose			Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms	PLOS ONE			English	Article							IN-VITRO; ANTIBIOTIC CONCENTRATIONS; INHIBITORY CONCENTRATIONS; BACTERICIDAL ACTIVITY; CELL-WALL; EPIDERMIDIS; EXPRESSION; AGR; MECHANISMS; PENETRATION	Ceftaroline (CPT) is a novel cephalosporin with in vitro activity against Staphylococcus aureus. Ceftaroline exhibits a level of binding affinity for PBPs in S. aureus including PBP2a of methicillin-resistant S. aureus (MRSA). The aims of this study were to investigate the morphological, physiological and molecular responses of MRSA clinical strains and MRSA biofilms to sub-MICs (1/4 and 1/16 MIC) of ceftaroline by using transmission, scanning and confocal microscopy. We have also used quantitative Real-Time PCR to study the effect of sub-MICs of ceftaroline on the expression of the staphylococcal icaA, agrA, sarA and sasF genes in MRSA biofilms. In one set of experiments, ceftaroline was able to inhibit biofilm formation in all strains tested at MIC, however, a strain dependent behavior in presence of sub-MICs of ceftaroline was shown. In a second set of experiments, destruction of preformed biofilms by addition of ceftaroline was evaluated. Ceftaroline was able to inhibit biofilm formation at MIC in all strains tested but not at the sub-MICs. Destruction of preformed biofilms was strain dependent because the biofilm formed by a matrix-producing strain was resistant to a challenge with ceftaroline at MIC, whereas in other strains the biofilm was sensitive. At sub-MICs, the impact of ceftaroline on expression of virulence genes was strain-dependent at 1/4 MIC and no correlation between ceftaroline-enhanced biofilm formation and gene regulation was established at 1/16 MIC. Our findings suggest that sub-MICs of ceftaroline enhance bacterial attachment and biofilm formation by some, but not all, MRSA strains and, therefore, stress the importance of maintaining effective bactericidal concentrations of ceftaroline to fight biofilm-MRSA related infections.	[Lazaro-Diez, Maria; Remuzgo-Martinez, Sara; Rodriguez-Mirones, Cristina; Martinez-Martinez, Luis; Ramos-Vivas, Jose] Hosp Univ Marques de Valdecilla, Serv Microbiol, Santander, Cantabria, Spain; [Lazaro-Diez, Maria; Remuzgo-Martinez, Sara; Rodriguez-Mirones, Cristina; Martinez-Martinez, Luis; Ramos-Vivas, Jose] Inst Invest Marques de Valdecilla IDIVAL, Santander, Cantabria, Spain; [Rodriguez-Mirones, Cristina; Martinez-Martinez, Luis; Ramos-Vivas, Jose] Inst Salud Carlos III, REIPI, Madrid, Spain; [Acosta, Felix] Univ Las Palmas Gran Canaria, Grp Invest Acuicultura, Arucas, Gran Canaria, Spain; [Icardo, Jose M.] Univ Cantabria, Dept Anat & Biol Celular, E-39005 Santander, Cantabria, Spain; [Martinez-Martinez, Luis] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Cantabria, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Instituto de Salud Carlos III; Universidad de Las Palmas de Gran Canaria; Universidad de Cantabria; Universidad de Cantabria	Ramos-Vivas, J (corresponding author), Hosp Univ Marques de Valdecilla, Serv Microbiol, Santander, Cantabria, Spain.; Ramos-Vivas, J (corresponding author), Inst Invest Marques de Valdecilla IDIVAL, Santander, Cantabria, Spain.	jvivas@idival.org	Martínez, Luis Martínez/U-1801-2017; Lázaro-Díez, María/AAA-1529-2020; Icardo, Jose Manuel/ABH-5431-2020; Ramos-Vivas, J/G-3643-2016	Martínez, Luis Martínez/0000-0002-6091-4045; Lázaro-Díez, María/0000-0002-6098-8052; Icardo, Jose Manuel/0000-0001-9543-2444; Ramos-Vivas, J/0000-0001-8795-519X; ACOSTA ARBELO, FELIX ANTONIO/0000-0002-1098-7529	AstraZeneca [IDIVAL CSI 13/08]	AstraZeneca(AstraZeneca)	This study was supported by an unrestricted grant from AstraZeneca (IDIVAL CSI 13/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Barber KE, 2014, ANTIMICROB AGENTS CH, V58, P2989, DOI 10.1128/AAC.02764-13; Biek D, 2010, J ANTIMICROB CHEMOTH, V65, piv9, DOI 10.1093/jac/dkq251; Blickwede M, 2004, J VET MED B, V51, P293, DOI 10.1111/j.1439-0450.2004.00767.x; Braga PC, 1997, J ANTIMICROB CHEMOTH, V39, P79, DOI 10.1093/jac/39.1.79; Brooks JL, 2012, ADV APPL MICROBIOL, V81, P63, DOI 10.1016/B978-0-12-394382-8.00002-2; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Frank KL, 2007, ANTIMICROB AGENTS CH, V51, P888, DOI 10.1128/AAC.01052-06; Gil C, 2014, INFECT IMMUN, V82, P1017, DOI 10.1128/IAI.01419-13; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Gomes DLR, 2013, J MED MICROBIOL, V62, P754, DOI 10.1099/jmm.0.052373-0; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Institute CaLS, 2012, M7A9 CLSI; Joo HS, 2010, ANTIMICROB AGENTS CH, V54, P4942, DOI 10.1128/AAC.00064-10; Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12; Kaplan JB, 2011, INT J ARTIF ORGANS, V34, P737, DOI 10.5301/ijao.5000027; Kaplan JB, 2011, RES MICROBIOL, V162, P535, DOI 10.1016/j.resmic.2011.03.008; Khodaverdian V, 2013, ANTIMICROB AGENTS CH, V57, P3645, DOI 10.1128/AAC.00269-13; Landini G, 2015, INT J ANTIMICROB AG, V45, P551, DOI 10.1016/j.ijantimicag.2015.01.001; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Long SW, 2014, ANTIMICROB AGENTS CH, V58, P6668, DOI 10.1128/AAC.03622-14; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Odenholt I, 2001, INT J ANTIMICROB AG, V17, P1, DOI 10.1016/S0924-8579(00)00243-0; Pottinger PS, 2013, MED CLIN N AM, V97, P601, DOI 10.1016/j.mcna.2013.02.005; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Saravolatz L, 2010, ANTIMICROB AGENTS CH, V54, P3027, DOI 10.1128/AAC.01516-09; Saravolatz LD, 2011, CLIN INFECT DIS, V52, P1156, DOI 10.1093/cid/cir147; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Smith K, 2010, ANTIMICROB AGENTS CH, V54, P380, DOI 10.1128/AAC.00155-09; Stefani S, 2003, CLIN MICROBIOL INFEC, V9, P1179, DOI 10.1111/j.1469-0691.2003.00698.x; Subrt N, 2011, J ANTIMICROB CHEMOTH, V66, P979, DOI 10.1093/jac/dkr043; SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Valle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002843; Van Acker H, 2014, TRENDS MICROBIOL, V22, P326, DOI 10.1016/j.tim.2014.02.001; Villegas-Estrada A, 2008, J AM CHEM SOC, V130, P9212, DOI 10.1021/ja8029448; Werth BJ, 2014, ANTIMICROB AGENTS CH, V58, P3177, DOI 10.1128/AAC.00088-14; Zhou XX, 2015, SCIENCE, V348, P574, DOI 10.1126/science.aaa1511	44	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147569	10.1371/journal.pone.0147569	http://dx.doi.org/10.1371/journal.pone.0147569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800524	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300126
J	Wolf, K; Braun, A; Haining, EJ; Tseng, YL; Kraft, P; Schuhmann, MK; Gotru, SK; Chen, WC; Hermanns, HM; Stoll, G; Lesch, KP; Nieswandt, B				Wolf, Karen; Braun, Attila; Haining, Elizabeth J.; Tseng, Yu-Lun; Kraft, Peter; Schuhmann, Michael K.; Gotru, Sanjeev K.; Chen, Wenchun; Hermanns, Heike M.; Stoll, Guido; Lesch, Klaus-Peter; Nieswandt, Bernhard			Partially Defective Store Operated Calcium Entry and Hem(ITAM) Signaling in Platelets of Serotonin Transporter Deficient Mice	PLOS ONE			English	Article							REUPTAKE INHIBITORS; ISCHEMIC-STROKE; THROMBO-INFLAMMATION; 5-HT TRANSPORT; 5-HYDROXYTRYPTAMINE; RISK; ACTIVATION; AGGREGATION; HEMOSTASIS; CITALOPRAM	Background Serotonin (5-hydroxytryptamin, 5-HT) is an indolamine platelet agonist, biochemically derived from tryptophan. 5-HT is secreted from the enterochromaffin cells into the gastrointestinal tract and blood. Blood 5-HT has been proposed to regulate hemostasis by acting as a vasoconstrictor and by triggering platelet signaling through 5-HT receptor 2A (5HTR2A). Although platelets do not synthetize 5-HT, they take 5-HT up from the blood and store it in their dense granules which are secreted upon platelet activation. Objective To identify the molecular composite of the 5-HT uptake system in platelets and elucidate the role of platelet released 5-HT in thrombosis and ischemic stroke. Methods: 5-HT transporter knockout mice (5Htt(-/-)) were analyzed in different in vitro and in vivo assays and in a model of ischemic stroke. Results In 5Htt(-/-) platelets, 5-HT uptake from the blood was completely abolished and agonist-induced Ca2+ influx through store operated Ca2+ entry (SOCE), integrin activation, degranulation and aggregation responses to glycoprotein VI (GPVI) and C-type lectin-like receptor 2 (CLEC-2) were reduced. These observed in vitro defects in 5Htt(-/-) platelets could be normalized by the addition of exogenous 5-HT. Moreover, reduced 5-HT levels in the plasma, an increased bleeding time and the formation of unstable thrombi were observed ex vivo under flow and in vivo in the abdominal aorta and carotid artery of 5Htt(-/-) mice. Surprisingly, in the transient middle cerebral artery occlusion (tMCAO) model of ischemic stroke 5Htt(-/-) mice showed nearly normal infarct volume and the neurological outcome was comparable to control mice. Conclusion Although secreted platelet 5-HT does not appear to play a crucial role in the development of reperfusion injury after stroke, it is essential to amplify the second phase of platelet activation through SOCE and plays an important role in thrombus stabilization.	[Wolf, Karen; Braun, Attila; Haining, Elizabeth J.; Gotru, Sanjeev K.; Chen, Wenchun; Nieswandt, Bernhard] Univ Hosp Wurzburg, Inst Expt Biomed, Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany; [Tseng, Yu-Lun] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Psychiat, Taipei, Taiwan; [Kraft, Peter; Schuhmann, Michael K.; Stoll, Guido] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Lesch, Klaus-Peter] Univ Hosp Wurzburg, Dept Mol Psychiat, Wurzburg, Germany; [Hermanns, Heike M.] Univ Hosp Wurzburg, Dept Med Clin & Policlin 2, Hepatol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Braun, A; Nieswandt, B (corresponding author), Univ Hosp Wurzburg, Inst Expt Biomed, Wurzburg, Germany.; Nieswandt, B (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany.	attila.braun@virchow.uni-wuerzburg.de; bernhard.nieswandt@virchow.uni-wuerzburg.de	Lesch, Klaus-Peter/J-4906-2013; Chen, Wenchun/C-8912-2017	Lesch, Klaus-Peter/0000-0001-8348-153X; Chen, Wenchun/0000-0002-7159-7161	Deutsche Forschungsgemeinschaft [SFB 688]; Deutsche Forschungsgemeinschaft (Ministry of Science and Technology (Taiwan) [NSC-101-2314-B-039-037]; University of Wuerzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Ministry of Science and Technology (Taiwan); University of Wuerzburg	Funded by Deutsche Forschungsgemeinschaft (SFB 688 to BN (TPA01), AB (TPA18) and GS (TPB01), Ministry of Science and Technology (Taiwan) to YT (NSC-101-2314-B-039-037), and University of Wuerzburg in the funding program Open Access Publishing (BN).	Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; Alberio Lorenzo J, 2004, Curr Hematol Rep, V3, P338; Anglin R, 2014, AM J GASTROENTEROL, V109, P810, DOI 10.1038/ajg.2014.82; Asada M, 2009, NEOPLASIA, V11, P408, DOI 10.1593/neo.81630; BAUMGARTNER HR, 1968, NATURE, V218, P137, DOI 10.1038/218137a0; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Bischoff SC, 2009, AM J PHYSIOL-GASTR L, V296, pG685, DOI 10.1152/ajpgi.90685.2008; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BORN GVR, 1959, J PHYSIOL-LONDON, V146, P472, DOI 10.1113/jphysiol.1959.sp006206; Braun A, 2011, FRONT BIOSCI-LANDMRK, V16, P2144, DOI 10.2741/3844; Canan F, 2011, THROMB RES, V127, P57, DOI 10.1016/j.thromres.2010.07.017; Carneiro AMD, 2008, J CLIN INVEST, V118, P1544, DOI 10.1172/JCI33374; Cloez-Tayarani I, 2007, J LEUKOCYTE BIOL, V81, P599, DOI 10.1189/jlb.0906544; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; Deppermann C, 2013, J CLIN INVEST, V123, P3331, DOI 10.1172/JCI69210; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Eddahibi S, 2000, J CLIN INVEST, V105, P1555, DOI 10.1172/JCI8678; Espinera AR, 2013, NEUROSCIENCE, V247, P1, DOI 10.1016/j.neuroscience.2013.04.011; Frankhauser P, 2006, NEUROSCI LETT, V399, P197, DOI 10.1016/j.neulet.2006.01.062; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Gobin V, 2014, INT IMMUNOPHARMACOL, V20, P148, DOI 10.1016/j.intimp.2014.02.030; GOLINO P, 1989, CIRCULATION, V79, P154, DOI 10.1161/01.CIR.79.1.154; GOLINO P, 1991, NEW ENGL J MED, V324, P641, DOI 10.1056/NEJM199103073241001; Hallback I, 2012, PHARMACOL REP, V64, P979, DOI 10.1016/S1734-1140(12)70894-0; Hankey GJ, 2014, STROKE, V45, P1917, DOI 10.1161/STROKEAHA.114.005844; HYTTEL J, 1994, INT CLIN PSYCHOPHARM, V9, P19, DOI 10.1097/00004850-199403001-00004; Jiang HY, 2015, CLIN GASTROENTEROL H, V13, P42, DOI 10.1016/j.cgh.2014.06.021; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lesch KP, 2005, PROG NEURO-PSYCHOPH, V29, P1062, DOI 10.1016/j.pnpbp.2005.03.012; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Mazepa M, 2013, ARTERIOSCL THROM VAS, V33, P1747, DOI 10.1161/ATVBAHA.113.301790; McCann SK, 2014, STROKE, V45, P3055, DOI 10.1161/STROKEAHA.114.006304; McFarlane A, 2001, AM HEART J, V142, P617, DOI 10.1067/mhj.2001.116766; Mead GE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009286.pub2; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; Mercado CP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02795; MORAN PM, 1995, P NATL ACAD SCI USA, V92, P5341, DOI 10.1073/pnas.92.12.5341; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; NISHIO H, 1995, EUR J PHARM-MOLEC PH, V288, P149, DOI 10.1016/0922-4106(95)90189-2; Pavanetto M, 2011, CELL PHYSIOL BIOCHEM, V27, P139, DOI 10.1159/000325216; Persico AM, 2003, NEUROREPORT, V14, P341, DOI 10.1097/01.wnr.0000058244.21747.83; Qi RM, 1996, THROMB RES, V81, P43, DOI 10.1016/0049-3848(95)00212-X; Sander K, 2014, EMJ NEUROL, V1, P53; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; Schmitt A, 2007, J NEURAL TRANSM, V114, P1107, DOI 10.1007/s00702-007-0724-6; Schuhmann MK, 2015, J CEREBR BLOOD F MET, V35, P6, DOI 10.1038/jcbfm.2014.175; Selim MH, 2012, STROKE, V43, P3154, DOI 10.1161/STROKEAHA.112.657635; Serebruany VL, 2006, AM J MED, V119, P113, DOI 10.1016/j.amjmed.2005.03.044; Stegner D, 2013, J THROMB HAEMOST, V11, P1430, DOI 10.1111/jth.12293; Szasz R, 2003, CURR OPIN HEMATOL, V10, P351, DOI 10.1097/00062752-200309000-00005; TRANZER JP, 1966, NATURE, V212, P1574, DOI 10.1038/2121574a0; Tseng YL, 2010, THROMB RES, V126, P517, DOI 10.1016/j.thromres.2010.09.017; TUOMISTO J, 1976, NATURE, V262, P596, DOI 10.1038/262596a0; Turetta L, 2002, CELL CALCIUM, V31, P235, DOI 10.1016/S0143-4160(02)00052-0; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Watts SW, 2012, PHARMACOL REV, V64, P359, DOI 10.1124/pr.111.004697; Watts SW, 2002, HYPERTENSION, V39, P825, DOI 10.1161/hy0302.104668; WESTER P, 1992, STROKE, V23, P870, DOI 10.1161/01.STR.23.6.870; Zarpellon A, 2008, CELL PHYSIOL BIOCHEM, V21, P87, DOI 10.1159/000113750; Ziu E, 2012, J MOL CELL CARDIOL, V52, P1112, DOI 10.1016/j.yjmcc.2012.02.004; ZUCKER MB, 1955, J APPL PHYSIOL, V7, P432, DOI 10.1152/jappl.1955.7.4.432; ZUCKER MB, 1958, ANN NY ACAD SCI, V75, P203, DOI 10.1111/j.1749-6632.1958.tb36867.x	69	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147664	10.1371/journal.pone.0147664	http://dx.doi.org/10.1371/journal.pone.0147664			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800051	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300137
J	Wong, QWL; Vaz, C; Lee, QY; Zhao, TY; Luo, R; Archer, SK; Preiss, T; Tanavde, V; Vardy, LA				Wong, Queenie Wing-Lei; Vaz, Candida; Lee, Qian Yi; Zhao, Tian Yun; Luo, Raymond; Archer, Stuart K.; Preiss, Thomas; Tanavde, Vivek; Vardy, Leah A.			Embryonic Stem Cells Exhibit mRNA Isoform Specific Translational Regulation	PLOS ONE			English	Article							EXON JUNCTION COMPLEX; 3' UNTRANSLATED REGIONS; NONCODING RNAS; PLURIPOTENCY; TRANSCRIPTION; PRECURSORS; EXPRESSION; MICRORNAS; INSIGHTS; REVEALS	The presence of multiple variants for many mRNAs is a major contributor to protein diversity. The processing of these variants is tightly controlled in a cell-type specific manner and has a significant impact on gene expression control. Here we investigate the differential translation rates of individual mRNA variants in embryonic stem cells (ESCs) and in ESC derived Neural Precursor Cells (NPCs) using polysome profiling coupled to RNA sequencing. We show that there are a significant number of detectable mRNA variants in ESCs and NPCs and that many of them show variant specific translation rates. This is correlated with differences in the UTRs of the variants with the 5'UTR playing a predominant role. We suggest that mRNA variants that contain alternate UTRs are under different post-transcriptional controls. This is likely due to the presence or absence of miRNA and protein binding sites that regulate translation rate. This highlights the importance of addressing translation rate when using mRNA levels as a read out of protein abundance. Additional analysis shows that many annotated non-coding mRNAs are present on the polysome fractions in ESCs and NPCs. We believe that the use of polysome fractionation coupled to RNA sequencing is a useful method for analysis of the translation state of many different RNAs in the cell.	[Wong, Queenie Wing-Lei; Zhao, Tian Yun; Tanavde, Vivek; Vardy, Leah A.] ASTAR, Inst Med Biol, Immunos, 8A Biomed Grove, Singapore 138648, Singapore; [Vaz, Candida; Lee, Qian Yi; Tanavde, Vivek] ASTAR, Bioinformat Inst, 30 Biopolis St, Singapore 138671, Singapore; [Luo, Raymond] Life Technol, 10 Biopolis Rd, Singapore 138670, Singapore; [Archer, Stuart K.] Monash Univ, Monash Bioinformat Platform, Clayton, Vic, Australia; [Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res JCSMR, Dept Genome Sci, EMBL Australia Collaborating Grp, Canberra, ACT, Australia; [Preiss, Thomas] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Vardy, Leah A.] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Thermo Fisher Scientific; Monash University; Australian National University; John Curtin School of Medical Research; Victor Chang Cardiac Research Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Vardy, LA (corresponding author), ASTAR, Inst Med Biol, Immunos, 8A Biomed Grove, Singapore 138648, Singapore.; Vardy, LA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	leah.vardy@imb.a-star.edu.sg	Tanavde, Vivek/B-4758-2011; Vaz, Candida/HHZ-7196-2022; Preiss, Thomas/F-7355-2010	Tanavde, Vivek/0000-0001-7404-5568; Preiss, Thomas/0000-0001-6273-784X; Vaz, Candida/0000-0002-6650-7889; Lee, Qian Yi/0000-0001-9200-0910; Vardy, Leah/0000-0003-4186-684X; Archer, Stuart/0000-0003-0450-1243	Agency for Science, Technology and Research, Singapore; Australian Research Council [DP1300101928]; Agency for Science, Technology and Research	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Australian Research Council(Australian Research Council); Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR))	QWLW, CV, QYL, TYZ, VT and LAV were funded by the Agency for Science, Technology and Research, Singapore. Raymond Luo, a co-author in this study, is employed by Life Technologies, 10 Biopolis Road, Singapore 138670. The funder provided support in the form of salaries for authors [RL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. RL was involved in data analysis. The specific roles of the author is articulated in the 'author contributions' section. TP acknowledges funding from the Australian Research Council (grant DP1300101928).; We thank the Agency for Science, Technology and Research for funding and Dr Austin Smith for the Sox1-GFP ESC cell line. We are grateful to the ACRF Biomolecular Resource Facility at Australian National University for the RNASeq library preparation and sequencing. TP acknowledges funding from the Australian Research Council (grant DP1300101928).	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen KN, 2015, WORLD J STEM CELLS, V7, P1, DOI 10.4252/wjsc.v7.i1.1; Clancy JL, 2011, RNA, V17, P1025, DOI 10.1261/rna.2567611; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; de Klerk E, 2012, NUCLEIC ACIDS RES, V40, P9089, DOI 10.1093/nar/gks655; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Hayashi R, 2014, GENE DEV, V28, P1772, DOI 10.1101/gad.245738.114; Hynes CJ, 2012, IUBMB LIFE, V64, P872, DOI 10.1002/iub.1082; Ibi M, 2011, J CELL SCI, V124, P857, DOI 10.1242/jcs.075705; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Inoko A, 2012, J CELL BIOL, V197, P391, DOI 10.1083/jcb.201106101; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Li MA, 2012, BIOESSAYS, V34, P670, DOI 10.1002/bies.201200019; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lu XY, 2013, NAT CELL BIOL, V15, P1141, DOI 10.1038/ncb2839; Malone CD, 2014, GENE DEV, V28, P1786, DOI 10.1101/gad.245829.114; Mattijssen S, 2010, WIRES RNA, V1, P102, DOI 10.1002/wrna.9; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pollard SM, 2006, METHOD ENZYMOL, V418, P151, DOI 10.1016/S0076-6879(06)18010-6; Ruiz-Orera J, 2014, ELIFE, V3, DOI 10.7554/eLife.03523; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sterne-Weiler T, 2013, GENOME RES, V23, P1615, DOI 10.1101/gr.148585.112; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; van Heesch S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r6; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Ye J, 2014, CELL STEM CELL, V15, P271, DOI 10.1016/j.stem.2014.08.010; Yeo JC, 2013, CELL RES, V23, P20, DOI 10.1038/cr.2012.172; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang DW, 2012, GENE DEV, V26, P461, DOI 10.1101/gad.182998.111	43	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0143235	10.1371/journal.pone.0143235	http://dx.doi.org/10.1371/journal.pone.0143235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799392	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300002
J	Zhang, YT; Hodgson, NW; Trivedi, MS; Abdolmaleky, HM; Fournier, M; Cuenod, M; Do, KQ; Deth, RC				Zhang, Yiting; Hodgson, Nathaniel W.; Trivedi, Malav S.; Abdolmaleky, Hamid M.; Fournier, Margot; Cuenod, Michel; Do, Kim Quang; Deth, Richard C.			Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-METHYLATION; METHIONINE SYNTHASE; METHYLENETETRAHYDROFOLATE REDUCTASE; EPIGENETIC REGULATION; METABOLIC BIOMARKERS; CEREBROSPINAL-FLUID; SPECTRUM DISORDERS; GAMMA OSCILLATIONS; GLUTATHIONE	Many studies indicate a crucial role for the vitamin B-12 and folate-dependent enzyme methionine synthase (MS) in brain development and function, but vitamin B-12 status in the brain across the lifespan has not been previously investigated. Vitamin B-12 (cobalamin, Cbl) exists in multiple forms, including methylcobalamin (MeCbl) and adenosylcobalamin (AdoCbl), serving as cofactors for MS and methylmalonylCoA mutase, respectively. We measured levels of five Cbl species in postmortem human frontal cortex of 43 control subjects, from 19 weeks of fetal development through 80 years of age, and 12 autistic and 9 schizophrenic subjects. Total Cbl was significantly lower in older control subjects (> 60 yrs of age), primarily reflecting a > 10-fold age-dependent decline in the level of MeCbl. Levels of inactive cyanocobalamin (CNCbl) were remarkably higher in fetal brain samples. In both autistic and schizophrenic subjects MeCbl and AdoCbl levels were more than 3-fold lower than age-matched controls. In autistic subjects lower MeCbl was associated with decreased MS activity and elevated levels of its substrate homocysteine (HCY). Low levels of the antioxidant glutathione (GSH) have been linked to both autism and schizophrenia, and both total Cbl and MeCbl levels were decreased in glutamate-cysteine ligase modulatory subunit knockout (GCLM-KO) mice, which exhibit low GSH levels. Thus our findings reveal a previously unrecognized decrease in brain vitamin B-12 status across the lifespan that may reflect an adaptation to increasing antioxidant demand, while accelerated deficits due to GSH deficiency may contribute to neurodevelopmental and neuropsychiatric disorders.	[Zhang, Yiting; Hodgson, Nathaniel W.; Trivedi, Malav S.; Deth, Richard C.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Hodgson, Nathaniel W.] Harvard Univ, Sch Med, Lab Nutr & Metab BIDMC, Dept Surg, Boston, MA 02215 USA; [Trivedi, Malav S.; Deth, Richard C.] Nova SE Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL 33328 USA; [Abdolmaleky, Hamid M.] Boston Univ, Sch Med, Dept Med Biomed Genet Sect Genet & Genom, Boston, MA 02118 USA; [Fournier, Margot; Cuenod, Michel; Do, Kim Quang] Univ Lausanne Hosp, Dept Psychiat, Ctr Psychiat Neurosci, Lausanne, Switzerland	Northeastern University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Nova Southeastern University; Boston University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Deth, RC (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.; Deth, RC (corresponding author), Nova SE Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL 33328 USA.	rdeth@nova.edu	Do, Kim Q./G-6694-2016; Deth, Richard/AFV-2608-2022	Do, Kim Q./0000-0003-1968-1646; Fournier, Margot/0000-0001-8906-1907; Mostafavi Abdolmaleky, Hamid/0000-0002-8872-5174	Autism Research Institute; National Center of Competence in Research; Simons Foundation; Autism Speaks	Autism Research Institute; National Center of Competence in Research(Swiss National Science Foundation (SNSF)); Simons Foundation; Autism Speaks	This work was supported by the Autism Research Institute (http://www.autism.com) to RD and the National Center of Competence in Research (http://www.snf.ch) to KD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some tissue, biological specimens or data used in this research was obtained from Autism BrainNet that is sponsored by the Simons Foundation and Autism Speaks. The authors also acknowledge the Autism Tissue Program that was the predecessor to Autism BrainNet and the Australian Brain Bank Network (ABBN) for their assistance in providing samples.	Adams JB, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-34; Al-Farsi YM, 2013, NUTRITION, V29, P537, DOI 10.1016/j.nut.2012.09.014; Al-Gadani Y, 2009, CLIN BIOCHEM, V42, P1032, DOI 10.1016/j.clinbiochem.2009.03.011; Andersson RH, 2012, P NATL ACAD SCI USA, V109, P13118, DOI 10.1073/pnas.1201011109; [Anonymous], 2007, J PHYSL; Auta J, 2013, SCHIZOPHR RES, V150, P312, DOI 10.1016/j.schres.2013.07.030; BAKER H, 1984, J NEUROSCI RES, V11, P419, DOI 10.1002/jnr.490110409; Beyer K, 2003, NEUROREPORT, V14, P1391, DOI 10.1097/01.wnr.0000073683.00308.0e; Bosco P, 2004, J NEUROL NEUROSUR PS, V75, P1036, DOI 10.1136/jnnp.2003.025866; Bose S, 2007, J PHYSIOL-LONDON, V581, P457, DOI 10.1113/jphysiol.2007.129171; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Chauhan A, 2012, NEUROCHEM RES, V37, P1681, DOI 10.1007/s11064-012-0775-4; Cheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089128; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; COHEN SM, 1974, BIOL PSYCHIAT, V8, P209; Deth R, 2008, NEUROTOXICOLOGY, V29, P190, DOI 10.1016/j.neuro.2007.09.010; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Duarte JMD, 2012, BIOL PSYCHIAT, V71, P1006, DOI 10.1016/j.biopsych.2011.07.035; Eren E, 2010, CLIN LAB, V56, P513; Fernandez-Roig S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-41; Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Frustaci A, 2012, FREE RADICAL BIO MED, V52, P2128, DOI 10.1016/j.freeradbiomed.2012.03.011; Frye RE, 2013, MOL PSYCHIATR, V18, P369, DOI 10.1038/mp.2011.175; Gapp K, 2014, NEUROSCIENCE, V264, P99, DOI 10.1016/j.neuroscience.2012.11.040; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gille D, 2015, NUTR REV, V73, P106, DOI 10.1093/nutrit/nuu011; Grady DL, 2013, J NEUROSCI, V33, P286, DOI 10.1523/JNEUROSCI.3515-12.2013; Gueant JL, 2013, BIOCHIMIE, V95, P1033, DOI 10.1016/j.biochi.2013.01.020; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Haidemenos A, 2007, PROG NEURO-PSYCHOPH, V31, P1289, DOI 10.1016/j.pnpbp.2007.05.011; Hannibal L, 2008, CLIN CHEM LAB MED, V46, P1739, DOI 10.1515/CCLM.2008.356; Hodgson N, 2013, J ALZHEIMERS DIS, V36, P197, DOI 10.3233/JAD-130101; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Imbard A, 2013, INT J ENV RES PUB HE, V10, P4352, DOI 10.3390/ijerph10094352; James SJ, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.87; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jensen LL, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12086; Kale A, 2010, PSYCHIAT RES, V175, P47, DOI 10.1016/j.psychres.2009.01.013; Kemperman RFJ, 2006, PROSTAG LEUKOTR ESS, V74, P75, DOI 10.1016/j.plefa.2005.11.004; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kirsch SH, 2013, CLIN CHEM LAB MED, V51, P139, DOI 10.1515/cclm-2012-0673; Kozyraki R, 2013, BIOCHIMIE, V95, P1002, DOI 10.1016/j.biochi.2012.11.004; Kulak A, 2012, BEHAV BRAIN RES, V226, P563, DOI 10.1016/j.bbr.2011.10.020; Kuznetsova AY, 2008, J COMPUT NEUROSCI, V24, P314, DOI 10.1007/s10827-007-0057-3; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Lai JH, 2010, BRAIN RES, V1359, P227, DOI 10.1016/j.brainres.2010.08.064; Li Z, 2014, J BIOL CHEM, V289, P16487, DOI 10.1074/jbc.M114.567339; Luder A S, 2008, J Inherit Metab Dis, V31 Suppl 3, P493, DOI 10.1007/s10545-007-0760-2; Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7; Mitchell ES, 2014, NEUROSCI BIOBEHAV R, V47, P307, DOI 10.1016/j.neubiorev.2014.08.006; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Muntjewerff JW, 2006, MOL PSYCHIATR, V11, P143, DOI 10.1038/sj.mp.4001746; Muratore CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056927; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Ooka S, 2003, ARTHRITIS RES THER, V5, pR174, DOI 10.1186/ar754; Park LK, 2012, P NUTR SOC, V71, P75, DOI 10.1017/S0029665111003302; Pasca SP, 2009, J CELL MOL MED, V13, P4229, DOI 10.1111/j.1582-4934.2008.00463.x; Pascale Crissey L, 2011, Fluids Barriers CNS, V8, P21, DOI 10.1186/2045-8118-8-21; Peerbooms OLJ, 2011, BRAIN BEHAV IMMUN, V25, P1530, DOI 10.1016/j.bbi.2010.12.006; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Pu DH, 2013, AUTISM RES, V6, P384, DOI 10.1002/aur.1300; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Saedisomeolia Ahmad, 2011, J Res Med Sci, V16 Suppl 1, pS437; Selhub J, 1999, ANN INTERN MED, V131, P331, DOI 10.7326/0003-4819-131-5-199909070-00003; Sharma A, 1999, MOL PSYCHIATR, V4, P235, DOI 10.1038/sj.mp.4000522; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Solomon LR, 2015, EUR J CLIN NUTR, V69, P687, DOI 10.1038/ejcn.2014.272; Spuch C, 2010, RECENT PATENTS ENDOC, V4, P190, DOI 10.2174/1872214811004030190; Ssonko Michael, 2014, BMC Res Notes, V7, P90, DOI 10.1186/1756-0500-7-90; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; Steullet P, 2010, J NEUROSCI, V30, P2547, DOI 10.1523/JNEUROSCI.3857-09.2010; STURMAN JA, 1970, J NEUROCHEM, V17, P1117, DOI 10.1111/j.1471-4159.1970.tb02268.x; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; TALLAN HH, 1958, J BIOL CHEM, V230, P707; Tarazi FI, 1999, MOL PSYCHIATR, V4, P529, DOI 10.1038/sj.mp.4000674; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Waly M, 2004, MOL PSYCHIATR, V9, P358, DOI 10.1038/sj.mp.4001476; Waly MI, 2011, ALCOHOL CLIN EXP RES, V35, P277, DOI 10.1111/j.1530-0277.2010.01343.x; WORMPETERSEN J, 1964, ACTA NEUROL SCAND, V40, P241; Wu YL, 2013, J NEUROL SCI, V335, P14, DOI 10.1016/j.jns.2013.09.006; Yang Y, 2002, J BIOL CHEM, V277, P49446, DOI 10.1074/jbc.M209372200; Zhang Y, OXID MED AND CELL LO; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	89	88	91	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146797	10.1371/journal.pone.0146797	http://dx.doi.org/10.1371/journal.pone.0146797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799654	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300037
J	Rakipovski, G; Lykkesfeldt, J; Raun, K				Rakipovski, Gunaj; Lykkesfeldt, Jens; Raun, Kirsten			Pulsatile Hyperglycaemia Induces Vascular Oxidative Stress and GLUT 1 Expression More Potently than Sustained Hyperglycaemia in Rats on High Fat Diet	PLOS ONE			English	Article							GLUCOSE ENHANCES APOPTOSIS; APOLIPOPROTEIN E-DEFICIENT; INSULIN-RESISTANCE; ENDOTHELIAL DYSFUNCTION; POSTPRANDIAL HYPERGLYCEMIA; DIABETIC-PATIENTS; LIVER; METABOLISM; ACTIVATION; MUSCLE	Introduction Pulsatile hyperglycaemia resulting in oxidative stress may play an important role in the development of macrovascular complications. We investigated the effects of sustained vs. pulsatile hyperglycaemia in insulin resistant rats on markers of oxidative stress, enzyme expression and glucose metabolism in liver and aorta. We hypothesized that liver's ability to regulate the glucose homeostasis under varying states of hyperglycaemia may indirectly affect oxidative stress status in aorta despite the amount of glucose challenged with. Methods Animals were infused with sustained high (SHG), low (SLG), pulsatile (PLG) glucose or saline (VEH) for 96 h. Oxidative stress status and key regulators of glucose metabolism in liver and aorta were investigated. Results Similar response in plasma lipid oxidation was observed in PLG as in SHG. Likewise, in aorta, PLG and SHG displayed increased expression of glucose transporter 1 (GLUT1), gp-91(PHOX) and super oxide dismutase (SOD), while only the PLG group showed increased accumulation of oxidative stress and oxidised low density lipoprotein (oxLDL) in aorta. Conclusion Pulsatile hyperglycaemia induced relatively higher levels of oxidative stress systemically and in aorta in particular than overt sustained hyperglycaemia thus supporting the clinical observations that pulsatile hyperglycaemia is an independent risk factor for diabetes related macrovascular complications.	[Rakipovski, Gunaj; Lykkesfeldt, Jens] Univ Copenhagen, Dept Expt Anim Models, Sect Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Rakipovski, Gunaj; Raun, Kirsten] Novo Nordisk AS, Global Res, Dept Diabet Pharmacol, Malov, Denmark	University of Copenhagen; Novo Nordisk	Rakipovski, G (corresponding author), Univ Copenhagen, Dept Expt Anim Models, Sect Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark.; Rakipovski, G (corresponding author), Novo Nordisk AS, Global Res, Dept Diabet Pharmacol, Malov, Denmark.	GuRa@novonordisk.com	Lykkesfeldt, Jens/A-1072-2011	Lykkesfeldt, Jens/0000-0002-6514-8407	Novo Nordisk A/S	Novo Nordisk A/S(Novo Nordisk)	Novo Nordisk A/S provided support in the form of salaries for authors KR and GR, and had an additional role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Aljada A, 2000, J CLIN ENDOCR METAB, V85, P2572, DOI 10.1210/jc.85.7.2572; Aljada A, 2001, J CLIN ENDOCR METAB, V86, P450, DOI 10.1210/jc.86.1.450; Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; Artwohl M, 2007, EUR J CLIN INVEST, V37, P643, DOI 10.1111/j.1365-2362.2007.01838.x; ASSIMACOPOULOSJEANNET F, 1995, METABOLISM, V44, P228, DOI 10.1016/0026-0495(95)90270-8; Azuma K, 2006, ARTERIOSCL THROM VAS, V26, P2275, DOI 10.1161/01.ATV.0000239488.05069.03; BRICHARD SM, 1993, DIABETOLOGIA, V36, P292, DOI 10.1007/BF00400230; Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1707, DOI 10.1001/jama.295.14.1707; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Ceriello A, 2000, DIABETES, V49, P2170, DOI 10.2337/diabetes.49.12.2170; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Cersosimo E, 2006, DIABETES-METAB RES, V22, P423, DOI 10.1002/dmrr.634; Chen MY, 2001, BIOCHEM BIOPH RES CO, V287, P962, DOI 10.1006/bbrc.2001.5674; Ciapaite J, 2011, BBA-MOL CELL BIOL L, V1811, P441, DOI 10.1016/j.bbalip.2011.05.005; Ellger B, 2006, DIABETES, V55, P1096, DOI 10.2337/diabetes.55.04.06.db05-1434; Gao L, 2008, VET CLIN N AM-SMALL, V38, P137, DOI 10.1016/j.cvsm.2007.10.004; Harrison DG, 2003, J RENIN-ANGIO-ALDO S, V4, P51, DOI 10.3317/jraas.2003.014; Hodgkinson AD, 2003, DIABETES, V52, P846, DOI 10.2337/diabetes.52.3.846; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Horvath EM, 2009, DIABETOLOGIA, V52, P952, DOI 10.1007/s00125-009-1304-0; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Koo JR, 2003, KIDNEY INT, V63, P195, DOI 10.1046/j.1523-1755.2003.00728.x; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Ling PR, 2007, CRIT CARE MED, V35, P555, DOI 10.1097/01.CCM.0000253310.02180.C2; Lykkesfeldt J, 2007, CLIN CHIM ACTA, V380, P50, DOI 10.1016/j.cca.2007.01.028; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Matsunami T, 2010, INT J CLIN EXP PATHO, V3, P177; Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Nakhjavani M, 2010, LIPIDS, V45, P321, DOI 10.1007/s11745-010-3401-8; Nawano M, 2000, AM J PHYSIOL-ENDOC M, V278, pE535, DOI 10.1152/ajpendo.2000.278.3.E535; Node K, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-23; O'Donnell RW, 2003, ENDOTHELIUM-J ENDOTH, V10, P291, DOI 10.1080/10623320390272280; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; Oakes ND, 1997, DIABETES, V46, P1768, DOI 10.2337/diabetes.46.11.1768; OSCHRY Y, 1982, J LIPID RES, V23, P1099; Piarulli F, 2009, DIABETOLOGIA, V52, P1419, DOI 10.1007/s00125-009-1367-y; Sun Q, 2014, WORLD J DIABETES, V5, P89, DOI 10.4239/wjd.v5.i2.89; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Quagliaro L, 2007, NUTR METAB CARDIOVAS, V17, P257, DOI 10.1016/j.numecd.2006.01.007; Rakipovski G, 2011, DIABETES VASC DIS RE, V8, P295, DOI 10.1177/1479164111421033; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Sena CM, 2011, BRIT J PHARMACOL, V163, P424, DOI 10.1111/j.1476-5381.2011.01230.x; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; Sugimoto R, 2005, LIVER INT, V25, P1018, DOI 10.1111/j.1478-3231.2005.01130.x; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Taskinen MR, 1996, ANN MED, V28, P335, DOI 10.3109/07853899608999090; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Topp BB, 2004, DIABETOLOGIA, V47, P1602, DOI 10.1007/s00125-004-1493-5; Zhao Y, 2008, J NUCL MED, V49, P1707, DOI 10.2967/jnumed.108.051847	56	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147412	10.1371/journal.pone.0147412	http://dx.doi.org/10.1371/journal.pone.0147412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790104	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100086
J	Arterbery, AS; Bogue, CW				Arterbery, Adam S.; Bogue, Clifford W.			Hhex Is Necessary for the Hepatic Differentiation of Mouse ES Cells and Acts via Vegf Signaling	PLOS ONE			English	Article							HOMEOBOX GENE HEX; LIVER DEVELOPMENT REQUIRES; ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA TRANSPORT; EMBRYONIC STEM-CELLS; DEFINITIVE ENDODERM; IN-VITRO; HEPATOCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEIN	Elucidating the molecular mechanisms involved in the differentiation of stem cells to hepatic cells is critical for both understanding normal developmental processes as well as for optimizing the generation of functional hepatic cells for therapy. We performed in vitro differentiation of mouse embryonic stem cells (mESCs) with a null mutation in the homeobox gene Hhex and show that Hhex(-/-) mESCs fail to differentiate from definitive endoderm (Sox17(+)/Foxa2(+)) to hepatic endoderm (Alb(+)/Dlk(+)). In addition, hepatic culture elicited a >7-fold increase in Vegfa mRNA expression in Hhex(-/-) cells compared to Hhex(+/+) cells. Furthermore, we identified VEGFR2(+)/ALB(+)/CD34(-) in early Hhex(+/+) hepatic cultures. These cells were absent in Hhex(-/-) cultures. Finally, through manipulation of Hhex and Vegfa expression, gain and loss of expression experiments revealed that Hhex shares an inverse relationship with the activity of the Vegf signaling pathway in supporting hepatic differentiation. In summary, our results suggest that Hhex represses Vegf signaling during hepatic differentiation of mouse ESCs allowing for cell-type autonomous regulation of Vegfr2 activity independent of endothelial cells.	[Arterbery, Adam S.; Bogue, Clifford W.] Yale Univ, Dept Pediat, Yale Sch Med, Sect Crit Care Med, New Haven, CT 06520 USA	Yale University	Arterbery, AS (corresponding author), Yale Univ, Dept Pediat, Yale Sch Med, Sect Crit Care Med, New Haven, CT 06520 USA.	adam.arterbery@yale.edu	Bogue, Clifford/AAD-3832-2019	Bogue, Clifford/0000-0002-2688-687X	NIH [DK061146-06A2, 5T32HL07272-32]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061146, R56DK061146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by financial assistance from NIH Grants DK061146-06A2 to CWB and 5T32HL07272-32 to CWB/ASA.	Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bogue CW, 2003, P NATL ACAD SCI USA, V100, P556, DOI 10.1073/pnas.0236979100; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Bossard P, 2000, DEVELOPMENT, V127, P4915; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136; Crawford LW, 2010, TOXICOL PATHOL, V38, P872, DOI 10.1177/0192623310374329; CROMPTON MR, 1992, NUCLEIC ACIDS RES, V20, P5661, DOI 10.1093/nar/20.21.5661; D'Elia AV, 2002, J CLIN ENDOCR METAB, V87, P1376, DOI 10.1210/jc.87.3.1376; Delisle Juliette Cuvelier, 2008, BMC Res Notes, V1, P136, DOI 10.1186/1756-0500-1-136; Dufort D, 1998, DEVELOPMENT, V125, P3015; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Ghosh B, 2000, PEDIATR RES, V48, P634, DOI 10.1203/00006450-200011000-00014; Goldman O, 2013, CELL STEM CELL, V12, P748, DOI 10.1016/j.stem.2013.04.026; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gouysse G, 2002, J HEPATOL, V37, P730, DOI 10.1016/S0168-8278(02)00282-9; Guo Y, 2003, BLOOD, V102, P2428, DOI 10.1182/blood-2003-02-0634; Hallaq H, 2004, DEVELOPMENT, V131, P5197, DOI 10.1242/dev.01393; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; HOUSSAINT E, 1980, CELL DIFFER DEV, V9, P269, DOI 10.1016/0045-6039(80)90026-3; Hunter MP, 2007, DEV BIOL, V308, P355, DOI 10.1016/j.ydbio.2007.05.028; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Jones EA, 2001, J ANAT, V198, P555, DOI 10.1046/j.1469-7580.2001.19850555.x; Jones EA, 2002, EXP CELL RES, V272, P15, DOI 10.1006/excr.2001.5396; Kallas A, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/298163; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Keng VW, 2000, BIOCHEM BIOPH RES CO, V276, P1155, DOI 10.1006/bbrc.2000.3548; Kim Peter T W, 2012, Results Probl Cell Differ, V55, P303, DOI 10.1007/978-3-642-30406-4_17; Kubo A, 2005, BLOOD, V105, P4590, DOI 10.1182/blood-2004-10-4137; Kubo A, 2010, HEPATOLOGY, V51, P633, DOI 10.1002/hep.23293; Kwon GS, 2006, DEV DYNAM, V235, P2549, DOI 10.1002/dvdy.20843; Lemaigre FP, 2003, MECH DEVELOP, V120, P81; Liu Y, 2014, STEM CELLS, V32, P1515, DOI 10.1002/stem.1695; Livigni A, 2009, CURR PROTOC STEM CEL, DOI [10.1002/9780470151808.sc01g03s10, DOI 10.1002/9780470151808.SCO1G03S10]; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Myint Z, 1999, J BIOCHEM-TOKYO, V125, P795, DOI 10.1093/oxfordjournals.jbchem.a022351; Nakagawa T, 2003, ARTERIOSCL THROM VAS, V23, P231, DOI 10.1161/01.ATV.0000052670.55321.87; Noy P, 2012, NUCLEIC ACIDS RES, V40, P9008, DOI 10.1093/nar/gks687; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; Oh U, 2006, J INFECT DIS, V193, P1557, DOI 10.1086/503874; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; Pan YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017536; Pierreux CE, 2010, DEV BIOL, V347, P216, DOI 10.1016/j.ydbio.2010.08.024; Puppin C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-192; Schroeder Insa S., 2009, V530, P219, DOI 10.1007/978-1-59745-471-1_12; Shiraki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024228; Snykers S, 2009, STEM CELLS, V27, P577, DOI 10.1634/stemcells.2008-0963; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Soufi A, 2008, BIOCHEM J, V412, P399, DOI 10.1042/BJ20080035; Stanger BZ, 2009, TXB GASTROENTEROLOGY, P567; Tanaka T, 1999, BIOCHEM J, V339, P111, DOI 10.1042/0264-6021:3390111; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; Wallace KN, 2001, GENESIS, V30, P141, DOI 10.1002/gene.1050; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Williams H, 2008, J MOL BIOL, V383, P10, DOI 10.1016/j.jmb.2008.08.004; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	67	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146806	10.1371/journal.pone.0146806	http://dx.doi.org/10.1371/journal.pone.0146806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784346	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400066
J	Barbour, AG				Barbour, Alan G.			Multiple and Diverse vsp and vlp Sequences in Borrelia miyamotoi, a Hard Tick-Borne Zoonotic Pathogen	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; ANTIGENIC VARIATION; LINEAR PLASMIDS; SURFACE PROTEIN; MOUSE MODEL; HERMSII; GENOME; EXPRESSION; VECTOR; GENES	Based on chromosome sequences, the human pathogen Borrelia miyamotoi phylogenetically clusters with species that cause relapsing fever. But atypically for relapsing fever agents, B. miyamotoi is transmitted not by soft ticks but by hard ticks, which also are vectors of Lyme disease Borrelia species. To further assess the relationships of B. miyamotoi to species that cause relapsing fever, I investigated extrachromosomal sequences of a North American strain with specific attention on plasmid-borne vsp and vlp genes, which are the underpinnings of antigenic variation during relapsing fever. For a hybrid approach to achieve assemblies that spanned more than one of the paralogous vsp and vlp genes, a database of short-reads from next-generation sequencing was supplemented with long-reads obtained with real-time DNA sequencing from single polymerase molecules. This yielded three contigs of 31, 16, and 11 kb, which each contained multiple and diverse sequences that were homologous to vsp and vlp genes of the relapsing fever agent B. hermsii. Two plasmid fragments had coding sequences for plasmid partition proteins that differed from each other from paralogous proteins for the megaplasmid and a small plasmid of B. miyamotoi. One of 4 vsp genes, vsp1, was present at two loci, one of which was downstream of a candiate prokaryotic promoter. A limited RNA-seq analysis of a population growing in the blood of mice indicated that of the 4 different vsp genes vsp1 was the one that was expressed. The findings indicate that B. miyamotoi has at least four types of plasmids, two or more of which bear vsp and vlp gene sequences that are as numerous and diverse as those of relapsing fever Borrelia. The database and insights from these findings provide a foundation for further investigations of the immune responses to this pathogen and of the capability of B. miyamotoi for antigenic variation.	[Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Barbour, AG (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.; Barbour, AG (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA.	abarbour@uci.edu		Barbour, Alan/0000-0002-0719-5248	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [AI-100236, AI-114859]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI100236, R56AI114859] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by grants AI-100236 and AI-114859 from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to A.G.B.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barbour A, 2005, TICK BORNE DIS HUMAN, P220; Barbour A.G., 2010, BORRELIA MOL BIOL HO, P333; Barbour AG, 2000, EMERG INFECT DIS, V6, P449, DOI 10.3201/eid0605.000502; Barbour AG, 2000, INFECT IMMUN, V68, P7114, DOI 10.1128/IAI.68.12.7114-7121.2000; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Barbour AG, 2014, INFECT GENET EVOL, V27, P551, DOI 10.1016/j.meegid.2014.04.022; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; CADAVID D, 1994, J EXP MED, V179, P631, DOI 10.1084/jem.179.2.631; Cadavid D, 1997, INFECT IMMUN, V65, P3352, DOI 10.1128/IAI.65.8.3352-3360.1997; CARTER CJ, 1994, INFECT IMMUN, V62, P2792, DOI 10.1128/IAI.62.7.2792-2799.1994; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chaconas G, 2005, MOL MICROBIOL, V58, P625, DOI 10.1111/j.1365-2958.2005.04872.x; Dai QY, 2006, MOL MICROBIOL, V60, P1329, DOI 10.1111/j.1365-2958.2006.05177.x; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fonville M, 2014, EMERG INFECT DIS, V20, P1244, DOI 10.3201/eid2007.131525; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Hamase A, 1996, FEMS MICROBIOL LETT, V140, P131, DOI 10.1111/j.1574-6968.1996.tb08326.x; Hinnebusch BJ, 1998, INFECT IMMUN, V66, P432, DOI 10.1128/IAI.66.2.432-440.1998; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; Hue F, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00713-13; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; KITTEN T, 1990, P NATL ACAD SCI USA, V87, P6077, DOI 10.1073/pnas.87.16.6077; Kobryn K, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.MDNA3-0023-2014, DOI 10.1128/MICR0BI0LSPEC.MDNA3-0023-2014]; Krause PJ, 2015, CLIN MICROBIOL INFEC, V21, P631, DOI 10.1016/j.cmi.2015.02.006; Krause PJ, 2014, EMERG INFECT DIS, V20, P1183, DOI 10.3201/eid2007.131587; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; MARGOLIS N, 1994, J BACTERIOL, V176, P6427, DOI 10.1128/JB.176.21.6427-6432.1994; Margos G, 2015, TICKS TICK-BORNE DIS, V6, P181, DOI 10.1016/j.ttbdis.2014.12.001; MEIER JT, 1985, CELL, V41, P403, DOI 10.1016/S0092-8674(85)80013-1; Miller SC, 2013, J BACTERIOL, V195, P3629, DOI 10.1128/JB.00347-13; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; NORRIS SJ, 1995, INFECT IMMUN, V63, P2206, DOI 10.1128/IAI.63.6.2206-2212.1995; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Pennington PM, 1999, MOL MICROBIOL, V34, P1120, DOI 10.1046/j.1365-2958.1999.01675.x; Pennington PM, 1997, INFECT IMMUN, V65, P285, DOI 10.1128/IAI.65.1.285-292.1997; Pennington PM, 1999, INFECT IMMUN, V67, P4637, DOI 10.1128/IAI.67.9.4637-4645.1999; PLASTERK RHA, 1985, NATURE, V318, P257, DOI 10.1038/318257a0; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Raffel SJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004056; RESTREPO BI, 1992, MOL MICROBIOL, V6, P3299, DOI 10.1111/j.1365-2958.1992.tb02198.x; Rich SM, 2001, P NATL ACAD SCI USA, V98, P15038, DOI 10.1073/pnas.071042098; Salkeld DJ, 2014, EMERG INFECT DIS, V20, P493, DOI 10.3201/eid2003.130668; Sarkar A, 2011, J BACTERIOL, V193, P5365, DOI 10.1128/JB.01496-10; Sato K, 2014, EMERG INFECT DIS, V20, P1391, DOI 10.3201/eid2008.131761; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Sonenshine DE, 2014, BIOL TICKS; Wagemakers A, 2015, TRENDS PARASITOL, V31, P260, DOI 10.1016/j.pt.2015.03.008; Wagemakers A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-418; Xu QL, 2008, MICROB PATHOGENESIS, V45, P70, DOI 10.1016/j.micpath.2008.03.002; Zhong HM, 2006, J BACTERIOL, V188, P909, DOI 10.1128/JB.188.3.909-918.2006; Zhong JM, 2004, MOL MICROBIOL, V51, P729, DOI 10.1046/j.1365-2958.2003.03849.x	59	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146283	10.1371/journal.pone.0146283	http://dx.doi.org/10.1371/journal.pone.0146283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785134	gold, Green Published			2022-12-26	WOS:000368528400029
J	Chojenta, CL; Lucke, JC; Forder, PM; Loxton, DJ				Chojenta, Catherine L.; Lucke, Jayne C.; Forder, Peta M.; Loxton, Deborah J.			Maternal Health Factors as Risks for Postnatal Depression: A Prospective Longitudinal Study	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; SOCIAL SUPPORT; SYMPTOMS; WOMEN; PREVALENCE; PREDICTORS; PREGNANCY; BIRTH	Purpose While previous studies have identified a range of potential risk factors for postnatal depression (PND), none have examined a comprehensive set of risk factors at a population-level using data collected prospectively. The aim of this study was to explore the relationship between a range of factors and PND and to construct a model of the predictors of PND. Methods Data came from 5219 women who completed Survey 5 of the Australian Longitudinal Study on Women's Health in 2009 and reported giving birth to a child. Results Over 15% of women reported experiencing PND with at least one of their children. The strongest positive associations were for postnatal anxiety (OR = 13.79, 95% CI = 10.48, 18.13) and antenatal depression (OR = 9.23, 95% CI = 6.10, 13.97). Positive associations were also found for history of depression and PND, low SF-36 Mental Health Index, emotional distress during labour, and breastfeeding for less than six months. Conclusions Results indicate that understanding a woman's mental health history plays an important role in the detection of those who are most vulnerable to PND. Treatment and management of depression and anxiety earlier in life and during pregnancy may have a positive impact on the incidence of PND.	[Chojenta, Catherine L.; Forder, Peta M.; Loxton, Deborah J.] Univ Newcastle, Res Ctr Generat Hlth & Ageing, Callaghan, NSW 2308, Australia; [Lucke, Jayne C.] La Trobe Univ, Fac Hlth Sci, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia	University of Newcastle; La Trobe University	Chojenta, CL (corresponding author), Univ Newcastle, Res Ctr Generat Hlth & Ageing, Callaghan, NSW 2308, Australia.	Catherine.Chojenta@newcastle.edu.au	Lucke, Jayne C/A-5538-2008; Chojenta, Catherine L/B-2521-2008	Lucke, Jayne C/0000-0002-2885-5292; Chojenta, Catherine L/0000-0002-2541-4491	Australian Government Department of Health	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This work was supported by the Australian Government Department of Health provides funding for the Australian Longitudinal Study on Women's Health.; The research on which this paper is based was conducted as part of the Australian Longitudinal Study on Women's Health, the University of Newcastle and the University of Queensland. We are grateful to the Australian Government Department of Health for funding, to the staff of ALSWH and to the women who provided the survey data. Researchers in the Research Centre for Generational Health and Ageing at the University of Newcastle are members of the Hunter Medical Research Institute (HMRI).	Australian Institute of Health and Welfare. National Health Data Dictionary, NAT HLTH DAT DICT VE; Beck CT, 1996, NURS RES, V45, P297, DOI 10.1097/00006199-199609000-00008; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Boury JM, 2004, WOMEN HEALTH, V39, P19, DOI 10.1300/J013v39n03_02; Brown S, 1994, MISSING VOICES EXPER; Buist AE, 2008, AUST NZ J PSYCHIAT, V42, P66, DOI 10.1080/00048670701732749; Certain HE, 2008, JOGNN-J OBST GYN NEO, V37, P35, DOI [10.1111/j.1552-6909.2007.00200.x, 10.1111/J.1552-6909.2007.00200.x]; COLLINS NL, 1993, J PERS SOC PSYCHOL, V65, P1243, DOI 10.1037/0022-3514.65.6.1243; Dagher RK, 2012, ARCH WOMEN MENT HLTH, V15, P31, DOI 10.1007/s00737-011-0252-0; Davey HL, 2011, MATERN CHILD HLTH J, V15, P866, DOI 10.1007/s10995-008-0314-8; Dennis CL, 2012, CAN J PSYCHIAT, V57, P537, DOI 10.1177/070674371205700904; Dennis CLE, 2004, ACTA PSYCHIAT SCAND, V110, P338, DOI 10.1111/j.1600-0447.2004.00337.x; Eastwood JG, 2011, AUST NZ J PSYCHIAT, V45, P1040, DOI 10.3109/00048674.2011.619160; Haga SM, 2012, ARCH WOMEN MENT HLTH, V15, P175, DOI 10.1007/s00737-012-0274-2; IBM Corp, 2010, IBM SPSS STAT WIND V; LaCoursiere DY, 2010, BJOG-INT J OBSTET GY, V117, P1011, DOI 10.1111/j.1471-0528.2010.02569.x; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Le Strat Y, 2011, J AFFECT DISORDERS, V135, P128, DOI 10.1016/j.jad.2011.07.004; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; National Health and Medical Research Council, 2000, POSTN DEPR SYST REV; NORBECK JS, 1984, RES NURS HEALTH, V7, P61, DOI 10.1002/nur.4770070110; O'Hara MW, 2013, POSTPARTUM DEPRESSIO, P379; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Price SK, 2009, J RURAL HEALTH, V25, P158, DOI 10.1111/j.1748-0361.2009.00212.x; Rosner B., 2006, FUNDAMENTALS BIOSTAT; SARASON IG, 1986, J PERS SOC PSYCHOL, V50, P845, DOI 10.1037/0022-3514.50.4.845; Sartorius N, 1996, BRIT J PSYCHIAT, V168, P38, DOI 10.1192/S0007125000298395; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tuohy Alan, 2008, Psychol Health Med, V13, P43, DOI 10.1080/13548500701294531; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; White T, 2006, J REPROD INFANT PSYC, V24, P107, DOI 10.1080/02646830600643874; Wilton G, 2009, MCN-AM J MATERN-CHIL, V34, P297, DOI 10.1097/01.NMC.0000360422.06486.c4; Wu LL, 2001, J HUM RESOUR, V36, P520, DOI 10.2307/3069629; Yim IS, 2015, ANNU REV CLIN PSYCHO, V11, P99, DOI 10.1146/annurev-clinpsy-101414-020426	36	26	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147246	10.1371/journal.pone.0147246	http://dx.doi.org/10.1371/journal.pone.0147246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26785131	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400128
J	Cruz-Bermudez, A; Vicente-Blanco, RJ; Hernandez-Sierra, R; Montero, M; Alvarez, J; Manrique, MG; Blazquez, A; Martin, MA; Ayuso, C; Garesse, R; Fernandez-Moreno, MA				Cruz-Bermudez, Alberto; Vicente-Blanco, Ramiro J.; Hernandez-Sierra, Rosana; Montero, Mayte; Alvarez, Javier; Gonzalez Manrique, Mar; Blazquez, Alberto; Angel Martin, Miguel; Ayuso, Carmen; Garesse, Rafael; Fernandez-Moreno, Miguel A.			Functional Characterization of Three Concomitant MtDNA LHON Mutations Shows No Synergistic Effect on Mitochondrial Activity	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; COMPLEX I; DNA MUTATIONS; OXIDATIVE-PHOSPHORYLATION; CHINESE FAMILY; HUMAN-CELLS; DEFECTS; CHAIN; COMPLEMENTATION; HOMEOSTASIS	The presence of more than one non-severe pathogenic mutation in the same mitochondrial DNA (mtDNA) molecule is very rare. Moreover, it is unclear whether their co-occurrence results in an additive impact on mitochondrial function relative to single mutation effects. Here we describe the first example of a mtDNA molecule harboring three Leber's hereditary optic neuropathy (LHON)-associated mutations (m.11778G>A, m.14484T>C, m.11253T>C) and the analysis of its genetic, biochemical and molecular characterization in transmitochondrial cells (cybrids). Extensive characterization of cybrid cell lines harboring either the 3 mutations or the single classic m.11778G>A and m.14484T>C mutations revealed no differences in mitochondrial function, demonstrating the absence of a synergistic effect in this model system. These molecular results are in agreement with the ophthalmological characteristics found in the triple mutant patient, which were similar to those carrying single mtDNA LHON mutations.	[Cruz-Bermudez, Alberto; Vicente-Blanco, Ramiro J.; Hernandez-Sierra, Rosana; Garesse, Rafael; Fernandez-Moreno, Miguel A.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Madrid, Spain; [Cruz-Bermudez, Alberto; Vicente-Blanco, Ramiro J.; Hernandez-Sierra, Rosana; Garesse, Rafael; Fernandez-Moreno, Miguel A.] Univ Autonoma Madrid, Fac Med, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Cruz-Bermudez, Alberto; Vicente-Blanco, Ramiro J.; Hernandez-Sierra, Rosana; Blazquez, Alberto; Angel Martin, Miguel; Garesse, Rafael; Fernandez-Moreno, Miguel A.] Hosp 12 Octubre i 12, Inst Invest Sanitaria, Madrid, Spain; [Cruz-Bermudez, Alberto; Vicente-Blanco, Ramiro J.; Hernandez-Sierra, Rosana; Blazquez, Alberto; Angel Martin, Miguel; Ayuso, Carmen; Garesse, Rafael; Fernandez-Moreno, Miguel A.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Montero, Mayte; Alvarez, Javier] Univ Valladolid, Fac Med, Dept Bioquim Biol Mol & Fisiol, Valladolid, Spain; [Gonzalez Manrique, Mar] Univ Rey Juan Carlos, Hosp Mostoles, Madrid 28935, Spain; [Ayuso, Carmen] UAM, IIS Fdn Jimenez Diaz Univ Hosp IIS FJD, Dept Genet, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Universidad Rey Juan Carlos; Autonomous University of Madrid; Fundacion Jimenez Diaz	Garesse, R; Fernandez-Moreno, MA (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Madrid, Spain.; Garesse, R; Fernandez-Moreno, MA (corresponding author), Univ Autonoma Madrid, Fac Med, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.; Garesse, R; Fernandez-Moreno, MA (corresponding author), Hosp 12 Octubre i 12, Inst Invest Sanitaria, Madrid, Spain.; Garesse, R; Fernandez-Moreno, MA (corresponding author), Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.	rafael.garesse@uam.es; miguel.fernandez@uam.es	Garesse, Rafael/F-3836-2012; Bermúdez, Alberto Cruz/AAE-1341-2021; Blázquez Encinar, Alberto/S-4425-2018; Alvarez, Javier/K-8210-2014; Montero, Mayte/K-8212-2014; Fernandez-Moreno, Miguel Angel/K-4425-2017; Martin, Miguel A/S-2758-2018	Bermúdez, Alberto Cruz/0000-0001-5136-7011; Blázquez Encinar, Alberto/0000-0002-6479-3615; Alvarez, Javier/0000-0003-0636-5521; Montero, Mayte/0000-0001-7702-6653; Fernandez-Moreno, Miguel Angel/0000-0002-3461-0726; Martin, Miguel A/0000-0003-4741-772X; Vicente-Blanco, Ramiro/0000-0002-8615-7417; Ayuso, Carmen/0000-0002-9242-7065	Instituto de Salud Carlos III [PI 04/1001, PI12/01683, PI13/00556]; Comunidad Autonoma de Madrid [S2010/BMD-2402]; Fundacion Mutua Madrilena [10.04.02.0064]; Spanish Ministry of Economy and Competitiveness [BFU2011-25763]; FEDER funds from the E.U	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER funds from the E.U	This work was supported by Instituto de Salud Carlos III, http://www.isciii.es/, PI 04/1001 to M.A.F.M.; Instituto de Salud Carlos III, http://www.isciii.es/, PI12/01683 to M.A.M.; Instituto de Salud Carlos III, http://www.isciii.es/, PI13/00556 to R.G.; Comunidad Autonoma de Madrid, http://www.madrid.org/cs/Satellite?pagename=ComunidadMadrid/Home, S2010/BMD-2402 to R.G.; Fundacion Mutua Madrilena, http://www.fundacionmutua.es/, 10.04.02.0064 to M.A.F.M.; The Spanish Ministry of Economy and Competitiveness, http://www.mineco.gob.es/, BFU2011-25763 to J.A.; FEDER funds from the E.U. to R.G., http://ec.europa.eu/regional_policy/es/funding/erdf/.	Achilli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042242; Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Brandt U, 2011, BBA-BIOENERGETICS, V1807, P1364, DOI 10.1016/j.bbabio.2011.04.006; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L; Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623; CHOMYN A, 1994, AM J HUM GENET, V54, P966; Cruz-Bermudez A, 2015, ONCOTARGET, V6, P13628, DOI 10.18632/oncotarget.3698; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126; Drose S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001128; Echevarria L, 2014, BIOCHEM J, V460, P91, DOI 10.1042/BJ20131107; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Gallardo ME, 2012, EUR HEART J, V33, P346, DOI 10.1093/eurheartj/ehr280; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117; HARDING AE, 1995, AM J HUM GENET, V57, P77; Haroon MF, 2007, NEUROBIOL DIS, V28, P237, DOI 10.1016/j.nbd.2007.07.021; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Howell N, 2002, J NEURO-OPHTHALMOL, V22, P262, DOI 10.1097/00041327-200212000-00002; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Khan NA, 2013, MOL VIS, V19, P1282; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kirches E, 2011, CURR GENOMICS, V12, P44, DOI 10.2174/138920211794520150; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Melberg A, 2009, EUR J MED GENET, V52, P47, DOI 10.1016/j.ejmg.2008.10.004; Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Montero M, 2002, FASEB J, V16, P1955, DOI 10.1096/fj.02-0553fje; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Qiao C, 2015, MOL MED REP, V12, P3067, DOI 10.3892/mmr.2015.3714; RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Shu L, 2012, INT J OPHTHALMOL-CHI, V5, P28, DOI 10.3980/j.issn.2222-3959.2012.01.06; Tonska K, 2008, MITOCHONDRION, V8, P383, DOI 10.1016/j.mito.2008.08.002; Trevelyan AJ, 2010, BRAIN, V133, P787, DOI 10.1093/brain/awq023; Vallejo CG, 2013, BIOCHIMIE, V95, P1171, DOI 10.1016/j.biochi.2013.01.001; von Kleist-Retzow JC, 2007, EXP CELL RES, V313, P3076, DOI 10.1016/j.yexcr.2007.04.015; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wei QP, 2007, BIOCHEM BIOPH RES CO, V357, P910, DOI 10.1016/j.bbrc.2007.04.025; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002; Zhang JJ, 2010, BIOCHEM BIOPH RES CO, V399, P647, DOI 10.1016/j.bbrc.2010.07.135; Zhang SR, 2008, MITOCHONDRION, V8, P205, DOI 10.1016/j.mito.2008.02.003; Zickermann V, 2008, J BIOENERG BIOMEMBR, V40, P475, DOI 10.1007/s10863-008-9171-9	60	14	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146816	10.1371/journal.pone.0146816	http://dx.doi.org/10.1371/journal.pone.0146816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784702	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400068
J	Ebrahim, S; Mndende, XK; Kharsany, ABM; Mbulawa, ZZA; Naranbhai, V; Frohlich, J; Werner, L; Samsunder, N; Karim, QA; Williamson, AL				Ebrahim, Sumayyah; Mndende, Xolani K.; Kharsany, Ayesha B. M.; Mbulawa, Zizipho Z. A.; Naranbhai, Vivek; Frohlich, Janet; Werner, Lise; Samsunder, Natasha; Karim, Quarraisha Abdool; Williamson, Anna-Lise			High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							ACQUISITION; PREVALENCE; EFFICACY; HIV; EPIDEMIOLOGY; VACCINATION; PERSISTENCE; PREVENTION; CONCURRENT; DURATION	Objectives HPV infection causes cervical cancer, yet information on prevalence and risk factors for HPV in Africa remain sparse. This study describes the prevalence of HPV genotypes and risk factors associated with HPV among young women <= 30 years of age in KwaZulu-Natal (KZN), South Africa. Methods Cervicovaginal lavage samples were tested for HPV genotypes in 224 women enrolled in a prospective cohort study. Clinical, behavioural and demographic data were collected. We measured prevalence of HPV genotypes and using logistic regression, examined for factors associated with HPV. Results Median age of participants was 21 years [interquartile range (IQR): 18-23]. The overall prevalence of HPV was 76.3%(171/224) with multiple and single genotypes prevalent in 56.3% and 20.1% of women respectively. Proportion of women with high-risk genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56 and 58) was 54.5%. Women not living with their partner [adjusted odds ratio (aOR)] = 3.42 95% CI1.22-9.60; p = 0.019), was significantly associated with HPV infection and high-risk HPV genotype infection. Conclusion The high burden of HPV and associated risk behaviours highlight the need to intensify behavioural interventions to prevent HPV acquisition in young women. The large scale delivery of HPV vaccine should be prioritised to prevent HPV acquisition and reduce HPV-related morbidity.	[Ebrahim, Sumayyah] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Surg, Durban, South Africa; [Mndende, Xolani K.; Mbulawa, Zizipho Z. A.; Williamson, Anna-Lise] Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa; [Mndende, Xolani K.; Mbulawa, Zizipho Z. A.; Williamson, Anna-Lise] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Kharsany, Ayesha B. M.; Naranbhai, Vivek; Frohlich, Janet; Werner, Lise; Samsunder, Natasha; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Nelson R Mandela Sch Med, Durban, South Africa; [Mbulawa, Zizipho Z. A.] Groote Schuur Hosp, Natl Inst Communicable Dis, Ctr HIV & STIs, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Naranbhai, Vivek] Univ Oxford, Nuffield Dept Med, Oxford, England; [Karim, Quarraisha Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Williamson, Anna-Lise] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa	University of Kwazulu Natal; University of Cape Town; University of Cape Town; University of Kwazulu Natal; National Institute for Communicable Diseases (NICD); University of Cape Town; University of Oxford; Columbia University; University of Cape Town	Ebrahim, S (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Surg, Durban, South Africa.	ebrahims@ukzn.ac.za	Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X; Naranbhai, Vivek/0000-0003-4281-8882; Williamson, Anna-Lise/0000-0002-5467-1200; Ebrahim, Sumayyah/0000-0001-9822-6347	Columbia University-Southern African Fogarty AIDS International Training and Research Program (AITRP) through the Fogarty International Center, National Institutes of Health [5 D43 TW000231-18]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; National Health Laboratory Service Research Trust; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER	Columbia University-Southern African Fogarty AIDS International Training and Research Program (AITRP) through the Fogarty International Center, National Institutes of Health; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; National Health Laboratory Service Research Trust; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Sumayyah Ebrahim was supported by the Columbia University-Southern African Fogarty AIDS International Training and Research Program (AITRP) through the Fogarty International Center, National Institutes of Health (grant# 5 D43 TW000231-18). Some of this work is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. Funding for the HPV laboratory work was also provided by the National Health Laboratory Service Research Trust and student (XKM) bursary by Poliomyelitis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, 2013, J IMMUNOL TECH INFEC, V2, DOI [10.4172/2329-9541.1000106, DOI 10.4172/2329-9541.1000106]; Bonanni P, 2009, VACCINE, V27, pA46, DOI 10.1016/j.vaccine.2008.10.085; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Campos NG, 2011, J INFECT DIS, V203, P823, DOI 10.1093/infdis/jiq131; Gattoc L, 2013, OBSTET GYN CLIN N AM, V40, P177, DOI 10.1016/j.ogc.2013.03.007; Giuliano AR, 2001, CANCER EPIDEM BIOMAR, V10, P1129; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Koulova A, 2008, VACCINE, V26, P6529, DOI 10.1016/j.vaccine.2008.08.067; Longatto Filho A, 2010, GYNECOLOGIC OBSTET I, P1; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Marais DJ, 2008, J CLIN MICROBIOL, V46, P732, DOI 10.1128/JCM.01322-07; Marks M, 2011, INT J CANCER, V128, P2962, DOI 10.1002/ijc.25628; McDonald AC, 2014, FRONTIERS ONCOLOGY, V4, P1; Moodley I, 2013, SAMJ S AFR MED J, V103, P318, DOI 10.7196/SAMJ.6414; Morrison CS, 2009, BEST PRACT RES CL OB, V23, P263, DOI 10.1016/j.bpobgyn.2008.11.004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Myer L, 2004, SEX TRANSM DIS, V31, P174, DOI 10.1097/01.OLQ.0000114942.41998.58; Richter K, 2013, SAMJ S AFR MED J, V103, P313, DOI 10.7196/SAMJ.6514; Rousseau MC, 2001, J INFECT DIS, V184, P1508, DOI 10.1086/324579; Shisana O, 2014, S AFRICAN NATL HIV P; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Tarkowski TA, 2004, J INFECT DIS, V189, P46, DOI 10.1086/380466; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0; Vinodhini K, 2012, ARCH GYNECOL OBSTET, V285, P771, DOI 10.1007/s00404-011-2155-8; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; World Health Organization, 2007, HUM PAP HPV VACC TEC	32	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146603	10.1371/journal.pone.0146603	http://dx.doi.org/10.1371/journal.pone.0146603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785408	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400052
J	Mahjabeen, I; Kayani, MA				Mahjabeen, Ishrat; Kayani, Mahmood Akhtar			Loss of Mitochondrial Tumor Suppressor Genes Expression Is Associated with Unfavorable Clinical Outcome in Head and Neck Squamous Cell Carcinoma: Data from Retrospective Study	PLOS ONE			English	Article							DOWN-REGULATION; ENHANCED PROLIFERATION; POOR-PROGNOSIS; SIRT3; METABOLISM; CANCER; REPAIR; DNA; INVASION; DAMAGE	Mitochondrial genes play important roles in cellular energy metabolism, free radical generation, and apoptosis. Dysregulation of these genes have long been suspected to contribute to the generation of reactive oxygen species (ROS), increased proliferation and progression of cancer. A family of orthologues of yeast silent information regulator 3 (SIRT3), 4 (SIRT4) and mitochondrial tumor suppressor 1 (MTUS1) are important mitochondrial tumor suppressor genes which play an important role in the progression of multiple cancers. However, their role in the development of oxidative stress, enhanced proliferation and progression of head and neck squamous cell carcinoma (HNSCC) has not yet been studied. In this study we aimed to test the association between reduced mitochondrial tumor suppressor genes' activities and enhancement in tissue oxidative stress and cell proliferation in HNSCC cases. The expression of mitochondrial tumor suppressor genes (SIRT3, SIRT4 and MTUS1), mitochondrial DNA repair gene (OGG1-2a) and a proliferation marker (Ki-67) was studied in a study cohort of 120 HNSCC patients and controls with reverse transcriptase polymerase chain reaction (RT-PCR) and real-time PCR (qPCR) in order to determine the potential prognostic significance of these genes. A statistically significant downregulation of SIRT3 (p<0.001), SIRT4 (p<0.0001), MTUS1 (p<0.002) and OGG1 (p<0.0001) was observed in HNSCC compared to control samples. Ki-67 was also overexpressed (p<0.0001) in HNSCC versus control samples. Additionally, to explore gene-gene relationship, we observed a positive spearmen correlation between SIRT3 versus SIRT4 (r = 0.523***, p<0.0001), SIRT3 versus MTUS1 (r = 0.273***, p<0.001), SIRT3 versus OGG1-2a (r = 0.213*, p<0.03), SIRT4 versus OGG1 (r = 0.338***, p<0.0001) and MTUS1 versus OGG1-2a (r = 0.215*, p<0.03) in HNSCC cases. A negative spearman correlation was observed between OGG1 versus Ki-67 (r = -0.224**, p<0.01) and OGG1-2a versus Ki-67 (r = -0.224**, p<0.01) in HNSCC cases. Here we report that the deregulation of mitochondrial tumor suppressor genes (SIRT3, SIRT4 and MTUS1) in relation to decreased expression of mitochondrial DNA repair gene OGG1-2a and increased proliferation (measured by proliferation marker Ki-67) may be considered important factors in the development of head and neck squamous cell carcinoma.	[Mahjabeen, Ishrat; Kayani, Mahmood Akhtar] COMSATS Inst Informat Technol, Dept Biosci, Canc Genet & Epigenet Res Grp, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Kayani, MA (corresponding author), COMSATS Inst Informat Technol, Dept Biosci, Canc Genet & Epigenet Res Grp, Islamabad, Pakistan.	mkayani@comsats.edu.pk	; Kayani, Mahmood/I-7760-2015	Mahjabeen, Ishrat/0000-0002-6392-672X; Kayani, Mahmood/0000-0001-9886-180X				Bacolod MD, 2010, J MOL DIAGN, V12, P552, DOI 10.2353/jmoldx.2010.100098; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Desouki MM, 2014, HUM PATHOL, V45, P1071, DOI 10.1016/j.humpath.2014.01.004; Ding XQ, 2012, MOL ONCOL, V6, P73, DOI 10.1016/j.molonc.2011.11.002; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Li HQ, 2013, INT J ONCOL, V43, P1420, DOI 10.3892/ijo.2013.2103; Louis SNS, 2010, PROSTATE, V70, P1563, DOI 10.1002/pros.21192; Mahjabeen I, 2014, TUMOR BIOL, V35, P5971, DOI 10.1007/s13277-014-1792-5; Mahjabeen I, 2013, MUTAGENESIS, V28, P213, DOI 10.1093/mutage/ges074; Mahjabeen I, 2012, MED ONCOL, V29, P3620, DOI 10.1007/s12032-012-0300-2; Mambo E, 2005, ONCOGENE, V24, P4496, DOI 10.1038/sj.onc.1208669; Paz-Elizur T, 2003, J NATL CANCER I, V95, P1312, DOI 10.1093/jnci/djg033; Petruzzelli GJ, 2000, ORL J OTO-RHINO-LARY, V62, P178, DOI 10.1159/000027744; Rodrigues-Ferreira S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007239; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sebastian C, 2010, CELL, V143, P667, DOI 10.1016/j.cell.2010.11.009; Seibold S, 2003, FASEB J, V17, P1180, DOI 10.1096/fj.02-0934fje; Wang ZX, 2015, CANCER INFORM, V14, P1, DOI [10.4137/CIn.s13976, 10.4137/CIN.S13976]; Xiao K, 2013, ONCOL REP, V30, P1323, DOI 10.3892/or.2013.2604; Yu Jinsheng, 2009, BMC Res Notes, V2, P109, DOI 10.1186/1756-0500-2-109; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051703; Zhao TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1209-x; Zhu YM, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-15; Zuern C, 2010, ONCOL REP, V23, P183, DOI 10.3892/or_00000621	28	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146948	10.1371/journal.pone.0146948	http://dx.doi.org/10.1371/journal.pone.0146948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785117	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400083
J	Wei, C; Luo, SL; Ma, XC; Ren, H; Zhang, J; Pan, LM				Wei, Chao; Luo, Senlin; Ma, Xincheng; Ren, Hao; Zhang, Ji; Pan, Limin			Locally Embedding Autoencoders: A Semi-Supervised Manifold Learning Approach of Document Representation	PLOS ONE			English	Article							NETWORK	Topic models and neural networks can discover meaningful low-dimensional latent representations of text corpora; as such, they have become a key technology of document representation. However, such models presume all documents are non-discriminatory, resulting in latent representation dependent upon all other documents and an inability to provide discriminative document representation. To address this problem, we propose a semi-supervised manifold-inspired autoencoder to extract meaningful latent representations of documents, taking the local perspective that the latent representation of nearby documents should be correlative. We first determine the discriminative neighbors set with Euclidean distance in observation spaces. Then, the autoencoder is trained by joint minimization of the Bernoulli cross-entropy error between input and output and the sum of the square error between neighbors of input and output. The results of two widely used corpora show that our method yields at least a 15% improvement in document clustering and a nearly 7% improvement in classification tasks compared to comparative methods. The evidence demonstrates that our method can readily capture more discriminative latent representation of new documents. Moreover, some meaningful combinations of words can be efficiently discovered by activating features that promote the comprehensibility of latent representation.	[Wei, Chao; Luo, Senlin; Ma, Xincheng; Ren, Hao; Zhang, Ji; Pan, Limin] Beijing Inst Technol, Beijing 10081, Peoples R China	Beijing Institute of Technology	Pan, LM (corresponding author), Beijing Inst Technol, Beijing 10081, Peoples R China.	panlimin.bit@gmail.com			National Information Security 242 Project of China [2005C48]; Technology Innovation Program of Beijing Institute of Technology [2011CX01015]	National Information Security 242 Project of China; Technology Innovation Program of Beijing Institute of Technology	This work was supported in part by the National Information Security 242 Project of China under Grant No. 2005C48, and the Technology Innovation Program of Beijing Institute of Technology under Grant No. 2011CX01015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin M, 2002, ADV NEUR IN, V14, P585; Bengio Y., 2006, ADV NEURAL INFORM PR, V19; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bishop C.M., 2006, PATTERN RECOGN, V4, P12; Blei D. M., 2003, J MACHINE LEARNING R; Blei David M., 2007, P ANN C NEUR INF PRO, P121; Boyd-Graber J.L., 2009, ADV NEURAL INFORM PR, P185; Cai D., 2009, P 26 ANN INT C MACHI, P105; Cai D., 2008, P 17 ACM C INFORM KN, P911; Cao Z, 2015, NOVEL NEURAL TOPIC M; Chen XB, 2014, KNOWL-BASED SYST, V70, P154, DOI 10.1016/j.knosys.2014.06.020; Cheng XQ, 2014, IEEE T KNOWL DATA EN, V26, P2928, DOI 10.1109/TKDE.2014.2313872; Cui L, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P133; De Smet W, 2013, DATA MIN KNOWL DISC, V26, P533, DOI 10.1007/s10618-012-0270-1; Fan MY, 2014, IEEE T IMAGE PROCESS, V23, P2133, DOI 10.1109/TIP.2014.2312643; Hinton G.E., 2009, ADV NEURAL INFORM PR, P1607; Hofmann T., 1999, P 1999 INT C RES DEV; Huh S, 2012, ACM T KNOWL DISCOV D, V5, DOI 10.1145/2086737.2086740; Kausar N, 2011, COMM COM INF SC, V253, P24; Larochelle H., 2012, ADV NEURAL INFORM PR, P2708; Laszlo Lovasz MD, 2009, AM MATH SOC, P367; Luo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082119; Mountassir A, 2014, LECT NOTES ARTIF INT, V8556, P442, DOI 10.1007/978-3-319-08979-9_34; NARAYANAN H., 2010, ADV NEURAL INFORM PR, V2, P1786; Phan X., 2008, P 17 INT C WORLD WID, P91, DOI 10.1145/1367497.1367510; Ranzato M., 2008, P 25 INT C MACHINE L, P792, DOI DOI 10.1145/1390156.1390256; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Shan HH, 2011, DATA MIN KNOWL DISC, V23, P1, DOI 10.1007/s10618-010-0198-2; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tu Loring W., 2011, INTRO MANIFOLDS, P47; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Wang W, 2014, IEEE COMPUT SOC CONF, P496, DOI 10.1109/CVPRW.2014.79; Wu H, 2012, PATTERN RECOGN, V45, P617, DOI 10.1016/j.patcog.2011.04.029; Wu S, 2013, MAYOCLINICNLP CORE S, P148; Zeng J, 2013, IEEE T PATTERN ANAL, V35, P1121, DOI 10.1109/TPAMI.2012.185; Zhang WN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0071511, 10.1371/journal.pone.0107941]; Zhu J, 2012, J MACH LEARN RES, V13, P2237	41	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146672	10.1371/journal.pone.0146672	http://dx.doi.org/10.1371/journal.pone.0146672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784692	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400057
J	Yang, L; Yan, J; Tang, XH; Xu, XL; Yu, W; Wu, HB				Yang, Li; Yan, Jing; Tang, Xinhua; Xu, Xiaoling; Yu, Wei; Wu, Haibin			Prevalence, Awareness, Treatment, Control and Risk Factors Associated with Hypertension among Adults in Southern China, 2013	PLOS ONE			English	Article							GLOBAL BURDEN; MANAGEMENT; POPULATION; COMMUNITY	To investigate the prevalence, awareness, treatment, control of hypertension and their associated factors in southern China. A cross-sectional survey was conducted in 5 cities of urban areas and 5 counties of rural areas in Southern China in 2013, a stratified multistage random sampling method was used to select a representative sample. Recruitment included a total of 19254 participants aged 15 or older. Socio-demographic profiles, examinations were administrated on each subject. Multilevel logistic regression models were used to identify the risk factors of hypertension, awareness, treatment, and control. Overall, the prevalence of hypertension and pre-hypertension are 24.59% and 32.11%, respectively in southern China. Among all the hypertensive patients, 67.43% were aware of their condition, 55.76% took anti-hypertension medication recent two weeks, and 30.79% had their blood pressure controlled. Compared with male, female hypertensive patients had higher rates of hypertension awareness, treatment and control. Age, gender, marital status, living areas, education, BMI, waist circumference, visceral adipose index (VAI), high body fat percentage (BFP) and family hypertension history correlated with the prevalence of hypertension. SBP/DBP increased with VAI and BFP increasing. There is an increasing prevalence of hypertension and high pre-hypertension in the general population in southern China, but levels of awareness, treatment, and control remain relatively low, especially for young and middle-aged population. Innovative strategies including of adopting appropriate anti-hypertensive medication therapy and healthy lifestyles should be taken.	[Yang, Li; Yan, Jing; Tang, Xinhua; Xu, Xiaoling; Yu, Wei] Zhejiang Hosp, Zhejiang Prov Ctr Cardiovasc Dis Control & Preven, Hangzhou, Zhejiang, Peoples R China; [Wu, Haibin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Yan, J; Tang, XH (corresponding author), Zhejiang Hosp, Zhejiang Prov Ctr Cardiovasc Dis Control & Preven, Hangzhou, Zhejiang, Peoples R China.	zjicu@vip.163.com; phoebe84331@163.com			National Key RAMP;D Program in the Twelfth Five-year Plan from the Chinese Ministry of Science and Technology [2011BAI11B01]	National Key RAMP;D Program in the Twelfth Five-year Plan from the Chinese Ministry of Science and Technology	This study was supported by the National Key R&D Program in the Twelfth Five-year Plan (No. 2011BAI11B01) from the Chinese Ministry of Science and Technology.r Sources of funding, this research was supported by the National Key R&D Program in the Twelfth Five-year Plan (No. 2011BAI11B01) from the Chinese Ministry of Science and Technology.	Amato MC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/730827; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Bharucha NE, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-1; Bowman TS, 2007, J AM COLL CARDIOL, V50, P2085, DOI 10.1016/j.jacc.2007.08.017; Cai L, 2012, CLIN EXP HYPERTENS, V34, P45, DOI 10.3109/10641963.2011.618206; Committee for Revision of Chinese Guidelines for Prevention and Treatment of Patients with Hypertension, 2005, CHIN J HYPERTENS, V134, P2; Diederichs C, 2014, J HYPERTENS, V32, P1405, DOI 10.1097/HJH.0000000000000211; Do HTP, 2015, AM J HYPERTENS, V28, P89, DOI 10.1093/ajh/hpu092; Fodor JG, 2008, CAN J CARDIOL, V24, P503, DOI 10.1016/S0828-282X(08)70626-3; Grucza RA, 2010, ARCH GEN PSYCHIAT, V67, P1301, DOI 10.1001/archgenpsychiatry.2010.155; Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; Hazarika N C, 2003, J Assoc Physicians India, V51, P567; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Huang YL, 2014, AM HEART J, V167, P160, DOI 10.1016/j.ahj.2013.10.023; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Khanam MA, 2015, BMC PUBLIC HEALTH, V15, DOI [10.1186/s12889-015-1520-0, 10.1186/s12889-015-2471-1]; LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819; Lawes CM, 2000, J HYPERTENS, V2006, P423; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li Y., 2014, BIOMED RES IN, V2014, P14, DOI DOI 10.1186/1471-2458-14-903; Liang Ke, 2014, AM J HYPERTENS, V5, P1; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malekzadeh MM, 2013, J HYPERTENS, V31, P1364, DOI 10.1097/HJH.0b013e3283613053; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Meng XJ, 2011, J HYPERTENS, V29, P1303, DOI 10.1097/HJH.0b013e328347f79e; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Rahman MM, 2015, J HYPERTENS, V33, P465, DOI 10.1097/HJH.0000000000000421; Vigna-Taglianti F, 2009, J EPIDEMIOL COMMUN H, V63, P722, DOI 10.1136/jech.2008.081513; WanFen Yip, 2013, J HYPERTENSION, V31, P000; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062469; Wang ZW, 2014, INT J CARDIOL, V174, P721, DOI 10.1016/j.ijcard.2014.03.117; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Wyatt SB, 2008, HYPERTENSION, V51, P650, DOI 10.1161/HYPERTENSIONAHA.107.100081	35	46	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146181	10.1371/journal.pone.0146181	http://dx.doi.org/10.1371/journal.pone.0146181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784948	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400027
J	Boughorbel, S; Al-Ali, R; Elkum, N				Boughorbel, Sabri; Al-Ali, Rashid; Elkum, Naser			Model Comparison for Breast Cancer Prognosis Based on Clinical Data	PLOS ONE			English	Article							STATISTICS	We compared the performance of several prediction techniques for breast cancer prognosis, based on AU-ROC performance (Area Under ROC) for different prognosis periods. The analyzed dataset contained 1,981 patients and from an initial 25 variables, the 11 most common clinical predictors were retained. We compared eight models from a wide spectrum of predictive models, namely; Generalized Linear Model (GLM), GLM-Net, Partial Least Square (PLS), Support Vector Machines (SVM), Random Forests (RF), Neural Networks, k-Nearest Neighbors (k-NN) and Boosted Trees. In order to compare these models, paired t-test was applied on the model performance differences obtained from data resampling. Random Forests, Boosted Trees, Partial Least Square and GLMNet have superior overall performance, however they are only slightly higher than the other models. The comparative analysis also allowed us to define a relative variable importance as the average of variable importance from the different models. Two sets of variables are identified from this analysis. The first includes number of positive lymph nodes, tumor size, cancer grade and estrogen receptor, all has an important influence on model predictability. The second set incudes variables related to histological parameters and treatment types. The short term vs long term contribution of the clinical variables are also analyzed from the comparative models. From the various cancer treatment plans, the combination of Chemo/Radio therapy leads to the largest impact on cancer prognosis.	[Boughorbel, Sabri; Al-Ali, Rashid] Sidra Med & Res Ctr, Biomed Informat Div, Doha, Qatar; [Elkum, Naser] Sidra Med & Res Ctr, Div Clin Epidemiol, Doha, Qatar	Sidra Medical & Research Center; Sidra Medical & Research Center	Boughorbel, S (corresponding author), Sidra Med & Res Ctr, Biomed Informat Div, Doha, Qatar.	sboughorbel@sidra.org	Elkum, Naser/AAU-5555-2020	Elkum, Naser/0000-0002-0457-0444; Boughorbel, Sabri/0000-0003-2734-3356				Ahmed A, 2012, BREAST CANC METASTAS, P1; Alteri R., 2013, BREAST CANC FACTS FI; Bishop C.M., 1995, NEURAL NETWORKS PATT; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bridle John S, 1990, NEUROCOMPUTING, P227, DOI DOI 10.1007/978-3-642-76153-9_28; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Burke H. B., 1995, Advances in Neural Information Processing Systems 7, P1063; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Delen D, 2005, ARTIF INTELL MED, V34, P113, DOI 10.1016/j.artmed.2004.07.002; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Eloranta S, 2013, CANCER CAUSE CONTROL, V24, P505, DOI 10.1007/s10552-012-0141-5; Endo A., 2008, INT J BIOMED SOFT CO, V13, P11, DOI DOI 10.24466/IJBSCHS.13.2_11; Eugster Manuel J.A., 2008, EXPLORATORY INFERENT; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Kuhn M., 2013, PACKAGEAPPLIEDPREDIC, DOI DOI 10.1007/978-1-4614-6849-3; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Maglogiannis I, 2009, APPL INTELL, V30, P24, DOI 10.1007/s10489-007-0073-z; Max K., 2015, CARET MODEL TRAINING; Max K., 2015, VARIABLE IMPORTANCE; QUESENBERRY CP, 1989, AM J PUBLIC HEALTH, V79, P1643, DOI 10.2105/AJPH.79.12.1643; WOLD S, 1983, LECT NOTES MATH, V973, P286; Wolpert DH, 1996, NEURAL COMPUT, V8, P1341, DOI 10.1162/neco.1996.8.7.1341	25	25	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146413	10.1371/journal.pone.0146413	http://dx.doi.org/10.1371/journal.pone.0146413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771838	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300017
J	Ohira, S; Inoue, T; Iwao, K; Takahashi, E; Tanihara, H				Ohira, Saori; Inoue, Toshihiro; Iwao, Keiichiro; Takahashi, Eri; Tanihara, Hidenobu			Factors Influencing Aqueous Proinflammatory Cytokines and Growth Factors in Uveitic Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; MITOMYCIN-C; PSEUDOPHAKIC EYES; FACTOR-BETA; HUMOR; TRABECULECTOMY; PHACOEMULSIFICATION; CHEMOKINES; PROFILES; PHACOTRABECULECTOMY	Purpose To analyze the effects of factors on aqueous humor proinflammatory cytokine and growth factor levels in patients with uveitic glaucoma (UG). Methods In this cross-sectional study, we enrolled 143 participants: 1) UG patients (n = 39); 2) primary open-angle glaucoma (POAG) patients (n = 36); and 3) cataract surgery patients, as a comparative group (n = 68). Aqueous humor samples were obtained at the start of surgery. Aqueous cytokine levels were determined using a multiplex immunoassay (xMAP and the Human Cytokine/Chemokine Panel I). Results In UG cases, mean interleukin (IL)-6, IL-8, monocyte chemotactic protein (MCP)-1, tumor necrosis factor (TNF)-alpha, platelet-derived growth factor (PDGF)-AA, PDGF-AB/BB, and VEGF levels were 171.1, 214.5, 2791.7, 3.5, 23.9, 5.4, and 168.9 pg/mL, respectively, and were higher than those in cataract (non-glaucomatous) cases except PDGF. Levels of IL-6, MCP-1, and VEGF were higher in UG cases than in POAG cases. UG cases with a history of phacoemulsification displayed significantly higher levels of IL-6 (P = 0.0164), IL-8 (P = 0.0003), MCP-1 (P = 0.0465), and PDGF-AB/BB (P = 0.0062) compared to the phakic cases. The presence of cells in the anterior chamber was related to higher levels of IL-8 (P = 0.0002), TNF-alpha (P = 0.0037), and PDGF-AB/BB (P = 0.0009). The level of PDGF-AB/BB was higher in infectious uveitis than in non-infectious uveitis (P = 0.0211). The level of transforming growth factor (TGF)-beta 2 was negatively correlated with the levels of MCP-1 (adjusted R-2 = 0.28, t = -2.45, P = 0.031) and TNF-alpha (adjusted R-2 = 0.27, t = -2.43, P = 0.032). Conclusion A history of phacoemulsification, the presence of cells in the anterior chamber, and infectious uveitis were related to aqueous proinflammatory cytokine levels in patients with UG. TGF-beta 2 might be an anti-inflammatory factor in aqueous humor of UG patients.	[Ohira, Saori; Inoue, Toshihiro; Iwao, Keiichiro; Takahashi, Eri; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan	Kumamoto University	Inoue, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	noel@da2.so-net.ne.jp		Iwao, Keiichiro/0000-0002-4102-9374; Inoue, Toshihiro/0000-0003-3769-7609	JSPS KAKENHI [26293375, 15K15636, 26462664]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 26293375, 15K15636, and 26462664. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2012, CYTOKINE, V59, P377, DOI 10.1016/j.cyto.2012.04.030; Abu El-Asrar AM, 2011, IMMUNOBIOLOGY, V216, P1004, DOI 10.1016/j.imbio.2011.03.007; Abu El-Asrar AM, 2004, AM J OPHTHALMOL, V138, P401, DOI 10.1016/j.ajo.2004.04.046; Awai-Kasaoka N, 2012, J CATARACT REFR SURG, V38, P419, DOI 10.1016/j.jcrs.2011.09.035; BROADWAY DC, 1993, EYE, V7, P495, DOI 10.1038/eye.1993.108; Curnow SJ, 2006, CURR OPIN OPHTHALMOL, V17, P532, DOI 10.1097/ICU.0b013e32801094b5; Curnow SJ, 2005, INVEST OPHTH VIS SCI, V46, P4251, DOI 10.1167/iovs.05-0444; DEBOER JH, 1994, INVEST OPHTH VIS SCI, V35, P3702; Howe LJ, 1996, CURR EYE RES, V15, P1149, DOI 10.3109/02713689608995149; Inoue T, 2014, CLIN EXP OPHTHALMOL, V42, P334, DOI 10.1111/ceo.12204; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Iwao K, 2014, J GLAUCOMA, V23, P88, DOI 10.1097/IJG.0b013e3182685167; Kaburaki T, 2009, EYE, V23, P1509, DOI [10.1038/eye.2009.117, 10.1038/eye.2009.117-cme]; Kawai M, 2012, INVEST OPHTH VIS SCI, V53, P7951, DOI 10.1167/iovs.12-10231; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Kojima S, 2015, JAMA OPHTHALMOL, V133, P148, DOI 10.1001/jamaophthalmol.2014.4489; Kuiper JJW, 2011, AM J OPHTHALMOL, V152, P177, DOI 10.1016/j.ajo.2011.01.031; Landers J, 2012, OPHTHALMOLOGY, V119, P694, DOI 10.1016/j.ophtha.2011.09.043; Min Seong Hee, 2006, Korean J Ophthalmol, V20, P162; NOROSE K, 1994, INVEST OPHTH VIS SCI, V35, P33; Ogata-Iwao M, 2013, ACTA OPHTHALMOL, V91, pe500, DOI 10.1111/aos.12133; Ohira S, 2015, INVEST OPHTH VIS SCI, V56, P3541, DOI 10.1167/iovs.14-15918; Ooi KGJ, 2006, INVEST OPHTH VIS SCI, V47, P272, DOI 10.1167/iovs.05-0790; Park UC, 2006, AM J OPHTHALMOL, V142, P1005, DOI 10.1016/j.ajo.2006.07.018; Siddique SS, 2013, SURV OPHTHALMOL, V58, P1, DOI 10.1016/j.survophthal.2012.04.006; Sijssens KM, 2007, EXP EYE RES, V85, P443, DOI 10.1016/j.exer.2007.06.011; Takase H, 2006, INVEST OPHTH VIS SCI, V47, P1557, DOI 10.1167/iovs.05-0836; Takihara Y, 2014, JAMA OPHTHALMOL, V132, P69, DOI 10.1001/jamaophthalmol.2013.5605; Takihara Y, 2011, ARCH OPHTHALMOL-CHIC, V129, P152, DOI 10.1001/archophthalmol.2010.348; Taylor AW, 2003, OCUL IMMUNOL INFLAMM, V11, P231, DOI 10.1076/ocii.11.4.231.18269; Valentincic NV, 2011, MOL VIS, V17, P2003; van Kooij B, 2006, AM J OPHTHALMOL, V142, P192, DOI 10.1016/j.ajo.2006.02.052; Verma MJ, 1997, CURR EYE RES, V16, P1202, DOI 10.1076/ceyr.16.12.1202.5034	34	42	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147080	10.1371/journal.pone.0147080	http://dx.doi.org/10.1371/journal.pone.0147080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771310	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300061
J	Tarnow, P; Hutzler, C; Grabiger, S; Schon, K; Tralau, T; Luch, A				Tarnow, Patrick; Hutzler, Christoph; Grabiger, Stefan; Schoen, Karsten; Tralau, Tewes; Luch, Andreas			Estrogenic Activity of Mineral Oil Aromatic Hydrocarbons Used in Printing Inks	PLOS ONE			English	Article							BREAST-CANCER-CELLS; GENE-EXPRESSION; RECEPTOR-ALPHA; RECYCLED PAPERBOARD; RESPONSIVE GENES; MCF-7 CELLS; CATHEPSIN-D; ACTIVATION; REPORTER; TOXICITY	The majority of printing inks are based on mineral oils (MOs) which contain complex mixtures of saturated and aromatic hydrocarbons. Consumer exposure to these oils occurs either through direct skin contacts or, more frequently, as a result of MO migration into the contents of food packaging that was made from recycled newspaper. Despite this ubiquitous and frequent exposure little is known about the potential toxicological effects, particularly with regard to the aromatic MO fractions. From a toxicological point of view the huge amount of alkylated and unsubstituted compounds therein is reason for concern as they can harbor genotoxicants as well as potential endocrine disruptors. The aim of this study was to assess both the genotoxic and estrogenic potential of MOs used in printing inks. Mineral oils with various aromatic hydrocarbon contents were tested using a battery of in vitro assays selected to address various endpoints such as estrogen-dependent cell proliferation, activation of estrogen receptor a or transcriptional induction of estrogenic target genes. In addition, the comet assay has been applied to test for genotoxicity. Out of 15 MOs tested, 10 were found to potentially act as xenoestrogens. For most of the oils the effects were clearly triggered by constituents of the aromatic hydrocarbon fraction. From 5 oils tested in the comet assay, 2 showed slight genotoxicity. Altogether it appears that MOs used in printing inks are potential endocrine disruptors and should thus be assessed carefully to what extent they might contribute to the total estrogenic burden in humans.	[Tarnow, Patrick; Hutzler, Christoph; Grabiger, Stefan; Schoen, Karsten; Tralau, Tewes; Luch, Andreas] German Fed Inst Risk Assessment BfR, Dept Chem & Prod Safety, Max Dohrn Str 8-10, D-10598 Berlin, Germany	Federal Institute for Risk Assessment	Tarnow, P (corresponding author), German Fed Inst Risk Assessment BfR, Dept Chem & Prod Safety, Max Dohrn Str 8-10, D-10598 Berlin, Germany.	Patrick.Tarnow@bfr.bund.de		Hutzler, Christoph/0000-0003-0299-8559; Tralau, Tewes/0000-0002-7857-4237	German Federal Institute for Risk Assessment [SFP1322-526]	German Federal Institute for Risk Assessment	This work was supported by an intramural grant at the German Federal Institute for Risk Assessment (SFP1322-526).	Ahmed S, 2009, TOXICOL SCI, V111, P254, DOI 10.1093/toxsci/kfp144; Beck S, 1997, INT J ONCOL, V10, P1051; Bergman A., 2012, STATE SCI ENDOCRINE; Biedermann M, 2013, FOOD ADDIT CONTAM A, V30, P885, DOI 10.1080/19440049.2013.786189; Biedermann M, 2012, J CHROMATOGR A, V1255, P56, DOI 10.1016/j.chroma.2012.05.095; Biedermann M, 2011, PACKAG TECHNOL SCI, V24, P61, DOI 10.1002/pts.914; Biedermann M, 2009, J AGR FOOD CHEM, V57, P8711, DOI 10.1021/jf901375e; Bohonowych JES, 2008, TOXICOL SCI, V102, P278, DOI 10.1093/toxsci/kfn011; Boney-Montoya J, 2010, MOL ENDOCRINOL, V24, P346, DOI 10.1210/me.2009-0429; Bretschneider N, 2008, MOL ONCOL, V2, P182, DOI 10.1016/j.molonc.2008.05.004; Brinkmann J, 2013, TOXICOL SCI, V131, P351, DOI 10.1093/toxsci/kfs316; CAVAILLES V, 1989, MOL ENDOCRINOL, V3, P552, DOI 10.1210/mend-3-3-552; Charles GD, 2000, TOXICOL SCI, V55, P320, DOI 10.1093/toxsci/55.2.320; COOMBS MM, 1976, CANCER RES, V36, P4525; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; EFSA, 2012, EFSA J, V10; EuPIA, 2013, CEPE ANN REP; Evans RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043606; Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y; Genter MB, 2006, BIOCHEM BIOPH RES CO, V348, P120, DOI 10.1016/j.bbrc.2006.07.025; Gozgit JM, 2004, TOXICOL APPL PHARM, V196, P58, DOI 10.1016/j.taap.2003.12.003; Grob K., 1991, Journal of High Resolution Chromatography and Chromatography Communications, V14, P33, DOI 10.1002/jhrc.1240140109; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Klinge CM, 1999, MOL CELL ENDOCRINOL, V157, P105, DOI 10.1016/S0303-7207(99)00165-3; Lorenzini R, 2013, FOOD ADDIT CONTAM A, V30, P760, DOI 10.1080/19440049.2013.766765; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; RICE JE, 1987, J TOXICOL ENV HEALTH, V21, P525, DOI 10.1080/15287398709531040; Safe S, 2003, CHEM RES TOXICOL, V16, P807, DOI 10.1021/tx034036r; Salaberria I, 2014, J TOXICOL ENV HEAL A, V77, P506, DOI 10.1080/15287394.2014.886983; Schreiner CA, 2003, J TOXICOL ENV HEAL B, V6, P161, DOI 10.1080/10937400306472; Shanle EK, 2011, CHEM RES TOXICOL, V24, P6, DOI 10.1021/tx100231n; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Sutter CH, 2009, P NATL ACAD SCI USA, V106, P4266, DOI 10.1073/pnas.0900874106; Tarnow P, 2013, TOXICOL IN VITRO, V27, P1467, DOI 10.1016/j.tiv.2013.03.003; Thorne N, 2012, CHEM BIOL, V19, P1060, DOI 10.1016/j.chembiol.2012.07.015; Vinggaard AM, 2000, CHEM RES TOXICOL, V13, P1214, DOI 10.1021/tx000146b; Vollmer A, 2011, EUR FOOD RES TECHNOL, V232, P175, DOI 10.1007/s00217-010-1376-6; Vondracek J, 2002, TOXICOL SCI, V70, P193, DOI 10.1093/toxsci/70.2.193; Vrabie CM, 2011, ENVIRON TOXICOL CHEM, V30, P973, DOI 10.1002/etc.463; Wormke M, 2003, MOL CELL BIOL, V23, P1843, DOI 10.1128/MCB.23.6.1843-1855.2003; ZACHAREWSKI TR, 1994, CANCER RES, V54, P2707	47	22	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147239	10.1371/journal.pone.0147239	http://dx.doi.org/10.1371/journal.pone.0147239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771904	Green Submitted, gold, Green Published			2022-12-26	WOS:000368628300073
J	El Asmar, Z; Terrand, J; Jenty, M; Host, L; Mlih, M; Zerr, A; Justiniano, H; Matz, RL; Boudier, C; Scholler, E; Garnier, JM; Bertaccini, D; Thierse, D; Schaeffer, C; Van Dorsselaer, A; Herz, J; Bruban, V; Boucher, P				El Asmar, Zeina; Terrand, Jerome; Jenty, Marion; Host, Lionel; Mlih, Mohamed; Zerr, Aurelie; Justiniano, Helene; Matz, Rachel L.; Boudier, Christian; Scholler, Estelle; Garnier, Jean-Marie; Bertaccini, Diego; Thierse, Daniele; Schaeffer, Christine; Van Dorsselaer, Alain; Herz, Joachim; Bruban, Veronique; Boucher, Philippe			Convergent Signaling Pathways Controlled by LRP1 (Receptor-related Protein 1) Cytoplasmic and Extracellular Domains Limit Cellular Cholesterol Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; atherosclerosis; cholesterol regulation; transgenic mice; Wnt pathway; lipoprotein receptor-related protein 1 (LRP1)	BINDING CASSETTE TRANSPORTER; FATTY-ACID SYNTHESIS; VASCULAR WALL; TYROSINE PHOSPHORYLATION; ADIPOSE-TISSUE; TGF-BETA; ABCG1; EFFLUX; EXPRESSION; MEMBRANE	The low density lipoprotein receptor-related protein 1 (LRP1) is a ubiquitously expressed cell surface receptor that protects from intracellular cholesterol accumulation. However, the underlying mechanisms are unknown. Here we show that the extracellular () chain of LRP1 mediates TGF-induced enhancement of Wnt5a, which limits intracellular cholesterol accumulation by inhibiting cholesterol biosynthesis and by promoting cholesterol export. Moreover, we demonstrate that the cytoplasmic () chain of LRP1 suffices to limit cholesterol accumulation in LRP1(-/-) cells. Through binding of Erk2 to the second of its carboxyl-terminal NPXY motifs, LRP1 -chain positively regulates the expression of ATP binding cassette transporter A1 (ABCA1) and of neutral cholesterol ester hydrolase (NCEH1). These results highlight the unexpected functions of LRP1 and the canonical Wnt5a pathway and new therapeutic potential in cholesterol-associated disorders including cardiovascular diseases.	[El Asmar, Zeina; Terrand, Jerome; Jenty, Marion; Host, Lionel; Mlih, Mohamed; Zerr, Aurelie; Justiniano, Helene; Matz, Rachel L.; Boudier, Christian; Scholler, Estelle; Bruban, Veronique; Boucher, Philippe] Univ Strasbourg, UMR 7213, CNRS, 74 Route Rhin,CS 60024, F-67401 Illkirch Graffenstaden, France; [Garnier, Jean-Marie] Univ Strasbourg, CNRS UMR 7104, INSERM 964, IGBMC, F-67401 Illkirch Graffenstaden, France; [Bertaccini, Diego; Thierse, Daniele; Schaeffer, Christine; Van Dorsselaer, Alain] Univ Strasbourg, UMR 7178, CNRS, F-67087 Strasbourg, France; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bruban, V; Boucher, P (corresponding author), Univ Strasbourg, UMR 7213, CNRS, 74 Route Rhin,CS 60024, F-67401 Illkirch Graffenstaden, France.	veronique.bruban@unistra.fr; philippe.boucher@unistra.fr	Asmar, Zeina El/AAR-7053-2021; Mlih, Mohamed/O-4834-2019; Boudier, Christian/N-3841-2018	Mlih, Mohamed/0000-0003-3491-9616; Boudier, Christian/0000-0002-5534-6389; Terrand, jerome/0000-0002-8169-7713; MATZ, Rachel/0000-0001-5832-7063; Boucher, Philippe/0000-0002-3928-9812	Fondation de France; Fondation pour la Recherche Medicale (FRM); Agence Nationale de la Recherche [ANR-06-Physio-032-01, ANR-09-BLAN-0121-01]; National Institutes of Health [HL63762]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093382] Funding Source: NIH RePORTER	Fondation de France(Fondation de France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from Fondation de France, Fondation pour la Recherche Medicale (FRM), and the Agence Nationale de la Recherche (ANR-06-Physio-032-01 and ANR-09-BLAN-0121-01). This work was also supported by National Institutes of Health Grant HL63762 (to J. H.).	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Argmann CA, 2001, ARTERIOSCL THROM VAS, V21, P2011, DOI 10.1161/hq1201.099426; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Buchmann J, 2007, ENDOCRINOLOGY, V148, P1561, DOI 10.1210/en.2006-1244; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Ghosh S, 2003, J LIPID RES, V44, P1833, DOI 10.1194/jlr.M300162-JLR200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Hu YW, 2010, J ATHEROSCLER THROMB, V17, P493, DOI 10.5551/jat.3152; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; KOVANEN PT, 1975, J LIPID RES, V16, P211; KRAUSE BR, 1984, J LIPID RES, V25, P97; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lorkowski S, 2001, BIOCHEM BIOPH RES CO, V283, P821, DOI 10.1006/bbrc.2001.4863; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Malgor R, 2014, INFLAMM RES, V63, P277, DOI 10.1007/s00011-013-0697-x; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Oram JF, 2003, J BIOL CHEM, V278, P52379, DOI 10.1074/jbc.M310695200; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Phillips MC, 2014, J BIOL CHEM, V289, P24020, DOI 10.1074/jbc.R114.583658; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sekiya M, 2011, J ATHEROSCLER THROMB, V18, P359, DOI 10.5551/jat.7013; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Tarling EJ, 2012, BBA-MOL CELL BIOL L, V1821, P386, DOI 10.1016/j.bbalip.2011.07.011; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Tsaousi A, 2011, CURR OPIN LIPIDOL, V22, P350, DOI 10.1097/MOL.0b013e32834aa701; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Woldt E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2087; Xie Q, 2006, ARTERIOSCL THROM VAS, V26, pE143, DOI 10.1161/01.ATV.0000245790.47112.b2; Xu DQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9100; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006853; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	51	25	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5116	5127		10.1074/jbc.M116.714485	http://dx.doi.org/10.1074/jbc.M116.714485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26792864	hybrid, Green Published			2022-12-26	WOS:000371640600024
J	Davis, KC; Allen, J; Duke, J; Nonnemaker, J; Bradfield, B; Farrelly, MC; Shafer, P; Novak, S				Davis, Kevin C.; Allen, Jane; Duke, Jennifer; Nonnemaker, James; Bradfield, Brian; Farrelly, Matthew C.; Shafer, Paul; Novak, Scott			Correlates of Marijuana Drugged Driving and Openness to Driving While High: Evidence from Colorado and Washington	PLOS ONE			English	Article							CANNABIS	Aims A potential unintended consequence of legalizing recreational marijuana is increased marijuana-related driving impairment. Some states where recreational marijuana is legal have begun implementing interventions to mitigate driving under the influence (DUI) of marijuana, including media campaigns to increase knowledge about DUI laws. However, little is known about the associations between knowledge of DUI laws and marijuana DUI behavior. In this study, we provide new data from a survey of marijuana users in Colorado and Washington to examine associations between marijuana drugged driving and two potential behavioral precursors of marijuana DUI. We also explore other factors that may influence marijuana DUI. Methods Data are from an online survey of marijuana users in Colorado and Washington. Respondents who reported any marijuana use in the past 30 days (n = 865) served as the analytic sample. We examined prevalence of two behavioral outcomes: (1) any driving of a motor vehicle while high in the past year and (2) driving a motor vehicle within 1 hour of using marijuana 5 or more times in the past month. Additional outcomes measuring willingness to drive while high were also assessed. Logistic regressions were used to estimate each outcome as a function of two multi-item scales measuring knowledge of the legal consequences of driving high and perceptions that driving while high is not safe. Additional covariates for potential confounders were included in each model. Results Prevalence of past-year driving while under the influence of marijuana was 43.6% among respondents. The prevalence of driving within 1 hour of using marijuana at least 5 times in the past month was 23.9%. Increased perception that driving high is unsafe was associated with lower odds of past-year marijuana DUI (OR = 0.31, P < 0.01) and lower past-month odds of driving 5 or more times within 1 hour of using marijuana (OR = 0.26, P < 0.01). Increased knowledge of marijuana DUI laws was also associated with lower odds of each of these outcomes (OR = 0.63, P < 0.01, OR = 0.69, P = 0.02, respectively). Post-estimation Wald tests confirmed the negative associations with marijuana DUI were greater in magnitude for safety perceptions than knowledge of DUI laws. Increased perceptions that driving while high is unsafe was associated with significantly lower willingness to drive after using marijuana while increased knowledge of marijuana DUI laws was not associated with these outcomes. Conclusions Despite recent interventions targeting public awareness of the legal consequences of marijuana DUI, our results suggest that knowledge of these laws is a weaker predictor of DUI behavior than perceptions that driving high is unsafe. In addition, safety perceptions predict decreased openness to driving high while knowledge of DUI laws was not associated with openness. These findings suggest that interventions for reducing the incidence of marijuana DUI are likely to be more successful by targeting safety perceptions related to marijuana DUI rather than knowledge of DUI laws. We caution that because these data are limited to an online convenience sample, results may not be generalizable beyond our sample.	[Davis, Kevin C.; Allen, Jane; Duke, Jennifer; Nonnemaker, James; Bradfield, Brian; Farrelly, Matthew C.; Shafer, Paul; Novak, Scott] RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Davis, KC (corresponding author), RTI Int, Res Triangle Pk, NC USA.	kcdavis@rti.org		Appleyard Allen, Jane/0000-0001-7914-1866; Bradfield, Brian/0000-0002-0593-3518; nonnemaker, james/0000-0003-1044-7482; Shafer, Paul/0000-0003-0654-5821; Farrelly, Matthew/0000-0002-6035-1596; Davis, Kevin/0000-0001-8517-1295; duke, jennifer/0000-0002-4643-2429	RTI International	RTI International	This study was funded and conducted independently by RTI International.	Bandura A., 1986, SOCIAL FDN THOUGHT A; Berning A, 2015, J DRUG ADDICT ED ERA; Carmines E. G., 1979, RELIABILITY VALIDITY, DOI DOI 10.4135/9781412985642; Colorado Department of Public Health and Environment, 2014, INFL FACT HLTH LIV S; Compton R.P., 2015, J DRUG ADDICTION ED, V11, P29; Couper FJ, 2014, J ANAL TOXICOL, V38, P569, DOI 10.1093/jat/bku090; Danton K., 2003, HEALTH EDUC J, V62, P50, DOI [10.1177/001789690306200106, DOI 10.1177/001789690306200106, DOI 10.1177/001789690306200106GREENE2018]; Ferner M, 2015, OBAMA PREDICTS BRIGH; Fishbein M., 1975, BELIEF ATTITUDE INTE; Gurman S, 2014, COLORADO DEATHS STOK; Hartman RL, 2013, CLIN CHEM, V59, P478, DOI 10.1373/clinchem.2012.194381; Hughes T., 2014, MARIJUANA EDIBLES PA; Kelly E, 2004, DRUG ALCOHOL REV, V23, P319, DOI 10.1080/09595230412331289482; Monte AA, 2015, JAMA-J AM MED ASSOC, V313, P241, DOI 10.1001/jama.2014.17057; MOSKOWITZ H, 1985, ACCIDENT ANAL PREV, V17, P323, DOI 10.1016/0001-4575(85)90034-X; OHanlon JF, 1993, 808078 DOT HS; Salomonsen-Sautel S, 2014, DRUG ALCOHOL DEPEN, V140, P137, DOI 10.1016/j.drugalcdep.2014.04.008; Sewell RA, 2009, AM J ADDICTION, V18, P185, DOI 10.1080/10550490902786934; Terry P, 2005, ADDICT BEHAV, V30, P619, DOI 10.1016/j.addbeh.2004.08.007	19	36	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146853	10.1371/journal.pone.0146853	http://dx.doi.org/10.1371/journal.pone.0146853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26800209	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300042
J	Kersten, B; Rampant, PF; Mader, M; Le Paslier, MC; Bounon, R; Berard, A; Vettori, C; Schroeder, H; Leple, JC; Fladung, M				Kersten, Birgit; Rampant, Patricia Faivre; Mader, Malte; Le Paslier, Marie-Christine; Bounon, Remi; Berard, Aurelie; Vettori, Cristina; Schroeder, Hilke; Leple, Jean-Charles; Fladung, Matthias			Genome Sequences of Populus tremula Chloroplast and Mitochondrion: Implications for Holistic Poplar Breeding	PLOS ONE			English	Article							ORGANELLAR GENOMES; PLASTID GENOMES; SNP MARKERS; GENES; DNA; EXPRESSION; SUBSTITUTION; ANNOTATION; PROTEINS; NUCLEUS	Complete Populus genome sequences are available for the nucleus (P. trichocarpa; section Tacamahaca) and for chloroplasts (seven species), but not for mitochondria. Here, we provide the complete genome sequences of the chloroplast and the mitochondrion for the clones P. tremula W52 and P. tremula x P. alba 717-1B4 (section Populus). The organization of the chloroplast genomes of both Populus clones is described. A phylogenetic tree constructed from all available complete chloroplast DNA sequences of Populus was not congruent with the assignment of the related species to different Populus sections. In total, 3,024 variable nucleotide positions were identified among all compared Populus chloroplast DNA sequences. The 5-prime part of the LSC from trnH to atpA showed the highest frequency of variations. The variable positions included 163 positions with SNPs allowing for differentiating the two clones with P. tremula chloroplast genomes (W52, 717-1B4) from the other seven Populus individuals. These potential P. tremula-specific SNPs were displayed as a whole-plastome barcode on the P. tremula W52 chloroplast DNA sequence. Three of these SNPs and one InDel in the trnH-psbA linker were successfully validated by Sanger sequencing in an extended set of Populus individuals. The complete mitochondrial genome sequence of P. tremula is the first in the family of Salicaceae. The mitochondrial genomes of the two clones are 783,442 bp (W52) and 783,513 bp (717-1B4) in size, structurally very similar and organized as single circles. DNA sequence regions with high similarity to the W52 chloroplast sequence account for about 2% of the W52 mitochondrial genome. The mean SNP frequency was found to be nearly six fold higher in the chloroplast than in the mitochondrial genome when comparing 717-1B4 with W52. The availability of the genomic information of all three DNA-containing cell organelles will allow a holistic approach in poplar molecular breeding in the future.	[Kersten, Birgit; Schroeder, Hilke; Fladung, Matthias] Thunen Inst Forest Genet, Genome Res, Grosshansdorf, Germany; [Rampant, Patricia Faivre; Le Paslier, Marie-Christine; Bounon, Remi; Berard, Aurelie] INRA, URGV Plant Genom Res, Evry, France; [Mader, Malte; Schroeder, Hilke] Thunen Inst Forest Genet, Ecol Genet, Grosshansdorf, Germany; [Vettori, Cristina] CNR, Inst Biosci & Bioresources IBBR, Sesto Fiorentino, Italy; [Leple, Jean-Charles] INRA, Res Unit AGPF, Orleans, France	Johann Heinrich von Thunen Institute; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Johann Heinrich von Thunen Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); INRAE	Kersten, B (corresponding author), Thunen Inst Forest Genet, Genome Res, Grosshansdorf, Germany.	birgit.kersten@ti.bund.de	LEPLE, Jean charles/L-9604-2014; LEPLE, Jean-Charles/AAT-7414-2021; Vettori, Cristina/L-4651-2013	LEPLE, Jean charles/0000-0003-4125-0738; LEPLE, Jean-Charles/0000-0003-4125-0738; Vettori, Cristina/0000-0003-2475-773X; Kersten, Birgit/0000-0001-9900-9133; Fladung, Matthias/0000-0001-9301-8581; Mader, Malte/0000-0002-4808-2717	Federal Ministry of Education and Research [0315914A]; Agence Nationale pour la Recherche [ANR-2010-KBBE-007-01]; Thuenen Institute; INRA; CNR	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Thuenen Institute; INRA; CNR(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by the Federal Ministry of Education and Research (http://www.bmbf.de/en/) [Grant 0315914A] and by the Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr/en/) [ANR-2010-KBBE-007-01] in the scope of the project "Tree For Joules" within the program "Transnational Plant Alliance for Novel Technologies" (PLANT-KBBE). This work was further supported by the Thuenen Institute, INRA and CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, PLANT CELL, V14, P931, DOI 10.1105/tpc.010483; Adams KL, 2001, GENETICS, V158, P1289; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BARRETT JW, 1993, GENOME, V36, P87, DOI 10.1139/g93-012; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Chen Ke, 2011, Scientific Research and Essays, V6, P4048; Dereeper A, 2015, NUCLEIC ACIDS RES, V43, pW295, DOI 10.1093/nar/gkv351; Dickmann D, 1993, CULTURE POPLARS E N; Eckenwalder James E., 1996, P7; Feng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071710; GALLO LA, 1985, SILVAE GENET, V34, P208; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; Hanner R., 2009, DATA STANDARDS BARCO; Heinze B., 1998, Forest Genetics, V5, P31; Huang DI, 2014, NEW PHYTOL, V204, P693, DOI 10.1111/nph.12956; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Kersten B, 2015, TREES-STRUCT FUNCT, V29, P575, DOI 10.1007/s00468-014-1136-5; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Ky CL, 2000, THEOR APPL GENET, V101, P669, DOI 10.1007/s001220051529; Lemoine M, 1973, THESIS U NANCY FRANC; LEPLE JC, 1992, PLANT CELL REP, V11, P137, DOI 10.1007/BF00232166; Lexer C, 2005, MOL ECOL, V14, P1045, DOI 10.1111/j.1365-294X.2005.02469.x; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Licht LA, 2005, BIOMASS BIOENERG, V28, P203, DOI 10.1016/j.biombioe.2004.08.015; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Muse SV, 2000, PLANT MOL BIOL, V42, P25, DOI 10.1023/A:1006319803002; Neale DB, 2008, CURR OPIN PLANT BIOL, V11, P149, DOI 10.1016/j.pbi.2007.12.004; Okumura S, 2006, TRANSGENIC RES, V15, P637, DOI 10.1007/s11248-006-9009-3; PopGenIE, POP GEN INT EXPL V3; RAJORA OP, 1992, CURR GENET, V22, P141, DOI 10.1007/BF00351474; Richardson AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-29; Rivarola M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021743; Sabir JSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094158; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Schroeder H, 2012, PLANT BIOLOGY, V14, P374, DOI 10.1111/j.1438-8677.2011.00502.x; Schroeder H, 2010, SILVAE GENET, V59, P257, DOI 10.1515/sg-2010-0036; SCHROEDER H, 2011, BMC P, V5, P56, DOI DOI 10.1186/1753-6561-5-S7-P56; Schroeder H, 2015, IFOREST, V8, P544, DOI 10.3832/ifor1326-007; Shearman JR, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-45; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Skuza L, 2013, COMPREHENSIVE SURVEY OF INTERNATIONAL SOYBEAN RESEARCH - GENETICS, PHYSIOLOGY, AGRONOMY AND NITROGEN RELATIONSHIPS, P553, DOI 10.5772/52028; Slavov GT, 2010, PLANT GENET GENOMICS, V8, P15, DOI 10.1007/978-1-4419-1541-2_2; Smith DR, 2015, GENOME BIOL EVOL, V7, P1227, DOI 10.1093/gbe/evv069; Stanton BJ, 2010, GENETICS GENOMICS PO, P368; Stettler R.F., 1996, BIOL POPULUS ITS IMP; Stoppel R, 2013, PLANTA, V237, P441, DOI 10.1007/s00425-012-1782-z; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Walle IV, 2007, BIOMASS BIOENERG, V31, P276, DOI 10.1016/j.biombioe.2007.01.002; Walter C, 2010, NAT BIOTECHNOL, V28, P656, DOI 10.1038/nbt0710-656; Wang ZS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103645; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wullschleger SD, 2002, PLANT CELL, V14, P2651, DOI 10.1105/tpc.141120; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124083; Yao N, 2002, PLANT J, V30, P567, DOI 10.1046/j.1365-313X.2002.01314.x; Yu J, 2008, J INTEGR PLANT BIOL, V50, P929, DOI 10.1111/j.1744-7909.2008.00679.x; Zhang QJ, 2014, COMPLETE CHLOROPLAST; Zhu AD, 2014, MOL BIOL EVOL, V31, P1228, DOI 10.1093/molbev/msu079	68	40	44	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147209	10.1371/journal.pone.0147209	http://dx.doi.org/10.1371/journal.pone.0147209			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800039	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300073
J	Zhu, QB; Zhou, H; Zhang, AP; Gao, RF; Yang, SM; Zhao, CH; Wang, Y; Hu, JB; Goswami, R; Gong, LL; Li, QF				Zhu, Qibo; Zhou, Huang; Zhang, Aipin; Gao, Rufei; Yang, Shumin; Zhao, Changhong; Wang, Yue; Hu, Jinbo; Goswami, Richa; Gong, Lilin; Li, Qifu			Serum LBP Is Associated with Insulin Resistance in Women with PCOS	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; LIPOPOLYSACCHARIDE-BINDING PROTEIN; CHRONIC INFLAMMATION; OBESITY; ENDOTOXEMIA; MARKER	Introduction Lipopolysaccharide-binding protein (LBP) is closely associated with many metabolic disorders. However, no study has been done to explore the relationship between LBP and polycystic ovary syndrome (PCOS). The objective of this study was to investigate whether the serum LBP level is elevated and associated with insulin resistance (IR) in PCOS. Participants and Design In this cross-sectional study, 117 PCOS patients and 121 age-matched controls were recruited. Hyperinsulinemic-euglycemic clamp was performed with an expression of M value for insulin sensitivity. Fasting serum samples were collected to detect LBP, lipids, insulin, sex hormones and high sensitive C reactive protein (hs-CRP). Pearson's correlation and multiple linear regression was used to analyze the associations between M value and LBP level. Settings The study was performed in a clinical research center. Results Compared with controls, PCOS subjects had a significantly higher LBP concentration (33.03 +/- 14.59 vs. 24.35 +/- 10.31 mu g/ml, p<0.001), and lower M value (8.21 +/- 3.06 vs. 12.31 +/- 1.72 mg/min/kg, p<0.001). Both in lean and overweight/obese individuals, serum LBP level was higher in PCOS subjects than that in controls. M value was negatively correlated with body mass index (BMI), fasting serum insulin, triglycerides, low-density lipoprotein cholesterol (LDL-c), free testosterone, high sensitive C reactive protein (hs-CRP) and LBP, whereas positively correlated with high-density lipoprotein cholesterol (HDL-c) and sex hormone binding globulin (SHBG). Serum LBP level was associated with M value after adjusting for BMI, fasting serum insulin, SHBG, as well as hs-CRP. Conclusion Serum LBP level significantly is elevated in PCOS, and is independently associated with IR in PCOS.	[Zhu, Qibo; Zhou, Huang; Zhang, Aipin; Gao, Rufei; Yang, Shumin; Zhao, Changhong; Wang, Yue; Hu, Jinbo; Goswami, Richa; Gong, Lilin; Li, Qifu] Chongqing Med Univ, Affiliated Hosp 1, Chongqing 400016, Peoples R China	Chongqing Medical University	Li, QF (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing 400016, Peoples R China.	liqifu@yeah.net	Hu, Jinbo/AAB-7109-2021	Li, Qifu/0000-0003-3904-410X	National Natural Science Foundation of China [81170751, 81370954]; National Key Clinical Specialties Construction Program of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Clinical Specialties Construction Program of China	This work was supported by National Natural Science Foundation of China, Grants 81170751 and 81370954 (to QFL), and the National Key Clinical Specialties Construction Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carmina E, 2012, Minerva Ginecol, V64, P501; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Ciampelli M, 2005, J CLIN ENDOCR METAB, V90, P1398, DOI 10.1210/jc.2004-0410; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fulghesu AM, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/389317; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; HERNANDEZ ER, 1988, ENDOCRINOLOGY, V122, P2034, DOI 10.1210/endo-122-5-2034; Hu WH, 2011, EUR J OBSTET GYN R B, V157, P53, DOI 10.1016/j.ejogrb.2011.03.015; Kaya C, 2010, FERTIL STERIL, V93, P1200, DOI 10.1016/j.fertnstert.2008.10.070; Kelly CCJ, 2001, J CLIN ENDOCR METAB, V86, P2453, DOI 10.1210/jc.86.6.2453; Kheirandish-Gozal L, 2014, J CLIN ENDOCR METAB, V99, P656, DOI 10.1210/jc.2013-3327; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Legro RS, 2004, OBSTET GYNECOL SURV, V59, P141, DOI 10.1097/01.OGX.0000109523.25076.E2; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Moreno-Navarrete JM, 2013, DIABETOLOGIA, V56, P2524, DOI 10.1007/s00125-013-3015-9; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Moreno-Navarrete JM, 2012, INT J OBESITY, V36, P1442, DOI 10.1038/ijo.2011.256; Olszanecka-Glinianowicz M, 2007, EUR J OBSTET GYN R B, V133, P197, DOI 10.1016/j.ejogrb.2006.10.037; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Tremellen K, 2012, MED HYPOTHESES, V79, P104, DOI 10.1016/j.mehy.2012.04.016; Wang Y, 2006, FERTIL STERIL, V86, P223, DOI 10.1016/j.fertnstert.2005.12.037; Yang SM, 2011, FERTIL STERIL, V95, P1749, DOI 10.1016/j.fertnstert.2011.01.136; Yang SM, 2011, J CLIN ENDOCR METAB, V96, P831, DOI 10.1210/jc.2010-2140; Zhang YF, 2006, ENDOCRINE, V29, P419, DOI 10.1385/ENDO:29:3:419	26	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145337	10.1371/journal.pone.0145337	http://dx.doi.org/10.1371/journal.pone.0145337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799617	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300005
J	Lyu, IJ; Lee, JY; Kong, M; Park, KA; Oh, SY				Lyu, In Jeong; Lee, Ju-Yeun; Kong, Mingui; Park, Kyung-Ah; Oh, Sei Yeul			Surgical Responses of Medial Rectus Muscle Recession in Thyroid Eye Disease-Related Esotropia	PLOS ONE			English	Article							STRABISMUS SURGERY; GRAVES OPHTHALMOPATHY; ORBITAL DECOMPRESSION; ORBITOPATHY; MANAGEMENT; MYOPATHY; MOTILITY; OUTCOMES; SUBTYPE	We evaluate the surgical outcomes and surgical responses of medial rectus muscle (MR) recession patients with thyroid eye disease (TED)-related esotropia (ET). The surgical dose-response curves 1 week postoperatively and at the final visit were analyzed. Univariable and multivariable linear regression analyses were applied to investigate factors influencing surgical dose-response. A total of 43 patients with TED-related ET that underwent MR recession were included. The final success rate was 86.0% and the rate of undercorrection was 14.0%. The surgical dose-response curves of TED-related ET showed a gentle slope compared with those of standard surgical tables. In the univariable model, simultaneous vertical rectus muscle recession was the only significant factor influencing surgical dose-response of MR recession in TED-related ET (beta = -0.397, P = 0.044). In a model adjusted for age, sex, type of surgery, and preoperative horizontal angle of deviation, simultaneous vertical rectus muscle recession showed marginal significance (beta = -0.389, P = 0.064). The surgical dose-response curve of TED-related ET was unique. Simultaneous vertical rectus muscle recession was associated with increased surgical dose-response in TED-related ET.	[Lyu, In Jeong; Lee, Ju-Yeun; Kong, Mingui; Park, Kyung-Ah; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Lyu, In Jeong] Eulji Univ, Sch Med, Eulji Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Eulji University	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	syoh@skku.edu						Asman P, 2003, ACTA OPHTHALMOL SCAN, V81, P437, DOI 10.1034/j.1600-0420.2003.00147.x; Ben Simon GJ, 2015, GRAEFES ARCH CLIN EX; Boergen K P, 1989, Dev Ophthalmol, V20, P159; Coats DK, 1999, OPHTHALMOLOGY, V106, P324, DOI 10.1016/S0161-6420(99)90071-4; Dagi LR, 2011, OPHTHAL PLAST RECONS, V27, P102, DOI 10.1097/IOP.0b013e3181e9a063; Dal Canto AJ, 2006, OPHTHALMOLOGY, V113, P2324, DOI 10.1016/j.ophtha.2006.04.036; De Hoog J, 2010, EYE, V24, P1011, DOI 10.1038/eye.2009.267; DEWAARD R, 1983, DOC OPHTHALMOL, V56, P41, DOI 10.1007/BF00154707; DUNN WJ, 1986, OPHTHALMOLOGY, V93, P470; Dyer J.A., 1977, T AM OPHTHAL SOC, V74, P425; El-Kaissi S, 2004, INTERN MED J, V34, P482, DOI 10.1111/j.1445-5994.2004.00662.x; ELLIS FD, 1979, OPHTHALMOLOGY, V86, P2059; FORBES GS, 1982, RADIOLOGY, V142, P387, DOI 10.1148/radiology.142.2.7054827; GARDNER TA, 1990, OPHTHALMIC SURG LAS, V21, P519; Kaspar M, 2002, THYROID, V12, P187, DOI 10.1089/105072502753600115; KENDLER DL, 1993, ARCH OPHTHALMOL-CHIC, V111, P197, DOI 10.1001/archopht.1993.01090020051022; Kerr Natalie C, 2011, Trans Am Ophthalmol Soc, V109, P168; Kim MH, 2013, J AAPOS, V17, P188, DOI 10.1016/j.jaapos.2012.10.019; Kraus D J, 1993, Trans Am Ophthalmol Soc, V91, P67; Kuriyan AE, 2013, INVEST OPHTH VIS SCI, V54, P7370, DOI 10.1167/iovs.13-12741; LONG JC, 1966, ARCH OPHTHALMOL-CHIC, V75, P634; LUEDER GT, 1992, OPHTHALMOLOGY, V99, P993; Metz H S, 1984, J Pediatr Ophthalmol Strabismus, V21, P220; MILLER JE, 1965, ARCH OPHTHALMOL-CHIC, V74, P509; Mocan MC, 2007, J PEDIAT OPHTH STRAB, V44, P93, DOI 10.3928/01913913-20070301-02; NUGENT RA, 1990, RADIOLOGY, V177, P675, DOI 10.1148/radiology.177.3.2243967; NUNERY WR, 1993, OPHTHALMIC PLAST REC, V9, P77, DOI 10.1097/00002341-199306000-00001; Peragallo JH, 2013, STRABISMUS, V21, P23, DOI 10.3109/09273972.2012.762533; Prendiville P, 2000, OPHTHALMOLOGY, V107, P545, DOI 10.1016/S0161-6420(99)00145-1; Ruttum MS, 2000, J AAPOS, V4, P102, DOI 10.1067/mpa.2000.103872; SCOTT WE, 1981, OPHTHALMOLOGY, V88, P493; SKOV CMB, 1984, CAN J OPHTHALMOL, V19, P269; Tian S, 2007, ACTA OPHTHALMOL SCAN, V85, P431, DOI 10.1111/j.1600-0420.2007.00877.x; Volpe NJ, 2012, J AAPOS, V16, P518, DOI 10.1016/j.jaapos.2012.08.010	34	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146779	10.1371/journal.pone.0146779	http://dx.doi.org/10.1371/journal.pone.0146779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796354	Green Submitted, Green Published, gold			2022-12-26	WOS:000368530300012
J	Mukadi, P; Lejon, V; Barbe, B; Gillet, P; Nyembo, C; Lukuka, A; Likwela, J; Lumbala, C; Mbaruku, J; Vander Veken, W; Mumba, D; Lutumba, P; Muyembe, JJ; Jacobs, J				Mukadi, Pierre; Lejon, Veerle; Barbe, Barbara; Gillet, Philippe; Nyembo, Christophe; Lukuka, Albert; Likwela, Joris; Lumbala, Crispin; Mbaruku, Justin; Vander Veken, Wim; Mumba, Dieudonne; Lutumba, Pascal; Muyembe, Jean-Jacques; Jacobs, Jan			Performance of Microscopy for the Diagnosis of Malaria and Human African Trypanosomiasis by Diagnostic Laboratories in the Democratic Republic of the Congo: Results of a Nation-Wide External Quality Assessment	PLOS ONE			English	Article							SLEEPING SICKNESS; IMPACT; TESTS; FILMS	The present External Quality Assessment (EQA) assessed microscopy of blood parasites among diagnostic laboratories in the Democratic Republic of the Congo. The EQA addressed 445 participants in 10/11 provinces (October 2013-April 2014). Participants were sent a panel of five slides and asked to return a routinely stained slide which was assessed for quality of preparation and staining. Response rate was 89.9% (400/445). For slide 1 (no parasites), 30.6% participants reported malaria, mostly Plasmodium falciparum. Only 11.0% participants reported slide 2 (Plasmodium malariae) correctly, 71.0% reported "malaria" or "Plasmodium falciparum" (considered acceptable). Slide 3 contained Plasmodium falciparum (109/mu l) and Trypanosoma brucei brucei trypomastigotes: they were each reported by 32.5% and 16.5% participants respectively, 6.0% reported both. Slide 4 (Trypanosoma) was recognised by 44.9% participants. Slide 5 (Plasmodium ovale) was correctly reported by 6.2% participants, another 68.8% replied "malaria" or "Plasmodium falciparum" (considered acceptable). Only 13.6% of routine slides returned were correctly prepared and stained. The proportion of correct/acceptable scores for at least 4/5 slides was higher among EQA-experienced participants compared to first time participants (40.9% versus 22.4%, p = 0.001) and higher among those being trained < 2 years ago compared to those who were not (42.9% versus 26.3%, p = 0.01). Among diagnostic laboratories in Democratic Republic of the Congo, performance of blood parasite microscopy including non-falciparum species and Trypanosoma was poor. Recent training and previous EQA participation were associated with a better performance.	[Mukadi, Pierre; Mumba, Dieudonne; Lutumba, Pascal; Muyembe, Jean-Jacques] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Mukadi, Pierre; Nyembo, Christophe; Lutumba, Pascal] Univ Lubumbashi, Lubumbashi, DEM REP CONGO; [Lejon, Veerle] Inst Rech Dev, Montpellier, France; [Barbe, Barbara; Gillet, Philippe; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Lukuka, Albert; Likwela, Joris] Natl Malaria Control Program, Kinshasa, DEM REP CONGO; [Lumbala, Crispin; Mbaruku, Justin; Vander Veken, Wim] Natl Human African Trypanosomiasis Control Progra, Kinshasa, DEM REP CONGO; [Mumba, Dieudonne; Lutumba, Pascal; Muyembe, Jean-Jacques] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium	Institute Nacional de Recherche Biomedical; Institut de Recherche pour le Developpement (IRD); Institute of Tropical Medicine (ITM); Universite de Kinshasa; KU Leuven	Lejon, V (corresponding author), Inst Rech Dev, Montpellier, France.	veerle.lejon@ird.fr	Jacobs, Jan/GRX-7316-2022; Lejon, Veerle/AAG-4213-2020; Lejon, Veerle/AAG-5024-2020	Lejon, Veerle/0000-0002-6795-0962; gillet, philippe/0000-0001-5878-6446	Belgian Development Agency; National programme of sleeping sickness control in DRC; Institutional Collaboration INRB-ITM (Network Program on Laboratory Quality Management) [3.21]	Belgian Development Agency; National programme of sleeping sickness control in DRC; Institutional Collaboration INRB-ITM (Network Program on Laboratory Quality Management)	This study was funded by Directorate General of Development Cooperation of the Belgian Government through Trypano 4 project between Belgian Development Agency and the National programme of sleeping sickness control in DRC, and through the Institutional Collaboration INRB-ITM (Network Program on Laboratory Quality Management, Project 3.21). Pierre Mukadi has a scholarship of ITM through DGD Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MAL MICR QUAL ASS MA; Ayalew Freshwork, 2014, BMC Res Notes, V7, P839, DOI 10.1186/1756-0500-7-839; Central Intelligence Agency, WORLD FACTB 2013 201; Cnops L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-370; Coghlan B, 2009, DISASTER MED PUBLIC, V3, P88, DOI 10.1097/DMP.0b013e3181a6e952; Cooperation Technique Belge, 2008, DOSS TECHN FIN APP L; Dini L, 2003, T ROY SOC TROP MED H, V97, P675, DOI 10.1016/S0035-9203(03)80101-3; Hasker E, 2012, PLOS NEGLECT TROP D, V6, P1; Ishengoma DRS, 2010, ANN TROP MED PARASIT, V104, P123, DOI 10.1179/136485910X12607012373993; Kahama-Maro J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-332; Kettelhut MM, 2003, J CLIN PATHOL, V56, P927, DOI 10.1136/jcp.56.12.927; Lejon V, 2013, B WORLD HEALTH ORGAN, V91, P718, DOI 10.2471/BLT.13.126474; Lutumba P, 2006, TROP MED INT HEALTH, V11, P470, DOI 10.1111/j.1365-3156.2006.01591.x; Maguire Jason D, 2006, Malar J, V5, P92; McKenzie FE, 2003, AM J TROP MED HYG, V69, P372, DOI 10.4269/ajtmh.2003.69.372; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; MIEZAN TW, 1994, B SOC PATHOL EXOT, V87, P101; MILNE LM, 1994, J CLIN PATHOL, V47, P740, DOI 10.1136/jcp.47.8.740; Moura S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-437; Mukadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071442; Mukadi P, 2013, B WORLD HEALTH ORGAN, V91, P441, DOI 10.2471/BLT.12.112706; Mukadi P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-308; Obare P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-113; Programme National de Lutte contre la Trypanosomiase Humaine Africaine, 2014, RAPP ANN ACT LUTT TR; Programme National de Lutte contre le Paludisme, 2013, PLAN STRAT NAT LUTT; Programme National de Lutte contre le Paludisme, 2014, RAPP ANN ACT LUTT PA; Programme National de Lutte contre le Paludisme, 2010, MAN FORM DIAGN LAB P; Sarkinfada F, 2009, J INFECT DEV COUNTR, V3, P20, DOI 10.3855/jidc.101; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Thomson S, 2000, ARCH PATHOL LAB MED, V124, P57; Tuijn CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028348; Wafula R, 2014, AM J TROP MED HYG, V91, P481, DOI 10.4269/ajtmh.14-0133; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World-Health-Organization, 2005, MAL LIGHT MICR CREAT	35	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146450	10.1371/journal.pone.0146450	http://dx.doi.org/10.1371/journal.pone.0146450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788725	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100032
J	Trilling, DE				Trilling, David E.			The Surface Age of Sputnik Planum, Pluto, Must Be Less than 10 Million Years	PLOS ONE			English	Article							KUIPER-BELT OBJECTS; SIZE DISTRIBUTION	Data from the New Horizons mission to Pluto show no craters on Sputnik Planum down to the detection limit (2 km for low resolution data, 625 m for high resolution data). The number of small Kuiper Belt Objects that should be impacting Pluto is known to some degree from various astronomical surveys. We combine these geological and telescopic observations to make an order of magnitude estimate that the surface age of Sputnik Planum must be less than 10 million years. This maximum surface age is surprisingly young and implies that this area of Pluto must be undergoing active resurfacing, presumably through some cryo-geophysical process. We discuss three possible resurfacing mechanisms and the implications of each one for Pluto's physical properties.	[Trilling, David E.] No Arizona Univ, Dept Phys & Astron, Flagstaff, AZ 86011 USA; [Trilling, David E.] Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA	Northern Arizona University	Trilling, DE (corresponding author), No Arizona Univ, Dept Phys & Astron, Flagstaff, AZ 86011 USA.; Trilling, DE (corresponding author), Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA.	david.trilling@nau.edu						Bernstein GM, 2004, ASTRON J, V128, P1364, DOI 10.1086/422919; Bierhaus EB, 2015, ICARUS, V246, P165, DOI 10.1016/j.icarus.2014.05.044; de Elia GC, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201014884; Fraser WC, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/100; Fraser WC, 2009, ASTROPHYS J, V706, P119, DOI 10.1088/0004-637X/706/1/119; Greenstreet S, 2015, ICARUS, V258, P267, DOI 10.1016/j.icarus.2015.05.026; Melosh H.J., 2011, PLANETARY SURFACE PR, DOI 10.1017/CBO9780511977848; Parker AH, 2015, LUNAR PLANET SCI C; Schlichting HE, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/150; Scott T. A., 1976, Physics Reports. Physics Letters Section C, V27c, P89, DOI 10.1016/0370-1573(76)90032-6; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Yamashita Y, 2010, ICARUS, V207, P972, DOI 10.1016/j.icarus.2009.11.032	12	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147386	10.1371/journal.pone.0147386	http://dx.doi.org/10.1371/journal.pone.0147386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790001	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100085
J	Cantin, D; Djeddi, D; Carriere, V; Samson, N; Nault, S; Jia, WL; Beck, J; Praud, JP				Cantin, Danny; Djeddi, Djamal; Carriere, Vincent; Samson, Nathalie; Nault, Stephanie; Jia, Wan Lu; Beck, Jennifer; Praud, Jean-Paul			Inhibitory Effect of Nasal Intermittent Positive Pressure Ventilation on Gastroesophageal Reflux	PLOS ONE			English	Article							LOWER ESOPHAGEAL SPHINCTER; NONSEDATED NEWBORN LAMBS; AIRWAY PRESSURE; MUSCLE-ACTIVITY; PRETERM LAMBS; INFANTS; APNEA	Non-invasive intermittent positive pressure ventilation can lead to esophageal insufflations and in turn to gastric distension. The fact that the latter induces transient relaxation of the lower esophageal sphincter implies that it may increase gastroesophageal refluxes. We previously reported that nasal Pressure Support Ventilation (nPSV), contrary to nasal Neurally-Adjusted Ventilatory Assist (nNAVA), triggers active inspiratory laryngeal closure. This suggests that esophageal insufflations are more frequent in nPSV than in nNAVA. The objectives of the present study were to test the hypotheses that: i) gastroesophageal refluxes are increased during nPSV compared to both control condition and nNAVA; ii) esophageal insufflations occur more frequently during nPSV than nNAVA. Polysomno-graphic recordings and esophageal multichannel intraluminal impedance pHmetry were performed in nine chronically instrumented newborn lambs to study gastroesophageal refluxes, esophageal insufflations, states of alertness, laryngeal closure and respiration. Recordings were repeated without sedation in control condition, nPSV (15/4 cmH(2)O) and nNAVA (similar to 15/4 cmH(2)O). The number of gastroesophageal refluxes recorded over six hours, expressed as median (interquartile range), decreased during both nPSV (1 (0, 3)) and nNAVA [1 (0, 3)] compared to control condition (5 (3, 10)), (p < 0.05). Meanwhile, the esophageal insufflation index did not differ between nPSV (40 (11, 61) h(-1)) and nNAVA (10 (9, 56) h(-1)) (p = 0.8). In conclusion, nPSV and nNAVA similarly inhibit gastroesophageal refluxes in healthy newborn lambs at pressures that do not lead to gastric distension. In addition, the occurrence of esophageal insufflations is not significantly different between nPSV and nNAVA. The strong inhibitory effect of nIPPV on gastroesophageal refluxes appears identical to that reported with nasal continuous positive airway pressure.	[Cantin, Danny; Djeddi, Djamal; Carriere, Vincent; Samson, Nathalie; Nault, Stephanie; Jia, Wan Lu; Praud, Jean-Paul] Univ Sherbrooke, Dept Pediat, Neonatal Resp Res Unit, Sherbrooke, PQ J1K 2R1, Canada; [Cantin, Danny; Carriere, Vincent; Samson, Nathalie; Nault, Stephanie; Jia, Wan Lu; Praud, Jean-Paul] Univ Sherbrooke, Dept Physiol, Sherbrooke, PQ J1K 2R1, Canada; [Djeddi, Djamal] Univ Picardie Jules Verne, Dept Pediat, Amiens, France; [Beck, Jennifer] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Beck, Jennifer] St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Beck, Jennifer] Ryerson Univ, iBEST, Toronto, ON, Canada; [Beck, Jennifer] St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada	University of Sherbrooke; University of Sherbrooke; Picardie Universites; Universite de Picardie Jules Verne (UPJV); University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Praud, JP (corresponding author), Univ Sherbrooke, Dept Pediat, Neonatal Resp Res Unit, Sherbrooke, PQ J1K 2R1, Canada.; Praud, JP (corresponding author), Univ Sherbrooke, Dept Physiol, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Paul.Praud@USherbrooke.ca			Faculte de Medecine et des Sciences de la Sante of the Universite de Sherbrooke; Canadian Institutes of Health Research [RS-286032]; Canada Research Chair in Neonatal Respiratory Physiology; Fonds de la recherche Quebec - Sante	Faculte de Medecine et des Sciences de la Sante of the Universite de Sherbrooke; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Neonatal Respiratory Physiology; Fonds de la recherche Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	DC was supported by a training scholarship from the Faculte de Medecine et des Sciences de la Sante of the Universite de Sherbrooke. JPP: The study was funded by an operating grant from the Canadian Institutes of Health Research (RS-286032) and the Canada Research Chair in Neonatal Respiratory Physiology. JPP is a member of the Sherbrooke University Hospital Research Center, which is funded by the Fonds de la recherche Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei A, 2008, GASTROENTEROLOGY, V134, P1322, DOI 10.1053/j.gastro.2008.02.031; Barwing J, 2009, INTENS CARE MED, V35, P1809, DOI 10.1007/s00134-009-1587-0; Boudaa N, 2013, J APPL PHYSIOL, V114, P637, DOI 10.1152/japplphysiol.00599.2012; Campanozzi A, 2009, PEDIATRICS, V123, P779, DOI 10.1542/peds.2007-3569; Carriere V, 2015, CRIT CARE MED, V43, pE296, DOI 10.1097/CCM.0000000000001080; Carron M, 2013, BRIT J ANAESTH, V110, P896, DOI 10.1093/bja/aet070; Czinn SJ, 2013, PEDIATR DRUGS, V15, P19, DOI 10.1007/s40272-012-0004-2; DeMauro SB, 2014, CURR OPIN PEDIATR, V26, P157, DOI 10.1097/MOP.0000000000000066; DiBlasi RM, 2011, RESP CARE, V56, P1273, DOI 10.4187/respcare.01376; Djeddi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107736; Djeddi D, 2012, J PEDIATR GASTR NUTR, V55, P745, DOI 10.1097/MPG.0b013e318263cae0; Hadj-Ahmed MA, 2015, NEONATOLOGY, V107, P199, DOI 10.1159/000369120; Hadj-Ahmed MA, 2012, J APPL PHYSIOL, V113, P63, DOI 10.1152/japplphysiol.01496.2011; Hershcovici T, 2011, NEUROGASTROENT MOTIL, V23, P819, DOI 10.1111/j.1365-2982.2011.01738.x; Hill NS, 1997, RESP CARE, V42, P432; Jadcherla SR, 2015, PEDIATR RES, V77, P99, DOI 10.1038/pr.2014.147; JOUNIEAUX V, 1995, J APPL PHYSIOL, V79, P186, DOI 10.1152/jappl.1995.79.1.186; KERR P, 1992, CHEST, V101, P1539, DOI 10.1378/chest.101.6.1539; KERR P, 1993, J CLIN GASTROENTEROL, V17, P276, DOI 10.1097/00004836-199312000-00002; Lagarde S, 2010, ANESTH ANALG, V110, P1676, DOI 10.1213/ANE.0b013e3181d8a14c; Lightdale JR, 2013, PEDIATRICS, V131, pE1684, DOI 10.1542/peds.2013-0421; Mathai Ss, 2012, Med J Armed Forces India, V68, P12, DOI 10.1016/S0377-1237(11)60123-8; Moreau-Bussiere F, 2007, J APPL PHYSIOL, V102, P2149, DOI 10.1152/japplphysiol.00891.2006; Pandolifino JE, 2006, GASTROENTEROLOGY, V131, P1725, DOI 10.1053/j.gastro.2006.09.009; Renolleau S, 1999, AM J RESP CRIT CARE, V159, P1396, DOI 10.1164/ajrccm.159.5.9807088; ROSEN CL, 1986, AM J DIS CHILD, V140, P547, DOI 10.1001/archpedi.1986.02140200057027; Samson N, 2005, J APPL PHYSIOL, V99, P1636, DOI 10.1152/japplphysiol.00464.2005; Samson N, 2011, RESP PHYSIOL NEUROBI, V179, P111, DOI 10.1016/j.resp.2011.09.008; Shepherd K, 2013, J CLIN SLEEP MED, V9, P13, DOI 10.5664/jcsm.2328; Shepherd KL, 2007, AM J PHYSIOL-GASTR L, V292, pG1200, DOI 10.1152/ajpgi.00476.2006; Tawk M, 2006, CHEST, V130, P1003, DOI 10.1378/chest.130.4.1003; Wenzl TG, 2012, J PEDIATR GASTR NUTR, V55, P230, DOI 10.1097/MPG.0b013e3182592b65	32	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146742	10.1371/journal.pone.0146742	http://dx.doi.org/10.1371/journal.pone.0146742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785264	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400062
J	Cashman, TJ; Josowitz, R; Johnson, BV; Gelb, BD; Costa, KD				Cashman, Timothy J.; Josowitz, Rebecca; Johnson, Bryce V.; Gelb, Bruce D.; Costa, Kevin D.			Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							FACIO-CUTANEOUS SYNDROME; GERMLINE BRAF; CARDIOMYOCYTES; MUTATIONS; DIVERSITY; LEOPARD; MODELS; GROWTH	Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death that often goes undetected in the general population. HCM is also prevalent in patients with cardio-facio-cutaneous syndrome (CFCS), which is a genetic disorder characterized by aberrant signaling in the RAS/MAPK signaling cascade. Understanding the mechanisms of HCM development in such RASopathies may lead to novel therapeutic strategies, but relevant experimental models of the human condition are lacking. Therefore, the objective of this study was to develop the first 3D human engineered cardiac tissue (hECT) model of HCM. The hECTs were created using human cardiomyocytes obtained by directed differentiation of induced pluripotent stem cells derived from a patient with CFCS due to an activating BRAF mutation. The mutant myocytes were directly conjugated at a 3:1 ratio with a stromal cell population to create a tissue of defined composition. Compared to healthy patient control hECTs, BRAF-hECTs displayed a hypertrophic phenotype by culture day 6, with significantly increased tissue size, twitch force, and atrial natriuretic peptide (ANP) gene expression. Twitch characteristics reflected increased contraction and relaxation rates and shorter twitch duration in BRAF-hECTs, which also had a significantly higher maximum capture rate and lower excitation threshold during electrical pacing, consistent with a more arrhythmogenic substrate. By culture day 11, twitch force was no longer different between BRAF and wild-type hECTs, revealing a temporal aspect of disease modeling with tissue engineering. Principal component analysis identified diastolic force as a key factor that changed from day 6 to day 11, supported by a higher passive stiffness in day 11 BRAF-hECTs. In summary, human engineered cardiac tissues created from BRAF mutant cells recapitulated, for the first time, key aspects of the HCM phenotype, offering a new in vitro model for studying intrinsic mechanisms and screening new therapeutic approaches for this lethal form of heart disease.	[Cashman, Timothy J.; Johnson, Bryce V.; Costa, Kevin D.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA; [Josowitz, Rebecca; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Costa, KD (corresponding author), Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA.	kevin.costa@mssm.edu	Cashman, Tim/M-7738-2019	Cashman, Timothy/0000-0001-6238-129X	NIH [F30 HL118923, R01 HL113499, T32 GM008553, T32 HD075735]; American Heart Association [12PRE12060254]; NIH/NHLBI PEN contract [HHSN268201000045C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113499, F30HL118923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH/NHLBI PEN contract; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH (F30 HL118923 to T.J.C. and R01 HL113499 to B.D.G.), the American Heart Association (12PRE12060254 to R.J.), funding to T.J.C. by NIH (T32 GM008553 and T32 HD075735), and to K.D.C by NIH/NHLBI PEN contract HHSN268201000045C.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Allanson JE, 2011, AM J MED GENET C, V157C, P129, DOI 10.1002/ajmg.c.30295; Arad M, 2002, HUM MOL GENET, V11, P2499, DOI 10.1093/hmg/11.20.2499; Armour CM, 2008, J MED GENET, V45, P249, DOI 10.1136/jmg.2007.054460; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; de Lange WJ, 2011, CIRC RES, V109, P8, DOI 10.1161/CIRCRESAHA.111.242354; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Gago-Lopez N, 2014, STEM CELL REP, V2, P576, DOI 10.1016/j.stemcr.2014.03.003; Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522; Hirt MN, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0307-z; Kirkton RD, 2012, EUROPACE, V14, pV40, DOI 10.1093/europace/eus269; Komae H, 2015, J TISSUE ENG REGEN M; Konno T, 2010, CURR OPIN CARDIOL, V25, P205, DOI 10.1097/HCO.0b013e3283375698; Ma Z, 2014, BIOMATERIALS, V35, P1367, DOI 10.1016/j.biomaterials.2013.10.052; Maron BJ, 2014, J AM COLL CARDIOL, V64, P83, DOI 10.1016/j.jacc.2014.05.003; Mortazavi Mohammed, 2013, Adv Pediatr, V60, P201, DOI 10.1016/j.yapd.2013.04.015; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Nonaka M, 2014, WORLD J CARDIOL, V6, P1245, DOI 10.4330/wjc.v6.i12.1245; Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]; Onan D, 2004, MOL ENDOCRINOL, V18, P2344, DOI 10.1210/me.2003-0309; Pakladok T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087457; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roberts A, 2006, J MED GENET, V43, P833, DOI 10.1136/jmg.2006.042796; Rodriguez-Viciana P, 2008, METHOD ENZYMOL, V438, P277, DOI 10.1016/S0076-6879(07)38019-1; Ruan HM, 2007, CIRCULATION, V116, P596, DOI 10.1161/CIRCULATIONAHA.106.682773; Sala V, 2012, MOL MED, V18, P938, DOI 10.2119/molmed.2011.00512; Sarkozy A, 2009, HUM MUTAT, V30, P695, DOI 10.1002/humu.20955; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Schoenfeld JR, 1998, J MOL CELL CARDIOL, V30, P2269, DOI 10.1006/jmcc.1998.0787; Serrao GW, 2012, TISSUE ENG PT A, V18, P1322, DOI [10.1089/ten.tea.2011.0278, 10.1089/ten.TEA.2011.0278]; Shephard R, 2009, J CARDIOVASC TRANSL, V2, P471, DOI 10.1007/s12265-009-9120-y; Thavandiran N, 2013, P NATL ACAD SCI USA, V110, pE4698, DOI 10.1073/pnas.1311120110; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Turnbull IC, 2014, FASEB J, V28, P644, DOI 10.1096/fj.13-228007; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wang JX, 2013, BIOMATERIALS, V34, P8878, DOI 10.1016/j.biomaterials.2013.07.039; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Yoon G, 2007, DEV MED CHILD NEUROL, V49, P894, DOI 10.1111/j.1469-8749.2007.00894.x; Zheng MZ, 2004, AM J PHYSIOL-HEART C, V286, pH424, DOI 10.1152/ajpheart.00110.2003	43	48	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146697	10.1371/journal.pone.0146697	http://dx.doi.org/10.1371/journal.pone.0146697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784941	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400059
J	Fekry, B; Esmaeilniakooshkghazi, A; Krupenko, SA; Krupenko, NI				Fekry, Baharan; Esmaeilniakooshkghazi, Amin; Krupenko, Sergey A.; Krupenko, Natalia I.			Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner	PLOS ONE			English	Article							CANCER-CELLS; SPHINGOLIPID METABOLISM; ENDOPLASMIC-RETICULUM; INDUCED APOPTOSIS; PHOTODYNAMIC THERAPY; THYMIDYLATE SYNTHASE; CARCINOMA-CELLS; DOWN-REGULATION; UP-REGULATION; TUMOR-CELLS	We previously reported that ceramide synthase 6 (CerS6) is elevated in response to folate stress in cancer cells, leading to enhanced production of C-16-ceramide and apoptosis. Antifolate methotrexate (MTX), a drug commonly used in chemotherapy of several types of cancer, is a strong inhibitor of folate metabolism. Here we investigated whether this drug targets CerS6. We observed that CerS6 protein was markedly elevated in several cancer cell lines treated with MTX. In agreement with the enzyme elevation, its product C-16-ceramide was also strongly elevated, so as several other ceramide species. The increase in C16-ceramide, however, was eliminated in MTX-treated cells lacking CerS6 through siRNA silencing, while the increase in other ceramides sustained. Furthermore, the siRNA silencing of CerS6 robustly protected A549 lung adenocarcinoma cells from MTX toxicity, while the silencing of another ceramide synthase, CerS4, which was also responsive to folate stress in our previous study, did not interfere with the MTX effect. The rescue effect of CerS6 silencing upon MTX treatment was further confirmed in HCT116 and HepG2 cell lines. Interestingly, CerS6 itself, but not CerS4, induced strong antiproliferative effect in several cancer cell lines if elevated by transient transfection. The effect of MTX on CerS6 elevation was likely p53 dependent, which is in agreement with the hypothesis that the protein is a transcriptional target of p53. In line with this notion, lometrexol, the antifolate inducing cytotoxicity through the p53-independent mechanism, did not affect CerS6 levels. We have also found that MTX induces the formation of ER aggregates, enriched with CerS6 protein. We further demonstrated that such aggregation requires CerS6 and suggests that it is an indication of ER stress. Overall, our study identified CerS6 and ceramide pathways as a novel MTX target.	[Fekry, Baharan; Esmaeilniakooshkghazi, Amin; Krupenko, Sergey A.; Krupenko, Natalia I.] Univ N Carolina, Inst Nutr Res, Kannapolis, NC USA; [Krupenko, Sergey A.; Krupenko, Natalia I.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina; University of North Carolina Chapel Hill	Krupenko, NI (corresponding author), Univ N Carolina, Inst Nutr Res, Kannapolis, NC USA.; Krupenko, NI (corresponding author), Univ N Carolina, Dept Nutr, Chapel Hill, NC USA.	natalia_krupenko@unc.edu	Fekry, Baharan/GLT-6510-2022	Fekry, Baharan/0000-0003-1218-4161	National Cancer Institute [CA193782, CA095030]; National Institute of Diabetes and Digestive and Kidney Diseases [DK54388]; NATIONAL CANCER INSTITUTE [R01CA095030, R01CA193782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Cancer Institute grants CA193782 (to NIK) and CA095030 (to SAK), and National Institute of Diabetes and Digestive and Kidney Diseases grant DK54388 (to SAK). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	ALLEGRA CJ, 1985, J BIOL CHEM, V260, P9720; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Bailey SW, 2009, P NATL ACAD SCI USA, V106, P15424, DOI 10.1073/pnas.0902072106; Bajgelman MC, 2006, PROSTATE, V66, P1455, DOI 10.1002/pros.20462; Bareford MD, 2012, CANCER BIOL THER, V13, P793, DOI 10.4161/cbt.20562; Bareford MD, 2011, CANCER RES, V71, P4955, DOI 10.1158/0008-5472.CAN-11-0898; Bertino JR, 2009, BEST PRACT RES CL HA, V22, P577, DOI 10.1016/j.beha.2009.09.004; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bronder JL, 2003, J BIOL CHEM, V278, P48861, DOI 10.1074/jbc.M304844200; Bronder JL, 2002, CANCER RES, V62, P5236; CHABNER BA, 1985, J CLIN INVEST, V76, P907, DOI 10.1172/JCI112088; Cruickshanks N, 2015, CANCER BIOL THER, V16, P733, DOI 10.1080/15384047.2015.1026509; Ebel P, 2013, J BIOL CHEM, V288, P21433, DOI 10.1074/jbc.M113.479907; Eberle M, 2014, BIOCHEM PHARMACOL, V92, P326, DOI 10.1016/j.bcp.2014.08.016; Edmond V, 2015, ONCOGENE, V34, P996, DOI 10.1038/onc.2014.55; Ehrhardt H, 2008, ONCOGENE, V27, P783, DOI 10.1038/sj.onc.1210666; Epstein S, 2012, J LIPID RES, V53, P412, DOI 10.1194/jlr.M022186; Floros KV, 2006, BIOL CHEM, V387, P1629, DOI 10.1515/BC.2006.203; Florou D, 2013, CANCER BIOL THER, V14, P587, DOI 10.4161/cbt.24591; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gibson RJ, 2005, CLIN EXP MED, V4, P188, DOI 10.1007/s10238-004-0055-y; Goldman ID, 2010, CURR OPIN INVEST DR, V11, P1409; Gurova KV, 2003, CANCER RES, V63, P2905; Hajj C, 2015, BIOL CHEM, V396, P669, DOI 10.1515/hsz-2014-0302; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harvald EB, 2015, APOPTOSIS, V20, P658, DOI 10.1007/s10495-015-1108-2; Hoeferlin LA, 2013, J BIOL CHEM, V288, P12880, DOI 10.1074/jbc.M113.461798; Hou Q, 2011, J LIPID RES, V52, P278, DOI 10.1194/jlr.M012161; Huang WY, 2011, BIOCHEM PHARMACOL, V81, P510, DOI 10.1016/j.bcp.2010.11.014; Jaffe N, 2014, ADV EXP MED BIOL, V804, P1, DOI 10.1007/978-3-319-04843-7_1; Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kuznetsov JN, 2011, MOL CANCER THER, V10, P437, DOI 10.1158/1535-7163.MCT-10-0777; Laethem RM, 1998, BLOOD, V91, P4350, DOI 10.1182/blood.V91.11.4350.411k27_4350_4360; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; MILNER RE, 1991, J BIOL CHEM, V266, P7155; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Nihal M, 2014, ARCH BIOCHEM BIOPHYS, V563, P101, DOI 10.1016/j.abb.2014.04.019; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Paci A, 2014, EUR J CANCER, V50, P2010, DOI 10.1016/j.ejca.2014.04.014; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Paschall AV, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-24; Paul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127558; Plant D, 2014, NAT REV RHEUMATOL, V10, P329, DOI 10.1038/nrrheum.2014.16; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Schiffmann S, 2010, BIOCHEM PHARMACOL, V80, P1632, DOI 10.1016/j.bcp.2010.08.012; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schull S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.62; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Separovic D, 2012, ANTICANCER RES, V32, P753; Separovic D, 2011, BIOCHEM BIOPH RES CO, V409, P372, DOI 10.1016/j.bbrc.2011.04.091; Shen Y, 2015, EXP CELL RES, V334, P207, DOI 10.1016/j.yexcr.2015.04.010; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Tirodkar TS, 2015, J BIOL CHEM, V290, P13157, DOI 10.1074/jbc.M114.631325; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Varadarajan S, 2012, CELL DEATH DIFFER, V19, P1896, DOI 10.1038/cdd.2012.108; Varadarajan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056603; Visentin M, 2012, HEMATOL ONCOL CLIN N, V26, P629, DOI 10.1016/j.hoc.2012.02.002; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51; Yacoub A, 2010, CANCER RES, V70, P1120, DOI 10.1158/0008-5472.CAN-09-4043	69	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146618	10.1371/journal.pone.0146618	http://dx.doi.org/10.1371/journal.pone.0146618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783755	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400053
J	Hayez, A; Roegiers, E; Malaisse, J; Balau, B; Sterpin, C; Achouri, Y; De Rouvroit, CL; Poumay, Y; Michiels, C; De Backer, O				Hayez, Aurelle; Roegiers, Edith; Malaisse, Jeremy; Balau, Benoit; Sterpin, Christiane; Achouri, Younes; De Rouvroit, Catherine Lambert; Poumay, Yves; Michiels, Carine; De Backer, Olivier			TMEM45A Is Dispensable for Epidermal Morphogenesis, Keratinization and Barrier Formation	PLOS ONE			English	Article							LAMELLAR GRANULES; DIFFERENTIATION; KERATINOCYTES; EXPRESSION	TMEM45A gene encodes an initially uncharacterized predicted transmembrane protein. We previously showed that this gene is highly expressed in keratinocytes where its expression correlates with keratinization, suggesting a role in normal epidermal physiology. To test this hypothesis, we generated TMEM45A knockout mice and found that these mice develop without any evident phenotype. The morphology of the epidermis assessed by histology and by labelling differentiation markers in immunofluorescence was not altered. Toluidine blue permeability assay showed that the epidermal barrier develops normally during embryonic development. We also showed that depletion of TMEM45A in human keratinocytes does not alter their potential to form in vitro 3D-reconstructed epidermis. Indeed, epidermis with normal morphogenesis were generated from TMEM45A-silenced keratinocytes. Their expression of differentiation markers quantified by RT-qPCR and evidenced by immunofluorescence labelling as well as their barrier function estimated by Lucifer yellow permeability were similar to the control epidermis. In summary, TMEM45A gene expression is dispensable for epidermal morphogenesis, keratinization and barrier formation. If this protein plays a role in the epidermis, its experimental depletion can possibly be compensated by other proteins in the two experimental models analyzed in this study.	[Hayez, Aurelle; Malaisse, Jeremy; Balau, Benoit; Sterpin, Christiane; De Rouvroit, Catherine Lambert; Poumay, Yves; De Backer, Olivier] Univ Namur, URPhyM NARILIS, Namur, Belgium; [Roegiers, Edith; Michiels, Carine] Univ Namur, URBC NARILIS, Namur, Belgium; [Achouri, Younes] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	University of Namur; University of Namur; Universite Catholique Louvain	Michiels, C (corresponding author), Univ Namur, URBC NARILIS, Namur, Belgium.	carine.michiels@unamur.be	Poumay, Yves/G-4525-2016	Poumay, Yves/0000-0001-5200-3367; ACHOURI, Younes/0000-0001-7409-1441	FRIA (Fonds de la Recherche Industrielle et Agricole, FNRS, Belgium); Televie grant (FNRS- National Funds for Scientific Research, Belgium)	FRIA (Fonds de la Recherche Industrielle et Agricole, FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Televie grant (FNRS- National Funds for Scientific Research, Belgium)	AH is a research fellow funded by FRIA (Fonds de la Recherche Industrielle et Agricole, FNRS, Belgium). ER is financed by Televie grant (FNRS- National Funds for Scientific Research, Belgium).	Akiyama M, 2011, DERM-ENDOCRINOL, V3, P107, DOI 10.4161/derm.3.2.15136; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Fartasch M, 2004, J INVEST DERMATOL, V122, pXI; Flamant L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-391; Frankart A, 2012, EXP DERMATOL, V21, P871, DOI 10.1111/exd.12020; Gerber PA, 2014, BIOL CHEM, V395, P577, DOI 10.1515/hsz-2013-0279; Gerber PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063949; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hayez A, 2014, EXP DERMATOL, V23, P339, DOI 10.1111/exd.12403; Inoue K, 2014, J INVEST DERMATOL, V134, P1465, DOI 10.1038/jid.2013.516; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Jarnik M, 2002, J INVEST DERMATOL, V118, P102, DOI 10.1046/j.0022-202x.2001.01661.x; Madison K C, 1998, J Investig Dermatol Symp Proc, V3, P80; Mattiuzzo NR, 2011, EXP DERMATOL, V20, P113, DOI 10.1111/j.1600-0625.2010.01188.x; Minner F, 2010, METHODS MOL BIOL, V585, P71, DOI 10.1007/978-1-60761-380-0_6; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Norlen L, 2001, J INVEST DERMATOL, V117, P830; Okada N, 2011, PROTEIN EXPRES PURIF, V77, P118, DOI 10.1016/j.pep.2011.01.011; Taylor JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007651; Tsuchisaka A, 2014, J INVEST DERMATOL, V134, P1194, DOI 10.1038/jid.2014.15	22	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147069	10.1371/journal.pone.0147069	http://dx.doi.org/10.1371/journal.pone.0147069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785122	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400104
J	Sheng, J; Yang, YP; Ma, YX; Qin, T; Hu, ZH; Hong, SD; Zhou, T; Huang, Y; Zhao, HY; Zhang, L				Sheng, Jin; Yang, Yun-Peng; Ma, Yu-Xiang; Qin, Tao; Hu, Zhi-Huang; Hong, Shao-Dong; Zhou, Ting; Huang, Yan; Zhao, Hong-Yun; Zhang, Li			Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs	PLOS ONE			English	Article							CELL LUNG-CANCER; SYSTEMIC INFLAMMATORY RESPONSE; GROWTH-FACTOR RECEPTOR; PREDICTS; CHEMOTHERAPY; OUTCOMES; MULTICENTER; MUTATIONS; GEFITINIB; THERAPY	Objective This study was designed to demonstrate the prognostic value of prognostic nutritional index (PNI), a reflection systemic immunonutritional status, on the long-term survival of patients taking epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs). Methods In this retrospective study, eligible advanced NSCLC patients with sensitive EGFR mutations (exon 19 deletion or L858R in exon 21) were included to investigate the correlation between the PNI and overall survival (OS). The PNI was calculated as 10 x serum albumin value (g/dl) + 0.005 x peripheral lymphocyte count (per mm(3)). The prognostic significance of PNI and other clinicopathologic factors was identified by univariate and multivariate analysis. Results Finally, 144 patients met the inclusion criteria. The optimal cut-off value of PNI for survival stratification was 48.78. Compared with high PNI group (n = 81), low PNI (n = 63) was significantly associated with elevated C-reactive protein (CRP) level and non-response to TKIs. Overall survival was superior in the high PNI group (HR, 0.44, p = 0.004), especially for patient with L858R (HR, 0.37, p = 0.009) rather than 19 deletion (HR, 0.69, p = 0.401). The independent prognostic value of PNI was validated by multivariate analysis. Conclusion This pilot investigation demonstrated that low prognostic nutritional index correlates with worse survival for patients with advanced NSCLC and taking EGFR-TKIs. The assessment of a convenient index, known as PNI, worth attention in routine clinical practice for patients following EGFR-TKIs treatment.	[Sheng, Jin; Yang, Yun-Peng; Ma, Yu-Xiang; Qin, Tao; Hu, Zhi-Huang; Hong, Shao-Dong; Zhou, Ting; Huang, Yan; Zhao, Hong-Yun; Zhang, Li] Sun Yat Sen Univ, Ctr Canc, Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sheng, Jin; Yang, Yun-Peng; Ma, Yu-Xiang; Qin, Tao; Hu, Zhi-Huang; Hong, Shao-Dong; Zhou, Ting; Huang, Yan; Zhao, Hong-Yun; Zhang, Li] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Sheng, Jin; Yang, Yun-Peng; Ma, Yu-Xiang; Qin, Tao; Hu, Zhi-Huang; Hong, Shao-Dong; Zhou, Ting; Huang, Yan; Zhao, Hong-Yun; Zhang, Li] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China	Zhang, L (corresponding author), Sun Yat Sen Univ, Ctr Canc, Med Oncol, Guangzhou 510275, Guangdong, Peoples R China.; Zhang, L (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	zhangli6@mail.sysu.edu.cn			National Natural Science Foundation of China [81372502, 81201917]; National High Technology Research and Development Program of China [2012AA02A502]; Innovative drug R&D center based on real-time high-throughput cell-based screening platform and large capacity compound library [2013ZX09401003-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Innovative drug R&D center based on real-time high-throughput cell-based screening platform and large capacity compound library	This study was supported by: National Natural Science Foundation of China (Grant No. 81372502, and 81201917), National High Technology Research and Development Program of China (Grant No. 2012AA02A502) and Innovative drug R&D center based on real-time high-throughput cell-based screening platform and large capacity compound library (Grant No. 2013ZX09401003-002). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The preliminary result was present at the 16th World Conference on Lung Cancer, Denver, USA, September 6-9, 2015 (Oral, Abstract ID46: Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs). We thank the patients who participated in this study and their families; the medical, nursing, and research staffs at the study centers. This study was supported by: National Natural Science Foundation of China (Grant No. 81372502, and 81201917), National High Technology Research and Development Program of China (Grant No. 2012AA02A502) and Innovative drug R&D center based on real-time high-throughput cell-based screening platform and large capacity compound library (Grant No. 2013ZX09401003-002).	Azab BN, 2013, AM J SURG, V206, P764, DOI 10.1016/j.amjsurg.2013.03.007; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; BUZBY GP, 1980, AM J SURG, V139, P160, DOI 10.1016/0002-9610(80)90246-9; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P1236, DOI 10.6004/jnccn.2012.0130; Hofbauer Sebastian L, 2015, Urol Oncol, V33, DOI 10.1016/j.urolonc.2014.08.005; Hong S, 2014, TUMOUR BIOL; Hubbard TJE, 2011, BRIT J SURG, V98, P1032, DOI 10.1002/bjs.7608; Lee CK, 2015, J CLIN ONCOL, V33, P1958, DOI 10.1200/JCO.2014.58.1736; Leung EYL, 2012, J THORAC ONCOL, V7, P655, DOI 10.1097/JTO.0b013e318244ffe1; Maeda K, 2014, WORLD J SURG, V38, P1217, DOI 10.1007/s00268-013-2386-x; Masago K, 2010, ONCOLOGY-BASEL, V79, P355, DOI 10.1159/000323486; Migita K, 2013, ANN SURG ONCOL, V20, P2647, DOI 10.1245/s10434-013-2926-5; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nozoe T, 2012, SURG TODAY, V42, P532, DOI 10.1007/s00595-011-0061-0; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Pinato DJ, 2014, BRIT J CANCER, V110, P1930, DOI 10.1038/bjc.2014.145; Pinato DJ, 2012, TRANSL RES, V160, P146, DOI 10.1016/j.trsl.2012.01.011; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Sachlova M, 2014, NUTR CANCER, V66, P1362, DOI 10.1080/01635581.2014.956261; Sagawa Masano, 2008, Gan To Kagaku Ryoho, V35, P2253; Sanchez-Lara K, 2012, NUTR CANCER, V64, P526, DOI 10.1080/01635581.2012.668744; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Uramoto H, 2007, BRIT J CANCER, V96, P857, DOI 10.1038/sj.bjc.6603665; Wu KL, 2015, LUNG CANCER, V88, P187, DOI 10.1016/j.lungcan.2015.02.012; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yang ZJ, 2014, TUMOR BIOL, V35, P12165, DOI 10.1007/s13277-014-2524-6; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yao ZH, 2013, J CANCER RES CLIN, V139, P2117, DOI 10.1007/s00432-013-1523-0; Zhang L, 2012, LANCET ONCOL, V13, P466, DOI 10.1016/S1470-2045(12)70117-1; ZHANG Y, 2014, PLOS COMPUT BIOL, V10, DOI DOI 10.1371/JOURNAL.PONE.0107161; Zhang YX, 2015, CLIN LUNG CANCER, V16, P144, DOI 10.1016/j.cllc.2014.09.008; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	34	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147226	10.1371/journal.pone.0147226	http://dx.doi.org/10.1371/journal.pone.0147226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784943	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400126
J	Au, KY; Pong, JCH; Ling, WL; Li, JCB				Au, Kin Yi; Pong, John C. H.; Ling, Wai Lim; Li, James C. B.			MiR-1303 Regulates Mycobacteria Induced Autophagy by Targeting Atg2B	PLOS ONE			English	Article							MICRORNA BIOGENESIS; CELLS; TRANSLATION; MACROPHAGES; INITIATION; ELEGANS; DEFENSE; DISEASE; LIN-14; DECAY	MicroRNAs are emerging post-transcriptional regulators of gene expressions in both innate immunity and adaptive immunity. In mycobacteria infection, autophagy plays an important role in innate defense mechanism and is tightly regulated by the autophagy-related proteins. Here, we show that Atg2B is involved in the regulation of mycobacteria-induced autophagy. MiR-1303, which function is not defined yet, is found to negatively regulate mycobacteria-induced Atg2B protein production, ultimately down-regulate mycobacteria-induced autophagy. MiR-1303 production is shown to be upregulated during BCG infection and its production is regulated by PI3K and NF kappa B. It is also demonstrated that miR-1303 targets putative target sites on Atg2B and possibly represses its translation.	[Au, Kin Yi; Pong, John C. H.; Ling, Wai Lim; Li, James C. B.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Li, JCB (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	jamesli@hkucc.hku.hk	Li, Chun Bong/C-4493-2009	Li, Chun Bong/0000-0002-7156-0318	Health and Medical Research Fund Hong Kong [13121172]	Health and Medical Research Fund Hong Kong	This work was supported by a grant from Health and Medical Research Fund Hong Kong (13121172), http://rfs1.fhb.gov.hk/english/welcome/welcome.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cecconi F, 2011, EMBO J, V30, P4517, DOI 10.1038/emboj.2011.387; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kleinnijenhuis J, 2011, IMMUNOLOGY, V134, P341, DOI 10.1111/j.1365-2567.2011.03494.x; Kovaleva V, 2012, CANCER RES, V72, P1763, DOI 10.1158/0008-5472.CAN-11-3671; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu JZ, 2012, AUTOPHAGY, V8, P873, DOI 10.4161/auto.19629; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064; Zullo AJ, 2012, J BIOL CHEM, V287, P12668, DOI 10.1074/jbc.M111.320135	32	17	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146770	10.1371/journal.pone.0146770	http://dx.doi.org/10.1371/journal.pone.0146770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771516	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300034
J	Lin, JD; Lin, CF; Chung, WB; Chiou, MT; Lin, CN				Lin, Jung-Da; Lin, Chuen-Fu; Chung, Wen-Bin; Chiou, Ming-Tang; Lin, Chao-Nan			Impact of Mated Female Nonproductive Days in Breeding Herd after Porcine Epidemic Diarrhea Virus Outbreak	PLOS ONE			English	Article							SUBSEQUENT REPRODUCTIVE-PERFORMANCE; UNITED-STATES; PRIMIPAROUS SOWS; FEED-INTAKE; LACTATION; STRAINS; PIGS; EMERGENCE; GERMANY; KOREA	Porcine epidemic diarrhea virus (PEDV) is an important pathogen that has a significant economic impact on the swine industry by imposing a high rate of mortality in suckling piglets. However, limited information on the productivity values of gilts and sows infected with PEDV is available. Here, we evaluate the productivity index in gilts and sows during the 1-year period before (19 January 2013 to 18 January 2014) and after (19 January 2014 to 18 January 2015) a PEDV outbreak from a 2000-sow breeding herd in Taiwan. The farrowing rate (FR), return rate (RR), total pigs born per litter (TB), pigs born alive per litter (BA), weaning pigs per litter (WPL), pre-weaning mortality, percentage of sows mated by 7 days after weaning, weaning to first service interval (WFSI), mated female nonproductive days (NPDs), replacement rate of sows and sow culling rate were compared using productive records. The FR (-9.6%), RR (+9.8%), TB (-1.6), BA (-1.1), WPL (-1.1), sows mated by 7 days after weaning (-6.9%), WFSI (+0.8 days), NPDs (+6.9 days) and sow culling rate (+7.2%) were significantly different between the 1-year pre-PEDV outbreak period and the post-PEDV outbreak period. Impacts of the PEDV infection on the reproductive performance were more severe in pregnant gilts than in sows. In conclusion, these findings indicate that the outbreak of PEDV caused an increase in the rate of NPDs in breeding herds.	[Lin, Jung-Da] Natl Chung Cheng Univ, Dept Business Adm, Chiayi 621, Taiwan; [Lin, Chuen-Fu] Natl Chiayi Univ, Dept Vet Med, Chiayi 60004, Taiwan; [Chung, Wen-Bin; Chiou, Ming-Tang; Lin, Chao-Nan] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Med, Pingtung 91201, Taiwan; [Chung, Wen-Bin; Chiou, Ming-Tang; Lin, Chao-Nan] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Anim Dis Diagnost Ctr, Pingtung 91201, Taiwan	National Chung Cheng University; National Chiayi University; National Pingtung University Science & Technology; National Pingtung University Science & Technology	Chiou, MT; Lin, CN (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Med, Pingtung 91201, Taiwan.; Chiou, MT; Lin, CN (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Vet Med, Anim Dis Diagnost Ctr, Pingtung 91201, Taiwan.	mtchiou@mail.npust.edu.tw; cnlin6@mail.npust.edu.tw						Almond GW., 2006, DIS SWINE, V9, P113; Alvarez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120532; Chiou MT, 2014, AUSTIN VIROL RETROVI, V1, P4; Choi JC, 2014, INFECT GENET EVOL, V26, P348, DOI 10.1016/j.meegid.2014.06.005; Hanke D, 2015, EMERG INFECT DIS, V21, P493, DOI 10.3201/eid2103.141165; King VL, 1998, PREV VET MED, V35, P255, DOI 10.1016/S0167-5877(98)00068-3; Koketsu Y, 1996, J ANIM SCI, V74, P2875; Koketsu Y, 2005, J ANIM SCI, V83, P1406; Koketsu Y, 1998, ANIM REPROD SCI, V52, P153, DOI 10.1016/S0378-4320(98)00093-1; Koketsu Y, 2009, J VET MED SCI, V71, P263, DOI 10.1292/jvms.71.263; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Lin CN, 2014, J VET MED SCI; Mejia-Guadarrama CA, 2002, J ANIM SCI, V80, P3286; Olanratmanee EO, 2010, ANIM REPROD SCI, V122, P42, DOI 10.1016/j.anireprosci.2010.07.004; Oldham J, 1972, PIG FARMING, V10, P72; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; PIJPERS A, 1993, VET REC, V132, P129, DOI 10.1136/vr.132.6.129; Puranaveja S, 2009, EMERG INFECT DIS, V15, P1112, DOI 10.3201/eid1507.081256; Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166; Stadler J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0454-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Sun DB, 2016, J VET MED SCI, V78, P355, DOI 10.1292/jvms.15-0446; Suzuki T, 2015, INFECT GENET EVOL, V36, P363, DOI 10.1016/j.meegid.2015.10.017; SVAJGR AJ, 1974, J ANIM SCI, V38, P100, DOI 10.2527/jas1974.381100x; Taylor D.J., 1999, DIS SWINE, P1029; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Yang H, 2000, J ANIM SCI, V78, P993	27	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147316	10.1371/journal.pone.0147316	http://dx.doi.org/10.1371/journal.pone.0147316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771383	gold, Green Published, Green Submitted			2022-12-26	WOS:000368628300075
J	Halpin, JC; Huang, B; Sun, M; Street, TO				Halpin, Jackson C.; Huang, Bin; Sun, Ming; Street, Timothy O.			Crowding Activates Heat Shock Protein 90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; chaperone; conformational change; heat shock protein 90 (Hsp90); macromolecular crowding	MOLECULAR CHAPERONE HSP90; ESCHERICHIA-COLI HSP90; CONFORMATIONAL-CHANGES; ENDOPLASMIC-RETICULUM; ATPASE CYCLE; STABILITY; NUCLEOTIDE; STATES; MECHANISM; DYNAMICS	Hsp90 is a dimeric ATP-dependent chaperone involved in the folding, maturation, and activation of diverse target proteins. Extensive in vitro structural analysis has led to a working model of Hsp90's ATP-driven conformational cycle. An implicit assumption is that dilute experimental conditions do not significantly perturb Hsp90 structure and function. However, Hsp90 undergoes a dramatic open/closed conformational change, which raises the possibility that this assumption may not be valid for this chaperone. Indeed, here we show that the ATPase activity of Hsp90 is highly sensitive to molecular crowding, whereas the ATPase activities of Hsp60 and Hsp70 chaperones are insensitive to crowding conditions. Polymer crowders activate Hsp90 in a non-saturable manner, with increasing efficacy at increasing concentration. Crowders exhibit a non-linear relationship between their radius of gyration and the extent to which they activate Hsp90. This experimental relationship can be qualitatively recapitulated with simple structure-based volume calculations comparing open/closed configurations of Hsp90. Thermodynamic analysis indicates that crowding activation of Hsp90 is entropically driven, which is consistent with a model in which excluded volume provides a driving force that favors the closed active state of Hsp90. Multiple Hsp90 homologs are activated by crowders, with the endoplasmic reticulum-specific Hsp90, Grp94, exhibiting the highest sensitivity. Finally, we find that crowding activation works by a different mechanism than co-chaperone activation and that these mechanisms are independent. We hypothesize that Hsp90 has a higher intrinsic activity in the cell than in vitro.	[Halpin, Jackson C.; Huang, Bin; Sun, Ming; Street, Timothy O.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University	Street, TO (corresponding author), Brandeis Univ, 415 South St, Waltham, MA 02454 USA.	tstreet@brandeis.edu		Halpin, Jackson/0000-0003-4085-1064	National Institutes of Health [R01 GM115356]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM115356 ( to T. O. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Benton LA, 2012, BIOCHEMISTRY-US, V51, P9773, DOI 10.1021/bi300909q; Bron P, 2008, BIOL CELL, V100, P413, DOI 10.1042/BC20070149; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Ghaemmaghami S, 2001, NAT STRUCT BIOL, V8, P879, DOI 10.1038/nsb1001-879; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Krukenberg KA, 2009, PROTEIN SCI, V18, P1815, DOI 10.1002/pro.191; Krukenberg KA, 2009, J MOL BIOL, V390, P278, DOI 10.1016/j.jmb.2009.04.080; Lavery LA, 2014, MOL CELL, V53, P330, DOI 10.1016/j.molcel.2013.12.023; Li J, 2013, NAT STRUCT MOL BIOL, V20, P326, DOI 10.1038/nsmb.2502; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Partridge JR, 2014, ELIFE, V3, DOI 10.7554/eLife.03487; Reid C, 1997, BIOPHYS J, V72, P1022, DOI 10.1016/S0006-3495(97)78754-X; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Sarkar M, 2013, P NATL ACAD SCI USA, V110, P19342, DOI 10.1073/pnas.1312678110; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wang Y, 2014, MOL PHARMACEUT, V11, P1391, DOI 10.1021/mp400521b; Wayne N, 2011, METHODS MOL BIOL, V787, P33, DOI 10.1007/978-1-61779-295-3_3; Wearsch PA, 1997, J BIOL CHEM, V272, P5152, DOI 10.1074/jbc.272.8.5152; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504	34	14	14	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6447	6455		10.1074/jbc.M115.702928	http://dx.doi.org/10.1074/jbc.M115.702928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797120	Green Published, hybrid			2022-12-26	WOS:000372894200032
J	Nonaka, T; Suzuki, G; Tanaka, Y; Kametani, F; Hirai, S; Okado, H; Miyashita, T; Saitoe, M; Akiyama, H; Masai, H; Hasegawa, M				Nonaka, Takashi; Suzuki, Genjiro; Tanaka, Yoshinori; Kametani, Fuyuki; Hirai, Shinobu; Okado, Haruo; Miyashita, Tomoyuki; Saitoe, Minoru; Akiyama, Haruhiko; Masai, Hisao; Hasegawa, Masato			Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1 Triggers Mislocalization and Accumulation of TDP-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ALS (Lou Gehrig disease); phosphorylation; protein aggregation; protein kinase; casein kinase 1; frontotemporal lobar degeneration (FTLD); TAR DNA-binding protein of 43 kDa (TDP-43)	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PATHOLOGICAL ALPHA-SYNUCLEIN; NUCLEAR FACTOR TDP-43; NEURODEGENERATIVE-DISEASES; CFTR EXON-9; CDC7 KINASE; IN-VIVO; AGGREGATION; TOXICITY	Intracellular aggregates of phosphorylated TDP-43 are a major component of ubiquitin-positive inclusions in the brains of patients with frontotemporal lobar degeneration and ALS and are considered a pathological hallmark. Here, to gain insight into the mechanism of intracellular TDP-43 accumulation, we examined the relationship between phosphorylation and aggregation of TDP-43. We found that expression of a hyperactive form of casein kinase 1 (CK11-317, a C-terminally truncated form) promotes mislocalization and cytoplasmic accumulation of phosphorylated TDP-43 (ubiquitin- and p62-positive) in cultured neuroblastoma SH-SY5Y cells. Insoluble phosphorylated TDP-43 prepared from cells co-expressing TDP-43 and CK11-317 functioned as seeds for TDP-43 aggregation in cultured cells, indicating that CK11-317-induced aggregated TDP-43 has prion-like properties. A striking toxicity and alterations of TDP-43 were also observed in yeast expressing TDP-43 and CK11-317. Therefore, abnormal activation of CK1 causes phosphorylation of TDP-43, leading to the formation of cytoplasmic TDP-43 aggregates, which, in turn, may trigger neurodegeneration.	[Nonaka, Takashi; Suzuki, Genjiro; Tanaka, Yoshinori; Kametani, Fuyuki; Akiyama, Haruhiko; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dementia Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Hirai, Shinobu; Okado, Haruo] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Miyashita, Tomoyuki; Saitoe, Minoru] Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science	Nonaka, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Dementia Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	nonaka-tk@igakuken.or.jp	Kametani, Fuyuki/G-4752-2011; Nonaka, Takashi/L-8572-2017	Kametani, Fuyuki/0000-0001-9125-7001; Saitoe, Minoru/0000-0001-9731-4214; Tanaka, Yoshinori/0000-0003-1428-0683; Nonaka, Takashi/0000-0002-0830-9403	MEXT KAKENHI [26111730, 26117005, 23240050]; JSPS KAKENHI [23228004]; MHLW [12946221]; Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis of the Japan Agency for Medical Research and Development; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25115006, 26251004, 14J03307] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MHLW(Ministry of Health, Labour and Welfare, Japan); Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT KAKENHI Grants 26111730 (to T. N.) and 26117005 and 23240050 (to M. H.), JSPS KAKENHI Grant 23228004 (to M. H.), MHLW Grant 12946221 (to M. H.), a grant-in-aid for research on rare and intractable diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis of the Japan Agency for Medical Research and Development (to M. H.), and a grant from the Takeda Science Foundation (to T. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Carlomagno Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090452; Choksi DK, 2014, HUM MOL GENET, V23, P1025, DOI 10.1093/hmg/ddt498; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Kitamura R, 2011, J BIOL CHEM, V286, P23031, DOI 10.1074/jbc.M111.243311; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; Liachko NF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004803; Liachko NF, 2013, ANN NEUROL, V74, P39, DOI 10.1002/ana.23870; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Masuda-Suzukake M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0088-8; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yamada M, 2014, CELL CYCLE, V13, P1859, DOI 10.4161/cc.29251; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	43	74	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5473	5483		10.1074/jbc.M115.695379	http://dx.doi.org/10.1074/jbc.M115.695379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26769969	Green Published, hybrid			2022-12-26	WOS:000372551800003
J	Rahman, MH; Jha, MK; Kim, JH; Nam, Y; Lee, MG; Go, Y; Harris, RA; Park, DH; Kook, H; Lee, IK; Suk, K				Rahman, Md Habibur; Jha, Mithilesh Kumar; Kim, Jong-Heon; Nam, Youngpyo; Lee, Maan Gee; Go, Younghoon; Harris, Robert A.; Park, Dong Ho; Kook, Hyun; Lee, In-Kyu; Suk, Kyoungho			Pyruvate Dehydrogenase Kinase-mediated Glycolytic Metabolic Shift in the Dorsal Root Ganglion Drives Painful Diabetic Neuropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; dorsal root ganglia; lactic acid; metabolism; neuron; pyruvate dehydrogenase kinase (PDC kinase); glia; glycolytic metabolic shift; painful neuropathy	SATELLITE GLIAL-CELLS; SENSING ION CHANNELS; LACTIC-ACIDOSIS; OXIDATIVE STRESS; SPINAL-CORD; TACTILE ALLODYNIA; SENSORY NEURONS; SCIATIC-NERVE; IN-VITRO; LACTATE	The dorsal root ganglion (DRG) is a highly vulnerable site in diabetic neuropathy. Under diabetic conditions, the DRG is subjected to tissue ischemia or lower ambient oxygen tension that leads to aberrant metabolic functions. Metabolic dysfunctions have been documented to play a crucial role in the pathogenesis of diverse pain hypersensitivities. However, the contribution of diabetes-induced metabolic dysfunctions in the DRG to the pathogenesis of painful diabetic neuropathy remains ill-explored. In this study, we report that pyruvate dehydrogenase kinases (PDK2 and PDK4), key regulatory enzymes in glucose metabolism, mediate glycolytic metabolic shift in the DRG leading to painful diabetic neuropathy. Streptozotocin-induced diabetes substantially enhanced the expression and activity of the PDKs in the DRG, and the genetic ablation of Pdk2 and Pdk4 attenuated the hyperglycemia-induced pain hypersensitivity. Mechanistically, Pdk2/4 deficiency inhibited the diabetes-induced lactate surge, expression of pain-related ion channels, activation of satellite glial cells, and infiltration of macrophages in the DRG, in addition to reducing central sensitization and neuroinflammation hallmarks in the spinal cord, which probably accounts for the attenuated pain hypersensitivity. Pdk2/4-deficient mice were partly resistant to the diabetes-induced loss of peripheral nerve structure and function. Furthermore, in the experiments using DRG neuron cultures, lactic acid treatment enhanced the expression of the ion channels and compromised cell viability. Finally, the pharmacological inhibition of DRG PDKs or lactic acid production substantially attenuated diabetes-induced pain hypersensitivity. Taken together, PDK2/4 induction and the subsequent lactate surge induce the metabolic shift in the diabetic DRG, thereby contributing to the pathogenesis of painful diabetic neuropathy.	[Rahman, Md Habibur; Jha, Mithilesh Kumar; Kim, Jong-Heon; Nam, Youngpyo; Lee, Maan Gee; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Brain Sci & Engn Inst, Dept Pharmacol,Plus KNU Biomed Convergence Progra, 680 Gukchaebosang St, Daegu 41944, South Korea; [Go, Younghoon; Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, 680 Gukchaebosang St, Daegu 41944, South Korea; [Park, Dong Ho] Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, 680 Gukchaebosang St, Daegu 41944, South Korea; [Harris, Robert A.] Indiana Univ Sch Med, Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Kook, Hyun] Chonnam Natl Univ, Sch Med, Dept Pharmacol, Gwangju 501746, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Chonnam National University	Suk, K (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, 680 Gukchaebosang St, Daegu 41944, South Korea.	ksuk@knu.ac.kr	Kook, Hyun/AAR-5405-2021; Lee, In-Kyu/AAR-6374-2021	Kook, Hyun/0000-0002-0740-1806; Jha, Mithilesh Kumar/0000-0002-9526-0053; Maan-Gee, Lee/0000-0002-0172-1593	Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea [A111345]; Basic Science Research Program through the National Research Foundation - Korean Ministry of Education, Science, and Technology [2008-0062282, 2015R1A2A1A10051958]	Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation - Korean Ministry of Education, Science, and Technology	This work was supported by Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea, Grant A111345. This work was also supported by the Basic Science Research Program through the National Research Foundation funded by the Korean Ministry of Education, Science, and Technology, Grants 2008-0062282 and 2015R1A2A1A10051958. The authors declare that they have no conflicts of interest with the contents of this article.	Arumugam R, 2010, ENDOCRINOLOGY, V151, P3074, DOI 10.1210/en.2010-0049; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Aslam A., 2014, PAIN RES TREAT, V2014, DOI DOI 10.1155/2014/412041; Baloh RH, 2008, NEUROSCIENTIST, V14, P12, DOI 10.1177/1073858407307354; Ton BHT, 2013, ACTA HISTOCHEM, V115, P840, DOI 10.1016/j.acthis.2013.04.007; Bishnoi M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-52; Bocarsly ME, 2015, P NATL ACAD SCI USA, V112, P15731, DOI 10.1073/pnas.1511593112; Brenneis C, 2013, J NEUROSCI, V33, P315, DOI 10.1523/JNEUROSCI.2804-12.2013; BROCK FE, 1990, SCHWEIZ MED WSCHR, V120, P1477; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Chopra K, 2010, J PAIN, V11, P950, DOI 10.1016/j.jpain.2010.01.006; Chu XP, 2013, ADV EXP MED BIOL, V961, P419, DOI 10.1007/978-1-4614-4756-6_36; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Doupis J, 2009, J CLIN ENDOCR METAB, V94, P2157, DOI 10.1210/jc.2008-2385; Fox A, 1999, PAIN, V81, P307, DOI 10.1016/S0304-3959(99)00024-X; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Galloway C, 2013, CYTOKINE, V63, P1, DOI 10.1016/j.cyto.2013.04.009; Gao Yong-Jing, 2009, Open Pain J, V2, P11; GEORGADZE AK, 1985, FARMAKOL TOKSIKOL, V48, P101; Gibbons CH, 2015, BRAIN, V138, P43, DOI 10.1093/brain/awu307; GREENE DA, 1979, J NEUROCHEM, V33, P1007, DOI 10.1111/j.1471-4159.1979.tb05237.x; Greig Marni, 2014, Handb Clin Neurol, V126, P559, DOI 10.1016/B978-0-444-53480-4.00037-0; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hanani M, 2014, J CELL MOL MED, V18, P2367, DOI 10.1111/jcmm.12406; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hayashi Toshihiro, 2011, Brain and Nerve (Tokyo), V63, P1307; Herbst EAF, 2014, AM J PHYSIOL-REG I, V306, pR102, DOI 10.1152/ajpregu.00150.2013; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Hwang Hye Suk, 2011, Exp Neurobiol, V20, P144, DOI 10.5607/en.2011.20.3.144; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Jasmin L, 2010, NEURON GLIA BIOL, V6, P63, DOI 10.1017/S1740925X10000098; Jeoung NH, 2012, BIOCHEM J, V443, P829, DOI 10.1042/BJ20112197; Jha Mithilesh Kumar, 2013, Brain Tumor Res Treat, V1, P57, DOI 10.14791/btrt.2013.1.2.57; Jha MK, 2014, EXP NEUROL, V254, P41, DOI 10.1016/j.expneurol.2014.01.009; Jha MK, 2014, PROTEOMICS, V14, P378, DOI 10.1002/pmic.201300236; Jha MK, 2012, CURR NEUROPHARMACOL, V10, P393, DOI 10.2174/157015912804143586; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; KADEKARO M, 1985, P NATL ACAD SCI USA, V82, P6010, DOI 10.1073/pnas.82.17.6010; Kadic AJ, 2014, NEUROSCIENCE, V256, P302, DOI 10.1016/j.neuroscience.2013.10.032; Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27; KEMPSKI O, 1988, STROKE, V19, P385, DOI 10.1161/01.STR.19.3.385; Kennedy JM, 2000, BRAIN, V123, P2118, DOI 10.1093/brain/123.10.2118; Kim SJ, 2011, P NATL ACAD SCI USA, V108, P3371, DOI 10.1073/pnas.1019755108; Kim TJ, 2007, J PAIN, V8, P59, DOI 10.1016/j.jpain.2006.06.003; Kishi M, 2002, DIABETES, V51, P819, DOI 10.2337/diabetes.51.3.819; KRAIG RP, 1987, J CEREBR BLOOD F MET, V7, P379, DOI 10.1038/jcbfm.1987.80; Krzymien J, 2013, POL ARCH MED WEWN, V123, P91, DOI 10.20452/pamw.1619; Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014; KURLEMANN G, 1995, EUR J PEDIATR, V154, P928, DOI 10.1007/BF01957508; Kwon MJ, 2013, J NEUROSCI, V33, P15095, DOI 10.1523/JNEUROSCI.0278-13.2013; Laferriere A, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-49; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lee Y, 2005, MOL CELLS, V20, P315; Liang HS, 2014, CYTOTHERAPY, V16, P523, DOI 10.1016/j.jcyt.2013.11.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOIKE JD, 1993, J IMMUNOL, V150, P1951; Luft FC, 2001, J AM SOC NEPHROL, V12, pS15; Macauley SL, 2015, J CLIN INVEST, V125, P2463, DOI 10.1172/JCI79742; Mansikka H, 2004, ANESTHESIOLOGY, V100, P912, DOI 10.1097/00000542-200404000-00022; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; McGuire JF, 2009, DIABETES, V58, P2677, DOI 10.2337/db09-0594; Morten KJ, 1998, NEUROLOGY, V51, P1331, DOI 10.1212/WNL.51.5.1331; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naruse K, 2005, DIABETES, V54, P1823, DOI 10.2337/diabetes.54.6.1823; Naruse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027458; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; Nukada H, 2011, BRAIN RES, V1373, P172, DOI 10.1016/j.brainres.2010.11.084; Ohashi T, 2013, INT J CANCER, V133, P1107, DOI 10.1002/ijc.28114; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Pabbidi RM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-9; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Phillips LK, 2015, NAT REV ENDOCRINOL, V11, P112, DOI 10.1038/nrendo.2014.202; Polonsky KS, 2012, NEW ENGL J MED, V367, P1332, DOI 10.1056/NEJMra1110560; Puljak L, 2009, J NEUROSCI METH, V177, P397, DOI 10.1016/j.jneumeth.2008.10.029; Qi J, 2011, J IMMUNOL, V186, P6417, DOI 10.4049/jimmunol.1001241; Radu BM, 2014, CELL BIOCHEM BIOPHYS, V68, P9, DOI 10.1007/s12013-013-9678-5; Rahman MH, 2016, CURR PHARM DESIGN, V22, P738, DOI 10.2174/1381612822666151204001234; Ramos-Nino Maria E, 2013, ISRN Oncol, V2013, P697521, DOI 10.1155/2013/697521; Rinnankoski-Tuikka R, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-53; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Rogatzki MJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00022; Sala F, 1999, ANN NY ACAD SCI, V890, P133, DOI 10.1111/j.1749-6632.1999.tb07989.x; Sasaki H, 1997, ACTA NEUROPATHOL, V93, P118, DOI 10.1007/s004010050592; Schmeichel AM, 2003, DIABETES, V52, P165, DOI 10.2337/diabetes.52.1.165; Shakeel M, 2015, DIABETES METAB SYND, V9, P373, DOI 10.1016/j.dsx.2014.04.029; SIESJO BK, 1985, J CEREBR BLOOD F MET, V5, P253, DOI 10.1038/jcbfm.1985.32; Sima AAF, 1999, DIABETOLOGIA, V42, P773, DOI 10.1007/s001250051227; Sotelo-Hitschfeld T, 2015, J NEUROSCI, V35, P4168, DOI 10.1523/JNEUROSCI.5036-14.2015; Stacpoole PW, 1998, DRUG METAB REV, V30, P499, DOI 10.3109/03602539808996323; Stacpoole PW, 1998, ENVIRON HEALTH PERSP, V106, P989, DOI 10.1289/ehp.98106s4989; STAUB F, 1993, J NEUROL SCI, V119, P79, DOI 10.1016/0022-510X(93)90194-4; Staub F, 1994, Anasthesiol Intensivmed Notfallmed Schmerzther, V29, P203, DOI 10.1055/s-2007-996719; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Tao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071997; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Tsuda M, 2008, GLIA, V56, P378, DOI 10.1002/glia.20623; Wang DM, 2014, EUR J PHARMACOL, V728, P59, DOI 10.1016/j.ejphar.2014.01.057; WATKINS PJ, 1969, BMJ-BRIT MED J, V1, P744, DOI 10.1136/bmj.1.5646.744; Weisberg LS, 2015, CLIN J AM SOC NEPHRO, V10, P1476, DOI 10.2215/CJN.10871014; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; YAGIHASHI S, 1995, DIABETES METAB REV, V11, P193, DOI 10.1002/dmr.5610110304; Zhao WC, 2014, NEUROSCI LETT, V560, P81, DOI 10.1016/j.neulet.2013.12.019; ZOCHODNE DW, 1991, BRAIN RES, V559, P89, DOI 10.1016/0006-8993(91)90290-C; Zochodne DW, 2001, BRAIN, V124, P2319, DOI 10.1093/brain/124.11.2319	112	39	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					6011	6025		10.1074/jbc.M115.699215	http://dx.doi.org/10.1074/jbc.M115.699215			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26769971	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000372551800045
J	Pugh, RJ; Slee, JB; Farwell, SLN; Li, YQ; Barthol, T; Patton, WA; Lowe-Krentz, LJ				Pugh, Raymond J.; Slee, Joshua B.; Farwell, Sara Lynn N.; Li, Yaqiu; Barthol, Trista; Patton, Walter A.; Lowe-Krentz, Linda J.			Transmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ERK; heparin-binding protein; receptor; signal transduction; vascular smooth muscle cells	CULTURED ENDOTHELIAL-CELLS; SULFATE PROTEOGLYCANS; KINASE ACTIVATION; PROLIFERATION; CAVEOLAE; SYNDECAN-1; BINDING; GROWTH; ATHEROSCLEROSIS; ENDOCYTOSIS	Vascular cell responses to exogenous heparin have been documented to include decreased vascular smooth muscle cell proliferation following decreased ERK pathway signaling. However, the molecular mechanism(s) by which heparin interacts with cells to induce those responses has remained unclear. Previously characterized monoclonal antibodies that block heparin binding to vascular cells have been found to mimic heparin effects. In this study, those antibodies were employed to isolate a heparin binding protein. MALDI mass spectrometry data provide evidence that the protein isolated is transmembrane protein 184A (TMEM184A). Commercial antibodies against three separate regions of the TMEM184A human protein were used to identify the TMEM184A protein in vascular smooth muscle cells and endothelial cells. A GFP-TMEM184A construct was employed to determine colocalization with heparin after endocytosis. Knockdown of TMEM184A eliminated the physiological responses to heparin, including effects on ERK pathway activity and BrdU incorporation. Isolated GFP-TMEM184A binds heparin, and overexpression results in additional heparin uptake. Together, these data support the identification of TMEM184A as a heparin receptor in vascular cells.	[Slee, Joshua B.; Farwell, Sara Lynn N.; Li, Yaqiu; Barthol, Trista; Lowe-Krentz, Linda J.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Pugh, Raymond J.] Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA; [Patton, Walter A.] Lebanon Valley Coll, Dept Chem, Annville, PA 17003 USA; [Slee, Joshua B.] DeSales Univ, Dept Nat Sci, Center Valley, PA 18034 USA; [Pugh, Raymond J.] Penn State Univ, 403 Wartik Lab, University Pk, PA 16802 USA	Lehigh University; Lehigh University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lowe-Krentz, LJ (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	ljl0@lehigh.edu	LI, Yaqiu/GRY-7432-2022		Public Health Service [HL54269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL054269] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Public Health Service Contract Grant HL54269 (to L. J. L. K.).	Baeyens N, 2014, P NATL ACAD SCI USA, V111, P17308, DOI 10.1073/pnas.1413725111; BARZU T, 1985, BIOCHIM BIOPHYS ACTA, V845, P196, DOI 10.1016/0167-4889(85)90177-6; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Best D, 2009, DEV DYNAM, V238, P223, DOI 10.1002/dvdy.21827; Blaukovitch CI, 2010, J CELL BIOCHEM, V110, P382, DOI 10.1002/jcb.22543; BUSCH SJ, 1992, J CELL BIOL, V116, P31, DOI 10.1083/jcb.116.1.31; CASTELLOT JJ, 1985, J CELL PHYSIOL, V124, P13, DOI 10.1002/jcp.1041240104; CASTELLOT JJ, 1981, J CELL BIOL, V90, P372, DOI 10.1083/jcb.90.2.372; Chen KY, 2013, J BIOL CHEM, V288, P13988, DOI 10.1074/jbc.M112.444737; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Chiodelli P, 2015, MOLECULES, V20, P6342, DOI 10.3390/molecules20046342; CLOWES AW, 1977, NATURE, V265, P625, DOI 10.1038/265625a0; Couchman JR, 2015, INT J EXP PATHOL, V96, P1, DOI 10.1111/iep.12112; Ebong EE, 2014, INTEGR BIOL-UK, V6, P338, DOI 10.1039/c3ib40199e; Farwell SLN, 2016, J BIOL CHEM, V291, P5342, DOI 10.1074/jbc.M115.681288; Fasciano S, 2005, J BIOL CHEM, V280, P15682, DOI 10.1074/jbc.M411458200; Gilotti AC, 2014, J CELL PHYSIOL, V229, P2142, DOI 10.1002/jcp.24677; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Li X, 2012, THROMB RES, V129, pE223, DOI 10.1016/j.thromres.2012.03.003; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; Obunike JC, 2001, J BIOL CHEM, V276, P8934, DOI 10.1074/jbc.M008813200; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; OTTLINGER ME, 1993, J BIOL CHEM, V268, P19173; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; PATTON WA, 1995, BIOCHEM J, V311, P461, DOI 10.1042/bj3110461; PUKAC LA, 1990, CELL REGUL, V1, P435, DOI 10.1091/mbc.1.5.435; Pukac LA, 1997, J CELL PHYSIOL, V172, P69, DOI 10.1002/(SICI)1097-4652(199707)172:1<69::AID-JCP8>3.0.CO;2-B; Rath G, 2009, J PHYSIOL PHARMACOL, V60, P105; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; REILLY CF, 1989, J BIOL CHEM, V264, P6990; Savage JM, 2001, J CELL PHYSIOL, V187, P283, DOI 10.1002/jcp.1076; Singh A, 2015, J BIOL CHEM, V290, P15421, DOI 10.1074/jbc.M115.655845; Slee J.B., 2012, HEPARIN PROPERTIES U, P59; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stewart MD, 2015, J BIOL CHEM, V290, P941, DOI 10.1074/jbc.M114.608455; Thourani VH, 2000, AM J PHYSIOL-HEART C, V278, pH2084, DOI 10.1152/ajpheart.2000.278.6.H2084; Vlodavsky I, 2013, MATRIX BIOL, V32, P241, DOI 10.1016/j.matbio.2013.03.002; Voyvodic PL, 2014, J BIOL CHEM, V289, P9547, DOI 10.1074/jbc.M113.541573; Xie-Zukauskas H, 2013, VASC PHARMACOL, V58, P313, DOI 10.1016/j.vph.2012.12.003; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Zeng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086249; Zeng Y, 2013, AM J PHYSIOL-HEART C, V305, pH811, DOI 10.1152/ajpheart.00764.2012	45	14	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5326	5341		10.1074/jbc.M115.681122	http://dx.doi.org/10.1074/jbc.M115.681122			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26769966	Green Published, hybrid			2022-12-26	WOS:000371640600042
J	Belstrom, D; Holmstrup, P; Bardow, A; Kokaras, A; Fiehn, NE; Paster, BJ				Belstrom, Daniel; Holmstrup, Palle; Bardow, Allan; Kokaras, Alexis; Fiehn, Nils-Erik; Paster, Bruce J.			Temporal Stability of the Salivary Microbiota in Oral Health	PLOS ONE			English	Article							PERIODONTAL-DISEASE; BIOMARKERS; PATTERNS; INDIVIDUALS; DIVERSITY; ANALYTES; LESIONS; RNA	Objectives Saliva is a biological fluid suitable for biomarker analysis, and differences in the salivary microbiota in oral health and disease have been reported. For such comparative analyses, time of sampling is critical since the bacterial composition may vary throughout the day, i.e., diurnal variation. The purpose of this study is to compare the salivary microbiome over time to determine the optimal time for sampling. Design Stimulated saliva samples were collected from 5 orally healthy individuals in 4 h intervals for 24 h, and collection was repeated 7 days later (number of samples per person, n = 12, total number of samples, n = 60). Salivary microbiota was analyzed using the Human Oral Microbe Identification using Next Generation Sequencing (HOMINGS), and statistical analysis was performed using the Kruskal-Wallis test with Benjamini-Hochberg's correction for multiple comparisons, cluster analysis, principal component analysis and correspondence analysis. Results From a total of 60 saliva samples, 477 probe targets were collectively identified with a mean number of probes per sample of 207 (range: 153-307). Little or no variation in microbial profiles within subjects was observed over time. Conclusions Although there was considerable variation between subjects, microbial profiles within subjects were stable throughout a 24 hour period and after 1 week. Since there is little or no evidence of diurnal variation of the salivary microbiome, time of sampling of saliva is not critical for perturbation or other microbial studies.	[Belstrom, Daniel; Holmstrup, Palle] Univ Copenhagen, Sect Periodontol Microbiol & Community Dent, Fac Hlth & Med Sci, Sch Dent, Copenhagen, Denmark; [Bardow, Allan] Univ Copenhagen, Sch Dent, Dept Oral Med, Copenhagen, Denmark; [Kokaras, Alexis; Paster, Bruce J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Fiehn, Nils-Erik] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark; [Paster, Bruce J.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA	University of Copenhagen; University of Copenhagen; Harvard University; Forsyth Institute; University of Copenhagen; Harvard University; Harvard School of Dental Medicine	Belstrom, D (corresponding author), Univ Copenhagen, Sect Periodontol Microbiol & Community Dent, Fac Hlth & Med Sci, Sch Dent, Copenhagen, Denmark.	dbel@sund.ku.dk	Paster, Bruce J/AAP-8559-2021		Danish Dental Association; Danish Foundation of Mutual Efforts in Dental Care; Trygfonden; Simon Spies Foundation; NIH [DE021565]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021565] Funding Source: NIH RePORTER	Danish Dental Association; Danish Foundation of Mutual Efforts in Dental Care; Trygfonden; Simon Spies Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by external financial support by: the Danish Dental Association, the Danish Foundation of Mutual Efforts in Dental Care, Trygfonden, and the Simon Spies Foundation. It was also funded in part from NIH grant DE021565 (BJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Belstrom D, 2014, CARIES RES, V48, P368, DOI 10.1159/000357502; Belstrom D., 2014, J ORAL MICROBIOL, V4, P1; Belstrom D, 2015, J ORAL MICROBIOL, P1; Belstrom D, 2014, J CLIN PERIODONTOL, V41, P104, DOI 10.1111/jcpe.12190; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Ebersole JL, 2013, J CLIN IMMUNOL, V33, P271, DOI 10.1007/s10875-012-9771-3; Giannobile W V, 2011, Adv Dent Res, V23, P375, DOI 10.1177/0022034511420434; Giannobile WV, 2009, PERIODONTOL 2000, V50, P52, DOI 10.1111/j.1600-0757.2008.00288.x; Gomes BPFA, 2015, J ENDODONT, V41, P1975, DOI 10.1016/j.joen.2015.08.022; Gursoy UK, 2013, J CLIN PERIODONTOL, V40, P18, DOI 10.1111/jcpe.12020; Gursoy UK, 2011, DIS MARKERS, V30, P299, DOI [10.3233/DMA-2011-0788, 10.1155/2011/621484]; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Kinney JS, 2011, J DENT RES, V90, P752, DOI 10.1177/0022034511399908; Kongstad J, 2013, ACTA ODONTOL SCAND, V71, P1560, DOI 10.3109/00016357.2013.776701; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Meschiari CA, 2013, CLIN CHIM ACTA, V421, P140, DOI 10.1016/j.cca.2013.03.008; Miller CS, 2010, BIOMARK MED, V4, P171, DOI 10.2217/BMM.09.68; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Rasiah IA, 2005, ARCH ORAL BIOL, V50, P779, DOI 10.1016/j.archoralbio.2005.02.001; Rathnayake N, 2013, J CLIN PERIODONTOL, V40, P140, DOI 10.1111/jcpe.12038; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schafer CA, 2014, MONOGR ORAL SCI, V24, P88, DOI 10.1159/000358791; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sexton WM, 2011, J CLIN PERIODONTOL, V38, P434, DOI 10.1111/j.1600-051X.2011.01706.x; Spear GT, 2005, FEMS IMMUNOL MED MIC, V45, P129, DOI 10.1016/j.femsim.2005.03.002; Teles RP, 2009, J PERIODONTAL RES, V44, P411, DOI 10.1111/j.1600-0765.2008.01119.x; Thomas MV, 2009, J PERIODONTOL, V80, P1146, DOI 10.1902/jop.2009.080654; Tobon-Arroyave SI, 2008, ARCH ORAL BIOL, V53, P346, DOI 10.1016/j.archoralbio.2007.11.005; Yakob Maha, 2014, Curr Oral Health Rep, V1, P133; Yoshizawa JM, 2013, CLIN MICROBIOL REV, V26, P781, DOI 10.1128/CMR.00021-13; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010	35	83	83	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147472	10.1371/journal.pone.0147472	http://dx.doi.org/10.1371/journal.pone.0147472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799067	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300111
J	Cunha, JPS; Choupina, HMP; Rocha, AP; Fernandes, JM; Achilles, F; Loesch, AM; Vollmar, C; Hartl, E; Noachtar, S				Cunha, Joao Paulo Silva; Choupina, Hugo Miguel Pereira; Rocha, Ana Patricia; Fernandes, Jose Maria; Achilles, Felix; Loesch, Anna Mira; Vollmar, Christian; Hartl, Elisabeth; Noachtar, Soheyl			NeuroKinect: A Novel Low-Cost 3Dvideo-EEG System for Epileptic Seizure Motion Quantification	PLOS ONE			English	Article							UPPER-LIMB AUTOMATISMS; TEMPORAL-LOBE; MOVEMENT QUANTIFICATION; ACCELEROMETRY; SEMIOLOGY	Epilepsy is a common neurological disorder which affects 0.5-1% of the world population. Its diagnosis relies both on Electroencephalogram (EEG) findings and characteristic seizure -induced body movements - called seizure semiology. Thus, synchronous EEG and (2D) video recording systems (known as Video-EEG) are the most accurate tools for epilepsy diagnosis. Despite the establishment of several quantitative methods for EEG analysis, seizure semiology is still analyzed by visual inspection, based on epileptologists' subjective interpretation of the movements of interest (MOIs) that occur during recorded seizures. In this contribution, we present NeuroKinect, a low-cost, easy to setup and operate solution for a novel 3Dvideo-EEG system. It is based on a RGB-D sensor (Microsoft Kinect camera) and performs 24/7 monitoring of an Epilepsy Monitoring Unit (EMU) bed. It does not require the attachment of any reflectors or sensors to the patient's body and has a very low maintenance load. To evaluate its performance and usability, we mounted a state-of-the-art 6-camera motion-capture system and our low-cost solution over the same EMU bed. A comparative study of seizure-simulated MOIs showed an average correlation of the resulting 3D motion trajectories of 84.2%. Then, we used our system on the routine of an EMU and collected 9 different seizures where we could perform 3D kinematic analysis of 42 MOIs arising from the temporal (TLE) (n = 19) and extratemporal (ETE) brain regions (n = 23). The obtained results showed that movement displacement and movement extent discriminated both seizure MOI groups with statistically significant levels (mean = 0.15 m vs. 0.44 m, p<0.001; mean = 0.068 m(3) vs. 0.14 m(3), p< 0.05, respectively). Furthermore, TLE MOIs were significantly shorter than ETE (mean = 23 seconds vs 35 seconds, p< 0.01) and presented higher jerking levels (mean = 345 ms(-3) vs 172 ms(-3), p< 0.05). Our newly implemented 3D approach is faster by 87.5% in extracting body motion trajectories when compared to a 2D frame by frame tracking procedure. We conclude that this new approach provides a more comfortable (both for patients and clinical professionals), simpler, faster and lower-cost procedure than previous approaches, therefore providing a reliable tool to quantitatively analyze MOI patterns of epileptic seizures in the routine of EMUs around the world. We hope this study encourages other EMUs to adopt similar approaches so that more quantitative information is used to improve epilepsy diagnosis.	[Cunha, Joao Paulo Silva; Choupina, Hugo Miguel Pereira] Univ Porto, Inst Syst Engn & Comp Technol & Sci INESC TEC, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Cunha, Joao Paulo Silva; Choupina, Hugo Miguel Pereira] Univ Porto, Fac Engn FEUP, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Rocha, Ana Patricia; Fernandes, Jose Maria] Univ Aveiro, Inst Elect & Informat Engn Aveiro IEETA, P-3800 Aveiro, Portugal; [Rocha, Ana Patricia; Fernandes, Jose Maria] Univ Aveiro, Dept Elect Telecommun & Informat, P-3800 Aveiro, Portugal; [Choupina, Hugo Miguel Pereira; Achilles, Felix; Loesch, Anna Mira; Vollmar, Christian; Hartl, Elisabeth; Noachtar, Soheyl] Univ Munich, Dept Neurol, Epilepsy Ctr, D-80539 Munich, Germany; [Achilles, Felix] Tech Univ Munich, Chair Comp Aided Med Proc, D-80290 Munich, Germany	INESC TEC; Universidade do Porto; Universidade do Porto; Universidade de Aveiro; Universidade de Aveiro; University of Munich; Technical University of Munich	Cunha, JPS (corresponding author), Univ Porto, Inst Syst Engn & Comp Technol & Sci INESC TEC, Rua Campo Alegre 823, P-4100 Porto, Portugal.; Cunha, JPS (corresponding author), Univ Porto, Fac Engn FEUP, Rua Campo Alegre 823, P-4100 Porto, Portugal.	jcunha@ieee.org	Rocha, Ana Patrícia/A-7991-2019; Cunha, João Paulo/AAL-1526-2021; Fernandes, Jose Maria/A-1331-2012; Cunha, Joao Paulo/F-9039-2010	Rocha, Ana Patrícia/0000-0002-4094-7982; Fernandes, Jose Maria/0000-0002-0681-9354; Choupina, Hugo/0000-0003-0864-3003; Vollmar, Christian/0000-0002-4630-7484; Cunha, Joao Paulo/0000-0003-4131-9045	ERDF (European Regional Development Fund) through the COMPETE Programme (operational programme for competitiveness); Portuguese Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) [EEI/UI0127/2014, UID/CEC/00127/2013, PTDC/SAUBEB/72305/2006, PTDC/NEU-SCC/0767/2012, UID/EEA/50014/2013]	ERDF (European Regional Development Fund) through the COMPETE Programme (operational programme for competitiveness); Portuguese Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology)	This work is partially funded by the ERDF (European Regional Development Fund) through the COMPETE Programme (operational programme for competitiveness) and by Portuguese Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) within the projects Incentivo EEI/UI0127/2014 and UID/CEC/00127/2013, MovEpil3D (PTDC/SAUBEB/72305/2006), MDAS (PTDC/NEU-SCC/0767/2012) and UID/EEA/50014/2013 granted to INESC TEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asus, 2014, ASUS XTION PRO LIVE; BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984; Becq G, 2011, COMPUT BIOL MED, V41, P46, DOI 10.1016/j.compbiomed.2010.11.005; Bleasel A, 1997, EPILEPSIA, V38, P168, DOI 10.1111/j.1528-1157.1997.tb01093.x; Burrus N., 2014, KINECT CALIBRATION; Chen L, 2009, EPILEPSY BEHAV, V14, P344, DOI 10.1016/j.yebeh.2008.11.007; Cook JL, 2013, BRAIN, V136, P2816, DOI 10.1093/brain/awt208; Cunha J. P. Silva, 2009, 11th International Congress of the IUPESM. World Congress on Medical Physics and Biomedical Engineering. Image Processing, Biosignal Processing, Modelling and Simulation, Biomechanics, P1435, DOI 10.1007/978-3-642-03882-2_380; Cunha JPS, 2003, P ANN INT IEEE EMBS, V25, P671, DOI 10.1109/IEMBS.2003.1279851; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gabel Moshe, 2012, Annu Int Conf IEEE Eng Med Biol Soc, V2012, P1964, DOI 10.1109/EMBC.2012.6346340; Galna B, 2014, GAIT POSTURE; GIBSON JJ, 1957, PSYCHOL REV, V64, P288, DOI 10.1037/h0044277; Han J, 2013, IEEE T CYBERNETICS; Hollander M., 2013, NONPARAMETRIC STAT M, VVolume 751; HORN BKP, 1981, P SOC PHOTO-OPT INST, V281, P319; Jarque CM, 2011, INT ENCY STAT SCI, P701, DOI [10.1007/978-3-642-04898-2_319, DOI 10.1007/978-3-642-04898-2_319]; Karayiannis NB, 2005, EPILEPSIA, V46, P901, DOI 10.1111/j.1528-1167.2005.56504.x; Karayiannis NB, 2003, P ANN INT IEEE EMBS, V25, P874, DOI 10.1109/IEMBS.2003.1279904; Li Z, 1999, P 11 INT C EMG CLIN, V110, P128; Li ZJ, 2002, IEEE T BIO-MED ENG, V49, P565, DOI 10.1109/TBME.2002.1001971; Luders H, 2000, ATLAS CLASSIFICATION; Medical Optima, 2014, XLTEK EEG; Microsoft, 2014, KIN WIND V2; Microsoft, 2014, KIN SDK 1 5; Microsoft, 2014, KIN WIND DEV PROGR P; Mirzadjanova Z, 2010, EPILEPSIA, V51, P2140, DOI 10.1111/j.1528-1167.2010.02599.x; Nijsen TME, 2007, IEEE T BIO-MED ENG, V54, P2073, DOI 10.1109/TBME.2007.895114; Nijsen TME, 2005, EPILEPSY BEHAV, V7, P74, DOI 10.1016/j.yebeh.2005.04.011; Noachtar S, 2009, EPILEPSY BEHAV, V15, P2, DOI 10.1016/j.yebeh.2009.02.029; O'Dwyer R, 2007, EPILEPSIA, V48, P524, DOI 10.1111/j.1528-1167.2006.00967.x; Patel K., 2009, P 3 INT C PERV COMP, P1, DOI DOI 10.4108/ICST.PERVASIVEHEALTH2009.6019; Remi J, 2011, EPILEPSIA, V52, P1447, DOI 10.1111/j.1528-1167.2011.03076.x; Remi J, 2011, EPILEPSY BEHAV, V20, P642, DOI 10.1016/j.yebeh.2011.01.020; Rocha AP, 2014, IEEE ENG MED BIO, P3126, DOI 10.1109/EMBC.2014.6944285; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Cunha JPS, 2013, EPILEPSY BEHAV, V27, P404, DOI 10.1016/j.yebeh.2013.02.026; Cunha JPS, 2012, MED ENG PHYS, V34, P938, DOI 10.1016/j.medengphy.2011.10.013; SoftKinetic, 2014, DS311; Stone EE, 2011, IEEE ENG MED BIO, P6491, DOI 10.1109/IEMBS.2011.6091602; Systems Innovation, 2014, MAXTRAQ; Tezer FI, 2013, EPILEPTIC DISORD, V15, P338, DOI 10.1684/epd.2013.0597; Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24	43	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145669	10.1371/journal.pone.0145669	http://dx.doi.org/10.1371/journal.pone.0145669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799795	gold, Green Submitted, Green Published			2022-12-26	WOS:000368655300007
J	Dupas, J; Goanvec, C; Feray, A; Guernec, A; Alain, C; Guerrero, F; Mansourati, J				Dupas, Julie; Goanvec, Christelle; Feray, Annie; Guernec, Anthony; Alain, Charlene; Guerrero, Francois; Mansourati, Jacques			Progressive Induction of Type 2 Diabetes: Effects of a Reality-Like Fructose Enriched Diet in Young Wistar Rats	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; CARDIAC-HYPERTROPHY; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; FATTY-ACIDS; HOMA-IR; HYPERTENSION; NEPHROPATHY	Purpose The aim of this study was to characterize short and medium-lasting effects of fructose supplementation on young Wistar rats. The diet was similar to actual human consumption. Methods Three week old male rats were randomly divided into 2 groups: control (C; n = 16), fructose fed (FF; n = 16) with a fructose enriched drink for 6 or 12 weeks. Bodyweight, fasting glycemia and systolic blood pressure were monitored. Glucose tolerance was evaluated using an oral glucose tolerance test. Insulinemia was measured concomitantly and enable us to calculate insulin resistance markers (HOMA-IR, Insulin Sensitivity Index for glycemia: ISI-gly). Blood chemistry analyses were performed. Results After six weeks of fructose supplementation, rats were not overweight but presented increased fasting glycemia, reduced glucose tolerance, and lower insulin sensitivity compared to control group. Systolic blood pressure and heart weight were also increased without any change in renal function (theoretical creatinine clearance). After twelve weeks of fructose supplementation, FF rats had increased bodyweight and presented insulin resistance (higher HOMA-IR, lower ISI-gly). Rats also presented higher heart volume and lower ASAT/ALAT ratio (presumed liver lesion). Surprisingly, the Total Cholesterol/Triglycerides ratio was increased only after six weeks of fructose supplementation, predicting a higher LDL presence and thus a higher risk of developing cardiovascular disease. This risk was no longer present after twelve weeks of a fructose enriched diet. Conclusion On young Wistar rats, six weeks of fructose supplementation is sufficient to induce signs of metabolic syndrome. After twelve weeks of fructose enriched diet, rats are insulin resistant. This model enabled us to study longitudinally the early development of type 2 diabetes.	[Dupas, Julie; Goanvec, Christelle; Feray, Annie; Guernec, Anthony; Alain, Charlene; Guerrero, Francois; Mansourati, Jacques] Univ Bretagne Occidentale, Optimisat Regulat Physiol, Brest, France; [Goanvec, Christelle] Univ Bretagne Occidentale, UFR Sci & Tech, Brest, France; [Feray, Annie; Guernec, Anthony; Guerrero, Francois] Univ Bretagne Occidentale, UFR Sport & Educ Phys, Brest, France; [Mansourati, Jacques] CHU Brest, Dept Cardiol, F-29285 Brest, France	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest	Dupas, J (corresponding author), Univ Bretagne Occidentale, Optimisat Regulat Physiol, Brest, France.	julie.dupas@univ-brest.fr		Guerrero, Francois/0000-0002-0283-3503				Amerand A, 2006, UNDERSEA HYPERBAR M, V33, P157; Aydin A, 2001, CLIN BIOCHEM, V34, P65, DOI 10.1016/S0009-9120(00)00199-5; Baker HJ, 1979, BIOL AND DIS; BEERS RF, 1952, J BIOL CHEM, V195, P133; Belfiore F, 1998, MOL GENET METAB, V63, P134, DOI 10.1006/mgme.1997.2658; Bettaieb A, 2014, FREE RADICAL BIO MED, V72, P247, DOI 10.1016/j.freeradbiomed.2014.04.011; Bhatia S, 2003, CLIN BIOCHEM, V36, P557, DOI 10.1016/S0009-9120(03)00094-8; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; da Silva RJ, 2011, CLINICS, V66, P1793, DOI 10.1590/S1807-59322011001000019; de Moura RF, 2009, BRIT J NUTR, V101, P1178, DOI 10.1017/S0007114508066774; Dimo T, 2002, J ETHNOPHARMACOL, V83, P183, DOI 10.1016/S0378-8741(02)00162-9; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Egbuonu A. C. C., 2013, American Journal of Biochemistry and Molecular Biology, V3, P50, DOI 10.3923/ajbmb.2013.50.60; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Haeri MR, 2009, PHYTOTHER RES, V23, P61, DOI 10.1002/ptr.2557; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Lamarche B, 1999, DIABETES METAB, V25, P199; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Ndlovu T, 2007, AFR J BIOTECHNOL, P6; Patel J, 2009, INDIAN J BIOCHEM BIO, V46, P66; PICKART L, 1983, ATHEROSCLEROSIS, V46, P21, DOI 10.1016/0021-9150(83)90160-0; Pranprawit A, 2013, J SCI FOOD AGR, V93, P3191, DOI 10.1002/jsfa.6240; Rector RS, 2010, AM J PHYSIOL-ENDOC M, V298, pE1179, DOI 10.1152/ajpendo.00703.2009; Ribeiro R, 2005, DIABETOLOGIA, V48, P976, DOI 10.1007/s00125-005-1714-6; Ross SW, 2001, COMP BIOCHEM PHYS C, V130, P289, DOI 10.1016/S1532-0456(01)00243-5; Schianca GPC, 2006, DIABETES-METAB RES, V22, P111, DOI 10.1002/dmrr.560; Seghrouchni I, 2002, CLIN CHIM ACTA, V321, P89, DOI 10.1016/S0009-8981(02)00099-2; SEN S, 1974, CIRC RES, V35, P775, DOI 10.1161/01.RES.35.5.775; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wright E, 2006, INT J CLIN PRACT, V60, P308, DOI 10.1111/j.1368-5031.2006.00825.x; Yoshida Akihiro, 2004, J Atheroscler Thromb, V11, P215; Yuan G, 2007, ENDOCRINOLOGY, V148, P2016, DOI 10.1210/en.2006-0602; Zamami Y, 2008, BIOL PHARM BULL, V31, P2103, DOI 10.1248/bpb.31.2103	45	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146821	10.1371/journal.pone.0146821	http://dx.doi.org/10.1371/journal.pone.0146821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799836	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300039
J	Greene, E				Greene, Ernest			Recognizing Words and Reading Sentences with Microsecond Flash Displays	PLOS ONE			English	Article							LIGHT-ADAPTATION; GANGLION-CELLS; MODULATION SENSITIVITY; SPECTRAL SENSITIVITY; CONE PHOTORECEPTORS; LUMINOUS SENSATION; VISUAL RESPONSE; RECOGNITION; PERCEPTION; FREQUENCY	Strings of dots can be used to construct easily identifiable letters, and these in turn can be used to write words and sentences. Prior work found that respondents could identify individual letters when all the dots were simultaneously flashed for an ultra-brief duration. Four of the experiments reported here constructed five-letter words with these dot-letters and a fifth experiment used them to write complete sentences. Respondents were able to recognize individual words that were displayed with a single, simultaneous ultra-brief flash of all the letters. Further, sentences could be efficiently read with a sequence of simultaneous flashes at a frequency that produced perceptual fusion. One experiment determined the frequency range that would produce flicker-fusion. Two experiments established the relation of intensity to probability of recognition with single flashes and with fused-flicker frequencies. Another established the intensities at which flicker-fused and steady displays were judged to be equal in brightness. The final experiment used those flicker-fused and steady intensities to display sentences. The two display conditions were read with equal efficiency, even though the flicker-fused displays provided light stimulation only 0.003% of the time.	[Greene, Ernest] Univ So Calif, Dept Psychol, Lab Neurometr Res, Los Angeles, CA 90089 USA	University of Southern California	Greene, E (corresponding author), Univ So Calif, Dept Psychol, Lab Neurometr Res, Los Angeles, CA 90089 USA.	egreene@usc.edu			Quest for Truth Foundation; Neuropsychology Foundation	Quest for Truth Foundation; Neuropsychology Foundation	Quest for Truth Foundation and Neuropsychology Foundation provided some funding. No grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA TS, 1964, VISION RES, V4, P391, DOI 10.1016/0042-6989(64)90011-2; ANDERSON DA, 1966, J OPT SOC AM, V56, P1607, DOI 10.1364/JOSA.56.001607; Arnold W, 1934, J GEN PHYSIOL, V18, P97, DOI 10.1085/jgp.18.1.97; Baddeley A. D, 1986, WORKING MEMORY; BATTERSBY WS, 1953, J EXP PSYCHOL, V46, P154, DOI 10.1037/h0062884; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; BERMAN SM, 1979, BIOL CYBERN, V34, P171, DOI 10.1007/BF00336968; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; BINDER JR, 1992, BRAIN, V115, P1807, DOI 10.1093/brain/115.6.1807; BLACKWELL HR, 1963, J OPT SOC AM, V53, P129, DOI 10.1364/JOSA.53.000129; BOUMAN MA, 1952, J OPT SOC AM, V42, P617, DOI 10.1364/JOSA.42.000617; Broca A, 1902, CR HEBD ACAD SCI, V134, P831; Bruno JL, 2008, NEUROIMAGE, V39, P1988, DOI 10.1016/j.neuroimage.2007.10.044; BURR DC, 1993, J OPT SOC AM A, V10, P1706, DOI 10.1364/JOSAA.10.001706; Cao LH, 2014, P NATL ACAD SCI USA, V111, P2752, DOI 10.1073/pnas.1400268111; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; Corwin TR, 1974, VISION RES, V14, P1675; Crozier WJ, 1941, J GEN PHYSIOL, V24, P635, DOI 10.1085/jgp.24.5.635; Crozier WJ, 1941, J GEN PHYSIOL, V25, P89, DOI 10.1085/jgp.25.1.89; Crozier WJ, 1941, J GEN PHYSIOL, V24, P505, DOI 10.1085/jgp.24.4.505; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; DEJERINE J., 1892, MEMOIRES SOC BIOL, V4, P61; ERIKSEN CW, 1967, J EXP PSYCHOL, V74, P476, DOI 10.1037/h0024765; ESTES WK, 1975, J EXP PSYCHOL GEN, V104, P122, DOI 10.1037/0096-3445.104.2.122; Fizeau H, 1851, COMPTE RENDUE SEANCE, V33, P349; Flowers DL, 2004, NEUROIMAGE, V21, P829, DOI 10.1016/j.neuroimage.2003.10.002; FREDERIKSEN JR, 1976, J EXP PSYCHOL HUMAN, V2, P361, DOI 10.1037/0096-1523.2.3.361; Friedburg C, 2004, J PHYSIOL-LONDON, V556, P819, DOI 10.1113/jphysiol.2004.061523; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Grainger J, 2012, CUR ISS PSYCHOL LANG, P159; Granit R, 1931, AM J PHYSIOL, V98, P644, DOI 10.1152/ajplegacy.1931.98.4.644; Greene E, 2015, ATTEN PERCEPT PSYCHO, V77, P1955, DOI 10.3758/s13414-015-0913-6; Greene E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123458; Greene E, 2014, I-PERCEPTION, V5, P87, DOI 10.1068/i0639rep; HABER RN, 1969, Q J EXP PSYCHOL, V21, P43, DOI 10.1080/14640746908400193; HAMER RD, 1992, J OPT SOC AM A, V9, P1889, DOI 10.1364/JOSAA.9.001889; HAMER RD, 1992, INVEST OPHTH VIS SCI, V33, P704; Hancock PJB, 2008, J VISION, V8, DOI 10.1167/8.7.21; Hecht S, 1933, J GEN PHYSIOL, V17, P269, DOI 10.1085/jgp.17.2.269; Hecht S, 1936, J GEN PHYSIOL, V19, P965, DOI 10.1085/jgp.19.6.965; Hecht S, 1937, PHYSIOL REV, V17, P239, DOI 10.1152/physrev.1937.17.2.239; HERRICK RM, 1972, J OPT SOC AM, V62, P104, DOI 10.1364/JOSA.62.000104; Houpt JW, 2014, ACTA PSYCHOL, V145, P118, DOI 10.1016/j.actpsy.2013.10.013; Houpt JW, 2012, J MATH PSYCHOL, V56, P341, DOI 10.1016/j.jmp.2012.05.004; HUDSON PTW, 1985, J MEM LANG, V24, P46, DOI 10.1016/0749-596X(85)90015-4; IKEDA M, 1965, J OPT SOC AM, V55, P1527, DOI 10.1364/JOSA.55.001527; James KH, 2005, COGN AFFECT BEHAV NE, V5, P451; Jensen RJ, 2007, J NEURAL ENG, V4, pS1, DOI 10.1088/1741-2560/4/1/S01; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; JOHNSTON JC, 1981, PERCEPTION PRINT REA, P65; Kleitman N, 1924, CR SOC BIOL, V91, P453; Kraft TW, 1998, VISION RES, V38, P3663, DOI 10.1016/S0042-6989(97)00371-4; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Kronbichler M, 2007, J COGNITIVE NEUROSCI, V19, P1584, DOI 10.1162/jocn.2007.19.10.1584; LANDIS C, 1954, PHYSIOL REV, V34, P259, DOI 10.1152/physrev.1954.34.2.259; Lee BB, 2007, J VISION, V7, DOI 10.1167/7.14.1; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Leff AP, 2001, BRAIN, V124, P510, DOI 10.1093/brain/124.3.510; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; MASSARO DW, 1973, J EXP PSYCHOL, V100, P349, DOI 10.1037/h0035681; MASSARO DW, 1979, ACTA PSYCHOL, V43, P413, DOI 10.1016/0001-6918(79)90033-7; MATTHEWS HR, 1990, J PHYSIOL-LONDON, V420, P447, DOI 10.1113/jphysiol.1990.sp017922; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MEIJER JG, 1978, VISION RES, V18, P1111, DOI 10.1016/0042-6989(78)90093-7; Miller GA, 1954, J GEN PSYCHOL, V50, P129, DOI 10.1080/00221309.1954.9710109; MILLER JL, 1993, VISUAL NEUROSCI, V10, P653, DOI 10.1017/S0952523800005356; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Neisser U., 1967, COGNITIVE PSYCHOL; NELSON TM, 1965, J PSYCHOL, V59, P185, DOI 10.1080/00223980.1965.9916792; NUNN BJ, 1984, NATURE, V309, P264, DOI 10.1038/309264a0; OSAKA N, 1977, PERCEPT PSYCHOPHYS, V22, P63, DOI 10.3758/BF03206081; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; PINNEO LR, 1967, J NEUROL SCI, V5, P303, DOI 10.1016/0022-510X(67)90138-4; Plateau J. A. F., 1830, ANN PHYS-LEIPZIG, P304; Pokorny J, 2001, COLOR RES APPL, V26, pS140, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL31>3.0.CO;2-N; Polk TA, 2002, J EXP PSYCHOL GEN, V131, P65, DOI 10.1037//0096-3445.131.1.65; REICHER GM, 1969, J EXP PSYCHOL, V81, P275, DOI 10.1037/h0027768; RICHARDSON JTE, 1976, BRIT J PSYCHOL, V67, P315, DOI 10.1111/j.2044-8295.1976.tb01518.x; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Rood ON, 1871, AM J SCI ARTS, V2, P159; Sakurai Y, 2000, J NEUROL SCI, V178, P42, DOI 10.1016/S0022-510X(00)00363-4; SCHNAPF JL, 1980, NATURE, V287, P239, DOI 10.1038/287239a0; SCHNAPF JL, 1987, NATURE, V325, P439, DOI 10.1038/325439a0; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Starrfelt R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00519; Stone J., 1983, PARALLEL PROCESSING, DOI DOI 10.1007/978-1-4684-4433-9; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Talbot H.F., 1834, LOND EDINB PHIL MAG, V29, P321, DOI DOI 10.1080/14786443408648474; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Townsend JT, 2004, PSYCHOL REV, V111, P1003, DOI 10.1037/0033-295x.111.4.1003; Townsend JT, 1995, J MATH PSYCHOL, V39, P321, DOI 10.1006/jmps.1995.1033; UCHIKAWA K, 1993, J OPT SOC AM A, V10, P1697, DOI 10.1364/JOSAA.10.001697; UETSUKI T, 1970, J OPT SOC AM, V60, P377, DOI 10.1364/JOSA.60.000377; van Hateren JH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-34; VANDENBRINK G, 1954, J OPT SOC AM, V44, P616, DOI 10.1364/JOSA.44.000616; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wheatstone Charles, 1834, PHILOS T ROY SOC LON, V124, P583, DOI [10.1098/rspl.180.0178, DOI 10.1098/RSPL.1830.0178]; WHEELER DD, 1970, COGNITIVE PSYCHOL, V1, P59, DOI 10.1016/0010-0285(70)90005-8	108	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145697	10.1371/journal.pone.0145697	http://dx.doi.org/10.1371/journal.pone.0145697			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26800027	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300009
J	Nicholson, BA; West, AC; Mangiamele, P; Barbieri, N; Wannemuehler, Y; Nolan, LK; Logue, CM; Li, GW				Nicholson, Bryon A.; West, Aaron C.; Mangiamele, Paul; Barbieri, Nicolle; Wannemuehler, Yvonne; Nolan, Lisa K.; Logue, Catherine M.; Li, Ganwu			Genetic Characterization of ExPEC-Like Virulence Plasmids among a Subset of NMEC	PLOS ONE			English	Article							PATHOGENIC ESCHERICHIA-COLI; NEONATAL MENINGITIS; NUCLEOTIDE-SEQUENCE; STRAINS; RESISTANCE; PROTEIN; IDENTIFICATION; COMMENSAL; REPA; EPIDEMIOLOGY	Neonatal Meningitis Escherichia coli (NMEC) is one of the most common causes of neonatal bacterial meningitis in the US and elsewhere resulting in mortality or neurologic deficits in survivors. Large plasmids have been shown experimentally to increase the virulence of NMEC in the rat model of neonatal meningitis. Here, 9 ExPEC-like plasmids were isolated from NMEC and sequenced to identify the core and accessory plasmid genes of ExPEC-like virulence plasmids in NMEC and create an expanded plasmid phylogeny. Results showed sequenced virulence plasmids carry a strongly conserved core of genes with predicted functions in five distinct categories including: virulence, metabolism, plasmid stability, mobile elements, and unknown genes. The major functions of virulence-associated and plasmid core genes serve to increase in vivo fitness by adding multiple iron uptake systems to the genetic repertoire to facilitate NMEC's survival in the host's low iron environment, and systems to enhance bacterial resistance to host innate immunity. Phylogenetic analysis based on these core plasmid genes showed that at least two lineages of ExPEC-like plasmids could be discerned. Further, virulence plasmids from Avian Pathogenic E. coli and NMEC plasmids could not be differentiated based solely on the genes of the core plasmid genome.	[Nicholson, Bryon A.; Mangiamele, Paul; Barbieri, Nicolle; Wannemuehler, Yvonne; Nolan, Lisa K.; Logue, Catherine M.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [West, Aaron C.] Iowa State Univ, Dept Chem, Coll Liberal Arts & Sci, Ames, IA USA; [Li, Ganwu] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, 1802 Univ Blvd, Ames, IA 50011 USA; [Li, Ganwu] Nanjing Agr Univ, Coll Vet Med, Dept Vet Prevent Med, Nanjing 210095, Jiangsu, Peoples R China	Iowa State University; Iowa State University; Iowa State University; Nanjing Agricultural University	Li, GW (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, 1802 Univ Blvd, Ames, IA 50011 USA.; Li, GW (corresponding author), Nanjing Agr Univ, Coll Vet Med, Dept Vet Prevent Med, Nanjing 210095, Jiangsu, Peoples R China.	liganwu@iastate.edu	Barbieri, Nicolle Lima/L-6477-2013; Li, Ganwu/AAC-7423-2020; Barbieri, Nicolle/AAB-3223-2020	Barbieri, Nicolle Lima/0000-0002-8223-6580; Logue, Catherine/0000-0002-6098-2662	National Institute of Health [AI101517]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101517] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the National Institute of Health (www.nih.gov) grant AI101517. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur DC, 2003, EMBO J, V22, P6346, DOI 10.1093/emboj/cdg607; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; BINNS MM, 1982, INFECT IMMUN, V35, P654, DOI 10.1128/IAI.35.2.654-659.1982; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Cusumano CK, 2010, INFECT IMMUN, V78, P1457, DOI 10.1128/IAI.01260-09; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Grimwood K, 2000, ARCH DIS CHILD, V83, P111, DOI 10.1136/adc.83.2.111; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Ingmer H, 2001, MOL MICROBIOL, V42, P519, DOI 10.1046/j.1365-2958.2001.02661.x; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 1996, J INFECT DIS, V173, P920, DOI 10.1093/infdis/173.4.920; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P2360, DOI 10.1128/AEM.02634-07; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Johnson TJ, 2012, J BACTERIOL, V194, P2846, DOI 10.1128/JB.06375-11; Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Klein M, 1996, DNA SEQUENCE, V6, P351, DOI 10.3109/10425179609047574; La Ragione RM, 2002, RES VET SCI, V73, P27, DOI 10.1016/S0034-5288(02)00075-9; Lemaitre C, 2014, J BACTERIOL, V196, P1343, DOI 10.1128/JB.01153-13; Lemaitre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074423; Li GW, 2005, INFECT IMMUN, V73, P2818, DOI 10.1128/IAI.73.5.2818-2827.2005; Logue CM, 2012, APPL ENVIRON MICROB, V78, P5824, DOI 10.1128/AEM.07869-11; Lynne AM, 2007, AVIAN DIS, V51, P771, DOI 10.1637/0005-2086(2007)51[771:COASOT]2.0.CO;2; MANEN D, 1992, P NATL ACAD SCI USA, V89, P8923, DOI 10.1073/pnas.89.19.8923; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Peigne C, 2009, INFECT IMMUN, V77, P2272, DOI 10.1128/IAI.01333-08; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Ruiz-Perez F, 2011, P NATL ACAD SCI USA, V108, P12881, DOI 10.1073/pnas.1101006108; Salipante SJ, 2015, GENOME RES, V25, P119, DOI 10.1101/gr.180190.114; Sand O, 2003, MICROBIOL-SGM, V149, P2107, DOI 10.1099/mic.0.26363-0; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Tarjan R, 1972, SIAM J COMPUT, V1, P15; Thomassin JL, 2012, INFECT IMMUN, V80, P483, DOI 10.1128/IAI.05674-11; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Tivendale KA, 2009, J CLIN MICROBIOL, V47, P2513, DOI 10.1128/JCM.00391-09; TRIBE DE, 1976, J BACTERIOL, V127, P1085, DOI 10.1128/JB.127.3.1085-1097.1976; Wijetunge DSS, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0547-9; Wijetunge DSS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0203-9; Williams LE, 2006, APPL ENVIRON MICROB, V72, P4899, DOI 10.1128/AEM.00354-06; XIA GX, 1993, J BACTERIOL, V175, P4165, DOI 10.1128/JB.175.13.4165-4175.1993; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147757	10.1371/journal.pone.0147757	http://dx.doi.org/10.1371/journal.pone.0147757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800268	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300139
J	Solanki, A; Mohanty, P; Shukla, P; Rao, A; Ghosh, K; Vundinti, BR				Solanki, Avani; Mohanty, Purvi; Shukla, Pallavi; Rao, Anita; Ghosh, Kanjaksha; Vundinti, Babu Rao			FANCA Gene Mutations with 8 Novel Molecular Changes in Indian Fanconi Anemia Patients	PLOS ONE			English	Article							COMPLEMENTATION GROUP; IDENTIFICATION; SPECTRUM; DELETION	Fanconi anemia (FA), a rare heterogeneous genetic disorder, is known to be associated with 19 genes and a spectrum of clinical features. We studied FANCA molecular changes in 34 unrelated and 2 siblings of Indian patients with FA and have identified 26 different molecular changes of FANCA gene, of which 8 were novel mutations (a small deletion c.2500delC, 4 non-sense mutations c. 2182C>T, c.2630C>G, c.3677C>G, c.3189G>A; and 3 missense mutations; c.1273G>C, c.3679G>C, and c.3992T>C). Among these only 16 patients could be assigned FA-A complementation group, because we could not confirm single exon deletions detected by MLPA or cDNA amplification by secondary confirmation method and due to presence of heterozygous non-pathogenic variations or heterozygous pathogenic mutations. An effective molecular screening strategy should be developed for confirmation of these mutations and determining the breakpoints for single exon deletions.	[Solanki, Avani; Mohanty, Purvi; Shukla, Pallavi; Rao, Anita; Ghosh, Kanjaksha; Vundinti, Babu Rao] Natl Inst Immunohaematol ICMR, Dept Cytogenet, Mumbai, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Vundinti, BR (corresponding author), Natl Inst Immunohaematol ICMR, Dept Cytogenet, Mumbai, Maharashtra, India.	vbaburao@hotmail.com	Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565	Indian Council of Medical Research [56/1/2009-BMS]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by 56/1/2009-BMS from the Indian Council of Medical Research, http://icmr.nic.in/.	Adachi D, 2002, HUM MOL GENET, V11, P3125, DOI 10.1093/hmg/11.25.3125; Ameziane N, 2008, HUM MUTAT, V29, P159, DOI 10.1002/humu.20625; Arthur NBJ, 2014, 56 ASH ANN M EXP, P508; Bogliolo M, 2015, CURR OPIN GENET DEV, V33, P32, DOI 10.1016/j.gde.2015.07.002; Castella M, 2011, BLOOD, V117, P3759, DOI 10.1182/blood-2010-08-299917; Chandra S, 2005, MOL THER, V12, P976, DOI 10.1016/j.ymthe.2005.04.021; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Faivre L, 2000, BLOOD, V96, P4064; Flynn EK, 2014, HUM MUTAT, V35, P1342, DOI 10.1002/humu.22680; Gille JJP, 2012, ANEMIA, V2012, DOI 10.1155/2012/603253; He F, 2015, ANNU REV GENET, V49, P339, DOI 10.1146/annurev-genet-112414-054639; Levran O, 2005, HUM MUTAT, V25, P142, DOI 10.1002/humu.20125; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Moghrabi NN, 2009, GENET MED, V11, P183, DOI 10.1097/GIM.0b013e318193ba67; Morgan NV, 1999, AM J HUM GENET, V65, P1330, DOI 10.1086/302627; Neveling K, 2009, MUTAT RES-FUND MOL M, V668, P73, DOI 10.1016/j.mrfmmm.2009.05.006; Oostra AB, 2012, ANEMIA, V2012, DOI 10.1155/2012/238731; SASAKI MS, 1973, CANCER RES, V33, P1829; Shimamura A, 2010, BLOOD REV, V24, P101, DOI 10.1016/j.blre.2010.03.002; Shukla P, 2013, GENE, V518, P470, DOI 10.1016/j.gene.2013.01.016; Solomon PJ, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0142-6; Tachibana A, 1999, HUM MUTAT, V13, P237, DOI 10.1002/(SICI)1098-1004(1999)13:3<237::AID-HUMU8>3.3.CO;2-6; Tamary H, 2000, BRIT J HAEMATOL, V111, P338, DOI 10.1046/j.1365-2141.2000.02323.x; Tipping AJ, 2001, P NATL ACAD SCI USA, V98, P5734, DOI 10.1073/pnas.091402398; Wijker M, 1999, EUR J HUM GENET, V7, P52, DOI 10.1038/sj.ejhg.5200248; Yagasaki H, 2004, HUM MUTAT, V24, P481, DOI 10.1002/humu.20099	26	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147016	10.1371/journal.pone.0147016	http://dx.doi.org/10.1371/journal.pone.0147016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799702	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300054
J	Harkenrider, M; Sharma, R; De Vleesschauwer, D; Tsao, L; Zhang, XT; Chern, M; Canlas, P; Zuo, SM; Ronald, PC				Harkenrider, Mitch; Sharma, Rita; De Vleesschauwer, David; Tsao, Li; Zhang, Xuting; Chern, Mawsheng; Canlas, Patrick; Zuo, Shimin; Ronald, Pamela C.			Overexpression of Rice Wall-Associated Kinase 25 (OsWAK25) Alters Resistance to Bacterial and Fungal Pathogens	PLOS ONE			English	Article							GUANYLYL CYCLASE ACTIVITY; ARABIDOPSIS-THALIANA; SYSTEMIC RESISTANCE; DISEASE-RESISTANCE; MAGNAPORTHE-GRISEA; GENE; RECEPTOR; EXPRESSION; EXPANSION; INTERACTS	Wall-associated kinases comprise a sub-family of receptor-like kinases that function in plant growth and stress responses. Previous studies have shown that the rice wall-associated kinase, OsWAK25, interacts with a diverse set of proteins associated with both biotic and abiotic stress responses. Here, we show that wounding and BTH treatments induce OsWAK25 transcript expression in rice. We generated OsWAK25 overexpression lines and show that these lines exhibit a lesion mimic phenotype and enhanced expression of rice NH1 (NPR1 homolog 1), OsPAL2, PBZ1 and PR10. Furthermore, these lines show resistance to the hemibiotrophic pathogens, Xanthomonas oryzae pv. oryzae (Xoo) and Magnaporthe oryzae, yet display increased susceptibility to necrotrophic fungal pathogens, Rhizoctonia solani and Cochliobolus miyabeanus.	[Harkenrider, Mitch; Sharma, Rita; Tsao, Li; Chern, Mawsheng; Canlas, Patrick; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Sharma, Rita; Chern, Mawsheng; Ronald, Pamela C.] Joint BioEnergy Inst, Emeryville, CA USA; [De Vleesschauwer, David] Univ Ghent, Lab Phytopathol, B-9000 Ghent, Belgium; [Zhang, Xuting; Zuo, Shimin] Yangzhou Univ, Ctr Modern Prod Technol Grain Crops, Jiangsu Key Lab Crop Genet & Physiol & Coinnovat, Yangzhou 225009, Jiangsu, Peoples R China	University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Ghent University; Yangzhou University	Ronald, PC (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.; Ronald, PC (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	pcronald@ucdavis.edu	Sharma, Rita/G-2425-2017; Ronald, Pamela/AAK-7664-2020		NSF CREATE-IGERT program at UC Davis [DGE-0653984]; Joint BioEnergy Institute - Office of Science, Office of Biological and Environmental Research of the U.S. Department of Energy [DE-AC02-05CH11231]; NIH [GM55962]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055962] Funding Source: NIH RePORTER	NSF CREATE-IGERT program at UC Davis; Joint BioEnergy Institute - Office of Science, Office of Biological and Environmental Research of the U.S. Department of Energy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Partial funding for this research was provided to MH by the NSF CREATE-IGERT program at UC Davis (Award Number DGE-0653984). Additional funding was through the Joint BioEnergy Institute supported by the Office of Science, Office of Biological and Environmental Research of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Additional support was given by NIH GM55962 to PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon DI, 1938, AM J BOT, V25, P322, DOI 10.2307/2436754; Ashton AR, 2011, P NATL ACAD SCI USA, V108, pE96, DOI 10.1073/pnas.1101007108; Berkowitz GA, 2011, P NATL ACAD SCI USA, V108, pE97, DOI 10.1073/pnas.1103313108; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Chern M, 2005, PLANT J, V43, P623, DOI 10.1111/j.1365-313X.2005.02485.x; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Chern MS, 2001, PLANT J, V27, P101, DOI 10.1046/j.1365-313x.2001.01070.x; De Vleesschauwer D, 2008, PLANT PHYSIOL, V148, P1996, DOI 10.1104/pp.108.127878; De Vleesschauwer D, 2006, MOL PLANT MICROBE IN, V19, P1406, DOI 10.1094/MPMI-19-1406; Decreux A, 2005, PLANT CELL PHYSIOL, V46, P268, DOI 10.1093/pcp/pci026; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Ding XD, 2009, PLANT PHYSIOL, V149, P1478, DOI 10.1104/pp.108.128298; Feng JX, 2011, EUR J PLANT PATHOL, V131, P221, DOI 10.1007/s10658-011-9801-7; He ZH, 1996, J BIOL CHEM, V271, P19789, DOI 10.1074/jbc.271.33.19789; He ZH, 1998, PLANT J, V14, P55, DOI 10.1046/j.1365-313X.1998.00092.x; Hu W, 2014, PLANT SOIL, V384, P335, DOI 10.1007/s11104-014-2204-8; Jo Y, 2011, PROTOPLASMA, V248, P191, DOI 10.1007/s00709-010-0251-4; Kohorn BD, 2012, MOL PLANT, V5, P841, DOI 10.1093/mp/ssr096; Li H, 2009, PLANT MOL BIOL, V69, P337, DOI 10.1007/s11103-008-9430-5; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Meier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008904; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Qi M, 2002, PHYTOPATHOLOGY, V92, P870, DOI 10.1094/PHYTO.2002.92.8.870; Qi Z, 2010, P NATL ACAD SCI USA, V107, P21193, DOI 10.1073/pnas.1000191107; Rosli HG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r139; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Schweizer P, 1997, PLANT PHYSIOL, V114, P79, DOI 10.1104/pp.114.1.79; Seo YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002020; Thuan NTN, 2006, EUR J PLANT PATHOL, V114, P381, DOI 10.1007/s10658-006-0002-8; Tocquard K, 2014, TREE GENET GENOMES, V10, P1135, DOI 10.1007/s11295-014-0748-7; Verica JA, 2002, PLANT PHYSIOL, V129, P455, DOI 10.1104/pp.011028; Wei T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059720; Wong A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-48; Yang K, 2014, CROP J, V2, P255, DOI 10.1016/j.cj.2014.04.010; Zhang SB, 2005, PLANT PHYSIOL, V139, P1107, DOI 10.1104/pp.105.069005; Zuo SM, 2013, THEOR APPL GENET, V126, P1257, DOI 10.1007/s00122-013-2051-7	36	41	46	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147310	10.1371/journal.pone.0147310	http://dx.doi.org/10.1371/journal.pone.0147310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795719	gold, Green Submitted, Green Published			2022-12-26	WOS:000368530300028
J	van den Akker, GGH; Surtel, DAM; Cremers, A; Richardson, SM; Hoyland, JA; van Rhijn, LW; Voncken, JW; Welting, TJM				van den Akker, Guus G. H.; Surtel, Don A. M.; Cremers, Andy; Richardson, Stephen M.; Hoyland, Judith A.; van Rhijn, Lodewijk W.; Voncken, Jan Willem; Welting, Tim J. M.			Novel Immortal Cell Lines Support Cellular Heterogeneity in the Human Annulus Fibrosus	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; GENE-EXPRESSION; NUCLEUS PULPOSUS; ARTICULAR CHONDROCYTES; MOUSE IMPLICATIONS; ASCORBIC-ACID; DEGENERATION; COLLAGEN; PHENOTYPE; IDENTIFICATION	Introduction Loss of annulus fibrosus (AF) integrity predisposes to disc herniation and is associated with IVD degeneration. Successful implementation of biomedical intervention therapy requires in-depth knowledge of IVD cell biology. We recently generated unique clonal human nucleus pulposus (NP) cell lines. Recurring functional cellular phenotypes from independent donors provided pivotal evidence for cell heterogeneity in the mature human NP. In this study we aimed to generate and characterize immortal cell lines for the human AF from matched donors. Methods Non-degenerate healthy disc material was obtained as surplus surgical material. AF cells were immortalized by simian virus Large T antigen (SV40LTAg) and human telomerase (hTERT) expression. Early passage cells and immortalized cell clones were characterized based on marker gene expression under standardized culturing and in the presence of Transforming Growth factor beta (TGF beta). Results The AF-specific expression signature included COL1A1, COL5A1, COL12A1, SFRP2 and was largely maintained in immortal AF cell lines. Remarkably, TGF beta induced rapid 3D sheet formation in a subgroup of AF clones. This phenotype was associated with inherent differences in Procollagen type I processing and maturation, and correlated with differential mRNA expression of Prolyl 4-hydroxylase alpha polypeptide 1 and 3 (P4HA1,3) and Lysyl oxidase (LOX) between clones and differential P4HA3 protein expression between AF cells in histological sections. Conclusion We report for the first time the generation of representative human AF cell lines. Gene expression profile analysis and functional comparison of AF clones revealed variation between immortalized cells and suggests phenotypic heterogeneity in the human AF. Future characterization of AF cellular (sub-)populations aims to combine identification of additional specific AF marker genes and their biological relevance. Ultimately this knowledge will contribute to clinical application of cell-based technology in IVD repair.	[van den Akker, Guus G. H.; Surtel, Don A. M.; Cremers, Andy; van Rhijn, Lodewijk W.; Welting, Tim J. M.] Maastricht Univ, Med Ctr, Dept Orthopaed Surg, NL-6200 MD Maastricht, Netherlands; [van den Akker, Guus G. H.; Voncken, Jan Willem] Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Richardson, Stephen M.; Hoyland, Judith A.] Univ Manchester, Inst Inflammat & Repair, Ctr Tissue Injury & Repair, Manchester, Lancs, England	Maastricht University; Maastricht University; University of Manchester	Welting, TJM (corresponding author), Maastricht Univ, Med Ctr, Dept Orthopaed Surg, NL-6200 MD Maastricht, Netherlands.; Voncken, JW (corresponding author), Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.	w.voncken@maastrichtuniversity.nl; t.welting@maastrichtuniversity.nl	Richardson, Stephen/A-4124-2009; van den Akker, Guus/A-1642-2016; van den Akker, Guus/AAD-9536-2019	Richardson, Stephen/0000-0002-7637-4135; van den Akker, Guus/0000-0002-7071-1487; 	Project P2.01 IDiDAS; Dutch Arthritis Foundation [LLP14]; Programme for Advanced Medical Education; Fundacao Calouste Gulbenkian; Fundacao Champalimaud; Ministerio da Saude; Fundacao para a Ciencia e Tecnologia; Apifarma, Portugal	Project P2.01 IDiDAS; Dutch Arthritis Foundation; Programme for Advanced Medical Education; Fundacao Calouste Gulbenkian(European Commission); Fundacao Champalimaud; Ministerio da Saude; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Apifarma, Portugal	This study was supported by Project P2.01 IDiDAS (LWvR, TJMW); LLP14 Grant Dutch Arthritis Foundation (JWV, LWvR); Programme for Advanced Medical Education, Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude, Fundacao para a Ciencia e Tecnologia and Apifarma, Portugal. None of the funding sources had any role in study design, data collection, analysis and interpretation, writing of the manuscript or the decision to submit the manuscript for publication.; Approval for all experimental sections of the current study and informed consent for publication of patient details and accompanying images in this manuscript was obtained as an integral part of the MUMC-MERC approval 08-4-028. For immunohistochemical studies informed consent was obtained from the donor's relatives and approval for the study was granted by the North West Research Ethics Committee. The approvals are held by the authors and are available for review by the Editor-in-Chief. The authors thank R. Bernards (NKI Amsterdam, the Netherlands) for hTERT (human telomerase) cDNA, R. Bank (University of Groningen, Netherlands) for useful discussions and suggestions on Collagen detection and P. Willems (MUMC, Netherlands) for medical ethical reflections. Funding: Project P2.01 IDiDAS (LWvR, TJMW); LLP14 Grant Dutch Arthritis Foundation (JWV, LWvR); Programme for Advanced Medical Education, Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude, Fundacao para a Ciencia e Tecnologia and Apifarma, Portugal. None of the funding sources had any role in study design, data collection, analysis and interpretation, writing of the manuscript or the decision to submit the manuscript for publication.	Adams MA, 1996, J BONE JOINT SURG BR, V78B, P965, DOI 10.1302/0301-620X78B6.1287; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x; Attia M, 2011, BIOMATERIALS, V32, P450, DOI 10.1016/j.biomaterials.2010.09.010; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Brayda-Bruno M, 2014, EUR SPINE J, V23, pS315, DOI 10.1007/s00586-013-2960-9; Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Chou AI, 2008, TISSUE ENG PT A, V14, P2079, DOI 10.1089/ten.tea.2007.0337; CHRIST B, 1992, ANN ANAT, V174, P23, DOI 10.1016/S0940-9602(11)80337-7; Clouet J, 2009, JOINT BONE SPINE, V76, P614, DOI 10.1016/j.jbspin.2009.07.002; Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262; DECLERCK YA, 1980, BIOCHEM J, V186, P217, DOI 10.1042/bj1860217; ESTERVIG DN, 1990, J CELL PHYSIOL, V142, P552, DOI 10.1002/jcp.1041420314; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; Gilbert HTJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3229; Gruber HE, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-63; Gruber HE, 2011, SPINE J, V11, P782, DOI 10.1016/j.spinee.2011.06.012; Gruber HE, 2010, SPINE J, V10, P721, DOI 10.1016/j.spinee.2010.05.014; Guillaume O, 2014, ACTA BIOMATER, V10, P1985, DOI 10.1016/j.actbio.2013.12.037; Guterl CC, 2013, EUR CELLS MATER, V25, P1; Hayes AJ, 2011, EUR CELLS MATER, V21, P1; Hayes AJ, 2011, EUR CELLS MATER, V22, P226, DOI 10.22203/eCM.v022a18; Hayes AJ, 2011, HISTOCHEM CELL BIOL, V136, P163, DOI 10.1007/s00418-011-0835-x; Ivanov V, 2005, J CARDIOVASC PHARM, V46, P570, DOI 10.1097/01.fjc.0000179432.73007.45; Jin L, 2013, EUR SPINE J, V22, P1090, DOI 10.1007/s00586-013-2663-2; Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d; Kroemer KE, 2010, SKELETAL STRUCTURES, P1; Lama P, 2013, BONE JOINT J, V95B, P1127, DOI [10.1302/0301-620X.95B8.31660, 10.1302/0301-620X.95138.31660]; Lampot JD, 2015, CELL TRANSPLANT, V24, P1053, DOI 10.3727/096368914X681054; Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y; Lehmann HC, 2012, STEM CELLS DEV, V21, P423, DOI 10.1089/scd.2010.0513; Lin Z, 2006, TISSUE ENG, V12, P1971, DOI 10.1089/ten.2006.12.1971; Lui PPY, 2014, AM J SPORT MED, V42, P681, DOI 10.1177/0363546513517539; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; Minogue BM, 2010, ARTHRITIS RHEUM-US, V62, P3695, DOI 10.1002/art.27710; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nosikova YS, 2012, J ANAT, V221, P577, DOI 10.1111/j.1469-7580.2012.01537.x; Occleston NL, 2008, J BIOMAT SCI-POLYM E, V19, P1047, DOI 10.1163/156856208784909345; Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x; Prickaerts P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-12; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; ROBERTSON WV, 1953, J BIOL CHEM, V201, P689; Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; SCHWARZ RI, 1981, MOL CELL BIOL, V1, P843, DOI 10.1128/MCB.1.9.843; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; TAKEZAWA T, 1993, EXP CELL RES, V208, P430, DOI 10.1006/excr.1993.1265; van den Akker GGH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4597; Wang JY, 2001, SPINE, V26, P1747, DOI 10.1097/00007632-200108150-00003; Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012; Yu JS, 2014, BIOMATERIALS, V35, P3516, DOI 10.1016/j.biomaterials.2014.01.015	56	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0144497	10.1371/journal.pone.0144497	http://dx.doi.org/10.1371/journal.pone.0144497			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794306	Green Submitted, Green Published, gold			2022-12-26	WOS:000368530300001
J	Tochitani, S; Ikeno, T; Ito, T; Sakurai, A; Yamauchi, T; Matsuzaki, H				Tochitani, Shiro; Ikeno, Takahiro; Ito, Tatsuhito; Sakurai, Asuka; Yamauchi, Tomoki; Matsuzaki, Hideo			Administration of Non-Absorbable Antibiotics to Pregnant Mice to Perturb the Maternal Gut Microbiota Is Associated with Alterations in Offspring Behavior	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; PERINATAL UNDERNUTRITION; BRAIN-DEVELOPMENT; RESTRICTION; HEALTH; STRESS; IMPACT; MODEL; ABNORMALITIES; MALTREATMENT	There is increasing evidence that the gut microbiota plays a major role in host health and disease. In this study, we examined whether perturbation of the maternal gut microbiota during pregnancy, induced by administration of non-absorbable antibiotics to pregnant dams, influences the behavior of offspring. Terminal restriction fragment length polymorphism analyses of fecal bacterial composition showed that the relative abundance of the bacterial order Lactobacillales was lower in offspring born from antibiotic-treated dams (20.7 +/- 3.4%) than in control offspring (42.1 +/- 6.2%) at P24, while the relative abundance of the bacterial family Clostridium subcluster XIVa was higher in offspring born from antibiotic-treated dams (34.2 +/- 5.0%) than in control offspring (16.4 +/- 3.3%). Offspring born from antibiotic-treated dams exhibited low locomotor activity in both familiar and novel environments, and preferred to explore in the peripheral area of an unfamiliar field at postnatal week 4. At postnatal weeks 7-8, no difference was observed in the level of locomotor activity between control offspring and offspring from antibiotic-treated dams, while the tendency for the offspring from antibiotic-treated dams to be less engaged in exploring the inside area was still observed. The behavioral phenotypes of the offspring from antibiotic-treated dams at postnatal week 4 could be rescued to a considerable extent through fostering of these offspring by normal dams from postnatal day 1. Although the detailed underlying mechanisms are not fully elucidated, the present results suggest that administration of non-absorbable antibiotics to pregnant dams to perturb the maternal gut microbiota during pregnancy leads to alterations in the behavior of their offspring.	[Tochitani, Shiro; Matsuzaki, Hideo] Univ Fukui, Div Dev Mental Funct, Res Ctr Child Mental Dev, Fukui 9101193, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Osaka Univ, Div Dev Higher Brain Funct, Dept Child Dev, United Grad Sch Child Dev, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Kanazawa Univ, Suita, Osaka 5650871, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 5650871, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Chiba Univ, Suita, Osaka 5650871, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Univ Fukui, Suita, Osaka 5650871, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Univ Fukui, Res & Educ Program Life Sci, Fukui 9108507, Japan; [Ikeno, Takahiro; Ito, Tatsuhito; Sakurai, Asuka; Yamauchi, Tomoki; Matsuzaki, Hideo] Univ Fukui, Sch Med, Fac Med Sci, Fukui 9101193, Japan	University of Fukui; Osaka University; Kanazawa University; Hamamatsu University School of Medicine; Chiba University; University of Fukui; University of Fukui; University of Fukui	Tochitani, S (corresponding author), Univ Fukui, Div Dev Mental Funct, Res Ctr Child Mental Dev, Fukui 9101193, Japan.; Tochitani, S (corresponding author), Osaka Univ, Div Dev Higher Brain Funct, Dept Child Dev, United Grad Sch Child Dev, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Tochitani, S (corresponding author), Kanazawa Univ, Suita, Osaka 5650871, Japan.; Tochitani, S (corresponding author), Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 5650871, Japan.; Tochitani, S (corresponding author), Chiba Univ, Suita, Osaka 5650871, Japan.; Tochitani, S (corresponding author), Univ Fukui, Suita, Osaka 5650871, Japan.; Tochitani, S (corresponding author), Univ Fukui, Res & Educ Program Life Sci, Fukui 9108507, Japan.	tochitani.shiro@gmail.com	MATSUZAKI, HIDEO/AAE-5246-2020	MATSUZAKI, HIDEO/0000-0002-6869-1261; Tochitani, Shiro/0000-0001-5765-3668	Research and Education Program for Life Science at University of Fukui; Yakult Bio-Science Foundation	Research and Education Program for Life Science at University of Fukui; Yakult Bio-Science Foundation	This work was supported by a grant for exploratory research from the Research and Education Program for Life Science at University of Fukui (to ST) and a grant for general scientific research from the Yakult Bio-Science Foundation (to ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Blevins CR, 2015, EVOLUTION MED PUBLIC, DOI [10.1093/emph/eov007, DOI 10.1093/EMPH/E0V007]; Aomatsu T, 2012, DIGESTION, V86, P129, DOI 10.1159/000339777; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Blaze J, 2013, DEV NEUROSCI-BASEL, V35, P306, DOI 10.1159/000350716; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Borre YE, 2014, ADV EXP MED BIOL, V817, P373, DOI 10.1007/978-1-4939-0897-4_17; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Cicchetti D, 2005, ANNU REV CLIN PSYCHO, V1, P409, DOI 10.1146/annurev.clinpsy.1.102803.144029; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Collins SM, 2013, CURR OPIN MICROBIOL, V16, P240, DOI 10.1016/j.mib.2013.06.004; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; De Palma G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8735; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; Ghosh SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108577; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Groer MW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-38; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hinde K, 2015, SCIENCE, V348, P1427, DOI 10.1126/science.aac7436; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Imaeda H, 2012, DIGESTION, V86, P250, DOI 10.1159/000341508; Ishikawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100627; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Jacka FN, 2013, J AM ACAD CHILD PSY, V52, P1038, DOI 10.1016/j.jaac.2013.07.002; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Jasarevic E, 2015, NEUROBIOL STRESS, V1, P81, DOI 10.1016/j.ynstr.2014.10.005; Kohata Y, 2015, DIGEST DIS SCI, V60, P2654, DOI 10.1007/s10620-015-3662-4; Leonhardt M, 2003, BIOL REPROD, V68, P390, DOI 10.1095/biolreprod.102.003269; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lopatina O, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00133; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mikami K, 2012, PHARMACEUTICALS-BASE, V5, P629, DOI 10.3390/ph5060629; Miyazawa K, 2015, MICROBIOL IMMUNOL, V59, P99, DOI 10.1111/1348-0421.12226; Nagashima K., 2006, Bioscience and Microflora, V25, P99; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Oda Y, 2011, BIOFACTORS, V37, P31, DOI 10.1002/biof.132; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Shiozaki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111374; Silverman JL, 2013, NEUROPHARMACOLOGY, V64, P268, DOI 10.1016/j.neuropharm.2012.07.013; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Tanigawa T, 2013, EUR J PHARMACOL, V704, P64, DOI 10.1016/j.ejphar.2013.02.010; Tochitani S, 2008, BIOCHEM BIOPH RES CO, V372, P691, DOI 10.1016/j.bbrc.2008.05.127; Tochitani S, 2010, NEUROSCI LETT, V472, P128, DOI 10.1016/j.neulet.2010.01.071; Toth SL, 2013, DEV PSYCHOPATHOL, V25, P1601, DOI 10.1017/S0954579413000795; Tousen Y, 2011, METABOLISM, V60, P1425, DOI 10.1016/j.metabol.2011.02.009; Trujillo V, 2016, STRESS, V19, P91, DOI 10.3109/10253890.2015.1105958; Unno T, 2015, J AGR FOOD CHEM, V63, P7952, DOI 10.1021/acs.jafc.5b02649; Verdu EF, 2006, GUT, V55, P182, DOI 10.1136/gut.2005.066100; Vieau D, 2007, PSYCHONEUROENDOCRINO, V32, pS16, DOI 10.1016/j.psyneuen.2007.03.014; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Wang T, 2015, BENEF MICROBES, V6, P707, DOI 10.3920/BM2014.0177; Wattez JS, 2014, J DEV ORIG HLTH DIS, V5, P109, DOI 10.1017/S2040174413000548; Yoda K, 2012, J APPL MICROBIOL, V113, P155, DOI 10.1111/j.1365-2672.2012.05316.x; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013	70	87	88	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0138293	10.1371/journal.pone.0138293	http://dx.doi.org/10.1371/journal.pone.0138293			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789865	gold, Green Published			2022-12-26	WOS:000368529100001
J	Alberto, AVP; Faria, RX; de Menezes, JRL; Surrage, A; da Rocha, NC; Ferreira, LGB; Frutuoso, VD; Martins, MA; Alves, LA				Pinto Alberto, Anael Viana; Faria, Robson Xavier; Lacerda de Menezes, Joao Ricardo; Surrage, Andrea; da Rocha, Natasha Cristina; Braga Ferreira, Leonardo Gomes; Frutuoso, Valber da Silva; Martins, Marco Aurelio; Alves, Luiz Anastacio			Role of P2 Receptors as Modulators of Rat Eosinophil Recruitment in Allergic Inflammation	PLOS ONE			English	Article							OXYGEN RADICAL PRODUCTION; ANTIGEN-PRESENTING CELLS; EXTRACELLULAR ATP; PHARMACOLOGICAL CHARACTERIZATION; ALVEOLAR MACROPHAGES; PURINERGIC RECEPTORS; INTRACELLULAR CA2+; LUNG INFLAMMATION; DENDRITIC CELLS; NUCLEOTIDES	ATP and other nucleotides are released from cells through regulated pathways or following the loss of plasma membrane integrity. Once outside the cell, these compounds can activate P2 receptors: P2X ionotropic receptors and G protein-coupled P2Y receptors. Eosinophils represent major effector cells in the allergic inflammatory response and they are, in fact, associated with several physiological and pathological processes. Here we investigate the expression of P2 receptors and roles of those receptors in murine eosinophils. In this context, our first step was to investigate the expression and functionality of the P2X receptors by patch clamping, our results showed a potency ranking order of ATP>ATP gamma S>2meSATP>ADP>alpha beta meATP>beta gamma meATP>BzATP>UTP>UDP>cAMP. This data suggest the presence of P2X1, P2X2 and P2X7. Next we evaluate by microfluorimetry the expression of P2Y receptors, our results based in the ranking order of potency (UTP>ATP gamma S>ATP>UDP>ADP>2meSATP>alpha beta meATP) suggests the presence of P2Y2, P2Y4, P2Y6 and P2Y11. Moreover, we confirmed our findings by immunofluorescence assays. We also did chemotaxis assays to verify whether nucleotides could induce migration. After 1 or 2 hours of incubation, ATP increased migration of eosinophils, as well as ATP gamma S, a less hydrolysable analogue of ATP, while suramin a P2 blocker abolished migration. In keeping with this idea, we tested whether these receptors are implicated in the migration of eosinophils to an inflammation site in vivo, using a model of rat allergic pleurisy. In fact, migration of eosinophils has increased when ATP or ATP gamma S were applied in the pleural cavity, and once more suramin blocked this effect. We have demonstrated that rat eosinophils express P2X and P2Y receptors. In addition, the activation of P2 receptors can increase migration of eosinophils in vitro and in vivo, an effect blocked by suramin.	[Pinto Alberto, Anael Viana; Faria, Robson Xavier; da Rocha, Natasha Cristina; Braga Ferreira, Leonardo Gomes; Alves, Luiz Anastacio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comunicacao Celular, Rio De Janeiro, Brazil; [Martins, Marco Aurelio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Inflamacao, Rio De Janeiro, Brazil; [Lacerda de Menezes, Joao Ricardo] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Neuroanat Celular, Rio De Janeiro, Brazil; [Surrage, Andrea; Frutuoso, Valber da Silva] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Alves, LA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comunicacao Celular, Rio De Janeiro, Brazil.	alveslaa@ioc.fiocruz.br	Menezes, João R. L./D-5668-2012		Instituto Oswaldo Cruz; CAPES	Instituto Oswaldo Cruz; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Instituto Oswaldo Cruz and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Bowler JW, 2003, BRIT J PHARMACOL, V140, P567, DOI 10.1038/sj.bjp.0705459; BRUIJNZEEL PLB, 1994, ANN NY ACAD SCI, V725, P259, DOI 10.1111/j.1749-6632.1994.tb39808.x; Burnstock G, 2009, BRAZ J MED BIOL RES, V42, P3, DOI 10.1590/S0100-879X2008005000037; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Burnstock G, 1995, Pharm Acta Helv, V69, P231, DOI 10.1016/0031-6865(94)00043-U; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Coutinho-Silva R, 2005, BIOCHEM PHARMACOL, V69, P641, DOI 10.1016/j.bcp.2004.11.012; Desreumaux P, 1996, CURR OPIN IMMUNOL, V8, P790, DOI 10.1016/S0952-7915(96)80006-9; Dichmann S, 2000, BLOOD, V95, P973, DOI 10.1182/blood.V95.3.973.003k47_973_978; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Ferrari D, 2000, FEBS LETT, V486, P217, DOI 10.1016/S0014-5793(00)02306-1; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Idzko M, 2003, BRIT J PHARMACOL, V138, P1244, DOI 10.1038/sj.bjp.0705145; Idzko M, 2001, J CELL PHYSIOL, V188, P329, DOI 10.1002/jcp.1129; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Ilatovskaya DV, 2013, AM J PHYSIOL-CELL PH, V305, pC1050, DOI 10.1152/ajpcell.00138.2013; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Legrand Fanny, 2008, V415, P215, DOI 10.1007/978-1-59745-570-1_13; MARTINS MA, 1993, J LEUKOCYTE BIOL, V53, P104, DOI 10.1002/jlb.53.1.104; MARTINS MA, 1989, BRAZ J MED BIOL RES, V22, P1151; Mohanty JG, 2001, J ALLERGY CLIN IMMUN, V107, P849, DOI 10.1067/mai.2001.114658; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; Myrtek D, 2007, PURINERG SIGNAL, V3, P5, DOI 10.1007/s11302-006-9032-0; Myrtek D, 2008, J IMMUNOL, V181, P2181, DOI 10.4049/jimmunol.181.3.2181; Neves JS, 2010, J ALLERGY CLIN IMMUN, V125, P477, DOI 10.1016/j.jaci.2009.11.029; Padigel UM, 2006, INFECT IMMUN, V74, P3232, DOI 10.1128/IAI.02067-05; Ralevic V, 1998, PHARMACOL REV, V50, P413; Shi HZ, 2004, J LEUKOCYTE BIOL, V76, P520, DOI 10.1189/jlb.0404228; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Vanderstocken G, 2010, J IMMUNOL, V185, P3702, DOI 10.4049/jimmunol.0903908; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; WALKER C, 1991, INT ARCH ALLER A IMM, V94, P248, DOI 10.1159/000235373; WEINSTOCK JV, 1988, J IMMUNOL, V141, P961; WELLER PF, 1991, P NATL ACAD SCI USA, V88, P7430, DOI 10.1073/pnas.88.16.7430; Zosky GR, 2008, CLIN EXP ALLERGY, V38, P829, DOI 10.1111/j.1365-2222.2007.02884.x; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	41	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145392	10.1371/journal.pone.0145392	http://dx.doi.org/10.1371/journal.pone.0145392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784445	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400012
J	Hsu, HC; Chang, WM; Wu, JY; Huang, CC; Lu, FJ; Chuang, YW; Chang, PJ; Chen, KH; Hong, CZ; Yeh, RH; Liu, TZ; Chen, CH				Hsu, Hung-Chih; Chang, Wen-Ming; Wu, Jin-Yi; Huang, Chin-Chin; Lu, Fung-Jou; Chuang, Yi-Wen; Chang, Pey-Jium; Chen, Kai-Hua; Hong, Chang-Zern; Yeh, Rang-Hui; Liu, Tsan-Zon; Chen, Ching-Hsein			Folate Deficiency Triggered Apoptosis of Synoviocytes: Role of Overproduction of Reactive Oxygen Species Generated via NADPH Oxidase/Mitochondrial Complex II and Calcium Perturbation	PLOS ONE			English	Article							NF-KAPPA-B; FIBROBLAST-LIKE SYNOVIOCYTES; FOLIC-ACID SUPPLEMENTATION; INCREASED OXIDATIVE STRESS; NEURAL-TUBE DEFECTS; PLASMA HOMOCYSTEINE; PROTEIN-EXTRACT; CELLS; OSTEOARTHRITIS; DISEASE	Despite a plethora of literature has documented that osteoarthritis (OA) is veritably associated with oxidative stress-mediated chondrocyte death and matrix degradation, yet the possible involvement of synoviocyte abnormality as causative factor of OA has not been thoroughly investigated. For this reason, we conduct the current studies to insight into how synoviocytes could respond to an episode of folate-deprived (FD) condition. First, when HIG-82 synoviocytes were cultivated under FD condition, a time-dependent growth impediment was observed and the demise of these cells was demonstrated to be apoptotic in nature mediated through FD-evoked overproduction of reactive oxygen species (ROS) and drastically released of cytosolic calcium (Ca2+) concentrations. Next, we uncovered that FD-evoked ROS overproduction could only be strongly suppressed by either mitochondrial complex II inhibitors (TTFA and carboxin) or NADPH oxidase (NOX) inhibitors (AEBSF and apocynin), but not by mitochondrial complex I inhibitor (rotenone) and mitochondrial complex III inhibitor (antimycin A). Interestingly, this selective inhibition of FD-evoked ROS by mitochondrial complex II and NOX inhibitors was found to correlate excellently with the suppression of cytosolic Ca2+ release and reduced the magnitude of the apoptotic TUNEL-positive cells. Taken together, we present the first evidence here that FD-triggered ROS overproduction in synoviocytes is originated from mitochondrial complex II and NOX. Both elevated ROS in tandem with cytosolic Ca2+ overload serve as final arbitrators for apoptotic lethality of synoviocytes cultivated under FD condition. Thus, folate supplementation may be beneficial to patients with OA.	[Hsu, Hung-Chih; Chang, Wen-Ming; Chuang, Yi-Wen; Chen, Kai-Hua; Yeh, Rang-Hui] Chia Yi Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Hsu, Hung-Chih; Chang, Wen-Ming; Chuang, Yi-Wen; Chen, Kai-Hua] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Hsu, Hung-Chih; Chang, Pey-Jium] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Hsu, Hung-Chih] Chia Yi Chang Gung Mem Hosp, Ctr Adv Integrat Sports Med, Chiayi, Taiwan; [Wu, Jin-Yi; Huang, Chin-Chin; Chen, Ching-Hsein] Natl Chiayi Univ, Collage Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi 60004, Taiwan; [Lu, Fung-Jou] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hong, Chang-Zern] Hung Kuang Univ, Dept Phys Therapy, Taichung, Taiwan; [Liu, Tsan-Zon] Taipei Med Univ & Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung University; Chang Gung Memorial Hospital; National Chiayi University; Chung Shan Medical University; Hungkuang University; Taipei Medical University; Taipei Medical University Hospital	Chen, CH (corresponding author), Natl Chiayi Univ, Collage Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi 60004, Taiwan.; Liu, TZ (corresponding author), Taipei Med Univ & Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan.	tzliu@tmuh.org.tw; chench@mail.ncyu.edu.tw		Chang, Pey-Jium/0000-0002-6492-0346	Chang Gung Memorial Hospital, R.O.C. [CMRPG6B0471]; National Science Council, Taiwan (National Science Council's) [NSC 102-2320-B-415-005-MY3]	Chang Gung Memorial Hospital, R.O.C.(Chang Gung Memorial Hospital); National Science Council, Taiwan (National Science Council's)	This study was supported by Chang Gung Memorial Hospital, R.O.C. (CMRPG6B0471, W.M.C.) and in part by National Science Council, Taiwan (NSC 102-2320-B-415-005-MY3; National Science Council's, C.H.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; Buckwalter JA, 2013, CARTILAGE, V4, P286, DOI 10.1177/1947603513495889; Chen CH, 2011, FOOD CHEM TOXICOL, V49, P494, DOI 10.1016/j.fct.2010.11.031; Chern CL, 2001, BIOMED PHARMACOTHER, V55, P434, DOI 10.1016/S0753-3322(01)00095-6; Clarke R, 2004, AGE AGEING, V33, P34, DOI 10.1093/ageing/afg109; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Cutolo M, 2001, ANN RHEUM DIS, V60, P729, DOI 10.1136/ard.60.8.729; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; Ding XQ, 2015, INT IMMUNOPHARMACOL, V26, P153, DOI 10.1016/j.intimp.2015.03.024; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; GEORGESCU HI, 1988, IN VITRO CELL DEV B, V24, P1015; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; HARRISON RJ, 1971, BRIT J HAEMATOL, V20, P623, DOI 10.1111/j.1365-2141.1971.tb00800.x; Hsieh TJ, 2006, FOOD CHEM TOXICOL, V44, P344, DOI 10.1016/j.fct.2005.08.005; Hsu HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077931; Hwang SY, 2011, AM J PHYSIOL-RENAL, V300, pF189, DOI 10.1152/ajprenal.00272.2010; Iwanaga T, 2000, ARCH HISTOL CYTOL, V63, P17, DOI 10.1679/aohc.63.17; Kao TT, 2014, NEUROBIOL DIS, V71, P234, DOI 10.1016/j.nbd.2014.08.004; Kim YI, 1999, J NUTR BIOCHEM, V10, P66, DOI 10.1016/S0955-2863(98)00074-6; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Lebiedzinska A, 2008, TOXICOL MECH METHOD, V18, P463, DOI 10.1080/15376510701623870; Li D, 2012, AM J MED SCI, V344, P486, DOI 10.1097/MAJ.0b013e3182579dc6; Lindenbaum J., 1995, FOLATE HLTH DIS, P43; Lominadze D, 2006, AM J PHYSIOL-HEART C, V290, pH1206, DOI 10.1152/ajpheart.00376.2005; Lopez HL, 2012, PM&R, V4, pS155, DOI 10.1016/j.pmrj.2012.02.023; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Novakovic P, 2006, CARCINOGENESIS, V27, P916, DOI 10.1093/carcin/bgi312; Ong PL, 2008, FOOD CHEM TOXICOL, V46, P1535, DOI 10.1016/j.fct.2007.12.015; Ovey IS, 2015, NEUROSCIENCE, V284, P225, DOI 10.1016/j.neuroscience.2014.09.078; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Rogers EJ, 2007, NEW ENGL J MED, V357, P421, DOI 10.1056/NEJMc066569; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Tjiattas L, 2004, AGING CELL, V3, P71, DOI 10.1111/j.1474-9728.2004.00086.x; UELAND PM, 1989, J LAB CLIN MED, V114, P473; Vacek TP, 2013, CLIN CHEM LAB MED, V51, P579, DOI 10.1515/cclm-2012-0605; Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1; Wen SW, 2008, CAN MED ASSOC J, V179, P1263, DOI 10.1503/cmaj.080859; Yang CR, 2014, J MOL MED, V92, P1147, DOI 10.1007/s00109-014-1192-8; Yang JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094180; Yeh CH, 2011, PROCESS BIOCHEM, V46, P1599, DOI 10.1016/j.procbio.2011.04.015; Yu DH, 2012, EXP MOL MED, V44, P529, DOI 10.3858/emm.2012.44.9.060; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523	46	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146440	10.1371/journal.pone.0146440	http://dx.doi.org/10.1371/journal.pone.0146440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771387	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300019
J	Broussard, TC; Miller, DJ; Jackson, P; Nourse, A; White, SW; Rock, CO				Broussard, Tyler C.; Miller, Darcie J.; Jackson, Pamela; Nourse, Amanda; White, Stephen W.; Rock, Charles O.			Biochemical Roles for Conserved Residues in the Bacterial Fatty Acid-binding Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; fatty acid; fatty acid-binding protein; site-directed mutagenesis; Staphylococcus aureus (S; aureus); fatty acid; fatty acid kinase	STAPHYLOCOCCUS-AUREUS; DIHYDROXYACETONE KINASE; ANALYTICAL ULTRACENTRIFUGATION; CRYSTAL-STRUCTURE; GENE-EXPRESSION; IDENTIFICATION; REVEALS; PATHWAY; COMPLEX; DOMAIN	Fatty acid kinase (Fak) is a ubiquitous Gram-positive bacterial enzyme consisting of an ATP-binding protein (FakA) that phosphorylates the fatty acid bound to FakB. In Staphylococcus aureus, Fak is a global regulator of virulence factor transcription and is essential for the activation of exogenous fatty acids for incorporation into phospholipids. The 1.2- x-ray structure of S. aureus FakB2, activity assays, solution studies, site-directed mutagenesis, and in vivo complementation were used to define the functions of the five conserved residues that define the FakB protein family (Pfam02645). The fatty acid tail is buried within the protein, and the exposed carboxyl group is bound by a Ser-93-fatty acid carboxyl-Thr-61-His-266 hydrogen bond network. The guanidinium of the invariant Arg-170 is positioned to potentially interact with a bound acylphosphate. The reduced thermal denaturation temperatures of the T61A, S93A, and H266A FakB2 mutants illustrate the importance of the hydrogen bond network in protein stability. The FakB2 T61A, S93A, and H266A mutants are 1000-fold less active in the Fak assay, and the R170A mutant is completely inactive. All FakB2 mutants form FakA(FakB2)(2) complexes except FakB2(R202A), which is deficient in FakA binding. Allelic replacement shows that strains expressing FakB2 mutants are defective in fatty acid incorporation into phospholipids and virulence gene transcription. These conserved residues are likely to perform the same critical functions in all bacterial fatty acid-binding proteins.	[Broussard, Tyler C.; Jackson, Pamela; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Miller, Darcie J.; Nourse, Amanda; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Charles.rock@stjude.org	White, Stephen W/N-8164-2018	Nourse, Amanda/0000-0003-4595-5321	National Institutes of Health from NIGMS [GM034496]; NIAID [T32 AI106700]; Cancer Center Support [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI106700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Center Support; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM034496 (to C. O. R.) from NIGMS, Training Grant T32 AI106700 from NIAID (to T. C. B.), and Cancer Center Support Grant CA21765 and by the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Balbo A., 2007, CURR PROTOC IMMUNOL, V18; Bose JL, 2014, INFECT IMMUN, V82, P1813, DOI 10.1128/IAI.01655-13; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; Brown P. H., 2008, CURR PROTOC IMMUNOL, V18; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghirlando R, 2014, ANAL BIOCHEM, V458, P37, DOI 10.1016/j.ab.2014.04.029; Kinch LN, 2005, PROTEIN SCI, V14, P360, DOI 10.1110/ps.041114805; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehman MK, 2016, METHODS MOL BIOL, V1373, P89, DOI 10.1007/7651_2014_187; Mihalek I, 2006, BIOINFORMATICS, V22, P1656, DOI 10.1093/bioinformatics/btl157; Nan J, 2009, ACTA CRYSTALLOGR D, V65, P440, DOI 10.1107/S0907444909007756; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P2182, DOI 10.1128/AAC.02307-12; Sabirova JS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1956-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schulze-Gahmen U, 2003, PROTEINS, V50, P526, DOI 10.1002/prot.10305; Shi R, 2011, P NATL ACAD SCI USA, V108, P1302, DOI 10.1073/pnas.1012596108; Siebold C, 2003, J BIOL CHEM, V278, P48236, DOI 10.1074/jbc.M305942200; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011; Zhao HY, 2012, ANAL CHEM, V84, P9513, DOI 10.1021/ac302357w; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248; Zurbriggen A, 2008, J BIOL CHEM, V283, P35789, DOI 10.1074/jbc.M804893200	33	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6292	6303		10.1074/jbc.M115.706820	http://dx.doi.org/10.1074/jbc.M115.706820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26774272	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000372894200020
J	Huang, LH; Melton, EM; Li, HB; Sohn, P; Rogers, MA; Mulligan-Kehoe, MJ; Fiering, SN; Hickey, WF; Chang, CCY; Chang, TY				Huang, Li-Hao; Melton, Elaina M.; Li, Haibo; Sohn, Paul; Rogers, Maximillian A.; Mulligan-Kehoe, Mary Jo; Fiering, Steven N.; Hickey, William F.; Chang, Catherine C. Y.; Chang, Ta-Yuan			Myeloid Acyl-CoA:Cholesterol Acyltransferase 1 Deficiency Reduces Lesion Macrophage Content and Suppresses Atherosclerosis Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acyltransferase; atherosclerosis; cholesterol; cholesterol metabolism; macrophage	COA-CHOLESTEROL ACYLTRANSFERASE; HAMSTER OVARY CELLS; MICE; COENZYME; EXPRESSION; MONOCYTES; PROLIFERATION; XANTHOMATOSIS; ACCUMULATION; DEGRADATION	Acyl-CoA:cholesterol acyltransferase 1 (Acat1) converts cellular cholesterol to cholesteryl esters and is considered a drug target for treating atherosclerosis. However, in mouse models for atherosclerosis, global Acat1 knockout (Acat1(-/-)) did not prevent lesion development. Acat1(-/-) increased apoptosis within lesions and led to several additional undesirable phenotypes, including hair loss, dry eye, leukocytosis, xanthomatosis, and a reduced life span. To determine the roles of Acat1 in monocytes/macrophages in atherosclerosis, we produced a myeloid-specific Acat1 knockout (Acat1(-M/-M)) mouse and showed that, in the Apoe knockout (Apoe(-/-)) mouse model for atherosclerosis, Acat1(-M/-M) decreased the plaque area and reduced lesion size without causing leukocytosis, dry eye, hair loss, or a reduced life span. Acat1(-M/-M) enhanced xanthomatosis in apoe(-/-) mice, a skin disease that is not associated with diet-induced atherosclerosis in humans. Analyses of atherosclerotic lesions showed that Acat1(-M/-M) reduced macrophage numbers and diminished the cholesterol and cholesteryl ester load without causing detectable apoptotic cell death. Leukocyte migration analysis in vivo showed that Acat1(-M/-M) caused much fewer leukocytes to appear at the activated endothelium. Studies in inflammatory (Ly6C(hi)-positive) monocytes and in cultured macrophages showed that inhibiting ACAT1 by gene knockout or by pharmacological inhibition caused a significant decrease in integrin 1 (CD29) expression in activated monocytes/macrophages. The sparse presence of lesion macrophages without Acat1 can therefore, in part, be attributed to decreased interaction between inflammatory monocytes/macrophages lacking Acat1 and the activated endothelium. We conclude that targeting ACAT1 in a myeloid cell lineage suppresses atherosclerosis progression while avoiding many of the undesirable side effects caused by global Acat1 inhibition.	[Huang, Li-Hao; Melton, Elaina M.; Li, Haibo; Sohn, Paul; Rogers, Maximillian A.; Chang, Catherine C. Y.; Chang, Ta-Yuan] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Mulligan-Kehoe, Mary Jo] Geisel Sch Med Dartmouth, Dept Surg, Vasc Sect, Lebanon, NH 03756 USA; [Fiering, Steven N.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; [Hickey, William F.] Geisel Sch Med Dartmouth, Dept Pathol, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Chang, CCY; Chang, TY (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	Catherine.Chang@Dartmouth.Edu; Ta.Yuan.Chang@Dartmouth.Edu		Melton, Elaina/0000-0002-4030-7766; Rogers, Maximillian/0000-0001-9277-3200	National Institutes of Health [RO1-HL060306, 1F32HL124953]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060306, F32HL124953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant RO1-HL060306 (to T. Y. C. and C. C. Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Postdoctoral Fellowship 1F32HL124953.	Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Chang CCY, 2000, J BIOL CHEM, V275, P28083; CHANG CCY, 1986, BIOCHEMISTRY-US, V25, P1700, DOI 10.1021/bi00355a039; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Clahsen T, 2008, J LEUKOCYTE BIOL, V84, P1521, DOI 10.1189/jlb.0308178; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Drinane M, 2009, CIRC RES, V104, P337, DOI 10.1161/CIRCRESAHA.108.184622; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Gaudreault N, 2012, ARTERIOSCL THROM VAS, V32, P264, DOI 10.1161/ATVBAHA.111.238964; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Huang LH, 2013, ARTERIOSCL THROM VAS, V33, P2081, DOI 10.1161/ATVBAHA.112.301080; Ikenoya M, 2007, ATHEROSCLEROSIS, V191, P290, DOI 10.1016/j.atherosclerosis.2006.05.048; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kusunoki J, 2001, CIRCULATION, V103, P2604; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Rong JX, 2013, ARTERIOSCL THROM VAS, V33, P4, DOI 10.1161/ATVBAHA.112.252056; Sakashita N, 2010, J LIPID RES, V51, P1263, DOI [10.1194/jlr.M900288-JLR200, 10.1194/jlr.M900288]; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200	28	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6232	6244		10.1074/jbc.M116.713818	http://dx.doi.org/10.1074/jbc.M116.713818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26801614	Green Published, hybrid			2022-12-26	WOS:000372894200015
J	Deng, XY; Qin, XJ; Chen, L; Jia, Q; Zhang, YH; Zhang, ZY; Lei, DS; Ren, G; Zhou, ZH; Wang, Z; Li, Q; Xie, W				Deng, Xiangyu; Qin, Xiangjing; Chen, Lei; Jia, Qian; Zhang, Yonghui; Zhang, Zhiyong; Lei, Dongsheng; Ren, Gang; Zhou, Zhihong; Wang, Zhong; Li, Qing; Xie, Wei			Large Conformational Changes of Insertion 3 in Human Glycyl-tRNA Synthetase (hGlyRS) during Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; Charcot-Marie-Tooth disease (CMT); conformational change; crystal structure; enzyme mechanism	MARIE-TOOTH-DISEASE; MUSCULAR-ATROPHY; GARS; MUTATIONS; NEUROPATHY; 2D; PURIFICATION; PHENOTYPES; SEQUENCE; DYNAMICS	Glycyl-tRNA synthetase (GlyRS) is the enzyme that covalently links glycine to cognate tRNA for translation. It is of great research interest because of its nonconserved quaternary structures, unique species-specific aminoacylation properties, and noncanonical functions in neurological diseases, but none of these is fully understood. We report two crystal structures of human GlyRS variants, in the free form and in complex with tRNA(Gly) respectively, and reveal new aspects of the glycylation mechanism. We discover that insertion 3 differs considerably in conformation in catalysis and that it acts like a switch and fully opens to allow tRNA to bind in a cross-subunit fashion. The flexibility of the protein is supported by molecular dynamics simulation, as well as enzymatic activity assays. The biophysical and biochemical studies suggest that human GlyRS may utilize its flexibility for both the traditional function (regulate tRNA binding) and alternative functions (roles in diseases).	[Deng, Xiangyu; Chen, Lei; Jia, Qian; Zhou, Zhihong; Xie, Wei] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, 135 West Xingang Rd, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Xiangyu; Chen, Lei; Jia, Qian; Zhou, Zhihong; Wang, Zhong; Li, Qing; Xie, Wei] Sun Yat Sen Univ, Ctr Cellular & Struct Biol, Guangzhou 510006, Guangdong, Peoples R China; [Wang, Zhong; Li, Qing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China; [Qin, Xiangjing] Chinese Acad Sci, South China Sea Inst, Guangzhou 510301, Guangdong, Peoples R China; [Zhang, Yonghui; Zhang, Zhiyong] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhang, Yonghui; Zhang, Zhiyong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Lei, Dongsheng; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Xie, W (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, 135 West Xingang Rd, Guangzhou 510275, Guangdong, Peoples R China.	xiewei6@mail.sysu.edu.cn	Ren, Gang/B-1567-2012; Lei, Dongsheng/K-3485-2012; Lei, Dongsheng/AAH-4177-2020	Ren, Gang/0000-0002-8036-2321; Lei, Dongsheng/0000-0003-1640-0693; Xie, Wei/0000-0003-2410-2135; Jia, Qian/0000-0002-1629-6622	National Sciences Foundation of China [31100579, 31270760]; Guangdong Innovative Research Team Program [2011Y038]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153] Funding Source: NIH RePORTER	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Sciences Foundation of China Grants 31100579 and 31270760 and Guangdong Innovative Research Team Program 2011Y038. The authors declare that they have no conflicts of interest with the contents of this article.	Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bienfait HME, 2007, NEUROLOGY, V68, P1658, DOI 10.1212/01.wnl.0000263479.97552.94; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CUSACK S, 1993, BIOCHIMIE, V75, P1077, DOI 10.1016/0300-9084(93)90006-E; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; Desarnaud F, 1998, J NEUROCHEM, V71, P1765; DIGNAM SS, 1984, J BIOL CHEM, V259, P4043; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Freist W, 1996, BIOL CHEM H-S, V377, P343; Griffin LB, 2014, HUM MUTAT, V35, P1363, DOI 10.1002/humu.22681; Guo RT, 2009, J BIOL CHEM, V284, P28968, DOI 10.1074/jbc.M109.030692; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; James PA, 2006, NEUROLOGY, V67, P1710, DOI 10.1212/01.wnl.0000242619.52335.bc; Jani-Acsadi A, 2008, SEMIN NEUROL, V28, P185, DOI 10.1055/s-2008-1062264; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KERN D, 1981, BIOCHEMISTRY-US, V20, P122, DOI 10.1021/bi00504a021; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Lee HJ, 2012, J PERIPHER NERV SYST, V17, P418, DOI 10.1111/j.1529-8027.2012.00442.x; LOGAN DT, 1995, EMBO J, V14, P4156, DOI 10.1002/j.1460-2075.1995.tb00089.x; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; McPherson A, 2006, J STRUCT BIOL, V156, P387, DOI 10.1016/j.jsb.2006.09.006; Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; Qin XJ, 2014, J BIOL CHEM, V289, P20359, DOI 10.1074/jbc.M114.557249; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Saporta MA, 2013, NEUROL CLIN, V31, P597, DOI 10.1016/j.ncl.2013.01.009; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL P, 1995, J MOL EVOL, V40, P531; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Shi Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02349; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590; SKRE H, 1974, CLIN GENET, V6, P98; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; SURGUCHOV AP, 1975, EUR J BIOCHEM, V54, P175, DOI 10.1111/j.1432-1033.1975.tb04127.x; THOMAS PK, 1974, J NEUROL NEUROSUR PS, V37, P68, DOI 10.1136/jnnp.37.1.68; Vallat JM, 2013, CURR OPIN NEUROL, V26, P473, DOI 10.1097/WCO.0b013e328364c04b; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhu XD, 2009, P NATL ACAD SCI USA, V106, P15944, DOI 10.1073/pnas.0901872106	60	10	11	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5740	5752		10.1074/jbc.M115.679126	http://dx.doi.org/10.1074/jbc.M115.679126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26797133	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000372551800023
J	Becker, A; Zhang, P; Allmann, L; Meilinger, D; Bertulat, B; Eck, D; Hofstaetter, M; Bartolomei, G; Hottiger, MO; Schreiber, V; Leonhardt, H; Cardoso, MC				Becker, Annette; Zhang, Peng; Allmann, Lena; Meilinger, Daniela; Bertulat, Bianca; Eck, Daniel; Hofstaetter, Maria; Bartolomei, Giody; Hottiger, Michael O.; Schreiber, Valerie; Leonhardt, Heinrich; Cardoso, M. Cristina			Poly(ADP-ribosyl)ation of Methyl CpG Binding Domain Protein 2 Regulates Chromatin Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						5-methylcytosine; chromatin remodeling; DNA methylation; heterochromatin; post-translational modification (PTM); MeCP2; PARP-1; chromatin binding and organization; poly(ADP-ribosyl)ation	RETT-SYNDROME; DNA-REPAIR; HISTONE DEACETYLASE; BDNF TRANSCRIPTION; MECP2; MUTATIONS; PHOSPHORYLATION; ASSOCIATION; CELLS; DIFFERENTIATION	The epigenetic information encoded in the genomic DNA methylation pattern is translated by methylcytosine binding proteins like MeCP2 into chromatin topology and structure and gene activity states. We have shown previously that the MeCP2 level increases during differentiation and that it causes large-scale chromatin reorganization, which is disturbed by MeCP2 Rett syndrome mutations. Phosphorylation and other posttranslational modifications of MeCP2 have been described recently to modulate its function. Here we show poly(ADP-ribosyl)ation of endogenous MeCP2 in mouse brain tissue. Consequently, we found that MeCP2 induced aggregation of pericentric heterochromatin and that its chromatin accumulation was enhanced in poly(ADP-ribose) polymerase (PARP) 1(-/-) compared with wild-type cells. We mapped the poly(ADP-ribosyl)ation domains and engineered MeCP2 mutation constructs to further analyze potential effects on DNA binding affinity and large-scale chromatin remodeling. Single or double deletion of the poly(ADP-ribosyl)ated regions and PARP inhibition increased the heterochromatin clustering ability of MeCP2. Increased chromatin clustering may reflect increased binding affinity. In agreement with this hypothesis, we found that PARP-1 deficiency significantly increased the chromatin binding affinity of MeCP2 in vivo. These data provide novel mechanistic insights into the regulation of MeCP2-mediated, higher-order chromatin architecture and suggest therapeutic opportunities to manipulate MeCP2 function.	[Becker, Annette; Zhang, Peng; Allmann, Lena; Bertulat, Bianca; Eck, Daniel; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany; [Meilinger, Daniela; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci, Dept Biol, D-82152 Planegg Martinsried, Germany; [Hofstaetter, Maria] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bartolomei, Giody; Hottiger, Michael O.] Univ Zurich, Dept Mol Mech Dis, CH-8057 Zurich, Switzerland; [Schreiber, Valerie] Strasbourg Univ, CNRS, Ecole Super Biotechnol Strasbourg, UMR7242 Biotechnol & Cell Signaling,Lab Excellenc, BP10413, F-67412 Illkirch Graffenstaden, France	Technical University of Darmstadt; University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cardoso, MC (corresponding author), Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	cardoso@bio.tu-darmstadt.de	Schreiber, Valérie/M-5007-2016; Leonhardt, Heinrich/B-2791-2014; Hottiger, Michael O./J-7747-2013	Schreiber, Valérie/0000-0003-0507-639X; Hottiger, Michael O./0000-0002-7323-2270	Deutsche Forschungsgemeinschaft [DFG CA 198/4]; Chinese Scholarship Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chinese Scholarship Council(China Scholarship Council)	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG CA 198/4 and 7 (to M.C.C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship of the Chinese Scholarship Council.	Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Becker A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053730; Bellini E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00236; Bertulat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047848; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Casas-Delucchi CS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks784; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; De Vos M, 2014, J BIOL CHEM, V289, P16223, DOI 10.1074/jbc.M113.527424; Finch KE, 2012, ACS CHEM BIOL, V7, P563, DOI 10.1021/cb200506t; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jost KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026499; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Kaufmann U, 1999, J CELL SCI, V112, P55; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Marchi M, 2007, EPIGENETICS-US, V2, P187, DOI 10.4161/epi.2.3.5057; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Rajan M, 2015, FEBS OPEN BIO, V5, P779, DOI 10.1016/j.fob.2015.09.005; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	35	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4873	4881		10.1074/jbc.M115.698357	http://dx.doi.org/10.1074/jbc.M115.698357			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26772194	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000371640600003
J	Demberg, V; Sayeed, A				Demberg, Vera; Sayeed, Asad			The Frequency of Rapid Pupil Dilations as a Measure of Linguistic Processing Difficulty	PLOS ONE			English	Article							LOCUS-COERULEUS; LOAD; MODULATION; RESPONSES; STATE	While it has long been known that the pupil reacts to cognitive load, pupil size has received little attention in cognitive research because of its long latency and the difficulty of separating effects of cognitive load from the light reflex or effects due to eye movements. A novel measure, the Index of Cognitive Activity (ICA), relates cognitive effort to the frequency of small rapid dilations of the pupil. We report here on a total of seven experiments which test whether the ICA reliably indexes linguistically induced cognitive load: three experiments in reading (a manipulation of grammatical gender match / mismatch, an experiment of semantic fit, and an experiment comparing locally ambiguous subject versus object relative clauses, all in German), three dual-task experiments with simultaneous driving and spoken language comprehension (using the same manipulations as in the single-task reading experiments), and a visual world experiment comparing the processing of causal versus concessive discourse markers. These experiments are the first to investigate the effect and time course of the ICA in language processing. All of our experiments support the idea that the ICA indexes linguistic processing difficulty. The effects of our linguistic manipulations on the ICA are consistent for reading and auditory presentation. Furthermore, our experiments show that the ICA allows for usage within a multi-task paradigm. Its robustness with respect to eye movements means that it is a valid measure of processing difficulty for usage within the visual world paradigm, which will allow researchers to assess both visual attention and processing difficulty at the same time, using an eye-tracker. We argue that the ICA is indicative of activity in the locus caeruleus area of the brain stem, which has recently also been linked to P600 effects observed in psycholinguistic EEG experiments.	[Demberg, Vera; Sayeed, Asad] Univ Saarland, Cluster Excellence MMCI, D-66123 Saarbrucken, Germany	Saarland University	Demberg, V (corresponding author), Univ Saarland, Cluster Excellence MMCI, D-66123 Saarbrucken, Germany.	vera@coli.uni-saarland.de	Demberg, Vera/AAL-3992-2021	Demberg, Vera/0000-0002-8834-0020	German Research Foundation (DFG); Cluster of Excellence Multimodal Computing and Interaction [EXC284]	German Research Foundation (DFG)(German Research Foundation (DFG)); Cluster of Excellence Multimodal Computing and Interaction	This work was supported by German Research Foundation (DFG); both authors were supported by the Cluster of Excellence Multimodal Computing and Interaction EXC284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, HUMAN FACTORS ASSIST; [Anonymous], 2013, LINEAR MIXED EFFECTS; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bader M, 1999, J PSYCHOLINGUIST RES, V28, P121, DOI 10.1023/A:1023206208142; Bartels M., 2012, P S EYE TRACK RES AP, P161, DOI [10.1145/2168556.2168582, DOI 10.1145/2168556.2168582]; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Demberg V., 2013, P ANN M COGN SCI SOC, V35, P2154; Drenhaus H., 2014, P 36 ANN M COGN SCI; Engelhardt PE, 2010, Q J EXP PSYCHOL, V63, P639, DOI 10.1080/17470210903469864; Fine AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077661; Frank S., 2012, P 34 ANN C COGN SCI, P1554; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; HYONA J, 1995, Q J EXP PSYCHOL-A, V48, P598; JUST MA, 1993, CAN J EXP PSYCHOL, V47, P310, DOI 10.1037/h0078820; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Klingner J, 2008, PROCEEDINGS OF THE EYE TRACKING RESEARCH AND APPLICATIONS SYMPOSIUM (ETRA 2008), P69, DOI 10.1145/1344471.1344489; Koehne J., 2013, P 35 ANN M COGN SCI, P2760, DOI DOI 10.1016/J.BRAINRES.2007.05.079; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; LOEWENFELD I. E., 1993, PUPIL ANATOMY PHYSL, VII; Mahr A, 2012, ADJ P 4 INT C AUT US, P88; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Marshall S. P., 2002, New Century, New Trends. Proceedings of the 2002 IEEE 7th Conference on Human Factors and Power Plants (Cat. No.02CH37355), P7, DOI 10.1109/HFPP.2002.1042860; Marshall S. P., 2000, US Patent, Patent No. [US-6090051-A, 6090051, 6,090,051]; Marshall SP, 2007, AVIAT SPACE ENVIR MD, V78, pB165; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Sassenhagen J, 2014, BRAIN LANG, V137, P29, DOI 10.1016/j.bandl.2014.07.010; SCHLUROFF M, 1982, BRAIN LANG, V17, P133, DOI 10.1016/0093-934X(82)90010-4; Schroder M., 2003, International Journal of Speech Technology, V6, P365, DOI 10.1023/A:1025708916924; Schwalm M, 2008, PUPILLOMETRIE METHOD; Tromp J, 2016, Q J EXP PSYCHOL, V69, P1093, DOI 10.1080/17470218.2015.1065282; VIVIANI P, 1990, J MOTOR BEHAV, V22, P407; Wood S., 2014, GAMM4 GEN ADDITIVE M; Wood S.N., 2001, R R NEWS, V1, P20; Xiang M, 2014, LANGUAGE COGNITION N; Zellin M, 2011, INT J PSYCHOPHYSIOL, V81, P133, DOI 10.1016/j.ijpsycho.2011.05.009	40	39	39	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146194	10.1371/journal.pone.0146194	http://dx.doi.org/10.1371/journal.pone.0146194			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799065	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300015
J	Leclair, N; Thormer, G; Sorge, I; Ritter, L; Schuster, V; Hirsch, FW				Leclair, Nadine; Thoermer, Gregor; Sorge, Ina; Ritter, Lutz; Schuster, Volker; Hirsch, Franz Wolfgang			Whole-Body Diffusion-Weighted Imaging in Chronic Recurrent Multifocal Osteomyelitis in Children	PLOS ONE			English	Article							CRMO	Objective Chronic recurrent multifocal osteomyelitis/ chronic non-bacterial osteomyelitis (CRMO/ CNO) is a rare auto-inflammatory disease and typically manifests in terms of musculoskeletal pain. Because of a high frequency of musculoskeletal disorders in children/adolescents, it can be quite challenging to distinguish CRMO/ CNO from nonspecific musculosketetal pain or from malignancies. The purpose of this study was to evaluate the visibility of CRMO lesions in a whole-body diffusion-weighted imaging (WB-DWI) technique and its potential clinical value to better characterize MR-visible lesions. Material and Methods Whole-body imaging at 3T was performed in 16 patients (average: 13 years) with confirmed CRMO. The protocol included 2D Short Tau Inversion Recovery (STIR) imaging in coronal and axial orientation as well as diffusion-weighted imaging in axial orientation. Visibility of lesions in DWI and STIR was evaluated by two readers in consensus. The apparent diffusion coefficient (ADC) was measured for every lesion and corresponding reference locations. Results A total of 33 lesions (on average 2 per patient) visible in STIR and DWI images (b = 800 s/ mm2 and ADC maps) were included, predominantly located in the long bones. With a mean value of 1283 mm(2)/s in lesions, the ADC was significantly higher than in corresponding reference regions (782 mm(2)/s). By calculating the ratio (lesion to reference), 82% of all lesions showed a relative signal increase of 10% or higher and 76% (25 lesions) showed a signal increase of more than 15%. The median relative signal increase was 69%. Conclusion This study shows that WB-DWI can be reliably performed in children at 3T and predominantly, the ADC values were substantially elevated in CRMO lesions. WB-DWI in conjunction with clinical data is seen as a promising technique to distinguish benign inflammatory processes (in terms of increased ADC values) from particular malignancies.	[Leclair, Nadine; Sorge, Ina; Ritter, Lutz; Hirsch, Franz Wolfgang] Leipzig Univ Hosp, Dept Paediat Radiol, Leipzig, Germany; [Thoermer, Gregor] Siemens Healthcare GmbH, Diagnost Imaging, Magnet Resonance Imaging, Erlangen, Germany; [Schuster, Volker] Leipzig Univ Hosp, Dept Paediat Rheumatol, Leipzig, Germany	Leipzig University; Siemens AG; Leipzig University	Leclair, N (corresponding author), Leipzig Univ Hosp, Dept Paediat Radiol, Leipzig, Germany.	nadine.leclair@medizin.uni-leipzig.de	Hirsch, Franz Wolfgang/AAF-4708-2020	Hirsch, Franz Wolfgang/0000-0003-0960-3740	Siemens Healthcare	Siemens Healthcare(Siemens AG)	The funder (Siemens Healthcare) provided support in the form of salaries for author G.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ai F, 2012, RHEUMATOL INT, V32, P4005, DOI 10.1007/s00296-011-2333-9; Beck C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2992; Biffar A, 2010, EUR J RADIOL, V76, P298, DOI 10.1016/j.ejrad.2010.05.020; Blackledge MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091779; Falip C, 2013, PEDIATR RADIOL, V43, P355, DOI 10.1007/s00247-012-2544-6; Fritz J, 2009, RADIOLOGY, V252, P842, DOI 10.1148/radiol.2523081335; Giedion A, ANN RADIOL, V197, P329; Girschick HJ, 2007, NAT CLIN PRACT RHEUM, V3, P733, DOI 10.1038/ncprheum0653; Guerin-Pfyffer S, 2012, JOINT BONE SPINE, V79, P616, DOI 10.1016/j.jbspin.2011.12.001; Hauer MP, 1998, PEDIATR RADIOL, V28, P846, DOI 10.1007/s002470050479; Hillengass J, 2011, BRIT J HAEMATOL, V153, P721, DOI 10.1111/j.1365-2141.2011.08658.x; Jansson AF, 2011, ACTA PAEDIATR, V100, P1150, DOI 10.1111/j.1651-2227.2011.02205.x; Krohmer S, 2010, EUR J RADIOL, V74, P256, DOI 10.1016/j.ejrad.2009.01.037; Lee SK, 2014, MAGN RESON MED, V71, P1813, DOI 10.1002/mrm.24824; Messiou C, 2011, EUR RADIOL, V21, P1713, DOI 10.1007/s00330-011-2116-4; Neubauer H, 2012, PEDIATR RHEUMATOL, V10, DOI 10.1186/1546-0096-10-20; Nonomura Y, 2001, J MAGN RESON IMAGING, V13, P757, DOI 10.1002/jmri.1105; Padhani AR, 2011, RADIOLOGY, V261, P700, DOI 10.1148/radiol.11110474; Padhani AR, 2011, CANC IMAGING, V11, P129, DOI DOI 10.1102/1470-7330.2011.9034; Thormer G, 2012, EUR RADIOL, V22, P1820, DOI 10.1007/s00330-012-2432-3; von Kalle T, 2013, ROFO-FORTSCHR RONTG, V185, P655, DOI 10.1055/s-0033-1335283; Wipff J, 2011, JOINT BONE SPINE, V78, P555, DOI 10.1016/j.jbspin.2011.02.010	22	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147523	10.1371/journal.pone.0147523	http://dx.doi.org/10.1371/journal.pone.0147523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799970	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300120
J	Liu, B; Luo, J; Li, W; Long, XF; Zhang, YQ; Zeng, ZG; Tian, YQ				Liu, Bo; Luo, Jin; Li, Wei; Long, Xiu-Feng; Zhang, Yu-Qin; Zeng, Zhi-Gang; Tian, Yong-Qiang			Erwinia teleogrylli sp nov., a Bacterial Isolate Associated with a Chinese Cricket	PLOS ONE			English	Article							DNA HYBRIDIZATION; SEQUENCE-ANALYSIS; PANTOEA; PLANTS; TREES	A bacterial isolate (SCU-B244(T)) was obtained in China from crickets (Teleogryllus occipitalis) living in cropland deserted for approximately 10 years. The isolated bacteria were Gram-negative, facultatively anaerobic, oxidase-negative rods. A preliminary analysis of the 16S rRNA gene sequence indicated that the strain belongs to either the genus Erwinia or Pantoea. Analysis of multilocus sequence typing based on concatenated partial atpD, gyrB and infB gene sequences and physiological and biochemical characteristics indicated that the strain belonged to the genus Erwinia, as member of a new species as it was distinct from other known Erwinia species. Further analysis of the 16S rRNA gene showed SCU-B244(T) to have 94.71% identity to the closest species of that genus, Erwinia oleae (DSM 23398(T)), which is below the threshold of 97% used to discriminate bacterial species. DNA-DNA hybridization results (5.78 +/- 2.52%) between SCU-B244(T) and Erwinia oleae (DSM 23398(T)) confirmed that SCU-B244(T) and Erwinia oleae (DSM 23398(T)) represent different species combined with average nucleotide identity values which range from 72.42% to 74.41. The DNA G+C content of SCU-B244(T) was 55.32 mol%, which also differs from that of Erwinia oleae (54.7 to 54.9 mol%). The polyphasic taxonomic approach used here confirmed that the strain belongs to the Erwinia group and represents a novel species. The name Erwinia teleogrylli sp. nov. is proposed for this novel taxon, for which the type strain is SCU-B244(T) (= CGMCC 1.12772(T) = DSM 28222(T) = KCTC 42022(T)).	[Liu, Bo; Long, Xiu-Feng; Tian, Yong-Qiang] Sichuan Univ, Coll Light Ind Text & Food Engn, Key Lab Leather Chem & Engn, Chengdu 610064, Sichuan, Peoples R China; [Liu, Bo; Luo, Jin; Li, Wei] Sichuan Univ, Coll Chem Engn, Dept Pharmaceut & Biol Engn, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Yu-Qin] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Zhang, Yu-Qin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zeng, Zhi-Gang] Chengdu Univ, Sichuan Ind Inst Antibiot, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chengdu University	Tian, YQ (corresponding author), Sichuan Univ, Coll Light Ind Text & Food Engn, Key Lab Leather Chem & Engn, Chengdu 610064, Sichuan, Peoples R China.	yqtian@scu.edu.cn	Liu, Bo/HCG-9782-2022; Zhang, Yu-Qin/AEH-7339-2022; LI, feng/HIR-1703-2022	Liu, Bo/0000-0003-1685-7968; Zhang, Yu-Qin/0000-0002-1739-6705; Luo, Jin/0000-0001-6126-9394				Brady C, 2008, SYST APPL MICROBIOL, V31, P447, DOI 10.1016/j.syapm.2008.09.004; Brady CL, 2011, INT J SYST EVOL MICR, V61, P932, DOI 10.1099/ijs.0.022921-0; Brady CL, 2010, INT J SYST EVOL MICR, V60, P2430, DOI 10.1099/ijs.0.017301-0; Brady CL, 2010, INT J SYST EVOL MICR, V60, P484, DOI 10.1099/ijs.0.012070-0; Brady CL, 2009, INT J SYST EVOL MICR, V59, P2339, DOI 10.1099/ijs.0.009241-0; DELEY J, 1970, EUR J BIOCHEM, V12, P133; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gerhardt P, 1981, MANUAL METHODS GEN B; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura M, 1984, NEUTRAL THEORY MOL E; Li WJ, 2007, INT J SYST EVOL MICR, V57, P1424, DOI 10.1099/ijs.0.64749-0; Lopez MM, 2011, INT J SYST EVOL MICR, V61, P561, DOI 10.1099/ijs.0.020479-0; Mergaert J, 1999, INT J SYST BACTERIOL, V49, P377, DOI 10.1099/00207713-49-2-377; Moretti C, 2000, FUTURE ROLE PESTICID; Moretti C, 2011, INT J SYST EVOL MICR, V61, P2745, DOI 10.1099/ijs.0.026336-0; Popp A, 2010, INT J SYST EVOL MICR, V60, P2786, DOI 10.1099/ijs.0.019430-0; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Xiang WS, 2011, INT J SYST EVOL MICR, V61, P1165, DOI 10.1099/ijs.0.023283-0	27	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146596	10.1371/journal.pone.0146596	http://dx.doi.org/10.1371/journal.pone.0146596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800121	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300026
J	Wang, HW; Su, SH; Wang, YL; Chang, ST; Liao, KH; Lo, HH; Chiu, YL; Hsieh, TH; Huang, TS; Lin, CS; Cheng, SM; Cheng, CC				Wang, Hsei-Wei; Su, Shu-Han; Wang, Yen-Li; Chang, Shih-Ting; Liao, Ko-Hsun; Lo, Hung-Hao; Chiu, Ya-Lin; Hsieh, Tsung-Han; Huang, Tse-Shun; Lin, Chin-Sheng; Cheng, Shu-Meng; Cheng, Cheng-Chung			MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared Irradiation	PLOS ONE			English	Article							COLONY-FORMING CELLS; REPEATED THERMAL THERAPY; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE PRODUCTION; PROGENITOR CELLS; DIABETES-MELLITUS; BONE-MARROW; MYOCARDIAL-INFARCTION; PROMOTES ANGIOGENESIS; HEART-DISEASE	Diabetes mellitus (DM) is a metabolic disease that is increasing worldwide. Furthermore, it is associated with the deregulation of vascular-related functions, which can develop into major complications among DM patients. Endothelial colony forming cells (ECFCs) have the potential to bring about medical repairs because of their post-natal angiogenic activities; however, such activities are impaired by high glucose-(HG) and the DM-associated conditions. Far-infrared radiation (FIR) transfers energy as heat that is perceived by the thermoreceptors in human skin. Several studies have revealed that FIR improves vascular endothelial functioning and boost angiogenesis. FIR has been used as anti-inflammatory therapy and as a clinical treatment for peripheral circulation improvement. In addition to vascular repair, there is increasing evidence to show that FIR can be applied to a variety of diseases, including cardiovascular disorders, hypertension and arthritis. Yet mechanism of action of FIR and the biomarkers that indicate FIR effects remain unclear. MicroRNA-134 (miR-134-5p) was identified by small RNA sequencing as being increased in high glucose (HG) treated dfECFCs (HG-dfECFCs). Highly expressed miR-134 was also validated in dmECFCs by RT-qPCR and it is associated with impaired angiogenic activities of ECFCs. The functioning of ECFCs is improved by FIR treatment and this occurs via a reduction in the level of miR-134 and an increase in the NRIP1 transcript, a direct target of miR-134. Using a mouse ischemic hindlimb model, the recovery of impaired blood flow in the presence of HG-dfECFCs was improved by FIR pretreatment and this enhanced functionality was decreased when there was miR-134 overexpression in the FIR pretreated HG-dfECFCs. In conclusion, our results reveal that the deregulation of miR-134 is involved in angiogenic defects found in DMpatients. FIR treatment improves the angiogenic activity of HG-dfECFCs and dmECFCs and FIR has potential as a treatment for DM. Detection of miR-134 expression in FIR-treated ECFCs should help us to explore further the effectiveness of FIR therapy.	[Wang, Hsei-Wei; Su, Shu-Han; Wang, Yen-Li; Liao, Ko-Hsun; Lo, Hung-Hao; Chiu, Ya-Lin; Hsieh, Tsung-Han] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wang, Hsei-Wei] Natl Yang Ming Univ, VGH YM Genome Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Su, Shu-Han] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Su, Shu-Han] Acad Sinica, Taipei 115, Taiwan; [Chang, Shih-Ting] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Huang, Tse-Shun] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Lin, Chin-Sheng; Cheng, Shu-Meng; Cheng, Cheng-Chung] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; University of California System; University of California San Diego; National Defense Medical Center; Tri-Service General Hospital	Cheng, CC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	chengcc@mail.ndmctsgh.edu.tw			Tri-Service General Hospital [TSGH-C103-023, TSGH c104-028]; Ministry of Science and Technology [MOST] [103-2321-B-010-026, 103-2911-I-010-506, 104-2911-I-010-506, 104-2321-B-010-027]; Veterans General Hospitals University System of Taiwan (VGHUST) Joint Research Program; Tsou's Foundation [VGHUST103-G7-2-3]; National Health Research Institutes [NHRI-EX103-10254SI]; Taipei City Hospital [10401-62-014]; National Science Council [102-2911-I-010-503, 101-2320-B-010-059-MY3]; National Yang-Ming University [Ministry of Education, Aim for the Top University Plan]; UST-UCSD International Center for Excellence in Advanced Bioengineering - Taiwan MOST I-RiCE Program [103-2911-I-009-101]	Tri-Service General Hospital; Ministry of Science and Technology [MOST](Ministry of Science and Technology, China); Veterans General Hospitals University System of Taiwan (VGHUST) Joint Research Program; Tsou's Foundation; National Health Research Institutes(National Health Research Institutes, Japan); Taipei City Hospital; National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University [Ministry of Education, Aim for the Top University Plan](Ministry of Education, Taiwan); UST-UCSD International Center for Excellence in Advanced Bioengineering - Taiwan MOST I-RiCE Program	Provide materials: Tri-Service General Hospital [TSGH-C103-023, TSGH c104-028] Cheng-Chung Cheng received these fundings. Provide regents, human resources: Ministry of Science and Technology [MOST; 103-2321-B-010-026, 103-2911-I-010-506, and 104-2911-I-010-506 and 104-2321-B-010-027], Veterans General Hospitals University System of Taiwan (VGHUST) Joint Research Program, Tsou's Foundation [VGHUST103-G7-2-3], National Health Research Institutes [NHRI-EX103-10254SI], Taipei City Hospital [10401-62-014], National Science Council [102-2911-I-010-503, 101-2320-B-010-059-MY3] and National Yang-Ming University [Ministry of Education, Aim for the Top University Plan]. This work was also supported in part by the UST-UCSD International Center for Excellence in Advanced Bioengineering sponsored by the Taiwan MOST I-RiCE Program [103-2911-I-009-101]. Hsei-Wei Wang received these fundings.	Akasaki Y, 2006, CIRC J, V70, P463, DOI 10.1253/circj.70.463; Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Beever R, 2009, CAN FAM PHYSICIAN, V55, P691; Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Caporali A, 2011, CIRCULATION, V123, P282, DOI 10.1161/CIRCULATIONAHA.110.952325; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2013, JOINT BONE SPINE, V80, P70, DOI 10.1016/j.jbspin.2012.02.015; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Cheng CC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-447; Cheng WC, 2013, NUCLEIC ACIDS RES, V41, pD285, DOI 10.1093/nar/gks1238; Chi WY, 2014, BRAIN RES, V1592, P22, DOI 10.1016/j.brainres.2014.09.072; Clore JN, 2002, METABOLISM, V51, P1471, DOI 10.1053/meta.2002.35202; Critser PJ, 2010, MICROVASC RES, V80, P23, DOI 10.1016/j.mvr.2010.03.001; Dubois C, 2010, J AM COLL CARDIOL, V55, P2232, DOI 10.1016/j.jacc.2009.10.081; Eckel RH, 2002, CIRCULATION, V105, P2923, DOI 10.1161/01.CIR.0000017823.53114.4C; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Golden SH, 2011, AM J CARDIOL, V108, p59B, DOI 10.1016/j.amjcard.2011.03.017; Grundmann S, 2011, CIRCULATION, V123, P999, DOI 10.1161/CIRCULATIONAHA.110.000323; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Gui J, 2015, PLACENTA, V36, P410, DOI 10.1016/j.placenta.2015.01.195; Guo WX, 2008, ARCH MED RES, V39, P434, DOI 10.1016/j.arcmed.2008.02.001; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Ho PC, 2009, CELL METAB, V10, P516, DOI 10.1016/j.cmet.2009.09.012; HONDA K, 1988, INT J BIOMETEOROL, V32, P92, DOI 10.1007/BF01044900; Hsu JBK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-300; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang PH, 2013, ARTERIOSCL THROM VAS, V33, P709, DOI 10.1161/ATVBAHA.112.300318; Huang PH, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-99; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Iliopoulos D, 2010, J LIPID RES, V51, P1513, DOI 10.1194/jlr.M004812; Imamura M, 2001, J AM COLL CARDIOL, V38, P1083, DOI 10.1016/S0735-1097(01)01467-X; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jiang HL, 2010, ATHEROSCLEROSIS, V210, P71, DOI 10.1016/j.atherosclerosis.2009.10.032; Jiang QJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101774; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kihara T, 2002, J AM COLL CARDIOL, V39, P754, DOI 10.1016/S0735-1097(01)01824-1; Kim F, 2005, ARTERIOSCL THROM VAS, V25, P989, DOI 10.1161/01.ATV.0000160549.60980.a8; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Kyrou I, 2009, CURR OPIN PHARMACOL, V9, P787, DOI 10.1016/j.coph.2009.08.007; Lin CC, 2007, J AM SOC NEPHROL, V18, P985, DOI 10.1681/ASN.2006050534; Liu H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-476; Liu YY, 2015, DNA CELL BIOL, V34, P429, DOI 10.1089/dna.2014.2629; Lloyd BJ, 2003, J MICROWAVE POWER EE, V38, P213; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Masuda A, 2005, PSYCHOTHER PSYCHOSOM, V74, P288, DOI 10.1159/000086319; Medina RJ, 2010, INVEST OPHTH VIS SCI, V51, P5906, DOI 10.1167/iovs.09-4951; Moubarik C, 2011, STEM CELL REV REP, V7, P208, DOI 10.1007/s12015-010-9157-y; Mukai N, 2008, EXP CELL RES, V314, P430, DOI 10.1016/j.yexcr.2007.11.016; Narayan KMV, 2006, DIABETES CARE, V29, P2114, DOI 10.2337/dc06-1136; Nautiyal J, 2013, TRENDS ENDOCRIN MET, V24, P451, DOI 10.1016/j.tem.2013.05.001; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Rau CS, 2011, PHOTOCHEM PHOTOBIOL, V87, P441, DOI 10.1111/j.1751-1097.2010.00853.x; Salem KA, 2013, MOL CELL BIOCHEM, V380, P83, DOI 10.1007/s11010-013-1662-2; Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Seya Y, 2006, EUR J PHARMACOL, V553, P54, DOI 10.1016/j.ejphar.2006.09.048; Shao Y, 2015, J MOL NEUROSCI, V56, P461, DOI 10.1007/s12031-015-0522-9; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Sobajima M, 2011, AM J PHYSIOL-HEART C, V301, pH548, DOI 10.1152/ajpheart.00103.2011; Sun HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079540; Tang YX, 2011, J MOL ENDOCRINOL, V47, P315, DOI 10.1530/JME-11-0082; Toyokawa H, 2003, EXP BIOL MED, V228, P724, DOI 10.1177/153537020322800612; Trombetta A, 2013, DIABETES, V62, P1245, DOI 10.2337/db12-0646; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Vatansever Fatma, 2012, Photonics Lasers Med, V4, P255; Wang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098070; Wang HW, 2014, ARTERIOSCL THROM VAS, V34, P857, DOI 10.1161/ATVBAHA.113.303001; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xue J, 2013, EXP CLIN ENDOCR DIAB, V121, P37, DOI 10.1055/s-0032-1323683; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yu SY, 2006, PHOTODERMATOL PHOTO, V22, P78, DOI 10.1111/j.1600-0781.2006.00208.x; Zeng Z, 2015, AM J PHYSIOL-CELL PH, V308, pC308, DOI 10.1152/ajpcell.00275.2013; Zhuang GL, 2012, EMBO J, V31, P3513, DOI 10.1038/emboj.2012.183	86	20	20	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147067	10.1371/journal.pone.0147067	http://dx.doi.org/10.1371/journal.pone.0147067			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799933	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300056
J	Ye, XL; Qian, Y; Wang, Q; Yuan, WZ; Mo, XY; Li, YQ; Jiang, ZG; Xu, W; Deng, Y; Wan, YQ; Fan, XW; Wu, XS; Wang, YQ				Ye, Xiangli; Qian, Yu; Wang, Qian; Yuan, Wuzhou; Mo, Xiaoyang; Li, Yongqing; Jiang, Zhigang; Xu, Wei; Deng, Yun; Wan, Yongqi; Fan, Xiongwei; Wu, Xiushan; Wang, Yuequn			SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; MUSCLE GENE-EXPRESSION; TRANSCRIPTION FACTOR; GROWTH-FACTOR; TARGET; DIFFERENTIATION; ACTIVATION; PROTEIN; T(8/21); BOP	Previous studies have demonstrated that Smyd1 plays a critical role in cardiomyocyte differentiation, cardiac morphogenesis and myofibril organization. In this study, we uncovered a novel function of Smyd1 in the regulation of endothelial cells (ECs). Our data showed that Smyd1 is expressed in vascular endothelial cells, and knockdown of SMYD1 in endothelial cells impairs EC migration and tube formation. Furthermore, Co-IP and GST pull-down assays demonstrated that SMYD1 is associated with the Serum Response Factor (SRF). EMSA assays further showed that SMYD1 forms a complex with SRF and enhances SRF DNA binding activity. Our studies indicate that SMYD1 serves as an SRF-interacting protein, enhances SRF DNA binding activity, and is required for EC migration and tube formation to regulate angiogenesis.	[Ye, Xiangli; Yuan, Wuzhou; Mo, Xiaoyang; Li, Yongqing; Jiang, Zhigang; Xu, Wei; Deng, Yun; Wan, Yongqi; Fan, Xiongwei; Wu, Xiushan; Wang, Yuequn] Hunan Normal Univ, Coll Life Sci, Key Lab MOE Dev Biol & Prot Chem, Ctr Heart Dev, Changsha 410081, Hunan, Peoples R China; [Ye, Xiangli; Qian, Yu; Wang, Qian] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Ye, Xiangli; Qian, Yu; Wang, Qian] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Ye, Xiangli] Hunan Normal Univ, Coll Med, Changsha 410013, Hunan, Peoples R China	Hunan Normal University; East China Normal University; East China Normal University; Hunan Normal University	Fan, XW; Wu, XS; Wang, YQ (corresponding author), Hunan Normal Univ, Coll Life Sci, Key Lab MOE Dev Biol & Prot Chem, Ctr Heart Dev, Changsha 410081, Hunan, Peoples R China.	fansha1234@aliyun.com; xiushanwu2003@aliyun.com; yuequnwang@yahoo.com		Xu, Wei/0000-0003-1549-4237	National Natural Science Foundation of China [81270291, 31572349, 31171318, 30930054, 81170229, 31171402, 81170088, 31172044, 31071999, 30970425, 31272396, 81270156, 81370451, 81400304, 31472060, 81470377, 81470449]; Hunan Provincial Natural Science Foundation of China [12JJ3117, 2015JJ3087]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [2013-448-6]; Scientific Research Fund of Hunan Provincial Education Department [14A093]; Construct Program of the Key Discipline of Basic Medicine in Hunan Province; Open Research Fund Program of Shanghai Key Laboratory of Regulatory Biology and Institute of Biomedical Sciences of East China Normal University [2012LRB02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province; Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Construct Program of the Key Discipline of Basic Medicine in Hunan Province; Open Research Fund Program of Shanghai Key Laboratory of Regulatory Biology and Institute of Biomedical Sciences of East China Normal University	This study was supported in part by grants from the National Natural Science Foundation of China (Nos. 81270291, 31572349, 31171318, 30930054, 81170229, 31171402, 81170088, 31172044, 31071999, 30970425, 31272396, 81270156, 81370451, 81400304, 31472060, 81470377, 81470449), Hunan Provincial Natural Science Foundation of China (Nos. 12JJ3117, 2015JJ3087), the Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (No. 2013-448-6), the Scientific Research Fund of Hunan Provincial Education Department (No. 14A093), the Construct Program of the Key Discipline of Basic Medicine in Hunan Province, and the Open Research Fund Program of Shanghai Key Laboratory of Regulatory Biology and Institute of Biomedical Sciences of East China Normal University (No. 2012LRB02).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Del Carratore R, 2012, BIOMED PHARMACOTHER, V66, P312, DOI 10.1016/j.biopha.2011.11.004; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Franco CA, 2009, CELL ADHES MIGR, V3, P264, DOI 10.4161/cam.3.3.8291; Franco CA, 2008, DEV CELL, V15, P448, DOI 10.1016/j.devcel.2008.07.019; Glinskii OV, 2008, CELL CYCLE, V7, P1385, DOI 10.4161/cc.7.10.5819; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088143; Kottakis F, 2011, MOL CELL, V43, P285, DOI 10.1016/j.molcel.2011.06.020; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Mack CP, 2000, CIRC RES, V86, P221, DOI 10.1161/01.RES.86.2.221; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; MOHUN TJ, 1991, EMBO J, V10, P933, DOI 10.1002/j.1460-2075.1991.tb08027.x; Mohun TJ, 1993, MOL CELL BIOL, V13, P6907; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; PHILLIPS GD, 1993, J SUBMICR CYTOL PATH, V25, P149; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860	31	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146468	10.1371/journal.pone.0146468	http://dx.doi.org/10.1371/journal.pone.0146468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799706	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300022
J	Kiat, Y; Izhaki, I				Kiat, Yosef; Izhaki, Ido			Moult Strategies Affect Age Differences in Autumn Migration Timing in East Mediterranean Migratory Passerines	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; WING MOLT; SYLVIIDAE; MIGRANTS; DURATION; RANGE; BIRDS; MASS	Adult passerines renew their flight feathers at least once every year. This complete moult occurs either in the breeding areas, just after breeding (summer moult), or, in some long-distance migratory species, at the non-breeding areas, after arrival to the southern wintering area at the end of autumn migration (winter moult). The aim of this study was to relate moult strategies with the DMD, the difference in median migration date, through Israel, between juveniles and adults. Our data on autumn migration timing in juveniles and adults was based on ringing data of 49,125 individuals belonging to 23 passerine species that breed in Europe and Western Asia and migrate through Israel. We found that DMD was associated with moult timing. In all species that perform a winter moult, adults preceded juveniles during autumn. Among migrants who perform a summer moult, we found evidence of both migration timing patterns: juveniles preceding adults or adults preceding juveniles. In addition, in summer moulters, we found a significant, positive correlation between mean breeding latitude and DMD. Although previous studies described that moult duration and extent can be affected by migration, we suggest that moult strategies affect both migration timing and migration strategy. These two moult strategies (summer or winter moult) also represent two unique migration strategies. Our findings highlight the evolutionary interplay between moult and migration strategies.	[Kiat, Yosef] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Movement Ecol Lab, Edmond J Safra Campus, Jerusalem, Israel; [Izhaki, Ido] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel	Hebrew University of Jerusalem; University of Haifa	Kiat, Y (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Movement Ecol Lab, Edmond J Safra Campus, Jerusalem, Israel.	yosefkiat@gmail.com	Izhaki, Ido/I-9712-2019	Izhaki, Ido/0000-0002-4525-4683; Kiat, Yosef/0000-0002-3485-3517				ALERSTAM T, 1982, ORNIS SCAND, V13, P25, DOI 10.2307/3675970; [Anonymous], 2014, R LANG ENV STAT COMP; Barta Z, 2008, PHILOS T R SOC B, V363, P211, DOI 10.1098/rstb.2007.2136; Benson AM, 2001, AUK, V118, P513, DOI 10.1642/0004-8038(2001)118[0513:TOBROA]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler LK, 2002, AUK, V119, P1010, DOI 10.1642/0004-8038(2002)119[1010:MMIWTP]2.0.CO;2; Carlisle JD, 2005, AUK, V122, P1070, DOI 10.1642/0004-8038(2005)122[1070:MSAADI]2.0.CO;2; Cramp S., 1994, BIRDS W PALEARCTIC; de la Hera I, 2012, AUK, V129, P222, DOI 10.1525/auk.2012.11212; de la Hera I, 2010, J AVIAN BIOL, V41, P609, DOI 10.1111/j.1600-048X.2010.05075.x; ELLEGREN H, 1991, ORNIS SCAND, V22, P340, DOI 10.2307/3676506; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; FRUMKIN R, 1995, J ORNITHOL, V136, P127, DOI 10.1007/BF01651235; Ginn H. B., 1983, MOULT BIRDS BTO GUID; Hall KSS, 2004, EVOL ECOL, V18, P85, DOI 10.1023/B:EVEC.0000017848.20735.8b; Hall KSS, 2001, IBIS, V143, P580; HOLMGREN N, 1995, EVOL ECOL, V9, P354, DOI 10.1007/BF01237759; Jakubas D, 2010, NATURWISSENSCHAFTEN, V97, P505, DOI 10.1007/s00114-010-0666-y; Jenni L., 2011, MOULT AGEING EUROPEA; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; Neto JM, 2008, BIRD STUDY, V55, P78, DOI 10.1080/00063650809461507; Newton I, 2010, MIGRATION ECOLOGY BI; Newton I, 2011, J ORNITHOL, V152, P169, DOI 10.1007/s10336-011-0689-y; Newton Ian, 2009, Ringing & Migration, V24, P220; NIKOLAUS G, 1991, Ringing and Migration, V12, P46; Norman SC, 1997, IBIS, V139, P617, DOI 10.1111/j.1474-919X.1997.tb04684.x; Orme D., 2013, CAPER PACKAGE COMP A; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; PRICE T, 1981, IBIS, V123, P131, DOI 10.1111/j.1474-919X.1981.tb00920.x; Rguibi-Idrissi H, 2003, IBIS, V145, P650, DOI 10.1046/j.1474-919X.2003.00208.x; Rohwer Sievert, 2005, P87; Rubolini D, 2015, CURR ZOOL, V61, P959, DOI 10.1093/czoolo/61.6.959; Shirihai H., 2001, SYLVIA WARBLERS IDEN; Shirihai H., 1996, BIRDS ISRAEL; SNOW DW, 1967, GUIDE MOULT BRIT BIR; Svensson E, 1999, BIOL J LINN SOC, V67, P263, DOI 10.1006/bijl.1998.0302; Svensson L., 1992, IDENTIFICATION GUIDE; THOMAS D K, 1977, Ringing and Migration, V1, P125; UNDERHILL LG, 1992, IBIS, V134, P286, DOI 10.1111/j.1474-919X.1992.tb03811.x; Voelker G, 1998, AUK JSTOR, P142; Yom-Tov Y, 1988, ZOOGEOGRAPHY ISRAEL	42	9	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147471	10.1371/journal.pone.0147471	http://dx.doi.org/10.1371/journal.pone.0147471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26797292	Green Published, gold, Green Submitted			2022-12-26	WOS:000368530300037
J	Ravishankar, S; Ambady, A; Swetha, RG; Anbarasu, A; Ramaiah, S; Sambandamurthy, VK				Ravishankar, Sudha; Ambady, Anisha; Swetha, Rayapadi G.; Anbarasu, Anand; Ramaiah, Sudha; Sambandamurthy, Vasan K.			Essentiality Assessment of Cysteinyl and Lysyl-tRNA Synthetases of Mycobacterium smegmatis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN STRUCTURES; EDITING DOMAIN; YBAK PROTEIN; YADB GENE; I-TASSER; INHIBITORS; TUBERCULOSIS; MYCOTHIOL; TRANSLATION	Discovery of mupirocin, an antibiotic that targets isoleucyl-tRNA synthetase, established aminoacyl-tRNA synthetase as an attractive target for the discovery of novel antibacterial agents. Despite a high degree of similarity between the bacterial and human aminoacyl-tRNA synthetases, the selectivity observed with mupirocin triggered the possibility of targeting other aminoacyl-tRNA synthetases as potential drug targets. These enzymes catalyse the condensation of a specific amino acid to its cognate tRNA in an energy-dependent reaction. Therefore, each organism is expected to encode at least twenty aminoacyl-tRNA synthetases, one for each amino acid. However, a bioinformatics search for genes encoding aminoacyl-tRNA synthetases from Mycobacterium smegmatis returned multiple genes for glutamyl (GluRS), cysteinyl (CysRS), prolyl (ProRS) and lysyl (LysRS) tRNA synthetases. The pathogenic mycobacteria, namely, Mycobacterium tuberculosis and Mycobacterium leprae, were also found to possess two genes each for CysRS and LysRS. A similar search indicated the presence of additional genes for LysRS in gram negative bacteria as well. Herein, we describe sequence and structural analysis of the additional aminoacyl-tRNA synthetase genes found in M. smegmatis. Characterization of conditional expression strains of Cysteinyl and Lysyl-tRNA synthetases generated in M. smegmatis revealed that the canonical aminoacyl-tRNA synthetase are essential, while the additional ones are not essential for the growth of M. smegmatis.	[Ravishankar, Sudha; Ambady, Anisha; Sambandamurthy, Vasan K.] AstraZeneca India Pvt Ltd, Bellary Rd, Bengaluru 560024, Karnataka, India; [Ravishankar, Sudha; Swetha, Rayapadi G.; Anbarasu, Anand; Ramaiah, Sudha] VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India; [Ambady, Anisha] Gangagen Biotechnol Pvt Ltd, Bengaluru, Karnataka, India; [Sambandamurthy, Vasan K.] Mazumdar Shaw Med Ctr, MSCTR, Bengaluru, Karnataka, India	AstraZeneca; Vellore Institute of Technology	Ravishankar, S (corresponding author), AstraZeneca India Pvt Ltd, Bellary Rd, Bengaluru 560024, Karnataka, India.; Ravishankar, S (corresponding author), VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India.	mailsuravi01@gmail.com	Anbarasu, Anand/U-6323-2019; Ramaiah, Sudha/T-3682-2019	, Rayapadi G Swetha/0000-0002-6299-7825	AstraZeneca India Pvt Ltd.	AstraZeneca India Pvt Ltd.	The authors received no specific funding for this work. AstraZeneca India Pvt Ltd. provided support in the form of salaries for authors SR, AA and VKS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bartholow TG, 2014, BIOCHEMISTRY-US, V53, P1059, DOI 10.1021/bi401279r; Beyer D, 2004, ANTIMICROB AGENTS CH, V48, P525, DOI 10.1128/AAC.48.2.525-532.2004; Blaise M, 2005, BIOCHIMIE, V87, P847, DOI 10.1016/j.biochi.2005.03.007; Blaise M, 2004, NUCLEIC ACIDS RES, V32, P2768, DOI 10.1093/nar/gkh608; Blaise M, 2008, J MOL BIOL, V381, P1224, DOI 10.1016/j.jmb.2008.06.053; Blanchard SC, 2010, CHEM BIOL, V17, P633, DOI 10.1016/j.chembiol.2010.06.003; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; BRETON R, 1986, J BIOL CHEM, V261, P610; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dubois DY, 2004, P NATL ACAD SCI USA, V101, P7530, DOI 10.1073/pnas.0401634101; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Ernst CM, 2015, MBIO, V6, DOI 10.1128/mBio.02340-14; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Gurcha SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113568; Hoffmann M, 2009, J MOL MODEL, V15, P665, DOI 10.1007/s00894-008-0421-x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu QH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02475; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Jarvest RL, 2002, J MED CHEM, V45, P1959, DOI 10.1021/jm025502x; Kumar S, 2012, J BIOL CHEM, V287, P3175, DOI 10.1074/jbc.M111.313619; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maloney E, 2009, 2 DOMAIN LYSX PROTEI, V5; Martinis SA, 2010, FEBS LETT, V584, P455, DOI 10.1016/j.febslet.2009.11.071; Nam SH, 2015, ONCOTARGET, V6, P21655, DOI 10.18632/oncotarget.4130; Ochsner UA, 2007, EXPERT OPIN INV DRUG, V16, P1599; Oka M, 2015, ARCH BIOCHEM BIOPHYS, V579, P33, DOI 10.1016/j.abb.2015.05.014; Oku Y, 2004, MICROBIOL-SGM, V150, P45, DOI 10.1099/mic.0.26706-0; ONESTI S, 1995, STRUCTURE, V3, P163, DOI 10.1016/S0969-2126(01)00147-2; PARENTI MA, 1987, CLIN PHARMACY, V6, P761; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Raghunand TR, 2006, INT J ANTIMICROB AG, V28, P36, DOI 10.1016/j.ijantimicag.2006.01.012; Ravishankar S, 2015, TUBERCULOSIS, V95, P589, DOI 10.1016/j.tube.2015.05.004; Ravishankar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134562; Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002; Reddy BKK, 2014, ANTIMICROB AGENTS CH, V58, P3312, DOI 10.1128/AAC.00140-14; Robinson A, 2013, NAT REV MICROBIOL, V11, P303, DOI 10.1038/nrmicro2994; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Salazar JC, 2004, P NATL ACAD SCI USA, V101, P7536, DOI 10.1073/pnas.0401982101; Salowe SP, 2009, J BIOL CHEM, V284, P9656, DOI 10.1074/jbc.M809013200; Sareen D, 2003, J BACTERIOL, V185, P6736, DOI 10.1228/JB.185.22.6736-6740.2003; Sareen D, 2002, BIOCHEMISTRY-US, V41, P6885, DOI 10.1021/bi012212u; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Stefanska AL, 2000, J ANTIBIOT, V53, P345, DOI 10.7164/antibiotics.53.345; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Suzuki T, 2010, FEBS LETT, V584, P272, DOI 10.1016/j.febslet.2009.11.085; Tandon M, 2004, BIOORG MED CHEM LETT, V14, P1909, DOI 10.1016/j.bmcl.2004.01.094; Teng M, 2013, J MED CHEM, V56, P1748, DOI 10.1021/jm301756m; Tremblay LW, 2008, BIOCHEMISTRY-US, V47, P13326, DOI 10.1021/bi801708f; Tshori S, 2013, AMINOACY TRNA SYNTHE; Wards BJ, 1996, FEMS MICROBIOL LETT, V145, P101, DOI 10.1016/0378-1097(96)00394-1; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 1999, GENOME RES, V9, P689; Wright M, 2014, BIOORG MED CHEM LETT, V24, P2346, DOI 10.1016/j.bmcl.2014.03.064; Yanagisawa T, NATURE STRU MOL BIOL, V17, P1136; Yu XY, 2004, BIOORG MED CHEM LETT, V14, P1343, DOI 10.1016/j.bmcl.2003.11.082; Yu XY, 2001, BIOORG MED CHEM LETT, V11, P541, DOI 10.1016/S0960-894X(00)00697-1; Zhang H, 2000, PROTEINS, V40, P86, DOI 10.1002/(SICI)1097-0134(20000701)40:1<86::AID-PROT100>3.0.CO;2-Y; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao YX, 2014, INT J MOL SCI, V15, P1358, DOI 10.3390/ijms15011358	68	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147188	10.1371/journal.pone.0147188	http://dx.doi.org/10.1371/journal.pone.0147188			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794499	Green Published, gold, Green Submitted			2022-12-26	WOS:000368530300022
J	Sheen, YS; Liao, YH; Lin, MH; Chiu, HC; Jee, SH; Liau, JY; Chang, YL; Chu, CY				Sheen, Yi-Shuan; Liao, Yi-Hua; Lin, Ming-Hsien; Chiu, Hsien-Ching; Jee, Shiou-Hwa; Liau, Jau-Yu; Chang, Yih-Leong; Chu, Chia-Yu			Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma	PLOS ONE			English	Article							MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; IMP-3 EXPRESSION; MELANOGENESIS; CELLS; HMGA2; IDENTIFICATION; PROGRESSION; QUEENSLAND; MUTATIONS	Insulin-like growth factor-II mRNA-binding protein 3 (IMP-3) is an RNA-binding protein expressed in multiple cancers, including melanomas. However, the expression of IMP-3 has not been investigated in acral lentiginous melanoma (ALM). This study sought to elucidate its prognostic value in ALMs. IMP-3 expression was studied in 93 patients diagnosed with ALM via immunohistochemistry. Univariate and multivariate analyses for survival were performed, according to clinical and histologic parameters, using the Cox proportional hazard model. Survival curves were graphed using the Kaplan-Meier method. IMP-3 was over-expressed in 70 out of 93 tumors (75.3%). IMP-3 expression correlated with thick and high-stage tumor and predicted poorer overall, melanoma-specific, recurrence-free and distant metastasis-free survivals (P = 0.002, 0.006, 0.008 and 0.012, respectively). Further analysis showed that patients with tumor thickness <= 4.0 mm and positive IMP-3 expression had a significantly worse melanoma-specific survival than those without IMP-3 expression (P = 0.048). IMP-3 (hazard ratio 3.67, 95% confidence intervals 1.35-9.97, P = 0.011) was confirmed to be an independent prognostic factor for melanoma-specific survival in multivariate survival analysis. Positive IMP-3 expression was an important prognostic factor for ALMs.	[Sheen, Yi-Shuan; Liao, Yi-Hua; Chiu, Hsien-Ching; Jee, Shiou-Hwa; Chu, Chia-Yu] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Sheen, Yi-Shuan; Liao, Yi-Hua; Chiu, Hsien-Ching; Jee, Shiou-Hwa; Chu, Chia-Yu] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Sheen, Yi-Shuan; Liau, Jau-Yu; Chang, Yih-Leong] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Lin, Ming-Hsien] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Lin, Ming-Hsien] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Surg, Hisn Chu, Taiwan; [Liau, Jau-Yu; Chang, Yih-Leong] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chu, CY (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.; Chu, CY (corresponding author), Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.	chiayu@ntu.edu.tw	Sheen, Yi-Shuan/HGA-1172-2022	CHANG, YIH-LEONG/0000-0001-5309-0554; LIAO, YI-HUA/0000-0002-4434-3780; Sheen, Yi-Shuan/0000-0002-8743-7496; CHIU, HSIEN-CHING/0000-0002-1409-8470; JEE, SHIOU-HWA/0000-0001-6737-6297; LIAU, JAU-YU/0000-0002-1336-3850	Ministry of Science and Technology of Taiwan [MOST 103-2314-B-002-065-MY3]; National Taiwan University Hospital [NTUH 101-N1950, NTUH 102-N2274, NTUH 103-N2597, NTUH 104-M2835]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This project was supported by an unrestricted Grant No. MOST 103-2314-B-002-065-MY3 (CYC) from the Ministry of Science and Technology of Taiwan (https://www.most.gov.tw/en/public) and by unrestricted Grants No. NTUH 101-N1950, NTUH 102-N2274, NTUH 103-N2597 and NTUH 104-M2835 (YSS) from the National Taiwan University Hospital (http://www.ntuh.gov.tw/en/default_P.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chang John Wen-Cheng, 2010, Chang Gung Med J, V33, P602; Chen YJ, 1999, J AM ACAD DERMATOL, V41, P945, DOI 10.1016/S0190-9622(99)70251-3; Chi ZH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-85; Chokoeva AA, 2015, J BIOL REG HOMEOS AG, V29, P695; Chraybi M, 2013, HUM PATHOL, V44, P1902, DOI 10.1016/j.humpath.2013.01.025; Egger ME, 2012, AM J SURG, V204, P874, DOI 10.1016/j.amjsurg.2012.05.013; Gao Tian-wen, 2004, Beijing Da Xue Xue Bao Yi Xue Ban, V36, P469; Garbe C, 2000, CANCER-AM CANCER SOC, V89, P1269, DOI 10.1002/1097-0142(20000915)89:6<1269::AID-CNCR11>3.0.CO;2-C; Geller AC, 2013, J CLIN ONCOL, V31, P4172, DOI 10.1200/JCO.2012.47.3728; Jeng YM, 2009, BRIT J SURG, V96, P66, DOI 10.1002/bjs.6438; Jeng YM, 2008, HEPATOLOGY, V48, P1118, DOI 10.1002/hep.22459; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Jonson L, 2014, CELL REP, V7, P539, DOI 10.1016/j.celrep.2014.03.015; KREMENTZ ET, 1982, ANN SURG, V195, P632, DOI 10.1097/00000658-198205000-00013; Lee HY, 2012, ANN ACAD MED SINGAP, V41, P17; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Lin SA, 2013, J INVEST DERMATOL, V133, P579, DOI 10.1038/jid.2012.338; Luk NM, 2004, CLIN EXP DERMATOL, V29, P600, DOI 10.1111/j.1365-2230.2004.01644.x; Mayer JE, 2014, J AM ACAD DERMATOL, V71, DOI [10.1016/j.jaad.2014.05.045, 10.1016/j.jaad.2014.05.046]; Mervic L, 2012, ACTA DERMATOVEN ALP, V21, P27, DOI 10.2478/v10162-012-0008-1; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Owen SA, 2001, CANCER-AM CANCER SOC, V91, P983, DOI 10.1002/1097-0142(20010301)91:5<983::AID-CNCR1088>3.0.CO;2-J; Pryor JG, 2008, MODERN PATHOL, V21, P431, DOI 10.1038/modpathol.3801016; Raskin L, 2013, J INVEST DERMATOL, V133, P2585, DOI 10.1038/jid.2013.197; REINTGEN DS, 1982, JAMA-J AM MED ASSOC, V248, P1856, DOI 10.1001/jama.248.15.1856; Sheen YS, 2015, J INVEST DERMATOL, V135, P1065, DOI 10.1038/jid.2014.480; SLINGLUFF CL, 1990, J SURG ONCOL, V45, P91, DOI 10.1002/jso.2930450207; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Sng J, 2009, J AM ACAD DERMATOL, V61, P426, DOI 10.1016/j.jaad.2009.03.031; Tanaka H, 1999, J Epidemiol, V9, pS129; Wu CE, 2015, J FORMOS MED ASSOC, V114, P415, DOI 10.1016/j.jfma.2013.06.018; Yamazaki N, 2015, MELANOMA RES, V25, P9, DOI 10.1097/CMR.0000000000000091; Youl PH, 2013, BRIT J DERMATOL, V168, P136, DOI 10.1111/j.1365-2133.2012.11064.x; Yu LM, 2010, J CUTAN PATHOL, V37, P316, DOI 10.1111/j.1600-0560.2009.01428.x; Yuan RH, 2009, ANN SURG ONCOL, V16, P1711, DOI 10.1245/s10434-009-0446-0	39	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147431	10.1371/journal.pone.0147431	http://dx.doi.org/10.1371/journal.pone.0147431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796627	gold, Green Published, Green Submitted			2022-12-26	WOS:000368530300033
J	Saadi, Y; Yanto, ITR; Herawan, T; Balakrishnan, V; Chiroma, H; Risnumawan, A				Saadi, Younes; Yanto, Iwan Tri Riyadi; Herawan, Tutut; Balakrishnan, Vimala; Chiroma, Haruna; Risnumawan, Anhar			Ringed Seal Search for Global Optimization via a Sensitive Search Model	PLOS ONE			English	Article							GENETIC ALGORITHMS; BROWNIAN-MOTION; LEVY; EXPLORATION; EXPLOITATION; METAHEURISTICS; DIVERSITY; PATTERNS; BEHAVIOR; BALANCE	The efficiency of a metaheuristic algorithm for global optimization is based on its ability to search and find the global optimum. However, a good search often requires to be balanced between exploration and exploitation of the search space. In this paper, a new metaheuristic algorithm called Ringed Seal Search (RSS) is introduced. It is inspired by the natural behavior of the seal pup. This algorithm mimics the seal pup movement behavior and its ability to search and choose the best lair to escape predators. The scenario starts once the seal mother gives birth to a new pup in a birthing lair that is constructed for this purpose. The seal pup strategy consists of searching and selecting the best lair by performing a random walk to find a new lair. Affected by the sensitive nature of seals against external noise emitted by predators, the random walk of the seal pup takes two different search states, normal state and urgent state. In the normal state, the pup performs an intensive search between closely adjacent lairs; this movement is modeled via a Brownian walk. In an urgent state, the pup leaves the proximity area and performs an extensive search to find a new lair from sparse targets; this movement is modeled via a Levy walk. The switch between these two states is realized by the random noise emitted by predators. The algorithm keeps switching between normal and urgent states until the global optimum is reached. Tests and validations were performed using fifteen benchmark test functions to compare the performance of RSS with other baseline algorithms. The results show that RSS is more efficient than Genetic Algorithm, Particles Swarm Optimization and Cuckoo Search in terms of convergence rate to the global optimum. The RSS shows an improvement in terms of balance between exploration (extensive) and exploitation (intensive) of the search space. The RSS can efficiently mimic seal pups behavior to find best lair and provide a new algorithm to be used in global optimization problems.	[Saadi, Younes; Herawan, Tutut; Balakrishnan, Vimala; Risnumawan, Anhar] Univ Malaya, Dept Informat Syst, Kuala Lumpur 50603, Malaysia; [Yanto, Iwan Tri Riyadi] Univ Ahmad Dahlan, Dept Comp Sci, Jalan Kapas 9, Yogyakarta 55165, Indonesia; [Chiroma, Haruna] Fed Coll Educ, Dept Comp Sci, Gombe, Nigeria	Universiti Malaya; Universitas Ahmad Dahlan	Saadi, Y (corresponding author), Univ Malaya, Dept Informat Syst, Kuala Lumpur 50603, Malaysia.	younes@siswa.um.edu.my	Balakrishnan, Vimala/F-4037-2011; Risnumawan, Anhar/GQZ-7674-2022; Herawan, Tutut/AAB-6534-2021; Risnumawan, Anhar/GRJ-1061-2022	Balakrishnan, Vimala/0000-0002-6859-4488; Herawan, Tutut/0000-0001-9262-9137; Tri Riyadi Yanto, Iwan/0000-0001-6477-1697	University of Malaya High Impact Research [UM.C/625/HIR/MOHE/SC/13/2]; University of Malaya High Impact Research Grant from Ministry of Higher Education Malaysia [UM.C/625/HIR/MOHE/SC/13/2]	University of Malaya High Impact Research; University of Malaya High Impact Research Grant from Ministry of Higher Education Malaysia	This work was funded by University of Malaya High Impact Research (Grant number: UM.C/625/HIR/MOHE/SC/13/2). The fund support for this research includes data collection and analysis, decision to publish and preparation of the manuscript.; This work is supported by University of Malaya High Impact Research Grant no vote UM.C/625/HIR/MOHE/SC/13/2 from Ministry of Higher Education Malaysia. We are grateful to Kirsten Durward for the valuable comments on an early draft of the manuscript.	Adra SF, 2011, IEEE T EVOLUT COMPUT, V15, P183, DOI 10.1109/TEVC.2010.2058117; Alba E, 2005, IEEE T EVOLUT COMPUT, V9, P126, DOI 10.1109/TEVC.2005.843751; Alok AK, 1701, SOFT COMPUT, P1; Alok AK, 2015, APPL INTELL, P1; Arani BO, 2013, SWARM EVOL COMPUT, V11, P1, DOI 10.1016/j.swevo.2012.12.004; Araujo L, 2011, IEEE T EVOLUT COMPUT, V15, P456, DOI 10.1109/TEVC.2010.2064322; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Bandyopadhyay S, 2008, IEEE T EVOLUT COMPUT, V12, P269, DOI 10.1109/TEVC.2007.900837; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106373; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Blackwell T., 2007, EVOLUTIONARY COMPUTA, V51, P29, DOI DOI 10.1007/978-3-540-49774-5_2; Blum C, 2003, ACM COMPUT SURV, V35, P268, DOI 10.1145/937503.937505; Blum C, 2011, APPL SOFT COMPUT, V11, P4135, DOI 10.1016/j.asoc.2011.02.032; Bogon Tjorben, 2012, Multiagent System Technologies. Proceedings 10th German Conference, MATES 2012, P30, DOI 10.1007/978-3-642-33690-4_5; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Chelouah R, 2000, EUR J OPER RES, V123, P256, DOI 10.1016/S0377-2217(99)00255-6; Chen G, 2009, IEEE T EVOLUT COMPUT, V13, P661, DOI 10.1109/TEVC.2008.2011742; Chifu VR, 2011, STUD COMPUT INTELL, V382, P93; Chuang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037018; Crepinsek M, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2480741.2480752; Cuevas E, 2014, APPL INTELL, V40, P256, DOI 10.1007/s10489-013-0458-0; Dees ND, 2009, ROLE STOCHASTIC RESO; Doctor S, 2004, IEEE C EVOL COMPUTAT, P1390, DOI 10.1109/CEC.2004.1331059; Duman E, 2008, INT REV COMPUTERS SO; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Fernandes CM, 2013, APPL INTELL, V39, P279, DOI 10.1007/s10489-012-0413-5; Fogel L. J., 1966, ARTIF INTELL; Gandomi AH, 2013, COMMUN NONLINEAR SCI, V18, P89, DOI 10.1016/j.cnsns.2012.06.009; Gandomi AH, 2012, COMPUT MATH APPL, V63, P191, DOI 10.1016/j.camwa.2011.11.010; Gautestad AO, 2012, J R SOC INTERFACE, V9, P2332, DOI 10.1098/rsif.2012.0059; Ghauri SA, 2012, INT CONF INTERNET, P175; GJERTZ I, 1986, Polar Research, V4, P65; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Gwak J, 2013, APPL INTELL, V38, P384, DOI 10.1007/s10489-012-0378-4; HAMMILL MO, 1991, MAR MAMMAL SCI, V7, P123, DOI 10.1111/j.1748-7692.1991.tb00559.x; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Ito H, 2013, J ETHOL, V31, P23, DOI 10.1007/s10164-012-0344-y; Jamil Momin, 2013, International Journal of Mathematical Modelling and Numerical Optimisation, V4, P150; Jong D., 1975, ANAL BEHAV CLASS GEN; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Knysh DS, 2010, J COMPUT SYS SC INT+, V49, P579, DOI 10.1134/S1064230710040088; Kovacs KM, 1996, J MAMMAL, V77, P1085, DOI 10.2307/1382789; Koza J.R, 1990, TECHNICAL REPORT STA; Kumar A, 2011, DESIGN OPTIMIZATION, P264; Kunnasranta M, 2001, POLAR BIOL, V24, P171, DOI 10.1007/s003000000192; Le Boeuf BJ, 2000, J EXP BIOL, V203, P3265; Li X., 2013, GENE, V7, P8; Liang J, 2013, 201212 ZHENGZHOU U; Liu SH, 2013, APPL SOFT COMPUT, V13, P3792, DOI 10.1016/j.asoc.2013.05.010; Liu SH, 2009, INT J KNOWL-BASED IN, V13, P185, DOI 10.3233/KES-2009-0184; Liu SH, 2007, APPLIED COMPUTING 2007, VOL 1 AND 2, P738; LYDERSEN C, 1986, Polar Research, V4, P57; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Nurzaman SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016168; Paenke I, 2009, ADAPT BEHAV, V17, P153, DOI 10.1177/1059712309103566; Pilfold NW, 2014, POPUL ECOL, V56, P129, DOI 10.1007/s10144-013-0396-z; Pilfold NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041429; Plank MJ, 2008, J R SOC INTERFACE, V5, P1077, DOI 10.1098/rsif.2008.0006; Rajabioun R, 2011, APPL SOFT COMPUT, V11, P5508, DOI 10.1016/j.asoc.2011.05.008; Rardin RL, 2001, J HEURISTICS, V7, P261, DOI 10.1023/A:1011319115230; Reynolds AM, 2009, PHYSICA A, V388, P561, DOI 10.1016/j.physa.2008.11.007; Robert UG-A, 2007, ROBERT RINGED SEAL P; Rochat Y., 1995, Journal of Heuristics, V1, P147, DOI 10.1007/BF02430370; Saha S, 2015, USE SEMISUPERVISED C; Sati Dayal C., 2011, International Journal of Applied Engineering Research, V2, P52; Schulte T, 2014, BALANCING EXPLORATIO; Senthilnath J, 2013, CLUSTERING USING LEV, P65; Sims DW, 2012, J ANIM ECOL, V81, P432, DOI 10.1111/j.1365-2656.2011.01914.x; Singh G, 2015, ROLE PARTICLE SWARM, P255; SRINIVAS M, 1994, COMPUTER, V27, P17, DOI 10.1109/2.294849; Tan KC, 2009, EUR J OPER RES, V197, P701, DOI 10.1016/j.ejor.2008.07.025; Vidal T, 2012, OPER RES, V60, P611, DOI 10.1287/opre.1120.1048; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Williams Michael T., 2006, Aquatic Mammals, V32, P311, DOI 10.1578/AM.32.3.2006.311; Xin-She Yang, 2012, Unconventional Computation and Natural Computation. Proceedings of the 11th International Conference, UCNC 2012, P240, DOI 10.1007/978-3-642-32894-7_27; Yanagida T, 2007, BIOSYSTEMS, V88, P228, DOI 10.1016/j.biosystems.2006.08.012; Yang X., 2008, NATURE INSPIRED META, V2nd; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Yang XS, 2014, APPL MATH INFORM SCI, V8, P977, DOI 10.12785/amis/080306; Yang XS, 2014, NEURAL COMPUT APPL, V24, P169, DOI 10.1007/s00521-013-1367-1; Yang XS, 2012, ENG COMPUTATION, V29, P464, DOI 10.1108/02644401211235834; Yang XS, 2010, RESEARCH AND DEVELOPMENT IN INTELLIGENT SYSTEMS XXVI, P209, DOI 10.1007/978-1-84882-983-1_15; Yang XS, 2010, STUD COMPUT INTELL, V284, P101; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169, DOI 10.1007/978-3-642-04944-6_14	92	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0144371	10.1371/journal.pone.0144371	http://dx.doi.org/10.1371/journal.pone.0144371			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790131	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000368529100003
J	Cripps, JK; Martin, JK; Coulson, G				Cripps, Jemma K.; Martin, Jennifer K.; Coulson, Graeme			Anthelmintic Treatment Does Not Change Foraging Strategies of Female Eastern Grey Kangaroos, Macropus giganteus	PLOS ONE			English	Article							GASTROINTESTINAL NEMATODE; TRADE-OFFS; HELMINTH INFECTIONS; SOCIAL-ORGANIZATION; GRAZING BEHAVIOR; FECAL AVOIDANCE; PARASITE RISK; RED; RUMINANTS; HERBIVORE	Large mammalian herbivores are commonly infected with gastrointestinal helminths. Heavily parasitised hosts are likely to have increased nutritional requirements and would be predicted to increase their food intake to compensate for costs of being parasitised, but experimental tests of the impacts of these parasites on the foraging efficiency of hosts are lacking, particularly in free-ranging wildlife. We conducted a field experiment on a population of free-ranging eastern grey kangaroos (Macropus giganteus) to test this prediction, removing nematodes from one group of adult females using an anthelmintic treatment. We then carried out observations before and following treatment to assess the influence of parasites on foraging behaviour. Contrary to our predictions, the manipulation of parasite burdens did not result in changes in any of the key foraging variables we measured. Our results suggest that despite carrying large burdens of gastrointestinal parasites, the foraging strategy of female kangaroos is likely be driven by factors unrelated to parasitism, and that kangaroos in high nutritional environments may be able acquire sufficient nutrients to offset the costs of parasitism. We conclude that the drivers of forage intake likely differ between domesticated and free-ranging herbivores, and that free-ranging hosts are likely more resilient to parasitism.	[Cripps, Jemma K.; Martin, Jennifer K.; Coulson, Graeme] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [Cripps, Jemma K.] Univ Melbourne, Ctr Vet Clin, Fac Vet Sci, Werribee, Vic, Australia	University of Melbourne; University of Melbourne	Cripps, JK (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia.; Cripps, JK (corresponding author), Univ Melbourne, Ctr Vet Clin, Fac Vet Sci, Werribee, Vic, Australia.	crippsj@unimelb.edu.au	Cripps, Jemma/V-2293-2019		Holsworth Wildlife Research Endowment; University of Melbourne's Animal Ethics Committee [1011709]	Holsworth Wildlife Research Endowment; University of Melbourne's Animal Ethics Committee	This work was supported by the Holsworth Wildlife Research Endowment (http://www.eqt.com.au/not-for-profit-organisations/confirmed-2015-programs/holsworth-grants.aspx) through a grant to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Holsworth Wildlife Research Endowment. We thank Rachel Kane and staff at Anglesea Golf Club for logistic support, and the many volunteers who assisted with fieldwork. Special thanks to Ian Beveridge, Michelle Wilson and Sarah Garnick for perceptive comments on early drafts of the manuscript. Thanks to Mark Elgar for discussions around experimental design, Christine Andersen for technical assistance and Rachel Sore for statistical advice. This research was carried out with approval from The University of Melbourne's Animal Ethics Committee (project 1011709) and the Department of Sustainability and Environment (research permit 10005557).	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; APPLEBY MC, 1980, BEHAVIOUR, V74, P294, DOI 10.1163/156853980X00519; Arneberg P, 1996, PARASITOLOGY, V112, P213, DOI 10.1017/S003118200008478X; ARUNDEL JH, 1990, AUST WILDLIFE RES, V17, P39; Ayele WY, 2001, VET MED-CZECH, V46, P205, DOI 10.17221/7878-VETMED; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Balic A, 2000, ADV PARASIT, V45, P181, DOI 10.1016/S0065-308X(00)45005-0; Banks PB, 2000, AUSTRAL ECOL, V25, P283, DOI 10.1046/j.1442-9993.2000.01039.x; BEVERIDGE I, 1978, INT J PARASITOL, V8, P379, DOI 10.1016/0020-7519(78)90036-X; BEVERIDGE I, 1979, AUST WILDLIFE RES, V6, P69; Beveridge I, 2001, INT J PARASITOL, V31, P976, DOI 10.1016/S0020-7519(01)00200-4; Blumstein DT, 2000, JWATCHER V 1 0 INTRO; Brambilla A, 2013, ANIM BEHAV, V86, P153, DOI 10.1016/j.anbehav.2013.05.006; Cameron A., 2003, RESO EXCEL V 4 0 FAE; CLARKE J, 1985, J ZOOL, V207, P537; CLARKE JL, 1995, AUST J ZOOL, V43, P519, DOI 10.1071/ZO9950519; CLARKE JL, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P611; Colditz IG, 2008, PARASITE IMMUNOL, V30, P63, DOI 10.1111/j.1365-3024.2007.00964.x; Colditz IG, 1996, INT J PARASITOL, V26, P869, DOI 10.1016/S0020-7519(96)80058-0; Coop RL, 1999, VET PARASITOL, V84, P187, DOI 10.1016/S0304-4017(99)00070-9; Cooper J, 2000, APPL ANIM BEHAV SCI, V69, P15, DOI 10.1016/S0168-1591(00)00116-7; Coulson Graeme, 2014, Animals, V4, P272, DOI 10.3390/ani4020272; Coulson G, 2009, WILDLIFE RES, V36, P57, DOI 10.1071/WR08038; Cripps J, 2015, AUST J ZOOL, V63, P163, DOI 10.1071/ZO15003; Cripps J, 2013, J WILDLIFE DIS, V49, P535, DOI 10.7589/2012-06-151; Cripps JK, 2011, BIOL LETTERS, V7, P859, DOI 10.1098/rsbl.2011.0526; Downes B.J., 2002, MONITORING ECOLOGICA; FABIYI JP, 1987, INT J PARASITOL, V17, P435, DOI 10.1016/0020-7519(87)90119-6; Fleurance G, 2007, APPL ANIM BEHAV SCI, V108, P288, DOI 10.1016/j.applanim.2006.11.019; Forbes AB, 2000, VET PARASITOL, V90, P111, DOI 10.1016/S0304-4017(00)00218-1; Fox MT, 1997, VET PARASITOL, V72, P285, DOI 10.1016/S0304-4017(97)00102-7; FREELAND WJ, 1980, ECOLOGY, V61, P1297, DOI 10.2307/1939037; Garnick SW, 2010, BEHAV ECOL, V21, P129, DOI 10.1093/beheco/arp162; Gelin U, 2013, ANIM BEHAV, V86, P885, DOI 10.1016/j.anbehav.2013.08.016; Gooderham K, 2011, BEHAV ECOL, V22, P1195, DOI 10.1093/beheco/arr112; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Gunn A, 2003, WILDLIFE SOC B, V31, P117; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; Hughes, 1993, DIET SELECTION INTER; Hutchings MR, 1999, J ANIM ECOL, V68, P310, DOI 10.1046/j.1365-2656.1999.00287.x; Hutchings MR, 1998, ANIM SCI, V67, P97, DOI 10.1017/S1357729800009838; Hutchings MR, 2003, P NUTR SOC, V62, P361, DOI 10.1079/PNS2003243; Hutchings MR, 2002, OECOLOGIA, V132, P453, DOI 10.1007/s00442-002-0971-z; Inwood D, 2008, TOO CLOSE FOR COMFORT : CONTENTIOUS ISSUES IN HUMAN-WILDLIFE ENCOUNTERS, P1; Irvine RJ, 2006, PARASITOLOGY, V133, P465, DOI 10.1017/S0031182006000606; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; JARMAN PJ, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P527; JOHNSON CN, 1987, AUST WILDLIFE RES, V14, P133; JOHNSTON JT, 1984, NEW ZEAL VET J, V32, P177, DOI 10.1080/00480169.1984.35114; Jones OR, 2006, CAN J ZOOL, V84, P685, DOI 10.1139/Z06-045; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; King W. J., 2011, Australian Mammalogy, V33, P47, DOI 10.1071/AM10029; Kirmani SN, 2010, OECOLOGIA, V164, P349, DOI 10.1007/s00442-010-1717-y; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Liu SM, 2003, AUST J EXP AGR, V43, P1409, DOI 10.1071/EA03017; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Loyacano AF, 2002, VET PARASITOL, V107, P227, DOI 10.1016/S0304-4017(02)00130-9; LOZANO GA, 1991, OIKOS, V60, P391, DOI 10.2307/3545084; Maguire G, 2006, J ZOOL, V268, P261, DOI 10.1111/j.1469-7998.2005.00026.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mercer JG, 2000, PARASITOLOGY, V120, P641, DOI 10.1017/S0031182099005922; Mignon-Grasteau S, 2005, LIVEST PROD SCI, V93, P3, DOI 10.1016/j.livprodsci.2004.11.001; Moe SR, 2010, RANGIFER, V19, P55; Mulder RA, 2010, WILDLIFE RES, V37, P440, DOI 10.1071/WR10007; Newey S, 2004, P ROY SOC B-BIOL SCI, V271, pS413, DOI 10.1098/rsbl.2004.0202; O'Connor LJ, 2006, VET PARASITOL, V142, P1, DOI 10.1016/j.vetpar.2006.08.035; OKELLY JC, 1988, ANIM REPROD SCI, V16, P177, DOI 10.1016/0378-4320(88)90011-5; Owen-Smith RN., 2002, CAMB ST ECO, DOI 10.1017/CBO9780511525605; Pedersen AB, 2015, TRENDS PARASITOL, V31, P200, DOI 10.1016/j.pt.2015.02.004; POOLE WE, 1982, AUST WILDLIFE RES, V9, P9; POPPI DP, 1990, PROC NEW ZEAL SOC AN, V50, P237; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Ruckstuhl KE, 2003, BEHAV ECOL SOCIOBIOL, V54, P167, DOI 10.1007/s00265-003-0615-2; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Smith LA, 2006, BEHAV ECOL, V17, P591, DOI 10.1093/beheco/ark004; SOUTHWELL C, 1987, MAMMALIA, V51, P211, DOI 10.1515/mamm.1987.51.2.211; Sykes A. R., 1987, The nutrition of herbivores., P211; Tompkins DM, 1999, PARASITOL TODAY, V15, P311, DOI 10.1016/S0169-4758(99)01484-2; van der Wal R, 2000, OECOLOGIA, V124, P19, DOI 10.1007/s004420050020; vanHoutert MFJ, 1996, INT J PARASITOL, V26, P1151, DOI 10.1016/S0020-7519(96)00120-8; WATSON DM, 1993, WILDLIFE RES, V20, P785, DOI 10.1071/WR9930785; Watson Maggie J., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P190, DOI 10.1016/j.ijppaw.2013.05.001; Wilson ME, 2013, WILDLIFE RES, V40, P403, DOI 10.1071/WR13050; WOOD IB, 1995, VET PARASITOL, V58, P181, DOI 10.1016/0304-4017(95)00806-2; Worsley-Tonks KEL, 2015, ANIM BEHAV, V108, P47, DOI 10.1016/j.anbehav.2015.07.018	90	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147384	10.1371/journal.pone.0147384	http://dx.doi.org/10.1371/journal.pone.0147384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784582	Green Published, gold			2022-12-26	WOS:000368528400145
J	Glaser, L; Carstensen, M; Shaw, S; Robbe-Austerman, S; Wunschmann, A; Grear, D; Stuber, T; Thomsen, B				Glaser, Linda; Carstensen, Michelle; Shaw, Sheryl; Robbe-Austerman, Suelee; Wunschmann, Arno; Grear, Dan; Stuber, Tod; Thomsen, Bruce			Descriptive Epidemiology and Whole Genome Sequencing Analysis for an Outbreak of Bovine Tuberculosis in Beef Cattle and White-Tailed Deer in Northwestern Minnesota	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; DIAGNOSIS	Bovine tuberculosis (bTB) was discovered in a Minnesota cow through routine slaughter surveillance in 2005 and the resulting epidemiological investigation led to the discovery of infection in both cattle and white-tailed deer in the state. From 2005 through 2009, a total of 12 beef cattle herds and 27 free-ranging white-tailed deer (Odocoileus virginianus) were found infected in a small geographic region of northwestern Minnesota. Genotyping of isolates determined both cattle and deer shared the same strain of bTB, and it was similar to types found in cattle in the southwestern United States and Mexico. Whole genomic sequencing confirmed the introduction of this infection into Minnesota was recent, with little genetic divergence. Aggressive surveillance and management efforts in both cattle and deer continued from 2010-2012; no additional infections were discovered. Over 10,000 deer were tested and 705 whole herd cattle tests performed in the investigation of this outbreak.	[Glaser, Linda] Minnesota Board Anim Hlth, St Paul, MN USA; [Carstensen, Michelle] Minnesota Dept Nat Resources, Wildlife Hlth Program, Forest Lake, MN USA; [Shaw, Sheryl] Anim & Plant Hlth Inspect Serv, Vet Serv, USDA, Madison, WI USA; [Robbe-Austerman, Suelee; Stuber, Tod; Thomsen, Bruce] Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs, Vet Serv, USDA, Ames, IA USA; [Wunschmann, Arno] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, Vet Diagnost Lab, St Paul, MN 55108 USA; [Grear, Dan] Anim & Plant Hlth Inspect Serv, Ctr Epidemiol, Vet Serv, USDA, Ft Collins, CO USA; [Grear, Dan] Anim & Plant Hlth Inspect Serv, Ctr Anim Hlth, Vet Serv, USDA, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Glaser, L (corresponding author), Minnesota Board Anim Hlth, St Paul, MN USA.	Linda.Glaser@state.mn.us		Grear, Daniel/0000-0002-5478-1549	Minnesota State Legislature; Department of Natural Resources (DNR); state funds, the U.S. Department of Agriculture; U.S Dept. of Agriculture; state funding through the University of Minnesota; Commodity Credit Corporation; federal government funding	Minnesota State Legislature; Department of Natural Resources (DNR); state funds, the U.S. Department of Agriculture; U.S Dept. of Agriculture(United States Department of Agriculture (USDA)); state funding through the University of Minnesota; Commodity Credit Corporation; federal government funding	This data was collected during the control and eradication effort by state and federal animal health regulatory authorities. State funding sources used during this control program included general fund dollars and additional disease control funds appropriated by the Minnesota State Legislature to the Board of Animal Health (BAH) and Department of Natural Resources (DNR). In addition to state funds, the U.S. Department of Agriculture provided funding to these two agencies (BAH, DNR) to assist in the increased program activities for this control effort. The U.S Dept. of Agriculture funding sources included funding appropriated through Congress as well as from the Commodity Credit Corporation. The additional funds provided indemnity for infected herds, contracting accredited veterinarians for live animal cattle testing, and paying federal animal health staff for temporary duty assignments to work in Minnesota on the control effort. Funding for laboratory work performed at the Minnesota Veterinary Diagnostic Laboratory was provided by state funding through the University of Minnesota. Funding for the laboratory at the National Veterinary Services Laboratory is provided by federal government funding to the US Dept. Agriculture, Animal Plant Health Inspection Service, Veterinary Services. The US Dept. Agriculture along with all state animal health agencies cooperatively developed the guidelines and requirements for the bovine tuberculosis eradication program. These requirements and guidelines were used for this disease eradication effort in Minnesota and guided the live animal testing, cattle movement data collection, and wildlife surveillance requirements. The data reported in this article was generated during this eradication effort.	[Anonymous], 2014, TRACER V1 6; [Anonymous], 2005, 9145011 USDA APHIS; [Anonymous], 2008, ASS RISK ASS MINN PR; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Carstensen Michelle, 2011, Veterinary Medicine International, P413240, DOI 10.4061/2011/413240; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Driscoll JR, 2009, METHODS MOL BIOL, V551, P117, DOI 10.1007/978-1-60327-999-4_10; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Martinez LR, 2008, J VET DIAGN INVEST, V20, P707, DOI 10.1177/104063870802000601; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller J, 1997, J VET DIAGN INVEST, V9, P244, DOI 10.1177/104063879700900304; Norby B, 2004, J VET DIAGN INVEST, V16, P126, DOI 10.1177/104063870401600206; Palmer MV, 2004, AM J VET RES, V65, P1483, DOI 10.2460/ajvr.2004.65.1483; Rambaut A., 2014, FIGTREE V1 4 2 TREE; Robbe-Austerman S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-74; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Thacker TC, 2015, VET MICROBIOL, V180, P75, DOI 10.1016/j.vetmic.2015.07.006	22	29	30	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145735	10.1371/journal.pone.0145735	http://dx.doi.org/10.1371/journal.pone.0145735			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785113	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400018
J	Jia, LF; Song, Q; Zhou, CY; Li, XM; Pi, LH; Ma, XR; Li, H; Lu, XY; Shen, YP				Jia, Lifeng; Song, Qi; Zhou, Chenyang; Li, Xiaoming; Pi, Lihong; Ma, Xiuru; Li, Hui; Lu, Xiuying; Shen, Yupeng			Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling	PLOS ONE			English	Article							CANCER-CELLS; TUMOR-GROWTH; HEPATOCELLULAR-CARCINOMA; CONSTITUTIVE ACTIVATION; ANTITUMOR-ACTIVITY; IN-VITRO; PATHWAY; TRANSDUCER; TRANSCRIPTION-3; APOPTOSIS	Developing drugs that can effectively block STAT3 activation may serve as one of the most promising strategy for cancer treatment. Currently, there is no putative STAT3 inhibitor that can be safely and effectively used in clinic. In the present study, we investigated the potential of dihydroartemisinin (DHA) as a putative STAT3 inhibitor and its antitumor activities in head and neck squamous cell carcinoma (HNSCC). The inhibitory effects of DHA on STAT3 activation along with its underlying mechanisms were studied in HNSCC cells. The antitumor effects of DHA against HNSCC cells were explored both in vitro and in vivo. An investigation on cooperative effects of DHA with cisplatin in killing HNSCC cells was also implemented. DHA exhibited remarkable and specific inhibitory effects on STAT3 activation via selectively blocking Jak2/STAT3 signaling. Besides, DHA significantly inhibited HNSCC growth both in vitro and in vivo possibly through induction of apoptosis and attenuation of cell migration. DHA also synergized with cisplatin in tumor inhibition in HNSCC cells. Our findings demonstrate that DHA is a putative STAT3 inhibitor that may represent a new and effective drug for cancer treatment and therapeutic sensitization in HNSCC patients.	[Jia, Lifeng; Zhou, Chenyang; Lu, Xiuying; Shen, Yupeng] Third Med Mil Univ, Postgrad Sch, Chongqing 400038, Peoples R China; [Jia, Lifeng; Song, Qi; Zhou, Chenyang; Li, Xiaoming] Bethune Int Peace Hosp, Dept Otolaryngol Head & Neck Surg, Shijiazhuang 050081, Hebei Province, Peoples R China; [Song, Qi] Med Coll PLA, Postgrad Sch, Beijing 100700, Peoples R China; [Pi, Lihong] Hebei Gen Hosp, Dept Otolaryngol, Shijiazhuang 050051, Hebei Province, Peoples R China; [Ma, Xiuru] Hebei Coll Tradit Chinese Med, Dept Basic Sci, Shijiazhuang 050061, Hebei Province, Peoples R China; [Li, Hui] Bethune Int Peace Hosp, Dept Pathol, Shijiazhuang 050081, Hebei Province, Peoples R China	Army Medical University	Li, XM (corresponding author), Bethune Int Peace Hosp, Dept Otolaryngol Head & Neck Surg, Shijiazhuang 050081, Hebei Province, Peoples R China.	xmlmo@126.com			Key Projects for Applied Basic Research of Hebei Province, China [14967721D]	Key Projects for Applied Basic Research of Hebei Province, China	This work was supported by Key Projects for Applied Basic Research of Hebei Province, China, Grant No. 14967721D to XML.; This work was supported by Key Projects for Applied Basic Research of Hebei Province, China, Grant No. 14967721D to X Li.	Adachi M, 2012, ORAL ONCOL, V48, P1220, DOI 10.1016/j.oraloncology.2012.06.006; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Blaskovich MA, 2003, CANCER RES, V63, P1270; Boehm AL, 2008, MOL PHARMACOL, V73, P1632, DOI 10.1124/mol.107.044636; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Cognetti DM, 2008, CANCER-AM CANCER SOC, V113, P1911, DOI 10.1002/cncr.23654; Flobinus A, 2014, J ANTIMICROB CHEMOTH, V69, P34, DOI 10.1093/jac/dkt346; Gao N, 2011, APOPTOSIS, V16, P511, DOI 10.1007/s10495-011-0580-6; Gu F, 2010, ONCOL REP, V23, P671, DOI 10.3892/or_00000683; Handrick R, 2010, MOL CANCER THER, V9, P2497, DOI 10.1158/1535-7163.MCT-10-0051; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Huang C, 2006, CANCER SCI, V97, P1417, DOI 10.1111/j.1349-7006.2006.00340.x; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1045, DOI 10.1111/j.1745-7254.2007.00612.x; Kamran MZ, 2013, BIOMED PHARMACOTHER, V67, P399, DOI 10.1016/j.biopha.2013.03.020; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li CY, 2009, MOL CANCER THER, V8, P2211, DOI 10.1158/1535-7163.MCT-09-0327; Li T, 2012, INT IMMUNOPHARMACOL, V12, P144, DOI 10.1016/j.intimp.2011.11.004; Li XM, 2010, EXP THER MED, V1, P947, DOI 10.3892/etm.2010.156; Liu JW, 2012, PLANTA MED, V78, P1568, DOI 10.1055/s-0032-1315121; Lu JJ, 2011, INVEST NEW DRUG, V29, P1276, DOI 10.1007/s10637-010-9481-8; Lu JJ, 2010, BIOCHEM PHARMACOL, V80, P22, DOI 10.1016/j.bcp.2010.02.016; Masuda M, 2002, CANCER RES, V62, P3351; Nam S, 2012, MOL ONCOL, V6, P484, DOI 10.1016/j.molonc.2012.05.002; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Onimoe GI, 2012, INVEST NEW DRUG, V30, P916, DOI 10.1007/s10637-011-9645-1; Pi LH, 2014, ONCOL LETT, V7, P685, DOI 10.3892/ol.2013.1753; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sen M, 2012, CLIN CANCER RES, V18, P4986, DOI 10.1158/1078-0432.CCR-12-0792; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Song X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-114; Timofeeva OA, 2013, P NATL ACAD SCI USA, V110, P1267, DOI 10.1073/pnas.1211805110; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wong AL, 2015, ANN ONCOL, V26, P998, DOI 10.1093/annonc/mdv026; Wu C, 2013, MOLECULES, V18, P6866, DOI 10.3390/molecules18066866; Yokogami K, 2013, BRAIN TUMOR PATHOL, V30, P135, DOI 10.1007/s10014-012-0122-0; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang CZ, 2012, BIOCHEM PHARMACOL, V83, P1278, DOI 10.1016/j.bcp.2012.02.002; Zhang XL, 2013, CANCER RES, V73, P1922, DOI 10.1158/0008-5472.CAN-12-3175; Zhang XL, 2011, INT J CANCER, V129, P2502, DOI 10.1002/ijc.25909; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	43	39	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147157	10.1371/journal.pone.0147157	http://dx.doi.org/10.1371/journal.pone.0147157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784960	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400115
J	Jin, X; Li, SS; Bondy, B; Zhong, WW; Oginsky, MF; Wu, Y; Johnson, CM; Zhang, S; Cui, NR; Jiang, C				Jin, Xin; Li, Shanshan; Bondy, Brian; Zhong, Weiwei; Oginsky, Max F.; Wu, Yang; Johnson, Christopher M.; Zhang, Shuang; Cui, Ningren; Jiang, Chun			Identification of a Group of GABAergic Neurons in the Dorsomedial Area of the Locus Coeruleus	PLOS ONE			English	Article							NORADRENERGIC NEURONS; MECP2-NULL MICE; CERULEUS; CORTEX; GABA; MODULATION; NUCLEUS; SYSTEM; SLEEP	The locus coeruleus (LC)-norepinephrine (NE) system in the brainstem plays a critical role in a variety of behaviors is an important target of pharmacological intervention to several neurological disorders. Although GABA is the major inhibitory neurotransmitter of LC neurons, the modulation of LC neuronal firing activity by local GABAergic interneurons remains poorly understood with respect to their precise location, intrinsic membrane properties and synaptic modulation. Here, we took an optogenetic approach to address these questions. Channelrhodopsin (ChR2) in a tandem with the yellow fluorescent protein (YFP) was expressed in GABAergic neurons under the control of glutamic acid decarboxylase 2 (GAD2) promoter. Immediately dorsomedial to the LC nucleus, a group of GABAergic neurons was observed. They had small soma and were densely packed in a small area, which we named the dorsomedial LC or dmLC nucleus. These GABAergic neurons showed fast firing activity, strong inward rectification and spike frequency adaptation. Lateral inhibition among these GABAergic neurons was observed. Optostimulation of the dmLC area drastically inhibited LC neuronal firing frequency, expanded the spike intervals, and reset their pacemaking activity. Analysis of the light evoked inhibitory postsynaptic currents (IPSCs) indicated that they were monosynaptic. Such light evoked IPSCs were not seen in slices where this group of GABAergic neurons was absent. Thus, an isolated group of GABAergic neurons is demonstrated in the LC area, whose location, somatic morphology and intrinsic membrane properties are clearly distinguishable from adjacent LC neurons. They interact with each and may inhibit LC neurons as well as a part of local neuronal circuitry in the LC.	[Jin, Xin; Li, Shanshan; Bondy, Brian; Zhong, Weiwei; Oginsky, Max F.; Wu, Yang; Johnson, Christopher M.; Zhang, Shuang; Cui, Ningren; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Jin, Xin] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Li, Shanshan] Harbin Med Univ, Sch Pharm, Harbin, Heilongjiang, Peoples R China	University System of Georgia; Georgia State University; Yale University; Harbin Medical University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA USA.	cjiang@gsu.edu			NIH [NS073875]; International Rett Syndrome Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH (NS073875) and the International Rett Syndrome Research Foundation.	Aston-Jones G, 2004, J NEUROSCI, V24, P2313, DOI 10.1523/JNEUROSCI.5339-03.2004; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Blanco L, 2013, NEUROSCIENCE, V247, P351, DOI 10.1016/j.neuroscience.2013.05.047; Cui NR, 2011, J NEUROPHYSIOL, V105, P2791, DOI 10.1152/jn.00759.2010; Dimitrov EL, 2013, J COMP NEUROL, V521, P2373, DOI 10.1002/cne.23291; ENNIS M, 1989, J NEUROSCI, V9, P2973; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Howells FM, 2012, METAB BRAIN DIS, V27, P267, DOI 10.1007/s11011-012-9287-9; Jin X, 2013, AM J PHYSIOL-CELL PH, V305, pC1151, DOI 10.1152/ajpcell.00195.2013; Jin X, 2013, AM J PHYSIOL-CELL PH, V304, pC844, DOI 10.1152/ajpcell.00399.2012; Kaur S, 1997, NEUROSCI LETT, V223, P105, DOI 10.1016/S0304-3940(97)13410-3; KISVARDAY ZF, 1993, J COMP NEUROL, V327, P398, DOI 10.1002/cne.903270307; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; MASUKO S, 1986, J NEUROSCI, V6, P3229; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026	16	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146470	10.1371/journal.pone.0146470	http://dx.doi.org/10.1371/journal.pone.0146470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785258	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400040
J	Namjoshi, DR; Cheng, WH; Carr, M; Martens, KM; Zareyan, S; Wilkinson, A; McInnes, KA; Cripton, PA; Wellington, CL				Namjoshi, Dhananjay R.; Cheng, Wai Hang; Carr, Michael; Martens, Kris M.; Zareyan, Shahab; Wilkinson, Anna; McInnes, Kurt A.; Cripton, Peter A.; Wellington, Cheryl L.			Chronic Exposure to Androgenic-Anabolic Steroids Exacerbates Axonal Injury and Microgliosis in the CHIMERA Mouse Model of Repetitive Concussion	PLOS ONE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; RECEPTOR MESSENGER-RNA; NATIONAL-FOOTBALL-LEAGUE; BRAIN-INJURY; HEAD-INJURY; POSTCONCUSSION SYNDROME; PROTEIN-TAU; MALE-MICE; SEROTONIN; IMPACT	Concussion is a serious health concern. Concussion in athletes is of particular interest with respect to the relationship of concussion exposure to risk of chronic traumatic encephalopathy (CTE), a neurodegenerative condition associated with altered cognitive and psychiatric functions and profound tauopathy. However, much remains to be learned about factors other than cumulative exposure that could influence concussion pathogenesis. Approximately 20% of CTE cases report a history of substance use including androgenic-anabolic steroids (AAS). How acute, chronic, or historical AAS use may affect the vulnerability of the brain to concussion is unknown. We therefore tested whether antecedent AAS exposure in young, male C57BI/6 mice affects acute behavioral and neuropathological responses to mild traumatic brain injury (TBI) induced with the CHIMERA (Closed Head Impact Model of Engineered Rotational Acceleration) platform. Male C57Bl/6 mice received either vehicle or a cocktail of three AAS (testosterone, nandrolone and 17 alpha-methyltestosterone) from 8-16 weeks of age. At the end of the 7th week of treatment, mice underwent two closed-head TBI or sham procedures spaced 24 h apart using CHIMERA. Post-repetitive TBI (rTBI) behavior was assessed for 7 d followed by tissue collection. AAS treatment induced the expected physiological changes including increased body weight, testicular atrophy, aggression and downregulation of brain 5-HT1B receptor expression. rTBI induced behavioral deficits, widespread axonal injury and white matter microgliosis. While AAS treatment did not worsen post-rTBI behavioral changes, AAS-treated mice exhibited significantly exacerbated axonal injury and microgliosis, indicating that AAS exposure can alter neuronal and innate immune responses to concussive TBI.	[Namjoshi, Dhananjay R.; Cheng, Wai Hang; Carr, Michael; Martens, Kris M.; Zareyan, Shahab; Wilkinson, Anna; Wellington, Cheryl L.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [McInnes, Kurt A.; Cripton, Peter A.] Univ British Columbia, Dept Biomech Engn, Vancouver, BC V5Z 1M9, Canada; [Cripton, Peter A.; Wellington, Cheryl L.] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Wellington, CL (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.; Wellington, CL (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC V5Z 1M9, Canada.	wcheryl@mail.ubc.ca	Cripton, Peter Alec/AAC-8268-2020; Meijer, Anna/K-5118-2016	Cripton, Peter Alec/0000-0002-5067-0833; Cheng, Wai Hang/0000-0002-3408-9184; McInnes, Kurt/0000-0001-5931-2963	Canadian Institutes of Health Research [MOP 123461]; Alzheimer Society Research Program Doctoral award; Comissao Technica de Atribuicao de Bolsas para Estudos Pos-Graduados Macao	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Research Program Doctoral award; Comissao Technica de Atribuicao de Bolsas para Estudos Pos-Graduados Macao	This work was supported by operating funding from the Canadian Institutes of Health Research (MOP 123461) to CLW (http://www.cihrirsc.gc.ca/e/193.htm). WHC is supported by Alzheimer Society Research Program Doctoral award (http://www.alzheimer.ca/en/Research/Alzheimer-Society-Research-Program) and Comissao Technica de Atribuicao de Bolsas para Estudos Pos-Graduados Macao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambar G, 2009, GENES BRAIN BEHAV, V8, P161, DOI 10.1111/j.1601-183X.2008.00458.x; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bonaventure P, 1998, NEUROSCIENCE, V82, P469; Bressan S, 2016, J PAEDIATR CHILD H, V52, P151, DOI 10.1111/jpc.12967; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Clark AS, 2003, NEUROSCI BIOBEHAV R, V27, P413, DOI 10.1016/S0149-7634(03)00064-2; Coccaro EF, 2015, CNS SPECTRUMS, V20, P295, DOI 10.1017/S1092852915000310; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Cunningham RL, 2013, HORM BEHAV, V64, P350, DOI 10.1016/j.yhbeh.2012.12.009; de Boer SF, 2005, EUR J PHARMACOL, V526, P125, DOI 10.1016/j.ejphar.2005.09.065; Duke AA, 2013, PSYCHOL BULL, V139, P1148, DOI 10.1037/a0031544; Evans NA, 2004, AM J SPORT MED, V32, P534, DOI 10.1177/0363546503262202; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gerberding JL, 2003, THE REPORT TO CONGRE; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grimes JM, 2002, PHARMACOL BIOCHEM BE, V73, P713, DOI 10.1016/S0091-3057(02)00880-8; Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003; Hoffman JR, 2006, J SPORT SCI MED, V5, P182; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Kindlundh AMS, 2003, NEUROSCIENCE, V119, P113, DOI 10.1016/S0306-4522(03)00120-9; Kubala KH, 2008, BRAIN RES, V1232, P21, DOI 10.1016/j.brainres.2008.07.065; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levin B, 2014, NEUROCRIT CARE, V20, P334, DOI 10.1007/s12028-013-9931-1; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Marshall-Gradisnik S, 2009, CENT EUR J BIOL, V4, P19, DOI 10.2478/s11535-008-0058-x; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mills JD, 2012, NEUROSURGERY, V70, P205, DOI 10.1227/NEU.0b013e3182250918; Millspaugh J, 1937, US NAVAL MED B, V35, P297; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Penatti CAA, 2009, J NEUROSCI, V29, P12484, DOI 10.1523/JNEUROSCI.3108-09.2009; Popova N K, 2008, Neurosci Behav Physiol, V38, P471, DOI 10.1007/s11055-008-9004-7; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Robinson S, 2012, HORM BEHAV, V61, P67, DOI 10.1016/j.yhbeh.2011.10.004; Sagoe D, 2014, ANN EPIDEMIOL, V24, P383, DOI 10.1016/j.annepidem.2014.01.009; SANCHEZ C, 1993, PSYCHOPHARMACOLOGY, V110, P53, DOI 10.1007/BF02246950; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Turillazzi E, 2011, MINI-REV MED CHEM, V11, P374, DOI 10.2174/138955711795445925; van Amsterdam J, 2010, REGUL TOXICOL PHARM, V57, P117, DOI 10.1016/j.yrtph.2010.02.001; Varnas K, 2005, SYNAPSE, V56, P21, DOI 10.1002/syn.20128; VIRKKUNEN M, 1995, J PSYCHIATR NEUROSCI, V20, P271	66	30	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146540	10.1371/journal.pone.0146540	http://dx.doi.org/10.1371/journal.pone.0146540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784694	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400046
J	Schimming, O; Schmitt, I; Bode, HB				Schimming, Olivia; Schmitt, Imke; Bode, Helge B.			Identification of the Sfp-Type PPTase EppA from the Lichenized Fungus Evernia prunastri	PLOS ONE			English	Article							PHOSPHOPANTETHEINYL TRANSFERASE; BACILLUS-SUBTILIS; 4'-PHOSPHOPANTETHEINYL TRANSFERASE; POSTTRANSLATIONAL MODIFICATION; XANTHORIA-PARIETINA; SECONDARY-PRODUCT; NATURAL-PRODUCT; BLUE PIGMENT; FATTY-ACID; POLYKETIDE	In the last decades, natural products from lichens have gained more interest for pharmaceutical application due to the broad range of their biological activity. However, isolation of the compounds of interest directly from the lichen is neither feasible nor sustainable due to slow growth of many lichens. In order to develop a pipeline for heterologous expression of lichen biosynthesis gene clusters and thus the sustainable production of their bioactive compounds we have identified and characterized the phosphopantheteinyl transferase (PPTase) EppA from the lichen Evernia prunastri. The Sfp-type PPTase EppA was functionally characterized through heterologous expression in E. coli using the production of the blue pigment indigoidine as readout and by complementation of a lys5 deletion in S. cerevisiae.	[Schimming, Olivia; Bode, Helge B.] Goethe Univ Frankfurt, Fachbereich Biowissensch, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Schmitt, Imke] Senckenberg Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Bode, HB (corresponding author), Goethe Univ Frankfurt, Fachbereich Biowissensch, Max von Laue Str 9, D-60438 Frankfurt, Germany.	h.bode@bio.uni-frankfurt.de	Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909	Hessian Ministry of Science and Art via the LOEWE research focus "Integrative fungal research (IPF)"	Hessian Ministry of Science and Art via the LOEWE research focus "Integrative fungal research (IPF)"	This work was supported by the Hessian Ministry of Science and Art via the LOEWE research focus "Integrative fungal research (IPF)".; This work was supported by the Hessian Ministry of Science and Art via the LOEWE research focus "Integrative fungal research (IPF)". The authors thank Eckhard Boles for useful discussions regarding all aspects of yeast molecular biology, and Anjuli Meiser, Francesco Dal Grande and Jurgen Otte for providing the draft genome of E. prunastri.	Ahmadjian V, 1993, THE LICHEN SYMBIOSIS; [Anonymous], 2006, COLD SPRING HARB PRO, DOI [10.1101/pdb.rec8190, DOI 10.1101/PDB.REC8190]; [Anonymous], 2006, COLD SPRING HARBOR P, V2006; Basile A, 2015, INT J MOL SCI, V16, P7861, DOI 10.3390/ijms16047861; Beld J, 2014, NAT PROD REP, V31, P61, DOI 10.1039/c3np70054b; Bode HB, 2005, ANGEW CHEM INT EDIT, V44, P6828, DOI 10.1002/anie.200501080; BORELL CW, 1988, CURR GENET, V13, P299, DOI 10.1007/BF00424423; Boustie Joel, 2005, Plant Genetic Resources Characterization and Utilization, V3, P273, DOI 10.1079/PGR200572; Brachmann AO, 2012, J BIOTECHNOL, V157, P96, DOI 10.1016/j.jbiotec.2011.10.002; Burkholder PR, 1944, P NATL ACAD SCI USA, V30, P250, DOI 10.1073/pnas.30.9.250; Clarke KM, 2005, J AM CHEM SOC, V127, P11234, DOI 10.1021/ja052911k; Copp JN, 2006, APPL ENVIRON MICROB, V72, P2298, DOI 10.1128/AEM.72.4.2298-2305.2006; CULBERSON CF, 1992, EXP MYCOL, V16, P52, DOI 10.1016/0147-5975(92)90041-O; EMMERICH R, 1993, PHYTOCHEMISTRY, V33, P1389, DOI 10.1016/0031-9422(93)85097-B; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Finking R, 2002, J BIOL CHEM, V277, P50293, DOI 10.1074/jbc.M205042200; Gagunashvili AN, 2009, MYCOL RES, V113, P354, DOI 10.1016/j.mycres.2008.11.011; Gaitatzis N, 2001, J BIOCHEM, V129, P119, DOI 10.1093/oxfordjournals.jbchem.a002821; Gibson D., 2009, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2009.77, DOI 10.1038/NPROT.2009.77]; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOLLAPUDI SR, 1994, J NAT PROD, V57, P934, DOI 10.1021/np50109a009; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hamada N, 1996, BRYOLOGIST, V99, P71, DOI 10.2307/3244441; Huneck S, 1999, NATURWISSENSCHAFTEN, V86, P559, DOI 10.1007/s001140050676; Kealey JT, 1998, P NATL ACAD SCI USA, V95, P505, DOI 10.1073/pnas.95.2.505; Kegler C, 2014, CHEMBIOCHEM, V15, P826, DOI 10.1002/cbic.201300602; Keszenman-Pereyra D, 2003, CURR GENET, V43, P186, DOI 10.1007/s00294-003-0382-7; Nguyen KH, 2013, NAT PROD REP, V30, P1490, DOI 10.1039/c3np70064j; Knop W., 1844, LIEBIGS ANN CHEM, V49, P103, DOI [10.1002/jlac.18440490202, DOI 10.1002/JLAC.18440490202]; La Clair, 2004, CHEM BIOL, V11, P195, DOI [10.1016/j.chembiol.2004.02.010, DOI 10.1016/J.CHEMBIOL.2004.02.010]; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAUTERWEIN M, 1995, ANTIMICROB AGENTS CH, V39, P2541, DOI 10.1128/AAC.39.11.2541; Miao V, 2001, TRENDS BIOTECHNOL, V19, P349, DOI 10.1016/S0167-7799(01)01700-0; Mofid MR, 2004, BIOCHEMISTRY-US, V43, P4128, DOI 10.1021/bi036013h; Mootz HD, 2002, FEMS MICROBIOL LETT, V213, P51, DOI 10.1016/S0378-1097(02)00760-7; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Muller M, 2012, METAB ENG, V14, P325, DOI 10.1016/j.ymben.2012.04.002; Muggia L, 2009, SIM NEWS, P85; Muller K, 2001, APPL MICROBIOL BIOT, V56, P9, DOI 10.1007/s002530100684; Murugan E, 2008, FEBS LETT, V582, P1097, DOI 10.1016/j.febslet.2008.02.061; Myers JA, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-4; Park SH, 2014, APPL ENVIRON MICROB, V80, P2645, DOI 10.1128/AEM.00470-14; Park SY, 2013, ANTIMICROB AGENTS CH, V57, P5536, DOI 10.1128/AAC.01137-13; Park SY, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00357-14; Park SY, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00695-13; Pfeifer BA, 2001, MICROBIOL MOL BIOL R, V65, P106, DOI 10.1128/MMBR.65.1.106-118.2001; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Schimming O, 2014, CHEMBIOCHEM, V15, P1290, DOI 10.1002/cbic.201402065; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Siewers V, 2009, METAB ENG, V11, P391, DOI 10.1016/j.ymben.2009.08.002; Sinnemann SJ, 2000, CURR GENET, V37, P333, DOI 10.1007/s002940050536; Solhaug KA, 1996, OECOLOGIA, V108, P412, DOI 10.1007/BF00333715; Stack D, 2007, MICROBIOL-SGM, V153, P1297, DOI 10.1099/mic.0.2006/006908-0; Stocker-Worgotter E, 2008, NAT PROD REP, V25, P188, DOI 10.1039/b606983p; Vijayakumar C. S., 2000, Fitoterapia, V71, P564, DOI 10.1016/S0367-326X(00)00209-4; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Wang YY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-34; Yeast extract-peptone-dextrose growth medium (YEPD), 2010, COLD SPRING HARBOR P, V2010, DOI [10.1101/pdb.rec12161, DOI 10.1101/PDB.REC12161]; Yu DY, 2013, J IND MICROBIOL BIOT, V40, P159, DOI 10.1007/s10295-012-1207-9	60	1	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145624	10.1371/journal.pone.0145624	http://dx.doi.org/10.1371/journal.pone.0145624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784935	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400016
J	Willkomm, S; Deerberg, A; Heidemann, J; Flugge, F; Meine, J; Hu, R; Far, RKK; Restle, T				Willkomm, Sarah; Deerberg, Andrea; Heidemann, Johannes; Fluegge, Friedemann; Meine, Janica; Hu, Rui; Far, Rosel Kretschmer-Kazemi; Restle, Tobias			Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; RISC-LOADING COMPLEX; BINDING PROTEIN; HUMAN ARGONAUTE2; TRBP; PACT; DICER; INTERFERENCE; RECOGNITION	The human TAR RNA-binding protein (hTRBP) and protein activator of protein kinase R (hPACT) are important players in RNA interference (RNAi). Together with hArgonaute2 (hAgo2) and hDicer they have been reported to form the RISC-loading complex (RLC). Among other functions, hTRBP was suggested to assist the loading of hAgo2 with small interfering RNAs (siRNAs) within the RLC. Although several studies have been conducted to evaluate the specific functions of hTRBP and hPACT in RNAi, exact mechanisms and modes of action are still unknown. Here, we present a biochemical study further evaluating the role of hTRBP and hPACT in hAgo2-loading. We found that both proteins enhance hAgo2-mediated RNA cleavage significantly; even a hAgo2 mutant impaired in siRNA binding shows full cleavage activity in the presence of hTRBP or hPACT. Pre-steady state binding studies reveal that the assembly of wildtype-hAgo2 (wt-hAgo2) and siRNAs remains largely unaffected, whereas the binding of mutant hAgo2-PAZ9 to siRNA is restored by adding either hTRBP or hPACT. We conclude that both proteins assist in positioning the siRNA within hAgo2 to ensure optimal binding and cleavage. Overall, our data indicate that hTRBP and hPACT are part of a regulative system of RNAi that is important for efficient target RNA cleavage.	[Willkomm, Sarah] Univ Regensburg, Single Mol Biochem Lab, Inst Microbiol, D-93053 Regensburg, Germany; [Willkomm, Sarah; Deerberg, Andrea; Heidemann, Johannes; Fluegge, Friedemann; Meine, Janica; Hu, Rui; Far, Rosel Kretschmer-Kazemi; Restle, Tobias] Med Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Mol Med, D-23538 Lubeck, Germany	University of Regensburg; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck	Restle, T (corresponding author), Med Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Mol Med, D-23538 Lubeck, Germany.	restle@imm.uni-luebeck.de	Fluegge, Friedemann/AAA-5987-2020	Kretschmer-Kazemi Far, Rosel/0000-0002-2363-7499	Graduate School for Computing in Medicine and Life Sciences at the University of Lubeck; German National Academic Foundation	Graduate School for Computing in Medicine and Life Sciences at the University of Lubeck; German National Academic Foundation	S.W. acknowledges funding by the Graduate School for Computing in Medicine and Life Sciences at the University of Lubeck and A.D. by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; Chen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9899; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Deerberg A, 2013, P NATL ACAD SCI USA, V110, P17850, DOI 10.1073/pnas.1217838110; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gredell JA, 2010, BIOCHEMISTRY-US, V49, P3148, DOI 10.1021/bi902189s; Gupta V, 2003, VIROLOGY, V315, P283, DOI 10.1016/S0042-6822(03)00589-0; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Huang X, 2002, BIOCHEM J, V366, P175, DOI 10.1042/BJ20020204; Kim Y, 2014, CELL REP, V9, P1061, DOI 10.1016/j.celrep.2014.09.039; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069; Lee HY, 2013, NUCLEIC ACIDS RES, V41, P6568, DOI 10.1093/nar/gkt361; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Noland CL, 2013, RNA, V19, P639, DOI 10.1261/rna.037424.112; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063434; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146814	10.1371/journal.pone.0146814	http://dx.doi.org/10.1371/journal.pone.0146814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784517	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400067
J	Li, YJ; Wang, YG; An, B; Xu, H; Liu, Y; Zhang, LC; Ma, HY; Wang, WM				Li, Y. J.; Wang, Y. G.; An, B.; Xu, H.; Liu, Y.; Zhang, L. C.; Ma, H. Y.; Wang, W. M.			A Practical Anodic and Cathodic Curve Intersection Model to Understand Multiple Corrosion Potentials of Fe-Based Glassy Alloys in OH- Contained Solutions	PLOS ONE			English	Article							ALKALINE AQUEOUS-ELECTROLYTES; BULK METALLIC GLASSES; SOFT-MAGNETIC-ALLOYS; ELECTROCHEMICAL-BEHAVIOR; FERROSILICIDES FEXSI; STAINLESS-STEEL; PHOSPHORIC-ACID; FILM GROWTH; SCAN RATE; PASSIVATION	A practical anodic and cathodic curve intersection model, which consisted of an apparent anodic curve and an imaginary cathodic line, was proposed to explain multiple corrosion potentials occurred in potentiodynamic polarization curves of Fe-based glassy alloys in alkaline solution. The apparent anodic curve was selected from the measured anodic curves. The imaginary cathodic line was obtained by linearly fitting the differences of anodic curves and can be moved evenly or rotated to predict the number and value of corrosion potentials.	[Li, Y. J.; Wang, Y. G.; An, B.; Xu, H.; Liu, Y.; Wang, W. M.] Shandong Univ, Key Lab Liquid Solid Struct Evolut & Proc Mat, Minist Educ, Jinan 250061, Peoples R China; [Zhang, L. C.] Edith Cowan Univ, Sch Engn, 270 Joondalup Dr, Perth, WA 6027, Australia; [Ma, H. Y.] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Shandong, Peoples R China	Shandong University; Edith Cowan University; Shandong University	Wang, WM (corresponding author), Shandong Univ, Key Lab Liquid Solid Struct Evolut & Proc Mat, Minist Educ, Jinan 250061, Peoples R China.	weiminw@sdu.edu.cn	Wang, Weimin/AAC-4153-2020; zhang, lai/GVS-4725-2022; Zhang, Lai-Chang/B-9769-2011	Wang, Weimin/0000-0002-4789-6399; Zhang, Lai-Chang/0000-0003-0661-2051	National Natural Science Foundation of China [51171091, 51471099]; National Basic Research Program of China (973 Program) [2012CB825702]; Excellent Youth Project of Shandong Natural Science Foundation [JQ201012]; Australian Research Council (ARC) Discovery Projects [DP130103592]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Excellent Youth Project of Shandong Natural Science Foundation; Australian Research Council (ARC) Discovery Projects(Australian Research Council)	The work is supported by the National Natural Science Foundation of China (No. 51171091 and No. 51471099), the National Basic Research Program of China (973 Program) (No. 2012CB825702), the Excellent Youth Project of Shandong Natural Science Foundation (No. JQ201012) and the Australian Research Council (ARC) Discovery Projects (DP130103592).	Almeida CMVB, 2001, MATER CHEM PHYS, V69, P261, DOI 10.1016/S0254-0584(00)00458-2; Amaral ST, 1999, CORROS SCI, V41, P759, DOI 10.1016/S0010-938X(98)00149-8; An B, 2014, J ALLOY COMPD, V593, P16, DOI 10.1016/j.jallcom.2014.01.086; An B, 2014, EFFECTS COOLING RATE; CALANDRA AJ, 1974, ELECTROCHIM ACTA, V19, P901, DOI 10.1016/0013-4686(74)85041-3; Casella IG, 2002, J ELECTROANAL CHEM, V534, P31, DOI 10.1016/S0022-0728(02)01100-2; Cekerevac M, 2012, CORROS SCI, V64, P204, DOI 10.1016/j.corsci.2012.07.019; Escriva-Cerdan C, 2012, CORROS SCI, V56, P114, DOI 10.1016/j.corsci.2011.11.014; Green ML, 2001, J APPL PHYS, V90, P2057, DOI 10.1063/1.1385803; Guenbour A, 2006, APPL SURF SCI, V253, P2362, DOI 10.1016/j.apsusc.2006.05.005; Gui Q, 2012, COMPOSITION TECHNOLO; Han Y, 2015, J MATER RES, V30, P547, DOI 10.1557/jmr.2014.389; Inoue A, 2006, INTERMETALLICS, V14, P936, DOI 10.1016/j.intermet.2006.01.038; Kelly RG., 2002, ELECTROCHEM TECHNOL, DOI DOI 10.1201/9780203909133; KELSALL GH, 1991, J ELECTROCHEM SOC, V138, P941, DOI 10.1149/1.2085751; KELSALL GH, 1991, J ELECTROCHEM SOC, V138, P931, DOI 10.1149/1.2085750; LEE TS, 1971, J ELECTROCHEM SOC, V118, P1278, DOI 10.1149/1.2408305; Li YJ, 2014, J NON-CRYST SOLIDS, V392, P51, DOI 10.1016/j.jnoncrysol.2014.03.030; Lu ZP, 2006, CORROS SCI, V48, P3049, DOI 10.1016/j.corsci.2005.11.014; MANNING PE, 1980, CORROSION, V36, P468, DOI 10.5006/0010-9312-36.9.468; Meng GZ, 2014, J MATER SCI TECHNOL, V30, P253, DOI [10.1016/j.jmst.2013.07.810, 10.1016/j.jmst.2013.07.010]; Nakagawa M, 1999, J DENT RES, V78, P1568, DOI 10.1177/00220345990780091201; Naumkin AV, 2012, POWELL CJ NIST STAND; Pan C, 2012, J ELECTROCHEM SOC, V159, pC453, DOI 10.1149/2.034211jes; Pan C, 2011, ELECTROCHIM ACTA, V56, P7740, DOI 10.1016/j.electacta.2011.05.106; Pang SJ, 2002, ACTA MATER, V50, P489, DOI 10.1016/S1359-6454(01)00366-4; Pyun SI, 2000, J SOLID STATE ELECTR, V4, P267, DOI 10.1007/s100080050203; Qiao YX, 2009, ELECTROCHIM ACTA, V54, P2298, DOI 10.1016/j.electacta.2008.10.038; Qiao YX, 2009, CORROS SCI, V51, P979, DOI 10.1016/j.corsci.2009.02.026; Refaey SAM, 2006, ELECTROCHIM ACTA, V51, P2942, DOI 10.1016/j.electacta.2005.09.033; Sato K, 2003, APPL SURF SCI, V216, P376, DOI 10.1016/S0169-4332(03)00445-8; Shi MJ, 2015, INTERMETALLICS, V61, P16, DOI 10.1016/j.intermet.2015.02.010; Srinivasan S., 1966, ELECTROCHIM ACTA, V11, P321; URQUIDIMACDONALD M, 1987, J ELECTROCHEM SOC, V134, P41, DOI 10.1149/1.2100433; Wang ZB, 2014, ELECTROCHIM ACTA, V135, P526, DOI 10.1016/j.electacta.2014.05.055; Xu Y, 2011, APPL MECH MATER, V66-68, P1094, DOI 10.4028/www.scientific.net/AMM.66-68.1094; Ye SL, 2013, J ALLOY COMPD, V562, P143, DOI 10.1016/j.jallcom.2013.02.006; Ye W, 2006, ELECTROCHIM ACTA, V51, P4426, DOI 10.1016/j.electacta.2005.12.034; Yi Y, 2013, CORROS SCI, V74, P92, DOI 10.1016/j.corsci.2013.04.028; Yim CD, 2015, CORROS SCI, V90, P597, DOI 10.1016/j.corsci.2014.11.003; YOSHIZAWA Y, 1988, J APPL PHYS, V64, P6044, DOI 10.1063/1.342149; Zarrouk A, 2015, CORROS SCI, V90, P572, DOI 10.1016/j.corsci.2014.10.052; Zhang XL, 2009, CORROS SCI, V51, P581, DOI 10.1016/j.corsci.2008.12.005; Zhang YC, 2012, ELECTROCHIM ACTA, V69, P12, DOI 10.1016/j.electacta.2012.01.023	44	14	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146421	10.1371/journal.pone.0146421	http://dx.doi.org/10.1371/journal.pone.0146421			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771194	gold, Green Published, Green Submitted			2022-12-26	WOS:000368628300018
J	Wang, XY; Li, CQ; Guo, DH; Wang, XY; Wei, S; Geng, YF; Wang, EY; Wang, ZH; Zhao, XW; Su, MJ; Liu, QJ; Zhang, SY; Feng, L; Sun, DB				Wang, Xinyu; Li, Chunqiu; Guo, Donghua; Wang, Xinyu; Wei, Shan; Geng, Yufei; Wang, Enyu; Wang, Zhihui; Zhao, Xiwen; Su, Mingjun; Liu, Qiujin; Zhang, Siyao; Feng, Li; Sun, Dongbo			Co-Circulation of Canine Coronavirus I and IIa/b with High Prevalence and Genetic Diversity in Heilongjiang Province, Northeast China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; DIARRHEIC DOGS; FECAL SAMPLES; IDENTIFICATION; GENOTYPE; RNA	To trace the evolution of canine coronavirus (CCoV), 201 stool samples from diarrheic dogs in northeast China were subjected to reverse transcription-polymerase chain reactions (RT-PCRs) targeting the partial M and S genes of CCoV, followed by an epidemiological analysis. M gene RT-PCRs showed that 28.36% (57/201) of the samples were positive for CCoV; of the 57 positive samples, CCoV-I and CCoV-II accounted for 15.79% (9/57) and 84.21% (48/57), respectively. A sequence comparison of the partial M gene revealed nucleotide homologies of 88.4%-100% among the 57 CCoV strains, and 88.7%-96.2% identity between the 57 CCoV strains and the Chinese reference strain HF3. The CCoV-I and CCoV-II strains exhibited genetic diversity when compared with reference strains from China and other countries. The 57 CCoV strains exhibited high co-infection rates with canine kobuvirus (CaKV) (33.33%) and canine parvovirus-2 (CPV-2) (31.58%). The CCoV prevalence in diarrheic dogs differed significantly with immunization status, regions, seasons, and ages. Moreover, 28 S genes were amplified from the 57 CCoV-positive samples, including 26 CCoV-IIa strains, one CCoV-IIb strain, and one CCoV-I strain. A sequence comparison of the partial S gene revealed 86.3%-100% nucleotide identity among the 26 CCoV-IIa strains, and 89.6%-92.2% identity between the 26 CCoV-IIa strains and the Chinese reference strain V1. The 26 CCoV-IIa strains showed genetic diversity when compared with reference strains from China and other countries. Our data provide evidence that CCoV-I, CCoV-IIa, and CCoV-IIb strains co-circulate in the diarrhoetic dogs in northeast China, high co-infection rates with CaKV and CPV-2 were observed, and the CCoV-II strains exhibited high prevalence and genetic diversity.	[Wang, Xinyu; Li, Chunqiu; Guo, Donghua; Wang, Xinyu; Wei, Shan; Geng, Yufei; Wang, Enyu; Wang, Zhihui; Zhao, Xiwen; Su, Mingjun; Liu, Qiujin; Zhang, Siyao; Sun, Dongbo] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, 5 Xinfeng Rd, Daqing 163319, Peoples R China; [Feng, Li] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, 427 Maduan St, Harbin 150001, Peoples R China	Heilongjiang Bayi Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Sun, DB (corresponding author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, 5 Xinfeng Rd, Daqing 163319, Peoples R China.	dongbosun@126.com	Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022; Feng, Li/GQQ-3764-2022	Wang, Xin/0000-0002-4457-7376; 	Program for New Century Excellent Talents in Heilongjiang Provincial University [1252-NCET-016]; National Natural Science Foundation of China [31472209]	Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Program for New Century Excellent Talents in Heilongjiang Provincial University (grant no. 1252-NCET-016), and the National Natural Science Foundation of China (grant no. 31472209).	Bandai C, 1999, J VET MED SCI, V61, P731, DOI 10.1292/jvms.61.731; Binn L N, 1974, Proc Annu Meet U S Anim Health Assoc, P359; Buonavoglia C, 2006, EMERG INFECT DIS, V12, P492, DOI 10.3201/eid1203.050839; Buonavoglia D, 2000, MICROBIOLOGICA, V23, P93; Cavalli A, 2014, J VET DIAGN INVEST, V26, P563, DOI 10.1177/1040638714538965; Choi S, 2014, J VET MED SCI, V76, P1141, DOI 10.1292/jvms.13-0585; Costa EM, 2014, VET MICROBIOL, V168, P8, DOI 10.1016/j.vetmic.2013.10.002; Decaro N, 2005, J VIROL METHODS, V130, P72, DOI 10.1016/j.jviromet.2005.06.005; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; Decaro N, 2015, VIRUS RES, V210, P100, DOI 10.1016/j.virusres.2015.07.018; Decaro N, 2013, J CLIN MICROBIOL, V51, P83, DOI 10.1128/JCM.02466-12; Decaro N, 2011, VET CLIN N AM-SMALL, V41, P1121, DOI 10.1016/j.cvsm.2011.07.005; Decaro N, 2011, VET J, V187, P195, DOI 10.1016/j.tvjl.2009.10.027; Decaro N, 2009, J VIROL, V83, P15332, DOI 10.1128/JVI.01937-08; Di Martino B, 2013, VET MICROBIOL, V166, P246, DOI 10.1016/j.vetmic.2013.05.007; Erles K, 2009, VIRUS RES, V141, P21, DOI 10.1016/j.virusres.2008.12.009; Gao FS, 2009, J VET SCI, V10, P261, DOI 10.4142/jvs.2009.10.3.261; Geng YF, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0131886, 10.1371/journal.pone.0137288]; Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071; Jeoung SY, 2014, J VET SCI, V15, P495, DOI 10.4142/jvs.2014.15.4.495; King A. M., 2012, VIRUS TAXONOMY CLASS; Lau SKP, 2012, J GEN VIROL, V93, P1573, DOI 10.1099/vir.0.042531-0; Le Poder S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/609465; Li C, 2015, J VET MED SCI; Licitra BN, 2014, VIRUSES-BASEL, V6, P3363, DOI 10.3390/v6083363; Ma GG, 2008, VIRUS GENES, V36, P491, DOI 10.1007/s11262-008-0214-4; Mesquita JR, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-107; Ntafis V, 2011, VET MICROBIOL, V151, P238, DOI 10.1016/j.vetmic.2011.03.008; Ntafis V, 2013, INFECT GENET EVOL, V16, P129, DOI 10.1016/j.meegid.2013.01.014; Pinto LD, 2014, VET J, V202, P659, DOI 10.1016/j.tvjl.2014.09.006; Pratelli A, 2004, J CLIN MICROBIOL, V42, P1797, DOI 10.1128/JCM.42.4.1797-1799.2004; Pratelli A, 2004, VET MICROBIOL, V99, P43, DOI 10.1016/j.vetmic.2003.07.009; Pratelli A, 2003, MICROBIOLOGICA, V26, P151; Pratelli A, 2003, J VIROL METHODS, V107, P213, DOI 10.1016/S0166-0934(02)00246-X; Pratelli A, 1999, J VIROL METHODS, V80, P11, DOI 10.1016/S0166-0934(99)00017-8; Regan AD, 2012, VIROLOGY, V430, P90, DOI 10.1016/j.virol.2012.04.013; Soma T, 2011, RES VET SCI, V90, P205, DOI 10.1016/j.rvsc.2010.05.027; Stavisky J, 2012, INFECT GENET EVOL, V12, P1419, DOI 10.1016/j.meegid.2012.04.010; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terada Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106534; Wang Y, 2006, BERL MUNCH TIERARZTL, V119, P35	41	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146975	10.1371/journal.pone.0146975	http://dx.doi.org/10.1371/journal.pone.0146975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771312	gold, Green Published, Green Submitted			2022-12-26	WOS:000368628300047
J	Bognar, MK; Vincendeau, M; Erdmann, T; Seeholzer, T; Grau, M; Linnemann, JR; Ruland, J; Scheel, CH; Lenz, P; Ott, G; Lenz, G; Hauck, SM; Krappmann, D				Bognar, M. K.; Vincendeau, M.; Erdmann, T.; Seeholzer, T.; Grau, M.; Linnemann, J. R.; Ruland, J.; Scheel, C. H.; Lenz, P.; Ott, G.; Lenz, G.; Hauck, S. M.; Krappmann, D.			Oncogenic CARMA1 couples NF-kappa B and beta-catenin signaling in diffuse large B-cell lymphomas	ONCOGENE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; RNA INTERFERENCE; INTESTINAL TUMORIGENESIS; CARD11 MUTATIONS; ABC-DLBCL; ACTIVATION; INHIBITION; EXPRESSION; IMMUNITY; CANCER	Constitutive activation of the antiapoptotic nuclear factor-kappa B (NF-kappa B) signaling pathway is a hallmark of the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphomas (DLBCL). Recurrent oncogenic mutations are found in the scaffold protein CARMA1 (CARD11) that connects B-cell receptor (BCR) signaling to the canonical NF-kappa B pathway. We asked how far additional downstream processes are activated and contribute to the oncogenic potential of DLBCL-derived CARMA1 mutants. To this end, we expressed oncogenic CARMA1 in the NF-kappa B negative DLBCL lymphoma cell line BJAB. By a proteomic approach we identified recruitment of beta-catenin and its destruction complex consisting of APC, AXIN1, CK1a and GSK3 beta to oncogenic CARMA1. Recruitment of the beta-catenin destruction complex was independent of CARMA1-BCL10-MALT1 complex formation or constitutive NF-kappa B activation and promoted the stabilization of beta-catenin. The beta-catenin destruction complex was also recruited to CARMA1 in ABC DLBCL cell lines, which coincided with elevated beta-catenin expression. In line, beta-catenin was frequently detected in non-GCB DLBCL biopsies that rely on chronic BCR signaling. Increased beta-catenin amounts alone were not sufficient to induce classical WNT target gene signatures, but could augment TCF/LEF-dependent transcriptional activation in response to WNT signaling. In conjunction with NF-kappa B, beta-catenin enhanced expression of immunosuppressive interleukin-10 and suppressed antitumoral CCL3, indicating that beta-catenin can induce a favorable tumor microenvironment. Thus, parallel activation of NF-kappa B and beta-catenin signaling by gain-of-function mutations in CARMA1 augments WNT stimulation and is required for regulating the expression of distinct NF-kappa B target genes to trigger cell-intrinsic and extrinsic processes that promote DLBCL lymphomagenesis.	[Bognar, M. K.; Vincendeau, M.; Seeholzer, T.; Krappmann, D.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Mol Toxicol & Pharmacol, Res Unit Cellular Signal Integrat, Ingolstaedter Landstr 1, D-85764 Neuherberg, Bayern, Germany; [Erdmann, T.; Grau, M.; Lenz, G.] Univ Hosp Munster, Dept Med A, Translat Oncol, Albert Schweitzer Campus 1, Munster, Germany; [Erdmann, T.; Lenz, G.] Cluster Excellence EXC 1003, Cells Mot, Munster, Germany; [Grau, M.; Lenz, P.] Univ Marburg, Dept Phys, Marburg, Germany; [Linnemann, J. R.; Scheel, C. H.] Helmholtz Zentrum Munchen, Inst Stem Cell Res, German Res Ctr Environm Hlth, Neuherberg, Germany; [Ruland, J.] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, Munich, Germany; [Ruland, J.] German Canc Consortium DKTK, Heidelberg, Germany; [Ruland, J.] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Ott, G.] Robert Bosch Krankenhaus, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Dept Clin Pathol, Stuttgart, Germany; [Hauck, S. M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Prot Sci, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munster; Philipps University Marburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); German Center for Infection Research; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Krappmann, D (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Mol Toxicol & Pharmacol, Res Unit Cellular Signal Integrat, Ingolstaedter Landstr 1, D-85764 Neuherberg, Bayern, Germany.	daniel.krappmann@helmholtz-muenchen.de	Krappmann, Daniel/ABF-4038-2021; Vincendeau, Michelle/AAD-4320-2022; Krappmann, Daniel/AAT-4354-2021; Hauck, Stefanie/B-3300-2013; Ruland, Jürgen/Q-6680-2018	Krappmann, Daniel/0000-0001-7640-3234; Krappmann, Daniel/0000-0001-7640-3234; Hauck, Stefanie/0000-0002-1630-6827; Ruland, Jürgen/0000-0002-8381-3597; Lenz, Peter/0000-0001-7705-3950; Seeholzer, Thomas/0000-0002-1115-3358; Grau, Michael/0000-0003-1909-0133	Deutsche Krebshilfe; Else Krner-Fresenius-Stiftung; Swiss National Science Foundation (Sinergia grant); Deutsche Forschungsgemeinschaft (DFG) [EXC 1003]; Philipps-University Marburg (Doctoral Scholarship); Deutsche Krebshilfe [109434]	Deutsche Krebshilfe(Deutsche Krebshilfe); Else Krner-Fresenius-Stiftung; Swiss National Science Foundation (Sinergia grant)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Philipps-University Marburg (Doctoral Scholarship); Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank Bernhard Kloo for support. The following material was kindly provided by: pMD2.G (Addgene # 12259), psPAX2 (Addgene # 12260), pLVTHM (Addgene # 12247) and pLV-tTRKRAB-red (Addgene # 12250) from Didier Trono; TCF/LEF luciferase reporter from Roel Nusse (Addgene # 24307). Support: Deutsche Krebshilfe, Else Krner-Fresenius-Stiftung, Swiss National Science Foundation (Sinergia grant), Deutsche Forschungsgemeinschaft (DFG EXC 1003) to GL; Philipps-University Marburg (Doctoral Scholarship) to MG; Deutsche Krebshilfe (# 109434) to DK.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Chin M, 2009, ONCOGENE, V28, P2100, DOI 10.1038/onc.2009.74; Christian SL, 2002, J IMMUNOL, V169, P758, DOI 10.4049/jimmunol.169.2.758; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Etet PFS, 2013, BBA-REV CANCER, V1835, P1, DOI 10.1016/j.bbcan.2012.08.002; Fu CM, 2015, P NATL ACAD SCI USA, V112, P2823, DOI 10.1073/pnas.1414167112; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Ge XL, 2012, MOL MED REP, V5, P1433, DOI 10.3892/mmr.2012.835; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Jeelall YS, 2012, J EXP MED, V209, P1907, DOI 10.1084/jem.20112744; Koch R, 2014, BLOOD, V123, P2189, DOI 10.1182/blood-2013-08-523886; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042775; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lovatt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012794; Nagel D, 2014, ONCOGENE, V33, P5655, DOI 10.1038/onc.2013.565; Nagel D, 2012, CANCER CELL, V22, P825, DOI 10.1016/j.ccr.2012.11.002; Nakashima E, 1996, PHARMACEUT RES, V13, P1896, DOI 10.1023/A:1016057830271; Naylor TL, 2011, CANCER RES, V71, P2643, DOI 10.1158/0008-5472.CAN-10-2525; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nogai H, 2013, BLOOD, V122, P2242, DOI 10.1182/blood-2013-06-508028; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Ramakrishna E, 2009, CANCER RES, V69, P1448, DOI 10.1158/0008-5472.CAN-08-1160; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Schimmack G, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0049-7; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Tandon B, 2011, MODERN PATHOL, V24, P1433, DOI 10.1038/modpathol.2011.103; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yaguchi T, 2012, J IMMUNOL, V189, P2110, DOI 10.4049/jimmunol.1102282; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024	54	31	32	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	32					4269	4281		10.1038/onc.2015.493	http://dx.doi.org/10.1038/onc.2015.493			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3YY	26776161	Green Published, hybrid			2022-12-26	WOS:000382149800011
J	Kim, CH; Kim, YD; Choi, EK; Kim, HR; Na, BR; Im, SH; Jun, CD				Kim, Chang-Hyun; Kim, Young-Dae; Choi, Eun-Kyung; Kim, Hye-Ran; Na, Bo-Ra; Im, Sin-Hyeog; Jun, Chang-Duk			Nuclear Speckle-related Protein 70 Binds to Serine/Arginine-rich Splicing Factors 1 and 2 via an Arginine/Serine-like Region and Counteracts Their Alternative Splicing Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; CD44; dimerization; heterogeneous nuclear ribonucleoprotein (hnRNP); RNA binding protein; NSrp70; RS-like region; SR protein; coiled-coil domain; nuclear speckle	PRE-MESSENGER-RNA; GENOME-WIDE ANALYSIS; SR PROTEINS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; COILED-COILS; RECOGNITION; DOMAINS; CD44; SPECIFICITY	Nuclear speckles are subnuclear storage sites containing pre-mRNA splicing machinery. Proteins assembled in nuclear speckles are known to modulate transcription and pre-mRNA processing. We have previously identified nuclear speckle-related protein 70 (NSrp70) as a novel serine/arginine (SR)-related protein that co-localizes with classical SR proteins such as serine/arginine-rich splicing factor 1 (SRSF1 or ASF/SF2) and SRSF2 (SC35). NSrp70 mediates alternative splice site selection, targeting several pre-mRNAs, including CD44 exon v5. Here we demonstrated that NSrp70 interacts physically with two SR proteins, SRSF1 and SRSF2, and reverses their splicing activity in terms of CD44 exon v5 as exon exclusion. The NSrp70 RS-like region was subdivided into three areas. Deletion of the first arginine/serine-rich-like region (RS1) completely abrogated binding to the SR proteins and to target mRNA and also failed to induce splicing of CD44 exon v5, suggesting that RS1 is critical for NSrp70 functioning. Interestingly, RS1 deletion also resulted in the loss of NSrp70 and SR protein speckle positioning, implying a potential scaffolding role for NSrp70 in nuclear speckles. NSrp70 contains an N-terminal coiled-coil domain that is critical not only for self-oligomerization but also for splicing activity. Consistently, deletion of the coiled-coil domain resulted in indefinite formation of nuclear speckles. Collectively, these results demonstrate that NSrp70 acts as a new molecular counterpart for alternative splicing of target RNA, counteracting SRSF1 and SRSF2 splicing activity.	[Kim, Chang-Hyun; Choi, Eun-Kyung; Kim, Hye-Ran; Na, Bo-Ra; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Immune Synapse Res Ctr, Sch Life Sci, Gwangju 500712, South Korea; [Kim, Young-Dae] Korea Res Inst Biosci & Biotechnol, Stem Cell Res Ctr, 125 Gwahak Ro, Daejeon 3414, South Korea; [Im, Sin-Hyeog] Pohang Univ Sci & Technol, Inst Basic Sci, Acad Immunol & Microbiol Inst, Pohang 790784, South Korea; [Im, Sin-Hyeog] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea	Gwangju Institute of Science & Technology (GIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Jun, CD (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, 123 Cheomdangwagi Ro, Gwangju 500712, South Korea.	cdjun@gist.ac.kr	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856	Basic Science Program through National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning [2015R1 A2A1A15052658]; Creative Research Initiative Program through National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning [2015R1A3A2066253]; Basic Science Program through NRF - Ministry of Education, Korea [2013R1A6A3A04064259]; Bio Imaging Research Center at the Gwangju Institute of Science and Technology	Basic Science Program through National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning; Creative Research Initiative Program through National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning; Basic Science Program through NRF - Ministry of Education, Korea; Bio Imaging Research Center at the Gwangju Institute of Science and Technology	This work was supported by Basic Science Program Grant 2015R1 A2A1A15052658 and Creative Research Initiative Program Grant 2015R1A3A2066253 through National Research Foundation (NRF) grants funded by the Ministry of Science, ICT, and Future Planning; by Basic Science Program Grant 2013R1A6A3A04064259 through NRF grants funded by the Ministry of Education, Korea, and the Bio Imaging Research Center at the Gwangju Institute of Science and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Bell MV, 1998, MOL CELL BIOL, V18, P5930, DOI 10.1128/MCB.18.10.5930; Bradley T, 2015, RNA, V21, P75, DOI 10.1261/rna.043893.113; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Fakan Stanislav, 1994, Trends in Cell Biology, V4, P86, DOI 10.1016/0962-8924(94)90180-5; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; FU XD, 1995, RNA, V1, P663; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kim YD, 2011, NUCLEIC ACIDS RES, V39, P4300, DOI 10.1093/nar/gkq1267; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lee MW, 2015, NUCLEIC ACIDS RES, V43, P3826, DOI 10.1093/nar/gkv156; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Loh TJ, 2014, ONCOL REP, V31, P273, DOI 10.3892/or.2013.2812; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mahrenholz CC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004994; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Moulton VR, 2010, J BIOL CHEM, V285, P12490, DOI 10.1074/jbc.M109.091660; Oberstrass FC, 2006, NAT STRUCT MOL BIOL, V13, P160, DOI 10.1038/nsmb1038; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Townley-Tilson WHD, 2006, RNA, V12, P1853, DOI 10.1261/rna.76006; Tripathi V, 2012, MOL BIOL CELL, V23, P3694, DOI 10.1091/mbc.E12-03-0206; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yang C, 2012, EXP THER MED, V4, P79, DOI 10.3892/etm.2012.543; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	43	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6169	6181		10.1074/jbc.M115.689414	http://dx.doi.org/10.1074/jbc.M115.689414			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797131	hybrid, Green Published			2022-12-26	WOS:000372894200011
J	Kappen, C				Kappen, Claudia			Developmental Patterning as a Quantitative Trait: Genetic Modulation of the Hoxb6 Mutant Skeletal Phenotype	PLOS ONE			English	Article							VERTEBRAL COLUMN; HOMEOTIC TRANSFORMATIONS; PRESOMITIC MESODERM; SEGMENTATION CLOCK; RETINOIC ACID; PROXIMAL RIBS; MOUSE EMBRYO; MICE; EXPRESSION; ABNORMALITIES	The process of patterning along the anterior-posterior axis in vertebrates is highly conserved. The function of Hox genes in the axis patterning process is particularly well documented for bone development in the vertebral column and the limbs. We here show that Hoxb6, in skeletal elements at the cervico-thoracic junction, controls multiple independent aspects of skeletal pattern, implicating discrete developmental pathways as substrates for this transcription factor. In addition, we demonstrate that Hoxb6 function is subject to modulation by genetic factors. These results establish Hox-controlled skeletal pattern as a quantitative trait modulated by gene-gene interactions, and provide evidence that distinct modifiers influence the function of conserved developmental genes in fundamental patterning processes.	[Kappen, Claudia] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Dev Biol, 6400 Perkins Rd, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kappen, C (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Dev Biol, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	claudia.kappen@pbrc.edu			Basil O'Connor Starter Scholar Research Award from the March of Dimes Birth Defects Foundation; Mayo Foundation for Medical Education and Research; Nebraska Research Initiative; Munroe-Meyer Institute through the Center for Human Molecular Genetics; Peggy M. Pennington Cole Endowed Chair in Developmental Biology at Pennington Biomedical Research Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS R21-AR052731]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR052731] Funding Source: NIH RePORTER	Basil O'Connor Starter Scholar Research Award from the March of Dimes Birth Defects Foundation; Mayo Foundation for Medical Education and Research; Nebraska Research Initiative; Munroe-Meyer Institute through the Center for Human Molecular Genetics; Peggy M. Pennington Cole Endowed Chair in Developmental Biology at Pennington Biomedical Research Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in parts by a Basil O'Connor Starter Scholar Research Award from the March of Dimes Birth Defects Foundation, Mayo Foundation for Medical Education and Research, the Nebraska Research Initiative, Munroe-Meyer Institute through the Center for Human Molecular Genetics, and by the Peggy M. Pennington Cole Endowed Chair in Developmental Biology at Pennington Biomedical Research Center. Funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases was received through NIAMS R21-AR052731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Allan D, 2001, DEV BIOL, V240, P46, DOI 10.1006/dbio.2001.0455; Bardeen CR, 1904, ANAT ANZEIGER, V25, P497; Bonyadi M, 1997, NAT GENET, V15, P207, DOI 10.1038/ng0297-207; Burke AC, 2003, DEV CELL, V4, P159, DOI 10.1016/S1534-5807(03)00033-9; Capecchi MR, 1996, ANN NY ACAD SCI, V785, P34, DOI 10.1111/j.1749-6632.1996.tb56241.x; Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; CHEN JM, 1953, J ANAT, V87, P130; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; Denans N, 2015, ELIFE, V4, DOI 10.7554/eLife.04379; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; DUBOULE D, 1994, DEVELOPMENT, P135; Dubrulle J, 2002, CURR OPIN GENET DEV, V12, P519, DOI 10.1016/S0959-437X(02)00335-0; Etter LE, 1944, AM J ROENTGENOL RADI, V51, P359; Freitas C, 2001, DEVELOPMENT, V128, P5139; Galis F, 1999, J EXP ZOOL, V285, P19, DOI 10.1002/(SICI)1097-010X(19990415)285:1<19::AID-JEZ3>3.0.CO;2-Z; GOLDSTEIN RS, 1992, DEVELOPMENT, V116, P441; Goodman FR, 2003, LANCET, V362, P651, DOI 10.1016/S0140-6736(03)14187-6; Green EL, 1941, GENETICS, V26, P192; GREEN EL, 1951, GENETICS, V36, P391; GREGG BC, 1983, J EMBRYOL EXP MORPH, V73, P135; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; GRUNEBERG H, 1950, J GENET, V50, P112, DOI 10.1007/BF02986799; Gruneberg H, 1952, GENETICS MOUSE, P353; Gruneberg H, 1963, PATHOLOGY DEV; Guttentag AR, 1999, RADIOGRAPHICS, V19, P1125, DOI 10.1148/radiographics.19.5.g99se011125; HALD HJ, 1995, ROFO FORTSCHR RONTG, V163, P4, DOI 10.1055/s-2007-1015936; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; HART CP, 1988, GENETICS, V118, P319; Hide T, 2002, DEVELOPMENT, V129, P4347; Huang RJ, 2003, DEV BIOL, V255, P30, DOI 10.1016/S0012-1606(02)00051-9; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; JOHNSON DR, 1992, J ANAT, V180, P507; Kallapur S, 1999, MOL REPROD DEV, V52, P341, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;341::AID-MRD2&gt;3.0.CO;2-N; Kappen C, 2004, GENESIS, V39, P155, DOI 10.1002/gene.20036; Kappen C, 2000, AM J HEMATOL, V65, P111, DOI 10.1002/1096-8652(200010)65:2<111::AID-AJH4>3.0.CO;2-Z; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KOSTIC D, 1994, MECH DEVELOP, V46, P231, DOI 10.1016/0925-4773(94)90073-6; Kuhne K, 1932, Z MORPHOL ANTHROPOL, V30, P1; Leitges M, 2000, DEVELOPMENT, V127, P2259; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Mansouri A, 2000, DEVELOPMENT, V127, P2251; Mark M, 1999, P NUTR SOC, V58, P609, DOI 10.1017/S0029665199000798; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; MURAKAMI U, 1963, J EMBRYOL EXP MORPH, V11, P107; Niederreither K, 2002, DEVELOPMENT, V129, P3563; Nowicki JL, 2000, DEVELOPMENT, V127, P4265; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Olivera-Martinez I, 2000, DEVELOPMENT, V127, P4611; Parisi MA, 2003, GASTROENTEROLOGY, V125, P1428, DOI 10.1016/j.gastro.2003.08.021; Peters H, 1999, DEVELOPMENT, V126, P5399; Pinsonneault J, 1997, EMBO J, V16, P2032, DOI 10.1093/emboj/16.8.2032; PRIMMETT DRN, 1989, DEVELOPMENT, V105, P119; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; RANCOURT DE, 1995, GENE DEV, V9, P108, DOI 10.1101/gad.9.1.108; ROSEN B, 1993, TRENDS GENET, V9, P162, DOI 10.1016/0168-9525(93)90162-B; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sadler T W, 2000, Chest Surg Clin N Am, V10, P237; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; SEARLE AG, 1954, J GENET, V52, P413, DOI 10.1007/BF02981534; Selleri L, 2001, DEVELOPMENT, V128, P3543; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; SOFAER JA, 1985, J ANAT, V140, P131; Stieve H, 1921, Z ANAT ENTWGESCH, V60, P307; Sudo H, 2001, DEV BIOL, V232, P284, DOI 10.1006/dbio.2001.0198; THEILER K, 1988, ADV ANAT EMBRYOL CEL, V112, P1; Vasiliauskas D, 2001, CELL, V106, P133, DOI 10.1016/S0092-8674(01)00442-1; WALLIN J, 1994, DEVELOPMENT, V120, P1109; WEBER W, 1950, J GENET, V50, P174, DOI 10.1007/BF02986801; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Yueh YG, 1998, P NATL ACAD SCI USA, V95, P9956, DOI 10.1073/pnas.95.17.9956; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6	79	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146019	10.1371/journal.pone.0146019	http://dx.doi.org/10.1371/journal.pone.0146019			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800342	gold, Green Submitted, Green Published			2022-12-26	WOS:000368655300012
J	Miyagi, T; Tanaka, S; Hide, I; Shirafuji, T; Sakai, N				Miyagi, Tatsuhiro; Tanaka, Shigeru; Hide, Izumi; Shirafuji, Toshihiko; Sakai, Norio			The Subcellular Dynamics of the Gs-Linked Receptor GPR3 Contribute to the Local Activation of PKA in Cerebellar Granular Neurons	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CONSTITUTIVE ACTIVITY; AXONAL-TRANSPORT; HIPPOCAMPAL-NEURONS; MOLECULAR-CLONING; FRET-BIOSENSORS; ORPHAN RECEPTOR; ACTIN DYNAMICS; POLARIZATION; KINESIN	G-protein-coupled receptor (GPR) 3 is a member of the GPR family that constitutively activates adenylate cyclase. We have reported that the expression of GPR3 in cerebellar granular neurons (CGNs) contributes to neurite outgrowth and modulates neuronal proliferation and survival. To further identify its role, we have analyzed the precise distribution and local functions of GPR3 in neurons. The fluorescently tagged GPR3 protein was distributed in the plasma membrane, the Golgi body, and the endosomes. In addition, we have revealed that the plasma membrane expression of GPR3 functionally up-regulated the levels of PKA, as measured by a PKA FRET indicator. Next, we asked if the PKA activity was modulated by the expression of GPR3 in CGNs. PKA activity was highly modulated at the neurite tips compared to the soma. In addition, the PKA activity at the neurite tips was up-regulated when GPR3 was transfected into the cells. However, local PKA activity was decreased when endogenous GPR3 was suppressed by a GPR3 siRNA. Finally, we determined the local dynamics of GPR3 in CGNs using time-lapse analysis. Surprisingly, the fluorescent GPR3 puncta were transported along the neurite in both directions over time. In addition, the anterograde movements of the GPR3 puncta in the neurite were significantly inhibited by actin or microtubule polymerization inhibitors and were also disturbed by the Myosin II inhibitor blebbistatin. Moreover, the PKA activity at the tips of the neurites was decreased when blebbistatin was administered. These results suggested that GPR3 was transported along the neurite and contributed to the local activation of PKA in CGN development. The local dynamics of GPR3 in CGNs may affect local neuronal functions, including neuronal differentiation and maturation.	[Miyagi, Tatsuhiro; Tanaka, Shigeru; Hide, Izumi; Shirafuji, Toshihiko; Sakai, Norio] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan	Hiroshima University	Tanaka, S (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan.	tanakamd@hiroshima-u.ac.jp	Tanaka, Shigeru/O-3908-2015; Sakai, Norio/AAM-5822-2021	Tanaka, Shigeru/0000-0003-3247-9098; Sakai, Norio/0000-0002-6648-8761	JSPS KAKENHI [15K09317]; Ministry of Education, Science, Sports and Culture; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; Japanese Smoking Research Foundation; Grants-in-Aid for Scientific Research [15K09317, 25293061] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 15K09317, the Ministry of Education, Science, Sports and Culture Grant-in-Aid for Scientific Research (to S.T.), and by grants from the Mitsubishi Pharma Research Foundation (to S.T.) and the Takeda Science Foundation (to S.T.). This work was also supported in part by the Japanese Smoking Research Foundation (to N.S. & S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Burnette DT, 2008, DEV CELL, V15, P163, DOI 10.1016/j.devcel.2008.05.016; CACERES A, 1986, J NEUROSCI, V6, P714; Claeysen S, 1999, MOL PHARMACOL, V55, P910; DOTTI CG, 1988, J NEUROSCI, V8, P1454; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Funahashi Y, 2014, CURR OPIN NEUROBIOL, V27, P215, DOI 10.1016/j.conb.2014.04.009; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Lasek RJ, 1984, J CELL BIOL 2, V99, p212s; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lowther KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065365; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Powell SK, 1997, J NEUROBIOL, V32, P223, DOI 10.1002/(SICI)1097-4695(199702)32:2<223::AID-NEU7>3.0.CO;2-A; Ruiz-Medina J, 2011, NEUROPHARMACOLOGY, V61, P43, DOI 10.1016/j.neuropharm.2011.02.014; Ruthel G, 1999, J NEUROBIOL, V39, P97, DOI 10.1002/(SICI)1097-4695(199904)39:1<97::AID-NEU8>3.0.CO;2-Z; Ruthel G, 1998, CELL MOTIL CYTOSKEL, V40, P160, DOI 10.1002/(SICI)1097-0169(1998)40:2<160::AID-CM5>3.0.CO;2-J; SAEKI Y, 1993, FEBS LETT, V336, P317, DOI 10.1016/0014-5793(93)80828-I; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Spiering D, 2013, METHOD CELL BIOL, V114, P593, DOI 10.1016/B978-0-12-407761-4.00025-7; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Tanaka S, 2014, NEUROBIOL DIS, V68, P215, DOI 10.1016/j.nbd.2014.04.007; Tanaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005922; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Tourino C, 2012, BRIT J PHARMACOL, V167, P892, DOI 10.1111/j.1476-5381.2012.02043.x; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Valverde O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004704; Verveer PJ, 2006, CSH PROTOCOLS, V2006, DOI [10.1101/pdb.prot4598, DOI 10.1101/PDB.PR0T4598]; Wang D, 2012, P NATL ACAD SCI USA, V109, pE3558, DOI 10.1073/pnas.1219203110; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730	48	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147466	10.1371/journal.pone.0147466	http://dx.doi.org/10.1371/journal.pone.0147466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800526	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300110
J	Choe, E; Drnevich, J; Williams, MM				Choe, Eunsoo; Drnevich, Jenny; Williams, Martin M., II			Identification of Crowding Stress Tolerance Co-Expression Networks Involved in Sweet Corn Yield	PLOS ONE			English	Article							PLANT-POPULATION; GENE-EXPRESSION; DROUGHT TOLERANCE; CYANOBACTERIAL FLAVODOXIN; TRANSCRIPTION FACTOR; TRANSGENIC TOBACCO; DYNAMIC CHANGES; USE EFFICIENCY; AFFECTS GROWTH; DRY-MATTER	Tolerance to crowding stress has played a crucial role in improving agronomic productivity in field corn; however, commercial sweet corn hybrids vary greatly in crowding stress tolerance. The objectives were to 1) explore transcriptional changes among sweet corn hybrids with differential yield under crowding stress, 2) identify relationships between phenotypic responses and gene expression patterns, and 3) identify groups of genes associated with yield and crowding stress tolerance. Under conditions of crowding stress, three high-yielding and three low-yielding sweet corn hybrids were grouped for transcriptional and phenotypic analyses. Transcriptional analyses identified from 372 to 859 common differentially expressed genes (DEGs) for each hybrid. Large gene expression pattern variation among hybrids and only 26 common DEGs across all hybrid comparisons were identified, suggesting each hybrid has a unique response to crowding stress. Over-represented biological functions of DEGs also differed among hybrids. Strong correlation was observed between: 1) modules with up-regulation in high-yielding hybrids and yield traits, and 2) modules with up-regulation in low-yielding hybrids and plant/ear traits. Modules linked with yield traits may be important crowding stress response mechanisms influencing crop yield. Functional analysis of the modules and common DEGs identified candidate crowding stress tolerant processes in photosynthesis, glycolysis, cell wall, carbohydrate/nitrogen metabolic process, chromatin, and transcription regulation. Moreover, these biological functions were greatly inter-connected, indicating the importance of improving the mechanisms as a network.	[Choe, Eunsoo; Williams, Martin M., II] USDA ARS, Global Change & Photosynthesis Res Unit, Urbana, IL USA; [Drnevich, Jenny] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA	United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Williams, MM (corresponding author), USDA ARS, Global Change & Photosynthesis Res Unit, Urbana, IL USA.	martin.williams@ars.usda.gov		Williams, Martin/0000-0002-6302-7724				Allison JCS, 1997, ANN APPL BIOL, V131, P339, DOI [10.1111/j.1744-7348.1997.tb05160.x, 10.1111/j.1744-7348.1969.tb05474.x]; BAENZIGER PS, 1980, CROP SCI, V20, P444, DOI 10.2135/cropsci1980.0011183X002000040005x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco NE, 2011, PLANT J, V65, P922, DOI 10.1111/j.1365-313X.2010.04479.x; Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; Borras L, 2001, CROP SCI, V41, P1816, DOI 10.2135/cropsci2001.1816; BOYLE MG, 1991, CROP SCI, V31, P1246, DOI 10.2135/cropsci1991.0011183X003100050033x; BUNTING ES, 1973, J AGR SCI-CAMBRIDGE, V81, P455, DOI 10.1017/S0021859600086512; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Cox WJ, 1996, AGRON J, V88, P489, DOI 10.2134/agronj1996.00021962008800030022x; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Downs GS, 2013, PLANT PHYSIOL, V161, P1830, DOI 10.1104/pp.112.213231; Doyle SM, 2010, J EXP BOT, V61, P473, DOI 10.1093/jxb/erp320; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Duvick DN, 2005, MAYDICA, V50, P193; Duvick D.N., 1997, DEV DROUGHT LOW N TO, P332; DWYER LM, 1991, CAN J PLANT SCI, V71, P1, DOI 10.4141/cjps91-001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feild TS, 2001, PLANT PHYSIOL, V127, P566, DOI 10.1104/pp.010063; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; FRY SC, 1989, PHYSIOL PLANTARUM, V75, P532, DOI 10.1111/j.1399-3054.1989.tb05620.x; Fu JJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-63; Geilfus CM, 2010, PLANT PHYSIOL BIOCH, V48, P993, DOI 10.1016/j.plaphy.2010.09.011; Gopalakrishna R, 2001, BIOCHEM BIOPH RES CO, V284, P574, DOI 10.1006/bbrc.2001.4992; Gutzat R, 2012, CURR OPIN PLANT BIOL, V15, P568, DOI 10.1016/j.pbi.2012.08.007; Hanke GT, 2008, PHOTOCHEM PHOTOBIOL, V84, P1302, DOI 10.1111/j.1751-1097.2008.00411.x; Hashemi AM, 2005, AGRON J, V97, P839, DOI 10.2134/agronj2003.0241; HASLETT BG, 1973, BIOCHEM J, V136, P697, DOI 10.1042/bj1360697; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Holtgrefe S, 2003, PLANT PHYSIOL, V133, P1768, DOI 10.1104/pp.103.026013; Huebert DJ, 2012, MOL CELL BIOL, V32, P1645, DOI 10.1128/MCB.06170-11; Humbert S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-3; IREMIREN GO, 1980, EXP AGR, V16, P321, DOI 10.1017/S001447970001108X; Jan A, 2004, PLANT PHYSIOL, V136, P3670, DOI 10.1104/pp.104.052274; Kakkar RK, 2002, PHYSIOL PLANTARUM, V116, P281, DOI 10.1034/j.1399-3054.2002.1160302.x; KARLEN DL, 1985, AGRON J, V77, P393, DOI 10.2134/agronj1985.00021962007700030010x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar A, 1997, TRENDS PLANT SCI, V2, P124, DOI 10.1016/S1360-1385(97)01013-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; LI ZC, 1993, PLANTA, V191, P349, DOI 10.1007/BF00195692; Liu CT, 2014, PLANT MOL BIOL, V84, P19, DOI 10.1007/s11103-013-0115-3; Liu W, 2015, PLANT PHYSIOL, V168, P343, DOI 10.1104/pp.15.00030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansfield BD, 2014, CROP SCI, V54, P157, DOI 10.2135/cropsci2013.04.0252; MCCULLOUGH DE, 1994, CAN J PLANT SCI, V74, P479, DOI 10.4141/cjps94-088; MERTENS E, 1990, PLANT PHYSIOL, V93, P584, DOI 10.1104/pp.93.2.584; Muramoto T, 2002, PLANT PHYSIOL, V130, P1958, DOI 10.1104/pp.008128; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Neter J., 1996, APPL LINEAR STAT MOD; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Sawers RJH, 2005, TRENDS PLANT SCI, V10, P138, DOI 10.1016/j.tplants.2005.01.004; Scheibe R, 2012, PLANT CELL ENVIRON, V35, P202, DOI 10.1111/j.1365-3040.2011.02319.x; Schluter U, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-442; SCHRAUDNER M, 1992, PLANT PHYSIOL, V99, P1321, DOI 10.1104/pp.99.4.1321; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw R. H., 1977, World Meteorological Organization: Agrometeorology of the maize (corn) crop., P119; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Smith AM, 2008, PLANT J, V54, P546, DOI 10.1111/j.1365-313X.2008.03468.x; Smith KT, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001371; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sokol A, 2007, PLANTA, V227, P245, DOI 10.1007/s00425-007-0612-1; St Pierre S, 2011, PLANT GENOME-US, V4, P47, DOI 10.3835/plantgenome2010.08.0020; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tardieu F, 2003, TRENDS PLANT SCI, V8, P9, DOI 10.1016/S1360-1385(02)00008-0; Tardieu F, 2010, CURR OPIN PLANT BIOL, V13, P206, DOI 10.1016/j.pbi.2009.12.012; Tognetti VB, 2006, PLANT CELL, V18, P2035, DOI 10.1105/tpc.106.042424; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; Urano K, 2004, BIOCHEM BIOPH RES CO, V313, P369, DOI 10.1016/j.bbrc.2003.11.119; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Voss I, 2008, PHYSIOL PLANTARUM, V133, P584, DOI 10.1111/j.1399-3054.2008.01112.x; Walden R, 1997, PLANT PHYSIOL, V113, P1009, DOI 10.1104/pp.113.4.1009; Wang BQ, 2011, BIOCHEM BIOPH RES CO, V413, P10, DOI 10.1016/j.bbrc.2011.08.015; Weiste C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4883; Weston DJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-16; Williams MM, 2015, AGRON J, V107, P1782, DOI 10.2134/agronj15.0011; Williams MM, 2012, FIELD CROP RES, V128, P55, DOI 10.1016/j.fcr.2011.12.007; Xu P, 2014, J EXP BOT, V65, P4285, DOI 10.1093/jxb/eru202; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao MR, 2012, PLANT CELL REP, V31, P671, DOI 10.1007/s00299-011-1185-9	87	12	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147418	10.1371/journal.pone.0147418	http://dx.doi.org/10.1371/journal.pone.0147418			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796516	Green Submitted, gold, Green Published			2022-12-26	WOS:000368530300032
J	Rainone, V; Martelli, C; Ottobrini, L; Biasin, M; Borelli, M; Lucignani, G; Trabattoni, D; Clerici, M				Rainone, Veronica; Martelli, Cristina; Ottobrini, Luisa; Biasin, Mara; Borelli, Manuela; Lucignani, Giovanni; Trabattoni, Daria; Clerici, Mario			Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy	PLOS ONE			English	Article							IMMUNE-RESPONSES; EXPRESSION; MELANOMA; ANTIGENS; SUBSETS; CD4(+)	Introduction Dendritic cells play a key role as initiators of T-cell responses, and even if tumour antigen-loaded dendritic cells can induce anti-tumour responses, their efficacy has been questioned, suggesting a need to enhance immunization strategies. Matherials & Methods We focused on the characterization of bone marrow-derived dendritic cells pulsed with whole tumour lysate (TAA-DC), as a source of known and unknown antigens, in a mouse model of breast cancer (MMTV-Ras). Dendritic cells were evaluated for antigen uptake and for the expression of MHC class I/II and costimulatory molecules and markers associated with maturation. Results Results showed that antigen-loaded dendritic cells are characterized by a phenotypically semi-mature/mature profile and by the upregulation of genes involved in antigen presentation and T-cell priming. Activated dendritic cells stimulated T-cell proliferation and induced the production of high concentrations of IL-12p70 and IFN-gamma but only low levels of IL-10, indicating their ability to elicit a T(H)1-immune response. Furthermore, administration of Antigen loaded-Dendritic Cells in MMTV-Ras mice evoked a strong anti-tumour response in vivo as demonstrated by a general activation of immunocompetent cells and the release of T(H)1 cytokines. Conclusion Data herein could be useful in the design of antitumoral DC-based therapies, showing a specific activation of immune system against breast cancer.	[Rainone, Veronica; Biasin, Mara; Borelli, Manuela; Trabattoni, Daria] Univ Milan, Chair Immunol, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Martelli, Cristina; Ottobrini, Luisa; Clerici, Mario] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Martelli, Cristina; Ottobrini, Luisa; Lucignani, Giovanni] Univ Milan, Ctr Mol & Cellular Imaging IMAGO, Milan, Italy; [Ottobrini, Luisa] Natl Res Council CNR, Inst Mol Bioimaging & Physiol IBFM, Milan, Italy; [Lucignani, Giovanni] Univ Milan, Dept Hlth Sci, Milan, Italy; [Lucignani, Giovanni] San Paolo Hosp, Nucl Med Unit, Dept Diagnost Serv, Milan, Italy; [Clerici, Mario] Don C Gnocchi Fdn IRCCS, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Milan; San Paolo-Polo Universitaria Hospital; IRCCS Fondazione Don Carlo Gnocchi Onlus	Clerici, M (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.; Clerici, M (corresponding author), Don C Gnocchi Fdn IRCCS, Milan, Italy.	mario.clerici@unimi.it	Trabattoni, Daria/G-7424-2012; Lucignani, Giovanni/C-6773-2008; Ottobrini, Luisa/K-7608-2016; Martelli, Cristina/P-4426-2017; biasin, mara/G-7426-2012	Trabattoni, Daria/0000-0001-9535-3359; Lucignani, Giovanni/0000-0002-9674-8958; Ottobrini, Luisa/0000-0002-5002-6845; Martelli, Cristina/0000-0003-0023-9110; biasin, mara/0000-0003-3671-4235	PRIN (Progetti di Rilevante Interesse Nazionale, Health Ministry) [20082NHWH9_001]; AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG-9311]; Italian program PRIN [20082NHWH9_001]	PRIN (Progetti di Rilevante Interesse Nazionale, Health Ministry)(Ministry of Education, Universities and Research (MIUR)); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Italian program PRIN	This work was supported by PRIN 2008 (Progetti di Rilevante Interesse Nazionale, Health Ministry, project no. 20082NHWH9_001) received by MC and AIRC (Associazione Italiana per la Ricerca sul Cancro; funded project no IG-9311) received by MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by the Italian program PRIN 2008 (project no. 20082NHWH9_001) and by AIRC (Associazione Italiana per la Ricerca sul Cancro) funded project no IG-9311. All the authors have read the manuscript and approve the final version herein attached.	Aerts-Toegaert C, 2007, EUR J IMMUNOL, V37, P686, DOI 10.1002/eji.200636535; Ahmad M, 2004, CANCER IMMUNOL IMMUN, V53, P844, DOI 10.1007/s00262-004-0540-x; Bai L, 2002, INT J ONCOL, V20, P247; Baker K, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00664, 10.3389/fimmu.2014.00408]; Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; Caux C, 2002, TRANSPLANTATION, V73, pS7, DOI 10.1097/00007890-200201151-00005; Chiang CLL, 2010, SEMIN IMMUNOL, V22, P132, DOI 10.1016/j.smim.2010.02.004; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; De Vries IJ, 2008, CANCER RES, V63, P12; de Vries IJM, 2003, CLIN CANCER RES, V9, P5091; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Fulda S, 2002, ONCOGENE, V21, P2295, DOI 10.1038/sj.onc.1205255; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Gooch JL, 2000, CELL GROWTH DIFFER, V11, P335; Gunn MD, 2003, SEMIN IMMUNOL, V15, P271, DOI 10.1016/j.smim.2003.08.004; Hart JP, 2004, J IMMUNOL, V172, P70, DOI 10.4049/jimmunol.172.1.70; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Mackensen A, 2000, INT J CANCER, V86, P385, DOI 10.1002/(SICI)1097-0215(20000501)86:3<385::AID-IJC13>3.0.CO;2-T; Malumbres M, 2003, NAT REV CANCER, V3, P708, DOI 10.1038/nrc1193; Martelli C, 2012, MOL IMAGING BIOL, V14, P183, DOI 10.1007/s11307-011-0496-0; Melero I, 2000, GENE THER, V7, P1167, DOI 10.1038/sj.gt.3301234; Mocellin S, 2005, J LEUKOCYTE BIOL, V78, P1043, DOI 10.1189/jlb.0705358; Mocellin S, 2001, J IMMUNOTHER, V24, P392, DOI 10.1097/00002371-200109000-00002; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Neller MA, 2008, SEMIN IMMUNOL, V20, P286, DOI 10.1016/j.smim.2008.09.006; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Ridolfi Ruggero, 2004, J Transl Med, V2, P27; Saito K, 2005, EXP CELL RES, V310, P229, DOI 10.1016/j.yexcr.2005.07.014; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satthaporn S, 2001, J ROY COLL SURG EDIN, V46, P9; Shumway NM, 2009, BIODRUGS, V23, P277, DOI 10.2165/11313490-000000000-00000; Sogn JA, 1998, IMMUNITY, V9, P757, DOI 10.1016/S1074-7613(00)80641-X; Srivastava Pramod K, 2005, Curr Oncol Rep, V7, P104, DOI 10.1007/s11912-005-0035-8; Zanetti M, 2003, ANN NY ACAD SCI, V987, P249, DOI 10.1111/j.1749-6632.2003.tb06056.x; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhang XS, 2005, J IMMUNOL, V175, P2931, DOI 10.4049/jimmunol.175.5.2931	43	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146622	10.1371/journal.pone.0146622	http://dx.doi.org/10.1371/journal.pone.0146622			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795765	Green Published, gold, Green Submitted			2022-12-26	WOS:000368530300009
J	Aerts, L; Craessaerts, K; De Strooper, B; Morais, VA				Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.			In Vitro Comparison of the Activity Requirements and Substrate Specificity of Human and Triboleum castaneum PINK1 Orthologues	PLOS ONE			English	Article							PARKINSONS-DISEASE; CATALYTIC-ACTIVITY; INSULIN-RECEPTOR; PHOSPHORYLATION; MUTATIONS; PROTEIN; UBIQUITIN; ACTIVATION	Mutations in the gene encoding the mitochondrial kinase PINK1 cause early-onset familial Parkinson's disease. To understand the biological function of PINK1 and its role in the pathogenesis of Parkinson's disease, it is useful to study its kinase activity towards substrates both in vivo and in vitro. For in vitro kinase assays, a purified Triboleum castaneum PINK1 insect orthologue is often employed, because it displays higher levels of activity when compared to human PINK1. We show, however, that the activity requirements, and more importantly the substrate specificity, differ between both orthologues. While Triboleum castaneum PINK1 readily phosphorylates the PINKtide peptide and Histone H1 in vitro, neither of these non-physiological substrates is phosphorylated by human PINK1. Nonetheless, both Tc and human PINK1 phosphorylate Parkin and Ubiquitin, two physiological substrates of PINK1. Our results show that the substrate selectivity differs among PINK1 orthologues, an important consideration that should be taken into account when extrapolating findings back to human PINK1.	[Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Flemish Inst Biotechnol VIB, Ctr Biol Dis, Leuven, Belgium; [Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Katholieke Univ Leuven, Ctr Human Genet, Leuven Inst Neurodegenerat Disorders, Leuven, Belgium; [Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Katholieke Univ Leuven, Univ Hosp Leuven, Leuven, Belgium; [De Strooper, Bart] UCL, Inst Neurol, London, England; [Morais, Vanessa A.] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; University of London; University College London; Universidade de Lisboa	De Strooper, B; Morais, VA (corresponding author), Flemish Inst Biotechnol VIB, Ctr Biol Dis, Leuven, Belgium.; De Strooper, B; Morais, VA (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Leuven Inst Neurodegenerat Disorders, Leuven, Belgium.; De Strooper, B; Morais, VA (corresponding author), Katholieke Univ Leuven, Univ Hosp Leuven, Leuven, Belgium.; De Strooper, B (corresponding author), UCL, Inst Neurol, London, England.; Morais, VA (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	Bart.DeStrooper@cme.vib-kuleuven.be; vmorais@medicina.ulisboa.pt	de+Strooper, Bart/Z-1638-2019; Aerts, Liesbeth/J-7946-2015	Aerts, Liesbeth/0000-0002-7981-8176; Morais, Vanessa/0000-0002-0830-0548	Flemish agency for Innovation by Science and Technology (IWT); Fund for Scientific Research Flanders (FWO); Hercules Foundation; Federal Office for Scientific Affairs [IAP P7/16]; VIB; IWT doctoral grant; Fundacao para a Ciencia e a Tecnologia (FCT) [IF/01693/2014]; Alzheimer's disease research program at Janssen Pharmaceutica; Alzheimer's disease research program at Envivo; Alzheimer's disease research program at Remynd NV; Methusalem grant of the Flemish Government; research fund KU Leuven	Flemish agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research Flanders (FWO)(FWO); Hercules Foundation; Federal Office for Scientific Affairs; VIB; IWT doctoral grant; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Alzheimer's disease research program at Janssen Pharmaceutica; Alzheimer's disease research program at Envivo; Alzheimer's disease research program at Remynd NV; Methusalem grant of the Flemish Government; research fund KU Leuven(KU Leuven)	This work was supported by the Flemish agency for Innovation by Science and Technology (IWT), the Fund for Scientific Research Flanders (FWO), research fund KU Leuven, the Hercules Foundation, the Federal Office for Scientific Affairs (IAP P7/16), a Methusalem grant of the Flemish Government, and VIB. LA is supported by an IWT doctoral grant. BDS is the Arthur Bax and Anna Vanluffelen chair for Alzheimer's disease. VAM is supported by the Fundacao para a Ciencia e a Tecnologia (FCT) for the FCT Investigator Grant (IF/01693/2014). BDS is a paid consultant for the Alzheimer's disease research programs at Janssen Pharmaceutica, Envivo, and Remynd NV. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Flemish agency for Innovation by Science and Technology (IWT), the Fund for Scientific Research Flanders (FWO), research fund KU Leuven, the Hercules Foundation, the Federal Office for Scientific Affairs (IAP P7/16), a Methusalem grant of the Flemish Government, and VIB. LA is supported by an IWT doctoral grant. BDS is the Arthur Bax and Anna Vanluffelen chair for Alzheimer's disease. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts L, 2015, BIOCHEM SOC T, V43, P280, DOI 10.1042/BST20150002; Aerts L, 2015, J BIOL CHEM, V290, P2798, DOI 10.1074/jbc.M114.620906; Arena G, 2013, CELL DEATH DIFFER, V20, P920, DOI 10.1038/cdd.2013.19; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; BONISCHNETZLER M, 1986, J BIOL CHEM, V261, P5281; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; MASSAGUE J, 1982, J BIOL CHEM, V257, P6729; Matenia D, 2012, J BIOL CHEM, V287, P8174, DOI 10.1074/jbc.M111.262287; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Sim CH, 2012, HUM MUTAT, V33, P1408, DOI 10.1002/humu.22127; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012	29	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146083	10.1371/journal.pone.0146083	http://dx.doi.org/10.1371/journal.pone.0146083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784449	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400023
J	McCullough, SJ; O'Donoghue, L; Saunders, KJ				McCullough, Sara J.; O'Donoghue, Lisa; Saunders, Kathryn J.			Six Year Refractive Change among White Children and Young Adults: Evidence for Significant Increase in Myopia among White UK Children	PLOS ONE			English	Article							SCHOOL-CHILDREN; CLINICAL-EVALUATION; ACCOMMODATIVE LAG; PARENTAL HISTORY; OCULAR BIOMETRY; RISK-FACTORS; ERROR; PREVALENCE; CHILDHOOD; SCHOOLCHILDREN	Objective To determine six-year spherical refractive error change among white children and young adults in the UK and evaluate differences in refractive profiles between contemporary Australian children and historical UK data. Design Population-based prospective study. Participants The Northern Ireland Childhood Errors of Refraction (NICER) study Phase 1 examined 1068 children in two cohorts aged 6-7 years and 12-13 years. Prospective data for six-year follow-up (Phase 3) are available for 212 12-13 year olds and 226 18-20 year olds in each cohort respectively. Methods Cycloplegic refractive error was determined using binocular open-field autorefraction (Shin-Nippon NVision-K 5001, cyclopentolate 1%). Participants were defined by spherical equivalent refraction (SER) as myopic SER <=-0.50D, emmetropic -0.50D< SER<+ 2.00 or hyperopic SER >=+ 2.00D. Main Outcome Measures Proportion and incidence of myopia. Results The proportion of myopes significantly increased between 6-7 years (1.9%) and 12-13 years (14.6%) (p<0.001) but not between 12-13 and 18-20 years (16.4% to 18.6%, p = 0.51). The estimated annual incidence of myopia was 2.2% and 0.7% for the younger and older cohorts respectively. There were significantly more myopic children in the UK at age 12-13 years in the NICER study (16.4%) than reported in Australia (4.4%) (p<0.001). However by 17 years the proportion of myopia neared equivalence in the two populations (NICER 18.6%, Australia 17.7%, p = 0.75). The proportion of myopic children aged 12-13 years in the present study (2006-2008) was 16.4%, significantly greater than that reported for children aged 10-16 years in the 1960' s (7.2%, p = 0.01). The proportion of hyperopes in the younger NICER cohort decreased significantly over the six year period (from 21.7% to 14.2%, p = 0.04). Hyperopes with SER >=+ 3.50D in both NICER age cohorts demonstrated persistent hyperopia. Conclusions The incidence and proportion of myopia are relatively low in this contemporary white UK population in comparison to other worldwide studies. The proportion of myopes in the UK has more than doubled over the last 50 years in children aged between 10-16 years and children are becoming myopic at a younger age. Differences between the proportion of myopes in the UK and in Australia apparent at 12-13 years were eliminated by 17 years of age.	[McCullough, Sara J.; O'Donoghue, Lisa; Saunders, Kathryn J.] Univ Ulster, Sch Biomed Sci, Biomed Sci Res Inst, Cromore Rd, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University	McCullough, SJ (corresponding author), Univ Ulster, Sch Biomed Sci, Biomed Sci Res Inst, Cromore Rd, Coleraine BT52 1SA, Londonderry, North Ireland.	sj.mccullough@ulster.ac.uk	Saunders, Kathryn/C-2328-2013	Saunders, Kathryn/0000-0002-9289-5731; McCullough, Sara/0000-0002-4438-1154	College of Optometrists, London, UK; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005803] Funding Source: NIH RePORTER	College of Optometrists, London, UK; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by The College of Optometrists, London, UK Grant name: The Northern Ireland Childhood Errors of Refraction Study - Phase 3 Refractive development in childhood and early adulthood. http://www.college-optometrists.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2010, GEOGR DISTR POP; Breslin KMM, 2013, INVEST OPHTH VIS SCI, V54, P4843, DOI 10.1167/iovs.13-11813; Candy TR, 2012, INVEST OPHTH VIS SCI, V53, P143, DOI 10.1167/iovs.11-8174; Castagno VD, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-163; Czepita Damian, 2008, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V54, P17; Davies LN, 2003, OPTOMETRY VISION SCI, V80, P320, DOI 10.1097/00006324-200304000-00011; DOBSON V, 1989, INVEST OPHTH VIS SCI, V30, P1146; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; French AN, 2013, OPHTHALMOLOGY, V120, P1482, DOI 10.1016/j.ophtha.2012.12.018; French AN, 2013, OPHTHAL PHYSL OPT, V33, P318, DOI 10.1111/opo.12045; French AN, 2012, INVEST OPHTH VIS SCI, V53, P4021, DOI 10.1167/iovs.12-9556; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Horwood AM, 2011, BRIT J OPHTHALMOL, V95, P231, DOI 10.1136/bjo.2009.177378; INGRAM RM, 1979, BRIT J OPHTHALMOL, V63, P339, DOI 10.1136/bjo.63.5.339; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Jones LA, 2005, INVEST OPHTH VIS SCI, V46, P2317, DOI 10.1167/iovs.04-0945; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2010, INVEST OPHTH VIS SCI, V51, P115, DOI 10.1167/iovs.08-3210; Kulp MT, 2012, AM J OPHTHALMOL, V154, P297, DOI 10.1016/j.ajo.2012.02.035; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Logan NS, 2011, OPHTHAL PHYSL OPT, V31, P550, DOI 10.1111/j.1475-1313.2011.00862.x; Mallen EAH, 2015, OPHTHAL PHYSL OPT, V35, P622, DOI 10.1111/opo.12254; McCullough SJ, 2014, OPHTHAL PHYSL OPT, V34, P685; Mcknight CM, 2014, AM J OPHTHALMOL, V158, P1079, DOI 10.1016/j.ajo.2014.07.033; Mezer E, 2015, GRAEF ARCH CLIN EXP, V253, P1013, DOI 10.1007/s00417-015-3033-z; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P324; Mutti DO, 2009, OPTOMETRY VISION SCI, V86, P666, DOI 10.1097/OPX.0b013e3181a6174f; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; Northern Ireland Statistics and Research Agency, 2013, POP MIGR EST NO STAT; Northern Ireland Statistics and Research Agency, 2011, CENS 2011 KEY STAT N; O'Donoghue L, 2010, BRIT J OPHTHALMOL, V94, P1150, DOI 10.1136/bjo.2009.167965; O'Donoghue L, 2010, BRIT J OPHTHALMOL, V94, P1155, DOI 10.1136/bjo.2009.176040; O'Donoghue L, 2015, INVEST OPHTH VIS SCI, V56, P1524, DOI 10.1167/iovs.14-15549; Ojaimi E, 2005, OPHTHAL EPIDEMIOL, V12, P59, DOI 10.1080/09286580490921296; PARSSINEN O, 1993, INVEST OPHTH VIS SCI, V34, P2794; Pennie FC, 2001, VISION RES, V41, P2799, DOI 10.1016/S0042-6989(01)00169-9; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2005, INVEST OPHTH VIS SCI, V46, P51, DOI 10.1167/iovs.04-0565; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Sleszynski P, 2014, GEOGR POL, V87, P61, DOI 10.7163/GPol.2014.4; SORSBY A, 1961, Memo Med Res Counc, V301(Special), P1; Tang WC, 2014, OPHTHAL PHYSL OPT, V34, P89, DOI 10.1111/opo.12098; Tarczy-Hornoch K, 2012, J AAPOS, V16, P112, DOI 10.1016/j.jaapos.2011.10.015; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI DOI 10.1001/ARCH0PHTHALM0L.2009.303; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700; Williams KM, 2015, OPHTHALMOLOGY, V122, P1489, DOI 10.1016/j.ophtha.2015.03.018; Zadnik K, 1999, INVEST OPHTH VIS SCI, V40, P1936; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	49	54	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146332	10.1371/journal.pone.0146332	http://dx.doi.org/10.1371/journal.pone.0146332			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783753	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400031
J	Yang, N; Moermond, TC; Lloyd, H; Xu, Y; Dou, L; Zhang, K; Yue, BS; Ran, JH				Yang, Nan; Moermond, Timothy C.; Lloyd, Huw; Xu, Yu; Dou, Liang; Zhang, Kai; Yue, Bisong; Ran, Jianghong			Effects of Supplementary Feeding on the Breeding Ecology of the Buff-Throated Partridge in a Tibetan Sacred Site, China	PLOS ONE			English	Article							AVES GALLIFORMES PHASIANIDAE; FLORIDA SCRUB-JAYS; FOOD SUPPLEMENTATION; TETRAOPHASIS-SZECHENYII; REPRODUCTIVE SUCCESS; SEASONAL DECLINE; BODY CONDITION; TIME; POPULATION; SURVIVAL	Our goal was to document effects of year-round supplemental feeding on breeding ecology of the Buff-throated Partridge, Tetraophasis szechenyii, within a Tibetan sacred site. We evaluated effects of supplemental feeding used as religious/cultural practices which could potentially aid conservation of endangered phasianids. We compared fed breeding groups to neighboring nonfed groups. Fed groups initiated first clutches significantly earlier than nonfed groups. Earlier laying groups within fed and nonfed groups showed significantly lower hatching rates than later groups; however, fed groups showed significantly higher hatching rates than nonfed groups laying in the same period. Earlier laying increased opportunities to renest. All six fed groups with clutch failures renested compared to only one of five nonfed groups with clutch failures. Fed female breeders showed significantly greater investment in their young with larger clutches and larger eggs, which likely increased survivability of early hatchlings. We observed no predation on birds at feeding sites and recorded only four cases of predation on incubating females, which showed no detectable difference between fed and nonfed groups. Ground-nesting birds typically face high risks of predation. Ten of the 48 groups nested in trees, which occurs in few phasianid species. Tree nests showed significantly higher hatching rates compared to ground nests; however, we found no significant difference in tree nesting between fed and nonfed groups. This partridge is one of four gallinaceous species with cooperative breeding. Breeding groups with helpers had significantly greater reproductive success than single pairs, and fed female breeders with helpers laid bigger eggs than single pairs. Comparing annual reproductive output per group, fed groups not only produced significantly more independent young (>= 150 days post-hatching), their young hatched significantly earlier, which likely have greater reproductive value over later hatched young of nonfed groups. Supplemental feeding year-round is likely what enabled the successes of the fed partridges.	[Yang, Nan; Moermond, Timothy C.; Xu, Yu; Dou, Liang; Zhang, Kai; Yue, Bisong; Ran, Jianghong] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China; [Lloyd, Huw] Manchester Metropolitan Univ, Div Biol & Conservat Ecol, Sch Sci & Environm, Chester St, Manchester M15 6BH, Lancs, England	Sichuan University; Manchester Metropolitan University	Ran, JH (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China.	rjhong-01@163.com		Yue, Bisong/0000-0001-6731-538X; Xu, Yu/0000-0002-9437-3267	National Natural Sciences Foundation of China [31172105]; Rufford Small Grant Foundation (UK)	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Rufford Small Grant Foundation (UK)	This study was funded by the National Natural Sciences Foundation of China (No. 31172105, http://www.nsfc.gov.cn) to JR. Nan Yang was supported in part by the Rufford Small Grant Foundation (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Will Stein for useful comments, Zhang Man for her help in remaking Fig 1, Beibei Du and Wen Lin for office work, and Pinjia Que and Pengfei Yu for their help in the field work. We thank Richard Van Koningsveld for his valuable advice and generous assistance with application of new statistical analyses. This study was funded by the National Natural Sciences Foundation of China (No. 31172105, http://www.nsfc.gov.cn) to JR. Nan Yang was supported in part by the Rufford Small Grant Foundation (UK).	Anderson DM, 2005, BIODIVERS CONSERV, V14, P3065, DOI 10.1007/s10531-004-0316-9; Aparicio JM, 2002, ECOLOGY, V83, P873, DOI 10.1890/0012-9658(2002)083[0873:EOFSAH]2.0.CO;2; ARCESE P, 1985, J ANIM ECOL, V54, P817, DOI 10.2307/4380; ARCESE P, 1988, J ANIM ECOL, V57, P119, DOI 10.2307/4768; Beauchamp G, 1999, BEHAV ECOL, V10, P675, DOI 10.1093/beheco/10.6.675; Bortolotti GR, 2009, AUK, V126, P831, DOI 10.1525/auk.2009.08197; Bourgault P, 2009, J FIELD ORNITHOL, V80, P127, DOI 10.1111/j.1557-9263.2009.00214.x; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; BRITTINGHAM MC, 1988, ECOLOGY, V69, P581, DOI 10.2307/1941007; Cant MA, 2005, BEHAV ECOL, V16, P708, DOI 10.1093/beheco/ari051; Castro I, 2003, BIOL CONSERV, V114, P271, DOI 10.1016/S0006-3207(03)00046-6; Clout MN, 2002, BIOL CONSERV, V107, P13, DOI 10.1016/S0006-3207(01)00267-1; Daan S., 1988, P392; De Neve L, 2004, J AVIAN BIOL, V35, P246, DOI 10.1111/j.0908-8857.2004.03162.x; De Neve L, 2002, ANIM BEHAV, V63, P975, DOI 10.1006/anbe.2001.1989; Deng WH, 2005, ORYX, V39, P158, DOI 10.1017/S0030605305000396; DHINDSA MS, 1990, IBIS, V132, P595, DOI 10.1111/j.1474-919X.1990.tb00283.x; Dhondt AA, 1998, J WILDLIFE DIS, V34, P265, DOI 10.7589/0090-3558-34.2.265; Draycott RAH, 1998, J WILDLIFE MANAGE, V62, P557, DOI 10.2307/3802329; Du Plessis MA, 1998, ECOLOGY EVOLUTION CO, P117; Dunn E.H., 1999, BIRDS YOUR FEEDER GU; DUNN EH, 1994, J FIELD ORNITHOL, V65, P8; Ekman J, 2006, J AVIAN BIOL, V37, P289, DOI 10.1111/j.2006.0908-8857.03666.x; Fleischer AL, 2003, CONDOR, V105, P515, DOI 10.1650/7224; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; Hale AM, 2006, CONDOR, V108, P107, DOI 10.1650/0010-5422(2006)108[0107:GLITBW]2.0.CO;2; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; Heffner RA, 1996, ECOLOGY, V77, P2558, DOI 10.2307/2265754; HOCHACHKA W, 1990, ECOLOGY, V71, P1279, DOI 10.2307/1938265; HOGSTEDT G, 1981, J ANIM ECOL, V50, P219, DOI 10.2307/4041; Hoodless AN, 1999, J APPL ECOL, V36, P147, DOI 10.1046/j.1365-2664.1999.00388.x; JANSSON C, 1981, OIKOS, V37, P313, DOI 10.2307/3544122; Johnsgard Paul A, 1999, PHEASANTS WORLD BIOL; Kelly JF, 1997, ECOLOGY, V78, P2504; Klaus S, 2003, J ORNITHOL, V144, P197, DOI 10.1007/BF02465647; Ligon J. David, 2004, P5, DOI 10.1017/CBO9780511606816.002; Liu FW, 2014, ZOOL SCI, V31, P160, DOI 10.2108/zsj.31.160; Long CR, 2007, THESIS W VIRGINIA U; Lu TC, 2006, CHINA ENDEMIC BIRDS, P54; Lu X, 2005, ARDEA, V93, P17; Lu X, 2003, IBIS, V145, P657, DOI 10.1046/j.1474-919X.2003.00204.x; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; MAYFIELD HF, 1975, WILSON BULL, V87, P456; Meijer T, 1999, IBIS, V141, P399, DOI 10.1111/j.1474-919X.1999.tb04409.x; Meng Y, 2010, J NAT HIST, V44, P2955, DOI 10.1080/00222933.2010.502596; Miehe G, 2003, MT RES DEV, V23, P324, DOI 10.1659/0276-4741(2003)023[0324:SFIT]2.0.CO;2; Millan J, 2003, WILDLIFE BIOL, V9, P229, DOI 10.2981/wlb.2003.055; Murray BG, 2000, CONDOR, V102, P470, DOI 10.1650/0010-5422(2000)102[0470:MARSIB]2.0.CO;2; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Nan W. Y, 2001, NATL RES QINGHAI, V12, P23; Newton I., 1998, POPULATION LIMITATIO; NILSSON JA, 1994, J ANIM ECOL, V63, P200, DOI 10.2307/5595; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Nilsson JA, 2000, OIKOS, V88, P351, DOI 10.1034/j.1600-0706.2000.880214.x; Ridley AR, 2008, J AVIAN BIOL, V39, P389, DOI 10.1111/j.2008.0908-8857.04479.x; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; ROBB LA, 1992, J ANIM ECOL, V61, P215, DOI 10.2307/5524; ROWE L, 1994, AM NAT, V143, P698, DOI 10.1086/285627; Salick J, 2007, BIODIVERS CONSERV, V16, P693, DOI 10.1007/s10531-005-4381-5; Schoech SJ, 2003, AUK, V120, P1114, DOI 10.1642/0004-8038(2003)120[1114:DDATPI]2.0.CO;2; Schoech SJ, 2007, J ORNITHOL, V148, pS625, DOI 10.1007/s10336-007-0177-6; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Shen XL, 2008, THESIS PEKING U; Shen Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095786, 10.1371/journal.pone.0087894]; SVENSSON E, 1995, ECOLOGY, V76, P1804, DOI 10.2307/1940712; Svensson E, 1997, EVOLUTION, V51, P1276, DOI 10.1111/j.1558-5646.1997.tb03974.x; Townsend DE, 1999, WILDLIFE SOC B, V27, P1074; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; VONBROMSSEN A, 1980, ORNIS SCAND, V11, P173, DOI 10.2307/3676121; Wang S., 2004, CHINA SPECIES RED LI; Wright J, 2001, P ROY SOC B-BIOL SCI, V268, P821, DOI 10.1098/rspb.2000.1574; Xu Y, 2013, ETHOL ECOL EVOL, V25, P289, DOI 10.1080/03949370.2013.800161; Xu Y, 2011, J ORNITHOL, V152, P695, DOI 10.1007/s10336-011-0651-z; Xu Y, 2010, ZOOL STUD, V49, P461; Xu Y, 2008, ORNIS FENNICA, V85, P126; Yang N, 2011, ARDEA, V99, P199, DOI 10.5253/078.099.0210; Yang Nan, 2009, Chinese Journal of Zoology, V44, P48; Yu PF, 2010, SICHUAN J ZOOL, V30, P74; Zeng LJ, 2014, THESIS U CALIFORNIA; Zhang Baiping, 2002, Journal of Geographical Sciences, V12, P135; Zhang K, 2011, WILSON J ORNITHOL, V123, P93, DOI 10.1676/10-035.1; Zhang Zheng-Wang, 2003, Shengwu Duoyangxing, V11, P414; Zheng GM, 1998, CHINA RED DATA BOOK, P104	83	5	5	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146568	10.1371/journal.pone.0146568	http://dx.doi.org/10.1371/journal.pone.0146568			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784961	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400048
J	Kim, CS; Vanture, S; Cho, M; Klapperich, CM; Wang, C; Huang, FW				Kim, Chloe S.; Vanture, Sarah; Cho, Margaret; Klapperich, Catherine M.; Wang, Catharine; Huang, Franklin W.			Awareness, Interest, and Preferences of Primary Care Providers in Using Point-of-Care Cancer Screening Technology	PLOS ONE			English	Article							BREAST; PREVENTION; BARRIERS	Well-developed point-of-care (POC) cancer screening tools have the potential to provide better cancer care to patients in both developed and developing countries. However, new medical technology will not be adopted by medical providers unless it addresses a population's existing needs and end-users' preferences. The goals of our study were to assess primary care providers' level of awareness, interest, and preferences in using POC cancer screening technology in their practice and to provide guidelines to biomedical engineers for future POC technology development. A total of 350 primary care providers completed a one-time self-administered online survey, which took approximately 10 minutes to complete. A $50 Amazon gift card was given as an honorarium for the first 100 respondents to encourage participation. The description of POC cancer screening technology was provided in the beginning of the survey to ensure all participants had a basic understanding of what constitutes POC technology. More than half of the participants (57%) stated that they heard of the term "POC technology" for the first time when they took the survey. However, almost all of the participants (97%) stated they were either "very interested" (68%) or "some-what interested" (29%) in using POC cancer screening technology in their practice. Demographic characteristics such as the length of being in the practice of medicine, the percentage of patients on Medicaid, and the average number of patients per day were not shown to be associated with the level of interest in using POC. These data show that there is a great interest in POC cancer screening technology utilization among this population of primary care providers and vast room for future investigations to further understand the interest and preferences in using POC cancer technology in practice. Ensuring that the benefits of new technology outweigh the costs will maximize the likelihood it will be used by medical providers and patients.	[Kim, Chloe S.; Vanture, Sarah; Cho, Margaret; Klapperich, Catherine M.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Wang, Catharine] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA; [Huang, Franklin W.] Harvard Univ, Sch Med, Boston, MA USA; [Huang, Franklin W.] Dana Farber Canc Inst, Boston, MA 02115 USA	Boston University; Boston University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Klapperich, CM (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Huang, FW (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Huang, FW (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	catherin@bu.edu; Franklin_Huang@dfci.harvard.edu	Wang, Catharine/AHB-4212-2022	Wang, Catharine/0000-0001-8584-2781	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIBIB-NIH) [5-U54-EB015403]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB015403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES014562] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIBIB-NIH); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Research reported in this paper was supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIBIB-NIH) under the grant number: 5-U54-EB015403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Mangione for his helpful comments during the survey design phase. Research reported in this paper was supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIBIB-NIH) under the grant number: 5-U54-EB015403.	Arvey SR, 2012, HEALTH EDUC BEHAV, V39, P352, DOI 10.1177/1090198111418110; Bender JL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2661; Chan CPY, 2013, ANNU REV ANAL CHEM, V6, P191, DOI 10.1146/annurev-anchem-062012-092641; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; Garrett Paula, 2006, Perspect Health Inf Manag, V3, P9; Long SY, 2013, ARCH GYNECOL OBSTET, V288, P113, DOI 10.1007/s00404-012-2697-4; Louie RF, 2000, LAB MED, V31, P402, DOI 10.1309/0Y5F-B7NP-5Y67-GW7T; Martin JL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-74; Matteucci E, 2011, MINI-REV MED CHEM, V11, P178, DOI 10.2174/138955711794519474; Meissner HI, 2012, AM J PREV MED, V43, P584, DOI 10.1016/j.amepre.2012.08.016; Obort Aniebietabasi S, 2013, Rev Urol, V15, P97; Panayi ND, 2013, FUTURE ONCOL, V9, P613, DOI [10.2217/FON.13.42, 10.2217/fon.13.42]; Philip EJ, 2010, CANCER CAUSE CONTROL, V21, P1685, DOI 10.1007/s10552-010-9597-3; Phillips M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090226; Price CP, 2001, BMJ-BRIT MED J, V322, P1285, DOI 10.1136/bmj.322.7297.1285; Roth RG, 2014, RADIOGRAPHICS, V34, pE89, DOI 10.1148/rg.344130087; Tejeda S, 2013, J WOMENS HEALTH, V22, P507, DOI 10.1089/jwh.2012.3590; Wallner Paul E, 2008, J Am Coll Radiol, V5, P1125, DOI 10.1016/j.jacr.2008.06.008; Wang SQ, 2011, LAB CHIP, V11, P3411, DOI 10.1039/c1lc20479c; Weinstein RS, 2014, AM J MED, P127; Wiwanitkit V, 2011, OTOLARYNG HEAD NECK, V145, P880, DOI 10.1177/0194599811420804	21	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0145215	10.1371/journal.pone.0145215	http://dx.doi.org/10.1371/journal.pone.0145215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771309	gold, Green Published			2022-12-26	WOS:000368628300005
J	Gillmaier, N; Schunder, E; Kutzner, E; Tlapak, H; Rydzewski, K; Herrmann, V; Stammler, M; Lasch, P; Eisenreich, W; Heuner, K				Gillmaier, Nadine; Schunder, Eva; Kutzner, Erika; Tlapak, Hana; Rydzewski, Kerstin; Herrmann, Vroni; Staemmler, Maren; Lasch, Peter; Eisenreich, Wolfgang; Heuner, Klaus			Growth-related Metabolism of the Carbon Storage Poly-3-hydroxybutyrate in Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; isotopic tracer; lipid metabolism; metabolism; pathogenesis; Legionella; polyhydroxybutyrate	AMINO-ACID-REQUIREMENTS; BACTERIAL POLYHYDROXYALKANOATES; INTRACELLULAR GROWTH; LIQUID-MEDIUM; VIRULENCE; REPLICATION; EXPRESSION; DIFFERENTIATION; BIOSYNTHESIS; MACROPHAGES	Legionella pneumophila, the causative agent of Legionnaires disease, has a biphasic life cycle with a switch from a replicative to a transmissive phenotype. During the replicative phase, the bacteria grow within host cells in Legionella-containing vacuoles. During the transmissive phenotype and the postexponential (PE) growth phase, the pathogens express virulence factors, become flagellated, and leave the Legionella-containing vacuoles. Using C-13 labeling experiments, we now show that, under in vitro conditions, serine is mainly metabolized during the replicative phase for the biosynthesis of some amino acids and for energy generation. During the PE phase, these carbon fluxes are reduced, and glucose also serves as an additional carbon substrate to feed the biosynthesis of poly-3-hydroxybuyrate (PHB), an essential carbon source for transmissive L. pneumophila. Whole-cell FTIR analysis and comparative isotopologue profiling further reveal that a putative 3-ketothiolase (Lpp1788) and a PHB polymerase (Lpp0650), but not enzymes of the crotonyl-CoA pathway (Lpp0931-0933) are involved in PHB metabolism during the PE phase. However, the data also reflect that additional bypassing reactions for PHB synthesis exist in agreement with in vivo competition assays using Acanthamoeba castellannii or human macrophage-like U937 cells as host cells. The data suggest that substrate usage and PHB metabolism are coordinated during the life cycle of the pathogen.	[Gillmaier, Nadine; Kutzner, Erika; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, Lichtenbergstr 4, D-85747 Garching, Germany; [Schunder, Eva; Tlapak, Hana; Rydzewski, Kerstin; Herrmann, Vroni; Heuner, Klaus] Robert Koch Inst, Working Grp Cellular Interact Bacterial Pathogens, ZBS 2,Seestr 10, D-13353 Berlin, Germany; [Staemmler, Maren; Lasch, Peter] Robert Koch Inst, Prote & Spect ZBS 6, Nordufer 20, D-13353 Berlin, Germany	Technical University of Munich; Robert Koch Institute; Robert Koch Institute	Eisenreich, W (corresponding author), Tech Univ Munich, Lehrstuhl Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.; Heuner, K (corresponding author), Robert Koch Inst, Working Grp Cellular Interact Bacterial Pathogens, ZBS 2,Seestr 10, D-13353 Berlin, Germany.	wolfgang.eisenreich@ch.tum.de; heunerk@rki.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Lasch, Peter/0000-0001-6193-3144	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany [EI 384/4-2, HE 2845/6-1, SPP 1316]; Robert Koch Institute, Berlin, Germany	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany(German Research Foundation (DFG)); Robert Koch Institute, Berlin, Germany	This work was supported by Grants EI 384/4-2 and HE 2845/6-1 from the Deutsche Forschungsgemeinschaft DFG SPP 1316, Bonn, Germany (to W. E. and K. H., respectively) and the Robert Koch Institute, Berlin, Germany. The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSON AJ, 1990, INT J BIOL MACROMOL, V12, P102, DOI 10.1016/0141-8130(90)90060-N; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Aurass P, 2009, APPL ENVIRON MICROB, V75, P4506, DOI 10.1128/AEM.00187-09; Ayub ND, 2006, FEMS MICROBIOL LETT, V264, P125, DOI 10.1111/j.1574-6968.2006.00446.x; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Brzuszkiewicz E, 2013, INT J MED MICROBIOL, V303, P514, DOI 10.1016/j.ijmm.2013.07.003; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Edwards RL, 2009, MOL MICROBIOL, V71, P1190, DOI [10.1111/j.1365-2958.2009.06593.x, 10.1111/j.1365-2958.2008.06593.x]; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Fonseca MV, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00012; Fonseca Maris V., 2008, P213; Garduno RA, 2002, INFECT IMMUN, V70, P6273, DOI 10.1128/IAI.70.11.6273-6283.2002; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Harada E, 2010, J BACTERIOL, V192, P2892, DOI 10.1128/JB.01535-09; Hayashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011718; Herrmann V, 2011, INT J MED MICROBIOL, V301, P133, DOI 10.1016/j.ijmm.2010.08.016; HEUNER K, 1995, INFECT IMMUN, V63, P2499, DOI 10.1128/IAI.63.7.2499-2507.1995; Heuner K, 1999, FEMS MICROBIOL LETT, V175, P69, DOI 10.1016/S0378-1097(99)00160-3; Heuner K., 2016, HOST PATHOGEN INTERA; Hoffman PS, 2008, INFEC AGENT, P113; James BW, 1999, APPL ENVIRON MICROB, V65, P822; Kadouri D, 2005, CRIT REV MICROBIOL, V31, P55, DOI 10.1080/10408410590899228; KEEN MG, 1984, CURR MICROBIOL, V11, P81, DOI 10.1007/BF01567708; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lautner M, 2013, J BACTERIOL, V195, P1583, DOI 10.1128/JB.01739-12; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; MAUCHLINE WS, 1992, J GEN MICROBIOL, V138, P2371, DOI 10.1099/00221287-138-11-2371; Molmeret M, 2010, ENVIRON MICROBIOL, V12, P704, DOI 10.1111/j.1462-2920.2009.02114.x; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Naumann D., 2008, P SPIE, V6853; O'Shaughnessy JB, 2003, BIOTECHNIQUES, V35, P112; OLDHAM LJ, 1985, J GEN MICROBIOL, V131, P697; PINE L, 1979, J CLIN MICROBIOL, V9, P615; Poirier Y, 2002, PROG LIPID RES, V41, P131, DOI 10.1016/S0163-7827(01)00018-2; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; REEVES MW, 1981, J CLIN MICROBIOL, V13, P688, DOI 10.1128/JCM.13.4.688-695.1981; Reich-Slotky R, 2009, J BACTERIOL, V191, P5262, DOI 10.1128/JB.00175-09; RISTROPH JD, 1981, J CLIN MICROBIOL, V13, P115, DOI 10.1128/JCM.13.1.115-119.1981; RISTROPH JD, 1980, J CLIN MICROBIOL, V11, P19, DOI 10.1128/JCM.11.1.19-21.1980; Robertson P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00670; ROWBOTHAM TJ, 1986, ISRAEL J MED SCI, V22, P678; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sauer JD, 2005, P NATL ACAD SCI USA, V102, P9924, DOI 10.1073/pnas.0502767102; Schulz T, 2012, ARCH MICROBIOL, V194, P977, DOI 10.1007/s00203-012-0833-y; Schunder E, 2014, J BIOL CHEM, V289, P21040, DOI 10.1074/jbc.M114.570085; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; TESH MJ, 1981, J CLIN MICROBIOL, V13, P865, DOI 10.1128/JCM.13.5.865-869.1981; TESH MJ, 1983, J BACTERIOL, V154, P1104, DOI 10.1128/JB.154.3.1104-1109.1983; Thi NAN, 2007, ANAL BIOANAL CHEM, V387, P1769, DOI 10.1007/s00216-006-0829-z; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x	52	23	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6471	6482		10.1074/jbc.M115.693481	http://dx.doi.org/10.1074/jbc.M115.693481			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26792862	Green Published, hybrid			2022-12-26	WOS:000372894200034
J	Jiang, L; Wu, XH; He, F; Liu, Y; Hu, XQ; Takeda, S; Qing, Y				Jiang, Lei; Wu, Xiaohua; He, Fang; Liu, Ying; Hu, Xiaoqing; Takeda, Shunichi; Qing, Yong			Genetic Evidence for Genotoxic Effect of Entecavir, an Anti-Hepatitis B Virus Nucleotide Analog	PLOS ONE			English	Article							STRAND BREAK REPAIR; INDUCED DNA-DAMAGE; POSTREPLICATION REPAIR; HOMOLOGOUS RECOMBINATION; VERTEBRATE CELLS; DT40 CELLS; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL BREAKS; RAD51 PARALOGS; POLYMERASE	Nucleoside analogues (NAs) have been the most frequently used treatment option for chronic hepatitis B patients. However, they may have genotoxic potentials due to their interference with nucleic acid metabolism. Entecavir, a deoxyguanosine analog, is one of the most widely used oral antiviral NAs against hepatitis B virus. It has reported that entecavir gave positive responses in both genotoxicity and carcinogenicity assays. However the genotoxic mechanism of entecavir remains elusive. To evaluate the genotoxic mechanisms, we analyzed the effect of entecavir on a panel of chicken DT40 B -lymphocyte isogenic mutant cell line deficient in DNA repair and damage tolerance pathways. Our results showed that Parp1(-/-) mutant cells defective in single -strand break (SSB) repair were the most sensitive to entecavir. Ubc13(-/-) and translesion-DNA-synthesis deficient cells including Radl 8(-/-) and Rev3(-/-) were hypersensitive to entecavir. XPA(-/-) mutant deficient in nucleotide excision repair was also slightly sensitive to entecavir. y-H2AX foci forming assay confirmed the existence of DNA damage by entecavir in Parpr'-, Radl 8(-/-) and Brcal(-/-) mutants. Karyotype assay further showed entecavir-induced chromosomal aberrations, especially the chromosome gaps in Parp1(-/-), Brcar'-, Radl 8(-/-) and Rev3(-/-) cells when compared with wild -type cells. These genetic comprehensive studies clearly identified the genotoxic potentials of entecavir and suggested that SSB and postreplication repair pathways may suppress entecavir-induced genotoxicity.	[Jiang, Lei; Liu, Ying; Hu, Xiaoqing; Qing, Yong] Sichuan Univ, West China Sch Pharm, Dept Pharmacol, Chengdu 610041, Sichuan, Peoples R China; [Wu, Xiaohua] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Wu, Xiaohua] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Wu, Xiaohua] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Sichuan, Peoples R China; [He, Fang] Sichuan Univ, West China Hosp, Ctr Infect Dis, Div Mol Biol Infect Dis,State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Takeda, Shunichi] Kyoto Univ, Dept Radiat Genet, Grad Sch Med, Kyoto 6068501, Japan	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Kyoto University	Qing, Y (corresponding author), Sichuan Univ, West China Sch Pharm, Dept Pharmacol, Chengdu 610041, Sichuan, Peoples R China.	qingyongxy@yahoo.co.jp		Takeda, Shunichi/0000-0002-7924-7991	Science and Technology Support Program of Sichuan Province, China [2012SZ0147]; Administration of Traditional Chinese Medicine of Sichuan Province, China [12-3-340]	Science and Technology Support Program of Sichuan Province, China; Administration of Traditional Chinese Medicine of Sichuan Province, China	This work was supported by Science and Technology Support Program of Sichuan Province, China (No.2012SZ0147) and the Administration of Traditional Chinese Medicine of Sichuan Province, China (No.12-3-340). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2004, J BIOL CHEM, V279, P37343, DOI 10.1074/jbc.M313910200; [Anonymous], 1985, INT SYSTEM HUMAN CYT; Asaad AM, 2015, BRAZ J INFECT DIS, V19, P525, DOI 10.1016/j.bjid.2015.03.007; Brambilla G, 2012, MUTAGENESIS, V27, P387, DOI 10.1093/mutage/ger094; Bristol-Myers Squibb, BAR ENT US PRESCR IN; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Brown JA, 2012, CHEM RES TOXICOL, V25, P225, DOI 10.1021/tx200458s; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Caldecott KW, 2014, EXP CELL RES, V329, P2, DOI 10.1016/j.yexcr.2014.08.027; Caldecott KW, 2014, SCIENCE, V343, P260, DOI 10.1126/science.1248234; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Danoy P, 2007, BIOCHEM BIOPH RES CO, V352, P763, DOI 10.1016/j.bbrc.2006.11.083; Evans TJ, 2010, DNA REPAIR, V9, P1292, DOI 10.1016/j.dnarep.2010.09.017; Friedrich A, 2011, REGUL TOXICOL PHARM, V60, P225, DOI 10.1016/j.yrtph.2011.04.001; Fung J, 2014, J GASTROEN HEPATOL, V29, P428, DOI 10.1111/jgh.12499; Godon C, 2008, NUCLEIC ACIDS RES, V36, P4454, DOI 10.1093/nar/gkn403; Hatanaka A, 2005, MOL CELL BIOL, V25, P1124, DOI 10.1128/MCB.25.3.1124-1134.2005; Hochegger H, 2004, BIOESSAYS, V26, P151, DOI 10.1002/bies.10403; Hsiang YH, 1985, J BIOL CHEM, V260, P8; Hu J, 2012, ENVIRON SCI TECHNOL, V46, P4607, DOI 10.1021/es300020e; Innaimo SF, 1997, ANTIMICROB AGENTS CH, V41, P1444, DOI 10.1128/AAC.41.7.1444; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Martin P, 2015, CLIN GASTROENTEROL H, V13, P2071, DOI 10.1016/j.cgh.2015.07.007; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Matsuzaki Y, 2002, NUCLEIC ACIDS RES, V30, P3273, DOI 10.1093/nar/gkf440; Mazzucco CE, 2008, ANTIMICROB AGENTS CH, V52, P598, DOI 10.1128/AAC.01122-07; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Mizutani A, 2004, CANCER RES, V64, P3144, DOI 10.1158/0008-5472.CAN-03-3489; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000828; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Prasad R, 2012, NUCLEIC ACIDS RES, V40, P11571, DOI 10.1093/nar/gks898; Qing Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002148; Santantonio TA, 2014, WORLD J HEPATOL, V6, P284, DOI 10.4254/wjh.v6.i5.284; Seifer M, 1998, ANTIMICROB AGENTS CH, V42, P3200, DOI 10.1128/AAC.42.12.3200; Smirnova M, 2003, MUTAT RES-FUND MOL M, V532, P117, DOI 10.1016/j.mrfmmm.2003.08.026; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Talorete TPN, 2006, CYTOTECHNOLOGY, V52, P189, DOI 10.1007/s10616-007-9057-4; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Tian F, 2013, P NATL ACAD SCI USA, V110, P13558, DOI 10.1073/pnas.1306534110; Wu XH, 2006, CANCER RES, V66, P748, DOI 10.1158/0008-5472.CAN-05-2884; Yamamoto KN, 2011, ENVIRON MOL MUTAGEN, V52, P547, DOI 10.1002/em.20656; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039; Yang SW, 2015, J GASTROEN HEPATOL, V30, P1175, DOI 10.1111/jgh.12921; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	52	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147440	10.1371/journal.pone.0147440	http://dx.doi.org/10.1371/journal.pone.0147440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800464	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300109
J	Kinoshita, A; Locher, L; Tienken, R; Meyer, U; Danicke, S; Rehage, J; Huber, K				Kinoshita, Asako; Locher, Lena; Tienken, Reka; Meyer, Ulrich; Daenicke, Sven; Rehage, Juergen; Huber, Korinna			Associations between Forkhead Box O1 (FoxO1) Expression and Indicators of Hepatic Glucose Production in Transition Dairy Cows Supplemented with Dietary Nicotinic Acid	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ENERGY-DENSE DIET; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NIACIN SUPPLEMENTATION; INSULIN-RESISTANCE; SOMATOTROPIC AXIS; METABOLISM; LACTATION; NUTRIENT	Forkhead box protein O1 (FoxO1) is a transcription factor which promotes hepatic glucose production (HGP) by up-regulating the transcription of gluconeogenic enzymes in monogastric species. The activity of FoxO1 is inhibited by insulin-induced phosphorylation. The aims of the present study were to find associations between FoxO1 expression and variables associated with HGP as affected by feeding regimen in dairy cows during the transition period. Twenty one healthy German Holstein cows were allocated to four groups (LC-CON, HC-CON, LC-NA with 5 cows/group and HC-NA with 6 cows/group, respectively). Cows received 0 (LC-CON and HC-CON) or 24 (LC-NA and HC-NA) g/d nicotinic acid with high (HC) or low (LC) concentrate proportion from -42 days (-41.8 + 4.8; mean + standard deviation) relative to expected calving date (d-42) to d24. Liver biopsy was taken at d-42, 1, 21, and 100. The total protein expression of FoxO1 (tFoxO1) and the extent of phosphorylation of FoxO1 at serine 256 (pFoxO1) were analysed semiquantitatively by Western Blotting. The expression of hepatic mRNA of FoxO1 and seven genes associated with HGP was measured by real-time RT-PCR. Mixed model and Pearson's correlation were used for statistical evaluation with the level of significance at P<0.05. No dietary effect was observed either on feed intake, energy balance, or on the concentration of blood metabolites. Neither time nor diet affected the expression of FoxO1 total protein and mRNA. A NA x concentrate interaction was found in pFoxO1. However, no corresponding dietary effect was found in the mRNA expression of investigated genes. Different patterns of correlations between FoxO1-related variables and investigated indicators for HGP were found at d21 and 100. The results indicated that the regulation of HGP did not take place on the levels of mRNA and protein expression and the phosphorylation of FoxO1 in dairy cows in early lactation.	[Kinoshita, Asako; Huber, Korinna] Univ Vet Med Hannover, Dept Physiol, Hannover, Lower Saxony, Germany; [Locher, Lena] Univ Munich, Ctr Vet Clin Med, Clin Ruminants Ambulatory & Herd Hlth Serv, Munich, Bavaria, Germany; [Tienken, Reka; Meyer, Ulrich; Daenicke, Sven] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Anim Nutr, Braunschweig, Lower Saxony, Germany; [Rehage, Juergen] Univ Vet Med Hannover, Clin Cattle, Hannover, Lower Saxony, Germany	University of Veterinary Medicine Hannover, Foundation; University of Munich; Friedrich Loeffler Institute; University of Veterinary Medicine Hannover, Foundation	Huber, K (corresponding author), Univ Vet Med Hannover, Dept Physiol, Hannover, Lower Saxony, Germany.	korinna.huber@uni-hohenheim.de			Deutsche Forschungsgemeinschaft [DA 558/6-1, HU 838/12-1, RE 819/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) with grant numbers DA 558/6-1, HU 838/12-1, and RE 819/7-1. SD, KH, and JR received the grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation for this work.	Agca C, 2002, PHYSIOL GENOMICS, V11, P53, DOI 10.1152/physiolgenomics.00108.2001; Aschemann M, 2012, ARCH ANIM NUTR, V66, P303, DOI 10.1080/1745039X.2012.697353; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Choi S, 2011, METABOLISM, V60, P134, DOI 10.1016/j.metabol.2010.02.013; Graber M, 2010, J DAIRY SCI, V93, P5200, DOI 10.3168/jds.2010-3265; Grala TM, 2013, PHYSIOL GENOMICS, V45, P1157, DOI 10.1152/physiolgenomics.00134.2013; Greenfield RB, 2000, J DAIRY SCI, V83, P1228, DOI 10.3168/jds.S0022-0302(00)74989-7; Gross J, 2011, J DAIRY SCI, V94, P3484, DOI 10.3168/jds.2011-4251; Guo Shaodong, 2013, Drug Discov Today Dis Mech, V10, pe27; Hayirli A, 2006, VET RES COMMUN, V30, P749, DOI 10.1007/s11259-006-3320-6; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kang I, 2011, J CLIN ENDOCR METAB, V96, P3048, DOI 10.1210/jc.2011-1104; Kenez A, 2015, J ANIM SCI, V93, P4012, DOI 10.2527/jas.2014-8833; Kenez A, 2014, J DAIRY SCI, V97, P3626, DOI 10.3168/jds.2013-7662; Khan M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-85; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Littell RC, 1998, J ANIM SCI, V76, P1216; Loor JJ, 2006, PHYSIOL GENOMICS, V27, P29, DOI 10.1152/physiolgenomics.00036.2006; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Mendonca LGD, 2013, J DAIRY SCI, V96, P3588, DOI 10.3168/jds.2012-5804; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Neuvians TP, 2003, ENDOCRINE, V22, P93, DOI 10.1385/ENDO:22:2:93; Niehoff ID, 2009, BRIT J NUTR, V101, P5, DOI 10.1017/S0007114508043377; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Pires JAA, 2007, J DAIRY SCI, V90, P4635, DOI 10.3168/jds.2007-0146; Reynolds CK, 2003, J DAIRY SCI, V86, P1201, DOI 10.3168/jds.S0022-0302(03)73704-7; Rozen S, 2000, Methods Mol Biol, V132, P365; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Schulz K, 2014, J DAIRY RES, V81, P257, DOI 10.1017/S0022029914000107; Tienken R, 2015, ARCH ANIM NUTR, V69, P319, DOI 10.1080/1745039X.2015.1073002; Titgemeyer E. C., 2011, International Journal of Dairy Science, V6, P134, DOI 10.3923/ijds.2011.134.141; Titgemeyer EC, 2011, J DAIRY SCI, V94, P4962, DOI 10.3168/jds.2011-4193; van Dorland HA, 2009, J DAIRY SCI, V92, P1924, DOI 10.3168/jds.2008-1454; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Zachut M, 2013, J DAIRY SCI, V96, P5656, DOI 10.3168/jds.2012-6142; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	42	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146670	10.1371/journal.pone.0146670	http://dx.doi.org/10.1371/journal.pone.0146670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800252	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300027
J	Li, RL; Chai, MW; Qiu, GY				Li, Ruili; Chai, Minwei; Qiu, Guo Yu			Distribution, Fraction, and Ecological Assessment of Heavy Metals in Sediment Plant System in Mangrove Forest, South China Sea	PLOS ONE			English	Article							SEQUENTIAL EXTRACTION PROCEDURE; ACID-VOLATILE SULFIDE; SURFACE SEDIMENTS; RISK-ASSESSMENT; QUALITY GUIDELINES; COMPREHENSIVE ASSESSMENT; SPATIAL VARIATION; MARINE-SEDIMENTS; MIYUN RESERVOIR; SEWAGE-SLUDGE	Overlying water, sediment, rhizosphere sediment and mangrove seedlings in the Futian mangrove forest were analyzed for heavy metals. The results showed that mangrove plant acidified sediment and increased organic matter contents. Except for chromium (Cr), nickel (Ni) and copper (Cu) in Aegiceras corniculatum sediment, heavy metals in all sediments were higher than in overlying water, rhizosphere sediment and mangrove root. Heavy metals in Avicennia marina sediments were higher than other sediments. The lower heavy metal biological concentration factors (BCFs) and translocation factors (TFs) indicated that mangrove plant adopted exclusion strategy. The geo-accumulation index, potential ecological risk index and risk assessment code (RAC) demonstrated that heavy metals have posed a considerable ecological risk, especially for cadmium (Cd). Heavy metals (Cr, Ni, Cu and Cd) mainly existed in the reducible fractions. These findings provide actual heavy metal accumulations in sediment -plant ecosystems in mangrove forest, being important in designing the long-term management and conservation policies for managers of mangrove forest.	[Li, Ruili] Peking Univ, Sch Environm & Energy, Shenzhen Key Lab Heavy Met Pollut Control & Reuti, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China; [Chai, Minwei] PKU HKUST Shenzhen HongKong Inst, Shenzhen Key Lab Environm Simulat & Pollut Contro, Shenzhen 518057, Peoples R China; [Qiu, Guo Yu] Peking Univ, Shenzhen Grad Sch, Sch Environm & Energy, Shenzhen 518055, Peoples R China	Peking University; University Town of Shenzhen; Hong Kong University of Science & Technology; Peking University; Peking University; University Town of Shenzhen	Chai, MW (corresponding author), PKU HKUST Shenzhen HongKong Inst, Shenzhen Key Lab Environm Simulat & Pollut Contro, Shenzhen 518057, Peoples R China.; Qiu, GY (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Environm & Energy, Shenzhen 518055, Peoples R China.	chaimw@pkusz.edu.cn; qiugy@pkusz.edu.cn			Program of Science and Technology of Shenzhen [JCYJ20120829170028566, JCYJ20140903101847739, JCYJ20130402164725017]; National Natural Science Foundation of China [31400446]; Program of Assessment and Restoration of Mangrove Geiwei of Shenzhen Bay	Program of Science and Technology of Shenzhen; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Assessment and Restoration of Mangrove Geiwei of Shenzhen Bay	Funding provided by Program of Science and Technology of Shenzhen JCYJ20120829170028566, Ruili Li; Program of Science and Technology of ShenzhenJCYJ20140903101847739, Ruili Li; Program of Science and Technology of Shenzhen JCYJ20130402164725017, Ruili Li; and Program of National Natural Science Foundation of China (31400446), Ruili Li.; This work was financially supported by the Program of Science and Technology of Shenzhen (JCYJ20120829170028566, JCYJ20130402164725017, JCYJ20140903101847739), and the Program of National Natural Science Foundation of China (31400446), and the Program of Assessment and Restoration of Mangrove Geiwei of Shenzhen Bay. We thank Dr. Hualin Xu from the Neilingding-Futian National Nature Reserve of Guangdong, Futian National Nature Reserve for critically reading and revising the manuscript.	Abdel-Satar AM, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4592-5; Chai MW, 2014, MAR POLLUT BULL, V84, P115, DOI 10.1016/j.marpolbul.2014.05.028; Clark MW, 1998, CHEM GEOL, V149, P147, DOI 10.1016/S0009-2541(98)00034-5; Cui S, 2007, ENVIRON GEOL, V51, P1043, DOI 10.1007/s00254-006-0373-3; Cuong DT, 2006, APPL GEOCHEM, V21, P1335, DOI 10.1016/j.apgeochem.2006.05.001; Dahmani-Muller H, 2000, ENVIRON POLLUT, V109, P231, DOI 10.1016/S0269-7491(99)00262-6; De Jonge M, 2012, WATER RES, V46, P2205, DOI 10.1016/j.watres.2012.01.052; Fernandes LL, 2012, CHEM ECOL, V28, P435, DOI 10.1080/02757540.2012.666527; Fitz WJ, 2002, J BIOTECHNOL, V99, P259, DOI 10.1016/S0168-1656(02)00218-3; Gao XL, 2012, MAR POLLUT BULL, V64, P1529, DOI 10.1016/j.marpolbul.2012.04.026; Greger M, 2008, PLANT SOIL, V312, P195, DOI 10.1007/s11104-008-9725-y; Guo TZ, 1997, ENVIRON INT, V23, P305; Gupta S, 2008, ENVIRON GEOL, V55, P731, DOI 10.1007/s00254-007-1025-y; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; He B, 2014, ENVIRON GEOCHEM HLTH, V36, P467, DOI 10.1007/s10653-013-9574-3; Huang HJ, 2011, BIORESOURCE TECHNOL, V102, P10346, DOI 10.1016/j.biortech.2011.08.117; Huang XX, 2013, ENVIRON MONIT ASSESS, V185, P8525, DOI 10.1007/s10661-013-3193-4; Kumar A, 2012, ENVIRON MONIT ASSESS, V184, P3027, DOI 10.1007/s10661-011-2168-6; [李崇 Li Chong], 2008, [生态环境, Ecology and Environment], V17, P560; [李存焕 Li Cunhuan], 2013, [广东农业科学, Guangdong Agricultural Sciences], V40, P53; Li GG, 2013, MAR POLLUT BULL, V76, P420, DOI 10.1016/j.marpolbul.2013.08.032; Li J, 1988, ENV BACKGROUND VALUE; Li LZ, 2014, ENVIRON POLLUT, V188, P144, DOI 10.1016/j.envpol.2014.02.003; Lian YW, 1999, J WOOD SCI, V45, P343, DOI 10.1007/BF00833501; Liu JC, 2010, MAR POLLUT BULL, V60, P1209, DOI 10.1016/j.marpolbul.2010.03.029; Long ER, 1998, ENVIRON TOXICOL CHEM, V17, P714, DOI 10.1002/etc.5620170428; Lu HL, 2007, ENVIRON EXP BOT, V61, P159, DOI 10.1016/j.envexpbot.2007.05.007; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; MacDonald DD, 1996, ECOTOXICOLOGY, V5, P253, DOI 10.1007/BF00118995; Man YB, 2010, ENVIRON INT, V36, P570, DOI 10.1016/j.envint.2010.04.014; MARTIN JM, 1979, MAR CHEM, V7, P173, DOI 10.1016/0304-4203(79)90039-2; Mei XQ, 2014, WATER RES, V50, P147, DOI 10.1016/j.watres.2013.12.004; Morgan B, 2012, SCI TOTAL ENVIRON, V438, P463, DOI 10.1016/j.scitotenv.2012.08.088; MULLER G, 1981, CHEM ZTG, V105, P157; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; Na GS, 2013, MAR POLLUT BULL, V69, P233, DOI 10.1016/j.marpolbul.2012.12.028; Nath B, 2013, SCI TOTAL ENVIRON, V463, P667, DOI 10.1016/j.scitotenv.2013.06.024; Panda UC, 2010, J COASTAL RES, V26, P860, DOI 10.2112/08-1077.1; Perin G, 1985, P INT C HEAV MET ENV, P454; Perry CT, 2009, ESTUAR COAST SHELF S, V81, P225, DOI 10.1016/j.ecss.2008.10.019; Poynton CY, 2004, PLANTA, V219, P1080, DOI 10.1007/s00425-004-1304-8; Rath P, 2009, J HAZARD MATER, V163, P632, DOI 10.1016/j.jhazmat.2008.07.048; Rathinasabapathi B, 2006, CAN J MICROBIOL, V52, P695, DOI 10.1139/W06-017; Rauret G, 1999, J ENVIRON MONITOR, V1, P57, DOI 10.1039/a807854h; Ribeiro AP, 2013, MAR POLLUT BULL, V68, P55, DOI 10.1016/j.marpolbul.2012.12.023; Sakan S, 2015, ENVIRON EARTH SCI, V73, P6625, DOI 10.1007/s12665-014-3886-1; Sekomo CB, 2011, WATER AIR SOIL POLL, V214, P321, DOI 10.1007/s11270-010-0426-9; SEPA (State Environmental Protection Administration of China), 2002, MAR SED QUAL 18668 2; Shi G, 2010, ENVIRON POLLUT, V158, P694, DOI 10.1016/j.envpol.2009.10.020; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; Sundaray SK, 2011, J HAZARD MATER, V186, P1837, DOI 10.1016/j.jhazmat.2010.12.081; TAM NFY, 1995, HYDROBIOLOGIA, V295, P149, DOI 10.1007/BF00029122; Tam NFY, 2000, ENVIRON POLLUT, V110, P195, DOI 10.1016/S0269-7491(99)00310-3; Taylor S.R., 1985, CONTINENTAL CRUST IT; THOMAS RP, 1994, ANAL CHIM ACTA, V286, P423, DOI 10.1016/0003-2670(94)85088-7; US-EPA, 1996, SW 846 TEST METHOD 3; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Wu QH, 2014, ECOTOX ENVIRON SAFE, V104, P143, DOI 10.1016/j.ecoenv.2014.02.017; Xie HaiWei, 2010, Guangxi Zhiwu / Guihaia, V30, P64; Yang YQ, 2012, MAR POLLUT BULL, V64, P1947, DOI 10.1016/j.marpolbul.2012.04.024; Yohannes YB, 2013, ENVIRON SCI POLLUT R, V20, P8663, DOI 10.1007/s11356-013-1821-8; Yoon J, 2006, SCI TOTAL ENVIRON, V368, P456, DOI 10.1016/j.scitotenv.2006.01.016; Younis AM, 2014, ENVIRON MONIT ASSESS, V186, P3567, DOI 10.1007/s10661-014-3639-3; Yu RL, 2010, ENVIRON MONIT ASSESS, V163, P241, DOI 10.1007/s10661-009-0830-z; Yuan HZ, 2011, ENVIRON GEOCHEM HLTH, V33, P67, DOI 10.1007/s10653-010-9323-9; Zhai YB, 2014, BIORESOURCE TECHNOL, V159, P72, DOI 10.1016/j.biortech.2014.02.049; Zhang J, 2001, GUANGZHOU ENV SCI, V16, P36; Zhang RF, 2013, J COASTAL RES, V29, P1341, DOI 10.2112/JCOASTRES-D-11-00215.1; Zhou HX, 2008, PEDOSPHERE, V18, P77, DOI 10.1016/S1002-0160(07)60105-2; Zhou YW, 2010, MAR POLLUT BULL, V60, P1319, DOI 10.1016/j.marpolbul.2010.03.010; Zhu XF, 2013, ENVIRON MONIT ASSESS, V185, P6049, DOI 10.1007/s10661-012-3005-2; Zhuang W, 2014, MAR POLLUT BULL, V83, P352, DOI 10.1016/j.marpolbul.2014.03.039	72	82	84	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147308	10.1371/journal.pone.0147308	http://dx.doi.org/10.1371/journal.pone.0147308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800267	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300091
J	Olshefsky, A; Shehata, L; Kuldell, N				Olshefsky, Audrey; Shehata, Laila; Kuldell, Natalie			Site-Directed Mutagenesis to Improve Sensitivity of a Synthetic Two-Component Signaling System	PLOS ONE			English	Article							LIGHT	Two-component signaling (2CS) systems enable bacterial cells to respond to changes in their local environment, often using a membrane-bound sensor protein and a cytoplasmic responder protein to regulate gene expression. Previous work has shown that Escherichia coli's natural EnvZ/OmpR 2CS could be modified to construct a light-sensing bacterial photography system. The resulting bacterial photographs, or "co/iroids," rely on a phosphotransfer reaction between Cph8, a synthetic version of EnvZ that senses red light, and OmpR. Gene expression changes can be visualized through upregulation of a LacZ reporter gene by phosphorylated OmpR. Unfortunately, basal LacZ expression leads to a detectable reporter signal even when cells are grown in the light, diminishing the contrast of the co/iroids. We performed site-directed mutagenesis near the phosphotransfer site of Cph8 to isolate mutants with potentially improved image contrast. Five mutants were examined, but only one of the mutants, T541S, increased the ratio of dark/light gene expression, as measured by P-galactosidase activity. The ratio changed from 2.57 fold in the starting strain to 5.59 in the T541S mutant. The ratio decreased in the four other mutant strains we examined. The phenotype observed in the T541S mutant strain may arise because the serene sidechain is chemically similar but physically smaller than the threonine sidechain. This may minimally change the protein's local structure, but may be less sterically constrained when compared to threonine, resulting in a higher probability of a phosphotransfer event. Our initial success pairing synthetic biology and site-directed mutagenesis to optimize the bacterial photography system's performance encourages us to imagine further improvements to the performance of this and other synthetic systems, especially those based on 2CS signaling.	[Olshefsky, Audrey; Shehata, Laila; Kuldell, Natalie] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kuldell, Natalie] BioBuilder Educ Fdn, Cambridge, MA USA	Massachusetts Institute of Technology (MIT)	Kuldell, N (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Kuldell, N (corresponding author), BioBuilder Educ Fdn, Cambridge, MA USA.	nkuldell@mit.edu						Chu T, 2015, APPL ENV MICROBOL, V81; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dutta R, 2000, J BIOL CHEM, V275, P38645, DOI 10.1074/jbc.M005872200; Gardner L, 2012, CURR OPIN CHEM BIOL, V16, P292, DOI 10.1016/j.cbpa.2012.04.010; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Rodrigo G, 2007, BMC SYSTEMS BIOL S1, V1, P1; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	9	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147494	10.1371/journal.pone.0147494	http://dx.doi.org/10.1371/journal.pone.0147494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799494	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300115
J	Wei, YC; Liu, QH; Dong, HY; Zhou, ZC; Hao, YP; Chen, XL; Xu, LY				Wei, Yongcheng; Liu, Qinghua; Dong, Hongyu; Zhou, Zhichun; Hao, Yanping; Chen, Xuelian; Xu, Liuyi			Selection of Reference Genes for Real-Time Quantitative PCR in Pinus massoniana Post Nematode Inoculation	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS; HOUSEKEEPING GENES; RT-PCR; EXPRESSION; QUANTIFICATION; IDENTIFICATION; NORMALIZATION; VALIDATION; MODEL; WILT	Pinus massoniaia Lamb has gained more and more attention as the most important tree species for timber and forestation in South China. Gene expression studies are of great importance to identify new and elite cultivars. Real-time quantitative PCR, a highly sensitive and specific method, is commonly used in the analysis of gene expression. The appropriate reference genes must be employed to normalize the calculation program for ascertaining repeatable and significant results. Herein, eleven housekeeping genes were evaluated during different stages of P. massoniana post nematode inoculation in this study. Three statistical approaches such as geNorm, NormFinder and BestKeeper were selected to analyze the stability of candidate genes. The results indicated that U2af and beta-TUB were the most stable reference genes. These two genes could be used for the normalization in most of the experiments of P. massoniana, while Histone and AK were the least stable ones. In addition, EF expressed at the lowest average Ct value was the most abundant candidate gene. As an important gene associated with defense mechanisms, ABC transporter was analyzed by qRT-PCR, and the results were used to confirm the reliability of two genes. The selected reference genes in the present study will be conducive to future gene expression normalized by qRT-PCR in P. massoniana.	[Wei, Yongcheng; Liu, Qinghua; Dong, Hongyu; Zhou, Zhichun] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang 311400, Zhejiang, Peoples R China; [Wei, Yongcheng] Zhejiang Prov Key Lab Tree Breeding, Fuyang 311400, Zhejiang, Peoples R China; [Liu, Qinghua] State Forestry Adm Engn Res Ctr Masson Pine, Fuyang 311400, Zhejiang, Peoples R China; [Hao, Yanping; Chen, Xuelian; Xu, Liuyi] Anhui Acad Forestry, Hefei 230000, Anhui, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Liu, QH (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang 311400, Zhejiang, Peoples R China.; Liu, QH (corresponding author), State Forestry Adm Engn Res Ctr Masson Pine, Fuyang 311400, Zhejiang, Peoples R China.	liuqinghua642@163.com	hao, yan/HGB-0465-2022		National Science & Technology Pillar Program of China [2012BAD01B02]; National Natural Science Foundation of China [31470670]; National High-tech R&D Program of China (863 Program) [2011AA10020302]	National Science & Technology Pillar Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China)	The work was supported by the following: 1. National Science & Technology Pillar Program of China (No. 2012BAD01B02, http://kjzc.jhgl.org/), Principal Investigator: Zhichun Zhou; 2. National Natural Science Foundation of China (No. 31470670), Principal Investigator: Qinghua Liu; and 3. National High-tech R&D Program of China (863 Program) (No. 2011AA10020302), Principal Investigator: Yi Zhang.	Alonso P, 2007, TREE PHYSIOL, V27, P1721, DOI 10.1093/treephys/27.12.1721; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Dong LM, 2011, MOL BIOL REP, V38, P5017, DOI 10.1007/s11033-010-0648-3; DROPKIN VH, 1981, PLANT DIS, V65, P1022, DOI 10.1094/PD-65-1022; Forestry Agency Ministry of Agriculture Forestry and Fisheries of Japan, 2010, ANN REP TRENDS FOR F; Fukuda, 1997, J FORESTRY RES, V2, P171; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Goncalves S, 2005, PLANTA, V222, P556, DOI 10.1007/s00425-005-1562-0; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Ichihara Y, 2000, PLANT DIS, V84, P675, DOI 10.1094/PDIS.2000.84.6.675; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; KURODA K, 1991, EUR J FOREST PATHOL, V21, P430; Kuroda K., 1992, Journal of the Japanese Forestry Society, V74, P383; Kusumoto D, 2014, J FOREST RES-JPN, V19, P285, DOI 10.1007/s10310-013-0417-y; KUSUNOKI M, 1987, Annals of the Phytopathological Society of Japan, V53, P622, DOI 10.3186/jjphytopath.53.622; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; ODANI K, 1985, Journal of the Japanese Forestry Society, V67, P366; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratnaparkhe SM, 2009, PLANTA, V230, P339, DOI 10.1007/s00425-009-0949-8; Sang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082927; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Tamura H., 1984, Journal of the Japanese Forestry Society, V66, P306; Thellin O, 2009, BIOTECHNOL ADV, V27, P323, DOI 10.1016/j.biotechadv.2009.01.010; Tokushige Y., 1969, Journal of the Japanese Forestry Society, V51, P193; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Vasquez-Robinet C, 2010, PLANT PHYSIOL BIOCH, V48, P256, DOI 10.1016/j.plaphy.2009.12.005; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; [王晓锋 Wang Xiaofeng], 2013, [分子植物育种, Molecular Plant Breeding], V11, P385; Wang Z, 2010, AFR J MICROBIOL RES, V4, P437; Xu L.-Y., 2012, CHINA SCI TECHNOL, V26, P27, DOI DOI 10.3969/J.ISSN.1000-8101.2012.04.007; Yamada Toshihiro, 1993, Annals of the Phytopathological Society of Japan, V59, P659, DOI 10.3186/jjphytopath.59.659; Yang B. J., 2003, PINE WOOD NEMATODE D, P6	47	14	15	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147224	10.1371/journal.pone.0147224	http://dx.doi.org/10.1371/journal.pone.0147224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800152	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300074
J	Brown, LR; Komoroske, LM; Wagner, RW; Morgan-King, T; May, JT; Connon, RE; Fangue, NA				Brown, Larry R.; Komoroske, Lisa M.; Wagner, R. Wayne; Morgan-King, Tara; May, Jason T.; Connon, Richard E.; Fangue, Nann A.			Coupled Downscaled Climate Models and Ecophysiological Metrics Forecast Habitat Compression for an Endangered Estuarine Fish	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; CHANGE IMPACTS; CHANGE SCENARIOS; THERMAL TOLERANCE; DELTA SMELT; MARINE; COASTAL; STRESS; CALIFORNIA; PERFORMANCE	Climate change is driving rapid changes in environmental conditions and affecting population and species' persistence across spatial and temporal scales. Integrating climate change assessments into biological resource management, such as conserving endangered species, is a substantial challenge, partly due to a mismatch between global climate forecasts and local or regional conservation planning. Here, we demonstrate how outputs of global climate change models can be downscaled to the watershed scale, and then coupled with ecophysiological metrics to assess climate change effects on organisms of conservation concern. We employed models to estimate future water temperatures (2010-2099) under several climate change scenarios within the large heterogeneous San Francisco Estuary. We then assessed the warming effects on the endangered, endemic Delta Smelt, Hypomesus transpacificus, by integrating localized projected water temperatures with thermal sensitivity metrics (tolerance, spawning and maturation windows, and sublethal stress thresholds) across life stages. Lethal temperatures occurred under several scenarios, but sublethal effects resulting from chronic stressful temperatures were more common across the estuary (median > 60 days above threshold for > 50% locations by the end of the century). Behavioral avoidance of such stressful temperatures would make a large portion of the potential range of Delta Smelt unavailable during the summer and fall. Since Delta Smelt are not likely to migrate to other estuaries, these changes are likely to result in substantial habitat compression. Additionally, the Delta Smelt maturation window was shortened by 18-85 days, revealing cumulative effects of stressful summer and fall temperatures with early initiation of spring spawning that may negatively impact fitness. Our findings highlight the value of integrating sublethal thresholds, life history, and in situ thermal heterogeneity into global change impact assessments. As downscaled climate models are becoming widely available, we conclude that similar assessments at management-relevant scales will improve the scientific basis for resource management decisions.	[Brown, Larry R.; Morgan-King, Tara; May, Jason T.] US Geol Survey, Calif Water Sci Ctr, Sacramento, CA USA; [Komoroske, Lisa M.] NOAA, Natl Res Council, Natl Marine Fisheries Serv, La Jolla, CA USA; [Komoroske, Lisa M.; Fangue, Nann A.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Wagner, R. Wayne] Univ Texas Austin, Dept Geol Sci, Austin, TX USA; [Connon, Richard E.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA	United States Department of the Interior; United States Geological Survey; National Academies of Sciences, Engineering & Medicine; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Davis; University of Texas System; University of Texas Austin; University of California System; University of California Davis	Brown, LR (corresponding author), US Geol Survey, Calif Water Sci Ctr, Sacramento, CA USA.	lrbrown@usgs.gov		Wagner, Wayne/0000-0002-3978-2025	Priority Ecosystem Science Programs of the U.S. Geological Survey; Delta Stewardship Council through the Delta Science Program; University of California Agricultural Experiment Station [2098-H]; United States Department of Interior, Bureau of Reclamation [R12AP20018]; State and Federal Contractors Water Agency [201301957]; California Delta Stewardship Council [201015533]; California Sea Grant Delta Science Doctoral Fellowship [R/SF-56]; National Academies, National Research Council post-doctoral research fellowship	Priority Ecosystem Science Programs of the U.S. Geological Survey; Delta Stewardship Council through the Delta Science Program; University of California Agricultural Experiment Station(University of California System); United States Department of Interior, Bureau of Reclamation; State and Federal Contractors Water Agency; California Delta Stewardship Council; California Sea Grant Delta Science Doctoral Fellowship; National Academies, National Research Council post-doctoral research fellowship	Funding to LRB, TM-K, and JTM was provided by the Priority Ecosystem Science Programs of the U.S. Geological Survey, and by a grant from the Delta Stewardship Council through the Delta Science Program. This work represents contribution 69 of the "CASCaDE: Computational Assessments of Scenarios of Change for the Delta Ecosystem" project. This work was supported by the University of California Agricultural Experiment Station [grant number 2098-H to NAF], the United States Department of Interior, Bureau of Reclamation [contract number R12AP20018 to REC and NAF], the State and Federal Contractors Water Agency [grant number 201301957 to REC] and the California Delta Stewardship Council [contract number 201015533 to REC and NAF]. Partial funding was provided to LMK by the California Sea Grant Delta Science Doctoral Fellowship R/SF-56 and the National Academies, National Research Council post-doctoral research fellowship. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagenal T.B., 1978, P75; Baxter R, 2015, AN UPDATED CONCEPTUA; Bennett WA, 2015, ESTUAR COAST, V38, P826, DOI 10.1007/s12237-014-9877-3; Bennett W.A., 2005, SAN FRANCISCO ESTUAR, V3, P2, DOI [DOI 10.15447/SFEWS.2005V3ISS2ART1, 10.15447/sfews.2005v3iss2art1]; Bennett WA, 1997, COPEIA, P77; Bennett WA, 1997, T AM FISH SOC, V126, P841, DOI 10.1577/1548-8659(1997)126<0841:CTAPOO>2.3.CO;2; Bennett WA, 2008, INTERPLAY OF ENVIRON; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Brekke LD, 2004, J AM WATER RESOUR AS, V40, P149, DOI 10.1111/j.1752-1688.2004.tb01016.x; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Brown LR, 2013, ESTUAR COAST, V36, P754, DOI 10.1007/s12237-013-9585-4; CAMPBELL PM, 1992, BIOL REPROD, V47, P1140, DOI 10.1095/biolreprod47.6.1140; Cavanaugh KC, 2015, GLOBAL CHANGE BIOL, V21, P1928, DOI 10.1111/gcb.12843; Cayan D, 2009, CLIMATE CHANGE SCENA; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cloern JE, 2007, P NATL ACAD SCI USA, V104, P18561, DOI 10.1073/pnas.0706151104; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Cloern JE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044774; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Day JW, 2008, ESTUAR COAST, V31, P477, DOI 10.1007/s12237-008-9047-6; Dege M, 2004, AM FISH S S, V39, P49; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Dettinger M.D., 2005, SAN FRANCISCO ESTUAR, V3; Dettinger MD, 2013, CLIMATIC CHANGE, V116, P17, DOI 10.1007/s10584-012-0501-x; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048; Feyrer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067829; FIELDS R, 1987, T AM FISH SOC, V116, P856, DOI 10.1577/1548-8659(1987)116<856:CACTMO>2.0.CO;2; Fiol DF, 2007, FEBS J, V274, P5790, DOI 10.1111/j.1742-4658.2007.06099.x; Fry F.E.J., 1971, P1; Groot C., 1995, PACIFIC SALMON LIFE; Gustafson EJ, 2015, GLOBAL CHANGE BIOL, V21, P843, DOI 10.1111/gcb.12713; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hasenbein M, 2013, INTEGR COMP BIOL, V53, P620, DOI 10.1093/icb/ict082; Helsel D. R., 2002, 4A3 USGS, V4, pA3, DOI DOI 10.3133/TWRI04A3; Hidalgo HG, 2008, DOWNSCALING WITH CON; Hochachka P., 2002, BIOCH ADAPTATION MEC; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hofmann G, 2009, ANNU REV PHYSIOL, V404, P16, DOI DOI 10.1146/ANNUREV-PHYSI0L-021909-135900; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; IPCC (Intergovernmental Panel on Climate Change), 2014, WORKING GROUP II CON; IPCC (Intergovernmental Panel on Climate Change), 2007, CONTRIBUTION WORKING, P793; Kimmerer W., 2004, ESTUARY WATERSHED SC, V2, DOI 10.15447/sfews.2004v2iss1art1; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Komoroske LM, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou008; Komoroske LM, 2015, MOL ECOL, V24, P4960, DOI 10.1111/mec.13373; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lawrence DJ, 2015, J ANIM ECOL, V84, P879, DOI 10.1111/1365-2656.12332; Lawrence DJ, 2014, ECOL APPL, V24, P895, DOI 10.1890/13-0753.1; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Luoma Samuel N., 2015, San Francisco Estuary & Watershed Science, V13, P7; Marteinsdottir G, 1998, J FISH BIOL, V52, P1241, DOI 10.1111/j.1095-8649.1998.tb00969.x; Maurer EP, 2010, HYDROL EARTH SYST SC, V14, P1125, DOI 10.5194/hess-14-1125-2010; McCormick SD, 2013, FISH PHYSIOL, V32, P1; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; Nakicenovic N, 2000, SPECIAL REPORT EMISS; Nobriga Matthew L., 2008, San Francisco Estuary & Watershed Science, V6, P1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Schulte PM, 2014, J EXP BIOL, V217, P23, DOI 10.1242/jeb.089722; Snover AK, 2013, CONSERV BIOL, V27, P1147, DOI 10.1111/cobi.12163; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Sommer T, SAN FRANCISCO ESTUAR, V11, P2; Sommer T, 2011, SAN FRANCISCO ESTUAR, V9, P2; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Swanson C, 1998, J EXP BIOL, V201, P333; Thomson J.R., 2010, ECOLOGICAL APPL, V20, P181, DOI DOI 10.1890/09-0998.1; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Wagner RW, 2011, ESTUAR COAST, V34, P544, DOI 10.1007/s12237-010-9369-z; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; Yates D, 2008, CLIMATIC CHANGE, V91, P335, DOI 10.1007/s10584-008-9427-8	79	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146724	10.1371/journal.pone.0146724	http://dx.doi.org/10.1371/journal.pone.0146724			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796147	Green Published, Green Submitted, gold			2022-12-26	WOS:000368530300011
J	Ciach, K; Niedoszytko, M; Abacjew-Chmylko, A; Pabin, I; Adamski, P; Leszczynska, K; Preis, K; Olszewska, H; Wydra, DG; Hansdorfer-Korzon, R				Ciach, Katarzyna; Niedoszytko, Marek; Abacjew-Chmylko, Anna; Pabin, Izabela; Adamski, Przemyslaw; Leszczynska, Katarzyna; Preis, Krzysztof; Olszewska, Hanna; Wydra, Dariusz G.; Hansdorfer-Korzon, Rita			Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM)	PLOS ONE			English	Article							INDOLENT SYSTEMIC MASTOCYTOSIS; COMPLICATING PREGNANCY; CUTANEOUS MASTOCYTOSIS; ANESTHETIC MANAGEMENT; URTICARIA PIGMENTOSA; MAST-CELLS; C-KIT; MUTATION; ANAPHYLAXIS; MECHANISMS	Objective To present current guidelines regarding treatment of mastocytosis in pregnancy on the example of observed patients. Design Case control national study. Setting Polish Center of the European Competence Network on Mastocytosis (ECNM). Population or Sample 23 singleton spontaneous pregnancies in 17 women diagnosed with mastocytosis in years 1999-2014, before becoming pregnant. Methods Prospective analysis outcomes of pregnancies and deliveries. Main Outcome Measures Survey developed in cooperation with the Spanish Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Red Espanola de Mastocitosis (REMA), Spain. Results All 23 pregnancies resulted from natural conception. Obstetrical complications recorded in the first trimester included spontaneous miscarriage (5 pregnancies). Four patients delivered preterm, including one delivery due to preeclampsia at 26 weeks which resulted with neonate death due to extreme prematurity. Five women delivered via cesarean: four due to obstetrical indications and one due to mastocytosis, during which no anesthesia related complications were recorded. Of patients delivering vaginally, two received extradural anesthesia, three required oxytocin infusion due to uterine hypotonia. No labor complications were recorded. In one woman with pregnancy-induced hypertension, early puerperium was complicated by the presence of persistent arterial hypertension. One neonate was born with the signs of cutaneous mastocytosis. Another neonate was diagnosed with Patau syndrome. Four women were treated for mastocytosis prior to conception and continued therapy after becoming pregnant. One patient was put on medications in the first trimester due to worsening of her symptoms. Pregnancy exerted only a slight effect on the intensity and frequency of mastocytosis-related symptoms observed. Worsening of the disease-related symptoms was documented in only four patients (23%). None of the patients showed the signs of anaphylaxis, either before becoming pregnant, or during pregnancy and puerperium. Conclusions There is no contraindication to pregnancy when mastocystosis-related pathologies are under appropriate medical control.	[Ciach, Katarzyna; Pabin, Izabela; Adamski, Przemyslaw; Leszczynska, Katarzyna; Preis, Krzysztof] Med Univ Gdansk, Dept Obstet, Gdansk, Poland; [Niedoszytko, Marek] Med Univ Gdansk, Dept Allergol, Gdansk, Poland; [Abacjew-Chmylko, Anna; Olszewska, Hanna; Wydra, Dariusz G.] Med Univ Gdansk, Dept Gynecol Gynecol Oncol & Gynecol Endocrinol, Gdansk, Poland; [Hansdorfer-Korzon, Rita] Med Univ Gdansk, Dept Physiotherapy, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Ciach, K (corresponding author), Med Univ Gdansk, Dept Obstet, Gdansk, Poland.	kciach@wp.pl	Hansdorfer-Korzon, Rita/U-2883-2018; Wydra, Dariusz G/F-5186-2016; Wydra, Dariusz/ABD-1189-2020; Niedoszytko, Marek/U-1250-2018	Hansdorfer-Korzon, Rita/0000-0003-3777-9153; Wydra, Dariusz G/0000-0002-6755-1478; Niedoszytko, Marek/0000-0003-1089-1911; Wydra, Dariusz/0000-0002-4510-9558				Akin C, 2004, BLOOD, V103, P3222, DOI 10.1182/blood-2003-11-3816; *AM COLL RAD, 2007, PRACT GUID TECHN STA, P73; Bruns S. B., 2003, Journal of Allergy and Clinical Immunology, V111, pS323, DOI 10.1016/S0091-6749(03)81179-X; Castells MC, 2004, ALLERGY ASTHMA PROC, V25, P33; Ciach K, 2014, ALERGOL POL, V1, P166, DOI 10.1016/j.alergo.2014.11.003; COLLADA JCG, 2000, REV ESP ANESTESIOL R, V47, P326; Cunningham FG, 1997, WILLIAMS OBSTET, P261; DONAHUE JG, 1995, OBSTET GYNECOL, V85, P813, DOI 10.1016/0029-7844(94)00305-W; Einarson A, 1997, ANN ALLERG ASTHMA IM, V78, P183, DOI 10.1016/S1081-1206(10)63385-6; Garfield RE, 2006, AM J OBSTET GYNECOL, V194, P261, DOI 10.1016/j.ajog.2005.05.011; Greenhawt M, 2007, CURR OPIN ALLERGY CL, V7, P387, DOI 10.1097/ACI.0b013e3282a6443e; Gupta S, 1998, INT J OBSTET ANESTH, V7, P261, DOI 10.1016/S0959-289X(98)80049-6; Horny HP AC, 2008, WHO CLASSIFICATION T, P54; Kehoe SL, 2006, OBSTET GYNECOL, V107, P514, DOI 10.1097/01.AOG.0000174579.44885.db; Kristensen T, 2014, AM J HEMATOL, V89, P493, DOI 10.1002/ajh.23672; Lange M, 2016, ACTA DERM-VENEREOL, V96, P292, DOI 10.2340/00015555-2210; Maatouk A, 2013, J GYNECOL OBST BIO R, V42, P117, DOI 10.1016/j.jgyn.2011.11.010; Madendag IC, 2010, TAIWAN J OBSTET GYNE, V49, P192, DOI 10.1016/S1028-4559(10)60040-X; Matito A, 2011, INT ARCH ALLERGY IMM, V156, P104, DOI 10.1159/000321954; Metcalfe DD, 2001, LEUKEMIA RES, V25, P577, DOI 10.1016/S0145-2126(01)00046-7; MULLINS RJ, 1991, LANCET, V338, P1279, DOI 10.1016/0140-6736(91)92152-R; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Notter A, 1969, Bull Fed Soc Gynecol Obstet Lang Fr, V21, P455; Rausz E, 2013, BRIT J HAEMATOL, V160, P216, DOI 10.1111/bjh.12086; RUDOLPH MI, 1993, BRIT J OBSTET GYNAEC, V100, P1125, DOI 10.1111/j.1471-0528.1993.tb15178.x; Schwarz EB, 2008, DRUG SAFETY, V31, P775, DOI 10.2165/00002018-200831090-00006; Shank JJ, 2009, OBSTET GYNECOL, V114, P415, DOI 10.1097/AOG.0b013e3181a20721; SOTER NA, 1991, J INVEST DERMATOL, V96, pS32, DOI 10.1111/1523-1747.ep12468973; Ulbrich F, 2013, INT J OBSTET ANESTH, V22, P243, DOI 10.1016/j.ijoa.2013.03.011; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; van Doormaal JJ, 2013, J ALLERGY CLIN IMMUN, V131, P1429, DOI 10.1016/j.jaci.2012.10.015; Villeneuve V, 2006, CAN J ANAESTH, V53, P380, DOI 10.1007/BF03022503; Wasag B, 2011, EXP HEMATOL, V39, P859, DOI 10.1016/j.exphem.2011.05.009; Watson KD, 2012, OBSTET GYNECOL, V119, P486, DOI 10.1097/AOG.0b013e318242d3c5; Wolbing F, 2013, ALLERGY, V68, P1085, DOI 10.1111/all.12193; Woidacki K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00231; Worobec AS, 2000, OBSTET GYNECOL, V95, P391, DOI 10.1016/S0029-7844(99)00591-8	37	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146924	10.1371/journal.pone.0146924	http://dx.doi.org/10.1371/journal.pone.0146924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796887	Green Submitted, Green Published, gold			2022-12-26	WOS:000368530300015
J	Loe, H; Nes, BM; Wisloff, U				Loe, Henrik; Nes, Bjarne M.; Wisloff, Ulrik			Predicting VO2peak from Submaximal- and Peak Exercise Models: The HUNT 3 Fitness Study, Norway	PLOS ONE			English	Article							MAXIMAL OXYGEN-UPTAKE; CARDIORESPIRATORY FITNESS; HEART-RATE; AEROBIC CAPACITY; ALL-CAUSE; TREADMILL; MORTALITY; EQUATIONS; WALKING; VO2MAX	Purpose Peak oxygen uptake (VO2peak) is seldom assessed in health care settings although being inversely linked to cardiovascular risk and all-cause mortality. The aim of this study was to develop VO2peak prediction models for men and women based on directly measured VO2peak from a large healthy population Methods VO2peak prediction models based on submaximal- and peak performance treadmill work were derived from multiple regression analysis. 4637 healthy men and women aged 20-90 years were included. Data splitting was used to generate validation and cross-validation samples. Results The accuracy for the peak performance models were 10.5% (SEE = 4.63 mL.kg(-1).min(-1)) and 11.5% (SEE = 4.11 mL.kg(-1).min(-1)) for men and women, respectively, with 75% and 72% of the variance explained. For the submaximal performance models accuracy were 14.1% (SEE = 6.24 mL.kg(-1).min(-1)) and 14.4% (SEE = 5.17 mL.kg(-1).min(-1)) for men and women, respectively, with 55% and 56% of the variance explained. The validation and cross-validation samples displayed SEE and variance explained in agreement with the total sample. Cross-classification between measured and predicted VO2peak accurately classified 91% of the participants within the correct or nearest quintile of measured VO2peak. Conclusion Judicious use of the exercise prediction models presented in this study offers valuable information in providing a fairly accurate assessment of VO2peak, which may be beneficial for risk stratification in health care settings.	[Loe, Henrik; Nes, Bjarne M.; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Loe, Henrik] Valnesfjord Rehabil Ctr, Valnesfjord, Norway	Norwegian University of Science & Technology (NTNU)	Wisloff, U (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway.	Ulrik.wisloff@ntnu.no	Nes, Bjarne Martens/I-2903-2016	Nes, Bjarne Martens/0000-0002-9958-8179; Wisloff, Ulrik/0000-0002-7211-3587	K.G. Jebsen Foundation; Norwegian Council on cardiovascular Disease; Research Council of Norway; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Valnesfjord Rehabilitation Center	K.G. Jebsen Foundation; Norwegian Council on cardiovascular Disease; Research Council of Norway(Research Council of Norway); Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Valnesfjord Rehabilitation Center	This study was funded by K.G. Jebsen Foundation, The Norwegian Council on cardiovascular Disease, The Research Council of Norway, Foundation for Cardiovascular Research at St. Olav's Hospital, Norwegian State Railways, Roche Norway Incorporated and Valnesfjord Rehabilitation Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, ACSMS GUIDELINES FOR; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; Astrand PO, 2003, PHYSIOLOGICAL BASES; Billinger SA, 2012, MED SCI SPORT EXER, V44, P1539, DOI 10.1249/MSS.0b013e31824f5be4; Cao ZB, 2013, J PHYS ACT HEALTH, V10, P280, DOI 10.1123/jpah.10.2.280; Cao ZB, 2010, MED SCI SPORT EXER, V42, P179, DOI 10.1249/MSS.0b013e3181af238d; Cao ZB, 2009, EUR J APPL PHYSIOL, V105, P289, DOI 10.1007/s00421-008-0902-8; Cink R E, 1981, Br J Sports Med, V15, P182; Coquart JBJ, 2010, EUR J APPL PHYSIOL, V110, P645, DOI 10.1007/s00421-010-1524-5; Esco MR, 2012, J STRENGTH COND RES, V26, P1920, DOI 10.1519/JSC.0b013e318238e863; Evans HJL, 2015, J SCI MED SPORT, V18, P183, DOI 10.1016/j.jsams.2014.03.006; FAULKNER JA, 1971, J APPL PHYSIOL, V30, P457, DOI 10.1152/jappl.1971.30.4.457; Faulkner J, 2007, EUR J APPL PHYSIOL, V101, P397, DOI 10.1007/s00421-007-0508-6; Guazzi M, 2012, CIRCULATION, V126, P2261, DOI 10.1161/CIR.0b013e31826fb946; Gupta S, 2011, CIRCULATION, V123, P1377, DOI 10.1161/CIRCULATIONAHA.110.003236; HEIL DP, 1995, MED SCI SPORT EXER, V27, P599; HERMANSE.L, 1969, J APPL PHYSIOL, V26, P31, DOI 10.1152/jappl.1969.26.1.31; JACKSON AS, 1990, MED SCI SPORT EXER, V22, P863, DOI 10.1249/00005768-199012000-00021; Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004; Kendall KL, 2012, J STRENGTH COND RES, V26, P733, DOI 10.1519/JSC.0b013e318225f3ac; Kilding AE, 2006, J SPORT MED PHYS FIT, V46, P366; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Koutlianos N, 2013, HIPPOKRATIA, V17, P136; Lamberts RP, 2014, INT J SPORTS MED, V35, P217, DOI 10.1055/s-0033-1349139; Larsen GE, 2002, RES Q EXERCISE SPORT, V73, P66, DOI 10.1080/02701367.2002.10608993; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Loe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064319; Magrani P, 2010, ARQ BRAS CARDIOL, V94, P763, DOI 10.1590/S0066-782X2010005000054; Malek MH, 2005, J STRENGTH COND RES, V19, P559; Malek MH, 2004, MED SCI SPORT EXER, V36, P1427, DOI 10.1249/01.MSS.0000135795.60449.CE; Marsh CE, 2012, J STRENGTH COND RES, V26, P548, DOI 10.1519/JSC.0b013e3181bac56e; MILES DS, 1980, MED SCI SPORT EXER, V12, P14; MIYAMURA M, 1972, J APPL PHYSIOL, V32, P185, DOI 10.1152/jappl.1972.32.2.185; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nes BM, 2011, MED SCI SPORT EXER, V43, P2024, DOI 10.1249/MSS.0b013e31821d3f6f; OJA P, 1991, INT J SPORTS MED, V12, P356, DOI 10.1055/s-2007-1024694; Okura Tomohiro, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P255, DOI 10.2114/jpa.20.255; Roca J, 1997, EUR RESPIR J, V10, P2662; ROSNER B., 2006, FUNDAMENTALS OF BIOS; Rotstein A, 2005, MED SCI SPORT EXER, V37, P1864, DOI 10.1249/01.mss.0000177217.12977.2f; ROWELL LB, 1964, J APPL PHYSIOL, V19, P919, DOI 10.1152/jappl.1964.19.5.919; Skalski J, 2012, CIRCULATION, V126, P2465, DOI 10.1161/CIRCULATIONAHA.112.110460; Stamatakis E, 2013, EUR HEART J, V34, P750, DOI 10.1093/eurheartj/ehs097; Swain DP, 1997, MED SCI SPORT EXER, V29, P1104, DOI 10.1097/00005768-199708000-00017; Tsiaras V, 2010, PEDIATR EXERC SCI, V22, P624, DOI 10.1123/pes.22.4.624; Turvey MT, 1999, J MOTOR BEHAV, V31, P265, DOI 10.1080/00222899909600993; Uth N, 2004, EUR J APPL PHYSIOL, V91, P111, DOI 10.1007/s00421-003-0988-y; Wier LT, 2006, MED SCI SPORT EXER, V38, P555, DOI 10.1249/01.mss.0000193561.64152	49	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0144873	10.1371/journal.pone.0144873	http://dx.doi.org/10.1371/journal.pone.0144873			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794677	Green Submitted, Green Published, gold			2022-12-26	WOS:000368530300003
J	Prins-van Ginkel, AC; Berbers, GAM; Grundeken, LH; Tcherniaeva, I; Wittenberns, JI; Elberse, K; Mollema, L; de Melker, HE; Knol, MJ				Prins-van Ginkel, Annemarijn C.; Berbers, Guy A. M.; Grundeken, Lucienne H.; Tcherniaeva, Irina; Wittenberns, Jelle I.; Elberse, Karin; Mollema, Liesbeth; de Melker, Hester E.; Knol, Mirjam J.			Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era	PLOS ONE			English	Article							7-VALENT CONJUGATE VACCINE; COMMUNITY-LEVEL PREDICTORS; STREPTOCOCCUS-PNEUMONIAE; RISK-FACTORS; NASOPHARYNGEAL CARRIAGE; YOUNG-CHILDREN; DISEASE; NETHERLANDS; POPULATION; POLYSACCHARIDES	Introduction Introduction of pneumococcal conjugate vaccines (PCVs) for infants decreased overall invasive pneumococcal disease (IPD), while non-vaccine serotype IPD increased. To fully understand this serotype replacement, knowledge about serotype dynamics in the pre-vaccine era is needed. In addition to IPD surveillance and carriage studies, the serotype replacement can be investigated by serosurveillance studies. The current study compared the results of two Dutch serosurveillance studies conducted in 1995-1996 (PIENTER1) and 2006-2007 (PIENTER2). Methods Participants in these studies donated a blood sample and completed a questionnaire. Pneumococcal antibodies of serotypes included in PCV13 were measured with a fluorescent-bead based multiplex immunoassay. Geometric mean antibody concentrations (GMCs) and determinants of pneumococcal antibody levels were investigated. Results GMCs were higher in PIENTER2 for serotypes 1, 6A, 6B, 9V, 18C, 19F and 23F and lower for 3 and 5. Age, day care attendance, household size, vaccination coverage, and urbanisation rate were associated with pneumococcal antibodies in children. Education level, ethnicity, age, low vaccination coverage sample, urbanisation rate, and asthma/COPD were associated with pneumococcal antibodies in elderly. The determinants significantly associated with pneumococcal IgG were slightly different for the elderly in PIENTER1 compared to the elderly in PIENTER2. Conclusion Although most of the serotype antibody levels remained stable, some of the serotype-specific antibody levels varied during the pre-vaccine era, indicating that exposure of certain serotypes changes without interference of PCVs.	[Prins-van Ginkel, Annemarijn C.; Berbers, Guy A. M.; Grundeken, Lucienne H.; Tcherniaeva, Irina; Wittenberns, Jelle I.; Elberse, Karin; Mollema, Liesbeth; de Melker, Hester E.; Knol, Mirjam J.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Prins-van Ginkel, AC (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	annemarijn.van.ginkel@rivm.nl		Prins-van Ginkel, Annemarijn/0000-0002-0767-736X	Ministry of Health, Welfare and Sports (VWS)	Ministry of Health, Welfare and Sports (VWS)	The PIENTER-studies were financed by the Ministry of Health, Welfare and Sports (VWS).	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Balmer P, 2007, CLIN VACCINE IMMUNOL, V14, P1442, DOI 10.1128/CVI.00264-07; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2001, J CLIN MICROBIOL, V39, P3316, DOI 10.1128/JCM.39.9.3316-3320.2001; Cekmez Ferhat, 2009, Int J Biomed Sci, V5, P101; Ciruela P, 2013, VACCINE, V31, P960, DOI 10.1016/j.vaccine.2012.11.102; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; Elberse KEM, 2011, VACCINE, V29, P1029, DOI 10.1016/j.vaccine.2010.11.054; Elberse KEM, 2010, CLIN VACCINE IMMUNOL, V17, P674, DOI 10.1128/CVI.00408-09; Helferty M, 2013, INT J CIRCUMPOL HEAL, V72, P666, DOI 10.3402/ijch.v72i0.21606; Hsieh YC, 2012, PEDIATR INFECT DIS J, V31, pE163, DOI 10.1097/INF.0b013e31825cb9f9; Hsu KK, 2014, EPIDEMIOL INFECT, V142, P379, DOI 10.1017/S0950268813000794; Huang SS, 2004, AM J EPIDEMIOL, V159, P645, DOI 10.1093/aje/kwh088; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Jung JA, 2010, POSTGRAD MED, V122, P116, DOI 10.3810/pgm.2010.09.2208; Keck JW, 2014, VACCINE, V32, P6478, DOI 10.1016/j.vaccine.2014.09.037; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Mollema L, 2009, PIENTER 2 PROJECT 2; Torne AN, 2014, VACCINE, V32, P3644, DOI 10.1016/j.vaccine.2014.04.066; Roche A, 2007, ARCH DIS CHILD, V92, P1073, DOI 10.1136/adc.2007.126359; Sankilampi U, 1997, INT J EPIDEMIOL, V26, P420, DOI 10.1093/ije/26.2.420; Simell B, 2008, CLIN VACCINE IMMUNOL, V15, P1391, DOI 10.1128/CVI.00110-08; Ueno M, 2013, JPN J INFECT DIS, V66, P22, DOI 10.7883/yoken.66.22; van der Klis FRM, 2009, NETH J MED, V67, P301; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147437	10.1371/journal.pone.0147437	http://dx.doi.org/10.1371/journal.pone.0147437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796783	Green Submitted, Green Published, gold			2022-12-26	WOS:000368530300034
J	Singh, R; Nawale, L; Sarkar, D; Suresh, CG				Singh, Ruby; Nawale, Laxman; Sarkar, Dhiman; Suresh, C. G.			Two Chitotriose-Specific Lectins Show Anti-Angiogenesis, Induces Caspase-9-Mediated Apoptosis and Early Arrest of Pancreatic Tumor Cell Cycle	PLOS ONE			English	Article							CONCANAVALIN-A; CANCER; PROLIFERATION; ACTIVATION; AUTOPHAGY; GROWTH	The antiproliferative activity of two chito-specific agglutinins purified from Benincasa hispida (BhL) and Datura innoxia (DiL9) of different plant family origin was investigated on various cancer cell lines. Both lectins showed chitotriose specificity, by inhibiting lectin hemagglutinating activity. On further studies, it was revealed that these agglutinins caused remarkable concentration-dependent antiproliferative effect on human pancreatic cancerous cells but not on the normal human umbilical vein endothelial cells even at higher doses determined using MTT assay. The GI(50) values were approximately 8.4 mu g ml(-1) (0.247 mu M) and 142 mu g ml(-1) (14.8 mu M) for BhL and DiL9, respectively, against PANC-1 cells. The growth inhibitory effect of these lectins on pancreatic cancer cells were shown to be a consequence of lectin cell surface binding and triggering G(0)/G(1) arrest, mitochondrial membrane depolarization, sustained increase of the intracellular calcium release and the apoptotic signal is amplified by activation of caspases executing cell death. Interestingly, these lectins also showed anti-angiogenic activity by disrupting the endothelial tubulogenesis. Therefore, we report for the first time two chito-specific lectins specifically binding to tumor glycans; they can be considered to be a class of molecules with antitumor activity against pancreatic cancer cells mediated through caspase dependent mitochondrial apoptotic pathway.	[Singh, Ruby; Suresh, C. G.] CSIR Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India; [Nawale, Laxman; Sarkar, Dhiman] CSIR Natl Chem Lab, Combichem Bioresource Ctr, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Suresh, CG (corresponding author), CSIR Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India.; Sarkar, D (corresponding author), CSIR Natl Chem Lab, Combichem Bioresource Ctr, Pune, Maharashtra, India.	d.sarkar@ncl.res.in; cg.suresh@ncl.res.in	Sarkar, Dhiman/AAK-7481-2020	Sarkar, Dhiman/0000-0002-3912-1104; Nawale, Laxman/0000-0002-9538-6561	CSIR, New Delhi, India	CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	RS received Senior Research Fellowship of CSIR, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RS received Senior Research Fellowship of CSIR, New Delhi, India. RS is a registered PhD student of AcSIR and DS & CGS are faculty of AcSIR.	AUB JC, 1965, P NATL ACAD SCI USA, V54, P400, DOI 10.1073/pnas.54.2.400; Belotti D, 1996, CLIN CANCER RES, V2, P1843; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; De Mejia EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445; Folkman J, 2001, THROMB HAEMOSTASIS, V86, P23; Folkman J, 1992, Semin Cancer Biol, V3, P65; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gastman B, 2004, BIOCHEM BIOPH RES CO, V316, P263, DOI 10.1016/j.bbrc.2004.02.043; Han SJ, 2009, J GYNECOL ONCOL, V20, P113, DOI 10.3802/jgo.2009.20.2.113; Haugland RP, 1996, HDB FLUORESCENT PROB, P266; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kang TB, 2007, J BIOCHEM MOL BIOL, V40, P959; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Li WW, 2011, BIOCHEM BIOPH RES CO, V414, P282, DOI 10.1016/j.bbrc.2011.09.072; Lin H, 2010, BRIT J PHARMACOL, V161, P1661, DOI 10.1111/j.1476-5381.2010.00989.x; Liu B, 2010, CANCER LETT, V287, P1, DOI 10.1016/j.canlet.2009.05.013; Liu B, 2009, ARCH BIOCHEM BIOPHYS, V482, P1, DOI 10.1016/j.abb.2008.12.003; Lyu SY, 2002, ARCH PHARM RES, V25, P93, DOI 10.1007/BF02975269; Marvibaigi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/785479; McCarter C, 2015, PROTEOM CLIN APPL, V7, P632; McLane Mary Ann, 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P327, DOI 10.2174/1568006043335880; Minamiguchi K, 2001, INT J CANCER, V93, P307, DOI 10.1002/ijc.1321; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pilorget A, 2007, J CELL PHYSIOL, V211, P307, DOI 10.1002/jcp.20935; Pujari R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079311; Pusztai A, 2008, FRONT BIOSCI-LANDMRK, V13, P1130, DOI 10.2741/2750; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; Roukos V, 2015, NAT PROTOC, V10, P334, DOI 10.1038/nprot.2015.016; Savanur MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110107; Shiratsuchi A, 1998, BIOCHEM BIOPH RES CO, V246, P549, DOI 10.1006/bbrc.1998.8663; Singh R, 2015, INT J BIOCH RES REV, V9, P1; Suen YK, 2000, APOPTOSIS, V5, P369, DOI 10.1023/A:1009691727077; Tatsuta T, 2013, INT J ONCOL, V43, P1402, DOI 10.3892/ijo.2013.2092; Valentiner U, 2003, ANTICANCER RES, V23, P1197; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Van Huyen JPD, 2002, MOL MED, V8, P600, DOI 10.1007/BF03402170; Vijayan M, 1999, CURR OPIN STRUC BIOL, V9, P707, DOI 10.1016/S0959-440X(99)00034-2; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3	42	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146110	10.1371/journal.pone.0146110	http://dx.doi.org/10.1371/journal.pone.0146110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795117	gold, Green Published, Green Submitted			2022-12-26	WOS:000368530300005
J	Li, Y; Mendiratta, S; Ehrhardt, K; Kashyap, N; White, MA; Bleris, L				Li, Yi; Mendiratta, Saurabh; Ehrhardt, Kristina; Kashyap, Neha; White, Michael A.; Bleris, Leonidas			Exploiting the CRISPR/Cas9 PAM Constraint for Single-Nucleotide Resolution Interventions	PLOS ONE			English	Article							DUAL-RNA; GENOME; TRANSCRIPTION; ENDONUCLEASE; EFFECTORS; CAS9	CRISPR/Cas9 is an enabling RNA-guided technology for genome targeting and engineering. An acute DNA binding constraint of the Cas9 protein is the Protospacer Adjacent Motif (PAM). Here we demonstrate that the PAM requirement can be exploited to specifically target single-nucleotide heterozygous mutations while exerting no aberrant effects on the wild-type alleles. Specifically, we target the heterozygous G13A activating mutation of KRAS in colorectal cancer cells and we show reversal of drug resistance to a MEK small-molecule inhibitor. Our study introduces a new paradigm in genome editing and therapeutic targeting via the use of gRNA to guide Cas9 to a desired protospacer adjacent motif.	[Li, Yi; Ehrhardt, Kristina; Kashyap, Neha; Bleris, Leonidas] Univ Texas Dallas, Dept Bioengn, 800 West Campbell Rd, Richardson, TX 75080 USA; [Li, Yi; Ehrhardt, Kristina; Kashyap, Neha; Bleris, Leonidas] Univ Texas Dallas, Ctr Syst Biol, 800 West Campbell Rd, Richardson, TX 75080 USA; [Mendiratta, Saurabh; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Bleris, Leonidas] Univ Texas Dallas, Dept Elect Engn, 800 West Campbell Rd, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas	Bleris, L (corresponding author), Univ Texas Dallas, Dept Bioengn, 800 West Campbell Rd, Richardson, TX 75080 USA.; Bleris, L (corresponding author), Univ Texas Dallas, Ctr Syst Biol, 800 West Campbell Rd, Richardson, TX 75080 USA.; Bleris, L (corresponding author), Univ Texas Dallas, Dept Elect Engn, 800 West Campbell Rd, Richardson, TX 75080 USA.	bleris@utdallas.edu			US National Institutes of Health (NIH) [GM096271, CA170018]; US National Science Foundation (NSF) CAREER grant [1351354]; University of Texas at Dallas; Robert Welch Foundation [I-1414]; Directorate For Engineering [1351354] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R21CA170018, R35CA197717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM096271] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF) CAREER grant(National Science Foundation (NSF)); University of Texas at Dallas; Robert Welch Foundation(The Welch Foundation); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) grants GM096271, CA170018, the US National Science Foundation (NSF) CAREER grant 1351354, the University of Texas at Dallas, and Robert Welch Foundation (I-1414).	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2015, GENE THER; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hilton I. B., 2015, NAT BIOTECHNOL; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Kleinstiver B. P., 2015, NATURE; Kuscu C, 2014, NAT BIOTECHNOL; Li Y, 2014, ASSEMBLY VALIDATION, V4; Li Y, 2012, TRANSCRIPTION ACTIVA, V2; Liao J, 2015, NAT GENET; Little AS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001752; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moore R, 2015, NUCLEIC ACIDS RES, V43, P1297, DOI 10.1093/nar/gku1326; Moore R, 2014, ACS SYNTH BIOL, V3, P708, DOI 10.1021/sb400137b; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schreiber T, 2014, NUCLEIC ACIDS RES, V42, P7160, DOI 10.1093/nar/gku341; Taylor DW, 2015, SCIENCE; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Yang LH, 2014, METHODS MOL BIOL, V1114, P245, DOI 10.1007/978-1-62703-761-7_16; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240	27	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0144970	10.1371/journal.pone.0144970	http://dx.doi.org/10.1371/journal.pone.0144970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788852	Green Published, Green Submitted, gold			2022-12-26	WOS:000368529100005
J	Passey, SL; Bozinovski, S; Vlahos, R; Anderson, GP; Hansen, MJ				Passey, Samantha L.; Bozinovski, Steven; Vlahos, Ross; Anderson, Gary P.; Hansen, Michelle J.			Serum Amyloid A Induces Toll-Like Receptor 2-Dependent Inflammatory Cytokine Expression and Atrophy in C2C12 Skeletal Muscle Myotubes	PLOS ONE			English	Article							PEPTIDE RECEPTOR; PROTEIN BREAKDOWN; MYOBLAST MODELS; MESSENGER-RNA; IGF-I; COPD; MORTALITY; EXACERBATIONS; DYSFUNCTION; ACTIVATION	Background Skeletal muscle wasting is an important comorbidity of Chronic Obstructive Pulmonary Disease (COPD) and is strongly correlated with morbidity and mortality. Patients who experience frequent acute exacerbations of COPD (AECOPD) have more severe muscle wasting and reduced recovery of muscle mass and function after each exacerbation. Serum levels of the pro-inflammatory acute phase protein Serum Amyloid A (SAA) can rise more than 1000-fold in AECOPD and are predictively correlated with exacerbation severity. The direct effects of SAA on skeletal muscle are poorly understood. Here we have examined SAA effects on pro-inflammatory cachectic cytokine expression (IL-6 and TNF alpha) and atrophy in C2C12 myotubes. Results SAA increased IL-6 (31-fold) and TNF alpha (6.5-fold) mRNA levels compared to control untreated cells after 3h of SAA treatment, and increased secreted IL-6 protein at 24h. OxPAPC, a dual TLR2 and TLR4 inhibitor, reduced the response to SAA by approximately 84% compared to SAA alone, and the TLR2 neutralising antibody T2.5 abolished SAA-induced expression of IL-6, indicating that SAA signalling in C2C12 myotubes is primarily via TLR2. SAA also reduced myotube width by 10-13% and induced a 2.5-fold increase in the expression of the muscle atrophy gene Atrogin-1, suggesting direct effects of SAA on muscle wasting. Blocking of TLR2 inhibited the SAA-induced decrease in myotube width and Atrogin-1 gene expression, indicating that SAA induces atrophy through TLR2. Conclusions These data demonstrate that SAA stimulates a robust pro-inflammatory response in skeletal muscle myotubes via the TLR2-dependent release of IL-6 and TNF alpha. Furthermore, the observed atrophy effects indicate that SAA could also be directly contributing to the wasting and poor recovery of muscle mass. Therapeutic strategies targeting this SAA-TLR2 axis may therefore ameliorate muscle wasting in AECOPD and a range of other inflammatory conditions associated with loss of muscle mass.	[Passey, Samantha L.; Bozinovski, Steven; Vlahos, Ross; Anderson, Gary P.; Hansen, Michelle J.] Univ Melbourne, Lung Hlth Res Ctr, Dept Pharmacol & Therapeut, Parkville, Vic 3052, Australia; [Passey, Samantha L.; Bozinovski, Steven; Vlahos, Ross] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia	University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Passey, SL; Hansen, MJ (corresponding author), Univ Melbourne, Lung Hlth Res Ctr, Dept Pharmacol & Therapeut, Parkville, Vic 3052, Australia.; Passey, SL (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia.	Samantha.Passey@rmit.edu.au; mjhansen@unimelb.edu.au	Vlahos, Ross/AAM-3837-2020	Vlahos, Ross/0000-0001-8443-7071; Bozinovski, Steven/0000-0001-6533-8641; Anderson, Gary/0000-0001-6580-3398; Passey, Samantha/0000-0002-9782-3032	National Health and Medical Research Council of Australia [628492]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a National Health and Medical Research Council of Australia project grant to MJH (grant number 628492, www.nhmrc.gov.au). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari K, 2012, POSTGRAD MED J, V88, P372, DOI 10.1136/postgradmedj-2011-130293; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Bizzarro V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048246; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Bozinovski S, 2008, AM J RESP CRIT CARE, V177, P269, DOI 10.1164/rccm.200705-678OC; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Cattaneo F, 2013, INT J MOL SCI, V14, P7193, DOI 10.3390/ijms14047193; Chen KQ, 2008, J LEUKOCYTE BIOL, V83, P1467, DOI 10.1189/jlb.0907607; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Cho WCS, 2010, BRIT J CANCER, V102, P1731, DOI 10.1038/sj.bjc.6605700; Decramer M, 1997, EUR RESPIR J, V10, P417, DOI 10.1183/09031936.97.10020417; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Frost RA, 2006, AM J PHYSIOL-REG I, V290, pR773, DOI 10.1152/ajpregu.00490.2005; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; GOODMAN MN, 1991, AM J PHYSIOL, V260, pE727, DOI 10.1152/ajpendo.1991.260.5.E727; GOODMAN MN, 1994, P SOC EXP BIOL MED, V205, P182; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Hughes DC, 2016, BIOGERONTOLOGY, V17, P619, DOI 10.1007/s10522-015-9621-9; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Koga T, 2008, FEBS LETT, V582, P579, DOI 10.1016/j.febslet.2008.01.022; Kumon Y, 1999, J RHEUMATOL, V26, P785; Lakota K, 2013, MICROVASC RES, V90, P55, DOI 10.1016/j.mvr.2013.07.011; Langhans C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092048; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maltais Francois, 2014, Am J Respir Crit Care Med, V189, pe15, DOI 10.1164/rccm.201402-0373ST; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; O'Reilly S, 2014, IMMUNOLOGY, V143, P331, DOI 10.1111/imm.12260; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; Player DJ, 2014, BIOTECHNOL LETT, V36, P1113, DOI 10.1007/s10529-014-1464-y; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Sharples AP, 2011, CURR OPIN CLIN NUTR, V14, P230, DOI 10.1097/MCO.0b013e3283457ade; Sharples AP, 2010, J CELL PHYSIOL, V225, P240, DOI 10.1002/jcp.22252; Shin EH, 2006, BIOCHEM BIOPH RES CO, V341, P1317, DOI 10.1016/j.bbrc.2006.01.098; Spruit MA, 2003, THORAX, V58, P752, DOI 10.1136/thorax.58.9.752; Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Tamamoto T, 2013, VET IMMUNOL IMMUNOP, V155, P190, DOI 10.1016/j.vetimm.2013.06.010; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; van Aubel RAMH, 2007, MOL IMMUNOL, V44, P3702, DOI 10.1016/j.molimm.2007.04.001; Vilaro J, 2010, RESP MED, V104, P1896, DOI 10.1016/j.rmed.2010.05.001; Waechter V, 2012, J IMMUNOL, V188, P1856, DOI 10.4049/jimmunol.1101788; Yende S, 2006, THORAX, V61, P10, DOI 10.1136/thx.2004.034181; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	53	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146882	10.1371/journal.pone.0146882	http://dx.doi.org/10.1371/journal.pone.0146882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784349	gold, Green Published			2022-12-26	WOS:000368528400077
J	Boccaccio, A; Uva, AE; Fiorentino, M; Mori, G; Monno, G				Boccaccio, Antonio; Uva, Antonio Emmanuele; Fiorentino, Michele; Mori, Giorgio; Monno, Giuseppe			Geometry Design Optimization of Functionally Graded Scaffolds for Bone Tissue Engineering: A Mechanobiological Approach	PLOS ONE			English	Article							MANDIBULAR DISTRACTION OSTEOGENESIS; MECHANO-REGULATION MODEL; HYDROXYAPATITE CERAMICS; DIFFERENTIATION; FABRICATION; POROSITY; REGENERATION; ANGIOGENESIS; SIMULATION; BODIES	Functionally Graded Scaffolds (FGSs) are porous biomaterials where porosity changes in space with a specific gradient. In spite of their wide use in bone tissue engineering, possible models that relate the scaffold gradient to the mechanical and biological requirements for the regeneration of the bony tissue are currently missing. In this study we attempt to bridge the gap by developing a mechanobiology-based optimization algorithm aimed to determine the optimal graded porosity distribution in FGSs. The algorithm combines the parametric finite element model of a FGS, a computational mechano-regulation model and a numerical optimization routine. For assigned boundary and loading conditions, the algorithm builds iteratively different scaffold geometry configurations with different porosity distributions until the best microstructure geometry is reached, i.e. the geometry that allows the amount of bone formation to be maximized. We tested different porosity distribution laws, loading conditions and scaffold Young's modulus values. For each combination of these variables, the explicit equation of the porosity distribution law-i.e the law that describes the pore dimensions in function of the spatial coordinates-was determined that allows the highest amounts of bone to be generated. The results show that the loading conditions affect significantly the optimal porosity distribution. For a pure compression loading, it was found that the pore dimensions are almost constant throughout the entire scaffold and using a FGS allows the formation of amounts of bone slightly larger than those obtainable with a homogeneous porosity scaffold. For a pure shear loading, instead, FGSs allow to significantly increase the bone formation compared to a homogeneous porosity scaffolds. Although experimental data is still necessary to properly relate the mechanical/biological environment to the scaffold microstructure, this model represents an important step towards optimizing geometry of functionally graded scaffolds based on mechanobiological criteria.	[Boccaccio, Antonio; Uva, Antonio Emmanuele; Fiorentino, Michele; Monno, Giuseppe] Politecn Bari, Dipartimento Meccan Matemat & Management, I-70126 Bari, Italy; [Mori, Giorgio] Univ Foggia, Dipartimento Med Clin & Sperimentale, I-71122 Foggia, Italy	Politecnico di Bari; University of Foggia	Boccaccio, A (corresponding author), Politecn Bari, Dipartimento Meccan Matemat & Management, I-70126 Bari, Italy.	a.boccaccio@poliba.it	Uva, Antonio Emmanuele/A-9673-2012; Fiorentino, Michele/M-6976-2015; Mori, Giorgio/P-1370-2014	Fiorentino, Michele/0000-0003-2197-6574; Mori, Giorgio/0000-0001-6731-0247; BOCCACCIO, ANTONIO/0000-0002-9623-7189; Uva, Antonio/0000-0001-7271-6137				Bailey BM, 2013, ACTA BIOMATER, V9, P8254, DOI 10.1016/j.actbio.2013.05.012; Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372; Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336; Boccaccio A, 2008, MED BIOL ENG COMPUT, V46, P283, DOI 10.1007/s11517-007-0247-1; Boccaccio A, 2007, ANN BIOMED ENG, V35, P1940, DOI 10.1007/s10439-007-9367-x; Boccaccio A, 2012, MED BIOL ENG COMPUT, V50, P947, DOI 10.1007/s11517-012-0937-1; Boccaccio A, 2011, INT J BIOL SCI, V7, P112, DOI 10.7150/ijbs.7.112; Boccaccio A, 2008, J MECH MED BIOL, V8, P203, DOI 10.1142/S0219519408002644; Boccaccio A, 2016, INT J BIOL SCI, V12, P1, DOI 10.7150/ijbs.13158; Boccaccio A, 2011, J ORTHOP RES, V29, P433, DOI 10.1002/jor.21231; Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003; Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9; Chua CK, 2011, MRS BULL, V36, P1006, DOI 10.1557/mrs.2011.271; Coelho PG, 2015, MED ENG PHYS, V37, P287, DOI 10.1016/j.medengphy.2015.01.004; Dias MR, 2014, MED ENG PHYS, V36, P448, DOI 10.1016/j.medengphy.2014.02.010; Feng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049955; Giannitelli SM, 2015, MAT SCI ENG C-MATER, V51, P329, DOI 10.1016/j.msec.2015.03.002; Guyot Y, 2014, BIOMECH MODEL MECHAN, V13, P1361, DOI 10.1007/s10237-014-0577-5; Hendrikson WJ, 2014, BIOTECHNOL BIOENG, V111, P1864, DOI 10.1002/bit.25231; Huiskes R, 1997, J MATER SCI-MATER M, V8, P785, DOI 10.1023/A:1018520914512; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Lee BT, 2006, J EUR CERAM SOC, V26, P3525, DOI 10.1016/j.jeurceramsoc.2005.12.017; Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002; Lu WW, 2003, J MATER SCI-MATER M, V14, P1039, DOI 10.1023/B:JMSM.0000004000.56814.9e; Macchetta A, 2009, ACTA BIOMATER, V5, P1319, DOI 10.1016/j.actbio.2008.11.009; Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047; Miao XG, 2010, MATERIALS, V3, P26, DOI 10.3390/ma3010026; Muthutantri A, 2008, J R SOC INTERFACE, V5, P1459, DOI 10.1098/rsif.2008.0092; Pan Z, 2015, REGEN BIOMATER, V2, P9, DOI 10.1093/rb/rbv001; Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; Rainer A, 2012, ANN BIOMED ENG, V40, P966, DOI 10.1007/s10439-011-0465-4; Rodriguez-Lorenzo LM, 2004, MATER RES BULL, V39, P83, DOI 10.1016/j.materresbull.2003.09.014; Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064; Sandino C, 2010, BIOMATERIALS, V31, P2446, DOI 10.1016/j.biomaterials.2009.11.063; Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8; Wieding J, 2014, J MECH BEHAV BIOMED, V37, P56, DOI 10.1016/j.jmbbm.2014.05.002; Yang JW, 2015, J CRANIOFAC SURG, V26, pE148, DOI 10.1097/SCS.0000000000001383; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Yavari SA, 2014, J BIOMECH, V47, P2700, DOI 10.1016/j.jbiomech.2014.05.006; Zadpoor AA, 2015, BIOMATER SCI-UK, V3, P231, DOI 10.1039/c4bm00291a	42	67	70	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146935	10.1371/journal.pone.0146935	http://dx.doi.org/10.1371/journal.pone.0146935			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771746	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300044
J	Okazaki, F; Matsunaga, N; Okazaki, H; Azuma, H; Hamamura, K; Tsuruta, A; Tsurudome, Y; Ogino, T; Hara, Y; Suzuki, T; Hyodo, K; Ishihara, H; Kikuchi, H; To, H; Aramaki, H; Koyanagi, S; Ohdo, S				Okazaki, Fumiyasu; Matsunaga, Naoya; Okazaki, Hiroyuki; Azuma, Hiroki; Hamamura, Kengo; Tsuruta, Akito; Tsurudome, Yuya; Ogino, Takashi; Hara, Yukinori; Suzuki, Takuya; Hyodo, Kenji; Ishihara, Hiroshi; Kikuchi, Hiroshi; To, Hideto; Aramaki, Hironori; Koyanagi, Satoru; Ohdo, Shigehiro			Circadian Clock in a Mouse Colon Tumor Regulates Intracellular Iron Levels to Promote Tumor Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian; circadian rhythm; iron; iron metabolism; pharmacology	TRANSFERRIN RECEPTOR; MOLECULAR CONTROL; DNA-SYNTHESIS; GROWTH-FACTOR; METABOLISM; CANCER; PROTEINS; RHYTHM; CELL; EXPRESSION	Iron is an important biological catalyst and is critical for DNA synthesis during cell proliferation. Cellular iron uptake is enhanced in tumor cells to support increased DNA synthesis. Circadian variations in DNA synthesis and proliferation have been identified in tumor cells, but their relationship with intracellular iron levels is unclear. In this study, we identified a 24-h rhythm in iron regulatory protein 2 (IRP2) levels in colon-26 tumors implanted in mice. Our findings suggest that IRP2 regulates the 24-h rhythm of transferrin receptor 1 (Tfr1) mRNA expression post-transcriptionally, by binding to RNA stem-loop structures known as iron-response elements. We also found that Irp2 mRNA transcription is promoted by circadian clock genes, including brain and muscle Arnt-like 1 (BMAL1) and the circadian locomotor output cycles kaput (CLOCK) heterodimer. Moreover, growth in colon-26(19) tumors expressing the clock-mutant protein (CLOCK19) was low compared with that in wild-type colon-26 tumor. The time-dependent variation of cellular iron levels, and the proliferation rate in wild-type colon-26 tumor was decreased by CLOCK19 expression. Our findings suggest that circadian organization contributes to tumor cell proliferation by regulating iron metabolism in the tumor.	[Okazaki, Fumiyasu; To, Hideto] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Med Pharmaceut, Toyama 9300194, Japan; [Okazaki, Fumiyasu; Matsunaga, Naoya; Azuma, Hiroki; Tsuruta, Akito; Tsurudome, Yuya; Ogino, Takashi; Hara, Yukinori; Ohdo, Shigehiro] Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Fukuoka 8128582, Japan; [Koyanagi, Satoru] Kyushu Univ, Fac Pharmaceut Sci, Dept Global Healthcare Sci, Fukuoka 8128582, Japan; [Okazaki, Hiroyuki; Hamamura, Kengo; Aramaki, Hironori] Daiichi Univ Pharm, Dept Mol Biol, Fukuoka 8158511, Japan; [Aramaki, Hironori] Daiichi Univ Pharm, Drug Innovat Res Ctr, Fukuoka 8158511, Japan; [Suzuki, Takuya; Hyodo, Kenji; Ishihara, Hiroshi] Pharmaceut Sci & Technol Core Funct Unit, Formulat Res, Ibaraki 3002635, Japan; [Kikuchi, Hiroshi] Eisai & Co Ltd, Eisai Prod Creat Syst, Chief Innovat Officer Grp, Ibaraki 3002635, Japan	University of Toyama; Kyushu University; Kyushu University; Eisai Co Ltd	Ohdo, S (corresponding author), 3-1-1 Maidashi Higashi Ku, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020	Koyanagi, Satoru/0000-0003-4849-2377; matsunaga2, naoya2/0000-0001-6226-8473; Hamamura, Kengo/0000-0001-9146-8554; Tsurudome, Yuya/0000-0002-6454-9778	Uehara Memorial Foundation; Japan Research Foundation for Clinical Pharmacology; Japan Society for the Promotion of Science (JSPS) [25-4175]; Fukuoka Foundation for Sound Health; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology, Japan;  [25253038];  [25136716];  [25670079];  [15K08098];  [26860097];  [15K19167];  [15H06795K]; Grants-in-Aid for Scientific Research [15H06795] Funding Source: KAKEN	Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Research Foundation for Clinical Pharmacology; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health); Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology, Japan; ; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (A; 25253038) (to S. O.), Scientific Research on Innovative Areas (25136716) (to S. O.), and Challenging Exploratory Research (25670079) (to S. O.), the Uehara Memorial Foundation (to S. O.), Grant-in-Aid for Scientific Research (C; 15K08098) (to N. M.) and Grant-in-Aid for Young Scientists (B; 26860097) (to F. O.), Grant-in-Aid for Young Scientists (B; 15K19167) (to H. O.), and Grant-in-Aid for Young Scientists (Start-up; 15H06795K) (to K. H.), the Japan Research Foundation for Clinical Pharmacology (to N. M.), a Grant-in-Aid for JSPS Fellows (25-4175) (to K. H.) from the Japan Society for the Promotion of Science (JSPS), the Fukuoka Foundation for Sound Health, and the Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abbaspour N, 2014, J RES MED SCI, V19, P164; Alvarez JD, 2002, NATURE, V419, P798, DOI 10.1038/419798a; Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Fairweather-Tait SJ, 2004, P NUTR SOC, V63, P519, DOI 10.1079/PNS2004394; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Henderson BR, 1996, BIOESSAYS, V18, P739, DOI 10.1002/bies.950180909; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Huang X, 2003, MUTAT RES-FUND MOL M, V533, P153, DOI 10.1016/j.mrfmmm.2003.08.023; Koyanagi S, 2003, CANCER RES, V63, P7277; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Nakagawa H, 2008, J PHARMACOL SCI, V107, P401, DOI 10.1254/jphs.08080FP; NIITSU Y, 1987, TOHOKU J EXP MED, V153, P239, DOI 10.1620/tjem.153.239; Okazaki F, 2010, CANCER RES, V70, P6238, DOI 10.1158/0008-5472.CAN-10-0184; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; SMAALAND R, 1991, BLOOD, V77, P2603; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; TROWBRIDGE IS, 1982, P NATL ACAD SCI-BIOL, V79, P1175, DOI 10.1073/pnas.79.4.1175; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wood PA, 2006, MOL CANCER THER, V5, P2023, DOI 10.1158/1535-7163.MCT-06-0177	29	26	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7017	7028		10.1074/jbc.M115.713412	http://dx.doi.org/10.1074/jbc.M115.713412			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26797126	Green Published, hybrid			2022-12-26	WOS:000373299700037
J	Gu, XD; Wu, ZP; Huang, Y; Wagner, MA; Baleanu-Gogonea, C; Mehl, RA; Buffa, JA; DiDonato, AJ; Hazen, LB; Fox, PL; Gogonea, V; Parks, JS; DiDonato, JA; Hazen, SL				Gu, Xiaodong; Wu, Zhiping; Huang, Ying; Wagner, Matthew A.; Baleanu-Gogonea, Camelia; Mehl, Ryan A.; Buffa, Jennifer A.; DiDonato, Anthony J.; Hazen, Leah B.; Fox, Paul L.; Gogonea, Valentin; Parks, John S.; DiDonato, Joseph A.; Hazen, Stanley L.			A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; atherosclerosis; cholesterol; high-density lipoprotein (HDL); post-translational modification (PTM); LCAT	CASSETTE TRANSPORTER 1; APOA-I; TANGIER-DISEASE; NATURAL MUTATIONS; HUMAN ATHEROMA; LECITHIN; HDL; LCAT; DEFICIENCY; ACTIVATION	The interaction of lecithin-cholesterol acyltransferase (LCAT) with apolipoprotein A-I (apoA-I) plays a critical role in high-density lipoprotein (HDL) maturation. We previously identified a highly solvent-exposed apoA-I loop domain (Leu(159)-Leu(170)) in nascent HDL, the so-called solar flare (SF) region, and proposed that it serves as an LCAT docking site (Wu, Z., Wagner, M. A., Zheng, L., Parks, J. S., Shy, J. M., 3rd, Smith, J. D., Gogonea, V., and Hazen, S. L. (2007) Nat. Struct. Mol. Biol. 14, 861-868). The stability and role of the SF domain of apoA-I in supporting HDL binding and activation of LCAT are debated. Here we show by site-directed mutagenesis that multiple residues within the SF region (Pro(165), Tyr(166), Ser(167), and Asp(168)) of apoA-I are critical for both LCAT binding to HDL and LCAT catalytic efficiency. The critical role for possible hydrogen bond interaction at apoA-I Tyr(166) was further supported using reconstituted HDL generated from apoA-I mutants (Tyr(166) Glu or Asn), which showed preservation in both LCAT binding affinity and catalytic efficiency. Moreover, the in vivo functional significance of NO2-Tyr(166)-apoA-I, a specific post-translational modification on apoA-I that is abundant within human atherosclerotic plaque, was further investigated by using the recombinant protein generated from E. coli containing a mutated orthogonal tRNA synthetase/tRNA(CUA) pair enabling site-specific insertion of the unnatural amino acid into apoA-I. NO2-Tyr(166)-apoA-I, after subcutaneous injection into hLCAT(Tg/Tg), apoA-I-/- mice, showed impaired LCAT activation in vivo, with significant reduction in HDL cholesteryl ester formation. The present results thus identify multiple structural features within the solvent-exposed SF region of apoA-I of nascent HDL essential for optimal LCAT binding and catalytic efficiency.	[Gu, Xiaodong; Wu, Zhiping; Huang, Ying; Wagner, Matthew A.; Baleanu-Gogonea, Camelia; Buffa, Jennifer A.; DiDonato, Anthony J.; Hazen, Leah B.; Fox, Paul L.; Gogonea, Valentin; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Mehl, Ryan A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Parks, John S.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Oregon State University; Wake Forest University	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, 9500 Euclid Ave,NE-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021		National Institutes of Health [P01 HL076491, R01 HL119962]; Esperion; PG; Abbott; Astra Zeneca; Pfizer Inc.; Roche; Takeda; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL119962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Esperion; PG(Procter & Gamble); Abbott(Abbott Laboratories); Astra Zeneca(AstraZeneca); Pfizer Inc.(Pfizer); Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01 HL076491 and R01 HL119962 (to J. S. P.). S. L. H. is named as co-inventor on pending patents held by the Cleveland Clinic relating to cardiovascular and inflammation diagnostics. S. L. H. reports having been paid as a consultant for the following companies: Esperion and P&G. S. L. H. reports receiving research funds from Abbott, Astra Zeneca, P&G, Pfizer Inc., Roche, and Takeda. S. L. H. Hazen reports having the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from the following companies: Cleveland Heart Lab, Siemens, Esperion, Frantz Biomarkers, LLC. All other authors have no relationships to disclose. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander ET, 2005, BIOCHEMISTRY-US, V44, P5409, DOI 10.1021/bi047412v; Bochem AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090967; Bochem AE, 2013, J LIPID RES, V54, P1698, DOI 10.1194/jlr.P033449; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Boes E, 2009, EXP GERONTOL, V44, P136, DOI 10.1016/j.exger.2008.11.003; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Carlson L. A., 1979, LANCET, V2, P922; Chisholm JW, 1999, J LIPID RES, V40, P1512; Cho KH, 2001, J LIPID RES, V42, P379; Daum U, 1999, J LIPID RES, V40, P486; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; Duivenvoorden R, 2011, J AM COLL CARDIOL, V58, P2481, DOI 10.1016/j.jacc.2010.11.092; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Fotakis P, 2015, BIOCHEMISTRY-US, V54, P3348, DOI 10.1021/acs.biochem.5b00180; Fotakis P, 2013, J LIPID RES, V54, P3293, DOI 10.1194/jlr.M043489; Furbee JW, 2002, ATHEROSCLEROSIS, V165, P89, DOI 10.1016/S0021-9150(02)00201-0; Furbee JW, 2002, J BIOL CHEM, V277, P3511, DOI 10.1074/jbc.M109883200; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gogonea V, 2013, J LIPID RES, V54, P966, DOI 10.1194/jlr.M032763; Gorshkova IN, 2006, BIOCHEMISTRY-US, V45, P1242, DOI 10.1021/bi051669r; Hoang A, 2003, BBA-MOL CELL BIOL L, V1631, P72, DOI 10.1016/S1388-1981(02)00357-8; Holvoet P, 2000, ARTERIOSCL THROM VAS, V20, P459, DOI 10.1161/01.ATV.20.2.459; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Jin LH, 1999, BIOCHEMISTRY-US, V38, P15659, DOI 10.1021/bi9916729; Koukos G, 2007, BIOCHEMISTRY-US, V46, P10713, DOI 10.1021/bi7003203; Kunnen S, 2012, J LIPID RES, V53, P1783, DOI 10.1194/jlr.R024513; Leren TP, 1997, J LIPID RES, V38, P121; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Miettinen HE, 1997, ARTERIOSCL THROM VAS, V17, P3021, DOI 10.1161/01.ATV.17.11.3021; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Roshan B, 2011, J CLIN LIPIDOL, V5, P493, DOI 10.1016/j.jacl.2011.07.002; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Saeedi R, 2015, CLIN BIOCHEM, V48, P472, DOI 10.1016/j.clinbiochem.2014.08.014; Schaefer EJ, 2014, CURR OPIN LIPIDOL, V25, P194, DOI 10.1097/MOL.0000000000000074; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shih AY, 2008, BIOPHYS J, V94, pL87, DOI 10.1529/biophysj.108.131581; Sorci-Thomas MG, 2009, CLIN LIPIDOL, V4, P113, DOI 10.2217/17584299.4.1.113; Sviridov D, 2002, J LIPID RES, V43, P1283, DOI 10.1194/jlr.M100437/JLR200; Sviridov D, 1996, J BIOL CHEM, V271, P33277, DOI 10.1074/jbc.271.52.33277; van den Bogaard B, 2012, ATHEROSCLEROSIS, V225, P481, DOI 10.1016/j.atherosclerosis.2012.09.022; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	46	14	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6386	6395		10.1074/jbc.M115.696088	http://dx.doi.org/10.1074/jbc.M115.696088			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797122	hybrid, Green Published			2022-12-26	WOS:000372894200027
J	Randall, CJ; Jordan-Garza, AG; Muller, EM; van Woesik, R				Randall, Carly J.; Jordan-Garza, Adan G.; Muller, Erinn M.; van Woesik, Robert			Does Dark-Spot Syndrome Experimentally Transmit among Caribbean Corals?	PLOS ONE			English	Article							BLACK-BAND DISEASE; TEMPERATURE ANOMALIES; MONTASTRAEA-FAVEOLATA; REEF SYSTEM; PREVALENCE; SUSCEPTIBILITY; PATHOGEN; INFECTION; STRESS	Over the last half-century, coral diseases have contributed to the rapid decline of coral populations throughout the Caribbean region. Some coral diseases appear to be potentially infectious, yet little is known about their modes of transmission. This study experimentally tested whether dark-spot syndrome on Siderastrea siderea was directly or indirectly transmissible to neighboring coral colonies. We also tested whether open wounds were necessary to facilitate disease transmission. At the completion of the experiments, we sampled bacterial communities on diseased, exposed, and healthy coral colonies to determine whether bacterial pathogens had transmitted to the susceptible colonies. We saw no evidence of either direct or waterborne transmission of dark-spot syndrome, and corals that received lesions by direct contact with diseased tissue, healed and showed no signs of infection. There were no significant differences among bacterial communities on healthy, exposed, and diseased colonies, although nine individual ribotypes were significantly higher in diseased corals compared with healthy and exposed corals, indicating a lack of transmission. Although our experiments do not fully refute the possibility that dark-spot syndrome is infectious and transmissible, our results suggest that in situ macroscopic signs of dark-spot syndrome are not always contagious.	[Randall, Carly J.; Jordan-Garza, Adan G.; van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL USA; [Muller, Erinn M.] Mote Marine Lab, Sarasota, FL 34236 USA; [Jordan-Garza, Adan G.] Univ Veracruzana, Tuxpan, Veracruz, Mexico	Florida Institute of Technology; Mote Marine Laboratory & Aquarium; Universidad Veracruzana	Randall, CJ (corresponding author), Florida Inst Technol, Dept Biol Sci, Melbourne, FL USA.	crandall2012@my.fit.edu	Jordán-Garza, Adán Guillermo/ABE-4089-2021; Randall, Carly J./H-4195-2019	Jordán-Garza, Adán Guillermo/0000-0002-9856-2276; Randall, Carly J./0000-0001-8112-3552	National Science Foundation [OCE-1219804]; Directorate For Geosciences [1219804] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this study was provided by the National Science Foundation award #OCE-1219804 awarded to RvW.	Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; Alker AP, 2001, HYDROBIOLOGIA, V460, P105, DOI 10.1023/A:1013145524136; [Anonymous], 2014, R LANG ENV STAT COMP; Antonius A, 1999, CORAL REEFS, V18, P300, DOI 10.1007/s003380050199; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Borger JL, 2005, CORAL REEFS, V24, P139, DOI 10.1007/s00338-004-0434-6; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Bruckner AW, 1997, B MAR SCI, V61, P919; Bythell J, 2004, CORAL HEALTH AND DISEASE, P351; Carricart-Ganivet JP, 2011, DIS AQUAT ORGAN, V95, P181, DOI 10.3354/dao02359; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; Cervino J, 2001, HYDROBIOLOGIA, V460, P53, DOI 10.1023/A:1013166617140; Clemens E, 2015, CORAL REEFS, P1; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fox J., 2019, R COMPANION APPL REG, V.; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GARZONFERREIRA J, 1998, REEF ENCOUNTER, V24, P10; Gignoux-Wolfsohn SA, 2012, SCI REP, V2, P1; Gil-Agudelo DL, 2007, CAN J MICROBIOL, V53, P465, DOI 10.1139/W07-002; Gil-Agudelo DL, 2004, CORAL HEALTH AND DISEASE, P337; Gil-Agudelo DL, 2001, B MAR SCI, V69, P619; Gochfeld DJ, 2006, DIS AQUAT ORGAN, V69, P53, DOI 10.3354/dao069053; Hall ER, 2012, P 12 INT COR REEF S, P1; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Jordan-Garza AG, 2011, DIS AQUAT ORGAN, V96, P83, DOI 10.3354/dao02368; Kellogg CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108767; Kline DI, 2011, SCI REP-UK, V1, DOI 10.1038/srep00007; Kooperman N, 2007, FEMS MICROBIOL LETT, V276, P106, DOI 10.1111/j.1574-6968.2007.00921.x; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Oksanen J., **DATA OBJECT**; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Peters G, 2011, USERFRIENDLYSCIENCE; Porter JW, 2011, J EXP MAR BIOL ECOL, V408, P79, DOI 10.1016/j.jembe.2011.07.027; PORTER JW, 2001, HYDROBIOLOGIA, V1, P24; Pratte ZA, 2015, J INVERTEBR PATHOL, V125, P42, DOI 10.1016/j.jip.2014.12.009; Randall CJ, 2014, ECOLOGY, V95, P1981, DOI 10.1890/13-0774.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Renegar D.A., 2008, P 11 INT COR REEF S, P185; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Rodriguez S, 2009, CORAL REEFS, V28, P67, DOI 10.1007/s00338-008-0419-y; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Santavy D.L., 1997, P607; Smith GW, 1998, REV BIOL TROP, V46, P205; Stedman T.L, 1976, STEDMANS MED DICT; Sudek M, 2015, DIS AQUAT ORGAN, V113, P59, DOI 10.3354/dao02828; Sussman M, 2003, ENVIRON MICROBIOL, V5, P250, DOI 10.1046/j.1462-2920.2003.00424.x; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062580; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Weil E, 2009, CARIBB J SCI, V45, P221; Weil E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P465, DOI 10.1007/978-94-007-0114-4_27; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155	64	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147493	10.1371/journal.pone.0147493	http://dx.doi.org/10.1371/journal.pone.0147493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788918	Green Submitted, gold, Green Published			2022-12-26	WOS:000368529100090
J	Hu, ML; Yang, SL; Yang, L; Cheng, YZ; Zhang, H				Hu, Minling; Yang, Shuangli; Yang, Li; Cheng, Yanzhen; Zhang, Hua			Interleukin-22 Alleviated Palmitate-Induced Endoplasmic Reticulum Stress in INS-1 Cells through Activation of Autophagy	PLOS ONE			English	Article							OXIDATIVE STRESS; HOMEOSTASIS; EXPRESSION; IMMUNITY; IL-22; MASS	Objective Stimulation with saturated fatty acids has been shown to induce oxidative stress and endoplasmic reticulum (ER) stress in beta cells and has been recognized as an important component of the pathogenesis of type 2 diabetes (T2D). Interleukin-22 (IL-22) plays a critical role in preventing beta cells from oxidative and ER stress, and autophagy is associated with the survival and function of beta cells. However, whether IL-22 alleviates cellular stress through activation of autophagy is unclear. In this study, we investigated the effects of IL-22 on rat insulin-secreting cells and the mechanisms underlying IL-22 and lipotoxicity-induced oxidative and ER stress in vitro. Methods The levels of reactive oxygen species (ROS) were detected by flow cytometry and fluorescence microscopy. The protein expression of glucose-regulated protein 78 (GRP78), C/EBP homologous protein (CHOP), microtubule-associated protein light chain 3B (LC3B) and Bcl-2-interacting myosin-like coiled-coil protein (Beclin-1) were evaluated by western blot. Transmission electron microscopy was utilized to observe the process of autophagy. Results Palmitate induced increased levels of ROS and the overexpression of GRP78 and CHOP, whereas these effects were partly reversed by treatment with IL-22. Furthermore, IL-22 upregulated the protein expression of Beclin-1 and the conversion of LC3B-I to LC3B-II. Moreover, the aforementioned effects were partly suppressed by treating cells with 3-methyladenine (3-MA), an autophagy inhibitor. Conclusions Our results suggest that IL-22 alleviated the oxidative and ER stress induced by palmitate, which was likely mediated by autophagy. These findings could facilitate the development of novel therapeutic strategies to suppress the progression of T2D.	[Hu, Minling; Yang, Shuangli; Yang, Li; Cheng, Yanzhen; Zhang, Hua] Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Zhang, H (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China.	jimzhua123@163.com			Guangzhou Science Technology and Innovation Commission; special grant for diabetic research in Guangzhou [2014J4100129]	Guangzhou Science Technology and Innovation Commission; special grant for diabetic research in Guangzhou	This work was supported by Guangzhou Science Technology and Innovation Commission and a special grant for diabetic research in Guangzhou (No. 2014J4100129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Avitabile S, 2015, J INVEST DERMATOL, V135, P2862, DOI 10.1038/jid.2015.278; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bikopoulos G, 2008, J ENDOCRINOL, V196, P455, DOI 10.1677/JOE-07-0174; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chen YY, 2013, INT J MOL MED, V32, P1401, DOI 10.3892/ijmm.2013.1530; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Feng DC, 2012, INT J BIOL SCI, V8, P249, DOI 10.7150/ijbs.3967; Fonseca SG, 2009, CURR OPIN PHARMACOL, V9, P763, DOI 10.1016/j.coph.2009.07.003; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Hill Thomas, 2013, Cell Regen, V2, P2, DOI 10.1186/2045-9769-2-2; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; IDF Diabet Atlas Grp, 2015, DIABETES RES CLIN PR, V109, P461, DOI 10.1016/j.diabres.2015.05.037; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Liu H, 2010, EYE, V24, P137, DOI 10.1038/eye.2009.20; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Mitra A, 2012, CYTOKINE, V60, P38, DOI 10.1016/j.cyto.2012.06.316; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sharma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025269; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Woo KJ, 2007, BIOCHEM PHARMACOL, V73, P68, DOI 10.1016/j.bcp.2006.09.015; Yin JJ, 2013, INT J ENDOCRINOL MET, V11, P184, DOI 10.5812/ijem.8088	41	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146818	10.1371/journal.pone.0146818	http://dx.doi.org/10.1371/journal.pone.0146818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784895	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400069
J	Wang, MR; Zheng, WK; Zhu, XH; Xu, J; Cai, BG; Zhang, YQ; Zheng, F; Zhou, LF; Yang, ZG; Zhang, X; Wang, CJ; Nie, SN; Zhu, J				Wang, Maorong; Zheng, Wenkai; Zhu, Xuhui; Xu, Jing; Cai, Binggang; Zhang, Yiqing; Zheng, Feng; Zhou, Linfu; Yang, Zhiguo; Zhang, Xin; Wang, Changjun; Nie, Shinan; Zhu, Jin			A Human Anti-Toll Like Receptor 4 Fab Fragment Inhibits Lipopolysaccharide-Induced Pro-Inflammatory Cytokines Production in Macrophages	PLOS ONE			English	Article							NEGATIVE REGULATION; HEPATIC-FIBROSIS; STELLATE CELLS; RECOGNITION; TLR4; ACTIVATION; ENDOTOXIN	The results of clinical and experimental studies suggest that endotoxin/toll-like receptor 4 (TLR4)-mediated proinflammatory and profibrotic signaling activation is critical in the development of hepatic fibrosis. However, studies examining the role of specific TLR4 inhibitor are still lacking. The present study was aimed to prepare a human anti-TLR4 Fab fragment, named hTLR4-Fab01, and to explore its immune activity. We screened the positive clone of anti-human TLR4 phagemid from a human phage-display antibody library using recombinant TLR4 protein, which was used as template cDNA for the amplification of variable regions of the heavy (V-H) chain and light chain (V-L), then coupled with highly conserved regions of the heavy chain domain 1 (CH1) and the light chain (CL), respectively. Thus, the prokaryotic expression vector pETDuet-1 of hTLR4-Fab01 was constructed and transformed into Escherichia coli (E. coli) BL21. The characteristic of hTLR4-Fab01 was examined by SDS-PAGE, Western blotting, ELISA, affinity and kinetics assay. Further, our data demonstrate that hTLR4-Fab01 could specifically bind to TLR4, and its treatment obviously attenuated the proinflammatory effect, characterized by less LPS-induced TNF-alpha, IL-1, IL-6 and IL-8 production in human macrophages. In conclusion, we have successfully prepared the hTLR4-Fab01 with efficient activity for blocking LPS-induced proinflammatory cytokines production, suggesting that the hTLR4-Fab01 may be a potential candidate for the treatment of hepatic fibrosis.	[Wang, Maorong; Zheng, Wenkai; Xu, Jing; Zhang, Yiqing; Yang, Zhiguo; Zhang, Xin] Nanjing Jingdu Hosp, Inst Liver Dis, Nanjing 210002, Jiangsu, Peoples R China; [Zhu, Xuhui; Zheng, Feng; Wang, Changjun; Zhu, Jin] Huadong Med Inst Biotech, Nanjing 210002, Jiangsu, Peoples R China; [Zhu, Jin] NJMU, Dept Pathol, Key Lab Antibody Tech, Minist Hlth, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Maorong; Cai, Binggang] Anhui Med Univ, Bayi Clin Coll, Nanjing 210002, Jiangsu, Peoples R China; [Zhu, Xuhui; Nie, Shinan] Nanjing Univ, Jinling Hosp, Dept Emergency Med, Sch Med, Nanjing 210002, Jiangsu, Peoples R China; [Zhou, Linfu] Nanjing Med Univ, Dept Resp Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Anhui Medical University; Nanjing University; Nanjing Medical University	Wang, MR (corresponding author), Nanjing Jingdu Hosp, Inst Liver Dis, Nanjing 210002, Jiangsu, Peoples R China.; Zhu, J (corresponding author), Huadong Med Inst Biotech, Nanjing 210002, Jiangsu, Peoples R China.; Zhu, J (corresponding author), NJMU, Dept Pathol, Key Lab Antibody Tech, Minist Hlth, Nanjing 210029, Jiangsu, Peoples R China.; Wang, MR (corresponding author), Anhui Med Univ, Bayi Clin Coll, Nanjing 210002, Jiangsu, Peoples R China.	maorongwang@126.com; zhujin1968@njmu.edu.cn			Chinese National Twelfth Five-year Plan Project [2013ZX09J13110-05B]; Eleventh Five-year Plan Project of PLA [08G023]; Social development project of Jiangsu Province [BE2015651]; Jiangsu Province Science Foundation for Youths [SBK2014041529]	Chinese National Twelfth Five-year Plan Project; Eleventh Five-year Plan Project of PLA; Social development project of Jiangsu Province; Jiangsu Province Science Foundation for Youths	This work was supported by the Grant (2013ZX09J13110-05B) from Chinese National Twelfth Five-year Plan Project, the Grant (08G023) from Eleventh Five-year Plan Project of PLA, the Grant (BE2015651) from Social development project of Jiangsu Province and the Grant (SBK2014041529) Jiangsu Province Science Foundation for Youths. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Brodsky I, 2007, CELL, V130, P979, DOI 10.1016/j.cell.2007.09.009; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cai BG, 2015, INT J MOL SCI, V16, P25502, DOI 10.3390/ijms161025502; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Cong M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/158547; Ding GP, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475809; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Ge H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117463; Huang JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10660; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Li JD, 2007, PROTEIN ENG DES SEL, V20, P491, DOI 10.1093/protein/gzm038; Li JD, 2007, J IMMUNOL METHODS, V318, P113, DOI 10.1016/j.jim.2006.10.010; Li JT, 2008, J GASTROENTEROL, V43, P419, DOI 10.1007/s00535-008-2180-y; Liang YH, 2012, CLIN BIOCHEM, V45, P1689, DOI 10.1016/j.clinbiochem.2012.09.001; Liao YJ, 2005, MOL BIOTECHNOL, V31, P41, DOI 10.1385/MB:31:1:041; Lin H, 2014, INT J CANCER, V134, P1239, DOI 10.1002/ijc.28451; Liu J, 2012, CELL MOL IMMUNOL, V9, P197, DOI 10.1038/cmi.2012.12; LOOMANS EEMG, 1995, J IMMUNOL METHODS, V184, P207, DOI 10.1016/0022-1759(95)00089-S; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Perugorria MJ, 2013, HEPATOLOGY, V57, P1238, DOI 10.1002/hep.26108; Pol Ewa, 2010, J Vis Exp, DOI 10.3791/1746; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x; Trebicka J, 2011, EUR J GASTROEN HEPAT, V23, P1218, DOI 10.1097/MEG.0b013e32834a75dc; Yang MJ, 2015, NAT IMMUNOL, V16, P1253, DOI 10.1038/ni.3258; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013	31	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146856	10.1371/journal.pone.0146856	http://dx.doi.org/10.1371/journal.pone.0146856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785354	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400074
J	Janssenswillen, S; Bossuyt, F				Janssenswillen, Sunita; Bossuyt, Franky			Male Courtship Pheromones Induce Cloacal Gaping in Female Newts (Salamandridae)	PLOS ONE			English	Article							SEX-PHEROMONE; CHEMICAL CUES; CRESTED NEWT; COMMUNICATION; ATTRACTANTS; RECEPTIVITY; PHYLOGENY; AMPHIBIA; SODEFRIN; BEHAVIOR	Pheromones are an important component of sexual communication in courting salamanders, but the number of species in which their use has been demonstrated with behavioral evidence remains limited. Here we developed a behavioral assay for demonstrating courtship pheromone use in the aquatically courting Iberian ribbed newt Pleurodeles waltl. By performing an in-depth study of the courtship behavior, we show that females invariably open their cloaca (cloacal gaping) before engaging in pinwheel behavior, the circling movement that is the prelude to spermatophore uptake. In contrast, cloacal gaping was not observed in failed courtships, where females escaped or displayed thanatosis. Since gaping mainly occurred during male amplexus and cloacal imposition, which is the obvious period of pheromone transfer, we next investigated whether male courtship water (i.e., water holding courtship pheromones) alone was able to induce this reaction in females. These tests showed that courtship water induced cloacal gaping significantly more than water, even in the absence of a male. Cloacal gaping thus provides a simple and robust test for demonstrating courtship pheromone use in the Iberian ribbed newt. Since opening the cloaca is an essential prerequisite for spermatophore pick-up in all internally fertilizing salamanders, we hypothesize that variations on this assay will also be useful in several other species.	[Janssenswillen, Sunita; Bossuyt, Franky] Vrije Univ Brussel, Dept Biol, Amphibian Evolut Lab, Brussels, Belgium	Vrije Universiteit Brussel	Bossuyt, F (corresponding author), Vrije Univ Brussel, Dept Biol, Amphibian Evolut Lab, Brussels, Belgium.	fbossuyt@vub.ac.be		Bossuyt, Franky/0000-0001-6804-9271	European Research Council starting grant (project TAPAS) [ERC 204509]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G013308, G026715N]; Agentschap voor Innovatie door Wetenschap en Technologie Vlaanderen [093428]; SRP Growth Funding Program of Vrije Universiteit Brussel	European Research Council starting grant (project TAPAS); Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Agentschap voor Innovatie door Wetenschap en Technologie Vlaanderen; SRP Growth Funding Program of Vrije Universiteit Brussel	This work was supported by a European Research Council starting grant (http://erc.europa.eu/) (ERC 204509, project TAPAS) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (http://www.fwo.be/) (grant nos. G013308 and G026715N). SJ is supported by the Agentschap voor Innovatie door Wetenschap en Technologie Vlaanderen (http://www.iwt.be/) (grant no. 093428) and the SRP Growth Funding Program of the Vrije Universiteit Brussel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold S.J., 1977, P141; Arnold SJ., 1982, BIOCH ASP EVOL BIOL, P173; ARNOLD SJ, 1972, THESIS U MICHIGAN AN; BELVEDERE P, 1988, MONIT ZOOL ITAL, V22, P397; BRODIE ED, 1977, COPEIA, P523, DOI 10.2307/1443271; CARPENTER CC, 1977, AM ZOOL, V17, P217; Cummins SF, 2012, NAT PROD REP, V29, P642, DOI 10.1039/c2np00102k; DAWLEY EM, 1984, HERPETOLOGICA, V40, P101; DENNIS D S, 1976, Journal of the Kansas Entomological Society, V49, P48; DOLE JW, 1974, COPEIA, P230, DOI 10.2307/1443028; Dytham C., 2011, CHOOSING USING STAT; Gallien L, 1952, B SOC ZOOL FR, V97, P456; GILLINGHAM J C, 1987, P184; Greene MJ, 2000, HERPETOLOGICA, V56, P166; Griffiths RA, 1996, NEWTS SALAMANDERS EU; Halliday T.R., 1977, P185; Halliday T.R., 1990, Advances in the Study of Behavior, V19, P137, DOI 10.1016/S0065-3454(08)60202-8; Hansen LS, 2008, BEHAV ECOL, V19, P546, DOI 10.1093/beheco/arm165; Houck LD, 2003, REPROD BIOL PHYLOGEN, V1, P383; Houck LD, 2008, CHEM SIGNAL, V11, P213, DOI 10.1007/978-0-387-73945-8_20; Iwata T, 1999, FEBS LETT, V457, P400, DOI 10.1016/S0014-5793(99)01062-5; Janssenswillen S, 2015, MOL BIOL EVOL, V32, P472, DOI 10.1093/molbev/msu316; Kikuyama S, 1999, REV REPROD, V4, P1; KIKUYAMA S, 1995, SCIENCE, V267, P1643, DOI 10.1126/science.7886452; MALACARNE G, 1984, MONIT ZOOL ITAL, V18, P33; MALACARNE G, 1987, COPEIA, P245; Nakada T, 2007, PEPTIDES, V28, P774, DOI 10.1016/j.peptides.2006.12.006; Noble GK, 1937, B AM MUS NAT HIST, V73, P673; Osikowski A, 2008, ZOOL SCI, V25, P587, DOI 10.2108/zsj.25.587; Poschadel JR, 2007, ACTA ETHOL, V10, P35, DOI 10.1007/s10211-007-0025-y; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; SALTHE SN, 1967, COPEIA, P100; Salvador A., 1999, HDB REPTILIEN AMPHIB, P209; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Secondi J, 2005, ETHOLOGY, V111, P726, DOI 10.1111/j.1439-0310.2005.01096.x; SEVER DM, 1981, HERPETOLOGICA, V37, P142; SEVER DM, 1992, ANAT REC, V233, P229, DOI 10.1002/ar.1092330206; Shine R, 2005, EVOLUTION, V59, P2426; Sparreboom Max, 2014, P9; *SPSS INC, 2005, SPSS WIND REL 14 0 0; TOYODA F, 1994, PHYSIOL BEHAV, V55, P569, DOI 10.1016/0031-9384(94)90118-X; Treer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056538; VERRELL P, 1982, ANIM BEHAV, V30, P1224, DOI 10.1016/S0003-3472(82)80215-7; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Woodley SK, 2010, J COMP PHYSIOL A, V196, P713, DOI 10.1007/s00359-010-0540-6; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1	47	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0144985	10.1371/journal.pone.0144985	http://dx.doi.org/10.1371/journal.pone.0144985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771882	gold, Green Submitted, Green Published			2022-12-26	WOS:000368628300003
J	Wennman, A; Oliw, EH; Karkehabadi, S; Chen, Y				Wennman, Anneli; Oliw, Ernst H.; Karkehabadi, Saeid; Chen, Yang			Crystal Structure of Manganese Lipoxygenase of the Rice Blast Fungus Magnaporthe oryzae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme mechanism; fatty acid oxidation; lipoxygenase pathway; metalloenzyme	CYANOTHECE SP; BIOSYNTHESIS; COMPLEX; IRON; HYDROPEROXIDE; EXPRESSION; MECHANISM; SUGGESTS; FEATURES; PRODUCT	Lipoxygenases (LOX) are non-heme metal enzymes, which oxidize polyunsaturated fatty acids to hydroperoxides. All LOX belong to the same gene family, and they are widely distributed. LOX of animals, plants, and prokaryotes contain iron as the catalytic metal, whereas fungi express LOX with iron or with manganese. Little is known about metal selection by LOX and the adjustment of the redox potentials of their protein-bound catalytic metals. Thirteen three-dimensional structures of animal, plant, and prokaryotic FeLOX are available, but none of MnLOX. The MnLOX of the most important plant pathogen, the rice blast fungus Magnaporthe oryzae (Mo), was expressed in Pichia pastoris. Mo-MnLOX was deglycosylated, purified to homogeneity, and subjected to crystal screening and x-ray diffraction. The structure was solved by sulfur and manganese single wavelength anomalous dispersion to a resolution of 2.0 . The manganese coordinating sphere is similar to iron ligands of coral 8R-LOX and soybean LOX-1 but is not overlapping. The Asn-473 is positioned on a short loop (Asn-Gln-Gly-Glu-Pro) instead of an -helix and forms hydrogen bonds with Gln-281. Comparison with FeLOX suggests that Phe-332 and Phe-525 might contribute to the unique suprafacial hydrogen abstraction and oxygenation mechanism of Mo-MnLOX by controlling oxygen access to the pentadiene radical. Modeling suggests that Arg-525 is positioned close to Arg-182 of 8R-LOX, and both residues likely tether the carboxylate group of the substrate. An oxygen channel could not be identified. We conclude that Mo-MnLOX illustrates a partly unique variation of the structural theme of FeLOX.	[Wennman, Anneli; Oliw, Ernst H.; Karkehabadi, Saeid; Chen, Yang] Uppsala Univ, Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; [Karkehabadi, Saeid] Swedish Univ Agr Sci, Dept Chem & Biotechnol, Box 7015, SE-75007 Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Oliw, EH (corresponding author), Uppsala Univ, Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden.	Ernst.oliw@farmbio.uu.se			Vetenskapsradet Grant [K2013-67X-06523-31-3]; Knut and Alice Wallenberg Foundation [KAW2004.0123]	Vetenskapsradet Grant; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by Vetenskapsradet Grant K2013-67X-06523-31-3 and The Knut and Alice Wallenberg Foundation Grant KAW2004.0123. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andreou A, 2010, J BIOL CHEM, V285, P14178, DOI 10.1074/jbc.M109.094771; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cristea M, 2005, ARCH BIOCHEM BIOPHYS, V434, P201, DOI 10.1016/j.abb.2004.10.026; Cristea M, 2006, J BIOL CHEM, V281, P17612, DOI 10.1074/jbc.M510311200; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Garreta A, 2013, FASEB J, V27, P4811, DOI 10.1096/fj.13-235952; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Goldsmith CR, 2005, J AM CHEM SOC, V127, P9904, DOI 10.1021/ja039283w; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; Heshof R, 2014, APPL MICROBIOL BIOT, V98, P1261, DOI 10.1007/s00253-013-5392-x; Hornsten L, 2002, EUR J BIOCHEM, V269, P2690, DOI 10.1046/j.1432-1033.2002.02936.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobe MJ, 2014, J BIOL CHEM, V289, P8562, DOI 10.1074/jbc.M113.543777; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Neau DB, 2014, J BIOL CHEM, V289, P31905, DOI 10.1074/jbc.M114.599662; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; NELSON MJ, 1988, BIOCHEMISTRY-US, V27, P4273, DOI 10.1021/bi00412a011; Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626; Newie J, 2016, J LIPID RES, V57, P276, DOI 10.1194/jlr.M064980; Oliw EH, 2004, LIPIDS, V39, P319, DOI 10.1007/s11745-004-1235-1; Oliw EH, 2008, J LIPID RES, V49, P420, DOI 10.1194/jlr.M700514-JLR200; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296; SkrzypczakJankun E, 1997, PROTEINS, V29, P15, DOI [10.1002/(SICI)1097-0134(199709)29:1&lt;15::AID-PROT2&gt;3.0.CO;2-E, 10.1002/(SICI)1097-0134(199709)29:1<15::AID-PROT2>3.3.CO;2-F]; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Wennman A, 2015, ARCH BIOCHEM BIOPHYS, V583, P87, DOI 10.1016/j.abb.2015.07.014; Wennman A, 2015, J LIPID RES, V56, P1606, DOI 10.1194/jlr.M060178; Wennman A, 2013, J LIPID RES, V54, P762, DOI 10.1194/jlr.M033787; Wennman A, 2012, J BIOL CHEM, V287, P31757, DOI 10.1074/jbc.M112.364331; Xu S, 2012, STRUCTURE, V20, P1490, DOI 10.1016/j.str.2012.06.003; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182	46	46	47	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8130	8139		10.1074/jbc.M115.707380	http://dx.doi.org/10.1074/jbc.M115.707380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26783260	hybrid, Green Published			2022-12-26	WOS:000374056700030
J	Moore, BD; Jin, RU; Lo, HY; Jung, M; Wang, HY; Battle, MA; Wollheim, CB; Urano, F; Mills, JC				Moore, Benjamin D.; Jin, Ramon U.; Lo, Heiyong; Jung, Min; Wang, Haiyan; Battle, Michele A.; Wollheim, Claes B.; Urano, Fumihiko; Mills, Jason C.			Transcriptional Regulation of X-Box-binding Protein One (XBP1) by Hepatocyte Nuclear Factor 4 (HNF4) Is Vital to Beta-cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); endoplasmic reticulum (ER); hepatocyte nuclear factor 4 (HNF-4); insulin secretion; X-box binding protein 1 (XBP1)	ENDOPLASMIC-RETICULUM STRESS; INSULIN-SECRETION; FACTOR 4-ALPHA; MESSENGER-RNA; TARGET GENES; MODY1 GENE; ER STRESS; EXPRESSION; CA2+; DIFFERENTIATION	The transcription factor, X-box-binding protein-1 (XBP1), controls the development and maintenance of the endoplasmic reticulum (ER) in multiple secretory cell lineages. We show here that Hepatocyte Nuclear Factor 4 (HNF4) directly induces XBP1 expression. Mutations in HNF4 cause Mature-Onset Diabetes of the Young I (MODYI), a subset of diabetes characterized by diminished GSIS. In mouse models, cell lines, and ex vivo islets, using dominant negative and human- disease-allele point mutants or knock-out and knockdown models, we show that disruption of HNF4 caused decreased expression of XBP1 and reduced cellular ER networks. GSIS depends on ER Ca2+ signaling; we show that diminished XBP1 and/or HNF4 in -cells led to impaired ER Ca2+ homeostasis. Restoring XBP1 expression was sufficient to completely rescue GSIS in HNF4- deficient -cells. Our findings uncover a transcriptional relationship between HNF4 and Xbp1 with potentially broader implications about MODYI and the importance of transcription factor signaling in the regulation of secretion.	[Moore, Benjamin D.; Jin, Ramon U.; Lo, Heiyong; Jung, Min; Mills, Jason C.] Washington Univ, Div Gastroenterol, Dept Med, St Louis, MO 63110 USA; [Moore, Benjamin D.; Jin, Ramon U.; Lo, Heiyong; Jung, Min; Mills, Jason C.] Washington Univ, Div Gastroenterol, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Moore, Benjamin D.; Jin, Ramon U.; Lo, Heiyong; Jung, Min; Mills, Jason C.] Washington Univ, Div Gastroenterol, Dept Dev Biol, St Louis, MO 63110 USA; [Wang, Haiyan] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Battle, Michele A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Wollheim, Claes B.] Lund Univ, Skane Univ Hosp, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, S-20502 Malmo, Sweden; [Wollheim, Claes B.] Univ Geneva, Univ Med Ctr, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-41211 Geneva, Switzerland; [Urano, Fumihiko] Washington Univ, Sch Med, Div Endocrinol, Dept Med, St Louis, MO 63110 USA; [Urano, Fumihiko] Washington Univ, Sch Med, Div Endocrinol, Dept Metab, St Louis, MO 63110 USA; [Urano, Fumihiko] Washington Univ, Sch Med, Div Endocrinol, Dept Lipid Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Roche Holding; Medical College of Wisconsin; Lund University; Skane University Hospital; University of Geneva; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mills, JC (corresponding author), Washington Univ, Div Gastroenterol, Dept Med, St Louis, MO 63110 USA.; Mills, JC (corresponding author), Washington Univ, Div Gastroenterol, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Mills, JC (corresponding author), Washington Univ, Div Gastroenterol, Dept Dev Biol, St Louis, MO 63110 USA.	jmills@wustl.edu	Mills, Jason/AAA-6688-2021; Urano, Fumihiko/AAF-4492-2020	Mills, Jason/0000-0002-0402-4662; Wollheim, Claes/0000-0002-4570-9879	National Institutes of Health NIDDK [DK094989, DK052574, DK087873]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087873, P30DK020579, R01DK094989, P30DK052574, R56DK087873, R01DK105129] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health NIDDK awards DK094989 and DK052574 (to J. C. M.), DK087873 (to M. A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; ALAM MS, 1995, PHYS REV LETT, V74, P2885, DOI 10.1103/PhysRevLett.74.2905; Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bagwell AM, 2005, DIABETES, V54, P1185, DOI 10.2337/diabetes.54.4.1185; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cattin AL, 2009, MOL CELL BIOL, V29, P6294, DOI 10.1128/MCB.00939-09; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Furuta H, 1997, DIABETES, V46, P1652, DOI 10.2337/diabetes.46.10.1652; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Hara T, 2014, ENDOCRINOLOGY, V155, P758, DOI 10.1210/en.2013-1519; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hu CCA, 2009, EMBO J, V28, P1624, DOI 10.1038/emboj.2009.117; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; Im Hogune, 2004, Methods Mol Biol, V284, P129; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Leber JH, 2004, PLOS BIOL, V2, P1197, DOI 10.1371/journal.pbio.0020235; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lindner T, 1997, J CLIN INVEST, V100, P1400, DOI 10.1172/JCI119660; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Martino MEB, 2009, J BIOL CHEM, V284, P14904, DOI 10.1074/jbc.M809180200; Mills JC, 2012, BIOESSAYS, V34, P10, DOI 10.1002/bies.201100089; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Muniappan L, 2009, METHODS MOL BIOL, V590, P131, DOI 10.1007/978-1-60327-378-7_8; Nolan AL, 2009, METHODS MOL BIOL, V560, P43, DOI 10.1007/978-1-59745-448-3_4; Ogawa N, 2004, GENES CELLS, V9, P95, DOI 10.1111/j.1365-2443.2004.00704.x; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Pearson ER, 2005, DIABETOLOGIA, V48, P878, DOI 10.1007/s00125-005-1738-y; Sato Y, 2012, J BIOL CHEM, V287, P23236, DOI 10.1074/jbc.M112.368779; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	55	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6146	6157		10.1074/jbc.M115.685750	http://dx.doi.org/10.1074/jbc.M115.685750			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26792861	hybrid, Green Published			2022-12-26	WOS:000372894200009
J	Romano, FB; Tang, YZ; Rossi, KC; Monopoli, KR; Ross, JL; Heuck, AP				Romano, Fabian B.; Tang, Yuzhou; Rossi, Kyle C.; Monopoli, Kathryn R.; Ross, Jennifer L.; Heuck, Alejandro P.			Type 3 Secretion Translocators Spontaneously Assemble a Hexadecameric Transmembrane Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; membrane transport; oligomer; protein translocation; single-molecule biophysics; type III secretion system (T3SS)	DIPYRROMETHENEBORON DIFLUORIDE BODIPY; MEMBRANE-PROTEIN INSERTION; HOST-CELL MEMBRANES; SYSTEM TIP COMPLEX; TOXIN T-DOMAIN; III SECRETION; PSEUDOMONAS-AERUGINOSA; PORE FORMATION; DIPHTHERIA-TOXIN; SHIGELLA-FLEXNERI	A type 3 secretion system is used by many bacterial pathogens to inject proteins into eukaryotic cells. Pathogens insert a translocon complex into the target eukaryotic membrane by secreting two proteins known as translocators. How these translocators form a translocon in the lipid bilayer and why both proteins are required remains elusive. Pseudomonas aeruginosa translocators PopB and PopD insert pores into membranes forming homo- or hetero-complexes of undetermined stoichiometry. Single-molecule fluorescence photobleaching experiments revealed that PopD formed mostly hexameric structures in membranes, whereas PopB displayed a bi-modal distribution with 6 and 12 subunits peaks. However, individually the proteins are not functional for effector translocation. We have found that when added together, the translocators formed distinct hetero-complexes containing 8 PopB and 8 PopD molecules. Thus, the interaction between PopB and PopD guide the assembly of a unique hetero-oligomer in membranes.	[Romano, Fabian B.; Tang, Yuzhou; Monopoli, Kathryn R.; Ross, Jennifer L.; Heuck, Alejandro P.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Rossi, Kyle C.; Heuck, Alejandro P.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Ross, Jennifer L.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Heuck, AP (corresponding author), 710 N Pleasant St,LGRT 1228, Amherst, MA 01003 USA.	heuck@umass.edu	Romano-Chernac, Fabian B./K-9396-2019; Ross, Jennifer L/D-7208-2012	Ross, Jennifer L/0000-0002-4838-3798; Rossi, Kyle/0000-0003-0607-7802; Heuck, Alejandro/0000-0002-7786-3109	National Institute of General Medical Sciences of the National Institutes of Health [R01GM097414]; National Science Foundation [DMR-1207783]; Direct For Biological Sciences [1344203] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515, R01GM097414] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of General Medical Sciences of the National Institutes of Health under award number R01GM097414 (to A. P. H.) and National Science Foundation Grant DMR-1207783 (to J. L. R.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of General Medical Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Adam PR, 2014, PROTEINS, V82, P3013, DOI 10.1002/prot.24662; Arant RJ, 2014, CHEMPHYSCHEM, V15, P600, DOI 10.1002/cphc.201301092; Bergstrom F, 2002, J AM CHEM SOC, V124, P196, DOI 10.1021/ja010983f; Chang JH, 2007, MOL MICROBIOL, V66, P1548, DOI 10.1111/j.1365-2958.2007.06024.x; Chenal A, 2002, J BIOL CHEM, V277, P43425, DOI 10.1074/jbc.M204148200; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Dey S, 2012, PROTEIN J, V31, P401, DOI 10.1007/s10930-012-9416-7; Diaz-Valencia JD, 2011, BIOPHYS J, V100, P2440, DOI 10.1016/j.bpj.2011.03.062; Dickenson NE, 2013, BIOCHEMISTRY-US, V52, P8790, DOI 10.1021/bi400755f; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; Epler CR, 2009, INFECT IMMUN, V77, P2754, DOI 10.1128/IAI.00190-09; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gawrisch K., 2005, STRUCTURE BIOL MEMBR, P147; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Groulx N, 2011, J BIOL CHEM, V286, P42274, DOI 10.1074/jbc.M111.296103; Hume PJ, 2003, MOL MICROBIOL, V49, P425, DOI 10.1046/j.1365-2958.2003.03559.x; Johnson Benjamin B, 2014, Subcell Biochem, V80, P63, DOI 10.1007/978-94-017-8881-6_5; KAROLIN J, 1994, J AM CHEM SOC, V116, P7801, DOI 10.1021/ja00096a042; Kaufman MR, 2000, MICROBIOL-UK, V146, P2531, DOI 10.1099/00221287-146-10-2531; Kaya S, 2003, ANN NY ACAD SCI, V986, P278, DOI 10.1111/j.1749-6632.2003.tb07185.x; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; Mikhalyov I, 2002, PHYS CHEM CHEM PHYS, V4, P5663, DOI 10.1039/b206357n; Montagner C, 2011, J BACTERIOL, V193, P6923, DOI 10.1128/JB.05555-11; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Mounier J, 2012, CELL HOST MICROBE, V12, P381, DOI 10.1016/j.chom.2012.07.010; Mounier J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000271; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Osiecki JC, 2001, MOL MICROBIOL, V42, P469, DOI 10.1046/j.1365-2958.2001.02654.x; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x; Rosconi MP, 2004, BIOCHEMISTRY-US, V43, P9127, DOI 10.1021/bi049354j; Ross JL, 2010, METHOD CELL BIOL, V95, P521, DOI 10.1016/S0091-679X(10)95026-7; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009; Senerovic L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.124; Song XD, 2001, ANAL CHIM ACTA, V442, P79, DOI 10.1016/S0003-2670(01)01128-X; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0; Thuduppathy GR, 2006, BIOCHEMISTRY-US, V45, P14533, DOI 10.1021/bi0616652; Vallis AJ, 1999, INFECT IMMUN, V67, P2040; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Vargas-Uribe M, 2013, BIOCHEMISTRY-US, V52, P7901, DOI 10.1021/bi400926k; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Wang Y, 1997, J BIOL CHEM, V272, P25091, DOI 10.1074/jbc.272.40.25091; WEST SEH, 1995, GENE, V160, P81, DOI 10.1016/0378-1119(95)00236-Y; Yeow EKL, 2007, BIOPHYS J, V92, P3098, DOI [10.1529/biophysj.106.099424, 10.1529/biophysj. 106.099424]; Zhuang XW, 2000, P NATL ACAD SCI USA, V97, P14241, DOI 10.1073/pnas.97.26.14241	62	15	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6304	6315		10.1074/jbc.M115.681031	http://dx.doi.org/10.1074/jbc.M115.681031			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26786106	hybrid, Green Published			2022-12-26	WOS:000372894200021
J	Guo, BB; Bellingham, SA; Hill, AF				Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.			Stimulating the Release of Exosomes Increases the Intercellular Transfer of Prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; exosome (vesicle); extracellular vesicles; prion; prion disease; exosomes; monensin; neutral sphingomy; neutral sphingomyelinase; transwell	PROTEIN; SECRETION; ASSOCIATION; VESICLES; BETA; GLYCOSYLATION; INFECTIVITY; INHIBITION; MECHANISM; COFACTOR	Exosomes are small extracellular vesicles released by cells and play important roles in intercellular communication and pathogen transfer. Exosomes have been implicated in several neurodegenerative diseases, including prion disease and Alzheimer disease. Prion disease arises upon misfolding of the normal cellular prion protein, PrPC, into the disease-associated isoform, PrPSc. The disease has a unique transmissible etiology, and exosomes represent a novel and efficient method for prion transmission. The precise mechanism by which prions are transmitted from cell to cell remains to be fully elucidated, although three hypotheses have been proposed: direct cell-cell contact, tunneling nanotubes, and exosomes. Given the reported presence of exosomes in biological fluids and in the lipid and nucleic acid contents of exosomes, these vesicles represent an ideal mechanism for encapsulating prions and potential cofactors to facilitate prion transmission. This study investigates the relationship between exosome release and intercellular prion dissemination. Stimulation of exosome release through treatment with an ionophore, monensin, revealed a corresponding increase in intercellular transfer of prion infectivity. Conversely, inhibition of exosome release using GW4869 to target the neutral sphingomyelinase pathway induced a decrease in intercellular prion transmission. Further examination of the effect of monensin on PrP conversion revealed that monensin also alters the conformational stability of PrPC, leading to increased generation of proteinase K-resistant prion protein. The findings presented here provide support for a positive relationship between exosome release and intercellular transfer of prion infectivity, highlighting an integral role for exosomes in facilitating the unique transmissible nature of prions.	[Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Hill, Andrew F.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia	University of Melbourne; University of Melbourne; La Trobe University	Hill, AF (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia.	andrew.hill@latrobe.edu.au	Hill, Andrew F./AAH-2854-2020; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F/B-4527-2009	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Guo, Belinda/0000-0003-2146-8561	Australian National Health and Medical Research Council [628946, 400202]; Australian Postgraduate Award; Faculty of Medicine, Dentistry and Health Sciences; Bellberry Indigenous Health Fellowship (Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne); Australian Research Council [FT100100560]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Faculty of Medicine, Dentistry and Health Sciences; Bellberry Indigenous Health Fellowship (Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne); Australian Research Council(Australian Research Council)	This study was funded by Australian National Health and Medical Research Council Grants 628946 and 400202.; Supported by an Australian Postgraduate Award and Faculty of Medicine, Dentistry and Health Sciences top-up scholarship.; Supported by a Bellberry Indigenous Health Fellowship (Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne).; Supported by Australian Research Council Future Fellowship Grant FT100100560.	Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Back N, 1996, HISTOCHEM J, V28, P591, DOI 10.1007/BF02331379; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cancellotti E, 2013, EMBO J, V32, P756, DOI 10.1038/emboj.2013.6; Cancellotti E, 2010, J VIROL, V84, P3464, DOI 10.1128/JVI.02374-09; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Harrison CF, 2010, J BIOL CHEM, V285, P20213, DOI 10.1074/jbc.M109.093310; Izquierdo-Useros N, 2009, BLOOD, V113, P2732, DOI 10.1182/blood-2008-05-158642; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; KUISMANEN E, 1985, J VIROL, V55, P813, DOI 10.1128/JVI.55.3.813-822.1985; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; LeBlanc AC, 1999, J NEUROCHEM, V72, P1832, DOI 10.1046/j.1471-4159.1999.0721832.x; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Nitrini R, 1997, ANN NEUROL, V42, P138, DOI 10.1002/ana.410420203; O'Neill HC, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.16pe8; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rabesandratana H, 1998, BLOOD, V91, P2573, DOI 10.1182/blood.V91.7.2573.2573_2573_2580; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rasband W., 2006, IMAGEJ; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Schatzl HM, 1997, J VIROL, V71, P8821; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vilette D, 2015, CELL MOL LIFE SCI, V72, P4409, DOI 10.1007/s00018-015-1945-8; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	52	85	89	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5128	5137		10.1074/jbc.M115.684258	http://dx.doi.org/10.1074/jbc.M115.684258			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26769968	Green Published, hybrid			2022-12-26	WOS:000371640600025
J	Demchenko, NL; Chapman, JW; Durkina, VB; Fadeev, VI				Demchenko, Natalia L.; Chapman, John W.; Durkina, Valentina B.; Fadeev, Valeriy I.			Life History and Production of the Western Gray Whale's Prey, Ampelisca eschrichtii Kroyer, 1842 (Amphipoda, Ampeliscidae)	PLOS ONE			English	Article							NORTHERN BERING-SEA; SAKHALIN ISLAND; ROBUSTUS; SHELF; OKHOTSK; RUSSIA; POPULATION; COMMUNITY; ABUNDANCE; PATTERNS	Ampelisca eschrichtii are among the most important prey of the Western North Pacific gray whales, Eschrichtius robustus. The largest and densest known populations of this amphipod occur in the gray whale's Offshore feeding area on the Northeastern Sakhalin Island Shelf. The remote location, ice cover and stormy weather at the Offshore area have prevented winter sampling. The incomplete annual sampling has confounded efforts to resolve life history and production of A. eschrichtii. Expanded comparisons of population size structure and individual reproductive development between late spring and early fall over six sampling years between 2002 and 2013 however, reveal that A. eschrichtii are gonochoristic, iteroparous, mature at body lengths greater than 15 mm and have a two-year life span. The low frequencies of brooding females, the lack of early stage juveniles, the lack of individual or population growth or biomass increases over late spring and summer, all indicate that growth and reproduction occur primarily in winter, when sampling does not occur. Distinct juvenile and adult size cohorts additionally indicate growth and juvenile production occurs in winter through spring under ice cover. Winter growth thus requires that winter detritus or primary production are critical food sources for these ampeliscid populations and yet, the Offshore area and the Eastern Sakhalin Shelf ampeliscid communities may be the most abundant and productive amphipod population in the world. These A. eschrichtii populations are unlikely to be limited by western gray whale predation. Whether benthic community structure can limit access and foraging success of western gray whales is unclear.	[Demchenko, Natalia L.; Fadeev, Valeriy I.] Russian Acad Sci, Lab Ecol Shelf Communities, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Vladivostok 690022, Russia; [Chapman, John W.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, 2030 Marine Sci Dr, Newport, OR 97365 USA; [Durkina, Valentina B.] Russian Acad Sci, Lab Cytophysiol, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia	Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Oregon State University; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences	Demchenko, NL (corresponding author), Russian Acad Sci, Lab Ecol Shelf Communities, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Vladivostok 690022, Russia.	demnal@hotmail.com	Demchenko, Natalia L./G-8634-2012; Durkina, Valentina/AAH-3314-2022; Durkina, Valentina/CAA-3700-2022	Demchenko, Natalia L./0000-0003-0479-3370; Durkina, Valentina/0000-0003-2659-3847; Durkina, Valentina/0000-0003-2659-3847	Exxon Neftegas, Ltd. [A2308506]; Sakhalin Energy Investment Co; Far Eastern Branch of the Russian Academy of Sciences [13-III-B-06-057]	Exxon Neftegas, Ltd.; Sakhalin Energy Investment Co; Far Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences)	Support for sample collections and partial financial support of NLD for sample analyses were provided by Exxon Neftegas, Ltd. No A2308506, by Sakhalin Energy Investment Co and partly by a grant to NLD from the Far Eastern Branch of the Russian Academy of Sciences 13-III-B-06-057. JWC and VBD were not funded. VIF is deceased. The funders supported the collection of the samples. They did not collect the samples for the express purpose of this study and did not participate in or support the analyses, decision to publish or in the preparation of the manuscript. NLD did not receive other funding (whether external or internal to her organization) that was reported previously.	Bogoslovskaya LS, 1996, PRIRODA, V12, P42; Bosin AA, 2010, OCEANOLOGY+, V50, P175, DOI 10.1134/S0001437010020037; Bradford Amanda L., 2008, Endangered Species Research, V6, P1, DOI 10.3354/esr00106; Budnikova LL, 2012, RUSS J MAR BIOL+, V38, P149, DOI 10.1134/S1063074012020022; Budnikova L.L, 2003, IZVESTIA TINRO, V135, P197; Buyanovsky AI, 2011, PROBL FISH, V12, P274; Carretta JV, 2014, GRAY WHALE ESCHRICHT, P171; Chapman JW, 2014, J CRUSTACEAN BIOL, V34, P349, DOI 10.1163/1937240X-00002236; Clarke KR, 1994, CHANGE MARINE COMMUN; Coyle KO, 2007, DEEP-SEA RES PT II, V54, P2906, DOI 10.1016/j.dsr2.2007.08.026; COYLE KO, 1994, MAR ECOL PROG SER, V107, P233, DOI 10.3354/meps107233; Crisp D. J., 1984, METHODS STUDY MARINE, P284; Demchenko N., 2011, IZV TINRO, V166, P244; Demchenko N.L., 2010, Zoologica Baetica, V21, P143; Dulepova EP, 2008, IZV TINRO, V154, P90; Fadeev V. I., 2007, RESPONSE MARINE BIOT, P213; Fadeev VI, 2009, INT WHAL COMM 61 ANN, P1; Fadeev VI, 2011, BENTHOS STUDIES FEED, P4; Fadeev VI, 2011, INT WHAL COMM 63 ANN, P1; Gayanilo F.C., 2005, WORLDFISH CTR NO 7, P168; Gorley C.K., 2006, GETTING STARTED PRIM; HIGHSMITH RC, 1990, NATURE, V344, P862, DOI 10.1038/344862a0; HIGHSMITH RC, 1991, AM ZOOL, V31, P861; HIGHSMITH RC, 1992, MAR ECOL PROG SER, V83, P141, DOI 10.3354/meps083141; Hunt GL, 2002, PROG OCEANOGR, V55, P5, DOI 10.1016/S0079-6611(02)00067-8; Johnson SR, 2007, ENVIRON MONIT ASSESS, V134, P1, DOI 10.1007/s10661-007-9813-0; KANNEWORFF EBBE, 1965, OPHELIA, V2, P305; Kedra M, 2012, ESTUAR COAST SHELF S, V114, P183, DOI 10.1016/j.ecss.2012.08.015; KIM SL, 1989, CAN J ZOOL, V67, P1531, DOI 10.1139/z89-218; Koblikov V.N., 1982, Izvestiya Tikhookeanskogo Nauchno-Issledovatel'skogo Instituta Rybnogo Khozyaistva i Okeanografii, V106, P90; Kudrjaschov VA., 1968, SOSTAV ZAKONOMERNOST, P86; Laake Jeffrey L., 2012, Journal of Cetacean Research and Management, V12, P287; Leuteritz T.E., 2008, IUCN RED LIST THREAT; Maminov M. K., 2002, MARINE MAMMALS HOLAR, P170; Markina NP, 1984, IZV TINRO, V109, P109; Meier SK, 2007, ENVIRON MONIT ASSESS, V134, P107, DOI 10.1007/s10661-007-9811-2; MILLS EL, 1967, J FISH RES BOARD CAN, V24, P305, DOI 10.1139/f67-030; Moore SE, 2003, CAN J ZOOL, V81, P734, DOI 10.1139/Z03-043; Nadtochiy V.A., 2004, IZV TIKHOOKEAN NAUCH, V139, P317; Nakatsuka T, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014029; Napp JM, 2001, FISH OCEANOGR, V10, P61, DOI 10.1046/j.1365-2419.2001.00155.x; Nerini M., 1984, P423; Norkko A, 2007, ECOLOGY, V88, P2810, DOI 10.1890/06-1396.1; Pasternak F. A., 1957, Trud Okean, V23, P237; Punt Andre E., 2012, Journal of Cetacean Research and Management, V12, P15; Rigolet C, 2012, ESTUAR COAST SHELF S, V113, P259, DOI 10.1016/j.ecss.2012.08.014; Rodkina SA, 2008, 1 FAR E INT S LIF SC, P65; Rugh DJ, 2005, J CETACEAN RES MANAG, V7, P1; Rutenko AN, 2014, RUSS METEOROL HYDRO+, V39, P335, DOI 10.3103/S1068373914050070; Rutenko AN, 2009, RUSS METEOROL HYDROL, V34, P93, DOI 10.3103/S1068373909020058; Schumacher JD, 2003, CLIMATE CHANGE SE BE; Shevchenko GV, 2004, J PHYS OCEANOGR, V34, P2470, DOI 10.1175/JPO2632.1; Sobolevskii EI, 2000, RUSS J ECOL+, V31, P126, DOI 10.1007/BF02828368; Sorokin YI, 2002, J PLANKTON RES, V24, P453, DOI 10.1093/plankt/24.5.453; Sosnin V. A., 2007, Russian Meteorology and Hydrology, V32, P50, DOI 10.3103/S1068373907010074; Sumich J., 2014, E ROBUSTUS BIOL HUMA; Tyurneva OY, 2010, RUSS J MAR BIOL+, V36, P117, DOI 10.1134/S1063074010020069; Tyurneva OY, 2012, INT WHAL COMM 65 SCI, P1; Tzvetkova N, 1975, PRIBREZHNYE GAMMARID; Vladimirov VA, 2010, INT WHAL COMM 62 ANN, P1; Vladimirov VA, 2012, DISTRIBUTION ABUNDAN, P1; Weller DW, 1999, MAR MAMMAL SCI, V15, P1208, DOI 10.1111/j.1748-7692.1999.tb00886.x; Weslawski Jan Marcin, 2002, Polish Polar Research, V23, P253; WILDISH DJ, 1981, CAN J FISH AQUAT SCI, V38, P1019, DOI 10.1139/f81-140; Yablokov A.V., 1984, P465; Yakovlev YM, 2014, PHOTOIDENTIFICATION, P66; Zakharkov SP, 2007, OCEANOLOGY+, V47, P519, DOI 10.1134/S0001437007040091	67	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147304	10.1371/journal.pone.0147304	http://dx.doi.org/10.1371/journal.pone.0147304			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800185	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300090
J	Downs, J; Stahlhut, M; Wong, K; Syhler, B; Bisgaard, AM; Jacoby, P; Leonard, H				Downs, Jenny; Stahlhut, Michelle; Wong, Kingsley; Syhler, Birgit; Bisgaard, Anne-Marie; Jacoby, Peter; Leonard, Helen			Validating the Rett Syndrome Gross Motor Scale	PLOS ONE			English	Article							MECP2; MUTATIONS; DIAGNOSIS; SEVERITY	Rett syndrome is a pervasive neurodevelopmental disorder associated with a pathogenic mutation on the MECP2 gene. Impaired movement is a fundamental component and the Rett Syndrome Gross Motor Scale was developed to measure gross motor abilities in this population. The current study investigated the validity and reliability of the Rett Syndrome Gross Motor Scale. Video data showing gross motor abilities supplemented with parent report data was collected for 255 girls and women registered with the Australian Rett Syndrome Database, and the factor structure and relationships between motor scores, age and genotype were investigated. Clinical assessment scores for 38 girls and women with Rett syndrome who attended the Danish Center for Rett Syndrome were used to assess consistency of measurement. Principal components analysis enabled the calculation of three factor scores: Sitting, Standing and Walking, and Challenge. Motor scores were poorer with increasing age and those with the p.Arg133Cys, p.Arg294* or p.Arg306Cys mutation achieved higher scores than those with a large deletion. The repeatability of clinical assessment was excellent (intraclass correlation coefficient for total score 0.99, 95% CI 0.93-0.98). The standard error of measurement for the total score was 2 points and we would be 95% confident that a change 4 points in the 45-point scale would be greater than within-subject measurement error. The Rett Syndrome Gross Motor Scale could be an appropriate measure of gross motor skills in clinical practice and clinical trials.	[Downs, Jenny; Wong, Kingsley; Jacoby, Peter; Leonard, Helen] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Downs, Jenny] Curtin Univ, Fac Hlth Sci, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia; [Stahlhut, Michelle; Syhler, Birgit; Bisgaard, Anne-Marie] Rigshosp, Dept Clin Genet, Ctr Rett Syndrome, DK-2100 Copenhagen, Denmark	Telethon Kids Institute; University of Western Australia; Curtin University; Rigshospitalet; University of Copenhagen	Downs, J (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.; Downs, J (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia.	Jenny.Downs@telethonkids.org.au	Wong, Kingsley/I-6935-2013; Leonard, Helen/A-1010-2013; Downs, Jenny/R-9947-2017	Wong, Kingsley/0000-0001-5178-6080; Leonard, Helen/0000-0001-6405-5834; Downs, Jenny/0000-0001-7358-9037; Stahlhut, Michelle/0000-0002-4551-5265	National Health and Medical Research Council [303189, 1004384, 572742, 572568]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this study has been received from the National Health and Medical Research Council project grant #303189 (HL) and #1004384 (HL, JD), program grant #572742 (HL), and a research fellowship #572568 (HL) (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anderson A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-87; Avery LM, 2003, ARCH PHYS MED REHAB, V84, P697, DOI 10.1016/S0003-9993(03)04896-7; Bebbington A, 2008, NEUROLOGY, V70, P868, DOI 10.1212/01.wnl.0000304752.50773.ec; Bebbington A, 2012, EUR J HUM GENET, V20, P921, DOI 10.1038/ejhg.2012.34; Cuddapah VA, 2014, J MED GENET, V51, P152, DOI 10.1136/jmedgenet-2013-102113; Downs J, 2013, LIFE QUALITY OUTCOME; Downs JA, 2008, NEUROPEDIATRICS, V39, P205, DOI 10.1055/s-0028-1104575; Fehr S, 2011, PEDIATR RES, V70, P313, DOI 10.1203/PDR.0b013e3182242461; Fehr S, 2011, J CHILD NEUROL, V26, P980, DOI 10.1177/0883073811401396; Foley KR, 2011, J CHILD NEUROL, V26, P1237, DOI 10.1177/0883073811402688; Fyfe S, 2007, J AUTISM DEV DISORD, V37, P1636, DOI 10.1007/s10803-006-0293-9; Hagberg B, 2002, MENT RETARD DEV D R, V8, P61, DOI 10.1002/mrdd.10020; Humphreys P, 2015, DEV MED CHILD NEUROL; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Van Ginkel JR, 2014, J STAT COMPUT SIM, V84, P2298, DOI 10.1080/00949655.2013.788654; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	20	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147555	10.1371/journal.pone.0147555	http://dx.doi.org/10.1371/journal.pone.0147555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800272	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300123
J	Dutov, P; Antipova, O; Varma, S; Orgel, JPRO; Schieber, JD				Dutov, Pavel; Antipova, Olga; Varma, Sameer; Orgel, Joseph P. R. O.; Schieber, Jay D.			Measurement of Elastic Modulus of Collagen Type I Single Fiber	PLOS ONE			English	Article							FIBRIL SIZE; TRACKING	Collagen fibers are the main components of the extra cellular matrix and the primary contributors to the mechanical properties of tissues. Here we report a novel approach to measure the longitudinal component of the elastic moduli of biological fibers under conditions close to those found in vivo and apply it to type I collagen from rat tail tendon. This approach combines optical tweezers, atomic force microscopy, and exploits Euler-Bernoulli elasticity theory for data analysis. This approach also avoids drying for measurements or visualization, since samples are freshly extracted. Importantly, strains are kept below 0.5%, which appear consistent with the linear elastic regime. We find, surprisingly, that the longitudinal elastic modulus of type I collagen cannot be represented by a single quantity but rather is a distribution that is broader than the uncertainty of our experimental technique. The longitudinal component of the single-fiber elastic modulus is between 100 MPa and 360 MPa for samples extracted from different rats and/or different parts of a single tail. Variations are also observed in the fibril-bundle / fibril diameter with an average of 325 +/- 40 nm. Since bending forces depend on the diameter to the fourth power, this variation in diameter is important for estimating the range of elastic moduli. The remaining variations in the modulus may be due to differences in composition of the fibril-bundles, or the extent of the proteoglycans constituting fibril-bundles, or that some single fibrils may be of fibril-bundle size.	[Dutov, Pavel; Antipova, Olga; Orgel, Joseph P. R. O.; Schieber, Jay D.] IIT, Ctr Mol Study Condensed Soft Matter, Chicago, IL 60616 USA; [Dutov, Pavel; Schieber, Jay D.] IIT, Chem & Biol Engn Dept, Chicago, IL 60616 USA; [Antipova, Olga; Orgel, Joseph P. R. O.] IIT, Dept Biol, Chicago, IL 60616 USA; [Antipova, Olga; Orgel, Joseph P. R. O.; Schieber, Jay D.] IIT, Dept Phys, Chicago, IL 60616 USA; [Antipova, Olga; Orgel, Joseph P. R. O.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Antipova, Olga; Orgel, Joseph P. R. O.] BioCAT, APS Argonne Natl Lab, Sect 18,9700 S Cass Ave, Argonne, IL USA; [Varma, Sameer] Univ S Florida, Dept Phys, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of South Florida	Schieber, JD (corresponding author), IIT, Ctr Mol Study Condensed Soft Matter, Chicago, IL 60616 USA.; Schieber, JD (corresponding author), IIT, Chem & Biol Engn Dept, Chicago, IL 60616 USA.; Schieber, JD (corresponding author), IIT, Dept Phys, Chicago, IL 60616 USA.	schieber@iit.edu			DARPA [W911NF-09-1-0378]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The authors acknowledge financial support of DARPA grant W911NF-09-1-0378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; BIRK DE, 1989, P NATL ACAD SCI USA, V86, P4549, DOI 10.1073/pnas.86.12.4549; Dutov P, 2013, OPT LETT, V38, P4923, DOI 10.1364/OL.38.004923; Eulero L, 1744, METHODUS INVENIENDI; Farman GP, 2010, BIOPHYS J, V99, P2978, DOI 10.1016/j.bpj.2010.09.003; Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966; Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007; Gross J, 1948, J EXP MED; Kotlo K, 2012, J PROTEOMICS, V77, P1, DOI 10.1016/j.jprot.2012.05.041; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Magnusson SP, 2002, MATRIX BIOL, V21, P369, DOI 10.1016/S0945-053X(02)00011-2; Masic A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6942; Munster S, 2013, P NATL ACAD SCI USA, V110, P12197, DOI 10.1073/pnas.1222787110; Orgel JPRO, 2011, CONNECT TISSUE RES, V52, P18, DOI 10.3109/03008207.2010.511354; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089519; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Press W., 1992, NUMERICAL RECIPES FO; Shayegan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070590; Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052; Shen ZLL, 2010, BIOPHYS J, V99, P1986, DOI 10.1016/j.bpj.2010.07.021; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sun YL, 2002, BIOCHEM BIOPH RES CO, V295, P382, DOI 10.1016/S0006-291X(02)00685-X; van der Rijt JAJ, 2006, MACROMOL BIOSCI, V6, P697, DOI 10.1002/mabi.200600063; Velegol D, 2001, BIOPHYS J, V81, P1786, DOI 10.1016/S0006-3495(01)75829-8; Wozniak A, 2009, SINGLE MOL FORCE SPE, P467; Yang L, 2008, BIOPHYS J, V94, P2204, DOI 10.1529/biophysj.107.111013; Zeltz C, 2014, BBA-GEN SUBJECTS, V1840, P2533, DOI 10.1016/j.bbagen.2013.12.022	33	59	59	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145711	10.1371/journal.pone.0145711	http://dx.doi.org/10.1371/journal.pone.0145711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800120	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300010
J	Raes, EJ; Bodrossy, L; de Kamp, JV; Holmes, B; Hardman-Mountford, N; Thompson, PA; McInnes, AS; Waite, AM				Raes, Eric J.; Bodrossy, Levente; de Kamp, Jodie Van; Holmes, Bronwyn; Hardman-Mountford, Nick; Thompson, Peter A.; McInnes, Allison S.; Waite, Anya M.			Reduction of the Powerful Greenhouse Gas N2O in the South-Eastern Indian Ocean	PLOS ONE			English	Article							NITROUS-OXIDE REDUCTASE; DENITRIFYING BACTERIA; DENITRIFICATION RATES; NOSZ; NITRIFICATION; DIVERSITY; PACIFIC; NITRATE; SYSTEM; GENES	Nitrous oxide (N2O) is a powerful greenhouse gas and a key catalyst of stratospheric ozone depletion. Yet, little data exist about the sink and source terms of the production and reduction of N2O outside the well-known oxygen minimum zones (OMZ). Here we show the presence of functional marker genes for the reduction of N2O in the last step of the denitrification process (nitrous oxide reductase genes; nosZ) in oxygenated surface waters (180-250 O-2 mu mol.kg(-1)) in the south-eastern Indian Ocean. Overall copy numbers indicated that nosZ genes represented a significant proportion of the microbial community, which is unexpected in these oxygenated waters. Our data show strong temperature sensitivity for nosZ genes and reaction rates along a vast latitudinal gradient (32 degrees S-12 degrees S). These data suggest a large N2O sink in the warmer Tropical waters of the south-eastern Indian Ocean. Clone sequencing from PCR products revealed that most denitrification genes belonged to Rhodobacteraceae. Our work highlights the need to investigate the feedback and tight linkages between nitrification and denitrification (both sources of N2O, but the latter also a source of bioavailable N losses) in the understudied yet strategic Indian Ocean and other oligotrophic systems.	[Raes, Eric J.; Hardman-Mountford, Nick] Univ Western Australia, Oceans Inst, M047 35 Stirling Hwy, Crawley, WA 6009, Australia; [Bodrossy, Levente; de Kamp, Jodie Van; Holmes, Bronwyn; Thompson, Peter A.] CSIRO Oceans & Atmosphere Flagship, GPO Box 1538, Hobart, Tas 7001, Australia; [Raes, Eric J.; Hardman-Mountford, Nick] CSIRO Oceans & Atmosphere Flagship, Private Bag 5, Wembley, WA 6913, Australia; [McInnes, Allison S.] Univ Technol Sydney, Plant Funct Biol & Climate Change, City Campus 15 Broadway, Ultimo, NSW 2007, Australia; [Waite, Anya M.] Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Technology Sydney; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Raes, EJ (corresponding author), Univ Western Australia, Oceans Inst, M047 35 Stirling Hwy, Crawley, WA 6009, Australia.; Raes, EJ (corresponding author), CSIRO Oceans & Atmosphere Flagship, Private Bag 5, Wembley, WA 6913, Australia.	eric.raes@research.uwa.edu.au	Waite, Anya M/A-5492-2015; van de Kamp, Jodie L/E-9423-2015; Bodrossy, Levente/B-8054-2009; Thompson, Peter/A-2361-2012; McInnes, Allison/H-5694-2016	Waite, Anya M/0000-0003-2965-0296; van de Kamp, Jodie L/0000-0003-2167-0938; Bodrossy, Levente/0000-0001-6940-452X; Raes, Eric/0000-0002-4131-9312; Thompson, Peter/0000-0002-9504-5433; McInnes, Allison/0000-0002-8340-3133	University of Western Australia; CSIRO Wealth from Oceans postgraduate top-up scholarship	University of Western Australia; CSIRO Wealth from Oceans postgraduate top-up scholarship	E. J. Raes received an Australian Postgraduate scholarship from the University of Western Australia and a CSIRO Wealth from Oceans postgraduate top-up scholarship.	Bouskill NJ, 2012, ENVIRON MICROBIOL, V14, P714, DOI 10.1111/j.1462-2920.2011.02623.x; BROECKER WS, 1974, EARTH PLANET SC LETT, V23, P100, DOI 10.1016/0012-821X(74)90036-3; BUTLER JH, 1989, J GEOPHYS RES-ATMOS, V94, P14865, DOI 10.1029/JD094iD12p14865; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Codispoti LA, 2010, SCIENCE, V327, P1339, DOI 10.1126/science.1184945; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Ducey TF, 2015, J ENVIRON QUAL, V44, P1011, DOI 10.2134/jeq2014.09.0403; Freing A, 2012, PHILOS T R SOC B, V367, P1245, DOI 10.1098/rstb.2011.0360; Gao H, 2010, ISME J, V4, P417, DOI 10.1038/ismej.2009.127; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Harhangi HR, 2012, APPL ENVIRON MICROB, V78, P752, DOI 10.1128/AEM.07113-11; Iribar A, 2015, ECOL ENG, V80, P191, DOI 10.1016/j.ecoleng.2015.02.002; Jayakumar A, 2009, GEOPHYS MONOGR SER, V185, P187, DOI 10.1029/2008GM000730; Klawonn I, 2015, ISME J; Kloos K, 2001, AUST J PLANT PHYSIOL, V28, P991; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Li YH, 2006, DEEP-SEA RES PT I, V53, P94, DOI 10.1016/j.dsr.2005.09.009; Montzka S.A., 2011, OZONE DEPLETING SUBS, P516; Naqvi S, 2003, BIOGEOCHEMISTRY; Naqvi SWA, 2010, BIOGEOSCIENCES, V7, P2159, DOI 10.5194/bg-7-2159-2010; Naqvi SWA, 1998, NATURE, V394, P462, DOI 10.1038/28828; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Nogales B, 2002, APPL ENVIRON MICROB, V68, P5017, DOI 10.1128/AEM.68.10.5017-5025.2002; O'Malley MA, 2007, NAT REV MICROBIOL, V5, P647, DOI 10.1038/nrmicro1711; Pearce A., 2011, MARINE HEAT WAVE W A; Pearce A, 2007, MAR FRESHWATER RES, V58, P914, DOI 10.1071/MF07082; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Raes EJ, 2014, MAR ECOL PROG SER; Raes EJ, 2015, GLOBAL BIOGEOCHEM CY, V29, P1283, DOI 10.1002/2015GB005194; Rich JJ, 2003, APPL ENVIRON MICROB, V69, P5974, DOI 10.1128/AEM.69.10.5974-5982.2003; Sabaty M, 1999, J BACTERIOL, V181, P6028, DOI 10.1128/JB.181.19.6028-6032.1999; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Takeshita Y, 2013, J GEOPHYS RES-OCEANS, V118, P5640, DOI 10.1002/jgrc.20399; Thompson PA, 2011, PROG OCEANOGR, V91, P345, DOI 10.1016/j.pocean.2011.02.011; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Villanueva L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00031; Voss M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0121; Waite AM, 2013, BIOGEOSCIENCES, V10, P5691, DOI 10.5194/bg-10-5691-2013; Waite AM, 2015, LIMNOL OCEA IN PRESS; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Wernberg T, 2012, NATURE CLIMATE CHANG; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Wyman M, 2013, APPL ENVIRON MICROB, V79, P2670, DOI 10.1128/AEM.03705-12; Wyrtki K., 1973, ECOL STUD, V3, P18, DOI [10.1007/978-3-642-65468-8_3, DOI 10.1007/978-3-642-65468-8_3]; Yool A, 2011, METHOD ENZYMOL, V486, P3, DOI [10.1016/S0076-6879(11)86001-5, 10.1016/B978-0-12-381294-0.00001-8]; YOSHINARI T, 1980, APPL ENVIRON MICROB, V39, P81, DOI 10.1128/AEM.39.1.81-84.1980; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	53	13	13	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145996	10.1371/journal.pone.0145996	http://dx.doi.org/10.1371/journal.pone.0145996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800249	Green Published, gold			2022-12-26	WOS:000368655300011
J	Rogans, SJ; Rey, C				Rogans, Sarah Jane; Rey, Chrissie			Unveiling the Micronome of Cassava (Manihot esculenta Crantz)	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; PLANT MICRORNAS; TARGET GENES; SIRNA BIOGENESIS; SMALL RNAS; FUNCTIONAL DIVERSIFICATION; ARABIDOPSIS; MIRNA; BINDING; EVOLUTION	MicroRNAs (miRNAs) are an important class of endogenous non-coding single-stranded small RNAs (21-24 nt in length), which serve as post-transcriptional negative regulators of gene expression in plants. Despite the economic importance of Manihot esculenta Crantz (cassava) only 153 putative cassava miRNAs (from multiple germplasm) are available to date in miRBase (Version 21), and identification of a number of miRNAs from the cassava EST database have been limited to comparisons with Arabidopsis. In this study, mature sequences of all known plant miRNAs were used as a query for homologous searches against cassava EST and GSS databases, and additional identification of novel and conserved miRNAs were gleaned from next generation sequencing (NGS) of two cassava landraces (T200 from southern Africa and TME3 from West Africa) at three different stages post explant transplantation and acclimatization. EST and GSS derived data revealed 259 and 32 miRNAs in cassava, and one of the miRNA families (miR2118) from previous studies has not been reported in cassava. NGS data collectively displayed expression of 289 conserved miRNAs in leaf tissue, of which 230 had not been reported previously. Of the 289 conserved miRNAs identified in T200 and TME3, 208 were isomiRs. Thirty-nine novel cassava-specific miRNAs of low abundance, belonging to 29 families, were identified. Thirty-eight (98.6%) of the putative new miRNAs identified by NGS have not been previously reported in cassava. Several miRNA targets were identified in T200 and TME3, highlighting differential temporal miRNA expression between the two cassava landraces. This study contributes to the expanding knowledge base of the micronome of this important crop.	[Rogans, Sarah Jane; Rey, Chrissie] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa	University of Witwatersrand	Rey, C (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa.	chrissie.rey@wits.ac.za			National Research Foundation (ZA) [93467, 73895]	National Research Foundation (ZA)	This work was supported by National Research Foundation (ZA) Grant number: 93467; National Research Foundation (ZA) Grant Number: 73895. www.nrf.ac.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Ghani, 2013, Pure and Applied Biology, V2, P104; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Amiteye S, 2011, AFR J BIOTECHNOL, V10, P2562; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Ballen-Taborda C, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/857986; Baloch I. A., 2014, Pure and Applied Biology, V3, P72; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; CARTER SE, 1993, APPL GEOGR, V13, P353, DOI 10.1016/0143-6228(93)90037-2; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dhandapani V, 2011, MOL CELLS, V32, P21, DOI 10.1007/s10059-011-2313-7; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; FAO, 2013, SAV GROW CASS GUID S; Frazier TP, 2011, METHODS MOL BIOL, V678, P13, DOI 10.1007/978-1-60761-682-5_2; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Gehrig HH, 2000, PLANT MOL BIOL REP, V18, P369, DOI 10.1007/BF02825065; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hwang DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064238; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Lakhotia N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-6; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Mallory AC, 2008, CURR OPIN PLANT BIOL, V11, P560, DOI 10.1016/j.pbi.2008.06.008; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Panda D, 2014, GENE, V537, P333, DOI 10.1016/j.gene.2014.01.010; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Patanun O, 2013, MOL BIOTECHNOL, V53, P257, DOI 10.1007/s12033-012-9521-z; Perez-Quintero AL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-29; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Qiu CX, 2007, GENE, V395, P49, DOI 10.1016/j.gene.2007.01.034; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Unver T., 2009, INT J PLANT GENOMICS, V2009, P1, DOI [10.1155/2009/198680, DOI 10.1155/2009/198680]; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JY, 2012, GENE, V505, P300, DOI 10.1016/j.gene.2012.06.002; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Xia J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-634; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Yu B, 2008, P NATL ACAD SCI USA, V105, P10073, DOI 10.1073/pnas.0804218105; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zuo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-7	102	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147251	10.1371/journal.pone.0147251	http://dx.doi.org/10.1371/journal.pone.0147251			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799216	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300080
J	Wu, J; Cui, W; Cai, Q; Fei, J; Zhang, SD; Han, TQ; Hu, H; Jiang, ZY				Wu, Jian; Cui, Wei; Cai, Qu; Fei, Jian; Zhang, Sheng-Dao; Han, Tian-Quan; Hu, Hai; Jiang, Zhao-Yan			The NPC1L1 Polymorphism 1679C > G Is Associated with Gallstone Disease in Chinese Patients	PLOS ONE			English	Article							PICK C1-LIKE 1; CHOLESTEROL ABSORPTION; GENETIC-VARIATION; GALLBLADDER BILE; PLANT STEROLS; EZETIMIBE; HYPERCHOLESTEROLEMIA; RISK; POPULATION; SATURATION	Niemann Pick Type C1 Like 1 (NPC1L1) protein plays a key role in intestinal and hepatic cholesterol metabolism in humans. Genetic variation in NPC1L1 has been widely studied in recent years. We analyzed NPC1L1 single nucleotide polymorphisms in Chinese gallstone disease patients to investigate their association with gallstone disease. NPC1L1 mRNA expression was also measured in liver biopsies from patients with cholesterol gallstone disease and compared between genotypes. The G allele of the g1679C>G (rs2072183) polymorphism was significantly more prevalent in patients with gallstones compared with gallstone-free subjects. Moreover, patients carrying the G allele had lower hepatic NPC1L1 mRNA expression and higher biliary cholesterol (molar percentages) and cholesterol saturation index. Our study suggests that the G allele of the NPC1L1 polymorphism g1679C>G may be a positive marker of gallstone formation risk.	[Wu, Jian; Hu, Hai; Jiang, Zhao-Yan] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Hepatobiliary & Pancreat Surg, Shanghai 200092, Peoples R China; [Wu, Jian; Cai, Qu; Fei, Jian; Zhang, Sheng-Dao; Han, Tian-Quan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg,Shanghai Inst Digest Surg, Shanghai 200030, Peoples R China; [Cui, Wei] Yijishan Hosp, Wannan Med Coll, Dept Surg, Nanjing, Jiangsu, Peoples R China	Tongji University; Shanghai Jiao Tong University; Wannan Medical College	Hu, H; Jiang, ZY (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Hepatobiliary & Pancreat Surg, Shanghai 200092, Peoples R China.	huhailc@sina.com; zhaoyanjiang@gmail.com		hu, hai/0000-0001-7915-6873	National Natural Science Foundation of China [81270537, 81070367, 81170428]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81270537, 81070367 and 81170428).	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; CAREY MC, 1978, J LIPID RES, V19, P945; Chen CW, 2009, J HUM GENET, V54, P242, DOI 10.1038/jhg.2009.18; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cui W, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-17; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Ference BA, 2015, J AM COLL CARDIOL, V66, P1086, DOI 10.1016/j.jacc.2015.06.1311; Ference BA, 2015, J AM COLL CARDIOL, V65, P1552, DOI 10.1016/j.jacc.2015.02.020; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Gustafsson U, 2000, EUR J CLIN INVEST, V30, P1099, DOI 10.1046/j.1365-2362.2000.00740.x; Hegele Robert A, 2005, Lipids Health Dis, V4, P16, DOI 10.1186/1476-511X-4-16; Jiang ZY, 2009, BIOCHEM BIOPH RES CO, V379, P49, DOI 10.1016/j.bbrc.2008.11.131; Jungst D, 2004, J LAB CLIN MED, V144, P134, DOI 10.1016/j.lab.2004.04.012; Kashiwabara Y, 2014, J CLIN PHARM THER, V39, P551, DOI 10.1111/jcpt.12176; KESANIEMI YA, 1987, EUR J CLIN INVEST, V17, P391, DOI 10.1111/j.1365-2362.1987.tb01132.x; Lauridsen BK, 2015, EUR HEART J, V36, P1601, DOI 10.1093/eurheartj/ehv108; Lupattelli G, 2013, J CLIN LIPIDOL, V7, P147, DOI 10.1016/j.jacl.2012.12.003; Maeda T, 2010, J ATHEROSCLER THROMB, V17, P356, DOI 10.5551/jat.2451; Martin B, 2010, NUTR METAB CARDIOVAS, V20, P236, DOI 10.1016/j.numecd.2009.03.023; Miao L, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-61; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Miquel JF, 1998, GASTROENTEROLOGY, V114, P1016, DOI 10.1016/S0016-5085(98)70322-1; Nissinen MJ, 2008, BRIT J NUTR, V99, P370, DOI 10.1017/S0007114507811998; Pisciotta L, 2007, ATHEROSCLEROSIS, V194, pE116, DOI 10.1016/j.atherosclerosis.2006.10.036; Pisciotta L, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-123; Polisecki E, 2010, J LIPID RES, V51, P1201, DOI 10.1194/jlr.P001172; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Stein A, 2012, WORLD J GASTROENTERO, V18, P5789, DOI 10.3748/wjg.v18.i40.5789; Tang WQ, 2011, BBA-MOL CELL BIOL L, V1811, P549, DOI 10.1016/j.bbalip.2011.05.013; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Wang HH, 2008, GASTROENTEROLOGY, V134, P2101, DOI 10.1053/j.gastro.2008.03.011; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200; Zhao H, 2008, LIPIDS, V43, P1155, DOI 10.1007/s11745-008-3241-y	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147562	10.1371/journal.pone.0147562	http://dx.doi.org/10.1371/journal.pone.0147562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800364	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300124
J	Xu, YQ; Zhang, ZH; Chen, XY; Li, RX; Li, D; Feng, SQ				Xu, Yunqiang; Zhang, Zhenhui; Chen, Xuyi; Li, Ruixin; Li, Dong; Feng, Shiqing			A Silk Fibroin/Collagen Nerve Scaffold Seeded with a Co-Culture of Schwann Cells and Adipose-Derived Stem Cells for Sciatic Nerve Regeneration	PLOS ONE			English	Article							PERIPHERAL-NERVES; REPAIR; FIBROIN; AXON; DIFFERENTIATION; RECOVERY; CONDUIT; GAP	As a promising alternative to autologous nerve grafts, tissue-engineered nerve grafts have been extensively studied as a way to bridge peripheral nerve defects and guide nerve regeneration. The main difference between autogenous nerve grafts and tissue-engineered nerve grafts is the regenerative microenvironment formed by the grafts. If an appropriate regenerative microenvironment is provided, the repair of a peripheral nerve is feasible. In this study, to mimic the body's natural regenerative microenvironment closely, we co-cultured Schwann cells (SCs) and adipose-derived stem cells (ADSCs) as seed cells and introduced them into a silk fibroin (SF)/collagen scaffold to construct a tissue-engineered nerve conduit (TENC). Twelve weeks after the three different grafts (plain SF/collagen scaffold, TENC, and autograft) were transplanted to bridge 1-cm long sciatic nerve defects in rats, a series of electrophysiological examinations and morphological analyses were performed to evaluate the effect of the tissue-engineered nerve grafts on peripheral nerve regeneration. The regenerative outcomes showed that the effect of treatment with TENCs was similar to that with autologous nerve grafts but superior to that with plain SF/collagen scaffolds. Meanwhile, no experimental animals had inflammation around the grafts. Based on this evidence, our findings suggest that the TENC we developed could improve the regenerative microenvironment and accelerate nerve regeneration compared to plain SF/collagen and may serve as a promising strategy for peripheral nerve repair.	[Xu, Yunqiang; Zhang, Zhenhui; Li, Dong; Feng, Shiqing] Tianjin Med Univ, Gen Hosp, Dept Orthoped, Tianjin, Peoples R China; [Chen, Xuyi] Affiliated Brain Hosp Armed Logist, Dept Neurosurg, Tianjin, Peoples R China; [Li, Ruixin] Acad Mil & Med Sci, Inst Med Equipment, Tianjin, Peoples R China	Tianjin Medical University; Academy of Military Medical Sciences - China	Xu, YQ (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Orthoped, Tianjin, Peoples R China.	docxu@sina.com			National Natural Science Foundation of China [81101362, 11102235]; Special Projects of National Science and Technology Cooperation with Russia [2014DFR31210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Projects of National Science and Technology Cooperation with Russia	This study was funded by the National Natural Science Foundation of China (Grant 81101362, Grant 11102235.), the Special Projects of National Science and Technology Cooperation with Russia (2014DFR31210).	Alberti KA, 2014, BIOMATERIALS, V35, P3551, DOI 10.1016/j.biomaterials.2013.12.082; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120; Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M; Frattini F, 2012, TISSUE ENG PT A, V18, P2030, DOI [10.1089/ten.tea.2011.0496, 10.1089/ten.TEA.2011.0496]; Gordon T, 2009, NEUROSURGERY, V65, pA132, DOI 10.1227/01.NEU.0000335650.09473.D3; Goto E, 2010, J BIOSCI BIOENG, V109, P512, DOI 10.1016/j.jbiosc.2009.11.002; Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002; Honkanen H, 2007, EUR J NEUROSCI, V26, P953, DOI 10.1111/j.1460-9568.2007.05726.x; IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0; Jaing TH, 2014, CELL TRANSPLANT, V23, P493, DOI 10.3727/096368914X678300; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Lehmann HC, 2016, BRAIN RES, V1638, P97, DOI 10.1016/j.brainres.2015.10.040; Liao DP, 2010, ARCH MED SCI, V6, P145, DOI 10.5114/aoms.2010.13885; MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4; Murakami T, 2003, BRAIN RES, V974, P17, DOI 10.1016/S0006-8993(03)02539-3; Nagase T, 2007, J CRANIOFAC SURG, V18, P49, DOI 10.1097/01.scs.0000249357.66720.d2; Pfister LA, 2007, J BIOMED MATER RES A, V80A, P932, DOI 10.1002/jbm.a.31052; Ruan Y, 2005, MACROMOL BIOSCI, V1, P419; Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Schmidt T, 2011, TISSUE ENG PART C-ME, V17, P1161, DOI [10.1089/ten.TEC.2011.0201, 10.1089/ten.tec.2011.0201]; Shreiber DI, 2003, BIOPHYS J, V84, P4102, DOI 10.1016/S0006-3495(03)75135-2; Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799; Stang F, 2005, BIOMATERIALS, V26, P3083, DOI 10.1016/j.biomaterials.2004.07.060; Taha MF, 2014, J BIOTECHNOL, V172, P1, DOI 10.1016/j.jbiotec.2013.11.028; Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001; Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004; Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]; Zurita M, 2007, NEUROREPORT, V18, P1713, DOI 10.1097/WNR.0b013e3282f0d3b0	34	73	77	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147184	10.1371/journal.pone.0147184	http://dx.doi.org/10.1371/journal.pone.0147184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799619	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300069
J	Cheney, KL; White, A; Mudianta, IW; Winters, AE; Quezada, M; Capon, RJ; Mollo, E; Garson, MJ				Cheney, Karen L.; White, Andrew; Mudianta, I. Wayan; Winters, Anne E.; Quezada, Michelle; Capon, Robert J.; Mollo, Ernesto; Garson, Mary J.			Choose Your Weaponry: Selective Storage of a Single Toxic Compound, Latrunculin A, by Closely Related Nudibranch Molluscs	PLOS ONE			English	Article							MARINE SPONGE; OPISTHOBRANCH MOLLUSKS; SECONDARY METABOLITES; CHEMICAL DEFENSE; DORID NUDIBRANCH; NATURAL-PRODUCTS; DITERPENES; SEQUESTRATION; CONSTITUENTS; MACROLIDES	Natural products play an invaluable role as a starting point in the drug discovery process, and plants and animals use many interesting biologically active natural products as a chemical defense mechanism against predators. Among marine organisms, many nudibranch gastropods are known to derive defensive metabolites from the sponges they eat. Here we investigated the putative sequestration of the toxic compound latrunculin A-a 16-membered macrolide that prevents actin polymerization within cellular processes-which has been identified from sponge sources, by five closely related nudibranch molluscs of the genus Chromodoris. Only latrunculin A was present in the rim of the mantle of these species, where storage reservoirs containing secondary metabolites are located, whilst a variety of secondary metabolites were found in their viscera. The species studied thus selectively accumulate latrunculin A in the part of the mantle that is more exposed to potential predators. This study also demonstrates that latrunculin-containing sponges are not their sole food source. Latrunculin A was found to be several times more potent than other compounds present in these species of nudibranchs when tested by in vitro and in vivo toxicity assays. Anti-feedant assays also indicated that latrunculin A was unpalatable to rock pool shrimps, in a dose-dependent manner. These findings led us to propose that this group of nudibranchs has evolved means both to protect themselves from the toxicity of latrunculin A, and to accumulate this compound in the mantle rim for defensive purposes. The precise mechanism by which the nudibranchs sequester such a potent compound from sponges without disrupting their own key physiological processes is unclear, but this work paves the way for future studies in this direction. Finally, the possible occurrence of both visual and chemosensory Mllerian mimicry in the studied species is discussed.	[Cheney, Karen L.; White, Andrew; Winters, Anne E.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [White, Andrew; Mudianta, I. Wayan; Garson, Mary J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Quezada, Michelle; Capon, Robert J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Mollo, Ernesto] CNR, Ist Chim Biomol, Pozzuoli, Italy; [Mudianta, I. Wayan] Ganesha Univ Educ, Jl Udayana 11, Singaraja 81116, Bali, Indonesia	University of Queensland; University of Queensland; University of Queensland; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Ganesha University of Education	Cheney, KL (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	k.cheney@uq.edu.au	Mudianta, I Wayan/AAN-5829-2020; Cheney, Karen/L-3427-2018; Capon, Robert/G-9238-2012; Mollo, Ernesto/F-7842-2013; Cheney, Karen L/A-6827-2013; White, Andrew/C-8001-2017	Mudianta, I Wayan/0000-0002-0388-3828; Cheney, Karen/0000-0001-5622-9494; Capon, Robert/0000-0002-8341-7754; Mollo, Ernesto/0000-0001-7379-1788; Cheney, Karen L/0000-0001-5622-9494; Winters, Anne/0000-0003-2840-6267; White, Andrew/0000-0002-9481-1079	Australian and Pacific Science Foundation (APSF); Australia Research Council (ARC); University of Queensland; University of Queensland from the Institute for Molecular Bioscience; Australian Government	Australian and Pacific Science Foundation (APSF); Australia Research Council (ARC)(Australian Research Council); University of Queensland(University of Queensland); University of Queensland from the Institute for Molecular Bioscience; Australian Government(Australian GovernmentCGIAR)	The authors thank the Australian and Pacific Science Foundation (APSF); the Australia Research Council (ARC); and The University of Queensland (Promoting Women Fellowship to K.L.C., a UQ International Postgraduate Award to I.W.M., and support from the Institute for Molecular Bioscience to R.J.C.). A.E.W. was supported by a Postgraduate Endeavour Award from the Australian Government. M.Q. acknowledges the Mexican Council for Science and Technology (CONACYT).	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Avila C, 1995, OCEANOGR MAR BIOL, V33, P487; Avila C, 1997, MAR ECOL PROG SER, V150, P171, DOI 10.3354/meps150171; Benkendorff K, 2010, BIOL REV, V85, P757, DOI 10.1111/j.1469-185X.2010.00124.x; Blount JD, 2009, P ROY SOC B-BIOL SCI, V276, P871, DOI 10.1098/rspb.2008.1407; BOBZIN SC, 1989, J ORG CHEM, V54, P3902, DOI 10.1021/jo00277a029; BOBZIN SC, 1989, J ORG CHEM, V54, P5727, DOI 10.1021/jo00285a019; CAMBIE RC, 1987, J NAT PROD, V50, P948, DOI 10.1021/np50053a033; Carbone M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062075; CARMICHAEL J, 1987, CANCER RES, V47, P936; Cheney KL, 2014, J EVOLUTION BIOL, V27, P676, DOI 10.1111/jeb.12348; Cimino Guido, 2009, Proceedings of the California Academy of Sciences, V60, P175; CORLEY DG, 1988, J ORG CHEM, V53, P3644, DOI 10.1021/jo00250a053; Cortesi F, 2010, J EVOLUTION BIOL, V23, P1509, DOI 10.1111/j.1420-9101.2010.02018.x; de Cook S.C., 2002, SYSTEMA PORIFERA GUI, P1028, DOI [10.1007/978-1-4615-0747-5, DOI 10.1007/978-1-4615-0747-5]; EISNER T, 1981, SCIENCE, V213, P476, DOI 10.1126/science.7244647; FAULKNER DJ, 1983, MAR ECOL PROG SER, V13, P295, DOI 10.3354/meps013295; Ferreira M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00266; FONTANA A, 1994, EXPERIENTIA, V50, P510, DOI 10.1007/BF01920760; Garson MJ, 2004, CHEM AUSTR, V71, P16; Gerwick WH, 2012, CHEM BIOL, V19, P85, DOI 10.1016/j.chembiol.2011.12.014; Gohli J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005779; Gordaliza M, 2010, MAR DRUGS, V8, P2849, DOI 10.3390/md8122849; Graham SK, 2010, J CHEM CRYSTALLOGR, V40, P468, DOI 10.1007/s10870-009-9679-9; Haber M, 2010, BIOL BULL-US, V218, P181, DOI 10.1086/BBLv218n2p181; Hamann MT, 1996, J ORG CHEM, V61, P6594, DOI 10.1021/jo960877+; HAMANN MT, 1993, J ORG CHEM, V58, P6565, DOI 10.1021/jo00076a012; HAMBLEY TW, 1986, TETRAHEDRON LETT, V27, P3281, DOI 10.1016/S0040-4039(00)84775-9; Hartmann T, 1997, PHYTOCHEMISTRY, V45, P489, DOI 10.1016/S0031-9422(97)00009-5; Hayot C, 2006, TOXICOL APPL PHARM, V211, P30, DOI 10.1016/j.taap.2005.06.006; Hirayama Y, 2016, AUST J CHEM, V69, P136, DOI 10.1071/CH15203; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; JOHNSON S, 1983, PAC SCI, V37, P251; KAKOU Y, 1987, J NAT PROD, V50, P482, DOI 10.1021/np50051a023; KARUSO P, 1986, AUST J CHEM, V39, P1629, DOI 10.1071/CH9861629; KASHMAN Y, 1980, TETRAHEDRON LETT, V21, P3629, DOI 10.1016/0040-4039(80)80255-3; Konishi H, 2009, ANTICANCER RES, V29, P2091; Marin A, 1997, J MOLLUS STUD, V63, P431, DOI 10.1093/mollus/63.3.431; Martin-Algarra S, 2009, EUR J CANCER, V45, P732, DOI 10.1016/j.ejca.2008.12.005; McPhail K, 1997, TETRAHEDRON, V53, P4655, DOI 10.1016/S0040-4020(97)00198-1; MEBS D, 1985, J CHEM ECOL, V11, P713, DOI 10.1007/BF00988300; Mollo E, 2005, CHEMOECOLOGY, V15, P31, DOI 10.1007/s00049-005-0289-5; Mollo E, 2008, P NATL ACAD SCI USA, V105, P4582, DOI 10.1073/pnas.0709355105; Mollo E, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00092; Mudianta IW, 2014, PURE APPL CHEM, V86, P995, DOI 10.1515/pac-2013-1111; NEEMAN I, 1975, MAR BIOL, V30, P293, DOI 10.1007/BF00390634; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; OKUDA RK, 1985, EXPERIENTIA, V41, P1355, DOI 10.1007/BF01952094; PAWLIK JR, 1988, J EXP MAR BIOL ECOL, V119, P99, DOI 10.1016/0022-0981(88)90225-0; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; PIKA J, 1995, TETRAHEDRON, V51, P8189, DOI 10.1016/0040-4020(95)00440-J; Rudman WB, 2007, MOLLUSCAN RES, V27, P60; RUDMAN WB, 1981, ZOOL J LINN SOC-LOND, V72, P219, DOI 10.1111/j.1096-3642.1981.tb01571.x; RUDMAN WB, 1991, J MOLLUS STUD, V57, P167, DOI 10.1093/mollus/57.2.167; Salazar R, 2013, CANCER CHEMOTH PHARM, V72, P75, DOI 10.1007/s00280-013-2170-5; Sanders Miranda L., 1996, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V66, P117; Saporito RA, 2012, CHEMOECOLOGY, V22, P159, DOI 10.1007/s00049-011-0088-0; Slattery M, 1998, J EXP MAR BIOL ECOL, V226, P33, DOI 10.1016/S0022-0981(97)00240-2; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Suciati, 2011, AUST J CHEM, V64, P757, DOI 10.1071/CH11036; Uddin MH, 2009, CHEM PHARM BULL, V57, P885, DOI 10.1248/cpb.57.885; Wagele H, 2006, OCEANOGR MAR BIOL, V44, P197; WALKER RP, 1981, J ORG CHEM, V46, P1098, DOI 10.1021/jo00319a012; Weldon PJ, 2013, CHEMOECOLOGY, V23, P201, DOI 10.1007/s00049-013-0140-3	64	43	43	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145134	10.1371/journal.pone.0145134	http://dx.doi.org/10.1371/journal.pone.0145134			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788920	Green Published, Green Submitted, gold			2022-12-26	WOS:000368529100006
J	Li, SS; Zhang, Y; Wang, JH; Yang, YF; Miao, C; Guo, YF; Zhang, ZD; Cao, QC; Shui, WQ				Li, Shanshan; Zhang, Yong; Wang, Jihua; Yang, Yunfei; Miao, Chen; Guo, Yufeng; Zhang, Zhidan; Cao, Qichen; Shui, Wenqing			Combining Untargeted and Targeted Proteomic Strategies for Discrimination and Quantification of Cashmere Fibers	PLOS ONE			English	Article							KERATIN; IDENTIFICATION; WOOL; HAIR	Cashmere is regarded as a specialty and luxury fiber due to its scarcity and high economic value. For fiber quality assessment, it is technically very challenging to distinguish and quantify the cashmere fiber from yak or wool fibers because of their highly similar physical appearance and substantial protein sequence homology. To address this issue, we propose a workflow combining untargeted and targeted proteomics strategies for selecting, verifying and quantifying biomarkers for cashmere textile authentication. Untargeted proteomic surveys were first applied to identify 174, 157, and 156 proteins from cashmere, wool and yak fibers, respectively. After marker selection at different levels, peptides turned out to afford much higher selectivity than proteins for fiber species discrimination. Subsequently, parallel reaction monitoring (PRM) methods were developed for ten selected peptide markers. The PRM-based targeted analysis of peptide markers enabled accurate determination of fiber species and cashmere percentages in different fiber mixtures. Furthermore, collective use of these peptide makers allowed us to discriminate and quantify cashmere fibers in commercial finished fabrics that have undergone heavy chemical treatments. Cashmere proportion measurement in fabric samples using our proteomic approach was in good agreement with results from traditional light microscopy, yet our method can be more readily standardized to become an objective and robust assay for assessing authenticity of fibers and textiles. We anticipate that the proteomic strategies presented in our study could be further implicated in discovery of quality trait markers for other products containing highly homologous proteomes.	[Li, Shanshan; Miao, Chen; Guo, Yufeng; Zhang, Zhidan; Cao, Qichen; Shui, Wenqing] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Zhang, Yong; Yang, Yunfei] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Wang, Jihua] Tianjin Text Engn Res Inst, Tianjin 300308, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Nankai University	Cao, QC; Shui, WQ (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China.	cao_qc@tib.cas.cn; shui_wq@tib.cas.cn	Zhang, Yong/X-5075-2019	Zhang, Yong/0000-0003-0513-8941	National Natural Science Foundation of China [31401150, 21505151]; Key Projects in the Tianjin Science & Technology Pillar Program [14ZCZDSY00062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Tianjin Science & Technology Pillar Program	This work was supported by (WQS) the National Natural Science Foundation of China (No. 31401150), http://www.nsfc.gov.cn; (QCC) the National Natural Science Foundation of China (No. 21505151), http://www.nsfc.gov.cn; (WQS) the Key Projects in the Tianjin Science & Technology Pillar Program (No. 14ZCZDSY00062), http://http://www.tstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AM, 2014, J PROTEOMICS, V103, P170, DOI 10.1016/j.jprot.2014.03.036; Ancheng W, 1987, J CHINA TEXTILE U, V13, P8; Baek JH, 2009, J PROTEOME RES, V8, P3625, DOI 10.1021/pr800853k; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Catherman AD, 2013, MOL CELL PROTEOMICS, V12, P3465, DOI 10.1074/mcp.M113.030114; Clerens S, 2010, J PROTEOMICS, V73, P1722, DOI 10.1016/j.jprot.2010.05.005; Gong H, 2012, DNA CELL BIOL, V31, P366, DOI 10.1089/dna.2011.1346; Gong H, 2011, EXP DERMATOL, V20, P815, DOI 10.1111/j.1600-0625.2011.01333.x; Gong H, 2011, MOL BIOL REP, V38, P5429, DOI 10.1007/s11033-011-0697-2; Gong H, 2010, ELECTROPHORESIS, V31, P3545, DOI 10.1002/elps.201000301; Hamlyn PF, 1998, J SOC DYERS COLOUR, V114, P78; Ji W, 2011, FORENSIC SCI INT, V208, P139, DOI 10.1016/j.forsciint.2010.11.017; Kerkhoff K, 2009, TEXT RES J, V79, P69, DOI 10.1177/0040517508090488; Koehn H, 2010, J PROTEOME RES, V9, P2920, DOI 10.1021/pr901106m; Koehn H, 2009, J PROTEOMICS, V73, P323, DOI 10.1016/j.jprot.2009.09.017; Langbein L, INT REV CYTOLOGY SUR, V243; Langbein L, 2007, J INVEST DERMATOL, V127, P1532, DOI 10.1038/sj.jid.5700734; LANGLEY KD, 1981, TEXT RES J, V51, P703, DOI 10.1177/004051758105101104; Lewin M., 2006, HDB FIBER CHEM; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; McLaren RJ, 1997, MAMM GENOME, V8, P938, DOI 10.1007/s003359900616; Paolella S, 2013, J MASS SPECTROM, V48, P919, DOI 10.1002/jms.3222; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Phan K-H, 1987, SCHRIFTENREIHE DWI, V101, P4; Phan K-H, 2004, 3 INT S SPEC FIBR DW; Plowman JE, 2012, J PROTEOMICS, V75, P4315, DOI 10.1016/j.jprot.2012.03.027; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Robotti E, 2013, J PROTEOM BIOINFORM, V3, DOI [10.4172/jpb.S3-003, DOI 10.4172/JPB.S3-003]; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Tonetti C, 2012, TEXT RES J, V82, P766, DOI 10.1177/0040517511433146; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Tucker DJ, 1990, P 2 INT S SPEC AN FI; Vineis C, 2014, TEXT RES J, V84, P953, DOI 10.1177/0040517513512394; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; WORTMANN FJ, 1986, TEXT RES J, V56, P442, DOI 10.1177/004051758605600708	35	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147044	10.1371/journal.pone.0147044	http://dx.doi.org/10.1371/journal.pone.0147044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789629	gold, Green Published			2022-12-26	WOS:000368529100054
J	Oosterman, JE; Belsham, DD				Oosterman, Johanneke E.; Belsham, Denise D.			Glucose Alters Per2 Rhythmicity Independent of AMPK, Whereas AMPK Inhibitor Compound C Causes Profound Repression of Clock Genes and AgRP in mHypoE-37 Hypothalamic Neurons	PLOS ONE			English	Article							O-GLCNAC TRANSFERASE; MESSENGER-RNA LEVELS; CIRCADIAN CLOCK; CELL MODELS; METABOLISM; BRAIN; PHOSPHORYLATION; INTEGRATION; EXPRESSION; PALMITATE	Specific neurons in the hypothalamus are regulated by peripheral hormones and nutrients to maintain proper metabolic control. It is unclear if nutrients can directly control clock gene expression. We have therefore utilized the immortalized, hypothalamic cell line mHypoE-37, which exhibits robust circadian rhythms of core clock genes. mHypoE-37 neurons were exposed to 0.5 or 5.5 mM glucose, comparable to physiological levels in the brain. Per2 and Bmal1 mRNAs were assessed every 3 hours over 36 hours. Incubation with 5.5 mM glucose significantly shortened the period and delayed the phase of Per2 mRNA levels, but had no effect on Bmal1. Glucose had no significant effect on phospho-GSK3 beta, whereas AMPK phosphorylation was altered. Thus, the AMPK inhibitor Compound C was utilized, and mRNA levels of Per2, Bmal1, Cryptochrome1 (Cry1), agouti-related peptide (AgRP), carnitine palmitoyltransferase 1C (Cpt1c), and O-linked N-acetylglucosamine transferase (Ogt) were measured. Remarkably, Compound C dramatically reduced transcript levels of Per2, Bmal1, Cry1, and AgRP, but not Cpt1c or Ogt. Because AMPK was not inhibited at the same time or concentrations as the clock genes, we suggest that the effect of Compound C on gene expression occurs through an AMPK-independent mechanism. The consequences of inhibition of the rhythmic expression of clock genes, and in turn downstream metabolic mediators, such as AgRP, could have detrimental effects on overall metabolic processes. Importantly, the effects of the most commonly used AMPK inhibitor Compound C should be interpreted with caution, considering its role in AMPK-independent repression of specific genes, and especially clock gene rhythm dysregulation.	[Oosterman, Johanneke E.; Belsham, Denise D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Oosterman, Johanneke E.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Belsham, Denise D.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Belsham, Denise D.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada	University of Toronto; University of Amsterdam; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Belsham, DD (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.; Belsham, DD (corresponding author), Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada.; Belsham, DD (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Belsham, DD (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada.	d.belsham@utoronto.ca			Natural Sciences and Engineering Research Council (NSERC); Canadian Institutes for Health Research (CIHR); Canada Foundation for Innovation; Canada Research Chairs Program; AMC PhD Scholarship	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); AMC PhD Scholarship	This work was supported by the Natural Sciences and Engineering Research Council (NSERC); Canadian Institutes for Health Research (CIHR); Canada Foundation for Innovation and Canada Research Chairs Program (DDB). AMC PhD Scholarship (JEO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge funding from the Natural Sciences and Engineering Research Council (NSERC); Canadian Institutes for Health Research (CIHR); Canada Foundation for Innovation and Canada Research Chairs Program (DDB). JEO was supported by an AMC PhD Scholarship. The authors thank Jennifer Chalmers, Alice Treen and Dean Tran for their generous support with the experiments. Many thanks to Dr. Leigh Wellhauser for invaluable insight and technical assistance.	Abe M, 2000, NEUROREPORT, V11, P3261, DOI 10.1097/00001756-200009280-00042; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; ASCHOFF J, 1984, ANN NY ACAD SCI, V423, P442, DOI 10.1111/j.1749-6632.1984.tb23452.x; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balsalobre A, 2002, CELL TISSUE RES, V309, P193, DOI 10.1007/s00441-002-0585-0; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Chalmers JA, 2014, MOL CELL ENDOCRINOL, V382, P262, DOI 10.1016/j.mce.2013.10.013; Dai RY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.419; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Fick LJ, 2011, BIOCHEM BIOPH RES CO, V413, P414, DOI 10.1016/j.bbrc.2011.08.103; Foster RG, 2007, CURR BIOL, V17, pR746, DOI 10.1016/j.cub.2007.07.007; Greco JA, 2014, AM J PHYSIOL-REG I, V307, pR1049, DOI 10.1152/ajpregu.00100.2014; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Jordan SD, 2013, MOL CELL ENDOCRINOL, V366, P163, DOI 10.1016/j.mce.2012.06.017; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Kaladchibachi Sevag A, 2007, J Circadian Rhythms, V5, P3, DOI 10.1186/1740-3391-5-3; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; la Fleur SE, 2003, J NEUROENDOCRINOL, V15, P315, DOI 10.1046/j.1365-2826.2003.01019.x; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee JS, 2007, DIABETES RES CLIN PR, V77, pS49, DOI 10.1016/j.diabres.2007.01.033; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Liu XN, 2014, MOL CANCER THER, V13, P596, DOI 10.1158/1535-7163.MCT-13-0579; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Oosterman JE, 2015, AM J PHYSIOL-REG I, V308, pR337, DOI 10.1152/ajpregu.00322.2014; Panda S, 2007, NEURON, V53, P619, DOI 10.1016/j.neuron.2007.02.017; Paul JR, 2012, NEUROSCIENCE, V226, P1, DOI 10.1016/j.neuroscience.2012.08.047; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schwartz GJ, 2000, NATURE, V404, P661; SILVER IA, 1994, J NEUROSCI, V14, P5068; Talamantes F., 1988, P2093; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	50	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146969	10.1371/journal.pone.0146969	http://dx.doi.org/10.1371/journal.pone.0146969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784927	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400091
J	Taylor, I; Wang, Y; Seitz, K; Baer, J; Bennewitz, S; Mooney, BP; Walker, JC				Taylor, Isaiah; Wang, Ying; Seitz, Kati; Baer, John; Bennewitz, Stefan; Mooney, Brian P.; Walker, John C.			Analysis of Phosphorylation of the Receptor-Like Protein Kinase HAESA during Arabidopsis Floral Abscission	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; ORGAN ABSCISSION; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; INNATE IMMUNITY; IN-VITRO; INFLORESCENCE-DEFICIENT; ACTIVATION; BRI1; AUTOPHOSPHORYLATION	Receptor-like protein kinases (RLKs) are the largest family of plant transmembrane signaling proteins. Here we present functional analysis of HAESA, an RLK that regulates floral organ abscission in Arabidopsis. Through in vitro and in vivo analysis of HAE phosphorylation, we provide evidence that a conserved phosphorylation site on a region of the HAE protein kinase domain known as the activation segment positively regulates HAE activity. Additional analysis has identified another putative activation segment phosphorylation site common to multiple RLKs that potentially modulates HAE activity. Comparative analysis suggests that phosphorylation of this second activation segment residue is an RLK specific adaptation that may regulate protein kinase activity and substrate specificity. A growing number of RLKs have been shown to exhibit biologically relevant dual specificity toward serine/threonine and tyrosine residues, but the mechanisms underlying dual specificity of RLKs are not well understood. We show that a phospho-mimetic mutant of both HAE activation segment residues exhibits enhanced tyrosine auto-phosphorylation in vitro, indicating phosphorylation of this residue may contribute to dual specificity of HAE. These results add to an emerging framework for understanding the mechanisms and evolution of regulation of RLK activity and substrate specificity.	[Taylor, Isaiah; Wang, Ying; Seitz, Kati; Baer, John; Bennewitz, Stefan; Walker, John C.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Taylor, Isaiah; Wang, Ying; Seitz, Kati; Baer, John; Bennewitz, Stefan; Mooney, Brian P.; Walker, John C.] Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO USA; [Mooney, Brian P.] Univ Missouri, Charles W Gehrke Prote Ctr, Columbia, MO USA; [Mooney, Brian P.] Univ Missouri, Bond Life Sci Ctr, Div Biochem, Columbia, MO USA; [Wang, Ying] Rutgers State Univ, Dept Food Sci, POB 231, New Brunswick, NJ 08903 USA; [Seitz, Kati] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI USA; [Seitz, Kati] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA; [Bennewitz, Stefan] Leibniz Inst Plant Biochem, Dept Cell & Metab Biol, Halle, Saale, Germany	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Rutgers State University New Brunswick; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Leibniz Institut fur Pflanzenbiochemie	Walker, JC (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.; Walker, JC (corresponding author), Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO USA.	walkerj@missouri.edu			National Science Foundation [MCB0743955]; National Institute of General Medical Sciences [5T32GM008396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation grant MCB0743955 to JW (NSF.gov). IT was supported by National Institute of General Medical Sciences grant 5T32GM008396 (NIGMS.NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2005, PROTEOMICS, V5, P4684, DOI 10.1002/pmic.200500021; Bajwa VS, 2013, PLANT PHYSIOL, V163, P30, DOI 10.1104/pp.113.221465; BHATTACHARYYA MK, 1994, PLANT J, V6, P957, DOI 10.1046/j.1365-313X.1994.6060957.x; Bojar D, 2014, PLANT J, V78, P31, DOI 10.1111/tpj.12445; Boller T, 2012, PEPTIDES DANGER SIGN, P163; Bryan A, 2012, RECEPTOR LIKE KINASE, P41; Burr CA, 2011, PLANT PHYSIOL, V156, P1837, DOI 10.1104/pp.111.175224; Butenko MA, 2003, PLANT CELL, V15, P2296, DOI 10.1105/tpc.014365; Butenko MA, 2014, PLANT CELL, V26, P1838, DOI 10.1105/tpc.113.120071; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cao YR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003313; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Cho SK, 2008, P NATL ACAD SCI USA, V105, P15629, DOI 10.1073/pnas.0805539105; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dubin MJ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-3; Gama L, 1999, BIOTECHNIQUES, V26, P814, DOI 10.2144/99265bm03; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gou XP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-19; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; HORN MA, 1994, BBA-PROTEIN STRUCT M, V1208, P65, DOI 10.1016/0167-4838(94)90160-0; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Jinn TL, 2000, GENE DEV, V14, P108; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Khan M, 2013, J BIOL CHEM, V288, P7519, DOI 10.1074/jbc.M112.384453; Kim BH, 2013, MOL CELLS, V35, P7, DOI 10.1007/s10059-013-2255-3; Klaus-Heisen D, 2011, J BIOL CHEM, V286, P11202, DOI 10.1074/jbc.M110.186171; Lease KA, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-2; Lewis MW, 2010, PLANT J, V62, P817, DOI 10.1111/j.1365-313X.2010.04194.x; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liljegren SJ, 2009, DEVELOPMENT, V136, P1909, DOI 10.1242/dev.033605; Lin WW, 2014, P NATL ACAD SCI USA, V111, P3632, DOI 10.1073/pnas.1318817111; Macho AP, 2014, SCIENCE, V343, P1509, DOI 10.1126/science.1248849; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Meyer MR, 2011, BIOCHEMISTRY-US, V50, P2170, DOI 10.1021/bi101935x; Mitra SK, 2015, PLANT J; Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Niederhuth CE, 2013, J INTEGR PLANT BIOL, V55, P1251, DOI 10.1111/jipb.12116; Niederhuth CE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-37; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oh MH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00175; Oh MH, 2012, P NATL ACAD SCI USA, V109, P327, DOI 10.1073/pnas.1108321109; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Oh MH, 2000, PLANT PHYSIOL, V124, P751, DOI 10.1104/pp.124.2.751; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schlosser A, 2001, ANAL CHEM, V73, P170, DOI 10.1021/ac000826j; Sessa G, 2000, EMBO J, V19, P2257, DOI 10.1093/emboj/19.10.2257; Sessa G, 2000, EUR J BIOCHEM, V267, P171, DOI 10.1046/j.1432-1327.2000.00979.x; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Somssich M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0598; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; Stenvik GE, 2008, PLANT CELL, V20, P1805, DOI 10.1105/tpc.108.059139; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Taylor I, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-22; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Wang J, 2014, CELL RES, V24, P1328, DOI 10.1038/cr.2014.132; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wu X, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00262; Xu JH, 2013, PROTEIN CELL, V4, P771, DOI 10.1007/s13238-013-3053-6; Yan LM, 2012, CELL RES, V22, P1304, DOI 10.1038/cr.2012.74; Yoshida S, 2005, J BIOL CHEM, V280, P9203, DOI 10.1074/jbc.M411665200; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zulawski M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-548	75	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147203	10.1371/journal.pone.0147203	http://dx.doi.org/10.1371/journal.pone.0147203			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784444	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400122
J	Yokochi, K; Kennington, WJ; Bencini, R				Yokochi, Kaori; Kennington, Winn Jason; Bencini, Roberta			An Endangered Arboreal Specialist, the Western Ringtail Possum (Pseudocheirus occidentalis), Shows a Greater Genetic Divergence across a Narrow Artificial Waterway than a Major Road	PLOS ONE			English	Article							RED-BACKED SALAMANDERS; HABITAT FRAGMENTATION; POPULATION; DISPERSAL; FLOW; CONSERVATION; PHILOPATRY; SOFTWARE; PATTERNS; DISTANCE	The fragmentation of habitats by roads and other artificial linear structures can have a profound effect on the movement of arboreal species due to their strong fidelity to canopies. Here, we used 12 microsatellite DNA loci to investigate the fine-scale spatial genetic structure and the effects of a major road and a narrow artificial waterway on a population of the endangered western ringtail possum (Pseudocheirus occidentalis) in Busselton, Western Australia. Using spatial autocorrelation analysis, we found positive genetic structure in continuous habitat over distances up to 600 m. These patterns are consistent with the sedentary nature of P. occidentalis and highlight their vulnerability to the effects of habitat fragmentation. Pairwise relatedness values and Bayesian cluster analysis also revealed significant genetic divergences across an artificial waterway, suggesting that it was a barrier to gene flow. By contrast, no genetic divergences were detected across the major road. While studies often focus on roads when assessing the effects of artificial linear structures on wildlife, this study provides an example of an often overlooked artificial linear structure other than a road that has a significant impact on wildlife dispersal leading to genetic subdivision.	[Yokochi, Kaori; Kennington, Winn Jason; Bencini, Roberta] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	University of Western Australia	Yokochi, K (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	yokochi.kaori@gmail.com	Kennington, Winn J/H-5182-2014; Bencini, Roberta/A-1426-2013	Kennington, Winn J/0000-0001-6100-6543; Bencini, Roberta/0000-0002-6927-5198; Yokochi, kaori/0000-0002-8474-9590	School of Animal Biology at The University of Western Australia; Main Roads Western Australia; Western Australian Department of Parks and Wildlife; Western Power; Satterley Property Group via Western Australian Department of Parks and Wildlife; Holsworth Wildlife Research Endowment [RA/1/411/330]; City of Busselton; Peppermint Park Eco Village; Camp Geographe; Abundant Life Centre; Christian Brethren Campsites; Legacy Camp; Possum Centre Busselton Inc.	School of Animal Biology at The University of Western Australia; Main Roads Western Australia; Western Australian Department of Parks and Wildlife; Western Power; Satterley Property Group via Western Australian Department of Parks and Wildlife; Holsworth Wildlife Research Endowment; City of Busselton; Peppermint Park Eco Village; Camp Geographe; Abundant Life Centre; Christian Brethren Campsites; Legacy Camp; Possum Centre Busselton Inc.	This work was conducted with funding from the School of Animal Biology at The University of Western Australia to KY (http://www.animals.uwa.edu.au), Main Roads Western Australia to RB (https://www.mainroads.wa.gov.au), the Western Australian Department of Parks and Wildlife to RB (http://www.dpaw.wa.gov.au), Western Power to RB (http://www.westernpower.com.au), the Satterley Property Group (http://satterley.com.au) to RB via Western Australian Department of Parks and Wildlife and the Holsworth Wildlife Research Endowment to KY (RA/1/411/330, http://www.eqt.com.au/not-for-profit-organisations/confirmed-2015-programs/holsworth-grants.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the School of Animal Biology at The University of Western Australia, Main Roads Western Australia, and the Western Australian Department of Parks and Wildlife for providing technical support for this project. We gratefully acknowledge Mr. Paul J. de Tores and Dr. Judy Clarke for providing valuable advice, support and training for the fieldwork. Yvette Hitchen at Helix Molecular Solutions Pty Ltd provided technical assistance with DNA extractions and conducted PCR and scoring of genotypes for this project. We would also like to thank the City of Busselton, Peppermint Park Eco Village, Camp Geographe, Abundant Life Centre, Christian Brethren Campsites, Legacy Camp and Possum Centre Busselton Inc. for their support and over 100 volunteers who helped us in the field. We thank Dr Miriam Goosem, Prof. Darryl Jones, and Adj/ Prof. Jeff Bowman for their invaluable comments on this manuscript as a part of a thesis review. We also would like to thank the academic reviewers of PLOS ONE for their comments.	Australian Bureau of Statistics, 2014, 3218 0 REG POP GROWT; Broquet T, 2006, MOL ECOL, V15, P1689, DOI 10.1111/j.1365-294X.2006.02878.x; Burbidge A.A., 2014, P15; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Clark RW, 2010, CONSERV BIOL, V24, P1059, DOI 10.1111/j.1523-1739.2009.01439.x; Clarke J., 2011, THESIS MURDOCH U; CLOUT MN, 1984, J ANIM ECOL, V53, P737, DOI 10.2307/4656; de Tores PJ, 2010, WILDLIFE RES, V37, P512, DOI 10.1071/WR10090; Dique DS, 2003, WILDLIFE RES, V30, P281, DOI 10.1071/WR02043; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Estes-Zumpe WA, 2010, J MAMMAL, V91, P208, DOI 10.1644/09-MAMM-A-032R.1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Goldingay RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080383; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harring-Harris K, 2014, THESIS U W AUSTR; Hazlitt SL, 2004, MOL ECOL, V13, P3621, DOI 10.1111/j.1365-294X.2004.02342.x; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JONES BA, 1994, WILDLIFE RES, V21, P175, DOI 10.1071/WR9940175; JONES BA, 1994, WILDLIFE RES, V21, P189, DOI 10.1071/WR9940189; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Lancaster ML, 2011, MOL ECOL, V20, P2258, DOI 10.1111/j.1365-294X.2011.05072.x; Lee T, 2010, WILDLIFE RES, V37, P156, DOI 10.1071/WR09134; Main Roads Western Australia, 2009, STAT TRAFF DIG 2003; Marsh DM, 2007, CAN J ZOOL, V85, P319, DOI 10.1139/Z07-008; Marsh DM, 2008, CONSERV GENET, V9, P603, DOI 10.1007/s10592-007-9377-0; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Molloy SW, 2014, ENVIRON CONSERV, V41, P176, DOI 10.1017/S0376892913000337; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; National Health and Medical Research Council, 2004, AUSTR COD PRACT CAR; NEI M, 1974, GENETICS, V76, P379; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pope LC, 2006, MOL ECOL, V15, P371, DOI 10.1111/j.1365-294X.2005.02815.x; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Quemere E, 2010, MOL ECOL, V19, P1606, DOI 10.1111/j.1365-294X.2010.04581.x; R Development Core Team, 2013, R LANG ENV STAT COMP; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Stow AJ, 2006, WILDLIFE RES, V33, P409, DOI 10.1071/WR06019; Taylor AM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017069, 10.1371/journal.pone.0026651]; Trimming E, 2009, SEM 55 M AUSTR MAMM, P24; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walker FM, 2008, MOL ECOL, V17, P1674, DOI 10.1111/j.1365-294X.2008.03701.x; Wilson K, 2009, CONSERV GENET RESOUR, V1, P123, DOI 10.1007/s12686-009-9030-y; Wilson KJ, 2009, THESIS MURDOCH U; Yokochi K, 2015, J MAMMAL, V96, P1284, DOI 10.1093/jmammal/gyv137	53	4	4	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146167	10.1371/journal.pone.0146167	http://dx.doi.org/10.1371/journal.pone.0146167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784921	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400026
J	Zhong, X; Song, YJ; Yang, P; Wang, Y; Jiang, SY; Zhang, X; Li, CY				Zhong, Xue; Song, Yunjia; Yang, Peng; Wang, Yao; Jiang, Shaoyun; Zhang, Xu; Li, Changyi			Titanium Surface Priming with Phase-Transited Lysozyme to Establish a Silver Nanoparticle-Loaded Chitosan/Hyaluronic Acid Antibacterial Multilayer via Layer-by-Layer Self-Assembly	PLOS ONE			English	Article							IN-VITRO; CYTOTOXICITY; IMPLANTS	Objectives The formation of biofilm around implants, which is induced by immediate bacterial colonization after installation, is the primary cause of post-operation infection. Initial surface modification is usually required to incorporate antibacterial agents on titanium (Ti) surfaces to inhibit biofilm formation. However, simple and effective priming methods are still lacking for the development of an initial functional layer as a base for subsequent coatings on titanium surfaces. The purpose of our work was to establish a novel initial layer on Ti surfaces using phase-transited lysozyme (PTL), on which multilayer coatings can incorporate silver nanoparticles (AgNP) using chitosan (CS) and hyaluronic acid (HA) via a layer-by-layer (LbL) self-assembly technique. Methods In this study, the surfaces of Ti substrates were primed by dipping into a mixture of lysozyme and tris(2-carboxyethyl)phosphine (TCEP) to obtain PTL-functionalized Ti substrates. The subsequent alternating coatings of HA and chitosan loaded with AgNP onto the precursor layer of PTL were carried out via LbL self-assembly to construct multilayer coatings on Ti substrates. Results The results of SEM and XPS indicated that the necklace-like PTL and self-assembled multilayer were successfully immobilized on the Ti substrates. The multilayer coatings loaded with AgNP can kill planktonic and adherent bacteria to 100% during the first 4 days. The antibacterial efficacy of the samples against planktonic and adherent bacteria achieved 65%-90% after 14 days. The sustained release of Ag over 14 days can prevent bacterial invasion until mucosa healing. Although the AgNP-containing structure showed some cytotoxicity, the toxicity can be reduced by controlling the Ag release rate and concentration. Conclusions The PTL priming method provides a promising strategy for fabricating long-term antibacterial multilayer coatings on titanium surfaces via the LbL self-assembly technique, which is effective in preventing implant-associated infections in the early stage.	[Zhong, Xue; Song, Yunjia; Wang, Yao; Jiang, Shaoyun; Zhang, Xu; Li, Changyi] Tianjin Med Univ, Hosp Stomatol, Sch Dent, Tianjin, Peoples R China; [Yang, Peng] Shaanxi Normal Univ, Coll Chem & Chem Engn, Minist Educ, Key Lab Appl Surface & Colloid Chem, Xian, Peoples R China	Tianjin Medical University; Shaanxi Normal University	Zhang, X; Li, CY (corresponding author), Tianjin Med Univ, Hosp Stomatol, Sch Dent, Tianjin, Peoples R China.	zhxden@gmail.com; cli02@tmu.edu.cn	Li, Changyi/GVS-6654-2022; YANG, Peng/F-5519-2010; gao, qiuying/AAO-3696-2021; Yang, Peng/J-8099-2019	YANG, Peng/0000-0002-0463-1024; 	National Natural Science Foundation of China [31470920, 21374057, 51303100]; Tianjin Research Program of Application Foundation and Advanced Technology [12JCZDJC22700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology	This work was funded by: 1) National Natural Science Foundation of China (Grant No: 31470920), http://www.nsfc.gov.cn/; 2) National Natural Science Foundation of China (Grant No: 21374057,51303100), http://www.nsfc.gov.cn/; 3) Tianjin Research Program of Application Foundation and Advanced Technology (Grant No: 12JCZDJC22700), http://www.tstc.gov.cn/.	Agarwal A, 2010, BIOMATERIALS, V31, P680, DOI 10.1016/j.biomaterials.2009.09.092; Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078; Camargo Igor Batista, 2015, Dent Clin North Am, V59, P57, DOI 10.1016/j.cden.2014.08.003; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; Hardes J, 2007, BIOMATERIALS, V28, P2869, DOI 10.1016/j.biomaterials.2007.02.033; He S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0169; Huang R, 2015, BIOMATERIALS, V53, P58, DOI 10.1016/j.biomaterials.2015.02.076; Jeon S, 2015, COLLOID SURFACE B, V129, P7, DOI 10.1016/j.colsurfb.2015.03.018; Koseki H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107588; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Lv HB, 2014, J DENT, V42, P1464, DOI 10.1016/j.jdent.2014.06.003; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018; Noda K, 2015, J PROSTHODONT RES, V59, P178, DOI 10.1016/j.jpor.2015.04.003; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Qiao SC, 2015, INT J NANOMED, V10, P653, DOI 10.2147/IJN.S73467; Qin H, 2014, BIOMATERIALS, V35, P9114, DOI 10.1016/j.biomaterials.2014.07.040; Sanpui P, 2008, INT J FOOD MICROBIOL, V124, P142, DOI 10.1016/j.ijfoodmicro.2008.03.004; Song W, 2015, INT J NANOMED, V10, P2335, DOI 10.2147/IJN.S76513; Wu ZF, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201400401; Yeo In-Sung, 2014, Open Biomed Eng J, V8, P114, DOI 10.2174/1874120701408010114; Zhang XM, 2013, MAT SCI ENG C-MATER, V33, P2816, DOI 10.1016/j.msec.2013.03.010; Zhang X, 2008, MAT SCI ENG C-BIO S, V28, P237, DOI 10.1016/j.msec.2006.12.007; Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463; Zhao Y, 2014, INT J NANOMED, V9, P5177, DOI 10.2147/IJN.S65386	29	54	57	6	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146957	10.1371/journal.pone.0146957	http://dx.doi.org/10.1371/journal.pone.0146957			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783746	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400086
J	Okamoto, T; Ozawa, Y; Kamoshita, M; Osada, H; Toda, E; Kurihara, T; Nagai, N; Umezawa, K; Tsubota, K				Okamoto, Tomohiro; Ozawa, Yoko; Kamoshita, Mamoru; Osada, Hideto; Toda, Eriko; Kurihara, Toshihide; Nagai, Norihiro; Umezawa, Kazuo; Tsubota, Kazuo			The Neuroprotective Effect of Rapamycin as a Modulator of the mTOR-NF-kappa B Axis during Retinal Inflammation	PLOS ONE			English	Article							ENDOTOXIN-INDUCED UVEITIS; II TYPE-1 RECEPTOR; DIABETIC MACULAR EDEMA; OCULAR INFLAMMATION; SUPPRESSION; MECHANISM; PATHWAY; DEGRADATION; RHODOPSIN; SIROLIMUS	Purpose The determination of the molecular mechanism underlying retinal pathogenesis and visual dysfunction during innate inflammation, and the treatment effect of rapamycin thereon. Methods The endotoxin-induced uveitis and retinitis mouse model was established by injecting lipopolysaccharide. The mice were subsequently treated with rapamycin, a mammalian target of rapamycin (mTOR) inhibitor. The rhodopsin mRNA and protein expression level in the retina and the photoreceptor outer segment (OS) length in immunohistochemical stainings were measured, and visual function was recorded by electroretinography. Inflammatory cytokines, their related molecules, mTOR, and LC3 levels were measured by real-time PCR and/or immunoblotting. Leukocyte adhesion during inflammation was analyzed using concanavalin A lectin. Results The post-transcriptional reduction in the visual pigment of rod photoreceptor cells, rhodopsin, OS shortening, and rod photoreceptor cell dysfunction during inflammation were suppressed by rapamycin. Activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) and induction of inflammatory cytokines, such as interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1), and the activation of the downstream signaling protein, signal transducer and activator of transcription 3 (STAT3), which reduces rhodopsin in the retina during inflammation, were attenuated by rapamycin. Increased leukocyte adhesion was also attenuated by rapamycin. Interestingly, although mTOR activation was observed after NF-kappa B activation, mTOR inhibition suppressed NF-kappa B activation at the early phase, indicating that the basal level of activated mTOR was sufficient to activate NF-kappa B in the retina. In addition, the inhibition of NF-kappa B suppressed mTOR activation, suggesting a positive feedback loop of mTOR and NF-kappa B during inflammation. The ratio of LC3II to LC3I, which reflects autophagy induction, was not changed by inflammation but was increased by rapamycin. Conclusions Our results propose the potential use of rapamycin as a neuroprotective therapy to suppress local activated mTOR levels, related inflammatory molecules, and the subsequent visual dysfunction during retinal inflammation.	[Okamoto, Tomohiro; Ozawa, Yoko; Kamoshita, Mamoru; Osada, Hideto; Toda, Eriko; Kurihara, Toshihide; Nagai, Norihiro] Keio Univ, Sch Med, Dept Ophthalmol, Lab Retinal Cell Biol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Okamoto, Tomohiro; Ozawa, Yoko; Kamoshita, Mamoru; Kurihara, Toshihide; Nagai, Norihiro; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med Screening, Nagakute, Aichi 4801195, Japan	Keio University; Keio University; Aichi Medical University	Ozawa, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Lab Retinal Cell Biol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.; Ozawa, Y (corresponding author), Keio Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ozawa@a5.keio.jp	Ozawa, Yoko/AAH-9888-2020; Kurihara, Toshihide/ABA-7058-2020	Kurihara, Toshihide/0000-0002-5457-2720; Osada, Hideto/0000-0001-9971-8992	JSPS KAKENHI [24592647]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research, JSPS KAKENHI to Y.O. (24592647).	Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Chen Y, 2013, J BIOL CHEM, V288, P7506, DOI 10.1074/jbc.M112.439935; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Dhingra R, 2013, CIRC-HEART FAIL, V6, P335, DOI 10.1161/CIRCHEARTFAILURE.112.000061; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Frosali S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/489821; Funk M, 2010, RETINA-J RET VIT DIS, V30, P1412, DOI 10.1097/IAE.0b013e3181e095c0; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hovland A, 2015, ATHEROSCLEROSIS, V241, P480, DOI 10.1016/j.atherosclerosis.2015.05.038; Kamoshita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103013; Kubota S, 2011, INVEST OPHTH VIS SCI, V52, P9142, DOI 10.1167/iovs.11-8041; Kubota S, 2009, INVEST OPHTH VIS SCI, V50, P3512, DOI 10.1167/iovs.08-2666; Kurihara T, 2008, DIABETES, V57, P2191, DOI 10.2337/db07-1281; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; McMaster WG, 2015, CIRC RES, V116, P1022, DOI 10.1161/CIRCRESAHA.116.303697; Miyake S, 2012, LAB INVEST, V92, P102, DOI 10.1038/labinvest.2011.132; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P4342, DOI 10.1167/iovs.06-1473; Nagai N, 2009, FREE RADICAL BIO MED, V47, P300, DOI 10.1016/j.freeradbiomed.2009.04.033; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oh IK, 2010, CURR EYE RES, V35, P1116, DOI 10.3109/02713683.2010.510257; Owen LA, 2013, CURR DIABETES REP, V13, P476, DOI 10.1007/s11892-013-0382-z; Ozawa Y, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/506137; Ozawa Y, 2011, EXP DIABETES RES, DOI 10.1155/2011/108328; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Park S, 2009, CANCER RES, V69, P4107, DOI 10.1158/0008-5472.CAN-09-0474; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Nguyen QD, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-32; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Sasaki M, 2009, INVEST OPHTH VIS SCI, V50, P1433, DOI 10.1167/iovs.08-2493; Satofuka S, 2006, INVEST OPHTH VIS SCI, V47, P2686, DOI 10.1167/iovs.05-1458; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Sen ES, 2015, NAT REV RHEUMATOL, V11, P338, DOI 10.1038/nrrheum.2015.20; Suzuki M, 2010, MOL VIS, V16, P1382; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Yoshida S, 2015, BRIT J OPHTHALMOL, V99, P960, DOI 10.1136/bjophthalmol-2014-306366	43	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146517	10.1371/journal.pone.0146517	http://dx.doi.org/10.1371/journal.pone.0146517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771918	Green Submitted, Green Published, gold			2022-12-26	WOS:000368628300024
J	Vermeij, GJ				Vermeij, Geerat J.			Gigantism and Its Implications for the History of Life	PLOS ONE			English	Article							DINOSAUR BODY TEMPERATURES; ATMOSPHERIC OXYGEN; SAUROPOD DINOSAURS; SIZE EVOLUTION; SEA-TURTLE; COPES RULE; GIANT; FOSSIL; PHYSIOLOGY; INCREASE	Gigantism-very large body size-is an ecologically important trait associated with competitive superiority. Although it has been studied in particular cases, the general conditions for the evolution and maintenance of gigantism remain obscure. I compiled sizes and dates for the largest species in 3 terrestrial and 7 marine trophic and habitat categories of animals from throughout the Phanerozoic. The largest species (global giants) in all categories are of post-Paleozoic age. Gigantism at this level appeared tens to hundreds of millions of years after mass extinctions and long after the origins of clades in which it evolved. Marine gigantism correlates with high planktic or seafloor productivity, but on land the correspondence between productivity and gigantism is weak at best. All global giants are aerobically active animals, not gentle giants with low metabolic demands. Oxygen concentration in the atmosphere correlates with gigantism in the Paleozoic but not thereafter, likely because of the elaboration of efficient gas-exchange systems in clades containing giants. Although temperature and habitat size are important in the evolution of very large size in some cases, the most important (and rare) enabling circumstance is a highly developed ecological infrastructure in which essential resources are abundant and effectively recycled and reused, permitting activity levels to increase and setting the stage for gigantic animals to evolve. Gigantism as a hallmark of competitive superiority appears to have lost its luster on land after the Mesozoic in favor of alternative means of achieving dominance, especially including social organization and coordinated food-gathering.	[Vermeij, Geerat J.] Univ Calif Davis, Dept Earth & Planetary Sci, One Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis	Vermeij, GJ (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, One Shields Ave, Davis, CA 95616 USA.	gjvermeij@ucdavis.edu						Abbott I.A., 1992, MARINE ALGAE CALIFOR; Allmon WD, 2014, PALEOBIOLOGY, V40, P256, DOI 10.1666/13065; ALTMANN SA, 1987, J ZOOL, V211, P215, DOI 10.1111/j.1469-7998.1987.tb01530.x; Amano K, 2011, NAUTILUS, V125, P29; Anderson PSL, 2007, BIOL LETTERS, V3, P76, DOI 10.1098/rsbl.2006.0569; Anderson RP, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0412; Arnaud P.M., 1974, TETHYS, V6, P567; Ausich W.I., 1985, Echinoderms, V1984, P3; Azzaroli A., 1958, Palaeontographia Italica, V52, P1; Bakker R. T., 1980, COLD LOOK WARM BLOOD, P351; Bates KT, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0215; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; Beu AG, 2009, PALAEOGEOGR PALAEOCL, V284, P191, DOI 10.1016/j.palaeo.2009.09.025; Beu AG., 2007, PALAEONTOL Z, V81, P267; Boyce CK, 2012, INT J PLANT SCI, V173, P561, DOI 10.1086/665820; Boyce CK, 2010, P ROY SOC B-BIOL SCI, V277, P3437, DOI 10.1098/rspb.2010.0485; Braddy SJ, 2008, BIOL LETTERS, V4, P106, DOI 10.1098/rsbl.2007.0491; Brink KS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4269; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Butler Mark J., 2006, P263, DOI 10.1002/9780470995969.ch8; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P12398, DOI 10.1073/pnas.0702040104; CHEN JY, 1994, SCIENCE, V264, P1304, DOI 10.1126/science.264.5163.1304; Childress JJ, 2011, J EXP BIOL, V214, P312, DOI 10.1242/jeb.049023; Cieri RL, 2014, P NATL ACAD SCI USA, V111, P17218, DOI 10.1073/pnas.1405088111; Clapham ME, 2012, P NATL ACAD SCI USA, V109, P10927, DOI 10.1073/pnas.1204026109; Clarke A, 2013, AM NAT, V182, P283, DOI 10.1086/671259; Clauset A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053967; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; Compagno LJV, 1925, FAO FISHERIES SYNOPS, V125, P1; Cristoffer C, 2003, J BIOGEOGR, V30, P1357, DOI 10.1046/j.1365-2699.2003.00926.x; CROWLEY TJ, 1989, GEOLOGY, V17, P457, DOI 10.1130/0091-7613(1989)017<0457:SCVOTS>2.3.CO;2; Damsgaard C, 2013, J EXP BIOL, V216, P1616, DOI 10.1242/jeb.080861; Day MO, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0834; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Denison R, 1978, PLACODERMS HDB PA AO, V2; Denny M. W., 1993, AIR WATER BIOL PHYS; Diamond J.M., 1984, P824; Domning DP., 1978, U CALIFORNIA PUBLICA, V118, P1; Droser ML, 2014, J PALEONTOL, V88, P145, DOI 10.1666/12-158; Dudley R, 1998, J EXP BIOL, V201, P1043; Dudley R., 2000, BIOMECHANICS INSECT; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; Falcon-Lang HJ, 2004, GEOLOGY, V32, P417, DOI 10.1130/G20371.1; Fenberg PB, 2008, MOL ECOL, V17, P209, DOI 10.1111/j.1365-294X.2007.03522.x; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Fitzgerald EMG, 2012, BIOL LETTERS, V8, P94, DOI 10.1098/rsbl.2011.0690; FORTELIUS M, 1993, ZOOL J LINN SOC-LOND, V108, P85, DOI 10.1006/zjls.1993.1018; Friedman M, 2012, P ROY SOC B-BIOL SCI, V279, P944, DOI 10.1098/rspb.2011.1381; Friedman M, 2010, SCIENCE, V327, P990, DOI 10.1126/science.1184743; Frobisch NB, 2013, P NATL ACAD SCI USA, V110, P1393, DOI 10.1073/pnas.1216750110; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; Ghisalberti M, 2014, CURR BIOL, V24, P305, DOI 10.1016/j.cub.2013.12.017; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Green WA, 2010, P ROY SOC B-BIOL SCI, V277, P2257, DOI 10.1098/rspb.2010.0224; Greene H. W., 1997, SNAKES EVOLUTION MYS; Greer A.E., 1974, Journal Herpet, V8, P381, DOI 10.2307/1562913; Gutierrez-Marco JC, 2009, GEOLOGY, V37, P443, DOI 10.1130/G25513A.1; Harrison JF, 2010, P ROY SOC B-BIOL SCI, V277, P1937, DOI 10.1098/rspb.2010.0001; Harzhauser M, 2008, PALAEONTOLOGY, V51, P199, DOI 10.1111/j.1475-4983.2007.00742.x; Harzhauser M, 2014, ACTA PALAEONTOL POL, V59, P367, DOI 10.4202/app.2011.0196; Hayami I, 1980, PALAEONTOLOGY, V23, P789; Head JJ, 2009, NATURE, V457, P715, DOI 10.1038/nature07671; Heeren T, 1997, MAR FRESHWATER RES, V48, P7, DOI 10.1071/MF96026; Heim NA, 2015, SCIENCE, V347, P867, DOI 10.1126/science.1260065; Heiss E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1028; Hennemann FH, 2008, ZOOTAXA, P1; HOLLAND CH, 1987, J GEOL SOC LONDON, V144, P1, DOI 10.1144/gsjgs.144.1.0001; Houssaye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076741; Houssaye A, 2013, PALAEONTOLOGY, V56, P647, DOI 10.1111/pala.12008; Huttenlocker AK, 2014, PEERJ, V2, DOI 10.7717/peerj.325; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Inuzuka Norihisa, 1996, Journal of the Geological Society of Japan, V102, P816; Isozaki Y, 2009, PALAEOGEOGR PALAEOCL, V284, P11, DOI 10.1016/j.palaeo.2009.08.022; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaeger Peter, 2001, Zoosystema, V23, P461; Jaffe AL, 2011, BIOL LETTERS, V7, P558, DOI 10.1098/rsbl.2010.1084; JANIS CM, 1991, ANN ZOOL FENN, V28, P201; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; Kauffman EG, 2007, J PALEONTOL, V81, P64, DOI 10.1666/0022-3360(2007)81[64:POGIPO]2.0.CO;2; Kear BP, 2006, BIOL LETT-UK, V2, P116, DOI 10.1098/rsbl.2005.0406; Kelly SRA, 2000, GEOL SOC SPEC PUBL, V177, P227, DOI 10.1144/GSL.SP.2000.177.01.13; Kemp T.S, 1982, MAMMAL LIKE REPTILES; Kiel S, 2010, TOP GEOBIOL, V33, P255, DOI 10.1007/978-90-481-9572-5_8; Kingsolver JG, 2004, EVOLUTION, V58; Klug C, 2015, LETHAIA, V48, P267, DOI 10.1111/let.12104; Klug C, 2010, LETHAIA, V43, P465, DOI 10.1111/j.1502-3931.2009.00206.x; Kollmann HA, 2014, GEODIVERSITAS, V36, P349, DOI 10.5252/g2014n3a2; Kozhov M., 1963, LAKE BAIKAL ITS LIFE, DOI 10.1007/978-94-015-7388-7; Ksepka DT, 2014, P NATL ACAD SCI USA, V111, P10624, DOI 10.1073/pnas.1320297111; Lane CE, 2006, J PHYCOL, V42, P493, DOI 10.1111/j.1529-8817.2006.00204.x; Larjavaara M, 2014, NEW PHYTOL, V202, P344, DOI 10.1111/nph.12656; Larjavaara M, 2012, GLOBAL ECOL BIOGEOGR, V21, P998, DOI 10.1111/j.1466-8238.2011.00740.x; LEIGH EG, 2008, TROPICAL FOREST COMM, P121; Lindberg DR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P67; Liu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep07142; Long J.A., 2001, P52, DOI 10.1002/9780470999295.ch10; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Mazzetta GV, 2004, HIST BIOL, V17, P1; MCCAMMON HM, 1973, J PALEONTOL, V47, P266; McClain CR, 2015, PEERJ, V2, DOI 10.7717/peerj.715; Menin Marcelo, 2005, Phyllomedusa, V4, P39; Meyer-Berthaud B, 2007, NATURE, V446, P861, DOI 10.1038/446861a; Moran AL, 2012, J EXP BIOL, V215, P1995, DOI 10.1242/jeb.067066; MORGAN G J, 1991, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V13, P189; Motani R, 2015, NATURE, V517, P485, DOI 10.1038/nature13866; Motani R, 2010, SCIENCE, V328, P1361, DOI 10.1126/science.1191409; Muir-Wood H. M., 1960, Memoirs Geological Society of America, V81, P1; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Novack-Gottshall PM, 2008, PALEOBIOLOGY, V34, P210, DOI 10.1666/0094-8373(2008)034[0210:EBTICM]2.0.CO;2; Novack-Gottshall PM, 2008, P NATL ACAD SCI USA, V105, P5430, DOI 10.1073/pnas.0709645105; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Osborne CP, 2002, PALAEOGEOGR PALAEOCL, V182, P15, DOI 10.1016/S0031-0182(01)00450-3; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Parham JF, 2010, J PALEONTOL, V84, P231, DOI 10.1666/09-077R.1; Parsons Michael J., 1992, Tropical Lepidoptera, V3, P33; Payne JL, 2005, PALEOBIOLOGY, V31, P269, DOI 10.1666/0094-8373(2005)031[0269:EDOGSA]2.0.CO;2; Payne JL, 2013, EVOLUTION, V67, P816, DOI 10.1111/j.1558-5646.2012.01807.x; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; PEEL JS, 1984, LETHAIA, V17, P211, DOI 10.1111/j.1502-3931.1984.tb01619.x; Pimiento C, 2015, PALAEONTOLOGY, V41, P469; Planavsky NJ, 2014, SCIENCE, V346, P635, DOI 10.1126/science.1258410; Polis G.A., 1990, P247; Poulsen CJ, 2015, SCIENCE, V348, P1238, DOI 10.1126/science.1260670; Pyenson ND, 2012, NATURE, V485, P498, DOI 10.1038/nature11135; Reisz Robert R., 2000, P9, DOI 10.1017/CBO9780511549717.003; RICHARDS AM, 1973, J ZOOL, V169, P195; Richards PW, 1952, TROPICAL RAIN FOREST; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Robinson J.M., 1990, HIST BIOL, V3, P189, DOI DOI 10.1080/08912969009386521; Rosa R, 2010, J MAR BIOL ASSOC UK, V90, P1375, DOI 10.1017/S0025315409991494; ROSEWATER JOSEPH, 1965, INDO PACIFIC MOLLUSCA, V1, P347; Rudkin DM, 2003, J PALEONTOL, V77, P99, DOI 10.1017/S0022336000043456; Ruxton G, 2014, J EXP BIOL, V217, P2627, DOI 10.1242/jeb.104919; Saarinen JJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2049; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sarko DK, 2010, MAR MAMMAL SCI, V26, P937, DOI 10.1111/j.1748-7692.2010.00384.x; Scarabino Victor, 1995, Memoires du Museum National d'Histoire Naturelle, V167, P189; Schoch RR, 2002, LETHAIA, V35, P309, DOI 10.1080/002411602320790634; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Seilacher Adolf, 1998, P423; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; SHEAR WA, 1990, CAN J ZOOL, V68, P1807, DOI 10.1139/z90-262; Shelley RM, 2000, TROP ZOOL, V13, P159, DOI 10.1080/03946975.2000.10531129; Shimada K, 2012, J VERTEBR PALEONTOL, V32, P1271, DOI 10.1080/02724634.2012.707997; SIGNOR PW, 1994, PALEOBIOLOGY, V20, P297, DOI 10.1017/S0094837300012793; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Smith FA, 2011, PHILOS T R SOC B, V366, P2364, DOI 10.1098/rstb.2011.0067; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Soibelzon LH, 2011, J PALEONTOL, V85, P69, DOI 10.1666/10-037.1; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Sperling EA, 2015, NATURE, V523, P451, DOI 10.1038/nature14589; Stein WE, 2007, NATURE, V446, P904, DOI 10.1038/nature05705; Stilwell J.D., 1992, ANTARCT RES SER, V55, P1, DOI DOI 10.1029/AR055; STRAATMAN R, 1975, Journal of the Lepidopterists' Society, V29, P85; Tamburello N, 2015, AM NAT, V186, P196, DOI 10.1086/682070; Taylor JD, 2010, TOP GEOBIOL, V33, P107, DOI 10.1007/978-90-481-9572-5_5; Taylor JD, 2009, PALAEONTOLOGY, V52, P95, DOI 10.1111/j.1475-4983.2008.00839.x; TEICHERT CURT, 1960, BREVIORA MUS COMP ZOOL [HARVARD], V128, P1; Thubaut J, 2013, ECOL EVOL, V3, P4748, DOI 10.1002/ece3.749; Tng DYP, 2012, NEW PHYTOL, V196, P1001, DOI 10.1111/j.1469-8137.2012.04359.x; Van Roy P, 2015, NATURE, V522, P77, DOI 10.1038/nature14256; Van Valkenburgh Blaire, 2002, Paleontological Society Papers, V8, P267; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; Verberk WCEP, 2011, ECOLOGY, V92, P1565, DOI 10.1890/10-2369.1; Vermeij GJ, 2008, ECOLOGY, V89, pS39, DOI 10.1890/07-0663.1; Vermeij GJ, 2013, ANNU REV EARTH PL SC, V41, P1, DOI 10.1146/annurev-earth-050212-124123; Vermeij GJ, 2013, BIOL J LINN SOC, V109, P497, DOI 10.1111/bij.12095; Vermeij GJ, 2012, BIOL J LINN SOC, V106, P776, DOI 10.1111/j.1095-8312.2012.01897.x; Vermeij GJ, 2012, EVOLUTION, V66, P2007, DOI 10.1111/j.1558-5646.2012.01592.x; Vermeij GJ, 2011, P ROY SOC B-BIOL SCI, V278, P2362, DOI 10.1098/rspb.2010.2362; Vermeij GJ, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P239; Vinther J, 2014, NATURE, V507, P496, DOI 10.1038/nature13010; von Cosel R, 1998, CR ACAD SCI III-VIE, V321, P655, DOI 10.1016/S0764-4469(98)80005-X; Ware JL, 2014, J BIOGEOGR, V41, P1291, DOI 10.1111/jbi.12273; Werner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028442; Wesselingh FP, 1999, VELIGER, V42, P67; Wilkinson DM, 2013, FUNCT ECOL, V27, P131, DOI 10.1111/1365-2435.12033; Witton MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013982; Worthy T. H., 2002, LOST WORLD MOA PREHI; Xiao SH, 2014, CURR BIOL, V24, pR120, DOI 10.1016/j.cub.2013.12.035; YANCEY TE, 1983, PALAEONTOLOGY, V26, P497; Yuan XL, 2002, GEOLOGY, V30, P363, DOI 10.1130/0091-7613(2002)030<0363:TSIAEC>2.0.CO;2	190	55	56	4	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146092	10.1371/journal.pone.0146092	http://dx.doi.org/10.1371/journal.pone.0146092			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771527	Green Published, gold			2022-12-26	WOS:000368628300007
J	Weiss, SJ; Mansell, TJ; Mortazavi, P; Knight, R; Gill, RT				Weiss, Sophie J.; Mansell, Thomas J.; Mortazavi, Pooneh; Knight, Rob; Gill, Ryan T.			Parallel Mapping of Antibiotic Resistance Alleles in Escherichia coli	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; SUPERVISED CLASSIFICATION; MULTIDRUG-RESISTANCE; CHROMOSOMAL GENES; DRUG-RESISTANCE; GENOME; COMMUNITY; SEQUENCE; EVOLUTION; ABUNDANCE	Chemical genomics expands our understanding of microbial tolerance to inhibitory chemicals, but its scope is often limited by the throughput of genome-scale library construction and genotype-phenotype mapping. Here we report a method for rapid, parallel, and deep characterization of the response to antibiotics in Escherichia coli using a barcoded genome-scale library, next-generation sequencing, and streamlined bioinformatics software. The method provides quantitative growth data (over 200,000 measurements) and identifies contributing antimicrobial resistance and susceptibility alleles. Using multivariate analysis, we also find that subtle differences in the population responses resonate across multiple levels of functional hierarchy. Finally, we use machine learning to identify a unique allelic and proteomic fingerprint for each antibiotic. The method can be broadly applied to tolerance for any chemical from toxic metabolites to next-generation biofuels and antibiotics.	[Weiss, Sophie J.; Mansell, Thomas J.; Gill, Ryan T.] Univ Colorado, Dept Chem & Biol Engn, 3415 Colorado Ave, Boulder, CO 80303 USA; [Mortazavi, Pooneh] Univ Colorado, Dept Comp Sci, 1111 Engn Dr ECOT 717, Boulder, CO 80303 USA; [Knight, Rob] Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr,MC 0602, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, 9500 Gilman Dr,MC 0404, La Jolla, CA 92093 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego; University of California System; University of California San Diego	Gill, RT (corresponding author), Univ Colorado, Dept Chem & Biol Engn, 3415 Colorado Ave, Boulder, CO 80303 USA.	rtg@colorado.edu		MANSELL, THOMAS/0000-0001-8807-4570; Knight, Rob/0000-0002-0975-9019	NIH/CU Molecular Biophysics Training Scholarship [T32 GM-065103]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER	NIH/CU Molecular Biophysics Training Scholarship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SJW was funded by the NIH/CU Molecular Biophysics Training Scholarship (T32 GM-065103).	Aitchison J, 1986, STAT ANAL COMPOSITIO; Amirkia VD, 2011, BIOINFORMATION, V5, P365, DOI 10.6026/97320630005365; Andersson DI, 2012, DRUG RESIST UPDATE, V15, P162, DOI 10.1016/j.drup.2012.03.005; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BLOOM SA, 1981, MAR ECOL PROG SER, V5, P125, DOI 10.3354/meps005125; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Doi Y, 2007, CLIN INFECT DIS, V45, P88, DOI 10.1086/518605; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Gill RT, 2002, P NATL ACAD SCI USA, V99, P7033, DOI 10.1073/pnas.102154799; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hillenmeyer ME, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r30; HURLEY JR, 1962, BEHAV SCI, V7, P258, DOI 10.1002/bs.3830070216; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Kadrmas JL, 1998, J BIOL CHEM, V273, P2799, DOI 10.1074/jbc.273.5.2799; Kaldalu M, 2004, ANTIMICROB AGENTS CH, V48, P890, DOI 10.1128/AAC.48.3.890-896.2004; Karatzas KAG, 2008, APPL ENVIRON MICROB, V74, P1508, DOI 10.1128/AEM.01931-07; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Knights D, 2011, ISME J, V5, P570, DOI 10.1038/ismej.2010.148; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwon DH, 2003, ANTIMICROB AGENTS CH, V47, P2169, DOI 10.1128/AAC.47.7.2169-2178.2003; Lawhorn BG, 2004, J BIOL CHEM, V279, P43555, DOI 10.1074/jbc.M404284200; Lazar V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.57; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Lynch MD, 2007, NAT METHODS, V4, P87, DOI 10.1038/NMETH946; Martin RG, 2004, MOL MICROBIOL, V53, P183, DOI 10.1111/j.1365-2958.2004.04080.x; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Piras C, 2012, MOL BIOSYST, V8, P1060, DOI 10.1039/c1mb05385j; Robinson DG, 2014, G3-GENES GENOM GENET, V4, P11, DOI 10.1534/g3.113.008565; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruiz C, 2010, ANTIMICROB AGENTS CH, V54, P2125, DOI 10.1128/AAC.01420-09; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Soo VWC, 2011, P NATL ACAD SCI USA, V108, P1484, DOI 10.1073/pnas.1012108108; Spoering AL, 2006, J BACTERIOL, V188, P5136, DOI 10.1128/JB.00369-06; TAMAKI S, 1971, J BACTERIOL, V105, P968, DOI 10.1128/JB.105.3.968-975.1971; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thorsing M, 2015, MICROBIOL-SGM, V161, P1999, DOI 10.1099/mic.0.000152; Toprak E, 2013, NAT PROTOC, V8, P555, DOI [10.1038/nprot.2013.021, 10.1038/nprot.nprot.2013.021]; Warnecke TE, 2010, METAB ENG, V12, P241, DOI 10.1016/j.ymben.2009.12.002; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu CX, 2006, PROTEOMICS, V6, P462, DOI 10.1002/pmic.200500219	69	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146916	10.1371/journal.pone.0146916	http://dx.doi.org/10.1371/journal.pone.0146916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771672	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300043
J	Yutthanasirikul, R; Nagano, T; Jimbo, H; Hihara, Y; Kanamori, T; Ueda, T; Haruyama, T; Konno, H; Yoshida, K; Hisabori, T; Nishiyama, Y				Yutthanasirikul, Rayakorn; Nagano, Takanori; Jimbo, Haruhiko; Hihara, Yukako; Kanamori, Takashi; Ueda, Takuya; Haruyama, Takamitsu; Konno, Hiroki; Yoshida, Keisuke; Hisabori, Toru; Nishiyama, Yoshitaka			Oxidation of a Cysteine Residue in Elongation Factor EF-Tu Reversibly Inhibits Translation in the Cyanobacterium Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; oxidative stress; redox regulation; translation; translation elongation factor	CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PHOTOSYSTEM-II; THIOREDOXIN; PHOTOINHIBITION; STRESS; TARGETS; PROTEIN; REPAIR; DAMAGE	Translational elongation is susceptible to inactivation by reactive oxygen species (ROS) in the cyanobacterium Synechocystis sp. PCC 6803, and elongation factor G has been identified as a target of oxidation by ROS. In the present study we examined the sensitivity to oxidation by ROS of another elongation factor, EF-Tu. The structure of EF-Tu changes dramatically depending on the bound nucleotide. Therefore, we investigated the sensitivity to oxidation in vitro of GTP- and GDP-bound EF-Tu as well as that of nucleotide-free EF-Tu. Assays of translational activity with a reconstituted translation system from Escherichia coli revealed that GTP-bound and nucleotide-free EF-Tu were sensitive to oxidation by H2O2, whereas GDP-bound EF-Tu was resistant to H2O2. The inactivation of EF-Tu was the result of oxidation of Cys-82, a single cysteine residue, and subsequent formation of both an intermolecular disulfide bond and sulfenic acid. Replacement of Cys-82 with serine rendered EF-Tu resistant to inactivation by H2O2, confirming that Cys-82 was a target of oxidation. Furthermore, oxidized EF-Tu was reduced and reactivated by thioredoxin. Gel-filtration chromatography revealed that some of the oxidized nucleotide-free EF-Tu formed large complexes of >30 molecules. Atomic force microscopy revealed that such large complexes dissociated into several smaller aggregates upon the addition of dithiothreitol. Immunological analysis of the redox state of EF-Tu in vivo showed that levels of oxidized EF-Tu increased under strong light. Thus, resembling elongation factor G, EF-Tu appears to be sensitive to ROS via oxidation of a cysteine residue, and its inactivation might be reversed in a redox-dependent manner.	[Yutthanasirikul, Rayakorn; Nagano, Takanori; Jimbo, Haruhiko; Hihara, Yukako; Nishiyama, Yoshitaka] Saitama Univ, Grad Sch Sci & Engn, Dept Biochem & Mol Biol, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan; [Kanamori, Takashi] GeneFrontier Corp, Todai Kashiwa Venture Plaza,5-4-19 Kashiwanoha, Kashiwa, Chiba 2770882, Japan; [Kanamori, Takashi; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan; [Haruyama, Takamitsu; Konno, Hiroki] Kanazawa Univ, BioAFM Frontier Res Ctr, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Yoshida, Keisuke; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan	Saitama University; University of Tokyo; Kanazawa University; Tokyo Institute of Technology	Nishiyama, Y (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Dept Biochem & Mol Biol, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	nishiyama@molbiol.saitama-u.ac.jp	Hisabori, Toru/E-5205-2014; Hihara, Yukako/AAO-6742-2020; Hihara, Yukako/E-3461-2010; Ueda, Takuya/K-5217-2014; Hihara, Yukako/AAX-2065-2020; Jimbo, Haruhiko/ABD-6644-2020; Yoshida, Keisuke/E-5231-2014	Hisabori, Toru/0000-0003-2046-0277; Hihara, Yukako/0000-0003-1916-2053; Ueda, Takuya/0000-0002-7760-8271; Yoshida, Keisuke/0000-0001-6542-6254; Jimbo, Haruhiko/0000-0001-9059-7223	Japan Society for the Promotion of Science [24570039, 25119704]; Cooperative Research Program of the Network Joint Research Center for Materials and Devices; Grants-in-Aid for Scientific Research [15H01177] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cooperative Research Program of the Network Joint Research Center for Materials and Devices; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science 24570039 and 25119704 ( to Y. N.) and from the Cooperative Research Program of the Network Joint Research Center for Materials and Devices ( to Y. N. and T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	ANBORGH PH, 1992, EUR J BIOCHEM, V208, P251, DOI 10.1111/j.1432-1033.1992.tb17180.x; Andersen GR, 2000, J MOL BIOL, V297, P421, DOI 10.1006/jmbi.2000.3564; Ando T, 2013, ANNU REV BIOPHYS, V42, P393, DOI 10.1146/annurev-biophys-083012-130324; ARAI KI, 1974, J BIOCHEM-TOKYO, V76, P293, DOI 10.1093/oxfordjournals.jbchem.a130571; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Brandes N, 2007, MOL MICROBIOL, V66, P901, DOI 10.1111/j.1365-2958.2007.05964.x; Cheng Z, 2012, MOL MICROBIOL, V85, P734, DOI 10.1111/j.1365-2958.2012.08135.x; De Laurentiis EI, 2011, BBA-PROTEINS PROTEOM, V1814, P684, DOI 10.1016/j.bbapap.2011.02.007; Ejima K, 2012, FEBS LETT, V586, P778, DOI 10.1016/j.febslet.2012.01.042; Fu J, 2012, J BOT, V2012, P1, DOI DOI 10.1155/2012/835836; Hisabori T, 2005, J EXP BOT, V56, P1463, DOI 10.1093/jxb/eri170; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; Hishiya S, 2008, PLANT CELL PHYSIOL, V49, P11, DOI 10.1093/pcp/pcm158; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Kojima K, 2007, MOL MICROBIOL, V65, P936, DOI 10.1111/j.1365-2958.2007.05836.x; Kojima K, 2009, J BIOL CHEM, V284, P18685, DOI 10.1074/jbc.M109.015131; Krab IM, 1998, BBA-GENE STRUCT EXPR, V1443, P1, DOI 10.1016/S0167-4781(98)00169-9; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Lindhoud S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041363; Mostertz J, 2003, MOL GENET GENOMICS, V269, P640, DOI 10.1007/s00438-003-0877-4; Nagano T, 2015, J BIOCHEM, V158, P165, DOI 10.1093/jb/mvv026; Nagano T, 2012, J BIOL CHEM, V287, P28697, DOI 10.1074/jbc.M112.378067; NAKAMURA S, 1981, J BIOCHEM, V90, P1117, DOI 10.1093/oxfordjournals.jbchem.a133563; Nishiyama Y, 2004, BIOCHEMISTRY-US, V43, P11321, DOI 10.1021/bi036178q; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Nishiyama Y, 2014, APPL MICROBIOL BIOT, V98, P8777, DOI 10.1007/s00253-014-6020-0; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Sedlak E, 2002, BBA-PROTEIN STRUCT M, V1597, P22, DOI 10.1016/S0167-4838(02)00270-4; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Takahashi S, 2007, PLANT PHYSIOL, V144, P487, DOI 10.1104/pp.107.097253; Takahashi S, 2009, PLANT PHYSIOL, V149, P1560, DOI 10.1104/pp.108.134122; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wu J, 2013, J BIOL CHEM, V288, P4755, DOI 10.1074/jbc.M112.413492; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	45	25	25	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5860	5870		10.1074/jbc.M115.706424	http://dx.doi.org/10.1074/jbc.M115.706424			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786107	Green Published, hybrid			2022-12-26	WOS:000372551800032
J	Kauppi, AM; Edin, A; Ziegler, I; Molling, P; Sjostedt, A; Gylfe, A; Stralin, K; Johansson, A				Kauppi, Anna M.; Edin, Alicia; Ziegler, Ingrid; Molling, Paula; Sjostedt, Anders; Gylfe, Asa; Stralin, Kristoffer; Johansson, Anders			Metabolites in Blood for Prediction of Bacteremic Sepsis in the Emergency Room	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; SEPTIC SHOCK; METABOLOMICS; SAMPLES; SPECTROSCOPY; ANTIBIOTICS; ENDOTOXEMIA; MORTALITY; SEVERITY; CULTURE	A metabolomics approach for prediction of bacteremic sepsis in patients in the emergency room (ER) was investigated. In a prospective study, whole blood samples from 65 patients with bacteremic sepsis and 49 ER controls were compared. The blood samples were analyzed using gas chromatography coupled to time-of-flight mass spectrometry. Multivariate and logistic regression modeling using metabolites identified by chromatography or using conventional laboratory parameters and clinical scores of infection were employed. A predictive model of bacteremic sepsis with 107 metabolites was developed and validated. The number of metabolites was reduced stepwise until identifying a set of 6 predictive metabolites. A 6-metabolite predictive logistic regression model showed a sensitivity of 0.91(95% CI 0.69-0.99) and a specificity 0.84 (95% CI 0.58-0.94) with an AUC of 0.93 (95% CI 0.89-1.01). Myristic acid was the single most predictive metabolite, with a sensitivity of 1.00 (95% CI 0.85-1.00) and specificity of 0.95 (95% CI 0.74-0.99), and performed better than various combinations of conventional laboratory and clinical parameters. We found that a metabolomics approach for analysis of acute blood samples was useful for identification of patients with bacteremic sepsis. Metabolomics should be further evaluated as a new tool for infection diagnostics.	[Kauppi, Anna M.; Edin, Alicia; Sjostedt, Anders; Gylfe, Asa; Johansson, Anders] Dept Clin Microbiol, Clin Bacteriol, Lab Mol Infect Med, Stockholm, Sweden; [Kauppi, Anna M.; Edin, Alicia; Sjostedt, Anders; Gylfe, Asa; Johansson, Anders] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Ziegler, Ingrid] Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden; [Molling, Paula] Univ Orebro, Fac Med & Hlth, Dept Lab Med, SE-70182 Orebro, Sweden; [Stralin, Kristoffer] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Umea University; Orebro University; Orebro University; Karolinska Institutet; Karolinska University Hospital	Johansson, A (corresponding author), Dept Clin Microbiol, Clin Bacteriol, Lab Mol Infect Med, Stockholm, Sweden.	anders.f.johansson@umu.se	Johansson, Anders/D-2928-2012; Sjöstedt, Anders/AAC-6575-2020; Johansson, Anders/H-9362-2017	Johansson, Anders/0000-0003-0548-5943; Sjöstedt, Anders/0000-0002-0768-8405; Johansson, Anders/0000-0003-0548-5943; Edin, Alicia/0000-0003-0309-1852	Umea University; Vasterbotten County Council [VLL-151871, VLL-495291, VLL-495361]	Umea University; Vasterbotten County Council	This work was supported by grants from Umea University and Vasterbotten County Council (VLL-151871, VLL-495291 and VLL-495361 to A.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2015, INTENS CARE MED, V41, P1739, DOI 10.1007/s00134-015-3978-8; Antti H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056971; Bartlett JG, 2013, CLIN INFECT DIS, V56, P1445, DOI 10.1093/cid/cit070; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Fiehn O, 2003, EUR J BIOCHEM, V270, P579, DOI 10.1046/j.1432-1033.2003.03427.x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; FREUND H, 1979, ANN SURG, V190, P571, DOI 10.1097/00000658-197911000-00003; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Howell L., 2013, GLOBAL RISKS 2013; Jiye A., 2005, ANAL CHEM, V77, P8086, DOI DOI 10.1021/AC051211V; Jo YH, 2013, AM J EMERG MED, V31, P545, DOI 10.1016/j.ajem.2012.10.017; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Josefson P, 2011, EUR J CLIN MICROBIOL, V30, P1127, DOI 10.1007/s10096-011-1201-6; Kamisoglu K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0783-2; Kamisoglu K, 2014, SHOCK, V42, P499, DOI 10.1097/SHK.0000000000000248; Laiakis EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012655; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Mickiewicz B, 2014, CRIT CARE MED, V42, P1140, DOI 10.1097/CCM.0000000000000142; Oehler RL, 2010, CLIN INFECT DIS, V50, P1268, DOI 10.1086/651602; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; Raymond DP, 2001, ANN SURG, V233, P549, DOI 10.1097/00000658-200104000-00011; Seymour CW, 2013, INTENS CARE MED, V39, P1423, DOI 10.1007/s00134-013-2935-7; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Sogaard M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-139; Stringer KA, 2015, SHOCK, V44, P200, DOI 10.1097/SHK.0000000000000406; Ziegler I, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-155	30	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147670	10.1371/journal.pone.0147670	http://dx.doi.org/10.1371/journal.pone.0147670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800189	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300138
J	Madlala, HP; Metzinger, T; van Heerden, FR; Musabayane, CT; Mubagwa, K; Dessy, C				Madlala, Hlengiwe P.; Metzinger, Thomas; van Heerden, Fanie R.; Musabayane, Cephas T.; Mubagwa, Kanigula; Dessy, Chantal			Vascular Endothelium-Dependent and Independent Actions of Oleanolic Acid and Its Synthetic Oleanane Derivatives as Possible Mechanisms for Hypotensive Effects	PLOS ONE			English	Article							ORUJO OLIVE OIL; URSOLIC ACIDS; TRITERPENOIDS; RELAXATION; RELEASE; DISEASE; LIVER; AORTA; RATS	Purpose Plant-derived oleanolic acid (OA) and its related synthetic derivatives (Br-OA and Me-OA) possess antihypertensive effects in experimental animals. The present study investigated possible underlying mechanisms in rat isolated single ventricular myocytes and in vascular smooth muscles superfused at 37 degrees C. Methods Cell shortening was assessed at 1 Hz using a video-based edge-detection system and the L-type Ca2+ current (Ica) was measured using the whole-cell patch-clamp technique in single ventricular myocytes. Isometric tension was measured using force transducer in isolated aortic rings and in mesenteric arteries. Vascular effects were measured in endothelium intact and denuded vessels in the presence of various enzyme or channel inhibitors. Results OA and its derivatives increased cell shortening in cardiomyocytes isolated from normotensive rats but had no effect in those isolated from hypertensive animals. These triterpenes also caused relaxation in aortic rings and in mesenteric arteries pre-contracted with either phenylephrine or KCI-enriched solution. The relaxation was only partially inhibited by endothelium denudation, and also partly inhibited by the cyclooxygenase (COX) inhibitor indomethacin, with no additional inhibitory effect of the NO synthase inhibitor, N-w-Nitro-Larginine. A combination of both ATP-dependent channel inhibition by glibenclaminde and voltage-dependent K+ channel inhibition by 4-aminopyridine was necessary to fully inhibit the relaxation. Conclusion These data indicate that the effects of OA and its derivatives are mediated via both endothelium-dependent and independent mechanisms suggesting the involvement of COX in the endothelium-dependent effects and of vascular muscle K+ channels in the endothelium independent effects. Finally, our results support the view that the antihypertensive action of OA and its derivatives is due to a decrease of vascular resistance with no negative inotropic effect on the heart.	[Madlala, Hlengiwe P.; Musabayane, Cephas T.] Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med & Med Sci, Durban, South Africa; [Metzinger, Thomas; Dessy, Chantal] Catholic Univ Louvain, Inst Expt & Clin Res, Pole Pharmacol & Therapeut, B-1200 Brussels, Belgium; [van Heerden, Fanie R.] Univ KwaZulu Natal, Sch Chem & Phys, Coll Agr Engn & Sci, Pietermaritzburg, South Africa; [Mubagwa, Kanigula] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium	University of Kwazulu Natal; Universite Catholique Louvain; University of Kwazulu Natal; KU Leuven	Dessy, C (corresponding author), Catholic Univ Louvain, Inst Expt & Clin Res, Pole Pharmacol & Therapeut, B-1200 Brussels, Belgium.	chantal.dessy@uclouvain.be	Van Heerden, Fanie R/A-5685-2008	Van Heerden, Fanie R/0000-0002-5710-7525	University of Leuven; Fonds de la Recherche Scientifique (FNRS)	University of Leuven(KU Leuven); Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by University of Leuven (http://www.ema2sa.eu; HPM) and Fonds de la Recherche Scientifique (FNRS) (http://www.fnrs.be/; CD).	Dongmo AB, 2011, J ETHNOPHARMACOL, V133, P204, DOI 10.1016/j.jep.2010.09.033; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Gao DW, 2009, PHYTOTHER RES, V23, P1257, DOI 10.1002/ptr.2603; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Gwanyanya A, 2006, AM J PHYSIOL-CELL PH, V291, pC627, DOI 10.1152/ajpcell.00074.2006; Houser SR, 2000, J MOL CELL CARDIOL, V32, P1595, DOI 10.1006/jmcc.2000.1206; Kamboj VP, 2000, CURR SCI INDIA, V78, P35; Madlala HP, 2012, RENAL FAILURE, V34, P767, DOI 10.3109/0886022X.2012.678172; Madlala HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128192; Mapanga RF, 2009, RENAL FAILURE, V31, P481, DOI 10.1080/08860220902963558; Martin R, 2012, BRIT J PHARMACOL, V166, P1708, DOI 10.1111/j.1476-5381.2012.01869.x; Martinez-Gonzalez J, 2008, J NUTR, V138, P443, DOI 10.1093/jn/138.3.443; Martinsen A, 2012, CELL CALCIUM, V52, P413, DOI 10.1016/j.ceca.2012.07.002; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Ozsoy-Sacan O, 2004, BIOSCI BIOTECH BIOCH, V68, P1640, DOI 10.1271/bbb.68.1640; Rodriguez-Rodriguez R, 2008, BRIT J PHARMACOL, V155, P535, DOI 10.1038/bjp.2008.289; Rodriguez-Rodriguez R, 2006, J AGR FOOD CHEM, V54, P2096, DOI 10.1021/jf0528512; Rodriguez-Rodriguezl R, 2004, BRIT J NUTR, V92, P635, DOI 10.1079/BJN20041231; Somova LI, 2004, PHYTOMEDICINE, V11, P121, DOI 10.1078/0944-7113-00329; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; VanderGraaf PH, 1995, BRIT J PHARMACOL, V116, P3237	22	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147395	10.1371/journal.pone.0147395	http://dx.doi.org/10.1371/journal.pone.0147395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799746	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300102
J	Degl'Innocenti, A; Parrilla, M; Harr, B; Teschke, M				Degl'Innocenti, Andrea; Parrilla, Marta; Harr, Bettina; Teschke, Meike			The Mouse Solitary Odorant Receptor Gene Promoters as Models for the Study of Odorant Receptor Gene Choice	PLOS ONE			English	Article							PUTATIVE PHEROMONE RECEPTORS; OLFACTORY SENSORY NEURONS; MULTIPLE SEQUENCE ALIGNMENT; MULTIGENE FAMILY; LABORATORY MOUSE; EXPRESSION; MICE; MAMMALS; GLOMERULI; GENOME	Background In vertebrates, several anatomical regions located within the nasal cavity mediate olfaction. Among these, the main olfactory epithelium detects most conventional odorants. Olfactory sensory neurons, provided with cilia exposed to the air, detect volatile chemicals via an extremely large family of seven-transmembrane chemoreceptors named odorant receptors. Their genes are expressed in a monogenic and monoallelic fashion: a single allele of a single odorant receptor gene is transcribed in a given mature neuron, through a still uncharacterized molecular mechanism known as odorant receptor gene choice. Aim Odorant receptor genes are typically arranged in genomic clusters, but a few are isolated (we call them solitary) from the others within a region broader than 1 Mb upstream and downstream with respect to their transcript's coordinates. The study of clustered genes is problematic, because of redundancy and ambiguities in their regulatory elements: we propose to use the solitary genes as simplified models to understand odorant receptor gene choice. Procedures Here we define number and identity of the solitary genes in the mouse genome (C57BL/6J), and assess the conservation of the solitary status in some mammalian orthologs. Furthermore, we locate their putative promoters, predict their homeodomain binding sites (commonly present in the promoters of odorant receptor genes) and compare candidate promoter sequences with those of wild-caught mice. We also provide expression data from histological sections. Results In the mouse genome there are eight intact solitary genes: Olfr19 (M12), Olfr49, Olfr266, Olfr267, Olfr370, Olfr371, Olfr466, Olfr1402; five are conserved as solitary in rat. These genes are all expressed in the main olfactory epithelium of three-day-old mice. The C57BL/6J candidate promoter of Olfr370 has considerably varied compared to its wild-type counterpart. Within the putative promoter for Olfr266 a homeodomain binding site is predicted. As a whole, our findings favor Olfr266 as a model gene to investigate odorant receptor gene choice.	[Degl'Innocenti, Andrea; Parrilla, Marta] Max Planck Inst Biophys, Frankfurt, Germany; [Degl'Innocenti, Andrea] Univ Pisa, Dipartimento Biol, Unita Biol Cellulare & Sviluppo, Pisa, Italy; [Harr, Bettina; Teschke, Meike] Max Planck Inst Evolut Biol, Abt Evolut Genet, D-24306 Plon, Germany	Max Planck Society; University of Pisa; Max Planck Society	Degl'Innocenti, A (corresponding author), Max Planck Inst Biophys, Frankfurt, Germany.; Degl'Innocenti, A (corresponding author), Univ Pisa, Dipartimento Biol, Unita Biol Cellulare & Sviluppo, Pisa, Italy.	adeglinno@yahoo.com			Max Planck Society	Max Planck Society(Max Planck Society)	The study was generously funded by the Max Planck Society.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Breer H, 2006, CELL MOL LIFE SCI, V63, P1465, DOI 10.1007/s00018-006-6108-5; Bressel OC, 2016, J COMP NEUROL, V524, P199, DOI 10.1002/cne.23835; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hoppe R, 2000, GENOMICS, V66, P284, DOI 10.1006/geno.2000.6205; Hoppe R, 2006, GENOMICS, V87, P711, DOI 10.1016/j.ygeno.2006.02.005; Ibarra-Soria X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004593; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Kaluza JF, 2004, J NEUROSCI RES, V76, P442, DOI 10.1002/jnr.20083; Kanageswaran N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113170; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khan M, 2013, MOL CELL NEUROSCI, V57, P120, DOI 10.1016/j.mcn.2013.08.001; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Logan DW, 2012, CURR BIOL, V22, P1998, DOI 10.1016/j.cub.2012.08.041; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Markenscoff-Papadimitriou E, 2014, CELL, V159, P543, DOI 10.1016/j.cell.2014.09.033; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nellaker C, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r45; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Niimura Y, 2014, GENOME RES, V24, P1485, DOI 10.1101/gr.169532.113; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Plessy C, 2012, GENOME RES, V22, P486, DOI 10.1101/gr.126201.111; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Pyrski M, 2001, J NEUROSCI, V21, P4637, DOI 10.1523/JNEUROSCI.21-13-04637.2001; Qasba P, 1998, J NEUROSCI, V18, P227; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rastogi P A, 2000, Methods Mol Biol, V132, P47; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Royal SJ, 1999, J NEUROSCI, V19, P9856; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shum EY, 2015, NUCL ACIDS RES; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Vassalli A, 2011, MOL CELL NEUROSCI, V46, P381, DOI 10.1016/j.mcn.2010.11.001; Wong K, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r72; Yalcin B, 2012, MAMM GENOME, V23, P490, DOI 10.1007/s00335-012-9402-6; Yalcin B, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r18; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Young JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-561; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zozulya S, 2001, GENOME BIOL, V2	85	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0144698	10.1371/journal.pone.0144698	http://dx.doi.org/10.1371/journal.pone.0144698			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794459	Green Published, gold, Green Submitted			2022-12-26	WOS:000368530300002
J	An, YY; Qi, L; Wang, LJ				An, Yuyan; Qi, Lin; Wang, Liangju			ALA Pretreatment Improves Waterlogging Tolerance of Fig Plants	PLOS ONE			English	Article							PHOTOSYNTHETIC GAS-EXCHANGE; 5-AMINOLEVULINIC ACID; FICUS-CARICA; GENE-EXPRESSION; PROLINE ACCUMULATION; OXYGEN DEFICIENCY; INDUCED INCREASE; SALINITY STRESS; BRASSICA-NAPUS; SEEDLINGS	5-aminolevulinic acid (ALA), a natural and environmentally friendly plant growth regulator, can improve plant tolerance to various environmental stresses. However, whether ALA can improve plant waterlogging tolerance is unknown. Here, we investigated the effects of ALA pretreatment on the waterlogging-induced damage of fig (Ficus carica Linn.) plants, which often suffer from waterlogging stress. ALA pretreatment significantly alleviated stress-induced morphological damage, increased leaf relative water content (RWC), and reduced leaf superoxide anion (O-2 (radical anion)) production rate and malonaldehyde (MDA) content in fig leaves, indicating ALA mitigates waterlogging stress of fig plants. We further demonstrated that ALA pretreatment largely promoted leaf chlorophyll content, photosynthetic electron transfer ability, and photosynthetic performance index, indicating ALA significantly improves plant photosynthetic efficiency under waterlogging stress. Moreover, ALA pretreatment significantly increased activities of leaf superoxide dismutase (SOD) and peroxidase (POD), root vigor, and activities of root alcohol dehydrogenase (ADH), and lactate dehydrogenase (LDH), indicating ALA also significantly improves antioxidant ability and root function of fig plants under waterlogging stress. Taken together, ALA pretreatment improves waterlogging tolerance of fig plants significantly, and the promoted root respiration, leaf photosynthesis, and antioxidant ability may contribute greatly to this improvement. Our data firstly shows that ALA can improve plant waterlogging tolerance.	[An, Yuyan; Qi, Lin; Wang, Liangju] Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, LJ (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China.	wlj@njau.edu.cn			Agricultural Key Science and Technology project of Jiangsu Province, China [BE2012339, BE2013327]; Fundamental Research Funds for the Central Universities [KJQN201538]; National Natural Science Foundation of China [31401820]; Natural Science Foundation of Jiangsu Province, China [BK20140702]	Agricultural Key Science and Technology project of Jiangsu Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This research was supported by the Agricultural Key Science and Technology project of Jiangsu Province, China (BE2012339, BE2013327; LW), the Fundamental Research Funds for the Central Universities (KJQN201538; YA), the National Natural Science Foundation of China (31401820; YA) and the Natural Science Foundation of Jiangsu Province, China (BK20140702; YA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2002, PLANT SCI, V163, P117, DOI 10.1016/S0168-9452(02)00080-8; Akram NA, 2013, J PLANT GROWTH REGUL, V32, P663, DOI 10.1007/s00344-013-9325-9; An YY, 2011, S AFR J BOT, V77, P446, DOI 10.1016/j.sajb.2010.11.003; An YY, 2013, ACTA PHYSIOL PLANT, V35, P959, DOI 10.1007/s11738-012-1139-z; [Anonymous], 2003, FUNCT PLANT BIOL; Ashraf M. A., 2012, African Journal of Agricultural Research, V7, P1976; Badgujar SB, 2014, PHARM BIOL, V52, P1487, DOI 10.3109/13880209.2014.892515; Bailey-Serres J, 2012, PLANT PHYSIOL, V160, P1698, DOI 10.1104/pp.112.208173; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Balestrasse KB, 2010, PHYTOCHEMISTRY, V71, P2038, DOI 10.1016/j.phytochem.2010.07.012; Banti V, 2013, INT J MOL SCI, V14, P4734, DOI 10.3390/ijms14034734; Barolo MI, 2014, FOOD CHEM, V164, P119, DOI 10.1016/j.foodchem.2014.04.112; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bertolde FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108705; Bindu RC, 1998, PLANT GROWTH REGUL, V26, P15, DOI 10.1023/A:1006098005335; Borella J, 2014, SCI AGR, V71, P499, DOI 10.1590/0103-9016-2014-0044; Ciarmiello LF, 2015, S AFR J BOT, V97, P40, DOI 10.1016/j.sajb.2014.11.012; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; Czarnecki O, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00236; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Dennis ES, 2000, J EXP BOT, V51, P89, DOI 10.1093/jexbot/51.342.89; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Felle HH, 2005, ANN BOT-LONDON, V96, P519, DOI 10.1093/aob/mci207; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hotta Y, 1998, J PESTIC SCI, V23, P29; Hotta Y, 1997, PLANT GROWTH REGUL, V22, P109, DOI 10.1023/A:1005883930727; Irfan M, 2010, PROTOPLASMA, V241, P3, DOI 10.1007/s00709-009-0098-8; Juntawong P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00658; KENNEDY RA, 1992, PLANT PHYSIOL, V100, P1, DOI 10.1104/pp.100.1.1; Korkmaz A, 2010, ENVIRON EXP BOT, V67, P495, DOI 10.1016/j.envexpbot.2009.07.009; Kreuzwieser J, 2014, PLANT CELL ENVIRON, V37, P2245, DOI 10.1111/pce.12310; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Limami AM, 2014, PLANTA, V239, P531, DOI 10.1007/s00425-013-2015-9; Liu D, 2011, J AGRON CROP SCI, V197, P284, DOI 10.1111/j.1439-037X.2011.00465.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MORGAN JM, 1984, ANNU REV PLANT PHYS, V35, P299, DOI 10.1146/annurev.pp.35.060184.001503; Mustroph A, 2003, PHYSIOL PLANTARUM, V117, P508, DOI 10.1034/j.1399-3054.2003.00051.x; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Naeem MS, 2010, PLANT SOIL, V332, P405, DOI 10.1007/s11104-010-0306-5; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; Sairam RK, 2008, BIOL PLANTARUM, V52, P401, DOI 10.1007/s10535-008-0084-6; Sairam RK, 2009, J PLANT PHYSIOL, V166, P602, DOI 10.1016/j.jplph.2008.09.005; SASIKALA C, 1994, BIOTECHNOL PROGR, V10, P451, DOI 10.1021/bp00029a001; Shabala S, 2014, PLANT CELL ENVIRON, V37, P2216, DOI 10.1111/pce.12339; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Vemmos SN, 2013, SCI HORTIC-AMSTERDAM, V160, P198, DOI 10.1016/j.scienta.2013.05.036; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang LJ, 2005, J INTEGR PLANT BIOL, V47, P1084, DOI 10.1111/j.1744-7909.2005.00150.x; Wang LJ, 2004, PHYSIOL PLANTARUM, V121, P258, DOI 10.1111/j.0031-9317.2004.00319.x; Watanabe K, 2000, PLANT GROWTH REGUL, V32, P99, DOI 10.1023/A:1006369404273; WATERS I, 1991, J EXP BOT, V42, P1437, DOI 10.1093/jxb/42.11.1437; Xu XW, 2014, SCI HORTIC-AMSTERDAM, V179, P388, DOI 10.1016/j.scienta.2014.10.001; Yang ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116283; Yiu JC, 2009, PLANT PHYSIOL BIOCH, V47, P710, DOI 10.1016/j.plaphy.2009.03.007; Yiu JC, 2009, SCI HORTIC-AMSTERDAM, V120, P306, DOI 10.1016/j.scienta.2008.11.020; Youssef T, 2008, J PLANT GROWTH REGUL, V27, P1, DOI 10.1007/s00344-007-9025-4; Zhang J, 2012, BIOL PLANTARUM, V56, P780, DOI 10.1007/s10535-012-0136-9; Zhang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127982; Zhang ZJ, 2006, PLANT GROWTH REGUL, V49, P27, DOI 10.1007/s10725-006-0011-9; Zhen A, 2012, BIOL PLANTARUM, V56, P566, DOI 10.1007/s10535-012-0118-y; Zhou J, 2003, ECON FOR RES, V21, P90	62	33	38	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147202	10.1371/journal.pone.0147202	http://dx.doi.org/10.1371/journal.pone.0147202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789407	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100066
J	Brunoldi, M; Bozzini, G; Casale, A; Corvisiero, P; Grosso, D; Magnoli, N; Alessi, J; Bianchi, CN; Mandich, A; Morri, C; Povero, P; Wurtz, M; Melchiorre, C; Viano, G; Cappanera, V; Fanciulli, G; Bei, M; Stasi, N; Taiuti, M				Brunoldi, Marco; Bozzini, Giorgio; Casale, Alessandra; Corvisiero, Pietro; Grosso, Daniele; Magnoli, Nicodemo; Alessi, Jessica; Bianchi, Carlo Nike; Mandich, Alberta; Morri, Carla; Povero, Paolo; Wurtz, Maurizio; Melchiorre, Christian; Viano, Gianni; Cappanera, Valentina; Fanciulli, Giorgio; Bei, Massimiliano; Stasi, Nicola; Taiuti, Mauro			A Permanent Automated Real-Time Passive Acoustic Monitoring System for Bottlenose Dolphin Conservation in the Mediterranean Sea	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; WHISTLE CHARACTERISTICS; TOUR BOATS; CLASSIFICATION; DISTURBANCE; EXTRACTION; RESPONSES; PATTERNS; NOISE; OCEAN	Within the framework of the EU Life+ project named LIFE09 NAT/IT/000190 ARION, a permanent automated real-time passive acoustic monitoring system for the improvement of the conservation status of the transient and resident population of bottlenose dolphin (Tursiops truncatus) has been implemented and installed in the Portofino Marine Protected Area (MPA), Ligurian Sea. The system is able to detect the simultaneous presence of dolphins and boats in the area and to give their position in real time. This information is used to prevent collisions by diffusing warning messages to all the categories involved (tourists, professional fishermen and so on). The system consists of two gps-synchronized acoustic units, based on a particular type of marine buoy (elastic beacon), deployed about 1 km off the Portofino headland. Each one is equipped with a four-hydrophone array and an onboard acquisition system which can record the typical social communication whistles emitted by the dolphins and the sound emitted by boat engines. Signals are pre-filtered, digitized and then broadcast to the ground station via wi-fi. The raw data are elaborated to get the direction of the acoustic target to each unit, and hence the position of dolphins and boats in real time by triangulation.	[Brunoldi, Marco; Bozzini, Giorgio; Casale, Alessandra; Corvisiero, Pietro; Grosso, Daniele; Magnoli, Nicodemo; Taiuti, Mauro] Univ Genoa, Dept Phys, Genoa, Italy; [Alessi, Jessica; Bianchi, Carlo Nike; Mandich, Alberta; Morri, Carla; Povero, Paolo; Wurtz, Maurizio] Univ Genoa, Dept Earth Environm & Life Sci, Genoa, Italy; [Melchiorre, Christian; Viano, Gianni] SOFTECO Sismat Srl, Genoa, Italy; [Cappanera, Valentina; Fanciulli, Giorgio] Minist Environm & Protect Terr & Sea, Area Marina Protetta Portofino, Santa Margherita Ligure, Genoa, Italy; [Bei, Massimiliano; Stasi, Nicola] Minist Infrastruct & Transport, Direz Marittima Genova, Genoa, Italy	University of Genoa; University of Genoa	Brunoldi, M (corresponding author), Univ Genoa, Dept Phys, Genoa, Italy.	brunoldi@fisica.unige.it	Grosso, Daniele/R-4212-2016; Grosso, Daniele/GXM-9039-2022; Alessi, Jessica/S-4350-2018	Grosso, Daniele/0000-0002-0699-3459; Alessi, Jessica/0000-0002-3814-702X; Magnoli, Nicodemo/0000-0001-5372-4836; Bianchi, Carlo Nike/0000-0003-1071-3285; Morri, Carla/0000-0003-4520-2741; Casale, Alessandra/0000-0001-9090-1002	European Commission [LIFE09 NAT/IT/000190 ARION]; European Union (EU)	European Commission(European CommissionEuropean Commission Joint Research Centre); European Union (EU)(CGIAREuropean Commission)	This work has been entirely funded by the European Commission within the framework of the ARION project (grant number: LIFE09 NAT/IT/000190 ARION). The funding organization did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials. The authors Christian Melchiorre (C. Melchiorre) and Gianni Viano (GV) are employed by the commercial IT company named Softeco Sismat S.r.l. Softeco Sismat S.r.l. is one of the four beneficiaries of the project: 1. University of Genova (coordinating beneficiary) 2. Direzione Marittima di Genova (associated beneficiary) 3. Portofino Marine Protected Area (associated beneficiary) 4. Softeco Sismat S.r.l. (associated beneficiary) The funder provided support in the form of salaries for authors C. Melchiorre and GV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; This study received financial support by European Union (EU). We wish to thank Massimiliano (Capo) Bei for both logistical and technical support at the Portofino lighthouse. Thanks to P. Campodonico, G. Mastrocola and S. Venturini (Portofino MPA) for the great availability in boat transport to the detection units. A special thank to W.M.X. Zimmer and G. Pavan for their support in detection and tracking algorithms development.	Ainslie MA, 1998, J ACOUST SOC AM, V103, P1671, DOI 10.1121/1.421258; Alessi J, 2014, J COAST CONSERV, V18, P449, DOI 10.1007/s11852-014-0330-3; Allen MC, 2000, MAR MAMMAL SCI, V16, P815, DOI 10.1111/j.1748-7692.2000.tb00974.x; AU WWL, 1974, J ACOUST SOC AM, V56, P1280, DOI 10.1121/1.1903419; Bazua-Duran C, 2004, AN ACAD BRAS CIENC, V76, P386, DOI 10.1590/S0001-37652004000200030; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Bejder Lars, 2003, P229; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Branstetter BK, 2012, J ACOUST SOC AM, V131, P1613, DOI 10.1121/1.3676694; BUCK JR, 1993, J ACOUST SOC AM, V94, P2497, DOI 10.1121/1.407385; Chung KW, 2011, ADV ACOUS VIB, V2011, DOI 10.1155/2011/952798; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Esfahanian Mahdi, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P6038, DOI 10.1109/ICASSP.2014.6854763; Esfahanian M, 2013, J ACOUST SOC AM, V134, pEL105, DOI 10.1121/1.4811162; EU, 2007, DIAB DIR; FREITAG LE, 1993, J ACOUST SOC AM, V93, P2197, DOI 10.1121/1.406681; Gannier A, 2010, APPL ACOUST, V71, P1063, DOI 10.1016/j.apacoust.2010.05.019; Gnone Guido, 2005, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V146, P39; Gubbins Cara, 2002, Aquatic Mammals, V28, P24; Halkias XC, 2006, APPL ACOUST, V67, P1164, DOI 10.1016/j.apacoust.2006.05.006; Harley HE, 2008, BEHAV PROCESS, V77, P243, DOI 10.1016/j.beproc.2007.11.002; Hastie GD, 2003, MAR MAMMAL SCI, V19, P74, DOI 10.1111/j.1748-7692.2003.tb01093.x; Janik VM, 1996, MAR MAMMAL SCI, V12, P597, DOI 10.1111/j.1748-7692.1996.tb00073.x; Jensen FH, 2012, J ACOUST SOC AM, V131, P582, DOI 10.1121/1.3662067; Ketten DR, 2004, MARINE MAMMAL AUDITO; Lemon M, 2006, BIOL CONSERV, V127, P363, DOI 10.1016/j.biocon.2005.08.016; Lopez BD, 2011, MAMM BIOL, V76, P180, DOI 10.1016/j.mambio.2010.06.006; Lusseau D, 2005, MAR ECOL PROG SER, V295, P265, DOI 10.3354/meps295265; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Lusseau D, 2004, ECOL SOC, V9; Lusseau D, 2006, MAR MAMMAL SCI, V22, P802, DOI 10.1111/j.1748-7692.2006.00052.x; Marini C, 2015, J ENVIRON MANAGE, V150, P9, DOI 10.1016/j.jenvman.2014.11.008; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mohammad B, 2011, IEEE J OCEANIC ENG, V36, P431, DOI 10.1109/JOE.2010.2060790; Morri C, 1988, B MUS I BIOL U GEN S, V52, P213; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; Ou H, 2013, J ACOUST SOC AM, V133, P301, DOI 10.1121/1.4770251; Parravicini V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075767; Pirotta E, 2015, BIOL CONSERV, V181, P82, DOI 10.1016/j.biocon.2014.11.003; Richardson WJ, 1996, J MAR BIOL ASSOC UK, V76, P550; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Salmona P, 2001, OCEAN COAST MANAGE, V44, P39, DOI 10.1016/S0964-5691(00)00084-3; Seekings PJ, 2010, OC 10 IEEE SYDN NSW, P1, DOI DOI 10.1109/OCEANSSYD.2010.5603596; Simmonds M., 2002, CETACEAN HABITAT LOS; TURIN GL, 1960, IRE T INFORM THEOR, V6, P311, DOI 10.1109/TIT.1960.1057571; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; WENZ GM, 1962, J ACOUST SOC AM, V34, P1936, DOI 10.1121/1.1909155; Zimmer W. M. X., 2011, PASSIVE ACOUSTIC MON, DOI [10.1017/CBO9780511977107, DOI 10.1017/CB09780511977107]	50	15	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145362	10.1371/journal.pone.0145362	http://dx.doi.org/10.1371/journal.pone.0145362			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789265	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100009
J	Ezewuiro, O; Grushko, TA; Kocherginsky, M; Habis, M; Hurteau, JA; Mills, KA; Hunn, J; Olopade, OI; Fleming, GF; Romero, IL				Ezewuiro, Obiageli; Grushko, Tatyana A.; Kocherginsky, Masha; Habis, Mohammed; Hurteau, Jean A.; Mills, Kathryn A.; Hunn, Jessica; Olopade, Olufunmilayo I.; Fleming, Gini F.; Romero, Iris L.			Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy	PLOS ONE			English	Article							MORTALITY; PROLIFERATION; OVERWEIGHT; OBESITY; CELLS; RISK	There is increasing evidence that metformin, a commonly used treatment for diabetes, might have the potential to be repurposed as an economical and safe cancer therapeutic. The aim of this study was to determine whether stage III-IV or recurrent endometrial cancer patients who are using metformin during treatment with chemotherapy have improved survival. To test this we analyzed a retrospective cohort of subjects at two independent institutions who received chemotherapy for stage III-IV or recurrent endometrial cancer from 1992 to 2011. Diagnosis of diabetes, metformin use, demographics, endometrial cancer clinicopathologic parameters, and survival duration were abstracted. The primary outcome was overall survival. The final cohort included 349 patients, 31 (8.9%) had diabetes and used metformin, 28 (8.0%) had diabetes but did not use metformin, and 291 (83.4%) did not have diabetes. The results demonstrate that the median overall survival was 45.6 months for patients with diabetes who used metformin compared to 12.5 months for patients with diabetes who did not use metformin and 28.5 months for patients without diabetes (log-rank test comparing the three groups P = 0.006). In a model adjusted for confounders, the difference in survival between the three groups remained statistically significant (P = 0.023). The improvement in survival among metformin users was not explained by better baseline health status or more aggressive use of chemotherapy. Overall, the findings in this retrospective cohort of endometrial cancer patients with stage III-IV or recurrent disease treated with chemotherapy indicate that patients with diabetes who were concurrently treated with metformin survived longer than patients with diabetes who did not use metformin.	[Ezewuiro, Obiageli; Grushko, Tatyana A.; Olopade, Olufunmilayo I.; Fleming, Gini F.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kocherginsky, Masha] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Habis, Mohammed; Mills, Kathryn A.; Hunn, Jessica; Romero, Iris L.] Univ Chicago, Dept Obstet & Gynecol, Gordon Ctr Integrat Sci, Chicago, IL 60637 USA; [Hurteau, Jean A.] NorthShore Univ Hlth Syst, Dept Obstet & Gynecol, Chicago, IL USA	University of Chicago; University of Chicago; University of Chicago; NorthShore University Health System	Romero, IL (corresponding author), Univ Chicago, Dept Obstet & Gynecol, Gordon Ctr Integrat Sci, Chicago, IL 60637 USA.	iromero@uchicago.edu	Romero, Iris/N-8451-2018	Romero, Iris/0000-0001-5849-5024	National Cancer Institute [NCI P50 CA136393, NCI T32 CA009566, NCI K12 CA139160]; CTSA-ITM CS [UL1 RR024999]; National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [2K12HD000849-26]; Biostatistics Core Facility of the University of Chicago Medicine Comprehensive Cancer Center [NCI CA014599]; Entertainment Industry Foundation National Women's Cancer Research Alliance Program; American Board of Obstetrics and Gynecology; Biological Sciences Division; Institute for Translational Medicine, CTSA from the National Institutes of Health [UL1 TR000430]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014599, P50CA136393, T32CA009566, K12CA139160] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CTSA-ITM CS; National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Biostatistics Core Facility of the University of Chicago Medicine Comprehensive Cancer Center; Entertainment Industry Foundation National Women's Cancer Research Alliance Program; American Board of Obstetrics and Gynecology; Biological Sciences Division; Institute for Translational Medicine, CTSA from the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research is supported by grants from the National Cancer Institute NCI P50 CA136393 (GF and ILR), NCI T32 CA009566 (OE), NCI K12 CA139160 (TAG), CTSA-ITM CS UL1 RR024999 (TAG), National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (2K12HD000849-26) (ILR), Biostatistics Core Facility of the University of Chicago Medicine Comprehensive Cancer Center (NCI CA014599), Entertainment Industry Foundation National Women's Cancer Research Alliance Program (OIO), and American Board of Obstetrics and Gynecology (ILR). The REDCap project at the University of Chicago is hosted and managed by the Center for Research Informatics and funded by the Biological Sciences Division and by the Institute for Translational Medicine, CTSA grant number UL1 TR000430 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cantrell LA, 2010, GYNECOL ONCOL, V116, P92, DOI 10.1016/j.ygyno.2009.09.024; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Febbraro T, 2014, GYNECOL ONCOL, V135, P614, DOI 10.1016/j.ygyno.2014.10.011; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Hanna RK, 2012, GYNECOL ONCOL, V125, P458, DOI 10.1016/j.ygyno.2012.01.009; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Ho AMH, 2013, ANAESTHESIA, V68, P126, DOI 10.1111/anae.12120; Iglesias DA, 2013, MOL CANCER THER, V12, P2847, DOI 10.1158/1535-7163.MCT-13-0439; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Ko EM, 2014, GYNECOL ONCOL, V132, P438, DOI 10.1016/j.ygyno.2013.11.021; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Laskov I, 2014, GYNECOL ONCOL, V134, P607, DOI 10.1016/j.ygyno.2014.06.014; Legro RS, 2013, J CLIN ENDOCR METAB, V98, P4565, DOI 10.1210/jc.2013-2350; Liao CY, 2014, GYNECOL ONCOL, V135, P163, DOI 10.1016/j.ygyno.2014.07.095; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Mitsuhashi A, 2014, CANCER-AM CANCER SOC, V120, P2986, DOI 10.1002/cncr.28853; Nevadunsky NS, 2014, GYNECOL ONCOL, V132, P236, DOI 10.1016/j.ygyno.2013.10.026; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Rutanen EM, 1998, GYNECOL ENDOCRINOL, V12, P399, DOI 10.3109/09513599809012842; Sarfstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061537; Schrauwen S, 2015, GYNECOL ONCOL, V138, P378, DOI 10.1016/j.ygyno.2015.06.006; Schuler KM, 2013, J CLIN ONCOL, V31; Soliman PT, 2013, SOC GYNECOLOGIC S15; Sterne J, 1957, MAROC MED, V36, P1295; Stine JE, 2014, OBSTET GYNECOL SURV, V69, P477, DOI 10.1097/OGX.0000000000000092; Zhang YY, 2014, INT J BIOL MARKER, V29, pE21, DOI 10.5301/jbm.5000047; Zhang ZB, 2011, INT J GYNECOL CANCER, V21, P213, DOI 10.1097/IGC.0b013e318207dac7	32	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147145	10.1371/journal.pone.0147145	http://dx.doi.org/10.1371/journal.pone.0147145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788855	Green Published, Green Submitted, gold			2022-12-26	WOS:000368529100061
J	Reisland, MA; Lambert, JE				Reisland, Melissa Ann; Lambert, Joanna E.			Sympatric Apes in Sacred Forests: Shared Space and Habitat Use by Humans and Endangered Javan Gibbons (Hylobates moloch)	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; PREDATION RISK; GORILLA GROUP; DISTURBANCE; ECOTOURISM; CONSEQUENCES; CONSERVATION; POPULATION; IMPACTS; ECOLOGY	In this research, we use a combination of ethnographic observation and GIS analysis to explore the use of space by humans and gibbons (Hylobates moloch) to determine areas of potential space competition in the sacred forest and nature reserve Cagar Alam Leuweung Sancang in West Java, Indonesia. More specifically, we test whether gibbons respond to the presence of humans in a manner consistent with predator-avoidance and predicted that the gibbon study subjects would avoid areas visited by humans (Risk-Disturbance Hypothesis). Data were collected August 2010-June 2011. We collected GPS locations and behavioral data on both the humans (6,652 hours) and the gibbons (1,253 hours) in the forest using 10 minute instantaneous sampling. Results indicate that humans preferentially assemble at the most sacred spot in the forest (Cikajayaan waterfall). Two gibbon groups' home ranges encompassed most of the sacred areas. Group B avoided areas of high human use, as high human use areas and high gibbon use areas did not overlap. Group C, though, continued to use areas that were heavily visited by humans. We thus found partial support for the Risk-Disturbance Hypothesis, although the variation in gibbon response to human disturbance indicates behavioral flexibility. We suggest that understanding the effects of shared space on wildlife is necessary for informing conservation policy in human-visited forests.	[Reisland, Melissa Ann] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Reisland, Melissa Ann; Lambert, Joanna E.] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA	University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder	Reisland, MA (corresponding author), Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA.; Reisland, MA (corresponding author), Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.	melissa.reisland@colorado.edu			Fulbright Institute of International Education; Primate Conservation, Inc. (PCI) [879]; International Primatological Society	Fulbright Institute of International Education; Primate Conservation, Inc. (PCI); International Primatological Society	This study was funded by a fellowship from the Fulbright Institute of International Education (http://www.iie.org/fulbright), a conservation grant from Primate Conservation, Inc. (PCI #879; http://www.primate.org), and a conservation grant from International Primatological Society (http://www.internationalprimatologicalsociety.org). All funds were awarded to MAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amo L, 2006, BIOL CONSERV, V131, P402, DOI 10.1016/j.biocon.2006.02.015; ARCGis Help, 2012, ARCGIS DESKT HELP ME; Brown Joel S., 2007, P437; Buckley R., 2004, Environmental impacts of ecotourism, P211, DOI 10.1079/9780851998107.0211; Cipolletta C, 2003, INT J PRIMATOL, V24, P1207, DOI 10.1023/B:IJOP.0000005988.52177.45; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Constantine R, 2001, MAR MAMMAL SCI, V17, P689, DOI 10.1111/j.1748-7692.2001.tb01293.x; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P1, DOI 10.1007/978-4-431-87771-4; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P65, DOI 10.1007/978-4-431-87771-4_4; de la Torre S, 2000, BIOL CONSERV, V94, P153, DOI 10.1016/S0006-3207(99)00183-4; DORRANCE MJ, 1975, J WILDLIFE MANAGE, V39, P563, DOI 10.2307/3800399; Duchesne M, 2000, BIOL CONSERV, V96, P311, DOI 10.1016/S0006-3207(00)00082-3; Dudek G., 2000, COMPUTATIONAL PRINCI; EDWARDS J, 1983, OECOLOGIA, V60, P185, DOI 10.1007/BF00379520; Frid A, 2002, CONSERV ECOL, V6; Fuentes A, 2012, ANNU REV ANTHROPOL, V41, P101, DOI 10.1146/annurev-anthro-092611-145808; Gander H, 1997, BIOL CONSERV, V79, P107, DOI 10.1016/S0006-3207(96)00102-4; Geertz Cliffod, 1963, AGR INVOLUTION; Gill JA, 1996, J APPL ECOL, V33, P786, DOI 10.2307/2404948; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Gill Jennifer A., 2000, Conservation Biology Series (Cambridge), V2, P51; GRIFFITHS M, 1993, CONSERV BIOL, V7, P623, DOI 10.1046/j.1523-1739.1993.07030623.x; Grossberg R, 2003, ENVIRON CONSERV, V30, P40, DOI 10.1017/S0376892903000031; Guillemain M, 2007, BIODIVERS CONSERV, V16, P3633, DOI 10.1007/s10531-007-9160-z; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gurmaya KJ, 1995, PRIMATE SURV POPULAT, P1; HAINESYOUNG R, 1993, LANDSCAPE ECOLOGY GE; Higginbottom K., 2004, WILDLIFE TOURISM IMP; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; HUNSAKER C, 2001, SPATIAL UNCERTAINTY; Kappeler M., 1984, P19; Kappeler M., 1981, THESIS U BASEL BASEL; Kim S, 2011, AM J PRIMATOL, V73, P270, DOI 10.1002/ajp.20893; Klailova M, 2010, AM J PRIMATOL, V72, P897, DOI 10.1002/ajp.20829; KOOL K M, 1992, Oryx, V26, P29; Kruger O, 2005, BIODIVERS CONSERV, V14, P579, DOI 10.1007/s10531-004-3917-4; Lafferty KD, 2001, BIOL CONSERV, V101, P315, DOI 10.1016/S0006-3207(01)00075-1; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lindquist G., 2000, NATURAL ENEMIES PEOP, P170; Lord A, 1997, BIOL CONSERV, V82, P15, DOI 10.1016/S0006-3207(97)00013-X; LOTT DF, 1995, BIOL CONSERV, V73, P23, DOI 10.1016/0006-3207(95)90053-5; Malo JE, 2011, BIODIVERS CONSERV, V20, P3477, DOI 10.1007/s10531-011-0136-7; Malone N.M., 2007, THESIS U OREGON EUGE; Malone N, 2012, AM J PHYS ANTHROPOL, V147, P202; Malone Nicholas, 2009, P241, DOI 10.1007/978-0-387-88604-6_12; MCLELLAN BN, 1989, WILDLIFE SOC B, V17, P269; Morris DW, 2000, ECOLOGY, V81, P2061, DOI 10.1890/0012-9658(2000)081[2061:OFMMPU]2.0.CO;2; Mourthe IMC, 2007, AM J PRIMATOL, V69, P706, DOI 10.1002/ajp.20405; Norman A, 2012, LIT AESTHET, V22, P20; Paterson J. D., 2005, COMMENSALISM CONFLIC, V4; Pelletier F., 2006, Ibex Journal of Mountain Ecology, V8, P15; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Reimers E, 2009, J WILDLIFE MANAGE, V73, P844, DOI 10.2193/2008-133; Reisland MAR, 2013, THESIS U WISCONSIN M; Rinaldi D, 1999, THESIS U GEORG AUGUS; Rode KD, 2007, J WILDLIFE MANAGE, V71, P929, DOI 10.2193/2006-075; Strier KB, 2010, AM J PRIMATOL, V72, P772, DOI 10.1002/ajp.20830; Supriatna Jatna, 2006, Primate Conservation, V21, P155, DOI 10.1896/0898-6207.21.1.155; Supriatna J, 2010, DEV PRIMATOL-PROG PR, P57, DOI 10.1007/978-1-4419-1560-3_5; Tabacow FP, 2009, AM ANTHROPOL, V111, P238, DOI 10.1111/j.1548-1433.2009.01116.x; Tilman David, 1997, Monographs in Population Biology, V30, P233; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Treves A., 2005, COMMENSALISM CONFLIC, P146; WESSING R, 1993, J SOUTHE ASIAN STUD, V24, P1, DOI 10.1017/S002246340000148X; Wolf ID, 2010, APPL ANIM BEHAV SCI, V126, P75, DOI 10.1016/j.applanim.2010.06.001	67	12	13	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146891	10.1371/journal.pone.0146891	http://dx.doi.org/10.1371/journal.pone.0146891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790025	Green Published, Green Submitted, gold			2022-12-26	WOS:000368529100043
J	Belgrad, BA; Griffen, BD				Belgrad, Benjamin A.; Griffen, Blaine D.			The Influence of Diet Composition on Fitness of the Blue Crab, Callinectes sapidus	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; CHASMAGNATHUS-GRANULATA DANA; ULVA-LACTUCA L; ESTUARINE CRAB; POPULATION-DYNAMICS; PREY-SIZE; EGG SIZE; PREDATOR; RATHBUN; PESTICIDES	The physiological condition and fecundity of an organism is frequently controlled by diet. As changes in environmental conditions often cause organisms to alter their foraging behavior, a comprehensive understanding of how diet influences the fitness of an individual is central to predicting the effect of environmental change on population dynamics. We experimentally manipulated the diet of the economically and ecologically important blue crab, Callinectes sapidus, to approximate the effects of a dietary shift from primarily animal to plant tissue, a phenomenon commonly documented in crabs. Crabs whose diet consisted exclusively of animal tissue had markedly lower mortality and consumed substantially more food than crabs whose diet consisted exclusively of seaweed. The quantity of food consumed had a significant positive influence on reproductive effort and long-term energy stores. Additionally, seaweed diets produced a three-fold decrease in hepatopancreas lipid content and a simultaneous two-fold increase in crab aggression when compared to an animal diet. Our results reveal that the consumption of animal tissue substantially enhanced C. sapidus fitness, and suggest that a dietary shift to plant tissue may reduce crab population growth by decreasing fecundity as well as increasing mortality. This study has implications for C. sapidus fisheries.	[Belgrad, Benjamin A.; Griffen, Blaine D.] Univ S Carolina, Marine Sci Program, Sch Earth Ocean & Environm, Columbia, SC 29208 USA; [Griffen, Blaine D.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Belgrad, BA (corresponding author), Univ S Carolina, Marine Sci Program, Sch Earth Ocean & Environm, Columbia, SC 29208 USA.	babelgra@eckerd.edu	Belgrad, Benjamin/AAH-2153-2021; Griffen, Blaine/AAC-6384-2021	Belgrad, Benjamin/0000-0003-2032-2210; 	National Science Foundation grant (NSF) [OCE-1129166]; University of South Carolina fellowship; Ohio Mayflower Society scholarship	National Science Foundation grant (NSF)(National Science Foundation (NSF)); University of South Carolina fellowship; Ohio Mayflower Society scholarship	This work was supported by a National Science Foundation grant to BG (NSF # OCE-1129166), a University of South Carolina fellowship to BB, and an Ohio Mayflower Society scholarship to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD WS, 1984, J EXP MAR BIOL ECOL, V80, P207, DOI 10.1016/0022-0981(84)90150-3; BAGENAL TB, 1969, J FISH BIOL, V1, P349, DOI 10.1111/j.1095-8649.1969.tb03882.x; Bergen BJ, 2001, ENVIRON TOXICOL CHEM, V20, P575, DOI 10.1002/etc.5620200317; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BLUNDON JA, 1982, J EXP MAR BIOL ECOL, V65, P47, DOI 10.1016/0022-0981(82)90175-7; Boucard CGV, 2004, AQUACULTURE, V236, P523, DOI 10.1016/j.aquaculture.2003.09.048; CAREW LB, 1964, J NUTR, V83, P300, DOI 10.1093/jn/83.4.300; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Darnell MZ, 2009, MAR ECOL PROG SER, V394, P153, DOI 10.3354/meps08295; Davis AM, 2011, J FISH BIOL, V78, P265, DOI 10.1111/j.1095-8649.2010.02862.x; Decker Mary Beth, 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P425; Dickinson GH, 2006, B MAR SCI, V79, P273; Dissanayake A, 2010, MAR ENVIRON RES, V70, P368, DOI 10.1016/j.marenvres.2010.07.004; Dittel AI, 2006, HYDROBIOLOGIA, V568, P379, DOI 10.1007/s10750-006-0204-2; Doughty P, 1997, OECOLOGIA, V110, P508, DOI 10.1007/s004420050187; DUNN EH, 1975, AUK, V92, P553, DOI 10.2307/4084609; Duquesne S, 2010, ISR J ECOL EVOL, V56, P433, DOI 10.1560/IJEE.56.3-4.433; Eagles-Smith CA, 2008, ECOL APPL, V18, pA213, DOI 10.1890/06-1415.1; Fiorenza M., 1999, ECOL MONOGR, V67, P203; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Gimenez L, 2001, J EXP MAR BIOL ECOL, V260, P241, DOI 10.1016/S0022-0981(01)00258-1; Gimenez L, 2003, MAR ECOL PROG SER, V249, P251, DOI 10.3354/meps249251; Gray JS, 2002, MAR POLLUT BULL, V45, P46, DOI 10.1016/S0025-326X(01)00323-X; Griffen BD, 2008, J ANIM ECOL, V77, P32, DOI 10.1111/j.1365-2656.2007.01304.x; Griffen BD, 2015, BIOL INVASIONS, V17, P2533, DOI 10.1007/s10530-015-0890-7; Griffen BD, 2015, ECOL EVOL, V5, P1474, DOI 10.1002/ece3.1427; Griffen BD, 2014, OECOLOGIA, V174, P121, DOI 10.1007/s00442-013-2751-3; Griffen BD, 2011, J EXP MAR BIOL ECOL, V406, P6, DOI 10.1016/j.jembe.2011.06.005; Griffen BD, 2011, J ANIM ECOL, V80, P854, DOI 10.1111/j.1365-2656.2011.01832.x; GUTHRIE RK, 1979, B ENVIRON CONTAM TOX, V21, P53, DOI 10.1007/BF01685385; Hanlon SM, 2013, COPEIA, P691, DOI 10.1643/CE-13-019; Hartnoll RG, 2006, HYDROBIOLOGIA, V557, P31, DOI 10.1007/s10750-005-9305-6; HAZLETT B. A., 1975, CRUSTACEANA, V28, P11, DOI DOI 10.1163/156854075X00801; Herbreteau F, 1997, BOT MAR, V40, P25, DOI 10.1515/botm.1997.40.1-6.25; Hines AH, 2007, BLUE CRAB CALLINECTE, P565; JOHNSON DA, 1985, J EXP MAR BIOL ECOL, V86, P73, DOI 10.1016/0022-0981(85)90043-7; Jorgensen HB, 1997, PEDOBIOLOGIA, V41, P307; KAROWE DN, 1989, J INSECT PHYSIOL, V35, P699, DOI 10.1016/0022-1910(89)90089-9; Kelly DW, 2005, FRESHWATER BIOL, V50, P127, DOI 10.1111/j.1365-2427.2004.01315.x; Kitaysky AS, 2006, P ROY SOC B-BIOL SCI, V273, P445, DOI 10.1098/rspb.2005.3351; KUCHARSKI LCR, 1991, COMP BIOCHEM PHYS A, V99, P215, DOI 10.1016/0300-9629(91)90261-A; LAUGHLIN RA, 1982, B MAR SCI, V32, P807; Leopoldo J, 2010, AQUACULTURE, V310, P84, DOI 10.1016/j.aquaculture.2010.09.038; Linton SM, 2007, J COMP PHYSIOL B, V177, P269, DOI 10.1007/s00360-006-0138-z; LITTLE EE, 1990, ARCH ENVIRON CON TOX, V19, P380, DOI 10.1007/BF01054982; Lucifora LO, 2009, ECOL RES, V24, P109, DOI 10.1007/s11284-008-0487-z; Macneale KH, 2010, FRONT ECOL ENVIRON, V8, P475, DOI 10.1890/090142; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; McBride MM, 2014, ICES J MAR SCI, V71, P1934, DOI 10.1093/icesjms/fsu002; McKinney RA, 2004, WILDLIFE BIOL, V10, P241, DOI 10.2981/wlb.2004.029; MICHELI F, 1995, J ANIM ECOL, V64, P63, DOI 10.2307/5827; Millikin MR, 1984, FAO FISH SYNOP, V138, P1; Moleon M, 2009, J BIOGEOGR, V36, P1502, DOI 10.1111/j.1365-2699.2009.02078.x; Montevecchi WA, 1997, ICES J MAR SCI, V54, P608, DOI 10.1006/jmsc.1997.0265; NMFS, 2013, FISH US 2012; Norris DR, 2007, J APPL ECOL, V44, P875, DOI 10.1111/j.1365-2664.2007.01329.x; Ortiz J, 2006, FOOD CHEM, V99, P98, DOI 10.1016/j.foodchem.2005.07.027; PARVATHY K, 1971, MAR BIOL, V10, P82, DOI 10.1007/BF02026770; Peraza MA, 1998, ENVIRON HEALTH PERSP, V106, P203, DOI 10.2307/3433921; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pickova J, 1997, CAN J FISH AQUAT SCI, V54, P2410, DOI 10.1139/cjfas-54-10-2410; Rathbun R., 1884, FISHERIES FISHERY 5, P775; Rathbun R., 1887, FISHERIES FISHERY IN, VII, P629; Reichmuth JM, 2011, HYDROBIOLOGIA, V658, P173, DOI 10.1007/s10750-010-0460-z; Reichmuth JM, 2009, ESTUAR COAST, V32, P298, DOI 10.1007/s12237-008-9130-z; Relyea RA, 2008, ECOL APPL, V18, P1728, DOI 10.1890/08-0454.1; Riley ME, 2014, AQUAT BIOL, V20, P35, DOI 10.3354/ab00543; Rosalino LM, 2005, MAMM BIOL, V70, P12, DOI 10.1078/1616-5047-00172; Sanchez-Paz A, 2007, J EXP MAR BIOL ECOL, V340, P184, DOI 10.1016/j.jembe.2006.09.006; Saric MM, 2002, BIOMETALS, V15, P175, DOI 10.1023/A:1015212929481; Shields JD, 2011, J INVERTEBR PATHOL, V106, P79, DOI 10.1016/j.jip.2010.09.015; Shpigel M, 1999, J SHELLFISH RES, V18, P227; Simpson S.J., 1990, P111; Simpson S.J., 1995, P251; Sinn DL, 2010, BEHAV ECOL SOCIOBIOL, V64, P693, DOI 10.1007/s00265-009-0887-2; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stocker AM, 2001, ETHOLOGY, V107, P727, DOI 10.1046/j.1439-0310.2001.00705.x; Undeland I, 1998, FOOD CHEM, V61, P355, DOI 10.1016/S0308-8146(97)00053-8; Vinoj Kumar V., 2007, J MAR BIOL ASSOC IND, V49, P35; VIRNSTEIN RW, 1977, ECOLOGY, V58, P1199, DOI 10.2307/1935076; Weinstein MP, 2009, ESTUAR COAST, V32, P1011, DOI 10.1007/s12237-009-9185-5; Weis JS, 2001, BIOSCIENCE, V51, P209, DOI 10.1641/0006-3568(2001)051[0209:EOCOBB]2.0.CO;2; WILLIAMS AB, 1974, FISH B-NOAA, V72, P685; WOLCOTT DL, 1992, AM ZOOL, V32, P370; XU XL, 1994, AQUACULTURE, V119, P359, DOI 10.1016/0044-8486(94)90300-X; Zhang L, 2009, BBA-MOL BASIS DIS, V1792, P417, DOI 10.1016/j.bbadis.2008.09.006; Zmora O, 2005, AQUACULTURE, V244, P129, DOI 10.1016/j.aquaculture.2004.11.012	87	30	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145481	10.1371/journal.pone.0145481	http://dx.doi.org/10.1371/journal.pone.0145481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784581	Green Published, gold			2022-12-26	WOS:000368528400013
J	Kang, SH; Choi, EW; Park, JW; Cho, KH; Do, JY				Kang, Seok Hui; Choi, Eun Woo; Park, Jong Won; Cho, Kyu Hyang; Do, Jun Young			Clinical Significance of the Edema Index in Incident Peritoneal Dialysis Patients	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; EXTRACELLULAR FLUID VOLUME; HEMODIALYSIS-PATIENTS; BODY-COMPOSITION; SODIUM REMOVAL; BLOOD-PRESSURE; ULTRAFILTRATION; DECLINE; CAPD; PREDICTORS	Background Proper monitoring for volume overload is important to improve prognosis in peritoneal dialysis (PD) patients. The association between volume status and residual renal function (RRF) remains an unresolved issue. The aim of the present study was to evaluate the association between the edema index and survival or RRF in incident PD patients. Patients and Methods We identified all adults who underwent PD. The edema index was defined as the ratio of extracellular fluid to total body fluid. Participants with available data regarding survivorship or non-survivorship during the first year after PD initiation were included in the area under the receiver operating characteristic curve analysis. The cutoff value of the edema index for 1-year mortality was >0.371 in men and >0.372 in women. Participants were divided into two groups according to the cutoff value of their baseline edema indices: High (>cutoff value) and Low (<= cutoff value). Survivors during the first year after PD initiation were divided into two groups according to the initial and 1-year edema index: Non-improvement (maintenance of criteria in the initial Low group during the year) and Other (all participants except those in the Non-improvement group). Results In total, 631 patients were enrolled in the present study. The cutoff value of the edema index for 1-year mortality was >0.371 in men and >0.372 in women. The respective mean initial RRF values (mL.min(-1).1.73 m(-2)) in the Low and High groups, respectively, were 4.88 +/- 4.09 and 4.21 +/- 3.28 in men (P = 0.108), and 3.19 +/- 2.57 and 2.98 +/- 2.70 in women (P = 0.531). There were no significant differences between groups in either sex. The respective mean RRF values at 1 year after PD initiation in the Low and High groups, respectively, were 3.56 +/- 4.35 and 2.73 +/- 2.53 in men, and 2.80 +/- 2.36 and 1.85 +/- 1.51 in women. RRF at 1 year after PD initiation was higher in the Low group than in the High group (men: P = 0.027; women: P = 0.001). In men, the cumulative 5-year survival rates were 78.7% and 46.2% in the Low and High groups, respectively, whereas in women, rates were 77.2% and 58.8% in the Low and High groups, respectively. For survivors during the first year after PD initiation, the Non-improvement group was associated with a poor survival rate compared with the Other group for both sexes. Conclusion A high edema index was associated with mortality in incident PD patients at baseline and follow-up. The edema index may be used as a new marker for predicting mortality in PD patients.	[Kang, Seok Hui; Choi, Eun Woo; Park, Jong Won; Cho, Kyu Hyang; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea	Yeungnam University; Yeungnam University Hospital	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.	jydo@med.yu.ac.kr	Barretti, Pasqual/AAK-7934-2021; Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836; Barretti, Pasqual/0000-0003-4979-4836	Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asci G, 2006, PERITON DIALYSIS INT, V26, P85; Bedogni G, 2002, EUR J CLIN NUTR, V56, P1143, DOI 10.1038/sj.ejcn.1601466; Castillo AA, 2002, AM J KIDNEY DIS, V40, P1301, DOI 10.1053/ajkd.2002.36907; Chamney PW, 2002, KIDNEY INT, V61, P2250, DOI 10.1046/j.1523-1755.2002.00377.x; Charra B, 1996, AM J NEPHROL, V16, P35, DOI 10.1159/000168968; Cheng LT, 2008, PERITON DIALYSIS INT, V28, P397; Cheng LT, 2005, AM J KIDNEY DIS, V45, P891, DOI 10.1053/j.ajkd.2005.01.037; Davies SJ, 2002, NEPHROL DIAL TRANSPL, V17, P1085, DOI 10.1093/ndt/17.6.1085; Dou YN, 2012, SEMIN DIALYSIS, V25, P377, DOI 10.1111/j.1525-139X.2012.01095.x; Dumler F, 2003, ASAIO J, V49, P282, DOI 10.1097/01.MAT.0000065465.52748.BB; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Gao N, 2011, CLIN NEPHROL, V76, P16, DOI 10.5414/CN106896; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Gunal AI, 2001, AM J KIDNEY DIS, V37, P588, DOI 10.1053/ajkd.2001.22085; HEIMBURGER O, 1990, KIDNEY INT, V38, P495, DOI 10.1038/ki.1990.231; Hufnagel C, 1999, NEPHROL DIAL TRANSPL, V14, P1224, DOI 10.1093/ndt/14.5.1224; Hur SM, 2014, KOREAN J INTERN MED, V29, P489, DOI 10.3904/kjim.2014.29.4.489; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Jones CH, 2002, AM J KIDNEY DIS, V39, P872, DOI 10.1053/ajkd.2002.32010; Karopadi AN, 2013, NEPHROL DIAL TRANSPL, V28, P2553, DOI 10.1093/ndt/gft214; Kausz AT, 2000, J AM SOC NEPHROL, V11, P2351, DOI 10.1681/ASN.V11122351; Kawaguchi Y, 1997, KIDNEY INT, V52, pS105; Koc M, 2002, NEPHROL DIAL TRANSPL, V17, P1661, DOI 10.1093/ndt/17.9.1661; Koh ES, 2015, AM J NEPHROL, V42, P91, DOI 10.1159/000439060; Konings CJAM, 2002, PERITON DIALYSIS INT, V22, P477; Kraemer M, 2006, KIDNEY INT, V69, P1609, DOI 10.1038/sj.ki.5000286; Lee SW, 2003, AM J KIDNEY DIS, V41, P1257, DOI 10.1016/S0272-6386(03)00358-5; Liao CT, 2008, PERITON DIALYSIS INT, V28, pS191; Liao CT, 2009, NEPHROL DIAL TRANSPL, V24, P2909, DOI 10.1093/ndt/gfp056; Lu YH, 2015, PERITON DIALYSIS INT, V35, P172, DOI 10.3747/pdi.2013.00060; Lysaght M J, 1991, ASAIO Trans, V37, P598; Mandelbaum A, 1996, NEPHROL DIAL TRANSPL, V11, P24; Mujais S, 2000, PERITON DIALYSIS INT, V20, pS5; Mujais S., 2009, NOLPH GOKALS TXB PER, V3, P505, DOI [10.1007/978-0-387-78940-8_17, DOI 10.1007/978-0-387-78940-8_17]; O'Lone EL, 2014, NEPHROL DIAL TRANSPL, V29, P1430, DOI 10.1093/ndt/gfu049; Papakrivopoulou E, 2012, NEPHROL DIAL TRANSPL, V27, P396, DOI 10.1093/ndt/gfr338; *PER DIAL AD WORK, 2006, AM J KIDNEY DIS S, V48, pS98; Rodriguez-Carmona A, 2004, AM J KIDNEY DIS, V44, P132, DOI 10.1053/j.ajkd.2004.03.035; Rodriguez-Carmona A, 2002, PERITON DIALYSIS INT, V22, P705; Sartorio A, 2005, EUR J CLIN NUTR, V59, P155, DOI 10.1038/sj.ejcn.1602049; Smit W, 2004, PERITON DIALYSIS INT, V24, P562; US Renal Data System, 2013, USRDS 2013 ANN DAT R; WANG ZM, 1992, AM J CLIN NUTR, V56, P19, DOI 10.1093/ajcn/56.1.19; WATSON PE, 1980, AM J CLIN NUTR, V33, P27, DOI 10.1093/ajcn/33.1.27; Wilson B, 2004, HEMODIAL INT, V11, P263; Woodrow G, 2007, PERITON DIALYSIS INT, V27, pS143; Wright S, 2010, CLIN J AM SOC NEPHRO, V5, P1828, DOI 10.2215/CJN.06230909; Yonova C, 2004, Minerva Urol Nefrol, V56, P367	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147070	10.1371/journal.pone.0147070	http://dx.doi.org/10.1371/journal.pone.0147070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785259	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400105
J	Li, L; Jiang, YX; Lao, SH; Yang, BY; Yu, SF; Zhang, YN; Wu, CY				Li, Li; Jiang, Yuxia; Lao, Suihua; Yang, Binyan; Yu, Sifei; Zhang, Yannan; Wu, Changyou			Mycobacterium tuberculosis-Specific IL-21(+)IFN-gamma(+)CD4(+) T Cells Are Regulated by IL-12	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; FOLLICULAR HELPER; IL-21 RECEPTOR; NKT CELLS; B-CELLS; DIFFERENTIATION; INTERLEUKIN-21; MECHANISMS; RESPONSES; CD4(+)	In the current study of Mycobacterium tuberculosis (MTB)-specific T and B cells, we found that MTB-specific peptides from early secreted antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10) induced the expression of IL-21 predominantly in CD4(+) T cells. A fraction of IL-21-expressing CD4(+) T cells simultaneously expressed Th1 cytokines but did not secrete Th2 or Th17 cytokines, suggesting that MTB-specific IL-21-expressing CD4(+) T cells were different from Th1, Th2 and Th17 subpopulations. The majority of MTB-specific IL-21-expressing CD4+ T cells co-expressed IFN-gamma and IL-21+ IFN-gamma(+) CD4(+) T cells exhibited obviously polyfunctionality. In addition, MTB-specific IL-21-expressing CD4(+) T cells displayed a CD45RO(+)CD62L(low)CCR7(low)CD40L(high)ICOS(high) phenotype. Bcl-6-expression was significantly higher in IL-21-expressing CD4(+) T cells than IL-21-CD4(+) T cells. Moreover, IL12 could up-regulate MTB-specific IL-21 expression, especially the frequency of IL-21+ IFN-gamma(+) CD4(+) T cells. Taken together, our results demonstrated that MTB-specific IL-21+ IFN-gamma(+)CD4(+) T cells from local sites of tuberculosis (TB) infection could be enhanced by IL-12, which have the features of both Tfh and Th1 cells and may have an important role in local immune responses against TB infection.	[Li, Li; Jiang, Yuxia; Yang, Binyan; Yu, Sifei; Zhang, Yannan; Wu, Changyou] Sun Yat Sen Univ, Key Lab Trop Dis Control Res, Zhongshan Sch Med, Inst Immunol,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Li, Li] Wuhan Pulm Hosp, Wuhan Inst TB Control, Wuhan, Peoples R China; [Lao, Suihua] Chest Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Wu, CY (corresponding author), Sun Yat Sen Univ, Key Lab Trop Dis Control Res, Zhongshan Sch Med, Inst Immunol,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	changyou_wu@yahoo.com			Guangdong Recruitment Program of Creative Research Groups [2009010058]; National Natural Science Foundation of China [31270942]; Natural Science Foundation of Guangdong Province [S2012010009159]; Hubei Provincial Natural Science Foundation of China [2015CFB255]; Program of China during the Twelfth Five-Year Plan Period [2013ZX10003007-002-003]	Guangdong Recruitment Program of Creative Research Groups; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of China during the Twelfth Five-Year Plan Period	This study was funded by grants from Guangdong Recruitment Program of Creative Research Groups (no. 2009010058), the National Natural Science Foundation of China (no. 31270942), the Natural Science Foundation of Guangdong Province (no. S2012010009159), Hubei Provincial Natural Science Foundation of China (no. 2015CFB255), and the Program of China during the Twelfth Five-Year Plan Period (no. 2013ZX10003007-002-003).	Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Chen MG, 2012, CELL MOL IMMUNOL, V9, P375, DOI 10.1038/cmi.2012.18; Collins M, 2003, IMMUNOL RES, V28, P131, DOI 10.1385/IR:28:2:131; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cummings KJ, 2007, PUBLIC HEALTH REP, V122, P683, DOI 10.1177/003335490712200517; Dolff S, 2011, ARTHRITIS RES THER, V13, pR157, DOI DOI 10.1186/AR3474; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Habib T, 2003, J ALLERGY CLIN IMMUN, V112, P1033, DOI 10.1016/j.jaci.2003.08.039; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Iannello A, 2010, J IMMUNOL, V184, P114, DOI 10.4049/jimmunol.0901967; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kumar NP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111098; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lazarevic V, 2002, AM J RESP CRIT CARE, V166, P1116, DOI 10.1164/rccm.2204027; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082196; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023700; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020165; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Mehta DS, 2004, IMMUNOL REV, V202, P84, DOI 10.1111/j.0105-2896.2004.00201.x; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2010, CELL MOL IMMUNOL, V7, P190, DOI 10.1038/cmi.2010.24; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Qiao D, 2011, INFECT IMMUN, V79, P3358, DOI 10.1128/IAI.00014-11; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Slight SR, 2013, J CLIN INVEST, V123, P712, DOI 10.1172/JCI65728; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Weinmann AS, 2014, IMMUNOL CELL BIOL, V92, P34, DOI 10.1038/icb.2013.49; Williams LD, 2014, J VIROL, V88, P10259, DOI 10.1128/JVI.00764-14; Williams LD, 2011, J VIROL, V85, P2316, DOI 10.1128/JVI.01476-10; Wu CY, 2015, ONCOTARGET, V6, P28633, DOI 10.18632/oncotarget.5764; Xiao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12781; Zhu XJ, 2010, J CLIN IMMUNOL, V30, P253, DOI 10.1007/s10875-009-9353-1	47	20	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147356	10.1371/journal.pone.0147356	http://dx.doi.org/10.1371/journal.pone.0147356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785168	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400140
J	Tseliou, E; Kanazawa, H; Dawkins, J; Gallet, R; Kreke, M; Smith, R; Middleton, R; Valle, J; Marban, L; Kar, S; Makkar, R; Marban, E				Tseliou, Eleni; Kanazawa, Hideaki; Dawkins, James; Gallet, Romain; Kreke, Michelle; Smith, Rachel; Middleton, Ryan; Valle, Jackelyn; Marban, Linda; Kar, Saibal; Makkar, Rajendra; Marban, Eduardo			Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology	PLOS ONE			English	Article							INTRAMYOCARDIAL INJECTION; CARDIAC REPAIR; INFARCTION; THERAPY; REGENERATION; TRANSPLANTATION; CARDIOSPHERES; ELEVATION; BIOMARKERS; EFFICACY	Single-vessel, intracoronary infusion of stem cells under stop-flow conditions has proven safe but achieves only limited myocardial coverage. Continuous flow intracoronary delivery to one or more coronary vessels may achieve broader coverage for treating cardiomyopathy, but has not been investigated. Using nonocclusive coronary guiding catheters, we infused allogeneic cardiosphere-derived cells (CDCs) either in a single vessel or sequentially in all three coronary arteries in porcine ischemic cardiomyopathy and used magnetic resonance imaging (MRI) to assess structural and physiological outcomes. Vehicle-infused animals served as controls. Single-vessel stop-flow and continuous-flow intracoronary infusion revealed equivalent effects on scar size and function. Sequential infusion into each of the three major coronary vessels under stop-flow or continuous-flow conditions revealed equal efficacy, but less elevation of necrotic biomarkers with continuous-flow delivery. In addition, multi-vessel delivery resulted in enhanced global and regional tissue function compared to a triple-vessel placebo-treated group. The functional benefits after global cell infusion were accompanied histologically by minimal inflammatory cellular infiltration, attenuated regional fibrosis and enhanced vessel density in the heart. Sequential multi-vessel non-occlusive delivery of CDCs is safe and provides enhanced preservation of left ventricular function and structure. The current findings provide preclinical validation of the delivery method currently undergoing clinical testing in the Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC) trial of CDCs in heart failure patients.	[Tseliou, Eleni; Dawkins, James; Gallet, Romain; Smith, Rachel; Middleton, Ryan; Valle, Jackelyn; Marban, Linda; Kar, Saibal; Makkar, Rajendra; Marban, Eduardo] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Kanazawa, Hideaki] Keio Univ, Sch Med, Tokyo, Japan; [Kreke, Michelle; Smith, Rachel; Marban, Linda; Marban, Eduardo] Capricor Inc, Los Angeles, CA USA	Cedars Sinai Medical Center; Keio University	Marban, E (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA USA.; Marban, E (corresponding author), Capricor Inc, Los Angeles, CA USA.	Eduardo.Marban@csmc.edu	Marban, Eduardo/GWC-8514-2022	Gallet, Romain/0000-0003-4595-509X	Cedars-Sinai Board of Governors Heart Stem Cell Center	Cedars-Sinai Board of Governors Heart Stem Cell Center	This work was supported by the Cedars-Sinai Board of Governors Heart Stem Cell Center. The Cedars-Sinai Board of Governors Heart Stem Cell Center provided support in the form of salaries for authors ET, HK, JD, JV, RM, RM, SK and EM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. RS, LM and MK are employed by Capricor Inc but did not participate in the funding of this study nor did they play a role in the study design, data collection, decision to publish, or preparation of the manuscript.	Amado LC, 2004, J AM COLL CARDIOL, V44, P2383, DOI 10.1016/j.jacc.2004.09.020; Aminzadeh MA, 2015, EUR HEART J, V36, P751, DOI 10.1093/eurheartj/ehu196; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Baldazzi F, 2008, EUR HEART J, V29, P1819, DOI 10.1093/eurheartj/ehn233; Behfar A, 2014, NAT REV CARDIOL, V11, P232, DOI 10.1038/nrcardio.2014.9; Byrne MJ, 2007, J AM COLL CARDIOL, V50, P1484, DOI 10.1016/j.jacc.2007.07.011; Castillo E, 2005, J CARDIOVASC MAGN R, V7, P783, DOI 10.1080/10976640500295417; Cheng K, 2012, STEM CELLS, V30, P2835, DOI 10.1002/stem.1184; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; Fasanaro P, 2015, CURR VASC PHARMACOL, V13, P305, DOI 10.2174/15701611113119990011; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Herbots L, 2009, EUR HEART J, V30, P662, DOI 10.1093/eurheartj/ehn532; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Houtgraaf JH, 2013, CIRC RES, V113, P153, DOI 10.1161/CIRCRESAHA.112.300730; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kali A, 2014, CIRC-CARDIOVASC IMAG, V7, P471, DOI 10.1161/CIRCIMAGING.113.001541; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Lara-Pezzi E, 2015, J CARDIOVASC TRANSL, V8, P3, DOI 10.1007/s12265-015-9606-8; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175; Malliaras K, 2014, EMBO MOL MED, V6, P760, DOI 10.1002/emmm.201303626; Malliaras K, 2013, CIRCULATION, V128, P2764, DOI 10.1161/CIRCULATIONAHA.113.002863; Malliaras K, 2014, STEM CELL TRANSL MED, V3, P2, DOI 10.5966/sctm.2013-0104; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Povsic TJ, 2012, AM HEART J, V164, P689, DOI 10.1016/j.ahj.2012.06.022; Rasmussen TL, 2011, CIRCULATION, V123, P1771, DOI 10.1161/CIRCULATIONAHA.109.858019; Rosen MR, 2014, J AM COLL CARDIOL, V64, P922, DOI 10.1016/j.jacc.2014.06.1175; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Stamm C, 2009, HEART LUNG CIRC, V18, P245, DOI 10.1016/j.hlc.2008.10.014; Suzuki G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113009; Traverse JH, 2011, AM HEART J, V162, P671, DOI 10.1016/j.ahj.2011.06.019; Tseliou E, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0443-8; Tseliou E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088590; Tseliou E, 2013, J AM COLL CARDIOL, V61, P1108, DOI 10.1016/j.jacc.2012.10.052; Vrtovec B, 2013, CIRC RES, V112, P165, DOI 10.1161/CIRCRESAHA.112.276519; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Yee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113805	48	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0144523	10.1371/journal.pone.0144523	http://dx.doi.org/10.1371/journal.pone.0144523			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784932	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400004
J	Xu, QQ; Jiang, YS; Wangkahart, E; Zou, J; Chang, MX; Yang, DQ; Secombes, CJ; Nie, P; Wang, TH				Xu, Qiaoqing; Jiang, Yousheng; Wangkahart, Eakapol; Zou, Jun; Chang, Mingxian; Yang, Daiqin; Secombes, Chris J.; Nie, Pin; Wang, Tiehui			Sequence and Expression Analysis of Interferon Regulatory Factor 10 (IRF10) in Three Diverse Teleost Fish Reveals Its Role in Antiviral Defense	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; IMMUNE-RESPONSES; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; MOLECULAR-CLONING; GENE; BIOACTIVITY; MODULATION; PARALOGUES	Background Interferon regulatory factor (IRF) 10 was first found in birds and is present in the genome of other tetrapods (but not humans and mice), as well as in teleost fish. The functional role of IRF10 in vertebrate immunity is relatively unknown compared to IRF1-9. The target of this research was to clone and characterize the IRF10 genes in three economically important fish species that will facilitate future evaluation of this molecule in fish innate and adaptive immunity. Molecular Characterization of IRF10 in Three Fish Species In the present study, a single IRF10 gene was cloned in grass carp Ctenopharyngodon idella and Asian swamp eel Monopterus albus, and two, named IRF10a and IRF10b, in rain-bow trout Oncorhynchus mykiss. The fish IRF10 molecules share highest identities to other vertebrate IRF10s, and have a well conserved DNA binding domain, IRF-associated domain, and an 8 exon/7 intron structure with conserved intron phase. The presence of an upstream ATG or open reading frame (ORF) in the 5'-untranslated region of different fish IRF10 cDNA sequences suggests potential regulation at the translational level, and this has been verified by in vitro transcription/translation experiments of the trout IRF10a cDNA, but would still need to be validated in fish cells. Expression Analysis of IRF10 In Vivo and In Vitro Both trout IRF10 paralogues are highly expressed in thymus, blood and spleen but are relatively low in head kidney and caudal kidney. Trout IRF10b expression is significantly higher than IRF10a in integumentary tissues i.e. gills, scales, skin, intestine, adipose fin and tail fins, suggesting that IRF10b may be more important in mucosal immunity. The expression of both trout IRF10 paralogues is up-regulated by recombinant IFN-gamma. The expression of the IRF10 genes is highly induced by Poly I:C in vitro and in vivo, and by viral infection, but is less responsive to peptidoglycan and bacterial infection, suggesting an important role of fish IRF10 in antiviral defense.	[Xu, Qiaoqing; Yang, Daiqin] Yangtze Univ, Sch Anim Sci, Jingzhou 434025, Hubei Prov, Peoples R China; [Xu, Qiaoqing; Jiang, Yousheng; Wangkahart, Eakapol; Zou, Jun; Secombes, Chris J.; Wang, Tiehui] Univ Aberdeen, Inst Biol & Environm Sci, Scottish Fish Immunol Res Ctr, Aberdeen AB24 2TZ, Scotland; [Xu, Qiaoqing; Chang, Mingxian; Nie, Pin] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Hubei Province, Peoples R China; [Jiang, Yousheng] Shanghai Ocean Univ, Coll Fishery & Life Sci, Shanghai 201306, Peoples R China	Yangtze University; University of Aberdeen; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Shanghai Ocean University	Wang, TH (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Scottish Fish Immunol Res Ctr, Aberdeen AB24 2TZ, Scotland.; Nie, P (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Hubei Province, Peoples R China.	pinnie@ihb.ac.cn; t.h.wang@abdn.ac.uk	Wangkahart, Eakapol/AAM-5099-2020	nie, pin/0000-0002-9492-2940; Wang, Tiehui/0000-0002-1148-8959	National Natural Science Foundation of China [31101928]; National Science and Technology Support Program of China [2013BAD20B06]; State Key Laboratory of Freshwater Ecology and Biotechnology [2010FB02]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) - Scottish Funding Council [HR09011]; National Scholarship Council of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) - Scottish Funding Council; National Scholarship Council of China	This research was supported financially by the National Natural Science Foundation of China (31101928), the National Science and Technology Support Program of China (2013BAD20B06), the State Key Laboratory of Freshwater Ecology and Biotechnology (2010FB02) and the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) funded by the Scottish Funding Council (grant reference HR09011). Q.X. and Y.J. were supported financially by the National Scholarship Council of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported financially by the National Natural Science Foundation of China (31101928), the National Science and Technology Support Program of China (2013BAD20B06), the State Key Laboratory of Freshwater Ecology and Biotechnology (2010FB02) and the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) funded by the Scottish Funding Council (grant reference HR09011). Q.X. and Y.J. were supported financially by the National Scholarship Council of China.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cain KD, 2000, FISH SHELLFISH IMMUN, V10, P651, DOI 10.1006/fsim.2000.0280; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Campbell S, 2009, DIS AQUAT ORGAN, V86, P205, DOI 10.3354/dao02127; Chen WJ, 2010, CELL SIGNAL, V22, P883, DOI 10.1016/j.cellsig.2009.12.005; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collet B, 2014, DEV COMP IMMUNOL, V43, P160, DOI 10.1016/j.dci.2013.08.017; Costa MM, 2011, MOL IMMUNOL, V48, P1903, DOI 10.1016/j.molimm.2011.05.027; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Harun NO, 2011, FISH SHELLFISH IMMUN, V31, P107, DOI 10.1016/j.fsi.2011.04.010; Hill JE, 2007, N AM J AQUACULT, V69, P139, DOI 10.1577/A05-070.1; Hong S, 2001, VET IMMUNOL IMMUNOP, V81, P1, DOI 10.1016/S0165-2427(01)00328-2; Hong S, 2013, J IMMUNOL, V191, P5959, DOI 10.4049/jimmunol.1301584; Huang B, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-22; Husain M, 2012, DEV COMP IMMUNOL, V38, P431, DOI 10.1016/j.dci.2012.07.010; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kochetov AV, 2008, FEBS LETT, V582, P1293, DOI 10.1016/j.febslet.2008.03.014; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li J, 1997, DIS AQUAT ORGAN, V29, P7, DOI 10.3354/dao029007; Li S, 2014, J IMMUNOL, V193, P1100, DOI 10.4049/jimmunol.1400253; Li YP, 2007, ARCH VIROL, V152, P463, DOI 10.1007/s00705-006-0878-9; MacKenzie SA, 2010, MOL IMMUNOL, V47, P1450, DOI 10.1016/j.molimm.2010.02.009; Maehr T, 2014, MOL IMMUNOL, V62, P186, DOI 10.1016/j.molimm.2014.06.021; Nehyba J, 2002, MOL CELL BIOL, V22, P3942, DOI 10.1128/MCB.22.11.3942-3957.2002; Nehyba J, 2009, MOL BIOL EVOL, V26, P2539, DOI 10.1093/molbev/msp167; *OFF INT EP, 2000, DIAGN MAN AQ AN DIS, P74; Roca FJ, 2007, MOL IMMUNOL, V44, P472, DOI 10.1016/j.molimm.2006.02.015; Shi Y, 2010, MOL BIOL REP, V37, P1483, DOI 10.1007/s11033-009-9544-0; Skall HF, 2005, J FISH DIS, V28, P509, DOI 10.1111/j.1365-2761.2005.00654.x; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Suzuki Y, 2011, FISH SHELLFISH IMMUN, V30, P67, DOI 10.1016/j.fsi.2010.09.010; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Wang T, 2003, IMMUNOGENETICS, V55, P615, DOI 10.1007/s00251-003-0622-5; Wang TH, 2014, DEV COMP IMMUNOL, V46, P194, DOI 10.1016/j.dci.2014.04.008; Wang TH, 2014, EUR J IMMUNOL, V44, P1541, DOI 10.1002/eji.201344273; Wang TH, 2011, IMMUNOGENETICS, V63, P235, DOI 10.1007/s00251-010-0508-2; Wang TH, 2011, J IMMUNOL, V186, P708, DOI 10.4049/jimmunol.1001203; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Xu QQ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-25; Xu QQ, 2010, VET IMMUNOL IMMUNOP, V134, P269, DOI 10.1016/j.vetimm.2009.10.020; Xu QQ, 2014, DEV COMP IMMUNOL, V45, P201, DOI 10.1016/j.dci.2014.03.002; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Zhu LY, 2013, DEV COMP IMMUNOL, V39, P39, DOI 10.1016/j.dci.2012.04.001	46	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147181	10.1371/journal.pone.0147181	http://dx.doi.org/10.1371/journal.pone.0147181			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783745	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400119
J	Laudy, AE; Mrowka, A; Krajewska, J; Tyski, S				Laudy, Agnieszka E.; Mrowka, Agnieszka; Krajewska, Joanna; Tyski, Stefan			The Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; HELICOBACTER-PYLORI; STENOTROPHOMONAS-MALTOPHILIA; FLUOROQUINOLONE RESISTANCE; ACINETOBACTER-BAUMANNII	Background Most patients with bacterial infections suffer from fever and various pains that require complex treatments with antibiotics, antipyretics, and analgaesics. The most common drugs used to relieve these symptoms are non-steroidal anti-inflammatory drugs (NSAIDs), which are not typically considered antibiotics. Here, we investigate the effects of NSAIDs on bacterial susceptibility to antibiotics and the modulation of bacterial efflux pumps. Methodology The activity of 12 NSAID active substances, paracetamol (acetaminophen), and eight relevant medicinal products was analyzed with or without pump inhibitors against 89 strains of Gram-negative rods by determining the MICs. Furthermore, the effects of NSAIDs on the susceptibility of clinical strains to antimicrobial agents with or without PA beta N (Phe-Arg-beta-naphtylamide) were measured. Results The MICs of diclofenac, mefenamic acid, ibuprofen, and naproxen, in the presence of PA beta N, were significantly (>= 4-fold) reduced, decreasing to 25-1600 mg/L, against the majority of the studied strains. In the case of acetylsalicylic acid only for 5 and 7 out of 12 strains of P. mirabilis and E. coli, respectively, a 4-fold increase in susceptibility in the presence of PA beta N was observed. The presence of Aspirin resulted in a 4-fold increase in the MIC of ofloxacin against only two strains of E. coli among 48 tested clinical strains, which included species such as E. coli, K. pneumoniae, P. aeruginosa, and S. maltophilia. Besides, the medicinal products containing the following NSAIDs, diclofenac, mefenamic acid, ibuprofen, and naproxen, did not cause the decrease of clinical strains' susceptibility to antibiotics. Conclusions The effects of PA beta N on the susceptibility of bacteria to NSAIDs indicate that some NSAIDs are substrates for efflux pumps in Gram-negative rods. Morever, Aspirin probably induced efflux-mediated resistance to fluoroquinolones in a few E. coli strains.	[Laudy, Agnieszka E.; Krajewska, Joanna; Tyski, Stefan] Med Univ Warsaw, Dept Pharmaceut Microbiol, Oczki 3 Str, PL-02007 Warsaw, Poland; [Mrowka, Agnieszka; Tyski, Stefan] Natl Med Inst, Dept Antibiot & Microbiol, Chelmska 30-34 Str, PL-00725 Warsaw, Poland	Medical University of Warsaw; National Medicines Institute Lekow (NIL)	Laudy, AE (corresponding author), Med Univ Warsaw, Dept Pharmaceut Microbiol, Oczki 3 Str, PL-02007 Warsaw, Poland.	alaudy@wp.pl	Laudy, Agnieszka/M-4930-2018; Laudy, Agnieszka/AAC-1000-2022; Tyski, Stefan/W-5271-2018; Krajewska, Joanna/ACL-3842-2022	Laudy, Agnieszka/0000-0002-5989-4462; Tyski, Stefan/0000-0003-3352-038X; Kociszewska, Agnieszka/0000-0002-2055-2588; Krajewska, Joanna/0000-0002-4963-9521	Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland [REGON: 006220910, NIP: 5262173856, KRS: 0000195643]; European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"	Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland; European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"	The study was supported by the Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland (REGON: 006220910, NIP: 5262173856, KRS: 0000195643; foundation of some reagents). Research was carried out with the use of CePT infrastructure financed by the European Union - the European Regional Development Fund within the Operational Programme "Innovative economy" for 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adabi M, 2015, INFECT CHEMOTHER, V47, P98, DOI 10.3947/ic.2015.47.2.98; Al-Bakri AG, 2009, J APPL MICROBIOL, V107, P280, DOI 10.1111/j.1365-2672.2009.04205.x; Axon J. M. C., 1992, P295; Baucheron S, 2002, MICROB DRUG RESIST, V8, P281, DOI 10.1089/10766290260469543; Bazyleu A, 2014, FEMS MICROBIOL LETT, V357, P136, DOI 10.1111/1574-6968.12530; Bown RL, 2002, INT J CLIN PRACT, V56, P132; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; Clinical and Laboratory Standards Institute, 2012, M7A9 CLIN LAB STAND, V11th; COHEN SP, 1993, J BACTERIOL, V175, P7856, DOI 10.1128/JB.175.24.7856-7862.1993; Dastidar SG, 2000, INT J ANTIMICROB AG, V14, P249, DOI 10.1016/S0924-8579(99)00159-4; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; Dutta NK, 2007, INT J ANTIMICROB AG, V30, P242, DOI 10.1016/j.ijantimicag.2007.04.018; FRANTZ B, 1995, SCIENCE, V270, P2017, DOI 10.1126/science.270.5244.2017; Hartog E, 2010, J ANTIMICROB CHEMOTH, V65, P888, DOI 10.1093/jac/dkq077; Hasdemir UO, 2004, J CLIN MICROBIOL, V42, P2701, DOI 10.1128/JCM.42.6.2701-2706.2004; Huang YW, 2013, J ANTIMICROB CHEMOTH, V68, P2498, DOI 10.1093/jac/dkt250; Kriengkauykiat J, 2005, ANTIMICROB AGENTS CH, V49, P565, DOI 10.1128/AAC.49.2.565-570.2005; Kristiansen JE, 2010, IN VIVO, V24, P751; Kruszewska H, 2012, ACTA POL PHARM, V69, P1368; Kruszewska H, 2010, ACTA POL PHARM, V67, P733; Kruszewska H, 2008, ACTA POL PHARM, V65, P779; Kruszewska Hanna, 2006, Acta Pol Pharm, V63, P457; Laudy AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119997; Lode HM, 2014, INT J ANTIMICROB AG, V43, P497, DOI 10.1016/j.ijantimicag.2014.02.014; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Mallea M, 2002, BIOCHEM BIOPH RES CO, V293, P1370, DOI 10.1016/S0006-291X(02)00404-7; Marquez B, 2005, BIOCHIMIE, V87, P1137, DOI 10.1016/j.biochi.2005.04.012; Martins M, 2008, INT J ANTIMICROB AG, V31, P198, DOI 10.1016/j.ijantimicag.2007.10.025; Mazumdar K, 2010, INT J ANTIMICROB AG, V36, P295, DOI 10.1016/j.ijantimicag.2010.05.003; Mazumdar K, 2006, IN VIVO, V20, P613; Nair BM, 2004, J CLIN INVEST, V113, P464, DOI 10.1172/JCi200419710; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Opperman TJ, 2014, ANTIMICROB AGENTS CH, V58, P722, DOI 10.1128/AAC.01866-13; Pages JM, 2009, BBA-PROTEINS PROTEOM, V1794, P826, DOI 10.1016/j.bbapap.2008.12.011; Piddock LJV, 2010, J ANTIMICROB CHEMOTH, V65, P1215, DOI 10.1093/jac/dkq079; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Poole K, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P349, DOI 10.1007/978-1-4614-1400-1_10; Price CTD, 2000, INT J BIOCHEM CELL B, V32, P1029, DOI 10.1016/S1357-2725(00)00042-X; Renau TE, 1999, J MED CHEM, V42, P4928, DOI 10.1021/jm9904598; Ribera A, 2002, J ANTIMICROB CHEMOTH, V49, P697, DOI 10.1093/jac/49.4.697; ROSNER JL, 1991, J BACTERIOL, V173, P5631, DOI 10.1128/jb.173.18.5631-5638.1991; ROSNER JL, 1985, P NATL ACAD SCI USA, V82, P8771, DOI 10.1073/pnas.82.24.8771; Saenz Y, 2004, J ANTIMICROB CHEMOTH, V53, P544, DOI 10.1093/jac/dkh117; Sanchez P, 2003, J ANTIMICROB CHEMOTH, V51, P1042, DOI 10.1093/jac/dkg181; Sedef Gocmen J, 2008, J DERMATOL TREAT, V19, P351, DOI 10.1080/09546630802050498; Shen ZQ, 2011, APPL ENVIRON MICROB, V77, P7128, DOI 10.1128/AEM.00763-11; Shirin H, 2006, J GASTROEN HEPATOL, V21, P1388, DOI 10.1111/j.1440-1746.2006.04194.x; Sonnet P, 2012, INT J ANTIMICROB AG, V39, P77, DOI 10.1016/j.ijantimicag.2011.08.005; Tamanai-Shacoori Z, 2004, CAN J ANAESTH, V51, P911, DOI 10.1007/BF03018889; Tamanai-Shacoori Z, 2007, ANESTH ANALG, V105, P524, DOI 10.1213/01.ane.0000267525.51017.b8; Tanabe H, 1997, J GEN APPL MICROBIOL, V43, P257, DOI 10.2323/jgam.43.257; Wang WH, 2003, GUT, V52, P490, DOI 10.1136/gut.52.4.490; WEISSMANN G, 1991, SCI AM, V264, P84, DOI 10.1038/scientificamerican0191-84; Wu KK, 2000, CIRCULATION, V102, P2022, DOI 10.1161/01.CIR.102.17.2022; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Yin Z, 2014, CHEM BIOL, V21, P481, DOI 10.1016/j.chembiol.2014.02.009; Zechini Barbara, 2009, Recent Pat Antiinfect Drug Discov, V4, P37; Zhang XP, 2009, WORLD J GASTROENTERO, V15, P919, DOI 10.3748/wjg.15.919	61	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147131	10.1371/journal.pone.0147131	http://dx.doi.org/10.1371/journal.pone.0147131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771525	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300063
J	Stockslager, MA; Samuels, BC; Allingham, RR; Klesmith, ZA; Schwaner, SA; Forest, CR; Ethier, CR				Stockslager, Max A.; Samuels, Brian C.; Allingham, R. Rand; Klesmith, Zoe A.; Schwaner, Stephen A.; Forest, Craig R.; Ethier, C. Ross			System for Rapid, Precise Modulation of Intraocular Pressure, toward Minimally-Invasive In Vivo Measurement of Intracranial Pressure	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; OPTIC-NERVE HEAD; OUTFLOW FACILITY; OCULAR RIGIDITY; LUMBAR PUNCTURE; GOLDMANN APPLANATION; UVEOSCLERAL OUTFLOW; GLAUCOMA; PULSATION; EYE	Pathologic changes in intracranial pressure (ICP) are commonly observed in a variety of medical conditions, including traumatic brain injury, stroke, brain tumors, and glaucoma. However, current ICP measurement techniques are invasive, requiring a lumbar puncture or surgical insertion of a cannula into the cerebrospinal fluid (CSF)-filled ventricles of the brain. A potential alternative approach to ICP measurement leverages the unique anatomy of the central retinal vein, which is exposed to both intraocular pressure (IOP) and ICP as it travels inside the eye and through the optic nerve; manipulating IOP while observing changes in the natural pulsations of the central retinal vein could potentially provide an accurate, indirect measure of ICP. As a step toward implementing this technique, we describe the design, fabrication, and characterization of a system that is capable of manipulating IOP in vivo with <0.1 mmHg resolution and settling times less than 2 seconds. In vitro tests were carried out to characterize system performance. Then, as a proof of concept, we used the system to manipulate IOP in tree shrews (Tupaia belangeri) while video of the retinal vessels was recorded and the caliber of a selected vein was quantified. Modulating IOP using our system elicited a rapid change in the appearance of the retinal vein of interest: IOP was lowered from 10 to 3 mmHg, and retinal vein caliber sharply increased as IOP decreased from 7 to 5 mmHg. Another important feature of this technology is its capability to measure ocular compliance and outflow facility in vivo, as demonstrated in tree shrews. Collectively, these proof-of-concept demonstrations support the utility of this system to manipulate IOP for a variety of useful applications in ocular biomechanics, and provide a framework for further study of the mechanisms of retinal venous pulsation.	[Stockslager, Max A.; Klesmith, Zoe A.; Schwaner, Stephen A.; Forest, Craig R.; Ethier, C. Ross] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Samuels, Brian C.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Allingham, R. Rand] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA; [Ethier, C. Ross] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Ethier, C. Ross] Emory Univ, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; University of Alabama System; University of Alabama Birmingham; Duke University; University System of Georgia; Georgia Institute of Technology; Emory University	Ethier, CR (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Ethier, CR (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	ross.ethier@bme.gatech.edu		Samuels, Brian/0000-0003-3860-6879; Ethier, Ross/0000-0001-6110-3052	National Institute of Health BRAIN Initiative Grant (NEI) [1-U01-MH106027-01]; National Institute of Health BRAIN Initiative Grant (NIMH) [1-U01-MH106027-01]; National Institutes of Health Single Cell Grant [1 R01 EY023173]; NATIONAL EYE INSTITUTE [R01EY023173, T32EY007092, P30EY006360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106027] Funding Source: NIH RePORTER	National Institute of Health BRAIN Initiative Grant (NEI); National Institute of Health BRAIN Initiative Grant (NIMH); National Institutes of Health Single Cell Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	CRE acknowledges the Georgia Research Alliance (gra.org). CRF acknowledges the National Institutes of Health BRAIN Initiative Grant (NEI and NIMH 1-U01-MH106027-01; nih.gov) and National Institutes of Health Single Cell Grant (1 R01 EY023173; nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SV, 2006, POSTGRAD MED J, V82, P713, DOI 10.1136/pgmj.2006.044792; Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; Boussommier-Calleja A, 2012, INVEST OPHTH VIS SCI, V53, P5838, DOI 10.1167/iovs.12-9923; Brubaker RF, 2003, SURV OPHTHALMOL, V48, pS17, DOI 10.1016/S0039-6257(03)00003-1; Brubaker RF, 2001, J GLAUCOMA, V10, pS45, DOI 10.1097/00061198-200110001-00017; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Chen W, P 2009 2 INT C BIOM, DOI [10.1109/BMEI.2009.5305808, DOI 10.1109/BMEI.2009.5305808]; Cheung CMG, 2004, BRIT J OPHTHALMOL, V88, P582, DOI 10.1136/bjo.2003.027219; Cioboata M, 2014, J Med Life, V7 Spec No. 2, P5; De Moraes CGV, 2008, J OPTOM, V01, P43; Eilaghi A, 2010, ANN BIOMED ENG, V38, P1586, DOI 10.1007/s10439-009-9879-7; EISENLOHR JE, 1962, INVEST OPHTH VISUAL, V1, P63; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Golzan SM, 2012, ANN BIOMED ENG, V40, P1940, DOI 10.1007/s10439-012-0563-y; GRANT WM, 1950, ARCH OPHTHALMOL-CHIC, V44, P204; GRANT WM, 1951, AMA ARCH OPHTHALMOL, V46, P113; Gurol ME, 2008, CURR ATHEROSCLER REP, V10, P324, DOI 10.1007/s11883-008-0050-y; Harder B, 2007, BR J OPHTHALMOL, V91, P399; HARRINGTON H, 1982, J NEUROSURG, V57, P703, DOI 10.3171/jns.1982.57.5.0703; Heimann H., 2010, ESSENTIALS OPHTHALMO, P67; Honjo M., 2011, ARCH OPHTHALMOL-CHIC, V119, P1171; Jacks AS, 2003, J NEUROL NEUROSUR PS, V74, P7, DOI 10.1136/jnnp.74.1.7; Kahook MY, 2013, CHANDLER AND GRANT'S GLAUCOMA, FIFTH EDITION, P1; KAST R, 1985, J NEUROL, V232, P260, DOI 10.1007/BF00313790; Kramer LA, 2012, RADIOLOGY, V263, P819, DOI 10.1148/radiol.12111986; Kymionis GD, 2008, J REFRACT SURG, V24, P173, DOI 10.3928/1081597X-20080201-08; Lee KJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0051-3; Lei YA, 2011, INVEST OPHTH VIS SCI, V52, P1865, DOI 10.1167/iovs.10-6019; Levine DN, 1998, MICROVASC RES, V56, P154, DOI 10.1006/mvre.1998.2098; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; Morgan WH, 1999, THESIS U W AUSTR; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; Ramulu PY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1335, DOI 10.1001/archophthalmol.2010.224; RUBEN JB, 1985, INVEST OPHTH VIS SCI, V26, P153; Sherwood JM, 2015, PLOS ONE UNPUB; Shetty AK, 1999, PEDIATRICS, V103, P1284, DOI 10.1542/peds.103.6.1284; Villamarin A, 2012, INVEST OPHTH VIS SCI, V53, P2831, DOI 10.1167/iovs.11-8752; Wall M, 2010, NEUROL CLIN, V28, P593, DOI 10.1016/j.ncl.2010.03.003; Wang AS, 2013, J GLAUCOMA, V22, P127, DOI 10.1097/IJG.0b013e3182254ba3; Wang J, 2013, INVEST OPHTH VIS SCI, V54, P1706, DOI 10.1167/iovs.12-9841	44	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147020	10.1371/journal.pone.0147020	http://dx.doi.org/10.1371/journal.pone.0147020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771837	Green Submitted, Green Published, gold			2022-12-26	WOS:000368628300052
J	Taylor, MA; Wappett, M; Delpuech, O; Brown, H; Chresta, CM				Taylor, M. A.; Wappett, M.; Delpuech, O.; Brown, H.; Chresta, C. M.			Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCC	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION; CANCER; METHYLATION; GEFITINIB; SURVIVAL; PATHWAY; TARGET; PD-1; OVEREXPRESSION	Non-small-cell lung cancer is the leading cause of cancer death worldwide and is comprised of several histological subtypes, the two most common being adenocarcinoma (AC) and squamous cell carcinoma (SCC). Targeted therapies have successfully improved response rates in patients with AC tumors. However, the majority of SCC tumors lack specific targetable mutations, making development of new treatment paradigms for this disease challenging. In the present study, we used iterative non-negative matrix factorization, an unbiased clustering method, on mRNA expression data from the cancer genome atlas (TCGA) and a panel of 24 SCC cell lines to classify three disease segments within SCC. Analysis of gene set enrichment and drug sensitivity identified an immune-evasion subtype that showed increased sensitivity to nuclear factor-kappa B and mitogen-activated protein kinase (MAPK) inhibition, a replication-stress associated subtype that showed increased sensitivity to ataxia telangiectasia inhibition, and a neuroendocrine-associated subtype that showed increased sensitivity to phosphoinositide 3-kinase and fibroblast growth factor receptor inhibition. Additionally, each of these subtypes exhibited a unique microRNA expression profile. Focusing on the immuneevasion subtype, bioinformatic analysis of microRNA promoters revealed enrichment for binding sites for the MAPK-driven ETS1 transcription factor. Indeed, we found that knockdown of ETS1 led to upregulation of eight microRNAs and downregulation of miR-29b in the immune-evasion subtype. Mechanistically, we found that miR-29b targets the DNA-demethylating enzyme, TET1, for downregulation resulting in decreased 5-hmC epigenetic modifications. Moreover, inhibition of MAPK signaling by gefitinib led to decreased ETS1 and miR-29b expression with a corresponding increase in TET1 expression and increase in 5-hmC. Collectively, our work identifies three subtypes of lung SCC that differ in drug sensitivity and shows a novel mechanism of miR-29b regulation by MAPK-driven ETS1 expression which leads to downstream changes in TET1-mediated epigenetic modifications.	[Taylor, M. A.; Wappett, M.; Delpuech, O.; Chresta, C. M.] AstraZeneca, R&D Oncol iMed, Room 33F83-7 Mereside,Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [Brown, H.] AstraZeneca, Personalised Healthcare & Biomarkers, Alderley Pk, Macclesfield, Cheshire, England	AstraZeneca; AstraZeneca	Taylor, MA (corresponding author), AstraZeneca, R&D Oncol iMed, Room 33F83-7 Mereside,Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	molly.taylor@astrazeneca.com		Taylor, Molly/0000-0002-7885-8395	AstraZeneca Postdoc Programme	AstraZeneca Postdoc Programme(AstraZeneca)	We thank the Targets Biology group at AstraZeneca for critical comments of the manuscript, and Henry Brown and Hayley Campbell for their scientific expertise on fluidigm experiments. Funding was provided by the AstraZeneca Postdoc Programme.	Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Azuma K, 2014, ANN ONCOL, V25, P1935, DOI 10.1093/annonc/mdu242; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; D'Incecco A, 2015, BRIT J CANCER, V112, P95, DOI 10.1038/bjc.2014.555; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Del Prete A, 2011, BIOCHEM MEDICA, V21, P264; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Dhillon T, 2010, J THORAC ONCOL, V5, P314, DOI 10.1097/JTO.0b013e3181ce6604; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Ficz G, 2014, GENOMICS, V104, P352, DOI 10.1016/j.ygeno.2014.08.017; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Jacobsen A, 2013, NAT STRUCT MOL BIOL, V20, P1325, DOI 10.1038/nsmb.2678; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin CL, 2014, NUCLEIC ACIDS RES, V42, P6956, DOI 10.1093/nar/gku372; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lan MS, 2009, FASEB J, V23, P2024, DOI 10.1096/fj.08-125971; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Li XY, 2013, ONCOL REP, V29, P1975, DOI 10.3892/or.2013.2298; Liao RG, 2012, LUNG CANCER MANAG, V1, P293, DOI 10.2217/LMT.12.40; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin YC, 2015, CLIN CANCER RES, V21, P428, DOI 10.1158/1078-0432.CCR-14-1150; Liu AH, 2009, INT J CLIN EXP PATHO, V2, P519; Liu SY, 2005, CELL PHYSIOL BIOCHEM, V16, P207, DOI 10.1159/000089846; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Lou YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097719; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marinov M, 2009, CLIN CANCER RES, V15, P1277, DOI 10.1158/1078-0432.CCR-08-2166; Nana-Sinkam SP, 2013, CHEST S, V143, pe30S; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Sajadian SO, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0133-x; Senbabaoglu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06207; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor Molly A, 2014, Mol Cell Ther, V2, P1, DOI 10.1186/2052-8426-2-30; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Weber A. M., 2014, PHARMACOL THERAPEUT, V149, P124; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wojtalla A, 2013, CLIN CANCER RES, V19, P96, DOI 10.1158/1078-0432.CCR-12-1138; Wu BK, 2014, CELL REP, V9, P1827, DOI 10.1016/j.celrep.2014.10.063; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020	49	26	30	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	33					4345	4357		10.1038/onc.2015.499	http://dx.doi.org/10.1038/onc.2015.499			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3ZU	26776158	hybrid, Green Published			2022-12-26	WOS:000382152100006
J	Chavoshi, S; Egorova, O; Lacdao, IK; Farhadi, S; Sheng, Y; Saridakis, V				Chavoshi, Sara; Egorova, Olga; Lacdao, Ira Kay; Farhadi, Sahar; Sheng, Yi; Saridakis, Vivian			Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); DNA viruses; viral protein; virology; X-ray crystallography; KSHV; USP7; vIRF1	UBIQUITIN-SPECIFIC PROTEASE; INTERFERON REGULATORY FACTOR; BINDING DOMAIN; CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; DNA-DAMAGE; HUMAN P53; PHOSPHORYLATION; STABILIZATION	Viral interferon regulatory factor 1 (vIRF1), a Kaposi sarcoma herpesvirus protein, destabilizes p53 by inhibiting p53 acetylation and Hdm2 phosphorylation. This leads to increased ubiquitination and degradation of p53 by Hdm2, which cripples the cellular p53-mediated antiviral response. Ubiquitin-specific protease 7 (USP7) deubiquitinates p53 and Hdm2 and regulates their stability. We identified an EGPS consensus sequence in vIRF1, which is identical to that found in Epstein-Barr virus nuclear antigen 1 (EBNA1) that interacts with the N-terminal domain of USP7 (USP7-NTD). GST pulldown assays demonstrated that vIRF1 interacts with USP7-NTD via its EGPS motif. NMR heteronuclear single quantum correlation (HSQC) analysis revealed chemical perturbations after titration of USP7-NTD with vIRF1 (44)SPGEGPSGTG(53) peptide. In contrast, these perturbations were reduced with a mutant vIRF1 peptide, (44)SPGEGPAGTG(53). Fluorescence polarization analysis indicated that the vIRF1 peptide interacted with USP7-NTD with a K-d of 2.0 m. The crystal structure of the USP7-NTD<bold>vIRF</bold>1 peptide complex revealed an identical mode of binding as that of the EBNA1 peptide to USP7-NTD. We also showed that USP7 interacts with vIRF1 in U2OS cells. Decreased levels of p53, but not Hdm2 or ataxia telangiectasia-mutated (ATM), were seen after expression of vIRF1, but not with a vIRF1 mutant protein. Our results support a new role for vIRF1 through deregulation of the deubiquitinating enzyme USP7 to inhibit p53-mediated antiviral responses.	[Chavoshi, Sara; Egorova, Olga; Lacdao, Ira Kay; Farhadi, Sahar; Sheng, Yi; Saridakis, Vivian] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	York University - Canada	Saridakis, V (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada.	vsaridak@yorku.ca			Canadian Institutes of Health Research (CIHR) [106583]; Canada Foundation for Innovation Leaders Opportunity Fund Program; Ontario Research Fund Research Infrastructure Program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation Leaders Opportunity Fund Program; Ontario Research Fund Research Infrastructure Program	This work was supported by Operating Grant 106583 from the Canadian Institutes of Health Research (CIHR) (to V. S. and Y. S.). Infrastructure was funded by the Canada Foundation for Innovation Leaders Opportunity Fund Program and the Ontario Research Fund Research Infrastructure Program (to V. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alibek K, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-3; Angeletti PC, 2008, ADV PHARMACOL, V56, P509, DOI 10.1016/S1054-3589(07)56016-3; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2003, J BIOL CHEM, V278, P36596, DOI 10.1074/jbc.M300776200; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen WG, 2010, J VIROL, V84, P3898, DOI 10.1128/JVI.01321-09; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Edelman DC, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-78; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Gillen J, 2015, J VIROL, V89, P4918, DOI 10.1128/JVI.02925-14; Hew K, 2013, NUCLEIC ACIDS RES, V41, P4295, DOI 10.1093/nar/gkt082; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Jacobs SR, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00019; Jager W, 2012, J VIROL, V86, P6745, DOI 10.1128/JVI.06840-11; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee HR, 2011, NAT STRUCT MOL BIOL, V18, P1336, DOI 10.1038/nsmb.2142; Li M, 2000, MOL CELL BIOL, V20, P8254, DOI 10.1128/MCB.20.21.8254-8263.2000; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; MEREDITH M, 1994, VIROLOGY, V200, P457, DOI 10.1006/viro.1994.1209; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Monleon Daniel, 2002, Journal of Structural and Functional Genomics, V2, P93, DOI 10.1023/A:1020499629298; Moore PS, 1998, TRENDS GENET, V14, P144, DOI 10.1016/S0168-9525(98)01408-5; Nakagawa K, 1999, MOL CELL BIOL, V19, P2828; Nakamura H, 2001, J VIROL, V75, P7572, DOI 10.1128/JVI.75.16.7572-7582.2001; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Pfoh R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004950; Pozharskaya VP, 2004, J VIROL, V78, P6621, DOI 10.1128/JVI.78.12.6621-6635.2004; Salsman J, 2012, J VIROL, V86, P806, DOI 10.1128/JVI.05442-11; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000100; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2013, J BIOL CHEM, V288, P16975, DOI 10.1074/jbc.M113.469262; Sarkari F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016598; Sarkari F, 2010, J MOL BIOL, V402, P825, DOI 10.1016/j.jmb.2010.08.017; Seo T, 2001, J VIROL, V75, P6193, DOI 10.1128/JVI.75.13.6193-6198.2001; Shadfan M, 2012, TRANSL CANCER RES, V1, P88, DOI 10.3978/j.issn.2218-676X.2012.04.02; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shin YC, 2006, J VIROL, V80, P2257, DOI 10.1128/JVI.80.5.2257-2266.2006; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; West JA, 2010, FUTURE VIROL, V5, P185, DOI 10.2217/FVL.10.5; Ye T, 2012, ANAL CHEM, V84, P994, DOI 10.1021/ac202548n	51	28	27	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6281	6291		10.1074/jbc.M115.710632	http://dx.doi.org/10.1074/jbc.M115.710632			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26786098	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000372894200019
J	Geddes, RI; Peterson, BL; Stein, DG; Sayeed, I				Geddes, Rastafa I.; Peterson, Bethany L.; Stein, Donald G.; Sayeed, Iqbal			Progesterone Treatment Shows Benefit in Female Rats in a Pediatric Model of Controlled Cortical Impact Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; WATER-MAZE; GENDER-DIFFERENCES; IMPROVED OUTCOMES; PREGNANT-WOMEN; CLINICAL-TRIAL; IMMATURE RATS; RECOVERY; NEUROPROTECTION	Purpose We recently showed that progesterone treatment can reduce lesion size and behavioral deficits after moderate-to-severe bilateral injury to the medial prefrontal cortex in immature male rats. Whether there are important sex differences in response to injury and progesterone treatment in very young subjects has not been given sufficient attention. Here we investigated progesterone's effects in the same model of brain injury but with pre-pubescent females. Methods Twenty-eight-day-old female Sprague-Dawley rats received sham (n = 14) or controlled cortical impact (CCI) (n = 21) injury, were given progesterone (8 mg/kg body weight) or vehicle injections on post-injury days (PID) 1-7, and underwent behavioral testing from PID 9-27. Brains were evaluated for lesion size at PID 28. Results Lesion size in vehicle-treated female rats with CCI injury was smaller than that previously reported for similarly treated age-matched male rats. Treatment with progesterone reduced the effect of CCI on extent of damage and behavioral deficits. Conclusion Pre-pubescent female rats with midline CCI injury to the frontal cortex have reduced morphological and functional deficits following progesterone treatment. While gender differences in susceptibility to this injury were observed, progesterone treatment produced beneficial effects in young rats of both sexes following CCI.	[Geddes, Rastafa I.; Peterson, Bethany L.; Stein, Donald G.; Sayeed, Iqbal] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA	Emory University	Stein, DG (corresponding author), Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA.	dstei04@emory.edu	Stein, Donald/AAJ-5139-2020	Geddes, Rastafa/0000-0002-7313-761X	Emory Center for Injury Control, National Institutes of Health [R49CE001494-04]; Emory University Summer Undergraduate Research Experience (SURE) program; National Institutes of Health [R49CE001494-04]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE001494] Funding Source: NIH RePORTER	Emory Center for Injury Control, National Institutes of Health; Emory University Summer Undergraduate Research Experience (SURE) program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Emory Center for Injury Control, National Institutes of Health grant no. R49CE001494-04 to DGS, the Emory University Summer Undergraduate Research Experience (SURE) program, and by unrestricted gifts to the Brain Research Laboratory from BHR Pharma and Allen and Company. There were no employer/employee relationships with either of the companies although DGS had a consulting agreement with BHR to provide pre-clinical information on the use of progesterone for the treatment of TBI. None of the authors currently participate in any licensing agreement or receive any royalties from BHR Pharma. Allen and Company is an investment firm with no commercial interests in pharmacology or any other matter relating to the authors' research. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of this or any other manuscript.; This work was supported by unrestricted gifts in support of research from BHR Pharma, Allen and Company, the Emory Center for Injury Control, National Institutes of Health grant no. R49CE001494-04 to DGS, and the Emory University Summer Undergraduate Research Experience (SURE) program. The authors would like to acknowledge the contributions of our undergraduate research trainees (William Godwin, Maydda Qureshi, Leea Richardson, and Noah Rosen) towards the completion of this work.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 2000, J NEUROTRAUM, V17, P929; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berry C, 2012, AM J SURG, V204, P558, DOI 10.1016/j.amjsurg.2011.07.012; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coughlan T, 2009, INT J NEUROSCI, V119, P1718, DOI 10.1080/00207450903116430; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Dableh Liliane J, 2011, J Pain Res, V4, P91, DOI 10.2147/JPR.S17009; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Frye CA, 2011, J PSYCHOPHARMACOL, V25, P421, DOI 10.1177/0269881109349836; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Haider AH, 2007, ARCH SURG-CHICAGO, V142, P875, DOI 10.1001/archsurg.142.9.875; Halliwell C, 2009, DEV NEUROREHABIL, V12, P269, DOI 10.3109/17518420903087715; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; HOLMES GL, 1984, DEV BRAIN RES, V16, P45, DOI 10.1016/0165-3806(84)90061-0; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; HULL EM, 1981, PHYSIOL BEHAV, V26, P401, DOI 10.1016/0031-9384(81)90166-9; Kallai J, 2005, BEHAV BRAIN RES, V159, P187, DOI 10.1016/j.bbr.2004.10.015; Kaore SN, 2012, J PHARM PHARMACOL, V64, P1040, DOI 10.1111/j.2042-7158.2012.01464.x; Kolb B, 2000, NEUROPHARMACOLOGY, V39, P756, DOI 10.1016/S0028-3908(99)00260-9; Kolb B, 2013, PROG BRAIN RES, V207, P35, DOI 10.1016/B978-0-444-63327-9.00005-9; Kolb B, 2011, DEV MED CHILD NEUROL, V53, P4, DOI 10.1111/j.1469-8749.2011.04054.x; Lacroix L, 2002, BEHAV BRAIN RES, V133, P69, DOI 10.1016/S0166-4328(01)00442-9; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luoma JI, 2012, J STEROID BIOCHEM, V131, P30, DOI 10.1016/j.jsbmb.2011.11.002; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Mueller SC, 2009, J CHILD PSYCHOL PSYC, V50, P1227, DOI 10.1111/j.1469-7610.2009.02112.x; Newhouse P, 2007, BEHAV BRAIN RES, V183, P1, DOI 10.1016/j.bbr.2007.05.011; PARKER V, 1986, NEUROPHARMACOLOGY, V25, P663, DOI 10.1016/0028-3908(86)90224-8; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Peterson BL, 2015, BEHAV BRAIN RES, V286, P152, DOI 10.1016/j.bbr.2015.03.005; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Reddy DS, 2010, NEUROPHARMACOLOGY, V59, P573, DOI 10.1016/j.neuropharm.2010.08.017; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Robertson CL, 2014, J BIOENERG BIOMEMBR; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Schieb LJ, 2013, MMWR-MORBID MORTAL W, V62, P721; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Singh M, 2005, ANN NY ACAD SCI, V1052, P145, DOI 10.1196/annals.1347.010; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Tsuji M, 2012, EXP NEUROL, V233, P214, DOI 10.1016/j.expneurol.2011.10.004; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wong R, 2013, J CEREBR BLOOD F MET, V33, P1362, DOI 10.1038/jcbfm.2013.120; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2012, AM J SURG, V204, P803, DOI 10.1016/j.amjsurg.2011.05.002; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46	81	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146419	10.1371/journal.pone.0146419	http://dx.doi.org/10.1371/journal.pone.0146419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799561	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300020
J	Girerd-Genessay, I; Baratin, D; Ferry, T; Chidiac, C; Ronin, V; Vanhems, P				Girerd-Genessay, Isabelle; Baratin, Dominique; Ferry, Tristan; Chidiac, Christian; Ronin, Vincent; Vanhems, Philippe			Higher HIV RNA Viral Load in Recent Patients with Symptomatic Acute HIV Infection in Lyon University Hospitals	PLOS ONE			English	Article							CAPTURE-RECAPTURE ESTIMATION; CD4 CELL COUNT; DISEASE PROGRESSION; PROGNOSTIC MARKERS; TRANSMISSION; FRANCE; COHORT; VIRULENCE; SURVIVAL; TYPE-1	Introduction Increased human immunodeficiency virus (HIV) virulence at infection has been suggested by a meta-analysis based on viral load and CD4 T lymphocytes (CD4) count during acute infection. This result was obtained after secondary analyses of large databases, facilitating the detection of differences. Similar finding in cohorts of more modest sample size would indicate that the effect could be more substantial. Methods Change from initial CD4 count and HIV viral load after acute HIV infection by calendar year was explored in patients treated at Lyon University hospitals. All patients admitted to our hospitals with acute HIV infection between 1996 and 2013 were included in our study. Initial CD4 count and viral load before the start of anti-retroviral treatment were analyzed. Trends over time were assessed in linear models. Results Initial CD4 count remained similar over time. However, in 2006-2013, initial viral load rose significantly (+1.12 log(10)/ml/year, p = 0.01). Conclusion Our data, obtained from a single hospital cohort, confirmed findings from a large meta-analysis, showed increased initial viremia at acute HIV infection since 2006 and suggesting potentially higher HIV virulence in recent years.	[Girerd-Genessay, Isabelle; Baratin, Dominique; Vanhems, Philippe] Hosp Civils Lyon, Hop Edouard Herriot, Infect Control & Epidemiol Unit, Lyon, France; [Ferry, Tristan; Chidiac, Christian] Hosp Civils Lyon, Dept Infect Dis, Lyon, France; [Ronin, Vincent] Hosp Civils Lyon, Hop Croix Rousse, Infect Control & Epidemiol Unit, Lyon, France; [Vanhems, Philippe] ENS Lyon, Emerging Pathogens Lab, Ctr Int Rech Infectiol, Fondat Merieux,CNRS,INSERM,U1111,UMR5308, F-69007 Lyon, France	CHU Lyon; CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Vanhems, P (corresponding author), Hosp Civils Lyon, Hop Edouard Herriot, Infect Control & Epidemiol Unit, Lyon, France.	philippe.vanhems@chu-lyon.fr	Ferry, Tristan/M-5108-2014	ferry, tristan/0000-0003-3082-7001				Bernillon P, 2000, INT J EPIDEMIOL, V29, P168, DOI 10.1093/ije/29.1.168; Cazein F, 2014, B EPIDEMIOLOGIQUE HE, V9-10, P154; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Hoen B, 2007, MALADIES INFECTIEUSE, P468; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Institut de Veille Sanitaire, 2013, INC INF VIH; Lewden C, 2006, EPIDEMIOL INFECT, V134, P1345, DOI 10.1017/S095026880600639X; Marzel A, 2015, CLIN INFECT DIS; Matheron S, 2003, AIDS, V17, P2593, DOI 10.1097/00002030-200312050-00006; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Pantazis N, 2014, LANCET HIV, V1, pE119, DOI 10.1016/S2352-3018(14)00002-2; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Philippe Morlat, 2013, PRISE CHARGE MED PER; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Tassie JM, 1999, AIDS, V13, P1881, DOI 10.1097/00002030-199910010-00010; Toure A, 2012, AIDS CARE, V24, P1272, DOI 10.1080/09540121.2012.656574	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146978	10.1371/journal.pone.0146978	http://dx.doi.org/10.1371/journal.pone.0146978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799390	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300050
J	Kwon, MJ; O'Loughlin, EJ; Boyanov, MI; Brulc, JM; Johnston, ER; Kemner, KM; Antonopoulos, DA				Kwon, Man Jae; O'Loughlin, Edward J.; Boyanov, Maxim I.; Brulc, Jennifer M.; Johnston, Eric R.; Kemner, Kenneth M.; Antonopoulos, Dionysios A.			Impact of Organic Carbon Electron Donors on Microbial Community Development under Iron- and Sulfate-Reducing Conditions	PLOS ONE			English	Article							URANIUM-CONTAMINATED AQUIFER; LEPIDOCROCITE GAMMA-FEOOH; SUBSURFACE SEDIMENTS; SP-NOV; FERRIC IRON; DISSIMILATORY REDUCTION; METHANE PRODUCTION; FE(III) REDUCTION; GEN-NOV; GROUNDWATER	Although iron- and sulfate-reducing bacteria in subsurface environments have crucial roles in biogeochemical cycling of C, Fe, and S, how specific electron donors impact the compositional structure and activity of native iron-and/or sulfate-reducing communities is largely unknown. To understand this better, we created bicarbonate-buffered batch systems in duplicate with three different electron donors (acetate, lactate, or glucose) paired with ferrihydrite and sulfate as the electron acceptors and inoculated them with subsurface sediment as the microbial inoculum. Sulfate and ferrihydrite reduction occurred simultaneously and were faster with lactate than with acetate. 16S rRNA-based sequence analysis of the communities over time revealed that Desulfotomaculum was the major driver for sulfate reduction coupled with propionate oxidation in lactate-amended incubations. The reduction of sulfate resulted in sulfide production and subsequent abiotic reduction of ferrihydrite. In contrast, glucose promoted faster reduction of ferrihydrite, but without reduction of sulfate. Interestingly, the glucose-amended incubations led to two different biogeochemical trajectories among replicate bottles that resulted in distinct coloration (white and brown). The two outcomes in geochemical evolution might be due to the stochastic evolution of the microbial communities or subtle differences in the initial composition of the fermenting microbial community and its development via the use of different glucose fermentation pathways available within the community. Synchrotron-based x-ray analysis indicated that siderite and amorphous Fe(II) were formed in the replicate bottles with glucose, while ferrous sulfide and vivianite were formed with lactate or acetate. These data sets reveal that use of different C utilization pathways projects significant changes in microbial community composition over time that uniquely impact both the geochemistry and mineralogy of subsurface environments.	[Kwon, Man Jae; O'Loughlin, Edward J.; Boyanov, Maxim I.; Kemner, Kenneth M.; Antonopoulos, Dionysios A.] Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Kwon, Man Jae] Korea Inst Sci & Technol, Gangneung Inst, Kangnung 210340, South Korea; [Brulc, Jennifer M.; Johnston, Eric R.; Antonopoulos, Dionysios A.] Argonne Natl Lab, Inst Genom & Syst Biol, 9700 S Cass Ave, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; Korea Institute of Science & Technology (KIST); United States Department of Energy (DOE); Argonne National Laboratory	Antonopoulos, DA (corresponding author), Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.; Antonopoulos, DA (corresponding author), Argonne Natl Lab, Inst Genom & Syst Biol, 9700 S Cass Ave, Argonne, IL 60439 USA.	dion@anl.gov	Antonopoulos, Dionysios/ABE-6212-2020; Johnston, Eric R/J-1051-2019; BM, MRCAT/G-7576-2011; O'Loughlin, Edward/C-9565-2013	Antonopoulos, Dionysios/0000-0002-2238-5031; Johnston, Eric R/0000-0002-3217-7711; O'Loughlin, Edward/0000-0003-1607-9529	Subsurface Biogeochemical Research Program, Office of Biological and Environmental Research, Office of Science, U.S. Department of Energy (DOE) [DE-AC02-06CH11357]; Argonne Director's Postdoctoral Fellowship Program; KIST - Gangneung Institute [2Z04221]; Korea Ministry of Environment [2013000540005]	Subsurface Biogeochemical Research Program, Office of Biological and Environmental Research, Office of Science, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Argonne Director's Postdoctoral Fellowship Program; KIST - Gangneung Institute; Korea Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This research is part of the Subsurface Science Scientific Focus Area at Argonne National Laboratory, supported by the Subsurface Biogeochemical Research Program, Office of Biological and Environmental Research, Office of Science, U.S. Department of Energy (DOE), under contract DE-AC02-06CH11357. MRCAT/EnviroCAT operations are supported by DOE and the MRCAT/EnviroCAT member institutions. MJK was supported by the Argonne Director's Postdoctoral Fellowship Program, and part of this work was also supported by KIST - Gangneung Institute (Grant no. 2Z04221) and Korea Ministry of Environment as The GAIA Project-2013000540005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO MD, 1992, LANGMUIR, V8, P1671; Ahmed B, 2012, APPL ENVIRON MICROB, V78, P8001, DOI 10.1128/AEM.01844-12; Akob DM, 2008, APPL ENVIRON MICROB, V74, P3159, DOI 10.1128/AEM.02881-07; Anandkumar B, 2009, MATER CORROS, V60, P730, DOI 10.1002/maco.200805177; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Barlett M, 2012, BIODEGRADATION, V23, P535, DOI 10.1007/s10532-011-9531-8; Barton LL, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P1, DOI 10.1017/CBO9780511541490; Benning LG, 1999, GEOCHEMISTRY OF THE EARTH'S SURFACE, P429; Bethke CM, 2008, GEOLOGY, V36, P739, DOI 10.1130/G24859A.1; Borch T, 2007, ENVIRON SCI TECHNOL, V41, P166, DOI 10.1021/es060695p; Boyanov MI, 2007, GEOCHIM COSMOCHIM AC, V71, P1898, DOI 10.1016/j.gca.2007.01.025; Burkhardt EM, 2011, APPL ENVIRON MICROB, V77, P3132, DOI 10.1128/AEM.02085-10; Burkhardt EM, 2010, ENVIRON SCI TECHNOL, V44, P177, DOI 10.1021/es902038e; Callister SJ, 2010, ENVIRON SCI TECHNOL, V44, P8897, DOI 10.1021/es101029f; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DAUMAS S, 1988, A VAN LEEUW J MICROB, V54, P165, DOI 10.1007/BF00419203; [Department of Energy US DOE US], 1999, FIN SIT OBS WORK PLA; Donald R, 1999, GEOCHIM COSMOCHIM AC, V63, P2019, DOI 10.1016/S0016-7037(99)00140-4; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards L, 2007, GEOCHIM COSMOCHIM AC, V71, P643, DOI 10.1016/j.gca.2006.09.017; FRANCIS AJ, 1988, APPL ENVIRON MICROB, V54, P1009, DOI 10.1128/AEM.54.4.1009-1014.1988; Fredrickson JK, 1998, GEOCHIM COSMOCHIM AC, V62, P3239, DOI 10.1016/S0016-7037(98)00243-9; Garcia-Balboa C, 2010, WATER AIR SOIL POLL, V207, P213, DOI 10.1007/s11270-009-0130-9; Geets J, 2005, J SOIL SEDIMENT, V5, P149, DOI 10.1065/jss2004.12.125; Goorissen HP, 2003, INT J SYST EVOL MICR, V53, P1223, DOI 10.1099/ijs.0.02476-0; Handley KM, 2015, ENVIRON MICROBIOL, V17, P622, DOI 10.1111/1462-2920.12467; Haveman SA, 2008, APPL ENVIRON MICROB, V74, P4277, DOI 10.1128/AEM.02901-07; He Q, 2003, APPL ENVIRON MICROB, V69, P2712, DOI 10.1128/AEM.69.5.2712-2718.2003; Herbert RB, 1998, CHEM GEOL, V144, P87, DOI 10.1016/S0009-2541(97)00122-8; Jakobsen R, 1999, GEOCHIM COSMOCHIM AC, V63, P137, DOI 10.1016/S0016-7037(98)00272-5; Jorand F, 2011, SCI TOTAL ENVIRON, V409, P2586, DOI 10.1016/j.scitotenv.2011.03.030; Jorand FPA, 2013, GEOMICROBIOL J, V30, P600, DOI 10.1080/01490451.2012.746403; Kemner KM, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P1183; Kemner KM, 2005, ELEMENTS, V1, P217, DOI 10.2113/gselements.1.4.217; Kirk MF, 2004, GEOLOGY, V32, P953, DOI 10.1130/G20842.1; Komlos J, 2008, J ENVIRON QUAL, V37, P2058, DOI 10.2134/jeq2007.0665; Komlos J, 2007, WATER RES, V41, P2996, DOI 10.1016/j.watres.2007.03.019; Kropf AJ, 2010, AIP CONF PROC, V1234, P299, DOI 10.1063/1.3463194; Kwon Man Jae, 2014, [The Journal of Korean Society of Soil and Groundwater Environment, 지하수토양환경], V19, P54; Kwon MJ, 2014, GEOCHIM COSMOCHIM AC, V129, P177, DOI 10.1016/j.gca.2013.09.037; LAANBROEK HJ, 1981, ARCH MICROBIOL, V128, P330, DOI 10.1007/BF00422540; Lee JH, 2012, ENVIRON SCI TECHNOL, V46, P3721, DOI 10.1021/es204528m; Lentini CJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00404; Lovley D.R., 2000, ENV MICROBE METAL IN; LOVLEY DR, 1989, APPL ENVIRON MICROB, V55, P3234, DOI 10.1128/AEM.55.12.3234-3236.1989; LOVLEY DR, 1987, GEOMICROBIOL J, V5, P375, DOI 10.1080/01490458709385975; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P2636, DOI 10.1128/AEM.53.11.2636-2641.1987; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Madigan M.T., 2006, BROCK BIOL MICROORGA; MIN H, 1990, ARCH MICROBIOL, V153, P399, DOI 10.1007/BF00249012; N'Guessan AL, 2010, ISME J, V4, P253, DOI 10.1038/ismej.2009.115; Neal AL, 2001, GEOCHIM COSMOCHIM AC, V65, P223, DOI 10.1016/S0016-7037(00)00537-8; Nevin KP, 2000, ENVIRON SCI TECHNOL, V34, P2472, DOI 10.1021/es991181b; Nevin KP, 2003, APPL ENVIRON MICROB, V69, P3672, DOI 10.1128/AEM.69.6.3672-3675.2003; Newville M, 1995, PROGRAM AUTOBK VERSI; O'Loughlin EJ, 2013, ENVIRON SCI TECHNOL, V47, P9157, DOI 10.1021/es400627j; O'Loughlin EJ, 2011, ACS SYM SER, V1071, P477; O'Loughlin EJ, 2010, ENVIRON SCI TECHNOL, V44, P4570, DOI 10.1021/es100294w; Oyekola OO, 2009, WATER RES, V43, P3345, DOI 10.1016/j.watres.2008.11.044; Petrie L, 2003, APPL ENVIRON MICROB, V69, P7467, DOI 10.1128/AEM.69.12.7467-7479.2003; PFENNIG N, 1976, ARCH MICROBIOL, V110, P3, DOI 10.1007/BF00416962; Plugge CM, 2002, INT J SYST EVOL MICR, V52, P391, DOI 10.1099/00207713-52-2-391; Poulton SW, 2003, CHEM GEOL, V202, P79, DOI 10.1016/S0009-2541(03)00237-7; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Raza W, 2010, CURR MICROBIOL, V61, P390, DOI 10.1007/s00284-010-9624-3; Rickard D., 1969, STOCKHOLM CONTRIBUTI, V20, P49; Roden EE, 2003, ENVIRON SCI TECHNOL, V37, P1319, DOI 10.1021/es026038o; Schwertmann U., 2000, IRON OXIDES LAB PREP, DOI DOI 10.1002/9783527613229; Seeliger S, 2002, FEMS MICROBIOL LETT, V211, P65, DOI 10.1111/j.1574-6968.2002.tb11204.x; Sergent AS, 2011, CHEM GEOL, V289, P86, DOI 10.1016/j.chemgeo.2011.07.016; SORENSEN J, 1982, APPL ENVIRON MICROB, V43, P319; SPORMANN AM, 1988, ARCH MICROBIOL, V150, P374, DOI 10.1007/BF00408310; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Straub KL, 2004, APPL ENVIRON MICROB, V70, P5744, DOI 10.1128/AEM.70.10.5744-5749.2004; Thamdrup B, 2000, METHODS IN ECOSYSTEM SCIENCE, P86; VAUGHAN DJ, 1991, SCI PROG, V75, P371; WIDDEL F, 1977, ARCH MICROBIOL, V112, P119, DOI 10.1007/BF00446665; Wilkins MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057819; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; Yao H, 1999, BIOGEOCHEMISTRY, V47, P269, DOI 10.1007/BF00992910; Yelton AP, 2013, ENVIRON SCI TECHNOL, V47, P6500, DOI 10.1021/es4006674	86	30	30	3	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146689	10.1371/journal.pone.0146689	http://dx.doi.org/10.1371/journal.pone.0146689			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800443	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300029
J	Li, GY; Hayward, IN; Jenkins, BR; Rothfuss, HM; Young, CH; Nevalainen, MT; Muth, A; Thompson, PR; Navratil, AM; Cherrington, BD				Li, Guangyuan; Hayward, Isaac N.; Jenkins, Brittany R.; Rothfuss, Heather M.; Young, Coleman H.; Nevalainen, Marja T.; Muth, Aaron; Thompson, Paul R.; Navratil, Amy M.; Cherrington, Brian D.			Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID 9 Cells and Expressed in the Lactating Mouse Mammary Gland	PLOS ONE			English	Article							BREAST-CANCER CELLS; CASEIN GENE-TRANSCRIPTION; GLUCOCORTICOID-RECEPTOR; IN-VITRO; PROTEIN; STAT5; BETA; ACTIVATION; DIFFERENTIATION; CITRULLINATION	Peptidylarginine deiminases (PADs) post-translationally convert arginine into neutral citrulline residues. Our past work shows that PADs are expressed in the canine and murine mammary glands; however, the mechanisms regulating PAD expression and the function of citrullination in the normal mammary gland are unclear. Therefore, the first objective herein was to investigate regulation of PAD expression in mammary epithelial cells. We first examined PAD levels in CID-9 cells, which were derived from the mammary gland of mid-pregnant mice. PAD3 expression is significantly higher than all other PAD isoforms and mediates protein citrullination in CID-9 cells. We next hypothesized that prolactin regulates PAD3 expression. To test this, CID-9 cells were stimulated with 5 pg/mL of prolactin for 48 hours which significantly increases PAD3 mRNA and protein expression. Use of a JAK2 inhibitor and a dominant negative (DN)-STAT5 adenovirus indicate that prolactin stimulation of PAD3 expression is mediated by the JAK2/STAT5 signaling pathway in CID-9 cells. In addition, the human PAD3 gene promoter is prolactin responsive in CID-9 cells. Our second objective was to investigate the expression and activity of PAD3 in the lactating mouse mammary gland. PAD3 expression in the mammary gland is highest on lactation day 9 and coincident with citrullinated proteins such as histones. Use of the PAD3 specific inhibitor, C14-amidine, indicates that PAD3, in part, can citrullinate proteins in L9 mammary glands. Collectively, our results show that upregulation of PAD3 is mediated by prolactin induction of the JAK2/STAT5 signaling pathway, and that PAD3 appears to citrullinate proteins during lactation.	[Li, Guangyuan; Hayward, Isaac N.; Jenkins, Brittany R.; Rothfuss, Heather M.; Young, Coleman H.; Navratil, Amy M.; Cherrington, Brian D.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Nevalainen, Marja T.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Muth, Aaron; Thompson, Paul R.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA	University of Wyoming; Medical College of Wisconsin; University of Massachusetts System; University of Massachusetts Worcester	Cherrington, BD (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	bcherrin@uwyo.edu	Li, Guangyuan/AAO-9049-2021	Li, Guangyuan/0000-0002-8241-4965; Cherrington, Brian/0000-0001-5847-2295; Young, Coleman/0000-0002-1109-2057	National Institute of General Medical Sciences from National Institutes of Health [2P20GM103432]; Wyoming Agricultural Experiment Station through National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch [232473]; NATIONAL CANCER INSTITUTE [R01CA113580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103432, R01GM079357] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from National Institutes of Health; Wyoming Agricultural Experiment Station through National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BDC: This project is supported in part by a grant from the National Institute of General Medical Sciences (2P20GM103432) from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BDC: This material is based upon work that is supported by Wyoming Agricultural Experiment Station by funding provided through the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch under #232473. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; AKIYAMA K, 1989, ENDOCRINOLOGY, V125, P1121, DOI 10.1210/endo-125-3-1121; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Chavanas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003408; Cherrington BD, 2012, J COMP PATHOL, V147, P139, DOI 10.1016/j.jcpa.2012.01.021; Cherrington BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041242; Cherrington BD, 2010, PLOS ONE, V5, DOI [10.1371/journal/pone.0011768, 10.1371/journal.pone.0011768]; Chumanevich AA, 2011, AM J PHYSIOL-GASTR L, V300, pG929, DOI 10.1152/ajpgi.00435.2010; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Dong S, 2006, BIOCHEM J, V397, P449, DOI 10.1042/BJ20051939; Horibata S, 2012, J REPROD DEVELOP, V58, P274, DOI 10.1262/jrd.2011-040; INAGAKI M, 1989, J BIOL CHEM, V264, P18119; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kavarthapu R, 2014, ONCOTARGET, V5, P9079, DOI 10.18632/oncotarget.2376; Keilhoff G, 2008, DEV NEUROBIOL, V68, P101, DOI 10.1002/dneu.20578; Knight JS, 2015, ANN RHEUM DIS, V74, P2199, DOI 10.1136/annrheumdis-2014-205365; Knuckley B, 2010, BIOCHEMISTRY-US, V49, P4852, DOI 10.1021/bi100363t; LAMENSA JWE, 1993, J NEUROCHEM, V61, P987, DOI 10.1111/j.1471-4159.1993.tb03612.x; Lange S, 2011, DEV BIOL, V355, P205, DOI 10.1016/j.ydbio.2011.04.015; Lechner J, 1997, J BIOL CHEM, V272, P20954, DOI 10.1074/jbc.272.33.20954; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; McElwee JL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-500; O'Leary KA, 2013, ENDOCRINOLOGY, V154, P4483, DOI 10.1210/en.2013-1533; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Raijmakers R, 2007, J MOL BIOL, V367, P1118, DOI 10.1016/j.jmb.2007.01.054; SCHMIDHAUSER C, 1990, P NATL ACAD SCI USA, V87, P9118, DOI 10.1073/pnas.87.23.9118; Senshu T, 1996, BIOCHEM BIOPH RES CO, V225, P712, DOI 10.1006/bbrc.1996.1240; Shen Q, 2011, J BIOL CHEM, V286, P14554, DOI 10.1074/jbc.M110.165704; Shi J, 2013, ANN RHEUM DIS, V72, P148, DOI 10.1136/annrheumdis-2012-201559; Stadler SC, 2013, P NATL ACAD SCI USA, V110, P11851, DOI 10.1073/pnas.1308362110; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; U KP, 2014, BBA-MOL CELL RES, V1843, P1162, DOI 10.1016/j.bbamcr.2014.02.018; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Willis V, 2011, J IMMUNOL, V186, P4396, DOI 10.4049/jimmunol.1001620; Wyszomierski SL, 2001, MOL ENDOCRINOL, V15, P228, DOI 10.1210/me.15.2.228; Yamashita H, 2003, ONCOGENE, V22, P1638, DOI 10.1038/sj.onc.1206277; Zhang XS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002112	39	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147503	10.1371/journal.pone.0147503	http://dx.doi.org/10.1371/journal.pone.0147503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799659	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300117
J	Shinn-Thomas, JH; del Campo, JJ; Wang, JJ; Mohler, WA				Shinn-Thomas, Jessica H.; del Campo, Jacob J.; Wang, Jianjun; Mohler, William A.			The EFF-1A Cytoplasmic Domain Influences Hypodermal Cell Fusions in C-elegans But Is Not Dependent on 14-3-3 Proteins	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; FUSOGEN EFF-1; ENTRY INHIBITORS; MEMBRANE-FUSION; MINIMOTIF MINER; SOMATIC-CELLS; VIRUS; PHOSPHORYLATION; MECHANISMS; TAIL	Background Regulatory and biophysical mechanisms of cell-cell fusion are largely unknown despite the fundamental requirement for fused cells in eukaryotic development. Only two cellular fusogens that are not of clear recent viral origin have been identified to date, both in nematodes. One of these, EFF-1, is necessary for most cell fusions in Caenorhabditis elegans. Unregulated EFF-1 expression causes lethality due to ectopic fusion between cells not developmentally programmed to fuse, highlighting the necessity of tight fusogen regulation for proper development. Identifying factors that regulate EFF-1 and its paralog AFF-1 could lead to discovery of molecular mechanisms that control cell fusion upstream of the action of a membrane fusogen. Bioinformatic analysis of the EFF-1A isoform's predicted cytoplasmic domain (endodomain) previously revealed two motifs that have high probabilities of interacting with 14-3-3 proteins when phosphorylated. Mutation of predicted phosphorylation sites within these motifs caused measurable loss of eff-1 gene function in cell fusion in vivo. Moreover, a human 14-3-3 isoform bound to EFF-1::GFP in vitro. We hypothesized that the two 14-3-3 proteins in C. elegans, PAR-5 and FTT-2, may regulate either localization or fusion-inducing activity of EFF-1. Methodology/Principal Findings Timing of fusion events was slightly but significantly delayed in animals unable to produce full-length EFF-1A. Yet, mutagenesis and live imaging showed that phosphoserines in putative 14-3-3 binding sites are not essential for EFF-1:: GFP accumulation at the membrane contact between fusion partner cells. Moreover, although the EFF-1A endodomain was required for normal rates of eff-1-dependent epidermal cell fusions, reduced levels of FTT-2 and PAR-5 did not visibly affect the function of wild-type EFF-1 in the hypodermis. Conclusions/Significance Deletion of the EFF-1A endodomain noticeably affects the timing of hypodermal cell fusions in vivo. However, prohibiting phosphorylation of candidate 14-3-3-binding sites does not impact localization of the fusogen. Hypodermal membrane fusion activity persists when 14-3-3 expression levels are reduced.	[Shinn-Thomas, Jessica H.; del Campo, Jacob J.; Wang, Jianjun; Mohler, William A.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Shinn-Thomas, Jessica H.] Utica Coll, Dept Biol, Utica, NY 13502 USA; [del Campo, Jacob J.] PepsiCo R&D, New Haven, CT 06511 USA; [Wang, Jianjun] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of Connecticut; PepsiCo; Jefferson University	Mohler, WA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, MC-6403,263 Farmington Ave, Farmington, CT 06030 USA.	jhthomas@utica.edu; mohler.william@gmail.com			National Institutes of Health [HD043156, RR022232]; NIH Office of Research Infrastructure Programs [P40 OD010440]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043156] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022232] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by HD043156, [http://www.nih.gov/], National Institutes of Health, to WAM; and RR022232, [http://www.nih.gov/], National Institutes of Health, to WAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Morgan Tucker, Min Han, Jeffrey Simske, David Pilgram, H. Robert Horvitz, Craig Hunter, and Sieu Sylvia Lee for generously supplying us with reagents and strains used in this study; John O'Donnell for assistance with EFF-1 localization studies; Ala Berdichevsky for communications regarding MT14355 genotype and phenotype; Diane Morton for discussing KK299 strain maintenance and par-5 loss-of-function phenotypes; and Monica Palacios-Boyce, Patrick Spica, and Emra Klempic for proofreading. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Aguilar HC, 2007, J VIROL, V81, P4520, DOI 10.1128/JVI.02205-06; Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Ali A, 2000, VIROLOGY, V276, P289, DOI 10.1006/viro.2000.0556; Avinoam O, 2011, CURR TOP MEMBR, V68, P209, DOI 10.1016/B978-0-12-385891-7.00009-X; Avinoam O, 2011, SCIENCE, V332, P589, DOI 10.1126/science.1202333; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Barry C, 2009, J VIROL, V83, P12185, DOI 10.1128/JVI.01667-09; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BRENNER S, 1974, GENETICS, V77, P71; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Chiorazzi M, 2013, P NATL ACAD SCI USA, V110, P3943, DOI 10.1073/pnas.1217271110; COHEN DI, 1992, SCIENCE, V256, P542, DOI 10.1126/science.1570514; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; del Campo JJ, 2005, CURR BIOL, V15, P413, DOI 10.1016/j.cub.2005.01.054; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Duelli DM, 2005, J CELL BIOL, V171, P493, DOI 10.1083/jcb.200507069; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Dutch RE, 2001, J VIROL, V75, P5363, DOI 10.1128/JVI.75.11.5363-5369.2001; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gattegno T, 2007, MOL BIOL CELL, V18, P1153, DOI 10.1091/mbc.E06-09-0855; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Gilleard JS, 1999, DEV BIOL, V208, P265, DOI 10.1006/dbio.1999.9202; Golinowski W, 1997, DEV PLANT PATHOL, V10, P80; Harkness Ty, 2013, Critical Reviews in Oncogenesis, V18, P19; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hatsugai N, 2009, GENE DEV, V23, P2496, DOI 10.1101/gad.1825209; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Keay S, 1996, J GEN VIROL, V77, P2597, DOI 10.1099/0022-1317-77-10-2597; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Li J, 2007, DEV BIOL, V301, P82, DOI 10.1016/j.ydbio.2006.10.013; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Lluis F, 2010, J CELL PHYSIOL, V223, P6, DOI 10.1002/jcp.22003; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; McKinnell JA, 2009, CURR OPIN HIV AIDS, V4, P513, DOI 10.1097/COH.0b013e328331d3d0; Melby Tom, 2009, V189, P177, DOI 10.1007/978-3-540-79086-0_7; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Mohler WA, 2006, EUREKAH BIOSCIENCE, V2, P12; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; Nguyen CQ, 1999, DEV BIOL, V207, P86, DOI 10.1006/dbio.1998.9173; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Oren-Suissa M, 2010, DEV DYNAM, V239, P1515, DOI 10.1002/dvdy.22284; Palma-Guerrero J, 2014, MOL MICROBIOL, V92, P164, DOI 10.1111/mmi.12545; Parris George E., 2013, Critical Reviews in Oncogenesis, V18, P1; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020; Plenefisch J, 2000, MOL BIOCHEM PARASIT, V105, P223, DOI 10.1016/S0166-6851(99)00179-6; PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Rasband W., 2006, IMAGEJ; Rasmussen JP, 2008, DEV CELL, V14, P559, DOI 10.1016/j.devcel.2008.01.019; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Sanges D, 2011, ADV EXP MED BIOL, V713, P137, DOI 10.1007/978-94-007-0763-4_9; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Schiller M. R., 2007, CURR PROTOC PROTEIN; SERGEL T, 1995, VIROLOGY, V210, P264, DOI 10.1006/viro.1995.1343; Shemer G, 2004, CURR BIOL, V14, P1587, DOI 10.1016/j.cub.2004.07.059; Shi YR, 2009, J CELL SCI, V122, P1607, DOI 10.1242/jcs.045203; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Shinn-Thomas JH, 2011, INT REV CEL MOL BIO, V289, P149, DOI 10.1016/B978-0-12-386039-2.00005-5; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sumer H, 2010, STEM CELLS DEV, V19, P239, DOI 10.1089/scd.2009.0142; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wang WF, 1996, J MOL EVOL, V43, P384; Wang WF, 1997, J MOL BIOL, V268, P619, DOI 10.1006/jmbi.1997.1002; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; YAO QH, 1995, J VIROL, V69, P7045, DOI 10.1128/JVI.69.11.7045-7053.1995; Yochem J, 1998, GENETICS, V149, P1323; Zeev-Ben-Mordehai T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4912	89	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146874	10.1371/journal.pone.0146874	http://dx.doi.org/10.1371/journal.pone.0146874			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800457	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300045
J	Elnakady, YA; Chatterjee, I; Bischoff, M; Rohde, M; Josten, M; Sahl, HG; Herrmann, M; Muller, R				Elnakady, Yasser A.; Chatterjee, Indranil; Bischoff, Markus; Rohde, Manfred; Josten, Michaele; Sahl, Hans-Georg; Herrmann, Mathias; Mueller, Rolf			Investigations to the Antibacterial Mechanism of Action of Kendomycin	PLOS ONE			English	Article							CELL-WALL SYNTHESIS; STAPHYLOCOCCUS-AUREUS; NATURAL-PRODUCTS; DRUG DISCOVERY; STRESS RESISTANCE; BACILLUS-SUBTILIS; STREPTOCOCCUS-PNEUMONIAE; BIOFILM FORMATION; ESCHERICHIA-COLI; CLP PROTEASE	Purpose The emergence of bacteria that are resistant to many currently used drugs emphasizes the need to discover and develop new antibiotics that are effective against such multi-resistant strains. Kendomycin is a novel polyketide that has a unique quinone methide ansa structure and various biological properties. This compound exhibits strong antibacterial activity against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Despite the promise of kendomycinin in several therapeutic areas, its mode of action has yet to be identified. Methods In this study, we used a multidisciplinary approach to gain insight into the antibacterial mechanism of this compound. Results The antibacterial activity of kendomycin appears to be bacteriostatic rather than bactericidal. Kendomycin inhibited the growth of the MRSA strain COL at a low concentration (MIC of 5 mu g/mL). Proteomic analysis and gene transcription profiling of kendomycin-treated cells indicated that this compound affected the regulation of numerous proteins and genes involved in central metabolic pathways, such as the tricarboxylic acid (TCA) cycle (SdhA) and gluconeogenesis (PckA and GapB), cell wall biosynthesis and cell division (FtsA, FtsZ, and MurAA), capsule production (Cap5A and Cap5C), bacterial programmed cell death (LrgA and CidA), the cellular stress response (ClpB, ClpC, ClpP, GroEL, DnaK, and GrpE), and oxidative stress (AhpC and KatA). Electron microscopy revealed that kendomycin strongly affected septum formation during cell division. Most kendomycin-treated cells displayed incomplete septa with abnormal morphology. Conclusions Kendomycin might directly or indirectly affect the cell division machinery, protein stability, and programmed cell death in S. aureus. Additional studies are still needed to obtain deeper insight into the mode of action of kendomycin.	[Elnakady, Yasser A.; Mueller, Rolf] Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany; [Elnakady, Yasser A.; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany; [Elnakady, Yasser A.] King Saud Univ, Fac Sci, Dept Zool, Riyadh, Saudi Arabia; [Chatterjee, Indranil; Bischoff, Markus; Herrmann, Mathias] Univ Saarland, Inst Med Microbiol & Hyg, Homburg, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Dept Med Microbiol, Bonn, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University; King Saud University; Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Bonn	Muller, R (corresponding author), Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany.; Muller, R (corresponding author), Univ Saarland, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany.	rolf.mueller@helmholtz-hzi.de	Elnakady, Yasser Abbass/GYJ-1602-2022; Müller, Rolf/B-1559-2008; Bischoff, Markus/D-2130-2014; Herrmann, Mathias/B-6475-2013; Elnakady, Yasser A./N-6882-2019	Müller, Rolf/0000-0002-1042-5665; Bischoff, Markus/0000-0001-6734-2732; Herrmann, Mathias/0000-0003-2638-2257; 	Deutsche Forschungsgemeinschaft [Bi 1350/1-2, He1850/8-1]; King Saud University, Deanship of Scientific Research, College of Science Research Centre	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); King Saud University, Deanship of Scientific Research, College of Science Research Centre(King Saud University)	This work was supported in part by the Deutsche Forschungsgemeinschaft (Bi 1350/1-2 and He1850/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by King Saud University, Deanship of Scientific Research, College of Science Research Centre, and in part by the Deutsche Forschungsgemeinschaft (Bi 1350/1-2 and He1850/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Bayles KW, 2003, TRENDS MICROBIOL, V11, P306, DOI 10.1016/S0966-842X(03)00144-6; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Bode HB, 2000, J CHEM SOC PERK T 1, P323, DOI 10.1039/a908387a; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Cebrian G, 2009, J APPL MICROBIOL, V107, P187, DOI 10.1111/j.1365-2672.2009.04194.x; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; Chatterjee I, 2011, INT J MED MICROBIOL, V301, P341, DOI 10.1016/j.ijmm.2010.10.002; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Du WS, 2000, J BACTERIOL, V182, P4146, DOI 10.1128/JB.182.15.4146-4152.2000; Duggal P, 2011, LARYNGOSCOPE, V121, P51, DOI 10.1002/lary.21214; Elnakady YA, 2007, CHEMBIOCHEM, V8, P1261, DOI 10.1002/cbic.200700050; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Gaupp R, 2010, J BACTERIOL, V192, P2385, DOI 10.1128/JB.01472-09; Gerth U, 1998, MOL MICROBIOL, V28, P787, DOI 10.1046/j.1365-2958.1998.00840.x; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gray Alexander I, 2012, Methods Mol Biol, V864, P515, DOI 10.1007/978-1-61779-624-1_20; Harvey A, 2010, IDRUGS, V13, P70; Harvey AL, 2010, EXPERT OPIN DRUG DIS, V5, P559, DOI 10.1517/17460441.2010.488263; Hesje CK, 2011, CURR EYE RES, V36, P94, DOI 10.3109/02713683.2010.534229; HIGHTON PJ, 1972, J BACTERIOL, V109, P1181, DOI 10.1128/JB.109.3.1181-1190.1972; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Ji HF, 2009, EMBO REP, V10, P194, DOI 10.1038/embor.2009.12; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; Kock H, 2004, MOL MICROBIOL, V51, P1087, DOI 10.1046/j.1365-2958.2003.03875.x; Kohler C, 2005, INT J MED MICROBIOL, V295, P547, DOI 10.1016/j.ijmm.2005.08.002; KORNBLUM J, 1986, EUR J CLIN MICROBIOL, V5, P714, DOI 10.1007/BF02013311; Lam KS, 2007, TRENDS MICROBIOL, V15, P279, DOI 10.1016/j.tim.2007.04.001; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Lowe JT, 2008, ORG LETT, V10, P3813, DOI 10.1021/ol801499s; Malachowa N, 2011, INFECT IMMUN, V79, P342, DOI 10.1128/IAI.00736-10; Martin HJ, 2010, ANGEW CHEM INT EDIT, V49, P5614, DOI 10.1002/anie.201000227; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; MIYAKAWA Y, 1980, J BACTERIOL, V141, P502, DOI 10.1128/JB.141.2.502-507.1980; Mondal S, 2012, ANTI-CANCER AGENT ME, V12, P49, DOI 10.2174/187152012798764697; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Park B, 2008, J BACTERIOL, V190, P2275, DOI 10.1128/JB.00006-08; Patwardhan B, 2010, INDIAN J EXP BIOL, V48, P220; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pohlit AM, 2013, MOLECULES, V18, P9219, DOI 10.3390/molecules18089219; Purves J, 2010, INFECT IMMUN, V78, P5223, DOI 10.1128/IAI.00762-10; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Scovill WH, 1996, J BACTERIOL, V178, P3362, DOI 10.1128/jb.178.11.3362-3364.1996; Senn MM, 2005, J BACTERIOL, V187, P8006, DOI 10.1128/JB.187.23.8006-8019.2005; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Tanaka K, 2010, ORG LETT, V12, P1700, DOI 10.1021/ol100229f; Tattevin P, 2011, MED MALADIES INFECT, V41, P167, DOI 10.1016/j.medmal.2010.11.017; Vasilevich NI, 2012, J MED CHEM, V55, P7003, DOI 10.1021/jm300344v; Veiga H, 2011, MOL MICROBIOL, V80, P1366, DOI 10.1111/j.1365-2958.2011.07651.x; Walther J, 2009, FEMS MICROBIOL LETT, V290, P156, DOI 10.1111/j.1574-6968.2008.01413.x; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Williams DR, 2005, ORG LETT, V7, P4161, DOI 10.1021/ol051512r; WILLIAMSON R, 1985, EUR J BIOCHEM, V151, P475, DOI 10.1111/j.1432-1033.1985.tb09126.x; Wolz C, 2002, INFECT IMMUN, V70, P2758, DOI 10.1128/IAI.70.6.2758-2762.2002; WYLIE EB, 1962, BIOCHIM BIOPHYS ACTA, V59, P450, DOI 10.1016/0006-3002(62)90195-6; Yan K, 2001, BIOCHEM BIOPH RES CO, V284, P515, DOI 10.1006/bbrc.2001.5008; Young R, 2002, J MOL MICROB BIOTECH, V4, P21; Yuan Y, 2004, J AM CHEM SOC, V126, P14720, DOI 10.1021/ja0447154; Zhanel GG, 2012, CLIN INFECT DIS, V54, pS214, DOI 10.1093/cid/cir920; Zhang J, 2011, J BIOL CHEM, V286, P37590, DOI 10.1074/jbc.M111.277848	69	14	14	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146165	10.1371/journal.pone.0146165	http://dx.doi.org/10.1371/journal.pone.0146165			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795276	Green Published, gold, Green Submitted			2022-12-26	WOS:000368530300006
J	Yang, CY; Yu, K; Wang, Y; Chen, SA; Liu, DD; Wang, ZY; Su, YN; Yang, SZ; Chen, TT; Livnat, I; Vilim, FS; Cropper, EC; Weiss, KR; Sweedler, JV; Jing, J				Yang, Chao-Yu; Yu, Ke; Wang, Ye; Chen, Song-An; Liu, Dan-Dan; Wang, Zheng-Yang; Su, Yan-Nan; Yang, Shao-Zhong; Chen, Ting-Ting; Livnat, Itamar; Vilim, Ferdinand S.; Cropper, Elizabeth C.; Weiss, Klaudiusz R.; Sweedler, Jonathan V.; Jing, Jian			Aplysia Locomotion: Network and Behavioral Actions of GdFFD, a D-Amino Acid-Containing Neuropeptide	PLOS ONE			English	Article							GASTRIC MILL ACTIVITY; ACHATINA-FULICA; MOTOR PROGRAMS; PEDAL PEPTIDE; SYNAPTIC CONNECTIONS; NEURAL CIRCUIT; VIDEO-TRACKING; NEURONS; GANGLIA; CALIFORNICA	One emerging principle is that neuromodulators, such as neuropeptides, regulate multiple behaviors, particularly motivated behaviors, e.g., feeding and locomotion. However, how neuromodulators act on multiple neural networks to exert their actions remains poorly understood. These actions depend on the chemical form of the peptide, e.g., an alternation of L-to D-form of an amino acid can endow the peptide with bioactivity, as is the case for the Aplysia peptide GdFFD (where dF indicates D-phenylalanine). GdFFD has been shown to act as an extrinsic neuromodulator in the feeding network, while the all L-amino acid form, GFFD, was not bioactive. Given that both GdFFD/GFFD are also present in pedal neurons that mediate locomotion, we sought to determine whether they impact locomotion. We first examined effects of both peptides on isolated ganglia, and monitored fictive programs using the parapedal commissural nerve (PPCN). Indeed, GdFFD was bioactive and GFFD was not. GdFFD increased the frequency with which neural activity was observed in the PPCN. In part, there was an increase in bursting spiking activity that resembled fictive locomotion. Additionally, there was significant activity between bursts. To determine how the peptide-induced activity in the isolated CNS is translated into behavior, we recorded animal movements, and developed a computer program to automatically track the animal and calculate the path of movement and velocity of locomotion. We found that GdFFD significantly reduced locomotion and induced a foot curl. These data suggest that the increase in PPCN activity observed in the isolated CNS during GdFFD application corresponds to a reduction, rather than an increase, in locomotion. In contrast, GFFD had no effect. Thus, our study suggests that GdFFD may act as an intrinsic neuromodulator in the Aplysia locomotor network. More generally, our study indicates that physiological and behavioral analyses should be combined to evaluate peptide actions.	[Yang, Chao-Yu; Yu, Ke; Wang, Ye; Chen, Song-An; Liu, Dan-Dan; Wang, Zheng-Yang; Su, Yan-Nan; Yang, Shao-Zhong; Chen, Ting-Ting; Jing, Jian] Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Collaborat Innovat Ctr Chem Life Sci,Sch Life Sci, State Key Lab Pharmaceut,Biotechnol Adv Inst Life, Nanjing 210008, Jiangsu, Peoples R China; [Livnat, Itamar; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Livnat, Itamar; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL USA; [Vilim, Ferdinand S.; Cropper, Elizabeth C.; Weiss, Klaudiusz R.; Jing, Jian] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Vilim, Ferdinand S.; Cropper, Elizabeth C.; Weiss, Klaudiusz R.; Jing, Jian] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA	Nanjing University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Jing, J (corresponding author), Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Collaborat Innovat Ctr Chem Life Sci,Sch Life Sci, State Key Lab Pharmaceut,Biotechnol Adv Inst Life, Nanjing 210008, Jiangsu, Peoples R China.; Jing, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Jing, J (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	jingj01@live.com	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Jing, Jian/0000-0003-1422-143X	National Natural Science Foundation of China [31371104, J1103512, J1210026]; National Institutes of Health [NS066587, NS070583, NS031609, MH051393]; National Undergraduate Innovation Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031609, R29NS031609, R01NS066587, R01NS070583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA037654] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Undergraduate Innovation Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Natural Science Foundation of China (Grant 31371104), the National Institutes of Health (Grants NS066587, NS070583, NS031609 and MH051393) and the National Undergraduate Innovation Program and National Natural Science Foundation of China (Grants J1103512 and J1210026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TW, 2012, CURR BIOL, V22, pR705, DOI 10.1016/j.cub.2012.08.011; Aguiar P, 2007, J NEUROSCI METH, V166, P66, DOI 10.1016/j.jneumeth.2007.06.020; Aguzzi J, 2009, SCI MAR, V73, P773, DOI 10.3989/scimar.2009.73n4773; Bai L, 2013, J BIOL CHEM, V288, P32837, DOI 10.1074/jbc.M113.486670; Bai Lu, 2009, Bioanal Rev, V1, P7; BERNHEIM SM, 1995, J COMP PHYSIOL A, V176, P131; Bevilacqua L, 2011, TRENDS COGN SCI, V15, P401, DOI 10.1016/j.tics.2011.07.009; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Bruno AM, 2015, NEURON, V86, P304, DOI 10.1016/j.neuron.2015.03.005; Crispim CF, 2012, COMPUT BIOL MED, V42, P257, DOI 10.1016/j.compbiomed.2011.12.002; FREDMAN SM, 1980, BRAIN RES BULL, V5, P179, DOI 10.1016/0361-9230(80)90191-4; FREDMAN SM, 1983, J NEUROPHYSIOL, V49, P1092, DOI 10.1152/jn.1983.49.5.1092; FUJIMOTO K, 1991, BIOCHEM BIOPH RES CO, V177, P847, DOI 10.1016/0006-291X(91)91867-C; FUJISAWA Y, 1992, COMP BIOCHEM PHYS C, V102, P91, DOI 10.1016/0742-8413(92)90049-D; Gruninger TR, 2007, MOL NEUROBIOL, V35, P1; HALL JD, 1990, J NEUROBIOL, V21, P858, DOI 10.1002/neu.480210604; HEINZEL HG, 1988, J NEUROPHYSIOL, V59, P528, DOI 10.1152/jn.1988.59.2.528; HEINZEL HG, 1988, J NEUROPHYSIOL, V59, P551, DOI 10.1152/jn.1988.59.2.551; HENING WA, 1979, BRAIN RES, V179, P231, DOI 10.1016/0006-8993(79)90441-4; Horn CC, 2004, J NEUROPHYSIOL, V92, P157, DOI 10.1152/jn.01190.2003; Hurwitz I, 2003, J NEUROPHYSIOL, V89, P2120, DOI 10.1152/jn.00497.2002; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1327, DOI 10.1152/jn.1996.75.4.1327; Iwakoshi E, 2000, PEPTIDES, V21, P623, DOI 10.1016/S0196-9781(00)00201-1; JACKLET JW, 1984, INT REV CYTOL, V89, P251, DOI 10.1016/S0074-7696(08)61305-4; JAHANPARWAR B, 1980, BRAIN RES BULL, V5, P169, DOI 10.1016/0361-9230(80)90190-2; JAHANPARWAR B, 1978, J NEUROPHYSIOL, V41, P600, DOI 10.1152/jn.1978.41.3.600; JAHANPARWAR B, 1979, BEHAV NEURAL BIOL, V27, P39, DOI 10.1016/S0163-1047(79)92744-4; Jing J, 2005, CURR BIOL, V15, P1712, DOI 10.1016/j.cub.2005.08.051; Jing J, 2001, J NEUROSCI, V21, P7349, DOI 10.1523/JNEUROSCI.21-18-07349.2001; Jing J, 2008, J NEUROSCI, V28, P12349, DOI 10.1523/JNEUROSCI.3855-08.2008; Jing J, 2007, J NEUROSCI, V27, P3490, DOI 10.1523/JNEUROSCI.0334-07.2007; Jing J, 2015, J NEUROSCI, V35, P9137, DOI 10.1523/JNEUROSCI.0180-15.2015; Jing J, 2009, REV NEUROSCIENCE, V20, P405; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katz PS, 1996, TRENDS NEUROSCI, V19, P54, DOI 10.1016/0166-2236(96)89621-4; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; KUPFERMA.I, 1974, BEHAV BIOL, V12, P317, DOI 10.1016/S0091-6773(74)91503-X; LLOYD PE, 1989, J NEUROSCI, V9, P312; Lum CS, 2005, J NEUROPHYSIOL, V94, P2427, DOI 10.1152/jn.00280.2005; MACKEY S, 1983, J NEUROSCI, V3, P1469; Marder E, 2014, ANNU REV NEUROSCI, V37, P329, DOI 10.1146/annurev-neuro-071013-013958; Morishita F, 1997, BIOCHEM BIOPH RES CO, V240, P354, DOI 10.1006/bbrc.1997.7659; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Mozzachiodi R, 2008, NAT NEUROSCI, V11, P1146, DOI 10.1038/nn.2184; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nusbaum MP, 2012, CURR OPIN NEUROBIOL, V22, P592, DOI 10.1016/j.conb.2012.01.003; OHTA N, 1991, BIOCHEM BIOPH RES CO, V178, P486, DOI 10.1016/0006-291X(91)90133-R; PEARSON WL, 1990, J NEUROBIOL, V21, P883, DOI 10.1002/neu.480210606; Ramazani RB, 2007, J NEUROSCI METH, V162, P171, DOI 10.1016/j.jneumeth.2007.01.005; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Sasaki K, 2009, J NEUROSCI, V29, P11732, DOI 10.1523/JNEUROSCI.3051-09.2009; Sieling F, 2014, CURR BIOL, V24, P941, DOI 10.1016/j.cub.2014.03.004; Strand FL, 1999, NEUROPEPTIDES REGULA; Thorsell A, 2010, EXP BIOL MED, V235, P1163, DOI 10.1258/ebm.2010.009331; VONDERPORTEN K, 1982, BEHAV NEURAL BIOL, V36, P1; Vorster APA, 2014, SLEEP, V37, P1453, DOI 10.5665/sleep.3992; Watts AG, 2002, STEVENS HDB EXPT PSY, V3, P563, DOI DOI 10.1002/0471214426.PAS0314; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; Wu JS, 2014, J NEUROSCI, V34, P6510, DOI 10.1523/JNEUROSCI.5094-13.2014; YasudaKamatani Y, 1997, PEPTIDES, V18, P347, DOI 10.1016/S0196-9781(96)00343-9; Zhang YL, 2012, NAT NEUROSCI, V15, P294, DOI 10.1038/nn.2990; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	63	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147335	10.1371/journal.pone.0147335	http://dx.doi.org/10.1371/journal.pone.0147335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796097	Green Submitted, gold, Green Published			2022-12-26	WOS:000368530300030
J	Ouyang, B; Jiang, LR; Teng, ZS				Ouyang, Bo; Jiang, Lurong; Teng, Zhaosheng			A Noise-Filtering Method for Link Prediction in Complex Networks	PLOS ONE			English	Article							CASCADING FAILURES; OPTIMIZATION; MODEL; RISK	Link prediction plays an important role in both finding missing links in networked systems and complementing our understanding of the evolution of networks. Much attention from the network science community are paid to figure out how to efficiently predict the missing/future links based on the observed topology. Real-world information always contain noise, which is also the case in an observed network. This problem is rarely considered in existing methods. In this paper, we treat the existence of observed links as known information. By filtering out noises in this information, the underlying regularity of the connection information is retrieved and then used to predict missing or future links. Experiments on various empirical networks show that our method performs noticeably better than baseline algorithms.	[Ouyang, Bo; Teng, Zhaosheng] Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China; [Jiang, Lurong] Zhejiang Sci Tech Univ, Sch Informat Sci & Technol, Hangzhou, Zhejiang, Peoples R China	Hunan University; Zhejiang Sci-Tech University	Ouyang, B (corresponding author), Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China.	ouyangbo@hnu.edu.cn			Fundamental Research Funds for the Central Universities of China [531107040852]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by Fundamental Research Funds for the Central Universities of China, Grant No. 531107040852. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge B. Y. Zhu, for his helpful suggestions. This work is supported by the Fundamental Research Funds for the Central Universities of China, Grant No. 531107040852.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Borrvall C, 2000, ECOL LETT, V3, P131, DOI 10.1046/j.1461-0248.2000.00130.x; BURT RS, 1976, SOC FORCES, V55, P93, DOI 10.2307/2577097; Cannistraci CV, 2013, SCI REP-UK, V3, DOI 10.1038/srep01613; Chung F., 1997, SPECTRAL GRAPH THEOR; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Horn RA., 1985, MATRIX ANAL; Huang XQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01219; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; Leskovec J., 2010, P 19 INT C WORLD WID, P641, DOI [10.1145/1772690.1772756, DOI 10.1145/1772690.1772756]; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2015, P NATL ACAD SCI USA, V112, P2325, DOI 10.1073/pnas.1424644112; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025102; Papadopoulos F, 2012, NATURE, V489, P537, DOI 10.1038/nature11459; Restrepo JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.094102; Scott J., 2012, SOCIAL NETWORK ANAL; Spring N, 2002, ACM SIGCOMM COMP COM, V32, P133, DOI 10.1145/964725.633039; Tan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107056; Ulanowicz R.E., 2005, US GEOL SURV PROGRAM, V114, P45; Vladimir B, PAJEK DATASETS; Vladimir B, 2006, PAJEK DATASETS; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang Peng, 2015, [Science China. Information Science, 中国科学. 信息科学], V58, P011101; Wang WQ, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/28004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westermarck J, 2013, MOL CELL PROTEOMICS, V12, P1752, DOI 10.1074/mcp.R113.027771; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055437; Zhang QM, 2014, ARXIV14103519; Zhao J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12261; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8; Zhu BY, 2015, SCI REP-UK, V5, DOI 10.1038/srep13707	45	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146925	10.1371/journal.pone.0146925	http://dx.doi.org/10.1371/journal.pone.0146925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788737	gold, Green Submitted, Green Published			2022-12-26	WOS:000368529100046
J	Rewatkar, PV; Parekh, HS; Parat, MO				Rewatkar, Prarthana V.; Parekh, Harendra S.; Parat, Marie-Odile			Molecular Determinants of the Cellular Entry of Asymmetric Peptide Dendrimers and Role of Caveolae	PLOS ONE			English	Article							ARGININE-RICH PEPTIDES; SURFACE-CHARGE; ANIONIC SITES; DIFFERENTIATED MICRODOMAINS; TRANSLOCATION MECHANISMS; CAPILLARY ENDOTHELIUM; PAMAM DENDRIMERS; LUMINAL SURFACE; DELIVERY; MEMBRANE	Caveolae are flask-shaped plasma membrane subdomains abundant in most cell types that participate in endocytosis. Caveola formation and functions require membrane proteins of the caveolin family, and cytoplasmic proteins of the cavin family. Cationic peptide dendrimers are non-vesicular chemical carriers that can transport pharmacological agents or genetic material across the plasma membrane. We prepared a panel of cationic dendrimers and investigated whether they require caveolae to enter into cells. Cell-based studies were performed using wild type or caveola-deficient i.e. caveolin-1 or PTRF gene-disrupted cells. There was a statistically significant difference in entry of cationic dendrimers between wild type and caveola-deficient cells. We further unveiled differences between dendrimers with varying charge density and head groups. Our results show, using a molecular approach, that (i) expression of caveola-forming proteins promotes cellular entry of cationic dendrimers and (ii) dendrimer structure can be modified to promote endocytosis in caveola-forming cells.	[Rewatkar, Prarthana V.; Parekh, Harendra S.; Parat, Marie-Odile] Univ Queensland, Sch Pharm, 20 Cornwall St, Woolloongabba, Qld 4102, Australia	University of Queensland	Parekh, HS; Parat, MO (corresponding author), Univ Queensland, Sch Pharm, 20 Cornwall St, Woolloongabba, Qld 4102, Australia.	h.parekh@uq.edu.au; m.parat@uq.edu.au	Parekh, Harendra S/D-6846-2011; Parekh, Harendra/P-3964-2019; Parat, Marie-Odile/G-4410-2010	Parekh, Harendra S/0000-0001-8792-4318; Parekh, Harendra/0000-0001-8792-4318; Parat, Marie-Odile/0000-0003-4895-7381	School of Pharmacy	School of Pharmacy	This study was entirely funded by internal funds from the School of Pharmacy to MOP and HSP.	Albertazzi L, 2012, BIOMACROMOLECULES, V13, P4089, DOI 10.1021/bm301384y; Billiet L, 2012, BIOMATERIALS, V33, P2980, DOI 10.1016/j.biomaterials.2011.12.027; Biswas S, 2013, PHARMACEUTICALS-BASE, V6, P161, DOI 10.3390/ph6020161; Buczkowski A, 2011, INT J PHARMACEUT, V408, P266, DOI 10.1016/j.ijpharm.2011.02.014; Bugno J, 2015, BIOMATER SCI-UK, V3, P1025, DOI 10.1039/c4bm00351a; Chaudhary N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001832; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Choi JS, 2004, J CONTROL RELEASE, V99, P445, DOI 10.1016/j.jconrel.2004.07.027; Cordes H, 2007, BIOMACROMOLECULES, V8, P3578, DOI 10.1021/bm7006168; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Futaki S, 2002, INT J PHARM, V245, P1, DOI 10.1016/S0378-5173(02)00337-X; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hill MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043041; Kaneshiro TL, 2009, BIOMATERIALS, V30, P5660, DOI 10.1016/j.biomaterials.2009.06.026; Kim TI, 2007, BIOMATERIALS, V28, P2061, DOI 10.1016/j.biomaterials.2006.12.013; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu XX, 2015, NANOSCALE, V7, P3867, DOI 10.1039/c4nr04759a; Maiti PK, 2004, MACROMOLECULES, V37, P6236, DOI 10.1021/ma035629b; Naka K, 2012, POLYM J, V44, P353, DOI 10.1038/pj.2011.145; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Parat MO, 2001, J BIOL CHEM, V276, P15776, DOI 10.1074/jbc.M006722200; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Perumal OP, 2008, BIOMATERIALS, V29, P3469, DOI 10.1016/j.biomaterials.2008.04.038; Rewatkar PV, 2015, ADV DRUG DELIVER REV, V91, P92, DOI 10.1016/j.addr.2015.01.003; Richter T, 2008, TRAFFIC, V9, P893, DOI 10.1111/j.1600-0854.2008.00733.x; Schlormann W, 2010, HISTOCHEM CELL BIOL, V133, P223, DOI 10.1007/s00418-009-0651-8; Shah N, 2011, J PEPT SCI, V17, P470, DOI 10.1002/psc.1347; Shah ND, 2014, PHARM RES-DORDR, V31, P3150, DOI 10.1007/s11095-014-1408-1; SIMIONESCU D, 1983, MICROVASC RES, V25, P85, DOI 10.1016/0026-2862(83)90045-6; SIMIONESCU M, 1981, J CELL BIOL, V90, P614, DOI 10.1083/jcb.90.3.614; SIMIONESCU N, 1981, J CELL BIOL, V90, P605, DOI 10.1083/jcb.90.3.605; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Topp A, 1999, MACROMOLECULES, V32, P7232, DOI 10.1021/ma9901240; Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021	38	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147491	10.1371/journal.pone.0147491	http://dx.doi.org/10.1371/journal.pone.0147491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788849	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100089
J	Fernandez-Murga, ML; Sanz, Y				Leonor Fernandez-Murga, M.; Sanz, Yolanda			Safety Assessment of Bacteroides uniformis CECT 7771 Isolated from Stools of Healthy Breast-Fed Infants	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROBIOTIC STRAINS; GENE-EXPRESSION; OBESITY; COLONIZATION; COMMENSAL; RISK; ACID; FOOD	Background Bacteroides uniformis CECT 7771 is a potential probiotic strain, originally isolated from the stools of healthy breast-feed infants. The strain showed pre-clinical efficacy in a mouse obesity model. The objective of this study was to evaluate its potential toxicity and translocation ability after acute oral administration to mice. Methods and Findings A safety study was conducted in immunocompetent and immunosuppressed C57BL-6 mice. Both mouse groups (n = 10 per group) were fed orally 2 x 10(9) colony forming units (cfu)/day of B. uniformis CECT 7771 or placebo by gavage for 6 days. Throughout this time, feed and water intake and body weight were monitored. Afterwards, mice were sacrificed and biological samples were collected to analyze blood and urine biochemistry, inflammatory and immune markers; gut mucosal histology and bacterial translocation to peripheral tissues. The results demonstrated that acute ingestion of this Bacteroides strain had no adverse effects on the animals' general health status or food intake, nor did it affect biochemical indicators of liver, kidney and pancreatic function or gut mucosal histology. Findings also demonstrated that administration did not lead to bacterial translocation to blood, liver or mesenteric lymph nodes. B. uniformis CECT 7771 also downregulated gene and protein expression (iNOS and PPAR-gamma) and inflammatory cytokines induced by immunosuppression. Conclusions The findings indicate that the acute oral consumption of B. uniformis CECT 7771 does not raise safety concerns in mice. Further studies in humans should be conducted.	[Leonor Fernandez-Murga, M.; Sanz, Yolanda] Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Unit, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Sanz, Y (corresponding author), Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Unit, Valencia, Spain.	yolsanz@iata.csic.es	Fernández-Murga, Leonor/N-3532-2019; Sanz, Yolanda/H-5498-2012	Fernández-Murga, Leonor/0000-0001-7123-9834; Sanz, Yolanda/0000-0002-1615-1976	EU [613979]	EU(European Commission)	This study was supported by the EU Project no 613979 (MyNewGut) from the 7th Framework Program.	Andreoletti O, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3938; Ank N, 2015, INT J ANTIMICROB AG, V46, P117, DOI 10.1016/j.ijantimicag.2015.02.024; Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Chenoll E, 2011, APPL ENVIRON MICROB, V77, P1335, DOI 10.1128/AEM.01820-10; Collins JK, 1998, INT DAIRY J, V8, P487, DOI 10.1016/S0958-6946(98)00073-9; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; Davis RL, 2005, NITRIC OXIDE-BIOL CH, V12, P200, DOI 10.1016/j.niox.2005.04.005; de Kivit S, 2014, FRONT IMMUNOL, V18, P5; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Ford HR, 1996, J PEDIATR SURG, V31, P486, DOI 10.1016/S0022-3468(96)90480-7; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Hong PY, 2008, APPL ENVIRON MICROB, V74, P2882, DOI 10.1128/AEM.02568-07; Jang BC, 2004, BIOCHEM PHARMACOL, V68, P2167, DOI 10.1016/j.bcp.2004.08.008; Kadowaki S, 2004, MOL CELL BIOCHEM, V262, P51, DOI 10.1023/B:MCBI.0000038215.89821.7f; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kumar H, 2015, CURR OPIN BIOTECH, V32, P99, DOI 10.1016/j.copbio.2014.11.021; Lara-Villoslada F, 2007, J DAIRY SCI, V90, P3583, DOI 10.3168/jds.2006-685; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA L, 1990, CURR MICROBIOL, V20, P177, DOI 10.1007/BF02091994; Martin R, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-71; Meile L, 2008, INT J FOOD MICROBIOL, V126, P316, DOI 10.1016/j.ijfoodmicro.2007.08.019; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Munoz JAM, 2011, APPL ENVIRON MICROB, V77, P8775, DOI 10.1128/AEM.05548-11; Munoz-Quezada S, 2013, BRIT J NUTR, V109, pS51, DOI 10.1017/S0007114512005211; Neef A, 2013, CURR OPIN CLIN NUTR, V16, P679, DOI 10.1097/MCO.0b013e328365c258; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Playne M., 1994, FOOD AUSTR, P46; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sanchez E, 2011, APPL ENVIRON MICROB, V77, P5316, DOI 10.1128/AEM.00365-11; Sanz Y, 2013, PHARMACOL RES, V69, P144, DOI 10.1016/j.phrs.2012.10.021; Stine KE, 1996, PRINCIPLES TOXICOLOG, P1; Wang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5432; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhou JS, 2000, INT J FOOD MICROBIOL, V56, P87, DOI 10.1016/S0168-1605(00)00219-1; [No title captured]	39	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145503	10.1371/journal.pone.0145503	http://dx.doi.org/10.1371/journal.pone.0145503			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784747	gold, Green Published, Green Submitted			2022-12-26	WOS:000368528400014
J	Pampalona, J; Roscioli, E; Silkworth, WT; Bowden, B; Genesca, A; Tusell, L; Cimini, D				Pampalona, Judit; Roscioli, Emanuele; Silkworth, William T.; Bowden, Brent; Genesca, Anna; Tusell, Laura; Cimini, Daniela			Chromosome Bridges Maintain Kinetochore-Microtubule Attachment throughout Mitosis and Rarely Break during Anaphase	PLOS ONE			English	Article							TOPOISOMERASE-II INHIBITION; SISTER-CHROMATID COHESION; MAMMARY EPITHELIAL-CELLS; DOUBLE-STRAND BREAKS; MAMMALIAN-CELLS; TELOMERE DYSFUNCTION; DNA-DAMAGE; MITOTIC INSTABILITY; SEGREGATION ERRORS; SPINDLE MECHANICS	Accurate chromosome segregation during cell division is essential to maintain genome stability, and chromosome segregation errors are causally linked to genetic disorders and cancer. An anaphase chromosome bridge is a particular chromosome segregation error observed in cells that enter mitosis with fused chromosomes/sister chromatids. The widely accepted Breakage/Fusion/Bridge cycle model proposes that anaphase chromosome bridges break during mitosis to generate chromosome ends that will fuse during the following cell cycle, thus forming new bridges that will break, and so on. However, various studies have also shown a link between chromosome bridges and aneuploidy and/or polyploidy. In this study, we investigated the behavior and properties of chromosome bridges during mitosis, with the idea to gain insight into the potential mechanism underlying chromosome bridge-induced aneuploidy. We find that only a small number of chromosome bridges break during anaphase, whereas the rest persist through mitosis into the subsequent cell cycle. We also find that the microtubule bundles (k-fibers) bound to bridge kinetochores are not prone to breakage/detachment, thus supporting the conclusion that k-fiber detachment is not the cause of chromosome bridge-induced aneuploidy. Instead, our data suggest that while the microtubules bound to the kinetochores of normally segregating chromosomes shorten substantially during anaphase, the k-fibers bound to bridge kinetochores shorten only slightly, and may even lengthen, during anaphase. This causes some of the bridge kinetochores/chromosomes to lag behind in a position that is proximal to the cell/spindle equator and may cause the bridged chromosomes to be segregated into the same daughter nucleus or to form a micronucleus.	[Pampalona, Judit; Roscioli, Emanuele; Silkworth, William T.; Bowden, Brent; Cimini, Daniela] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Pampalona, Judit; Genesca, Anna; Tusell, Laura] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Bellaterra, Spain; [Roscioli, Emanuele] Virginia Tech, Biocomplex Inst, Blacksburg, VA 24061 USA; [Pampalona, Judit] Inst Res Biomed Barcelona, Cell Div Grp, C Baldiri Reixac 10-12, E-08028 Barcelona, Spain; [Roscioli, Emanuele] Univ Warwick, Div Biomed Cell Biol, Warwick Med Sch, Mechanochem Cell Biol Bldg, Coventry CV4 7AL, W Midlands, England; [Silkworth, William T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Bowden, Brent] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Autonomous University of Barcelona; Virginia Polytechnic Institute & State University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Warwick; University of California System; University of California Los Angeles; Virginia Polytechnic Institute & State University	Cimini, D (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	cimini@vt.edu	Cimini, Daniela/A-3039-2016; Tusell, Laura/H-8699-2017; Genesca, Anna/J-4195-2017	Cimini, Daniela/0000-0002-4082-4894; Tusell, Laura/0000-0002-2848-345X; Pampalona, Judit/0000-0001-9454-0734; Genesca, Anna/0000-0002-0509-956X	Commonwealth Research Initiative; Fralin Research Institute; NSF [MCB-0842551, MCB-1517506]; HFSP grant [RGY0069/2010]; EURATOM grant [Dark. Risk GA 323216]; Ministerio de Economia y Competitividad grant [SAF2013-43801-P]; Instituto de Salud Carlos III [RD06/0020/1020]; Generalitat de Catalunya [2009 SGR-282, 2014 SGR-524, 2007FIC-00642, 2008BE100443];  [CSN2012-0001]; Direct For Biological Sciences [1517506] Funding Source: National Science Foundation	Commonwealth Research Initiative; Fralin Research Institute; NSF(National Science Foundation (NSF)); HFSP grant; EURATOM grant; Ministerio de Economia y Competitividad grant(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was partly funded by the Commonwealth Research Initiative and the Fralin Research Institute. Additional funding was provided by: NSF grants MCB-0842551 and MCB-1517506 and HFSP grant RGY0069/2010 to DC; EURATOM grant Dark. Risk GA 323216 and CSN2012-0001 grant to AG; Ministerio de Economia y Competitividad grant SAF2013-43801-P to LT; Instituto de Salud Carlos III grant RD06/0020/1020 and Generalitat de Catalunya grants 2009 SGR-282 and 2014 SGR-524 to AG and LT. JP was supported by Generalitat de Catalunya (grants 2007FIC-00642 and 2008BE100443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJER A, 1958, CHROMOSOMA, V9, P319; BAJER A, 1963, HEREDITAS, V50, P179; Bakhoum SF, 2014, CURR BIOL, V24, pR148, DOI 10.1016/j.cub.2014.01.019; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Cimini D, 1997, CYTOGENET CELL GENET, V76, P61, DOI 10.1159/000134517; CLARKE DJ, 1993, J CELL SCI, V105, P563; Compton DA, 2011, CURR OPIN CELL BIOL, V23, P109, DOI 10.1016/j.ceb.2010.08.007; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Diaz-Martinez LA, 2008, J CELL SCI, V121, P2107, DOI 10.1242/jcs.029132; DOWNES CS, 1991, P NATL ACAD SCI USA, V88, P8895, DOI 10.1073/pnas.88.20.8895; Falck GCM, 2002, MUTAGENESIS, V17, P111, DOI 10.1093/mutage/17.2.111; Fouladi B, 2000, RADIAT RES, V153, P795, DOI 10.1667/0033-7587(2000)153[0795:CORODD]2.0.CO;2; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gisselsson D, 2005, CELL CYCLE, V4, P1007, DOI 10.4161/cc.4.8.1884; Glanz C, 2007, NEUROPATH APPL NEURO, V33, P440, DOI 10.1111/j.1365-2990.2007.00832.x; GORBSKY GJ, 1994, CANCER RES, V54, P1042; GROTE SJ, 1981, INT J RADIAT BIOL, V39, P395, DOI 10.1080/09553008114550491; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Houchmandzadeh B, 1997, J CELL BIOL, V139, P1, DOI 10.1083/jcb.139.1.1; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jin YS, 2007, CLIN CANCER RES, V13, P1703, DOI 10.1158/1078-0432.CCR-06-2705; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Khodjakov A, 1996, J CELL BIOL, V132, P1093, DOI 10.1083/jcb.132.6.1093; Ladouceur AM, 2011, CURR BIOL, V21, pR388, DOI 10.1016/j.cub.2011.04.009; LaFountain JR, 2002, CELL MOTIL CYTOSKEL, V51, P16, DOI 10.1002/cm.10011; LaFountain JR, 2001, MOL BIOL CELL, V12, P4054, DOI 10.1091/mbc.12.12.4054; Lo AWI, 2002, MOL CELL BIOL, V22, P4836, DOI 10.1128/MCB.22.13.4836-4850.2002; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; McClintock B, 1944, GENETICS, V29, P478; McClintock B, 1941, GENETICS, V26, P234; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Montgomery E, 2003, CANCER BIOL THER, V2, P248, DOI 10.4161/cbt.2.3.362; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Nicholson JM, 2011, ADV CANCER RES, V112, P43, DOI 10.1016/B978-0-12-387688-1.00003-X; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Pampalona J, 2010, MUTAT RES-FUND MOL M, V683, P16, DOI 10.1016/j.mrfmmm.2009.10.001; Pampalona J, 2012, PLOS GENET, V8, P601, DOI 10.1371/journal.pgen.1002679; Pampalona J, 2010, GENE CHROMOSOME CANC, V49, P368, DOI 10.1002/gcc.20749; Poirier M, 2000, MOL BIOL CELL, V11, P269, DOI 10.1091/mbc.11.1.269; Quevedo O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002509; Remeseiro S, 2012, EMBO J, V31, P2076, DOI 10.1038/emboj.2012.11; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Samoshkin A, 2012, CHROMOSOMA, V121, P191, DOI 10.1007/s00412-011-0353-6; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Soler D, 2005, GENE CHROMOSOME CANC, V44, P339, DOI 10.1002/gcc.20244; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Stewenius Y, 2007, CLIN CANCER RES, V13, P6593, DOI 10.1158/1078-0432.CCR-07-1081; Sun MX, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015003; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tusell L, 2008, CYTOGENET GENOME RES, V122, P315, DOI 10.1159/000167818; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	68	37	38	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147420	10.1371/journal.pone.0147420	http://dx.doi.org/10.1371/journal.pone.0147420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784746	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400146
J	Shu, M; Zai, XL; Zhang, BN; Wang, R; Lin, ZH				Shu, Mao; Zai, Xiaoli; Zhang, Beina; Wang, Rui; Lin, Zhihua			Hypothyroidism Side Effect in Patients Treated with Sunitinib or Sorafenib: Clinical and Structural Analyses	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; ADVERSE DRUG-REACTIONS; RETINOID-X-RECEPTOR; THYROID-HORMONE; CANCER-PATIENTS; TRANSIENT HYPOTHYROIDISM; CELL; ASSOCIATION; ACID; PHARMACOLOGY	Tyrosine kinase inhibitors (TKIs) provide more effective targeted treatments for cancer, but are subject to a variety of adverse effects, such as hypothyroidism. TKI-induced hypothyroidism is a highly complicated issue, because of not only the unrealized toxicological mechanisms, but also different incidences of individual TKI drugs. While sunitinib is suspected for causing thyroid dysfunction more often than other TKIs, sorafenib is believed to be less risky. Here we integrated clinical data and in silico drug-protein interactions to examine the pharmacological distinction between sunitinib and sorafenib. Statistical analysis on the FDA Adverse Event Reporting System (FAERS) confirmed that sunitinib is more concurrent with hypothyroidism than sorafenib, which was observed in both female and male patients. Then, we used docking method and identified 3 proteins specifically binding to sunitinib but not sorafenib, i.e., retinoid X receptor alpha, retinoic acid receptors beta and gamma. As potential off-targets of sunitinib, these proteins are well known to assemble with thyroid hormone receptors, which can explain the profound impact of sunitinib on thyroid function. Taken together, we established a strategy of integrated analysis on clinical records and drug off-targets, which can be applied to explore the molecular basis of various adverse drug reactions.	[Shu, Mao; Zai, Xiaoli; Zhang, Beina; Wang, Rui; Lin, Zhihua] Chongqing Univ Technol, Sch Pharm & Bioengn, Chongqing 400054, Peoples R China; [Lin, Zhihua] Chongqing Univ, Sch Chem & Chem Engn, Chongqing 400044, Peoples R China	Chongqing University of Technology; Chongqing University	Shu, M; Lin, ZH (corresponding author), Chongqing Univ Technol, Sch Pharm & Bioengn, Chongqing 400054, Peoples R China.; Lin, ZH (corresponding author), Chongqing Univ, Sch Chem & Chem Engn, Chongqing 400044, Peoples R China.	sm7507@126.com; zhlin@cqut.edu.cn			National Natural Science Foundation of China [31170747, 81171508]; Key Project of Natural Science Foundation of Chong Qing [CSTC 2013JJB10004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Natural Science Foundation of Chong Qing	This study was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, 31170747, 81171508), Key Project of Natural Science Foundation of Chong Qing (CSTC 2013JJB10004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (31170747, 81171508), Key Project of Natural Science Foundation of Chong Qing (CSTC 2013JJB10004).	Ahmadieh H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/725410; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Bauer M, 2014, BIPOLAR DISORD, V16, P58, DOI 10.1111/bdi.12150; BERRODIN TJ, 1992, MOL ENDOCRINOL, V6, P1468, DOI 10.1210/me.6.9.1468; Boomsma MJ, 2011, RADIOTHER ONCOL, V99, P1, DOI 10.1016/j.radonc.2011.03.002; Chen H, 2014, MOL MED REP, V10, P2130, DOI 10.3892/mmr.2014.2399; Daimon M, 2012, JPN J CLIN ONCOL, V42, P742, DOI 10.1093/jjco/hys076; Desai J, 2006, ANN INTERN MED, V145, P660, DOI 10.7326/0003-4819-145-9-200611070-00008; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Fujiwara Y, 2012, INVEST NEW DRUG, V30, P1055, DOI 10.1007/s10637-011-9637-1; Ganguly D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004247; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Grossmann M, 2008, CLIN ENDOCRINOL, V69, P669, DOI 10.1111/j.1365-2265.2008.03253.x; Hadj-Kacem H, 2009, INT J IMMUNOGENET, V36, P85, DOI 10.1111/j.1744-313X.2009.00830.x; Hartmann JT, 2009, CURR DRUG METAB, V10, P470, DOI 10.2174/138920009788897975; Haugen BR, 2009, BEST PRACT RES CL EN, V23, P793, DOI 10.1016/j.beem.2009.08.003; Huang SC, 2009, THYROID, V19, P13, DOI 10.1089/thy.2008.0002; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lee S, 2005, MOL ENDOCRINOL, V19, P863, DOI 10.1210/me.2004-0210; Li ZG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1516-2; Luboshitzky R, 1996, ISRAEL J MED SCI, V32, P60; Luo H, 2011, NUCLEIC ACIDS RES, V39, pW492, DOI 10.1093/nar/gkr299; Mannavola D, 2007, J CLIN ENDOCR METAB, V92, P3531, DOI 10.1210/jc.2007-0586; Morganti S, 2005, J Endocrinol Invest, V28, P101; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Papaetis GS, 2009, BIODRUGS, V23, P377, DOI 10.2165/11318860-000000000-00000; Parks JS, 2010, PEDIATRICS, V125, pS54, DOI 10.1542/peds.2009-1975F; Piccinni C, 2011, DIABETES CARE, V34, P1369, DOI 10.2337/dc10-2412; Rezaeian S, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.13946; Riesenbeck LM, 2011, WORLD J UROL, V29, P807, DOI 10.1007/s00345-010-0627-2; Rini BI, 2007, JNCI-J NATL CANCER I, V99, P81, DOI 10.1093/jnci/djk008; Schmidinger M, 2011, CANCER-AM CANCER SOC, V117, P534, DOI 10.1002/cncr.25422; Sun LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060598; Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499; SURKS MI, 1995, NEW ENGL J MED, V333, P1688, DOI 10.1056/NEJM199512213332507; Torino F, 2009, NAT REV CLIN ONCOL, V6, P219, DOI 10.1038/nrclinonc.2009.4; Torino F, 2009, THYROID, V19, P539, DOI 10.1089/thy.2008.0367; Wang GJ, 2015, BIOCHEM BIOPH RES CO, V457, P249, DOI 10.1016/j.bbrc.2014.12.096; Wang KJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003315; Weng ZQ, 2015, ONCOTARGET, V6, P17031, DOI 10.18632/oncotarget.4400; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wolter P, 2008, BRIT J CANCER, V99, P448, DOI 10.1038/sj.bjc.6604497; Wong E, 2007, THYROID, V17, P351, DOI 10.1089/thy.2006.0308; Yamamoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102110; Yang L, 2013, J FUDAN U NATURAL SC, V2013, P6; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Yang L, 2011, INTERDISCIP SCI, V3, P22, DOI 10.1007/s12539-011-0051-8; Yang L, 2010, PLOS ONE, V5, pA71, DOI 10.1371/journal.pone.0009568; Yang L, 2009, NUCLEIC ACIDS RES, V37, pW406, DOI 10.1093/nar/gkp312; Zhang B, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/456747	54	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147048	10.1371/journal.pone.0147048	http://dx.doi.org/10.1371/journal.pone.0147048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784451	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400100
J	Fang, LL; Yu, J; Jiang, Z; Guo, XJ				Fang, Linlin; Yu, Jia; Jiang, Zhen; Guo, Xingjie			Preparation of a beta-Cyclodextrin-Based Open-Tubular Capillary Electrochromatography Column and Application for Enantioseparations of Ten Basic Drugs	PLOS ONE			English	Article							ALKYLTHIOL GOLD NANOPARTICLES; ELECTROMIGRATION TECHNIQUES; LIQUID-CHROMATOGRAPHY; SEPARATION; TRENDS	An open-tubular capillary electrochromatography column was prepared by chemically immobilized beta-cyclodextrin modified gold nanoparticles onto new surface with the prederivatization of (3-mercaptopropyl)-trimethoxysilane. The synthesized nanoparticles and the prepared column were characterized by transmission electron microscopy, scanning electron microscopy, infrared spectroscopy and ultraviolet visible spectroscopy. When the column was employed as the chiral stationary phase, no enantioselectivity was observed for ten model basic drugs. So beta-cyclodextrin was added to the background electrolyte as chiral additive to expect a possible synergistic effect occurring and resulting in a better separation. Fortunately, significant improvement in enantioselectivity was obtained for ten pairs of drug enantiomers. Then, the effects of beta-cyclodextrin concentration and background electrolyte pH on the chiral separation were investigated. With the developed separation mode, all the enantiomers (except for venlafaxine) were baseline separated in resolutions of 4.49, 1.68, 1.88, 1.57, 2.52, 2.33, 3.24, 1.63 and 3.90 for zopiclone, chlorphenamine maleate, brompheniramine maleate, dioxopromethazine hydrochloride, carvedilol, homatropine hydrobromide, homatropine methylbromide, venlafaxine, sibutramine hydrochloride and terbutaline sulfate, respectively. Further, the possible separation mechanism involved was discussed.	[Fang, Linlin; Yu, Jia; Jiang, Zhen; Guo, Xingjie] Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut Anal, Minist Educ, Shenyang, Liaoning Provin, Peoples R China	Shenyang Pharmaceutical University	Guo, XJ (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut Anal, Minist Educ, Shenyang, Liaoning Provin, Peoples R China.	syykdx410@163.com			National Natural Science Foundation of China [81473178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No.81473178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammazzalorso A, 2005, J CHROMATOGR A, V1088, P110, DOI 10.1016/j.chroma.2005.04.079; Aturki Z, 2014, ELECTROPHORESIS, V35, P3242, DOI 10.1002/elps.201400085; Cheong WJ, 2013, J CHROMATOGR A, V1308, P1, DOI 10.1016/j.chroma.2013.07.107; Davis BA, 2008, J CHROMATOGR B, V875, P102; Gubitz G, 2008, J CHROMATOGR A, V1204, P140, DOI 10.1016/j.chroma.2008.07.071; Haiss W, 2007, ANAL CHEM, V79, P4215, DOI 10.1021/ac0702084; Kapnissi-Christodoulou CP, 2003, ELECTROPHORESIS, V24, P3917, DOI 10.1002/elps.200305640; LEBELLE MJ, 1995, FORENSIC SCI INT, V71, P215, DOI 10.1016/0379-0738(94)01669-0; Li M, 2013, TALANTA, V109, P1, DOI 10.1016/j.talanta.2013.03.035; Liang RP, 2012, J CHROMATOGR A, V1266, P95, DOI 10.1016/j.chroma.2012.09.101; Liu FK, 2005, J CHROMATOGR A, V1083, P205, DOI 10.1016/j.chroma.2005.06.035; Liu Z, 2003, ELECTROPHORESIS, V24, P3917; Mangelings D, 2011, ELECTROPHORESIS, V32, P2583, DOI 10.1002/elps.201100009; MATHYS K, 1992, J CHROMATOGR, V593, P79, DOI 10.1016/0021-9673(92)80270-5; Matyska MT, 2001, J CHROMATOGR A, V924, P211, DOI 10.1016/S0021-9673(01)00830-5; Misl'anova C, 2003, J CHROMATOGR B, V797, P91, DOI 10.1016/j.jchromb.2003.07.018; O'Mahony T, 2003, J CHROMATOGR A, V1004, P181, DOI 10.1016/S0021-9673(03)00856-2; Scriba GKE, 2002, J PHARMACEUT BIOMED, V27, P373, DOI 10.1016/S0731-7085(01)00653-7; Wille K, 2012, TRAC-TREND ANAL CHEM, V35, P87, DOI 10.1016/j.trac.2011.12.003; Xue Y, 2015, ELECTROPHORESIS, V36, P124, DOI 10.1002/elps.201400312; Yang L, 2005, J SEP SCI, V28, P757, DOI 10.1002/jssc.200400075; Yang L, 2005, ANAL CHEM, V77, P1840, DOI 10.1021/ac048544x; Yu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120216; Zhao M, 2014, J SEP SCI, V37, P151, DOI 10.1002/jssc.201300831	24	16	17	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146292	10.1371/journal.pone.0146292	http://dx.doi.org/10.1371/journal.pone.0146292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771454	Green Submitted, Green Published, gold			2022-12-26	WOS:000368628300013
J	Mellem, D; Fischer, F; Jaspers, S; Wenck, H; Rubhausen, M				Mellem, Daniel; Fischer, Frank; Jaspers, Soeren; Wenck, Horst; Ruebhausen, Michael			Quality Saving Mechanisms of Mitochondria during Aging in a Fully Time-Dependent Computational Biophysical Model	PLOS ONE			English	Article							OXIDATIVE STRESS; RAT HEPATOCYTES; FUSION; FISSION; CELLS; DNA; TURNOVER; HYPERFUSION; DEGRADATION; BIOGENESIS	Mitochondria are essential for the energy production of eukaryotic cells. During aging mitochondria run through various processes which change their quality in terms of activity, health and metabolic supply. In recent years, many of these processes such as fission and fusion of mitochondria, mitophagy, mitochondrial biogenesis and energy consumption have been subject of research. Based on numerous experimental insights, it was possible to qualify mitochondrial behaviour in computational simulations. Here, we present a new biophysical model based on the approach of Figge et al. in 2012. We introduce exponential decay and growth laws for each mitochondrial process to derive its time-dependent probability during the aging of cells. All mitochondrial processes of the original model are mathematically and biophysically redefined and additional processes are implemented: Mitochondrial fission and fusion is separated into a metabolic outer-membrane part and a protein-related inner-membrane part, a quality-dependent threshold for mitophagy and mitochondrial biogenesis is introduced and processes for activity-dependent internal oxidative stress as well as mitochondrial repair mechanisms are newly included. Our findings reveal a decrease of mitochondrial quality and a fragmentation of the mitochondrial network during aging. Additionally, the model discloses a quality increasing mechanism due to the interplay of the mitophagy and biogenesis cycle and the fission and fusion cycle of mitochondria. It is revealed that decreased mitochondrial repair can be a quality saving process in aged cells. Furthermore, the model finds strategies to sustain the quality of the mitochondrial network in cells with high production rates of reactive oxygen species due to large energy demands. Hence, the model adds new insights to biophysical mechanisms of mitochondrial aging and provides novel understandings of the interdependency of mitochondrial processes.	[Mellem, Daniel; Ruebhausen, Michael] Univ Hamburg, Ctr Free Electron Laser Sci CFEL, Hamburg, Germany; [Mellem, Daniel; Fischer, Frank; Jaspers, Soeren; Wenck, Horst] Beiersdorf AG, Appl Biophys, Hamburg, Germany	University of Hamburg; Beiersdorf AG	Fischer, F (corresponding author), Beiersdorf AG, Appl Biophys, Hamburg, Germany.	frank.fischer@beiersdorf.com	Fischer, Frank/AFO-7637-2022	Fischer, Frank/0000-0002-7932-7174	Foundation of German Business; Beiersdorf AG	Foundation of German Business; Beiersdorf AG	This work was supported by Foundation of German Business: DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beiersdorf AG provided support in the form of salaries for authors DM, SJ, HW, FF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Berndt N, 2013, CELL BIOCHEM BIOPHYS, V67, P527, DOI 10.1007/s12013-013-9538-3; Brown GC, 2012, MITOCHONDRION, V12, P1, DOI 10.1016/j.mito.2011.02.001; Busch KB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0442; Cervinkova Z, 2007, ATLA-ALTERN LAB ANIM, V35, P353, DOI 10.1177/026119290703500303; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576; Hill A.V, 1910, J PHYSL, V40; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kampen NGv, 2007, STOCHASTIC PROCESSES; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LIPSKY NG, 1981, J BIOL CHEM, V256, P8652; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Lodish H., 2004, MOL CELL BIOL; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873; Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021; Patel PK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003108; Regmi SG, 2014, AGING-US, V6, P118, DOI 10.18632/aging.100639; Rolland SG, 2013, P NATL ACAD SCI USA, V110, pE2967, DOI 10.1073/pnas.1303872110; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Sgarbi G, 2014, AGING-US, V6, P296, DOI 10.18632/aging.100654; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Winter M.E., 2009, BASIC CLIN PHARMACOK; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	41	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146973	10.1371/journal.pone.0146973	http://dx.doi.org/10.1371/journal.pone.0146973			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771181	Green Submitted, gold, Green Published			2022-12-26	WOS:000368628300046
J	Schinagl, CW; Vrabl, P; Burgstaller, W				Schinagl, Christoph W.; Vrabl, Pamela; Burgstaller, Wolfgang			Adapting High-Resolution Respirometry to Glucose-Limited Steady State Mycelium of the Filamentous Fungus Penicillium ochrochloron: Method Development and Standardisation	PLOS ONE			English	Article							CITRIC-ACID PRODUCTION; CEPHALOSPORIN-C PRODUCTION; ELECTRON-TRANSPORT CHAIN; ASPERGILLUS-NIGER; ALTERNATIVE OXIDASE; NEUROSPORA-CRASSA; RESPIRATORY-CHAIN; CYANIDE-RESISTANT; ACREMONIUM-CHRYSOGENUM; CHEMOSTAT CULTURES	Fungal electron transport systems (ETS) are branched, involving alternative NADH dehydrogenases and an alternative terminal oxidase. These alternative respiratory enzymes were reported to play a role in pathogenesis, production of antibiotics and excretion of organic acids. The activity of these alternative respiratory enzymes strongly depends on environmental conditions. Functional analysis of fungal ETS under highly standardised conditions for cultivation, sample processing and respirometric assay are still lacking. We developed a highly standardised protocol to explore in vivo the ETS-and in particular the alternative oxidase-in Penicillium ochrochloron. This included cultivation in glucose-limited chemostat (to achieve a defined and reproducible physiological state), direct transfer without any manipulation of a broth sample to the respirometer (to maintain the physiological state in the respirometer as close as possible to that in the chemostat), and high-resolution respirometry (small sample volume and high measuring accuracy). This protocol was aimed at avoiding any changes in the physiological phenotype due to the high phenotypic plasticity of filamentous fungi. A stable oxygen consumption (< 5% change in 20 minutes) was only possible with glucose limited chemostat mycelium and a direct transfer of a broth sample into the respirometer. Steady state respiration was 29% below its maximum respiratory capacity. Additionally to a rotenone-sensitive complex I and most probably a functioning complex III, the ETS of P. ochrochloron also contained a cyanide-sensitive terminal oxidase (complex IV). Activity of alternative oxidase was present constitutively. The degree of inhibition strongly depended on the sequence of inhibitor addition. This suggested, as postulated for plants, that the alternative terminal oxidase was in dynamic equilibrium with complex IV-independent of the rate of electron flux. This means that the onset of activity does not depend on a complete saturation or inhibition of the cytochrome pathway.	[Schinagl, Christoph W.; Vrabl, Pamela; Burgstaller, Wolfgang] Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria	University of Innsbruck	Schinagl, CW (corresponding author), Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria.	christoph.schinagl@uibk.ac.at		Vrabl, Pamela/0000-0002-8104-8684	Austrian Science Fund (FWF) [P22220-B11]; University of Innsbruck; Austrian Science Fund (FWF) [P 22220] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF; www.fwf.ac.at) project P22220-B11 and a research fellowship of the University of Innsbruck (www.uibk.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZH, 2004, ENZYME MICROB TECH, V34, P10, DOI 10.1016/j.enzmictec.2003.07.008; Carneiro P, 2007, J MOL BIOL, V368, P1114, DOI 10.1016/j.jmb.2007.02.080; Costa C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00197; de Jonge LP, 2012, METABOLOMICS, V8, P727, DOI 10.1007/s11306-011-0367-3; Descheneau AT, 2005, GENETICS, V169, P123, DOI 10.1534/genetics.104.034017; Egli T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00287; Foster JW., 1949, CHEM ACTIVITIES FUNG; FRANZ A, 1991, APPL ENVIRON MICROB, V57, P769, DOI 10.1128/AEM.57.3.769-774.1991; Gallmetzer M, 2001, ANTON LEEUW INT J G, V79, P81, DOI 10.1023/A:1010295924549; Ganzera M, 2006, ANAL BIOCHEM, V359, P132, DOI 10.1016/j.ab.2006.09.012; Gibbs PA, 2000, CRIT REV BIOTECHNOL, V20, P17, DOI 10.1080/07388550091144177; Grahl N, 2012, MOL MICROBIOL, V84, P383, DOI 10.1111/j.1365-2958.2012.08034.x; GRIFFIN DH, 1994, FUNGAL PHYSL; Hattori T, 2008, J BIOSCI BIOENG, V105, P55, DOI 10.1263/jbb.105.55; Joseph-Horne T, 2000, PEST MANAG SCI, V56, P24, DOI 10.1002/(SICI)1526-4998(200001)56:1<24::AID-PS71>3.0.CO;2-Y; Joseph-Horne T, 2001, BBA-BIOENERGETICS, V1504, P179, DOI 10.1016/S0005-2728(00)00251-6; Karaffa L, 1996, BIOTECHNOL LETT, V18, P701, DOI 10.1007/BF00130769; KIRIMURA K, 1987, AGR BIOL CHEM TOKYO, V51, P1299, DOI 10.1080/00021369.1987.10868216; Kirimura K, 2000, BIOSCI BIOTECH BIOCH, V64, P2034, DOI 10.1271/bbb.64.2034; Kirimura K, 1996, FEMS MICROBIOL LETT, V141, P251, DOI 10.1016/0378-1097(96)00230-3; Kozma J, 1996, J BIOTECHNOL, V48, P59, DOI 10.1016/0168-1656(96)01400-9; KUBICEK CP, 1980, EUR J APPL MICROBIOL, V9, P101, DOI 10.1007/BF00503505; LAMBOWIT.AM, 1971, J BACTERIOL, V108, P1087, DOI 10.1128/JB.108.3.1087-1096.1971; Magnani T, 2008, J BIOENERG BIOMEMBR, V40, P631, DOI 10.1007/s10863-008-9191-5; Martins VP, 2011, EUKARYOT CELL, V10, P237, DOI 10.1128/EC.00194-10; Nargang FE, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P155; Nielsen J, 2007, TOPICS CURRENT GENET, P1, DOI DOI 10.1007/978-3-540-74719-2; PARRISH DJ, 1978, PLANT PHYSIOL, V62, P470, DOI 10.1104/pp.62.3.470; PROMPER C, 1993, EUR J BIOCHEM, V216, P223, DOI 10.1111/j.1432-1033.1993.tb18136.x; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; SIEDOW JN, 1980, PLANT PHYSIOL, V65, P669, DOI 10.1104/pp.65.4.669; Siedow JN, 2000, BBA-BIOENERGETICS, V1459, P432, DOI 10.1016/S0005-2728(00)00181-X; Slepecky RA, 2009, MYCOLOGIA, V101, P823, DOI 10.3852/08-197; Tanton LL, 2003, FUNGAL GENET BIOL, V39, P176, DOI 10.1016/S1087-1845(03)00002-1; Tudella VG, 2004, INT J BIOCHEM CELL B, V36, P162, DOI 10.1016/S1357-2725(03)00194-8; Uribe D, 2008, CAN J MICROBIOL, V54, P119, DOI 10.1139/w07-127; van Gulik WM, 2013, SAMPLING SAMPLE PREP, P1; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; Vrabl P, 2008, FUNGAL GENET BIOL, V45, P1380, DOI 10.1016/j.fgb.2008.07.017; WALLRATH J, 1991, APPL MICROBIOL BIOT, V36, P76, DOI 10.1007/BF00164702; Yukioka H, 1997, FUNGAL GENET BIOL, V22, P221, DOI 10.1006/fgbi.1997.1016; ZEHENTGRUBER O, 1980, FEMS MICROBIOL LETT, V8, P71, DOI 10.1016/0378-1097(80)90071-3; Zivic M, 2009, ANTON LEEUW INT J G, V95, P207, DOI 10.1007/s10482-008-9304-5	43	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146878	10.1371/journal.pone.0146878	http://dx.doi.org/10.1371/journal.pone.0146878			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771937	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300038
J	Yang, LB; Geng, ZH; Nickel, T; Johnson, C; Gao, L; Dutton, J; Hou, C; Zhang, JY				Yang, Libang; Geng, Zhaohui; Nickel, Thomas; Johnson, Caitlin; Gao, Lin; Dutton, James; Hou, Cody; Zhang, Jianyi			Differentiation of Human Induced-Pluripotent Stem Cells into Smooth-Muscle Cells: Two Novel Protocols	PLOS ONE			English	Article							VASCULAR TISSUE; MOLECULAR REGULATION; EPIGENETIC MEMORY; MODEL; GENERATION; ORIGIN; HEART	Conventional protocols for differentiating human induced-pluripotent stem cells (hiPSCs) into smooth-muscle cells (SMCs) can be inefficient and generally fail to yield cells with a specific SMC phenotype (i.e., contractile or synthetic SMCs). Here, we present two novel hiPSC-SMC differentiation protocols that yield SMCs with predominantly contractile or synthetic phenotypes. Flow cytometry analyses of smooth-muscle actin (SMA) expression indicated that similar to 45% of the cells obtained with each protocol assumed an SMC phenotype, and that the populations could be purified to similar to 95% via metabolic selection. Assessments of cellular mRNA and/or protein levels indicated that SMA, myosin heavy chain II, collagen 1, calponin, transgelin, connexin 43, and vimentin expression in the SMCs obtained via the Contractile SMC protocol and in SMCs differentiated via a traditional protocol were similar, while SMCs produced via the Sythetic SMC protocol expressed less calponin, more collagen 1, and more connexin 43. Differences were also observed in functional assessments of the two SMC populations: the two-dimensional surface area of Contractile SMCs declined more extensively (to 12% versus 44% of original size) in response to carbachol treatment, while quantification of cell migration and proliferation were greater in Synthetic SMCs. Collectively, these data demonstrate that our novel differentiation protocols can efficiently generate SMCs from hiPSCs.	[Yang, Libang; Nickel, Thomas; Johnson, Caitlin; Gao, Lin; Hou, Cody; Zhang, Jianyi] Univ Minnesota, Sch Med, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA; [Geng, Zhaohui; Dutton, James; Zhang, Jianyi] Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA; [Zhang, Jianyi] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA; [Johnson, Caitlin; Zhang, Jianyi] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA; [Zhang, Jianyi] Univ Alabama Birmingham, Dept Biomed Engn, Sch Med, Sch Engn, Birmingham, AL 35294 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham	Zhang, JY (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA.; Zhang, JY (corresponding author), Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA.; Zhang, JY (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA.; Zhang, JY (corresponding author), Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA.; Zhang, JY (corresponding author), Univ Alabama Birmingham, Dept Biomed Engn, Sch Med, Sch Engn, Birmingham, AL 35294 USA.	jayzhang@uab.edu	Zhang, Jianyi/N-1949-2018	Zhang, Jianyi/0000-0002-3955-6554; Hou, Cody/0000-0001-8692-6768	National Institute of Health [RO1 HL67828, RO1 HL95077, RO1 HL114120, UO1 HL100407]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067828, U01HL100407, R01HL114120, R01HL095077] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health RO1 HL67828; National Institute of Health RO1 HL95077; National Institute of Health RO1 HL114120; and National Institute of Health UO1 HL100407.	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Christen T, 2001, CIRCULATION, V103, P882, DOI 10.1161/01.CIR.103.6.882; Christen T, 1999, CIRC RES, V85, P99; Dash BC, 2015, BIOCHEM J, V465, P185, DOI 10.1042/BJ20141078; Fernandez CE, 2014, CURR OPIN CHEM ENG, V3, P83, DOI 10.1016/j.coche.2013.12.001; Franck D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056237; Hill KL, 2010, EXP HEMATOL, V38, P246, DOI 10.1016/j.exphem.2010.01.001; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Marchand M, 2014, STEM CELL TRANSL MED, V3, P91, DOI 10.5966/sctm.2013-0124; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park SW, 2010, BLOOD, V116, P5762, DOI 10.1182/blood-2010-04-280719; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Sundaram S, 2014, STEM CELL TRANSL MED, V3, P1535, DOI 10.5966/sctm.2014-0065; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Wang YY, 2014, BIOMATERIALS, V35, P8960, DOI 10.1016/j.biomaterials.2014.07.011; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Wong MM, 2015, JOVE-J VIS EXP, DOI 10.3791/52565; Ye L, 2015, METHODS MOL BIOL, V1299, P103, DOI 10.1007/978-1-4939-2572-8_8; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Zhang LY, 2015, CIRC-HEART FAIL, V8, P156, DOI 10.1161/CIRCHEARTFAILURE.114.001317; Zhang S, 2014, BIOMATERIALS, V35, P3786, DOI 10.1016/j.biomaterials.2014.01.037	27	35	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147155	10.1371/journal.pone.0147155	http://dx.doi.org/10.1371/journal.pone.0147155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771193	gold, Green Published, Green Submitted			2022-12-26	WOS:000368628300067
J	Chavez-Vargas, L; Adame-Garcia, SR; Cervantes-Villagrana, RD; Castillo-Kauil, A; Bruystens, JGH; Fukuhara, S; Taylor, SS; Mochizuki, N; Reyes-Cruz, G; Vazquez-Prado, J				Chavez-Vargas, Lydia; Rafael Adame-Garcia, Sendi; Daniel Cervantes-Villagrana, Rodolfo; Castillo-Kauil, Alejandro; Bruystens, Jessica G. H.; Fukuhara, Shigetomo; Taylor, Susan S.; Mochizuki, Naoki; Reyes-Cruz, Guadalupe; Vazquez-Prado, Jose			Protein Kinase A (PKA) Type I Interacts with P-Rex1, a Rac Guanine Nucleotide Exchange Factor: EFFECT ON PKA LOCALIZATION AND P-Rex1 SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanine nucleotide exchange factor (GEF); PDZ domain; protein kinase; protein kinase A (PKA); Rac (Rac GTPase); signal transduction	G-BETA-GAMMA; CANCER-CELL-MIGRATION; ANCHORING PROTEIN; CYCLIC-AMP; BREAST-CANCER; AKAP-LBC; REGULATORY SUBUNITS; MAMMALIAN TARGET; ACTIVATION; CAMP	Morphology of migrating cells is regulated by Rho GTPases and fine-tuned by protein interactions and phosphorylation. PKA affects cell migration potentially through spatiotemporal interactions with regulators of Rho GTPases. Here we show that the endogenous regulatory (R) subunit of type I PKA interacts with P-Rex1, a Rac guanine nucleotide exchange factor that integrates chemotactic signals. Type I PKA holoenzyme interacts with P-Rex1 PDZ domains via the CNB B domain of RI, which when expressed by itself facilitates endothelial cell migration. P-Rex1 activation localizes PKA to the cell periphery, whereas stimulation of PKA phosphorylates P-Rex1 and prevents its activation in cells responding to SDF-1 (stromal cell-derived factor 1). The P-Rex1 DEP1 domain is phosphorylated at Ser-436, which inhibits the DH-PH catalytic cassette by direct interaction. In addition, the P-Rex1 C terminus is indirectly targeted by PKA, promoting inhibitory interactions independently of the DEP1-PDZ(2) region. A P-Rex1 S436A mutant construct shows increased RacGEF activity and prevents the inhibitory effect of forskolin on sphingosine 1-phosphate-dependent endothelial cell migration. Altogether, these results support the idea that P-Rex1 contributes to the spatiotemporal localization of type I PKA, which tightly regulates this guanine exchange factor by a multistep mechanism, initiated by interaction with the PDZ domains of P-Rex1 followed by direct phosphorylation at the first DEP domain and putatively indirect regulation of the C terminus, thus promoting inhibitory intramolecular interactions. This reciprocal regulation between PKA and P-Rex1 might represent a key node of integration by which chemotactic signaling is fine-tuned by PKA.	[Vazquez-Prado, Jose] CINVESTAV IPN, Dept Pharmacol, Av Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico; [Rafael Adame-Garcia, Sendi; Castillo-Kauil, Alejandro; Reyes-Cruz, Guadalupe] CINVESTAV IPN, Dept Cell Biol, Mexico City 07360, DF, Mexico; [Fukuhara, Shigetomo; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr, Res Inst NCV, Dept Cell Biol, Osaka 5658565, Japan; [Bruystens, Jessica G. H.; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; National Cerebral & Cardiovascular Center - Japan; University of California System; University of California San Diego; University of California System; University of California San Diego	Vazquez-Prado, J (corresponding author), CINVESTAV IPN, Dept Pharmacol, Av Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico.	jvazquez@cinvestav.mx	Cervantes-Villagrana, Rodolfo Daniel/E-6804-2019; Cervantes-Villagrana, Rodolfo Daniel/T-6458-2019; VAZQUEZ-PRADO, JOSE/C-1630-2017	Cervantes-Villagrana, Rodolfo Daniel/0000-0002-6599-7994; VAZQUEZ-PRADO, JOSE/0000-0001-5797-6643	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) [152434, 240119]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26670107] Funding Source: KAKEN	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) Grants 152434 (to J. V.-P.) and 240119 (to G. R.-C.).	Ledezma-Sanchez BA, 2010, BIOCHEM BIOPH RES CO, V391, P1647, DOI 10.1016/j.bbrc.2009.12.108; Bachmann VA, 2013, P NATL ACAD SCI USA, V110, P8531, DOI 10.1073/pnas.1215902110; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Barber MA, 2012, BIOCHEM J, V443, P173, DOI 10.1042/BJ20112078; Bracho-Valdes I, 2011, IUBMB LIFE, V63, P896, DOI 10.1002/iub.558; Burdyga A, 2013, BBA-MOL CELL RES, V1833, P2664, DOI 10.1016/j.bbamcr.2013.06.011; Burgers PP, 2012, J BIOL CHEM, V287, P43789, DOI 10.1074/jbc.M112.395970; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Campbell AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053982; Montero JC, 2013, CELL SIGNAL, V25, P2281, DOI 10.1016/j.cellsig.2013.07.018; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Damoulakis G, 2014, J CELL SCI, V127, P2589, DOI 10.1242/jcs.153049; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Di Zazzo E, 2014, SCI WORLD J, DOI 10.1155/2014/565839; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Feng H, 2014, ONCOGENE, V33, P2504, DOI 10.1038/onc.2013.198; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Goicoechea SM, 2014, CELL ADHES MIGR, V8, P535, DOI 10.4161/cam.28721; Guilluy C, 2011, NAT PROTOC, V6, P2050, DOI 10.1038/nprot.2011.411; Hernandez-Garcia R, 2015, VASC PHARMACOL, V74, P60, DOI 10.1016/j.vph.2015.10.003; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hill K, 2006, METHOD ENZYMOL, V406, P26, DOI 10.1016/S0076-6879(06)06003-4; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Johnson KR, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-125; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Kim EK, 2012, EXP MOL MED, V44, P483, DOI 10.3858/emm.2012.44.8.055; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Lee JW, 2014, ANTICANCER RES, V34, P3447; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Lissandron V, 2006, J MUSCLE RES CELL M, V27, P399, DOI 10.1007/s10974-006-9077-2; Lu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081220; Lucato CM, 2015, J BIOL CHEM, V290, P20827, DOI 10.1074/jbc.M115.660456; Guzman-Hernandez ML, 2009, J BIOL CHEM, V284, P18334, DOI 10.1074/jbc.M109.008839; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1913, DOI 10.1074/jbc.M506034200; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Meiri D, 2012, MOL CELL, V45, P642, DOI 10.1016/j.molcel.2012.01.027; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Mizuno R, 2014, J EXP MED, V211, P1123, DOI 10.1084/jem.20132112; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; O'Leary AP, 2015, J CELL PHYSIOL, V230, P356, DOI 10.1002/jcp.24716; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rivard RL, 2009, CELL MOTIL CYTOSKEL, V66, P693, DOI 10.1002/cm.20399; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Smith FD, 2011, CELL CYCLE, V10, P731, DOI 10.4161/cc.10.5.14902; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Stefan E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1605; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Urano D, 2008, CELL SIGNAL, V20, P1545, DOI 10.1016/j.cellsig.2008.04.009; van Buul JD, 2014, CELL ADHES MIGR, V8, P108, DOI 10.4161/cam.27599; Vazquez-Prado J, 2004, METHOD ENZYMOL, V390, P259; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Zimmerman NP, 2015, MOL CARCINOGEN, V54, P203, DOI 10.1002/mc.22091	63	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6182	6199		10.1074/jbc.M115.712216	http://dx.doi.org/10.1074/jbc.M115.712216			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797121	Green Published, hybrid			2022-12-26	WOS:000372894200012
J	Puente, C; Hendrickson, RC; Jiang, XJ				Puente, Cindy; Hendrickson, Ronald C.; Jiang, Xuejun			Nutrient-regulated Phosphorylation of ATG13 Inhibits Starvation-induced Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); autophagy; mammalian target of rapamycin (mTOR); phosphorylation; TOR complex (TORC); Macroautophagy; ULK1	SACCHAROMYCES-CEREVISIAE; KINASE COMPLEX; PROTEIN; ULK1; AMPK; MUTANTS; ORGANIZATION; MACHINERY; INDUCTION; MITOPHAGY	Autophagy is a conserved catabolic process that utilizes a defined series of membrane trafficking events to generate a de novo double-membrane vesicle termed the autophagosome, which matures by fusing to the lysosome. Subsequently, the lysosome facilitates the degradation and recycling of the cytoplasmic cargo. In yeast, the upstream signals that regulate the induction of starvation-induced autophagy are clearly defined. The nutrient-sensing kinase Tor inhibits the activation of autophagy by regulating the formation of the Atg1-Atg13-Atg17 complex, through hyperphosphorylation of Atg13. However, in mammals, the ortholog complex ULK1-ATG13-FIP200 is constitutively formed. As such, the molecular mechanism by which mTOR regulates mammalian autophagy is unknown. Here we report the identification and characterization of novel nutrient-regulated phosphorylation sites on ATG13: Ser-224 and Ser-258. mTOR directly phosphorylates ATG13 on Ser-258 while Ser-224 is modulated by the AMPK pathway. In ATG13 knock-out cells reconstituted with an unphosphorylatable mutant of ATG13, ULK1 kinase activity is more potent, and amino acid starvation induced more rapid ATG13 and ULK1 translocation. These events culminated in a more rapid starvation-induced autophagy response. Therefore, ATG13 phosphorylation plays a crucial role in autophagy regulation.	[Puente, Cindy; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10065 USA; [Puente, Cindy] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10065 USA; [Hendrickson, Ronald C.] Mem Sloan Kettering Canc Ctr, Prote & Microchem Facil, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	jiangx@mskcc.org			National Institutes of Health NCI Cancer Center Support Grant [P30 CA008748]; NIH [F31GM103248, R01GM113013, R01CA166413]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA166413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113013, F31GM103248] Funding Source: NIH RePORTER	National Institutes of Health NCI Cancer Center Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health NCI Cancer Center Support Grant P30 CA008748 to Microchemistry and Proteomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, NIH F31GM103248 (to C. P.), NIH R01GM113013 (to X. J.), and NIH R01CA166413 (to X. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; Gammoh N, 2013, NAT STRUCT MOL BIOL, V20, P144, DOI 10.1038/nsmb.2475; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ha J, 2015, MOL ASPECTS MED, V46, P46, DOI 10.1016/j.mam.2015.08.002; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Petherick KJ, 2015, J BIOL CHEM, V290, P28726, DOI [10.1074/jbc.C114.627778, 10.1074/jbc.A114.627778]; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048	33	125	131	5	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					6026	6035		10.1074/jbc.M115.689646	http://dx.doi.org/10.1074/jbc.M115.689646			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26801615	hybrid, Green Published			2022-12-26	WOS:000372551800046
J	Berrondo, C; Flax, J; Kucherov, V; Siebert, A; Osinski, T; Rosenberg, A; Fucile, C; Richheimer, S; Beckham, CJ				Berrondo, Claudia; Flax, Jonathan; Kucherov, Victor; Siebert, Aisha; Osinski, Thomas; Rosenberg, Alex; Fucile, Christopher; Richheimer, Samuel; Beckham, Carla J.			Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR VESICLES; CELL-PROLIFERATION; DIAGNOSTIC MARKER; POOR-PROGNOSIS; UP-REGULATION; BIOMARKERS; TUMOR; INVASION; METASTASIS	Exosomes are 30-150nM membrane-bound secreted vesicles that are readily isolated from biological fluids such as urine (UEs). Exosomes contain proteins, micro RNA (miRNA), messenger RNA (mRNA), and long non-coding RNA (lncRNA) from their cells of origin. Although miRNA, protein and lncRNA have been isolated from serum as potential biomarkers for benign and malignant disease, it is unknown if lncRNAs in UEs from urothelial bladder cancer (UBC) patients can serve as biomarkers. lncRNAs are > 200 nucleotide long transcripts that do not encode protein and play critical roles in tumor biology. As the number of recognized tumor-associated lncRNAs continues to increase, there is a parallel need to include lncRNAs into biomarker discovery and therapeutic target algorithms. The lncRNA HOX transcript antisense RNA (HOTAIR) has been shown to facilitate tumor initiation and progression and is associated with poor prognosis in several cancers. The importance of HOTAIR in cancer biology has sparked interest in using HOTAIR as a biomarker and potential therapeutic target. Here we show HOTAIR and several tumor-associated lncRNAs are enriched in UEs from UBC patients with high-grade muscle-invasive disease (HGMI pT2pT4). Knockdown of HOTAIR in UBC cell lines reduces in vitro migration and invasion. Importantly, loss of HOTAIR expression in UBC cell lines alters expression of epithelial-to-mesenchyme transition (EMT) genes including SNAI1, TWIST1, ZEB1, ZO1, MMP1 LAMB3, and LAMC2. Finally, we used RNA-sequencing to identify four additional lncRNAs enriched in UBC patient UEs. These data, suggest that UE-derived lncRNA may potentially serve as biomarkers and therapeutic targets.	[Berrondo, Claudia; Flax, Jonathan; Richheimer, Samuel; Beckham, Carla J.] Univ Rochester, Dept Urol, Strong Mem Hosp Rochester, New York, NY USA; [Kucherov, Victor; Siebert, Aisha; Osinski, Thomas] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Rosenberg, Alex; Fucile, Christopher] Univ Rochester, Div Rheumatol & Immunol, Strong Mem Hosp Rochester, New York, NY USA	University of Rochester; University of Rochester; University of Rochester	Beckham, CJ (corresponding author), Univ Rochester, Dept Urol, Strong Mem Hosp Rochester, New York, NY USA.	carla_beckham@urmc.rochester.edu	Siebert, Aisha/AAI-7374-2021; Siebert, Aisha/AAF-3411-2020	Siebert, Aisha/0000-0001-6954-9163; 	CTSI at the University of Rochester [5UL1TR000042-09]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER	CTSI at the University of Rochester; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CTSI at the University of Rochester 5UL1TR000042-09.	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Alvarez S, 2013, TRANSPL P, V45, P3719, DOI 10.1016/j.transproceed.2013.08.079; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson HC, 2010, LAB INVEST, V90, P1549, DOI 10.1038/labinvest.2010.152; Armstrong DA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0466-2; Arscott W Tristram, 2011, Biomark Med, V5, P822; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Barutta F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073798; Batagov AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S18; Beckham CJ, 2014, J UROLOGY, V192, P583, DOI 10.1016/j.juro.2014.02.035; Borges FT, 2013, BRAZ J MED BIOL RES, V46, P824, DOI 10.1590/1414-431X20132964; Caivano A, 2015, TUMOR BIOL, V36, P9739, DOI 10.1007/s13277-015-3741-3; Cha DJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07197; Chen FJ, 2013, MOL CARCINOGEN, V52, P908, DOI 10.1002/mc.21944; Cieslik M, 2015, GENOME RES, V25, P1372, DOI 10.1101/gr.189621.115; Dear JW, 2013, PROTEOMICS, V13, P1572, DOI 10.1002/pmic.201200285; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dijkstra S, 2014, J UROLOGY, V191, P1132, DOI 10.1016/j.juro.2013.11.001; Doose G, 2015, P NATL ACAD SCI USA, V112, pE5261, DOI 10.1073/pnas.1505753112; Duan R, 2015, ONCOTARGET, V6, P27778, DOI 10.18632/oncotarget.4813; Duijvesz D, 2015, INT J CANCER, V137, P2869, DOI 10.1002/ijc.29664; Eissa S, 2015, TUMOR BIOL, V36, P9545, DOI 10.1007/s13277-015-3722-6; Eissa S, 2015, BIOMARKERS, V20, P212, DOI 10.3109/1354750X.2015.1062918; Erdbrugger U, 2016, J AM SOC NEPHROL, V27, P12, DOI 10.1681/ASN.2015010074; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fatima Roshan, 2015, Mol Cell Ther, V3, P5, DOI 10.1186/s40591-015-0042-6; Gamez-Valero A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00006; Gezer U, 2014, CELL BIOL INT, V38, P1076, DOI 10.1002/cbin.10301; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hajjari M, 2015, CANCER BIOL MED, V12, P1, DOI 10.7497/j.issn.2095-3941.2015.0006; Han YH, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.08.044; Heubach J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0371-8; Hou P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.249; Huang YP, 2015, STEM CELLS, V33, P3481, DOI 10.1002/stem.2225; Huebner AR, 2015, ADV EXP MED BIOL, V845, P43, DOI 10.1007/978-94-017-9523-4_5; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jenjaroenpun P, 2013, PEERJ, V1, DOI 10.7717/peerj.201; Kishikawa T, 2015, WORLD J GASTROENTERO, V21, P8527, DOI 10.3748/wjg.v21.i28.8527; Kladi-Skandali A, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/319861; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kogure Takayuki, 2013, Genes Cancer, V4, P261, DOI 10.1177/1947601913499020; Lee H, 2012, PEDIATR NEPHROL, V27, P317, DOI 10.1007/s00467-011-2035-2; Lewis JM, 2015, EXPERT REV MOL DIAGN, V15, P1187, DOI 10.1586/14737159.2015.1069709; Li Q, 2015, TUMOR BIOL, V36, P2007, DOI 10.1007/s13277-014-2807-y; Li SJ, 2015, AM J TRANSL RES, V7, P1390; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu Y, 2015, TOXICOL APPL PHARM, V282, P9, DOI 10.1016/j.taap.2014.10.022; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Martinez-Fernandez M, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0141-x; Matsui Y, 2012, INT J CANCER, V130, P521, DOI 10.1002/ijc.26008; Matullo G, 2016, INT J CANCER, V138, P2334, DOI 10.1002/ijc.29895; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Moon PG, 2011, PROTEOMICS, V11, P2459, DOI 10.1002/pmic.201000443; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Navabi H, 2005, BLOOD CELL MOL DIS, V35, P149, DOI 10.1016/j.bcmd.2005.06.008; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Ostenfeld MS, 2014, CANCER RES, V74, P5758, DOI 10.1158/0008-5472.CAN-13-3512; Peng P, 2011, ONCOL REP, V25, P749, DOI 10.3892/or.2010.1119; Qi P, 2013, MODERN PATHOL, V26, P155, DOI 10.1038/modpathol.2012.160; Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683; Real FX, 2014, EUR UROL, V66, P4, DOI 10.1016/j.eururo.2014.03.028; RIEGER KM, 1995, BRIT J CANCER, V72, P683, DOI 10.1038/bjc.1995.394; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Sawek S, 2016, TUMOR BIOL, V37, P4241, DOI 10.1007/s13277-015-4407-x; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Street JM, 2014, J UROLOGY, V192, P297, DOI 10.1016/j.juro.2014.05.050; Sun M, 2016, HISTOL HISTOPATHOL, V31, P33, DOI 10.14670/HH-11-655; Sun X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.269; Takahashi K, 2014, FEBS OPEN BIO, V4, P458, DOI 10.1016/j.fob.2014.04.007; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang JT, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0148-8; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Wu ZH, 2014, ONCOL REP, V32, P395, DOI 10.3892/or.2014.3186; Xu ZY, 2013, INT J BIOL SCI, V9, P587, DOI 10.7150/ijbs.6339; Yan TH, 2014, TUMOR BIOL, V35, P10249, DOI 10.1007/s13277-014-2344-8; Yang QQ, 2014, INT J CLIN EXP PATHO, V7, P1286; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Ying L, 2012, MOL BIOSYST, V8, P2289, DOI 10.1039/c2mb25070e; Zhang L, 2015, BREAST CANCER RES TR, V152, P199, DOI 10.1007/s10549-015-3431-2; Zhang ZZ, 2015, MOL CANCER THER, V14, P1162, DOI 10.1158/1535-7163.MCT-14-0695; Zhao H, 2013, J CELL BIOCHEM, V114, P2375, DOI 10.1002/jcb.24586; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Zhou H, 2008, KIDNEY INT, V74, P613, DOI 10.1038/ki.2008.206; Zhou L, 2016, TUMOR BIOL, V37, P15583, DOI 10.1007/s13277-015-4138-z; Zhu HX, 2015, BIOCHEM BIOPH RES CO, V467, P223, DOI 10.1016/j.bbrc.2015.10.002	92	189	205	7	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147236	10.1371/journal.pone.0147236	http://dx.doi.org/10.1371/journal.pone.0147236			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800519	gold, Green Submitted, Green Published			2022-12-26	WOS:000368655300078
J	Khodaparast, L; Khodaparast, L; Shahrooei, M; Stijlemans, B; Merckx, R; Baatsen, P; O'Gara, JP; Waters, E; Van Mellaert, L; Van Eldere, J				Khodaparast, Laleh; Khodaparast, Ladan; Shahrooei, Mohammad; Stijlemans, Benoit; Merckx, Rita; Baatsen, Pieter; O'Gara, James P.; Waters, Elaine; Van Mellaert, Lieve; Van Eldere, Johan			The Possible Role of Staphylococcus epidermidis LPxTG Surface Protein SesC in Biofilm Formation	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; FIBRONECTIN-BINDING PROTEINS; FOREIGN-BODY INFECTIONS; AUREUS; MATRIX; ICA; POLYSACCHARIDE; MECHANISMS; FIBRINOGEN; SORTASES	Staphylococcus epidermidis is the most common cause of device-associated infections. It has been shown that active and passive immunization in an animal model against protein SesC significantly reduces S. epidermidis biofilm-associated infections. In order to elucidate its role, knock-out of sesC or isolation of S. epidermidis sesC-negative mutants were attempted, however, without success. As an alternative strategy, sesC was introduced into Staphylococcus aureus 8325-4 and its isogenic icaADBC and srtA mutants, into the clinical methicillin-sensitive S. aureus isolate MSSA4 and the MRSA S. aureus isolate BH1CC, which all lack sesC. Transformation of these strains with sesC i) changed the biofilm phenotype of strains 8325-4 and MSSA4 from PIA-dependent to proteinaceous even though PIA synthesis was not affected, ii) converted the non-biofilm-forming strain 8325-4 ica::tet to a proteinaceous biofilm-forming strain, iii) impaired PIA-dependent biofilm formation by 8325-4 srtA::tet, iv) had no impact on protein-mediated biofilm formation of BH1CC and v) increased in vivo catheter and organ colonization by strain 8325-4. Furthermore, treatment with anti-SesC antibodies significantly reduced in vitro biofilm formation and in vivo colonization by these transformants expressing sesC. These findings strongly suggest that SesC is involved in S. epidermidis attachment to and subsequent biofilm formation on a substrate.	[Khodaparast, Laleh; Khodaparast, Ladan; Shahrooei, Mohammad; Merckx, Rita; Van Eldere, Johan] KU Leuven Univ Leuven, Univ Leuven, Lab Clin Bacteriol & Mycol, Dept Microbiol & Immunol, B-3000 Leuven, Belgium; [Stijlemans, Benoit] Vrije Univ Brussel, Lab Cellular & Mol Immunol, B-1050 Brussels, Belgium; [Stijlemans, Benoit] VIB, Dept Myeloid Cell Immunol, B-1050 Brussels, Belgium; [Baatsen, Pieter] Katholieke Univ Leuven, Univ Leuven, Ctr Human Genet, Electron Microscopy Facil,VIB Bio Imaging Core, B-3000 Leuven, Belgium; [O'Gara, James P.] Natl Univ Ireland, Sch Nat Sci, Dept Microbiol, Galway, Ireland; [Waters, Elaine] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Van Mellaert, Lieve] Katholieke Univ Leuven, Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res,Lab Mol Bacteriol, B-3000 Leuven, Belgium; [Van Eldere, Johan] Katholieke Univ Leuven, Univ Leuven, Univ Hosp Leuven, Dept Lab Med, B-3000 Leuven, Belgium	KU Leuven; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven; Ollscoil na Gaillimhe-University of Galway; University of Liverpool; KU Leuven; KU Leuven; University Hospital Leuven	Khodaparast, L; Van Eldere, J (corresponding author), KU Leuven Univ Leuven, Univ Leuven, Lab Clin Bacteriol & Mycol, Dept Microbiol & Immunol, B-3000 Leuven, Belgium.; Van Eldere, J (corresponding author), Katholieke Univ Leuven, Univ Leuven, Univ Hosp Leuven, Dept Lab Med, B-3000 Leuven, Belgium.	Laleh.khodaparast@switch.vib-kuleuven.be; Johan.vaneldere@uzleuven.be	O'Gara, James/GXG-4818-2022; Van Mellaert, Lieve/Q-4975-2017; Van Eldere, Johan/AAI-8965-2020; O'Gara, James/U-5641-2019; Stijlemans, Benoit/AAD-9122-2021; Waters, Elaine/C-8460-2018	Van Mellaert, Lieve/0000-0002-8584-8160; O'Gara, James/0000-0003-3866-7161; Stijlemans, Benoit/0000-0003-0082-9751; Khodaparast, Laleh/0000-0002-5865-7748; Waters, Elaine/0000-0002-6573-3462; Khodaparast, ladan/0000-0001-6373-8019				Arrecubieta C, 2009, PLOS PATHOG, P5, DOI DOI 10.1371/J0URNAL.PPAT.1000411; Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0; Buttner H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00014; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Cheung GYC, 2010, CURR OPIN INFECT DIS, V23, P208, DOI 10.1097/QCO.0b013e328337fecb; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Hennig S, 2007, INT J MED MICROBIOL, V297, P117, DOI 10.1016/j.ijmm.2006.12.001; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lazzell AL, 2009, J ANTIMICROB CHEMOTH, V64, P567, DOI 10.1093/jac/dkp242; Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Oosterlinck W, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/281312; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pereira M, 2002, J CELL SCI, V115, P609; Pintens V, 2008, MICROBIOL-SGM, V154, P2827, DOI 10.1099/mic.0.2007/015768-0; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Raad I, 1998, CLIN INFECT DIS, V26, P1182, DOI 10.1086/520285; Rawlinson LAB, 2011, J MED MICROBIOL, V60, P968, DOI 10.1099/jmm.0.025619-0; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shahrooei M, 2012, INFECT IMMUN, V80, P3660, DOI 10.1128/IAI.00104-12; Shahrooei M, 2009, INFECT IMMUN, V77, P3670, DOI 10.1128/IAI.01464-08; Singh R, 2010, J MED MICROBIOL, V59, P521, DOI 10.1099/jmm.0.017046-0; Uckay I, 2009, ANN MED, V41, P109, DOI 10.1080/07853890802337045; Van Wijngaerden E, 1999, J ANTIMICROB CHEMOTH, V44, P669, DOI 10.1093/jac/44.5.669; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x	44	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146704	10.1371/journal.pone.0146704	http://dx.doi.org/10.1371/journal.pone.0146704			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799073	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300031
J	Lee, WY; Do, JT; Park, C; Kim, JH; Chung, HJ; Kim, KW; Gil, CH; Kim, NH; Song, H				Lee, Won-Young; Do, Jeong Tae; Park, Chankyu; Kim, Jin Hoi; Chung, Hak-Jae; Kim, Kyung-Woon; Gil, Chang-Hyun; Kim, Nam-Hyung; Song, Hyuk			Identification of Putative Biomarkers for the Early Stage of Porcine Spermatogonial Stem Cells Using Next-Generation Sequencing	PLOS ONE			English	Article							IN-VITRO CULTURE; LIPOPOLYSACCHARIDE LPS; UNDIFFERENTIATED SPERMATOGONIA; EXTRACELLULAR-MATRIX; GERM-CELLS; RNA-SEQ; RECEPTOR; MOUSE; INSULIN; TESTIS	To identify putative biomarkers of porcine spermatogonial stem cells (pSSCs), total RNA sequencing (RNA-seq) analysis was performed on 5- and 180-day-old porcine testes and on pSSC colonies that were established under low temperature culture conditions as reported previously. In total, 10,184 genes were selected using Cufflink software, followed by a logarithm and quantile normalization of the pairwise scatter plot. The correlation rates of pSSCs compared to 5- and 180-day-old testes were 0.869 and 0.529, respectively and that between 5-and 180-day-old testes was 0.580. Hierarchical clustering data revealed that gene expression patterns of pSSCs were similar to 5-day-old testis. By applying a differential expression filter of four fold or greater, 607 genes were identified between pSSCs and 5-day-old testis, and 2118 genes were identified between the 5-and 180-day-old testes. Among these differentially expressed genes, 293 genes were upregulated and 314 genes were downregulated in the 5-day-old testis compared to pSSCs, and 1106 genes were upregulated and 1012 genes were downregulated in the 180-day-old testis compared to the 5-day-old testis. The following genes upregulated in pSSCs compared to 5-day-old testes were selected for additional analysis: matrix metallopeptidase 9 (MMP9), matrix metallopeptidase 1 (MMP1), glutathione peroxidase 1 (GPX1), chemokine receptor 1 (CCR1), insulin-like growth factor binding protein 3 (IGFBP3), CD14, CD209, and Kruppel-like factor 9 (KLF9). Expression levels of these genes were evaluated in pSSCs and in 5- and 180-day-old porcine testes. In addition, immunohistochemistry analysis confirmed their germ cell-specific expression in 5-and 180-day-old testes. These finding may not only be useful in facilitating the enrichment and sorting of porcine spermatogonia, but may also be useful in the study of the early stages of spermatogenic meiosis.	[Lee, Won-Young] Konkuk Univ, Coll Biomed & Hlth Sci, Res Inst Biomed & Hlth Sci, Dept Food Biosci, Chungju 380701, South Korea; [Do, Jeong Tae; Park, Chankyu; Kim, Jin Hoi; Song, Hyuk] Konkuk Univ, Dept Anim Biotechnol, 1 Hwayang Dong, Seoul 143701, South Korea; [Chung, Hak-Jae; Kim, Kyung-Woon] RDA, Natl Inst Anim Sci, Anim Biotechnol Div, Wanju Gun 565851, South Korea; [Gil, Chang-Hyun] Konkuk Univ, Sch Med, 1 Hwayang Dong, Seoul 143701, South Korea; [Kim, Nam-Hyung] Chungbuk Natl Univ, Coll Agr, Dept Anim Sci, Choung Ju 361763, South Korea	Konkuk University; Konkuk University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Konkuk University; Konkuk University Medical Center; Chungbuk National University	Song, H (corresponding author), Konkuk Univ, Dept Anim Biotechnol, 1 Hwayang Dong, Seoul 143701, South Korea.	songh@konkuk.ac.kr	Kim, Kyung-Woon/F-7287-2018; Park, Chankyu/D-8775-2011	Kim, Kyung-Woon/0000-0003-0225-9684; Park, Chankyu/0000-0003-4855-2210; Do, Jeong Tae/0000-0001-6721-1441; kim, jin-hoi/0000-0003-1232-5307	Next-Generation BioGreen 21 program, Rural Development Administration, Republic of Korea [PJ011076]	Next-Generation BioGreen 21 program, Rural Development Administration, Republic of Korea	This study was supported by grant PJ011076 from the Next-Generation BioGreen 21 program, Rural Development Administration, Republic of Korea.	Adham IM, 2001, MOL HUM REPROD, V7, P513, DOI 10.1093/molehr/7.6.513; Bang P, 1997, ENDOCRINOLOGY, V138, P3912, DOI 10.1210/en.138.9.3912; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buageaw A, 2005, BIOL REPROD, V73, P1011, DOI 10.1095/biolreprod.105.043810; Carninci P, 2009, NAT METHODS, V6, P711, DOI 10.1038/nmeth1009-711; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Goel S, 2008, REPRODUCTION, V135, P785, DOI 10.1530/REP-07-0476; Goel S, 2007, BIOL REPROD, V77, P127, DOI 10.1095/biolreprod.106.056879; Hirai H, 2014, CLIN EXP METASTAS, V31, P977, DOI 10.1007/s10585-014-9684-z; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kempisty Bartosz, 2006, Ginekol Pol, V77, P238; Kim YH, 2013, J ANIM SCI, V91, P3143, DOI 10.2527/jas.2012-6139; Krishnan P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1899-0; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Lee KH, 2013, REPROD DOMEST ANIM, V48, P954, DOI 10.1111/rda.12193; Lee WY, 2014, ANIM REPROD SCI, V150, P115, DOI 10.1016/j.anireprosci.2014.09.010; Lee WY, 2013, STEM CELL RES, V11, P1234, DOI 10.1016/j.scr.2013.08.008; Longin J, 2001, J CELL SCI, V114, P2125; Luke L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3359; Luo JP, 2006, MOL REPROD DEV, V73, P1531, DOI 10.1002/mrd.20529; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Neerincx M, 2015, ONCOGENESIS, V4, pe170; Ohta H, 2000, DEVELOPMENT, V127, P2125; Orwig KE, 2008, STEM CELLS, V26, P927, DOI 10.1634/stemcells.2007-0893; Pitetti JL, 2013, MOL ENDOCRINOL, V27, P814, DOI 10.1210/me.2012-1258; Prensner JR, 2014, LANCET ONCOL, V15, P1469, DOI 10.1016/S1470-2045(14)71113-1; Rajah Roopa, 1995, Progress in Growth Factor Research, V6, P273, DOI 10.1016/0955-2235(95)00012-7; Robinson LLL, 2001, MOL HUM REPROD, V7, P641, DOI 10.1093/molehr/7.7.641; Rodrigues A, 2008, BIOL REPROD, V79, P1135, DOI 10.1095/biolreprod.108.069930; Ryser S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-29; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Siu MKY, 2008, ADV EXP MED BIOL, V636, P74, DOI 10.1007/978-0-387-09597-4_5; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; SODER O, 1992, ENDOCRINOLOGY, V131, P2344, DOI 10.1210/en.131.5.2344; Sykorova V, 2015, ANTICANCER RES, V35, P2029; TOBIAS PS, 1993, J IMMUNOL, V150, P3011; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; ULEVITCH RJ, 1993, ADV IMMUNOL, V53, P267, DOI 10.1016/S0065-2776(08)60502-7; VANNELLI BG, 1988, FERTIL STERIL, V49, P666; Ventea S, 2012, STEM CELLS, V30, P1008, DOI 10.1002/stem.1077; Wang XY, 2015, INT J MOL SCI, V16, P26333, DOI 10.3390/ijms161125958; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yoon MJ, 2010, ANIM REPROD SCI, V122, P353, DOI 10.1016/j.anireprosci.2010.10.001; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	59	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147298	10.1371/journal.pone.0147298	http://dx.doi.org/10.1371/journal.pone.0147298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800048	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300089
J	Veltmann, M; Hollborn, M; Reichenbach, A; Wiedemann, P; Kohen, L; Bringmann, A				Veltmann, Moritz; Hollborn, Margrit; Reichenbach, Andreas; Wiedemann, Peter; Kohen, Leon; Bringmann, Andreas			Osmotic Induction of Angiogenic Growth Factor Expression in Human Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							NACL-INDUCED ACTIVATION; VITREORETINAL PROLIFERATIVE DISEASE; TRANSCRIPTION FACTOR TONEBP/OREBP; OXYGEN SPECIES CONTRIBUTE; PATHOGENIC T(H)17 CELLS; MACULAR DEGENERATION; HB-EGF; GENE-EXPRESSION; RISK-FACTORS; AGE	Background Although systemic hypertension is a risk factor of age-related macular degeneration, antihypertensive medications do not affect the risk of the disease. One condition that induces hypertension is high intake of dietary salt resulting in increased blood osmolarity. In order to prove the assumption that, in addition to hypertension, high osmolarity may aggravate neovascular retinal diseases, we determined the effect of extracellular hyperosmolarity on the expression of angiogenic cytokines in cultured human retinal pigment epithelial (RPE) cells. Methodology/Principal Findings Hyperosmolarity was induced by the addition of 100 mM NaCI or sucrose to the culture medium. Hypoxia and oxidative stress were induced by the addition of the hypoxia mimetic CoCl2 and H2O2, respectively. Alterations in gene expression were determined with realtime RT-PCR. Secretion of bFGF was evaluated by ELISA. Cell viability was determined by trypan blue exclusion. Nuclear factor of activated T cell 5 (NFAT5) expression was knocked down with siRNA. Hyperosmolarity induced transcriptional activation of bFGF, HB-EGF, and VEGF genes, while the expression of other cytokines such as EGF, PDGF-A, TGF-01, HGF, and PEDF was not or moderately altered. Hypoxia induced increased expression of the HB-EGF, EGF, PDGF-A, TGF-01, and VEGF genes, but not of the bFGF gene. Oxidative stress induced gene expression of HB-EGF, but not of bFGF. The hyperosmotic expression of the bFGF gene was dependent on the activation of p38a/0 MAPK, JNK, P13K, and the transcriptional activity of NFAT5. The hyperosmotic expression of the HB-EGF gene was dependent on the activation of p38a/0 MAPK, ERK1/2, and JNK. The hyperosmotic expression of bFGF, HB-EGF, and VEGF genes was reduced by inhibitors of TGF-01 superfamily activin receptor-like kinase receptors and the FGF receptor kinase, respectively. Hyperosmolarity induced secretion of bFGF that was reduced by inhibition of autocrine/paracrine TGF-01 signaling and by NFAT5 siRNA, respectively. Hyperosmolarity decreased the viability of the cells; this effect was not altered by exogenous bFGF and HBEGF. Various vegetable polyphenols (luteolin, quercetin, apigenin) inhibited the hyperosmotic expression of bFGF, HB-EGF, and NFAT5 genes. Conclusion Hyperosmolarity induces transcription of bFGF and HB-EGF genes, and secretion of bFGF from RPE cells. This is in part mediated by autocrine/paracrine TGF-131 and FGF signaling. It is suggested that high intake of dietary salt resulting in osmotic stress may aggravate neovascular retinal diseases via stimulation of the production of angiogenic factors in RPE cells, independent of hypertension.	[Veltmann, Moritz; Hollborn, Margrit; Wiedemann, Peter; Kohen, Leon; Bringmann, Andreas] Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany; [Veltmann, Moritz; Hollborn, Margrit; Wiedemann, Peter; Kohen, Leon; Bringmann, Andreas] Univ Leipzig, Hosp Eye, D-04109 Leipzig, Germany; [Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Kohen, Leon] Helios Klinikum Aue, Aue, Germany	Leipzig University; Leipzig University; Leipzig University; Helios Kliniken	Hollborn, M (corresponding author), Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany.; Hollborn, M (corresponding author), Univ Leipzig, Hosp Eye, D-04109 Leipzig, Germany.	hollbm@medizin.uni-leipzig.de	Reichenbach, Andreas/B-2510-2017		Deutsche Forschungsgemeinschaft [KO 1547/7-1, GRK 1097/1, RE 849/16-1]; Geschwister Freter Stiftung (Hannover, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Geschwister Freter Stiftung (Hannover, Germany)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (KO 1547/7-1 to L.K.; GRK 1097/1, RE 849/16-1, to A.R.) and the Geschwister Freter Stiftung (Hannover, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1993, BIOCHEM BIOPH RES CO, V193, P631, DOI 10.1006/bbrc.1993.1671; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Asakawa H, 1996, CELL BIOCHEM FUNCT, V14, P181; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Chen R, 2014, MOL VIS, V20, P242; Cheung Chris Yk, 2013, J Mol Signal, V8, P5, DOI 10.1186/1750-2187-8-5; Dias JRD, 2011, BRIT J OPHTHALMOL, V95, P1631, DOI 10.1136/bjo.2010.186361; Esposito E, 2002, NEUROBIOL AGING, V23, P719, DOI 10.1016/S0197-4580(02)00078-7; FAKTOROVICH EG, 1992, J NEUROSCI, V12, P3554; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Fraser-Bell S, 2008, AM J OPHTHALMOL, V145, P308, DOI 10.1016/j.ajo.2007.10.007; Granner T, 2013, BRIT J OPHTHALMOL, V97, P371, DOI 10.1136/bjophthalmol-2012-302002; Guillonneau X, 1997, EXP CELL RES, V233, P198, DOI 10.1006/excr.1997.3542; Harnett ME, 1999, INVEST OPHTH VIS SCI, V40, P2945; He FJ, 2005, HYPERTENSION, V45, P98, DOI 10.1161/01.HYP.0000149431.79450.a2; Hollborn M, 2005, MOL VIS, V11, P397; Hollborn M, 2004, GRAEF ARCH CLIN EXP, V242, P414, DOI 10.1007/s00417-004-0879-x; Hollborn M, 2006, CURR EYE RES, V31, P863, DOI 10.1080/02713680600888807; Hollborn M, 2015, MOL VIS, V21, P360; Hollborn M, 2009, INVEST OPHTH VIS SCI, V50, P4452, DOI 10.1167/iovs.08-3194; Hollborn MR, 2004, LAB INVEST, V84, P963, DOI 10.1038/labinvest.3700121; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Inoue Y, 2013, INVEST OPHTH VIS SCI, V54, P3815, DOI 10.1167/iovs.12-11236; Irarrazabal CE, 2006, P NATL ACAD SCI USA, V103, P8882, DOI 10.1073/pnas.0602911103; Izumi Y, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12000; Jo N, 2006, AM J PATHOL, V168, P2036, DOI 10.2353/ajpath.2006.050588; Kawasaka K, 1977, JPN J OPHTHALMOL, V31, P23; Kenney WL, 2001, MED SCI SPORT EXER, V33, P1524, DOI 10.1097/00005768-200109000-00016; KHAW KT, 1988, CIRCULATION, V77, P53, DOI 10.1161/01.CIR.77.1.53; Kippenberger S, 2005, FEBS LETT, V579, P207, DOI 10.1016/j.febslet.2004.11.077; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Koh YH, 2001, J BIOCHEM-TOKYO, V130, P351, DOI 10.1093/oxfordjournals.jbchem.a002993; Kuper C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00293; Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Miller JW, 2010, JPN J OPHTHALMOL, V54, P523, DOI 10.1007/s10384-010-0863-4; Miyakawa H, 1998, AM J PHYSIOL-RENAL, V274, pF753, DOI 10.1152/ajprenal.1998.274.4.F753; Mousa SA, 1999, J CELL BIOCHEM, V74, P135, DOI 10.1002/(SICI)1097-4644(19990701)74:1<135::AID-JCB15>3.3.CO;2-R; Nagineni CN, 2003, J CELL PHYSIOL, V197, P453, DOI 10.1002/jcp.10378; Obika Lf O, 2013, Niger J Physiol Sci, V28, P83; Orgul S, 1993, Ger J Ophthalmol, V2, P436; Oshima Y, 2004, J CELL PHYSIOL, V201, P393, DOI 10.1002/jcp.20110; Park SW, 2012, INVEST OPHTH VIS SCI, V53, P7718, DOI 10.1167/iovs.11-8790; Peng PH, 2008, EXP EYE RES, V86, P637, DOI 10.1016/j.exer.2008.01.008; Roth F, 2004, GRAEF ARCH CLIN EXP, V242, P710, DOI 10.1007/s00417-004-0976-x; Schlingemann RO, 2009, PROG BRAIN RES, V175, P253, DOI 10.1016/S0079-6123(09)17517-9; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; SHIRAO Y, 1987, INVEST OPHTH VIS SCI, V28, P2015; Silva KC, 2013, INVEST OPHTH VIS SCI, V54, P1325, DOI 10.1167/iovs.12-10647; Sivakumar V, 2008, J NEUROSCI RES, V86, P702, DOI 10.1002/jnr.21519; SOUBRANE G, 1994, CURR EYE RES, V13, P183, DOI 10.3109/02713689408995776; Steinberg R. H., 1985, PROGR RETINAL RES, P33, DOI 10.1016/0278-4327(85)90004-5; Tranos P, 2013, DRUG DES DEV THER, V7, P485, DOI 10.2147/DDDT.S43470; Van Leeuwen R, 2004, OPHTHALMOLOGY, V111, P1169, DOI 10.1016/j.ophtha.2003.10.024; Wang H, 2015, AM J PHYSIOL-RENAL, V308, pF140, DOI 10.1152/ajprenal.00471.2014; Weuste M, 2006, BIOCHEM BIOPH RES CO, V347, P310, DOI 10.1016/j.bbrc.2006.06.077; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yan Q, 2001, IN VITRO CELL DEV-AN, V37, P45; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P5620, DOI 10.1073/pnas.0801453105; Zhou XM, 2006, AM J PHYSIOL-RENAL, V290, pF1169, DOI 10.1152/ajprenal.00378.2005; Zhou XM, 2005, AM J PHYSIOL-RENAL, V289, pF377, DOI 10.1152/ajprenal.00463.2004	69	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147312	10.1371/journal.pone.0147312	http://dx.doi.org/10.1371/journal.pone.0147312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800359	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300092
J	Lovati, AB; Romano, CL; Bottagisio, M; Monti, L; De Vecchi, E; Previdi, S; Accetta, R; Drago, L				Lovati, Arianna Barbara; Romano, Carlo Luca; Bottagisio, Marta; Monti, Lorenzo; De Vecchi, Elena; Previdi, Sara; Accetta, Riccardo; Drago, Lorenzo			Modeling Staphylococcus epidermidis-Induced Non-Unions: Subclinical and Clinical Evidence in Rats	PLOS ONE			English	Article							STABILIZED SEGMENTAL DEFECT; COAGULASE-NEGATIVE STAPHYLOCOCCI; BIOFILM FORMATION; IN-VIVO; GRAFT INFECTION; OSTEOMYELITIS; FRACTURE; DEBRIDEMENT; AUTOLYSIN; AUREUS	S. epidermidis is one of the leading causes of orthopaedic infections associated with biofilm formation on implant devices. Open fractures are at risk of S. epidermidis transcutaneous contamination leading to higher non-union development compared to closed fractures. Although the role of infection in delaying fracture healing is well recognized, no in vivo models investigated the impact of subclinical low-grade infections on bone repair and non-union. We hypothesized that the non-union rate is directly related to the load of this commonly retrieved pathogen and that a low-grade contamination delays the fracture healing without clinically detectable infection. Rat femurs were osteotomized and stabilized with plates. Fractures were infected with a characterized clinical-derived methicillin-resistant S. epidermidis (103, 105, 108 colony forming units) and compared to uninfected controls. After 56 days, bone healing and osteomyelitis were clinically assessed and further evaluated by micro-CT, microbiological and histological analyses. The biofilm formation was visualized by scanning electron microscopy. The control group showed no signs of infection and a complete bone healing. The 103 group displayed variable response to infection with a 67% of altered bone healing and positive bacterial cultures, despite no clinical signs of infection present. The 105 and 108 groups showed severe signs of osteomyelitis and a non-union rate of 83-100%, respectively. The cortical bone reaction related to the periosteal elevation in the control group and the metal scattering detected by micro-CT represented limitations of this study. Ourmodel showed that an intraoperative low-grade S. epidermidis contamination might prevent the bone healing, even in the absence of infectious signs. Our findings also pointed out a dose-dependent effect between the S. epidermidis inoculum and non-union rate. This pilot study identifies a relevant preclinical model to assess the role of subclinical infections in orthopaedic and trauma surgery and to test specifically designed diagnostic, prevention and therapeutic strategies.	[Lovati, Arianna Barbara; Bottagisio, Marta] IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy; [Romano, Carlo Luca] IRCCS Galeazzi Orthopaed Inst, Dipartimento Chirurgia Ricostrutt & Infez Osteoar, Milan, Italy; [Monti, Lorenzo; Accetta, Riccardo] IRCCS Galeazzi Orthopaed Inst, Orthopaed & Traumatol, Milan, Italy; [De Vecchi, Elena; Drago, Lorenzo] IRCCS Galeazzi Orthopaed Inst, Lab Clin Chem & Microbiol, Milan, Italy; [Previdi, Sara] Mario Negri Inst Pharmacol Res, Dept Oncol, Lab Canc Cachexia AIRC Start Up, Via Eritrea 62, Milan, Italy; [Drago, Lorenzo] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Bottagisio, Marta] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; University of Milan	Lovati, AB (corresponding author), IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy.	arianna.lovati@grupposandonato.it	De Vecchi, Elena/B-8209-2017; Bottagisio, Marta/J-8212-2016; Monti, Lorenzo/AAB-2967-2020; Lovati, Arianna Barbara/J-8213-2016; ROMANO, CARLO LUCA/C-4310-2017	De Vecchi, Elena/0000-0001-9781-8607; Bottagisio, Marta/0000-0001-8105-5959; Lovati, Arianna Barbara/0000-0002-5230-9718; ROMANO, CARLO LUCA/0000-0001-6726-0593	Italian Ministry of Health (RC, Research Line 4) [62]	Italian Ministry of Health (RC, Research Line 4)	The financial support for this study was provided by the Italian Ministry of Health (RC 2014, Research Line 4, # 62). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalar C, 2006, ANZ J SURG, V76, P387, DOI 10.1111/j.1445-2197.2006.03728.x; Alt V, 2011, BONE, V48, P1146, DOI 10.1016/j.bone.2011.01.018; ANDRIOLE VT, 1973, J BONE JOINT SURG AM, VA 55, P1511, DOI 10.2106/00004623-197355070-00019; Bracho DO, 2009, ACAD EMERG MED, V16, P656, DOI 10.1111/j.1553-2712.2009.00439.x; Chauhan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037281; Chen XQ, 2007, J ORTHOP TRAUMA, V21, P693, DOI 10.1097/BOT.0b013e31815a7e91; Chen XQ, 2006, J BONE JOINT SURG AM, V88A, P1510, DOI 10.2106/JBJS.E.01136; Chen XQ, 2005, J ORTHOP RES, V23, P816, DOI 10.1016/j.orthres.2005.01.009; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Ciampolini J, 2000, POSTGRAD MED J, V76, P479, DOI 10.1136/pmj.76.898.479; Del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P4064, DOI 10.1128/AAC.00432-09; Drago L, 2012, CLIN ORTHOP RELAT R, V470, P2915, DOI 10.1007/s11999-012-2415-3; Esteban J, 2012, Open Orthop J, V6, P255, DOI 10.2174/1874325001206010255; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Garcia P, 2013, EUR CELLS MATER, V26, P1; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hirschfeld J, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.26102; Horst SA, 2012, AM J PATHOL, V181, P1206, DOI 10.1016/j.ajpath.2012.07.005; Hou Z, 2013, ANTIMICROB AGENTS CH, V57, P5045, DOI 10.1128/AAC.00504-13; Jonasson J, 2007, APMIS, V115, P668; Kim PH, 2012, CLIN ORTHOP RELAT R, V470, P3270, DOI 10.1007/s11999-012-2376-6; Kokubu T, 2003, J ORTHOP RES, V21, P503, DOI 10.1016/S0736-0266(02)00209-7; Lima ALL, 2014, BRAZ J INFECT DIS, V18, P526, DOI 10.1016/j.bjid.2013.12.005; Lovati AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067628; LOWY FD, 1983, ANN INTERN MED, V99, P834, DOI 10.7326/0003-4819-99-6-834; Mills LA, 2012, J BONE JOINT SURG BR, V94B, P865, DOI 10.1302/0301-620X.94B7.27370; Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]; O'Neill KR, 2012, BONE, V50, P1357, DOI 10.1016/j.bone.2012.03.008; Odekerken JCE, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-38; OSTERMANN PAW, 1994, ORTHOPEDICS, V17, P397; Qin H, 2014, BIOMATERIALS, V35, P9114, DOI 10.1016/j.biomaterials.2014.07.040; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Romano CL, 2012, HIP INT, V22, pS19, DOI 10.5301/HIP.2012.9566; Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279; RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231; Sacar M, 2007, J SURG RES, V139, P170, DOI 10.1016/j.jss.2006.10.003; Sanchez CJ, 2013, BIOMATERIALS, V34, P7533, DOI 10.1016/j.biomaterials.2013.06.026; Seligson D, 1999, CLIN ORTHOP RELAT R, P30; Southwood LL, 2004, J ORTHOP RES, V22, P66, DOI 10.1016/S0736-0266(03)00129-3; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Trampuz Andrej, 2008, Curr Infect Dis Rep, V10, P394, DOI 10.1007/s11908-008-0064-1; Van Praagh ADG, 2011, ANTIMICROB AGENTS CH, V55, P4081, DOI 10.1128/AAC.00147-11; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; WORLOCK P, 1988, BRIT J EXP PATHOL, V69, P235; Zhai HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102760	45	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147447	10.1371/journal.pone.0147447	http://dx.doi.org/10.1371/journal.pone.0147447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796958	gold, Green Submitted, Green Published			2022-12-26	WOS:000368530300035
J	Cruz, FF; Horta, LFB; Maia, LD; Lopes-Pacheco, M; da Silva, AB; Morales, MM; Goncalves-de-Albuquerque, CF; Takiya, CM; de Castro-Faria-Neto, HC; Rocco, PRM				Cruz, Fernanda Ferreira; Bastos Horta, Lucas Felipe; Maia, Ligia de Albuquerque; Lopes-Pacheco, Miqueias; da Silva, Andre Benedito; Morales, Marcelo Marco; Goncalves-de-Albuquerque, Cassiano Felippe; Takiya, Christina Maeda; de Castro-Faria-Neto, Hugo Caire; Macedo Rocco, Patricia Rieken			Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis	PLOS ONE			English	Article							TYROSINE-KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; IN-VITRO; MACROPHAGE POLARIZATION; KAPPA-B; ACTIVATION; VIVO; MECHANISMS; COLLAGEN; DISEASE	Silicosis is an occupational lung disease with no effective treatment. We hypothesized that dasatinib, a tyrosine kinase inhibitor, might exhibit therapeutic efficacy in silica-induced pulmonary fibrosis. Silicosis was induced in C57BL/6 mice by a single intratracheal administration of silica particles, whereas the control group received saline. After 14 days, when the disease was already established, animals were randomly assigned to receive DMSO or dasatinib (1 mg/kg) by oral gavage, twice daily, for 14 days. On day 28, lung morphofunction, inflammation, and remodeling were investigated. RAW 264.7 cells (a macrophage cell line) were incubated with silica particles, followed by treatment or not with dasatinib, and evaluated for macrophage polarization. On day 28, dasatinib improved lung mechanics, increased M2 macrophage counts in lung parenchyma and granuloma, and was associated with reduction of fraction area of granuloma, fraction area of collapsed alveoli, protein levels of tumor necrosis factor-alpha, interleukin-1 beta, transforming growth factor-beta, and reduced neutrophils, M1 macrophages, and collagen fiber content in lung tissue and granuloma in silicotic animals. Additionally, dasatinib reduced expression of iNOS and increased expression of arginase and metalloproteinase-9 in silicotic macrophages. Dasatinib was effective at inducing macrophage polarization toward the M2 phenotype and reducing lung inflammation and fibrosis, thus improving lung mechanics in a murine model of acute silicosis.	[Cruz, Fernanda Ferreira; Bastos Horta, Lucas Felipe; Maia, Ligia de Albuquerque; Lopes-Pacheco, Miqueias; da Silva, Andre Benedito; Macedo Rocco, Patricia Rieken] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Pulm Invest, BR-21941 Rio De Janeiro, Brazil; [Lopes-Pacheco, Miqueias; da Silva, Andre Benedito; Morales, Marcelo Marco] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Cellular & Mol Physiol, BR-21941 Rio De Janeiro, Brazil; [Goncalves-de-Albuquerque, Cassiano Felippe; de Castro-Faria-Neto, Hugo Caire] Fiocruz MS, Inst Oswaldo Cruz, Lab Immunopharmacol, BR-21045900 Rio De Janeiro, Brazil; [Takiya, Christina Maeda] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Cellular Pathol, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Pulm Invest, BR-21941 Rio De Janeiro, Brazil.	prmrocco@biof.ufrj.br	Gonçalves-de-Albuquerque, Cassiano Felippe/ABH-2409-2020; Gonçalves-de-Albuquerque, Cassiano Felippe/N-2815-2014; Lopes-Pacheco, Miquéias/I-1290-2017; Rocco, Patricia/I-7460-2012; Takiya, Christina/AAU-5959-2021; Cruz, Fernanda F/P-1193-2016; Lopes-Pacheco, Miquéias/AAM-7432-2020	Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Rocco, Patricia/0000-0003-1412-7136; Takiya, Christina/0000-0002-8019-628X; Cruz, Fernanda F/0000-0001-9443-3648; Lopes-Pacheco, Miquéias/0000-0002-7444-9359	European Community [HEALTH-F4-2011-282095]; Brazilian Council for Scientific and Technological Development (CNPq); Rio de Janeiro State Research Foundation (FAPERJ) (CNPq); Coordination for the Improvement of Higher Level Personnel (CAPES)	European Community(European Commission); Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Foundation (FAPERJ) (CNPq); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the European Community's Seventh Framework Programme [FP7-2007-2013] under grant agreement no. HEALTH-F4-2011-282095 (HCCFN, PRMR), Brazilian Council for Scientific and Technological Development (CNPq) (MMM, CMT, HCCFN, PRMR), the Rio de Janeiro State Research Foundation (FAPERJ) (CNPq) (MMM, CMT, HCCFN, PRMR) and Coordination for the Improvement of Higher Level Personnel (CAPES) (MMM, CMT, HCCFN, PRMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MA, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0118-x; BATES JHT, 1985, J APPL PHYSIOL, V59, P732, DOI 10.1152/jappl.1985.59.3.732; Blake SJ, 2008, BLOOD, V111, P4415, DOI 10.1182/blood-2008-02-138701; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/769214, DOI 10.1155/2013/769214]; Borges VM, 2002, AM J RESP CELL MOL, V27, P78, DOI 10.1165/ajrcmb.27.1.4717; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Chen C, 2013, ADV EXP MED BIOL, V765, P47, DOI 10.1007/978-1-4614-4989-8_7; Cowie RL, 2010, MURRAY NADELS TXB RE; Di Giuseppe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005689; Endo M, 2003, AM J PHYSIOL-LUNG C, V285, pL313, DOI 10.1152/ajplung.00434.2002; Faffe DS, 2001, J APPL PHYSIOL, V90, P1400, DOI 10.1152/jappl.2001.90.4.1400; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Fraser CK, 2009, EXP HEMATOL, V37, P1435, DOI 10.1016/j.exphem.2009.09.007; Futosi K, 2012, BLOOD, V119, P4981, DOI 10.1182/blood-2011-07-369041; Gratacap MP, 2009, BLOOD, V114, P1884, DOI 10.1182/blood-2009-02-205328; Greenberg MI, 2007, DM-DIS MON, V53, P394, DOI 10.1016/j.disamonth.2007.09.020; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Kang JL, 2006, TOXICOL SCI, V90, P470, DOI 10.1093/toxsci/kfj096; Kneidinger M, 2008, BLOOD, V111, P3097, DOI 10.1182/blood-2007-08-104372; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Lopes-Pacheco M, 2013, CELL PHYSIOL BIOCHEM, V32, P1681, DOI 10.1159/000356603; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Maron-Gutierrez T, 2011, EUR RESPIR J, V37, P1217, DOI 10.1183/09031936.00205009; Misson P, 2004, J LEUKOCYTE BIOL, V76, P926, DOI 10.1189/jlb.0104019; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Ozanne J, 2015, BIOCHEM J, V465, P271, DOI 10.1042/BJ20141165; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rabenau KE, 2014, CANCER GENET-NY, V207, P109, DOI 10.1016/j.cancergen.2014.02.006; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Rimal B, 2005, CURR OPIN PULM MED, V11, P169, DOI 10.1097/01.mcp.0000152998.11335.24; Schade AE, 2008, BLOOD, V111, P1366, DOI 10.1182/blood-2007-04-084814; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Vandyke K, 2010, J BONE MINER RES, V25, P1759, DOI 10.1002/jbmr.85; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Weibel ER., 1990, MODELS LUNG DIS MICR, P199; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Weng SY, 2014, J HEPATOL, V60, pS279, DOI 10.1016/S0168-8278(14)60795-9; Wilson HM, 2004, CURR OPIN NEPHROL HY, V13, P285, DOI 10.1097/00041552-200405000-00004; Zarbock A, 2011, ARCH BIOCHEM BIOPHYS, V510, P112, DOI 10.1016/j.abb.2011.02.009	42	47	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147005	10.1371/journal.pone.0147005	http://dx.doi.org/10.1371/journal.pone.0147005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789403	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100052
J	Xu, JT; Lowe, RJ; Ivey, GN; Jones, NL; Zhang, ZL				Xu, Jiangtao; Lowe, Ryan J.; Ivey, Gregory N.; Jones, Nicole L.; Zhang, Zhenlin			Ocean Transport Pathways to a World Heritage Fringing Coral Reef: Ningaloo Reef, Western Australia	PLOS ONE			English	Article							LEEUWIN CURRENT; SHELF CIRCULATION; BUOYANCY ARREST; DYNAMICS; PARTICLES; MESOSCALE; SIMULATE; MODEL	A Lagrangian particle tracking model driven by a regional ocean circulation model was used to investigate the seasonally varying connectivity patterns within the shelf circulation surrounding the 300 km long Ningaloo Reef in Western Australia (WA) during 2009-2010. Forward-in-time simulations revealed that surface water was transported equatorward and offshore in summer due to the upwelling-favorable winds. In winter, however, water was transported polewards down the WA coast due to the seasonally strong Leeuwin Current. Using backward-in-time simulations, the subsurface transport pathways revealed two main source regions of shelf water reaching Ningaloo Reef: (1) a year-round source to the northeast in the upper 100 m of water column; and (2) during the summer, an additional source offshore and to the west of Ningaloo in depths between similar to 30 and similar to 150 m. Transient wind-driven coastal upwelling, onshore geostrophic transport and stirring by offshore eddies were identified as the important mechanisms influencing the source water origins. The identification of these highly time-dependent transport pathways and source water locations is an essential step towards quantifying how key material (e.g., nutrients, larvae, contaminants, etc.) is exchanged between Ningaloo Reef and the surrounding shelf ocean, and how this is mechanistically coupled to the complex ocean dynamics in this region.	[Xu, Jiangtao; Ivey, Gregory N.; Jones, Nicole L.] Univ Western Australia, Sch Civil Environm & Min Engn, Crawley, Australia; [Xu, Jiangtao; Lowe, Ryan J.; Ivey, Gregory N.; Jones, Nicole L.; Zhang, Zhenlin] Univ Western Australia, UWA Oceans Inst, Crawley, Australia; [Lowe, Ryan J.; Zhang, Zhenlin] Univ Western Australia, Sch Earth & Environm, Crawley, Australia; [Lowe, Ryan J.] Univ Western Australia, ARC Ctr Excellence Coral Reef Studies, Crawley, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Xu, JT (corresponding author), Univ Western Australia, Sch Civil Environm & Min Engn, Crawley, Australia.; Xu, JT (corresponding author), Univ Western Australia, UWA Oceans Inst, Crawley, Australia.	jiangtao.xu@uwa.edu.au	Jones, Nicole/A-3549-2009; Ivey, Gregory N/K-5299-2012; Lowe, Ryan/A-5032-2012	Jones, Nicole/0000-0003-2550-4590; Ivey, Gregory N/0000-0003-2469-2470; Lowe, Ryan/0000-0002-7080-8406	Scholarship for International Research Fees at the University of Western Australia; Australian Research Council [DP120103036, DP0985221]; Pilbara Marine Conservation Program as part of the State of Western Australia's Net Conservation Benefits Fund; Australian Research Council Centre of Excellence for Coral Reef Studies [CE140100020]	Scholarship for International Research Fees at the University of Western Australia; Australian Research Council(Australian Research Council); Pilbara Marine Conservation Program as part of the State of Western Australia's Net Conservation Benefits Fund; Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	JX acknowledges support from a Scholarship for International Research Fees at the University of Western Australia. This work was supported by Australian Research Council Discovery Project grants (DP120103036 and DP0985221) with additional support provided by the Pilbara Marine Conservation Program as part of the State of Western Australia's Net Conservation Benefits Fund. RL also acknowledges support through the Australian Research Council Centre of Excellence for Coral Reef Studies (CE140100020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassin CJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023017; Batchelder HP, 2006, J ATMOS OCEAN TECH, V23, P727, DOI 10.1175/JTECH1874.1; Beardsley RC, 1985, INTRODUCTION TO THE; Brink KH, 2012, J PHYS OCEANOGR, V42, P644, DOI 10.1175/JPO-D-11-0143.1; Brink KH, 2010, J PHYS OCEANOGR, V40, P636, DOI 10.1175/2009JPO4267.1; Brink KH, 2010, J PHYS OCEANOGR, V40, P621, DOI 10.1175/2009JPO4266.1; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; CRESSWELL GR, 1980, DEEP-SEA RES, V27, P449, DOI 10.1016/0198-0149(80)90055-2; Cushman-Roisin B, 2010, INTRODUCTION TO GEOP; Domingues CM, 2007, DEEP-SEA RES PT II, V54, P797, DOI 10.1016/j.dsr2.2006.10.003; Feng M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001763; Feng M, 2005, J PHYS OCEANOGR, V35, P964, DOI 10.1175/JPO2730.1; GARRETT C, 1993, ANNU REV FLUID MECH, V25, P291, DOI 10.1146/annurev.fl.25.010193.001451; GODFREY JS, 1985, J PHYS OCEANOGR, V15, P481, DOI 10.1175/1520-0485(1985)015<0481:TLSEOT>2.0.CO;2; Haidvogel DB, 2008, J COMPUT PHYS, V227, P3595, DOI 10.1016/j.jcp.2007.06.016; Hanson CE, 2005, CONT SHELF RES, V25, P1561, DOI 10.1016/j.csr.2005.04.003; HOLLOWAY PE, 1995, DEEP-SEA RES PT I, V42, P285, DOI 10.1016/0967-0637(95)00004-P; Klein P, 2009, ANNU REV MAR SCI, V1, P351, DOI 10.1146/annurev.marine.010908.163704; Lowe RJ, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007653; MACCREADY P, 1991, J FLUID MECH, V223, P631, DOI 10.1017/S0022112091001581; Marchesiello P, 2010, J MAR RES, V68, P37, DOI 10.1357/002224010793079004; Meuleners MJ, 2008, DEEP-SEA RES PT I, V55, P261, DOI 10.1016/j.dsr.2007.12.004; North EW, 2008, MAR ECOL PROG SER, V359, P99, DOI 10.3354/meps07317; North EW, 2006, J MARINE SYST, V60, P365, DOI 10.1016/j.jmarsys.2005.08.003; North EW, 2011, GEOPHYS MONOGR SER, V195, P217, DOI 10.1029/2011GM001102; Ridgway KR, 2015, J GEOPHYS RES-OCEANS, V120, P6843, DOI 10.1002/2015JC011049; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; Rivas D, 2011, J PHYS OCEANOGR, V41, P88, DOI 10.1175/2010JPO4327.1; Rossi V, 2013, J GEOPHYS RES-OCEANS, V118, P3608, DOI 10.1002/jgrc.20242; Rossi V, 2013, J GEOPHYS RES-OCEANS, V118, P1211, DOI 10.1002/jgrc.20110; Roughan M, 2003, J PHYS OCEANOGR, V33, P2551, DOI 10.1175/1520-0485(2003)033<2551:AMSOTC>2.0.CO;2; Schlag Z, 2012, REPORT; SMITH RL, 1991, J PHYS OCEANOGR, V21, P323, DOI 10.1175/1520-0485(1991)021<0323:TLCOWA>2.0.CO;2; THOMPSON RORY, 1984, J PHYS OCEANOGR, V14, P623, DOI 10.1175/1520-0485(1984)014<0623:OOTLCO>2.0.CO;2; Visser AW, 1997, MAR ECOL PROG SER, V158, P275, DOI 10.3354/meps158275; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Wyatt ASJ, 2012, LIMNOL OCEANOGR, V57, P401, DOI 10.4319/lo.2012.57.2.0401; Wyatt ASJ, 2010, MAR ECOL PROG SER, V405, P113, DOI 10.3354/meps08508; Xu J, 2014, OCEAN DYNAMICS AND C; Xu JT, 2015, CONT SHELF RES, V95, P54, DOI 10.1016/j.csr.2014.12.013; Xu JT, 2013, J GEOPHYS RES-OCEANS, V118, P1099, DOI 10.1002/jgrc.20098	41	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145822	10.1371/journal.pone.0145822	http://dx.doi.org/10.1371/journal.pone.0145822			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790154	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100017
J	Bavi, R; Kumar, R; Choi, L; Lee, KW				Bavi, Rohit; Kumar, Raj; Choi, Light; Lee, Keun Woo			Exploration of Novel Inhibitors for Bruton's Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation	PLOS ONE			English	Article							X-LINKED AGAMMAGLOBULINEMIA; B-CELL MALIGNANCIES; POTENT INHIBITOR; BINDING PROTEIN; BTK; DOMAIN; LFM-A13; FAMILY; IDENTIFICATION; GENERATION	Bruton's tyrosine kinase (BTK) is a cytoplasmic, non-receptor tyrosine kinase which is expressed in most of the hematopoietic cells and plays an important role in many cellular signaling pathways. B cell malignancies are dependent on BCR signaling, thus making BTK an efficient therapeutic target. Over the last few years, significant efforts have been made in order to develop BTK inhibitors to treat B-cell malignancies, and autoimmunity or allergy/hypersensitivity but limited success has been achieved. Here in this study, 3D QSAR pharmacophore models were generated for Btk based on known IC50 values and experimental energy scores with extensive validations. The five features pharmacophore model, Hypo1, includes one hydrogen bond acceptor lipid, one hydrogen bond donor, and three hydrophobic features, which has the highest correlation coefficient (0.98), cost difference (112.87), and low RMS (1.68). It was further validated by the Fisher's randomization method and test set. The well validated Hypo1 was used as a 3D query to search novel Btk inhibitors with different chemical scaffold using high throughput virtual screening technique. The screened compounds were further sorted by applying ADMET properties, Lipinski's rule of five and molecular docking studies to refine the retrieved hits. Furthermore, molecular dynamic simulation was employed to study the stability of docked conformation and to investigate the binding interactions in detail. Several important hydrogen bonds with Btk were revealed, which includes the gatekeeper residues Glu475 and Met 477 at the hinge region. Overall, this study suggests that the proposed hits may be more effective inhibitors for cancer and autoimmune therapy.	[Bavi, Rohit; Kumar, Raj; Choi, Light; Lee, Keun Woo] GNU, RINS, PMBBRC, Div Appl Life Sci,Plus Program BK21,SSAC, 501 Jinju Daero, Jinju 52828, South Korea		Lee, KW (corresponding author), GNU, RINS, PMBBRC, Div Appl Life Sci,Plus Program BK21,SSAC, 501 Jinju Daero, Jinju 52828, South Korea.	kwlee@gnu.ac.kr	Bavi, Rohit/X-9173-2019; Kumar, Raj/C-4022-2016	Bavi, Rohit/0000-0003-3167-4131; Kumar, Raj/0000-0003-2328-8521	BK21 PLUS program of Ministry of Education and Human Resources Development, South Korea; Pioneer Research Center Program through the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning [NRF-2015M3C1A3023028]; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ01106202]	BK21 PLUS program of Ministry of Education and Human Resources Development, South Korea; Pioneer Research Center Program through the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	Dr. Rohit S. Bavi was financially supported by a postdoctoral fellowship from BK21 PLUS program of Ministry of Education and Human Resources Development, South Korea. This research was supported by the Pioneer Research Center Program through the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2015M3C1A3023028). This work was also supported by the Next-Generation BioGreen 21 Program (PJ01106202) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalipour A, 2013, BRIT J HAEMATOL, V163, P436, DOI 10.1111/bjh.12573; Barf T, 2012, J MED CHEM, V55, P6243, DOI 10.1021/jm3003203; Bonnet P, 2004, PROTEIN SCI, V13, P946, DOI 10.1110/ps.03129704; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chang BY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3400; CONLEY ME, 1985, J IMMUNOL, V134, P3070; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Debnath AK, 2002, J MED CHEM, V45, P41, DOI 10.1021/jm010360c; Di Paolo JA, NOVEL SPECIFIC BTK I; Fischer R, 1966, THE PRINCIPLE OF EXP; Goldberg DR, 2003, J MED CHEM, V46, P1337, DOI 10.1021/jm020446l; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; John S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S4; John S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S28; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Kang SW, 2001, EMBO J, V20, P5692, DOI 10.1093/emboj/20.20.5692; Kersseboom R, 2006, J IMMUNOL, V176, P4543, DOI 10.4049/jimmunol.176.8.4543; Kim KH, 2011, BIOORG MED CHEM LETT, V21, P6258, DOI 10.1016/j.bmcl.2011.09.008; Leandro MJ, 2009, CLIN EXP IMMUNOL, V157, P191, DOI 10.1111/j.1365-2249.2009.03978.x; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu WM, 2001, NAT IMMUNOL, V2, P939, DOI 10.1038/ni1001-939; Lou Y, 2012, J MED CHEM, V55, P4539, DOI 10.1021/jm300035p; Maas A, 2001, Dev Immunol, V8, P171, DOI 10.1155/2001/28962; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nore BF, 2003, BBA-PROTEINS PROTEOM, V1645, P123, DOI 10.1016/S1570-9639(02)00524-1; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Sakkiah S, 2010, EUR J MED CHEM, V45, P2132, DOI 10.1016/j.ejmech.2010.01.016; Sonawane KD, 2015, AMINO ACIDS, V47, P543, DOI 10.1007/s00726-014-1887-8; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Steindl T, 2004, J CHEM INF COMP SCI, V44, P1849, DOI 10.1021/ci049844i; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Uckun FM, 2007, BIOORGAN MED CHEM, V15, P800, DOI 10.1016/j.bmc.2006.10.050; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; van den Akker E, 2004, BIOL CHEM, V385, P409; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VIHINEN M, 1994, FEBS LETT, V350, P263, DOI 10.1016/0014-5793(94)00783-7; Vorontsov II, 2011, J COMPUT CHEM, V32, P1043, DOI 10.1002/jcc.21683; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; Wiestner A, 2013, J CLIN ONCOL, V31, P128, DOI 10.1200/JCO.2012.44.4281; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	51	21	23	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147190	10.1371/journal.pone.0147190	http://dx.doi.org/10.1371/journal.pone.0147190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784025	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400120
J	Bumdelger, B; Kokubo, H; Kamata, R; Fujii, M; Yoshimura, K; Aoki, H; Orita, Y; Ishida, T; Ohtaki, M; Nagao, M; Ishida, M; Yoshizumi, M				Bumdelger, Batmunkh; Kokubo, Hiroki; Kamata, Ryo; Fujii, Masayuki; Yoshimura, Koichi; Aoki, Hiroki; Orita, Yuichi; Ishida, Takafumi; Ohtaki, Megu; Nagao, Masataka; Ishida, Mari; Yoshizumi, Masao			Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; MATRIX METALLOPROTEINASES; SERUM OSTEOPROTEGERIN; VASCULAR CALCIFICATION; EXPRESSION; MATRIX-METALLOPROTEINASE-9; ATHEROSCLEROSIS; PROLIFERATION; PATHOGENESIS	Abdominal aortic aneurysms (AAAs), which commonly occur among elderly individuals, are accompanied by a risk of rupture and subsequent high mortality. Establishment of medical therapies for the prevention of AAAs requires further understanding of the molecular pathogenesis of this condition. This report details the possible involvement of Osteoprotegerin (OPG) in the prevention of AAAs through inhibition of Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). In CaCl2-induced AAA models, both internal and external diameters were significantly increased with destruction of elastic fibers in the media in Opg knockout (KO) mice, as compared to wild-type mice. Moreover, up-regulation of TRAIL expression was observed in the media by immunohistochemical analyses. Using a culture system, both the TRAIL-induced expression of matrix metalloproteinase-9 in smooth muscle cells (SMCs) and the chemoattractive effect of TRAIL on SMCs were inhibited by OPG. These data suggest that Opg may play a preventive role in the development of AAA through its antagonistic effect on Trail.	[Bumdelger, Batmunkh; Kokubo, Hiroki; Kamata, Ryo; Fujii, Masayuki; Ishida, Mari; Yoshizumi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Hiroshima, Japan; [Yoshimura, Koichi] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 830, Japan; [Orita, Yuichi; Ishida, Takafumi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan; [Ohtaki, Megu] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Environmetr & Biometr, Hiroshima, Japan; [Nagao, Masataka] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Forens Med, Hiroshima, Japan	Hiroshima University; Yamaguchi University; Kurume University; Hiroshima University; Hiroshima University; Hiroshima University	Yoshizumi, M (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Hiroshima, Japan.	yoshizum-tky@umin.ac.jp	Ohtaki, Megu/S-9927-2018; Ishida, Mari/L-8208-2016	Kamata, Ryo/0000-0001-6970-9657	Japanese Ministry of Education, Culture, Sports, Science and Technology in Japan; Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology in Japan.; The authors would like to thank Ms. Kumi Hashida, Ms. Yukiko Yoritsune, Mr. Hidemichi Miyahara, Mr. Masayoshi Takatani, and Ms. Chiho Taniguchi for their technical guidance. This study was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; Baud'huin M, 2013, CYTOKINE GROWTH F R, V24, P401, DOI 10.1016/j.cytogfr.2013.06.001; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Bobryshev YV, 1998, CARDIOVASC SURG, V6, P240, DOI 10.1016/S0967-2109(97)00168-3; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Bumdelger Batmunkh, 2013, Hiroshima Journal of Medical Sciences, V62, P63; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; Elmore JR, 1998, ANN VASC SURG, V12, P221, DOI 10.1007/s100169900144; Eskandari MK, 2005, J SURG RES, V123, P289, DOI 10.1016/j.jss.2004.07.247; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Forte A, 2010, CARDIOVASC RES, V88, P395, DOI 10.1093/cvr/cvq224; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Golledge J, 2010, ARTERIOSCL THROM VAS, V30, P1075, DOI 10.1161/ATVBAHA.110.206573; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Jono S, 2010, J THROMB HAEMOST, V8, P1170, DOI 10.1111/j.1538-7836.2010.03833.x; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Koole D, 2012, ARTERIOSCL THROM VAS, V32, P1497, DOI 10.1161/ATVBAHA.111.243592; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Moran CS, 2014, ARTERIOSCL THROM VAS, V34, P2609, DOI 10.1161/ATVBAHA.114.304587; Moran CS, 2005, CIRCULATION, V111, P3119, DOI 10.1161/CIRCULATIONAHA.104.464727; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Muhlenbeck F, 1998, J BIOL CHEM, V273, P33091, DOI 10.1074/jbc.273.49.33091; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Olesen P, 2005, DIABETOLOGIA, V48, P561, DOI 10.1007/s00125-004-1652-8; Orita Y, 2007, ARTERIOSCL THROM VAS, V27, P2058, DOI 10.1161/ATVBAHA.107.147868; Ovchinnikova O, 2009, ARTERIOSCL THROM VAS, V29, P1478, DOI 10.1161/ATVBAHA.109.188185; Papalambros E, 2003, INT J MOL MED, V12, P965; Pearce WH, 1996, ANN NY ACAD SCI, V800, P175; Price PA, 2001, ARTERIOSCL THROM VAS, V21, P1610, DOI 10.1161/hq1001.097102; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Schoppet M, 2003, J CLIN ENDOCR METAB, V88, P1024, DOI 10.1210/jc.2002-020775; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; Soe NN, 2009, J ATHEROSCLER THROMB, V16, P230, DOI 10.5551/jat.E422; THOMPSON EW, 1995, J ANDROL, V16, P28; TRAVO P, 1980, BLOOD VESSELS, V17, P110; Uzui H, 2014, J CARDIOVASC PHARM T, V19, P304, DOI 10.1177/1074248413511692; Wei W, 2010, MOL IMMUNOL, V47, P2475, DOI 10.1016/j.molimm.2010.06.004; Yamashita A, 2001, WORLD J SURG, V25, P259, DOI 10.1007/s002680020062; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147088	10.1371/journal.pone.0147088	http://dx.doi.org/10.1371/journal.pone.0147088			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783750	Green Published, gold, Green Submitted			2022-12-26	WOS:000368528400108
J	Gao, XJ; Zhang, GL; Shan, SG; Shang, YL; Chi, LF; Li, HJ; Cao, YF; Zhu, XQ; Zhang, MB; Yang, J				Gao, Xiangjing; Zhang, Guanglin; Shan, Shigang; Shang, Yunlong; Chi, Linfeng; Li, Hongjuan; Cao, Yifei; Zhu, Xinqiang; Zhang, Meibian; Yang, Jun			Depletion of Paraspeckle Protein 1 Enhances Methyl Methanesulfonate-Induced Apoptosis through Mitotic Catastrophe	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; DNA-DAMAGE; CELLS; MITOSIS; REPAIR; DEATH; KINASES; ARREST; GROWTH; AGENTS	Previously, we have shown that paraspeckle protein 1 (PSPC1), a protein component of paraspeckles that was involved in cisplatin-induced DNA damage response (DDR), probably functions at the G1/S checkpoint. In the current study, we further examined the role of PSPC1 in another DNA-damaging agent, methyl methanesulfonate (MMS)-induced DDR, in particular, focusing on MMS-induced apoptosis in HeLa cells. First, it was found that MMS treatment induced the expression of PSPC1. While MMS treatment alone can induce apoptosis, depletion of PSPC1 expression using siRNA significantly increased the level of apoptosis following MMS exposure. In contrast, overexpressing PSPC1 decreased the number of apoptotic cells. Interestingly, morphological observation revealed that many of the MMS-treated PSPC1-knockdown cells contained two or more nuclei, indicating the occurrence of mitotic catastrophe. Cell cycle analysis further showed that depletion of PSPC1 caused more cells entering the G2/M phase, a prerequisite of mitosis catastrophe. On the other hand, over-expressing PSPC1 led to more cells accumulating in the G1/S phase. Taken together, these observations suggest an important role for PSPC1 in MMS-induced DDR, and in particular, depletion of PSPC1 can enhance MMS-induced apoptosis through mitotic catastrophe.	[Gao, Xiangjing; Zhang, Meibian] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China; [Gao, Xiangjing; Zhang, Guanglin; Shan, Shigang; Chi, Linfeng; Zhu, Xinqiang; Yang, Jun] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Shang, Yunlong] Zhejiang CONBA Pharmaceut Co Ltd, Hangzhou 310058, Zhejiang, Peoples R China; [Chi, Linfeng] Zhejiang Univ, Sch Med, Affiliated Stomatol Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Hongjuan; Cao, Yifei; Yang, Jun] Hangzhou Normal Univ, Sch Med, Dept Toxicol, Hangzhou 310016, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Hangzhou Normal University	Zhang, MB (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China.; Yang, J (corresponding author), Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.; Yang, J (corresponding author), Hangzhou Normal Univ, Sch Med, Dept Toxicol, Hangzhou 310016, Zhejiang, Peoples R China.	mbzhang@cdc.zj.cn; gastate@zju.edu.cn		zhang, meibian/0000-0002-6839-737X	Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; National Natural Science Foundation of China [81172692, 81373036, 81472961, 81302398, 81502752]; Zhejiang Provincial Department of Science and Technology [2013C14016]; Zhejiang Provincial Department of Education [Y201328971]; Hangzhou City Commission of Science and Technology [20130633B27]; Ministry of Science and Technology of the People's Republic of China [2009DFB30390]; National Health and Family Planning Commission of China [WKJ2014-ZJ-0]; Postdoctoral Science Foundation of China [520000-X91504]; Fundamental Research Funds for the Central Universities [2014QNA7021]; Zhejiang CONBA Pharmaceutical Co. Ltd.	Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Department of Science and Technology; Zhejiang Provincial Department of Education; Hangzhou City Commission of Science and Technology; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Health and Family Planning Commission of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang CONBA Pharmaceutical Co. Ltd.	JY is a recipient of the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents. This work was funded by National Natural Science Foundation of China (Nos. 81172692, 81373036, 81472961, 81302398, 81502752, http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action), Zhejiang Provincial Department of Science and Technology (2013C14016, http://www.zjkjt.gov.cn/news/node01/detail0101/2013/0101_47060.htm), Zhejiang Provincial Department of Education (Y201328971), Hangzhou City Commission of Science and Technology (20130633B27, http://220.191.210.97:8080/WebHall/WebIndex.aspx), Ministry of Science and Technology of the People's Republic of China (2009DFB30390, http://finance.most.gov.cn/), National Health and Family Planning Commission of China (No. WKJ2014-ZJ-0, http://www.zjmed.org.cn/previewerlet.do?id=D4A9C5F17379B886F94E42A9BF39BB32), Postdoctoral Science Foundation of China (520000-X91504, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx) and Fundamental Research Funds for the Central Universities (2014QNA7021). The funder (Zhejiang CONBA Pharmaceutical Co. Ltd.) provided support in the form of salaries for author YLS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of YLS are articulated in the 'author contributions' section.	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; AYSCOUGH K, 1992, MOL GEN GENET, V232, P344, DOI 10.1007/BF00266236; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chen CA, 2013, J MED FOOD, V16, P869, DOI 10.1089/jmf.2012.2617; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Gao XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097174; Ha K, 2011, DNA REPAIR, V10, P252, DOI 10.1016/j.dnarep.2010.11.009; Hosseinimehr SJ, 2011, TOXICOL IND HEALTH, V27, P363, DOI 10.1177/0748233710387010; Hsu MH, 2012, TOXICOL APPL PHARM, V259, P219, DOI 10.1016/j.taap.2011.12.026; Jordan MA, 1996, CANCER RES, V56, P816; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Liang Xiaogong, 2003, Sichuan Da Xue Xue Bao Yi Xue Ban, V34, P549; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Lock RB, 1996, CANCER RES, V56, P4006; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MCINTOSH JR, 1984, NATURE, V312, P196, DOI 10.1038/312196b0; MOLZ L, 1989, GENETICS, V122, P773; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myojin R, 2004, BIOL REPROD, V71, P926, DOI 10.1095/biolreprod.104.028159; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Waxman DJ, 2003, CANCER RES, V63, P8563; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; Wu W, 2010, MUTAT RES-FUND MOL M, V691, P1, DOI 10.1016/j.mrfmmm.2010.06.002; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yu YK, 2006, TOXICOL IN VITRO, V20, P959, DOI 10.1016/j.tiv.2006.01.004	43	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146952	10.1371/journal.pone.0146952	http://dx.doi.org/10.1371/journal.pone.0146952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785254	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400084
J	Meijer, MF; Velleman, T; Boerboom, AL; Bulstra, SK; Otten, E; Stevens, M; Reininga, IHF				Meijer, Marrigje F.; Velleman, Ton; Boerboom, Alexander L.; Bulstra, Sjoerd K.; Otten, Egbert; Stevens, Martin; Reininga, Inge H. F.			The Validity of a New Low-Dose Stereoradiography System to Perform 2D and 3D Knee Prosthetic Alignment Measurements	PLOS ONE			English	Article							RELIABILITY; ROTATION	Introduction The EOS stereoradiography system has shown to provide reliable varus/valgus (VV) measurements of the lower limb in 2D (VV2D) and 3D (VV3D) after total knee arthroplasty (TKA). Validity of these measurements has not been investigated yet, therefore the purpose of this study was to determine validity of EOS VV2D and VV3D. Methods EOS images were made of a lower limb phantom containing a knee prosthesis, while varying VV angle from 15 degrees varus to 15 degrees valgus and flexion angle from 0 degrees to 20 degrees, and changing rotation from 20 degrees internal to 20 degrees external rotation. Differences between the actual VV position of the lower limb phantom and its position as measured on EOS 2D and 3D images were investigated. Results Rotation, flexion or VV angle alone had no major impact on VV2D or VV3D. Combination of VV angle and rotation with full extension did not show major differences in VV2D measurements either. Combination of flexion and rotation with a neutral VV angle showed variation of up to 7.4 degrees for VV2D; maximum variation for VV3D was only 1.5 degrees. A combination of the three variables showed an even greater distortion of VV2D, while VV3D stayed relatively constant. Maximum measurement difference between preset VV angle and VV2D was 9.8 degrees, while the difference with VV3D was only 1.9 degrees. The largest differences between the preset VV angle and VV2D were found when installing the leg in extreme angles, for example 15 degrees valgus, 20 degrees flexion and 20 degrees internal rotation. Conclusions After TKA, EOS VV3D were more valid than VV2D, indicating that 3D measurements compensate for malpositioning during acquisition. Caution is warranted when measuring VV angle on a conventional radiograph of a knee with a flexion contracture, varus or valgus angle and/or rotation of the knee joint during acquisition.	[Meijer, Marrigje F.; Boerboom, Alexander L.; Bulstra, Sjoerd K.; Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands; [Velleman, Ton] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Otten, Egbert] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Reininga, Inge H. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Meijer, MF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands.	m.f.meijer@umcg.nl	Reininga, Inge H.F./H-4250-2013; Stevens, Martin/A-5196-2013	Reininga, Inge H.F./0000-0003-1341-845X; Stevens, Martin/0000-0001-8183-6894	Zimmer (Warsaw, IN, USA)	Zimmer (Warsaw, IN, USA)	The authors of this manuscript have the following competing interests: One of the authors will be and has been paid as a consultant by Zimmer (Warsaw, IN, USA) for purposes of education and training in knee arthroplasty. The department receives research institutional support from Inspine (Schiedam, NL) and Stryker (Kalamazoo, Mich. USA). Nevertheless there has not been any direct funding related to this study.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brouwer R W, 2007, J Knee Surg, V20, P210; Fang DM, 2009, J ARTHROPLASTY, V24, P39, DOI 10.1016/j.arth.2009.04.034; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Gheno R, 2012, EUR RADIOL, V22, P765, DOI 10.1007/s00330-011-2308-y; Guenoun B, 2012, ORTHOP TRAUMATOL-SUR, V98, P506, DOI 10.1016/j.otsr.2012.03.014; JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709, DOI 10.1302/0301-620X.73B5.1894655; Kalifa G, 1998, PEDIATR RADIOL, V28, P557, DOI 10.1007/s002470050413; Lonner JH, 1996, CLIN ORTHOP RELAT R, P102; LOTKE PA, 1977, J BONE JOINT SURG AM, V59, P77, DOI 10.2106/00004623-197759010-00013; Meijer MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104613; Parratte S, 2010, J BONE JOINT SURG AM, V92A, P2143, DOI 10.2106/JBJS.I.01398; Radtke K, 2010, ARCH ORTHOP TRAUM SU, V130, P451, DOI 10.1007/s00402-009-0999-1; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; RITTER MA, 1994, CLIN ORTHOP RELAT R, P153; Ritter MA, 2011, J BONE JOINT SURG AM, V93A, P1588, DOI 10.2106/JBJS.J.00772; Swanson KE, 2000, CLIN ORTHOP RELAT R, P246; Thelen P, 2012, SKELETAL RADIOL, V41, P1287, DOI 10.1007/s00256-012-1438-x	18	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146187	10.1371/journal.pone.0146187	http://dx.doi.org/10.1371/journal.pone.0146187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771177	gold, Green Published, Green Submitted			2022-12-26	WOS:000368628300011
J	Qiao, YC; He, H; Jonsson, P; Sinha, I; Zhao, CY; Dahlman-Wright, K				Qiao, Yichun; He, Huan; Jonsson, Philip; Sinha, Indranil; Zhao, Chunyan; Dahlman-Wright, Karin			AP-1 Is a Key Regulator of Proinflammatory Cytokine TNF alpha-mediated Triple-negative Breast Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP-1); breast cancer; ChIP-sequencing (ChIP-seq); gene expression; tumor necrosis factor (TNF)	NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; LARGE GENE LISTS; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; BINDING-SITES; C-JUN; INFLAMMATION; EXPRESSION	Triple-negative breast cancer (TNBC) represents a highly aggressive form of breast cancer with limited treatment options. Proinflammatory cytokines such as TNF can facilitate tumor progression and metastasis. However, the mechanistic aspects of inflammation mediated TNBC progression remain unclear. Using ChIP-seq, we demonstrate that the cistrome for the AP-1 transcription factor c-Jun is comprised of 13,800 binding regions in TNF-stimulated TNBC cells. In addition, we show that c-Jun regulates nearly a third of the TNF-regulated transcriptome. Interestingly, high expression level of the c-Jun-regulated pro-invasion gene program is associated with poor clinical outcome in TNBCs. We further demonstrate that c-Jun drives TNF-mediated increase of malignant characteristics of TNBC cells by transcriptional regulation of Ninj1. As exemplified by the CXC chemokine genes clustered on chromosome 4, we demonstrate that NF-B might be a pioneer factor required for the regulation of TNF-inducible inflammatory genes, whereas c-Jun has little effect. Together, our results uncover AP-1 as an important determinant for inflammation-induced cancer progression, rather than inflammatory response.	[Qiao, Yichun; He, Huan; Sinha, Indranil; Zhao, Chunyan; Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Novum, S-14183 Huddinge, Sweden; [Jonsson, Philip] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, Ctr Mol Oncol, New York, NY 10065 USA; [Dahlman-Wright, Karin] Karolinska Inst, Sci Life Lab, S-17121 Solna, Sweden	Karolinska Institutet; Memorial Sloan Kettering Cancer Center; Karolinska Institutet	Zhao, CY; Dahlman-Wright, K (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Novum, S-14183 Huddinge, Sweden.	chunyan.zhao@ki.se; karin.dahlman-wright@ki.se	He, Huan/AAF-9644-2019; Qiao, yichun/Q-6498-2018	Sinha, Indranil/0000-0002-2513-5927; He, Huan/0000-0001-8123-5765; Jonsson, Philip/0000-0002-1537-0624	Swedish Cancer Society (Cancerfonden); Center for Biosciences	Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Center for Biosciences	This work was supported by the Swedish Cancer Society (Cancerfonden) and the Center for Biosciences. The authors declare that they have no conflicts of interest with the contents of this article.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Arnott CH, 2002, ONCOGENE, V21, P4728, DOI 10.1038/sj.onc.1205588; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen JS, 2001, BLOOD, V97, P2115, DOI 10.1182/blood.V97.7.2115; Cho SJ, 2013, P NATL ACAD SCI USA, V110, P9362, DOI 10.1073/pnas.1221242110; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dahlman-Wright K, 2012, CARCINOGENESIS, V33, P1684, DOI 10.1093/carcin/bgs223; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fanjul AN, 1998, CANCER RES, V58, P4607; Franco HL, 2015, MOL CELL, V58, P21, DOI 10.1016/j.molcel.2015.02.001; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Halade GV, 2013, PHARMACOL THERAPEUT, V139, P32, DOI 10.1016/j.pharmthera.2013.03.009; Haldosen LA, 2014, MOL CELL ENDOCRINOL, V382, P665, DOI 10.1016/j.mce.2013.08.005; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jurida L, 2015, CELL REP, V10, P726, DOI 10.1016/j.celrep.2015.01.001; Kee JY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-949; Kharman-Biz A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-441; Kim JW, 2001, MOL CELLS, V11, P151; Kyriakis JM, 1999, GENE EXPRESSION, V7, P217; Le Du F, 2015, ONCOTARGET, V6, P12890, DOI 10.18632/oncotarget.3849; Lee HJ, 2010, MOL CELLS, V29, P223, DOI 10.1007/s10059-010-0043-x; Li JJ, 1997, CANCER RES, V57, P3569; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lou YW, 2011, MOL IMMUNOL, V49, P4, DOI 10.1016/j.molimm.2011.08.006; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Qiao YC, 2015, ONCOTARGET, V6, P7804, DOI 10.18632/oncotarget.3158; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shiohara M, 1999, BLOOD, V93, P2057, DOI 10.1182/blood.V93.6.2057.406k04_2057_2066; Tang GL, 2001, MOL CELL, V8, P1005, DOI 10.1016/S1097-2765(01)00380-X; Wang B, 2015, FEBS OPEN BIO, V5, P147, DOI 10.1016/j.fob.2015.02.003; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zhao CY, 2014, CANCER RES, V74, P3983, DOI 10.1158/0008-5472.CAN-13-3396; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	45	63	65	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5068	5079		10.1074/jbc.M115.702571	http://dx.doi.org/10.1074/jbc.M115.702571			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26792858	hybrid, Green Published			2022-12-26	WOS:000371640600020
J	Fu, HL; Mueller, JL; Whitley, MJ; Cardona, DM; Willett, RM; Kirsch, DG; Brown, JQ; Ramanujam, N				Fu, Henry L.; Mueller, Jenna L.; Whitley, Melodi J.; Cardona, Diana M.; Willett, Rebecca M.; Kirsch, David G.; Brown, J. Quincy; Ramanujam, Nimmi			Structured Illumination Microscopy and a Quantitative Image Analysis for the Detection of Positive Margins in a Pre-Clinical Genetically Engineered Mouse Model of Sarcoma	PLOS ONE			English	Article							BREAST-CONSERVING SURGERY; FROZEN-SECTION ANALYSIS; LUMPECTOMY MARGINS; ACRIDINE-ORANGE; CONSERVATION; CANCER; TISSUE; RATES; STATISTICS; REEXCISION	Intraoperative assessment of surgical margins is critical to ensuring residual tumor does not remain in a patient. Previously, we developed a fluorescence structured illumination microscope (SIM) system with a single-shot field of view (FOV) of 2.1x1.6 mm (3.4 mm(2)) and sub-cellular resolution (4.4 mu m). The goal of this study was to test the utility of this technology for the detection of residual disease in a genetically engineered mouse model of sarcoma. Primary soft tissue sarcomas were generated in the hindlimb and after the tumor was surgically removed, the relevant margin was stained with acridine orange (AO), a vital stain that brightly stains cell nuclei and fibrous tissues. The tissues were imaged with the SIM system with the primary goal of visualizing fluorescent features from tumor nuclei. Given the heterogeneity of the background tissue (presence of adipose tissue and muscle), an algorithm known as maximally stable extremal regions (MSER) was optimized and applied to the images to specifically segment nuclear features. A logistic regression model was used to classify a tissue site as positive or negative by calculating area fraction and shape of the segmented features that were present and the resulting receiver operator curve (ROC) was generated by varying the probability threshold. Based on the ROC curves, the model was able to classify tumor and normal tissue with 77% sensitivity and 81% specificity (Youden's index). For an unbiased measure of the model performance, it was applied to a separate validation dataset that resulted in 73% sensitivity and 80% specificity. When this approach was applied to representative whole margins, for a tumor probability threshold of 50%, only 1.2% of all regions from the negative margin exceeded this threshold, while over 14.8% of all regions from the positive margin exceeded this threshold.	[Fu, Henry L.; Mueller, Jenna L.; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Whitley, Melodi J.; Kirsch, David G.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Cardona, Diana M.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Willett, Rebecca M.] Univ Wisconsin, Dept Elect & Comp Engn, 1415 Johnson Dr, Madison, WI 53706 USA; [Kirsch, David G.] Duke Univ, Sch Med, Dept Radiat Oncol, Durham, NC USA; [Brown, J. Quincy] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA	Duke University; Duke University; Duke University; University of Wisconsin System; University of Wisconsin Madison; Duke University; Tulane University	Fu, HL (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	henry.fu@duke.edu		Whitley, Melodi/0000-0002-8163-6881; Cardona, Diana/0000-0002-6877-2280	National Institutes of Health [R21 CA159936, BRP 1R01EB011574-01]; NATIONAL CANCER INSTITUTE [R21CA159936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health grant award R21 CA159936 and BRP 1R01EB011574-01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NATL CANC DATA BASE; Cabioglu N, 2007, ANN SURG ONCOL, V14, P1458, DOI 10.1245/s10434-006-9236-0; Chagpar AB, 2004, AM J SURG, V188, P399, DOI 10.1016/j.amjsurg.2004.06.020; D'Halluin F, 2009, BREAST, V18, P248, DOI 10.1016/j.breast.2009.05.002; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dillon MF, 2008, MODERN PATHOL, V21, P39, DOI 10.1038/modpathol.3800975; Dillon MF, 2007, ANN SURG ONCOL, V14, P1618, DOI 10.1245/s10434-006-9246-y; Esbona K, 2012, ANN SURG ONCOL, V19, P3236, DOI 10.1245/s10434-012-2492-2; Fu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068868; Gareau DS, 2009, OPT LETT, V34, P3235, DOI 10.1364/OL.34.003235; Gareau DS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149853; Ikeda, 1999, Breast Cancer, V6, P93, DOI 10.1007/BF02966914; Jeevan R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4505; Jorns JM, 2012, AM J CLIN PATHOL, V138, P657, DOI 10.1309/AJCP4IEMXCJ1GDTS; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Krolenko SA, 2006, CELL BIOL INT, V30, P933, DOI 10.1016/j.cellbi.2006.06.017; Kurniawan ED, 2008, ANN SURG ONCOL, V15, P2542, DOI 10.1245/s10434-008-0054-4; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; McCahill LE, 2012, JAMA-J AM MED ASSOC, V307, P467, DOI 10.1001/jama.2012.43; Mito JK, 2013, J PATHOL, V229, P132, DOI 10.1002/path.4099; Mueller JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066198; Mueller JL, 2015, RAPID MICROSCOPIC AP; Muldoon TJ, 2008, GASTROINTEST ENDOSC, V68, P737, DOI 10.1016/j.gie.2008.05.018; Muldoon TJ, 2007, OPT EXPRESS, V15, P16413, DOI 10.1364/OE.15.016413; Muldoon TJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3406386; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Olson TP, 2007, ANN SURG ONCOL, V14, P2953, DOI 10.1245/s10434-007-9437-1; Pisters PWT, 1996, J CLIN ONCOL, V14, P859, DOI 10.1200/JCO.1996.14.3.859; Riedl O, 2009, EJSO-EUR J SURG ONC, V35, P264, DOI 10.1016/j.ejso.2008.05.007; Sabolch A, 2012, AM J CLIN ONCOL-CANC, V35, P151, DOI 10.1097/COC.0b013e318209cd72; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Srivastava S, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907167; Tanbakuchi AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.027; Tanbakuchi AA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3207139; Tartter PI, 2000, AM J SURG, V179, P81, DOI 10.1016/S0002-9610(00)00272-5; Thill M, 2014, J SURG ONCOL, V110, P15, DOI 10.1002/jso.23634; Udovich JA, 2009, J MICROSC-OXFORD, V234, P124, DOI 10.1111/j.1365-2818.2009.03153.x	37	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147006	10.1371/journal.pone.0147006	http://dx.doi.org/10.1371/journal.pone.0147006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799613	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300053
J	Gundlach, E; Hoffmann, MM; Prasse, A; Heinzelmann, S; Ness, T				Gundlach, Enken; Hoffmann, Michael Marcus; Prasse, Antje; Heinzelmann, Sonja; Ness, Thomas			Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis	PLOS ONE			English	Article							TNF-ALPHA RELEASE; T-CELL-ACTIVATION; BRONCHOALVEOLAR LAVAGE; MEDICAL PROGRESS; SERUM MARKERS; RECEPTOR; PARAMETERS; UVEITIS; MANIFESTATION; EXPRESSION	Purpose To study the impact of soluble IL2 receptor (sIL2R), chest x-ray (CxR), and angiotensin-converting enzyme (ACE) as markers for sarcoidosis in uveitis patients. Design Retrospective study. Methods Serum concentrations of sIL2R and ACE were measured in patients with active uveitis. Those with elevated sIL2R and/or ACE values were examined for suspected systemic sarcoidosis. Main Outcome Measure Our main outcome parameters were the specificity and sensitivity of sIL2R, CxR and ACE in screening for ocular sarcoidosis. Results We measured 261 patients with uveitis for sarcoidosis using sIL2R and ACE between January 2008 and November 2011; sarcoidosis was been diagnosed using other tests (e.g. computer tomography, brochoalveolar lavage, biopsy) in 41 of 53 patients with elevated sIL2R values (>639 U/ml) and in one patient with normal sIL2R (582 U/ml). Their mean sIL2R value was 1310 U/ml, extending from 582 to 8659 U/ml. Only 9 patients, however, presented elevated ACE (>82 U/l). Their mean ACE value was 116.4 U/l, ranging from 84.1 to 175.5 U/l. IL2R specificity was 94% with 98% sensitivity. In contrast, ACE had a specificity of 99.5%, but a sensitivity of only 22%; the chest x-ray had a specificity of 100% with 50% sensitivity in detecting sarcoidosis. We observed the entire spectrum of uveitis: sixteen patients suffered from anterior, 8 from intermediate, 16 from posterior, and 2 from panuveitis. Conclusions An elevated level of soluble IL2R suggests sarcoidosis with uveitis more convincingly than ACE, making sIL2R a more effective marker parameter for sarcoidosis than ACE or chest x-ray in uveitis patients.	[Gundlach, Enken] Univ Eye Hosp Charite, Berlin, Germany; [Gundlach, Enken; Heinzelmann, Sonja; Ness, Thomas] Univ Hosp Freiburg, Ctr Eye, Freiburg, Germany; [Hoffmann, Michael Marcus] Univ Hosp Freiburg, Inst Clin Chem & Lab Med, Freiburg, Germany; [Prasse, Antje] Univ Hosp Freiburg, Dept Pneumol, Freiburg, Germany; [Prasse, Antje] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Prasse, Antje] Fraunhofer ITEM, Clin Res Ctr, Hannover, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Hannover Medical School	Ness, T (corresponding author), Univ Hosp Freiburg, Ctr Eye, Freiburg, Germany.	thomas.ness@uniklinik-freiburg.de	Prasse, Antje/AAY-6279-2020; Hoffmann, Michael M/D-4074-2015; Prasse, Antje/AAM-7521-2021; Heinzelmann, Sonja/AAN-5823-2021	Hoffmann, Michael M/0000-0001-8459-6080; Prasse, Antje/0000-0002-7336-7458; 				Abad S, 2009, REV MED INTERNE, V30, P492, DOI 10.1016/j.revmed.2008.08.011; Adan A, 2004, MED CLIN-BARCELONA, V122, P748, DOI 10.1157/13062195; AROCKERMETTINGER E, 1990, CURR EYE RES, V9, P25, DOI 10.3109/02713689008999415; Authier FJ, 1997, NEUROPATH APPL NEURO, V23, P132, DOI 10.1046/j.1365-2990.1997.d01-169.x; Baughman RP, 2012, SARCOIDOSIS VASC DIF, V29, P26; Baughman RP, 2011, AM J RESP CRIT CARE, V183, P573, DOI 10.1164/rccm.201006-0865CI; BAUGHMAN RP, 1984, AM REV RESPIR DIS, V129, P676, DOI 10.1164/arrd.1984.129.5.676; BENEZRA D, 1993, AM J OPHTHALMOL, V115, P26, DOI 10.1016/S0002-9394(14)73520-2; Beste C, 2014, BRAIN BEHAV IMMUN, V41, P126, DOI 10.1016/j.bbi.2014.05.005; Bezo C, 2013, J FR OPHTALMOL, DOI [10.1016/j.jfo.2012.06.029, DOI 10.1016/J.JF0.2012.06.029]; Biller H, 2009, SARCOIDOSIS VASC DIF, V26, P139; Birnbaum AD, 2011, ARCH OPHTHALMOL-CHIC, V129, P409, DOI 10.1001/archophthalmol.2011.52; CAMPEN DH, 1988, ARTHRITIS RHEUM, V31, P1358, DOI 10.1002/art.1780311103; Caspers LE, 2014, OCUL IMMUNOL INFLAMM, V22, P102, DOI 10.3109/09273948.2013.820836; Cremers J, 2012, EUR J GASTROEN HEPAT, V24, P17, DOI 10.1097/MEG.0b013e32834c7b71; CUMMINGS M M, 1956, Postgrad Med, V19, P437; Cunningham ET, 2014, OCUL IMMUNOL INFLAMM, V22, P253, DOI 10.3109/09273948.2014.941235; Evans M, 2007, OPHTHALMOLOGY, V114, P325, DOI 10.1016/j.ophtha.2006.05.074; Febvay C, 2015, BRIT J OPHTHALMOL, V99, P1372, DOI 10.1136/bjophthalmol-2014-306353; GILBERT S, 1993, AM REV RESPIR DIS, V148, P483, DOI 10.1164/ajrccm/148.2.483; Grutters JC, 2003, CHEST, V124, P186, DOI 10.1378/chest.124.1.186; GUNDELFINGER B, 1961, AM REV RESPIR DIS, V84, P109; Gungor S, 2015, INT IMMUNOPHARMACOL, V25, P174, DOI 10.1016/j.intimp.2015.01.015; Heiligenhaus A, 2011, OPHTHALMIC RES, V46, P9, DOI 10.1159/000321947; Heinle R, 2014, AUTOIMMUN REV, V13, P383, DOI 10.1016/j.autrev.2014.01.035; Herbort CP, 2009, OCUL IMMUNOL INFLAMM, V17, P160, DOI 10.1080/09273940902818861; Hunninghake GW, 1999, SARCOIDOSIS VASC DIF, V16, P149; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Judson MA, 2007, SEMIN RESP CRIT CARE, V28, P83, DOI 10.1055/s-2007-970335; Kawaguchi T, 2007, JPN J OPHTHALMOL, V51, P121, DOI 10.1007/s10384-006-0413-2; KUMAR A, 1987, J IMMUNOL, V139, P3680; LAWRENCE EC, 1988, AM REV RESPIR DIS, V137, P759, DOI 10.1164/ajrccm/137.4.759; MANGGE H, 1995, ARTHRITIS RHEUM, V38, P211, DOI 10.1002/art.1780380209; Martin CM, 2000, CURR EYE RES, V20, P287, DOI 10.1076/0271-3683(200004)20:4;1-5;FT287; Miyoshi S, 2010, CHEST, V137, P1391, DOI 10.1378/chest.09-1975; Mostard RLM, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-57; Muller W, 1983, Prax Klin Pneumol, V37 Suppl 1, P553; MULLERQUERNHEIM J, 1991, AM REV RESPIR DIS, V144, P1322; MURRAY PI, 1992, CURR EYE RES, V11, P193, DOI 10.3109/02713689208999532; Ness T, SOLUBLE INTERLEUKIN; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Papadaki T, 2010, ACTA OPHTHALMOL, V88, pe28, DOI 10.1111/j.1755-3768.2008.01422.x; Petereit HF, 2010, J NEUROL, V257, P1855, DOI 10.1007/s00415-010-5623-3; Power WJ, 1995, OPHTHALMOLOGY, V102, P2007, DOI 10.1016/S0161-6420(95)30763-4; Prasse A, 2008, AM J RESP CRIT CARE, V177, P330, DOI 10.1164/rccm.200705-742OC; RICKER W, 1949, AM J CLIN PATHOL, V19, P725; Rossman Milton D, 2007, Proc Am Thorac Soc, V4, P453, DOI 10.1513/pats.200607-138MS; Rothova A, 2000, BRIT J OPHTHALMOL, V84, P110, DOI 10.1136/bjo.84.1.110; Rufer F, 2014, ACTA OPHTHALMOL, V92, P249, DOI [10.1111/aos.12248, 10.1111/aos.12051]; SARTWELL PE, 1974, AM J EPIDEMIOL, V99, P250, DOI 10.1093/oxfordjournals.aje.a121609; STEGEMAN CA, 1993, CLIN EXP IMMUNOL, V91, P415; STUDDY PR, 1989, ANN CLIN BIOCHEM, V26, P13, DOI 10.1177/000456328902600102; Thorne JE, 2000, RETINA-J RET VIT DIS, V20, P8, DOI 10.1097/00006982-200001000-00002; Torun N, 2005, OPHTHALMIC RES, V37, P112, DOI 10.1159/000084271; Varron L, 2011, REV MED INTERNE, V32, P86, DOI 10.1016/j.revmed.2010.09.003; VINK A, 1990, EUR J IMMUNOL, V20, P1, DOI 10.1002/eji.1830200102; Wakefield D, 2010, OCUL IMMUNOL INFLAMM, V18, P5, DOI 10.3109/09273941003597276; WIGFALL DR, 1988, CLIN IMMUNOL IMMUNOP, V47, P354, DOI 10.1016/S0090-1229(88)80012-6; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; ZHENG L, 1995, AM J RESP CRIT CARE, V152, P1061, DOI 10.1164/ajrccm.152.3.7663784; Ziegenhagen MW, 2003, EUR RESPIR J, V21, P407, DOI 10.1183/09031936.03.00010403; Ziegenhagen MW, 1997, AM J RESP CRIT CARE, V156, P1586, DOI 10.1164/ajrccm.156.5.97-02050	63	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147258	10.1371/journal.pone.0147258	http://dx.doi.org/10.1371/journal.pone.0147258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799486	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300083
J	Roy, S; Tripathi, AM; Yadav, A; Mishra, P; Nautiyal, CS				Roy, Sribash; Tripathi, Abhinandan Mani; Yadav, Amrita; Mishra, Parneeta; Nautiyal, Chandra Shekhar			Identification and Expression Analyses of miRNAs from Two Contrasting Flower Color Cultivars of Canna by Deep Sequencing	PLOS ONE			English	Article							SMALL RNA; TRANSCRIPTION FACTORS; FLORAL DEVELOPMENT; MICRORNA; ARABIDOPSIS; GENES; BIOGENESIS; TIME; BIOSYNTHESIS; BOUNDARY	miRNAs are endogenous small RNA (sRNA) that play critical roles in plant development processes. Canna is an ornamental plant belonging to family Cannaceae. Here, we report for the first time the identification and differential expression of miRNAs in two contrasting flower color cultivars of Canna, Tropical sunrise and Red president. A total of 313 known miRNAs belonging to 78 miRNA families were identified from both the cultivars. Thirty one miRNAs (17 miRNA families) were specific to Tropical sunrise and 43 miRNAs (10 miRNA families) were specific to Red president. Thirty two and 18 putative new miRNAs were identified from Tropical sunrise and Red president, respectively. One hundred and nine miRNAs were differentially expressed in the two cultivars targeting 1343 genes. Among these, 16 miRNAs families targeting60 genes were involved in flower development related traits and five miRNA families targeting five genes were involved in phenyl propanoid and pigment metabolic processes. We further validated the expression analysis of a few miRNA and their target genes by qRT-PCR. Transcription factors were the major miRNA targets identified. Target validation of a few randomly selected miRNAs by RLM-RACE was performed but was successful with only miR162. These findings will help in understanding flower development processes, particularly the color development in Canna.	[Roy, Sribash; Tripathi, Abhinandan Mani; Yadav, Amrita; Mishra, Parneeta] Natl Bot Res Inst, Div Genet & Mol Biol, CSIR, Rana Pratap Marg, Lucknow 226001, Uttar Pradesh, India; [Roy, Sribash; Tripathi, Abhinandan Mani; Mishra, Parneeta] CSIR, Acad Sci & Innovat Res AcSIR, Natl Bot Res Inst Campus,Rana Pratap Marg, Lucknow, Uttar Pradesh, India; [Nautiyal, Chandra Shekhar] Natl Bot Res Inst, CSIR, Div Plant Microbe Interact, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Nautiyal, CS (corresponding author), Natl Bot Res Inst, CSIR, Div Plant Microbe Interact, Lucknow 226001, Uttar Pradesh, India.	nautiyalnbri@lycas.com	Tripathi, Abhinandan/ABF-2608-2020	Nautiyal, Chandra/0000-0003-3899-5034; MISHRA, PARNEETA/0000-0002-1047-3544	Council of Scientific and Industrial Research, New Delhi, India; University Grant Commission, New Delhi; Council for Scientific and Industrial Research (CSIR), New Delhi [OLP-088]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, New Delhi(University Grants Commission, India); Council for Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge University Grant Commission, New Delhi, for fellowship to AMT and PM. The work was supported by Council for Scientific and Industrial Research (CSIR), New Delhi granted project,OLP-088.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Biswabijayinee Patra, 2008, International Journal of Integrative Biology, V2, P129; Bocs S, 2014, PLANT AN GEN 22 C PL; Brousse C, 2014, NUCLEIC ACIDS RES, V42, P5270, DOI 10.1093/nar/gku157; Cartolano M, 2007, NAT GENET, V39, P901, DOI 10.1038/ng2056; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; CHEN BH, 1992, FOOD CHEM, V44, P61, DOI 10.1016/0308-8146(92)90259-5; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Devers EA, 2011, PLANT PHYSIOL, V156, P1990, DOI 10.1104/pp.111.172627; Dong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075978; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Glazinska P, 2009, J PLANT PHYSIOL, V166, P1801, DOI 10.1016/j.jplph.2009.05.011; Glinos E, 2011, PLANT SYST EVOL, V291, P49, DOI 10.1007/s00606-010-0379-x; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guan X, 2014, NATURE COMMUNICATION, P5; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Korbes AP, 2012, IDENTIFYING CONSERVE; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lakhotia N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-6; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Lee WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127526; Li CL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-277; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Luo Y, 2013, DEV BIOL, V380, P133, DOI 10.1016/j.ydbio.2013.05.009; MANCINELLI AL, 1984, PLANT CELL PHYSIOL, V25, P93; Mangrauthia SK, 2013, SALT STRESS PLANTS, P15, DOI [10.1007/978-1-4614-6108-1_2, DOI 10.1007/978-1-4614-6108-1_2]; May P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3145; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mishra T., 2012, FREE RADICALS ANTIOX, V2, P13, DOI DOI 10.5530/AX.2012.2.5; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nishihara M, 2011, BIOTECHNOL LETT, V33, P433, DOI 10.1007/s10529-010-0461-z; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Shen D, 2014, NEW PHYTOL, V204, P577, DOI 10.1111/nph.12934; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Vankar PS, 2008, INT J FOOD ENG, V4; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Varkonyi-Gasic E, 2012, PLANT MOL BIOL, V78, P417, DOI 10.1007/s11103-012-9877-2; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203; Weir I, 2004, DEVELOPMENT, V131, P915, DOI 10.1242/dev.00993; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yang TW, 2007, PLANT SCI, V172, P423, DOI 10.1016/j.plantsci.2006.10.009; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818	70	13	14	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147499	10.1371/journal.pone.0147499	http://dx.doi.org/10.1371/journal.pone.0147499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799570	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300116
J	Tang, XL; Perez-Cruzado, C; Fehrmann, L; Alvarez-Gonzalez, JG; Lu, YC; Kleinn, C				Tang, Xiaolu; Perez-Cruzado, Cesar; Fehrmann, Lutz; Gabriel Alvarez-Gonzalez, Juan; Lu, Yuanchang; Kleinn, Christoph			Development of a Compatible Taper Function and Stand-Level Merchantable Volume Model for Chinese Fir Plantations	PLOS ONE			English	Article							STEM TAPER; CARBON STORAGE; PINE; EQUATIONS; NORTHERN; SYSTEM	Chinese fir (Cunninghamia lanceolata [Lamb.] Hook) is one of the most important plantation tree species in China with good timber quality and fast growth. It covers an area of 8.54 million hectare, which corresponds to 21% of the total plantation area and 32% of total plantation volume in China. With the increasing market demand, an accurate estimation and prediction of merchantable volume at tree-and stand-level is becoming important for plantation owners. Although there are many studies on the total tree volume estimation from allometric models, these allometric models cannot predict tree-and stand-level merchantable volume at any merchantable height, and the stand-level merchantable volume model was not seen yet in Chinese fir plantations. This study aimed to develop (1) a compatible taper function for tree-level merchantable volume estimation, and (2) a stand-level merchantable volume model for Chinese fir plantations. This "taper function system" consisted in a taper function, a merchantable volume equation and a total tree volume equation. 46 Chinese fir trees were felled to develop the taper function in Shitai County, Anhui province, China. A second-order continuous autoregressive error structure corrected the inherent serial autocorrelation of different observations in one tree. The taper function and volume equations were fitted simultaneously after autocorrelation correction. The compatible taper function fitted well to our data and had very good performances in diameter and total tree volume prediction. The stand-level merchantable volume equation based on the ratio approach was developed using basal area, dominant height, quadratic mean diameter and top diameter (ranging from 0 to 30 cm) as independent variables. At last, a total stand-level volume table using stand basal area and dominant height as variables was proposed for local forest managers to simplify the stand volume estimation.	[Tang, Xiaolu; Perez-Cruzado, Cesar; Fehrmann, Lutz; Kleinn, Christoph] Univ Gottingen, Chair Forest Inventory & Remote Sensing, D-37073 Gottingen, Germany; [Gabriel Alvarez-Gonzalez, Juan] Univ Santiago de Compostela, Dept Ingn Agroforestal, Lugo, Spain; [Lu, Yuanchang] Chinese Acad Forestry, Inst Forest Resource Informat Tech, Dept Forest Management & Stat, Beijing, Peoples R China; [Tang, Xiaolu] Int Ctr Bamboo & Rattan, State Key Lab Bamboo & Rattan Sci, Beijing, Peoples R China	University of Gottingen; Universidade de Santiago de Compostela; Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF; International Centre for Bamboo & Rattan	Tang, XL (corresponding author), Univ Gottingen, Chair Forest Inventory & Remote Sensing, D-37073 Gottingen, Germany.; Tang, XL (corresponding author), Int Ctr Bamboo & Rattan, State Key Lab Bamboo & Rattan Sci, Beijing, Peoples R China.	lxtt2010@163.com	Kleinn, Christoph/AAG-1768-2020; Alvarez, Juan/GSD-7155-2022; Pérez-Cruzado, César/E-4011-2012; Tang, Xiaolu/C-3675-2014	Pérez-Cruzado, César/0000-0002-9878-7678; Tang, Xiaolu/0000-0001-5079-7650; Alvarez-Gonzalez, Juan Gabriel/0000-0002-5206-9128	Sino-German Cooperation on Innovative Technologies and Service Capacities of Multifunctional Forest Management (Lin2Value) - Federal Ministry of Education and Research (BMBF) [033L049-CAFYBB2012013]; Chinese Academy of Forestry	Sino-German Cooperation on Innovative Technologies and Service Capacities of Multifunctional Forest Management (Lin2Value) - Federal Ministry of Education and Research (BMBF); Chinese Academy of Forestry	This work was supported by Sino-German Cooperation on Innovative Technologies and Service Capacities of Multifunctional Forest Management (Lin2Value 033L049-CAFYBB2012013), funded by the Federal Ministry of Education and Research (BMBF) and the Chinese Academy of Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alder D, 1980, ESTUDIO FAO MONTES, V22, P80; Anta MB, 2007, ANN FOREST SCI, V64, P511, DOI 10.1051/forest:2007028; Barrio-Anta M, 2008, FOREST ECOL MANAG, V255, P1167, DOI 10.1016/j.foreco.2007.10.022; Bi HuiQuan, 1998, Australian Forestry, V61, P275; CAO Q V, 1980, Southern Journal of Applied Forestry, V4, P166; CAO QV, 1980, FOREST SCI, V26, P71; Chen GS, 2013, FOREST ECOL MANAG, V300, P68, DOI 10.1016/j.foreco.2012.07.046; CLUTTER JL, 1980, FOREST SCI, V26, P117; Cutini A., 2013, iForest, V6, P331; DEMAERSCHALK JP, 1972, FOREST SCI, V18, P241, DOI 10.1093/forestscience/18.3.241; Deusen P. C. van, 1981, Southern Journal of Applied Forestry, V5, P186; Dieguez-Aranda U, 2006, CAN J FOREST RES, V36, P1190, DOI 10.1139/X06-008; Fang ZX, 2000, FOREST SCI, V46, P1; FURNIVAL GEORGE M., 1961, FOREST SCI, V7, P337; Geng T.S., 2011, J ANHUI AGR SCI, V39, P482; Geng T. S., 2011, J ANHUI AGR SCI, V39, P451; Gregoire TG, 1996, J APPL STAT, V23, P257, DOI 10.1080/02664769624233; Hui GY, 1997, FORSTWISS CENTRALBL, V116, P315, DOI 10.1007/BF02766907; Jia Z, 2009, REPORT CHINESE FORES; Kozak A, 2004, FOREST CHRON, V80, P507, DOI 10.5558/tfc80507-4; KOZAK A, 1988, CAN J FOREST RES, V18, P1363, DOI 10.1139/x88-213; Lu C.M., 2010, GEOL ANHUI, V20, P120; Menendez-Miguelez M, 2014, ANN FOREST SCI, V71, P761, DOI 10.1007/s13595-014-0372-6; Navar J, 2013, ANN FOR RES, V56, P165; Pretzsch H, 2009, FOREST DYNAMICS, GROWTH AND YIELD: FROM MEASUREMENT TO MODEL, P1, DOI 10.1007/978-3-540-88307-4_1; REED DD, 1984, FOREST SCI, V30, P977; Rojo A, 2005, EUR J FOREST RES, V124, P177, DOI 10.1007/s10342-005-0066-6; SAS Institute Inc, 2007, SAS US GUID VERS 9 2; Tasissa G., 1997, Southern Journal of Applied Forestry, V21, P146; Teshome T, 2005, FOREST ECOL MANAG, V204, P171, DOI 10.1016/j.foreco.2004.07.064; Turski M, 2008, FOREST ECOL MANAG, V255, P2678, DOI 10.1016/j.foreco.2008.01.028; Wu ZL, 1984, CHINESE FIR BEIJING; Zhao MF, 2009, FOREST ECOL MANAG, V257, P1520, DOI 10.1016/j.foreco.2008.12.025	34	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147610	10.1371/journal.pone.0147610	http://dx.doi.org/10.1371/journal.pone.0147610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799399	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300130
J	Wang, TF; Zhao, M; Rotgans, BA; Strong, A; Liang, D; Ni, GY; Limpanont, Y; Ramasoota, P; McManus, DP; Cummins, SF				Wang, Tianfang; Zhao, Min; Rotgans, Bronwyn A.; Strong, April; Liang, Di; Ni, Guoying; Limpanont, Yanin; Ramasoota, Pongrama; McManus, Donald P.; Cummins, Scott F.			Proteomic Analysis of the Schistosoma mansoni Miracidium	PLOS ONE			English	Article							OPEN READING FRAME; HEAT-SHOCK-PROTEIN; COMPATIBILITY POLYMORPHISM; MOLECULAR CHARACTERIZATION; EXPRESSION PATTERNS; ECHINOSTOMA-CAPRONI; FASCIOLA-HEPATICA; SIGNAL PEPTIDES; GENOME; MODEL	Despite extensive control efforts, schistosomiasis continues to be a major public health problem in developing nations in the tropics and sub-tropics. The miracidium, along with the cercaria, both of which are water-borne and free-living, are the only two stages in the life-cycle of Schistosoma mansoni which are involved in host invasion. Miracidia penetrate intermediate host snails and develop into sporocysts, which lead to cercariae that can infect humans. Infection of the snail host by the miracidium represents an ideal point at which to interrupt the parasite's life-cycle. This research focuses on an analysis of the miracidium proteome, including those proteins that are secreted. We have identified a repertoire of proteins in the S. mansoni miracidium at 2 hours post-hatch, including proteases, venom allergen-like proteins, receptors and HSP70, which might play roles in snail-parasite interplay. Proteins involved in energy production and conservation were prevalent, as were proteins predicted to be associated with defence. This study also provides a strong foundation for further understanding the roles that neurohormones play in host-seeking by schistosomes, with the potential for development of novel anthelmintics that interfere with its various lifecycle stages.	[Wang, Tianfang; Zhao, Min; Rotgans, Bronwyn A.; Strong, April; Liang, Di; Ni, Guoying; Cummins, Scott F.] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld 4558, Australia; [Ni, Guoying] Griffith Univ, Griffith Hlth Inst, Sch Med Sci, Gold Coast, Qld 4222, Australia; [Limpanont, Yanin; Ramasoota, Pongrama] Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand; [McManus, Donald P.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia	University of the Sunshine Coast; Griffith University; Menzies Health Institute Queensland; Mahidol University; QIMR Berghofer Medical Research Institute	Cummins, SF (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld 4558, Australia.	scummins@usc.edu.au	Wang, Tianfang/L-5192-2016; Wang, Tianfang/AAG-4290-2020; Zhao, Min/J-6588-2019; Wang, Tianfang/GRO-0844-2022; McManus, Don/AAC-5394-2020; Ramasoota, Pongrama/W-3503-2019; Cummins, Scott/I-6420-2016	Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Zhao, Min/0000-0001-5498-3434; Wang, Tianfang/0000-0002-4876-7767; McManus, Don/0000-0001-6443-1449; Cummins, Scott/0000-0002-1454-2076	University of the Sunshine Coast internal grant; Australian Research Council [FT110100990]; University of the Sunshine Coast [URG 13/11]; Australian government	University of the Sunshine Coast internal grant; Australian Research Council(Australian Research Council); University of the Sunshine Coast; Australian government(Australian GovernmentCGIAR)	The authors thank the following for support for this work: University of the Sunshine Coast internal grant and Australian Research Council (FT110100990); University of the Sunshine Coast, URG 13/11. This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson KJ, 2015, PEPTIDES; ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; Aly HF, 2013, PARASITOL INT, V62, P380, DOI 10.1016/j.parint.2013.04.002; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Araujo-Montoya BO, 2011, EXP PARASITOL, V129, P284, DOI 10.1016/j.exppara.2011.07.008; Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351; Ballen D, 2002, EXP PARASITOL, V101, P164, DOI 10.1016/S0014-4894(02)00104-2; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Benitez L, 1998, PARASITOL RES, V84, P423, DOI 10.1007/s004360050422; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; Cass CL, 2007, MOL BIOCHEM PARASIT, V155, P84, DOI 10.1016/j.molbiopara.2007.06.002; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chalmers IW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-89; Chewawiwat N, 1999, J BIOCHEM, V125, P721, DOI 10.1093/oxfordjournals.jbchem.a022342; CHIANG CP, 1989, AM J PATHOL, V135, P1015; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosseau C, 2010, OIKOS, V119, P669, DOI 10.1111/j.1600-0706.2009.18040.x; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Curwen RS, 2004, MOL BIOCHEM PARASIT, V138, P57, DOI 10.1016/j.molbiopara.2004.06.016; Pitta MGD, 2013, MINI-REV MED CHEM, V13, P493; Dalton JP, 1997, PARASITOLOGY, V115, P29, DOI 10.1017/S0031182097001091; Danso-Appiah A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000528.pub2; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Don TA, 2008, INT J INFECT DIS, V12, pE39, DOI 10.1016/j.ijid.2007.10.007; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; El Aswad BEW, 2011, IMMUNOBIOLOGY, V216, P379, DOI 10.1016/j.imbio.2010.06.014; ElRidi R, 1996, INFECT IMMUN, V64, P4700, DOI 10.1128/IAI.64.11.4700-4705.1996; Espino AM, 2003, J PARASITOL, V89, P545, DOI 10.1645/GE-3113; Farias LP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001510; Freson K, 2003, HUM MOL GENET, V12, P1121, DOI 10.1093/hmg/ddg130; Fu XM, 2014, ACTA BIOCH BIOPH SIN, V46, P347, DOI 10.1093/abbs/gmt152; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gregory TR, 2003, GENOME, V46, P841, DOI [10.1139/g03-069, 10.1139/G03-069]; Guillou F, 2007, MOL BIOCHEM PARASIT, V155, P45, DOI 10.1016/j.molbiopara.2007.05.009; Haberl B, 2000, PARASITOLOGY, V120, P479, DOI 10.1017/S0031182099005697; Hanington PC, 2010, P NATL ACAD SCI USA, V107, P21087, DOI 10.1073/pnas.1011242107; Hernandez HJ, 1999, J IMMUNOL, V163, P3877; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Hrckova G, 2004, INT J PARASITOL, V34, P83, DOI 10.1016/j.ijpara.2003.10.007; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Kalbe M, 1997, PARASITOL RES, V83, P806, DOI 10.1007/s004360050344; Kappe G, 2004, PROTEINS, V57, P109, DOI 10.1002/prot.20220; King CH, 2009, NEW ENGL J MED, V360, P106, DOI 10.1056/NEJMp0808041; Koehler JW, 2007, MEM I OSWALDO CRUZ, V102, P83, DOI 10.1590/S0074-02762007000100014; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Lee JY, 2002, BIOCHEM BIOPH RES CO, V296, P1238, DOI 10.1016/S0006-291X(02)02062-4; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Luo QL, 2009, ACTA TROP, V112, P91, DOI 10.1016/j.actatropica.2009.06.011; MALDONADO JF, 1948, AM J TROP MED, V28, P645, DOI 10.4269/ajtmh.1948.s1-28.645; Martins VP, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/962538; Mathieson W, 2010, INT J PARASITOL, V40, P617, DOI 10.1016/j.ijpara.2009.10.014; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; McVeigh P, 2011, INT J PARASITOL, V41, P905, DOI 10.1016/j.ijpara.2011.03.010; McVeigh P, 2009, INT J PARASITOL, V39, P1243, DOI 10.1016/j.ijpara.2009.03.005; Merckelbach A, 2003, PARASITOL RES, V90, P493, DOI 10.1007/s00436-003-0888-4; Mitta G, 2012, DEV COMP IMMUNOL, V37, P1, DOI 10.1016/j.dci.2011.09.002; Mone Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000813; Morales ME, 2008, MOL BIOCHEM PARASIT, V157, P160, DOI 10.1016/j.molbiopara.2007.10.009; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Odegaard JI, 2014, PARASITE IMMUNOL, V36, P428, DOI 10.1111/pim.12084; Oh S, 2004, CANCER RES, V64, P2610, DOI 10.1158/0008-5472.CAN-03-2183; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pinheiro CS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/503068; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Prichard RK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001549; Quandt A., 2014, EUPA OPEN PROTEOMICS, V5, P21; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Rofatto HK, 2012, INT J PARASITOL, V42, P613, DOI 10.1016/j.ijpara.2012.04.008; Roger E, 2008, MOL BIOCHEM PARASIT, V157, P205, DOI 10.1016/j.molbiopara.2007.11.003; Roger E, 2008, MOL BIOCHEM PARASIT, V157, P217, DOI 10.1016/j.molbiopara.2007.11.015; Rosenberg SA, 2002, J IMMUNOL, V168, P2402, DOI 10.4049/jimmunol.168.5.2402; Schramm G, 2006, MOL BIOCHEM PARASIT, V147, P9, DOI 10.1016/j.molbiopara.2006.01.003; Schramm G, 2003, J BIOL CHEM, V278, P18384, DOI 10.1074/jbc.M300497200; Schramm G, 2009, MOL BIOCHEM PARASIT, V166, P4, DOI 10.1016/j.molbiopara.2009.02.003; SCHREIBER FG, 1949, J PARASITOL, V35, P91, DOI 10.2307/3273392; Sharma M, 2009, J MOL GRAPH MODEL, V27, P665, DOI 10.1016/j.jmgm.2008.10.009; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Stack C, 2011, ADV EXP MED BIOL, V712, P116, DOI 10.1007/978-1-4419-8414-2_8; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van de Vijver KK, 2006, GLYCOBIOLOGY, V16, P237, DOI 10.1093/glycob/cwj058; Vassilaki N, 2008, J VIROL, V82, P11503, DOI 10.1128/JVI.01640-08; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Wu XJ, 2009, MOL BIOCHEM PARASIT, V164, P32, DOI 10.1016/j.molbiopara.2008.11.005; Yoshino TP, 2014, INT J PARASITOL, V44, P551, DOI 10.1016/j.ijpara.2014.04.002; YOSHINO TP, 1993, J PARASITOL, V79, P23, DOI 10.2307/3283272; Zerlotini A, 2013, NUCLEIC ACIDS RES, V41, pD728, DOI 10.1093/nar/gks1087; Zhang SM, 2008, INNATE IMMUN-LONDON, V14, P175, DOI 10.1177/1753425908093800; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	101	25	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147247	10.1371/journal.pone.0147247	http://dx.doi.org/10.1371/journal.pone.0147247			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799066	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300079
J	Madenjian, CP; Jensen, OP; Rediske, RR; O'Keefe, JP; Vastano, AR; Pothoven, SA				Madenjian, Charles P.; Jensen, Olaf P.; Rediske, Richard R.; O'Keefe, James P.; Vastano, Anthony R.; Pothoven, Steven A.			Differences in Energy Expenditures and Growth Dilution Explain Higher PCB Concentrations in Male Summer Flounder	PLOS ONE			English	Article							TROUT SALVELINUS-NAMAYCUSH; POLYCHLORINATED BIPHENYL CONCENTRATIONS; SEXUAL DIFFERENCE; LAKE TROUT; PARALICHTHYS-DENTATUS; CONGENER DISTRIBUTIONS; OXYGEN-CONSUMPTION; STABLE-ISOTOPES; DIETARY UPTAKE; FISH	Comparison of polychlorinated biphenyl (PCB) concentrations between the sexes of mature fish may reveal important behavioral and physiological differences between the sexes. We determined whole-fish PCB concentrations in 23 female summer flounder Paralichthys dentatus and 27 male summer flounder from New Jersey coastal waters. To investigate the potential for differences in diet or habitat utilization between the sexes, carbon and nitrogen stable isotope ratios were also determined. In 5 of the 23 female summer flounder, PCB concentrations in the somatic tissue and ovaries were determined. In addition, we used bioenergetics modeling to assess the contribution of the growth dilution effect to the observed difference in PCB concentrations between the sexes. Whole-fish PCB concentrations for females and males averaged 87 and 124 ng/g, respectively; thus males were 43% higher in PCB concentration compared with females. Carbon and nitrogen stable isotope ratios did not significantly differ between the sexes, suggesting that diet composition and habitat utilization did not vary between the sexes. Based on PCB determinations in the somatic tissue and ovaries, we predicted that PCB concentration of females would increase by 0.6%, on average, immediately after spawning due to release of eggs. Thus, the change in PCB concentration due to release of eggs did not explain the higher PCB concentrations observed in males. Bioenergetics modeling results indicated that the growth dilution effect could account for males being 19% higher in PCB concentration compared with females. Thus, the bulk of the observed difference in PCB concentrations between the sexes was not explained by growth dilution. We concluded that a higher rate of energy expenditure in males, stemming from greater activity and a greater resting metabolic rate, was most likely the primary driver for the observed difference in PCB concentrations between the sexes.	[Madenjian, Charles P.] US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI USA; [Jensen, Olaf P.; Vastano, Anthony R.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Rediske, Richard R.] Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI USA; [O'Keefe, James P.] Michigan Dept Hlth & Human Serv, Bur Labs, Lansing, MI USA; [Pothoven, Steven A.] Natl Ocean & Atmospher Adm, Great Lakes Environm Res Lab, Lake Michigan Field Stn, Muskegon, MI USA	United States Department of the Interior; United States Geological Survey; Rutgers State University New Brunswick; Grand Valley State University; MDHHS - Michigan Department of Health & Human Services; National Oceanic Atmospheric Admin (NOAA) - USA	Madenjian, CP (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI USA.	cmadenjian@usgs.gov		Rediske, Richard/0000-0002-5048-1063	U. S. Geological Survey Great Lakes Science Center; Rutgers University	U. S. Geological Survey Great Lakes Science Center(United States Geological Survey); Rutgers University	This work was supported by the U. S. Geological Survey Great Lakes Science Center to CPM and Rutgers University to OPJ.	BALLSCHMITER K, 1992, HRC-J HIGH RES CHROM, V15, P260; BEAMISH FWH, 1964, CAN J ZOOLOG, V42, P189, DOI 10.1139/z64-017; Bodiguel X, 2009, SCI TOTAL ENVIRON, V408, P304, DOI 10.1016/j.scitotenv.2009.10.004; Booij K, 2003, ENVIRON SCI TECHNOL, V37, P4213, DOI 10.1021/es034147c; BORGMANN U, 1992, CAN J FISH AQUAT SCI, V49, P1086, DOI 10.1139/f92-120; Broell F, 2013, J EXP BIOL, V216, P1255, DOI 10.1242/jeb.077396; Burgess RM, 1999, ENVIRON POLLUT, V104, P373, DOI 10.1016/S0269-7491(98)00194-8; Burke BJ, 2002, T AM FISH SOC, V131, P120, DOI 10.1577/1548-8659(2002)131&lt;0120:ALFABM&gt;2.0.CO;2; Capossela KM, 2013, FISH B-NOAA, V111, P189, DOI 10.7755/FB.111.2.6; Carlson DL, 2010, ENVIRON SCI TECHNOL, V44, P2004, DOI 10.1021/es903191u; Carlson DL, 2005, ENVIRON SCI TECHNOL, V39, P7389, DOI 10.1021/es048023r; Cooke SJ, 2004, FUNCT ECOL, V18, P398, DOI 10.1111/j.0269-8463.2004.00878.x; Darnaude AM, 2004, OECOLOGIA, V138, P325, DOI 10.1007/s00442-003-1457-3; Frame G.M., 1996, J HIGH RES CHROMATOG, V19, P657, DOI DOI 10.1002/JHRC.1240191202; Gewurtz SB, 2011, ENVIRON INT, V37, P425, DOI 10.1016/j.envint.2010.11.005; HARTMAN KJ, 1995, CAN J FISH AQUAT SCI, V52, P1667, DOI 10.1139/f95-760; HESSELBERG RJ, 1990, J GREAT LAKES RES, V16, P121, DOI 10.1016/S0380-1330(90)71403-7; International Union of Pure and Applied Chemistry (IUPAC), 2012, REC ORG BIOCH NOM SY; Jude DJ, 2010, J GREAT LAKES RES, V36, P267, DOI 10.1016/j.jglr.2010.03.002; KAMMANN U, 1993, MAR POLLUT BULL, V26, P629, DOI 10.1016/0025-326X(93)90502-B; Kennish Michael J., 2005, Bulletin New Jersey Academy of Science, V50, P1; Kimbrough K.L., 2008, 74 NOAA NOS NCCOS; LOZAN JL, 1992, NETH J SEA RES, V29, P223, DOI 10.1016/0077-7579(92)90022-7; Madenjian CP, 2014, ARCH ENVIRON CON TOX, V66, P529, DOI 10.1007/s00244-014-0015-9; Madenjian CP, 2013, ARCH ENVIRON CON TOX, V65, P693, DOI 10.1007/s00244-013-9936-y; Madenjian CP, 2015, J GREAT LAKES RES, V41, P1185, DOI 10.1016/j.jglr.2015.09.010; Madenjian CP, 2014, SCI TOTAL ENVIRON, V493, P377, DOI 10.1016/j.scitotenv.2014.06.007; Madenjian CP, 2013, J GREAT LAKES RES, V39, P358, DOI 10.1016/j.jglr.2013.03.011; Madenjian CP, 2011, FISH FISH, V12, P451, DOI 10.1111/j.1467-2979.2011.00414.x; Madenjian CP, 2010, SCI TOTAL ENVIRON, V408, P1725, DOI 10.1016/j.scitotenv.2009.12.024; Madenjian CP, 2010, SCI TOTAL ENVIRON, V408, P1719, DOI 10.1016/j.scitotenv.2009.12.023; Madenjian CP, 2009, SCI TOTAL ENVIRON, V407, P4526, DOI 10.1016/j.scitotenv.2009.04.031; MADENJIAN CP, 1993, CAN J FISH AQUAT SCI, V50, P97, DOI 10.1139/f93-012; Madenjian CP, 2000, CAN J FISH AQUAT SCI, V57, P1025, DOI 10.1139/cjfas-57-5-1025; Madenjian CP, 1998, CAN J FISH AQUAT SCI, V55, P1085, DOI 10.1139/cjfas-55-5-1085; MALLOY KD, 1994, T AM FISH SOC, V123, P182, DOI 10.1577/1548-8659(1994)123<0182:EORLAL>2.3.CO;2; MARTHINSEN I, 1991, ARCH ENVIRON CON TOX, V20, P353, DOI 10.1007/BF01064402; Morgan EJ, 2010, ENVIRON SCI TECHNOL, V44, P5444, DOI 10.1021/es100450f; MORSE WW, 1981, J FISH BIOL, V19, P189, DOI 10.1111/j.1095-8649.1981.tb05823.x; Morson JM, 2015, MAR COAST FISH, V7, P393, DOI 10.1080/19425120.2015.1067261; Morson JM, 2012, N AM J FISH MANAGE, V32, P1201, DOI 10.1080/02755947.2012.728174; Murchie KJ, 2011, J EXP MAR BIOL ECOL, V396, P147, DOI 10.1016/j.jembe.2010.10.019; Narvaez DA, 2015, J MARINE SYST, V141, P136, DOI 10.1016/j.jmarsys.2014.08.007; NIIMI AJ, 1983, CAN J FISH AQUAT SCI, V40, P306, DOI 10.1139/f83-045; Pearson RF, 1996, ENVIRON SCI TECHNOL, V30, P1429, DOI 10.1021/es940626n; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pothoven SA, 2012, T AM FISH SOC, V141, P772, DOI 10.1080/00028487.2012.675911; Qiao P, 2000, ARCH ENVIRON CON TOX, V39, P369; RUDSTAM LG, 1989, J PLANKTON RES, V11, P971, DOI 10.1093/plankt/11.5.971; Rypel AL, 2007, CHEMOSPHERE, V68, P1707, DOI 10.1016/j.chemosphere.2007.03.046; Sackett DK, 2008, MAR ECOL PROG SER, V364, P199, DOI 10.3354/meps07391; Sackett DK, 2007, ESTUAR COAST SHELF S, V74, P119, DOI 10.1016/j.ecss.2007.03.027; SCHMIDT LJ, 1992, ARCH ENVIRON CON TOX, V23, P37, DOI 10.1007/BF00225993; Schulz-Bull DE, 1998, MAR CHEM, V61, P101, DOI 10.1016/S0304-4203(98)00010-3; SMITH KL, 1983, MAR BIOL, V76, P325, DOI 10.1007/BF00393036; Stapanian MA, 2014, ENVIRON TOXICOL CHEM, V33, P2448, DOI 10.1002/etc.2703; Stapanian MA, 2013, CHEMOSPHERE, V93, P1615, DOI 10.1016/j.chemosphere.2013.08.016; STEIMLE F W JR, 1985, Journal of Northwest Atlantic Fishery Science, V6, P117; Terceiro M, 2001, REV FISH BIOL FISHER, V11, P125, DOI 10.1023/A:1015260005887; Terceiro M, 2011, REV FISH BIOL FISHER, V21, P681, DOI 10.1007/s11160-011-9207-9; THAYER GW, 1973, FISH B-NOAA, V71, P289; U. S. Army Corps of Engineers U. S. Environmental Protection Agency, 2010, SIT MAN MON PLAN HIS; WEININGER D, 1978, THESIS U WISCONSIN M; Wuenschel M, 2010, 12 FLATF BIOL C 2010; Wuenschel MJ, 2013, FISH B-NOAA, V111, P352, DOI 10.7755/FB.111.4.5	66	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147223	10.1371/journal.pone.0147223	http://dx.doi.org/10.1371/journal.pone.0147223			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794728	Green Published, Green Submitted, gold			2022-12-26	WOS:000368530300023
J	Mills, CA; Godley, BJ; Hodgson, DJ				Mills, Cheryl A.; Godley, Brendan J.; Hodgson, David J.			Take Only Photographs, Leave Only Footprints: Novel Applications of Non-Invasive Survey Methods for Rapid Detection of Small, Arboreal Animals	PLOS ONE			English	Article							STOATS MUSTELA-ERMINEA; CAMERA TRAPS; TRACKING TUNNELS; ECOLOGY; POPULATIONS; AGREEMENT; DORMOUSE; MAMMALS; SITES	The development of appropriate wildlife survey techniques is essential to promote effective and efficient monitoring of species of conservation concern. Here, we demonstrate the utility of two rapid-assessment, non-invasive methods to detect the presence of elusive, small, arboreal animals. We use the hazel dormouse, Muscardinus avellanarius, a rodent of conservation concern, as our focal species. Prevailing hazel dormouse survey methods are prolonged (often taking months to years to detect dormice), dependent on season and habitat, and/or have low detection rates. Alternatives would be of great use to ecologists who undertake dormouse surveys, especially those assessing the need for mitigation measures, as legally required for building development projects. Camera traps and footprint tracking are well-established tools for monitoring elusive large terrestrial mammals, but are rarely used for small species such as rodents, or in arboreal habitats. In trials of these adapted methods, hazel dormice visited bait stations and were successfully detected by both camera traps and tracking equipment at each of two woodland study sites, within days to weeks of installation. Camera trap images and footprints were of adequate quality to allow discrimination between two sympatric small mammal species (hazel dormouse and wood mouse, Apodemus sylvaticus). We discuss the relative merits of these methods with respect to research aims, funds, time available and habitat.	[Mills, Cheryl A.; Godley, Brendan J.; Hodgson, David J.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England; [Mills, Cheryl A.] Keele Univ, Sch Life Sci, Keele ST5 5BG, Staffs, England	University of Exeter; Keele University	Hodgson, DJ (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England.	D.J.Hodgson@exeter.ac.uk	godley, brendan/O-1959-2019	godley, brendan/0000-0003-3845-0034				Alibhai Sky K., 2008, Endangered Species Research, V4, P205, DOI 10.3354/esr00067; Bright P.W., 2006, DORMOUSE CONSERVATIO; BRIGHT PW, 1994, J APPL ECOL, V31, P329, DOI 10.2307/2404547; Brown NP, 1996, NZ J ECOLOGY, V20, P271; Capizzi D, 2002, ITAL J ZOOL, V69, P25, DOI 10.1080/11250000209356434; CAREY AB, 1991, J MAMMAL, V72, P192, DOI 10.2307/1381996; Chanin P, 2003, 524 ENGL NAT; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; Glen AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067940; Glennon MJ, 2002, J MAMMAL, V83, P734, DOI 10.1644/1545-1542(2002)083<0734:AAFTFE>2.0.CO;2; Gurnell J., 2006, LIVE TRAPPING SMALL, VFourth edition, revised ed.; Huijser MP, 2000, BIOL CONSERV, V95, P111, DOI 10.1016/S0006-3207(00)00006-9; Jarvie S, 2014, NEW ZEAL J ZOOL, V41, P210, DOI 10.1080/03014223.2014.911753; Joseph LN, 2006, CONSERV BIOL, V20, P1679, DOI 10.1111/j.1523-1739.2006.00529.x; Kelly MJ, 2008, ANIM CONSERV, V11, P182, DOI 10.1111/j.1469-1795.2008.00179.x; KING CM, 1977, NEW ZEAL J ZOOL, V4, P193, DOI 10.1080/03014223.1977.9517953; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Marsh DM, 2008, CONSERV BIOL, V22, P647, DOI 10.1111/j.1523-1739.2008.00927.x; Mayer W. V., 1957, Journal of Mammalogy, V38, P531, DOI 10.2307/1376421; Mccallum J, 2013, MAMMAL REV, V43, P196, DOI 10.1111/j.1365-2907.2012.00216.x; Meek PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110832; National Dormouse Database, 2014, NAT DORM DAT; Palma ART, 2007, REV BRAS ZOOL, V24, P333, DOI 10.1590/S0101-81752007000200011; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; Ratz H, 2000, NEW ZEAL J ZOOL, V27, P57, DOI 10.1080/03014223.2000.9518210; Rendall AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086592; Reynolds JC, 2004, BIOL CONSERV, V120, P533, DOI 10.1016/j.biocon.2004.03.026; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Russell JC, 2009, ECOLOGY, V90, P2007, DOI 10.1890/08-1069.1; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Treweek J, 1996, J APPL ECOL, V33, P191, DOI 10.2307/2404742; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; VANAPELDOORN R, 1993, MAMMALIA, V57, P407, DOI 10.1515/mamm.1993.57.3.407; Watts CH, 2008, NEW ZEAL J ECOL, V32, P92	39	23	25	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146142	10.1371/journal.pone.0146142	http://dx.doi.org/10.1371/journal.pone.0146142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789632	Green Published, Green Submitted, gold			2022-12-26	WOS:000368529100026
J	Showmaker, KC; Bednarova, A; Gresham, C; Hsu, CY; Peterson, DG; Krishnan, N				Showmaker, Kurt C.; Bednarova, Andrea; Gresham, Cathy; Hsu, Chuan-Yu; Peterson, Daniel G.; Krishnan, Natraj			Insight into the Salivary Gland Transcriptome of Lygus lineolaris (Palisot de Beauvois)	PLOS ONE			English	Article							TARNISHED PLANT BUG; RNA-SEQ DATA; HEMIPTERA-MIRIDAE THRESHOLDS; XANTHINE DEHYDROGENASE; PROTEIN FAMILIES; GENOME SEQUENCE; GLUCOSE-OXIDASE; GENE-EXPRESSION; HOST PLANTS; ROSY LOCUS	The tarnished plant bug (TPB), Lygus lineolaris (Palisot de Beauvois) is a polyphagous, phytophagous insect that has emerged as a major pest of cotton, alfalfa, fruits, and vegetable crops in the eastern United States and Canada. Using its piercing-sucking mouthparts, TPB employs a "lacerate and flush" feeding strategy in which saliva injected into plant tissue degrades cell wall components and lyses cells whose contents are subsequently imbibed by the TPB. It is known that a major component of TPB saliva is the polygalacturonase enzymes that degrade the pectin in the cell walls. However, not much is known about the other components of the saliva of this important pest. In this study, we explored the salivary gland transcriptome of TPB using Illumina sequencing. After in silico conversion of RNA sequences into corresponding polypeptides, 25,767 putative proteins were discovered. Of these, 19,540 (78.83%) showed significant similarity to known proteins in the either the NCBI nr or Uniprot databases. Gene ontology (GO) terms were assigned to 7,512 proteins, and 791 proteins in the sialotranscriptome of TPB were found to collectively map to 107 Kyoto Encyclopedia of Genes and Genomes (KEGG) database pathways. A total of 3,653 Pfam domains were identified in 10,421 sialotranscriptome predicted proteins resulting in 12,814 Pfam annotations; some proteins had more than one Pfam domain. Functional annotation revealed a number of salivary gland proteins that potentially facilitate degradation of host plant tissues and mitigation of the host plant defense response. These transcripts/proteins and their potential roles in TPB establishment are described.	[Showmaker, Kurt C.; Gresham, Cathy; Hsu, Chuan-Yu; Peterson, Daniel G.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Showmaker, Kurt C.; Bednarova, Andrea; Krishnan, Natraj] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Bednarova, Andrea] Acad Sci, Ctr Biol, Inst Entomol, Branisovska 31, Ceske Budeaejovice 37005, Czech Republic; [Peterson, Daniel G.] Mississippi State Univ, Dept Plant & Soil Sci, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Mississippi State University	Krishnan, N (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.	nk260@msstate.edu	Krishnan, Natraj/H-2937-2019; KRISHNAN, NATRAJ/B-4856-2012; Bednarova, Andrea/C-5249-2016; Bednarova, Andrea/T-1874-2019	Krishnan, Natraj/0000-0001-6832-259X; KRISHNAN, NATRAJ/0000-0001-6832-259X; Bednarova, Andrea/0000-0002-6822-6351; Bednarova, Andrea/0000-0002-6822-6351; Peterson, Daniel/0000-0002-0274-5968; Showmaker, Kurt/0000-0002-6317-9402	Mississippi State University from National Science Foundation [269110-151250]; Experimental Program to Stimulate Competitive Research; Mississippi State University Schillig special teaching grant [365082]; United States Department of Agriculture, Agricultural Research Service from the Grant Agency of the University of South Bohemia [6402-21310-003-24S, 6402-21310-003-18S, 038/2014/P]; American Science Information Center, Czech-American Science and Technology Cooperative grant KONTAKT [LH 14047]	Mississippi State University from National Science Foundation; Experimental Program to Stimulate Competitive Research(National Science Foundation (NSF)NSF - Office of the Director (OD)); Mississippi State University Schillig special teaching grant; United States Department of Agriculture, Agricultural Research Service from the Grant Agency of the University of South Bohemia; American Science Information Center, Czech-American Science and Technology Cooperative grant KONTAKT	This research was supported by the start-up funds from Mississippi State University No. 269110-151250 from National Science Foundation, Experimental Program to Stimulate Competitive Research, and the Mississippi State University Schillig special teaching grant 365082 (N.K.), and in part through funding from United States Department of Agriculture, Agricultural Research Service awards 6402-21310-003-24S and 6402-21310-003-18S (D. G.P), Grant No. 038/2014/P from the Grant Agency of the University of South Bohemia (A.B.). The stay of A.B. in the lab of N.K. was partially covered from the American Science Information Center, Czech-American Science and Technology Cooperative grant KONTAKT No. LH 14047. The funding authorities had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alarcon-Chaidez FJ, 2007, INSECT BIOCHEM MOLEC, V37, P48, DOI 10.1016/j.ibmb.2006.10.002; Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; Allen ML, 2007, GENET MOL RES, V6, P206; Allen ML, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2701; Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Attwood TK, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas019; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourland F. M., 1999, Journal of Cotton Science, V3, P171; Bourland F, 2015, AGRON MONOGR, V57, P205, DOI 10.2134/agronmonogr57.2013.0025; Bourland FM, 2015, J PLANT REGIST, V9, P94, DOI 10.3198/jpr2014.05.0033crg; Bourland FM, 2013, J PLANT REGIST, V7, P135, DOI 10.3198/jpr2012.07.0011crc; Calvo E, 2006, INSECT BIOCHEM MOLEC, V36, P570, DOI 10.1016/j.ibmb.2006.04.005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Celorio-Mancera MD, 2009, ARCH INSECT BIOCHEM, V70, P122, DOI 10.1002/arch.20282; Celorio-Mancera MD, 2008, ARTHROPOD-PLANT INTE, V2, P215, DOI 10.1007/s11829-008-9050-7; Chivasa S, 2009, PLANT SIGNAL BEHAV, V4, P1078, DOI 10.4161/psb.4.11.9784; Chivasa S, 2009, PLANT J, V60, P436, DOI 10.1111/j.1365-313X.2009.03968.x; Choi JK, 2004, PROTEINS, V55, P22, DOI 10.1002/prot.10434; Cohen AC, 2000, J ENTOMOL SCI, V35, P301, DOI 10.18474/0749-8004-35.3.301; Cooper WR, 2013, ANN ENTOMOL SOC AM, V106, P86, DOI 10.1603/AN12096; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; Doyle WA, 1996, EUR J BIOCHEM, V239, P782, DOI 10.1111/j.1432-1033.1996.0782u.x; Dubey NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-241; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Francischetti IMB, 2005, INSECT BIOCHEM MOLEC, V35, P1142, DOI 10.1016/j.ibmb.2005.05.007; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Gore J, 2012, J ECON ENTOMOL, V105, P2007, DOI 10.1603/EC12079; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAY M, 1991, GENETICS, V127, P139; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; HANNY BW, 1977, ENVIRON ENTOMOL, V6, P460, DOI 10.1093/ee/6.3.460; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; HAYASHI Y, 1961, NATURE, V192, P756, DOI 10.1038/192756b0; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Hori K., 1992, P157; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Ji R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079612; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KEITH TP, 1987, GENETICS, V116, P67; Kirsch R, 2014, INSECT BIOCHEM MOLEC, V52, P33, DOI 10.1016/j.ibmb.2014.06.008; Kirsch Roy, 2012, BMC Genomics, V13, P587, DOI 10.1186/1471-2164-13-587; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Komoto N, 1999, INSECT MOL BIOL, V8, P73, DOI 10.1046/j.1365-2583.1999.810073.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Layton MB, 2000, SOUTHWEST ENTOMOL, P7; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lim MH, 2014, PLANT PHYSIOL, V164, P2054, DOI 10.1104/pp.113.233429; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Magalhaes LC, 2013, ENTOMOL EXP APPL, V146, P364, DOI 10.1111/eea.12035; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MAREDIA KM, 1994, SOUTHWEST ENTOMOL, V19, P63; Markovic O, 2001, PROTEIN ENG, V14, P615, DOI 10.1093/protein/14.9.615; Matsumoto Y, 2014, J INSECT PHYSIOL, V71, P170, DOI 10.1016/j.jinsphys.2014.10.010; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Morais DADL, 2011, NUCLEIC ACIDS RES, V39, pD427, DOI 10.1093/nar/gkq1130; Musser FR, 2009, J ECON ENTOMOL, V102, P2109, DOI 10.1603/029.102.0614; Musser FR, 2009, J ECON ENTOMOL, V102, P1827, DOI 10.1603/029.102.0513; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; O'Neill M. A., 2003, PLANT CELL WALL, P1, DOI DOI 10.1002/9781119312994.APR0067; Oates ME, 2015, NUCLEIC ACIDS RES, V43, pD227, DOI 10.1093/nar/gku1041; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oviedo MN, 2009, INSECT BIOCHEM MOLEC, V39, P382, DOI 10.1016/j.ibmb.2009.03.001; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pauchet Y, 2014, INSECT BIOCHEM MOLEC, V49, P1, DOI 10.1016/j.ibmb.2014.03.004; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Perera OP, 2007, MOL ECOL NOTES, V7, P987, DOI 10.1111/j.1471-8286.2007.01747.x; Perera OP, 2015, ANN ENTOMOL SOC AM, V108, P181, DOI 10.1093/aesa/sau016; Perera OP, 2012, J INVERTEBR PATHOL, V109, P11, DOI 10.1016/j.jip.2011.08.004; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ribeiro J.M.C., 1995, P74; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shackel KA, 2005, ARCH INSECT BIOCHEM, V58, P69, DOI 10.1002/arch.20033; Shelby Kent S., 2013, Insects, V4, P712, DOI 10.3390/insects4040712; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Singh H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25615; Smith Thomas M, 2006, Purinergic Signal, V2, P327, DOI 10.1007/s11302-005-5300-7; Snodgrass GL, 2009, J ECON ENTOMOL, V102, P699, DOI 10.1603/029.102.0231; Snodgrass GL, 2003, ENVIRON ENTOMOL, V32, P945, DOI 10.1603/0046-225X-32.5.945; Snodgrass GL, 2003, J ECON ENTOMOL, V96, P902, DOI 10.1603/0022-0493-96.3.902; Snodgrass GL, 1996, J ECON ENTOMOL, V89, P783, DOI 10.1093/jee/89.4.783; Snodgrass GL, 2000, J ECON ENTOMOL, V93, P441, DOI 10.1603/0022-0493-93.2.441; SNODGRASS GL, 1984, ENVIRON ENTOMOL, V13, P110, DOI 10.1093/ee/13.1.110; Snodgrass GL, 2008, SOUTHWEST ENTOMOL, V33, P173, DOI 10.3958/0147-1724-33.3.173; Stafford-Banks CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094447; Stiburek L, 2012, MOL BIOL CELL, V23, P1010, DOI 10.1091/mbc.E11-08-0674; STRONG FE, 1970, J ECON ENTOMOL, V63, P808, DOI 10.1093/jee/63.3.808; Su YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039303; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tian DL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036168, 10.1371/journal.pone.0042833]; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Walker WB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14133; Wheeler Alfred G. Jr., 2001, pi; Will T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00336; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; WILLIAMS L, 1987, J ECON ENTOMOL, V80, P527, DOI 10.1093/jee/80.2.527; Williams L, 2000, J ENTOMOL SCI, V35, P187, DOI 10.18474/0749-8004-35.2.187; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Yang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-328; YOUNG OP, 1986, ANN ENTOMOL SOC AM, V79, P747, DOI 10.1093/aesa/79.4.747; Zhang LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126391; Zhu Yu Cheng, 2012, PLoS One, V7, pe37586, DOI 10.1371/journal.pone.0037586; Zhu YC, 2015, PEST MANAG SCI, V71, P40, DOI 10.1002/ps.3761	135	16	18	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147197	10.1371/journal.pone.0147197	http://dx.doi.org/10.1371/journal.pone.0147197			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789269	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100065
J	Yesudhas, D; Anwar, MA; Panneerselvam, S; Durai, P; Shah, M; Choi, S				Yesudhas, Dhanusha; Anwar, Muhammad Ayaz; Panneerselvam, Suresh; Durai, Prasannavenkatesh; Shah, Masaud; Choi, Sangdun			Structural Mechanism behind Distinct Efficiency of Oct4/Sox2 Proteins in Differentially Spaced DNA Complexes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; HIGH-THROUGHPUT; BINDING DOMAIN; FORCE-FIELD; OCT4; SOX2; PLURIPOTENCY; CORE	The octamer-binding transcription factor 4 (Oct4) and sex-determining region Y (SRY)box 2 (Sox2) proteins induce various transcriptional regulators to maintain cellular pluripotency. Most Oct4/Sox2 complexes have either 0 base pairs (Oct4/Sox20bp) or 3 base pairs (Oct4/Sox23bp) separation between their DNA-binding sites. Results from previous biochemical studies have shown that the complexes separated by 0 base pairs are associated with a higher pluripotency rate than those separated by 3 base pairs. Here, we performed molecular dynamics (MD) simulations and calculations to determine the binding free energy and per-residue free energy for the Oct4/Sox20bp and Oct4/Sox23bp complexes to identify structural differences that contribute to differences in induction rate. Our MD simulation results showed substantial differences in Oct4/Sox2 domain movements, as well as secondary-structure changes in the Oct4 linker region, suggesting a potential reason underlying the distinct efficiencies of these complexes during reprogramming. Moreover, we identified key residues and hydrogen bonds that potentially facilitate protein-protein and protein-DNA interactions, in agreement with previous experimental findings. Consequently, our results confess that differential spacing of the Oct4/Sox2 DNA binding sites can determine the magnitude of transcription of the targeted genes during reprogramming.	[Yesudhas, Dhanusha; Anwar, Muhammad Ayaz; Panneerselvam, Suresh; Durai, Prasannavenkatesh; Shah, Masaud; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea	Ajou University	Choi, S (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.	sangdunchoi@ajou.ac.kr	Panneerselvam, Suresh/K-3994-2019; Anwar, Muhammad Ayaz/ABC-8104-2021; Shah, Masaud/K-8748-2016; Durai, Prasannavenkatesh/AAU-4782-2021	Panneerselvam, Suresh/0000-0001-9341-2861; Anwar, Muhammad Ayaz/0000-0002-8794-5589; Durai, Prasannavenkatesh/0000-0002-1538-8349	Korea Health Technology R&D Project through the Korea Health Industry Development Institute [HI14C1992]; Mid-Career Researcher Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2015R1A2A2A09001059]; Priority Research Centers Program [NRF 2012-0006687]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Mid-Career Researcher Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Priority Research Centers Program	This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (HI14C1992). This work was also partially supported by the Mid-Career Researcher Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (NRF-2015R1A2A2A09001059) and a grant from the Priority Research Centers Program (NRF 2012-0006687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Blanchet C, 2011, NUCLEIC ACIDS RES, V39, pW68, DOI 10.1093/nar/gkr316; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bredenberg J, 2002, PROTEINS, V49, P24, DOI 10.1002/prot.10195; Chen L, 2015, PHYS CHEM CHEM PHYS, V17, P5704, DOI 10.1039/c4cp05413j; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chillemi G, 2008, NUCLEIC ACIDS RES, V36, P5645, DOI 10.1093/nar/gkn558; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Govindaraj RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012713; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hays FA, 2005, P NATL ACAD SCI USA, V102, P7157, DOI 10.1073/pnas.0409455102; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hilser VJ, 2011, J BIOL CHEM, V286, P39675, DOI 10.1074/jbc.R111.278929; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jauch R, 2011, STEM CELLS, V29, P940, DOI 10.1002/stem.639; Jerabek S, 2014, BBA-GENE REGUL MECH, V1839, P138, DOI 10.1016/j.bbagrm.2013.10.001; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lambrughi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00435; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lu Q, 2007, J PHYS CHEM B, V111, P11538, DOI 10.1021/jp0742261; Maisuradze GG, 2009, J MOL BIOL, V385, P312, DOI 10.1016/j.jmb.2008.10.018; Manavalan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106542; Manavalan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015782; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Merino F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004287; Merino F, 2014, STRUCTURE, V22, P1274, DOI 10.1016/j.str.2014.06.014; Mesentean S, 2006, PROTEINS, V64, P210, DOI 10.1002/prot.20981; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pan YP, 2008, J PHYS CHEM B, V112, P6716, DOI 10.1021/jp800680w; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRIVE GG, 1991, J MOL BIOL, V217, P177, DOI 10.1016/0022-2836(91)90619-H; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Scaffidi P, 2001, J BIOL CHEM, V276, P47296, DOI 10.1074/jbc.M107619200; Schmidt R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-251; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tantin D, 2013, DEVELOPMENT, V140, P2857, DOI 10.1242/dev.095927; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; Upadhyay SK, 2014, MOL BIOSYST, V10, P3120, DOI 10.1039/c4mb00371c; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Yusuf D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r24; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	59	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147240	10.1371/journal.pone.0147240	http://dx.doi.org/10.1371/journal.pone.0147240			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790000	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100071
J	Andersen, NJ; Boguslawski, EA; Naidu, AS; Szot, C; Bromberg-White, JL; Kits, K; Kuk, CY; Holton, LE; St Croix, B; Chambers, CM; Duesbery, NS				Andersen, N. J.; Boguslawski, E. A.; Naidu, A. S.; Szot, C.; Bromberg-White, J. L.; Kits, K.; Kuk, C. Y.; Holton, L. E.; St Croix, B.; Chambers, C. M.; Duesbery, N. S.			Anthrax Toxin Receptor 1 Is Essential for Arteriogenesis in a Mouse Model of Hindlimb Ischemia	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; GROWTH; INFLAMMATION; EXPRESSION; PROLIFERATION; VENULES; CELLS	Anthrax toxin receptor 1/tumor endothelial marker 8 (Antxr1 or TEM8) is up-regulated in tumor vasculature and serves as a receptor for anthrax toxin, but its physiologic function is unclear. The objective of this study was to evaluate the role of Antxr1 in arteriogenesis. The role of Antxr1 in arteriogenesis was tested by measuring gene expression and immunohistochemistry in a mouse model of hindlimb ischemia using wild-type and ANTXR1(-/-)mice. Additional tests were performed by measuring gene expression in in vitro models of fluid shear stress and hypoxia, as well as in human muscle tissues obtained from patients having peripheral artery disease. We observed that Antxr1 expression transiently increased in ischemic tissues following femoral artery ligation and that its expression was necessary for arteriogenesis. In the absence of Antxr1, the mean arterial lumen area in ischemic tissues decreased. Antxr1 mRNA and protein expression was positively regulated by fluid shear stress, but not by hypoxia. Furthermore, Antxr1 expression was elevated in human peripheral artery disease requiring lower extremity bypass surgery. These findings demonstrate an essential physiologic role for Antxr1 in arteriogenesis and peripheral artery disease, with important implications for managing ischemia and other arteriogenesis-dependent vascular diseases.	[Andersen, N. J.; Holton, L. E.; Chambers, C. M.] Spectrum Hosp, Frederik Meijer Heart & Vasc Inst, 100 Michigan St NE, Grand Rapids, MI 49503 USA; [Andersen, N. J.; Boguslawski, E. A.; Naidu, A. S.; Bromberg-White, J. L.; Kits, K.; Kuk, C. Y.; Chambers, C. M.; Duesbery, N. S.] Van Andel Res Inst, Ctr Canc Cell Biol, Lab Canc & Dev Cell Biol, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA; [Szot, C.; St Croix, B.] NCI, Tumor Angiogenesis Sect, Ctr Canc Res, Bldg 560, Frederick, MD 21702 USA; [Kits, K.] Van Andel Educ Inst, Partners Sci Program, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA	Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Duesbery, NS (corresponding author), Van Andel Res Inst, Ctr Canc Cell Biol, Lab Canc & Dev Cell Biol, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	duesbery@vai.org		Andersen, Nicholas/0000-0001-5958-3210; Duesbery, Nicholas/0000-0002-5708-4984; Kuk, ChiuYing/0000-0001-9413-7830; DUESBERY, NICK/0000-0002-4258-5655	Van Andel Institute; Frederic Meijer Heart and Vascular Institute; intramural research program of the NCI, NIH, Department of Health and Social Services (DHSS); NATIONAL CANCER INSTITUTE [ZIABC010484] Funding Source: NIH RePORTER	Van Andel Institute; Frederic Meijer Heart and Vascular Institute; intramural research program of the NCI, NIH, Department of Health and Social Services (DHSS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was funded by the Van Andel Institute, the Frederic Meijer Heart and Vascular Institute, and the intramural research program of the NCI, NIH, Department of Health and Social Services (DHSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARORA N, 1993, J BIOL CHEM, V268, P3334; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; Duan HF, 2007, J NATL CANCER I, V99, P1551, DOI 10.1093/jnci/djm132; Ezaki T, 2001, AM J PATHOL, V158, P2043, DOI 10.1016/S0002-9440(10)64676-7; Felicetti P, 2007, CYTOTHERAPY, V9, P23, DOI 10.1080/14653240601048369; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; KNIGHTON DR, 1983, SCIENCE, V221, P1283, DOI 10.1126/science.6612342; Kochi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084047; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; McDonald Donald M, 2011, Proc Am Thorac Soc, V8, P504, DOI 10.1513/pats.201102-022MW; Meehan B, 2015, NEOPLASMA; Murphy TJ, 1999, AM J PATHOL, V155, P93, DOI 10.1016/S0002-9440(10)65104-8; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Niiyama H., 2009, J VIS EXP; Peters DE, 2012, BIOCHEM BIOPH RES CO, V422, P393, DOI 10.1016/j.bbrc.2012.04.160; Pipp F, 2004, ARTERIOSCL THROM VAS, V24, P1664, DOI 10.1161/01.ATV.0000138028.14390.e4; Ruan ZH, 2009, J IMMUNOTHER, V32, P486, DOI 10.1097/CJI.0b013e3181a1d134; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; St Croix B, 2000, SCIENCE, V289, P1197; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; Thurston G, 2000, MICROCIRCULATION, V7, P67, DOI 10.1038/sj.mn.7300155; Thurston G, 1998, AM J PATHOL, V153, P1099, DOI 10.1016/S0002-9440(10)65654-4; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; Wu WX, 2009, J IMMUNOL, V183, P5799, DOI 10.4049/jimmunol.0803406; Yang XM, 2010, VACCINE, V28, P7130, DOI 10.1016/j.vaccine.2010.07.014; Yu JL, 2003, BREAST CANCER RES, V5, P83, DOI 10.1186/bcr573; Zheng QP, 2013, GENE, V523, P195, DOI 10.1016/j.gene.2013.02.053	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146586	10.1371/journal.pone.0146586	http://dx.doi.org/10.1371/journal.pone.0146586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785120	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400049
J	Jaramillo-Ruiz, D; De La Mata, FJ; Gomez, R; Correa-Rocha, R; Munoz-Fernandez, MA				Jaramillo-Ruiz, Didiana; Javier De La Mata, Francisco; Gomez, Rafael; Correa-Rocha, Rafael; Angeles Munoz-Fernandez, Ma			Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; CARBOSILANE DENDRIMERS; EXPRESSION; CHEMISTRY; PROFILE; MODEL	Background HIV-1 has proved to infect regulatory T cells (Treg) modifying their phenotype and impairing their suppressive capacity. As Treg cells are a crucial component in the preservation of the immune homeostasis, we researched that the antiviral capacity of carboxilan dendrimers prevents the HIV-1 infection of Treg and their effects. The phenotype and suppressive capacity of Treg treated or non-treated with carbosilane dendrimers were studied by flow cytometry. Treated and non-treated Treg from healthy donors were infected with HIV-1(NL4.3). The infection of Treg cells by HIV-1, and protective effect of two dendrimers were determined by measuring antigen p24(gag) in the supernatant of the culture and intracellular. Results The Treg cells were treated with cationic and anionic carbosilane dendrimers. The results showed that both dendrimers did not modify the phenotype and functionality of Treg cells compared with non-treated Treg cells. Anionic dendrimers showed high biocompatibility with normal activity of the Treg cells and in antiviral assays. These dendrimers were highly active against HIV-1 preventing the infection of Treg, and were able to protect the Treg from the Foxp3 downregulation induced by the HIV-1 infection. Conclusions This is the first work showing that the in vitro use of anionic dendrimers prevent the HIV-1 replication and the infection of expanded Treg cells in culture, which raises the possibility to use Treg cells therapeutically in HIV-1-infected subjects.	[Jaramillo-Ruiz, Didiana; Correa-Rocha, Rafael; Angeles Munoz-Fernandez, Ma] Hosp Gen Univ Gregorio Maranon, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Spanish HIV HGM BioBank, Inst Invest Sanitaria Gregorio Maranon,Lab Inmuno, Madrid, Spain; [Javier De La Mata, Francisco; Gomez, Rafael] Univ Alcala de Henares, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Dept Quim Inorgan & Quim Organ, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala	Munoz-Fernandez, MA (corresponding author), Hosp Gen Univ Gregorio Maranon, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Spanish HIV HGM BioBank, Inst Invest Sanitaria Gregorio Maranon,Lab Inmuno, Madrid, Spain.	mmunoz.hgugm@gmail.com	Correa-Rocha, Rafael/C-8213-2011; Ramírez, Rafael Gómez/K-1216-2014	Correa-Rocha, Rafael/0000-0003-3456-9986; Ramírez, Rafael Gómez/0000-0001-6448-2414; Jaramillo, Didiana/0000-0003-0898-1723; Munoz-Fernandez/0000-0002-0813-4500	Plan Nacional R+D+I [RD12/0017/0037]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) [RETIC PT13/0010/0028]; Fondo de Investigacion Sanitaria (FIS) [PI12-00934, PI13/02016]; "Fundacion para la Investigacion y la Prevencion del Sida en Espana" (FIPSE), Comunidad de Madrid [S-2010/BMD-2351, S-2010/BMD-2332]; grant of "Miguel Servet II" Program [CPII13/00033]; VI National RDi Plan; Consolider Program; CIBER Actions; Instituto de Salud Carlos III; European Regional Development Fund; ISC III [PT13/0010/0028]; FIPSE; IniciativaIngenio; MIMECO [CTQ2011-23245]; CYTED [214RT0482]	Plan Nacional R+D+I; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); "Fundacion para la Investigacion y la Prevencion del Sida en Espana" (FIPSE), Comunidad de Madrid; grant of "Miguel Servet II" Program; VI National RDi Plan; Consolider Program(Spanish Government); CIBER Actions; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund(European Commission); ISC III(Instituto de Salud Carlos III); FIPSE; IniciativaIngenio(Spanish Government); MIMECO; CYTED	This work has been (partially) funded by the RD12/0017/0037, project as part of the Plan Nacional R+D+I and cofinanced by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), RETIC PT13/0010/0028, Fondo de Investigacion Sanitaria (FIS) (grant numbers PI12-00934, PI13/02016), CTQ2011-23245 (MIMECO), "Fundacion para la Investigacion y la Prevencion del Sida en Espana" (FIPSE), Comunidad de Madrid (grant numbers S-2010/BMD-2351 and S-2010/BMD-2332], CYTED 214RT0482, and R.C-R is supported by a grant of "Miguel Servet II" Program (CPII13/00033). CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008-2011, IniciativaIngenio 2010, the Consolider Program, and CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. Also, the authors thank Dr Maribel Clemente Mayoral for her technical assistance and advice as cell culture technician (CA10/01274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Centre of Transfusion of Madrid for the buffy coats and the Spanish HIV HGM BioBank supported by ISC III (Grant no PT13/0010/0028) and FIPSE. Also, we thank Dr Maribel Clemente Mayoral for her technical assistance and advice as cell culture technician (CA10/01274).	Angin M, 2014, J INFECT DIS, V210, P899, DOI 10.1093/infdis/jiu188; Angin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086920; Angin M, 2013, JOVE-J VIS EXP, DOI 10.3791/50244; Angin M, 2012, AIDS, V26, P2112, DOI 10.1097/QAD.0b013e328358cc75; Bermejo JF, 2007, CHEM-EUR J, V13, P483, DOI 10.1002/chem.200600594; Canavan JB, 2012, BLOOD, V119, pE57, DOI 10.1182/blood-2011-09-380048; Card CM, 2012, JAIDS-J ACQ IMM DEF, V59, P427, DOI 10.1097/QAI.0b013e3182454fcd; Chonco L, 2012, J CONTROL RELEASE, V161, P949, DOI 10.1016/j.jconrel.2012.04.050; Cordoba E. V., 2013, AIDS, DOI 10.1097/QAD.0b013e328361fa4a; Cordoba EV, 2013, NANOMED-NANOTECHNOL, V9, P972, DOI 10.1016/j.nano.2013.03.004; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Galan M, 2014, ORG BIOMOL CHEM, V12, P3222, DOI 10.1039/c4ob00162a; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gonzalo T, 2010, CHEMMEDCHEM, V5, P921, DOI 10.1002/cmdc.201000029; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Clemente MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085230; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Mendez-Lagares G, 2014, JAIDS-J ACQ IMM DEF, V65, P278, DOI 10.1097/QAI.0000000000000092; Moreno-Fernandez ME, 2012, J VIROL, V86, P10262, DOI 10.1128/JVI.00993-12; Moreno-Fernandez ME, 2009, J VIROL, V83, P12925, DOI 10.1128/JVI.01352-09; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Patton DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017359; Pion M, 2013, AIDS, V27, P2019, DOI 10.1097/QAD.0b013e32836253fd; Pion M, 2010, BIOMATERIALS, V31, P8749, DOI 10.1016/j.biomaterials.2010.07.093; Rasines B, 2012, DALTON T, V41, P12733, DOI 10.1039/c2dt31099f; Rittner K, 2002, MOL THER, V5, P104, DOI 10.1006/mthe.2002.0523; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schaier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034208; Sepulveda-Crespo D, 2014, NANOMED-NANOTECHNOL, V10, P609, DOI 10.1016/j.nano.2013.10.002; Simonetta F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00215; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381; Weber N, 2008, J CONTROL RELEASE, V132, P55, DOI 10.1016/j.jconrel.2008.07.035	36	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145760	10.1371/journal.pone.0145760	http://dx.doi.org/10.1371/journal.pone.0145760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785250	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400019
J	Montufar-Solis, D; Klein, JR				Montufar-Solis, Dina; Klein, John R.			Splenic Leukocytes Traffic to the Thyroid and Produce a Novel TSH beta Isoform during Acute Listeria monocytogenes Infection in Mice	PLOS ONE			English	Article							PERIPHERAL-BLOOD LEUKOCYTES; SPLICE VARIANT; IMMUNE-SYSTEM; THYROTROPIN; MONOCYTES; REGULATOR; EXPRESSION; SUBSETS; SUBUNIT; DISEASE	The thyroid stimulating hormone beta-subunit (TSH beta) with TSH alpha form a glycoprotein hormone that is produced by the anterior pituitary in the hypothalamus-pituitary-thyroid (HPT) axis. Although TSH beta has been known for many years to be made by cells of the immune system, the role of immune system TSH has remained unclear. Recent studies demonstrated that cells of the immune system produce a novel splice variant isoform of TSH beta (TSH beta v), but little if any native TSH beta. Here, we show that within three days of systemic infection of mice with Listeria monocytogenes, splenic leukocytes synthesized elevated levels of TSH beta v. This was accompanied by an influx of CD14(+), Ly6C(+), Ly6G(+) cells into the thyroid of infected mice, and increased levels of intrathyroidal TSH beta v gene expression. Adoptive transfer of carboxyfluorescein succinimidyl ester (CFSE)-labeled splenic leukocytes from infected mice into non-infected mice migrated into the thyroid as early as forty-eight hours post-cell transfer, whereas CFSE-labeled cells from non-infected mice failed to traffic to the thyroid. These findings demonstrate for the first time that during bacterial infection peripheral leukocytes produce elevated levels of TSH beta v, and that spleen cells traffic to the thyroid where they produce TSH beta v intrathyroidally.	[Montufar-Solis, Dina; Klein, John R.] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77054 USA	University of Texas System; University of Texas Health Science Center Houston	Klein, JR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77054 USA.	john.r.klein@uth.tmc.edu			Public Health Service from the National Institute of Digestion, Diabetes, and Kidney Disease [DK035566]; National Institute of Allergy and Infectious Diseases [AI100159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI100159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035566, R23DK035566] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Digestion, Diabetes, and Kidney Disease; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grant DK035566 from the National Institute of Digestion, Diabetes, and Kidney Disease and AI100159 from the National Institute of Allergy and Infectious Diseases. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baliram R, 2013, ENDOCRINOLOGY, V154, P4919, DOI 10.1210/en.2012-2234; CHEERS C, 1978, INFECT IMMUN, V19, P755, DOI 10.1128/IAI.19.3.755-762.1978; Drevets DA, 2004, J IMMUNOL, V172, P4418, DOI 10.4049/jimmunol.172.7.4418; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GORDON DF, 1988, DNA-J MOLEC CELL BIO, V7, P17, DOI 10.1089/dna.1988.7.17; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Kernbauer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065007; Klein JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00155; Klein JR, 2006, EXP BIOL MED, V231, P229; KRUGER TE, 1989, J IMMUNOL, V142, P744; Lindback T, 2011, APPL ENVIRON MICROB, V77, P3478, DOI 10.1128/AEM.02708-10; Liu CR, 2012, MOL BIOL REP, V39, P10019, DOI 10.1007/s11033-012-1871-x; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Schaefer JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056436; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Schaefer JS, 2011, FASEB J, V25, P29, DOI 10.1096/fj.10-168203; Schaefer JS, 2009, GEN COMP ENDOCR, V162, P241, DOI 10.1016/j.ygcen.2009.04.006; SMITH EM, 1983, P NATL ACAD SCI-BIOL, V80, P6010, DOI 10.1073/pnas.80.19.6010; Song JS, 2015, IMMUNOL LETT, V167, P41, DOI 10.1016/j.imlet.2015.07.002; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Vincent BH, 2009, GENES IMMUN, V10, P18, DOI 10.1038/gene.2008.69; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Zhou Q, 2002, HYBRIDOMA HYBRIDOM, V21, P75, DOI 10.1089/15368590252917674	28	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146111	10.1371/journal.pone.0146111	http://dx.doi.org/10.1371/journal.pone.0146111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771831	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300010
J	Orii, M; Kono, K; Wen, HI; Nakanishi, M				Orii, Minami; Kono, Keiko; Wen, Hsin-I; Nakanishi, Makoto			PP1-Dependent Formin Bnr1 Dephosphorylation and Delocalization from a Cell Division Site	PLOS ONE			English	Article							PROTEIN PHOSPHATASE; BNI1P; LOCALIZATION; CYTOKINESIS; MECHANISM; TYPE-1; CYCLE	Cell cycle ends with cytokinesis that is the physical separation of a cell into two daughter cells. For faithful cytokinesis, cells integrate multiple processes, such as actomyosin ring formation, contraction and plasma membrane closure, into coherent responses. Linear actin assembly by formins is essential for formation and maintenance of actomyosin ring. Although budding yeast's two formins, Bni1 and Bnr1, are known to switch their subcellular localization at the division site prior to cytokinesis, the underlying mechanisms were not completely understood. Here, we provide evidence showing that Bnr1 is dephosphorylated concomitant with its release from the division site. Impaired PP1/Glc7 activity delayed Bnr1 release and dephosphorylation, Bni1 recruitment and actomyosin ring formation at the division site. These results suggest the involvement of Glc7 in this regulation. Further, we identified Ref2 as the PP1 regulatory subunit responsible for this regulation. Taken together, Glc7 and Ref2 may have a role in actomyosin ring formation by modulating the localization of formins during cytokinesis.	[Orii, Minami; Kono, Keiko; Wen, Hsin-I; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan	Nagoya City University	Kono, K; Nakanishi, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	mkt-naka@med.nagoya-cu.ac.jp; kono@med.nagoya-cu.ac.jp		Kono, Keiko/0000-0003-4057-8790				Andrews PD, 2000, J CELL SCI, V113, P507; Atkins BD, 2013, J CELL BIOL, V202, P231, DOI 10.1083/jcb.201301090; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Bloecher A, 2000, J CELL BIOL, V149, P125, DOI 10.1083/jcb.149.1.125; Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; Bloom J, 2011, J BIOL CHEM, V286, P5434, DOI 10.1074/jbc.M110.205054; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Buttery SM, 2012, MOL BIOL CELL, V23, P4041, DOI 10.1091/mbc.E12-05-0395; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Desai A, 2008, SCIENCE, P1543, DOI [10.1126/science.1163086, DOI 10.1126/SCIENCE.1163086]; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Ferrer-Dalmau J, 2010, BIOCHEM J, V426, P355, DOI 10.1042/BJ20091909; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Kono K, 2012, CELL, V150, P151, DOI 10.1016/j.cell.2012.05.030; Mishra M, 2014, FEMS MICROBIOL REV, V38, P213, DOI 10.1111/1574-6976.12064; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; Nigavekar SS, 2002, ARCH BIOCHEM BIOPHYS, V404, P71, DOI 10.1016/S0003-9861(02)00231-X; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wloka C, 2011, BIOL CHEM, V392, P813, DOI 10.1515/BC.2011.083; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747	31	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146941	10.1371/journal.pone.0146941	http://dx.doi.org/10.1371/journal.pone.0146941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771880	Green Submitted, gold, Green Published			2022-12-26	WOS:000368628300045
J	Melin, AD; Kline, DW; Hiramatsu, C; Caro, T				Melin, Amanda D.; Kline, Donald W.; Hiramatsu, Chihiro; Caro, Tim			Zebra Stripes through the Eyes of Their Predators, Zebras, and Humans	PLOS ONE			English	Article							SPATIAL CONTRAST SENSITIVITY; COLOR-VISION; VISUAL RESOLUTION; ACUITY; PERCEPTION; SIZE; CAT	The century-old idea that stripes make zebras cryptic to large carnivores has never been examined systematically. We evaluated this hypothesis by passing digital images of zebras through species-specific spatial and colour filters to simulate their appearance for the visual systems of zebras' primary predators and zebras themselves. We also measured stripe widths and luminance contrast to estimate the maximum distances from which lions, spotted hyaenas, and zebras can resolve stripes. We found that beyond ca. 50 m (daylight) and 30 m (twilight) zebra stripes are difficult for the estimated visual systems of large carnivores to resolve, but not humans. On moonless nights, stripes are difficult for all species to resolve beyond ca. 9 m. In open treeless habitats where zebras spend most time, zebras are as clearly identified by the lion visual system as are similar-sized ungulates, suggesting that stripes cannot confer crypsis by disrupting the zebra's outline. Stripes confer a minor advantage over solid pelage in masking body shape in woodlands, but the effect is stronger for humans than for predators. Zebras appear to be less able than humans to resolve stripes although they are better than their chief predators. In conclusion, compared to the uniform pelage of other sympatric herbivores it appears highly unlikely that stripes are a form of anti-predator camouflage.	[Melin, Amanda D.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Melin, Amanda D.] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB T2N 1N4, Canada; [Melin, Amanda D.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 1N4, Canada; [Kline, Donald W.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Kline, Donald W.] Univ Calgary, Dept Surg Ophthalmol, Calgary, AB T2N 1N4, Canada; [Hiramatsu, Chihiro] Kyushu Univ, Fac Design, Dept Human Sci, Fukuoka 8158540, Japan; [Caro, Tim] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	Washington University (WUSTL); University of Calgary; University of Calgary; University of Calgary; University of Calgary; Kyushu University; University of California System; University of California Davis	Melin, AD (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.; Melin, AD (corresponding author), Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB T2N 1N4, Canada.; Melin, AD (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 1N4, Canada.	amanda.melin@ucalgary.ca		Melin, Amanda/0000-0002-0612-2514	Wenner Gren Foundation; National Sciences and Engineering Research Council of Canada; National Geographic Society; University of California Davis	Wenner Gren Foundation; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Geographic Society(National Geographic Society); University of California Davis(University of California System)	Funding was provided by the Wenner Gren Foundation (http://www.wennergren.org/) to ADM, the National Sciences and Engineering Research Council of Canada to ADM ( http://www.nserc-crsng.gc.ca/), the National Geographic Society (http://www.nationalgeographic.com/) to TC and University of California Davis to TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt PK, 2006, VISUAL NEUROSCI, V23, P429, DOI 10.1017/S095252380623342X; Ahnelt PK, 2006, 6 SCI M EUR ASS ZER; BIRCH D, 1979, VISION RES, V19, P933, DOI 10.1016/0042-6989(79)90029-4; BISTI S, 1974, J PHYSIOL-LONDON, V241, P201, DOI 10.1113/jphysiol.1974.sp010649; BLAKE R, 1988, TRENDS NEUROSCI, V11, P78, DOI 10.1016/0166-2236(88)90169-5; BLAKE R, 1974, VISION RES, V14, P1211, DOI 10.1016/0042-6989(74)90218-1; Calderone JB, 2003, BRAIN BEHAV EVOLUT, V62, P182, DOI 10.1159/000073270; Caro T, ZEBRA STRIP IN PRESS; Caro T, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150323; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Caro T, 2013, SEMIN CELL DEV BIOL, V24, P542, DOI 10.1016/j.semcdb.2013.03.016; Carroll J, 2001, J VISION, V1, P80, DOI 10.1167/1.2.2; Cronin TW, 2014, VISUAL ECOLOGY, P262; Darwin C., 1906, DESCENT MAN SELECTIO; DAUGMAN JG, 1986, BEHAV RES METH INSTR, V18, P559, DOI 10.3758/BF03201429; DeValois RL, 1988, SPATIAL VISION; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; EVANS DW, 1985, HUM FACTORS, V27, P637, DOI 10.1177/001872088502700602; GINSBURG AP, 1982, AM J OPTOM PHYS OPT, V59, P105; Ginsburg AP, 1978, VISUAL INFORM PROCES; GODFREY D, 1987, BIOL J LINN SOC, V32, P427, DOI 10.1111/j.1095-8312.1987.tb00442.x; Hanke FD, 2011, J COMP PHYSIOL A, V197, P203, DOI 10.1007/s00359-010-0600-y; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; JACOBSON SG, 1976, VISION RES, V16, P1141, DOI 10.1016/0042-6989(76)90254-6; Keller J, 2000, J NEUROSCI METH, V97, P103, DOI 10.1016/S0165-0270(00)00173-4; Kemp AD, 2014, ANAT REC, V297, P781, DOI 10.1002/ar.22892; Kingdon J., 1984, ENCY MAMMALS, P486; Kirk EC, 2006, FOLIA PRIMATOL, V77, P27, DOI 10.1159/000089694; Kruuk H., 1972, THE SPOTTED HYENA; Kwon M, 2012, VISION RES, V62, P139, DOI 10.1016/j.visres.2012.03.025; Matthews L, 1971, THE LIFE OF MAMMALS; Melin AD, 2013, VISION RES, V86, P87, DOI 10.1016/j.visres.2013.04.013; Melin AD, 2012, AM J PRIMATOL, V74, P185, DOI 10.1002/ajp.21996; Michael R, 2011, ACTA OPHTHALMOL, V89, P278, DOI 10.1111/j.1755-3768.2009.01665.x; Morris Animal Foundation, 2022, ANIMAL WATCHING FIEL; MUIR DW, 1973, SCIENCE, V180, P420, DOI 10.1126/science.180.4084.420; OWSLEY C, 1987, BRIT J OPHTHALMOL, V71, P791, DOI 10.1136/bjo.71.10.791; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; PASTERNAK T, 1981, VISION RES, V21, P1333, DOI 10.1016/0042-6989(81)90240-6; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Roth LSV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003711; Schaller G. B., 1972, SERENGETI LION; Schwartz S.H., 2010, VISUAL PERCEPTION CL; Selous FC, 1908, AFRICAN NATURE NOTES; Shapley R, 2009, VISION RES, V49, P907, DOI 10.1016/j.visres.2008.09.026; Souza Givago da Silva, 2011, Psychol. Neurosci., V4, P29, DOI 10.3922/j.psns.2011.1.005; Stevens M, 2008, P ROY SOC B-BIOL SCI, V275, P2639, DOI 10.1098/rspb.2008.0877; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; THAYER GH, 2009, CONCEALING COLOURATI; UHLRICH DJ, 1981, BEHAV BRAIN RES, V2, P291, DOI 10.1016/0166-4328(81)90013-9; Veilleux CC, 2014, BRAIN BEHAV EVOLUT, V83, P43, DOI 10.1159/000357830; WAAGE J K, 1981, Journal of the Entomological Society of Southern Africa, V44, P351; Wallace AR, 1896, DARWINISM EXPOSITION; Yokoyama S, 1999, GENETICS, V153, P919	58	21	21	9	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145679	10.1371/journal.pone.0145679	http://dx.doi.org/10.1371/journal.pone.0145679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799935	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300008
J	Sekhon, BK; Roubin, RH; Li, YM; Devi, PB; Nammi, S; Fan, K; Sze, DMY				Sekhon, Bhagwant Kaur; Roubin, Rebecca Heidi; Li, Yiming; Devi, Parimala B.; Nammi, Srinivas; Fan, Kei; Sze, Daniel Man-yuen			Evaluation of Selected Immunomodulatory Glycoproteins as an Adjunct to Cancer Immunotherapy	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSE; B-CELLS; THERAPY; THALIDOMIDE; VACCINE; BLOOD	Polysaccharopeptide (PSP), from Coriolus versicolor, has been used widely as an adjuvant to chemotherapy with demonstrated anti-tumor and broad immunomodulating effects. While PSP's mechanism of action still remains unknown, its enhanced immunomodulatory potential with acacia gum is of great interest. Acacia gum, which also contains polysaccharides and glycoproteins, has been demonstrated to be immunopotentiating. To elucidate whether PSP directly activates T-cell-dependent B-cell responses in vivo, we used a well-established hapten carrier system (Nitrophenyl-chicken gamma globulin (NP-CGG)). 6-week C57BL/6 male mice were immunised with 50 mu g of NP25-CGG alum precipitate intraperitoneally. Mice were gavaged daily with 50mg/kg PSP in a vehicle containing acacia gum and sacrificed at days 0, 4, 7, 10, 14 and 21. ELISA was used to measure the total and relative hapten-specific anti-NP IgA, IgM and IgG titre levels compared to the controls. It was found that PSP, combined with acacia gum, significantly increased total IgG titre levels at day 4 (P<0.05), decreased IgM titre levels at days 4 and 21 (P<0.05) with no alterations observed in the IgA or IgE titre levels at any of the time points measured. Our results suggest that while PSP combined with acacia gum appears to exert weak immunological effects through specific T-cell dependent B-cell responses, they are likely to be broad and non-specific which supports the current literature on PSP. We report for the first time the application of a well-established hapten-carrier system that can be used to characterise and delineate specific T-cell dependent B-cell responses of potential immunomodulatory glyco-protein-based herbal medicines combinations in vivo.	[Sekhon, Bhagwant Kaur; Roubin, Rebecca Heidi; Li, Yiming; Devi, Parimala B.; Nammi, Srinivas; Fan, Kei; Sze, Daniel Man-yuen] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Sze, Daniel Man-yuen] RMIT Univ, Sch Med Sci, Melbourne, Vic 3000, Australia; [Sze, Daniel Man-yuen] RMIT Univ, HIRi, Melbourne, Vic 3000, Australia; [Nammi, Srinivas] Univ Western Sydney, Sch Med Sci, Campbelltown, NSW 2560, Australia	University of Sydney; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Western Sydney University	Sze, DMY (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	bhagwant.sekhon@sydney.edu.au; daniel.sze@rmit.edu.au	Roubin, Rebecca/E-8133-2010; Nammi, Srinivas/I-2983-2013; Roubin, Rebecca/GQQ-0980-2022	Roubin, Rebecca/0000-0002-7444-8145; Nammi, Srinivas/0000-0002-4735-2789; Roubin, Rebecca/0000-0002-7444-8145	Cancer Institute NSW: DMS; National Institute of Complementary Medicines	Cancer Institute NSW: DMS; National Institute of Complementary Medicines	This work was supported by Cancer Institute NSW: DMS; National Institute of Complementary Medicines. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UH, 2013, CLIN PHARMACOL-ADV A, V5, P21, DOI 10.2147/CPAA.S45884; Anguille S, 2014, LANCET ONCOL, V15, pE257, DOI 10.1016/S1470-2045(13)70585-0; Ballal A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-139; Bertrand F, 2015, CANCER RES, V75, P2619, DOI 10.1158/0008-5472.CAN-14-2524; Brown RD, 2009, LEUKEMIA LYMPHOMA, V50, P1860, DOI 10.3109/10428190903216804; Cui T, 2003, BIOTECHNOL ADV, V21, P109, DOI 10.1016/S0734-9750(03)00002-8; Doi Y, 2006, FOOD CHEM TOXICOL, V44, P560, DOI 10.1016/j.fct.2005.09.002; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Eliza WLY, 2012, RECENT PATENTS INFLA, V6, P78, DOI [10.2174/187221312798889275, 10.2174/187221312798889310]; Engel AL, 2013, IMMUNOBIOLOGY, V218, P1468, DOI 10.1016/j.imbio.2013.05.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanzly M, 2014, UROLOGY, V83, DOI 10.1016/j.urology.2014.02.005; Hong F, 2011, PLANTA MED, V77, P817, DOI 10.1055/s-0030-1250574; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kallberg E, 2014, SCAND J IMMUNOL, V79, P237, DOI 10.1111/sji.12152; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; Lasek W, 2014, CANCER IMMUNOL IMMUN, V63, P419, DOI 10.1007/s00262-014-1523-1; Lee CL, 2006, ENZYME MICROB TECH, V38, P14, DOI 10.1016/j.enzmictec.2004.10.009; Lee Kuo-Hsiung, 2012, J Tradit Complement Med, V2, P84; Li J, 2010, BLOOD, V115, P3580, DOI 10.1182/blood-2009-10-246991; Liao M, 1993, P PSP INT S, P243; LIVINGSTON PO, 1994, VACCINE, V12, P1275, DOI 10.1016/S0264-410X(94)80052-2; Mamalis A, 2014, ARCH DERMATOL RES, V306, P511, DOI 10.1007/s00403-014-1457-7; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Naslund TI, 2013, J IMMUNOL, V190, P2712, DOI 10.4049/jimmunol.1203082; Nesher L, 2014, INFECTION, V42, P5, DOI 10.1007/s15010-013-0525-9; Ooi VEC, 2000, CURR MED CHEM, V7, P715; Ouyang Hua-Qiang, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P655; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Ribatti D, 2014, IMMUNOL LETT, V161, P96, DOI 10.1016/j.imlet.2014.05.010; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Sekhon BK, 2013, FOOD CHEM, V138, P2201, DOI 10.1016/j.foodchem.2012.11.009; STROBEL S, 1982, TOXICOL LETT, V14, P247, DOI 10.1016/0378-4274(82)90059-5; STROBEL S, 1986, FOOD ADDIT CONTAM, V3, P43; Sze DMY, 2006, CURR CANCER DRUG TAR, V6, P325, DOI 10.2174/156800906777441762; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Tanaka T, 1999, CARCINOGENESIS, V20, P1471, DOI 10.1093/carcin/20.8.1471; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; Vannucci L, 2013, INT J ONCOL, V43, P357, DOI 10.3892/ijo.2013.1974; Xuan NT, 2010, CELL PHYSIOL BIOCHEM, V25, P641, DOI 10.1159/000315083; Yang Q.Y., 1999, ADV RES PSP 1999, V1999', P5; YANG QY, 1992, EOS-RIV IMMUNOL, V12, P29; Zhang LY, 1999, ADV RES PSP 1999, P328; Zhu ZQ, 2015, J IMMUNOL, V195, P3482, DOI 10.4049/jimmunol.1401571	45	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146881	10.1371/journal.pone.0146881	http://dx.doi.org/10.1371/journal.pone.0146881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799072	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300047
J	Yang, J; Zhang, F; Li, J; Chen, JP; Zhang, HM				Yang, Jian; Zhang, Fen; Li, Jing; Chen, Jian-Ping; Zhang, Heng-Mu			Integrative Analysis of the microRNAome and Transcriptome Illuminates the Response of Susceptible Rice Plants to Rice Stripe Virus	PLOS ONE			English	Article							GENE-EXPRESSION; FACTOR FAMILY; ARABIDOPSIS; RESISTANCE; SYMPTOM; IDENTIFICATION; MOVEMENT; BIOLOGY; PROTEIN; NSVC4	Rice stripe virus (RSV) is one of the most serious rice viruses in East Asia. To investigate how rice responds to RSV infection, we integrated miRNA expression with parallel mRNA transcription profiling by deep sequencing. A total of 570 miRNAs were identified of which 69 miRNAs (56 up-regulated and 13 down-regulated) were significantly modified by RSV infection. Digital gene expression (DGE) analysis showed that 1274 mRNAs (431 up-regulated and 843 down-regulated genes) were differentially expressed as a result of RSV infection. The differential expression of selected miRNAs and mRNAs was confirmed by qRT-PCR. Gene ontology (GO) and pathway enrichment analysis showed that a complex set of miRNA and mRNA networks were selectively regulated by RSV infection. In particular, 63 differentially expressed miRNAs were found to be significantly and negatively correlated with 160 target mRNAs. Interestingly, 22 up-regulated miRNAs were negatively correlated with 24 down-regulated mRNAs encoding disease resistance-related proteins, indicating that the host defense responses were selectively suppressed by RSV infection. The suppression of both osa-miR1423-5p- and osa-miR1870-5p-mediated resistance pathways was further confirmed by qRT-PCR. Chloroplast functions were also targeted by RSV, especially the zeaxanthin cycle, which would affect the stability of thylakoid membranes and the biosynthesis of ABA. All these modifications may contribute to viral symptom development and provide new insights into the pathogenicity mechanisms of RSV.	[Yang, Jian; Zhang, Fen; Li, Jing; Chen, Jian-Ping; Zhang, Heng-Mu] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Key Lab Biotechnol Plant Protect MOA & Zhejiang P, Inst Virol & Biotechnol, Hangzhou 310021, Zhejiang, Peoples R China; [Zhang, Fen] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang Normal University	Zhang, HM (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Key Lab Biotechnol Plant Protect MOA & Zhejiang P, Inst Virol & Biotechnol, Hangzhou 310021, Zhejiang, Peoples R China.	jpchen2001@yahoo.com.cn; zhhengmu@tsinghua.org.cn			National Science and Technology Support Program [2012BAD19B03]; China 973 Program [2010CB126203, 2014CB160309]; Zhejiang Provincial Foundation for Natural Science [LQ14C14003]	National Science and Technology Support Program; China 973 Program(National Basic Research Program of China); Zhejiang Provincial Foundation for Natural Science(Natural Science Foundation of Zhejiang Province)	This work was funded by National Science and Technology Support Program (2012BAD19B03), the China 973 Program (2010CB126203 and 2014CB160309), and the Zhejiang Provincial Foundation for Natural Science (LQ14C14003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2001, PLANT PHYSIOL, V125, P1248, DOI 10.1104/pp.125.3.1248; Amano E., 1933, J PLANT PROT JPN, V20, P634; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen ZH, 2015, PLANT CELL REP, V34, P767, DOI 10.1007/s00299-015-1740-x; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; [丁新伦 Ding Xinlun], 2013, [福建农林大学学报. 自然科学版, Journal of Fujian Agriculture and Forestry University. Natural Science Edition], V42, P466; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Du ZG, 2011, MOL PLANT PATHOL, V12, P808, DOI [10.1111/J.1364-3703.2011.00716.X, 10.1111/j.1364-3703.2011.00716.x]; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; Fang XP, 2015, PROTEOMICS, V15, P1525, DOI 10.1002/pmic.201400384; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Havaux M, 1998, TRENDS PLANT SCI, V3, P147, DOI 10.1016/S1360-1385(98)01200-X; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kim K, 2012, MOL PLANT MICROBE IN, V25, P534, DOI 10.1094/MPMI-11-11-0282; Kong LF, 2014, MOL PLANT, V7, P691, DOI 10.1093/mp/sst158; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; KURIBAYASHI K., 1931, Journal of Plant Protection, V18, P565; Lewsey M, 2007, PLANT J, V50, P240, DOI 10.1111/j.1365-313X.2007.03042.x; Liang DL, 2005, VIRUS GENES, V31, P211, DOI 10.1007/s11262-005-1798-6; Liu LiHua, 2000, Acta Phytopathologica Sinica, V30, P306; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Mandadi KK, 2013, PLANT CELL, V25, P1489, DOI 10.1105/tpc.113.111658; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Ruan YL, 1984, PLANT PROT, V10, P22; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shimizu T, 2007, MOL PLANT MICROBE IN, V20, P247, DOI 10.1094/MPMI-20-3-0247; SHINKAI A., 1962, Bull. natn. Inst. agric. Sci., Tokyo, V14, P1; Shirako Y., 2012, VIRUS TAXONOMY, P771; Sun F, 2011, J PHYTOPATHOL, V159, P767, DOI 10.1111/j.1439-0434.2011.01840.x; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Tornero P, 2002, PLANT CELL, V14, P435, DOI 10.1105/tpc.010393; Wang BA, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0328-y; Wang HD, 2008, PLANT DIS, V92, P1190, DOI 10.1094/PDIS-92-8-1190; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5768; Wang Z, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-619; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Wu WQ, 2013, PLANT DIS, V97, P1181, DOI 10.1094/PDIS-02-12-0207-RE; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xiong RY, 2009, VIROLOGY, V387, P29, DOI 10.1016/j.virol.2009.01.045; Xu Y, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00269; Yang J, 2014, GENE, V548, P285, DOI 10.1016/j.gene.2014.07.048; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; [袁正杰 Yuan Zhengjie], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P45; Zhang C, 2012, VIROLOGY, V425, P113, DOI 10.1016/j.virol.2012.01.007; Zhang HengMu, 2007, Acta Phytophylacica Sinica, V34, P436; [张晓婷 ZHANG Xiaoting], 2008, [激光生物学报, Acta Laser Biology Sinica], V17, P620; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zheng WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082126; Zhou Tong, 2009, Scientia Agricultura Sinica, V42, P103	66	55	63	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146946	10.1371/journal.pone.0146946	http://dx.doi.org/10.1371/journal.pone.0146946			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799317	Green Submitted, Green Published, gold			2022-12-26	WOS:000368655300049
J	Melckenbeeck, I; Audenaert, P; Michoel, T; Colle, D; Pickavet, M				Melckenbeeck, Ine; Audenaert, Pieter; Michoel, Tom; Colle, Didier; Pickavet, Mario			An Algorithm to Automatically Generate the Combinatorial Orbit Counting Equations	PLOS ONE			English	Article								Graphlets are small subgraphs, usually containing up to five vertices, that can be found in a larger graph. Identification of the graphlets that a vertex in an explored graph touches can provide useful information about the local structure of the graph around that vertex. Actually finding all graphlets in a large graph can be time-consuming, however. As the graphlets grow in size, more different graphlets emerge and the time needed to find each graphlet also scales up. If it is not needed to find each instance of each graphlet, but knowing the number of graphlets touching each node of the graph suffices, the problem is less hard. Previous research shows a way to simplify counting the graphlets: instead of looking for the graphlets needed, smaller graphlets are searched, as well as the number of common neighbors of vertices. Solving a system of equations then gives the number of times a vertex is part of each graphlet of the desired size. However, until now, equations only exist to count graphlets with 4 or 5 nodes. In this paper, two new techniques are presented. The first allows to generate the equations needed in an automatic way. This eliminates the tedious work needed to do so manually each time an extra node is added to the graphlets. The technique is independent on the number of nodes in the graphlets and can thus be used to count larger graphlets than previously possible. The second technique gives all graphlets a unique ordering which is easily extended to name graphlets of any size. Both techniques were used to generate equations to count graphlets with 4, 5 and 6 vertices, which extends all previous results. Code can be found at https://github.com/IneMelckenbeeck/equation-generator and https://github.com/IneMelckenbeeck/graphlet-naming.	[Melckenbeeck, Ine; Audenaert, Pieter; Colle, Didier; Pickavet, Mario] Univ Ghent, iMinds, Dept Informat Technol INTEC, B-9000 Ghent, Belgium; [Michoel, Tom] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland	Ghent University; IMEC; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Melckenbeeck, I (corresponding author), Univ Ghent, iMinds, Dept Informat Technol INTEC, B-9000 Ghent, Belgium.	ine.melckenbeeck@intec.ugent.be	Pickavet, Mario J/E-9530-2019	Pickavet, Mario J/0000-0001-5817-7886; Melckenbeeck, Ine/0000-0003-0733-089X; Michoel, Tom/0000-0003-4749-4725	UGhent - iMinds; Roslin Institute Strategic Grant from the BBSRC [BB/J004235/1, BB/M020053/1]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211552, BB/M020053/1, BBS/E/D/20211551] Funding Source: researchfish; BBSRC [BBS/E/D/20211551, BBS/E/D/20211552, BB/M020053/1] Funding Source: UKRI	UGhent - iMinds; Roslin Institute Strategic Grant from the BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	IM, PA, DC and MP are funded by UGhent - iMinds. TM is supported by Roslin Institute Strategic Grant funding from the BBSRC (BB/J004235/1 and BB/M020053/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Demeyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061183; Hocevar T, 2014, BIOINFORMATICS, V30, P559, DOI 10.1093/bioinformatics/btt717; Houbraken M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097896; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301	5	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147078	10.1371/journal.pone.0147078	http://dx.doi.org/10.1371/journal.pone.0147078			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26797021	gold, Green Published, Green Submitted			2022-12-26	WOS:000368530300016
J	Simon, A; Subra, JF; Guilpain, P; Jeannin, P; Pignon, P; Blanchard, S; Garo, E; Jaillon, S; Chevailler, A; Renier, G; Puechal, X; Bottazzi, B; Mantovani, A; Delneste, Y; Augusto, JF				Simon, Amelie; Subra, Jean-Francois; Guilpain, Philippe; Jeannin, Pascale; Pignon, Pascale; Blanchard, Simon; Garo, Erwan; Jaillon, Sebastien; Chevailler, Alain; Renier, Gilles; Puechal, Xavier; Bottazzi, Barbara; Mantovani, Alberto; Delneste, Yves; Augusto, Jean-Francois			Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis	PLOS ONE			English	Article							LONG PENTRAXIN PTX3; C-REACTIVE PROTEIN; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; DISEASE-ACTIVITY; RECOGNITION; NEUTROPHILS; CELLS; MYELOPEROXIDASE; PATHOGENESIS; GRANULES	Objectives Pentraxin 3 (PTX3), in common with myeloperoxidase and proteinase 3, is stored in human neutrophil granules and is expressed on apoptotic neutrophil surface. We therefore investigated the presence of anti-PTX3 autoantibodies (aAbs) in the sera of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) patients. Methods Presence of anti-PTX3 autoantibodies was analysed by a specific enzyme-linked immunosorbent assay in sera from 150 patients with microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), and eosinophilic granulomatosis with polyangiitis (EGPA), and in sera of 227 healthy subjects (HS), 40 systemic sclerosis (SSc) patients, and 25 giant cell arteritis patients (GCA). Using indirect immunofluorescence on fixed human neutrophils, we also analyzed the staining pattern associated with the presence of anti-PTX3 aAbs. Results Anti-PTX3 aAbs were detected in 56 of 150 (37.3%) of the AAV patients (versus 12 of 227 (5.3%) of HS, p<0.001) and, interestingly, in 7 of 14 MPO and PR3 ANCA negative AAV patients. Moreover, by indirect immunofluorescence on fixed neutrophils, anti-PTX3 aAbs gave rise to a specific cytoplasmic fluorescence pattern distinct from the classical cytoplasmic (c-ANCA), perinuclear (p-ANCA), and atypical (a-ANCA) pattern. Anti-PTX3 aAbs levels were higher in patients with active AAV as compared to patients with inactive disease. Conclusion Our work suggests that PTX3 is as a novel ANCA antigen. Anti-PTX3 aAbs appear thus as a promising novel biomarker in the diagnosis of AAV, including in patients without detectable MPO and PR3 ANCA.	[Simon, Amelie; Subra, Jean-Francois; Augusto, Jean-Francois] Univ Hosp Angers, Dept Nephrol, Angers, France; [Simon, Amelie; Subra, Jean-Francois; Jeannin, Pascale; Pignon, Pascale; Blanchard, Simon; Garo, Erwan; Jaillon, Sebastien; Chevailler, Alain; Delneste, Yves; Augusto, Jean-Francois] Univ Angers, Canc Res Ctr Nantes Angers, LUNAM Univ, Angers, France; [Simon, Amelie; Subra, Jean-Francois; Jeannin, Pascale; Pignon, Pascale; Blanchard, Simon; Garo, Erwan; Jaillon, Sebastien; Chevailler, Alain; Delneste, Yves; Augusto, Jean-Francois] INSERM, UMR 892, Angers, France; [Simon, Amelie; Subra, Jean-Francois; Jeannin, Pascale; Pignon, Pascale; Blanchard, Simon; Garo, Erwan; Jaillon, Sebastien; Chevailler, Alain; Delneste, Yves; Augusto, Jean-Francois] CNRS, UMR 6299, Angers, France; [Simon, Amelie; Subra, Jean-Francois; Jeannin, Pascale; Pignon, Pascale; Blanchard, Simon; Garo, Erwan; Jaillon, Sebastien; Chevailler, Alain; Delneste, Yves; Augusto, Jean-Francois] LabEx IGO, Angers, France; [Guilpain, Philippe] Univ Hosp Montpellier, Dept Internal Med, Monptellier, France; [Jeannin, Pascale; Blanchard, Simon; Chevailler, Alain; Renier, Gilles; Delneste, Yves] Univ Hosp Angers, Immunol & Allergol Lab, Angers, France; [Puechal, Xavier] Hop Cochin, AP HP, Dept Internal Med, Natl Referral Ctr Rare System Autoimmune Dis, 27 Rue Faubourg St Jacques, F-75674 Paris, France; [Bottazzi, Barbara; Mantovani, Alberto] Ist Clin Humanitas, Immunol & Inflammat Res Lab, Milan, Italy	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Universite de Montpellier; CHU de Montpellier; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Humanitas Research Hospital	Augusto, JF (corresponding author), Univ Hosp Angers, Dept Nephrol, Angers, France.; Augusto, JF (corresponding author), Univ Angers, Canc Res Ctr Nantes Angers, LUNAM Univ, Angers, France.; Augusto, JF (corresponding author), INSERM, UMR 892, Angers, France.; Augusto, JF (corresponding author), CNRS, UMR 6299, Angers, France.; Augusto, JF (corresponding author), LabEx IGO, Angers, France.	jfaugusto@chu-angers.fr	Jean-François, Augusto/L-2887-2015; DELNESTE, Yves/K-7367-2015; JEANNIN, Pascale/K-8656-2015; Puéchal, Xavier/P-1555-2017; Mantovani, Alberto/HCI-7449-2022; Delneste, Yves/O-3956-2016; bottazzi, barbara/ABH-9274-2020; JAILLON, Sebastien/A-7537-2015	Jean-François, Augusto/0000-0003-1498-2132; DELNESTE, Yves/0000-0002-2142-596X; Puéchal, Xavier/0000-0003-3573-9203; Mantovani, Alberto/0000-0001-5578-236X; bottazzi, barbara/0000-0002-1930-9257; JAILLON, Sebastien/0000-0002-5600-855X; JEANNIN, Pascale/0000-0002-3666-3856; Garo, Erwan/0000-0003-4411-9161	Institut National de la Sante et de la Recherche Medicale, France; University of Angers; Agence Nationale de la Recherche (project Pentraximmune); Ministere de la Recherche et de l'Enseignement superieur (Bourse annee-recherche); Conseil General du Maine et Loire	Institut National de la Sante et de la Recherche Medicale, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Angers; Agence Nationale de la Recherche (project Pentraximmune)(French National Research Agency (ANR)); Ministere de la Recherche et de l'Enseignement superieur (Bourse annee-recherche); Conseil General du Maine et Loire(Region Pays de la Loire)	This work was supported by institutional grants from Institut National de la Sante et de la Recherche Medicale, France and the University of Angers and by a grant from the Agence Nationale de la Recherche (project Pentraximmune). Amelie Simon and Sebastien Jaillon were supported by grants from the Ministere de la Recherche et de l'Enseignement superieur (Bourse annee-recherche) and the Conseil General du Maine et Loire, respectively.	ALLES VV, 1994, BLOOD, V84, P3483; Augusto JF, 2009, RHEUMATOLOGY, V48, P442, DOI 10.1093/rheumatology/ken507; Bassi N, 2010, ANN RHEUM DIS, V69, P1704, DOI 10.1136/ard.2009.117804; Basu N, 2010, ANN RHEUM DIS, V69, P1744, DOI 10.1136/ard.2009.119032; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Falk RJ, 2010, J AM SOC NEPHROL, V21, P745, DOI 10.1681/ASN.2009121238; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Finkielman JD, 2007, ANN INTERN MED, V147, P611, DOI 10.7326/0003-4819-147-9-200711060-00005; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gilligan HM, 1996, J EXP MED, V184, P2231, DOI 10.1084/jem.184.6.2231; Gomez-Puerta JA, 2009, AM J PATHOL, V175, P1790, DOI 10.2353/ajpath.2009.090533; Harper L, 2001, KIDNEY INT, V59, P1729, DOI 10.1046/j.1523-1755.2001.0590051729.x; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Hu N, 2011, AUTOIMMUN REV, V10, P536, DOI 10.1016/j.autrev.2011.04.004; Jaillon S, 2009, CELL DEATH DIFFER, V16, P465, DOI 10.1038/cdd.2008.173; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Knight JS, 2012, CURR OPIN RHEUMATOL, V24, P441, DOI 10.1097/BOR.0b013e3283546703; Lionaki S, 2012, ARTHRITIS RHEUM-US, V64, P3452, DOI 10.1002/art.34562; Nauta AJ, 2005, KIDNEY INT, V67, P543, DOI 10.1111/j.1523-1755.2005.67111.x; Roth AJ, 2013, J CLIN INVEST, V123, P1773, DOI 10.1172/JCI65292; Sangaletti S, 2012, BLOOD, V120, P3007, DOI 10.1182/blood-2012-03-416156; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sjowall C, 2002, J AUTOIMMUN, V19, P155, DOI 10.1006/jaut.2002.0608; Stegeman CA, 2002, NEPHROL DIAL TRANSPL, V17, P2077, DOI 10.1093/ndt/17.12.2077; Talor MV, 2007, CLIN EXP IMMUNOL, V150, P42, DOI 10.1111/j.1365-2249.2007.03453.x; Tan Y, 2011, CLIN J AM SOC NEPHRO, V6, P93, DOI 10.2215/CJN.09051209; van Rossum AP, 2006, ARTHRITIS RHEUM-US, V54, P986, DOI 10.1002/art.21669; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Zandman-Goddard G, 2005, ANN RHEUM DIS, V64, P1698, DOI 10.1136/ard.2005.035832	40	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147091	10.1371/journal.pone.0147091	http://dx.doi.org/10.1371/journal.pone.0147091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26797217	gold, Green Published, Green Submitted			2022-12-26	WOS:000368530300017
J	Gerwing, TG; Drolet, D; Hamilton, DJ; Barbeau, MA				Gerwing, Travis G.; Drolet, David; Hamilton, Diana J.; Barbeau, Myriam A.			Relative Importance of Biotic and Abiotic Forces on the Composition and Dynamics of a Soft-Sediment Intertidal Community	PLOS ONE			English	Article							AMPHIPOD COROPHIUM-VOLUTATOR; ILYANASSA-OBSOLETA SAY; BOTTOM-UP CONTROL; TOP-DOWN; UPPER BAY; SUBSTRATE SELECTION; SPATIAL-PATTERNS; MUD SNAIL; MARINE-INVERTEBRATES; POPULATION-DYNAMICS	Top-down, bottom-up, middle-out and abiotic factors are usually viewed as main forces structuring biological communities, although assessment of their relative importance, in a single study, is rarely done. We quantified, using multivariate methods, associations between abiotic and biotic (top-down, bottom-up and middle-out) variables and infaunal population/community variation on intertidal mudflats in the Bay of Fundy, Canada, over two years. Our analysis indicated that spatial structural factors like site and plot accounted for most of the community and population variation. Although we observed a significant relationship between the community/populations and the biotic and abiotic variables, most were of minor importance relative to the structural factors. We suggest that community and population structure were relatively uncoupled from the structuring influences of biotic and abiotic factors in this system because of high concentrations of resources that sustain high densities of infauna and limit exploitative competition. Furthermore, we hypothesize that the infaunal community primarily reflects stochastic spatial events, namely a "first come, first served" process.	[Gerwing, Travis G.; Barbeau, Myriam A.] Univ New Brunswick, Dept Biol, POB 4400, Fredericton, NB E3B 5A3, Canada; [Drolet, David; Hamilton, Diana J.] Mt Allison Univ, Dept Biol, Sackville, NB E4L 1G7, Canada	University of New Brunswick; Mount Allison University	Gerwing, TG (corresponding author), Univ New Brunswick, Dept Biol, POB 4400, Fredericton, NB E3B 5A3, Canada.	t.g.gerwing@gmail.com	Gerwing, Travis/AAU-6569-2020	Gerwing, Travis/0000-0002-4433-1843	Natural Sciences and Engineering Research Council of Canada [365130, 227554, 327321]; New Brunswick Wildlife Trust Fund [B231-016, B232-016]; Mprime (a Canadian Network of Centres of Excellence for the mathematical sciences); Science Horizons Internship Program (Environment Canada); Canada Summer Job Program; Marguerite and Murray Vaughan Fellowships in Marine Sciences; UNB	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); New Brunswick Wildlife Trust Fund; Mprime (a Canadian Network of Centres of Excellence for the mathematical sciences); Science Horizons Internship Program (Environment Canada); Canada Summer Job Program; Marguerite and Murray Vaughan Fellowships in Marine Sciences; UNB	This study was funded by the Natural Sciences and Engineering Research Council of Canada (a Strategic Project Grant (365130) and Discovery grants to MAB (227554) and DJH (327321)), New Brunswick Wildlife Trust Fund grants to MAB (B231-016 and B232-016), Mprime (a Canadian Network of Centres of Excellence for the mathematical sciences), Science Horizons Internship Program (Environment Canada), and the Canada Summer Job Program. TGG received support from Marguerite and Murray Vaughan Fellowships in Marine Sciences, and UNB (including a President's Doctoral Tuition award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; AMBROSE WG, 1984, J MAR RES, V42, P633; AMBROSE WG, 1991, AM ZOOL, V31, P849; AMBROSE WG, 1984, J EXP MAR BIOL ECOL, V81, P115, DOI 10.1016/0022-0981(84)90002-9; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bertness M.D., 2007, ATLANTIC SHORELINES; BERTNESS MD, 1991, ECOLOGY, V72, P138, DOI 10.2307/1938909; Bracken MES, 2014, ECOLOGY, V95, P1458, DOI 10.1890/13-2094.1; Bringloe TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069091; Caliman A, 2013, ECOLOGY, V94, P1977, DOI 10.1890/12-1385.1; Cheverie AV, 2014, J SEA RES, V92, P102, DOI 10.1016/j.seares.2014.03.011; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Coffin MRS, 2008, J EXP MAR BIOL ECOL, V364, P110, DOI 10.1016/j.jembe.2008.07.030; Coffin MRS, 2012, J EXP MAR BIOL ECOL, V418, P12, DOI 10.1016/j.jembe.2012.03.002; COMMITO JA, 1985, MAR ECOL PROG SER, V26, P289, DOI 10.3354/meps026289; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; CONNOLLY RM, 1994, J EXP MAR BIOL ECOL, V180, P39; Coulthard ME, 2011, J EXP MAR BIOL ECOL, V397, P161, DOI 10.1016/j.jembe.2010.12.001; CRANFORD PJ, 1985, NETH J SEA RES, V19, P135, DOI 10.1016/0077-7579(85)90018-3; Crewe TL, 2001, ESTUAR COAST SHELF S, V53, P151, DOI 10.1006/ecss.2001.0795; Currie DJ, 2007, J BIOGEOGR, V34, P2009, DOI 10.1111/j.1365-2699.2007.01808.x; Davis B, 2014, MAR ECOL PROG SER, V500, P175, DOI 10.3354/meps10671; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DEWITT TH, 1985, J EXP MAR BIOL ECOL, V92, P97, DOI 10.1016/0022-0981(85)90024-3; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Drolet D., 2013, ESTUAR COAST, V36, P1; Drolet D, 2013, J EXP MAR BIOL ECOL, V441, P126, DOI 10.1016/j.jembe.2013.01.023; Drolet D, 2012, MAR ECOL PROG SER, V449, P197, DOI 10.3354/meps09495; Drolet D, 2011, MAR ECOL PROG SER, V431, P255, DOI 10.3354/meps09121; Dyer KR, 2000, CONT SHELF RES, V20, P1039, DOI 10.1016/S0278-4343(00)00011-X; Elmhagen B, 2007, ECOL LETT, V10, P197, DOI 10.1111/j.1461-0248.2006.01010.x; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Ferguson N, 2013, ECOLOGY, V94, P126, DOI 10.1890/12-0795.1; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finke DL, 2005, ECOL LETT, V8, P1299, DOI 10.1111/j.1461-0248.2005.00832.x; FLACH EC, 1992, NETH J SEA RES, V30, P81, DOI 10.1016/0077-7579(92)90048-J; FLACH EC, 1992, NETH J SEA RES, V29, P379, DOI 10.1016/0077-7579(92)90077-R; Flach EC, 1995, OCEANOGRAPHIC LIT RE, V42; Fletcher DJ, 2002, J EXP MAR BIOL ECOL, V273, P89, DOI 10.1016/S0022-0981(02)00142-9; Gerwing TG, 2015, NORTHEAST NAT, V22, P1, DOI 10.1656/045.022.m1201; Gerwing TG, 2015, J SEA RES, V97, P40, DOI 10.1016/j.seares.2015.01.001; Gerwing TG, 2015, INT J SEDIMENT RES, V30, P74, DOI 10.1016/S1001-6279(15)60008-7; Gerwing TG, 2013, MAR ECOL PROG SER, V487, P7, DOI 10.3354/meps10407; Ghasemi AF, 2014, J GREAT LAKES RES, V40, P692, DOI 10.1016/j.jglr.2014.05.004; GORDON DC, 1986, NETH J SEA RES, V20, P325, DOI 10.1016/0077-7579(86)90054-2; Gorley C.K., 2006, GETTING STARTED PRIM; Greenville AC, 2014, OECOLOGIA, V175, P1349, DOI 10.1007/s00442-014-2977-8; Hamilton DJ, 2006, HYDROBIOLOGIA, V567, P285, DOI 10.1007/s10750-006-0062-y; Hamilton DJ, 2003, CAN J ZOOL, V81, P1358, DOI 10.1139/Z03-130; Hamilton DJ, 2000, ECOL MONOGR, V70, P21, DOI 10.1890/0012-9615(2000)070[0021:DAIEOP]2.0.CO;2; HARGRAVE BT, 1983, CAN J FISH AQUAT SCI, V40, P229; Heck KL, 2007, ESTUAR COAST, V30, P371, DOI 10.1007/BF02819384; HICKLIN PW, 1987, WILSON BULL, V99, P540; Hughes JM, 2014, J EXP MAR BIOL ECOL, V459, P190, DOI 10.1016/j.jembe.2014.05.026; Johnson KD, 2014, MAR ECOL PROG SER, V507, P197, DOI 10.3354/meps10815; Jumars P. A., 2014, ANNU REV MAR SCI, V7, P1; Kelaher BP, 2001, J MAR BIOL ASSOC UK, V81, P917, DOI 10.1017/S0025315401004842; Kennedy K., 2012, THESIS U NEW BRUNSWI; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Levinton J, 2004, J EXP MAR BIOL ECOL, V300, P65, DOI 10.1016/j.jembe.2003.12.008; Loeuille N, 2008, AM NAT, V171, P788, DOI 10.1086/587745; Lu L, 2008, ESTUAR COAST, V31, P994, DOI 10.1007/s12237-008-9097-9; MacDonald EC, 2012, CONDOR, V114, P135, DOI 10.1525/cond.2012.100246; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCurdy DG, 2005, J CRUSTACEAN BIOL, V25, P558, DOI 10.1651/C-2539.1; MEADOWS PS, 1964, J EXP BIOL, V41, P499; MEADOWS PS, 1964, J ANIM ECOL, V33, P387, DOI 10.2307/2560; MEADOWS PS, 1967, J EXP BIOL, V47, P553; MEADOWS PS, 1964, J EXP BIOL, V41, P677; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; MENGE BA, 1991, J EXP MAR BIOL ECOL, V146, P69, DOI 10.1016/0022-0981(91)90255-U; Mermillod-Blondin F, 2006, AQUAT SCI, V68, P434, DOI 10.1007/s00027-006-0858-x; Murray F, 2014, MAR ECOL PROG SER, V516, P23, DOI 10.3354/meps11020; Nybakken J., 2005, MARINE BIOL ECOLOGIC; OLAFSSON EB, 1994, OCEANOGR MAR BIOL, V32, P65; Pagliosa PR, 2005, MAR ECOL-EVOL PERSP, V26, P246, DOI 10.1111/j.1439-0485.2005.00065.x; PETERSON CH, 1991, AM SCI, V79, P236; Pilditch CA, 2015, NEW ZEAL J MAR FRESH, V49, P224, DOI 10.1080/00288330.2014.995678; Pilditch CA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0795; Poysa H, 2004, OIKOS, V104, P612, DOI 10.1111/j.0030-1299.2004.12788.x; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Quijon PA, 2008, MAR ECOL PROG SER, V371, P85, DOI 10.3354/meps07691; RISK MJ, 1976, J SEDIMENT PETROL, V46, P411; Robar NDP, 2007, WATERBIRDS, V30, P116, DOI 10.1675/1524-4695(2007)030[0116:AMFEHU]2.0.CO;2; ROSE GA, 1989, CAN J FISH AQUAT SCI, V46, P1904, DOI 10.1139/f89-240; ROSEMOND AD, 1993, ECOLOGY, V74, P1264, DOI 10.2307/1940495; Scholz B, 2012, EUR J PHYCOL, V47, P120, DOI 10.1080/09670262.2012.665251; Schuldt A, 2014, OECOLOGIA, V176, P171, DOI 10.1007/s00442-014-3006-7; Searle SR., 1992, VARIANCE COMPONENTS; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Springer AM, 2014, P NATL ACAD SCI USA, V111, pE1880, DOI 10.1073/pnas.1319089111; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; STUART V, 1985, J EXP MAR BIOL ECOL, V88, P243, DOI 10.1016/0022-0981(85)90233-3; SUTHERLAND JP, 1974, AM NAT, V108, P859, DOI 10.1086/282961; Trites M, 2005, HYDROBIOLOGIA, V544, P299, DOI 10.1007/s10750-005-1696-x; Underwood, 1996, EXPT ECOLOGY THEIR L; van den Hoff J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2842; Vinueza LR, 2014, ECOL MONOGR, V84, P411, DOI 10.1890/13-0169.1; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; Woodin SA, 2010, INTEGR COMP BIOL, V50, P176, DOI 10.1093/icb/icq031; WOOTTON JT, 1994, ECOLOGY, V75, P151, DOI 10.2307/1939391	104	28	28	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147098	10.1371/journal.pone.0147098	http://dx.doi.org/10.1371/journal.pone.0147098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790098	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100058
J	Honig, G; Mader, S; Chen, HY; Porat, A; Ochani, M; Wang, P; Volpe, BT; Diamond, B				Honig, Gerard; Mader, Simone; Chen, Huiyi; Porat, Amit; Ochani, Mahendar; Wang, Ping; Volpe, Bruce T.; Diamond, Betty			Blood-Brain Barrier Deterioration and Hippocampal Gene Expression in Polymicrobial Sepsis: An Evaluation of Endothelial MyD88 and the Vagus Nerve	PLOS ONE			English	Article							TERM COGNITIVE IMPAIRMENT; TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; SYSTEMIC INFLAMMATION; SUBDIAPHRAGMATIC VAGOTOMY; PERIVASCULAR MACROPHAGES; NEUTROPHIL RECRUITMENT; LEUKOCYTE INFILTRATION; UP-REGULATION; SEPTIC SHOCK	Systemic infection can initiate or exacerbate central nervous system (CNS) pathology, even in the absence of overt invasion of bacteria into the CNS. Recent epidemiological studies have demonstrated that human survivors of sepsis have an increased risk of long-term neurocognitive decline. There is thus a need for improved understanding of the physiological mechanisms whereby acute sepsis affects the CNS. In particular, MyD88-dependent activation of brain microvascular endothelial cells and a resulting loss of blood-brain barrier integrity have been proposed to play an important role in the effects of systemic inflammation on the CNS. Signaling through the vagus nerve has also been considered to be an important component of CNS responses to systemic infection. Here, we demonstrate that blood-brain barrier permeabilization and hippocampal transcriptional responses during polymicrobial sepsis occur even in the absence of MyD88-dependent signaling in cerebrovascular endothelial cells. We further demonstrate that these transcriptional responses can occur without vagus nerve input. These results suggest that redundant signals mediate CNS responses in sepsis. Either endothelial or vagus nerve activation may be individually sufficient to transmit systemic inflammation to the central nervous system. Transcriptional activation in the forebrain in sepsis may be mediated by MyD88-independent endothelial mechanisms or by non-vagal neuronal pathways.	[Honig, Gerard; Mader, Simone; Chen, Huiyi; Porat, Amit; Diamond, Betty] Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA; [Ochani, Mahendar; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA; [Volpe, Bruce T.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA; [Honig, Gerard] Symbiot Hlth Inc, Roslyn Hts, NY USA	Northwell Health; Northwell Health; Northwell Health	Diamond, B (corresponding author), Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA.	bdiamond@nshs.edu	Honig, Gerard/ABB-5333-2020; volpe, b/U-8409-2019	Mader, Simone/0000-0002-2844-9091; Wang, Ping/0000-0002-1557-0394; Volpe, Bruce/0000-0002-1098-1848; Honig, Gerard/0000-0001-9147-7450	National Institute for Allergy and Infectious Diseases [3P01AI073693-02S1]; S.L.E. Lupus Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073693] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); S.L.E. Lupus Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the National Institute for Allergy and Infectious Diseases (grant 3P01AI073693-02S1). Simone Mader's work was supported by the S.L.E. Lupus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; [Anonymous], 2006, ENDOCRINOLOGY, V147, P4445, DOI [10.1210/en.2006-0465, DOI 10.1210/EN.2006-0465]; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; Barichello T, 2005, CRIT CARE MED, V33, P221, DOI 10.1097/01.CCM.0000150741.12906.BD; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Belevych N, 2010, BRAIN BEHAV IMMUN, V24, P1137, DOI 10.1016/j.bbi.2010.05.007; Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007; Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; Braun TP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-229; BRETDIBAT JL, 1995, BRAIN BEHAV IMMUN, V9, P242, DOI 10.1006/brbi.1995.1023; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Chung DW, 2010, CELL MOL NEUROBIOL, V30, P531, DOI 10.1007/s10571-009-9477-0; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Di Filippo M, 2013, NEUROBIOL DIS, V52, P229, DOI 10.1016/j.nbd.2012.12.009; Ding JQ, 2009, J IMMUNOL, V183, P4031, DOI 10.4049/jimmunol.0900105; Ebong S, 1999, INFECT IMMUN, V67, P6603; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Esen F, 2012, CRIT CARE MED, V40, P1214, DOI 10.1097/CCM.0b013e31823779ca; Fil D, 2011, METAB BRAIN DIS, V26, P49, DOI 10.1007/s11011-010-9231-9; Flierl MA, 2010, CRIT CARE, V14, DOI 10.1186/cc9035; Flierl MA, 2009, CRIT CARE, V13, DOI 10.1186/cc7710; Fung A, 2012, BRAIN RES, V1446, P144, DOI 10.1016/j.brainres.2012.01.061; Garcia-Bueno B, 2009, J NEUROSCI, V29, P12970, DOI 10.1523/JNEUROSCI.2373-09.2009; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Gosselin D, 2008, MOL PSYCHIATR, V13, P480, DOI 10.1038/sj.mp.4002122; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Hansen MK, 2000, AM J PHYSIOL-REG I, V278, pR331, DOI 10.1152/ajpregu.2000.278.2.R331; Hiraki S, 2012, SURGERY, V151, P313, DOI 10.1016/j.surg.2011.07.019; Hofer S, 2008, J SURG RES, V146, P276, DOI 10.1016/j.jss.2007.07.021; Honig G, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-82; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Imamura Y, 2011, NEUROSCIENCE, V187, P63, DOI 10.1016/j.neuroscience.2011.04.063; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jacob A, 2010, FASEB J, V24, P1682, DOI 10.1096/fj.09-138834; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Jin AY, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-12; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; King EG, 2014, LAB INVEST, V94, P4, DOI 10.1038/labinvest.2013.110; Kis B, 2002, J NEUROENDOCRINOL, V14, P283, DOI 10.1046/j.1365-2826.2002.00778.x; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Konsman JP, 2004, J COMP NEUROL, V472, P113, DOI 10.1002/cne.20052; LAYE S, 1995, AM J PHYSIOL-REG I, V268, pR1327, DOI 10.1152/ajpregu.1995.268.5.R1327; Maier SF, 1998, ANN NY ACAD SCI, V840, P289, DOI 10.1111/j.1749-6632.1998.tb09569.x; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Naert G, 2009, J INNATE IMMUN, V1, P480, DOI 10.1159/000225990; NIIJIMA A, 1995, J AUTONOM NERV SYST, V54, P137, DOI 10.1016/0165-1838(95)00003-G; Niijima A, 1996, J AUTONOM NERV SYST, V61, P287, DOI 10.1016/S0165-1838(96)00098-7; Osuchowski MF, 2009, CRIT CARE MED, V37, P1567, DOI 10.1097/CCM.0b013e31819df06b; Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623; Pan WH, 2008, AM J PHYSIOL-CELL PH, V294, pC1436, DOI 10.1152/ajpcell.00489.2007; Peck-Palmer OM, 2008, J LEUKOCYTE BIOL, V83, P1009, DOI 10.1189/jlb.0807528; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Puntener U, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-146; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Ruud J, 2013, FASEB J, V27, P1973, DOI 10.1096/fj.12-225433; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; Saper CB, 2010, NEURON, V65, P4, DOI 10.1016/j.neuron.2009.12.029; Scheiermann P, 2011, INT IMMUNOPHARMACOL, V11, P719, DOI 10.1016/j.intimp.2011.01.020; Schmitt C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-187; Secor D, 2010, INTENS CARE MED, V36, P1928, DOI 10.1007/s00134-010-1969-3; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Serrats J, 2009, BRAIN BEHAV IMMUN, V23, P1038, DOI 10.1016/j.bbi.2009.06.004; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Sharkey KA, 2014, AUTON NEUROSCI-BASIC, V182, P70, DOI 10.1016/j.autneu.2014.03.004; Sharshar T, 2005, CRIT CARE, V9, P37, DOI 10.1186/cc2951; Sharshar T, 2007, INTENS CARE MED, V33, P798, DOI 10.1007/s00134-007-0598-y; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Song DM, 2009, BLOOD, V114, P2521, DOI 10.1182/blood-2009-02-205914; Spulber S, 2009, J NEUROIMMUNOL, V208, P46, DOI 10.1016/j.jneuroim.2009.01.010; Srinivasan D, 2004, J NEUROSCI, V24, P6482, DOI 10.1523/JNEUROSCI.5712-03.2004; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Teeling JL, 2007, BRAIN BEHAV IMMUN, V21, P836, DOI 10.1016/j.bbi.2007.01.012; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Vachharjani V, 2005, MICROCIRCULATION, V12, P183, DOI 10.1080/10739680590904982; Vandenbroucke RE, 2012, J NEUROSCI, V32, P9805, DOI 10.1523/JNEUROSCI.0967-12.2012; Verant P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2870083; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Wang P, 2014, INT J MOL SCI, V15, P10101, DOI 10.3390/ijms150610101; WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R; Wiersinga WJ, 2011, CURR OPIN CRIT CARE, V17, P480, DOI 10.1097/MCC.0b013e32834a4aeb; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wuchert F, 2008, J NEUROIMMUNOL, V204, P66, DOI 10.1016/j.jneuroim.2008.07.017; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Yokoo H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051539; Yu MJ, 2014, J EXP MED, V211, P887, DOI 10.1084/jem.20131314; Yu Y, 2010, HYPERTENSION, V55, P652, DOI 10.1161/HYPERTENSIONAHA.109.142836; Zattoni M, 2011, J NEUROSCI, V31, P4037, DOI 10.1523/JNEUROSCI.6210-10.2011; Zhang YH, 2003, J COMP NEUROL, V463, P3, DOI 10.1002/cne.10743; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103; Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309; Zielinski MR, 2013, SLEEP, V36, P1227, DOI 10.5665/sleep.2892	110	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0144215	10.1371/journal.pone.0144215	http://dx.doi.org/10.1371/journal.pone.0144215			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790027	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100002
J	Royer, A; Montuire, S; Legendre, S; Discamps, E; Jeannet, M; Lecuyer, C				Royer, Aurelien; Montuire, Sophie; Legendre, Serge; Discamps, Emmanuel; Jeannet, Marcel; Lecuyer, Christophe			Investigating the Influence of Climate Changes on Rodent Communities at a Regional-Scale (MIS 1-3, Southwestern France)	PLOS ONE			English	Article							SMALL-MAMMAL DIVERSITY; LAST GLACIAL PERIOD; LATE-PLEISTOCENE; QUATERNARY HISTORY; WESTERN-EUROPE; VARIABILITY; RESPONSES; REFUGIA; COLONIZATION; FLUCTUATIONS	Terrestrial ecosystems have continuously evolved throughout the Late Pleistocene and the Holocene, deeply affected by both progressive environmental and climatic modifications, as well as by abrupt and large climatic changes such as the Heinrich or Dansgaard-Oeschger events. Yet, the impacts of these different events on terrestrial mammalian communities are poorly known, as is the role played by potential refugia on geographical species distributions. This study examines community changes in rodents of southwestern France between 50 and 10 ky BP by integrating 94 dated faunal assemblages coming from 37 archaeological sites. This work reveals that faunal distributions were modified in response to abrupt and brief climatic events, such as Heinrich events, without actually modifying the rodent community on a regional scale. However, the succession of events which operated between the Late Pleistocene and the Holocene gradually led to establishing a new rodent community at the regional scale, with intermediate communities occurring between the Bolling and the Allerod.	[Royer, Aurelien; Discamps, Emmanuel] Univ Bordeaux, CNRS, MCC, PACEA,UMR 5199, F-33615 Pessac, France; [Royer, Aurelien; Legendre, Serge; Lecuyer, Christophe] Univ Lyon 1, F-69622 Villeurbanne, France; [Royer, Aurelien; Legendre, Serge; Lecuyer, Christophe] Ecole Normale Super Lyon, Lab Geol Lyon, CNRS, UMR 5276, F-69622 Villeurbanne, France; [Montuire, Sophie] Univ Bourgogne, Biogeosci, CNRS, UMR 6282, 6 Blvd Gabriel, F-21000 Dijon, France; [Discamps, Emmanuel] Univ Bergen, AHKR Inst, Oysteinsgate 1,POB 7805, N-5020 Bergen, Norway; [Jeannet, Marcel] Aix Marseille Univ, LAMPEA, CNRS, UMR 7269,MMSH, 5 Rue Chateau Horloge,BP 647, F-13094 Aix En Provence 2, France; [Montuire, Sophie] Ecole Prat Hautes Etud, Lab EPHE PALEVO, F-21000 Dijon, France; [Lecuyer, Christophe] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; University of Bergen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Bourgogne; Institut Universitaire de France	Royer, A (corresponding author), Univ Bordeaux, CNRS, MCC, PACEA,UMR 5199, F-33615 Pessac, France.; Royer, A (corresponding author), Univ Lyon 1, F-69622 Villeurbanne, France.; Royer, A (corresponding author), Ecole Normale Super Lyon, Lab Geol Lyon, CNRS, UMR 5276, F-69622 Villeurbanne, France.	aurelien_royer@hotmail.com	Lecuyer, Christophe/AAO-8154-2021; Legendre, Serge/B-4042-2008; Royer, Aurélien/L-4641-2018	Legendre, Serge/0000-0003-4867-6790; Royer, Aurélien/0000-0002-0139-8765; Discamps, Emmanuel/0000-0002-2464-0761	Conseil General du departement de la Charente [CG16]; department of Charente (France) [CG16]	Conseil General du departement de la Charente; department of Charente (France)	This work was supported by funding from Conseil General du departement de la Charente (CG16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author of this study was granted by the department of Charente (CG16; France). Authors are grateful to Veronique Laroulandie, Mathieu Langlais and Marie Soressi for giving access to the material and for inviting A.R to study Peyrazet (Lot) and Les Cottes (Vienne). The authors also acknowledge the insightful comments made by Trenton Holliday. The authors would like to thank M. Hernandez Fernandez and an anonymous reviewer for their constructive remarks that greatly improved this paper.	Aguilar JP, 2008, CR PALEVOL, V7, P217, DOI 10.1016/j.crpv.2008.02.004; Allain J., 1985, GALLIA PR HIST, V28, P37; Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; Allen T. F. H., 1982, HIERARCHY PERSPECTIV; Auffray Jean-Christophe, 2009, Kasetsart Journal Natural Sciences, V43, P83; Belmaker M, 2011, QUATERNARY SCI REV, V30, P3196, DOI 10.1016/j.quascirev.2011.08.001; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Bertran P, 2014, BOREAS, V43, P699, DOI 10.1111/bor.12025; Bertran P, 2013, J ARCHAEOL SCI, V40, P2274, DOI 10.1016/j.jas.2013.01.012; Bertran P, 2009, J QUATERNARY SCI, V24, P259, DOI 10.1002/jqs.1220; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Bouchud J., 1968, GALLIA PREHISTOIRE, V11, P113; Bouchud J, 1952, B SOC PREHISTORIQUE, V49, P267; Bouchud J., 1975, EXCAVATION ABRI PATA, P69; Bouchud P, 1957, B STE ETUDES RECHERC, V7, P13; Brace S, 2012, P NATL ACAD SCI USA, V109, P20532, DOI 10.1073/pnas.1213322109; Brugal Jean Philip, 2004, BAR International Series, V1271, P39; BRUNETLECOMTE P, 1989, MAMMALIA, V53, P605, DOI 10.1515/mamm.1989.53.4.605; CHALINE J, 1995, PALAEOGEOGR PALAEOCL, V117, P229, DOI 10.1016/0031-0182(94)00137-W; Chaline J, 1974, PROIES RAPACES; Chaline J, 1965, B ASS FRANCAISE ETUD, V3-4, P243; Chaline J., 1972, CAHIERS PALEONTOLOGI; Chaline J, 1977, APPROCHE ECOLOGIQUE, P77; Champagne F., 1981, PIAGE SITE PREHISTOR; Clements F. E., 1916, PLANT SUCCESSION; Clot A., 1984, Munibe, V36, P33; Clot A, 1979, B SOC PREHISTORIQUE, V76, P324; Costamagno S., 2009, ELS PIRINEUS AREES C, P185; Costamagno S, 2001, MODE VIE MAGDALENIEN, P73; Coulonges L., 1963, GALL PREHIST, V7, P1; Cuenca-Bescos G, 1999, J HUM EVOL, V37, P353, DOI 10.1006/jhev.1999.0306; Cuenca-Bescos G, 2010, QUATERN INT, V212, P109, DOI 10.1016/j.quaint.2009.06.007; Cuenca-Bescos G, 2009, J ARCHAEOL SCI, V36, P947, DOI 10.1016/j.jas.2008.09.025; Deffontaine V, 2009, MOL ECOL, V18, P2489, DOI 10.1111/j.1365-294X.2009.04162.x; Delluc B, 1981, GALLIA PREHISTOIRE, V24, P1; Delpech F., 1989, TEMPS PREHISTOIRE, P48; DELPECH F., 1983, B LINSTITUT G OLOGIE, V34, P165; Delpech F., 2000, PALEO, V12, P97; Delpech F., 1999, PALEO, V11, P19, DOI DOI 10.3406/PAL.1999.1169; Desclaux E, 2003, PREHISTOIRE, P222; Discamps E, 2014, QUATERN INT, V337, P64, DOI 10.1016/j.quaint.2013.07.046; Discamps E, 2011, QUATERNARY SCI REV, V30, P2755, DOI 10.1016/j.quascirev.2011.06.009; Eastham A, 1995, MEMOIRE SOC PREHISTO, V22, P235; Eastham A., 1999, GALLIA PREHISTOIRE, V41, P113; Escarguel G, 2008, CR GEOSCI, V340, P602, DOI 10.1016/j.crte.2007.11.005; Fernandez MH, 2006, QUATERNARY RES, V65, P308, DOI 10.1016/j.yqres.2005.08.022; Fernandez-Garcia M, C R PALEVOL; Fletcher WJ, 2010, QUATERNARY SCI REV, V29, P2839, DOI 10.1016/j.quascirev.2009.11.015; Flojgaard C, 2009, J BIOGEOGR, V36, P1152, DOI 10.1111/j.1365-2699.2009.02089.x; Forcino FL, 2012, PALAEOGEOGR PALAEOCL, V365, P48, DOI 10.1016/j.palaeo.2012.09.011; Genty D, 2003, NATURE, V421, P833, DOI 10.1038/nature01391; Genty D, 2010, QUATERNARY SCI REV, V29, P2799, DOI 10.1016/j.quascirev.2010.06.035; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Goni MFS, 2008, QUATERNARY SCI REV, V27, P1136, DOI 10.1016/j.quascirev.2008.03.003; Graham RW, 1996, SCIENCE, V272, P1601; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harle Edouard, 1906, Bulletin de la Societe Geologique Ser 4, V6; Heikinheimo H, 2007, J BIOGEOGR, V34, P1053, DOI 10.1111/j.1365-2699.2006.01664.x; Fernandez MH, 2015, PALAEOBIO PALAEOENV, V95, P387, DOI 10.1007/s12549-015-0196-x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; Jackson ST, 2015, P NATL ACAD SCI USA, V112, P4915, DOI 10.1073/pnas.1403664111; Jeannet M, 2009, GROTTE TAILLIS COTEA, P105; Jeannet M, 2009, B PREHISTOIRE SUD OU, V17, P179; Jeannet M, 2001, REGION POITOU CHAREN, P304; Jeannet M, 2009, REV ARCHEOLOGIE LEST, V58, P5; Jeannet M., 2010, PREHISTORIES MEDITER, V1, P11; Kowalski K., 2001, PLEISTOCENE RODENTS; Kowalski Kazimierz, 1995, Acta Zoologica Cracoviensia, V38, P85; Langlais M, 2012, QUATERN INT, V272, P138, DOI 10.1016/j.quaint.2012.02.053; Le Louarn H., 2003, RONGEURS FRANCE FAUN; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Magri D, 2010, QUATERN INT, V219, P145, DOI 10.1016/j.quaint.2009.10.032; Maguire KC, 2015, ANNU REV ECOL EVOL S, V46, P343, DOI 10.1146/annurev-ecolsys-112414-054441; Lopez-Garcia JM, 2015, PALAEOGEOGR PALAEOCL, V435, P244, DOI 10.1016/j.palaeo.2015.06.022; Lopez-Garcia JM, 2013, GEOLOGY, V41, P267, DOI 10.1130/G33744.1; Lopez-Garcia JM, 2010, PALAEOGEOGR PALAEOCL, V292, P453, DOI 10.1016/j.palaeo.2010.04.006; Markova AK, 2010, QUATERN INT, V212, P149, DOI 10.1016/j.quaint.2009.02.010; Marquet J-C, 1973, CAHIERS CLAISE S2; Marquet J-C, 2005, GROTTE BOIS RAGOT GO, P373; Marquet JC, 1989, THESIS U DIJON; Mistrot V, 2001, THESIS U PARIS 1 PAN; Montuire S, 1997, BOREAS, V26, P355; O'Neill R. V., 1986, HIERARCHICAL CONCEPT; Oppliger J, 2008, THESIS U GENEVE FREN; PAILHAUGUE N, 2003, GROTTE VACHE ARIEGE, P73; PERRY DA, 1990, CONSERV BIOL, V4, P266, DOI 10.1111/j.1523-1739.1990.tb00288.x; Prevost MC, 1842, ANN SCI GEOL, P3; Prost S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010447; Rasmussen SO, QUAT SCI REV, V106, P14; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rofes J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14219; Royer A, 2013, THESIS ECOLE PRATIQU; Royer A, 2014, QUATERNARY RES, V82, P420, DOI 10.1016/j.yqres.2014.06.006; Royer A, 2013, QUATERNARY RES, V80, P113, DOI 10.1016/j.yqres.2013.03.007; Rull V, 2010, J BIOGEOGR, V37, P1623, DOI 10.1111/j.1365-2699.2010.02340.x; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Saint Girons, 1973, MAMMIFERES FRANCE B; Sanchezgoni MF, 2002, CLIM DYNAM, V19, P95, DOI 10.1007/s00382-001-0212-x; Schmitt T, 2008, MOL ECOL, V17, P2194, DOI 10.1111/j.1365-294X.2007.03687.x; SIMARD S, 1968, Naturaliste Canadien (Quebec), V95, P1435; Sitzia L, 2014, THESIS U BORDEAUX 1; Sokal R.R., 2012, BIOMETRY; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Sommer RS, 2009, MAMMAL REV, V39, P1, DOI 10.1111/j.1365-2907.2008.00137.x; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Talamo S, 2012, J ARCHAEOL SCI, V39, P175, DOI 10.1016/j.jas.2011.09.019; Tougard C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003532; Valdiosera CE, 2008, P NATL ACAD SCI USA, V105, P5123, DOI 10.1073/pnas.0712223105; Van Kolfschoten Thijs, 1995, Acta Zoologica Cracoviensia, V38, P73; Villa P, 2010, J ARCHAEOL SCI, V37, P919, DOI 10.1016/j.jas.2009.11.025; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wohlfarth B, 2008, GEOLOGY, V36, P407, DOI 10.1130/G24600A.1; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; [No title captured]	123	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145600	10.1371/journal.pone.0145600	http://dx.doi.org/10.1371/journal.pone.0145600			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789523	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100011
J	Chang, HY; Chen, CT; Lih, TM; Lynn, KS; Juo, CG; Hsu, WL; Sung, TY				Chang, Hui-Yin; Chen, Ching-Tai; Lih, T. Mamie; Lynn, Ke-Shiuan; Juo, Chiun-Gung; Hsu, Wen-Lian; Sung, Ting-Yi			iMet-Q: A User-Friendly Tool for Label-Free Metabolomics Quantitation Using Dynamic Peak-Width Determination	PLOS ONE			English	Article							MASS-SPECTROMETRY DATA; OPEN-SOURCE SOFTWARE; LC-MS; IDENTIFICATION; METABOLITES; ANNOTATION; EXTRACTION; PROTEOMICS; ALIGNMENT; PROFILE	Efficient and accurate quantitation of metabolites from LC-MS data has become an important topic. Here we present an automated tool, called iMet-Q (intelligent Metabolomic Quantitation), for label-free metabolomics quantitation from high-throughput MS1 data. By performing peak detection and peak alignment, iMet-Q provides a summary of quantitation results and reports ion abundance at both replicate level and sample level. Furthermore, it gives the charge states and isotope ratios of detected metabolite peaks to facilitate metabolite identification. An in-house standard mixture and a public Arabidopsis metabolome data set were analyzed by iMet-Q. Three public quantitation tools, including XCMS, MetAlign, and MZmine 2, were used for performance comparison. From the mixture data set, seven standard metabolites were detected by the four quantitation tools, for which iMet-Q had a smaller quantitation error of 12% in both profile and centroid data sets. Our tool also correctly determined the charge states of seven standard metabolites. By searching the mass values for those standard metabolites against Human Metabolome Database, we obtained a total of 183 metabolite candidates. With the isotope ratios calculated by iMet-Q, 49%(89 out of 183) metabolite candidates were filtered out. From the public Arabidopsis data set reported with two internal standards and 167 elucidated metabolites, iMet-Q detected all of the peaks corresponding to the internal standards and 167 metabolites. Meanwhile, our tool had small abundance variation (<= 0.19) when quantifying the two internal standards and had higher abundance correlation (>= 0.92) when quantifying the 167 metabolites. iMet-Q provides user-friendly interfaces and is publicly available for download at http://ms.iis.sinica.edu.tw/comics/Software_iMet-Q.html.	[Chang, Hui-Yin; Lih, T. Mamie] Acad Sinica, Taiwan Int Grad Program, Bioinformat Program, Taipei 11529, Taiwan; [Chang, Hui-Yin; Lih, T. Mamie] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 11221, Taiwan; [Chang, Hui-Yin; Chen, Ching-Tai; Lih, T. Mamie; Hsu, Wen-Lian; Sung, Ting-Yi] Acad Sinica, Inst Informat Sci, Taipei 11529, Taiwan; [Lynn, Ke-Shiuan] Fu Jen Catholic Univ, Dept Math, New Taipei 24205, Taiwan; [Juo, Chiun-Gung] Chang Gung Univ, Mol Med Res Ctr, Taoyuan 33302, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Fu Jen Catholic University; Chang Gung University	Sung, TY (corresponding author), Acad Sinica, Inst Informat Sci, Taipei 11529, Taiwan.	tsung@iis.sinica.edu.tw	Sung, Ting-Yi/AAQ-5413-2021; Hsu, Wen-Lian/ABB-2851-2020	Sung, Ting-Yi/0000-0002-6028-0409; Hsu, Wen-Lian/0000-0001-7061-3513	Ministry of Science and Technology of Taiwan [MOST103-2221-E-001-037]; Taiwan International Graduate Program; Academia Sinica	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan International Graduate Program; Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Academia Sinica, Ministry of Science and Technology of Taiwan (MOST103-2221-E-001-037), and Taiwan International Graduate Program.; We thank the support from Academia Sinica, Ministry of Science and Technology of Taiwan (MOST 103-2221-E-001-037), and Taiwan International Graduate Program. We also thank Wai-Kok Choong and Thejkiran Pitti for fruitful discussion on the manuscript.	Aberg KM, 2008, J CHROMATOGR A, V1192, P139, DOI 10.1016/j.chroma.2008.03.033; Baker M, 2011, NAT METHODS, V8, P117, DOI 10.1038/nmeth0211-117; Bedair M, 2008, TRAC-TREND ANAL CHEM, V27, P238, DOI 10.1016/j.trac.2008.01.006; Blekherman G, 2011, METABOLOMICS, V7, P329, DOI 10.1007/s11306-010-0270-3; Cleveland W.S., 1981, T AM STAT, V35, P54, DOI DOI 10.2307/2683591; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Ellis DI, 2007, PHARMACOGENOMICS, V8, P1243, DOI 10.2217/14622416.8.9.1243; Issaq HJ, 2009, J SEP SCI, V32, P2183, DOI 10.1002/jssc.200900152; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Katajamaa M, 2007, J CHROMATOGR A, V1158, P318, DOI 10.1016/j.chroma.2007.04.021; Keller BO, 2008, ANAL CHIM ACTA, V627, P71, DOI 10.1016/j.aca.2008.04.043; Kenar E, 2014, MOL CELL PROTEOMICS, V13, P348, DOI 10.1074/mcp.M113.031278; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Lynn KS, 2015, ANAL CHEM, V87, P2143, DOI 10.1021/ac503325c; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Matsuda F, 2010, PLANT PHYSIOL, V152, P566, DOI 10.1104/pp.109.148031; Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; Nagao T, 2014, ANAL CHIM ACTA, V813, P70, DOI 10.1016/j.aca.2014.01.032; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Roux A, 2011, CLIN BIOCHEM, V44, P119, DOI 10.1016/j.clinbiochem.2010.08.016; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sugimoto M, 2012, CURR BIOINFORM, V7, P96, DOI 10.2174/157489312799304431; Sugimoto M, 2010, METABOLOMICS, V6, P27, DOI 10.1007/s11306-009-0175-1; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Theodoridis GA, 2012, ANAL CHIM ACTA, V711, P7, DOI 10.1016/j.aca.2011.09.042; Tolstikov VV, 2003, ANAL CHEM, V75, P6737, DOI 10.1021/ac034716z; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; Werner E, 2008, J CHROMATOGR B, V871, P143, DOI 10.1016/j.jchromb.2008.07.004; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g	37	14	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146112	10.1371/journal.pone.0146112	http://dx.doi.org/10.1371/journal.pone.0146112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784691	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400024
J	Minatani, N; Waraya, M; Yamashita, K; Kikuchi, M; Ushiku, H; Kojo, K; Ema, A; Nishimiya, H; Kosaka, Y; Katoh, H; Sengoku, N; Tanino, H; Sidransky, D; Watanabe, M				Minatani, Naoko; Waraya, Mina; Yamashita, Keishi; Kikuchi, Mariko; Ushiku, Hideki; Kojo, Ken; Ema, Akira; Nishimiya, Hiroshi; Kosaka, Yoshimasa; Katoh, Hiroshi; Sengoku, Norihiko; Tanino, Hirokazu; Sidransky, David; Watanabe, Masahiko			Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer	PLOS ONE			English	Article							CYSTEINE DIOXYGENASE; METHYLATION; SYSTEM; CELLS; ANTIPORTER; SUBTYPES; GROWTH; TUMORS	Using pharmacological unmasking microarray, we identified promoter DNA methylation of cysteine dioxygenase 1 (CDO1) gene in human cancer. In this study, we assessed the clinicopathological significance of CDO1 methylation in primary breast cancer (BC) with no prior chemotherapy. The CDO1 DNA methylation was quantified by TaqMan methylation specific PCR (Q-MSP) in 7 BC cell lines and 172 primary BC patients with no prior chemotherapy. Promoter DNA of the CDO1 gene was hypermethylated in 6 BC cell lines except SK-BR3, and CDO1 gene expression was all silenced at mRNA level in the 7 BC cell lines. Quantification of CDO1 methylation was developed using Q-MSP, and assessed in primary BC. Among the clinicopathologic factors, CDO1 methylation level was not statistically significantly associated with any prognostic factors. The log-rank plot analysis elucidated that the higher methylation the tumors harbored, the poorer prognosis the patients exhibited. Using the median value of 58.0 as a cut-off one, disease specific survival in BC patients with CDO1 hypermethylation showed significantly poorer prognosis than those with hypomethylation (p = 0.004). Multivariate Cox proportional hazards model identified that CDO1 hypermethylation was prognostic factor as well as Ki-67 and hormone receptor status. The most intriguingly, CDO1 hypermethylation was of robust prognostic relevance in triple negative BC (p = 0.007). Promoter DNA methylation of CDO1 gene was robust prognostic indicator in primary BC patients with no prior chemotherapy. Prognostic relevance of the CDO1 promoter DNA methylation is worthy of being paid attention in triple negative BC cancer.	[Minatani, Naoko; Waraya, Mina; Yamashita, Keishi; Kikuchi, Mariko; Ushiku, Hideki; Kojo, Ken; Ema, Akira; Kosaka, Yoshimasa; Katoh, Hiroshi; Sengoku, Norihiko; Tanino, Hirokazu; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan; [Sidransky, David] Johns Hopkins Univ, Dept Otolaryngol, Baltimore, MD USA; [Nishimiya, Hiroshi] Yamato Municipal Hosp, Dept Surg, Yamato, Kanagawa, Japan	Kitasato University; Johns Hopkins University	Watanabe, M (corresponding author), Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan.	gekaw@med.kitasato-u.ac.jp	Tanino, Hirokazu/AAN-4455-2021					Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Dawson S J, 2009, Eur J Cancer, V45 Suppl 1, P27, DOI 10.1016/S0959-8049(09)70013-9; Dietrich D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-247; Friedrich K, 2008, CELL ONCOL, V30, P39; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jeschke J, 2013, CLIN CANCER RES, V19, P3201, DOI 10.1158/1078-0432.CCR-12-3751; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Joseph CA, 2007, CHEM COMMUN, P3338, DOI 10.1039/b702158e; Kataoka A, 2001, CLIN CANCER RES, V7, P2815; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Nishimiya H, 2014, ANTICANCER RES, V34, P259; Oien DB, 2007, BIOCHEM BIOPH RES CO, V352, P556, DOI 10.1016/j.bbrc.2006.11.063; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Sotgia F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2892; Stefansson OA, 2014, MOL ONCOL; Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y; Sueta A, 2012, BREAST CANCER RES TR, V132, P711, DOI 10.1007/s10549-011-1904-5; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Ueo H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12080; Wang F, 2014, BREAST CANCER RES TR, V147, P203, DOI 10.1007/s10549-014-3068-6; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113546	33	22	24	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0144862	10.1371/journal.pone.0144862	http://dx.doi.org/10.1371/journal.pone.0144862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785325	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400008
J	Basu, A; Cajigas-Du Ross, CK; Rios-Colon, L; Mediavilla-Varela, M; Daniels-Wells, TR; Leoh, LS; Rojas, H; Banerjee, H; Martinez, SR; Acevedo-Martinez, S; Casiano, CA				Basu, Anamika; Cajigas-Du Ross, Christina K.; Rios-Colon, Leslimar; Mediavilla-Varela, Melanie; Daniels-Wells, Tracy R.; Leoh, Lai Sum; Rojas, Heather; Banerjee, Hiya; Martinez, Shannalee R.; Acevedo-Martinez, Stephanny; Casiano, Carlos A.			LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR; PROTEOMIC ANALYSIS; HEAT-SHOCK; TRANSCRIPTIONAL REGULATION; LENTIVIRAL INTEGRATION; LYSOSOMAL PATHWAYS; PROTEIN EXPRESSION; PROGNOSTIC MARKER; CELL-DEATH; ERP57	Prostate cancer (PCa) mortality is driven by highly aggressive tumors characterized by metastasis and resistance to therapy, and this aggressiveness is mediated by numerous factors, including activation of stress survival pathways in the pro-inflammatory tumor micro-environment. LEDGF/p75, also known as the DFS70 autoantigen, is a stress transcription co-activator implicated in cancer, HIV-AIDS, and autoimmunity. This protein is targeted by autoantibodies in certain subsets of patients with PCa and inflammatory conditions, as well as in some apparently healthy individuals. LEDGF/p75 is overexpressed in PCa and other cancers, and promotes resistance to chemotherapy-induced cell death via the transactivation of survival proteins. We report in this study that overexpression of LEDGF/p75 in PCa cells attenuates oxidative stress-induced necrosis but not staurosporine-induced apoptosis. This finding was consistent with the observation that while LEDGF/p75 was robustly cleaved in apoptotic cells into a p65 fragment that lacks stress survival activity, it remained relatively intact in necrotic cells. Overexpression of LEDGF/p75 in PCa cells led to the upregulation of transcript and protein levels of the thiol-oxidoreductase ERp57 (also known as GRP58 and PDIA3), whereas its depletion led to ERp57 transcript downregulation. Chromatin immunoprecipitation and transcription reporter assays showed LEDGF/p75 binding to and transactivating the ERp57 promoter, respectively. Immunohistochemical analysis revealed significantly elevated co-expression of these two proteins in clinical prostate tumor tissues. Our results suggest that LEDGF/p75 is not an inhibitor of apoptosis but rather an antagonist of oxidative stress-induced necrosis, and that its overexpression in PCa leads to ERp57 upregulation. These findings are of significance in clarifying the role of the LEDGF/p75 stress survival pathway in PCa.	[Basu, Anamika; Cajigas-Du Ross, Christina K.; Rios-Colon, Leslimar; Mediavilla-Varela, Melanie; Daniels-Wells, Tracy R.; Leoh, Lai Sum; Martinez, Shannalee R.; Acevedo-Martinez, Stephanny; Casiano, Carlos A.] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Rojas, Heather] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA; [Banerjee, Hiya] Novartis Pharmaceut Oncol, E Hanover, NJ 08807 USA; [Casiano, Carlos A.] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92350 USA; [Daniels-Wells, Tracy R.; Leoh, Lai Sum] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA; [Mediavilla-Varela, Melanie] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Acevedo-Martinez, Stephanny] Univ Puerto Rico, Hosp Dr Federico Trilla, Dept Emergency Med, Carolina, PR 00924 USA	Loma Linda University; Loma Linda University; Novartis; Loma Linda University; University of California System; University of California Los Angeles; H Lee Moffitt Cancer Center & Research Institute; University of Puerto Rico; University of Puerto Rico at Carolina	Basu, A (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA.	abasu@llu.edu		Daniels-Wells, Tracy/0000-0002-8277-9702; Martinez, Shannalee/0000-0002-9682-0227	NIH [5R25GM060507, 5P20MD001632, 5P20MD006988]; Loma Linda University School of Medicine Center for Health Disparities and Molecular Medicine; medical research training internship [5P20MD006988]; NIH; Novartis;  [R25GM060507]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loma Linda University School of Medicine Center for Health Disparities and Molecular Medicine; medical research training internship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); ; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH grants 5R25GM060507, 5P20MD001632 and 5P20MD006988, and by Loma Linda University School of Medicine Center for Health Disparities and Molecular Medicine. CKCD, MMV, LRC, and SRM were supported by graduate training fellowships under grant R25GM060507. SAM was supported by a medical research training internship under grant 5P20MD006988. HB is employed by a commercial company-Novartis Pharmaceutical Oncology. The funders (NIH, Novartis) provided support in the form of salaries for authors (CAC, CKCD, MMV, LRC, SRM, SAM, HB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Albany C, 2014, ASIAN J ANDROL, V16, P359, DOI 10.4103/1008-682X.126400; Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Basu A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00116; Basu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030132; Basu A, 2012, PROSTATE, V72, P597, DOI 10.1002/pros.21463; Bhargavan B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.57; Bouvier M, 2003, MOL IMMUNOL, V39, P697, DOI 10.1016/S0161-5890(02)00261-4; Brown-Bryan TA, 2008, MOL CANCER RES, V6, P1293, DOI 10.1158/1541-7786.MCR-08-0125; Cesen MH, 2012, EXP CELL RES, V318, P1245, DOI 10.1016/j.yexcr.2012.03.005; Chay D, 2010, INT J ONCOL, V37, P399, DOI 10.3892/ijo_00000688; Chen GA, 2002, CLIN CANCER RES, V8, P2298; Choe MH, 2015, ONCOTARGET, V6, P2654, DOI 10.18632/oncotarget.3042; Chowdhury SKR, 2007, FREE RADICAL RES, V41, P1116, DOI 10.1080/10715760701579314; Christ F, 2013, VIROLOGY, V435, P102, DOI 10.1016/j.virol.2012.09.033; Cicchillitti L, 2009, J PROTEOME RES, V8, P1902, DOI 10.1021/pr800856b; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Cohen B, 2009, NEOPLASIA, V11, P921, DOI 10.1593/neo.09636; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Gijsbers R, 2011, J BIOL CHEM, V286, P41812, DOI 10.1074/jbc.M111.255711; Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36; Grillo C, 2006, FREE RADICAL BIO MED, V41, P1113, DOI 10.1016/j.freeradbiomed.2006.06.016; Hanus J, 2015, INVEST OPHTH VIS SCI, V56, P5048, DOI 10.1167/iovs.15-16401; Huang TS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-31; Kalinichenko SV, 2008, LUNG CANCER, V62, P173, DOI 10.1016/j.lungcan.2008.03.022; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Leitz J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003957; Leoh LS, 2012, MOL CANCER RES, V10, P378, DOI 10.1158/1541-7786.MCR-11-0314; Leys CM, 2007, SURGERY, V141, P41, DOI 10.1016/j.surg.2006.05.009; Liao CJ, 2011, CANCER SCI, V102, P2255, DOI 10.1111/j.1349-7006.2011.02102.x; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Long AC, 2004, EXP BIOL MED, V229, P1072, DOI 10.1177/153537020422901012; Matsui H, 2001, INVEST OPHTH VIS SCI, V42, P2935; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Menoret A, 2014, MOL CARCINOGEN, V53, pE11, DOI 10.1002/mc.21986; Mereau H, 2013, LEUKEMIA, V27, P1245, DOI 10.1038/leu.2013.10; Ochs RL, 2015, CLIN EXP ME IN PRESS; Orntoft TF, 2002, MOL CELL PROTEOMICS, V1, P37, DOI 10.1074/mcp.M100019-MCP200; Pacheco FJ, 2014, INFLAMM RES, V63, P859, DOI 10.1007/s00011-014-0760-2; Pacheco FJ, 2005, ARTHRITIS RHEUM-US, V52, P2133, DOI 10.1002/art.21147; Patterson SG, 2006, ONCOGENE, V25, P6113, DOI 10.1038/sj.onc.1209632; Pelech S, METHODS MOL BIOL, V218, P99; Pressinotti NC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-130; Santana-Codina N, 2013, MOL CELL PROTEOMICS, V12, P2111, DOI 10.1074/mcp.M112.022772; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Sardao VA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-11; Seliger B, 2010, CANCER IMMUNOL IMMUN, V59, P529, DOI 10.1007/s00262-009-0769-5; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Sharma P, 2000, BIOCHEM BIOPH RES CO, V276, P1320, DOI 10.1006/bbrc.2000.3606; Shin JH, 2008, NEUROSCI LETT, V435, P131, DOI 10.1016/j.neulet.2008.02.029; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Shiota M, 2011, FREE RADICAL BIO MED, V51, P1320, DOI 10.1016/j.freeradbiomed.2011.07.011; Shishkin SS, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1415, DOI 10.1134/S000629791313004X; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; Singh DP, 2006, J MOL BIOL, V355, P379, DOI 10.1016/j.jmb.2005.10.054; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; Ummanni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016833; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wu X, 2002, CELL DEATH DIFFER, V9, P915, DOI 10.1038/sj.cdd.4401063; Wu XW, 2001, ARTHRITIS RHEUM, V44, P2642, DOI 10.1002/1529-0131(200111)44:11<2642::AID-ART444>3.0.CO;2-8; Xu X, 2014, MOL CARCINOGEN, V53, P300, DOI 10.1002/mc.21977; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010	73	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146549	10.1371/journal.pone.0146549	http://dx.doi.org/10.1371/journal.pone.0146549			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771192	gold, Green Submitted, Green Published			2022-12-26	WOS:000368628300025
J	Kaur, S; Dhugga, KS; Gill, K; Singh, J				Kaur, Simerjeet; Dhugga, Kanwarpal S.; Gill, Kulvinder; Singh, Jaswinder			Novel Structural and Functional Motifs in cellulose synthase (CesA) Genes of Bread Wheat (Triticum aestivum, L.)	PLOS ONE			English	Article							EXPRESSION ANALYSIS; WALL; COMPLEXES; GROWTH; MAIZE; ORGANIZATION; BIOSYNTHESIS; SUPERFAMILY; EUCALYPTUS; SEQUENCE	Cellulose is the primary determinant of mechanical strength in plant tissues. Late-season lodging is inversely related to the amount of cellulose in a unit length of the stem. Wheat is the most widely grown of all the crops globally, yet information on its CesA gene family is limited. We have identified 22 CesA genes from bread wheat, which include homoeologs from each of the three genomes, and named them as TaCesAXA, TaCesAXB or TaCesAXD, where X denotes the gene number and the last suffix stands for the respective genome. Sequence analyses of the CESA proteins from wheat and their orthologs from barley, maize, rice, and several dicot species (Arabidopsis, beet, cotton, poplar, potato, rose gum and soybean) revealed motifs unique to monocots (Poales) or dicots. Novel structural motifs CQIC and SVICEXWFA were identified, which distinguished the CESAs involved in the formation of primary and secondary cell wall (PCW and SCW) in all the species. We also identified several new motifs specific to monocots or dicots. The conserved motifs identified in this study possibly play functional roles specific to PCW or SCW formation. The new insights from this study advance our knowledge about the structure, function and evolution of the CesA family in plants in general and wheat in particular. This information will be useful in improving culm strength to reduce lodging or alter wall composition to improve biofuel production.	[Kaur, Simerjeet; Singh, Jaswinder] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Dhugga, Kanwarpal S.] DuPont Pioneer, Genet Discovery, 7300 NW 62nd Ave, Johnston, IA USA; [Gill, Kulvinder] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Dhugga, Kanwarpal S.] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Estado De Mexic, Mexico	McGill University; DuPont; Pioneer Hi-Bred International, Inc.; Washington State University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Singh, J (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	jaswinder.singh@mcgill.ca		Dhugga, Kanwarpal/0000-0003-2477-3422	BIOFUEL NET CANADA	BIOFUEL NET CANADA	This study was supported by BIOFUEL NET CANADA (http://www.biofuelnet.ca/). The funders had no role in study design, data collection and analysis.	Appenzeller L, 2004, CELLULOSE, V11, P287, DOI 10.1023/B:CELL.0000046417.84715.27; Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray N, 2015, ARXIV150502710; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Carroll A, 2012, PLANT PHYSIOL, V160, P726, DOI 10.1104/pp.112.199208; Ching A, 2006, PLANTA, V224, P1174, DOI 10.1007/s00425-006-0299-8; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Csuros M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002150; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Dhugga KS, 2007, CROP SCI, V47, P2211, DOI 10.2135/cropsci2007.05.0299; Dhugga KS, 2001, CURR OPIN PLANT BIOL, V4, P488, DOI 10.1016/S1369-5266(00)00205-3; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Endo T, 2002, MOL BIOL EVOL, V19, P521, DOI 10.1093/oxfordjournals.molbev.a004107; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hamann T, 2004, CELLULOSE, V11, P279, DOI 10.1023/B:CELL.0000046340.99925.57; Hill JL, 2014, PLANT CELL; Holland N, 2000, PLANT PHYSIOL, V123, P1313, DOI 10.1104/pp.123.4.1313; Houston K, 2015, PLOS ONE, V10; Kaur R, 2013, FUNCT INTEGR GENOMIC, V13, P167, DOI 10.1007/s10142-013-0310-y; Kurek I, 2002, P NATL ACAD SCI USA, V99, P11109, DOI 10.1073/pnas.162077099; Li Shundai, 2014, Arabidopsis Book, V12, pe0169, DOI 10.1199/tab.0169; Lin Y, 2014, J PLANT BIOCHEM BIOT, V23, P199, DOI 10.1007/s13562-013-0202-1; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079329; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McFarlane HE, 2014, ANNU REV PLANT BIOL, V65, P69, DOI 10.1146/annurev-arplant-050213-040240; Mochida K., 2003, MGG Molecular Genetics and Genomics, V270, P371, DOI 10.1007/s00438-003-0939-7; Mochida K, 2013, PLANT CELL PHYSIOL, V54, P1931, DOI 10.1093/pcp/pct163; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pingault L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0601-9; Ranik M, 2006, TREE PHYSIOL, V26, P545, DOI 10.1093/treephys/26.5.545; Rayon C, 2014, REDESIGNING CELLULOS, P183; Richmond T., 2000, GENOME BIOL, V1, DOI 10.1186/GB-2000-1-4-REVIEWS3001; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Sethaphong L, 2013, P NATL ACAD SCI USA, V110, P7512, DOI 10.1073/pnas.1301027110; Slabaugh E, 2014, TRENDS PLANT SCI, V19, P99, DOI 10.1016/j.tplants.2013.09.009; Suzuki S, 2006, PLANT PHYSIOL, V142, P1233, DOI 10.1104/pp.106.086678; Takata N, 2015, PLANTA, V241, P29, DOI 10.1007/s00425-014-2217-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Tian JX, 2014, MOL GENET GENOMICS, V289, P439, DOI 10.1007/s00438-014-0824-6; Trapp SC, 2001, GENETICS, V158, P811; Wang DF, 2012, PLANT SCI, V196, P117, DOI 10.1016/j.plantsci.2012.08.002; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wang Y, 2013, NUCLEIC ACIDS RES, V41, pD1159, DOI 10.1093/nar/gks1109; Zhang QS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-27; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	52	18	24	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147046	10.1371/journal.pone.0147046	http://dx.doi.org/10.1371/journal.pone.0147046			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771740	Green Submitted, gold, Green Published			2022-12-26	WOS:000368628300058
J	Kvac, M; Havrdova, N; Hlaskova, L; Dankova, T; Kandera, J; Jezkova, J; Vitovec, J; Sak, B; Ortega, Y; Xiao, LH; Modry, D; Chelladurai, JRJJ; Prantlova, V; McEvoy, J				Kvac, Martin; Havrdova, Nikola; Hlaskova, Lenka; Dankova, Tereza; Kandera, Jiri; Jezkova, Jana; Vitovec, Jiri; Sak, Bohumil; Ortega, Ynes; Xiao, Lihua; Modry, David; Chelladurai, Jeba Rose Jennifer Jesudoss; Prantlova, Veronika; McEvoy, John			Cryptosporidium proliferans n. sp (Apicomplexa: Cryptosporidiidae): Molecular and Biological Evidence of Cryptic Species within Gastric Cryptosporidium of Mammals	PLOS ONE			English	Article							JAPANESE FIELD MICE; GENETIC DIVERSITY; MURIS INFECTION; ABOMASAL CRYPTOSPORIDIOSIS; PHYLOGENETIC ANALYSIS; GIARDIA-DUODENALIS; NATURAL INFECTION; GENOTYPES; PARVUM; PREVALENCE	The morphological, biological, and molecular characteristics of Cryptosporidium muris strain TS03 are described, and the species name Cryptosporidium proliferans n. sp. is proposed. Cryptosporidium proliferans obtained from a naturally infected East African mole rat (Tachyoryctes splendens) in Kenya was propagated under laboratory conditions in rodents (SCID mice and southern multimammate mice, Mastomys coucha) and used in experiments to examine oocyst morphology and transmission. DNA from the propagated C. proliferans isolate, and C. proliferans DNA isolated from the feces of an African buffalo (Syncerus caffer) in Central African Republic, a donkey (Equus africanus) in Algeria, and a domestic horse (Equus caballus) in the Czech Republic were used for phylogenetic analyses. Oocysts of C. proliferans are morphologically distinguishable from C. parvum and C. muris HZ206, measuring 6.8-8.8 (mean = 7.7 mu m) x 4.8-6.2 mu m (mean = 5.3) with a length to width ratio of 1.48 (n = 100). Experimental studies using an isolate originated from T. splendens have shown that the course of C. proliferans infection in rodent hosts differs from that of C. muris and C. andersoni. The prepatent period of 18-21 days post infection (DPI) for C. proliferans in southern multimammate mice (Mastomys coucha) was similar to that of C. andersoni and longer than the 6-8 DPI prepatent period for C. muris RN66 and HZ206 in the same host. Histopatologicaly, stomach glands of southern multimammate mice infected with C. proliferans were markedly dilated and filled with necrotic material, mucus, and numerous Cryptosporidium developmental stages. Epithelial cells of infected glands were atrophic, exhibited cuboidal or squamous metaplasia, and significantly proliferated into the lumen of the stomach, forming papillary structures. The epithelial height and stomach weight were six-fold greater than in non-infected controls. Phylogenetic analyses based on small subunit rRNA, Cryptosporidium oocyst wall protein, thrombospondin-related adhesive protein of Cryptosporidium-1, heat shock protein 70, actin, heat shock protein 90 (MS2), MS1, MS3, and M16 gene sequences revealed that C. proliferans is genetically distinct from C. muris and other previously described Cryptosporidium species.	[Kvac, Martin; Hlaskova, Lenka; Sak, Bohumil; Modry, David; Prantlova, Veronika] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic; [Kvac, Martin; Havrdova, Nikola; Vitovec, Jiri; Prantlova, Veronika] Univ South Bohemia, Fac Agr, Ceske Budejovice, Czech Republic; [Dankova, Tereza; Kandera, Jiri] Grammar Sch, Vimperk, Czech Republic; [Dankova, Tereza; Kandera, Jiri] High Sch Econ, Vimperk, Czech Republic; [Jezkova, Jana] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Ortega, Ynes] Univ Georgia, Dept Food Sci & Technol, Ctr Food Safety, Griffin, GA 30223 USA; [Xiao, Lihua] Ctr Dis Control & Prevent, Atlanta, GA USA; [Modry, David] Univ Vet & Pharmaceut Sci, Dept Pathol & Parasitol, Brno, Czech Republic; [Modry, David] CEITEC VFU, Brno, Czech Republic; [Chelladurai, Jeba Rose Jennifer Jesudoss; McEvoy, John] N Dakota State Univ, Vet & Microbiol Sci Dept, Fargo, ND 58105 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; University of Veterinary Sciences Brno; North Dakota State University Fargo	Kvac, M (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.; Kvac, M (corresponding author), Univ South Bohemia, Fac Agr, Ceske Budejovice, Czech Republic.	kvac@paru.cas.cz	Sak, Bohumil/G-9262-2014; Chelladurai, Jeba Jesudoss/AAJ-8621-2020; Chelladurai, Jeba R J Jesudoss/C-3813-2018; Modry, David/G-7815-2014; Prantlová, Veronika/ABE-8837-2021; Kvac, Martin/AAT-9533-2020; Xiao, Lihua/B-1704-2013; Kvac, Martin/G-7299-2014	Chelladurai, Jeba Jesudoss/0000-0003-3077-0201; Chelladurai, Jeba R J Jesudoss/0000-0003-3077-0201; Modry, David/0000-0001-9649-6255; Xiao, Lihua/0000-0001-8532-2727; Kvac, Martin/0000-0003-0013-6090; McEvoy, John/0000-0001-6843-5551	Ministry of Education, Youth and Sports of the Czech Republic [LH11061]; Czech Science Foundation [15-01090S]; Grant Agency of University of South Bohemia [011/2013/Z]; NIH [1R15AI067284-01A1]; CEITEC-Central European Institute of Technology from European Regional Development Fund [CZ.1.05/1.100/02.0068]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of University of South Bohemia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CEITEC-Central European Institute of Technology from European Regional Development Fund	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic (LH11061, to MK); the Czech Science Foundation (15-01090S, to MK); the Grant Agency of University of South Bohemia (011/2013/Z, to MK); the NIH (1R15AI067284-01A1, to JM); and CEITEC-Central European Institute of Technology (CZ.1.05/1.100/02.0068) from European Regional Development Fund (to DM).	ANDERSON BC, 1987, VET PATHOL, V24, P235, DOI 10.1177/030098588702400307; Anderson BC, 1998, J DAIRY SCI, V81, P3036, DOI 10.3168/jds.S0022-0302(98)75868-0; ANDERSON BC, 1991, J PROTOZOOL, V38, pS16; ARROWOOD MJ, 1987, J PARASITOL, V73, P314, DOI 10.2307/3282084; Aydin Y, 1996, VET PARASITOL, V66, P257, DOI 10.1016/S0304-4017(96)01007-2; CASEMORE DP, 1991, J CLIN PATHOL, V44, P445, DOI 10.1136/jcp.44.6.445; Chalmers RM, 1997, PARASITOL RES, V83, P478, DOI 10.1007/s004360050283; Crawshaw G.J., 1987, Erkrankungen der Zootiere, P353; Deng MQ, 1999, PARASITOL RES, V85, P733, DOI 10.1007/s004360050623; Dixon BR, 2008, J PARASITOL, V94, P1161, DOI 10.1645/GE-1485.1; Dubey JP, 2002, VET PATHOL, V39, P363, DOI 10.1354/vp.39-3-363; ESTEBAN E, 1995, J DAIRY SCI, V78, P1068, DOI 10.3168/jds.S0022-0302(95)76723-6; Fayer R, 2001, J PARASITOL, V87, P1415, DOI 10.1645/0022-3395(2001)087[1415:CCNSFD]2.0.CO;2; Fayer R., 1997, CRYPTOSPORIDIUM CRYP; Fayer Ronald, 2007, P1, DOI 10.1201/9781420052275.ch1; Fayer R, 2009, VET PARASITOL, V164, P192, DOI 10.1016/j.vetpar.2009.05.011; Feng Y, 2007, APPL ENVIRON MICROB, V73, P6475, DOI 10.1128/AEM.01034-07; Feng YY, 2011, J CLIN MICROBIOL, V49, P34, DOI 10.1128/JCM.01329-10; Graczyk TK, 1996, J PARASITOL, V82, P748, DOI 10.2307/3283886; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guyot K, 2001, J CLIN MICROBIOL, V39, P3472, DOI 10.1128/JCM.39.10.3472-3480.2001; Hikosaka K, 2005, PARASITOL RES, V97, P373, DOI 10.1007/s00436-005-1459-7; Hurkova L, 2003, J WILDLIFE DIS, V39, P441; ISEKI M, 1989, PARASITOL RES, V75, P218, DOI 10.1007/BF00931279; Jalovecka M, 2010, PARASITOL RES, V106, P1159, DOI 10.1007/s00436-010-1785-2; Jenkins MB, 2010, APPL ENVIRON MICROB, V76, P5757, DOI 10.1128/AEM.00434-10; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P4446, DOI 10.1128/AEM.71.8.4446-4454.2005; Karim MR, 2014, INT J PARASITOL, V44, P1039, DOI 10.1016/j.ijpara.2014.07.006; Katsumata T, 2000, AM J TROP MED HYG, V62, P70, DOI 10.4269/ajtmh.2000.62.70; KILANI RT, 1987, AM J TROP MED HYG, V36, P505, DOI 10.4269/ajtmh.1987.36.505; Kodadkova A, 2010, J PARASITOL, V96, P211, DOI 10.1645/GE-2212.1; Koudela B, 1998, VET PARASITOL, V76, P181, DOI 10.1016/S0304-4017(97)00217-3; Koyama Y, 2005, VET PARASITOL, V130, P323, DOI 10.1016/j.vetpar.2005.03.014; Kvac M, 2011, PARASITE IMMUNOL, V33, P210, DOI 10.1111/j.1365-3024.2010.01271.x; Kvac M, 2003, J VET MED B, V50, P451, DOI 10.1046/j.0931-1793.2003.00701.x; Kvac M, 2008, VET PARASITOL, V153, P363, DOI 10.1016/j.vetpar.2008.01.033; Kvac M, 2007, VET PARASITOL, V143, P229, DOI 10.1016/j.vetpar.2006.08.031; Kvac M, 2014, VET PARASITOL, V201, P9, DOI 10.1016/j.vetpar.2014.01.014; Kvac M, 2013, INT J PARASITOL, V43, P805, DOI 10.1016/j.ijpara.2013.04.007; Kvac M, 2013, EXP PARASITOL, V134, P438, DOI 10.1016/j.exppara.2013.04.007; Kvac M, 2012, EXP PARASITOL, V131, P107, DOI 10.1016/j.exppara.2012.03.016; Kvac M, 2009, VET PARASITOL, V163, P33, DOI 10.1016/j.vetpar.2009.03.047; Kvac M, 2009, VET PARASITOL, V160, P319, DOI 10.1016/j.vetpar.2008.11.007; Laatamna A, 2015, VET PARASITOL, V208, P135, DOI 10.1016/j.vetpar.2015.01.007; Lindsay DS, 2000, J EUKARYOT MICROBIOL, V47, P91, DOI 10.1111/j.1550-7408.2000.tb00016.x; Lv CC, 2009, APPL ENVIRON MICROB, V75, P7692, DOI 10.1128/AEM.01386-09; Matsui T, 2001, J VET MED SCI, V63, P319, DOI 10.1292/jvms.63.319; MCDONALD V, 1992, INFECT IMMUN, V60, P3325, DOI 10.1128/IAI.60.8.3325-3331.1992; Melicherova J, 2014, PARASITOLOGY, V141, P287, DOI 10.1017/S0031182013001637; MILACEK P, 1985, FOLIA PARASIT, V32, P50; Modry D, 2012, PARASITOL RES, V111, P471, DOI 10.1007/s00436-012-2821-1; Morgan UM, 1999, J PARASITOL, V85, P525, DOI 10.2307/3285789; Morgan UM, 1998, PARASITOLOGY, V117, P31, DOI 10.1017/S0031182098002765; Morgan-Ryan UM, 2002, J EUKARYOT MICROBIOL, V49, P433, DOI 10.1111/j.1550-7408.2002.tb00224.x; Murakoshi F, 2013, VET PARASITOL, V196, P184, DOI 10.1016/j.vetpar.2013.02.011; Nakai Y, 2004, J VET MED SCI, V66, P983, DOI 10.1292/jvms.66.983; Neumayerova H, 2008, VET PARASITOL, V153, P197, DOI 10.1016/j.vetpar.2008.02.009; Ng J, 2006, APPL ENVIRON MICROB, V72, P7548, DOI 10.1128/AEM.01352-06; Ng-Hublin JSY, 2013, INFECT GENET EVOL, V16, P5, DOI 10.1016/j.meegid.2013.01.011; ODONOGHUE PJ, 1995, INT J PARASITOL, V25, P139, DOI 10.1016/0020-7519(94)E0059-V; OZKUL IA, 1994, VET PARASITOL, V55, P129, DOI 10.1016/0304-4017(94)90062-0; PAVLASEK I, 1995, VET MED-CZECH, V40, P261; Pedraza-Diaz S, 2009, VET PARASITOL, V160, P204, DOI 10.1016/j.vetpar.2008.11.003; POSPISCHIL A, 1987, VET REC, V121, P379, DOI 10.1136/vr.121.16.379; Qi M, 2014, VET PARASITOL, V205, P518, DOI 10.1016/j.vetpar.2014.06.035; Qin SY, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-230; Ren XP, 2012, EXP PARASITOL, V130, P274, DOI 10.1016/j.exppara.2011.07.012; Rhee Jae Ku, 1999, Korean Journal of Parasitology, V37, P33, DOI 10.3347/kjp.1999.37.1.33; Rhee Jae Ku, 1995, Korean Journal of Parasitology, V33, P377, DOI 10.3347/kjp.1995.33.4.377; Rhee Jae Ku, 1998, Korean Journal of Parasitology, V36, P171, DOI 10.3347/kjp.1998.36.3.171; Robinson G, 2010, INT J PARASITOL, V40, P1539, DOI 10.1016/j.ijpara.2010.05.010; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003; Ryan UM, 2005, APPL ENVIRON MICROB, V71, P4992, DOI 10.1128/AEM.71.9.4992-4997.2005; Sak B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071840; Satoh M, 2003, APPL ENVIRON MICROB, V69, P691, DOI 10.1128/AEM.69.1.691-692.2003; SAUCH JF, 1991, APPL ENVIRON MICROB, V57, P3243, DOI 10.1128/AEM.57.11.3243-3247.1991; Siefker C, 2002, J PARASITOL, V88, P213, DOI 10.1645/0022-3395(2002)088[0213:MCOCSI]2.0.CO;2; Sreter T, 2000, J PARASITOL, V86, P1244, DOI 10.1645/0022-3395(2000)086[1244:MHSAGC]2.0.CO;2; Sulaiman IM, 2002, J PARASITOL, V88, P388, DOI 10.1645/0022-3395(2002)088[0388:MPAERO]2.0.CO;2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MA, 1999, VET PARASITOL, V86, P41, DOI 10.1016/S0304-4017(99)00114-4; TILLEY M, 1991, CAN J MICROBIOL, V37, P949, DOI 10.1139/m91-163; Traversa D, 2008, MOL CELL PROBE, V22, P122, DOI 10.1016/j.mcp.2007.11.001; Trout JM, 2006, J ZOO WILDLIFE MED, V37, P141, DOI 10.1638/05-06TYM-123005.1; Tyzzer E., 1907, P SOC EXP BIOL MED, V5, P12; Tyzzer E. E., 1912, Archiv fuer Protistenkunde Jena, V26; Tyzzer EE, 1910, J MED RES, V23, P487; UPTON SJ, 1989, J WILDLIFE DIS, V25, P20, DOI 10.7589/0090-3558-25.1.20; Valigurova A, 2007, J EUKARYOT MICROBIOL, V54, P495, DOI 10.1111/j.1550-7408.2007.00291.x; Vitovec J, 2006, J VET MED B, V53, P239, DOI 10.1111/j.1439-0450.2006.00950.x; Wagnerova P, 2015, PARASITOL RES, V114, P1619, DOI 10.1007/s00436-015-4353-y; Warren KS, 2003, AUST VET J, V81, P739, DOI 10.1111/j.1751-0813.2003.tb14602.x; Xiao LH, 2006, APPL ENVIRON MICROB, V72, P4461, DOI 10.1128/AEM.00370-06; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2004, APPL ENVIRON MICROB, V70, P891, DOI 10.1128/AEM.70.2.891-899.2004; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578	96	50	52	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147090	10.1371/journal.pone.0147090	http://dx.doi.org/10.1371/journal.pone.0147090			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771460	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300062
J	Vafaei, A; Ahmed, T; Freire, ADF; Zunzunegui, MV; Guerra, RO				Vafaei, Afshin; Ahmed, Tamer; Falcao Freire, Aline do N.; Zunzunegui, Maria Victoria; Guerra, Ricardo O.			Depression, Sex and Gender Roles in Older Adult Populations: The International Mobility in Aging Study (IMIAS)	PLOS ONE			English	Article							SELF-RATED HEALTH; CES-D; MASCULINITY; FEMININITY; SYMPTOMS; EPIDEMIOLOGY; SATISFACTION; PREVALENCE; INEQUALITY; DISORDERS	Objectives To assess the associations between gender roles and depression in older men and women and whether gender roles are independent risk factors for depression. Methods International cross-sectional study of adults between 65 and 74 years old (n = 1,967). Depression was defined by a score of 16 or over in the Center for Epidemiologic Studies Depression Scale (CES-D). A validated 12-item Bem Sex Role Inventory (BSRI) was used to classify participants in gender roles (Masculine, Feminine, Androgynous, and Undifferentiated) using research site medians of femininity and masculinity as cut-off points. Poisson regressions were fitted to estimate the prevalence ratios (PR) of depression for each gender role compared to the masculine role, adjusting for sex, sufficiency of income, education, marital status, self-rated health, and chronic conditions. Results Among men, 31.2% were androgynous, 26% were masculine, 14.4% were feminine, and 28.4% were undifferentiated; among women, the corresponding percentages were 32.7%, 14.9%, 27%, and 25.4%. Both in men and in women, depressive symptoms (CES-D >= 16) were more prevalent in those endorsing the undifferentiated type, compared to masculine, feminine or androgynous groups. However, after adjusting for potential confounders, compared to the masculine group only those endorsing the androgynous role were 28% less likely to suffer from depression: PR of 0.72 (95% CI: 0.55-0.93). In fully adjusted models, prevalence rates of depression were not different from masculine participants in the two other gender groups of feminine and undifferentiated. Conclusions Androgynous roles were associated with lower rates of depression in older adults, independently of being a man or a woman.	[Vafaei, Afshin] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Ahmed, Tamer; Zunzunegui, Maria Victoria] Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada; [Falcao Freire, Aline do N.; Guerra, Ricardo O.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil	Queens University - Canada; Universite de Montreal; Universidade Federal do Rio Grande do Norte	Vafaei, A (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.	5av14@queensu.ca	GUERRA, Ricardo/J-7586-2015	GUERRA, Ricardo/0000-0003-3824-3713; Ahmed, Tamer/0000-0002-5708-0270; Zunzunegui, Maria-Victoria/0000-0003-0827-2804	International Mobility in Aging Study (IMIAS) project: Canadian Institutes of Health Research (CIHR), Institute of Aging, New Emerging Team [AAM 108751]	International Mobility in Aging Study (IMIAS) project: Canadian Institutes of Health Research (CIHR), Institute of Aging, New Emerging Team(Canadian Institutes of Health Research (CIHR))	Data collection for this study was funded by the International Mobility in Aging Study (IMIAS) project: Canadian Institutes of Health Research (CIHR), Institute of Aging, New Emerging Team; gender differences in immobility; reference number AAM 108751. No other funds were received for analysis and preparing the manuscript.	Ahmed T, 2015, CANADIAN J IN PRESS; Almeida N, 2004, SOC SCI MED, V59, P1339, DOI 10.1016/j.socscimed.2003.11.037; Alvarado BE, 2007, J GERONTOL B-PSYCHOL, V62, pS226; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bassoff ES, 1982, COUNS PSYCHOL, V10, P7; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; BEM SL, 1977, J CONSULT CLIN PSYCH, V45, P196, DOI 10.1037//0022-006X.45.2.196; Blakely TA, 2002, SOC SCI MED, V54, P65, DOI 10.1016/S0277-9536(01)00007-7; Brown D, 1997, SEX ROLE IDENTITY DE; Carver LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076356; Connell R. W., 1995, MASCULINITIES; Connell R, 2011, S AFR REV SOCIOL, V42, P103, DOI 10.1080/21528586.2011.621242; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Costa E, 2007, AM J GERIAT PSYCHIAT, V15, P17, DOI 10.1097/01.JGP.0000230659.72417.a0; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Sousa ACPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102299; DOWNEY AM, 1984, PSYCHOL REP, V54, P811, DOI 10.2466/pr0.1984.54.3.811; FAVA GA, 1983, J CLIN PSYCHOL, V39, P249, DOI 10.1002/1097-4679(198303)39:2<249::AID-JCLP2270390218>3.0.CO;2-Y; Gale-Ross R, 2009, CAN J AGING, V28, P135, DOI 10.1017/S0714980809090187; Hunt K, 2007, INT J EPIDEMIOL, V36, P612, DOI 10.1093/ije/dym022; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; KRAMES L, 1988, SEX ROLES, V19, P713, DOI 10.1007/BF00288987; Lee C., 2002, PSYCHOL MENS HLTH; Lefkowitz ES, 2006, J PERS ASSESS, V87, P95, DOI 10.1207/s15327752jpa8701_08; Lehmann V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-109; Li CE, 2006, ADOLESCENCE, V41, P409; Maciel ACC, 2008, REV ASSOC MED BRAS, V54, P6; Mansdotter A, 2009, J EPIDEMIOL COMMUN H, V63, P408, DOI 10.1136/jech.2008.082628; McDonough P, 2001, SOC SCI MED, V52, P547, DOI 10.1016/S0277-9536(00)00159-3; Morin AJS, 2011, REV EPIDEMIOL SANTE, V59, P327, DOI 10.1016/j.respe.2011.03.061; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Oquendo MA, 2004, ACTA PSYCHIAT SCAND, V110, P446, DOI 10.1111/j.1600-0447.2004.00404.x; Patten SB, 2015, CAN J PSYCHIAT, V60, P23, DOI 10.1177/070674371506000106; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ried LD, 2002, J WOMEN HEALTH GEN-B, V11, P813, DOI 10.1089/15409990260430963; Rosenfiled S, 2012, HDB SOCIOLOGY MENTAL, P277; Ruiz-Grosso P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045413; Sachs-Ericsson N, 2000, SEX ROLES, V43, P605, DOI 10.1023/A:1007148407005; Sanchez-Santos M, 2011, EUR J AGEING, V8, P9; Shifren K, 1996, SEX ROLES, V34, P841, DOI 10.1007/BF01544319; Silva MT, 2014, REV BRAS PSIQUIATR, V36, P262, DOI 10.1590/1516-4446-2013-1294; Sinnott JD, 2011, HDB PSYCHOL AGING, P454; Subramanian SV, 2001, SOC SCI MED, V53, P9, DOI 10.1016/S0277-9536(00)00309-9; Sweeting H, 2014, SOC PSYCH PSYCH EPID, V49, P791, DOI 10.1007/s00127-013-0730-y; Szklo M, 2014, EPIDEMIOLOGY BASICS; Batistoni SST, 2007, REV SAUDE PUBL, V41, P598, DOI 10.1590/S0034-89102007000400014; Thomas JL, 2001, INT J PSYCHIAT MED, V31, P25, DOI 10.2190/FUFR-PK9F-6U10-JXRK; Twenge JM, 1997, SEX ROLES, V36, P305, DOI 10.1007/BF02766650; UNDP, 2014, HUM DEV REP; Vafaei A, 2014, ARCH GERONTOL GERIAT; Williams J.E., 1990, MEASURING SEX STEREO, VVol. 6; World Health Organization, 2008, The global burden of disease: 2004 update; Wrightsman L.S., 1991, MEASURES PERSONALITY, P573, DOI DOI 10.1016/B978-0-12-590241-0.50015-0	54	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146867	10.1371/journal.pone.0146867	http://dx.doi.org/10.1371/journal.pone.0146867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6ME	26771828	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300037
J	Cheung, S; Ma, L; Chan, PHW; Hu, HL; Mayor, T; Chen, HT; Measday, V				Cheung, Stephanie; Ma, Lina; Chan, Patrick H. W.; Hu, Hui-Lan; Mayor, Thibault; Chen, Hung-Ta; Measday, Vivien			Ty1 Integrase Interacts with RNA Polymerase III-specific Subcomplexes to Promote Insertion of Ty1 Elements Upstream of Polymerase (Pol) III-transcribed Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrase; retrovirus; RNA polymerase III; Saccharomyces cerevisiae; transposable element (TE); Ty1 element; retrotransposon; tRNA gene	NUCLEAR-LOCALIZATION SIGNAL; SACCHAROMYCES-CEREVISIAE; RETROTRANSPOSON TY1; STRUCTURAL BIOLOGY; TARGET PREFERENCE; SILENT CHROMATIN; NUCLEOSOMAL DNA; SUBUNITS; REVEALS; TRANSPOSITION	Retrotransposons are eukaryotic mobile genetic elements that transpose by reverse transcription of an RNA intermediate and are derived from retroviruses. The Ty1 retrotransposon of Saccharomyces cerevisiae belongs to the Ty1/Copia superfamily, which is present in every eukaryotic genome. Insertion of Ty1 elements into the S. cerevisiae genome, which occurs upstream of genes transcribed by RNA Pol III, requires the Ty1 element-encoded integrase (IN) protein. Here, we report that Ty1-IN interacts in vivo and in vitro with RNA Pol III-specific subunits to mediate insertion of Ty1 elements upstream of Pol III-transcribed genes. Purification of Ty1-IN from yeast cells followed by mass spectrometry (MS) analysis identified an enrichment of peptides corresponding to the Rpc82/34/31 and Rpc53/37 Pol III-specific subcomplexes. GFP-Trap purification of multiple GFP-tagged RNA Pol III subunits from yeast extracts revealed that the majority of Pol III subunits co-purify with Ty1-IN but not two other complexes required for Pol III transcription, transcription initiation factors (TF) IIIB and IIIC. In vitro binding studies with bacterially purified RNA Pol III proteins demonstrate that Rpc31, Rpc34, and Rpc53 interact directly with Ty1-IN. Deletion of the N-terminal 280 amino acids of Rpc53 abrogates insertion of Ty1 elements upstream of the hot spot SUF16 tRNA locus and abolishes the interaction of Ty1-IN with Rpc37. The Rpc53/37 complex therefore has an important role in targeting Ty1-IN to insert Ty1 elements upstream of Pol III-transcribed genes.	[Cheung, Stephanie; Mayor, Thibault; Measday, Vivien] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Cheung, Stephanie; Ma, Lina; Measday, Vivien] Univ British Columbia, Wine Res Ctr, Rm 325,2205 East Mall, Vancouver, BC V6T 1Z4, Canada; [Chan, Patrick H. W.; Mayor, Thibault] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Hu, Hui-Lan; Chen, Hung-Ta] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	University of British Columbia; University of British Columbia; University of British Columbia; Academia Sinica - Taiwan	Measday, V (corresponding author), Univ British Columbia, Wine Res Ctr, Rm 325,2205 East Mall, Vancouver, BC V6T 1Z4, Canada.	vmeasday@mail.ubc.ca	Chen, Hung-Ta/ABC-8094-2021	Chen, Hung-Ta/0000-0003-1192-0382	Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (DG) [RGPIN 355729-11]; CIHR [HOP-131559]; NSERC DG [RPGIN 326924-11]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (DG)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); NSERC DG(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by the Canadian Institutes of Health Research (CIHR) and Michael Smith Foundation for Health Research new investigator awards and Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (DG) Grant RGPIN 355729-11.; Supported by CIHR Grant HOP-131559 and NSERC DG Grant RPGIN 326924-11.	Acker J, 2013, BBA-GENE REGUL MECH, V1829, P283, DOI 10.1016/j.bbagrm.2012.10.002; Andrau JC, 1999, J MOL BIOL, V288, P511, DOI 10.1006/jmbi.1999.2724; Aye M, 2001, MOL CELL BIOL, V21, P7839, DOI 10.1128/MCB.21.22.7839-7851.2001; Bachman N, 2005, GENE DEV, V19, P955, DOI 10.1101/gad.1299105; Bachman N, 2004, GENOME RES, V14, P1232, DOI 10.1101/gr.2052904; Baller JA, 2012, GENOME RES, V22, P704, DOI 10.1101/gr.129585.111; Barnes CO, 2015, MOL CELL, V59, P258, DOI 10.1016/j.molcel.2015.06.034; BARTHOLOMEW B, 1993, MOL CELL BIOL, V13, P942, DOI 10.1128/MCB.13.2.942; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Brachmann CB, 1998, YEAST, V14, P115; Bridier-Nahmias A, 2015, SCIENCE, V348, P585, DOI 10.1126/science.1259114; Bridier-Nahmias A, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-22; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Carter R, 2010, MOL BIOL EVOL, V27, P1035, DOI 10.1093/molbev/msp316; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Connolly CM, 1997, FEBS LETT, V405, P305, DOI 10.1016/S0014-5793(97)00200-7; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Craigie R, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0026-2014; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Curcio MJ, 2007, MOL CELL BIOL, V27, P8874, DOI 10.1128/MCB.01095-07; Curcio MJ, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0053-2014; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; Dakshinamurthy A, 2010, GENETICS, V185, P1193, DOI 10.1534/genetics.110.119115; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; EICHINGER DJ, 1988, CELL, V54, P955, DOI 10.1016/0092-8674(88)90110-9; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Flores A, 1999, P NATL ACAD SCI USA, V96, P7815, DOI 10.1073/pnas.96.14.7815; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Griffith JL, 2003, GENETICS, V164, P867; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Ho KL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005109; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; HUET J, 1985, J BIOL CHEM, V260, P5304; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; JI H, 1993, CELL, V73, P1007, DOI 10.1016/0092-8674(93)90278-X; Kassavetis GA, 2010, J BIOL CHEM, V285, P2695, DOI 10.1074/jbc.M109.074013; Kenna MA, 1998, MOL CELL BIOL, V18, P1115, DOI 10.1128/MCB.18.2.1115; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; LALO D, 1993, P NATL ACAD SCI USA, V90, P5524, DOI 10.1073/pnas.90.12.5524; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Lane LA, 2011, STRUCTURE, V19, P90, DOI 10.1016/j.str.2010.11.009; Lannutti BJ, 1996, BIOCHEMISTRY-US, V35, P9821, DOI 10.1021/bi960525x; Lesage P, 2005, CYTOGENET GENOME RES, V110, P70, DOI 10.1159/000084940; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenzen K, 2007, STRUCTURE, V15, P1237, DOI 10.1016/j.str.2007.07.016; Moore SP, 1998, MOL CELL BIOL, V18, P1105, DOI 10.1128/MCB.18.2.1105; Mularoni L, 2012, GENOME RES, V22, P693, DOI 10.1101/gr.129460.111; Nyswaner KM, 2008, GENETICS, V178, P197, DOI 10.1534/genetics.107.082602; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Persinger J, 1996, J BIOL CHEM, V271, P33039, DOI 10.1074/jbc.271.51.33039; Qi XJ, 2012, J BIOL CHEM, V287, P18589, DOI 10.1074/jbc.M111.326025; Qi XJ, 2012, GENOME RES, V22, P681, DOI 10.1101/gr.131219.111; Rinckel LA, 1996, GENETICS, V142, P761; Risler JK, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-12; Sandmeyer S, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0057-2014; Scholes DT, 2001, GENETICS, V159, P1449; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sundararajan A, 2003, GENETICS, V163, P55; Tate JJ, 1998, NUCLEIC ACIDS RES, V26, P1421, DOI 10.1093/nar/26.6.1421; THUILLIER V, 1995, EMBO J, V14, P351, DOI 10.1002/j.1460-2075.1995.tb07009.x; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; WERNER M, 1993, J BIOL CHEM, V268, P20721; Wu CC, 2012, P NATL ACAD SCI USA, V109, P19232, DOI 10.1073/pnas.1211665109; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Yieh L, 2000, J BIOL CHEM, V275, P29800, DOI 10.1074/jbc.M003149200; Yieh L, 2002, J BIOL CHEM, V277, P25920, DOI 10.1074/jbc.M202729200; Zou S, 1997, P NATL ACAD SCI USA, V94, P7412, DOI 10.1073/pnas.94.14.7412	77	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6396	6411		10.1074/jbc.M115.686840	http://dx.doi.org/10.1074/jbc.M115.686840			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797132	hybrid, Green Published			2022-12-26	WOS:000372894200028
J	Lu, JS; Isaji, T; Im, S; Fukuda, T; Kameyama, A; Gu, JG				Lu, Jishun; Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Kameyama, Akihiko; Gu, Jianguo			Expression of N-Acetylglucosaminyltransferase III Suppresses 2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to 2,6-Sialylation Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; glycosyltransferase; integrin; N-linked glycosylation; sialyltransferase; bisecting GlcNAc	CMP-SIALIC ACID; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; BISECTING GLCNAC; BREAST-CANCER; LINKED OLIGOSACCHARIDES; SPONTANEOUS METASTASIS; BRANCH SPECIFICITY; MEMBRANE-PROTEINS; GENE-EXPRESSION; GLYCANS	N-Acetylglucosaminyltransferase III (GnT-III), which catalyzes the addition of the bisecting GlcNAc branch on N-glycans, is usually described as a metastasis suppressor. Overexpression of GnT-III inhibited migration in multiple types of tumor cells. However, these results seem controversial to the clinical observations for the increased expression of GnT-III in human hepatomas, glioma, and ovarian cancers. Here, we present evidence that these inconsistencies are mainly attributed to the different expression pattern of cell sialylation. In detail, we show that overexpression of GnT-III significantly inhibits 2,3-sialylation but not 2,6-sialylation. The migratory ability of cells without or with a low level of 2,6-sialylation is consistently suppressed after GnT-III overexpression. In contrast, the effects of GnT-III overexpression are variable in tumor cells that are highly 2,6-sialylated. Overexpression of GnT-III promotes the cell migration in glioma cells U-251 and hepatoma cells HepG2, although it has little influence in human breast cancer cell MDA-MB-231 and gastric cancer cell MKN-45. Interestingly, up-regulation of 2,6-sialylation by overexpressing -galactoside 2,6-sialyltranferase 1 in the 2,6-hyposialylated HeLa-S3 cells abolishes the anti-migratory effects of GnT-III. Conversely, depletion of 2,6-sialylation by knock-out of -galactoside 2,6-sialyltranferase 1 in 2,6-hypersialylated HepG2 cells endows GnT-III with the anti-migratory ability. Taken together, our data clearly demonstrate that high expression of 2,6-sialylation on the cell surface could affect the anti-migratory role of GnT-III, which provides an insight into the mechanistic roles of GnT-III in tumor metastasis.	[Lu, Jishun; Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Kameyama, Akihiko] Natl Inst Adv Ind Sci & Technol, Dept Life Sci & Biotechnol, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan	Tohoku Medical & Pharmaceutical University; National Institute of Advanced Industrial Science & Technology (AIST)	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Isaji, Tomoya/ABC-9285-2021; Kameyama, Akihiko/A-9641-2008; Gu, Jianguo/ABC-9257-2020	Kameyama, Akihiko/0000-0002-8229-4449; 	Japan Society for the Promotion of Science [15H04354, 15K14408]; Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [15K14408] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research 15H04354 ( to J. G.), by Challenging Exploratory Research Grant 15K14408 ( to J. G.) from the Japan Society for the Promotion of Science, and by a Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abelev G I, 1971, Adv Cancer Res, V14, P295, DOI 10.1016/S0065-230X(08)60523-0; Anugraham M, 2014, MOL CELL PROTEOMICS, V13, P2213, DOI 10.1074/mcp.M113.037085; Blidner AG, 2015, FEBS LETT, V589, P3407, DOI 10.1016/j.febslet.2015.08.037; BROCKHAUSEN I, 1988, BIOCHIMIE, V70, P1521, DOI 10.1016/0300-9084(88)90289-1; Bull C, 2014, BBA-REV CANCER, V1846, P238, DOI 10.1016/j.bbcan.2014.07.005; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049; Chen QM, 2008, CLIN EXP METASTAS, V25, P139, DOI 10.1007/s10585-007-9132-4; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461; Glavey SV, 2015, BLOOD REV, V29, P269, DOI 10.1016/j.blre.2015.01.003; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Guo HB, 2008, FEBS LETT, V582, P527, DOI 10.1016/j.febslet.2008.01.015; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Isaji T, 2010, METHOD ENZYMOL, V480, P445, DOI 10.1016/S0076-6879(10)80019-9; JOZIASSE DH, 1985, J BIOL CHEM, V260, P714; JOZIASSE DH, 1985, J BIOL CHEM, V260, P4941; JOZIASSE DH, 1987, J BIOL CHEM, V262, P2025; Koyota S, 2001, J BIOL CHEM, V276, P32867, DOI 10.1074/jbc.M102371200; Krzewinski-Recchi MA, 2003, EUR J BIOCHEM, V270, P950, DOI 10.1046/j.1432-1033.2003.03458.x; KURAYA N, 1992, J BIOCHEM, V112, P122, DOI 10.1093/oxfordjournals.jbchem.a123850; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lopez-Morales D, 2009, INVEST CLIN, V50, P45; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Mereiter S, 2016, BBA-GEN SUBJECTS, V1860, P1795, DOI 10.1016/j.bbagen.2015.12.016; Milflores-Flores L, 2012, J BIOSCIENCES, V37, P259, DOI 10.1007/s12038-012-9194-6; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PAULSON JC, 1978, J BIOL CHEM, V253, P5617; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ranjan A, 2013, J BIOSCIENCES, V38, P867, DOI 10.1007/s12038-013-9382-z; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Sethi MK, 2014, J PROTEOME RES, V13, P277, DOI 10.1021/pr400861m; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Song YH, 2010, CANCER RES, V70, P3361, DOI 10.1158/0008-5472.CAN-09-2719; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; Thomas GJ, 2001, J INVEST DERMATOL, V117, P67, DOI 10.1046/j.0022-202x.2001.01379.x; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang PH, 2002, GYNECOL ONCOL, V86, P45, DOI 10.1006/gyno.2002.6714; WANG X, 1990, Glycobiology, V1, P25, DOI 10.1093/glycob/1.1.25; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; Zhao YF, 2014, MOL CELL PROTEOMICS, V13, P520, DOI 10.1074/mcp.M113.034025; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	64	34	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5708	5720		10.1074/jbc.M115.712836	http://dx.doi.org/10.1074/jbc.M115.712836			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26801611	Green Published, hybrid			2022-12-26	WOS:000372551800021
J	Bui, DC; Son, H; Shin, JY; Kim, JC; Kim, H; Choi, GJ; Lee, YW				Bui, Duc-Cuong; Son, Hokyoung; Shin, Ji Young; Kim, Jin-Cheol; Kim, Hun; Choi, Gyung Ja; Lee, Yin-Won			The FgNot3 Subunit of the Ccr4-Not Complex Regulates Vegetative Growth, Sporulation, and Virulence in Fusarium graminearum	PLOS ONE			English	Article							GIBBERELLA-ZEAE; GENE-EXPRESSION; FUNCTIONAL ANALYSES; EUKARYOTIC CELLS; IN-VIVO; YEAST; PROTEIN; MODULE; WHEAT; NOT5	The Ccr4-Not complex is evolutionarily conserved and important for multiple cellular functions in eukaryotic cells. In this study, the biological roles of the FgNot3 subunit of this complex were investigated in the plant pathogenic fungus Fusarium graminearum. Deletion of Fg NOT3 resulted in retarded vegetative growth, retarded spore germination, swollen hyphae, and hyper -branching. The Delta Fgnot3 mutants also showed impaired sexual and asexual sporulation, decreased virulence, and reduced expression of genes related to conidiogenesis. Fgnot3 deletion mutants were sensitive to thermal stress, whereas NOT3 orthologs in other model eukaryotes are known to be required for cell wall integrity. We found that FgNot3 functions as a negative regulator of the production of secondary metabolites, including trichothecenes and zearalenone. Further functional characterization of other components of the Not module of the Ccr4-Not complex demonstrated that the module is conserved. Each subunit primarily functions within the context of a complex and might have distinct roles outside of the complex in F. graminearum. This is the first study to functionally characterize the Not module in filamentous fungi and provides novel insights into signal transduction pathways in fungal development.	[Bui, Duc-Cuong; Son, Hokyoung; Shin, Ji Young; Lee, Yin-Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Bui, Duc-Cuong; Son, Hokyoung; Shin, Ji Young; Lee, Yin-Won] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Son, Hokyoung] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Kim, Jin-Cheol] Chonnam Natl Univ, Div Appl Biosci & Biotechnol, Inst Environm Friendly Agr, Coll Agr & Life Sci, Gwangju, South Korea; [Kim, Hun; Choi, Gyung Ja] Korea Res Inst Chem Technol, Ecofriendly New Mat Res Grp, Res Ctr Biobased Chem, Div Convergence Chem, Daejeon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Chonnam National University; Korea Research Institute of Chemical Technology (KRICT)	Lee, YW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Lee, YW (corresponding author), Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea.	lee2443@snu.ac.kr	Bui, Duc Cuong/J-9740-2019	Bui, Duc Cuong/0000-0001-5366-6103; Son, Hokyoung/0000-0001-5080-7951	National Research Foundation of Korea (NRF) - Korean government [2013R1A6A3A04059121]; Cooperative Research Program for Agricultural Science and Technology Development, Rural Development Administration, Republic of Korea [PJ01085602]	National Research Foundation of Korea (NRF) - Korean government; Cooperative Research Program for Agricultural Science and Technology Development, Rural Development Administration, Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (2013R1A6A3A04059121) and the Cooperative Research Program for Agricultural Science and Technology Development (Project PJ01085602), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Bai YL, 1999, MOL CELL BIOL, V19, P6642; Bhaskar V, 2013, NAT STRUCT MOL BIOL, V20, P1281, DOI 10.1038/nsmb.2686; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Boland A, 2013, NAT STRUCT MOL BIOL, V20, P1289, DOI 10.1038/nsmb.2681; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; CAPPELLINI R, 1965, MYCOLOGIA, P962; Chen JJ, 2001, J MOL BIOL, V314, P683, DOI 10.1006/jmbi.2001.5162; Cheng SJ, 2005, INFECT IMMUN, V73, P7190, DOI 10.1128/IAI.73.11.7190-7197.2005; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Collart MA, 2013, CELL SIGNAL, V25, P743, DOI 10.1016/j.cellsig.2012.12.018; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; DENIS CL, 1984, GENETICS, V108, P833; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Guenther JC, 2005, MYCOLOGIA, V97, P229, DOI 10.3852/mycologia.97.1.229; Han YK, 2007, MOL MICROBIOL, V63, P768, DOI 10.1111/j.1365-2958.2006.05557.x; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; Hong SY, 2010, FUNGAL GENET BIOL, V47, P364, DOI 10.1016/j.fgb.2010.01.005; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028291; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Jonkers W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002724; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Kim H, 2011, MICROBIOL-SGM, V157, P2658, DOI 10.1099/mic.0.052506-0; Leslie J. F., 2006, FUSARIUM LAB MANUAL, V10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P54, DOI 10.1094/MPMI-03-10-0075; Maillet L, 2000, J MOL BIOL, V303, P131, DOI 10.1006/jmbi.2000.4131; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Min K, 2012, MOL PLANT MICROBE IN, V25, P1617, DOI 10.1094/MPMI-06-12-0149-R; Morita M, 2011, EMBO J, V30, P4678, DOI 10.1038/emboj.2011.320; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Oberholzer U, 1998, GENE, V207, P61, DOI 10.1016/S0378-1119(97)00605-7; Ohara T, 2004, GENETICS, V166, P113, DOI 10.1534/genetics.166.1.113; Panepinto John C., 2013, Frontiers in Genetics, V4, P302, DOI 10.3389/fgene.2013.00302; Park AR, 2012, FUNGAL GENET BIOL, V49, P511, DOI 10.1016/j.fgb.2012.05.006; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Sambrook J., 2001, MOL CLONING LAB MANU; Seo JA, 1996, MYCOPATHOLOGIA, V134, P31, DOI 10.1007/BF00437050; Son H, 2014, EUKARYOT CELL, V13, P87, DOI 10.1128/EC.00220-13; Son H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072915; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Son H, 2011, FUNGAL GENET BIOL, V48, P408, DOI 10.1016/j.fgb.2011.01.002; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Venturini G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003040; Villanyi Z, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004569; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yu J, 2014, CURR GENET, V60, P35, DOI 10.1007/s00294-013-0409-7; Zheng WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045432	57	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147481	10.1371/journal.pone.0147481	http://dx.doi.org/10.1371/journal.pone.0147481			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799401	gold, Green Published, Green Submitted			2022-12-26	WOS:000368655300114
J	Damm, T; Spiegel, H; Barth, S; Fischer, R; Naehring, J				Damm, Tatjana; Spiegel, Holger; Barth, Stefan; Fischer, Rainer; Naehring, Joerg			Development of a Competitive Cystatin C-Specific Bioassay Suitable for Repetitive Measurements	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; GLOMERULAR-FILTRATION-RATE; ACUTE KIDNEY INJURY; SERUM CREATININE; PROTEIN; MARKER; CELLS; GFR; ANTIBODIES; ANTIGEN	Human cystatin C (hCC), a cysteine protease inhibitor, has been proposed as a diagnostic marker because its serum levels correlate with certain cardiovascular and kidney diseases. All current hCC assays are based on ex vivo detection. Here we describe the generation and evaluation of antibodies that allow the repetitive binding and release of hCC and hCC-fusion proteins, a prerequisite for long-term measurement, which is required for compatibility with implantable biochip devices and for the development of innovative antibody-based assays suitable for continuous in vivo and in vitro monitoring. Recombinant hCC and hCC-fusion proteins were produced in Escherichia coli and HEK293T cells and were used to generate antibodies by hybridoma technology. After screening by indirect and sandwich ELI-SAs, 12 monoclonal hybridoma cell lines producing hCC-specific monoclonal antibodies were identified. To determine their hCC association and dissociation properties, the antibodies were analysed by surface plasmon resonance spectroscopy, revealing three with the desired fast binding and moderate-to-fast release characteristics. The analysis of binding and dissociation in the presence of hCC and hCC-fusion proteins using fluorescence-based replacement assays showed that mAb CyDI-4 was the most suitable for further analysis. The results showed that repetitive replacement on mAb CyDI-4 was possible and that most of the change in signal intensity occurred after 20-30 min. Furthermore, the suitability of mAb CyDI-4 for serum hCC measurement was confirmed by a fluorescence-based replacement assay using serially-diluted reference serum from the Institute for Reference Materials and Measurements (ERM-DA471/IFCC). Our results suggest that the assay covers the physiological and pathological ranges of hCC.	[Damm, Tatjana; Spiegel, Holger; Fischer, Rainer; Naehring, Joerg] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany; [Barth, Stefan; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biol, Aachen, Germany; [Barth, Stefan] Rhein Westfal TH Aachen, Inst Appl Med Engn, Aachen, Germany; [Damm, Tatjana] Rhein Westfal TH Aachen, IBMG, Aachen, Germany; [Barth, Stefan] Univ Cape Town, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	Fraunhofer Gesellschaft; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; University of Cape Town	Naehring, J (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	joerg.naehring@ime.fraunhofer.de	Barth, Stefan/F-7301-2012	Barth, Stefan/0000-0001-9589-653X	German Bundesministerium fur Bildung und Forschung [16SV5461]	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	German Bundesministerium fur Bildung und Forschung funding (16SV5461).	Ataei N, 2014, PEDIATR NEPHROL, V29, P133, DOI 10.1007/s00467-013-2586-5; Bel-Ochi NC, 2013, CLIN VACCINE IMMUNOL, V20, P468, DOI 10.1128/CVI.00512-12; Bhasin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082028; BUTLER EA, 1961, J CLIN PATHOL, V14, P172, DOI 10.1136/jcp.14.2.172; Conti M, 2006, CLIN CHEM LAB MED, V44, P288, DOI 10.1515/CCLM.2006.050; Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-9; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Feller T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079920; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Finney H, 2000, ANN CLIN BIOCHEM, V37, P49, DOI 10.1258/0004563001901524; Gauthier Sebastien, 2011, Front Biosci (Schol Ed), V3, P541, DOI 10.2741/s170; Grubb AO, 2001, ADV CLIN CHEM, V35, P63, DOI 10.1016/S0065-2423(01)35015-1; Hamed HM, 2013, INDIAN J CRIT CARE M, V17, P92, DOI 10.4103/0972-5229.114829; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; IEDB, 2011, IMM EP DAT AN RES; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; JACOBSSON B, 1995, HISTOPATHOLOGY, V26, P559, DOI 10.1111/j.1365-2559.1995.tb00275.x; Kaur G, 2010, AM J PATHOL, V177, P2256, DOI 10.2353/ajpath.2010.100461; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KYHSEANDERSEN J, 1994, CLIN CHEM, V40, P1921; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson A, 2008, CHRONOBIOL INT, V25, P1047, DOI 10.1080/07420520802553614; Lei JH, 2011, AM J TROP MED HYG, V85, P1054, DOI 10.4269/ajtmh.2011.11-0051; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Li X, 2013, J GERIATR CARDIOL, V10, P286, DOI 10.3969/j.issn.1671-5411.2013.03.001; LOFBERG H, 1979, SCAND J CLIN LAB INV, V39, P619, DOI 10.3109/00365517909108866; Mack ET, 2011, J AM CHEM SOC, V133, P11701, DOI 10.1021/ja2038084; Muntner P, 2009, KIDNEY INT, V76, P81, DOI 10.1038/ki.2009.76; Peuscher A, 2013, J IMMUNOASS IMMUNOCH, V35, P322; Polzikov MA, 2012, HYBRIDOMA, V31, P48, DOI 10.1089/hyb.2011.0078; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; Rule AD, 2013, KIDNEY INT, V83, P1169, DOI 10.1038/ki.2013.7; Sahakyan K, 2011, DIABETOLOGIA, V54, P1335, DOI 10.1007/s00125-011-2096-6; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; SIMONSEN O, 1985, SCAND J CLIN LAB INV, V45, P97, DOI 10.3109/00365518509160980; Stocker M, 2003, PROTEIN EXPRES PURIF, V28, P211, DOI 10.1016/S1046-5928(02)00709-X; Thakkar H, 1998, KIDNEY INT, V54, P1197, DOI 10.1046/j.1523-1755.1998.00098.x; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V216, P440, DOI 10.1016/j.atherosclerosis.2011.02.016; Waters WR, 2011, CLIN VACCINE IMMUNOL, V18, P1882, DOI 10.1128/CVI.05343-11; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086066; Xiong FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088777; Yu KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050438	46	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147177	10.1371/journal.pone.0147177	http://dx.doi.org/10.1371/journal.pone.0147177			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799562	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300068
J	Hawkes, AP; Weinberg, SL; Janusz, R; Demont-Heinrich, C; Vogt, RL				Hawkes, Allison P.; Weinberg, Stacy L.; Janusz, Ruth; Demont-Heinrich, Christine; Vogt, Richard L.			An Innovative Method of Measuring Changes in Access to Healthful Foods in School Lunch Programs: Findings from a Pilot Evaluation	PLOS ONE			English	Article								Introduction A large local health department in Colorado partnered with 15 school districts to develop an approach to evaluate changes in access to healthy foods in reimbursable school lunches and a la carte offerings. Materials and Methods School district nutrition managers were engaged at the start of this project. Health department dietitians developed criteria to classify food items as "Lower Fat and less added Sugar" (LFS) and "Higher Fat and more added Sugar" (HFS) based on the percentage of calories from fat and grams of added sugar. Lunch production sheets were obtained for two time periods, food items and the number of planned servings recorded. LFS and HFS planned servings were summed for each time period, and a LFS to HFS ratio calculated by dividing LFS planned servings by HFS planned servings. Additional analyses included calculating LFS: HFS ratios by school district, and for a la carte offerings. Results In 2009, the LFS: HFS ratio was 2.08, in 2011, 3.71 (P<0.0001). The method also detected changes in ratios at the school district level. For a la carte items, in 2009 the ratio of LFS: HFS was 0.53, and in 2011, 0.61 (not statistically significant). Conclusions This method detected an increase in the LFS: HFS ratio over time and demonstrated that the school districts improved access to healthful food/drink by changing the contents of reimbursable school lunches. The evaluation method discussed here can generate information that districts can use in helping sustain and expand their efforts to create healthier environments for children and adults. Although federal regulations now cover all food and beverages served during the school day, there are still opportunities to improve and measure changes in food served in other settings such as child care centers, youth correction facilities, or in schools not participating in the National School Lunch Program.	[Hawkes, Allison P.; Weinberg, Stacy L.; Janusz, Ruth; Demont-Heinrich, Christine; Vogt, Richard L.] Tricty Hlth Dept, Greenwood Village, CO USA; [Janusz, Ruth] Colorado Dept Publ Hlth & Environm, Hlth Facil & Emergency Med Serv Div, Denver, CO USA	Colorado Department of Public Health & Environment	Hawkes, AP (corresponding author), Tricty Hlth Dept, Greenwood Village, CO USA.	allisonphawkes@gmail.com			Centers for Disease Control and Prevention's Communities Putting Prevention to Work (CPPW) program [93.724]; CPPW grant; General Fund of the health department	Centers for Disease Control and Prevention's Communities Putting Prevention to Work (CPPW) program; CPPW grant; General Fund of the health department	Supported in part by a cooperative agreement from the Centers for Disease Control and Prevention's Communities Putting Prevention to Work (CPPW) program 93.724. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the US Department of Health and Human Services or the Centers for Disease Control and Prevention. APH, SW, RJ, CDH, and RLV received funding from the CPPW grant and from the General Fund of the health department for this evaluation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NUTR BAS MAN PLANN A; [Anonymous], 2012, FED REG; [Anonymous], 2002, AD CATCH COORD APPR; [Anonymous], 2013, FED REG, V78, P78; [Anonymous], 2012, PROD REC IS OLD VERS; [Anonymous], 2015, CAT FED DOM ASS; Bartholomew JB, 2006, J AM DIET ASSOC, V106, P248, DOI 10.1016/j.jada.2005.10.030; Center for Research Strategies, 2007, WELLNESS POLICY IMPL; Comparison of previous and current regulatory requirements under Final Rule, COMP PREV CURR REG R; Condon EM, 2009, J AM DIET ASSOC, V109, pS67, DOI 10.1016/j.jada.2008.10.062; Cullen KW, 2009, AM J PUBLIC HEALTH, V99, P706, DOI 10.2105/AJPH.2007.129387; [Food and Nutrition Service U. S. Department of Agriculture], 2010, HLTH US SCH CHALL AP, P65; National Research Council, 2007, NUTR STAND FOODS SCH, P117; National Research Council, 2010, SCH MEALS BUILD BLOC, P115; Nutrition standards in the National School Lunch and School Breakfast programs, 2011, FED REGISTER, V76, P2494; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; US Department of Agriculture (USDA) Food and Nutrition Service Office of Research and Analysis, 2012, SCH NUTR DIET ASS ST, VI	18	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146875	10.1371/journal.pone.0146875	http://dx.doi.org/10.1371/journal.pone.0146875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800523	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300046
J	Syed, MA; Choo-Wing, R; Homer, RJ; Bhandari, V				Syed, Mansoor A.; Choo-Wing, Rayman; Homer, Robert J.; Bhandari, Vineet			Role of Nitric Oxide Isoforms in Vascular and Alveolar Development and Lung Injury in Vascular Endothelial Growth Factor Overexpressing Neonatal Mice Lungs	PLOS ONE			English	Article							VEGF RECEPTOR INHIBITOR; COLLAGEN-IV CONTRIBUTES; BRONCHOPULMONARY DYSPLASIA; PULMONARY-HYPERTENSION; INDUCED ANGIOGENESIS; PREVENTS ALVEOLAR; ANIMAL-MODELS; MOUSE MODEL; HYPEROXIA; RATS	Background The role of vascular endothelial growth factor (VEGF)-induced 3 different nitric oxide synthase (NOS) isoforms in lung development and injury in the newborn (NB) lung are not known. We hypothesized that VEGF-induced specific NOS pathways are critical regulators of lung development and injury. Methodology We studied NB wild type (WT), lung epithelial cell-targeted VEGF165 doxycycline-inducible overexpressing transgenic (VEGFTG), VEGFTG treated with a NOS1 inhibitor (L-NIO), VEGFTG x NOS2(-/-) and VEGFTG x NOS3(+/-) mice in room air (RA) for 7 postnatal (PN) days. Lung morphometry (chord length), vascular markers (Ang1, Ang2, Notch2, vWF, CD31 and VE-cadherin), cell proliferation (Ki67), vascular permeability, injury and oxidative stress markers (hemosiderin, nitrotyrosine and 8-OHdG) were evaluated. Results VEGF overexpression in RA led to increased chord length and vascular markers at PN7, which were significantly decreased to control values in VEGFTG x NOS2(-/-) and VEGFTG x NOS3(+/-) lungs. However, we found no noticeable effect on chord length and vascular markers in the VEGFTG/NOS1 inhibited group. In the NB VEGFTG mouse model, we found VEGF-induced vascular permeability in the NB murine lung was partially dependent on NOS2 and NOS3-signaling pathways. In addition, the inhibition of NOS2 and NOS3 resulted in a significant decrease in VEGF-induced hemosiderin, nitrotyrosine-and 8-OHdG positive cells at PN7. NOS1 inhibition had no significant effect. Conclusion Our data showed that the complete absence of NOS2 and partial deficiency of NOS3 confers protection against VEGF-induced pathologic lung vascular and alveolar developmental changes, as well as injury markers. Inhibition of NOS1 does not have any modulating role on VEGF-induced changes in the NB lung. Overall, our data suggests that there is a significant differential regulation in the NOS-mediated effects of VEGF overexpression in the developing mouse lung.	[Syed, Mansoor A.; Choo-Wing, Rayman; Bhandari, Vineet] Yale Univ, Dept Pediat, Div Perinatal Med, Sch Med, 333 Cedar St, New Haven, CT 06520 USA; [Homer, Robert J.] Yale Univ, Dept Pathol, Sch Med, 310 Cedar St, New Haven, CT 06520 USA; [Syed, Mansoor A.; Bhandari, Vineet] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Choo-Wing, Rayman] Novartis Inst BioMed Res, Cambridge, MA USA	Yale University; Yale University; Drexel University; Novartis	Bhandari, V (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	vineet.bhandari@drexelmed.edu	syed, mansoor ali/I-6957-2018; Bhandari, Vineet/AAS-3365-2020; homer, robert/P-3884-2019; syed, Mansoor ali/G-8986-2013	homer, robert/0000-0002-2055-5885; syed, Mansoor ali/0000-0003-2697-7832	NHLBI of the National Institutes of Health, USA [HL85103]; department of pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085103] Funding Source: NIH RePORTER	NHLBI of the National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); department of pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant HL85103 (V.B.) from the NHLBI of the National Institutes of Health, USA. Additional funding from department of pediatrics (internal).	Altiok O, 2006, AM J RESP CRIT CARE, V173, P318, DOI 10.1164/rccm.200503-425OC; Asikainen TM, 2006, FASEB J, V20, P1698, DOI 10.1096/fj.06-5887fje; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V290, pL1111, DOI 10.1152/ajplung.00431.2005; Berger J, 2014, AM J PHYSIOL-LUNG C, V307, pL936, DOI 10.1152/ajplung.00159.2014; Bhandari V, 2008, AM J RESP CELL MOL, V39, P420, DOI 10.1165/rcmb.2007-0024OC; Bhandari V, 2006, P NATL ACAD SCI USA, V103, P11021, DOI 10.1073/pnas.0601057103; Bhandari V, 2012, AM J RESP CELL MOL, V46, P668, DOI 10.1165/rcmb.2011-0074OC; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Choo-Wing R, 2013, AM J RESP CELL MOL, V48, P749, DOI 10.1165/rcmb.2012-0381OC; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Demchenko IT, 2008, AM J PHYSIOL-LUNG C, V294, pL984, DOI 10.1152/ajplung.00420.2007; Ghelfi E, 2013, AM J PATHOL, V182, P1425, DOI 10.1016/j.ajpath.2012.12.009; Grisafi D, 2012, LUNG, V190, P419, DOI 10.1007/s00408-012-9382-z; Harijith A, 2011, AM J RESP CELL MOL, V44, P621, DOI 10.1165/rcmb.2010-0058OC; Knaapi J, 2015, PEDIATR PULM, V50, P164, DOI 10.1002/ppul.23011; Knaapi J, 2011, EXP LUNG RES, V37, P408, DOI 10.3109/01902148.2011.581738; Kunig AM, 2005, AM J PHYSIOL-LUNG C, V289, pL529, DOI 10.1152/ajplung.00336.2004; Kunig AM, 2006, AM J PHYSIOL-LUNG C, V291, pL1068, DOI 10.1152/ajplung.00093.2006; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Li Z, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-54; Lin YJ, 2005, PEDIATR RES, V58, P22, DOI 10.1203/01.PDR.0000163378.94837.3E; Lopez E, 2006, AM J RESP CELL MOL, V34, P738, DOI 10.1165/rcmb.2005-0254OC; Lu JI, 2007, J BIOL CHEM, V282, P22176, DOI 10.1074/jbc.M700063200; Maniscalco WM, 2002, AM J PHYSIOL-LUNG C, V282, pL811, DOI 10.1152/ajplung.00325.2001; Meller S, 2012, EXP LUNG RES, V38, P192, DOI 10.3109/01902148.2012.663454; O'Reilly MA, 2008, AM J RESP CRIT CARE, V177, P1103, DOI 10.1164/rccm.200712-1839OC; Ohta H, 2012, AM J PHYSIOL-LUNG C, V302, pL193, DOI 10.1152/ajplung.00349.2010; Okuma T, 2006, INT J EXP PATHOL, V87, P475, DOI 10.1111/j.1365-2613.2006.00502.x; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Persson HL, 2011, CHEST, V139, P361, DOI 10.1378/chest.10-0818; Stewart JA, 2011, AM J PHYSIOL-CELL PH, V300, pC968, DOI 10.1152/ajpcell.00059.2011; Sun HX, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-27; Sureshbabu A, 2015, RESP RES, V16, DOI 10.1186/s12931-014-0162-6; Syed MA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/457189; Tang JR, 2004, AM J PHYSIOL-LUNG C, V287, pL344, DOI 10.1152/ajplung.00291.2003; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Wang HF, 2011, AM J PHYSIOL-CELL PH, V300, pC979, DOI 10.1152/ajpcell.00368.2010; Yuba T, 2007, RESP MED, V101, P793, DOI 10.1016/j.rmed.2006.08.001; Zhang XF, 2010, CHINESE MED J-PEKING, V123, P929, DOI 10.3760/cma.j.issn.0366-6999.2010.07.030	40	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147588	10.1371/journal.pone.0147588	http://dx.doi.org/10.1371/journal.pone.0147588			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799210	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300128
J	Vigne, JD; Evin, A; Cucchi, T; Dai, LL; Yu, C; Hu, SM; Soulages, N; Wang, WL; Sun, ZY; Gao, JT; Dobney, K; Yuan, J				Vigne, Jean-Denis; Evin, Allowen; Cucchi, Thomas; Dai, Lingling; Yu, Chong; Hu, Songmei; Soulages, Nicolas; Wang, Weilin; Sun, Zhouyong; Gao, Jiangtao; Dobney, Keith; Yuan, Jing			Earliest "Domestic" Cats in China Identified as Leopard Cat (Prionailurus bengalensis)	PLOS ONE			English	Article							DIET; EVOLUTION; CYPRUS	The ancestor of all modern domestic cats is the wildcat, Felis silvestris lybica, with archaeological evidence indicating it was domesticated as early as 10,000 years ago in South-West Asia. A recent study, however, claims that cat domestication also occurred in China some 5,000 years ago and involved the same wildcat ancestor (F. silvestris). The application of geometric morphometric analyses to ancient small felid bones from China dating between 5,500 to 4,900 BP, instead reveal these and other remains to be that of the leopard cat (Prionailurus bengalensis). These data clearly indicate that the origins of a human-cat 'domestic' relationship in Neolithic China began independently from South-West Asia and involved a different wild felid species altogether. The leopard cat's 'domestic' status, however, appears to have been short-lived-its apparent subsequent replacement shown by the fact that today all domestic cats in China are genetically related to F. silvestris.	[Vigne, Jean-Denis; Evin, Allowen; Cucchi, Thomas; Dai, Lingling; Yu, Chong; Soulages, Nicolas] Univ Paris 04, Museum Natl Hist Nat, CNRS, UMR 7209,Archeozool,Archeobot Soc Prat & Environm, CP 56, Paris, France; [Evin, Allowen; Cucchi, Thomas; Yu, Chong; Dobney, Keith] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Dai, Lingling] Univ Chinese Acad Sci, Beijing, Peoples R China; [Hu, Songmei; Wang, Weilin; Sun, Zhouyong] Shaanxi Prov Inst Archaeol, Xian, Peoples R China; [Gao, Jiangtao; Yuan, Jing] Chinese Acad Social Sci, Inst Archaeol, Beijing, Peoples R China; [Evin, Allowen] Univ Montpellier, CNRS, Inst Sci Evolut, IRD,EPHE, CC 61,Pl Eugene Bataillon, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Aberdeen; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Social Sciences; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Vigne, JD (corresponding author), Univ Paris 04, Museum Natl Hist Nat, CNRS, UMR 7209,Archeozool,Archeobot Soc Prat & Environm, CP 56, Paris, France.	vigne@mnhn.fr	Cucchi, Thomas/Q-4014-2018	Cucchi, Thomas/0000-0001-6021-5001; Dobney, Keith/0000-0001-9036-4681; EVIN, Allowen/0000-0003-4515-1649; Yu, Chong/0000-0003-4171-2568	ERAnet Co-Reach project (European-Chinese Bioarchaeological Collaboration, Euch-Bioarch) [137]; Chinese Academy of Social Science; Agence National pour la Recherche (ANR) through the LabEx [ANR-10-LABX-0003-BCDiv, ANR-11-IDEX-0004-02]; Natural Environment Research Council [NE/F003382/2, NE/K005243/2, NE/K003259/2, NE/H005552/1, NE/H005269/1, NE/K003259/1, NE/F003382/1, NE/K005243/1] Funding Source: researchfish; NERC [NE/K003259/1, NE/F003382/1, NE/F003382/2, NE/K005243/2, NE/K005243/1, NE/K003259/2, NE/H005552/1, NE/H005269/1] Funding Source: UKRI	ERAnet Co-Reach project (European-Chinese Bioarchaeological Collaboration, Euch-Bioarch); Chinese Academy of Social Science; Agence National pour la Recherche (ANR) through the LabEx(French National Research Agency (ANR)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The ERAnet (https://ec.europa.eu) Co-Reach project no 137 (European-Chinese Bioarchaeological Collaboration, Euch-Bioarch) led by K. Dobney, and the Chinese Academy of Social Science funded this research. This research was also granted by the Agence National pour la Recherche (ANR, http://www.agence-nationale-recherche.fr/), through the LabEx ANR-10-LABX-0003-BCDiv, in the framework of the Investissements d'avenir programme (ANR-11-IDEX-0004-02).	Bar-Oz G, 2014, P NATL ACAD SCI USA, V111, pE876, DOI 10.1073/pnas.1324177111; BAYLAC M, 2012, RMORPH R GEOMETRIC M; Baylac M, 2005, DEV PRIMATOL-PROG PR, P145, DOI 10.1007/0-387-27614-9_6; Clutton-Brock J, 1981, DOMESTICATED ANIMALS; Cucchi T, 2002, C R PALEVOL, V1, P235, DOI 10.1016/S1631-0683(02)00033-7; Cucchi T, 2013, EVOLUTION OUR NEIGHB, P65; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; GOODALL C. R., 1995, CURRENT ISSUES STAT, P18; Grassman LI, 2005, J ZOOL, V266, P45, DOI 10.1017/S095283690500659X; Helgren JA., 2013, ENCY CAT BREEDS COMP; Hu S, 2005, ARCHAEOL CULT RELICS, V6, P72; Hu YW, 2014, P NATL ACAD SCI USA, V111, P116, DOI 10.1073/pnas.1311439110; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Le Brun A, 1984, FOUILLES RECENTES KH, P147; Malek J., 1993, CAT ANCIENT EGYPT; Montague MJ, 2014, P NATL ACAD SCI USA, V111, P17230, DOI 10.1073/pnas.1410083111; Pan QH, 2007, FIELD GUIDE MAMMALS; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Rohlf F. J., 2010, TPSDIG V 2 16; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Ross S., 2015, OTOCOLOBUS MANUL IUC; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Sicuro FL, 2011, BIOL J LINN SOC, V103, P176, DOI 10.1111/j.1095-8312.2011.01636.x; Smith Andrew T., 2008, P1; Sunquist M., 2002, WILDCATS WORLD; Tamada T, 2008, ZOOL SCI, V25, P154, DOI 10.2108/zsj.25.154; Van Neer W, 2014, J ARCHAEOL SCI, V45, P103, DOI 10.1016/j.jas.2014.02.014; Vigne J.-D, 2014, ENCY GLOBAL ARCHAEOL, P1175; Vigne J-D, 2004, SCIENCE, V304, P259; Vigne Jean-Denis, 2004, Anthropozoologica, V39, P249; Vigne JD, 2012, P NATL ACAD SCI USA, V109, P8445, DOI 10.1073/pnas.1201693109; VILA E, 1998, EXPLOITATION ANIMAUX; Wang Z., 2010, ARCHAEOLOGY, V2, P91; Wang Z., 2006, HIST TAMING CAT; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Yamaguchi N, 2004, BIOL J LINN SOC, V83, P47, DOI 10.1111/j.1095-8312.2004.00372.x; ZEDER MA, 2012, AGR DOMESTICATION EV, P227	39	17	17	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147295	10.1371/journal.pone.0147295	http://dx.doi.org/10.1371/journal.pone.0147295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799955	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300088
J	Beurskens, R; Haeger, M; Kliegl, R; Roecker, K; Granacher, U				Beurskens, Rainer; Haeger, Matthias; Kliegl, Reinhold; Roecker, Kai; Granacher, Urs			Postural Control in Dual-Task Situations: Does Whole-Body Fatigue Matter?	PLOS ONE			English	Article							MUSCLE FATIGUE; COGNITIVE TASK; ATTENTIONAL DEMANDS; BALANCE CONTROL; EXERCISE; GAIT; INTERFERENCE; POSITION; ANKLE; SWAY	Postural control is important to cope with demands of everyday life. It has been shown that both attentional demand (i.e., cognitive processing) and fatigue affect postural control in young adults. However, their combined effect is still unresolved. Therefore, we investigated the effects of fatigue on single-(ST) and dual-task (DT) postural control. Twenty young subjects (age: 23.7 +/- 2.7) performed an all-out incremental treadmill protocol. After each completed stage, one-legged-stance performance on a force platform under ST (i.e., one-legged-stance only) and DT conditions (i.e., one-legged-stance while subtracting serial 3s) was registered. On a second test day, subjects conducted the same balance tasks for the control condition (i.e., non-fatigued). Results showed that heart rate, lactate, and ventilation increased following fatigue (all p < 0.001; d = 4.2-21). Postural sway and sway velocity increased during DT compared to ST (all p < 0.001; d = 1.9-2.0) and fatigued compared to non-fatigued condition (all p < 0.001; d = 3.3-4.2). In addition, postural control deteriorated with each completed stage during the treadmill protocol (all p < 0.01; d = 1.9-3.3). The addition of an attention-demanding interference task did not further impede one-legged-stance performance. Although both additional attentional demand and physical fatigue affected postural control in healthy young adults, there was no evidence for an overadditive effect (i.e., fatigue-related performance decrements in postural control were similar under ST and DT conditions). Thus, attentional resources were sufficient to cope with the DT situations in the fatigue condition of this experiment.	[Beurskens, Rainer; Haeger, Matthias; Granacher, Urs] Univ Potsdam, Div Training & Movement Sci, Res Focus Cognit Sci, Potsdam, Germany; [Kliegl, Reinhold] Univ Potsdam, Dept Psychol, Div Cognit Psychol, Potsdam, Germany; [Roecker, Kai] Univ Furtwangen, Fac Appl Publ Hlth, Furtwangen, Germany; [Beurskens, Rainer] Heidelberg Univ, Agaples Bethanien Hosp Heidelberg, Geriatr Ctr, Heidelberg, Germany	University of Potsdam; University of Potsdam; Ruprecht Karls University Heidelberg	Beurskens, R (corresponding author), Univ Potsdam, Div Training & Movement Sci, Res Focus Cognit Sci, Potsdam, Germany.; Beurskens, R (corresponding author), Heidelberg Univ, Agaples Bethanien Hosp Heidelberg, Geriatr Ctr, Heidelberg, Germany.	rbeurskens@posteo.de	Kliegl, Reinhold/A-1276-2009; Kliegl, Reinhold/AAD-3463-2019; Granacher, Urs/GXM-3858-2022; Roecker, Kai/GOP-3245-2022; Meijer, Anna/K-5118-2016; Granacher, Urs/T-9900-2017; Granacher, Urs/N-1963-2019	Kliegl, Reinhold/0000-0002-0180-8488; Kliegl, Reinhold/0000-0002-0180-8488; Granacher, Urs/0000-0002-7095-813X; Roecker, Kai/0000-0003-1133-2548; Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Haeger, Mathias/0000-0001-9915-7478				Barry BK, 2007, INTEGR COMP BIOL, V47, P465, DOI 10.1093/icb/icm047; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Bisson EJ, 2011, GAIT POSTURE, V33, P83, DOI 10.1016/j.gaitpost.2010.10.001; Boyas S., 2011, Annals of Physical and Rehabilitation Medicine, V54, P88, DOI 10.1016/j.rehab.2011.01.001; Bredin SSD, 2013, CAN FAM PHYSICIAN, V59, P273; Brickenkamp R., 1981, HDB PSYCHOL PADAGOGI, P270; Chong RKY, 2010, NEUROPSYCHOLOGIA, V48, P2709, DOI 10.1016/j.neuropsychologia.2010.05.018; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Corbeil P, 2003, GAIT POSTURE, V18, P92, DOI 10.1016/S0966-6362(02)00198-4; COREN S, 1993, B PSYCHONOMIC SOC, V31, P1, DOI 10.3758/bf03334122; Douris PC, 2011, J STRENGTH COND RES, V25, P3299, DOI 10.1519/JSC.0b013e318215fa07; Enoka RM, 2011, J ELECTROMYOGR KINES, V21, P208, DOI 10.1016/j.jelekin.2010.10.006; Evans Daniel R, 2016, Pers Soc Psychol Rev, V20, P291, DOI 10.1177/1088868315597841; Finsterer J, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-218; Fitts RH, 2006, ACSMS ADV EXERCISE P, P178; Forestier N, 2002, MED SCI SPORT EXER, V34, P117, DOI 10.1097/00005768-200201000-00018; Frey I., 2002, EUR J SPORT SCI, V2, P1, DOI [DOI 10.1080/17461390200072406, 10.1080/17461390200072406]; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Granacher U, 2011, GERONTOLOGY, V57, P247, DOI 10.1159/000322196; Grassi B, 2015, EXERC SPORT SCI REV, V43, P75, DOI 10.1249/JES.0000000000000043; Hodges PW, 2002, EXP BRAIN RES, V144, P293, DOI 10.1007/s00221-002-1040-x; HUNTER IW, 1981, NEUROSCI LETT, V25, P155, DOI 10.1016/0304-3940(81)90324-4; Hwang JH, 2013, ANN REHABIL MED-ARM, V37, P347, DOI 10.5535/arm.2013.37.3.347; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Moore RD, 2012, J SPORT SCI, V30, P841, DOI 10.1080/02640414.2012.675083; Muehlbauer T, 2011, J STRENGTH COND RES, V25, P2228, DOI 10.1519/JSC.0b013e3181fb393b; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Prettin S, 2011, J SPORT MED PHYS FIT, V51, P179; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Reimer RC, 2010, J SCI MED SPORT, V13, P161, DOI 10.1016/j.jsams.2009.01.001; Schubert P, 2014, GAIT POSTURE, V39, P518, DOI 10.1016/j.gaitpost.2013.09.001; Simoneau M, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-22; Springer BK, 2009, GAIT POSTURE, V30, P50, DOI 10.1016/j.gaitpost.2009.02.014; Stensdotter AK, 2013, J MOTOR BEHAV, V45, P279, DOI 10.1080/00222895.2013.791241; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Vuillerme N, 2002, MED SCI SPORT EXER, V34, P1907, DOI 10.1097/00005768-200212000-00008; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zech A, 2012, J STRENGTH COND RES, V26, P1162, DOI 10.1519/JSC.0b013e31822dfbbb; Zhou JH, 2014, EUR J NEUROSCI, V39, P1343, DOI 10.1111/ejn.12492	42	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147392	10.1371/journal.pone.0147392	http://dx.doi.org/10.1371/journal.pone.0147392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796320	Green Published, Green Submitted, gold			2022-12-26	WOS:000368530300031
J	Foditsch, C; Oikonomou, G; Machado, VS; Bicalho, ML; Ganda, EK; Lima, SF; Rossi, R; Ribeiro, BL; Kussler, A; Bicalho, RC				Foditsch, Carla; Oikonomou, Georgios; Machado, Vinicius Silva; Bicalho, Marcela Luccas; Ganda, Erika Korzune; Lima, Svetlana Ferreira; Rossi, Rodolfo; Ribeiro, Bruno Leonardo; Kussler, Arieli; Bicalho, Rodrigo Carvalho			Lameness Prevalence and Risk Factors in Large Dairy Farms in Upstate New York. Model Development for the Prediction of Claw Horn Disruption Lesions	PLOS ONE			English	Article							WHITE LINE DISEASE; COW-LEVEL PREVALENCE; BODY CONDITION; SOLE ULCERS; MILK-YIELD; DIGITAL DERMATITIS; STALL SURFACE; TIME BUDGETS; FOOT LESIONS; HERD-LEVEL	The main objectives of this prospective cohort study were a) to describe lameness prevalence at drying off in large high producing New York State herds based on visual locomotion score (VLS) and identify potential cow and herd level risk factors, and b) to develop a model that will predict the probability of a cow developing claw horn disruption lesions (CHDL) in the subsequent lactation using cow level variables collected at drying off and/or available from farm management software. Data were collected from 23 large commercial dairy farms located in upstate New York. A total of 7,687 dry cows, that were less than 265 days in gestation, were enrolled in the study. Farms were visited between May 2012 and March 2013, and cows were assessed for body condition score (BCS) and VLS. Data on the CHDL events recorded by the farm employees were extracted from the Dairy-Comp 305 database, as well as information regarding the studied cows' health events, milk production, and reproductive records throughout the previous and subsequent lactation period. Univariable analyses and mixed multivariable logistic regression models were used to analyse the data at the cow level. The overall average prevalence of lameness (VLS > 2) at drying off was 14%. Lactation group, previous CHDL, mature equivalent 305-d milk yield (ME305), season, BCS at drying off and sire PTA for strength were all significantly associated with lameness at the drying off (cow-level). Lameness at drying off was associated with CHDL incidence in the subsequent lactation, as well as lactation group, previous CHDL and ME305. These risk factors for CHDL in the subsequent lactation were included in our predictive model and adjusted predicted probabilities for CHDL were calculated for all studied cows. ROC analysis identified an optimum cut-off point for these probabilities and using this cut-off point we could predict CHDL incidence in the subsequent lactation with an overall specificity of 75% and sensitivity of 59%. Using this approach, we would have detected 33% of the studied population as being at risk, eventually identifying 59% of future CHDL cases. Our predictive model could help dairy producers focusing their efforts on CHDL reduction by implementing aggressive preventive measures for high risk cows.	[Foditsch, Carla; Oikonomou, Georgios; Machado, Vinicius Silva; Bicalho, Marcela Luccas; Ganda, Erika Korzune; Lima, Svetlana Ferreira; Rossi, Rodolfo; Ribeiro, Bruno Leonardo; Kussler, Arieli; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Oikonomou, Georgios] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Warrington, Cheshire, England	Cornell University; University of Liverpool	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Ribeiro, Bruno Leonardo Mendonça/W-2138-2019; Ganda, Erika/AAD-6286-2020	Ribeiro, Bruno Leonardo Mendonça/0000-0002-4303-0504; Ganda, Erika/0000-0002-8735-0753; Rossi, Rodolfo/0000-0002-4776-1232	Elanco Animal Health; USDA/NIFA Federal Formula Funds project [NYC-478438]	Elanco Animal Health; USDA/NIFA Federal Formula Funds project	This study was supported by Elanco Animal Health (https://www.elanco.com), RCB received the grant; USDA/NIFA Federal Formula Funds project NYC-478438, RCB received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the dairy producers who participated in this study for granting us access to their facilities, cows and herd records, and Peter Hausser who helped identify cooperator farms. This project was funded by Elanco Animal Health and by the USDA/NIFA Federal Formula Funds project NYC-478438.	Alawneh JI, 2014, PREV VET MED, V113, P72, DOI 10.1016/j.prevetmed.2013.10.010; Amory JR, 2008, PREV VET MED, V83, P381, DOI 10.1016/j.prevetmed.2007.09.007; Barker ZE, 2010, J DAIRY SCI, V93, P932, DOI 10.3168/jds.2009-2309; Barker ZE, 2009, J DAIRY SCI, V92, P1971, DOI 10.3168/jds.2008-1590; BENNETT R., 2003, EC ASSESSMENT LIVEST; Bicalho RC, 2008, J DAIRY SCI, V91, P2653, DOI 10.3168/jds.2007-0744; Bicalho RC, 2007, J DAIRY SCI, V90, P3294, DOI 10.3168/jds.2007-0076; Bicalho RC, 2013, LIVEST SCI, V156, P96, DOI 10.1016/j.livsci.2013.06.007; Caixeta LS, 2011, CAN J VET RES, V75, P233; Calderon DF, 2011, J DAIRY SCI, V94, P2883, DOI 10.3168/jds.2010-3855; Cha E, 2010, PREV VET MED, V97, P1, DOI 10.1016/j.prevetmed.2010.07.011; Chapinal N, 2014, J DAIRY SCI, V97, P4309, DOI 10.3168/jds.2014-8089; Chapinal N, 2013, J DAIRY SCI, V96, P318, DOI 10.3168/jds.2012-5940; Clarkson MJ, 1996, VET REC, V138, P563, DOI 10.1136/vr.138.23.563; Cook NB, 2007, J DAIRY SCI, V90, P1674, DOI 10.3168/jds.2006-634; Cook NB, 2004, J DAIRY SCI, V87, P2912, DOI 10.3168/jds.S0022-0302(04)73422-0; Cook NB, 2003, J AM VET MED ASSOC, V223, P1324, DOI 10.2460/javma.2003.223.1324; Cramer G, 2008, J DAIRY SCI, V91, P3888, DOI 10.3168/jds.2008-1135; de Vries M, 2015, PREV VET MED, V118, P80, DOI 10.1016/j.prevetmed.2014.11.016; Domecq JJ, 1997, J DAIRY SCI, V80, P101, DOI 10.3168/jds.S0022-0302(97)75917-4; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Eicher SD, 2013, J DAIRY SCI, V96, P3639, DOI 10.3168/jds.2012-6049; Fjeldaas T, 2011, J DAIRY SCI, V94, P1243, DOI 10.3168/jds.2010-3173; Fregonesi JA, 2007, J DAIRY SCI, V90, P3349, DOI 10.3168/jds.2006-794; Gomez A, 2010, J DAIRY SCI, V93, P5772, DOI 10.3168/jds.2010-3436; Gonzalez LA, 2008, J DAIRY SCI, V91, P1017, DOI 10.3168/jds.2007-0530; Green LE, 2014, PREV VET MED, V113, P63, DOI 10.1016/j.prevetmed.2013.10.009; Hirst WM, 2002, PREV VET MED, V54, P191, DOI 10.1016/S0167-5877(02)00021-1; Holzhauer M, 2008, PREV VET MED, V85, P125, DOI 10.1016/j.prevetmed.2008.01.004; Husfeldt AW, 2012, J DAIRY SCI, V95, P5626, DOI 10.3168/jds.2011-5075; Huxley JN, 2004, VET REC, V155, P237, DOI 10.1136/vr.155.8.237; Huzzey JM, 2006, J DAIRY SCI, V89, P126, DOI 10.3168/jds.S0022-0302(06)72075-6; Linden TC, 2009, J DAIRY SCI, V92, P2580, DOI [10.3168/jds.2008-1603, 10.3168/jds.2008-1827]; Lischer CJ, 2002, VET REC, V151, P694; Machado VS, 2010, J DAIRY SCI, V93, P4071, DOI 10.3168/jds.2010-3177; Machado VS, 2011, AM J VET RES, V72, P1338, DOI 10.2460/ajvr.72.10.1338; Murray RD, 1996, VET REC, V138, P586, DOI 10.1136/vr.138.24.586; Oberbauer AM, 2013, J DAIRY SCI, V96, P605, DOI 10.3168/jds.2012-5485; Oikonomou G, 2013, J DAIRY SCI, V96, P3713, DOI 10.3168/jds.2012-6308; Raber M, 2004, VET J, V167, P258, DOI 10.1016/S1090-0233(03)00053-4; Tarlton JF, 2002, VET J, V163, P196, DOI 10.1053/tvjl.2001.0651; Telezhenko E, 2007, J DAIRY SCI, V90, P3716, DOI 10.3168/jds.2006-876; U.S. Department of Agriculture (USDA), 2010, OV US DAIR IND; Vanegas J, 2006, J DAIRY SCI, V89, P4251, DOI 10.3168/jds.S0022-0302(06)72471-7; Vergara CF, 2014, J DAIRY SCI, V97, P4127, DOI 10.3168/jds.2012-6440; von Keyserlingk MAG, 2012, J DAIRY SCI, V95, P7399, DOI 10.3168/jds.2012-5807; von Keyserlingk MAG, 2009, J DAIRY SCI, V92, P4101, DOI 10.3168/jds.2009-2326; Whay HR, 2003, VET REC, V153, P197, DOI 10.1136/vr.153.7.197	48	30	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146718	10.1371/journal.pone.0146718	http://dx.doi.org/10.1371/journal.pone.0146718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795970	Green Submitted, Green Published, gold			2022-12-26	WOS:000368530300010
J	Albers, HJ; Busby, GM; Hamaide, B; Ando, AW; Polasky, S				Albers, Heidi J.; Busby, Gwenlyn M.; Hamaide, Bertrand; Ando, Amy W.; Polasky, Stephen			Spatially-Correlated Risk in Nature Reserve Site Selection	PLOS ONE			English	Article							BIOLOGICAL RESERVES; CONSERVATION; EXTINCTION; ALGORITHMS; MODELS; LANDSCAPES; COVERAGE; DESIGN	Establishing nature reserves protects species from land cover conversion and the resulting loss of habitat. Even within a reserve, however, many factors such as fires and defoliating insects still threaten habitat and the survival of species. To address the risk to species survival after reserve establishment, reserve networks can be created that allow some redundancy of species coverage to maximize the expected number of species that survive in the presence of threats. In some regions, however, the threats to species within a reserve may be spatially correlated. As examples, fires, diseases, and pest infestations can spread from a starting point and threaten neighboring parcels' habitats, in addition to damage caused at the initial location. This paper develops a reserve site selection optimization framework that compares the optimal reserve networks in cases where risks do and do not reflect spatial correlation. By exploring the impact of spatially-correlated risk on reserve networks on a stylized landscape and on an Oregon landscape, this analysis demonstrates an appropriate and feasible method for incorporating such post-reserve establishment risks in the reserve site selection literature as an additional tool to be further developed for future conservation planning.	[Albers, Heidi J.] Univ Wyoming, Haub Sch Environm & Nat Resources, Dept Econ & Finance, Laramie, WY 82072 USA; [Busby, Gwenlyn M.] GreenWood Resources, Portland, OR 97201 USA; [Hamaide, Bertrand] St Louis Univ, Dept Econ Social & Polit Sci, Brussels, Belgium; [Ando, Amy W.] Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	University of Wyoming; University Saint-Louis - Bruxelles; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities	Hamaide, B (corresponding author), St Louis Univ, Dept Econ Social & Polit Sci, Brussels, Belgium.	bertrand.hamaide@usaintlouis.be	Polasky, Stephen/AAC-5341-2019	Ando, Amy/0000-0002-3279-8075; Albers, Heidi J/0000-0002-3775-7870; Hamaide, Bertrand/0000-0002-1240-8367	GreenWood Resources	GreenWood Resources	The authors received no specific funding for this work. GreenWood Resources provided support in the form of salaries for authors [GB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Arthur JL, 2004, ECOL APPL, V14, P1936, DOI 10.1890/02-5360; Bettinger P, 2002, SILVA FENN, V36, P561, DOI 10.14214/sf.545; Boston K, 1999, FOREST SCI, V45, P292; Camm JD, 1996, BIOL CONSERV, V78, P353, DOI 10.1016/0006-3207(95)00132-8; Camm JD, 2002, OPER RES, V50, P946, DOI 10.1287/opre.50.6.946.351; CBD (Convention on Biological Diversity), 2010, REV UPD STRAT PLAN T; Church RL, 1996, BIOL CONSERV, V76, P105, DOI 10.1016/0006-3207(95)00102-6; Cohon J.L., 2004, MULTIOBJECTIVE PROGR; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Dissanayake S, 2014, HDB EC BIODIVERSITY; Dissanayake STM, 2011, ECOL ECON, V70, P2225, DOI 10.1016/j.ecolecon.2011.06.015; Drechsler M, 2004, BIODIVERS CONSERV, V13, P141, DOI 10.1023/B:BIOC.0000004316.91025.8c; Fischer DT, 2005, ENVIRON MODEL ASSESS, V10, P215, DOI 10.1007/s10666-005-9005-7; Flowers R, 2011, FOREST HLTH HIGHLIGH; Haight RG, 2000, OPER RES, V48, P697, DOI 10.1287/opre.48.5.697.12411; Hamaide B, 2006, ECOL ECON, V56, P570, DOI 10.1016/j.ecolecon.2005.03.009; Hamaide B, 2014, SOCIO-ECON PLAN SCI, V48, P158, DOI 10.1016/j.seps.2014.03.003; Hiebeler D, 2000, ECOLOGY, V81, P1629, DOI 10.1890/0012-9658(2000)081[1629:POFLWS]2.0.CO;2; Hiebeler DE, 2007, J THEOR BIOL, V246, P136, DOI 10.1016/j.jtbi.2006.12.024; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; Horan R, 2005, REV AGR ECON, V27, P483, DOI 10.1111/j.1467-9353.2005.00248.x; Huang IB, 2011, SCI TOTAL ENVIRON, V409, P3578, DOI 10.1016/j.scitotenv.2011.06.022; Kallimanis AS, 2005, CONSERV BIOL, V19, P534, DOI 10.1111/j.1523-1739.2005.00418.x; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Liu GL, 2006, ECOL MODEL, V194, P421, DOI 10.1016/j.ecolmodel.2005.10.028; McCarthy MA, 2000, BIODIVERS CONSERV, V9, P47, DOI 10.1023/A:1008953426795; McCarthy MA, 2011, ECOL LETT, V14, P470, DOI 10.1111/j.1461-0248.2011.01608.x; McDonnell MD, 2002, ENVIRON MODEL ASSESS, V7, P107, DOI 10.1023/A:1015649716111; Moffett A, 2006, DIVERS DISTRIB, V12, P125, DOI 10.1111/j.1366-9516.2005.00202.x; Moilanen A, 2002, ECOL APPL, V12, P913, DOI 10.1890/1051-0761(2002)012[0913:SSDSS]2.0.CO;2; Moilanen A., 2009, SPATIAL CONSERVATION; MURRAY AT, 1995, OR SPEKTRUM, V17, P193, DOI 10.1007/BF01719265; Nalle DJ, 2002, ENVIRON MODEL ASSESS, V7, P99, DOI 10.1023/A:1015697632040; Onal H, 2006, OPER RES, V54, P379, DOI 10.1287/opre.1060.0272; Onal H, 2003, P ROY SOC B-BIOL SCI, V270, P1487, DOI 10.1098/rspb.2003.2393; Parkhurst GM, 2007, ECOL ECON, V64, P344, DOI 10.1016/j.ecolecon.2007.07.009; Polasky S, 2001, LAND ECON, V77, P68, DOI 10.2307/3146981; ReVelle CS, 2002, ENVIRON MODEL ASSESS, V7, P71, DOI 10.1023/A:1015641514293; Shaw DC, 2011, J FOREST, V109, P109; Turcotte DL, 1999, REP PROG PHYS, V62, P1377, DOI 10.1088/0034-4885/62/10/201; Visconti P, 2010, BIOL CONSERV, V143, P756, DOI 10.1016/j.biocon.2009.12.018; Williams JC, 2005, ENVIRON MODEL ASSESS, V10, P163, DOI 10.1007/s10666-005-9007-5; Williams JC, 2008, COMPUT OPER RES, V35, P488, DOI 10.1016/j.cor.2006.03.012; With KA, 1999, LANDSCAPE ECOL, V14, P73, DOI 10.1023/A:1008030215600; Ying X., 2012, THESIS VIRGINIA TECH	47	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146023	10.1371/journal.pone.0146023	http://dx.doi.org/10.1371/journal.pone.0146023			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789127	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100022
J	Borucki, MK; Lao, V; Hwang, M; Gardner, S; Adney, D; Munster, V; Bowen, R; Allen, JE				Borucki, Monica K.; Lao, Victoria; Hwang, Mona; Gardner, Shea; Adney, Danielle; Munster, Vincent; Bowen, Richard; Allen, Jonathan E.			Middle East Respiratory Syndrome Coronavirus Intra-Host Populations Are Characterized by Numerous High Frequency Variants	PLOS ONE			English	Article							DROMEDARY CAMELS; MERS-COV; NUCLEOCAPSID PROTEIN; ANTIBODIES; EMERGENCE	Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging human pathogen related to SARS virus. In vitro studies indicate this virus may have a broad host range suggesting an increased pandemic potential. Genetic and epidemiological evidence indicate camels serve as a reservoir for MERS virus but the mechanism of cross species transmission is unclear and many questions remain regarding the susceptibility of humans to infection. Deep sequencing data was obtained from the nasal samples of three camels that had been experimentally infected with a human MERS-CoV isolate. A majority of the genome was covered and average coverage was greater than 12,000x depth. Although only 5 mutations were detected in the consensus sequences, 473 intrahost single nucleotide variants were identified. Many of these variants were present at high frequencies and could potentially influence viral phenotype and the sensitivity of detection assays that target these regions for primer or probe binding.	[Borucki, Monica K.; Lao, Victoria; Hwang, Mona; Gardner, Shea; Allen, Jonathan E.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Adney, Danielle; Bowen, Richard] Colorado State Univ, Ft Collins, CO 80523 USA; [Munster, Vincent] NIH, Rocky Mt Labs, Hamilton, MT USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Colorado State University; National Institutes of Health (NIH) - USA	Borucki, MK (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA USA.	borucki2@llnl.gov	Munster, Vincent/I-7607-2018	Munster, Vincent/0000-0002-2288-3196; Allen, Jonathan/0000-0002-4359-8263	U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NIH S10 Instrumentation Grants [S10RR029668, S10RR027303]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR027303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001179] Funding Source: NIH RePORTER	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NIH S10 Instrumentation Grants; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation Grants S10RR029668 and S10RR027303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280; Agnihothram S, 2014, J INFECT DIS, V209, P995, DOI 10.1093/infdis/jit609; Aronesty E., 2011, EA UTILS COMMAND LIN; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Borucki MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052752; Bouvet M, 2014, J BIOL CHEM, V289, P25783, DOI 10.1074/jbc.M114.577353; Briese T, 2014, MBIO, V5, DOI 10.1128/mBio.01146-14; Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009; Chen Y, 2013, J VIROL, V87, P6296, DOI 10.1128/JVI.00061-13; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; Chen-Harris H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-96; Corman V, ASSAYS LAB CONFIRMAT; Corman VM, 2014, EMERG INFECT DIS, V20, P1319, DOI 10.3201/eid2008.140596; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Frey KG, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00324-14; Gardner Shea N., 2014, Advances in Bioinformatics, V2014, P101894, DOI 10.1155/2014/101894; Gitlin L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004529; Goh GKM, 2012, J PATHOG, V2012, DOI 10.1155/2012/738590; Goh GK-M, 2013, PLOS CURRENTS, V5; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Holtgrewe M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-210; Hurst KR, 2005, J VIROL, V79, P13285, DOI 10.1128/JVI.79.21.13285-13297.2005; Jackwood MW, 2012, INFECT GENET EVOL, V12, P1305, DOI 10.1016/j.meegid.2012.05.003; LU L, 2014, NAT COMMUN, V5; Luo HB, 2006, BIOCHEMISTRY-US, V45, P11827, DOI 10.1021/bi0609319; Mackay IM, VIRUS RES; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; ROUX L, 1991, ADV VIRUS RES, V40, P181; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Tang XC, 2014, P NATL ACAD SCI USA, V111, pE2018, DOI 10.1073/pnas.1402074111; Timm C, 2014, J VIROL, V88, P2623, DOI 10.1128/JVI.02675-13; Vabret A, 2006, J GEN VIROL, V87, P3349, DOI 10.1099/vir.0.82065-0; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Xu DP, 2004, NEW ENGL J MED, V350, P1366, DOI 10.1056/NEJMc032421; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146251	10.1371/journal.pone.0146251	http://dx.doi.org/10.1371/journal.pone.0146251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790002	gold, Green Published, Green Submitted			2022-12-26	WOS:000368529100029
J	Holstein, DM; Smith, TB; Paris, CB				Holstein, Daniel M.; Smith, Tyler B.; Paris, Claire B.			Depth-Independent Reproduction in the Reef Coral Porites astreoides from Shallow to Mesophotic Zones	PLOS ONE			English	Article							US VIRGIN-ISLANDS; STYLOPHORA-PISTILLATA; CARIBBEAN REEF; SEXUAL REPRODUCTION; RED-SEA; GROWTH; DEEP; VARIABILITY; SKELETONS; FECUNDITY	Mesophotic coral ecosystems between 30-150 m may be important refugia habitat for coral reefs and associated benthic communities from climate change and coastal development. However, reduced light at mesophotic depths may present an energetic challenge to the successful reproduction of light-dependent coral organisms, and limit this refugia potential. Here, the relationship of depth and fecundity was investigated in a brooding depth-generalist scleractinian coral, Porites astreoides from 5-37 m in the U.S. Virgin Islands (USVI) using paraffin tissue histology. Despite a trend of increasing planulae production with depth, no significant differences were found in mean peak planulae density between shallow, mid-depth and mesophotic sites. Differential planulae production over depth is thus controlled by P. astreoides coral cover, which peaks at 10 m and similar to 35 m in the USVI. These results suggest that mesophotic ecosystems are reproductive refuge for P. astreoides in the USVI, and may behave as refugia for P. astreoides metapopulations providing that vertical larval exchanges are viable.	[Holstein, Daniel M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Marine Biol & Fisheries, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Holstein, Daniel M.; Smith, Tyler B.] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Ocean Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA	University of Miami; University of the Virgin Islands; University of Miami	Holstein, DM (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Marine Biol & Fisheries, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.; Holstein, DM (corresponding author), Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA.	daniel.holstein@uvi.edu	Holstein, Daniel/ABA-6674-2020	Holstein, Daniel/0000-0002-9933-833X; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334	US National Science Foundation-Virgin Islands Experimental Program to Stimulate Competitive Research; Black Coral Penalty Fund; Natural Environment Research Council; European Union Future of Reefs in a Changing Environment project; National Science Foundation [OCE-0928423]; EU FORCE project	US National Science Foundation-Virgin Islands Experimental Program to Stimulate Competitive Research; Black Coral Penalty Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Union Future of Reefs in a Changing Environment project; National Science Foundation(National Science Foundation (NSF)); EU FORCE project	Research was supported by the US National Science Foundation-Virgin Islands Experimental Program to Stimulate Competitive Research (to TBS, CBP and DMH) and the Black Coral Penalty Fund (TBS). Further support was provided through the Natural Environment Research Council, European Union Future of Reefs in a Changing Environment project and the National Science Foundation OCE-0928423 (to CBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research was supported by the US National Science Foundation-Virgin Islands Experimental Program to Stimulate Competitive Research (to TBS, CBP and DMH) and the Black Coral Penalty Fund (TBS). Further support was provided through the Natural Environment Research Council and EU FORCE project and the National Science Foundation OCE-0928423 (to CBP). V. Brandtneris contributed to field operations, and A. Moulding and D.A. Renegar provided expertise in coral histology. P. Ruiz and S. Philip provided the Olympus VS120-S5 digital slide scanner. The research herein reflects the views of the authors and does not necessarily reflect the views of the funding agencies.	Armstrong RA, 2007, CORAL REEFS, V26, P945, DOI 10.1007/s00338-007-0286-y; Armstrong RA, 2006, CONT SHELF RES, V26, P194, DOI 10.1016/j.csr.2005.10.004; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-205; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; BOSSCHER H, 1993, CORAL REEFS, V12, P97, DOI 10.1007/BF00302109; Carricart-Ganivet JP, 2007, J EXP MAR BIOL ECOL, V351, P27, DOI 10.1016/j.jembe.2007.05.038; CHORNESKY EA, 1987, BIOL BULL-US, V172, P161, DOI 10.2307/1541790; Darling E, 2008, NEW PHYTOL, V178, P424, DOI 10.1111/j.1469-8137.2007.02349.x; GATTUSO JP, 1993, MAR ECOL PROG SER, V92, P267, DOI 10.3354/meps092267; GLEASON DF, 1995, MAR BIOL, V123, P693, DOI 10.1007/BF00349112; GOREAU TF, 1967, B MAR SCI, V17, P442; Green DH, 2011, J EXP MAR BIOL ECOL, V397, P220, DOI 10.1016/j.jembe.2010.12.004; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Holstein DM, 2016, CORAL REEFS, V35, P23, DOI 10.1007/s00338-015-1339-2; Holstein DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12407; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; KOJIS BL, 1984, CORAL REEFS, V3, P165, DOI 10.1007/BF00301961; Leichter JJ, 2006, MAR ECOL PROG SER, V316, P95, DOI 10.3354/meps316095; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Locker SD, 2010, CORAL REEFS, V29, P329, DOI 10.1007/s00338-010-0613-6; MCCLOSKEY LR, 1984, PROC R SOC SER B-BIO, V222, P215, DOI 10.1098/rspb.1984.0060; McGuire MP, 1998, CORAL REEFS, V17, P369, DOI 10.1007/s003380050141; Menza C, 2008, REV BIOL TROP, V56, P11; Prasetia R, 2016, CORAL REEFS, V35, P53, DOI 10.1007/s00338-015-1348-1; RICHMOND RH, 1987, B MAR SCI, V41, P594; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; RINKEVICH B, 1987, BIOL BULL, V173, P335, DOI 10.2307/1541546; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Serrano X., 2013, THESIS; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Smith TB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00107.1; Smith TB, 2010, CORAL REEFS, V29, P289, DOI 10.1007/s00338-009-0575-8; Smith TB, 2008, MAR POLLUT BULL, V56, P1983, DOI 10.1016/j.marpolbul.2008.08.015; Smith TB, 2011, ANN REPORT; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Villinski JT, 2003, MAR BIOL, V142, P1043, DOI 10.1007/s00227-002-0997-0; Wellington GM, 2003, MAR BIOL, V143, P1185, DOI 10.1007/s00227-003-1150-4; WOLGAST LJ, 1983, BOT GAZ, V144, P260, DOI 10.1086/337371; Xu DR, 2009, MAGN RESON IMAGING, V27, P311, DOI 10.1016/j.mri.2008.07.018	42	39	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146068	10.1371/journal.pone.0146068	http://dx.doi.org/10.1371/journal.pone.0146068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789408	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100024
J	Wiener, DJ; Doherr, MG; Muller, EJ; Welle, MM				Wiener, Dominique J.; Doherr, Marcus G.; Mueller, Eliane J.; Welle, Monika M.			Spatial Distribution of Stem Cell-Like Keratinocytes in Dissected Compound Hair Follicles of the Dog	PLOS ONE			English	Article							BULGE CELLS; EXISTENCE; LOCATION; ALOPECIA; RESIDE; NICHE; GUIDE; CYCLE; SKIN	Hair cycle disturbances are common in dogs and comparable to some alopecic disorders in humans. A normal hair cycle is maintained by follicular stem cells which are predominately found in an area known as the bulge. Due to similar morphological characteristics of the bulge area in humans and dogs, the shared particularity of compound hair follicles as well as similarities in follicular biomarker expression, the dog is a promising model to study human hair cycle and stem cell disorders. To gain insight into the spatial distribution of follicular keratinocytes with stem cell potential in canine compound follicles, we microdissected hair follicles in anagen and telogen from skin samples of freshly euthanized dogs. The keratinocytes isolated from different locations were investigated for their colony forming efficiency, growth and differentiation potential as well as clonal growth. Our results indicate that i) compound and single hair follicles exhibit a comparable spatial distribution pattern with respect to cells with high growth potential and stem cell-like characteristics, ii) the lower isthmus (comprising the bulge) harbors most cells with high growth potential in both, the anagen and the telogen hair cycle stage, iii) unlike in other species, colonies with highest growth potential are rather small with an irregular perimeter and iv) the keratinocytes derived from the bulbar region exhibit characteristics of actively dividing transit amplifying cells. Our results now provide the basis to conduct comparative studies of normal dogs and those with hair cycle disorders with the possibility to extend relevant findings to human patients.	[Wiener, Dominique J.; Mueller, Eliane J.; Welle, Monika M.] Univ Bern, Inst Anim Pathol, Vetsuisse Fac, Bern, Switzerland; [Wiener, Dominique J.; Mueller, Eliane J.; Welle, Monika M.] Univ Hosp Bern, Inselspital, Vetsuisse Fac, Dermfocus, CH-3010 Bern, Switzerland; [Doherr, Marcus G.] Free Univ Berlin, Dept Vet Med, Inst Vet Epidemiol & Biostat, Berlin, Germany; [Mueller, Eliane J.] Univ Hosp Bern, Inselspital, Dept Dermatol, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern; Free University of Berlin; University of Bern; University Hospital of Bern	Wiener, DJ (corresponding author), Univ Bern, Inst Anim Pathol, Vetsuisse Fac, Bern, Switzerland.; Wiener, DJ (corresponding author), Univ Hosp Bern, Inselspital, Vetsuisse Fac, Dermfocus, CH-3010 Bern, Switzerland.	dominique.wiener@vetsuisse.unibe.ch	Welle, Monika Maria/ABF-6113-2021; Wiener, Dominique Judith/AAN-3313-2021	Doherr, Marcus/0000-0003-0064-1708				BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chen CC, 2012, J DERMATOL SCI, V66, P3, DOI 10.1016/j.jdermsci.2012.02.007; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Gerhards NM, 2016, J HISTOCHEM CYTOCHEM, V64, P190, DOI 10.1369/0022155415627679; KOBAYASHI K, 1993, P NATL ACAD SCI USA, V90, P7391, DOI 10.1073/pnas.90.15.7391; Kobayashi T, 2010, J INVEST DERMATOL, V130, P1988, DOI 10.1038/jid.2010.68; Kobayashi T, 2009, VET DERMATOL, V20, P338, DOI 10.1111/j.1365-3164.2009.00815.x; LAVKER RM, 1983, J INVEST DERMATOL, V81, pS121, DOI 10.1111/1523-1747.ep12540880; Lyle S, 1998, J CELL SCI, V111, P3179; Muntener T, 2012, VET DERMATOL, V23, P206, DOI 10.1111/j.1365-3164.2012.01049.x; Muntener T, 2011, VET DERMATOL, V22, P383, DOI 10.1111/j.1365-3164.2011.00963.x; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Purba TS, 2014, BIOESSAYS, V36, P513, DOI 10.1002/bies.201300166; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Rompolas P, 2014, SEMIN CELL DEV BIOL, V25, P34, DOI 10.1016/j.semcdb.2013.12.005; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Wiener DJ, 2015, VET DERMATOL, V26, P198, DOI 10.1111/vde.12192	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146937	10.1371/journal.pone.0146937	http://dx.doi.org/10.1371/journal.pone.0146937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788850	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100047
J	Hald, T; Aspinall, W; Devleesschauwer, B; Cooke, R; Corrigan, T; Havelaar, AH; Gibb, HJ; Torgerson, PR; Kirk, MD; Angulo, FJ; Lake, RJ; Speybroeck, N; Hoffmann, S				Hald, Tine; Aspinall, Willy; Devleesschauwer, Brecht; Cooke, Roger; Corrigan, Tim; Havelaar, Arie H.; Gibb, Herman J.; Torgerson, Paul R.; Kirk, Martyn D.; Angulo, Fred J.; Lake, Robin J.; Speybroeck, Niko; Hoffmann, Sandra			World Health Organization Estimates of the Relative Contributions of Food to the Burden of Disease Due to Selected Foodborne Hazards: A Structured Expert Elicitation	PLOS ONE			English	Article							SOURCE ATTRIBUTION; HUMAN SALMONELLOSIS; PUBLIC-HEALTH; UNITED-STATES; HUMAN CAMPYLOBACTERIOSIS; RISK-ASSESSMENT; CLIMATE-CHANGE; OUTBREAK DATA; NEW-ZEALAND; JUDGMENT	Background The Foodborne Disease Burden Epidemiology Reference Group (FERG) was established in 2007 by the World Health Organization (WHO) to estimate the global burden of foodborne diseases (FBDs). This estimation is complicated because most of the hazards causing FBD are not transmitted solely by food; most have several potential exposure routes consisting of transmission from animals, by humans, and via environmental routes including water. This paper describes an expert elicitation study conducted by the FERG Source Attribution Task Force to estimate the relative contribution of food to the global burden of diseases commonly transmitted through the consumption of food. Methods and Findings We applied structured expert judgment using Cooke's Classical Model to obtain estimates for 14 subregions for the relative contributions of different transmission pathways for eleven diarrheal diseases, seven other infectious diseases and one chemical (lead). Experts were identified through international networks followed by social network sampling. Final selection of experts was based on their experience including international working experience. Enrolled experts were scored on their ability to judge uncertainty accurately and informatively using a series of subject-matter specific 'seed' questions whose answers are unknown to the experts at the time they are interviewed. Trained facilitators elicited the 5th, and 50th and 95th percentile responses to seed questions through telephone interviews. Cooke's Classical Model uses responses to the seed questions to weigh and aggregate expert responses. After this interview, the experts were asked to provide 5th, 50th, and 95th percentile estimates for the 'target' questions regarding disease transmission routes. A total of 72 experts were enrolled in the study. Ten panels were global, meaning that the experts should provide estimates for all 14 subregions, whereas the nine panels were subregional, with experts providing estimates for one or more subregions, depending on their experience in the region. The size of the 19 hazard-specific panels ranged from 6 to 15 persons with several experts serving on more than one panel. Pathogens with animal reservoirs (e.g. non-typhoidal Salmonella spp. and Toxoplasma gondii) were in general assessed by the experts to have a higher proportion of illnesses attributable to food than pathogens with mainly a human reservoir, where human-to-human transmission (e.g. Shigella spp. and Norovirus) or waterborne transmission (e.g. Salmonella Typhi and Vibrio cholerae) were judged to dominate. For many pathogens, the foodborne route was assessed relatively more important in developed subregions than in developing subregions. The main exposure routes for lead varied across subregions, with the foodborne route being assessed most important only in two subregions of the European region. Conclusions For the first time, we present worldwide estimates of the proportion of specific diseases attributable to food and other major transmission routes. These findings are essential for global burden of FBD estimates. While gaps exist, we believe the estimates presented here are the best current source of guidance to support decision makers when allocating resources for control and intervention, and for future research initiatives.	[Hald, Tine] Tech Univ Denmark, DK-2800 Lyngby, Denmark; [Aspinall, Willy] Aspinall & Associates, Tisbury, England; [Aspinall, Willy] Univ Bristol, Bristol, England; [Devleesschauwer, Brecht] Univ Ghent, Merelbeke, Belgium; [Devleesschauwer, Brecht; Speybroeck, Niko] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Devleesschauwer, Brecht] Inst Trop Med, B-2000 Antwerp, Belgium; [Cooke, Roger] Resources Future Inc, Washington, DC USA; [Cooke, Roger] Delft Univ Technol, Delft, Netherlands; [Corrigan, Tim] WHO, CH-1211 Geneva, Switzerland; [Havelaar, Arie H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Havelaar, Arie H.] Univ Florida, Gainesville, FL USA; [Havelaar, Arie H.] Univ Utrecht, Utrecht, Netherlands; [Gibb, Herman J.] Gibb Epidemiol Consulting LLC, Arlington, VA USA; [Torgerson, Paul R.] Univ Zurich, Zurich, Switzerland; [Kirk, Martyn D.] Australian Natl Univ, Canberra, ACT, Australia; [Angulo, Fred J.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Lake, Robin J.] Inst Environm Sci & Res, Christchurch, New Zealand; [Hoffmann, Sandra] Econ Res Serv, USDA, Washington, DC USA	Technical University of Denmark; University of Bristol; Ghent University; Universite Catholique Louvain; Institute of Tropical Medicine (ITM); Resources for the Future; Delft University of Technology; World Health Organization; Netherlands National Institute for Public Health & the Environment; State University System of Florida; University of Florida; Utrecht University; University of Zurich; Australian National University; Centers for Disease Control & Prevention - USA; Institute of Environmental Science & Research (ESR) - New Zealand; United States Department of Agriculture (USDA)	Hald, T (corresponding author), Tech Univ Denmark, DK-2800 Lyngby, Denmark.	tiha@food.dtu.dk	Torgerson, Paul R/A-7510-2010; Torgerson, Paul R/M-4447-2013; Havelaar, Arie H./P-8495-2014; Devleesschauwer, Brecht/G-9895-2018; Hald, Tine/B-5477-2016; Aspinall, Willy/AAW-1022-2020	Torgerson, Paul R/0000-0003-4277-9983; Torgerson, Paul R/0000-0003-4277-9983; Havelaar, Arie H./0000-0002-6456-5460; Devleesschauwer, Brecht/0000-0002-2867-6892; Hald, Tine/0000-0002-1115-9792; Aspinall, Willy/0000-0001-6014-6042; Speybroeck, Niko/0000-0003-3322-3502; Hoffmann, Sandra/0000-0003-2537-8731; Kirk, Martyn/0000-0001-5432-5984	Aspinall Associate; Gibb Epidemiology Consulting LLC; United Kingdom Natural Environment Research Council [Consortium on Risk in the Environment: Diagnostics, Integration, Benchmarking, Learning and Elicitation (CREDIBLE)] [NE/J017450/1]; Natural Environment Research Council [NE/J017450/1] Funding Source: researchfish; NERC [NE/J017450/1] Funding Source: UKRI	Aspinall Associate; Gibb Epidemiology Consulting LLC; United Kingdom Natural Environment Research Council [Consortium on Risk in the Environment: Diagnostics, Integration, Benchmarking, Learning and Elicitation (CREDIBLE)]; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was commissioned and paid for by the World Health Organization. Copyright in the original work on which this article is based belongs to WHO. The authors have been given permission to publish this article. Aspinall & Associate and Gibb Epidemiology Consulting LLC provided support in the form of salaries for authors [WA, HJG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The work by WPA was further supported by the United Kingdom Natural Environment Research Council [Consortium on Risk in the Environment: Diagnostics, Integration, Benchmarking, Learning and Elicitation (CREDIBLE); grant number NE/J017450/1]. This Council provided support in form of salary, but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.764; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3502; [Anonymous], 2014, R LANG ENV STAT COMP; Arnell NW, 2005, RISK ANAL, V25, P1419, DOI 10.1111/j.1539-6924.2005.00689.x; Aspinall W, 1998, PROBABILISTIC SAFETY ASSESSMENT AND MANAGEMENT (PSAM 4), VOLS 1-4, P2113; Aspinall WP, 2006, STATISTICS IN VOLCANOLOGY, P15; Aspinall W, 2010, NATURE, V463, P294, DOI 10.1038/463294a; Aspinall WP, 2015, PLOS ONE IN PRESS; Bamber JL, 2013, NAT CLIM CHANGE, V3, P424, DOI [10.1038/nclimate1778, 10.1038/NCLIMATE1778]; Baxter PJ, 2008, J VOLCANOL GEOTH RES, V178, P454, DOI 10.1016/j.jvolgeores.2008.08.015; Boysen L, 2014, EPIDEMIOL INFECT, V142, P1599, DOI 10.1017/S0950268813002719; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Chan M, 2014, LANCET, V384, P1910, DOI 10.1016/S0140-6736(14)62037-7; Cooke R.M., 1991, EXPERTS UNCERTAINTY; Cooke RM, 2004, J RISK RES, V7, P643, DOI 10.1080/1366987042000192237; Cooke RM, 2000, RADIAT PROT DOSIM, V90, P303, DOI 10.1093/oxfordjournals.rpd.a033152; Cooke RM, 2008, RELIAB ENG SYST SAFE, V93, P657, DOI 10.1016/j.ress.2007.03.005; Cooke RM, 2008, RELIAB ENG SYST SAFE, V93, P745, DOI 10.1016/j.ress.2007.03.017; Cooke RM, 2006, RELIAB ENG SYST SAFE, V91, P1364, DOI 10.1016/j.ress.2005.11.054; Cooke RM, 2015, NAT CLIM CHANGE, V5, P8, DOI 10.1038/nclimate2466; Davidson VJ, 2011, FOODBORNE PATHOG DIS, V8, P983, DOI 10.1089/fpd.2010.0786; De Knegt LV, 2015, EPIDEMIOL INFECT, V143, P1175, DOI 10.1017/S0950268814001903; Devleesschauwer B, 2015, PLOS ONE IN PRESS; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P959, DOI 10.1017/S0950268811002172; Evers E. G., 2008, International Journal of Risk Assessment & Management, V8, P174, DOI 10.1504/IJRAM.2008.016151; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Flandoli F, 2011, RELIAB ENG SYST SAFE, V96, P1292, DOI 10.1016/j.ress.2011.05.012; Gale P, 2010, EPIDEMIOL INFECT, V138, P214, DOI 10.1017/S0950268809990367; Gibb H, 2015, PLOS MED UNPUB; Gkogka E, 2011, EMERG INFECT DIS, V17, P1581, DOI 10.3201/eid1709.101766; Guo CF, 2011, FOODBORNE PATHOG DIS, V8, P509, DOI 10.1089/fpd.2010.0714; Hald T, 2004, RISK ANAL, V24, P255, DOI 10.1111/j.0272-4332.2004.00427.x; Havelaar AH, 2007, ZOONOSES PUBLIC HLTH, V54, P103, DOI 10.1111/j.1863-2378.2007.01036.x; Havelaar AH, 2015, PLOS MED IN PRESS; Havelaar AH, 2008, FOODBORNE PATHOG DIS, V5, P649, DOI 10.1089/fpd.2008.0115; Hoffmann S, 2007, J FOOD PROTECT, V70, P1220, DOI 10.4315/0362-028X-70.5.1220; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; Kirk MD, 2015, PLOS MED IN PRESS; Lake RJ, 2010, RISK ANAL, V30, P743, DOI 10.1111/j.1539-6924.2009.01269.x; Lempert R, 2004, CLIMATIC CHANGE, V65, P1, DOI 10.1023/B:CLIM.0000037561.75281.b3; Little CL, 2010, FOODBORNE PATHOG DIS, V7, P749, DOI 10.1089/fpd.2009.0439; Mangen MJJ, 2010, RISK ANAL, V30, P782, DOI 10.1111/j.1539-6924.2009.01291.x; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; Neri A, 2008, J VOLCANOL GEOTH RES, V178, P397, DOI 10.1016/j.jvolgeores.2008.05.014; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Pires SM, 2014, FOODBORNE PATHOG DIS, V11, P667, DOI 10.1089/fpd.2014.1744; Pires SM, 2013, FOODBORNE PATHOG DIS, V10, P206, DOI 10.1089/fpd.2012.1134; Pires SM, 2012, INT J FOOD MICROBIOL, V152, P129, DOI 10.1016/j.ijfoodmicro.2011.04.018; Pires SM, 2009, FOODBORNE PATHOG DIS, V6, P417, DOI 10.1089/fpd.2008.0208; Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P1351, DOI 10.1089/fpd.2010.0564; Ravel A, 2010, FOODBORNE PATHOG DIS, V7, P1463, DOI 10.1089/fpd.2010.0582; Rice J, 2007, MATH STAT DATA ANAL, P353; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Stein C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000161; Tauxe RV, 2010, INT J FOOD MICROBIOL, V139, pS16, DOI 10.1016/j.ijfoodmicro.2009.10.014; Torgerson PR, 2015, PLOS MED IN PRESS; Tyshenko M.G., 2012, INT J RISK ASSESS MA, V16, P48, DOI [10.1504/ijram.2012.047552, DOI 10.1504/IJRAM.2012.047552, 10.1504/IJRAM.2012.047552.]; Tyshenko MG, 2011, J TOXICOL ENV HEAL A, V74, P261, DOI 10.1080/15287394.2011.529783; Vally H, 2014, FOODBORNE PATHOG DIS, V11, P727, DOI 10.1089/fpd.2014.1746; Van der Fels-Klerx HJ, 2005, RISK ANAL, V25, P109, DOI 10.1111/j.0272-4332.2005.00571.x; von Krauss MPK, 2004, RISK ANAL, V24, P1515, DOI 10.1111/j.0272-4332.2004.00546.x; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203	63	118	119	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145839	10.1371/journal.pone.0145839	http://dx.doi.org/10.1371/journal.pone.0145839			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784029	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000368528400021
J	Jiang, DH; Xiao, XQ; Fu, TS; Mashaghi, A; Liu, QH; Hong, JX				Jiang, Donghong; Xiao, Xiangqian; Fu, Tongsheng; Mashaghi, Alireza; Liu, Qinghuai; Hong, Jiaxu			Transient Tear Film Dysfunction after Cataract Surgery in Diabetic Patients	PLOS ONE			English	Article							DRY EYE DISEASE; PHACOEMULSIFICATION; PREVALENCE; SENSATION; OUTCOMES; CHINA	Purpose Diabetes mellitus is an increasingly common systemic disease. Many diabetic patients seek cataract surgery for a better visual acuity. Unlike in the general population, the influence of cataract surgery on tear film function in diabetic patients remains elusive. The aim of this study was to evaluate the tear function in diabetic and nondiabetic patients following cataract surgery. Methods In this prospective, interventional case series, 174 diabetic patients without dry eye syndrome (DES) and 474 age-matched nondiabetic patients as control who underwent phacoemulsification were enrolled at two different eye centers between January 2011 and January 2013. Patients were followed up at baseline and at 7 days, 1 month, and 3 months postoperatively. Ocular symptom scores (Ocular Surface Disease Index, OSDI) and tear film function including tear film stability (tear film break-up time, TBUT), corneal epithelium integrity (corneal fluorescein staining, CFS), and tear secretion (Schirmer's I test, SIT) were evaluated. Results In total, 83.9% of the diabetic patients (146 cases with 185 eyes) and 89.0% of the nondiabetic patients (422 cases with 463 eyes) completed all check-ups after the interventions (P = 0.095). The incidence of DES was 17.1% in the diabetic patients and 8.1% in the nondiabetic patients at 7 days after cataract surgery. In the diabetic patients, the incidence of DES remained 4.8% at 1 month postoperatively and decreased to zero at 3 months after surgery. No DES was diagnosed in nondiabetic patients at either the 1-month or 3-month follow-up. Compared with the baseline, the diabetic patients had worse symptom scores and lower TBUT values at 7 days and 1 month but not at 3 months postoperatively. In the nondiabetic patients, symptom scores and TBUT values had returned to preoperative levels at 1-month check-up. CFS scores and SIT values did not change significantly postoperatively in either group (P = 0.916 and P = 0.964, respectively). Conclusions Diabetic patients undergoing cataract surgery are prone to DES. Ocular symptoms and tear film stability are transiently worsened in diabetic patients and are restored more slowly than those in nondiabetic patients.	[Jiang, Donghong; Xiao, Xiangqian] Second People Hosp, Dept Ophthalmol, Taixing, Peoples R China; [Fu, Tongsheng] People Hosp, Dept Ophthalmol, Yangzhong, Peoples R China; [Hong, Jiaxu] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai 200433, Peoples R China; [Liu, Qinghuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Mashaghi, Alireza; Hong, Jiaxu] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02114 USA; [Hong, Jiaxu] State Hlth Minist, Key Lab Myopia, Shangha, Peoples R China; [Hong, Jiaxu] Key Lab Visual Impairment & Restorat Shanghai, Shangha, Peoples R China; [Hong, Jiaxu] Xiamen Univ, Sch Life Sci, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Fujian, Peoples R China	Fudan University; Nanjing Medical University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Xiamen University	Hong, JX (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai 200433, Peoples R China.; Liu, QH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.; Hong, JX (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02114 USA.; Hong, JX (corresponding author), State Hlth Minist, Key Lab Myopia, Shangha, Peoples R China.; Hong, JX (corresponding author), Key Lab Visual Impairment & Restorat Shanghai, Shangha, Peoples R China.; Hong, JX (corresponding author), Xiamen Univ, Sch Life Sci, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Fujian, Peoples R China.	liuqh0545@126.com; jiaxu_hong@163.com	Mashaghi, Alireza/Q-8218-2017	Mashaghi, Alireza/0000-0002-2157-1211; Liu, Qinghuai/0000-0003-1605-1964	Key Clinic Medicine Research Program, the Ministry of Health, China [201302015]; National Science and Technology Research Program, the Ministry of Science and Technology, China [2012BAI08B01]; National Natural Science Foundation of China [81170817, 81200658, 81300735, 81270978, U1205025, 81330022]; Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai [13441900900, 13430720400]; Chinese Postdoctoral Fund [XMU135890]; New Technology Joint Research Project in Shanghai Hospitals [SHDC12014114]	Key Clinic Medicine Research Program, the Ministry of Health, China; National Science and Technology Research Program, the Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Postdoctoral Fund; New Technology Joint Research Project in Shanghai Hospitals	The authors were supported by grants from the Key Clinic Medicine Research Program, the Ministry of Health, China (201302015); the National Science and Technology Research Program, the Ministry of Science and Technology, China (2012BAI08B01); the National Natural Science Foundation of China (81170817, 81200658, 81300735, 81270978, U1205025, and 81330022); the Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai (13441900900, 13430720400); the Chinese Postdoctoral Fund (XMU135890); and the New Technology Joint Research Project in Shanghai Hospitals (SHDC12014114). The sponsor or funding organization had no role in the design or conduct of this research.	Alves MD, 2008, ARQ BRAS OFTALMOL, V71, P96, DOI 10.1590/S0004-27492008000700018; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Cetinkaya S, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0058-3; Chan JCN, 2014, LANCET DIABETES ENDO, V2, P969, DOI 10.1016/S2213-8587(14)70144-5; Cho Yang Kyeung, 2009, Korean J Ophthalmol, V23, P65, DOI 10.3341/kjo.2009.23.2.65; Chung Yeon Woong, 2013, Korean J Ophthalmol, V27, P167, DOI 10.3341/kjo.2013.27.3.167; Denoyer A, 2015, OPHTHALMOLOGY, V122, P669, DOI 10.1016/j.ophtha.2014.10.004; Dogru M, 2001, OPHTHALMOLOGY, V108, P586, DOI 10.1016/S0161-6420(00)00599-6; Esquenazi S, 2007, CLIN EXP OPHTHALMOL, V35, P545, DOI 10.1111/j.1442-9071.2007.01543.x; Gao SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107370; Gayton JL, 2009, CLIN OPHTHALMOL, V3, P405; Gemensky-Metzler AJ, 2015, VET OPHTHALMOL, V18, P472, DOI 10.1111/vop.12238; Han KE, 2014, AM J OPHTHALMOL, V157, P1144, DOI 10.1016/j.ajo.2014.02.036; Hardten DR, 2008, CORNEA, V27, P855, DOI 10.1097/ICO.0b013e31816f6854; Kanellopoulos AJ, 2014, J REFRACT SURG, V30, P348, DOI 10.3928/1081597X-20140416-04; Kasetsuwan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078657; Kohlhaas M, 1998, J CATARACT REFR SURG, V24, P1399, DOI 10.1016/S0886-3350(98)80237-X; Kymionis GD, 2006, J REFRACT SURG, V22, P511; Li XM, 2007, CORNEA, V26, pS16, DOI 10.1097/ICO.0b013e31812f67ca; Liang Qingfeng, 2014, Zhonghua Yan Ke Za Zhi, V50, P244; Liu NN, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/748654; Liu X, 2008, J ZHEJIANG UNIV-SC B, V9, P324, DOI 10.1631/jzus.B0710359; Lv HB, 2014, ACTA OPHTHALMOL, V92, pE96, DOI 10.1111/aos.12063; Misra SL, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/848659; Moon H, 2014, CORNEA, V33, P373, DOI 10.1097/ICO.0000000000000072; Murakami Y, 2012, OPHTHALMOLOGY, V119, P2220, DOI 10.1016/j.ophtha.2012.06.013; Najafi L, 2013, J DIABETES COMPLICAT, V27, P459, DOI 10.1016/j.jdiacomp.2013.04.006; Oh T, 2012, JPN J OPHTHALMOL, V56, P113, DOI 10.1007/s10384-012-0117-8; Ram J, 1998, J CATARACT REFR SURG, V24, P1119, DOI 10.1016/S0886-3350(98)80107-7; Ram J, 2002, J CATARACT REFR SURG, V28, P1386, DOI 10.1016/S0886-3350(02)01387-1; Sullivan BD, 2010, INVEST OPHTH VIS SCI, V51, P6125, DOI 10.1167/iovs.10-5390; Tomkins-Netzer O, 2015, PROG RETIN EYE RES, V48, P119, DOI 10.1016/j.preteyeres.2015.05.002; Xu XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132616; Yoon Kyung-Chul, 2004, Korean J Ophthalmol, V18, P168	34	25	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146752	10.1371/journal.pone.0146752	http://dx.doi.org/10.1371/journal.pone.0146752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771186	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300032
J	Luo, SY; Chen, S; Qin, YD; Chen, ZW				Luo, Sheng-Yong; Chen, Shuo; Qin, Yi-De; Chen, Zhi-Wu			Urotensin-II Receptor Antagonist SB-710411 Protects Rat Heart against IschemiaReperfusion Injury via RhoA/ROCK Pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; RHO-KINASE; DYSFUNCTION; PEPTIDE; ATHEROSCLEROSIS; HYPERTROPHY; APOPTOSIS; PRESSURE; CELLS	Aim SB-710411 is a rat selective urotensin-II (U-II) receptor antagonist, which can block U-II-induced contraction of the aorta and inhibit U-II-induced myocardial fibrosis in rats. However, the effect of SB-710411 on myocardial ischemia-reperfusion (I/R) injury is unclear. The present study was designed to investigate whether SB-710411 has a protective effect on myocardial I/R injury in rats and the possible mechanisms. Methods and Results Myocardial I/R injury was induced by occluding the left anterior descending coronary artery in adult male Sprague-Dawley rats. Hemodynamic parameters, electrocardiogram (ECG), infarct size, histological alteration, lactate dehydrogenase (LDH), creatine phosphokinase-MB (CK-MB), cardiac troponin I (cTnI), RhoA, and the protein expressions of U-II receptor (UTR), ROCK1 and ROCK2 were evaluated. Cardiac I/R injury significantly up-regulated the expressions of UTR, ROCK1 and ROCK2 proteins in rat myocardium. SB-710411 1.0 and 2.0 mu g/kg significantly reduced cardiac I/R-induced the infarct size and histological damage in rat myocardium, markedly inhibited the changes of hemodynamic parameters and the increases of ST-segment in ECG, the serum LDH and CK-MB activities and cTnI level in rats subjected to myocardial I/R injury. Furthermore, SB-710411 obviously prevented myocardial I/R-increased RhoA activity and UTR, ROCK1 and ROCK2 protein expressions. Conclusions Our results indicate that cardiac I/R injury increases myocardial UTR expression, and SB-710411 has a potent protective effect on myocardial I/R injury in rats. The cardioprotection may be associated with the inhibition of UTR-RhoA/ROCK pathway.	[Luo, Sheng-Yong; Chen, Zhi-Wu] Anhui Med Univ, Dept Pharmacol, Hefei, Anhui, Peoples R China; [Luo, Sheng-Yong] Anhui Acad Med Sci, Hefei, Anhui, Peoples R China; [Chen, Shuo] Liaoning Univ Tradit Chinese Med, Xinglin Coll, Shenyang, Liaoning, Peoples R China; [Qin, Yi-De] Anhui Med Univ, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China	Anhui Medical University; Liaoning University of Traditional Chinese Medicine; Anhui Medical University	Chen, ZW (corresponding author), Anhui Med Univ, Dept Pharmacol, Hefei, Anhui, Peoples R China.; Qin, YD (corresponding author), Anhui Med Univ, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China.	qinyide@hotmail.com; chpharmzw@163.com			National Natural Science Foundation of China [81374002, 30840104, 81173596]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant No. 81374002 (ZWC, No. 30840104 (ZWC) and No. 81173596 (ZWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Behm DJ, 2010, BRIT J PHARMACOL, V161, P207, DOI 10.1111/j.1476-5381.2010.00889.x; Behm DJ, 2004, EUR J PHARMACOL, V492, P113, DOI 10.1016/j.ejphar.2004.03.059; Behm DJ, 2002, BRIT J PHARMACOL, V137, P449, DOI 10.1038/sj.bjp.0704887; Bousette N, 2006, J MOL CELL CARDIOL, V41, P285, DOI 10.1016/j.yjmcc.2006.05.008; Chiu CZ, 2014, J ENDOCRINOL, V220, P233, DOI 10.1530/JOE-13-0261; Esposito G, 2011, BASIC RES CARDIOL, V106, P577, DOI 10.1007/s00395-011-0163-2; Fan J, 2014, BIOMED ENVIRON SCI, V27, P162, DOI 10.3967/bes2014.037; Forty EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083317; Gao S, 2012, PEPTIDES, V36, P199, DOI 10.1016/j.peptides.2012.05.004; Gonzalez J, 2014, WORLD J CARDIOL, V6, P353, DOI 10.4330/wjc.v6.i6.353; Grisk O, 2014, J HYPERTENS, V32, P2199, DOI 10.1097/HJH.0000000000000326; Guo J, 2013, ATHEROSCLEROSIS, V231, P384, DOI 10.1016/j.atherosclerosis.2013.10.003; Ikeda S, 2014, ARTERIOSCL THROM VAS, V34, P1260, DOI 10.1161/ATVBAHA.114.303320; Jani PP, 2013, PEPTIDES, V40, P72, DOI 10.1016/j.peptides.2012.12.014; Johns DG, 2004, N-S ARCH PHARMACOL, V370, P238, DOI 10.1007/s00210-004-0980-z; Liu Y, 2014, APOPTOSIS, V19, P1254, DOI 10.1007/s10495-014-1001-4; Ma LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103628; Ma LN, 2014, LAB INVEST, V94, P1083, DOI 10.1038/labinvest.2014.95; Matsubara M, 2010, ANN THORAC SURG, V89, P1532, DOI 10.1016/j.athoracsur.2010.01.065; Pakala R, 2008, CARDIOVASC REVASCULA, V9, P166, DOI 10.1016/j.carrev.2008.02.001; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Prosser HCG, 2008, PEPTIDES, V29, P770, DOI 10.1016/j.peptides.2007.08.013; Proulx CD, 2008, PEPTIDES, V29, P691, DOI 10.1016/j.peptides.2007.10.027; Riches K, 2014, CARDIOVASC REVASCULA, V15, P141, DOI 10.1016/j.carrev.2014.02.005; Rodriguez-Moyano M, 2013, CARDIOVASC RES, V100, P297, DOI 10.1093/cvr/cvt196; Shah SV, 2015, J RENAL NUTR, V25, P205, DOI 10.1053/j.jrn.2014.10.024; Sivaraman V, 2014, J CARDIOVASC PHARM T, V19, P83, DOI 10.1177/1074248413499973; Tolle M, 2008, PEPTIDES, V29, P743, DOI 10.1016/j.peptides.2007.08.029; Townsend PA, 2007, AM J PHYSIOL-HEART C, V293, pH928, DOI 10.1152/ajpheart.01135.2006; Tran L, 2010, AM J PHYSIOL-HEART C, V298, pH608, DOI 10.1152/ajpheart.00942.2009; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024036; Xu SK, 2009, TOHOKU J EXP MED, V219, P283, DOI 10.1620/tjem.219.283; Xue L, 2014, ASIAN PAC J TROP MED, V7, P280, DOI 10.1016/S1995-7645(14)60038-9; You ZP, 2012, ARTERIOSCL THROM VAS, V32, P1809, DOI 10.1161/ATVBAHA.112.252973; Yu ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099024; Zhang JY, 2012, CAN J PHYSIOL PHARM, V90, P637, DOI [10.1139/Y2012-048, 10.1139/y2012-048]; Zhao J, 2013, REGUL PEPTIDES, V182, P53, DOI 10.1016/j.regpep.2012.12.006; Zhou Ping, 2003, Shengli Xuebao, V55, P442	39	26	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146094	10.1371/journal.pone.0146094	http://dx.doi.org/10.1371/journal.pone.0146094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771557	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300008
J	Santermans, E; Robesyn, E; Ganyani, T; Sudre, B; Faes, C; Quinten, C; Van Bortel, W; Haber, T; Kovac, T; Van Reeth, F; Testa, M; Hens, N; Plachouras, D				Santermans, Eva; Robesyn, Emmanuel; Ganyani, Tapiwa; Sudre, Bertrand; Faes, Christel; Quinten, Chantal; Van Bortel, Wim; Haber, Tom; Kovac, Thomas; Van Reeth, Frank; Testa, Marco; Hens, Niel; Plachouras, Diamantis			Spatiotemporal Evolution of Ebola Virus Disease at Sub-National Level during the 2014 West Africa Epidemic: Model Scrutiny and Data Meagreness	PLOS ONE			English	Article							TRANSMISSION; LIBERIA	Background The Ebola outbreak in West Africa has infected at least 27,443 individuals and killed 11,207, based on data until 24 June, 2015, released by the World Health Organization (WHO). This outbreak has been characterised by extensive geographic spread across the affected countries Guinea, Liberia and Sierra Leone, and by localized hotspots within these countries. The rapid recognition and quantitative assessment of localised areas of higher transmission can inform the optimal deployment of public health resources. Methods A variety of mathematical models have been used to estimate the evolution of this epidemic, and some have pointed out the importance of the spatial heterogeneity apparent from incidence maps. However, little is known about the district-level transmission. Given that many response decisions are taken at sub-national level, the current study aimed to investigate the spatial heterogeneity by using a different modelling framework, built on publicly available data at district level. Furthermore, we assessed whether this model could quantify the effect of intervention measures and provide predictions at a local level to guide public health action. We used a two-stage modelling approach: a) a flexible spatiotemporal growth model across all affected districts and b) a deterministic SEIR compartmental model per district whenever deemed appropriate. Findings Our estimates show substantial differences in the evolution of the outbreak in the various regions of Guinea, Liberia and Sierra Leone, illustrating the importance of monitoring the outbreak at district level. We also provide an estimate of the time-dependent district-specific effective reproduction number, as a quantitative measure to compare transmission between different districts and give input for informed decisions on control measures and resource allocation. Prediction and assessing the impact of control measures proved to be difficult without more accurate data. In conclusion, this study provides us a useful tool at district level for public health, and illustrates the importance of collecting and sharing data.	[Santermans, Eva; Ganyani, Tapiwa; Faes, Christel; Kovac, Thomas; Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium; [Robesyn, Emmanuel; Sudre, Bertrand; Quinten, Chantal; Van Bortel, Wim; Testa, Marco; Plachouras, Diamantis] European Ctr Dis Prevent & Control, Stockholm, Sweden; [Haber, Tom; Kovac, Thomas; Van Reeth, Frank] tUL, iMinds, Expertise Ctr Digital Media, Diepenbeek, Belgium; [Testa, Marco] Univ Turin, Dept Publ Hlth, Turin, Italy; [Hens, Niel] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium	Hasselt University; European Centre for Disease Prevention & Control; IMEC; University of Turin	Santermans, E (corresponding author), Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium.	eva.santermans@uhasselt.be	Van Bortel, Wim/AFV-4687-2022; Van Bortel, Wim/AAU-5948-2021; Hens, Niel/M-4445-2017; Faes, Christel/E-1384-2017; Plachouras, Diamantis/AAA-9109-2020	Van Bortel, Wim/0000-0002-6644-518X; Hens, Niel/0000-0003-1881-0637; Faes, Christel/0000-0002-1878-9869; Plachouras, Diamantis/0000-0001-9637-7803; Ganyani, Tapiwa/0000-0002-9116-3117; VAN REETH, Frank/0000-0002-3705-7807	Methusalem research grant from the Flemish government; Antwerp University scientific chair in Evidence-Based Vaccinology; Hercules Foundation; Flemish Government-department EWI	Methusalem research grant from the Flemish government; Antwerp University scientific chair in Evidence-Based Vaccinology; Hercules Foundation; Flemish Government-department EWI	ES acknowledges support from a Methusalem research grant from the Flemish government awarded to Herman Goossens (Antwerpen University) en Geert Molenberghs (Hasselt University). NH acknowledges support from the Antwerp University scientific chair in Evidence-Based Vaccinology, financed in 2009-2015 by an unrestricted gift from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors further acknowledge Valeria Pelosi, for contribution in data collection and Yvan Hutin, for editorial support. The computational resources and services used in this work were provided by the VSC (Flemish Supercomputer Center), funded by the Hercules Foundation and the Flemish Government-department EWI.	Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; Azmon A, 2014, STAT MED, V33, P1176, DOI 10.1002/sim.6015; Bellan SE, 2014, LANCET, V384, P1499, DOI 10.1016/S0140-6736(14)61839-0; Chowell G, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002057, 10.1371/currents.outbreaks.8b55f4bad99ac5c5db3663e916803261]; Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Hawkes N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5089; King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347; Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]; Liberia MoHaSWRo, FACTS EB VIR DIS; Liu HN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106839, 10.1371/currents.outbreaks.b4690859d91684da963dc40e00f3da81]; Majumder Maimuna S, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c; Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6; Moha Sanitation, EB SIT REP; National Ebola Response Centre (NERC), 2014, EVD DAIL MOHS UPD; Nations U., W AFR EB OUTBR 2014; Nishiura H, 2014, EUROSURVEILLANCE, V19; Roberts GO, 2009, J COMPUT GRAPH STAT, V18, P349, DOI 10.1198/jcgs.2009.06134; Rosenthal JS, 2007, COMPUT STAT DATA AN, V51, P5467, DOI 10.1016/j.csda.2007.02.021; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sane J., 2015, OVERCOMING BARRIERS; WHO, 2015, EB OUTBR LIB IS; World Health Organization, 2014, CAS DEF REC EB MARB; World Health Organization, 2015, EB SIT REP 24 JUN 20; World Health Organization, 2015, EB SIT REP 18 MARCH	25	28	29	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147172	10.1371/journal.pone.0147172	http://dx.doi.org/10.1371/journal.pone.0147172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771513	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300069
J	Yang, Y; Yang, YF; Hou, JW; Ding, Y; Zhang, T; Zhang, Y; Wang, JY; Shi, CC; Fu, WW; Cai, ZZ				Yang, Yang; Yang, Yifu; Hou, Jianwei; Ding, Yue; Zhang, Tong; Zhang, Yong; Wang, Jianying; Shi, Chenchen; Fu, Wenwei; Cai, Zhenzhen			The Hydroxyl at Position C1 of Genipin Is the Active Inhibitory Group that Affects Mitochondrial Uncoupling Protein 2 in Panc-1 Cells	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; CANCER-CELLS; APOPTOSIS; GENIPOSIDE; EXPRESSION; CARCINOMA; ANTIGEN	Genipin (GNP) effectively inhibits uncoupling protein 2 (UCP2), which regulates the leakage of protons across the inner mitochondrial membrane. UCP2 inhibition may induce pancreatic adenocarcinoma cell death by increasing reactive oxygen species (ROS) levels. In this study, the hydroxyls at positions C10 (10-OH) and C1 (1-OH) of GNP were hypothesized to be the active groups that cause these inhibitory effects. Four GNP derivatives in which the hydroxyl at position C10 or C1 was replaced with other chemical groups were synthesized and isolated. Differences in the inhibitory effects of GNP and its four derivatives on pancreatic carcinoma cell (Panc-1) proliferation were assessed. The effects of GNP and its derivatives on apoptosis, UCP2 inhibition and ROS production were also studied to explore the relationship between GNP's activity and its structure. The derivatives with 1-OH substitutions, geniposide (1-GNP1) and 1-ethyl-genipin (1-GNP2) lacked cytotoxic effects, while the other derivatives that retained 1-OH, 10-piv-genipin (10-GNP1) and 10-acetic acid-genipin (10-GNP2) exerted biological effects similar to those of GNP, even in the absence of 10-OH. Thus, 1-OH is the key functional group in the structure of GNP that is responsible for GNP's apoptotic effects. These cytotoxic effects involve the induction of Panc-1 cell apoptosis through UCP2 inhibition and subsequent ROS production.	[Yang, Yang; Yang, Yifu; Shi, Chenchen; Cai, Zhenzhen] Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Expt Ctr Sci & Technol, Shanghai, Peoples R China; [Hou, Jianwei; Ding, Yue; Zhang, Tong; Zhang, Yong; Wang, Jianying] Shanghai Univ Tradit Chinese Med, Expt Ctr Teaching & Learning, Shanghai, Peoples R China; [Fu, Wenwei] Shanghai Univ Tradit Chinese Med, Innovat Tradit Chinese Med Lab, Coll Tradit Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Ding, Y; Zhang, T (corresponding author), Shanghai Univ Tradit Chinese Med, Expt Ctr Teaching & Learning, Shanghai, Peoples R China.	dingyue-2001@hotmail.com; zhangtongshutcm@hotmail.com	Fu, Wenwei/AAD-6756-2020		National Natural Science Foundation of China [81173561, 81274200, 81403175]; Shanghai Municipal Commission of Health and Family planning [20134Y053]; Youth Talent Sail Plan from Shanghai Committee of Science and Technology [14YF1411300]; Shanghai Committee of Science and Technology [13401900301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family planning; Youth Talent Sail Plan from Shanghai Committee of Science and Technology; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the following sources of funding: 1. National Natural Science Foundation of China [Grant No.81173561, TZ] and Project from Shanghai Municipal Commission of Health and Family planning [Grant No. 20134Y053, TZ]; 2. National Natural Science Foundation of China [81274200, ZZC]; and 3. National Natural Science Foundation of China [Grant No.81403175, YD], Youth Talent Sail Plan from Shanghai Committee of Science and Technology [Grant No. 14YF1411300, YD] and Project from Shanghai Committee of Science and Technology [Grant No. 13401900301, YD].	AKAO T, 1994, BIOL PHARM BULL, V17, P1573; Cao HL, 2010, BIOL PHARM BULL, V33, P1343, DOI 10.1248/bpb.33.1343; Chang YC, 2004, TOXICOL APPL PHARM, V198, P11, DOI 10.1016/j.taap.2004.03.004; Dalla Pozza E, 2012, BBA-MOL CELL RES, V1823, P1856, DOI 10.1016/j.bbamcr.2012.06.007; Dando I, 2013, BBA-MOL CELL RES, V1833, P672, DOI 10.1016/j.bbamcr.2012.10.028; DARLINGTON GJ, 1987, IN VITRO CELL DEV B, V23, P349; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Ding Y, 2011, ZHONG YAO CAI, V34, P1448; Ding Yue, 2011, Zhong Yao Cai, V34, P623; Donadelli M, 2015, WORLD J GASTROENTERO, V21, P3232, DOI 10.3748/wjg.v21.i11.3232; Feng QA, 2011, ACTA PHARMACOL SIN, V32, P519, DOI 10.1038/aps.2010.158; Filippi-Chiela EC, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-147; FUJIKAWA S, 1987, TETRAHEDRON LETT, V28, P4699, DOI 10.1016/S0040-4039(00)96601-2; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Hong HY, 2007, BIOCHEM BIOPH RES CO, V362, P307, DOI 10.1016/j.bbrc.2007.07.165; Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7; Hwa JS, 2011, KOREAN J PHYSIOL PHA, V15, P157, DOI 10.4196/kjpp.2011.15.3.157; Jeon WK, 2011, ARCH BIOCHEM BIOPHYS, V512, P119, DOI 10.1016/j.abb.2011.05.016; Jina HO, 2008, LUNG CANCER, V61, P317, DOI 10.1016/j.lungcan.2008.01.002; Kang K, 2010, BIOTECHNOL LETT, V32, P1045, DOI 10.1007/s10529-010-0277-x; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; LAN MS, 1990, CANCER RES, V50, P2997; Li CC, 2012, FOOD CHEM TOXICOL, V50, P2978, DOI 10.1016/j.fct.2012.05.054; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Lin Lin, 2010, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V27, P1327; Liu LM, 2014, ANTIOXID REDOX SIGN, V21, P1571, DOI 10.1089/ars.2013.5519; Lu Y, 2008, ACTA U TRAD MED SINE, V22, P76; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Okada K, 2007, AM J PHYSIOL-GASTR L, V292, pG1450, DOI 10.1152/ajpgi.00302.2006; OSHIMA T, 1988, J CHROMATOGR, V455, P410, DOI 10.1016/S0021-9673(01)82148-8; Qiu WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041391; Soltany-Rezaee-Rad M, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/185035; Tanaka M, 2009, BIOL PHARM BULL, V32, P1220, DOI 10.1248/bpb.32.1220; TOUYAMA R, 1994, CHEM PHARM BULL, V42, P1571; Yang X, 2013, J PHARMACOL SCI, V121, P272, DOI 10.1254/jphs.12234FP; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	38	2	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147026	10.1371/journal.pone.0147026	http://dx.doi.org/10.1371/journal.pone.0147026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771380	gold, Green Submitted, Green Published			2022-12-26	WOS:000368628300054
J	Collins, JA; Wood, ST; Nelson, KJ; Rowe, MA; Carlson, CS; Chubinskaya, S; Poole, LB; Furdui, CM; Loeser, RF				Collins, John A.; Wood, Scott T.; Nelson, Kimberly J.; Rowe, Meredith A.; Carlson, Cathy S.; Chubinskaya, Susan; Poole, Leslie B.; Furdui, Cristina M.; Loeser, Richard F.			Oxidative Stress Promotes Peroxiredoxin Hyperoxidation and Attenuates Pro-survival Signaling in Aging Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; cell signaling; osteoarthritis; oxidative stress; peroxiredoxin; redox signaling	HUMAN ARTICULAR CHONDROCYTES; ISOLATED RAT HEPATOCYTES; OSTEOGENIC PROTEIN-1; THIOL HOMEOSTASIS; DOWN-REGULATION; REDOX STATE; CELL-DEATH; MITOCHONDRIA; OSTEOARTHRITIS; MENADIONE	Oxidative stress-mediated post-translational modifications of redox-sensitive proteins are postulated as a key mechanism underlying age-related cellular dysfunction and disease progression. Peroxiredoxins (PRX) are critical intracellular antioxidants that also regulate redox signaling events. Age-related osteoarthritis is a common form of arthritis that has been associated with mitochondrial dysfunction and oxidative stress. The objective of this study was to determine the effect of aging and oxidative stress on chondrocyte intracellular signaling, with a specific focus on oxidation of cytosolic PRX2 and mitochondrial PRX3. Menadione was used as a model to induce cellular oxidative stress. Compared with chondrocytes isolated from young adult humans, chondrocytes from older adults exhibited higher levels of PRX1-3 hyperoxidation basally and under conditions of oxidative stress. Peroxiredoxin hyperoxidation was associated with inhibition of pro-survival Akt signaling and stimulation of pro-death p38 signaling. These changes were prevented in cultured human chondrocytes by adenoviral expression of catalase targeted to the mitochondria (MCAT) and in cartilage explants from MCAT transgenic mice. Peroxiredoxin hyperoxidation was observed in situ in human cartilage sections from older adults and in osteoarthritic cartilage. MCAT transgenic mice exhibited less age-related osteoarthritis. These findings demonstrate that age-related oxidative stress can disrupt normal physiological signaling and contribute to osteoarthritis and suggest peroxiredoxin hyperoxidation as a potential mechanism.	[Collins, John A.; Wood, Scott T.; Rowe, Meredith A.; Loeser, Richard F.] Univ N Carolina, Div Rheumatol Allergy & Immunol, 3300 Thurston Bldg,CB 7280, Chapel Hill, NC 27599 USA; [Collins, John A.; Wood, Scott T.; Rowe, Meredith A.; Loeser, Richard F.] Univ N Carolina, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB 7280, Chapel Hill, NC 27599 USA; [Nelson, Kimberly J.; Poole, Leslie B.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Rowe, Meredith A.; Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Carlson, Cathy S.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Chubinskaya, Susan] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; Rush University	Loeser, RF (corresponding author), Univ N Carolina, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB 7280, Chapel Hill, NC 27599 USA.	Richard_loeser@med.unc.edu	Wood, Scott/I-6133-2019; Core UNC, Hooker Imaging/AAE-1484-2022	Wood, Scott/0000-0002-6747-0547; Furdui, Cristina M./0000-0003-3771-7999; Poole, Leslie/0000-0003-0334-7328; Nelson, Kimberly/0000-0003-2464-7696	National Institute on Aging [RO1 AG044034]; Ciba-Geigy Endowed Chair of Biochemistry from Rush University Medical Center; NATIONAL INSTITUTE ON AGING [R01AG044034] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ciba-Geigy Endowed Chair of Biochemistry from Rush University Medical Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging Grant RO1 AG044034 (to R. F. L.) and the Ciba-Geigy Endowed Chair of Biochemistry from Rush University Medical Center (to S. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn J, 2013, APOPTOSIS, V18, P870, DOI 10.1007/s10495-013-0835-5; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Blanco FJ, 2011, NAT REV RHEUMATOL, V7, P161, DOI 10.1038/nrrheum.2010.213; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; delPeso L, 1997, SCIENCE, V278, P687; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P334, DOI 10.1016/0003-9861(84)90206-6; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gavriilidis C, 2013, ARTHRITIS RHEUM-US, V65, P378, DOI 10.1002/art.37782; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Jones DP, 2006, REJUV RES, V9, P169, DOI 10.1089/rej.2006.9.169; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Koike M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11722; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Levy YD, 2013, ANN RHEUM DIS, V72, P271, DOI 10.1136/annrheumdis-2012-201730; Loeser RF, 2003, ARTHRITIS RHEUM, V48, P2188, DOI 10.1002/art.11209; Loeser RF, 2002, ARTHRITIS RHEUM, V46, P2349, DOI 10.1002/art.10496; Loeser RF, 2014, ARTHRITIS RHEUMATOL, V66, P2201, DOI 10.1002/art.38641; Loeser RF, 2013, CURR OPIN RHEUMATOL, V25, P108, DOI 10.1097/BOR.0b013e32835a9428; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; McAmis WC, 2003, BBA-MOL CELL RES, V1641, P43, DOI 10.1016/S0167-4889(03)00063-6; McNulty MA, 2011, CARTILAGE, V2, P354, DOI 10.1177/1947603511402665; Nystrom T, 2012, GENE DEV, V26, P2001, DOI 10.1101/gad.200006.112; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Pelletier JP, 2001, J RHEUMATOL, V28, P2509; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Ruiz-Romero C, 2009, MOL CELL PROTEOMICS, V8, P172, DOI 10.1074/mcp.M800292-MCP200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Singh K, 2015, EMBO MOL MED, V7, P59, DOI 10.15252/emmm.201404082; SMITH PF, 1987, TOXICOL APPL PHARM, V89, P190, DOI 10.1016/0041-008X(87)90040-8; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; TOXOPEUS C, 1993, ARCH TOXICOL, V67, P674, DOI 10.1007/BF01973690; Ulici V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008866; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vilela M, 2013, METHOD ENZYMOL, V519, P253, DOI 10.1016/B978-0-12-405539-1.00009-9; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838	59	66	69	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6641	6654		10.1074/jbc.M115.693523	http://dx.doi.org/10.1074/jbc.M115.693523			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26797130	Green Published, hybrid			2022-12-26	WOS:000373299700003
J	Li, Q; Lex, RK; Chung, H; Giovanetti, SM; Ji, ZC; Ji, HK; Person, MD; Kim, J; Vokes, SA				Li, Qiang; Lex, Rachel K.; Chung, HaeWon; Giovanetti, Simone M.; Ji, Zhicheng; Ji, Hongkai; Person, Maria D.; Kim, Jonghwan; Vokes, Steven A.			The Pluripotency Factor NANOG Binds to GLI Proteins and Represses Hedgehog-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; embryonic stem cell; Hedgehog signaling pathway; stem cells; transcription repressor; GLI proteins; Nanog; repressor	EMBRYONIC STEM-CELLS; REGULATORY CIRCUITRY; INTERACTION NETWORK; SIGNALING PATHWAY; SELF-RENEWAL; SPINAL-CORD; EXPRESSION; DAX1; GENE; ACTIVATION	The Hedgehog (HH) signaling pathway is essential for the maintenance and response of several types of stem cells. To study the transcriptional response of stem cells to HH signaling, we searched for proteins binding to GLI proteins, the transcriptional effectors of the HH pathway in mouse embryonic stem (ES) cells. We found that both GLI3 and GLI1 bind to the pluripotency factor NANOG. The ectopic expression of NANOG inhibits GLI1-mediated transcriptional responses in a dose-dependent fashion. In differentiating ES cells, the presence of NANOG reduces the transcriptional response of cells to HH. Finally, we found that Gli1 and Nanog are co-expressed in ES cells at high levels. We propose that NANOG acts as a negative feedback component that provides stem cell-specific regulation of the HH pathway.	[Li, Qiang; Lex, Rachel K.; Chung, HaeWon; Giovanetti, Simone M.; Kim, Jonghwan; Vokes, Steven A.] Univ Texas Austin, Dept Mol Biosci, 2500 Speedway Stop A4800, Austin, TX 78712 USA; [Li, Qiang; Lex, Rachel K.; Chung, HaeWon; Giovanetti, Simone M.; Person, Maria D.; Kim, Jonghwan; Vokes, Steven A.] Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway Stop A4800, Austin, TX 78712 USA; [Person, Maria D.] Univ Texas Austin, Prote Facil, 2500 Speedway Stop A4800, Austin, TX 78712 USA; [Ji, Zhicheng; Ji, Hongkai] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Vokes, SA (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway Stop A4800, Austin, TX 78712 USA.	svokes@austin.utexas.edu	Ji, Zhicheng/I-5650-2019; Kim, Jonghwan/AAR-2815-2021	Ji, Zhicheng/0000-0002-9457-4704; Kim, Jonghwan/0000-0002-9919-9843; Vokes, Steven/0000-0002-1724-0102	National Institutes of Health [R01HG006282, R01HD073151]; Cancer Prevention Research Institute of Texas [RP120343, RP110782]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073151] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health Grants R01HG006282 (to H. J.) and R01HD073151 (to S. A. V.) and Cancer Prevention Research Institute of Texas Grants RP120343 (to S. A. V.) and RP110782 (to M. D. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Alvarez-Buylla A, 2014, SEMIN CELL DEV BIOL, V33, P105, DOI 10.1016/j.semcdb.2014.05.008; Asaoka Y, 2010, J BIOL CHEM, V285, P4185, DOI 10.1074/jbc.M109.038232; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang DF, 2009, STEM CELLS, V27, P812, DOI 10.1634/stemcells.2008-0657; Choi SC, 2012, J CELL PHYSIOL, V227, P3678, DOI 10.1002/jcp.24076; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Falkenstein KN, 2014, SEMIN CELL DEV BIOL, V33, P73, DOI 10.1016/j.semcdb.2014.05.010; Ferent J, 2014, STEM CELL REP, V3, P312, DOI 10.1016/j.stemcr.2014.05.016; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ji ZC, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv873; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Lee CF, 2013, J PROTEOME RES, V12, P4302, DOI 10.1021/pr400201d; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Li J, 2011, BIOCHEM BIOPH RES CO, V412, P660, DOI 10.1016/j.bbrc.2011.08.020; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Park HL, 2000, DEVELOPMENT, V127, P1593; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Platt KA, 1997, MECH DEVELOP, V62, P121, DOI 10.1016/S0925-4773(96)00648-X; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takata K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3338; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Uranishi K, 2013, MOL CELL BIOL, V33, P2056, DOI 10.1128/MCB.01520-12; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Wu G, 2013, BIOINFORMATICS, V29, P1182, DOI 10.1093/bioinformatics/btt108; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6042	58	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7171	7182		10.1074/jbc.M116.714857	http://dx.doi.org/10.1074/jbc.M116.714857			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26797124	Green Published, hybrid			2022-12-26	WOS:000373299700049
J	Fu, WM; Sun, J; Huang, GC; Liu, JC; Kaufman, A; Ryan, RJH; Ramanathan, SY; Venkatesh, T; Singh, B				Fu, Weimin; Sun, Joanne; Huang, Guochang; Liu, Jeffrey C.; Kaufman, Andrew; Ryan, Russell J. H.; Ramanathan, Suresh Y.; Venkatesh, Tadmiri; Singh, Bhuvanesh			Squamous Cell Carcinoma-related Oncogene (SCCRO) Family Members Regulate Cell Growth and Proliferation through Their Cooperative and Antagonistic Effects on Cullin Neddylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						head and neck cancer; lung cancer; oncogene; tumor suppressor gene; ubiquitylation (ubiquitination)	DROSOPHILA-MELANOGASTER; E3 LIGASE; UBIQUITIN-LIGASE; PROTEIN NEDD8; COMPETITION; MECHANISMS; STABILITY; LIGATION; GENE; CUL1	SCCRO (squamous cell carcinoma-related oncogene; also known as DCUN1D1) is a highly conserved gene that functions as an E3 in neddylation. Although inactivation of SCCRO in yeast results in lethality, SCCRO-/- mice are viable. The exclusive presence of highly conserved paralogues in higher organisms led us to assess whether compensation by SCCRO paralogues rescues lethality in SCCRO-/- mice. Using murine and Drosophila models, we assessed the in vivo activities of SCCRO and its paralogues in cullin neddylation. We found that SCCRO family members have overlapping and antagonistic activity that regulates neddylation and cell proliferation activities in vivo. In flies, both dSCCRO and dSCCRO3 promote neddylation and cell proliferation, whereas dSCCRO4 negatively regulates these processes. Analysis of somatic clones showed that the effects that these paralogues have on proliferation serve to promote cell competition, leading to apoptosis in clones with a net decrease in neddylation activity. We found that dSCCRO and, to a lesser extent, dSCCRO3 rescue the neddylation and proliferation defects promoted by expression of SCCRO4. dSCCRO and dSCCRO3 functioned cooperatively, with their coexpression resulting in an increase in both the neddylated cullin fraction and proliferation activity. In contrast, human SCCRO and SCCRO4 promote, and human SCCRO3 inhibits, neddylation and proliferation when expressed in flies. Our findings provide the first insights into the mechanisms through which SCCRO family members cooperatively regulate neddylation and cell proliferation.	[Fu, Weimin; Sun, Joanne; Huang, Guochang; Liu, Jeffrey C.; Kaufman, Andrew; Ryan, Russell J. H.; Ramanathan, Suresh Y.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Lab Epithelial Canc Biol, Dept Surg, New York, NY 10065 USA; [Venkatesh, Tadmiri] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Liu, Jeffrey C.] Temple Univ, Div Head & Neck Oncol Surg, Philadelphia, PA 19140 USA; [Kaufman, Andrew; Ramanathan, Suresh Y.] Mt Sinai Med Ctr, Dept Thorac Surg, New York, NY 10029 USA; [Ryan, Russell J. H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ryan, Russell J. H.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ryan, Russell J. H.] Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA	Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; City College of New York (CUNY); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Singh, B (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	singhb@mskcc.org		Ryan, Russell/0000-0001-8174-3962; Liu, Jeffrey/0000-0001-8377-0905	NCI, National Institutes of Health [P30 CA008748, U54CA137788/U54CA132378]; Hackers for Hope; NATIONAL CANCER INSTITUTE [U54CA132378, U54CA137788, P30CA008748] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hackers for Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant P30 CA008748, NCI, National Institutes of Health Grant U54CA137788/U54CA132378 (to B. S. and T. V.), and a grant from Hackers for Hope (to B. S.). The authors declare they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Bommelje CC, 2014, CLIN CANCER RES, V20, P372, DOI 10.1158/1078-0432.CCR-13-1252; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Estilo CL, 2003, CLIN CANCER RES, V9, P2300; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Huang GC, 2014, J BIOL CHEM, V289, P34728, DOI 10.1074/jbc.M114.585505; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kim SH, 2010, DEV BIOL, V346, P247, DOI 10.1016/j.ydbio.2010.07.031; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Ma T, 2008, CANCER SCI, V99, P2128, DOI 10.1111/j.1349-7006.2008.00929.x; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Morata G, 2007, DEV CELL, V13, P1, DOI 10.1016/j.devcel.2007.06.002; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reynolds PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002918; ROBERTSON HM, 1988, GENETICS, V118, P461; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Vincent JP, 2013, NAT REV MOL CELL BIO, V14, P581, DOI 10.1038/nrm3639; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045	44	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6200	6217		10.1074/jbc.M115.692756	http://dx.doi.org/10.1074/jbc.M115.692756			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26792857	Green Published, hybrid			2022-12-26	WOS:000372894200013
J	Kim, J; Medicherla, CB; Ma, CL; Feher, A; Kukar, N; Geevarghese, A; Goyal, P; Horn, E; Devereux, RB; Weinsaft, JW				Kim, Jiwon; Medicherla, Chaitanya B.; Ma, Claudia L.; Feher, Attila; Kukar, Nina; Geevarghese, Alexi; Goyal, Parag; Horn, Evelyn; Devereux, Richard B.; Weinsaft, Jonathan W.			Association of Right Ventricular Pressure and Volume Overload with Non-Ischemic Septal Fibrosis on Cardiac Magnetic Resonance	PLOS ONE			English	Article							LATE GADOLINIUM ENHANCEMENT; ARTERY SYSTOLIC PRESSURE; PULMONARY-HYPERTENSION; DILATED CARDIOMYOPATHY; WALL STRESS; MASS; MORTALITY; PATTERN	Background Non-ischemic fibrosis (NIF) on cardiac magnetic resonance (CMR) has been linked to poor prognosis, but its association with adverse right ventricular (RV) remodeling is unknown. This study examined a broad cohort of patients with RV dysfunction, so as to identify relationships between NIF and RV remodeling indices, including RV pressure load, volume and wall stress. Methods and Results The population comprised patients with RV dysfunction (EF<50%) undergoing CMR and transthoracic echo within a 14 day (5 3) interval. Cardiac structure, function, and NIF were assessed on CMR. Pulmonary artery systolic pressure (PASP) was measured on echo. 118 patients with RV dysfunction were studied, among whom 47% had NIF. Patients with NIF had lower RVEF (34 +/- 10 vs. 39 +/- 9%; p = 0.01) but similar LVEF (40 +/- 21 vs. 39 +/- 8%; p = 0.7) and LV volumes (p = NS). RV wall stress was higher with NIF (17 +/- 7 vs. 12 +/- 6 kPa; p<0.001) corresponding to increased RV end-systolic volume (143 +/- 79 vs. 110 +/- 36 ml; p = 0.006), myocardial mass (60 +/- 21 vs. 53 +/- 17 gm; p = 0.04), and PASP (52 +/- 18 vs. 41 +/- 18 mmHg; p = 0.001). NIF was associated with increased wall stress among subgroups with isolated RV (p = 0.005) and both RV and LV dysfunction (p = 0.003). In multivariable analysis, NIF was independently associated with RV volume (OR = 1.17 per 10 ml, [CI 1.041.32]; p = 0.01) and PASP (OR = 1.43 per 10 mmHg, [1.14-1.81]; p = 0.002) but not RV mass (OR = 0.91 per 10 gm, [0.69-1.20]; p = 0.5) [model x2 = 21; p<0.001]. NIF prevalence was higher in relation to PA pressure and RV dilation and was > 6-fold more common in the highest, vs. the lowest, common tertile of PASP and RV size (p<0.001). Conclusion Among wall stress components, NIF was independently associated with RV chamber dilation and afterload, supporting the concept that NIF is linked to adverse RV chamber remodeling.	[Kim, Jiwon; Medicherla, Chaitanya B.; Ma, Claudia L.; Feher, Attila; Geevarghese, Alexi; Goyal, Parag; Horn, Evelyn; Devereux, Richard B.; Weinsaft, Jonathan W.] Weill Cornell Med Coll, Dept Med, Greenberg Cardiol Div, New York, NY USA; [Kim, Jiwon; Weinsaft, Jonathan W.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Kukar, Nina; Weinsaft, Jonathan W.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center	Weinsaft, JW (corresponding author), Weill Cornell Med Coll, Dept Med, Greenberg Cardiol Div, New York, NY USA.; Weinsaft, JW (corresponding author), Weill Cornell Med Coll, Dept Radiol, New York, NY USA.; Weinsaft, JW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	jik9027@med.cornell.edu			United States National Institutes of Health [K23 HL102249-01]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102249] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was conducted with salary support as provided by the United States National Institutes of Health (grant number K23 HL102249-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter P, 2011, EUR J HEART FAIL, V13, P937, DOI 10.1093/eurjhf/hfr082; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Babu-Narayan SV, 2006, CIRCULATION, V113, P405, DOI 10.1161/CIRCULATIONAHA.105.548727; Blyth KG, 2005, EUR HEART J, V26, P1993, DOI 10.1093/eurheartj/ehi328; Codella NCF, 2008, RADIOLOGY, V248, P1004, DOI 10.1148/radiol.2482072016; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Freed BH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-11; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Kim J, 2014, INT J CARDIOVAS IMAG, V30, P1559, DOI 10.1007/s10554-014-0487-8; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Lehrke S, 2011, HEART, V97, P727, DOI 10.1136/hrt.2010.205542; Mauritz GJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-5; MCKENZIE JC, 1994, J MOL CELL CARDIOL, V26, P753, DOI 10.1006/jmcc.1994.1090; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Oikawa M, 2005, J AM COLL CARDIOL, V45, P1849, DOI 10.1016/j.jacc.2005.02.065; Otto C., 2012, PRACTICE CLIN ECHOCA; Sanz J, 2007, AM J CARDIOL, V100, P731, DOI 10.1016/j.amjcard.2007.03.094; Shehata ML, 2011, AM J ROENTGENOL, V196, P87, DOI 10.2214/AJR.09.4114; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; Swift AJ, 2014, JACC-CARDIOVASC IMAG, V7, P1209, DOI 10.1016/j.jcmg.2014.08.014; Tandri H, 2006, AM J CARDIOL, V98, P1660, DOI 10.1016/j.amjcard.2006.07.049; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477	25	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147349	10.1371/journal.pone.0147349	http://dx.doi.org/10.1371/journal.pone.0147349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799498	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300099
J	Berdej, SM; Armitage, DR				Berdej, Samantha M.; Armitage, Derek R.			Bridging Organizations Drive Effective Governance Outcomes for Conservation of Indonesia's Marine Systems	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; PROTECTED AREA NETWORKS; CORAL-REEF MANAGEMENT; ADAPTIVE COMANAGEMENT; KNOWLEDGE GENERATION; TRADE-OFFS; CHALLENGES; INSTITUTIONS; LANDSCAPE; DECLINE	This study empirically investigates the influence of bridging organizations on governance outcomes for marine conservation in Indonesia. Conservation challenges require ways of governing that are collaborative and adaptive across boundaries, and where conservation actions are better coordinated, information flows improved, and knowledge better integrated and mobilized. We combine quantitative social network analysis and qualitative data to analyze bridging organizations and their networks, and to understand their contributions and constraints in two case studies in Bali, Indonesia. The analysis shows 1) bridging organizations help to navigate the 'messiness' inherent in conservation settings by compensating for sparse linkages, 2) the particular structure and function of bridging organizations influence governing processes (i.e., collaboration, knowledge sharing) and subsequent conservation outcomes, 3) 'bridging' is accomplished using different strategies and platforms for collaboration and social learning, and 4) bridging organizations enhance flexibility to adjust to changing marine conservation contexts and needs. Understanding the organizations that occupy bridging positions, and how they utilize their positionality in a governance network is emerging as an important determinant of successful conservation outcomes. Our findings contribute to a relatively new body of literature on bridging organizations in marine conservation contexts, and add needed empirical investigation into their value to governance and conservation in Coral Triangle nations and beyond.	[Berdej, Samantha M.] Univ Waterloo, Environm Change & Governance Grp, Dept Geog & Environm Management, Waterloo, ON N2L 3G1, Canada; [Armitage, Derek R.] Univ Waterloo, Environm Change & Governance Grp, Sch Environm Resources & Sustainabil, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Berdej, SM (corresponding author), Univ Waterloo, Environm Change & Governance Grp, Dept Geog & Environm Management, Waterloo, ON N2L 3G1, Canada.	smberdej@uwaterloo.ca	Lobo, Diele/I-9106-2012; Armitage, Derek/ABE-6315-2020		International Development Research Centre of Canada [107473-99906075-011]; Social Sciences and Humanities Research Council of Canada [752-2014-1793, 410-2010-1109]; Social Sciences and Humanities - Research Council of Canada Partnership Grant for the Community Conservation Research Network [895-2011-1017]	International Development Research Centre of Canada(CGIAR); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Social Sciences and Humanities - Research Council of Canada Partnership Grant for the Community Conservation Research Network	This research was supported by an International Development Research Centre of Canada Award (no. 107473-99906075-011) to SB, Social Sciences and Humanities Research Council of Canada Awards to SB (no. 752-2014-1793) and DA (no. 410-2010-1109), as well as a Social Sciences and Humanities Funded by Research Council of Canada Partnership Grant for the Community Conservation Research Network (no. 895-2011-1017) to DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SM, 2014, SOCIAL RELATIONAL NE; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Armitage D, 2008, INT J COMMONS, V2, P2; Armitage D, 2008, GLOBAL ENVIRON CHANG, V18, P86, DOI 10.1016/j.gloenvcha.2007.07.002; Armitage D, 2012, CONSERV LETT, V5, P245, DOI 10.1111/j.1755-263X.2012.00238.x; Armitage DR, 2009, FRONT ECOL ENVIRON, V7, P95, DOI 10.1890/070089; Berdej S, 2015, CONSERVATIO IN PRESS; Berkes F, 2009, J ENVIRON MANAGE, V90, P1692, DOI 10.1016/j.jenvman.2008.12.001; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; BPS: Bandan Pusat Statistic Kabupaten Buleleng, 2014, STAT DAER KEC TEJ 20; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L, 2012, REEFS RISK REVISITED; Campbell SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050074; Cinner J, 2006, ECOL SOC, V11; Clifton J, 2012, SOC NATUR RESOUR, V25, P716, DOI 10.1080/08941920.2011.618487; Cohen PJ, 2012, CONSERV LETT, V5, P376, DOI 10.1111/j.1755-263X.2012.00255.x; Coral Triangle Initiative Secretariat, 2009, REG PLAN ACT COR TRI; Crona BI, 2012, ECOL SOC, V17, DOI 10.5751/ES-04534-170132; Crona BI, 2006, ECOL SOC, V11; Cros A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096332; CTC, 2014, NUS PEN EST MPA LEAR; CTC: Coral Triangle Center, 2015, US VIS MISS; CTI Leaders Declaration, 2009, COR TRIANGL IN LEAD; De Meo P, 2012, KNOWL-BASED SYST, V30, P136, DOI 10.1016/j.knosys.2012.01.007; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dougill AJ, 2010, ECOL SOC, V15; Erviani N., 2014, JAKARTA POST; Evans LS, 2011, ECOL SOC, V16; Fidelman P, 2014, OCEAN COAST MANAGE, V95, P117, DOI 10.1016/j.ocecoaman.2014.04.001; Fidelman P, 2012, MAR POLICY, V36, P42, DOI 10.1016/j.marpol.2011.03.007; Foale S, 2013, MAR POLICY, V38, P174, DOI 10.1016/j.marpol.2012.05.033; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Frey JB, 2014, INT J COMMONS, V8, P26; Green S. J., 2011, Conservation and Society, V9, P173, DOI 10.4103/0972-4923.86986; Hahn T, 2006, HUM ECOL, V34, P573, DOI 10.1007/s10745-006-9035-z; Hay I., 2010, QUALITATIVE RES METH, VThird; Hirsch PD, 2011, CONSERV BIOL, V25, P259, DOI 10.1111/j.1523-1739.2010.01608.x; Horigue V, 2012, OCEAN COAST MANAGE, V64, P15, DOI 10.1016/j.ocecoaman.2012.04.012; Jacobson Cynthia, 2012, Human Dimensions of Wildlife, V17, P333, DOI 10.1080/10871209.2012.709310; Kark S, 2015, CURR OPIN ENV SUST, V12, P12, DOI 10.1016/j.cosust.2014.08.005; LINI: Indonesian Nature Foundation, AB US; Lowry GT, 2009, COASTAL MANAGEMENT, V37, P335; Majors C, 2008, BIODIVERSITY AND HUMAN LIVELIHOODS IN PROTECTED AREAS: CASE STUDIES FROM THE MALAY ARCHIPELAGO, P241; Marin A, 2010, MAR POLICY, V34, P851, DOI 10.1016/j.marpol.2010.01.007; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mills M, 2010, CONSERV LETT, V3, P291, DOI 10.1111/j.1755-263X.2010.00134.x; Mustika PL, 2013, RAP B BIOL ASSESSMEN, V64; Newig J, 2010, ECOL SOC, V15; Olsson P, 2007, ECOL SOC, V12; Patlis JM, 2005, OCEAN COAST MANAGE, V48, P450, DOI 10.1016/j.ocecoaman.2005.04.005; Prell Christina., 2011, SOCIAL NETWORK ANAL; RC-I: Reef Check Indonesia, WHO WE ARE; Rosen F, 2013, MAR POLICY, V38, P195, DOI 10.1016/j.marpol.2012.05.036; Satria Arif, 2006, Environment Development and Sustainability, V8, P99, DOI 10.1007/s10668-005-0909-9; Schultz L, 2011, ENVIRON EDUC RES, V16, P645; von Heland F, 2014, GLOBAL ENVIRON CHANG, V29, P53, DOI 10.1016/j.gloenvcha.2014.08.003; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Weeks Rebecca, 2014, F1000Res, V3, P91, DOI 10.12688/f1000research.3886.3; Weeks R, 2014, COAST MANAGE, V42, P183, DOI 10.1080/08920753.2014.877768; Welly M, 2009, LOCAL COMMUNITY LEMB	62	45	46	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147142	10.1371/journal.pone.0147142	http://dx.doi.org/10.1371/journal.pone.0147142			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5CE	26794003	Green Published, gold, Green Submitted			2022-12-26	WOS:000368530300019
J	Koga, T; Minamizato, T; Kawai, Y; Miura, K; Takashi, I; Nakatani, Y; Sumita, Y; Asahina, I				Koga, Takamitsu; Minamizato, Tokutaro; Kawai, Yosuke; Miura, Kei-ichiro; Takashi, I; Nakatani, Yuya; Sumita, Yoshinori; Asahina, Izumi			Bone Regeneration Using Dentin Matrix Depends on the Degree of Demineralization and Particle Size	PLOS ONE			English	Article							FREEZE-DRIED BONE; RIDGE; ALLOGRAFTS; GRAFTS	Objectives This study aimed to examine the influence of particle size and extent of demineralization of dentin matrix on bone regeneration. Materials and Methods Extracted human teeth were pulverized and divided into 3 groups according to particle size; 200, 500, and 1000 mu m. Each group was divided into 3 groups depending on the extent of demineralization; undemineralized dentin (UDD), partially demineralized dentin matrix (PDDM), and completely demineralized dentin matrix (CDDM). The dentin sample was implanted into rat calvarial bone defects. After 4 and 8 weeks, the bone regeneration was evaluated with micro-CT images, histomorphometric and immunohistochemical analyses. Osteoblasts were cultured on UDD and DDM to evaluate the cell attachment using electron microscope. Results Micro-CT images and histological observation revealed that CDDM had largely resorbed but UDD had not, and both of them induced little bone formation, whereas all particle sizes of PDDM induced more new bone, especially the 1000 mu m. Electron microscopic observation showed osteoblasts attached to DDM but not to UDD. Conclusions PDDM with larger particle size induced prominent bone regeneration, probably because PDDM possessed a suitable surface for cell attachment. There might be an exquisite balance between its resorption and bone formation on it. PDDM could be considered as a potential bone substitute.	[Koga, Takamitsu; Minamizato, Tokutaro; Kawai, Yosuke; Miura, Kei-ichiro; Takashi, I; Nakatani, Yuya; Sumita, Yoshinori; Asahina, Izumi] Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Regenerat Oral Surg, Nagasaki 852, Japan	Nagasaki University	Asahina, I (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Regenerat Oral Surg, Nagasaki 852, Japan.	asahina@nagasaki-u.ac.jp	Kawai, Yosuke/S-4496-2019	Kawai, Yosuke/0000-0003-0666-1224; I, Takashi/0000-0001-5167-5268; Nakatani, Yuya/0000-0002-1289-3921	Japan Society for Promotion of Science [25293413, 2643017]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (25293413, 2643017) from the Japan Society for Promotion of Science.	AMES JR, 1981, ORAL SURG ORAL MED O, V51, P588, DOI 10.1016/S0030-4220(81)80005-9; Artzi Z, 2003, INT J ORAL MAX IMPL, V18, P440; Bath M., 2006, ILLUSTRATED DENT EMB, P49; BUTLER WT, 1977, J DENT RES, V56, P228, DOI 10.1177/00220345770560030601; Cammack GV, 2005, INT J PERIODONT REST, V25, P231; Endoh T, 1990, JPN SOC ORAL MAXILLO, V36, P898; FINKELMAN RD, 1990, J BONE MINER RES, V5, P717; FONSECA RJ, 1983, J ORAL MAXIL SURG, V41, P153, DOI 10.1016/0278-2391(83)90073-3; FUCINI SE, 1993, J PERIODONTOL, V64, P844, DOI 10.1902/jop.1993.64.9.844; Fugazzotto P A, 1986, Quintessence Int, V17, P461; GLOWACKI J, 1981, LANCET, V1, P959; Glowacki J, 2015, J ORAL MAXIL SURG, V73, pS126, DOI 10.1016/j.joms.2015.04.009; Gomes Mônica Fernandes, 2006, Braz. oral res., V20, P324, DOI 10.1590/S1806-83242006000400008; Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034; Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1; HOLMES R, 1984, CLIN ORTHOP RELAT R, P252; Ihoki M, 1991, JPN SOC ORAL MAXILLO, V37, P1923; INOUE T, 1986, J PERIODONTAL RES, V21, P243, DOI 10.1111/j.1600-0765.1986.tb01456.x; Ito k, 2008, ARCH BIOCERAM RES, V8, P166; KAWAI T, 1989, J DENT RES, V68, P1069, DOI 10.1177/00220345890680060301; KENT JN, 1983, J ORAL MAXIL SURG, V41, P629, DOI 10.1016/0278-2391(83)90016-2; Kim SG, 2001, J CRANIO MAXILL SURG, V29, P282, DOI 10.1054/jcms.2001.0236; Kim YK, 2010, ORAL SURG ORAL MED O, V109, P496, DOI 10.1016/j.tripleo.2009.10.017; Kluppel LE, 2013, J CRANIOFAC SURG, V24, P1074, DOI 10.1097/SCS.0b013e318286a0a3; Kon K, 2009, CLIN ORAL IMPLAN RES, V20, P1240, DOI 10.1111/j.1600-0501.2009.01798.x; Lee JY, 2013, J KOR ASSOC ORAL MAX, V39, P156, DOI 10.5125/jkaoms.2013.39.4.156; Li R, 2011, BIOMATERIALS, V32, P4525, DOI 10.1016/j.biomaterials.2011.03.008; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Murata M, 2012, J KOR ASSOC ORAL MAX, V38, P321, DOI 10.5125/jkaoms.2012.38.6.321; Piattelli A, 1996, BIOMATERIALS, V17, P1127, DOI 10.1016/0142-9612(96)85915-1; Scheven BAA, 2002, CELL BIOL INT, V26, P337, DOI 10.1006/cbir.2002.0860; SHAPOFF CA, 1980, J PERIODONTOL, V51, P625, DOI 10.1902/jop.1980.51.11.625; Simion M, 1998, Int J Periodontics Restorative Dent, V18, P8; Turonis James W, 2006, J Oral Implantol, V32, P55, DOI 10.1563/780.1; von Arx T, 1996, Int J Oral Maxillofac Implants, V11, P387; Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x; YAMASHITA F, 1985, CLIN ORTHOP RELAT R, P43; Yoshida T, 1998, J ENDODONT, V24, P581, DOI 10.1016/S0099-2399(98)80114-3; Young C, 1999, INT J ORAL MAX IMPL, V14, P72	39	51	60	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147235	10.1371/journal.pone.0147235	http://dx.doi.org/10.1371/journal.pone.0147235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795024	gold, Green Published, Green Submitted			2022-12-26	WOS:000368530300024
J	Niella, T; Stier-Moses, N; Sigman, M				Niella, Tamara; Stier-Moses, Nicolas; Sigman, Mariano			Nudging Cooperation in a Crowd Experiment	PLOS ONE			English	Article							TRUST GAME; EXPECTATIONS; BEHAVIOR; WORLD	We examine the hypothesis that driven by a competition heuristic, people don't even reflect or consider whether a cooperation strategy may be better. As a paradigmatic example of this behavior we propose the zero-sum game fallacy, according to which people believe that resources are fixed even when they are not. We demonstrate that people only cooperate if the competitive heuristic is explicitly overridden in an experiment in which participants play two rounds of a game in which competition is suboptimal. The observed spontaneous behavior for most players was to compete. Then participants were explicitly reminded that the competing strategy may not be optimal. This minor intervention boosted cooperation, implying that competition does not result from lack of trust or willingness to cooperate but instead from the inability to inhibit the competition bias. This activity was performed in a controlled laboratory setting and also as a crowd experiment. Understanding the psychological underpinnings of these behaviors may help us improve cooperation and thus may have vast practical consequences to our society.	[Niella, Tamara; Stier-Moses, Nicolas; Sigman, Mariano] Univ Torcuato Tella, C1428BIJ, Buenos Aires, DF, Argentina; [Stier-Moses, Nicolas; Sigman, Mariano] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Stier-Moses, Nicolas] Facebook Data Sci, San Francisco, CA USA	Universidad Torcuato Di Tella; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Facebook Inc	Sigman, M (corresponding author), Univ Torcuato Tella, C1428BIJ, Buenos Aires, DF, Argentina.; Sigman, M (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	sigman@utdt.edu	Stier-Moses, Nicolas/R-5236-2018	Stier-Moses, Nicolas/0000-0001-6380-1516	CONICET (El Consejo Nacional de Investigaciones Cientificas y Tecnicas) Argentina [PIP 112-201201-00450CO]; FONCYT (Fondo para la Investigacion Cientifica y Tecnologica) Argentina [PICT 2012-1324]; CONICET; FONCYT Argentina [PICT-2013-1653]; James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition - Scholar Award	CONICET (El Consejo Nacional de Investigaciones Cientificas y Tecnicas) Argentina; FONCYT (Fondo para la Investigacion Cientifica y Tecnologica) Argentina(FONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT Argentina(FONCyT); James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition - Scholar Award	Financial support from CONICET (El Consejo Nacional de Investigaciones Cientificas y Tecnicas) Argentina Grant PIP 112-201201-00450CO and FONCYT (Fondo para la Investigacion Cientifica y Tecnologica) Argentina Grant PICT 2012-1324. M.S. is sponsored by CONICET, FONCYT Argentina Grant PICT-2013-1653 and the James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition - Scholar Award.; We gratefully acknowledge financial support from CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) Argentina Grant PIP 112-201201-00450CO and FONCYT (Fondo para la Investigacion Cientifica y Tecnologica) Argentina Grant PICT 2012-1324. M.S. is sponsored by CONICET, FONCYT Argentina Grant PICT-2013-1653 and the James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition-Scholar Award. We would like to thank Gerry Garbulsky, Mariano Bergman, Jimena Jiterman, Gisela Braier, Belen Zanoni, Hermes Mazali, Gustavo Contreras Dvorak, Hernan Berdichevsky and Diego Golombek for substantial help in the development of this project.	Abbink K, 2006, EXP ECON, V9, P103, DOI 10.1007/s10683-006-5385-z; Branas-Garza P, 2007, J ECON PSYCHOL, V28, P477, DOI 10.1016/j.joep.2006.10.001; Branas-Garza P, 2011, J ECON BEHAV ORGAN, V78, P25, DOI 10.1016/j.jebo.2010.12.005; Camera G, 2013, P NATL ACAD SCI USA, V110, P14889, DOI 10.1073/pnas.1301888110; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Croson R, 1999, AM ECON REV, V89, P386, DOI 10.1257/aer.89.2.386; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; Eckel CC, 2001, ECON INQ, V39, P171, DOI 10.1093/ei/39.2.171; Eriksson K, 2014, JUDGM DECIS MAK, V9, P360; Exadaktylos F, 2013, NATURE SCI REPORTS; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Fiske ST, 2010, SOCIAL BEINGS CORE M, P531; Hayes BK, 2010, WIRES COGN SCI, V1, P278, DOI 10.1002/wcs.44; Heit E, 2000, PSYCHON B REV, V7, P569, DOI 10.3758/BF03212996; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Jousten A, 2010, EFFECTS EARLY RETIRE, P47; Kivikangas JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100318; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Levitt SD, 2008, SCIENCE, V319, P909, DOI 10.1126/science.1153640; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; MCCLINTOCK CG, 1972, BEHAV SCI, V17, P438, DOI 10.1002/bs.3830170505; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Ortega J, 2000, ECON J, V110, P92, DOI 10.1111/1468-0297.00492; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059; Van Lange P. A. M., 2000, EUROPEAN REV SOCIAL, V11, P297, DOI DOI 10.1080/14792772043000068; Wilson RK, 2006, POLIT RES QUART, V59, P189, DOI 10.1177/106591290605900202; Yamagishi T, 2013, ORGAN BEHAV HUM DEC, V120, P260, DOI 10.1016/j.obhdp.2012.06.002	30	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147125	10.1371/journal.pone.0147125	http://dx.doi.org/10.1371/journal.pone.0147125			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5CE	26797425	gold, Green Submitted, Green Published			2022-12-26	WOS:000368530300018
J	Urasaki, Y; Pizzorno, G; Le, TT				Urasaki, Yasuyo; Pizzorno, Giuseppe; Le, Thuc T.			Chronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in Mice	PLOS ONE			English	Article							LIPID-ACCUMULATION; INSULIN-RESISTANCE; PHOSPHORYLASE; DISEASE; PROTEIN; ACID; GENE; SUPPLEMENTATION; BIOSYNTHESIS; NUCLEOTIDES	Uridine is a pyrimidine nucleoside that exerts restorative functions in tissues under stress. Short-term co-administration of uridine with multiple unrelated drugs prevents drug-induced liver lipid accumulation. Uridine has the ability to modulate liver metabolism; however, the precise mechanism has not been delineated. In this study, long-term effects of uridine on liver metabolism were examined in both HepG2 cell cultures and C57BL/6J mice. We report that uridine administration was associated with O-GlcNAc modification of FOXO1, increased gluconeogenesis, reduced insulin signaling activity, and reduced expression of a liver-specific fatty acid binding protein FABP1. Long-term uridine feeding induced systemic glucose intolerance and severe liver lipid accumulation in mice. Our findings suggest that the therapeutic potentials of uridine should be designed for short-term acute administration.	[Urasaki, Yasuyo; Le, Thuc T.] Roseman Univ Hlth Sci, Coll Med, Dept Biomed Sci, 10530 Discovery Dr, Las Vegas, NV 89135 USA; [Pizzorno, Giuseppe] Desert Res Inst, 10530 Discovery Dr, Las Vegas, NV 89135 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Le, TT (corresponding author), Roseman Univ Hlth Sci, Coll Med, Dept Biomed Sci, 10530 Discovery Dr, Las Vegas, NV 89135 USA.	tle5@roseman.edu			Roseman University of Health Sciences	Roseman University of Health Sciences	This study is supported by start-up funds from Roseman University of Health Sciences to TTL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; BLAKE WL, 1990, BIOCHEM BIOPH RES CO, V173, P87, DOI 10.1016/S0006-291X(05)81025-3; Cao DL, 2005, J BIOL CHEM, V280, P21169, DOI 10.1074/jbc.M412343200; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Dudzinska W, 2013, PHYSIOL RES, V62, P163, DOI 10.33549/physiolres.932355; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; GALLAI V, 1992, ACTA NEUROL SCAND, V86, P3, DOI 10.1111/j.1600-0404.1992.tb08045.x; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guzman C, 2013, BBA-MOL CELL BIOL L, V1831, P803, DOI 10.1016/j.bbalip.2012.12.014; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hawkins M, 1997, J BIOL CHEM, V272, P4889, DOI 10.1074/jbc.272.8.4889; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; HRESKO RC, 1990, J BIOL CHEM, V265, P21075; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Le TT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-27; Le TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087179; Le TT, 2013, J LIPID RES, V54, P1044, DOI 10.1194/jlr.M034249; Le TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051092; Lebrecht D, 2007, HEPATOLOGY, V45, P72, DOI 10.1002/hep.21490; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Martin GG, 2015, ARCH BIOCHEM BIOPHYS, V580, P41, DOI 10.1016/j.abb.2015.06.009; McComsey GA, 2010, AIDS, V24, P2503, DOI 10.1097/QAD.0b013e32833ea9bc; McEvilly M, 2011, AM J HEALTH-SYST PH, V68, P1806, DOI 10.2146/ajhp100434; Pizzorno G, 1998, CLIN CANCER RES, V4, P1165; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Roosild TP, 2011, J STRUCT BIOL, V176, P229, DOI 10.1016/j.jsb.2011.08.002; Urasaki Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038418, DOI 10.1371/J0URNAL.P0NE.0038418]; Urasaki Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099728, DOI 10.1371/J0URNAL.P0NE.0099728]; VANGROENINGEN CJ, 1991, J NATL CANCER I, V83, P437; Wurtman RJ, 2014, NUTRIENTS, V6, P1701, DOI 10.3390/nu6041701; Wurtman RJ, 2000, BIOCHEM PHARMACOL, V60, P989, DOI 10.1016/S0006-2952(00)00436-6; Yamamoto T, 2010, NUCLEOS NUCLEOT NUCL, V29, P504, DOI 10.1080/15257771003740986; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Zhang W, 2015, NAT COMMUN, V6, P7079, DOI [10.1038/ncomms8079, DOI 10.1038/NC0MMS8079]; Zhang Y, 2004, MOL ENDOCRINOL, V18, P851, DOI 10.1210/me.2003-0285	37	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146994	10.1371/journal.pone.0146994	http://dx.doi.org/10.1371/journal.pone.0146994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789264	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100051
J	Cong, HR; Jiang, HQ; Peng, JT; Cui, SL; Liu, LJ; Wang, JW; Zhang, XJ				Cong, Hengri; Jiang, Hanqiu; Peng, Jingting; Cui, Shilei; Liu, Lijuan; Wang, Jiawei; Zhang, Xiaojun			Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis	PLOS ONE			English	Article							REGULATORY T-CELLS; B-CELLS; NEUROMYELITIS-OPTICA; GM-CSF; INDUCTION; IL-17; CYTOKINE; MEMORY; NERVE; BETA	Background Typical and atypical optic neuritis (ON) are two clinical types of autoimmune inflammatory diseases of the optic nerve that causes acute vision loss, and are difficult to distinguish in their early stages. The disturbance in the balance of Th17 and Treg lymphocytes is thought to play an essential role in these autoimmune inflammatory diseases. Objectives To detect the clinical relevance of Th17 and Treg in peripheral blood and the ratio of Treg/Th17 in patients with typical and atypical ON. To determine whether analysis of Th17 and Treg lymphocytes will provides insights into the different disease phenotypes of typical and atypical ON. Methods We studied a consecutive series of patients aged 14-70 years who presented to our neurological department with typical ON (n = 30) or atypical ON (n = 33) within 4 weeks of their acute attacks. Routine clinical tests and ophthalmological examination were performed in all patients. Blood samples were collected from untreated patients and from gender-and age-matched healthy controls (n = 30). The proportion of peripheral blood Th17 cells and Treg cells was determined by flow cytometry. Results Patients with atypical ON had a higher proportion of Th17 cells than patients with typical ON (3.61 +/- 1.56 vs 2.55 +/- 1.74, P<0.01) or controls (1.45 +/- 0.86, P<0.01). The proportion of Th17 cells in patients with typical ON was also markedly higher than in controls (P<0.01). The mean percentage of Treg cells in atypical ON (6.31 +/- 2.11) and typical ON (6.80 +/- 2.00) were significantly lower when compared to controls (8.29 +/- 2.32, both P<0.01). No significant difference in Treg frequency was observed between typical ON and atypical ON (p>0.05). Conclusions The frequency of Th17 cells is higher in atypical ON than typical ON, and patients with atypical ON have a greater imbalance of pro-inflammatory and regulatory cells than patients with typical ON when compared with controls. These changes are indicative of distinct pathological mechanisms and may provide useful information to distinguish typical and atypical ON.	[Cong, Hengri; Jiang, Hanqiu; Peng, Jingting; Cui, Shilei; Wang, Jiawei; Zhang, Xiaojun] Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Beijing 100730, Peoples R China; [Liu, Lijuan] Capital Med Univ, Beijing Tongren Hosp, Ctr Eye, Beijing 100730, Peoples R China	Capital Medical University; Capital Medical University	Zhang, XJ (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Beijing 100730, Peoples R China.	zxjune@gmail.com	zhang, jin/GXV-9154-2022		Beijing Education Commission technology development program project Grant [SQKM201210025016]; Chinese National Science-tech Supporting Plan [2012BAI08B06]	Beijing Education Commission technology development program project Grant; Chinese National Science-tech Supporting Plan	This work was supported by Beijing Education Commission technology development program project Grant No. SQKM201210025016 and Chinese National Science-tech Supporting Plan, Grant No. 2012BAI08B06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Babaloo Z, 2015, IMMUNOL LETT, V164, P76, DOI 10.1016/j.imlet.2015.01.001; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gaudreau S, 2007, J IMMUNOL, V179, P3638, DOI 10.4049/jimmunol.179.6.3638; Gaudreau S, 2010, CELL IMMUNOL, V265, P31, DOI 10.1016/j.cellimm.2010.06.010; Hua FL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/571302; Kale N, 2012, CURR OPIN OPHTHALMOL, V23, P472, DOI 10.1097/ICU.0b013e328358b202; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Knier B, 2015, J AUTOIMMUN, V56, P34, DOI 10.1016/j.jaut.2014.09.003; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krumbholz M, 2014, SEMIN IMMUNOPATHOL, V36, P339, DOI 10.1007/s00281-014-0424-x; Lai CT, 2011, J NEURO-OPHTHALMOL, V31, P16, DOI 10.1097/WNO.0b013e3181f8a693; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lau PPK, 2015, INT OPHTHALMOL, V35, P303, DOI 10.1007/s10792-014-9945-5; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li B, 2013, EXP NEUROL, V250, P239, DOI 10.1016/j.expneurol.2013.10.002; Li Y, 2011, J NEUROIMMUNOL, V234, P155, DOI 10.1016/j.jneuroim.2011.03.009; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lowther DE, 2012, IMMUNOL REV, V248, P156, DOI 10.1111/j.1600-065X.2012.01130.x; Malik A, 2014, INDIAN J OPHTHALMOL, V62, P982, DOI 10.4103/0301-4738.145986; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mitsdoerffer M, 2013, ANN NY ACAD SCI, V1283, P57, DOI 10.1111/nyas.12118; Peng JT, 2015, J NEUROL SCI, V349, P94, DOI 10.1016/j.jns.2014.12.031; Quan C, 2015, J NEUROIMMUNOL, V282, P45, DOI 10.1016/j.jneuroim.2015.03.016; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Tian AY, 2010, INT J MOL MED, V25, P869, DOI 10.3892/ijmm_00000416; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Varrin-Doyer M, 2012, ANN NEUROL, V72, P53, DOI 10.1002/ana.23651; Venken K, 2010, TRENDS MOL MED, V16, P58, DOI 10.1016/j.molmed.2009.12.003; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	39	4	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146270	10.1371/journal.pone.0146270	http://dx.doi.org/10.1371/journal.pone.0146270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785053	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400028
J	Crook, ED; Kroeker, KJ; Potts, DC; Rebolledo-Vieyra, M; Hernandez-Terrones, LM; Paytan, A				Crook, Elizabeth Derse; Kroeker, Kristy J.; Potts, Donald C.; Rebolledo-Vieyra, Mario; Hernandez-Terrones, Laura M.; Paytan, Adina			Recruitment and Succession in a Tropical Benthic Community in Response to In-Situ Ocean Acidification	PLOS ONE			English	Article							FILAMENTOUS TURF ALGAE; CORAL-REEFS; NUTRIENT ENRICHMENT; CARBONIC-ACID; CALCIFICATION; SETTLEMENT; SEAWATER; DISSOCIATION; THRESHOLDS; CONSTANTS	Ocean acidification is a pervasive threat to coral reef ecosystems, and our understanding of the ecological processes driving patterns in tropical benthic community development in conditions of acidification is limited. We deployed limestone recruitment tiles in low aragonite saturation (Omega(arag)) waters during an in-situ field experiment at Puerto Morelos, Mexico, and compared them to tiles placed in control zones over a 14-month investigation. The early stages of succession showed relatively little difference in coverage of calcifying organisms between the low Omega(arag) and control zones. However, after 14 months of development, tiles from the low Omega(arag) zones had up to 70% less cover of calcifying organisms coincident with 42% more fleshy algae than the controls. The percent cover of biofilm and turf algae was also significantly greater in the low Omega(arag) zones, while the number of key grazing taxa remained constant. We hypothesize that fleshy algae have a competitive edge over the primary calcified space holders, coralline algae, and that acidification leads to altered competitive dynamics between various taxa. We suggest that as acidification impacts reefs in the future, there will be a shift in community assemblages away from upright and crustose coralline algae toward more fleshy algae and turf, established in the early stages of succession.	[Crook, Elizabeth Derse] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA; [Crook, Elizabeth Derse; Paytan, Adina] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Kroeker, Kristy J.; Potts, Donald C.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Rebolledo-Vieyra, Mario; Hernandez-Terrones, Laura M.] Ctr Invest Cient Yucatan AC, Unidad Ciencias Agua UCIA, Cancun, Quintana Roo, Mexico	University of California System; University of California Irvine; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Centro de Investigacion Cientifica de Yucatan	Crook, ED (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA.; Crook, ED (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	e.crook@uci.edu		Kroeker, Kristy/0000-0002-5766-1999	National Science Foundation [1040952]; Environmental Protection Agency-Science to Achieve Results	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency-Science to Achieve Results	This work was supported by the National Science Foundation-1040952 (AP) (nsf.gov) and the Environmental Protection Agency-Science to Achieve Results (EDC) (epa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WH, 1973, PHYCOLOGIA, V2, P111; Andersson AJ, 2015, OCEANOGRAPHY, V28, P16; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Beddows PA, 2007, J HYDROL, V346, P18, DOI 10.1016/j.jhydrol.2007.08.013; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Connell SD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0442; Connell SD, 2011, J EXP MAR BIOL ECOL, V400, P296, DOI 10.1016/j.jembe.2011.02.031; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Crook ED, 2012, CORAL REEFS, V31, P239, DOI 10.1007/s00338-011-0839-y; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; de Putron SJ, 2011, CORAL REEFS, V30, P321, DOI 10.1007/s00338-010-0697-z; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Fabricius KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09537; Fabricius KE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2479; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Falkenberg LJ, 2013, MAR ECOL PROG SER, V492, P85, DOI 10.3354/meps10491; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; HILL AS, 1991, J MAR BIOL ASSOC UK, V71, P403, DOI 10.1017/S0025315400051675; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Johnson VR, 2013, MAR BIOL, V160, P1813, DOI 10.1007/s00227-011-1840-2; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; KENDRICK GA, 1991, J EXP MAR BIOL ECOL, V147, P47, DOI 10.1016/0022-0981(91)90036-V; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/NCLIMATE1680, 10.1038/nclimate1680]; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; LITTLER MM, 1984, J EXP MAR BIOL ECOL, V74, P13, DOI 10.1016/0022-0981(84)90035-2; Littler MM, 1972, ANN REV OCEANOG MAR, V10, P31; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; MEADOWS PS, 1963, NATURE, V198, P610, DOI 10.1038/198610b0; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pandolfi JM, 2011, SCIENCE, V334, P1495, DOI 10.1126/science.334.6062.1495; Paytan A, 2014, P NATL ACAD SCI USA, V111, pE302, DOI 10.1073/pnas.1319572111; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; SEBENS KP, 1986, ECOL MONOGR, V56, P73, DOI 10.2307/2937271; Short J, 2014, J EXP MAR BIOL ECOL, V456, P70, DOI 10.1016/j.jembe.2014.03.014; Solomon S., 2007, PHYS SCI BASIS WORKI; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Thacker RW, 2001, CORAL REEFS, V19, P318, DOI 10.1007/s003380000122; Thompson RC, 2004, ECOLOGY, V85, P1372, DOI 10.1890/03-0279; Thompson RC, 1998, HYDROBIOLOGIA, V375-76, P203, DOI 10.1023/A:1017036301082; Wallace D, 2006, MS EXCEL PROGRAM DEV; WILLIAMS SL, 1990, J PHYCOL, V26, P36, DOI 10.1111/j.0022-3646.1990.00036.x	57	18	18	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146707	10.1371/journal.pone.0146707	http://dx.doi.org/10.1371/journal.pone.0146707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784986	Green Published, gold			2022-12-26	WOS:000368528400060
J	Ndege, S; Washington, S; Kaaria, A; Prudhomme-O'Meara, W; Were, E; Nyambura, M; Keter, AK; Wachira, J; Braitstein, P				Ndege, Samson; Washington, Sierra; Kaaria, Alice; Prudhomme-O'Meara, Wendy; Were, Edwin; Nyambura, Monica; Keter, Alfred K.; Wachira, Juddy; Braitstein, Paula			HIV Prevalence and Antenatal Care Attendance among Pregnant Women in a Large Home-Based HIV Counseling and Testing Program in Western Kenya	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; SERVICES; AFRICA	Objective To describe the uptake of and factors associated with HIV prevalence among pregnant women in a large-scale home-based HIV counseling and testing (HBCT) program in western Kenya. Methods In 2007, the Academic Model Providing Access to Healthcare Program (AMPATH) initiated HBCT to all individuals aged >= 13 years and high-risk children <13 years. Included in this analysis were females aged 13-50 years, from 6 catchment areas (11/08-01/12). We used descriptive statistics and logistic regression to describe factors associated with HIV prevalence. Results There were 119,678 women eligible for analysis; median age 25 (interquartile range, IQR: 18-34) years. Of these, 7,396 (6.2%) were pregnant at the time of HBCT; 4,599 (62%) had ever previously tested for HIV and 2,995 (40.5%) had not yet attended ANC for their current pregnancy. Testing uptake among pregnant women was high (97%). HBCT newly identified 241 (3.3%) pregnant HIV-positive women and overall HIV prevalence among all pregnant women was 6.9%. HIV prevalence among those who had attended ANC in this pregnancy was 5.4% compared to 9.0% among those who had not. Pregnant women were more likely to newly test HIV-positive in HBCT if they had not attended ANC in the current pregnancy (AOR: 6.85, 95% CI: 4.49-10.44). Conclusions Pregnant women who had never attended ANC were about 6 times more likely to newly test HIV-positive compared to those who had attended ANC, suggesting that the cascade of services for prevention of mother-to-child HIV transmission should optimally begin at the home and village level if elimination of perinatal HIV transmission is to be achieved.	[Ndege, Samson; Kaaria, Alice; Prudhomme-O'Meara, Wendy; Were, Edwin; Nyambura, Monica; Keter, Alfred K.; Wachira, Juddy; Braitstein, Paula] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Ndege, Samson; Prudhomme-O'Meara, Wendy] Moi Univ, Sch Publ Hlth, Coll Hlth Sci, Eldoret, Kenya; [Washington, Sierra] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Kaaria, Alice] Moi Teaching & Referral Hosp, Eldoret, Kenya; [Prudhomme-O'Meara, Wendy] Duke Univ, Sch Med, Durham, NC USA; [Prudhomme-O'Meara, Wendy] Duke Global Hlth Inst, Durham, NC USA; [Were, Edwin; Wachira, Juddy; Braitstein, Paula] Moi Univ, Sch Med, Coll Hlth Sci, Eldoret, Kenya; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Braitstein, Paula] Indiana Univ, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Braitstein, Paula] Regenstrief Inst Inc, Indianapolis, IN USA	Moi University; Indiana University System; Indiana University Bloomington; Duke University; Duke University; Moi University; University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Braitstein, P (corresponding author), Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya.; Braitstein, P (corresponding author), Moi Univ, Sch Med, Coll Hlth Sci, Eldoret, Kenya.; Braitstein, P (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Braitstein, P (corresponding author), Indiana Univ, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA.; Braitstein, P (corresponding author), Regenstrief Inst Inc, Indianapolis, IN USA.	paula.braitstein@utoronto.ca		Were, Edwin/0000-0002-4783-0795; Kaaria, Alice/0000-0003-3830-6497	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060478] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; [Anonymous], 2014, WORLD AIDS DAY 2014; Delva W, 2010, TROP MED INT HEALTH, V15, P584, DOI 10.1111/j.1365-3156.2010.02499.x; Druce N, 2007, REPROD HEALTH MATTER, V15, P190, DOI 10.1016/S0968-8080(07)30337-6; Galarraga O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S5; Government of Kenya, 2010, DEM HLTH SURV 2008 2; Government of Kenya, 2015, KEN DEM HLTH SURV 20; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Kenya Demographic & Health Survey, 2011, KEN DEM HLTH SURV 20; Kimaiyo S, 2010, East Afr Med J, V87, P100; Magadi MA, 2007, SOC SCI MED, V64, P1311, DOI 10.1016/j.socscimed.2006.11.004; McTavish S, 2010, SOC SCI MED, V71, P1958, DOI 10.1016/j.socscimed.2010.09.007; O'Meara WP, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-55; Operario D, 2013, HEALTH PSYCHOL, V32, P932, DOI 10.1037/a0032760; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Suthar AB, 2013, B WORLD HEALTH ORGAN, V91, P46, DOI 10.2471/BLT.12.107003; Turan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044181; UNAIDS, 2014, PROGR REP GLOB PLAN; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Wachira J, 1999, J ACQUIRED IMMUNE DE; Wachira J, 2012, CLIN INFECT DIS, V54, P275, DOI 10.1093/cid/cir789; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; World Health Organization, 2012, PLANN IMPL MON HOM B; World Health Organization, 2013, CONS GUID US ANT TRE; World Health Organization, 2012, SERV DEL APPR HIV TE	28	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0144618	10.1371/journal.pone.0144618	http://dx.doi.org/10.1371/journal.pone.0144618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784957	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400005
J	Sullivan, K; Cramer-Morales, K; McElroy, DL; Ostrov, DA; Haas, K; Childers, W; Hromas, R; Skorski, T				Sullivan, Katherine; Cramer-Morales, Kimberly; McElroy, Daniel L.; Ostrov, David A.; Haas, Kimberly; Childers, Wayne; Hromas, Robert; Skorski, Tomasz			Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection	PLOS ONE			English	Article							ENRICHED FRAGMENT LIBRARIES; DRUG DISCOVERY; PROTEIN; CELLS; REPAIR; KINASE; CANCER; DOMAIN; LETHAL; BREAKS	It has been reported that inhibition of RAD52 either by specific shRNA or a small peptide aptamer induced synthetic lethality in tumor cell lines carrying BRCA1 and BRCA2 inactivating mutations. Molecular docking was used to screen two chemical libraries: 1) 1,217 FDA approved drugs, and 2) 139,735 drug-like compounds to identify candidates for interacting with DNA binding domain of human RAD52. Thirty six lead candidate compounds were identified that were predicted to interfere with RAD52 -DNA binding. Further biological testing confirmed that 9 of 36 candidate compounds were able to inhibit the binding of RAD52 to single-stranded DNA in vitro. Based on molecular binding combined with functional assays, we propose a model in which the active compounds bind to a critical "hotspot" in RAD52 DNA binding domain 1. In addition, one of the 9 active compounds, adenosine 5'-monophosphate (A5MP), and also its mimic 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) 5' phosphate (ZMP) inhibited RAD52 activity in vivo and exerted synthetic lethality against BRCA1 and BRCA2-mutated carcinomas. These data suggest that active, inhibitory RAD52 binding compounds could be further refined for efficacy and safety to develop drugs inducing synthetic lethality in tumors displaying deficiencies in BRCA1/2-mediated homologous recombination.	[Sullivan, Katherine; Cramer-Morales, Kimberly; Skorski, Tomasz] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Sullivan, Katherine; Cramer-Morales, Kimberly; Skorski, Tomasz] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [McElroy, Daniel L.; Ostrov, David A.] Univ Florida & Shands, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32610 USA; [Haas, Kimberly; Childers, Wayne] Temple Univ, Sch Pharm, Moulder Ctr Drug Discovery Res, Philadelphia, PA 19140 USA; [Hromas, Robert] Univ Florida & Shands, Coll Med, Dept Med, Gainesville, FL 32610 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; University of Florida	Skorski, T (corresponding author), Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA.; Skorski, T (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA.	tskorski@temple.edu			NIH [1R01 CA134458, 1R01 CA186238]; NATIONAL CANCER INSTITUTE [R01CA186238, T32CA078586, R01CA134458, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109645] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH 1R01 CA134458 and 1R01 CA186238 (T. Skorski).	Baines IC, 2006, DRUG DISCOV TODAY, V11, P334, DOI 10.1016/j.drudis.2006.02.007; Budke B, 2012, NUCL ACIDS RES; Chandramouly G, 2015, CHEM BIOL, V22, P1491, DOI 10.1016/j.chembiol.2015.10.003; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; HOWIE C, 1990, J CHEM SOC PERK T 1, P3129, DOI 10.1039/p19900003129; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Podszywalow-Bartnicka P, 2014, CELL CYCLE, V13, P3727, DOI 10.4161/15384101.2014.965013; Qin ZQ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-96; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Tallis M, 2014, CHROMOSOMA, V123, P79, DOI 10.1007/s00412-013-0442-9; Tiefenbrunn T, 2014, CHEM BIOL DRUG DES, V83, P141, DOI 10.1111/cbdd.12227; Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang G, 2015, BIOORGAN MED CHEM, V23, P7359, DOI 10.1016/j.bmc.2015.10.023; Waring MJ, 2010, EXPERT OPIN DRUG DIS, V5, P235, DOI 10.1517/17460441003605098; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095; Zimmermann MO, 2014, FUTURE MED CHEM, V6, P617, DOI [10.4155/FMC.14.20, 10.4155/fmc.14.20]	29	44	47	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147230	10.1371/journal.pone.0147230	http://dx.doi.org/10.1371/journal.pone.0147230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784987	Green Submitted, gold, Green Published			2022-12-26	WOS:000368528400127
J	Zabelina, DL; Colzato, L; Beeman, M; Hommel, B				Zabelina, Darya L.; Colzato, Lorenza; Beeman, Mark; Hommel, Bernhard			Dopamine and the Creative Mind: Individual Differences in Creativity Are Predicted by Interactions between Dopamine Genes DAT and COMT	PLOS ONE			English	Article							TRANSPORTER AVAILABILITY; DIVERGENT THINKING; GENOTYPE; ASSOCIATION; INHIBITION; ACHIEVEMENT; PERSONALITY; MODULATION; SCHIZOTYPY; OPENNESS	The dopaminergic (DA) system may be involved in creativity, however results of past studies are mixed. We attempted to clarify this putative relation by considering the mediofrontal and the nigrostriatal DA pathways, uniquely and in combination, and their contribution to two different measures of creativity-an abbreviated version of the Torrance Test of Creative Thinking, assessing divergent thinking, and a real-world creative achievement index. We found that creativity can be predicted from interactions between genetic polymorphisms related to frontal (COMT) and striatal (DAT) DA pathways. Importantly, the Torrance test and the real-world creative achievement index related to different genetic patterns, suggesting that these two measures tap into different aspects of creativity, and depend on distinct, but interacting, DA sub-systems. Specifically, we report that successful performance on the Torrance test is linked with dopaminergic polymorphisms associated with good cognitive flexibility and medium top-down control, or with weak cognitive flexibility and strong top-down control. The latter is particularly true for the originality factor of divergent thinking. High real-world creative achievement, on the other hand, as assessed by the Creative Achievement Questionnaire, is linked with dopaminergic polymorphisms associated with weak cognitive flexibility and weak top-down control. Taken altogether, our findings support the idea that human creativity relies on dopamine, and on the interaction between frontal and striatal dopaminergic pathways in particular. This interaction may help clarify some apparent inconsistencies in the prior literature, especially if the genes and/or creativity measures were analyzed separately.	[Zabelina, Darya L.] Northwestern Univ, Med Social Sci, Chicago, IL 60611 USA; [Colzato, Lorenza; Hommel, Bernhard] Leiden Univ, Inst Psychol Res, Leiden, Netherlands; [Colzato, Lorenza; Hommel, Bernhard] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Beeman, Mark] Northwestern Univ, Dept Psychol, Evanston, IL USA	Northwestern University; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Northwestern University	Zabelina, DL (corresponding author), Northwestern Univ, Med Social Sci, Chicago, IL 60611 USA.	darya.zabelina@u.northwestern.edu	Hommel, Bernhard/F-8173-2010; Zabelina, Darya/AAD-1985-2022	Hommel, Bernhard/0000-0003-4731-5125; Colzato, Lorenza/0000-0003-1735-1280	John Templeton Foundation [24467]; NSF Graduate Student Fellowship; NIH [T32 NS047987]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER	John Templeton Foundation; NSF Graduate Student Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by John Templeton Foundation Grant # 24467 to MB (http://www.templeton.org), NSF Graduate Student Fellowship to DLZ (https://www.nsfgrfp.org), and NIH T32 NS047987 grant to DLZ (http://grants.nih.gov/grants/funding/ac_search_results.htm?text_curr=t32&Search_Type=Activity).	ACTInc, 2014, NAT RANKS TEST SCOR; [Anonymous], 2015, SCOPUS; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Batey M, 2006, GENET SOC GEN PSYCH, V132, P355, DOI 10.3200/MONO.132.4.355-430; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Carson SH, 2005, CREATIVITY RES J, V17, P37, DOI 10.1207/s15326934crj1701_4; Carson SH, 2003, J PERS SOC PSYCHOL, V85, P499, DOI 10.1037/0022-3514.85.3.499; Carson SH, 2011, CAN J PSYCHIAT, V56, P144, DOI 10.1177/070674371105600304; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chen KC, 2012, PSYCHIAT RES-NEUROIM, V201, P218, DOI 10.1016/j.pscychresns.2011.07.003; Chermahini SA, 2010, COGNITION, V115, P458, DOI 10.1016/j.cognition.2010.03.007; College Board, 2012, COLL BOUND SEN TOT G; Colzato LS, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00008; Cools R, 2009, DOPAMINERGIC MODULAT; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; Cornish KM, 2005, MOL PSYCHIATR, V10, P686, DOI 10.1038/sj.mp.4001641; Coyle TR, 2008, INTELLIGENCE, V36, P719, DOI 10.1016/j.intell.2008.05.001; de Manzano O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010670; DeYoung CG, 2011, J RES PERS, V45, P364, DOI 10.1016/j.jrp.2011.04.002; Dreher JC, 2008, P NATL ACAD SCI USA, V105, P15106, DOI [10.1073/pnas.0802127105, 10.1073/pnas.0805517106]; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Flaherty AW, 2005, J COMP NEUROL, V493, P147, DOI 10.1002/cne.20768; Folley BS, 2005, SCHIZOPHR RES, V80, P271, DOI 10.1016/j.schres.2005.06.016; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Garcia-Garcia M, 2010, EUR J NEUROSCI, V31, P754, DOI 10.1111/j.1460-9568.2010.07102.x; Goff K., 2002, ABBREVIATED TORRANCE; GUILFORD JP, 1957, PSYCHOL REV, V64, P110, DOI 10.1037/h0048280; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hommel B, 2015, ADV MOTIVATION SCI; Jauk E, 2014, EUR J PERSONALITY, V28, P95, DOI 10.1002/per.1941; Joober R, 2002, ARCH GEN PSYCHIAT, V59, P662, DOI 10.1001/archpsyc.59.7.662; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; Kasof J, 1997, CREATIVITY RES J, V10, P303, DOI 10.1207/s15326934crj1004_2; Kunugi H, 1997, NEUROSCI LETT, V221, P202, DOI 10.1016/S0304-3940(96)13289-4; LUBOW RE, 1973, PSYCHOL BULL, V79, P398, DOI 10.1037/h0034425; Mayseless N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00502; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P1258, DOI 10.1037/0022-3514.52.6.1258; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Mohr C, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00184; Munafo MR, 2005, MOL PSYCHIATR, V10, P765, DOI 10.1038/sj.mp.4001664; Murphy M, 2013, CREATIVITY RES J, V25, P147, DOI 10.1080/10400419.2013.752305; Nijstad BA, 2010, EUR REV SOC PSYCHOL, V21, P34, DOI 10.1080/10463281003765323; Nusbaum EC, 2011, INTELLIGENCE, V39, P36, DOI 10.1016/j.intell.2010.11.002; Olincy A, 2010, SCHIZOPHR RES, V119, P175, DOI 10.1016/j.schres.2010.03.004; Reuter M, 2006, BRAIN RES, V1069, P190, DOI 10.1016/j.brainres.2005.11.046; Rokem A, 2012, CEREB CORTEX, V22, P1133, DOI 10.1093/cercor/bhr185; Runco MA, 2012, CREATIVITY RES J, V24, P92, DOI 10.1080/10400419.2012.650092; Runco MA, 2011, CREATIVITY RES J, V23, P376, DOI 10.1080/10400419.2011.621859; Sesack SR, 1998, J NEUROSCI, V18, P2697; Shumay E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022754; Silvia PJ, 2009, J RES PERS, V43, P1087, DOI 10.1016/j.jrp.2009.04.015; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Torrance EP, 1974, TORRANCE TESTS CREAT; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; Wegbreit E, 2012, J PROBL SOLVING, V4, P94, DOI 10.7771/1932-6246.1127; Winterer G, 2006, NEUROIMAGE, V32, P1722, DOI 10.1016/j.neuroimage.2006.05.058; Zabelina DL, 2015, NEUROPSYCHOLOGIA, V69, P77, DOI 10.1016/j.neuropsychologia.2015.01.034; Zabelina DL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01029; Zabelina DL, 2010, PSYCHOL AESTHET CREA, V4, P136, DOI 10.1037/a0017379; Zabelina DL, MEM COGNITI IN PRESS; Zhang S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00222	67	44	47	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146768	10.1371/journal.pone.0146768	http://dx.doi.org/10.1371/journal.pone.0146768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783754	gold, Green Published			2022-12-26	WOS:000368528400064
J	Tay, WT; Kerr, PJ; Jermiin, LS				Tay, W. T.; Kerr, P. J.; Jermiin, L. S.			Population Genetic Structure and Potential Incursion Pathways of the Bluetongue Virus Vector Culicoides brevitarsis (Diptera: Ceratopogonidae) in Australia	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; RIBOSOMAL-RNA GENE; MITOCHONDRIAL-DNA; BITING MIDGES; SPECIES COMPLEXES; KIEFFER DIPTERA; CLIMATE-CHANGE; IDENTIFICATION; TAXONOMY; IMICOLA	Culicoides brevitarsis is a vector of the bluetongue virus (BTV), which infects sheep and cattle. It is an invasive species in Australia with an assumed Asian/South East Asian origin. Using one mitochondrial marker (i.e., part of the cytochrome oxidase subunit I gene) and six nuclear markers, we inferred population genetic structure and possible incursion pathways for Australian C. brevitarsis. Nine mitochondrial haplotypes, with low nucleotide sequence diversity (0.0-0.7%) among these, were identified in a sample of 70 individuals from seven sites. Both sets of markers revealed a homogeneous population structure, albeit with evidence of isolation by distance and two genetically distinct clusters distributed along a north-to-south cline. No evidence of a cryptic species complex was found. The geographical distribution of the mitochondrial haplotypes is consistent with at least two incursion pathways into Australia since the arrival of suitable livestock hosts. By contrast, 15 mitochondrial haplotypes, with up to four times greater nucleotide sequence diversity (0.0-2.9%) among these, were identified in a sample of 16 individuals of the endemic C. marksi (sampled from a site in South Australia and another in New South Wales). A phylogenetic tree inferred using the mitochondrial marker revealed that the Australian and Japanese samples of C. brevitarsis are as evolutionarily different from one another as some of the other Australian species (e.g., C. marksi, C. henryi, C. pallidothorax) are. The phylogenetic tree placed four of the species endemic to Australia (C. pallidothorax, C. bundyensis, C. marksi, C. henryi) in a clade, with a fifth such species (C. bunrooensis) sharing a common ancestor with that clade and a clade comprising two Japanese species (C. verbosus, C. kibunensis).	[Tay, W. T.; Kerr, P. J.; Jermiin, L. S.] CSIRO, Black Mt Labs, Canberra, ACT 2601, Australia; [Kerr, P. J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney	Tay, WT (corresponding author), CSIRO, Black Mt Labs, Canberra, ACT 2601, Australia.	weetek.tay@csiro.au	Tay, Wee Tek/C-1818-2008; Jermiin, Lars Sommer/AAQ-7033-2020; Tay, Wee Tek/GPF-6142-2022; Jermiin, Lars Sommer/C-2458-2009	Tay, Wee Tek/0000-0002-8451-0811; Jermiin, Lars Sommer/0000-0002-9619-3809; Tay, Wee Tek/0000-0002-8451-0811; Jermiin, Lars Sommer/0000-0002-9619-3809	Australian Biosecurity CRC	Australian Biosecurity CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding was by the Australian Biosecurity CRC. The funder has no role in the project design, data analyses, and interpretation of results.	Ababneh F, 2006, BIOINFORMATICS, V22, P1225, DOI 10.1093/bioinformatics/btl064; Ababneh F., 2006, J MATH MODEL ALGOR, V5, P291; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ander M, 2013, MED VET ENTOMOL, V27, P323, DOI 10.1111/j.1365-2915.2012.01050.x; Augot D, 2013, J VECTOR ECOL, V38, P260, DOI 10.1111/j.1948-7134.2013.12039.x; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Behere GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053448; Bellis G, 2014, ZOOTAXA, V 3768, P401, DOI 10.11646/zootaxa.3768.4.1; Bellis GA, 2015, AUSTRAL ENTOMOL, V54, P332, DOI 10.1111/aen.12131; Bellis Glenn A., 2005, Arbovirus Research in Australia, V9, P33; BEVERIDGE I, 1981, J AUST ENTOMOL SOC, V20, P39; BISHOP AL, 1995, J AUST ENTOMOL SOC, V34, P289; Borkent A, 1997, B AM MUS NAT HIST, P5; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; Brokent A, 2012, WORLD SPECIES BITING; Bryant D, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P33; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; CAMPBELL MM, 1976, AUST J ZOOL, V24, P75, DOI 10.1071/ZO9760075; Cannon L. R. G., 1966, Journal of the Entomological Society of Queensland, V5, P7; Carew ME, 1997, INSECT SOC, V44, P7, DOI 10.1007/s000400050018; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Cetre-Sossah C, 2004, VET RES, V35, P325, DOI 10.1051/vetres:2004015; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conflitti IM, 2013, J MED ENTOMOL, V50, P1250, DOI 10.1603/ME13063; Cooper ED, 2014, TRENDS PLANT SCI, V19, P576, DOI 10.1016/j.tplants.2014.06.006; Dallas JF, 2003, MED VET ENTOMOL, V17, P379, DOI 10.1111/j.1365-2915.2003.00454.x; Daniels PW, 2004, VETER ITAL SER, V40, P94; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Doyle KA, 1992, OVERVIEW PERSPECTIVE; Dyce A.L., 2007, PICTORIAL ATLAS AUST, V1st; Dyce AL, 1989, BLUETONGUE VECTORS A; Dyce AL, 1982, P 3 S; Eagles D, 2013, PREV VET MED, V110, P312, DOI 10.1016/j.prevetmed.2013.02.022; Eagles D, 2012, MED VET ENTOMOL, V26, P334, DOI 10.1111/j.1365-2915.2011.01005.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Gomulski LM, 2005, SYST ENTOMOL, V30, P619, DOI 10.1111/j.1365-3113.2005.00286.x; Gongora J, 2011, ZOOL SCR, V40, P327, DOI 10.1111/j.1463-6409.2011.00480.x; Gordon Karl, 2010, P219; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hadj-Henni L, 2015, INFECT GENET EVOL, V33, P324, DOI 10.1016/j.meegid.2015.05.024; Harrup LE, 2015, INFECT GENET EVOL, V30, P249, DOI 10.1016/j.meegid.2014.12.018; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Holbrook FR, 1996, MED VET ENTOMOL, V10, P173, DOI 10.1111/j.1365-2915.1996.tb00725.x; HOLM S, 1979, SCAND J STAT, V6, P65; Jayaswal V, 2005, EVOL BIOINFORM, V1, P62; Jayaswal V, 2014, SYST BIOL, V63, P726, DOI 10.1093/sysbio/syu036; Jermiin Lars Sommer, 2008, V452, P331, DOI 10.1007/978-1-60327-159-2_16; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; JERMIIN LS, 1994, J MOL EVOL, V39, P160; KAY BH, 1978, J AUST ENTOMOL SOC, V17, P145; Kettle DS, 1998, MED VET ENTOMOL, V12, P367, DOI 10.1046/j.1365-2915.1998.00119.x; KETTLE DS, 1962, ANNU REV ENTOMOL, V7, P401, DOI 10.1146/annurev.en.07.010162.002153; Klee J, 2006, J INVERTEBR PATHOL, V91, P98, DOI 10.1016/j.jip.2005.10.012; Lee DJ, 1953, P LINNEAN SOC NEW S, V77, P269; Lehr MA, 2005, ANN ENTOMOL SOC AM, V98, P908, DOI 10.1603/0013-8746(2005)098[0908:CSITAN]2.0.CO;2; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; Matsumoto Y, 2009, J MED ENTOMOL, V46, P1099, DOI 10.1603/033.046.0517; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meiswinkel R, 2004, VETER ITAL SER, V40, P345; Muller M J, 1982, P 3 S; MULLER MJ, 1977, AUST J ZOOL, V25, P75, DOI 10.1071/ZO9770075; MURRAY MD, 1970, AUST VET J, V46, P138, DOI 10.1111/j.1751-0813.1970.tb01975.x; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Nolan DV, 2004, VETER ITAL SER, V40, P352; O'Mahony EM, 2007, J EUKARYOT MICROBIOL, V54, P103, DOI 10.1111/j.1550-7408.2006.00232.x; Onyango MG, 2015, VET RES, V46, DOI 10.1186/s13567-015-0250-8; Pages N, 2005, J MED ENTOMOL, V42, P1026, DOI 10.1603/0022-2585(2005)042[1026:DOCOAC]2.0.CO;2; Pages N, 2009, VET PARASITOL, V165, P298, DOI 10.1016/j.vetpar.2009.07.020; Perrin A, 2006, MED VET ENTOMOL, V20, P219, DOI 10.1111/j.1365-2915.2006.00616.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Quezada-Euan JJG, 2007, APIDOLOGIE, V38, P247, DOI 10.1051/apido:2007006; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ritchie A, 2004, GENOME, V47, P546, DOI [10.1139/g04-003, 10.1139/G04-003]; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schneider S., 2000, ARLEQUIN VERSION 20; Sebastiani F, 2001, MOL ECOL, V10, P1773, DOI 10.1046/j.0962-1083.2001.01319.x; SLATKIN M, 1995, GENETICS, V139, P457; Staden R, 2000, Methods Mol Biol, V132, P115; Standfast HA, 1992, P 2 INT S; Tabachnick WJ, 1996, ANNU REV ENTOMOL, V41, P23, DOI 10.1146/annurev.en.41.010196.000323; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tay WT, 2008, B ENTOMOL RES, V98, P509, DOI 10.1017/S000748530800583X; Tay WT, 2016, PEST MANAG SCI, V72, P1250, DOI 10.1002/ps.3805; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Tay WT, 2011, MYRMECOL NEWS, V15, P67; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Tay WT, 1997, MOL ECOL, V6, P403, DOI 10.1046/j.1365-294X.1997.t01-1-00198.x; Tay WT, 2001, MOL ECOL, V10, P167, DOI 10.1046/j.1365-294X.2001.01167.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wittmann EJ, 2000, VET J, V160, P107, DOI 10.1053/tvjl.2000.0470; Yanase T, 2013, J MED ENTOMOL, V50, P1105, DOI 10.1603/ME11235; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	100	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146699	10.1371/journal.pone.0146699	http://dx.doi.org/10.1371/journal.pone.0146699			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771743	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300030
J	Ai, ZC; Jing, W; Fang, L				Ai, Zhichao; Jing, Wei; Fang, Li			Cytokine-Like Protein 1 (Cytl1): A Potential Molecular Mediator in Embryo Implantation	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; ENDOMETRIAL RECEPTIVITY; GROWTH; ANGIOGENESIS	Cytokine-like protein 1 (CytI1), originally described as a protein expressed in CD34+ cells, was recently identified as a functional secreted protein involved in chondrogenesis and cartilage development. However, our knowledge of CytI1 is still limited. Here, we determined the CytI1 expression pattern regulated by ovarian hormones at both the mRNA and protein levels. We found that the endometrial expression of CytI1 in mice was low before or on the first day of gestation, significantly increased during embryo implantation, and then decreased at the end of implantation. We investigated the effects of CytI1 on endometrial cell proliferation, and the effects on the secretion of leukemia inhibitory factor (LIF) and heparin -binding epidermal growth factor (HB-EGF). We also explored the effect of CytI1 on endometrial adhesion properties in cell-cell adhesion assays. Our findings demonstrated that CytI1 is an ovarian hormone-dependent protein expressed in the endometrium that enhances the proliferation of HEC-1-A and RL95-2 cells, stimulates endometrial secretion of LIF and HB-EGF, and enhances the adhesion of HEC-1-A and RL95-2 cells to JAR spheroids. This study suggests that CytI1 plays an active role in the regulation of embryo implantation.	[Ai, Zhichao; Jing, Wei; Fang, Li] Dalian Med Univ, Dept Immunol, Dalian, Liaoning, Peoples R China	Dalian Medical University	Fang, L (corresponding author), Dalian Med Univ, Dept Immunol, Dalian, Liaoning, Peoples R China.	lifang16@hotmail.com			National Science Foundation of China [NSFC30772023]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Science Foundation of China (NSFC30772023). LF is the author who received the funding.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022256; d'Hauterive SP, 2005, NEUROIMMUNOMODULAT, V12, P157, DOI 10.1159/000084848; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dimitriadis E, 2010, INT J DEV BIOL, V54, P313, DOI 10.1387/ijdb.082772ed; Granot I, 2012, REPRODUCTION, V144, P661, DOI 10.1530/REP-12-0217; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Jeon J, 2011, J BIOL CHEM, V286, P27206, DOI 10.1074/jbc.M111.218065; Jessmon P, 2009, MOL REPROD DEV, V76, P1116, DOI 10.1002/mrd.21066; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Liu X, 2000, GENOMICS, V65, P283, DOI 10.1006/geno.2000.6170; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Steck T, 2004, EUR J OBSTET GYN R B, V112, P69, DOI 10.1016/S0301-2115(03)00315-4; Tomczak A, 2011, PROTEINS, V79, P1277, DOI 10.1002/prot.22963; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wen MJ, 2012, INT J ONCOL, V41, P1419, DOI 10.3892/ijo.2012.1552; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhou JH, 2014, CHEM-BIOL INTERACT, V219, P57, DOI 10.1016/j.cbi.2014.05.009	21	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147424	10.1371/journal.pone.0147424	http://dx.doi.org/10.1371/journal.pone.0147424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800213	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300106
J	Graham, NR; Fisher, BL; Girman, DJ				Graham, Natalie R.; Fisher, Brian L.; Girman, Derek J.			Phylogeography in Response to Reproductive Strategies and Ecogeographic Isolation in Ant Species on Madagascar: Genus Mystrium (Formicidae: Amblyoponinae)	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; DEPENDENT COLONY FOUNDATION; EVOLUTION; HYMENOPTERA; PHYLOGENY; PATTERNS; DIVERSIFICATION; SYSTEMATICS; DIVERSITY; ENDEMISM	The bulk of models used to understand the species diversification on Madagascar have been constructed using vertebrate taxa. It is not clear how these models affect less vagile species that may interact at a variety of spatial scales. Several studies on vertebrates have divided Madagascar into east-west bioclimatic regions, suggesting there is a fundamental division between eastern wet-adapted and western dry-adapted taxa. An alternative model of ecogeographic constraints shows a north-south division. We test whether the diversification in a small arthropod with variable degrees of dispersal conform to either model of ecogeographic constraints proposed for vertebrate taxa. We employ a molecular taxonomic dataset using similar to 2 kilobases nuDNA (Wg, LW Rh, Abd-A, 28s) and 790 basepairs mtDNA (CO1), along with geographic and habitat data, to examine the diversification patterns of the ant genus Mystrium Roger, 1862, (Subfamily Amblyoponinae) from Madagascar. The nuclear and mitochondrial phylogenies were both congruent with morphospecies as indicated in a recent revision of the genus. Species of Mystrium practice different colony reproductive strategies (winged queens vs non-winged queens). Alternate reproductive strategies led to inequalities in female dispersal ability among species, providing an additional layer for examination of the impacts of vagility on divergence, especially when measured using a maternally inherited locus. Mystrium species distribution patterns support these models of ecogeographic constraints. Reproductive strategy effected how Mystrium mtDNA lineages were associated with large-scale habitat distinctions and various topographical features. Furthermore, in some cases we find microgeographic population structure which appears to have been impacted by localized habitat differences (tsingy limestone formations, littoral forest) on a scale much smaller than that found in vertebrates. The current system offers a finer scale look at species diversification on the island, and helps achieve a more universal understanding of the generation of biodiversity on Madagascar.	[Graham, Natalie R.; Girman, Derek J.] Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA; [Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA	California State University System; Sonoma State University; California Academy of Sciences	Graham, NR (corresponding author), Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA.	Natalie_Graham@outlook.com		Graham, Natalie/0000-0001-7704-1132; Fisher, Brian/0000-0002-4653-3270	National Science Foundation [DEB-0072713, DEB-0344731, DEB-0842395, DEB-9981667]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation under Grant No. DEB-0072713 (BLF), DEB-0344731 (BLF), DEB-0842395(BLF), and DEB-9981667 (BLF and DJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; [Anonymous], 1971, INSECT SOC; Boumans L, 2007, MOL PHYLOGENET EVOL, V45, P822, DOI 10.1016/j.ympev.2007.05.028; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brown Jr WL, 1960, TRIBE AMBLYOPONINI M, V122, P145; Burney David A., 1997, P75; Clemencet J, 2005, MOL ECOL, V14, P3735, DOI 10.1111/j.1365-294X.2005.02706.x; Cronin AL, 2013, ANNU REV ENTOMOL, V58, P37, DOI 10.1146/annurev-ento-120811-153643; CROZIER RH, 1993, GENETICS, V133, P97; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doums C, 2002, MOL ECOL, V11, P2251, DOI 10.1046/j.1365-294X.2002.01619.x; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Fisher Brian L., 2005, Proceedings of the California Academy of Sciences, V56, P86; Fisher Brian L., 2000, P331; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 2003, NATURAL HIST MADAGAS; Graham Natalie, 2015, PHYLOGEOGRAPHY RESPO; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holldobler B., 1990, pi; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kaspari Michael, 2000, P89; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOECHLIN J, 1972, P145; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kuck P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021031; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Martins J, 2007, INSECT MOL BIOL, V16, P777, DOI 10.1111/j.1365-2583.2007.00771.x; MASUKO K, 1986, BEHAV ECOL SOCIOBIOL, V19, P249, DOI 10.1007/BF00300639; Menozzi C., 1929, Zoologischer Anzeiger Leipzig, V82, P518; Miller M.A., 2010, P GAT COMP ENV WORKS; Moat J., 1998, CHOROLOGY TAXONOMY E, P97; Molet M, 2006, INT UN STUD SOC INS; Molet M, 2007, ETHOLOGY, V113, P721, DOI 10.1111/j.1439-0310.2007.01376.x; Molet M, 2007, NATURWISSENSCHAFTEN, V94, P280, DOI 10.1007/s00114-006-0190-2; Molet M, 2012, AM NAT, V180, P328, DOI 10.1086/667368; Molet M, 2009, BIOL J LINN SOC, V98, P198, DOI 10.1111/j.1095-8312.2009.01257.x; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Moreau CS, 2009, MYRMECOL NEWS, V12, P201; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Ouellette GD, 2006, MOL PHYLOGENET EVOL, V40, P359, DOI 10.1016/j.ympev.2006.03.017; Pamilo P, 2007, MOL BIOL EVOL, V24, P1340, DOI 10.1093/molbev/msm055; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Peeters C, 2012, MYRMECOL NEWS, V16, P75; Raselimanana AP, 2009, MOL PHYLOGENET EVOL, V50, P336, DOI 10.1016/j.ympev.2008.10.004; RAXWORTHY CJ, 1995, J ZOOL, V235, P525, DOI 10.1111/j.1469-7998.1995.tb01767.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saux C, 2004, MOL PHYLOGENET EVOL, V33, P457, DOI 10.1016/j.ympev.2004.06.017; Schatz GE., 2000, MEMOIRES SOC BIOGEOG, V1, P1, DOI DOI 10.1002/14356007; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Smith SA, 2007, EVOLUTION, V61, P1188, DOI 10.1111/j.1558-5646.2007.00085.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Townsend TM, 2009, SYST BIOL, V58, P641, DOI 10.1093/sysbio/syp073; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Veress M, 2009, CARPATH J EARTH ENV, V4, P95; WARD PS, 1994, SYST ENTOMOL, V19, P159, DOI 10.1111/j.1365-3113.1994.tb00585.x; Weiser MD, 2010, BIOL LETTERS, V6, P769, DOI 10.1098/rsbl.2010.0151; Wells N, 2003, NATURAL HIST MADAGAS, P16; WHEELER GC, 1988, ENTOMOL NEWS, V99, P23; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Yoder AD, 2000, P NATL ACAD SCI USA, V97, P11325, DOI 10.1073/pnas.200121897; Yoder AD, 2005, P NATL ACAD SCI USA, V102, P6587, DOI 10.1073/pnas.0502092102; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Yoder AD, 2006, DEV PRIMATOL, P255, DOI 10.1007/0-387-31710-4_9; Yoshimura M, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.394.6446	79	0	0	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146170	10.1371/journal.pone.0146170	http://dx.doi.org/10.1371/journal.pone.0146170			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800442	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300013
J	Ikeura, K; Kawakita, T; Tsunoda, K; Nakagawa, T; Tsubota, K				Ikeura, Kazuhiro; Kawakita, Tetsuya; Tsunoda, Kazuyuki; Nakagawa, Taneaki; Tsubota, Kazuo			Characterization of Long-Term Cultured Murine Submandibular Gland Epithelial Cells	PLOS ONE			English	Article							HUMAN SALIVARY-GLAND; FUNCTIONAL-PROPERTIES; MYOEPITHELIAL CELLS; PROGENITOR-CELL; ACINAR-CELLS; CYCLIC-AMP; LINE; ESTABLISHMENT; PROLIFERATION; GROWTH	Purpose Human and rat salivary gland cell lines derived from tumors or genetic modification are currently available for research. Here, we attempted to culture and characterize longterm cultured cells spontaneously derived from wild type murine submandibular glands (SGs). Methods SGs were removed from 3-week-old C57B/6J female mice and dissociated by collagenase type 1 and hyaluronidase digestion. Isolated SG epithelial cells were cultured in low calcium, serum-free growth media in the presence of cholera toxin (CT) during early passages. Single-cell colonies were isolated by limiting dilution culture after 25 passages. Early- and late-stage cell cultures were characterized for keratin 14, keratin 18, alpha-smooth muscle actin, and p63 by immunostaining and quantitative real-time PCR analysis. Results SG epithelial cells cultured in optimized media maintained their proliferative ability and morphology for over 80 passages. Long-term cultured cells expressed keratin 14, keratin 18, and p63, indicative of an epithelial phenotype. Conclusions Epithelial cells originating from wild type murine SGs could be cultured for longer periods of time and remain phenotypically similar to ductal basal epithelium.	[Ikeura, Kazuhiro; Kawakita, Tetsuya; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Ikeura, Kazuhiro; Tsunoda, Kazuyuki; Nakagawa, Taneaki] Keio Univ, Sch Med, Dept Dent & Oral Surg, Tokyo, Japan	Keio University; Keio University	Kawakita, T (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	Kawakita@a2.keio.jp	tsunoda, kazuyuki/GLR-8745-2022					Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380; Almeida JL, 2014, CYTOTECHNOLOGY, V66, P133, DOI 10.1007/s10616-013-9545-7; Banh A, 2011, CLIN CANCER RES, V17, P7265, DOI 10.1158/1078-0432.CCR-11-0179; Bilal H, 2003, J HISTOCHEM CYTOCHEM, V51, P133, DOI 10.1177/002215540305100201; Castro-Munozledo F, 2008, EXP EYE RES, V86, P459, DOI 10.1016/j.exer.2007.11.017; Dimitriou ID, 2002, EUR J ORAL SCI, V110, P21, DOI 10.1034/j.1600-0722.2002.00152.x; GREEN H, 1978, CELL, V15, P801, DOI 10.1016/0092-8674(78)90265-9; Gueiros LA, 2009, GERODONTOLOGY, V26, P297, DOI 10.1111/j.1741-2358.2009.00284.x; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Han P, 2015, J PROSTHODONT RES, V59, P6, DOI 10.1016/j.jpor.2014.11.001; Hiraki A, 2002, J CELL PHYSIOL, V193, P55, DOI 10.1002/jcp.10149; Hoffman MP, 1996, J CELL SCI, V109, P2013; Imai A, 2004, ARCH BIOCHEM BIOPHYS, V422, P175, DOI 10.1016/j.abb.2003.12.021; Jensen DH, 2014, OR SURG OR MED OR PA, V117, P335, DOI 10.1016/j.oooo.2013.11.496; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Kim JH, 2009, J PHARMACOL EXP THER, V330, P403, DOI 10.1124/jpet.109.153023; Kimoto M, 2008, J HISTOCHEM CYTOCHEM, V56, P15, DOI 10.1369/jhc.7A7269.2007; Kozlowski MR, 2015, CURR EYE RES, V40, P501, DOI 10.3109/02713683.2014.935440; Kwak M, 2015, STEM CELLS DEV, V24, P565, DOI 10.1089/scd.2014.0355; Laoide BM, 1996, J CELL SCI, V109, P2789; Liu JB, 2007, EXP EYE RES, V84, P599, DOI 10.1016/j.exer.2006.11.014; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lombaert IMA, 2010, FRONT ORAL BIOL, V14, P90, DOI 10.1159/000313709; Ma X, 2009, INVEST OPHTH VIS SCI, V50, P2716, DOI 10.1167/iovs.08-2139; Masamune A, 2003, WORLD J GASTROENTERO, V9, P2751; Mishima K, 2012, STEM CELLS, V30, P1925, DOI 10.1002/stem.1173; Nanduri LSY, 2011, RADIOTHER ONCOL, V99, P367, DOI 10.1016/j.radonc.2011.05.085; Nelson J, 2013, ORAL DIS, V19, P236, DOI 10.1111/j.1601-0825.2012.01958.x; OKADA N, 1982, J INVEST DERMATOL, V79, P42, DOI 10.1111/1523-1747.ep12510580; Pringle S, 2013, STEM CELLS, V31, P613, DOI 10.1002/stem.1327; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Wang Y, 2009, ARCH ORAL BIOL, V54, P986, DOI 10.1016/j.archoralbio.2009.07.011; WIGLEY CB, 1976, J CELL SCI, V20, P149; YANAGAWA T, 1986, VIRCHOWS ARCH B, V51, P187, DOI 10.1007/BF02899028; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yaniv A, 2011, TISSUE ENG PART C-ME, V17, P69, DOI [10.1089/ten.tec.2010.0228, 10.1089/ten.TEC.2010.0228]	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147407	10.1371/journal.pone.0147407	http://dx.doi.org/10.1371/journal.pone.0147407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800086	Green Submitted, gold, Green Published			2022-12-26	WOS:000368655300105
J	Ishii, A; Kimura, T; Sadahiro, H; Kawano, H; Takubo, K; Suzuki, M; Ikeda, E				Ishii, Aya; Kimura, Tokuhiro; Sadahiro, Hirokazu; Kawano, Hiroo; Takubo, Keiyo; Suzuki, Michiyasu; Ikeda, Eiji			Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in Glioblastoma	PLOS ONE			English	Article							INITIATING CELLS; PERIVASCULAR NICHE; HYPOXIA-MARKER; POPULATION; GROWTH; PROLIFERATION; HIF-1-ALPHA; EXPRESSION; PATHWAY; PHOSPHORYLATION	Background Characterization of the niches for stem-like tumor cells is important to understand and control the behavior of glioblastomas. Cell-cycle quiescence might be a common mechanism underlying the long-term maintenance of stem-cell function in normal and neoplastic stem cells, and our previous study demonstrated that quiescence induced by hypoxia-inducible factor (HIF)-1a is associated with a high long-term repopulation capacity of hematopoietic stem cells. Based on this, we examined human astrocytoma tissues for HIF-la-regulated quiescent stem-like tumor cells as a candidate for long-term tumorigenic cells and characterized their niche histologically. Methods Multi-color immunohistochemistry was used to visualize HIF-1 alpha-expressing (HIF-1 alpha+) quiescent stem-like tumor cells and their niche in astrocytoma (WHO grade I I IV) tissues. This niche was modeled using spheroids of cultured glioblastoma cells and its contribution to tumorigenicity was evaluated by sphere formation assay. Results A small subpopulation of HIF-1 alpha+ quiescent stem-like tumor cells was found in glioblastomas but not in lower-grade astrocytomas. These cells were concentrated in the zone between large ischemic necroses and blood vessels and were closer to the necrotic tissues than to the blood vessels, which suggested that a moderately hypoxic microenvironment is their niche. We successfully modeled this niche containing cells of HIF-1 alpha+ quiescent stem like phenotype by incubating glioblastoma cell spheroids under an appropriately hypoxic condition, and the emergence of HIF-1 alpha+ quiescent stem-like cells was shown to be associated with an enhanced sphere-forming activity. Conclusions These data suggest that the "peri-necrotic niche" harboring HIF-1 alpha+ quiescent stem-like cells confers a higher tumorigenic potential on glioblastoma cells and therefore may be a therapeutic target to control the behavior of glioblastomas.	[Ishii, Aya; Kimura, Tokuhiro; Ikeda, Eiji] Yamaguchi Univ, Grad Sch Med, Dept Pathol, Ube, Yamaguchi 755, Japan; [Sadahiro, Hirokazu; Suzuki, Michiyasu] Yamaguchi Univ, Grad Sch Med, Dept Neurosurg, Ube, Yamaguchi 755, Japan; [Kawano, Hiroo] Yamaguchi Univ, Grad Sch Med, Dept Basic Lab Sci, Ube, Yamaguchi 755, Japan; [Takubo, Keiyo] Res Inst Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University	Kimura, T; Ikeda, E (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Pathol, Ube, Yamaguchi 755, Japan.	tkimura@yamaguchi-u.ac.jp; ikedae@yamaguchi-u.ac.jp	Takubo, Keiyo/AAX-5546-2020	Takubo, Keiyo/0000-0002-1736-7592; Ishii, Aya/0000-0002-3329-3634	Ministry of Education, Culture, Sports, Science and Technology of Japan [24592164, 26460434]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/) (24592164 to EI; 26460434 to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Beasley NJP, 2001, CANCER RES, V61, P5262; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Christensen K, 2008, J NEURO-ONCOL, V90, P157, DOI 10.1007/s11060-008-9648-8; Deleyrolle LP, 2011, BRAIN, V134, P1331, DOI 10.1093/brain/awr081; Dembinski JL, 2009, CLIN EXP METASTAS, V26, P611, DOI 10.1007/s10585-009-9260-0; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Freter R, 2010, STEM CELLS, V28, P1571, DOI 10.1002/stem.476; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Heng JCD, 2010, COLD SH Q B, V75, P237, DOI 10.1101/sqb.2010.75.003; Holyoake TL, 2001, BLOOD, V97, P720, DOI 10.1182/blood.V97.3.720; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Ikeda E, 2005, PATHOL INT, V55, P603, DOI 10.1111/j.1440-1827.2005.01877.x; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Mashiko R, 2011, J NEURO-ONCOL, V102, P43, DOI 10.1007/s11060-010-0292-8; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ortmann B, 2014, CELL MOL LIFE SCI, V71, P3569, DOI 10.1007/s00018-014-1645-9; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rota LM, 2012, J MAMMARY GLAND BIOL, V17, P119, DOI 10.1007/s10911-012-9258-0; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sundar SJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.9.FOCUS14494; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; The WHO, 2020, CLASSIFICATION TUMOU; Tonn J-C, 2006, NEUROONCOLOGY CNS TU; Vartanian A, 2014, NEURO-ONCOLOGY, V16, P1167, DOI 10.1093/neuonc/nou035; Wen W, 2010, CANCER RES, V70, P2010, DOI 10.1158/0008-5472.CAN-08-4910; Yan GN, 2014, J PATHOL, V234, P11, DOI 10.1002/path.4349; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	50	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147366	10.1371/journal.pone.0147366	http://dx.doi.org/10.1371/journal.pone.0147366			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799577	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300100
J	Semmler, T; Harrison, EM; Lubke-Becker, A; Ulrich, RG; Wieler, LH; Guenther, S; Stamm, I; Hanssen, AM; Holmes, MA; Vincze, S; Walther, B				Semmler, Torsten; Harrison, Ewan M.; Luebke-Becker, Antina; Ulrich, Rainer G.; Wieler, Lothar H.; Guenther, Sebastian; Stamm, Ivonne; Hanssen, Anne-Merethe; Holmes, Mark A.; Vincze, Szilvia; Walther, Birgit			A Look into the Melting Pot: The mecC-Harboring Region Is a Recombination Hot Spot in Staphylococcus stepanovicii	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN RESISTANCE; AUREUS; GENE; HOMOLOG; SCCMEC; POPULATIONS; PREVALENCE; PATHOGENS	Introduction Horizontal gene transfer (HGT) is an important driver for resistance-and virulence factor accumulation in pathogenic bacteria such as Staphylococcus aureus. Methods Here, we have investigated the downstream region of the bacterial chromosomal attachment site (attB) for the staphylococcal cassette chromosome mec (SCCmec) element of a commensal mecC-positive Staphylococcus stepanovicii strain (IMT28705; ODD4) with respect to genetic composition and indications of HGT. S. stepanovicii IMT28705 was isolated from a fecal sample of a trapped wild bank vole (Myodes glareolus) during a screening study (National Network on "Rodent-Borne Pathogens") in Germany. Whole genome sequencing (WGS) of IMT28705 together with the mecC-negative type strain CM7717 was conducted in order to comparatively investigate the genomic region downstream of attB (GenBank accession no. KR732654 and KR732653). Results The bank vole isolate (IMT28705) harbors a mecC gene which shares 99.2% nucleotide (and 98.5% amino acid) sequence identity with mecC of MRSA_LGA251. In addition, the mecC-encoding region harbors the typical blaZ-mecC-mecR1-mecI structure, corresponding with the class E mec complex. While the sequences downstream of attB in both S. stepanovicii isolates (IMT28705 and CM7717) are partitioned by 15 bp direct repeats, further comparison revealed a remarkable low concordance of gene content, indicating a chromosomal "hot spot" for foreign DNA integration and exchange. Conclusion Our data highlight the necessity for further research on transmission routes of resistance encoding factors from the environmental and wildlife resistome.	[Semmler, Torsten; Wieler, Lothar H.] Robert Koch Inst, Berlin, Germany; [Harrison, Ewan M.; Holmes, Mark A.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Luebke-Becker, Antina; Guenther, Sebastian; Vincze, Szilvia; Walther, Birgit] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany; [Ulrich, Rainer G.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Stamm, Ivonne] Vet Med Labor GmbH, Div IDEXX Labs, Ludwigsburg, Germany; [Hanssen, Anne-Merethe] UiT, Fac Hlth Sci, Dept Med Biol, Tromso, Norway	Robert Koch Institute; University of Cambridge; Free University of Berlin; Friedrich Loeffler Institute; Vet Med Labor GmbH; UiT The Arctic University of Tromso	Walther, B (corresponding author), Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany.	birgit.walther@fu-berlin.de	Semmler, Torsten/Q-7716-2018; Semmler, Torsten/O-9540-2019; Harrison, Ewan/I-5003-2013; Guenther, Sebastian/O-5005-2014	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Walther, Birgit/0000-0003-3112-5722; Harrison, Ewan/0000-0003-2720-0507; Guenther, Sebastian/0000-0003-0173-7314; Wieler, Lothar H./0000-0003-4365-3717	Federal Ministry of Education and Research (BMBF) through the National Research Platform for Zoonoses (MedVet-Staph) [01KI1301F]; Network "Rodent-borne Pathogens"; (NaUPa-net) [01KI1018, 01KI1303]; BMBF grant FBI-Zoo [01KI1012A]; MRC [G1001787] Funding Source: UKRI; Medical Research Council [G1001787] Funding Source: researchfish	Federal Ministry of Education and Research (BMBF) through the National Research Platform for Zoonoses (MedVet-Staph)(Federal Ministry of Education & Research (BMBF)); Network "Rodent-borne Pathogens"; (NaUPa-net); BMBF grant FBI-Zoo(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funder provided support in the form of salaries for authors [IS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was not financially supported by IDEXX. The specific roles of these authors are articulated in the 'author contributions' section. This work was supported by the Federal Ministry of Education and Research (BMBF) through the National Research Platform for Zoonoses (MedVet-Staph, grant no. 01KI1301F to BW) and Network "Rodent-borne Pathogens"; (NaUPa-net; grant nos. 01KI1018 and 01KI1303 to RGU). TS was financed through BMBF grant FBI-Zoo (grant no. 01KI1012A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arede P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002816; Balakuntla J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094293; Becker K, 2014, INT J MED MICROBIOL, V304, P794, DOI 10.1016/j.ijmm.2014.06.007; Boundy S, 2013, J BIOL CHEM, V288, P132, DOI 10.1074/jbc.M112.385138; Chlebowicz MA, 2014, INT J MED MICROBIOL, V304, P764, DOI 10.1016/j.ijmm.2014.05.010; Clinical and Laboratory Standards Institute (CLSI), 2020, VET01S2 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2013, VET01 S2 PERF STAND, p32/2; Couto I, 2003, J BACTERIOL, V185, P645, DOI 10.1128/JB.185.2.645-653.2003; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Deurenberg RH, 2005, ANTIMICROB AGENTS CH, V49, P4263, DOI 10.1128/AAC.49.10.4263-4271.2005; Everitt RG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4956; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Frey Y, 2013, J DAIRY SCI, V96, P2247, DOI 10.3168/jds.2012-6091; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gomez P, 2014, J ANTIMICROB CHEMOTH, V69, P2061, DOI 10.1093/jac/dku100; Hanselman BA, 2009, CAN VET J, V50, P954; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; Harrison EM, 2014, J ANTIMICROB CHEMOTH, V69, P911, DOI 10.1093/jac/dkt452; Harrison EM, 2013, ANTIMICROB AGENTS CH, V57, P1524, DOI 10.1128/AAC.01882-12; Hauschild T, 2010, SYST APPL MICROBIOL, V33, P457, DOI 10.1016/j.syapm.2010.08.007; Hauschild T, 2010, SYST APPL MICROBIOL, V33, P183, DOI 10.1016/j.syapm.2010.03.004; Hiramatsu K, 2013, INFECT CHEMOTHER, V45, P117, DOI 10.3947/ic.2013.45.2.117; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ito T, 2003, DRUG RESIST UPDATE, V6, P41, DOI 10.1016/S1368-7646(03)00003-7; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jacob J, 2014, BUNDESGESUNDHEITSBLA, V57, P511, DOI 10.1007/s00103-013-1924-x; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Loncaric I, 2013, J ANTIMICROB CHEMOTH, V68, P2222, DOI 10.1093/jac/dkt186; Malyszko I, 2014, J ANTIMICROB CHEMOTH, V69, P2003, DOI 10.1093/jac/dku043; McRobbie AM, 2012, BIOCHEM J, V442, P77, DOI 10.1042/BJ20111903; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Paterson GK, 2012, J ANTIMICROB CHEMOTH, V67, P2809, DOI 10.1093/jac/dks329; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Scharn CR, 2013, ANTIMICROB AGENTS CH, V57, P5233, DOI 10.1128/AAC.01058-13; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Skov R, 2014, J ANTIMICROB CHEMOTH, V69, P133, DOI 10.1093/jac/dkt341; Stepanovic S, 2006, J CLIN MICROBIOL, V44, P934, DOI 10.1128/JCM.44.3.934-937.2006; Tsubakishita S, 2010, ANTIMICROB AGENTS CH, V54, P4352, DOI 10.1128/AAC.00356-10; Ulrich RG, 2008, PARASITOL RES, V103, pS121, DOI 10.1007/s00436-008-1054-9; Walther B, 2012, EMERG INFECT DIS, V18, P2017, DOI 10.3201/eid1812.120238; Wang L, 2012, J BACTERIOL, V194, P486, DOI 10.1128/JB.05047-11; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009	46	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147150	10.1371/journal.pone.0147150	http://dx.doi.org/10.1371/journal.pone.0147150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799070	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300063
J	Shiwa, Y; Hachiya, T; Furukawa, R; Ohmomo, H; Ono, K; Kudo, H; Hata, J; Hozawa, A; Iwasaki, M; Matsuda, K; Minegishi, N; Satoh, M; Tanno, K; Yamaji, T; Wakai, K; Hitomi, J; Kiyohara, Y; Kubo, M; Tanaka, H; Tsugane, S; Yamamoto, M; Sobue, K; Shimizu, A				Shiwa, Yuh; Hachiya, Tsuyoshi; Furukawa, Ryohei; Ohmomo, Hideki; Ono, Kanako; Kudo, Hisaaki; Hata, Jun; Hozawa, Atsushi; Iwasaki, Motoki; Matsuda, Koichi; Minegishi, Naoko; Satoh, Mamoru; Tanno, Kozo; Yamaji, Taiki; Wakai, Kenji; Hitomi, Jiro; Kiyohara, Yutaka; Kubo, Michiaki; Tanaka, Hideo; Tsugane, Shoichiro; Yamamoto, Masayuki; Sobue, Kenji; Shimizu, Atsushi			Adjustment of Cell-Type Composition Minimizes Systematic Bias in Blood DNA Methylation Profiles Derived by DNA Collection Protocols	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; GENETIC RISK; CANCER; NORMALIZATION; PERFORMANCE; BIOBANKS; PACKAGE; STORAGE; SAMPLES; ARRAYS	Differences in DNA collection protocols may be a potential confounder in epigenome-wide association studies (EWAS) using a large number of blood specimens from multiple biobanks and/or cohorts. Here we show that pre -analytical procedures involved in DNA collection can induce systematic bias in the DNA methylation profiles of blood cells that can be adjusted by cell -type composition variables. In Experiment 1, whole blood from 16 volunteers was collected to examine the effect of a 24 h storage period at 4 C on DNA methylation profiles as measured using the Infinium HumanMethylation450 BeadChip array. Our statistical analysis showed that the P -value distribution of more than 450,000 CpG sites was similar to the theoretical distribution (in quantile-quantile plot, A = 1.03) when comparing two control replicates, which was remarkably deviated from the theoretical distribution (A = 1.50) when comparing control and storage conditions. We then considered cell -type composition as a possible cause of the observed bias in DNA methylation profiles and found that the bias associated with the cold storage condition was largely decreased (A adjusted = 1.14) by taking into account a cell -type composition variable. As such, we compared four respective sample collection protocols used in large-scale Japanese biobanks or cohorts as well as two control replicates. Systematic biases in DNA methylation profiles were observed between control and three of four protocols without adjustment of cell -type composition (A = 1.12-1.45) and no remarkable biases were seen after adjusting for cell -type composition in all four protocols (adjusted = 1.00-1.17). These results revealed important implications for comparing DNA methylation profiles between blood specimens from different sources and may lead to discovery of disease -associated DNA methylation markers and the development of DNA methylation profile -based predictive risk models.	[Shiwa, Yuh; Hachiya, Tsuyoshi; Satoh, Mamoru] Iwate Med Univ, Div Biobank & Data Management, Iwate Tohoku Med Megabank Org, Disaster Reconstruct Ctr, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Shiwa, Yuh; Hachiya, Tsuyoshi; Furukawa, Ryohei; Ohmomo, Hideki; Ono, Kanako; Satoh, Mamoru; Shimizu, Atsushi] Iwate Med Univ, Div Biomed Informat Anal, Iwate Tohoku Med Megabank Org, Disaster Reconstruct Ctr, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Kudo, Hisaaki; Minegishi, Naoko] Tohoku Univ, Dept Biobank, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan; [Hata, Jun] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan; [Hata, Jun] Kyushu Univ, Grad Sch Med Sci, Ctr Cohort Studies, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan; [Hozawa, Atsushi] Tohoku Univ, Prevent Med & Epidemiol, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan; [Iwasaki, Motoki; Yamaji, Taiki; Tsugane, Shoichiro] Natl Canc Ctr, Epidemiol & Prevent Grp, Res Ctr Canc Prevent & Screening, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan; [Matsuda, Koichi] Univ Tokyo, Mol Med Lab, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Satoh, Mamoru] Iwate Med Univ, Community Med Supports & Hlth Record Informat, Iwate Tohoku Med Megabank Org, Disaster Reconstruct Ctr, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Satoh, Mamoru] Iwate Med Univ, Div Biomed Informat Anal, Inst Biomed Sci, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Tanno, Kozo] Iwate Med Univ, Dept Hyg & Prevent Med, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Wakai, Kenji] Nagoya Univ, Dept Prevent Med, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan; [Hitomi, Jiro; Sobue, Kenji] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Disaster Reconstruct Ctr, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Hitomi, Jiro] Iwate Med Univ, Dept Anat, Sch Med, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Kiyohara, Yutaka] Kyushu Univ, Dept Environm Med, Grad Sch Med Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping Dev, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Tanaka, Hideo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Yamamoto, Masayuki] Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan; [Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Aoba Ku, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Sobue, Kenji] Iwate Med Univ, Dept Neurosci, Inst Biomed Sci, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan	Iwate Medical University; Iwate Medical University; Tohoku University; Kyushu University; Kyushu University; Tohoku University; National Cancer Center - Japan; University of Tokyo; Iwate Medical University; Iwate Medical University; Iwate Medical University; Nagoya University; Iwate Medical University; Iwate Medical University; Kyushu University; RIKEN; Aichi Cancer Center; Tohoku University; Tohoku University; Iwate Medical University	Shimizu, A (corresponding author), Iwate Med Univ, Div Biomed Informat Anal, Iwate Tohoku Med Megabank Org, Disaster Reconstruct Ctr, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan.	shimizu@iwate-med.ac.jp	Wakai, Kenji/I-7248-2014; Tsugane, Shoichiro/A-2424-2015; Yamamoto, Masayuki/A-4873-2010; Tanno, Kozo/HDM-5952-2022; Tanno, Kozo/ABE-5165-2020; Hachiya, Tsuyoshi/AAM-8691-2021; Matsuda, Koichi/D-4597-2011	Wakai, Kenji/0000-0001-7388-7157; Tsugane, Shoichiro/0000-0003-4105-2774; Yamamoto, Masayuki/0000-0002-9073-9436; Tanno, Kozo/0000-0002-1264-0684; Tanno, Kozo/0000-0002-1264-0684; Hachiya, Tsuyoshi/0000-0002-5274-3266; Ohmomo, Hideki/0000-0002-3524-6524; Matsuda, Koichi/0000-0001-7292-2686; xing zhi, shi zhi/0000-0003-3289-5681	Tohoku Medical Megabank Project from Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [221S0001, 15K09464] Funding Source: KAKEN	Tohoku Medical Megabank Project from Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Tohoku Medical Megabank Project (Special Account for reconstruction from the Great East Japan Earthquake) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Buhule OD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00354; Chen WA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-74; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Fiebig EW, 1997, CYTOMETRY, V29, P340, DOI 10.1002/(SICI)1097-0320(19971201)29:4<340::AID-CYTO11>3.0.CO;2-U; Harper KN, 2013, CANCER EPIDEM BIOMAR, V22, P1052, DOI 10.1158/1055-9965.EPI-13-0114; Hebels DGAJ, 2013, ENVIRON HEALTH PERSP, V121, P480, DOI 10.1289/ehp.1205657; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Irvin MR, 2014, CIRCULATION, V130, P565, DOI 10.1161/CIRCULATIONAHA.114.009158; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Koestler DC, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-8; Kuan PF, 2010, BIOINFORMATICS, V26, P2849, DOI 10.1093/bioinformatics/btq553; Lehne B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0600-x; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; NICHOLSON JKA, 1984, J IMMUNOL METHODS, V73, P29, DOI 10.1016/0022-1759(84)90028-0; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Seow WJ, 2014, ENVIRON MOL MUTAGEN, V55, P449, DOI 10.1002/em.21860; Sun C, 2013, PEDIATR RES, V73, P523, DOI 10.1038/pr.2013.6; Sun ZF, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-84; VANLAMBALGEN R, 1985, J IMMUNOL METHODS, V80, P39, DOI 10.1016/0022-1759(85)90162-0; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wang T, 2015, EPIGENETICS-US, V10, P662, DOI 10.1080/15592294.2015.1057384; Watson RWG, 2010, NAT REV CANCER, V10, P646, DOI 10.1038/nrc2913; Xu ZL, 2013, JNCI-J NATL CANCER I, V105, P694, DOI 10.1093/jnci/djt045	27	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147519	10.1371/journal.pone.0147519	http://dx.doi.org/10.1371/journal.pone.0147519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799745	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300118
J	Takahashi, Y; Somta, P; Muto, C; Iseki, K; Naito, K; Pandiyan, M; Natesan, S; Tomooka, N				Takahashi, Yu; Somta, Prakit; Muto, Chiaki; Iseki, Kohtaro; Naito, Ken; Pandiyan, Muthaiyan; Natesan, Senthil; Tomooka, Norihiko			Novel Genetic Resources in the Genus Vigna Unveiled from Gene Bank Accessions	PLOS ONE			English	Article							L. A.-RICH.; SUBGENUS CERATOTROPIS; RIBOSOMAL-RNA; DIVERSITY; LEGUMINOSAE; PAPILIONOIDEAE; DOMESTICATION; HYBRIDIZATION; PHYLOGENY; TOLERANCE	The genus Vigna (Fabaceae) consists of five subgenera, and includes more than 100 wild species. In Vigna, 10 crops have been domesticated from three subgenera, Vigna, Plectrotropis, and Ceratotropis. The habitats of wild Vigna species are so diverse that their genomes could harbor various genes responsible for environmental stress adaptation, which could lead to innovations in agriculture. Since some of the gene bank Vigna accessions were unidentified and they seemed to be novel genetic resources, these accessions were identified based on morphological traits. The phylogenetic positions were estimated based on the DNA sequences of nuclear rDNA-ITS and chloroplast atpB-rbcL spacer regions. Based on the results, the potential usefulness of the recently described species V. indica and V. sahyadriana, and some wild Vigna species, i.e., V. aconitifolia, V. dalzelliana, V. khandalensis, V. marina var. oblonga, and V. vexillata, was discussed.	[Takahashi, Yu; Muto, Chiaki; Iseki, Kohtaro; Naito, Ken; Tomooka, Norihiko] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan; [Somta, Prakit] Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Agron, Kamphaeng Saen, Nakhon Pathom, Thailand; [Pandiyan, Muthaiyan; Natesan, Senthil] Tamil Nadu Agr Univ, Coimbatore 641003, Tamil Nadu, India	National Institute of Agrobiological Sciences - Japan; Kasetsart University; Tamil Nadu Agricultural University	Tomooka, N (corresponding author), Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan.	tomooka@affrc.go.jp	Muthaiyan, Pandiyan/AAS-6049-2020; Muthaiyan, Pandiyan/AAO-9610-2020; NATESAN, SENTHIL/AAH-2917-2019	Muthaiyan, Pandiyan/0000-0002-0510-0444; NATESAN, SENTHIL/0000-0002-2930-0715; Naito, Ken/0000-0002-0273-7837; Iseki, Kohtaro/0000-0001-8721-1553	JSPS KAKENHI [13J09808, 26850006]; Grants-in-Aid for Scientific Research [26850006] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 13J09808 and 26850006 to YT. Role of funders: data collection and analysis.	Aitawade M. M., 2012, Rheedea, V22, P20; Arora RK, 1984, NBPGR SCI MONOGRAPH, V7; BABU C R, 1985, Bulletin of the Botanical Survey of India, V27, P1; Baker J.G., 1871, FLORA TROPICAL AFRIC, V2, P1; Baker JG, 1879, FLORA BRIT INDIA, P204; Bhattacharyya P. K., 1984, Seeds & Farms, V10, P33; BIRCH ANE, 1986, PHYTOCHEMISTRY, V25, P2745, DOI 10.1016/S0031-9422(00)83733-4; Bisht IS, 2005, GENET RESOUR CROP EV, V52, P53, DOI 10.1007/s10722-005-0286-0; Chankaew S, 2014, THEOR APPL GENET, V127, P691, DOI 10.1007/s00122-013-2251-1; CHAVAN VM, 1966, INDIAN J GENET PL BR, VA 26, P152; Damayanti F, 2010, CROP PASTURE SCI, V61, P785, DOI 10.1071/CP10060; Delgado-Salinas A, 2011, AM J BOT, V98, P1694, DOI 10.3732/ajb.1100069; Dixit T. M., 2011, Rheedea, V21, P1; Doi K, 2002, GENETICA, V114, P129, DOI 10.1023/A:1015158408227; Fatokun CA, 1996, ADV COWPEA RES, P50; Gaikwad Sayajirao P, 2014, Biodivers Data J, pe4281, DOI 10.3897/BDJ.2.e4281; Garba M., 1998, Proceedings of 2nd International Symposium on Tuberous Legumes, Celaya, Guanajuato, Mexico, 5-8 August 1996., P61; Goel S, 2002, MOL PHYLOGENET EVOL, V22, P1, DOI 10.1006/mpev.2001.1037; Gomathinayagam P, 1998, EUPHYTICA, V102, P203, DOI 10.1023/A:1018381614098; IITA, 1988, ANN REP RES HIGHL 19; IRVINE F. R., 1952, ECON BOT, V6, P23, DOI 10.1007/BF02859192; Jain H. K., 1980, Advances in legume science, P459; John KJ., 2009, INDIAN J PLANT GENET, V22, P138; Karuniawan A, 2006, GENET RESOUR CROP EV, V53, P213, DOI 10.1007/s10722-005-1654-5; Latha M., 2014, Webbia, V69, P49, DOI 10.1080/00837792.2014.893951; LAWN RJ, 1988, BIOLOGIST, V35, P267; Lawn RJ, 2002, AUST J AGR RES, V53, P1305, DOI 10.1071/AR02065; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; MARECHAL R, 1978, Boissiera, V28, P1; Maxted N, 2004, AFRICAN VIGNA ECOGEO; MILLER IL, 1981, TROP GRASSLANDS, V15, P39; Ogundiwin EA, 2002, PLANT BREEDING, V121, P517, DOI 10.1046/j.1439-0523.2002.00769.x; Padulosi S., 1993, Bulletin du Jardin Botanique National de Belgique, V62, P119, DOI 10.2307/3668270; Palmer JL, 2002, AUST J BOT, V50, P331, DOI 10.1071/BT01086; Palmgren MG, 2015, TRENDS PLANT SCI, V20, P155, DOI 10.1016/j.tplants.2014.11.003; Pandiyan M., 2010, Electronic Journal of Plant Breeding, V1, P600; Pasquet R. S., 2001, Kew Bulletin, V56, P223, DOI 10.2307/4119438; PIENAAR BJ, 1991, S AFR J BOT, V57, P236, DOI 10.1016/S0254-6299(16)30924-3; Raghavan SR, 1972, CURRENT SCI, V41, P429; Schrire B. D., 2005, LEGUMES WORLD, P393, DOI DOI 10.1017/S0960428606190198; Schumacher CF, 1827, BESKRIVELSE GUINEISK, P338; Sebastin Raveendar, 2015, Plant Breeding and Biotechnology, V3, P153, DOI 10.9787/PBB.2015.3.2.153; SEN N. K., 1960, Cytologia, V25, P195, DOI 10.1508/cytologia.25.195; Smartt J., 1990, GRAIN LEGUMES, P160; Sonnante G, 1996, GENET RESOUR CROP EV, V43, P157, DOI 10.1007/BF00126759; Sonnante G, 1997, ANN BOT-LONDON, V80, P741, DOI 10.1006/anbo.1997.0511; Takahashi Y, 2014, ANN REPORT EXPLORATI, V30, P29; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TATEISHI Y, 1990, SERIES ENTOM, V46, P189; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thuan NV, 1979, FLORE CAMBODGE LAOS, V17; Thulin M, 2004, SYST BOT, V29, P903, DOI 10.1600/0363644042451035; Tomooka N, 2010, P 14 NIAS INT WORKSH, P11; Tomooka N., 2002, ASIAN VIGNA GENUS VI; Tomooka N, 2006, PL GE BI EV, V1, P87; Tomooka N, 2014, PLANT GENET RESOUR-C, V12, pS168, DOI 10.1017/S1479262114000483; Tomooka N, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: LEGUME CROPS AND FORAGES, P291, DOI 10.1007/978-3-642-14387-8_15; VERDCOURT B, 1970, Kew Bulletin, V24, P507, DOI 10.2307/4102859; Vijaykumar A, 2010, J HERED, V101, P177, DOI 10.1093/jhered/esp084; Wong KC, 1997, PLANT RESOURCES SE A, P261; Yokoyama T, 2006, CAN J MICROBIOL, V52, P31, DOI 10.1139/W05-099; Yoon MS, 2000, J PLANT RES, V113, P375, DOI 10.1007/PL00013945; Zeven A. C., 1982, Dictionary of cultivated plants and their regions of diversity.	63	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147568	10.1371/journal.pone.0147568	http://dx.doi.org/10.1371/journal.pone.0147568			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800459	gold, Green Submitted, Green Published			2022-12-26	WOS:000368655300125
J	Tin, SPP; Lam, WWT; Yoon, S; Zhang, N; Xia, N; Zhang, WW; Ma, K; Fielding, R				Tin, Sze Pui Pamela; Lam, Wendy W. T.; Yoon, Sungwon; Zhang, Na; Xia, Nan; Zhang, Weiwei; Ma, Ke; Fielding, Richard			Workplace Health Promotion: Assessing the Cardiopulmonary Risks of the Construction Workforce in Hong Kong	PLOS ONE			English	Article							METABOLIC SYNDROME; PHYSICAL-ACTIVITY; EARLY RETIREMENT; MARITAL-STATUS; PREVALENCE; WORKERS; INTERVENTIONS; DISABILITY; BEHAVIOR; INDUSTRY	Objective Health needs of different employee subgroups within an industry can differ. We report the results of a workplace cardiopulmonary risk assessment targeting workers and support staff in the construction industry. Methods A free worksite-based cardiopulmonary risk assessment for 1,903 workers on infrastructural contracts across Hong Kong was initiated in May 2014. Cardiopulmonary risk screening was performed in 60-minute blocks for approximately 30 workers/block with individualized feedback and lifestyle counseling. Risk profiles stratified by occupational roles are differentiated using the. 2-test for categorical and Student's t-test for continuous variables. Results Most construction workers and clerks/professionals were male (83.2% and 71.2%, respectively) and Chinese (78.7% and 90.9%, respectively). Construction workers were older (mean: 44.9 years, SD 11.5) and less well-educated (6.1% received tertiary education) than clerks/professionals (35.0 years, 10.7; 72.6% received tertiary education), but more likely to be hypertensive (22.6% vs. 15.4%, p<0.001), overweight/obese (71.7% vs. 56.6%, p<0.001), centrally obese (53.1% vs. 35.5%, p<0.001), and have undesirable levels of high-density lipoprotein (41.6% vs. 35.8%, p<0.05) and diabetic levels of non-fasting blood glucose (4.3% vs. 1.6%, p<0.05). Up to 12.6% of construction workers and 9.7% of office clerks/professions had three or more metabolic syndrome risk factors. While construction workers were more likely than clerks/professionals to be daily smokers, they reported better work-related physical activity and diet. Conclusions Simple worksite health risk screening can identify potentially high-cardiopulmonary-risk construction industry employee subgroups for onward confirmatory referral. Separate cardiopulmonary health promotion strategies that account for the varying lifestyle profiles of the two employee subgroups in the industry appear justified.	[Tin, Sze Pui Pamela; Lam, Wendy W. T.; Yoon, Sungwon; Zhang, Na; Xia, Nan; Zhang, Weiwei; Ma, Ke; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Div Behav Sci, 5-F William MW Mong Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Tin, SPP (corresponding author), Univ Hong Kong, Sch Publ Hlth, Div Behav Sci, 5-F William MW Mong Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	pamtin@hku.hk	Xia, Nan/ABG-4600-2021; Lam, Wendy Wing Tak/C-4319-2009	Zhang, Na/0000-0003-3719-4008; Yoon, Sungwon/0000-0001-9458-6097; Lam, Wendy Wing Tak/0000-0003-2383-0149	QBE Hong Kong & Shanghai Insurance Limited	QBE Hong Kong & Shanghai Insurance Limited	This work was funded by QBE Hong Kong & Shanghai Insurance Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Arndt V, 2005, OCCUP ENVIRON MED, V62, P559, DOI 10.1136/oem.2004.018135; Biggs HC, 2012, VULNERABLE GROUPS IN, P3; Brenner H, 2000, OCCUP ENVIRON MED, V57, P615, DOI 10.1136/oem.57.9.615; Broderick JM, 2014, BRIT J CANCER, V111, P2377, DOI 10.1038/bjc.2014.248; Burton J., 2010, WHO HLTH WORKPLACE F; Centre_ for_ Health_ Protection, 2012, STAT BEH RISK FACT B; Construction Industry Council Hong Kong SAR, 2011, IND PERF REP 2011; Damman OC, 2014, J OCCUP ENVIRON MED, V56, P92, DOI 10.1097/JOM.0000000000000041; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Government of the Hong Kong SAR, 2012, REP MANP PROJ 2018; Groeneveld IF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-836; Groeneveld IF, 2010, SCAND J WORK ENV HEA, V36, P202, DOI 10.5271/sjweh.2891; Groeneveld IF, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-80; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Han KT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0109-0; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P357, DOI 10.5271/sjweh.2913; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Krause N, 2007, SCAND J WORK ENV HEA, V33, P405, DOI 10.5271/sjweh.1171; Poon SW, 2013, INT J CONSTR MANAG, V13, P69, DOI 10.1080/15623599.2013.10773206; Prabhakaran D, 2005, NATL MED J INDIA, V18, P59; Raum E, 2007, ANN EPIDEMIOL, V17, P417, DOI 10.1016/j.annepidem.2006.12.008; Rothenbacher D, 1998, J OCCUP ENVIRON MED, V40, P63, DOI 10.1097/00043764-199801000-00012; Ruzic L, 2003, OCCUP ENVIRON MED, V60, P983, DOI 10.1136/oem.60.12.983; Santini M, 2011, GIORNALE ITALIANO S, V34, P521; Sito P., 2014, S CHINA MORNING POST; Siu P., 2014, S CHINA MORNING POST; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; St George A, 2012, HEALTH PROMOT J AUST, V23, P134, DOI 10.1071/HE12134; State Building & Construction Trades Council of California, 2015, BUILT SEC BUILT 2015; Thabit H, 2013, DIABETES VASC DIS RE; Verweij LM, 2011, OBES REV, V12, P406, DOI 10.1111/j.1467-789X.2010.00765.x; Wang GR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-599; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; World Health Organziation Western Pacific Region, 2000, AS PAC PERSP RED OB	36	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146286	10.1371/journal.pone.0146286	http://dx.doi.org/10.1371/journal.pone.0146286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799393	Green Published, Green Submitted, gold			2022-12-26	WOS:000368655300018
J	Pietila, I; Prunskaite-Hyyrylainen, R; Kaisto, S; Tika, E; van Eerde, AM; Salo, AM; Garma, L; Miinalainen, I; Feitz, WF; Bongers, EMHF; Juffer, A; Knoers, NVAM; Renkema, KY; Myllyharju, J; Vainio, SJ				Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Tika, Elisavet; van Eerde, Albertien M.; Salo, Antti M.; Garma, Leonardo; Miinalainen, Ilkka; Feitz, Wout F.; Bongers, Ernie M. H. F.; Juffer, Andre; Knoers, Nine V. A. M.; Renkema, Kirsten Y.; Myllyharju, Johanna; Vainio, Seppo J.			Wnt5a Deficiency Leads to Anomalies in Ureteric Tree Development, Tubular Epithelial Cell Organization and Basement Membrane Integrity Pointing to a Role in Kidney Collecting Duct Patterning	PLOS ONE			English	Article							METANEPHRIC MESENCHYME; ORGANOGENESIS; EXPRESSION; TRANSFORMATION; MORPHOGENESIS; INDUCTION; PATHWAYS; COLLAGEN; NEPHRON; CATENIN	The Wnts can be considered as candidates for the Congenital Anomaly of Kidney and Urinary Tract, CAKUT diseases since they take part in the control of kidney organogenesis. Of them Wnt5a is expressed in ureteric bud (UB) and its deficiency leads to duplex collecting system (13/90) uni-or bilateral kidney agenesis (10/90), hypoplasia with altered pattern of ureteric tree organization (42/90) and lobularization defects with partly fused ureter trunks (25/90) unlike in controls. The UB had also notably less tips due to Wnt5a deficiency being at E15.5 306 and at E16.5 765 corresponding to 428 and 1022 in control (p<0.02; p<0.03) respectively. These changes due to Wnt5a knock out associated with anomalies in the ultrastructure of the UB daughter epithelial cells. The basement membrane (BM) was malformed so that the BM thickness increased from 46.3 nm to 71.2 nm (p<0.01) at E16.5 in the Wnt5a knock out when compared to control. Expression of a panel of BM components such as laminin and of type IV collagen was also reduced due to the Wnt5a knock out. The P4ha1 gene that encodes a catalytic subunit of collagen prolyl 4-hydroxylase I (C-P4H-I) in collagen synthesis expression and the overall C-P4H enzyme activity were elevated by around 26% due to impairment in Wnt5a function from control. The compound Wnt5a(+/-); P4ha1(+/-) embryos demonstrated Wnt5a(-/-) related defects, for example local hyperplasia in the UB tree. A R260H WNT5A variant was identified from renal human disease cohort. Functional studies of the consequence of the corresponding mouse variant in comparison to normal ligand reduced Wnt5a-signalling in vitro. Together Wnt5a has a novel function in kidney organogenesis by contributing to patterning of UB derived collecting duct development contributing putatively to congenital disease.	[Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Vainio, Seppo J.] Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dev Biol Lab, Oulu, Finland; [Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Vainio, Seppo J.] Infotech Oulu, Oulu, Finland; [Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Salo, Antti M.; Myllyharju, Johanna; Vainio, Seppo J.] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Tika, Elisavet; van Eerde, Albertien M.; Knoers, Nine V. A. M.; Renkema, Kirsten Y.] Univ Med Ctr Utrecht, Dept Genet, Ctr Mol Med, Utrecht, Netherlands; [Salo, Antti M.; Myllyharju, Johanna] Bioctr Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland; [Garma, Leonardo; Juffer, Andre] Univ Oulu, Fac Biochem & Mol Med, Bioctr Oulu, Oulu, Finland; [Miinalainen, Ilkka] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Feitz, Wout F.] Radboud Univ Nijmegen, Med Ctr, Radboudumc Amalia Childrens Hosp, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Bongers, Ernie M. H. F.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands	University of Oulu; University of Oulu; University of Oulu; Utrecht University; Utrecht University Medical Center; University of Oulu; University of Oulu; University of Oulu; Radboud University Nijmegen; Radboud University Nijmegen	Vainio, SJ (corresponding author), Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dev Biol Lab, Oulu, Finland.; Vainio, SJ (corresponding author), Infotech Oulu, Oulu, Finland.; Vainio, SJ (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	Seppo.Vainio@oulu.fi	Renkema, Kirsten Y./V-2385-2019; Feitz, W.F.J./H-8028-2014	Juffer, Andre/0000-0003-3533-0520; Miinalainen, Ilkka/0000-0002-3922-3442; Garma, Leonardo Daniel/0000-0003-1220-8397; van Eerde, Albertien M./0000-0001-5953-5956; Prunskaite-Hyyrylainen, Renata/0000-0001-5453-2983; Vainio, Seppo/0000-0001-9319-3566; Kaisto, Susanna/0000-0002-0484-1670	Academy of Finland [206038, 121647, 250900, 260056]; Centre of Excellence grant of the Academy of Finland [251314]; Sigrid Juselius Foundation; European Community [305608]; Dutch Kidney Foundation [KSTP10.004, KSTP12.010, CP11.18]; Fonds NutsOhra [1303-070]	Academy of Finland(Academy of Finland); Centre of Excellence grant of the Academy of Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Community(European Commission); Dutch Kidney Foundation; Fonds NutsOhra	This work was supported by the Academy of Finland (206038, 121647, 250900 and 260056), Centre of Excellence grant 2012-2017 of the Academy of Finland (251314), [http://www.aka.fi/en] to SV; the Sigrid Juselius Foundation, [http://www.sigridjuselius.fi/foundation] to SV; the European Community's Seventh Framework Program FP7/2009 under grant agreement 305608 (EURenOmics: European Consortium for High-Throughput Research in Rare Kidney Diseases) [http://eurenomics.eu/] to SV and NK; the Dutch Kidney Foundation (KSTP10.004, KSTP12.010, and CP11.18) [http://www.nierstichting.nl] to NK; and Fonds NutsOhra (1303-070) [http://www.fondsnutsohra.nl] to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chi LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027676; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Enzo Maria Vittoria, 2015, Mol Cell Ther, V3, P1, DOI 10.1186/s40591-015-0038-2; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Huang LW, 2014, NEPHRON EXP NEPHROL, V128, P80, DOI 10.1159/000368411; Itaranta P, 2002, GENESIS, V32, P259, DOI 10.1002/gene.10079; Jain S, 2009, ORGANOGENESIS, V5, P177, DOI 10.4161/org.5.4.10048; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kispert A, 1996, DEVELOPMENT, V122, P3627; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Krediet RT, 2010, NAT REV NEPHROL, V6, P451, DOI 10.1038/nrneph.2010.68; Lin YF, 2001, DEV DYNAM, V222, P26, DOI 10.1002/dvdy.1164; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miner JH, 2011, ORGANOGENESIS, V7, P75, DOI 10.4161/org.7.2.15275; Myllymaki SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019453; Nishita M, 2014, MOL CELL BIOL, V34, P3096, DOI 10.1128/MCB.00491-14; O'Brien LL, 2014, SEMIN CELL DEV BIOL, V36, P31, DOI 10.1016/j.semcdb.2014.08.014; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pietila I, 2014, NEPHRON EXP NEPHROL, V126, P40, DOI 10.1159/000360659; Queisser-Luft A., 2002, Archives of Gynecology and Obstetrics, V266, P163, DOI 10.1007/s00404-001-0265-4; Railo A, 2008, EXP CELL RES, V314, P2389, DOI 10.1016/j.yexcr.2008.04.010; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Seikaly MG, 2003, PEDIATR NEPHROL, V18, P796, DOI 10.1007/s00467-003-1158-5; Shi S, 2015, KIDNEY INT; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto H, 2015, J CELL SCI, V128, P1051, DOI 10.1242/jcs.163683; Yang DH, 2011, DEVELOPMENT, V138, P4535, DOI 10.1242/dev.071266; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Yun K., 2014, HUM MOL GENET; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	37	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147171	10.1371/journal.pone.0147171	http://dx.doi.org/10.1371/journal.pone.0147171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794322	Green Submitted, Green Published, gold			2022-12-26	WOS:000368530300021
J	Venter, WDF; Fairlie, L; Feldman, C; Cleaton-Jones, P; Chersich, M				Venter, Willem Daniel Francois; Fairlie, Lee; Feldman, Charles; Cleaton-Jones, Peter; Chersich, Matthew			Views of Medical Doctors Regarding the 2013 WHO Adult HIV Treatment Guidelines Indicate Variable Applicability for Routine Patient Monitoring, for Their Family Members and for Themselves, in South-Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTION; WOMEN	South African doctors (n = 211) experienced in antiretroviral therapy use were asked via an online questionnaire about the WHO 2013 adult antiretroviral integrated guidelines, as well as clinical and personal issues, in three hypothetical scenarios: directing the Minister of Health, advising a family member requiring therapy amidst unstable antiretroviral supplies, and where doctors themselves were HIV-positive. Doctors (54%) favoured the 500 cells/mu l WHO initiation threshold if advising the Minister; a third recommended retaining the 350 cells/mu l threshold used at the time of the survey. However, they favoured a higher initiation threshold for their family member. Doctors were 4.9 fold more likely to initiate modern treatment, irrespective of their CD4 cell count, for themselves than for public-sector patients (95% CI odds ratio = 3.33-7.33; P<0.001, although lower if limited to stavudine-containing regimens. Doctors were equally concerned about stavudine-induced lactic acidosis and lipoatrophy. The majority (84%) would use WHO-recommended first-line therapy, with concerns split between tenofovir-induced nephrotoxicity (55%), and efavirenz central nervous system effects (29%). A majority (61%), if HIV-positive, would pay for a pre-initiation resistance test, use influenza-prophylaxis (85%), but not INH-prophylaxis (61%), and treat their cholesterol and blood pressure concerns conventionally (63% and 60%). Over 60% wanted viral loads and creatinine measured six monthly. A third felt CD4 monitoring only necessary if clinically indicated or if virological failure occurred. They would use barrier prevention (83%), but not recommend pre-exposure prophylaxis, if their sexual partner was HIV-negative (68%). A minority would be completely open about their HIV status, but the majority would disclose to their sexual partners, close family and friends. Respondents were overwhelmingly in favour of continued antiretrovirals after breastfeeding. In conclusion, doctors largely supported adult WHO guidelines as public policy, although would initiate treatment at higher CD4 counts for their family and themselves. Resistance to INH-prophylaxis is unexpected and warrants investigation.	[Venter, Willem Daniel Francois; Fairlie, Lee; Chersich, Matthew] Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst RHI, Johannesburg, South Africa; [Feldman, Charles] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Div Pulmonol, Johannesburg, South Africa; [Feldman, Charles] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Cleaton-Jones, Peter] Univ Witwatersrand, Fac Hlth Sci, Steve Biko Ctr Bioeth, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Venter, WDF (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst RHI, Johannesburg, South Africa.	fventer@wrhi.ac.za	Cleaton-Jones, Peter E/L-4090-2016; Feldman, Charles/ABF-3315-2020	Feldman, Charles/0000-0002-6881-8314; Venter, Willem/0000-0002-4157-732X; chersich, matthew/0000-0002-4320-9168	President's Emergency Plan for AIDS Relief (PEPFAR); National Research Foundation (NRF); National Research Foundation	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Research Foundation (NRF); National Research Foundation	WDFV and LF are supported by the President's Emergency Plan for AIDS Relief (PEPFAR). CF is supported by the National Research Foundation (NRF).; PEPFAR supports WDFV and LF. Charles Feldman is supported by the National Research Foundation (SA). Thanks to the Southern African HIV Clinicians Society for distributing the survey to members.	[Anonymous], 2014, UNAIDS GAP REPORT; Bloomfield GS, 2014, JAIDS-J ACQ IMM DEF, V67, pS40, DOI 10.1097/QAI.0000000000000257; Bristow CC, 2012, INT J TUBERC LUNG D, V16, P1020, DOI 10.5588/ijtld.11.0744; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Doherty M., 2015, IAS 2015; Easterbrook PJ, 2014, AIDS, V28, pS93, DOI 10.1097/QAD.0000000000000253; Gallant JE, 2013, CLIN INFECT DIS, V57, P884, DOI 10.1093/cid/cit382; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Nelson LJ, 2014, AIDS, V28, pS217, DOI 10.1097/QAD.0000000000000239; Phillips T, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19242; Tudor C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-891	13	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0145911	10.1371/journal.pone.0145911	http://dx.doi.org/10.1371/journal.pone.0145911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794907	gold, Green Submitted, Green Published			2022-12-26	WOS:000368530300004
J	Stapleton, JA; Kim, J; Hamilton, JP; Wu, M; Irber, LC; Maddamsetti, R; Briney, B; Newton, L; Burton, DR; Brown, CT; Chan, C; Buell, CR; Whitehead, TA				Stapleton, James A.; Kim, Jeongwoon; Hamilton, John P.; Wu, Ming; Irber, Luiz C.; Maddamsetti, Rohan; Briney, Bryan; Newton, Linsey; Burton, Dennis R.; Brown, C. Titus; Chan, Christina; Buell, C. Robin; Whitehead, Timothy A.			Haplotype-Phased Synthetic Long Reads from Short-Read Sequencing	PLOS ONE			English	Article							RNA-SEQ EXPERIMENTS; ESCHERICHIA-COLI; GENOME SEQUENCE; HIGH-THROUGHPUT; SINGLE CELLS; TRANSCRIPTOME; ACCURATE; REVEALS; CONSTRUCTION; REPERTOIRE	Next-generation DNA sequencing has revolutionized the study of biology. However, the short read lengths of the dominant instruments complicate assembly of complex genomes and haplotype phasing of mixtures of similar sequences. Here we demonstrate a method to reconstruct the sequences of individual nucleic acid molecules up to 11.6 kilobases in length from short (150-bp) reads. We show that our method can construct 99.97%-accurate synthetic reads from bacterial, plant, and animal genomic samples, full-length mRNA sequences from human cancer cell lines, and individual HIV env gene variants from a mixture. The preparation of multiple samples can be multiplexed into a single tube, further reducing effort and cost relative to competing approaches. Our approach generates sequencing libraries in three days from less than one microgram of DNA in a single-tube format without custom equipment or specialized expertise.	[Stapleton, James A.; Chan, Christina; Whitehead, Timothy A.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Kim, Jeongwoon; Hamilton, John P.; Newton, Linsey; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Wu, Ming] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Irber, Luiz C.; Brown, C. Titus] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Irber, Luiz C.; Brown, C. Titus] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Maddamsetti, Rohan] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Maddamsetti, Rohan] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Briney, Bryan; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Briney, Bryan; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Briney, Bryan; Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Brown, C. Titus] Univ Calif Davis, Populat Hlth & Reprod, Davis, CA 95616 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; University of Michigan System; University of Michigan; Michigan State University; Michigan State University; Michigan State University; Michigan State University; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; University of California System; University of California Davis; Michigan State University	Whitehead, TA (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.; Whitehead, TA (corresponding author), Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA.	taw@egr.msu.edu	Irber, Luiz/ABE-1486-2021; Hamilton, John P/G-1379-2016	Irber, Luiz/0000-0003-4371-9659; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NIGMS [F32GM099291]; National Institutes of Health [5R21CA176854-02]; MIIE Commercialization Grant [AGR 2014-0200]; MSF from the State of Michigan [Case-48166]; NATIONAL CANCER INSTITUTE [R21CA176854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099291] Funding Source: NIH RePORTER	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NIGMS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIIE Commercialization Grant; MSF from the State of Michigan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award F32GM099291 from the NIGMS to JAS, National Institutes of Health (5R21CA176854-02), MIIE Commercialization Grant (AGR 2014-0200), and Grant Case-48166 of the 21st Century Jobs Trust Fund received through the MSF from the State of Michigan to TAW. Funds for the G. sempervirens genome and transcriptome analyses were provided by Michigan State University to CRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Bishara A, 2015, GENOME RES, V25, P1570, DOI 10.1101/gr.191189.115; Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Hong LZ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0517-9; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Li H., 2013, ARXIV 13033997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lundin S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01186; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; Menon R, 2014, J PROTEOME RES, V13, P212, DOI 10.1021/pr400773v; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Rungpragayphan S, 2002, J MOL BIOL, V318, P395, DOI 10.1016/S0022-2836(02)00094-3; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sharma SK, 2013, G3-GENES GENOM GENET, V3, P2031, DOI 10.1534/g3.113.007153; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Sharon I, 2015, GENOME RES, V25, P534, DOI 10.1101/gr.183012.114; Souza V, 1997, J EVOLUTION BIOL, V10, P743; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010554; Tilgner H, 2015, NAT BIOTECHNOL, V33, P736, DOI 10.1038/nbt.3242; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wu NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097505; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147229	10.1371/journal.pone.0147229	http://dx.doi.org/10.1371/journal.pone.0147229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789840	Green Published, Green Submitted, gold			2022-12-26	WOS:000368529100070
J	Wang, Y; Yan, FS; Lian, JM; Dou, SW				Wang, Ying; Yan, Feng-Shan; Lian, Jian-Min; Dou, She-Wei			Effects of Gestational Magnetic Resonance Imaging on Methylation Status of Leptin Promoter in the Placenta and Cord Blood	PLOS ONE			English	Article							IN-UTERO EXPOSURE; HIGH-FAT-DIET; DNA METHYLATION; MR EXPOSURE; FETAL-GROWTH; BODY-WEIGHT; EPIGENETICS; PREGNANCY; MOUSE; CHICK	Over the past two decades, magnetic resonance imaging (MRI) has been widely used for diagnosis in gestational women. Though it has several advantages, animal and human studies on the safety of MRI for the fetus remain inconclusive. Epigenetic modifications, which are crucial for cellular functioning, are prone to being affected by environmental changes. Therefore, we hypothesized that MRI during gestation may cause epigenetic modification alterations. Here, we investigated DNA methylation patterns of leptin promoter in the placenta and cord blood of women exposed to MRI during gestation. Results showed that average methylation levels of leptin in the placenta and cord blood were not affected by MRI. We also found that the methylation levels in the placenta and cord blood were not affected by different magnetic fields (1.5T and 3.0T MRI). However, if pregnant women were exposed to MRI at 15 to 20 weeks of gestation, the methylation level of leptin in cord blood was visibly lower than that of pregnant women exposed to MRI after 20-weeks of gestation (P = 0.037). mRNA expression level of leptin in cord blood was also altered, though mRNA expression of leptin in the placenta was not significantly affected. Therefore, we concluded that gestational MRI may not have major effects on the methylation level of leptin in cord blood and the placenta except for MRI applied before 20 weeks of gestation.	[Wang, Ying; Yan, Feng-Shan; Lian, Jian-Min; Dou, She-Wei] Zhengzhou Univ, Dept Radiol, Peoples Hosp, Henan Prov Peoples Hosp, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University	Dou, SW (corresponding author), Zhengzhou Univ, Dept Radiol, Peoples Hosp, Henan Prov Peoples Hosp, Zhengzhou 450052, Henan, Peoples R China.	doushewei2000@163.com						BAKER PN, 1994, AM J OBSTET GYNECOL, V170, P32; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; BEHR KP, 1991, DEUT TIERARZTL WOCH, V98, P149; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bouchard L, 2010, DIABETES CARE, V33, P2436, DOI 10.2337/dc10-1024; Briffa JF, 2015, AM J PHYSIOL-ENDOC M, V308, pE335, DOI 10.1152/ajpendo.00312.2014; Bulas D, 2013, SEMIN PERINATOL, V37, P301, DOI 10.1053/j.semperi.2013.06.005; Caprio M, 2001, TRENDS ENDOCRIN MET, V12, P65, DOI 10.1016/S1043-2760(00)00352-0; Carnes KI, 1996, MAGN RESON IMAGING, V14, P263, DOI 10.1016/0730-725X(95)02099-F; Chao HH, 2012, HISTOCHEM CELL BIOL, V137, P249, DOI 10.1007/s00418-011-0894-z; Coakley FV, 2004, AM J ROENTGENOL, V182, P243, DOI 10.2214/ajr.182.1.1820243; El Hajj N, 2014, REPRODUCTION, V148, pR111, DOI 10.1530/REP-14-0334; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Friedman Jeffrey M., 2011, Keio Journal of Medicine, V60, P1, DOI 10.2302/kjm.60.1; Garcia-Cardona MC, 2014, INT J OBESITY, V38, P1457, DOI 10.1038/ijo.2014.30; Ge ZJ, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.118141; Ge ZJ, 2014, ENVIRON HEALTH PERSP, V122, P159, DOI 10.1289/ehp.1307047; Giudicelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068268; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; HEINRICHS WL, 1988, MAGN RESON IMAGING, V6, P305, DOI 10.1016/0730-725X(88)90407-9; KANAL E, 1993, RADIOLOGY, V187, P395, DOI 10.1148/radiology.187.2.8475280; Khalyfa A, 2013, INT J OBESITY, V37, P1481, DOI 10.1038/ijo.2013.12; Lepercq J, 2001, J CLIN ENDOCR METAB, V86, P2409, DOI 10.1210/jc.86.6.2409; Lesseur C, 2013, MOL CELL ENDOCRINOL, V381, P160, DOI 10.1016/j.mce.2013.07.024; Magin RL, 2000, J MAGN RESON IMAGING, V12, P140, DOI 10.1002/1522-2586(200007)12:1<140::AID-JMRI15>3.0.CO;2-D; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; MEVISSEN M, 1994, TERATOLOGY, V50, P229, DOI 10.1002/tera.1420500308; Michel SCA, 2003, AM J ROENTGENOL, V180, P1159, DOI 10.2214/ajr.180.4.1801159; Myers C, 1998, BRIT J RADIOL, V71, P549, DOI 10.1259/bjr.71.845.9691901; Okuda Yasuyuki, 1999, Journal of Toxicological Sciences, V24, P79; Poutamo J, 1998, PRENATAL DIAG, V18, P1149, DOI 10.1002/(SICI)1097-0223(199811)18:11<1149::AID-PD421>3.0.CO;2-K; Schrey S, 2013, MOL HUM REPROD, V19, P764, DOI 10.1093/molehr/gat048; Shen WW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05282; Strizek B, 2015, RADIOLOGY, V275, P530, DOI 10.1148/radiol.14141382; Triulzi F, 2011, RADIOL MED, V116, P337, DOI 10.1007/s11547-011-0633-5; Vadeyar SH, 2000, AM J OBSTET GYNECOL, V182, P666, DOI 10.1067/mob.2000.103938; YIP YP, 1995, JMRI-J MAGN RESON IM, V5, P457, DOI 10.1002/jmri.1880050416; YIP YP, 1994, JMRI-J MAGN RESON IM, V4, P742, DOI 10.1002/jmri.1880040518; YIP YP, 1994, JMRI-J MAGN RESON IM, V4, P799, DOI 10.1002/jmri.1880040610; Yousefi M, 2013, INT J MOL EPIDEMIOL, V4, P86	41	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147371	10.1371/journal.pone.0147371	http://dx.doi.org/10.1371/journal.pone.0147371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789724	Green Submitted, gold, Green Published			2022-12-26	WOS:000368529100083
J	Han, HJ; Kwon, N; Choi, MA; Jung, KO; Piao, JY; Ngo, HKC; Kim, SJ; Kim, DH; Chung, JK; Cha, YN; Youn, H; Choi, BY; Min, SH; Surh, YJ				Han, Hyeong-Jun; Kwon, Nayoung; Choi, Min-A; Jung, Kyung Oh; Piao, Juan-Yu; Ngo, Hoang Kieu Chi; Kim, Su-Jung; Kim, Do-Hee; Chung, June-Key; Cha, Young-Nam; Youn, Hyewon; Choi, Bu Young; Min, Sang-Hyun; Surh, Young-Joon			Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1 alpha	PLOS ONE			English	Article							BREAST-CANCER; DIRECT PHOSPHORYLATION; FACTOR 1-ALPHA; GROWTH-FACTOR; BETA-CATENIN; CELL-CYCLE; FACTOR-I; S-PHASE; ANGIOGENESIS; EXPRESSION	Peptidyl prolyl isomerase (PIN1) regulates the functional activity of a subset of phosphoproteins through binding to phosphorylated Ser/Thr-Pro motifs and subsequently isomerization of the phosphorylated bonds. Interestingly, PIN1 is overexpressed in many types of malignancies including breast, prostate, lung and colon cancers. However, its oncogenic functions have not been fully elucidated. Here, we report that PIN1 directly interacts with hypoxia-inducible factor (HIF)-1 alpha in human colon cancer (HCT116) cells. PIN1 binding to HIF-1 alpha occurred in a phosphorylation-dependent manner. We also found that PIN1 interacted with HIF-1 alpha at both exogenous and endogenous levels. Notably, PIN1 binding stabilized the HIF-1 alpha protein, given that their levels were significantly increased under hypoxic conditions. The stabilization of HIF-1 alpha resulted in increased transcriptional activity, consequently upregulating expression of vascular endothelial growth factor, a major contributor to angiogenesis. Silencing of PIN1 or pharmacologic inhibition of its activity abrogated the angiogenesis. By utilizing a bioluminescence imaging technique, we were able to demonstrate that PIN1 inhibition dramatically reduced the tumor volume in a subcutaneous mouse xenograft model and angiogenesis as well as hypoxia-induced transcriptional activity of HIF-1 alpha. These results suggest that PIN1 interacting with HIF-1 alpha is a potential cancer chemopreventive and therapeutic target.	[Han, Hyeong-Jun; Kwon, Nayoung; Choi, Min-A; Piao, Juan-Yu; Ngo, Hoang Kieu Chi; Kim, Su-Jung; Kim, Do-Hee; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul 151742, South Korea; [Han, Hyeong-Jun; Piao, Juan-Yu; Ngo, Hoang Kieu Chi; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Jung, Kyung Oh; Chung, June-Key; Youn, Hyewon] Seoul Natl Univ, Dept Nucl Med, Seoul 136742, South Korea; [Jung, Kyung Oh; Chung, June-Key] Seoul Natl Univ, Biomed Sci, Seoul 136742, South Korea; [Jung, Kyung Oh; Chung, June-Key; Youn, Hyewon; Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul 136742, South Korea; [Kim, Su-Jung; Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea; [Cha, Young-Nam] Inha Univ, Coll Med, Inchon, South Korea; [Youn, Hyewon] Seoul Natl Univ Hosp, Canc Imaging Ctr, Seoul 136742, South Korea; [Choi, Bu Young] Seowon Univ, Sch Convergence Biosci & Technol, Dept Pharmaceut Sci & Engn, Cheongju 361742, South Korea; [Min, Sang-Hyun] New Drug Dev Ctr DGMIF, Daegu 701310, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inha University; Seoul National University (SNU); Seoul National University Hospital; Seowon University	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul 151742, South Korea.; Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea.; Surh, YJ (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul 136742, South Korea.; Surh, YJ (corresponding author), Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea.	surh@snu.ac.kr		Youn, Hyewon/0000-0003-1006-2689	Global Core Research Center (GCRC) from the National Research Foundation (NRF), Republic of Korea [2012-0001184]	Global Core Research Center (GCRC) from the National Research Foundation (NRF), Republic of Korea	This work was supported by Global Core Research Center (GCRC) grant (No. 2012-0001184) from the National Research Foundation (NRF), Republic of Korea.	Ahluwalia A, 2012, CURR MED CHEM, V19, P90, DOI 10.2174/092986712803413944; Bakker WJ, 2013, TRANSCR-AUSTIN, V4, P62, DOI 10.4161/trns.23680; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Driver JA, 2015, BBA-GEN SUBJECTS, V1850, P2069, DOI 10.1016/j.bbagen.2014.12.025; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukuda R, 2003, CANCER RES, V63, P2330; Gabellini C, 2006, ONCOGENE, V25, P5326, DOI 10.1038/sj.onc.1209631; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jalouli M, 2014, CELL SIGNAL, V26, P1649, DOI 10.1016/j.cellsig.2014.04.005; Kim CJ, 2005, WORLD J GASTROENTERO, V11, P5006, DOI 10.3748/wjg.v11.i32.5006; Kim JH, 2014, PHYTOTHER RES, V28, P238, DOI 10.1002/ptr.4986; Kuramochi J, 2006, J SURG ONCOL, V94, P155, DOI 10.1002/jso.20510; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lonati E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00001; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Ma JH, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/160140; Masood R, 2001, BLOOD, V98, P1904, DOI 10.1182/blood.V98.6.1904; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Miyashita H, 2003, ONCOL REP, V10, P1045; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Nakamura K, 2012, MOL CELL BIOL, V32, P2966, DOI 10.1128/MCB.05688-11; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sorrentino G, 2013, CELL DEATH DIFFER, V20, P198, DOI 10.1038/cdd.2012.112; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Toledo F, 2007, MOL CELL BIOL, V27, P1425, DOI 10.1128/MCB.00999-06; Tong Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.3; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Viola RJ, 2008, AM J ROENTGENOL, V191, P1779, DOI 10.2214/AJR.07.4060; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang JZ, 2013, MED HYPOTHESES, V81, P282, DOI 10.1016/j.mehy.2013.04.029; Warfel NA, 2013, CELL CYCLE, V12, P3689, DOI 10.4161/cc.26930; Wei S, 2015, NAT MED, V21, P457, DOI 10.1038/nm.3839; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu DZ, 2010, J BIOL CHEM, V285, P38944, DOI 10.1074/jbc.M110.160325; Yang QY, 2009, J BIOL CHEM, V284, P23980, DOI 10.1074/jbc.M109.022814; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008	55	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147038	10.1371/journal.pone.0147038	http://dx.doi.org/10.1371/journal.pone.0147038			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784107	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400098
J	Pienkowska, J; Gwozdziewicz, K; Skrobisz-Balandowska, K; Marek, I; Kostro, J; Szurowska, E; Studniarek, M				Pienkowska, Joanna; Gwozdziewicz, Katarzyna; Skrobisz-Balandowska, Katarzyna; Marek, Iwona; Kostro, Justyna; Szurowska, Edyta; Studniarek, Michal			Perfusion-CT - Can We Predict Acute Pancreatitis Outcome within the First 24 Hours from the Onset of Symptoms?	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ORGAN FAILURE; SEVERITY INDEX; ATLANTA CLASSIFICATION; NECROSIS; COMPLICATIONS; PERSISTENT; ISCHEMIA; SUPERIOR; IMPACT	Purpose Severe acute pancreatitis (AP) is still a significant clinical problem which is associated with a highly mortality. The aim of this study was the evaluation of prognostic value of CT regional perfusion measurement performed on the first day of onset of symptoms of AP, in assessing the risk of developing severe form of acute pancreatitis. Material and Methods 79 patients with clinical symptoms and biochemical criteria indicative of acute pancreatitis (acute upper abdominal pain, elevated levels of serum amylase and lipase) underwent perfusion CT within 24 hours after onset of symptoms. The follow-up examinations were performed after 4-6 days to detect progression of the disease. Perfusion parameters were compared in 41 people who developed severe form of AP (pancreatic and/or peripancreatic tissue necrosis) with parameters in 38 consecutive patients in whom course of AP was mild. Blood flow, blood volume, mean transit time and permeability surface area product were calculated in the three anatomic pancreatic subdivisions (head, body and tail). At the same time the patient's clinical status was assessed by APACHE II score and laboratory parameters such as CRP, serum lipase and amylase, AST, ALT, GGT, ALP and bilirubin were compared. Results Statistical differences in the perfusion parameters between the group of patients with mild and severe AP were shown. Blood flow, blood volume and mean transit time were significantly lower and permeability surface area product was significantly higher in patients who develop severe acute pancreatitis and presence of pancreatic and/or peripancreatic necrosis due to pancreatic ischemia. There were no statistically significant differences between the two groups in terms of evaluated on admission severity of pancreatitis assessed using APACHE II score and laboratory tests. Conclusions CT perfusion is a very useful indicator for prediction and selection patients in early stages of acute pancreatitis who are at risk of developing pancreatic and/or peripancreatic necrosis already on the first day of the onset of symptoms and can be used for treatment planning and monitoring of therapy of acute pancreatitis. Early suspicion of possible pancreatic necrosis both on the basis of scores based on clinical status and laboratory tests have low predictive value.	[Pienkowska, Joanna; Szurowska, Edyta] Med Univ Gdansk, Fac Hlth Sci, Dept Radiol 2, Gdansk, Poland; [Gwozdziewicz, Katarzyna; Skrobisz-Balandowska, Katarzyna; Studniarek, Michal] Med Univ Gdansk, Fac Med, Dept Radiol 1, Gdansk, Poland; [Marek, Iwona] Med Univ Gdansk, Dept Gastroenterol & Hepatol, Gdansk, Poland; [Kostro, Justyna] Med Univ Gdansk, Dept Gen Endocrine & Transplant Surg, Gdansk, Poland; [Studniarek, Michal] Med Univ Warsaw, Dept Diagnost Imaging, Warsaw, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Medical University of Warsaw	Gwozdziewicz, K (corresponding author), Med Univ Gdansk, Fac Med, Dept Radiol 1, Gdansk, Poland.	kgwozdziewicz@gumed.edu.pl	Skrobisz, Katarzyna/U-2132-2018; Pieńkowska, Joanna/U-6195-2018; Szurowska, Edyta/AAA-9505-2020	Skrobisz, Katarzyna/0000-0003-3710-9037; Pieńkowska, Joanna/0000-0002-7087-9888; Szurowska, Edyta/0000-0002-7042-4381; Studniarek, Michal/0000-0002-9200-1320	National Science Centre [G-86]	National Science Centre(National Science Centre, Poland)	This work was supported by the National Science Centre (https://www.ncn.gov.pl/) G-86 to JP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bali MA, 2008, RADIOLOGY, V247, P115, DOI 10.1148/radiol.2471070685; Balthazar EJ, 2002, RADIOLOGY, V223, P603, DOI 10.1148/radiol.2233010680; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bize PE, 2006, AM J ROENTGENOL, V186, P114, DOI 10.2214/AJR.04.1416; Bollen TL, 2007, PANCREAS, V35, P107, DOI 10.1097/mpa.0b013e31804fa189; Casas JD, 2004, AM J ROENTGENOL, V182, P569, DOI 10.2214/ajr.182.3.1820569; Chatzicostas C, 2003, J CLIN GASTROENTEROL, V36, P253, DOI 10.1097/00004836-200303000-00013; d'Assignies G, 2009, RADIOLOGY, V250, P407, DOI 10.1148/radiol.2501080291; Delrue L, 2012, ABDOM IMAGING, V37, P595, DOI 10.1007/s00261-011-9783-0; Garg PK, 2005, CLIN GASTROENTEROL H, V3, P159, DOI 10.1016/S1542-3565(04)00665-2; Grozinger G, 2014, ROFO-FORTSCHR RONTG, V186, P1082, DOI 10.1055/s-0034-1384876; Halonen KI, 2002, CRIT CARE MED, V30, P1274, DOI 10.1097/00003246-200206000-00019; Jin X, 2009, ABDOM IMAGING, V34, P759, DOI [10.1007/s00261-009-9564-1, DOI 10.1007/S00261-009-9564-1]; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Kandel S, 2009, EUR RADIOL, V19, P2641, DOI 10.1007/s00330-009-1453-z; Klauss M, 2012, J COMPUT ASSIST TOMO, V36, P237, DOI 10.1097/RCT.0b013e31824a099e; Knoepfli AS, 2007, ABDOM IMAGING, V32, P111, DOI 10.1007/s00261-006-9034-y; Lenhart DK, 2008, AM J ROENTGENOL, V190, P643, DOI 10.2214/AJR.07.2761; Li HO, 2014, ABDOM IMAGING, V39, P40, DOI 10.1007/s00261-013-0045-1; Malmstrom ML, 2012, PANCREAS, V41, P271, DOI 10.1097/MPA.0b013e3182240552; Miles KA, 2003, BRIT J RADIOL, V76, P220, DOI 10.1259/bjr/13564625; Mortele KJ, 2004, AM J ROENTGENOL, V183, P1261, DOI 10.2214/ajr.183.5.1831261; Motosugi U, 2012, EUR J RADIOL, V81, P2533, DOI 10.1016/j.ejrad.2011.11.054; O'Connor OJ, 2011, AM J ROENTGENOL, V197, pW221, DOI 10.2214/AJR.10.4338; Piacik M., 2011, TERAPIA, V5, P35; Roberts SE, 2013, ALIMENT PHARM THER, V38, P539, DOI 10.1111/apt.12408; Shinagare AB, 2015, ABDOM IMAGING, V40, P272, DOI 10.1007/s00261-014-0210-1; Spanier BWM, 2010, PANCREATOLOGY, V10, P222, DOI 10.1159/000243731; Stimac D, 2007, AM J GASTROENTEROL, V102, P997, DOI 10.1111/j.1572-0241.2007.01164.x; Takeda K, 2005, PANCREAS, V30, P40; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Tertulino FD, 2015, ABDOM IMAGING, V40, P265, DOI 10.1007/s00261-014-0205-y; Thandassery RB, 2013, HPB, V15, P523, DOI 10.1111/j.1477-2574.2012.00613.x; Thoeni RF, 2012, RADIOLOGY, V262, P751, DOI 10.1148/radiol.11110947; Triantopoulou C, 2007, PANCREAS, V35, P238, DOI 10.1097/MPA.0b013e3180619662; Tsuji Y, 2007, CLIN GASTROENTEROL H, V5, P1484, DOI 10.1016/j.cgh.2007.07.014; Tsuji Y, 2006, J GASTROEN HEPATOL, V21, P1506, DOI 10.1111/j.1440-1746.2006.04352.x; Tsuji Y, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/497386; Tsuji Y, 2010, J GASTROENTEROL, V45, P1155, DOI 10.1007/s00535-010-0267-8; Tsuji Y, 2010, PANCREAS, V39, P541, DOI 10.1097/MPA.0b013e3181c16037; Turkvatan A, 2015, DIAGN INTERV IMAG, V96, P161, DOI 10.1016/j.diii.2013.12.018; Turkvatan A, 2015, DIAGN INTERV IMAG, V96, P151, DOI 10.1016/j.diii.2013.12.017; Uhl W, 2002, PANCREAS, V24, P191, DOI 10.1097/00006676-200203000-00011; Wang X, 2013, PANCREAS, V42, P1255, DOI 10.1097/MPA.0b013e3182a5d6a7; Watanabe T, 2013, PANCREAS, V42, P180, DOI 10.1097/MPA.0b013e3182576295; Wichmann JL, 2014, EUR RADIOL, V24, P2927, DOI 10.1007/s00330-014-3300-0; Wig JD, 2009, J PANCREAS, V10, P271; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080468; Xu J, 2009, ABDOM IMAGING, V34, P759, DOI 10.1007/s00261-009-9564-1; Yadav AK, 2015, ABDOM IMAGING, V40, P488, DOI 10.1007/s00261-014-0226-6; Zaheer A, 2013, ABDOM IMAGING, V38, P125, DOI 10.1007/s00261-012-9908-0; Zerem E, 2014, WORLD J GASTROENTERO, V20, P13879, DOI 10.3748/wjg.v20.i38.13879; Zhang XP, 2009, HEPATOB PANCREAT DIS, V8, P351	53	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146965	10.1371/journal.pone.0146965	http://dx.doi.org/10.1371/journal.pone.0146965			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784348	gold, Green Submitted, Green Published			2022-12-26	WOS:000368528400088
J	Seimon, RV; Shi, YC; Slack, K; Lee, K; Fernando, HA; Nguyen, AD; Zhang, L; Lin, S; Enriquez, RF; Lau, J; Herzog, H; Sainsbury, A				Seimon, Radhika V.; Shi, Yan-Chuan; Slack, Katy; Lee, Kailun; Fernando, Hamish A.; Nguyen, Amy D.; Zhang, Lei; Lin, Shu; Enriquez, Ronaldo F.; Lau, Jackie; Herzog, Herbert; Sainsbury, Amanda			Intermittent Moderate Energy Restriction Improves Weight Loss Efficiency in Diet-Induced Obese Mice	PLOS ONE			English	Article							DISEASE RISK MARKERS; CALORIC RESTRICTION; OVERWEIGHT WOMEN; NEUROPEPTIDE-Y; BODY-WEIGHT; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; GLYCEMIC CONTROL; FEEDING STATUS; MAINTENANCE	Background Intermittent severe energy restriction is popular for weight management. To investigate whether intermittent moderate energy restriction may improve this approach by enhancing weight loss efficiency, we conducted a study in mice, where energy intake can be controlled. Methods Male C57/Bl6 mice that had been rendered obese by an ad libitum diet high in fat and sugar for 22 weeks were then fed one of two energy-restricted normal chow diets for a 12-week weight loss phase. The continuous diet (CD) provided 82% of the energy intake of age-matched ad libitum chow-fed controls. The intermittent diet (ID) provided cycles of 82% of control intake for 5-6 consecutive days, and ad libitum intake for 1-3 days. Weight loss efficiency during this phase was calculated as (total weight change) divided by [(total energy intake of mice on CD or ID)-(total average energy intake of controls)]. Subsets of mice then underwent a 3-week weight regain phase involving ad libitum re-feeding. Results Mice on the ID showed transient hyperphagia relative to controls during each 1-3-day ad libitum feeding period, and overall ate significantly more than CD mice (91.1 +/- 1.0 versus 82.2 +/- 0.5% of control intake respectively, n = 10, P<0.05). There were no significant differences between CD and ID groups at the end of the weight loss or weight regain phases with respect to body weight, fat mass, circulating glucose or insulin concentrations, or the insulin resistance index. Weight loss efficiency was significantly greater with ID than with CD (0.042 +/- 0.007 versus 0.018 +/- 0.001 g/kJ, n = 10, P<0.01). Mice on the CD exhibited significantly greater hypothalamic mRNA expression of proopiomelanocortin (POMC) relative to ID and control mice, with no differences in neuropeptide Y or agouti-related peptide mRNA expression between energy-restricted groups. Conclusion Intermittent moderate energy restriction may offer an advantage over continuous moderate energy restriction, because it induces significantly greater weight loss relative to energy deficit in mice.	[Seimon, Radhika V.; Fernando, Hamish A.; Sainsbury, Amanda] Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Boden Inst Obes Nutr Exercise & Eating Disorders, Camperdown, NSW, Australia; [Shi, Yan-Chuan; Slack, Katy; Lee, Kailun; Nguyen, Amy D.; Zhang, Lei; Lin, Shu; Lau, Jackie; Herzog, Herbert; Sainsbury, Amanda] St Vincents Hosp, Garvan Inst Med Res, Neurosci Div, Darlinghurst, NSW 2010, Australia; [Enriquez, Ronaldo F.] St Vincents Hosp, Garvan Inst Med Res, Bone Biol Div, Sydney, NSW 2010, Australia	University of Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Sainsbury, A (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Boden Inst Obes Nutr Exercise & Eating Disorders, Camperdown, NSW, Australia.; Sainsbury, A (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Neurosci Div, Darlinghurst, NSW 2010, Australia.	amanda.salis@sydney.edu.au	Seimon, Radhika/I-7746-2018	Seimon, Radhika/0000-0002-3903-4801; Salis, Amanda/0000-0001-9176-1574; Nguyen, Amy/0000-0003-4603-564X; lin, shu/0000-0002-4239-2028; , Herbert/0000-0002-1713-1029	National Health and Medical Research Council (NHMRC) of Australia; Endocrine Society of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Endocrine Society of Australia	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia via research project grants to AS and HH, as well as an Early Career Fellowship to RVS, postgraduate scholarships to ADN and JL, a Career Development Award to SL, and Research Fellowships to HH and AS. The authors are also grateful to the Endocrine Society of Australia for a Postdoctoral Award to RVS.; We thank the staff of the Garvan Institute Biological Testing Facility for facilitation of these experiments. This work was supported by the National Health and Medical Research Council (NHMRC) of Australia via research project grants to AS and HH, as well as an Early Career Fellowship to RVS, postgraduate scholarships to ADN and JL, a Career Development Award to SL, and Research Fellowships to HH and AS. We are also grateful to the Endocrine Society of Australia for a Postdoctoral Award to RVS.	Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Arguin H, 2012, MENOPAUSE, V19, P870, DOI 10.1097/gme.0b013e318250a287; Ash S, 2003, INT J OBESITY, V27, P797, DOI 10.1038/sj.ijo.0802295; Bailey BW, 2008, DIS MANAGE, V11, P176, DOI 10.1089/dis.2007.0002; Barnosky AR, 2014, TRANSL RES, V164, P302, DOI 10.1016/j.trsl.2014.05.013; Baumeier C, 2015, BBA-MOL CELL BIOL L, V1851, P566, DOI 10.1016/j.bbalip.2015.01.013; BECK B, 1990, BRAIN RES, V528, P245, DOI 10.1016/0006-8993(90)91664-3; Bonorden MJL, 2009, NUTR CANCER, V61, P265, DOI 10.1080/01635580802419798; Boulange CL, 2013, J PROTEOME RES, V12, P1956, DOI 10.1021/pr400051s; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Camps SGJA, 2013, AM J CLIN NUTR, V98, P917, DOI 10.3945/ajcn.113.062935; Chausse B, 2014, ENDOCRINOLOGY, V155, P2456, DOI 10.1210/en.2013-2057; Christensen P, 2011, CLIN OBES, V1, P31, DOI 10.1111/j.1758-8111.2011.00006.x; Compagnucci CV, 2002, NEUROIMMUNOMODULAT, V10, P153, DOI 10.1159/000067177; DEGROOT LCPGM, 1989, AM J CLIN NUTR, V50, P1314, DOI 10.1093/ajcn/50.6.1314; Dixon JB, 2015, DIABETES OBES METAB, V17, P91, DOI 10.1111/dom.12389; Doucet E, 2000, INT J OBESITY, V24, P906, DOI 10.1038/sj.ijo.0801251; Drapeau V, 2007, APPETITE, V48, P159, DOI 10.1016/j.appet.2006.08.002; Dutia R, 2012, ENDOCRINOLOGY, V153, P4246, DOI 10.1210/en.2012-1166; FABBRI A, 1989, J STEROID BIOCHEM, V32, P145, DOI 10.1016/0022-4731(89)90155-6; Friedl KE, 2000, J APPL PHYSIOL, V88, P1820, DOI 10.1152/jappl.2000.88.5.1820; Ganesh CB, 2013, FISH PHYSIOL BIOCHEM, V39, P627, DOI 10.1007/s10695-012-9725-y; Gayle D, 1999, AM J PHYSIOL-REG I, V277, pR1188, DOI 10.1152/ajpregu.1999.277.4.R1188; Gilbert JA, 2009, APPETITE, V52, P809, DOI 10.1016/j.appet.2009.04.003; Harvie M, 2013, 2 DAY DIET DIET 2 DA; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Harvie M, 2013, BRIT J NUTR, V110, P1534, DOI 10.1017/S0007114513000792; HILL JO, 1989, AM J CLIN NUTR, V50, P248, DOI 10.1093/ajcn/50.2.248; Horne BD, 2015, AM J CLIN NUTR, V102, P464, DOI 10.3945/ajcn.115.109553; Jang MY, 1998, J NUTR, V128, P2520, DOI 10.1093/jn/128.12.2520; Keogh JB, 2014, CLIN OBES, V4, P150, DOI 10.1111/cob.12052; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lin S, 2000, BRAIN RES, V875, P89, DOI 10.1016/S0006-8993(00)02580-4; Lv MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115147; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; Markovic TP, 2009, MED J AUSTRALIA, V190, P149, DOI 10.5694/j.1326-5377.2009.tb02319.x; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Mercer AJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00019; Millington GWM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-18; Mosley M, 2013, FASTDIET LOSE WEIGHT; Niskanen L, 2004, DIABETES OBES METAB, V6, P208, DOI 10.1111/j.1462-8902.2004.00335.x; Pedersen CR, 1999, AUTOIMMUNITY, V30, P243, DOI 10.3109/08916939908993805; Pierroz DD, 1996, ENDOCRINOLOGY, V137, P3, DOI 10.1210/en.137.1.3; Rossner S, 1998, INT J OBESITY, V22, P190, DOI 10.1038/sj.ijo.0800563; Rusli F, 2015, MOL NUTR FOOD RES, V59, P533, DOI 10.1002/mnfr.201400621; Sainsbury A, 2012, OBES REV, V13, P234, DOI 10.1111/j.1467-789X.2011.00948.x; Sainsbury A, 2010, MOL CELL ENDOCRINOL, V316, P109, DOI 10.1016/j.mce.2009.09.025; Schoeller DA, 2013, AM J CLIN NUTR, V97, P1413, DOI 10.3945/ajcn.113.062125; Seimon RV, 2015, MOL CELL ENDOCRINOL, V418, P153, DOI 10.1016/j.mce.2015.09.014; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Swart I, 2002, AM J PHYSIOL-REG I, V283, pR1020, DOI 10.1152/ajpregu.00501.2001; SWEENEY ME, 1993, AM J CLIN NUTR, V57, P127, DOI 10.1093/ajcn/57.2.127; Varady KA, 2011, OBES REV, V12, pE593, DOI 10.1111/j.1467-789X.2011.00873.x; Varady KA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-119; Weinsier RL, 2000, AM J CLIN NUTR, V71, P1138; Weinsier RL, 2000, AM J CLIN NUTR, V72, P1088; Westerterp-Plantenga MS, 2004, INT J OBESITY, V28, P57, DOI 10.1038/sj.ijo.0802461; Williams KV, 1998, DIABETES CARE, V21, P2, DOI 10.2337/diacare.21.1.2; WING RR, 1994, AM J MED, V97, P354, DOI 10.1016/0002-9343(94)90302-6; Wing RR, 2003, OBES RES, V11, P287, DOI 10.1038/oby.2003.43	62	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145157	10.1371/journal.pone.0145157	http://dx.doi.org/10.1371/journal.pone.0145157			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784324	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400011
J	Ando, K; Okada, Y; Akiba, M; Kondo, T; Kawamura, T; Okumura, M; Chen, FS; Date, H; Shiraishi, T; Iwasaki, A; Yamasaki, N; Nagayasu, T; Chida, M; Inoue, Y; Hirai, T; Seyama, K; Mishima, M				Ando, Katsutoshi; Okada, Yoshinori; Akiba, Miki; Kondo, Takashi; Kawamura, Tomohiro; Okumura, Meinoshin; Chen, Fengshi; Date, Hiroshi; Shiraishi, Takeshi; Iwasaki, Akinori; Yamasaki, Naoya; Nagayasu, Takeshi; Chida, Masayuki; Inoue, Yoshikazu; Hirai, Toyohiro; Seyama, Kuniaki; Mishima, Michiaki		Japanese Minist Hlth Labour Welf	Lung Transplantation for Lymphangioleiomyomatosis in Japan	PLOS ONE			English	Article							PULMONARY LYMPHANGIOLEIOMYOMATOSIS; RECURRENT LYMPHANGIOLEIOMYOMATOSIS; SIROLIMUS; EXPERIENCE; CHYLOTHORAX; MANAGEMENT; SOCIETY; HEART; GENE; TSC2	Background Lung transplantation has been established as the definitive treatment option for patients with advanced lymphangioleiomyomatosis (LAM). However, the prognosis after registration and the circumstances of lung transplantation with sirolimus therapy have never been reported. Methods In this national survey, we analyzed data from 98 LAM patients registered for lung transplantation in the Japan Organ Transplantation Network. Results Transplantation was performed in 57 patients as of March 2014. Survival rate was 86.7% at 1 year, 82.5% at 3 years, 73.7% at 5 years, and 73.7% at 10 years. Of the 98 patients, 21 had an inactive status and received sirolimus more frequently than those with an active history (67% vs. 5%, p<0.001). Nine of twelve patients who remained inactive as of March 2014 initiated sirolimus before or while on a waiting list, and remained on sirolimus thereafter. Although the statistical analysis showed no statistically significant difference, the survival rate after registration tended to be better for lung transplant recipients than for those who awaited transplantation (p = 0.053). Conclusions Lung transplantation is a satisfactory therapeutic option for advanced LAM, but the circumstances for pre-transplantation LAM patients are likely to alter with the use of sirolimus.	[Ando, Katsutoshi; Seyama, Kuniaki] Juntendo Univ, Fac Med, Div Resp Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan; [Ando, Katsutoshi; Seyama, Kuniaki] Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan; [Okada, Yoshinori; Akiba, Miki; Kondo, Takashi] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Aoba Ku, Seiryo Machi 4-1, Sendai, Miyagi 980, Japan; [Kawamura, Tomohiro; Okumura, Meinoshin] Osaka Univ, Dept Gen Thorac Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka, Japan; [Chen, Fengshi; Date, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto, Japan; [Shiraishi, Takeshi; Iwasaki, Akinori] Fukuoka Univ, Sch Med, Dept Gen Thorac Breast & Pediat Surg, Jonan ku, 7-45-1 Nanakuma, Fukuoka, Fukuoka 81401, Japan; [Yamasaki, Naoya; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Div Surg Oncol, Dept Translat Med Sci, 1-7-1 Sakamoto, Nagasaki 852, Japan; [Chida, Masayuki] Dokkyo Med Univ, Dept Gen Thorac Surg, 880 Kitakobayashi, Mibu, Tochigi, Japan; [Inoue, Yoshikazu] Kinki Chuo Chest Med Ctr, Natl Hosp Org, Clin Res Ctr, Kita Ku, 1180 Nagasonecho, Sakai, Osaka, Japan; [Inoue, Yoshikazu; Hirai, Toyohiro; Seyama, Kuniaki; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, Kawahara 54, Kyoto, Japan; [Inoue, Yoshikazu; Hirai, Toyohiro; Seyama, Kuniaki; Mishima, Michiaki] Minist Hlth Labour & Welf, Resp Failure Res Grp, Tokyo, Japan	Juntendo University; Tohoku University; Osaka University; Kyoto University; Fukuoka University; Nagasaki University; Dokkyo Medical University; Kyoto University	Seyama, K (corresponding author), Juntendo Univ, Fac Med, Div Resp Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan.; Seyama, K (corresponding author), Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan.; Seyama, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, Kawahara 54, Kyoto, Japan.; Seyama, K (corresponding author), Minist Hlth Labour & Welf, Resp Failure Res Grp, Tokyo, Japan.	kseyama@juntendo.ac.jp	Inoue, Yoshikazu/ABE-9772-2020		Ministry of Health, Labour and Welfare, Japan	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2013, RESPIR INVESTIG, V51, P175, DOI 10.1016/j.resinv.2013.03.002; Ando K, 2012, EUR J RADIOL, V81, P3925, DOI 10.1016/j.ejrad.2012.05.033; [Anonymous], 2004, Nihon Kokyuki Gakkai Zasshi, VSuppl, P1; Benden C, 2009, J HEART LUNG TRANSPL, V28, P1, DOI 10.1016/j.healun.2008.09.014; Boehler A, 1996, NEW ENGL J MED, V335, P1275, DOI 10.1056/NEJM199610243351704; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chen FS, 2009, ANN THORAC SURG, V87, pE6, DOI 10.1016/j.athoracsur.2008.07.107; ESTENNE M, 1984, LANCET, V1, P275; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Groetzner J, 2004, J HEART LUNG TRANSPL, V23, P632, DOI 10.1016/S1053-2498(03)00309-7; Hayashida M, 2007, RESPIROLOGY, V12, P523, DOI 10.1111/j.1440-1843.2007.01101.x; Hussein M, 2014, ANN THORAC MED, V9, P124, DOI 10.4103/1817-1737.128862; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; King-Biggs MB, 2003, TRANSPLANTATION, V75, P1437, DOI 10.1097/01.TP.0000064083.02120.2C; Kpodonu J, 2005, J HEART LUNG TRANSPL, V24, P1247, DOI 10.1016/j.healun.2004.09.013; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Machuca TN, 2011, TRANSPL P, V43, P236, DOI 10.1016/j.transproceed.2010.12.051; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Morton JM, 2008, J HEART LUNG TRANSPL, V27, P462, DOI 10.1016/j.healun.2008.01.005; Ohara T, 2008, ANN THORAC SURG, V86, pE7, DOI 10.1016/j.athoracsur.2008.07.062; Pechet TT, 2004, J HEART LUNG TRANSPL, V23, P301, DOI 10.1016/S1053-2498(03)00195-5; Reynaud-Gatibert M, 2008, TRANSPLANTATION, V86, P515, DOI 10.1097/TP.0b013e31817c15df; Sato M, 2014, GEN THORAC CARDIOVAS, V62, P594, DOI 10.1007/s11748-014-0418-6; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sugimoto R, 2008, J HEART LUNG TRANSPL, V27, P921, DOI 10.1016/j.healun.2008.05.012; Taveira-DaSilva AM, 2007, CHEST, V132, P1573, DOI 10.1378/chest.07-1205; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007	28	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146749	10.1371/journal.pone.0146749	http://dx.doi.org/10.1371/journal.pone.0146749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771878	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300031
J	Rodic, SZ; Knezevic, TI; Kisic-Tepavcevic, DB; Dackovic, JR; Dujmovic, I; Pekmezovic, TD; Drulovic, JS; Konstantinovic, LM				Rodic, Sindi Z.; Knezevic, Tatjana I.; Kisic-Tepavcevic, Darija B.; Dackovic, Jelena R.; Dujmovic, Irena; Pekmezovic, Tatjana D.; Drulovic, Jelena S.; Konstantinovic, Ljubica M.			Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88)	PLOS ONE			English	Article							GUIDELINES; QUALITY; IMPACT	Objective Multiple Sclerosis Spasticity Scale (MSSS)-88 has been developed for self-assessment of spasticity symptoms in patients with multiple sclerosis (MS). The objective of this study was to validate MSSS-88 and evaluate the psychometric properties in patients with MS in Serbia. Methods The study comprised 65 MS patients with spasticity. MSSS-88 consists of 88 items grouped in eight sections. Internal consistency of the MSSS-88(SR) subscales was determined using Cronbach's alpha coefficient. Test/retest reliability with an intra-class correlation coefficient (ICC) for each MSSS-88(SR) subscale was performed. Clinical validity of MSSS-88(SR) was determined by correlations with the Numeric Rating Scale (NRS) and the Modified Ashworth Scale (MAS). Results The range of Cronbach's alpha for all scales and ICC was 0.91-0.96 and 0.84-0.91, respectively. All ICCs were statistically significant (p<0.05). All evaluated subscales of MSSS-88 were significantly correlated with the NRS scale. The highest correlation coefficients were registered between the WL subscale and the EDSS and MAS, while the strongest relationship was observed between the MSS subscale and the NRS. Conclusion The Serbian translated version of this instrument may be useful as a clinical measure for spasticity and functionality in patients with MS.	[Rodic, Sindi Z.; Konstantinovic, Ljubica M.] Clin Rehabil Dr M Zotovic, Belgrade, Serbia; [Knezevic, Tatjana I.] Univ Chlidrens Hosp, Belgrade, Serbia; [Kisic-Tepavcevic, Darija B.; Dujmovic, Irena; Pekmezovic, Tatjana D.; Drulovic, Jelena S.; Konstantinovic, Ljubica M.] Univ Belgrade, Fac Med, Belgrade 11001, Serbia; [Kisic-Tepavcevic, Darija B.; Pekmezovic, Tatjana D.] Inst Epidemiol, Belgrade, Serbia; [Dackovic, Jelena R.; Dujmovic, Irena; Drulovic, Jelena S.] Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Rodic, SZ; Konstantinovic, LM (corresponding author), Clin Rehabil Dr M Zotovic, Belgrade, Serbia.; Konstantinovic, LM (corresponding author), Univ Belgrade, Fac Med, Belgrade 11001, Serbia.	sindirodic@gmail.com; ljkonstantinovic@yahoo.com	Konstantinovic, Ljubica/ACN-0358-2022	Konstantinovic, Ljubica/0000-0001-5906-1594				Barnes MP, 2003, NEUROREHAB NEURAL RE, V17, P66, DOI 10.1177/0888439002250449; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cook KF, 2007, J REHABIL RES DEV, V44, P363, DOI 10.1682/JRRD.2006.04.0036; Farrar JT, 2008, CLIN THER, V30, P974, DOI 10.1016/j.clinthera.2008.05.011; Flachenecker P, 2014, ACTA NEUROL SCAND, V129, P154, DOI 10.1111/ane.12202; Gothbi N, 2009, BRAIN INJURY, V23, P815, DOI 10.1080/02699050903200548; Haas Judith, 2011, Expert Rev Neurother, V11, P3; Henze T, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0119-y; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hobart JC, 2006, BRAIN, V129, P224, DOI 10.1093/brain/awh675; LANCE JW, 1980, NEUROLOGY, V30, P1303, DOI 10.1212/WNL.30.12.1303; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McGuigan C, 2004, NEUROLOGY, V62, P2103, DOI 10.1212/01.WNL.0000127604.84575.0D; Mori F, 2011, J NEUROL, V258, P1281, DOI 10.1007/s00415-011-5924-1; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, DOI DOI 10.1080/13607860500090011; PATY DW, 1998, MULTIPLE SCLEROSIS; Rizzo MA, 2004, MULT SCLER, V10, P589, DOI 10.1191/1352458504ms1085oa; Ware J., 1993, SF 36 HLTH SURVEY MA	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147042	10.1371/journal.pone.0147042	http://dx.doi.org/10.1371/journal.pone.0147042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771661	gold, Green Submitted, Green Published			2022-12-26	WOS:000368628300057
J	Kusevic, D; Kudithipudi, S; Jeltsch, A				Kusevic, Denis; Kudithipudi, Srikanth; Jeltsch, Albert			Substrate Specificity of the HEMK2 Protein Glutamine Methyltransferase and Identification of Novel Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; enzyme catalysis; post-translational modification (PTM); protein methylation; S-adenosylmethionine (SAM); enzyme specificity; methylglutamine	ESCHERICHIA-COLI; LYSINE METHYLTRANSFERASE; RELEASE FACTORS; PEPTIDE ARRAYS; GGQ MOTIF; METHYLATION; TRANSLATION; TERMINATION; GENE; CARCINOMA	Bacterial HEMK2 homologs initially had been proposed to be involved in heme biogenesis or to function as adenine DNA methyltransferase. Later it was shown that this family of enzymes has protein glutamine methyltransferase activity, and they methylate the glutamine residue in the GGQ motif of ribosomal translation termination factors. The murine HEMK2 enzyme methylates Gln(185) of the eukaryotic translation termination factor eRF1. We have employed peptide array libraries to investigate the peptide sequence recognition specificity of murine HEMK2. Our data show that HEMK2 requires a GQX(3)R motif for methylation activity. In addition, amino acid preferences were observed between the -3 and +7 positions of the peptide substrate (considering the target glutamine as 0), including a preference for Ser, Arg, and Gly at the +1 and a preference for Arg at the +7 position. Based on our specificity profile, we identified several human proteins that contain putative HEMK2 methylation sites and show that HEMK2 methylates 58 novel peptide substrates. After cloning, expression, and purification of the corresponding protein domains, we confirmed methylation for 11 of them at the protein level. Transfected CHD5 (chromodomain helicase DNA-binding protein 5) and NUT (nuclear protein in testis) were also demonstrated to be methylated by HEMK2 in human HEK293 cells. Our data expand the range of proteins potentially subjected to glutamine methylation significantly, but further investigation will be required to understand the function of HEMK2-mediated methylation in proteins other than eRF1.	[Kusevic, Denis; Kudithipudi, Srikanth; Jeltsch, Albert] Univ Stuttgart, Inst Biochem, Fac Chem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany	University of Stuttgart	Jeltsch, A (corresponding author), Univ Stuttgart, Inst Biochem, Fac Chem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	albert.jeltsch@ibc.uni-stuttgart.de	Jeltsch, Albert/O-7404-2014	Jeltsch, Albert/0000-0001-6113-9290	Deutsche Forschungsgemeinschaft [JE 252/25-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant JE 252/25-1. The authors declare that they have no conflicts of interest with the contents of this article.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Bujnicki JM, 1999, IUBMB LIFE, V48, P247, DOI 10.1080/713803519; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2010, CANCER GENET CYTOGEN, V203, P16, DOI 10.1016/j.cancergencyto.2010.06.007; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Heurgue-Hamard V, 2006, J BIOL CHEM, V281, P36140, DOI 10.1074/jbc.M608571200; Ishizawa T, 2008, BIOCHEM BIOPH RES CO, V373, P99, DOI 10.1016/j.bbrc.2008.05.176; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Kolla V, 2014, CANCER RES, V74, P652, DOI 10.1158/0008-5472.CAN-13-3056; Kudithipudi S, 2014, JOVE-J VIS EXP, DOI 10.3791/52203; Kudithipudi S, 2014, CHEM BIOL, V21, P226, DOI 10.1016/j.chembiol.2013.10.016; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Le Guen L, 1999, FEMS MICROBIOL LETT, V173, P175, DOI 10.1016/S0378-1097(99)00067-1; LHOEST J, 1977, MOL GEN GENET, V154, P175, DOI 10.1007/BF00330833; Liger D, 2011, NUCLEIC ACIDS RES, V39, P6249, DOI 10.1093/nar/gkr176; Liu P, 2010, MOL CELL BIOL, V30, P4245, DOI 10.1128/MCB.00218-10; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; NAKAYASHIKI T, 1995, GENE, V153, P67, DOI 10.1016/0378-1119(94)00805-3; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rathert P, 2008, CHEM BIOL, V15, P5, DOI 10.1016/j.chembiol.2007.11.013; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; Tessarz P, 2014, NATURE, V505, P564, DOI 10.1038/nature12819; Yang Z, 2004, J MOL BIOL, V340, P695, DOI 10.1016/j.jmb.2004.05.019	39	23	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6124	6133		10.1074/jbc.M115.711952	http://dx.doi.org/10.1074/jbc.M115.711952			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797129	Green Published, hybrid			2022-12-26	WOS:000372894200007
J	Chuang, PS; Hung, TC; Chang, HA; Huang, CK; Shiao, JC				Chuang, Po-Shun; Hung, Tzu-Chiao; Chang, Hung-An; Huang, Chien-Kang; Shiao, Jen-Chieh			The Species and Origin of Shark Fins in Taiwan's Fishing Ports, Markets, and Customs Detention: A DNA Barcoding Analysis	PLOS ONE			English	Article							HAMMERHEAD SHARKS; IDENTIFICATION; CONSERVATION; TRADE; MANAGEMENT; CATCHES; RAYS	The increasing consumption of shark products, along with the shark's fishing vulnerabilities, has led to the decrease in certain shark populations. In this study we used a DNA barcoding method to identify the species of shark landings at fishing ports, shark fin products in retail stores, and shark fins detained by Taiwan customs. In total we identified 23, 24, and 14 species from 231 fishing landings, 316 fin products, and 113 detained shark fins, respectively. All the three sample sources were dominated by Prionace glauca, which accounted for more than 30% of the collected samples. Over 60% of the species identified in the fin products also appeared in the port landings, suggesting the domestic-dominance of shark fin products in Taiwan. However, international trade also contributes a certain proportion of the fin product markets, as four species identified from the shark fin products are not found in Taiwan's waters, and some domestic-available species were also found in the customs-detained sample. In addition to the species identification, we also found geographical differentiation in the cox1 gene of the common thresher sharks (Alopias vulpinus), the pelagic thresher shark (A. pelagicus), the smooth hammerhead shark (Sphyrna zygaena), and the scalloped hammerhead shark (S. lewini). This result might allow fishing authorities to more effectively trace the origins as well as enforce the management and conservation of these sharks.	[Chuang, Po-Shun; Hung, Tzu-Chiao; Chang, Hung-An; Huang, Chien-Kang; Shiao, Jen-Chieh] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	National Taiwan University	Shiao, JC (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan.	jcshiao@ntu.edu.tw		Chuang, Po-Shun/0000-0003-3792-5421; SHIAO, JEN-CHIEH/0000-0002-3824-5738	Council of Agriculture, Executive Yuan (Taiwan, ROC) [101AS-11.2.1-FA-F6]; Ministry of Science and Technology of Taiwan; Fishery Agency	Council of Agriculture, Executive Yuan (Taiwan, ROC); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Fishery Agency	This study was financially supported by the Fishery Agency, Council of Agriculture, Executive Yuan (Taiwan, ROC) in the grant number: 101AS-11.2.1-FA-F6, and the Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beerkircher L, 2003, FISH B-NOAA, V101, P168; Beerkircher LR, 2002, MAR FISH REV, V64, P40; Bonfil R., 1994, OVERVIEW OF WORLD EL; Clarke S, 2007, MAR RESOUR ECON, V22, P305, DOI 10.1086/mre.22.3.42629561; Clarke S, 2008, AQUAT LIVING RESOUR, V21, P373, DOI 10.1051/alr:2008060; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Fong QSW, 2002, ECOL ECON, V40, P117, DOI 10.1016/S0921-8009(01)00273-7; Fowler SL, 2005, SHARKS RAYS CHIMAERA; Garrick JAF, 1982, SHARKS OF THE GENUS; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Liu SYV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079373; Molina JM, 2012, REV FISH BIOL FISHER, V22, P719, DOI 10.1007/s11160-012-9269-3; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Naylor GJP, 2012, B AM MUS NAT HIST, P1; NAYLOR GJP, 1992, CLADISTICS, V8, P295, DOI 10.1111/j.1096-0031.1992.tb00073.x; Pank M, 2001, MAR BIOTECHNOL, V3, P231, DOI 10.1007/s101260000071; Pinhal D, 2012, MAR BIOL, V159, P829, DOI 10.1007/s00227-011-1858-5; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Shotton R., 1999, CASE STUDIES MANAGEM; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Simpfendorfer CA, 2002, FISH RES, V55, P175; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; White WT, 2012, J FISH BIOL, V80, P897, DOI 10.1111/j.1095-8649.2012.03268.x; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	36	24	25	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147290	10.1371/journal.pone.0147290	http://dx.doi.org/10.1371/journal.pone.0147290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799827	gold, Green Published			2022-12-26	WOS:000368655300087
J	Sakaie, K; Takahashi, M; Remington, G; Wang, XF; Conger, A; Conger, D; Dimitrov, I; Jones, S; Frohman, A; Frohman, T; Sagiyama, K; Togao, O; Fox, RJ; Frohman, E				Sakaie, Ken; Takahashi, Masaya; Remington, Gina; Wang, Xiaofeng; Conger, Amy; Conger, Darrel; Dimitrov, Ivan; Jones, Stephen; Frohman, Ashley; Frohman, Teresa; Sagiyama, Koji; Togao, Osamu; Fox, Robert J.; Frohman, Elliot			Correlating Function and Imaging Measures of the Medial Longitudinal Fasciculus	PLOS ONE			English	Article							BRAIN-STEM; MULTIPLE-SCLEROSIS; DIFFUSION; SYSTEM; MRI; REGISTRATION; VALIDATION; ATLAS; INO; MS	Objective To test the validity of diffusion tensor imaging (DTI) measures of tissue injury by examining such measures in a white matter structure with well-defined function, the medial longitudinal fasciculus (MLF). Injury to the MLF underlies internuclear ophthalmoparesis (INO). Methods 40 MS patients with chronic INO and 15 healthy controls were examined under an IRB-approved protocol. Tissue integrity of the MLF was characterized by DTI parameters: longitudinal diffusivity (LD), transverse diffusivity (TD), mean diffusivity (MD) and fractional anisotropy (FA). Severity of INO was quantified by infrared oculography to measure versional disconjugacy index (VDI). Results LD was significantly lower in patients than in controls in the medulla-pons region of the MLF (p < 0.03). FA was also lower in patients in the same region (p < 0.0004). LD of the medullapons region correlated with VDI (R = -0.28, p < 0.05) as did FA in the midbrain section (R = 0.31, p < 0.02). Conclusions This study demonstrates that DTI measures of brain tissue injury can detect injury to a functionally relevant white matter pathway, and that such measures correlate with clinically accepted evaluation indices for INO. The results validate DTI as a useful imaging measure of tissue integrity.	[Sakaie, Ken; Jones, Stephen] Cleveland Clin, Imaging Inst, Cleveland, OH 44106 USA; [Takahashi, Masaya; Dimitrov, Ivan; Sagiyama, Koji; Togao, Osamu] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Remington, Gina; Conger, Amy; Conger, Darrel; Frohman, Ashley; Frohman, Teresa; Frohman, Elliot] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Wang, Xiaofeng] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Dimitrov, Ivan] Philips Med Syst, Cleveland, OH USA; [Fox, Robert J.] Cleveland Clin, Mellen Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cleveland Clinic Foundation; Philips; Philips Healthcare; Cleveland Clinic Foundation	Sakaie, K (corresponding author), Cleveland Clin, Imaging Inst, Cleveland, OH 44106 USA.	sakaiek@ccf.org	Togao, Osamu/AAE-4702-2022	Sagiyama, Koji/0000-0001-7253-0703; Dimitrov, Ivan/0000-0003-2686-6884	National Multiple Sclerosis Society [RG 4091 A3/1]; DADs Foundation	National Multiple Sclerosis Society(National Multiple Sclerosis Society); DADs Foundation	We gratefully acknowledge support from the National Multiple Sclerosis Society (RG 4091 A3/1) and from the DADs Foundation.	Aggarwal M, 2013, NEUROIMAGE, V74, P117, DOI 10.1016/j.neuroimage.2013.01.061; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Fox RJ, 2005, MULT SCLER J, V11, P140, DOI 10.1191/1352458505ms1142oa; Fox RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1179, DOI 10.1001/archneur.65.9.1179; Frohman EM, 2002, J NEUROL NEUROSUR PS, V73, P51, DOI 10.1136/jnnp.73.1.51; Frohman EM, 2001, NEUROLOGY, V57, P762, DOI 10.1212/WNL.57.5.762; Frohman TC, 2008, NEUROLOGY, V70, pE57, DOI 10.1212/01.wnl.0000310640.37810.b3; Frohman TC, 2003, NEUROLOGY, V61, P848, DOI 10.1212/01.WNL.0000085863.54218.72; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Napadow V, 2006, NEUROIMAGE, V32, P1113, DOI 10.1016/j.neuroimage.2006.05.050; Niemann K, 1999, J NEUROSURG, V90, P891, DOI 10.3171/jns.1999.90.5.0891; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Sakaie K, 2014, NEUROLOGY, V82, P182, DOI 10.1212/WNL.0000000000000016; Sakaie K, 2011, ANN NY ACAD SCI, V1233, P307, DOI 10.1111/j.1749-6632.2011.06156.x; Sakaie KE, 2010, MAGN RESON IMAGING, V28, P290, DOI 10.1016/j.mri.2009.07.004; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Takahashi M, 2000, RADIOLOGY, V216, P881, DOI 10.1148/radiology.216.3.r00se41881; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Wang XF, 2009, J NEUROSCI METH, V177, P232, DOI 10.1016/j.jneumeth.2008.09.030; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Wood SN, 2006, GEN ADDITIVE MODELS, pxvii	29	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147863	10.1371/journal.pone.0147863	http://dx.doi.org/10.1371/journal.pone.0147863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800522	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300142
J	Uddin, R; Sufian, M				Uddin, Reaz; Sufian, Muhammad			Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets	PLOS ONE			English	Article							ESSENTIAL GENES; PAN-GENOME; PROTEIN; HOST; PNEUMONIAE; DYNAMICS; UPDATE	Background Infections caused by Salmonella enterica, a Gram-negative facultative anaerobic bacteria belonging to the family of Enterobacteriaceae, are major threats to the health of humans and animals. The recent availability of complete genome data of pathogenic strains of the S. enterica gives new avenues for the identification of drug targets and drug candidates. We have used the genomic and metabolic pathway data to identify pathways and proteins essential to the pathogen and absent from the host. Methods We took the whole proteome sequence data of 42 strains of S. enterica and Homo sapiens along with KEGG-annotated metabolic pathway data, clustered proteins sequences using CD-HIT, identified essential genes using DEG database and discarded S. enterica homologs of human proteins in unique metabolic pathways (UMPs) and characterized hypothetical proteins with SVM-prot and InterProScan. Through this core proteomic analysis we have identified enzymes essential to the pathogen. Results The identification of 73 enzymes common in 42 strains of S. enterica is the real strength of the current study. We proposed all 73 unexplored enzymes as potential drug targets against the infections caused by the S. enterica. The study is comprehensive around S. enterica and simultaneously considered every possible pathogenic strain of S. enterica. This comprehensiveness turned the current study significant since, to the best of our knowledge it is the first subtractive core proteomic analysis of the unique metabolic pathways applied to any pathogen for the identification of drug targets. We applied extensive computational methods to shortlist few potential drug targets considering the druggability criteria e.g. Non-homologous to the human host, essential to the pathogen and playing significant role in essential metabolic pathways of the pathogen (i.e. S. enterica). In the current study, the subtractive proteomics through a novel approach was applied i.e. by considering only proteins of the unique metabolic pathways of the pathogens and mining the proteomic data of all completely sequenced strains of the pathogen, thus improving the quality and application of the results. We believe that the sharing of the knowledge from this study would eventually lead to bring about novel and unique therapeutic regimens against the infections caused by the S. enterica.	[Uddin, Reaz; Sufian, Muhammad] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi 75270, Pakistan; [Uddin, Reaz] UNSW Australia, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia	University of Karachi; University of New South Wales Sydney	Uddin, R (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi 75270, Pakistan.; Uddin, R (corresponding author), UNSW Australia, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia.	mriazuddin@iccs.edu	Sufian, Muhammad/K-4325-2016; Uddin, Reaz/I-5673-2017	Sufian, Muhammad/0000-0001-5944-2506; Uddin, Reaz/0000-0002-9928-4482	International Foundation for Science (IFS) [F/5378-1]; Higher Education Commission of Pakistan	International Foundation for Science (IFS)(International Foundation for Science); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	The study was supported by International Foundation for Science (IFS) grant# F/5378-1. The authors would also like to gratefully acknowledge the Higher Education Commission of Pakistan for providing fellowship during the study.	Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Betancor Laura, 2012, Open Microbiol J, V6, P5, DOI 10.2174/1874285801206010005; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Cui T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-118; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Hallam S., 2013, FAST BLAST 2013; Hao P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015964; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lilburn TG, 2009, BIOINF SYST BIOL INT; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Mastroeni P, 2013, MICROBES INFECT, V15, P849, DOI 10.1016/j.micinf.2013.10.003; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Naqvi AAT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124177; NCBI, 2014, NCBI FTP SERV 2014; NCBI, 2013, NCBI FTP SERVER 2013; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; PDB, 2014, RCSB PDB FTP SERVER; Popoff MY, 2003, RES MICROBIOL, V154, P173, DOI 10.1016/S0923-2508(03)00025-1; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Ravooru N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00291; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Shahbaaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084263; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Sun JS, 2012, J VET MED SCI, V74, P285, DOI 10.1292/jvms.11-0366; Teh BA, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-7; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Wangdi T, 2012, GUT MICROBES, V3, P88, DOI 10.4161/gmic.18602; Yang L, 2015, P NATL ACAD SCI USA, V112, P10810, DOI 10.1073/pnas.1501384112; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089197	41	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146796	10.1371/journal.pone.0146796	http://dx.doi.org/10.1371/journal.pone.0146796			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799565	gold, Green Submitted, Green Published			2022-12-26	WOS:000368655300036
J	Kaluza, J; Donald, RL; Gynther, IC; Leung, LKP; Allen, BL				Kaluza, Janina; Donald, R. Lesley; Gynther, Ian C.; Leung, Luke K-P.; Allen, Benjamin L.			The Distribution and Density of Water Mice (Xeromys myoides) in the Maroochy River of Southeast Queensland, Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; HABITATS; MAMMALS; WORLD	The water mouse is a small and vulnerable rodent present in coastal areas of south-west Papua New Guinea, and eastern Queensland and the Northern Territory of Australia. Current knowledge regarding the distribution of the water mouse is incomplete and the loss of one local population has been documented in southeast Queensland, a region where pressures from urban and industrial development are increasing. Water mouse populations have not been studied intensively enough to enable the primary factors responsible for the local decline to be identified. We surveyed the distribution and density of the water mouse along the Maroochy River of southeast Queensland, near the southern extent of the species' range, to gather baseline data that may prove valuable for detecting any future decline in this population's size or health. All areas of suitable habitat were surveyed on foot or by kayak or boat over a three-year period. We found 180 water mouse nests, of which similar to 94% were active. Permanent camera monitoring of one nest and limited supplementary live trapping suggested that up to three individual mice occupied active nests. Water mouse density was estimated to be 0.44 per hectare of suitable habitat along the Maroochy River. Should future monitoring reveal an adverse change in the water mouse population on the Maroochy River, a concerted effort should be made to identify contributing factors and address proximate reasons for the decline.	[Kaluza, Janina; Leung, Luke K-P.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld 4343, Australia; [Donald, R. Lesley] Dept Natl Pk Sport & Racing, Queensland Pk & Wildlife Serv, Maroochydore, Qld 4558, Australia; [Gynther, Ian C.] Dept Environm & Heritage Protect, Threatened Species Unit, Bellbowrie, Qld 4070, Australia; [Allen, Benjamin L.] Univ So Queensland, Inst Agr & Environm, Toowoomba, Qld 4350, Australia	University of Queensland; University of Southern Queensland	Kaluza, J (corresponding author), Univ Queensland, Sch Agr & Food Sci, Gatton, Qld 4343, Australia.	1mightywatermouse@gmail.com	Allen, Benjamin L./H-3066-2019	Allen, Benjamin L./0000-0002-1533-0163; Leung, Luke/0000-0002-8829-4925	Commonwealth Government program 'Caring for Our Country'; Wetland Care Australia	Commonwealth Government program 'Caring for Our Country'; Wetland Care Australia	This project was supported by funds provided by the Commonwealth Government program 'Caring for Our Country', and also the 'Coastal 20' funding program by Wetland Care Australia, which was facilitated by Cheryl Bolzenius. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball D, 2006, NZ MARINE SCI SOC RE, V47, P25; Ball Derek, 2004, Memoirs of the Queensland Museum, V49, P487; Benfer D, 2014, AUST J ZOOL, V62, P382, DOI 10.1071/ZO14019; Burnham M, 2000, NEW LOCALITY RECORDS; DERM (2010) National recovery plan for the water mouse (false water rat) Xeromys myoides, 2010, NAT REC WAT MOUS FAL; Duke NC, 2005, MAR POLLUT BULL, V51, P308, DOI 10.1016/j.marpolbul.2004.10.040; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Eslami-Andargoli L, 2009, ESTUAR COAST SHELF S, V85, P292, DOI 10.1016/j.ecss.2009.08.011; Gynther I., 2008, MAMMALS AUSTR, P664; Higgins A, 2009, J WATER RESOURCE PRO, V4, P237; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Lee SY, 2006, AUSTRAL ECOL, V31, P149, DOI 10.1111/j.1442-9993.2006.01581.x; McDonald G, 2006, FUTURE USE SUNSHINE; Rayment GE, 2003, P AUSTR SOC SUGAR CA, V25, P1; ROBERTSON AI, 1987, MAR BIOL, V96, P193, DOI 10.1007/BF00427019; Russell TL, 2009, AUSTR MAMMALOGY, V31; Saintilan N., 2000, WETL AUST, V18, P49, DOI [10.31646/wa.228, DOI 10.1071/MF9880117, DOI 10.31646/WA.228]; Smith RJ, 2008, RIPARIAN WETLAND ARE; Tasker Elizabeth M., 2002, Australian Mammalogy, V23, P77; Van Dyck S, 2006, AUSTR MAMMAL SOC NEW, V65; Van Dyck S., 2012, QUEENSLANDS THREATEN, P408; Van Dyck Steve, 2003, Memoirs of the Queensland Museum, V49, P453; Van Dyck Steve, 1997, Memoirs of the Queensland Museum, V42, P337; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112	24	1	1	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146133	10.1371/journal.pone.0146133	http://dx.doi.org/10.1371/journal.pone.0146133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789521	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000368529100025
J	Kenney, WF; Brenner, M; Curtis, JH; Arnold, TE; Schelske, CL				Kenney, William F.; Brenner, Mark; Curtis, Jason H.; Arnold, T. Elliott; Schelske, Claire L.			A Holocene Sediment Record of Phosphorus Accumulation in Shallow Lake Harris, Florida (USA) Offers New Perspectives on Recent Cultural Eutrophication	PLOS ONE			English	Article							CHEMICAL NATURE; ORGANIC-MATTER; VEGETATION; EVOLUTION; CLIMATE; APOPKA	We studied a complete Holocene sediment record from shallow (z(max) = 9.7 m) Lake Harris, Florida (USA) to infer the historical development of the lake and its current eutrophic status. We used Pb-210 and C-14 to date the 5.9-m sediment sequence (core LH-6-13) and determined accumulation rates for bulk sediment, organic matter, calcium carbonate, phosphorus fractions and biogenic silica fractions. The chronology of changes in sediment characteristics for LH-6-13 is consistent with the general paleoenvironmental framework established by core studies from other Florida lakes. Lake Harris began to fill with water in the early Holocene, ca. 10,680 cal a BP. A shift from carbonate-dominated to organic-rich sediments ca. 5,540 cal a BP corresponds to a transition to wetter climate in the middle Holocene. A rapid increase in diatom biogenic silica concentrations and accumulation rates ca. 2,600 cal a BP signals that the lake had deepened to its modern limnetic state. In LH-6-13, an up-core decrease in rates of accumulation for several sediment variables indicates time-course oligotrophication of the lake through the Holocene. In near-surface sediments, abrupt increases in the accumulation rates of these same variables indicate progressive cultural eutrophication after ca. AD 1900. Comparison of the modern state of Lake Harris to its condition 50-100 years ago provides a measure of the impact of recent cultural eutrophication. Because the pre-disturbance trajectory of this lake was one of oligotrophication, the true impact of cultural eutrophication is even greater than what is inferred from the changes over the past century.	[Kenney, William F.] Univ Florida, Land Use & Environm Change Inst, Gainesville, FL 32611 USA; [Brenner, Mark; Curtis, Jason H.; Arnold, T. Elliott; Schelske, Claire L.] Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kenney, WF (corresponding author), Univ Florida, Land Use & Environm Change Inst, Gainesville, FL 32611 USA.	kenney@ufl.edu			Land Use and Environmental Change Institute at the University of Florida	Land Use and Environmental Change Institute at the University of Florida	This project received no external funding and was funded internally. Funding was provided by the Land Use and Environmental Change Institute at the University of Florida.	APPLEBY PG, 1986, HYDROBIOLOGIA, V143, P21, DOI 10.1007/BF00026640; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Brenner M, 2006, J PALEOLIMNOL, V35, P129, DOI 10.1007/s10933-005-7881-0; Brenner M, 1996, HYDROBIOLOGIA, V331, P143, DOI 10.1007/BF00025415; Brenner M, 1995, LAKE RESERV MANAGE, V11, P255; CONLEY DJ, 1993, CAN J FISH AQUAT SCI, V50, P296, DOI 10.1139/f93-034; Danek LJ, 1991, BATHYMETRIC SEDIMENT; DAVIS MB, 1982, LIMNOL OCEANOGR, V27, P137, DOI 10.4319/lo.1982.27.1.0137; Donar C, 2009, NOVA HEDWIGIA, P57; ENGLEMAN EE, 1985, CHEM GEOL, V53, P125, DOI 10.1016/0009-2541(85)90025-7; Engstrom DR, 2000, NATURE, V408, P161, DOI 10.1038/35041500; [FDEP] Florida Department of Environmental Protection, 2001, BAS STAT REP; Fisher M.M., 1992, J PALEOLIMNOL, V7, P157; Fritz SC, 2004, HOLOCENE, V14, P828, DOI 10.1191/0959683604hl763rp; Fulton RS, 2008, LAKE RESERV MANAGE, V24, P139, DOI 10.1080/07438140809354057; Ginn BK, 2012, J GREAT LAKES RES, V38, P825, DOI 10.1016/j.jglr.2012.09.002; GRIMM EC, 1993, SCIENCE, V261, P198, DOI 10.1126/science.261.5118.198; Grimm EC, 2006, QUATERNARY SCI REV, V25, P2197, DOI 10.1016/j.quascirev.2006.04.008; Kenney WF, 2002, J PALEOLIMNOL, V27, P367, DOI 10.1023/A:1016075012581; Kenney WF, 2001, CAN J FISH AQUAT SCI, V58, P879, DOI 10.1139/cjfas-58-5-879; Kenney WF, 2016, ECOL INDIC, V60, P963, DOI 10.1016/j.ecolind.2015.08.046; Kenney WF, 2015, AQUAT GEOCHEM, V21, P1, DOI 10.1007/s10498-014-9241-z; Kenney WF, 2010, J PALEOLIMNOL, V44, P1039, DOI 10.1007/s10933-010-9472-y; Oldfield F., 1984, LAKE SEDIMENTS ENV H, P93; Riedinger-Whitmore MA, 2005, LAKE RESERV MANAGE, V21, P423, DOI 10.1080/07438140509354447; Schelske C.L., 1994, J PALEOLIMNOL, V10, P115, DOI [10.1007/BF00682508, DOI 10.1007/BF00682508]; SCHELSKE CL, 1986, HYDROBIOLOGIA, V143, P79, DOI 10.1007/BF00026648; Schottler SP, 2006, J PALEOLIMNOL, V36, P19, DOI 10.1007/s10933-006-0007-5; Smith VH, 2014, LIMNOL OCEANOGR, V59, P2217, DOI 10.4319/lo.2014.59.6.2217; Torres IC, 2014, AQUAT GEOCHEM, V20, P437, DOI 10.1007/s10498-014-9228-9; Turner BL, 2015, AQUAT GEOCHEM, V21, P7, DOI 10.1007/s10498-014-9242-y; VOLLENWEIDER R A, 1975, Schweizerische Zeitschrift fuer Hydrologie, V37, P53, DOI 10.1007/BF02505178; Waters MN, 2005, J PALEOLIMNOL, V33, P53, DOI 10.1007/s10933-004-1691-7; WATTS WA, 1992, ECOLOGY, V73, P1056, DOI 10.2307/1940180; WATTS WA, 1975, GEOLOGY, V3, P344, DOI 10.1130/0091-7613(1975)3<344:ALQROV>2.0.CO;2; WATTS WA, 1969, GEOL SOC AM BULL, V80, P631, DOI 10.1130/0016-7606(1969)80[631:APDFML]2.0.CO;2; WATTS WA, 1980, SCIENCE, V210, P325, DOI 10.1126/science.210.4467.325; WATTS WA, 1980, ANNU REV ECOL SYST, V11, P387, DOI 10.1146/annurev.es.11.110180.002131; WHITEHEAD D R, 1989, Journal of Paleolimnology, V2, P185; Whitmore TJ, 2006, J PALEOLIMNOL, V36, P353, DOI 10.1007/s10933-006-9000-2	41	11	11	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147331	10.1371/journal.pone.0147331	http://dx.doi.org/10.1371/journal.pone.0147331			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789518	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100081
J	Lee, SI; Yi, JK; Bae, WJ; Lee, S; Cha, HJ; Kim, EC				Lee, Sang-Im; Yi, Jin-Kyu; Bae, Won-Jung; Lee, Soojung; Cha, Hee-Jae; Kim, Eun-Cheol			Thymosin Beta-4 Suppresses Osteoclastic Differentiation and Inflammatory Responses in Human Periodontal Ligament Cells	PLOS ONE			English	Article							NF-KAPPA-B; CREVICULAR FLUID LEVELS; REACTIVE OXYGEN; EXPRESSION; TISSUE; NICOTINE; RANKL; GENE; ACTIVATION; IMPAIRMENT	Background Recent reports suggest that thymosin beta-4 (T beta 4) is a key regulator for wound healing and anti-inflammation. However, the role of T beta 4 in osteoclast differentiation remains unclear. Purpose The purpose of this study was to evaluate T beta 4 expression in H2O2-stimulated human periodontal ligament cells (PDLCs), the effects of T beta 4 activation on inflammatory response in PDLCs and osteoclastic differentiation in mouse bone marrow-derived macrophages (BMMs), and identify the underlying mechanism. Methods Reverse transcription-polymerase chain reactions and Western blot analyses were used to measure mRNA and protein levels, respectively. Osteoclastic differentiation was assessed in mouse bone marrow-derived macrophages (BMMs) using conditioned medium (CM) from H2O2-treated PDLCs. Results T beta 4 was down-regulated in H2O2-exposed PDLCs in dose-and time-dependent manners. T beta 4 activation with a T beta 4 peptide attenuated the H2O2-induced production of NO and PGE(2) and up-regulated iNOS, COX-2, and osteoclastogenic cytokines (TNF-alpha, IL-1 beta, IL-6, IL-8, and IL-17) as well as reversed the effect on RANKL and OPG in PDLCs. T beta 4 peptide inhibited the effects of H2O2 on the activation of ERK and JNK MAPK, and NF-kappa B in PDLCs. Furthermore, T beta 4 peptide inhibited osteoclast differentiation, osteoclast-specific gene expression, and p38, ERK, and JNK phosphorylation and NF-kappa B activation in RANKL-stimulated BMMs. In addition, H2O2 up-regulated Wnt5a and its cell surface receptors, Frizzled and Ror2 in PDLCs. Wnt5a inhibition by Wnt5a siRNA enhanced the effects of T beta 4 on H2O2-mediated induction of pro-inflammatory cytokines and osteoclastogenic cytokines as well as helping osteoclastic differentiation whereas Wnt5a activation by Wnt5a peptide reversed it. Conclusion In conclusion, this study demonstrated, for the first time, that T beta 4 was down-regulated in ROS-stimulated PDLCs as well as T beta 4 activation exhibited anti-inflammatory effects and anti-osteoclastogenesis in vitro. Thus, T beta 4 activation might be a therapeutic target for inflammatory osteolytic disease, such as periodontitis.	Dankook Univ, Sch Hlth Sci, Dept Dent Hyg, Cheonan, South Korea; [Yi, Jin-Kyu] Kyung Hee Univ, Sch Dent, Dept Conservat Dent, Seoul, South Korea; [Bae, Won-Jung; Kim, Eun-Cheol] Kyung Hee Univ, Sch Dent, Dept Oral & Maxillofacial Pathol, Seoul, South Korea; [Bae, Won-Jung; Kim, Eun-Cheol] Kyung Hee Univ, Sch Dent, Res Ctr Tooth & Periodontal Regenerat MRC, Seoul, South Korea; [Lee, Soojung] Kyung Hee Univ, Sch Dent, Dept Oral Physiol, Seoul, South Korea; [Cha, Hee-Jae] Kosin Univ, Coll Med, Dept Parasitol & Genet, Busan, South Korea	Dankook University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Kim, EC (corresponding author), Kyung Hee Univ, Sch Dent, Dept Oral & Maxillofacial Pathol, Seoul, South Korea.; Kim, EC (corresponding author), Kyung Hee Univ, Sch Dent, Res Ctr Tooth & Periodontal Regenerat MRC, Seoul, South Korea.	eckim@khu.ac.kr	Cha, Hee-Jae/AFO-8772-2022		National Research Foundation of Korea (NRF) - Korea government (MEST) [2012R1A5A2051384]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2012R1A5A2051384).	Abe D, 2011, J PERIODONTAL RES, V46, P345, DOI 10.1111/j.1600-0765.2011.01349.x; Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Badamchian M, 2003, INT IMMUNOPHARMACOL, V3, P1225, DOI 10.1016/S1567-5769(03)00024-9; Bao WK, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00149; Bolzoni M, 2013, LEUKEMIA, V27, P451, DOI 10.1038/leu.2012.190; Bostanci N, 2007, J CLIN PERIODONTOL, V34, P370, DOI 10.1111/j.1600-051X.2007.01061.x; Canakci CF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P619, DOI 10.1007/s10541-005-0161-9; Cha HJ, 2010, INT J DEV BIOL, V54, P135, DOI 10.1387/ijdb.082735hc; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Chen B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731039; Chen FM, 2009, MED RES REV, V29, P472, DOI 10.1002/med.20144; Choi BD, 2012, INT J MOL MED, V29, P841, DOI 10.3892/ijmm.2012.913; Conte E, 2012, ANN NY ACAD SCI, V1269, P69, DOI 10.1111/j.1749-6632.2012.06694.x; Crockford D, 2007, ANN NY ACAD SCI, V1112, P385, DOI 10.1196/annals.1415.051; Demmer RT, 2008, J PERIODONTOL, V79, P2112, DOI [10.1902/jop.2008.080139, 10.1902/jop.2008.080139 ]; Frohm M, 1996, EUR J BIOCHEM, V237, P86, DOI 10.1111/j.1432-1033.1996.0086n.x; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193; Golz L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/986264; GOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010, DOI 10.1073/pnas.56.3.1010; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; HALL TJ, 1995, BIOCHEM BIOPH RES CO, V207, P280, DOI 10.1006/bbrc.1995.1184; HANNAPPEL E, 1987, J CHROMATOGR, V397, P279, DOI 10.1016/S0021-9673(01)85010-X; Ho JH, 2010, J ORTHOP RES, V28, P131, DOI 10.1002/jor.20956; Ho JHC, 2007, INVEST OPHTH VIS SCI, V48, P27, DOI 10.1167/iovs.06-0826; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kitagawa M, 2006, BIOCHEM BIOPH RES CO, V349, P1050, DOI 10.1016/j.bbrc.2006.08.142; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026912; Kwon E, 2013, J ADV ORAL RES, V4, P1; Lee HJ, 2009, J PERIODONTOL, V80, P1281, DOI 10.1902/jop.2009.090098; Lee SI, 2014, J DENT RES, V93, P678, DOI 10.1177/0022034514535214; Lee SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061960; Lee SK, 2013, J CELL BIOCHEM, V114, P1183, DOI 10.1002/jcb.24461; Lim HD, 2012, J PINEAL RES, V53, P225, DOI 10.1111/j.1600-079X.2012.00991.x; LOW TLK, 1981, P NATL ACAD SCI-BIOL, V78, P1162, DOI 10.1073/pnas.78.2.1162; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Matsuo K, 2012, OR SURG OR MED OR PA, V114, P17, DOI 10.1016/j.tripleo.2011.05.025; Moseley R, 1998, CONNECT TISSUE RES, V37, P13, DOI 10.3109/03008209809028897; Nachmias VT, 1993, CURR OPIN CELL BIOL, V5, P56, DOI 10.1016/S0955-0674(05)80008-0; Nanbara H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034434; Park GJ, 2013, J PERIODONTAL RES, V48, P483, DOI 10.1111/jre.12030; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Philp D, 2004, MECH AGEING DEV, V125, P113, DOI 10.1016/j.mad.2003.11.005; Philp D, 2007, ANN NY ACAD SCI, V1112, P95, DOI 10.1196/annals.1415.009; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Reti R, 2008, EUR J ORAL SCI, V116, P424, DOI 10.1111/j.1600-0722.2008.00569.x; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.3.CO;2-C; SHIMAMURA R, 1990, BLOOD, V76, P977; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Sosne G, 2007, EXP EYE RES, V84, P663, DOI 10.1016/j.exer.2006.12.004; Vattakuzhi Y, 2012, ARTHRITIS RHEUM-US, V64, P2201, DOI 10.1002/art.34403; Waddington RJ, 2000, ORAL DIS, V6, P138; Yamaza H, 2001, INT J DEV BIOL, V45, P675; Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89; YU FX, 1994, CELL MOTIL CYTOSKEL, V27, P13, DOI 10.1002/cm.970270103; Yuan HW, 2010, INVEST OPHTH VIS SCI, V51, P2424, DOI 10.1167/iovs.09-3692; Zhao QX, 2010, INT J BIOCHEM CELL B, V42, P576, DOI 10.1016/j.biocel.2009.12.018; Zhao Y, 2014, J BIOL CHEM, V289, P21028, DOI 10.1074/jbc.M113.546523; Zhu TT, 2014, INT J MOL MED, V34, P816, DOI 10.3892/ijmm.2014.1832	62	21	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146708	10.1371/journal.pone.0146708	http://dx.doi.org/10.1371/journal.pone.0146708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789270	Green Submitted, Green Published, gold			2022-12-26	WOS:000368529100037
J	Weingarden, AR; Dosa, PI; DeWinter, E; Steer, CJ; Shaughnessy, MK; Johnson, JR; Khoruts, A; Sadowsky, MJ				Weingarden, Alexa R.; Dosa, Peter I.; DeWinter, Erin; Steer, Clifford J.; Shaughnessy, Megan K.; Johnson, James R.; Khoruts, Alexander; Sadowsky, Michael J.			Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth	PLOS ONE			English	Article							SPORE GERMINATION; PATHOGENICITY LOCUS; INFECTION; EPIDEMIOLOGY; POLYMORPHISM; STRAIN; SALTS	Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent Clostridium difficile infection (R-CDI), but its mechanisms remain poorly understood. Emerging evidence suggests that gut bile acids have significant influence on the physiology of C. difficile, and therefore on patient susceptibility to recurrent infection. We analyzed spore germination of 10 clinical C. difficile isolates exposed to combinations of bile acids present in patient feces before and after FMT. Bile acids at concentrations found in patients' feces prior to FMT induced germination of C. difficile, although with variable potency across different strains. However, bile acids at concentrations found in patients after FMT did not induce germination and inhibited vegetative growth of all C. difficile strains. Sequencing of the newly identified germinant receptor in C. difficile, CspC, revealed a possible correspondence of variation in germination responses across isolates with mutations in this receptor. This may be related to interstrain variability in spore germination and vegetative growth in response to bile acids seen in this and other studies. These results support the idea that intra-colonic bile acids play a key mechanistic role in the success of FMT, and suggests that novel therapeutic alternatives for treatment of R-CDI may be developed by targeted manipulation of bile acid composition in the colon.	[Weingarden, Alexa R.] Univ Minnesota, Dept Microbiol & Immunol, St Paul, MN 55108 USA; [Weingarden, Alexa R.; DeWinter, Erin; Khoruts, Alexander; Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Dosa, Peter I.] Univ Minnesota, Dept Med Chem, Inst Therapeut Discovery & Dev, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Shaughnessy, Megan K.; Johnson, James R.] Univ Minnesota, Dept Med, Div Infect Dis, Box 736 UMHC, Minneapolis, MN 55455 USA; [Shaughnessy, Megan K.; Johnson, James R.] Minneapolis Vet Affairs VA Healthcare Syst, Div Infect Dis, Minneapolis, MN USA; [Khoruts, Alexander] Univ Minnesota, Dept Med, Div Gastroenterol, Box 736 UMHC, Minneapolis, MN 55455 USA; [Khoruts, Alexander] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sadowsky, MJ (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.; Sadowsky, MJ (corresponding author), Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA.	Sadowsky@umn.edu	Sadowsky, Michael/J-2507-2016; Khoruts, Alexander/ABF-5119-2020	Sadowsky, Michael/0000-0001-8779-2781; Khoruts, Alexander/0000-0002-3205-3188; Dosa, Peter/0000-0002-0081-3867; Weingarden, Alexa/0000-0002-1567-1320	NIH [1R21-AI114722-01, UL1TR00114]; NIAID [R21AI-091907]; National Center for Allergy and Infectious Diseases [2T32AI055433-06A1]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091907, T32AI055433, R21AI114722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Allergy and Infectious Diseases; Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grant 1R21-AI114722-01 (AK, MJS, CC) and NIH Training Grant UL1TR00114 to University of Minnesota CTSI (ARW). Research reported in this publication was also supported, in part, by NIAID Grant R21AI-091907 (AK and MJS). MKS was supported by training grant award 2T32AI055433-06A1 from the National Center for Allergy and Infectious Diseases and the Office of Research and Development, Medical Research Service, Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Arroyo LG, 2005, J CLIN MICROBIOL, V43, P5341, DOI 10.1128/JCM.43.10.5341-5343.2005; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; Fuentes S, 2014, ISME J, V8, P1621, DOI 10.1038/ismej.2014.13; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Heeg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032381; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Khoruts A, 2015, CLIN GASTROENTEROL H, V13, P246, DOI 10.1016/j.cgh.2014.11.014; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Koenigsknecht MJ, 2015, INFECT IMMUN, V83, P934, DOI 10.1128/IAI.02768-14; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; MEKHJIAN HS, 1979, DIGEST DIS SCI, V24, P545, DOI 10.1007/BF01489324; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; MOIR A, 1990, ANNU REV MICROBIOL, V44, P531, DOI 10.1146/annurev.mi.44.100190.002531; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Seekatz AM, 2014, MBIO, V5, DOI 10.1128/mBio.00893-14; Shahinas D, 2012, MBIO, V3, DOI 10.1128/mBio.00338-12; Shankar V, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-13; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Surawicz CM, 2011, NAT REV GASTRO HEPAT, V8, P330, DOI 10.1038/nrgastro.2011.59; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135	44	109	113	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147210	10.1371/journal.pone.0147210	http://dx.doi.org/10.1371/journal.pone.0147210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789728	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100069
J	Basso, B; Giola, P; Dumont, B; Migliorati, MD; Cammarano, D; Pruneddu, G; Giunta, F				Basso, Bruno; Giola, Pietro; Dumont, Benjamin; Migliorati, Massimiliano De Antoni; Cammarano, Davide; Pruneddu, Giovanni; Giunta, Francesco			Tradeoffs between Maize Silage Yield and Nitrate Leaching in a Mediterranean Nitrate-Vulnerable Zone under Current and Projected Climate Scenarios	PLOS ONE			English	Article							NITROGEN-USE EFFICIENCY; CROPPING SYSTEM; SOIL CARBON; WHEAT; MANAGEMENT; MODEL; AGRICULTURE; FERTILIZER; TILLAGE; SLURRY	Future climatic changes may have profound impacts on cropping systems and affect the agronomic and environmental sustainability of current N management practices. The objectives of this work were to i) evaluate the ability of the SALUS crop model to reproduce experimental crop yield and soil nitrate dynamics results under different N fertilizer treatments in a farmer's field, ii) use the SALUS model to estimate the impacts of different N fertilizer treatments on NO3- leaching under future climate scenarios generated by twenty nine different global circulation models, and iii) identify the management system that best minimizes NO3- leaching and maximizes yield under projected future climate conditions. A field experiment (maize-triticale rotation) was conducted in a nitrate vulnerable zone on the west coast of Sardinia, Italy to evaluate N management strategies that include urea fertilization (NMIN), conventional fertilization with dairy slurry and urea (CONV), and no fertilization (N0). An ensemble of 29 global circulation models (GCM) was used to simulate different climate scenarios for two Representative Circulation Pathways (RCP6.0 and RCP8.5) and evaluate potential nitrate leaching and biomass production in this region over the next 50 years. Data collected from two growing seasons showed that the SALUS model adequately simulated both nitrate leaching and crop yield, with a relative error that ranged between 0.4% and 13%. Nitrate losses under RCP8.5 were lower than under RCP6.0 only for NMIN. Accordingly, levels of plant N uptake, N use efficiency and biomass production were higher under RCP8.5 than RCP6.0. Simulations under both RCP scenarios indicated that the NMIN treatment demonstrated both the highest biomass production and NO3- losses. The newly proposed best management practice (BMP), developed from crop N uptake data, was identified as the optimal N fertilizer management practice since it minimized NO3- leaching and maximized biomass production over the long term.	[Basso, Bruno; Dumont, Benjamin] Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA; [Basso, Bruno; Dumont, Benjamin] Michigan State Univ, WK Kellogg Biol Stn, E Lansing, MI 48824 USA; [Giola, Pietro; Pruneddu, Giovanni; Giunta, Francesco] Univ Sassari, Dipartimento Agr, Sez Sci Agron Coltivaz Erbacee & Genet SACEG, I-07100 Sassari, Italy; [Migliorati, Massimiliano De Antoni] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia; [Cammarano, Davide] James Hutton Inst, Dundee DD2 5DA, Scotland	Michigan State University; Michigan State University; University of Sassari; Queensland University of Technology (QUT); James Hutton Institute	Basso, B (corresponding author), Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA.; Basso, B (corresponding author), Michigan State Univ, WK Kellogg Biol Stn, E Lansing, MI 48824 USA.	basso@msu.edu	Basso, Bruno/AAF-1271-2019; Cammarano, Davide/CAF-3057-2022	Basso, Bruno/0000-0003-2090-4616; De Antoni Migliorati, Massimiliano/0000-0002-5651-5834; Dumont, Benjamin/0000-0001-8411-3990; Cammarano, Davide/0000-0003-0918-550X	Sardinian Regional Authorities (P.O.R. Sardegna F.S.E.); USDA NIFA Award [2015-68007-23133, 2011-68002-30190]	Sardinian Regional Authorities (P.O.R. Sardegna F.S.E.); USDA NIFA Award	This work has been partly supported by the Sardinian Regional Authorities (P.O.R. Sardegna F.S.E. 2007-2013) and USDA NIFA Award no. 2015-68007-23133 and 2011-68002-30190. Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus JF, 2001, AUST J EXP AGR, V41, P277, DOI 10.1071/EA00141; Basso B, 2005, AGR ECOSYST ENVIRON, V108, P329, DOI 10.1016/j.agee.2005.01.011; Basso B., 2015, ECOLOGY AGR LANDSCAP, P252; Basso B, 2007, EUR J AGRON, V26, P82, DOI 10.1016/j.eja.2006.08.008; Basso B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127333; Basso B, 2012, BIOSYST ENG, V113, P103, DOI 10.1016/j.biosystemseng.2012.06.012; Basso B, 2011, EUR J AGRON, V35, P215, DOI 10.1016/j.eja.2011.06.004; Basso B, 2011, EUR J AGRON, V35, P83, DOI 10.1016/j.eja.2011.04.002; Basso B, 2010, EUR J AGRON, V33, P132, DOI 10.1016/j.eja.2010.04.004; Carneiro JP, 2012, AGR ECOSYST ENVIRON, V160, P29, DOI 10.1016/j.agee.2011.09.001; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Cau P, 2007, HYDROL EARTH SYST SC, V4, P747, DOI DOI 10.5194/HESSD-4-747-2007; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Cubasch U., 2013, CLIMATE CHANGE 2013; Dauden A, 2004, EUR J AGRON, V21, P7, DOI 10.1016/S1161-0301(03)00056-X; Duan YH, 2014, FIELD CROP RES, V157, P47, DOI 10.1016/j.fcr.2013.12.012; Dumont B, 2015, EUR J AGRON, V65, P10, DOI 10.1016/j.eja.2015.01.003; Dzotsi KA, 2015, AGR SYST, V135, P31, DOI 10.1016/j.agsy.2014.12.003; Dzotsi KA, 2013, ECOL MODEL, V260, P62, DOI 10.1016/j.ecolmodel.2013.03.017; Edenhofer O., 2014, CONTRIBUTION WORKING; Fenn ME, 1998, ECOL APPL, V8, P706, DOI 10.1890/1051-0761(1998)008[0706:NEINAE]2.0.CO;2; FOX RH, 1978, SOIL SCI SOC AM J, V42, P751, DOI 10.2136/sssaj1978.03615995004200050019x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Giola P, 2012, EUR J AGRON, V38, P43, DOI 10.1016/j.eja.2011.12.001; HENZELL E. F., 1968, Transactions. 9th int. Congr. Soil Sci., Adelaide, 1968, V3, P513; INDORANTE SJ, 1990, SOIL SCI SOC AM J, V54, P560, DOI 10.2136/sssaj1990.03615995005400020047x; Jensen ES, 2012, AGRON SUSTAIN DEV, V32, P329, DOI 10.1007/s13593-011-0056-7; Jones J. W., 1998, Understanding options for agricultural production., P157; Kolberg RL, 1996, J PROD AGRIC, V9, P517, DOI 10.2134/jpa1996.0517; LECLERC B, 1995, BIOL AGRIC HORTIC, V11, P301, DOI 10.1080/01448765.1995.9754714; Ludwig B, 2011, J PLANT NUTR SOIL SC, V174, P350, DOI 10.1002/jpln.201000040; Michalczyk A, 2014, NUTR CYCL AGROECOSYS, V98, P203, DOI 10.1007/s10705-014-9606-0; MOSHREFI N, 1993, SOIL SCI, V155, P245, DOI 10.1097/00010694-199304000-00002; NORWOOD CA, 1990, J PROD AGRIC, V3, P356, DOI 10.2134/jpa1990.0356; OLeary GJ, 1996, AGR SYST, V52, P31, DOI 10.1016/0308-521X(96)00002-9; Olesen JE, 2007, CLIMATIC CHANGE, V81, P123, DOI 10.1007/s10584-006-9216-1; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Raper SCB, 2001, CLIM DYNAM, V17, P601, DOI 10.1007/PL00007931; Robertson GP, 2014, BIOSCIENCE, V64, P404, DOI 10.1093/biosci/biu037; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Rode M, 2008, WATER SA, V34, P490; Salazar F, 2012, AGR ECOSYST ENVIRON, V160, P23, DOI 10.1016/j.agee.2012.04.018; Sanchez JE, 2004, AGRON J, V96, P769, DOI 10.2134/agronj2004.0769; Saseendran SA, 2004, AGRON J, V96, P615, DOI 10.2134/agronj2004.0615; Senthilkumar S, 2009, SOIL SCI SOC AM J, V73, P2078, DOI 10.2136/sssaj2009.0044; Syswerda SP, 2012, AGR ECOSYST ENVIRON, V149, P10, DOI 10.1016/j.agee.2011.12.007; Tafteh A, 2012, INT J PLANT PROD, V6, P93; van der Laan M, 2014, AGR WATER MANAGE, V133, P74, DOI 10.1016/j.agwat.2013.10.017; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Velthof GL, 2009, J ENVIRON QUAL, V38, P402, DOI 10.2134/jeq2008.0108; Volk M, 2009, LAND USE POLICY, V26, P580, DOI 10.1016/j.landusepol.2008.08.005; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Whetton P. H., 2005, AUSTR CLIMATE CHANGE; Zavattaro L, 2012, AGR ECOSYST ENVIRON, V147, P24, DOI 10.1016/j.agee.2011.05.020; Zhou MH, 2014, PLANT SOIL, V374, P977, DOI 10.1007/s11104-013-1876-9; Zhou MH, 2012, ENVIRON POLLUT, V162, P361, DOI 10.1016/j.envpol.2011.12.001	58	10	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146360	10.1371/journal.pone.0146360	http://dx.doi.org/10.1371/journal.pone.0146360			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784113	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400032
J	Tyx, RE; Stanfill, SB; Keong, LM; Rivera, AJ; Satten, GA; Watson, CH				Tyx, Robert E.; Stanfill, Stephen B.; Keong, Lisa M.; Rivera, Angel J.; Satten, Glen A.; Watson, Clifford H.			Characterization of Bacterial Communities in Selected Smokeless Tobacco Products Using 16S rDNA Analysis	PLOS ONE			English	Article							NITRATE REDUCTION; TOTAL NICOTINE; UNITED-STATES; SWEDISH SNUS; NITRITE; SILVA; CORYNEBACTERIUM; NITROSAMINES; RESPIRATION; METABOLISM	The bacterial communities present in smokeless tobacco (ST) products have not previously reported. In this study, we used Next Generation Sequencing to study the bacteria present in U.S.-made dry snuff, moist snuff and Sudanese toombak. Sample diversity and taxonomic abundances were investigated in these products. A total of 33 bacterial families from four phyla, Actinobacteria, Firmicutes, Proteobacteria and Bacteroidetes, were identified. U.S.-produced dry snuff products contained a diverse distribution of all four phyla. Moist snuff products were dominated by Firmicutes. Toombak samples contained mainly Actinobacteria and Firmicutes (Aerococcaceae, Enterococcaceae, and Staphylococcaceae). The program PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) was used to impute the prevalence of genes encoding selected bacterial toxins, antibiotic resistance genes and other pro-inflammatory molecules. PICRUSt also predicted the presence of specific nitrate reductase genes, whose products can contribute to the formation of carcinogenic nitrosamines. Characterization of microbial community abundances and their associated genomes gives us an indication of the presence or absence of pathways of interest and can be used as a foundation for further investigation into the unique microbiological and chemical environments of smokeless tobacco products.	[Tyx, Robert E.; Stanfill, Stephen B.; Keong, Lisa M.; Rivera, Angel J.; Watson, Clifford H.] Ctr Dis Control & Prevent, Div Sci Lab, Atlanta, GA USA; [Satten, Glen A.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [Rivera, Angel J.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Keong, Lisa M.] Battelle Analyt Serv, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Tyx, RE (corresponding author), Ctr Dis Control & Prevent, Div Sci Lab, Atlanta, GA USA.	wyu3@cdc.gov	Rivera, Ángel/GRJ-2093-2022; Rivera, Angel J/ABF-3918-2021	Rivera, Angel J/0000-0002-0715-6273; Tyx, Robert/0000-0002-7514-9286	Battelle Analytical Services; U.S. Centers for Disease control and Prevention	Battelle Analytical Services; U.S. Centers for Disease control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Battelle Analytical Services, through a contract with U.S. Centers for Disease control and Prevention, provided support in the form of salaries for authors (LMK), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSEN RA, 1991, J AGR FOOD CHEM, V39, P1280, DOI 10.1021/jf00007a017; Averill BA, 1996, CHEM REV, V96, P2951, DOI 10.1021/cr950056p; Bernard KA, 2010, INT J SYST EVOL MICR, V60, P874, DOI 10.1099/ijs.0.012641-0; Bokulich NA, 2012, PLOS ONE, V7; Borgerding MF, 2012, REGUL TOXICOL PHARM, V64, P367, DOI 10.1016/j.yrtph.2012.09.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Centers for Disease Control and Prevention, 2019, OV CANC STAT; COCKRELL W T JR, 1989, Tobacco Science, V33, P55; Darwin A.J., 1996, REGULATION GENE EXPR, P343; Di Giacomo M, 2007, APPL ENVIRON MICROB, V73, P825, DOI 10.1128/AEM.02378-06; Fast B, 1996, ARCH MICROBIOL, V166, P361, DOI 10.1007/BF01682980; Fisher MT, 2012, FOOD CHEM TOXICOL, V50, P942, DOI 10.1016/j.fct.2011.11.035; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hartig E, 1999, J BACTERIOL, V181, P3658; Hempfling WPBG, 2004, METHOD REDUCTION TOB; Huang JW, 2010, APPL MICROBIOL BIOT, V88, P553, DOI 10.1007/s00253-010-2763-4; IARC, 2007, SMOK TOB SOM TOB SPE; IDRIS AM, 1991, CARCINOGENESIS, V12, P1115, DOI 10.1093/carcin/12.6.1115; Idris AM, 1998, ORAL ONCOL, V34, P558, DOI 10.1016/S1368-8375(98)00047-5; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larsson Lennart, 2008, Tob Induc Dis, V4, P4, DOI 10.1186/1617-9625-4-4; Lawler TS, 2013, FOOD CHEM TOXICOL, V57, P380, DOI 10.1016/j.fct.2013.03.011; Luque-Almagro VM, 2011, BIOCHEM SOC T, V39, P1838, DOI 10.1042/BST20110688; Mainar MS, 2015, INT J FOOD MICROBIOL, V212, P60, DOI 10.1016/j.ijfoodmicro.2015.03.009; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Nishimura T, 2007, APPL MICROBIOL BIOT, V75, P889, DOI 10.1007/s00253-007-0879-y; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pauly JL, 2011, J ONCOL, V2011, DOI 10.1155/2011/819129; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Richter P, 2008, NICOTINE TOB RES, V10, P1645, DOI 10.1080/14622200802412937; Rickert WS, 2009, REGUL TOXICOL PHARM, V53, P121, DOI 10.1016/j.yrtph.2008.12.004; ROWE JJ, 1994, MOL MICROBIOL, V12, P579, DOI 10.1111/j.1365-2958.1994.tb01044.x; Rubinstein I, 2002, CLIN DIAGN LAB IMMUN, V9, P1057, DOI 10.1128/CDLI.9.5.1057-1060.2002; Rutqvist LE, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-11; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; SPIEGELHALDER B, 1991, CRIT REV TOXICOL, V21, P241, DOI 10.3109/10408449109017911; Stanfill SB, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037465; Stepanov I, 2008, NICOTINE TOB RES, V10, P1773, DOI 10.1080/14622200802443544; Stewart V, 2002, J BACTERIOL, V184, P1314, DOI 10.1128/JB.184.5.1314-1323.2002; Su C, 2011, APPL MICROBIOL BIOT, V92, P1033, DOI 10.1007/s00253-011-3367-3; Vigliotta G, 2007, APPL MICROBIOL BIOT, V75, P633, DOI 10.1007/s00253-007-0867-2; Wahlberg I, 1999, AGRO FOOD IND HI TEC, V10, P23; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zakiullah, 2012, TOB CONTROL, V21, P396, DOI 10.1136/tc.2010.042630; Zheng HJ, 2013, NATURE, V497, P647, DOI 10.1038/nature12139; Zitomer N, 2015, J AGR FOOD CHEM	52	45	47	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146939	10.1371/journal.pone.0146939	http://dx.doi.org/10.1371/journal.pone.0146939			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784944	Green Published, Green Submitted, gold			2022-12-26	WOS:000368528400081
J	Nanavaty, V; Lama, R; Sandhu, R; Zhong, B; Kulman, D; Bobba, V; Zhao, AR; Li, BB; Su, B				Nanavaty, Vishal; Lama, Rati; Sandhu, Ranjodh; Zhong, Bo; Kulman, Daniel; Bobba, Viharika; Zhao, Anran; Li, Bibo; Su, Bin			Orally Active and Selective Tubulin Inhibitors as Anti-Trypanosome Agents	PLOS ONE			English	Article							ANTITRYPANOSOMAL AGENTS; SLEEPING SICKNESS; BRUCEI; IDENTIFICATION	Objectives There is an urgent need to develop a safe, effective, orally active, and inexpensive therapy for African trypanosomiasis due to the drawbacks of current drugs. Selective tubulin inhibitors have the potential to be promising drug candidates for the treatment of this disease, which is based on the tubulin protein structural difference between mammalian and trypanosome cells. We propose to identify novel tubulin inhibitors from a compound library developed based on the lead compounds that selectively target trypanosomiasis. Methods We used Trypanosoma brucei brucei as the parasite model, and human normal kidney cells and mouse microphage cells as the host model. Growth rates of both trypanosomes and mammalian cells were determined as a means to screen compounds that selectively inhibit the proliferation of parasites. Furthermore, we examined the cell cycle profile of the parasite and compared tubulin polymerization dynamics before and after the treatment using identified compounds. Last, in vivo anti-parasite activities of these compounds were determined in T. brucei-infected mice. Results Three compounds were selected that are 100 fold more effective against the growth of T. brucei cells than mammalian cells. These compounds caused cell cycle progression defects in T. brucei cells. Western analyses indicated that these compounds decreased tubulin polymerization in T. brucei cells. The in vivo investigation revealed that these compounds, when admitted orally, inhibited T. brucei cell proliferation in mouse blood. However, they were not potent enough to clear up the infection completely. Conclusions These compounds are promising lead compounds as orally active agents for drug development of anti-trypanosome agents. A more detail structure activity relationship (SAR) was summarized that will be used to guide future lead optimization to improve the selectivity and potency of the current compounds.	[Nanavaty, Vishal; Sandhu, Ranjodh; Kulman, Daniel; Li, Bibo] Cleveland State Univ, Coll Sci & Hlth Profess, Dept Biol Geo & Environm Sci, 2121 Euclid Ave, Cleveland, OH 44115 USA; [Lama, Rati; Zhong, Bo; Bobba, Viharika; Zhao, Anran; Su, Bin] Cleveland State Univ, Coll Sci & Hlth Profess, Dept Chem, 2121 Euclid Ave, Cleveland, OH 44115 USA; [Li, Bibo; Su, Bin] Cleveland State Univ, Coll Sci & Hlth Profess, Ctr Gene Regulat Hlth & Dis, 2121 Euclid Ave, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Li, BB (corresponding author), Cleveland State Univ, Coll Sci & Hlth Profess, Dept Biol Geo & Environm Sci, 2121 Euclid Ave, Cleveland, OH 44115 USA.; Su, B (corresponding author), Cleveland State Univ, Coll Sci & Hlth Profess, Dept Chem, 2121 Euclid Ave, Cleveland, OH 44115 USA.; Li, BB; Su, B (corresponding author), Cleveland State Univ, Coll Sci & Hlth Profess, Ctr Gene Regulat Hlth & Dis, 2121 Euclid Ave, Cleveland, OH 44115 USA.	b.li37@csuohio.edu; B.su@csuohio.edu	Bobba, Viharika/GLT-9560-2022; Sandhu, Ranjodh/AAN-5645-2020	Bobba, Viharika/0000-0003-3958-9388; Nanavaty, Vishal/0000-0001-7946-8076; Sandhu, Ranjodh/0000-0002-6459-7542	National Institutes of Health [R15AI 103889]; McNair scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI103889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McNair scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grant R15AI 103889 (B. Su) from National Institutes of Health, http://www.nih.gov/, and Daniel Kulman was supported by a McNair scholarship.	Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Fevre EM, 2005, LANCET, V366, P745, DOI 10.1016/S0140-6736(05)67179-6; Frankish H, 2003, LANCET, V362, P135, DOI 10.1016/S0140-6736(03)13900-1; Gudin S, 2006, EXP PARASITOL, V114, P118, DOI 10.1016/j.exppara.2006.02.018; Gull K, 2002, CURR PHARM DESIGN, V8, P241, DOI 10.2174/1381612023396212; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Heald R, 2002, J CELL SCI, V115, P3; Issa VS, 2010, LANCET, V376, P768, DOI 10.1016/S0140-6736(10)61372-4; Kuppens IELM, 2006, CURR CLIN PHARMACOL, V1, P57, DOI 10.2174/157488406775268200; Lama R, 2012, BIOORG MED CHEM LETT, V22, P5508, DOI 10.1016/j.bmcl.2012.07.023; OKUNO M, 1981, J CELL BIOL, V91, P689, DOI 10.1083/jcb.91.3.689; Steverding D, 2005, EXPERT OPIN INV DRUG, V14, P939, DOI 10.1517/13543784.14.8.939; Werbovetz KA, 2003, MOL PHARMACOL, V64, P1325, DOI 10.1124/mol.64.6.1325; Werbovetz KA, 2002, MINI-REV MED CHEM, V2, P519, DOI 10.2174/1389557023405648; Yi X, 2012, J MED CHEM, V55, P3425, DOI 10.1021/jm300100d; Zhong B, 2014, EUR J MED CHEM, V80, P243, DOI 10.1016/j.ejmech.2014.04.038; Zhong B, 2013, J MED CHEM, V56, P5306, DOI 10.1021/jm4004736	19	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146289	10.1371/journal.pone.0146289	http://dx.doi.org/10.1371/journal.pone.0146289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771307	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300012
J	Naouar, I; Boussoffara, T; Chenik, M; Gritli, S; Ben Ahmed, M; Hmida, NB; Bahi-Jaber, N; Bardi, R; Gorgi, Y; Ben Salah, A; Louzir, H				Naouar, Ikbel; Boussoffara, Thouraya; Chenik, Mehdi; Gritli, Sami; Ben Ahmed, Melika; Hmida, Nabil Belhadj; Bahi-Jaber, Narges; Bardi, Rafika; Gorgi, Yousr; Ben Salah, Afif; Louzir, Hechmi			Prediction of T Cell Epitopes from Leishmania major Potentially Excreted/Secreted Proteins Inducing Granzyme B Production	PLOS ONE			English	Article							IN-VITRO; INFECTED MACROPHAGES; MEDIATED-IMMUNITY; ANTIGEN; ELONGATION; PEPTIDE; CYTOTOXICITY; DONOVANI; MUCOSAL; RESPONSES	Leishmania-specific cytotoxic T cell response is part of the acquired immune response developed against the parasite and contributes to resistance to reinfection. Herein, we have used an immune-informatic approach for the identification, among Leishmania major potentially excreted/secreted proteins previously described, those generating peptides that could be targeted by the cytotoxic immune response. Seventy-eight nonameric peptides that are predicted to be loaded by HLA-A*0201 molecule were generated and their binding capacity to HLA-A2 was evaluated. These peptides were grouped into 20 pools and their immunogenicity was evaluated by in vitro stimulation of peripheral blood mononuclear cells from HLA-A(2+)-immune individuals with a history of zoonotic cutaneous leishmaniasis. Six peptides were identified according to their ability to elicit production of granzyme B. Furthermore, among these peptides 3 showed highest affinity to HLA-A*0201, one derived from an elongation factor 1-alpha and two from an unknown protein. These proteins could constitute potential vaccine candidates against leishmaniasis.	[Naouar, Ikbel; Boussoffara, Thouraya; Ben Ahmed, Melika; Hmida, Nabil Belhadj; Bahi-Jaber, Narges; Ben Salah, Afif; Louzir, Hechmi] Pasteur Inst Tunis, Lab Transmiss Control & Immunobiol Infect LR11 PT, Tunis, Tunisia; [Naouar, Ikbel; Boussoffara, Thouraya; Chenik, Mehdi; Ben Ahmed, Melika; Hmida, Nabil Belhadj; Ben Salah, Afif; Louzir, Hechmi] Univ Tunis El Manar, Tunis, Tunisia; [Chenik, Mehdi] Pasteur Inst Tunis, Lab Med Parasitol Biotechnol & Biomol, LR11-IPT-06, Tunis, Tunisia; [Gritli, Sami] Charles Nicolle Hosp, Dept Pathol, Tunis, Tunisia; [Gritli, Sami] Fac Med Tunis, Tunis, Tunisia; [Bahi-Jaber, Narges] UPSP EGEAL Inst Polytech LaSalle Beauvais, Beauvais, France; [Bardi, Rafika; Gorgi, Yousr] Charles Nicolle Hosp, Immunol Lab, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Hopital Charles Nicolle; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Universite de Tunis-El-Manar; Hopital Charles Nicolle	Boussoffara, T (corresponding author), Pasteur Inst Tunis, Lab Transmiss Control & Immunobiol Infect LR11 PT, Tunis, Tunisia.; Boussoffara, T (corresponding author), Univ Tunis El Manar, Tunis, Tunisia.	thouraya.boussoffara@pasteur.rns.tn	Ben Salah, Afif/AGW-8941-2022	Ben Salah, Afif/0000-0002-6696-4713; Ben Ahmed, Melika/0000-0002-3179-1648	National Institute of Allergy and Infection diseases [P50AI074178]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074178] Funding Source: NIH RePORTER	National Institute of Allergy and Infection diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by P50AI074178 from the National Institute of Allergy and Infection diseases to HL and ABS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayed Khaled, 2003, Saudi J Kidney Dis Transpl, V14, P39; BARRALNETTO M, 1995, PARASITE IMMUNOL, V17, P21, DOI 10.1111/j.1365-3024.1995.tb00962.x; Basu R, 2007, J INFECT DIS, V195, P1373, DOI 10.1086/513439; Bertholet S, 2005, INFECT IMMUN, V73, P6620, DOI 10.1128/IAI.73.10.6620-6628.2005; Bertholet S, 2006, J IMMUNOL, V177, P3525, DOI 10.4049/jimmunol.177.6.3525; Bousoffara T, 2004, J INFECT DIS, V189, P1265, DOI 10.1086/382031; Brodskyn CI, 1997, J IMMUNOL, V159, P4467; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; CARVALHO EM, 1985, J IMMUNOL, V135, P4144; CASTES M, 1983, CLIN IMMUNOL IMMUNOP, V27, P176, DOI 10.1016/0090-1229(83)90068-5; Chenik M, 2006, PARASITOLOGY, V132, P493, DOI 10.1017/S0031182005009546; Choi Christine M, 2002, Am J Clin Dermatol, V3, P91, DOI 10.2165/00128071-200203020-00003; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Daryani A, 2003, VET PARASITOL, V113, P123, DOI 10.1016/S0304-4017(03)00044-X; Das S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008222; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x; Gomez-Nunez M, 2006, LEUKEMIA RES, V30, P1293, DOI 10.1016/j.leukres.2006.02.010; Hotez P, 2006, ADV EXP MED BIOL, V582, P23; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; KEMP M, 1994, CLIN EXP IMMUNOL, V96, P410, DOI 10.1111/j.1365-2249.1994.tb06043.x; Kima PE, 1997, J IMMUNOL, V159, P1828; Lyke KE, 2005, INFECT IMMUN, V73, P5799, DOI 10.1128/IAI.73.9.5799-5808.2005; Mansueto P, 2007, INT J IMMUNOPATH PH, V20, P435, DOI 10.1177/039463200702000302; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Mustafa AS, 2002, MOL IMMUNOL, V39, P113, DOI 10.1016/S0161-5890(02)00048-2; Nandan D, 2005, CLIN IMMUNOL, V114, P266, DOI 10.1016/j.clim.2004.07.017; Nandan D, 2003, BIOCHEM BIOPH RES CO, V302, P646, DOI 10.1016/S0006-291X(03)00216-X; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Naouar I, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/636039; Novais FO, 2015, SEMIN IMMUNOPATHOL, V37, P251, DOI 10.1007/s00281-015-0475-7; Nylen S, 2010, J GLOB INFECT DIS, V2, P135, DOI 10.4103/0974-777X.62876; Pelte C, 2004, J IMMUNOL, V172, P6783, DOI 10.4049/jimmunol.172.11.6783; Piscopo TV, 2006, POSTGRAD MED J, V82, P649, DOI 10.1136/pgmj.2006.047340; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Roberts M. T. M., 2006, BR MED B, V75-76, P115, DOI [10.1093/bmb/ldl003, DOI 10.1093/BMB/ID1003]; RYAZANOV AG, 1991, FEBS LETT, V285, P170, DOI 10.1016/0014-5793(91)80798-8; Seyed N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001295; Shams H, 2004, J IMMUNOL, V173, P1966, DOI 10.4049/jimmunol.173.3.1966; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Stager S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00005; Suneetha PV, 2009, J IMMUNOL METHODS, V342, P33, DOI 10.1016/j.jim.2008.11.020; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147076	10.1371/journal.pone.0147076	http://dx.doi.org/10.1371/journal.pone.0147076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771180	Green Submitted, Green Published, gold			2022-12-26	WOS:000368628300060
J	Peng, HK; Lee, HC; Pan, JY; Marculescu, R				Peng, Huan-Kai; Lee, Hao-Chih; Pan, Jia-Yu; Marculescu, Radu			Data-Driven Engineering of Social Dynamics: Pattern Matching and Profit Maximization	PLOS ONE			English	Article								In this paper, we define a new problem related to social media, namely, the data-driven engineering of social dynamics. More precisely, given a set of observations from the past, we aim at finding the best short-term intervention that can lead to predefined long-term outcomes. Toward this end, we propose a general formulation that covers two useful engineering tasks as special cases, namely, pattern matching and profit maximization. By incorporating a deep learning model, we derive a solution using convex relaxation and quadratic-programming transformation. Moreover, we propose a data-driven evaluation method in place of the expensive field experiments. Using a Twitter dataset, we demonstrate the effectiveness of our dynamics engineering approach for both pattern matching and profit maximization, and study the multifaceted interplay among several important factors of dynamics engineering, such as solution validity, pattern-matching accuracy, and intervention cost. Finally, the method we propose is general enough to work with multi-dimensional time series, so it can potentially be used in many other applications.	[Peng, Huan-Kai; Marculescu, Radu] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA; [Lee, Hao-Chih] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Pan, Jia-Yu] Google Inc, Mountain View, CA USA	Carnegie Mellon University; Carnegie Mellon University; Google Incorporated	Peng, HK (corresponding author), Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA.	pumbaapeng@gmail.com	Marculescu, Radu/AAR-5320-2021	Marculescu, Radu/0000-0003-1826-7646	United States National Science Foundation [CCF-1314876]; Google Inc.	United States National Science Foundation(National Science Foundation (NSF)); Google Inc.(Google Incorporated)	HP and RM are both funded by the United States National Science Foundation Grant CCF-1314876 (http://www.nsf.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JP is supported by Google Inc. in the form of salary. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], P ICWSM; [Anonymous], ADV NEURAL INF PROCE, DOI DOI 10.1109/ICIP.2001.958968; Asur S, 2011, P ICWSM; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Boyd S., 2004, CONVEX OPTIMIZATION; Chen W, 2010, P ICDM DEC; Click A., 2009, TIME; Dow P, P ICWSM; Dumais S, 2012, P WWW; Gerber A.S., 2012, FIELD EXPT DESIGN AN; Gupta M, 2012, P AM SOC INFORM SCI; Jansen BJ, 2009, J AM SOC INF SCI TEC, V60, P2169, DOI 10.1002/asi.21149; Kleinberg Jon, 2002, P KDD; Lee H., 2009, P ANN INT C MACH LEA, P609; Lehmann J., 2012, P WWW; Leskovec J., 2005, P KDD; Lin Y, 2008, P WWW; Lin Y. -R., 2013, P ICWSM; Matsubara Y., 2012, P KDD; Naaman M, 2011, J AM SOC INF SCI TEC, V62, P902, DOI 10.1002/asi.21489; Peng HK, 2014, ASE INT C SOC COMP; Peng HK, 2013, P ASONAM; Peng HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118309; Romero D. M., 2011, P WWW; Szabo G., 2010, COMMUNICATIONS ACM; Wasserman L., 2004, ALL STAT CONCISE COU, V26; Wasserman L., 2005, ALL NONPARAMETRIC ST; Yang Jaewon, 2011, P WSDM	28	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146490	10.1371/journal.pone.0146490	http://dx.doi.org/10.1371/journal.pone.0146490			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771830	Green Published, Green Submitted, gold			2022-12-26	WOS:000368628300023
J	Schmidt, B; Gemeinholzer, B; Treloar, A				Schmidt, Birgit; Gemeinholzer, Birgit; Treloar, Andrew			Open Data in Global Environmental Research: The Belmont Forum's Open Data Survey	PLOS ONE			English	Article							DATA-MANAGEMENT; BIG DATA; CHALLENGES; SCIENTISTS; REUSE; COMMERCIALIZATION; REQUIREMENTS; REPOSITORIES; ECOLOGY	This paper presents the findings of the Belmont Forum's survey on Open Data which targeted the global environmental research and data infrastructure community. It highlights users' perceptions of the term "open data", expectations of infrastructure functionalities, and barriers and enablers for the sharing of data. A wide range of good practice examples was pointed out by the respondents which demonstrates a substantial uptake of data sharing through e-infrastructures and a further need for enhancement and consolidation. Among all policy responses, funder policies seem to be the most important motivator. This supports the conclusion that stronger mandates will strengthen the case for data sharing.	[Schmidt, Birgit] Univ Gottingen, State & Univ Lib, D-37073 Gottingen, Germany; [Gemeinholzer, Birgit] Univ Giessen, Systemat Bot, D-35390 Giessen, Germany; [Treloar, Andrew] Australian Natl Data Serv, Melbourne, Vic, Australia	University of Gottingen; Justus Liebig University Giessen	Schmidt, B (corresponding author), Univ Gottingen, State & Univ Lib, D-37073 Gottingen, Germany.	bschmidt@sub.uni-goettingen.de	Treloar, Andrew E/E-4356-2010; Gemeinholzer, Birgit/AAF-6401-2020; Schmidt, Birgit/AAB-6299-2022	Treloar, Andrew E/0000-0002-8911-3081; Schmidt, Birgit/0000-0001-8036-5859; gemeinholzer, birgit/0000-0002-9145-9284	US National Science Foundation [1358990]; UK Natural Environment Research Council [NE/LO14319/1]	US National Science Foundation(National Science Foundation (NSF)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors received no direct funding for this work; however, the work was done in the context of the Belmont Forum's E-Infrastructure and Data Management Collaborative Research Action (CRA), http://www.bfe-inf.org/. (See the note on the website: The Belmont Forum E-Infrastructures and Data Management Collaborative Research Action is supported by the participating Belmont Forum members listed at http://www.bfe-inf.org/info/participating-countries. This site is managed by a joint United States-United Kingdom Secretariat, supported by the US National Science Foundation under Grant No. 1358990 and the UK Natural Environment Research Council under Grant Ref NE/LO14319/1.)	AKERS K, 2013, INT J DIGITAL CURATI, V0008; [Anonymous], 2009, PATT INF US EXCH CAS, P2009; Auer S, 2007, LECT NOTES COMPUT SC, V4825, P722, DOI 10.1007/978-3-540-76298-0_52; Bach K, 2012, ECOL INFORM, V11, P16, DOI 10.1016/j.ecoinf.2011.11.008; Bendix J, 2012, ECOL INFORM, V11, P1, DOI 10.1016/j.ecoinf.2012.04.001; Bolukbasi B, 2013, SCIENCE, V342, P1041, DOI 10.1126/science.342.6162.1041-b; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Bryer J, 2013, LIKERT R PACKAGE ANA; Candela L, 2015, ECOL INFORM, V26, P162, DOI 10.1016/j.ecoinf.2014.07.006; Canhos V.P., 2004, Biodiversity Informatics, V1, P1; Costello MJ, 2009, BIOSCIENCE, V59, P418, DOI 10.1525/bio.2009.59.5.9; Cragin MH, 2010, PHILOS T R SOC A, V368, P4023, DOI 10.1098/rsta.2010.0165; CRANE D, 1969, AM SOCIOL REV, V34, P335, DOI 10.2307/2092499; Diekema AR, 2014, J ACAD LIBR, V40, P322, DOI 10.1016/j.acalib.2014.04.010; Duke CS, 2013, BIOSCIENCE, V63, P483, DOI 10.1525/bio.2013.63.6.10; Enke N, 2012, ECOL INFORM, V11, P25, DOI 10.1016/j.ecoinf.2012.03.004; Expert Advisory Group on Data Access [EAGDA], 2014, EST INC CHANG CULT S; Fecher B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118053; Feijen M., 2007, ARIADNE; Global Earth Observation System of Systems (GEOSS), 2010, GEOSS DAT SHAR ACT P; Haff T, 2014, SURVEY RESULTS ROCHE; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Henty M, 2008, INVESTIGATING DATA M; Hertzfeld HR, 2006, RES POLICY, V35, P825, DOI 10.1016/j.respol.2006.04.006; Hsu L, 2015, GEOMORPHOLOGY, V244, P180, DOI 10.1016/j.geomorph.2015.03.039; Huang XL, 2011, TRENDS ECOL EVOL, V26, P377, DOI 10.1016/j.tree.2011.05.006; Klump J, 2010, EGU GEN ASS C, P4923; Kratz John, 2014, F1000Res, V3, P94, DOI 10.12688/f1000research.3979.3; Kratz JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117619; Kuipers T, 2009, INSIGHT DIGITAL PRES; Lam A, 2011, RES POLICY, V40, P1354, DOI 10.1016/j.respol.2011.09.002; Lee D, 2014, OEPN DATA IRELAND BE; Lee D, 2014, OEPN DATA IRELAND OP; Lee D, 2014, OPEN DATA IRELAND OP; Luna-Reyes LF, 2008, SYST DYNAM REV, V24, P265, DOI 10.1002/sdr.404; Lyon E, 2007, DEALING RELATIONSHIP; Marx V, 2013, NATURE, V498, P255, DOI 10.1038/498255a; Michener W, 2011, TRENDS ECOL EVOL, P17; Molloy JC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001195; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; OECD, 2007, PRINC GUID ACC RES D; Parr CS, 2005, TRENDS ECOL EVOL, V20, P362, DOI 10.1016/j.tree.2005.04.023; Perkmann M, 2013, RES POLICY, V42, P423, DOI 10.1016/j.respol.2012.09.007; Peters DPC, 2010, TRENDS ECOL EVOL, V25, P592, DOI 10.1016/j.tree.2010.07.005; Piwowar HA, 2013, PEERJ, V1, DOI 10.7717/peerj.175; Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a; Schmidt B, 2015, BELMONT FORUM OPEN D; Specht A, 2015, SCI TOTAL ENVIRON, V534, P144, DOI 10.1016/j.scitotenv.2015.03.092; Stern S, 2004, MANAGE SCI, V50, P835, DOI 10.1287/mnsc.1040.0241; Swan A, 2008, SHARE NOT SHARE PUBL; Tennison J, 2014, OPEN DATA I BLO 0317; Tenopir C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134826; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Van Noorden Richard, 2013, Nature, V500, P243; Whitlock MC, 2011, TRENDS ECOL EVOL, V26, P61, DOI 10.1016/j.tree.2010.11.006; Wood J, 2010, RIDING WAVE EUROPE C	56	52	53	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146695	10.1371/journal.pone.0146695	http://dx.doi.org/10.1371/journal.pone.0146695			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6ME	26771577	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300029
J	Su, ML; Huang, WD; Zhu, BH				Su, Meiling; Huang, Wendong; Zhu, Banghao			Acetylshikonin from Zicao Prevents Obesity in Rats on a High-Fat Diet by Inhibiting Lipid Accumulation and Inducing Lipolysis	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; LITHOSPERMUM-ERYTHRORHIZON; PERILIPIN-A; SHIKONIN; STORAGE; CELLS	Various drugs have been developed to treat obesity, but these have undesirable secondary effects, and an efficient but non-toxic anti-obesity drug from natural sources is desired. This study investigated the anti-obesity effects and mechanisms of action of acetylshikonin (AS)-which is used in traditional Chinese medicine-in rats on a high-fat diet (HFD). Rats were fed a normal diet or an HFD; the latter group was received no treatment or were treated with 100, 300, or 900 mg/kg AS extract by intragastric administration for 6 weeks. In addition, 3T3-L1 adipocytes were treated with AS and the effects on adipogenesis and lipolysis were evaluated by western blot analysis of adipogenic transcription factors and lipidmetabolizing enzyme levels and the phosphorylation status of protein kinase (PK) A and hormone-sensitive lipase (HSL). AS prevented HFD-induced obesity including reduction in body weight, white adipose tissue content, liver mass, and serum triglyceride and free fatty acid levels in rats. It also suppressed the expression of adipogenic differentiation transcription factors and decreased the expression of the adipocyte-specific proteins HSL and adipose triglyceride lipase (ATGL). Furthermore, AS treatment induced lipolysis, leading to the release of glycerol and increased in PKA and HSL phosphorylation. These findings demonstrate that AS has anti-obesity effects in a rat model and may be a safe treatment for obesity in humans.	[Su, Meiling; Huang, Wendong; Zhu, Banghao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Cardiac & Cerebral Vasc Res Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhu, BH (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Cardiac & Cerebral Vasc Res Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhubh@mail.sysu.edu.cn			Joint Project of National Education Ministry and Guangdong province [2007B090400089, 2007A032702001]	Joint Project of National Education Ministry and Guangdong province	This study was supported by grants from the Joint Project of National Education Ministry and Guangdong province (Nos. 2007B090400089) and (2007A032702001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailhaud G, 2001, ANN ENDOCRINOL-PARIS, V62, pS43; Akkol EK, 2009, J ETHNOPHARMACOL, V124, P137, DOI 10.1016/j.jep.2009.03.019; Andujar I, 2013, PLANTA MED, V79, P1685, DOI 10.1055/s-0033-1350934; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Chen X, 2002, PHYTOTHER RES, V16, P199, DOI 10.1002/ptr.1100; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Garcia A, 2004, J BIOL CHEM, V279, P8409, DOI 10.1074/jbc.M311198200; Gwon SY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-207; Gwon SY, 2012, J AGR FOOD CHEM, V60, P9089, DOI 10.1021/jf3017404; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Hu YS, 2010, FITOTERAPIA, V81, P358, DOI 10.1016/j.fitote.2009.10.010; Kakkar AK, 2015, EUR J INTERN MED, V26, P89, DOI 10.1016/j.ejim.2015.01.005; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kim GW, 2014, CLIN PHARMACOL THER, V95, P53, DOI 10.1038/clpt.2013.204; Kratky D, 2014, BIOCHIMIE, V96, P106, DOI 10.1016/j.biochi.2013.06.023; Labib M, 2003, J CLIN PATHOL, V56, P17, DOI 10.1136/jcp.56.1.17; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lee H, 2011, LIFE SCI, V88, P294, DOI 10.1016/j.lfs.2010.12.004; Lee H, 2010, PHYTOTHER RES, V24, P344, DOI 10.1002/ptr.2942; Lee JE, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-29; Liu LR, 2011, OBESITY, V19, P2301, DOI 10.1038/oby.2011.176; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sabin MA, 2015, BEST PRACT RES CL EN, V29, P327, DOI 10.1016/j.beem.2015.04.003; SANKAWA U, 1977, CHEM PHARM BULL, V25, P2392; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Seo JB, 2012, BIOCHEM BIOPH RES CO, V417, P800, DOI 10.1016/j.bbrc.2011.12.039; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Stephens JM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001436; Stich V, 2004, P NUTR SOC, V63, P369, DOI 10.1079/PNS2004350; Sung RJ, 2015, J ETHNOPHARMACOL; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; TABATA M, 1975, YAKUGAKU ZASSHI, V95, P1376, DOI 10.1248/yakushi1947.95.11_1376; TANAKA S, 1986, J NAT PROD, V49, P466, DOI 10.1021/np50045a014; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Zeng Z, 2014, J ETHNOPHARMACOL, V154, P653, DOI 10.1016/j.jep.2014.04.038; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	42	23	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146884	10.1371/journal.pone.0146884	http://dx.doi.org/10.1371/journal.pone.0146884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771185	gold, Green Published, Green Submitted			2022-12-26	WOS:000368628300039
J	Shankar, E; Song, K; Corum, SL; Bane, KL; Wang, H; Kao, HY; Danielpour, D				Shankar, Eswar; Song, Kyung; Corum, Sarah L.; Bane, Kara L.; Wang, Hui; Kao, Hung-Ying; Danielpour, David			A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; androgen; androgen receptor; c-Fos; c-Jun transcription factor; MAPK; p38 MAPK; phorbol ester; prostate cancer; PKC	RAT VENTRAL PROSTATE; GROWTH-FACTOR-BETA; SERUM RESPONSE ELEMENT; CANCER-CELLS; KINASE-C; INDUCED APOPTOSIS; EPITHELIAL-CELLS; PHORBOL ESTER; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSCRIPTIONAL ACTIVITY	The transcription factor c-Fos controls many important cellular processes, including cell growth and apoptosis. c-Fos expression is rapidly elevated in the prostate upon castration-mediated androgen withdrawal through an undefined mechanism. Here we show that androgens (5-dihydrotestosterone and R1881) suppress c-Fos protein and mRNA expression induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) or EGF in human prostate cancer (PCa) cell lines. Such suppression transpires through a transcriptional mechanism, predominantly at the proximal serum response element of the c-fos promoter. We show that androgen signaling suppresses TPA-induced c-Fos expression through repressing a PKC/MEK/ERK/ELK-1 signaling pathway. Moreover, our results support the hypothesis that p38(MAPK), PI3K, and PKC are involved in the androgenic regulation of c-Fos through controlling MEK/ERK. Stable silencing of c-Fos and PKC with shRNAs suggests that R1881 promotes cell death induced by low-dose TPA through a mechanism that is dependent on both PKC and loss of c-Fos expression. Reciprocally, loss of either PKC or c-Fos activates p38(MAPK) while suppressing the activation of ERK1/2. We also provide the first demonstration that R1881 permits cell death induced by low-dose TPA in the LNCaP androgen-dependent PCa cell line and that TPA-induced cell death is independent of exogenous androgen in the castration-resistant variants of LNCaP, C4-2 and C4-2B. Acquisition of androgen-independent killing by TPA correlates with activation of p38(MAPK), suppression of ERK1/2, and loss of c-Fos. These results provide new insights into androgenic control of c-Fos and use of PKC inhibitors in PCa therapy.	[Kao, Hung-Ying; Danielpour, David] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Shankar, Eswar; Song, Kyung; Corum, Sarah L.; Bane, Kara L.; Danielpour, David] Case Western Reserve Univ, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Wang, Hui; Danielpour, David] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Danielpour, David] Univ Hosp Cleveland, Dept Urol, Cleveland, OH 44106 USA; [Song, Kyung] Wonkwang Univ, Coll Pharm, Iksan 570749, South Korea; [Wang, Hui] Athenex, Cranford, NJ 07016 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Wonkwang University	Danielpour, D (corresponding author), Div Gen Med Sci Oncol, Wolstein Res Bldg,Rm 3-532,2103 Cornell Ave, Cleveland, OH 44106 USA.	dxd49@case.edu	Shankar, Eswar/E-5139-2015	Shankar, Eswar/0000-0001-8968-838X	NCI/National Institutes of Health [R01CA092102, R01CA102074, R01CA134878]; NATIONAL CANCER INSTITUTE [R01CA134878, R01CA092102, R01CA102074] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NCI/National Institutes of Health Grants R01CA092102, R01CA102074, and R01CA134878 ( to D. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler J, 2010, MOL CELL BIOL, V30, P3767, DOI 10.1128/MCB.00899-09; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; BLUMBERG PM, 1988, CANCER RES, V48, P1; BUTTYAN R, 1988, MOL ENDOCRINOL, V2, P650, DOI 10.1210/mend-2-7-650; Buttyan R, 1999, TRENDS ENDOCRIN MET, V10, P47, DOI 10.1016/S1043-2760(98)00104-0; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Chmura SJ, 1996, CANCER RES, V56, P2711; COOKE PS, 1991, ENDOCRINOLOGY, V128, P2867, DOI 10.1210/endo-128-6-2867; Cui XX, 2002, ONCOL RES, V13, P169; Culig Z, 2005, ENDOCR-RELAT CANCER, V12, P229, DOI 10.1677/erc.1.00775a; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; DAY ML, 1994, CELL GROWTH DIFFER, V5, P735; Engedal N, 2002, ONCOGENE, V21, P1017, DOI 10.1038/sj.onc.1205167; Fang BJ, 2007, LEUKEMIA RES, V31, P1441, DOI 10.1016/j.leukres.2007.02.004; Feng ZW, 1998, ONCOGENE, V17, P2593, DOI 10.1038/sj.onc.1202195; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Garzotto M, 1999, CANCER RES, V59, P5194; Gavrielides MV, 2006, CANCER RES, V66, P11792, DOI 10.1158/0008-5472.CAN-06-1139; GRANT S, 1992, CANCER RES, V52, P6270; Gschwendt M, 1999, EUR J BIOCHEM, V259, P555, DOI 10.1046/j.1432-1327.1999.00120.x; HAIMOVITZFRIEDMAN A, 1994, CANCER RES, V54, P2591; Han ZT, 1998, P NATL ACAD SCI USA, V95, P5362, DOI 10.1073/pnas.95.9.5362; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; Hsu CC, 2013, MOL CELL ENDOCRINOL, V372, P12, DOI 10.1016/j.mce.2013.03.004; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; Ito Y, 2005, BONE, V37, P842, DOI 10.1016/j.bone.2005.04.030; IVANOVIC V, 1995, NAT MED, V1, P282, DOI 10.1038/nm0495-282; JARVIS WD, 1994, CANCER RES, V54, P1707; JOHANSEN FE, 1993, MOL CELL BIOL, V13, P4640, DOI 10.1128/MCB.13.8.4640; Johnson CM, 1997, J NEUROSCI, V17, P6189; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; KRONGRAD A, 1994, CANCER RES, V54, P6073; KYPRIANOU N, 1989, MOL ENDOCRINOL, V3, P1515, DOI 10.1210/mend-3-10-1515; Latinkic BV, 1996, NUCLEIC ACIDS RES, V24, P1345, DOI 10.1093/nar/24.7.1345; Leach DA, 2014, MOL CELL ENDOCRINOL, V384, P185, DOI 10.1016/j.mce.2014.01.004; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Liu GM, 2006, MOL CARCINOGEN, V45, P582, DOI 10.1002/mc.20189; Lucia MS, 1998, J CELL PHYSIOL, V175, P184, DOI 10.1002/(SICI)1097-4652(199805)175:2<184::AID-JCP8>3.0.CO;2-K; LUCIBELLO FC, 1989, CELL, V59, P999, DOI 10.1016/0092-8674(89)90756-3; MERZ VW, 1994, WORLD J UROL, V12, P96; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Mora GR, 1996, MOL CELL ENDOCRINOL, V124, P111, DOI 10.1016/S0303-7207(96)03939-1; Mora LB, 2002, CANCER RES, V62, P6659; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Patki M, 2013, J BIOL CHEM, V288, P11047, DOI 10.1074/jbc.M112.438473; PAVELIC K, 1991, International Journal of Developmental Biology, V35, P209; Perry KT, 1997, PROSTATE, V33, P133, DOI 10.1002/(SICI)1097-0045(19971001)33:2<133::AID-PROS7>3.0.CO;2-L; PIECHACZYK M, 1994, CRIT REV ONCOL HEMAT, V17, P93, DOI 10.1016/1040-8428(94)90021-3; RAO VN, 1992, ONCOGENE, V7, P2335; Sato N, 1997, J BIOL CHEM, V272, P17485, DOI 10.1074/jbc.272.28.17485; Schaar D, 2006, CANCER CHEMOTH PHARM, V57, P789, DOI 10.1007/s00280-005-0125-1; Schweizer L, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-4; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Sng JCG, 2004, BIOL PHARM BULL, V27, P606, DOI 10.1248/bpb.27.606; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Song K, 2008, CANCER RES, V68, P8173, DOI 10.1158/0008-5472.CAN-08-2290; Song K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061896; STANCOVSKI I, 1995, MOL CELL BIOL, V15, P7106; Stewart LMV, 2003, EXP CELL RES, V284, P303, DOI 10.1016/S0014(02)00037-X; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P742, DOI 10.1021/bi00147a029; Wen Y, 2000, CANCER RES, V60, P6841; Xiao LQ, 2009, MOL CARCINOGEN, V48, P187, DOI 10.1002/mc.20476; Zhang XP, 2007, CLIN CANCER RES, V13, P7181, DOI 10.1158/1078-0432.CCR-07-1133; Zhang XP, 2007, CANCER RES, V67, P9425, DOI 10.1158/0008-5472.CAN-07-1310	74	14	17	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5512	5526		10.1074/jbc.M115.694877	http://dx.doi.org/10.1074/jbc.M115.694877			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786102	hybrid, Green Published			2022-12-26	WOS:000372551800006
J	Agafonov, O; Selsto, CH; Thorsen, K; Xu, XM; Drengstig, T; Ruoff, P				Agafonov, Oleg; Selsto, Christina Helen; Thorsen, Kristian; Xu, Xiang Ming; Drengstig, Tormod; Ruoff, Peter			The Organization of Controller Motifs Leading to Robust Plant Iron Homeostasis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FIT; ARABIDOPSIS-THALIANA; METAL TRANSPORTER; REGULATED TRANSPORTER1; PERFECT ADAPTATION; VACUOLAR SYMPLAST; UPTAKE SYSTEM; IRT1; PROTEIN; EXPRESSION	Iron is an essential element needed by all organisms for growth and development. Because iron becomes toxic at higher concentrations iron is under homeostatic control. Plants face also the problem that iron in the soil is tightly bound to oxygen and difficult to access. Plants have therefore developed special mechanisms for iron uptake and regulation. During the last years key components of plant iron regulation have been identified. How these components integrate and maintain robust iron homeostasis is presently not well understood. Here we use a computational approach to identify mechanisms for robust iron homeostasis in non-graminaceous plants. In comparison with experimental results certain control arrangements can be eliminated, among them that iron homeostasis is solely based on an iron-dependent degradation of the transporter IRT1. Recent IRT1 overexpression experiments suggested that IRT1-degradation is iron-independent. This suggestion appears to be misleading. We show that iron signaling pathways under IRT1 overexpression conditions become saturated, leading to a breakdown in iron regulation and to the observed iron-independent degradation of IRT1. A model, which complies with experimental data places the regulation of cytosolic iron at the transcript level of the transcription factor FIT. Including the experimental observation that FIT induces inhibition of IRT1 turnover we found a significant improvement in the system's response time, suggesting a functional role for the FIT-mediated inhibition of IRT1 degradation. By combining iron uptake with storage and remobilization mechanisms a model is obtained which in a concerted manner integrates iron uptake, storage and remobilization. In agreement with experiments the model does not store iron during its high-affinity uptake. As an iron biofortification approach we discuss the possibility how iron can be accumulated even during high-affinity uptake.	[Agafonov, Oleg; Selsto, Christina Helen; Xu, Xiang Ming; Ruoff, Peter] Univ Stavanger, Ctr Organelle Res, Stavanger, Norway; [Thorsen, Kristian; Drengstig, Tormod] Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway	Universitetet i Stavanger; Universitetet i Stavanger	Ruoff, P (corresponding author), Univ Stavanger, Ctr Organelle Res, Stavanger, Norway.	peter.ruoff@uis.no		Ruoff, Peter/0000-0003-4430-0382	Program Area Fund "Organelle Biology" from the Faculty of Science and Technology, University of Stavanger; Program Area Fund "Biomedical data analysis group" from the Faculty of Science and Technology, University of Stavanger; University of Stavanger	Program Area Fund "Organelle Biology" from the Faculty of Science and Technology, University of Stavanger; Program Area Fund "Biomedical data analysis group" from the Faculty of Science and Technology, University of Stavanger; University of Stavanger	This research was funded by Program Area Fund "Organelle Biology" and the Program Area Fund "Biomedical data analysis group" from the Faculty of Science and Technology, University of Stavanger (https://www.uis.no/fakulteter-institutter-og-sentre/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financed in part by Program Area Funds from the University of Stavanger to TD and PR.	Alon U., 2006, INTRO SYSTEMS BIOL D; Andreev IM, 2008, RUSS J PLANT PHYSL+, V55, P843, DOI 10.1134/S1021443708060150; Ang J, 2013, BIOPHYS J, V104, P505, DOI 10.1016/j.bpj.2012.12.015; Ang J, 2010, J THEOR BIOL, V266, P723, DOI 10.1016/j.jtbi.2010.07.034; [Anonymous], 2010, PLANT PHYSL 5 EDITIO; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Bauer P, 2007, PLANT PHYSIOL BIOCH, V45, P260, DOI 10.1016/j.plaphy.2007.03.006; BECKER R, 1995, PLANT PHYSIOL, V108, P269, DOI 10.1104/pp.108.1.269; Blaby-Haas CE, 2014, J BIOL CHEM, V289, P28129, DOI 10.1074/jbc.R114.592618; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Briat JF, 2010, BBA-GEN SUBJECTS, V1800, P806, DOI 10.1016/j.bbagen.2009.12.003; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Claus J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037193; Cloutier M, 2009, J ROYAL SOC INTERFAC; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Curie C, 2003, ANNU REV PLANT BIOL, V54, P183, DOI 10.1146/annurev.arplant.54.031902.135018; De-Regil L, 2011, INTERMITTENT IRON SU; Drengstig T, 2012, BIOPHYS J, V103, P2000, DOI 10.1016/j.bpj.2012.09.033; Drengstig T, 2012, J PHYS CHEM B, V116, P5355, DOI 10.1021/jp3004568; Duc C, 2009, J BIOL CHEM, V284, P36271, DOI 10.1074/jbc.M109.059873; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Gollhofer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110468; Grossoehme NE, 2006, INORG CHEM, V45, P8500, DOI 10.1021/ic0606431; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4; Huang YS, 2012, PLANT CELL ENVIRON, V35, P917, DOI 10.1111/j.1365-3040.2011.02462.x; Hughes GM, 1964, HOMEOSTASIS FEEDBACK; Ingalls B.P., 2006, SYSTEM MODELING CELL, P243; Jain A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00100; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Jeong J, 2009, TRENDS PLANT SCI, V14, P280, DOI 10.1016/j.tplants.2009.02.006; Jolma IW, 2010, BIOPHYS J, V98, P743, DOI 10.1016/j.bpj.2009.11.013; Katebi, 2002, CONTROL ENG INTRO CO; Kerkeb L, 2008, PLANT PHYSIOL, V146, P1964, DOI 10.1104/pp.107.113282; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Langley L. L., 1973, HOMEOSTASIS ORIGINS; Ling HQ, 1999, P NATL ACAD SCI USA, V96, P7098, DOI 10.1073/pnas.96.12.7098; Lingam S, 2011, PLANT CELL, V23, P1815, DOI 10.1105/tpc.111.084715; Louie AH, 2010, FORESIGHT, V12, P18, DOI 10.1108/14636681011049848; Meiser J, 2011, PLANT PHYSIOL, V157, P2154, DOI 10.1104/pp.111.183285; Moore-Ede MC., 1982, CLOCKS TIME US; MOOREEDE MC, 1986, AM J PHYSIOL, V250, pR737, DOI 10.1152/ajpregu.1986.250.5.R737; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Ni XY, 2009, BIOPHYS J, V97, P1244, DOI 10.1016/j.bpj.2009.06.030; Pich A, 2001, PLANTA, V213, P967, DOI 10.1007/s004250100573; Radhakrishnan K., 1993, NASA REFERENCE PUBLI; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Rellan-Alvarez R, 2008, RAPID COMMUN MASS SP, V22, P1553, DOI 10.1002/rcm.3523; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; Rosen R, 2012, IFSR INT SER SYST SC, V1, P1, DOI 10.1007/978-1-4614-1269-4; Schmidt W, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P229, DOI 10.1007/1-4020-4743-6_11; Schulkin J., 2004, ALLOSTASIS HOMEOSTAS; Shin LJ, 2013, PLANT CELL, V25, P3039, DOI 10.1105/tpc.113.115212; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; Sivitz A, 2011, PLANT J, V66, P1044, DOI 10.1111/j.1365-313X.2011.04565.x; Thomine S, 2013, CURR OPIN PLANT BIOL, V16, P322, DOI 10.1016/j.pbi.2013.01.003; Thorsen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107766; Velikanov GA, 2007, RUSS J PLANT PHYSL+, V54, P683, DOI 10.1134/S1021443707050172; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Vert G, 2009, PLANTA, V229, P1171, DOI 10.1007/s00425-009-0904-8; Vigani G, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00316; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Walker EL, 2008, CURR OPIN PLANT BIOL, V11, P530, DOI 10.1016/j.pbi.2008.06.013; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26	76	4	4	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147120	10.1371/journal.pone.0147120	http://dx.doi.org/10.1371/journal.pone.0147120			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800438	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000368655300061
J	Cahill, CM; Zhu, WS; Oziolor, E; Yang, YJ; Tam, B; Rajanala, S; Rogers, JT; Walker, WA				Cahill, Catherine M.; Zhu, Weishu; Oziolor, Elias; Yang, Yao-Jong; Tam, Bosco; Rajanala, Susruthi; Rogers, Jack T.; Walker, W. Allan			Differential Expression of the Activator Protein 1 Transcription Factor Regulates Interleukin-1 beta Induction of Interleukin 6 in the Developing Enterocyte	PLOS ONE			English	Article							DEVELOPING HUMAN INTESTINE; C-JUN; SIGNAL-TRANSDUCTION; AP-1; IL-6; INJURY; HOMODIMERS; PHENOTYPE; STRESS; LIVER	The innate immune response is characterized by activation of transcription factors, nuclear factor kappa B and activator protein-1 and their downstream targets, the pro-inflammatory cytokines including interleukin 1 beta and interleukin 6. Normal development of this response in the intestine is critical to survival of the human neonate and delays can cause the onset of devastating inflammatory diseases such as necrotizing enterocolitis. Previous studies have addressed the role of nuclear factor kappa B in the development of the innate immune response in the enterocyte, however despite its central role in the control of multiple pro-inflammatory cytokine genes, little is known on the role of Activator Protein 1 in this response in the enterocyte. Here we show that the canonical Activator Protein 1 members, cJun and cFos and their upstream kinases JNK and p38 play an essential role in the regulation of interleukin 6 in the immature enterocyte. Our data supports a model whereby the cFos/cJun heterodimer and the more potent cJun homodimer downstream of JNK are replaced by less efficient JunD containing dimers, contributing to the decreased responsiveness to interleukin 1 beta and decreased interleukin 6 secretion observed in the mature enterocyte. The tissue specific expression of JunB in colonocytes and colon derived tissues together with its ability to repress Interleukin-1 beta induction of an Interleukin-6 gene reporter in the NCM-460 colonocyte suggests that induction of JunB containing dimers may offer an attractive therapeutic strategy for the control of IL-6 secretion during inflammatory episodes in this area of the intestine	[Cahill, Catherine M.; Tam, Bosco; Rajanala, Susruthi; Rogers, Jack T.] Massachusetts Gen Hosp, Dept Psychiat, Neurochem Lab, Charlestown, MA USA; [Cahill, Catherine M.; Zhu, Weishu; Tam, Bosco; Rajanala, Susruthi; Rogers, Jack T.; Walker, W. Allan] Harvard Univ, Sch Med, Charlestown, MA USA; [Zhu, Weishu; Walker, W. Allan] Massachusetts Gen Hosp Children, Dept Pediat, Mucosal Immunol & Biol Res Ctr, Charlestown, MA USA; [Oziolor, Elias] Baylor Univ, Dept Environm Sci, One Bear Pl 97266, Waco, TX 76798 USA; [Yang, Yao-Jong] Natl Cheng Kung Univ, Dept Pediat, Tainan 701, Taiwan; [Yang, Yao-Jong] Natl Cheng Kung Univ, Dept Internal Med, Tainan 701, Taiwan	Harvard University; Massachusetts General Hospital; Harvard University; Baylor University; National Cheng Kung University; National Cheng Kung University	Cahill, CM (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Neurochem Lab, Charlestown, MA USA.	ccahill@helix.mgh.harvard.edu	Oziolor, Elias/P-6961-2016	Oziolor, Elias/0000-0002-4078-1054; Rogers, Jack/0000-0003-1262-8578	National Institute of Child Health and Human Development [R01HD012437Supplement29, R01HD012437]; National Institute of Neurological Disorders and Stroke [NS077079-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077079] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	External Funding was obtained as follows: CMC R01HD012437Supplement29 (National Institute of Child Health and Human Development, https://www.nichd.nih.gov/Pages/index.aspx), WAW R01HD012437 (National Institute of Child Health and Human Development, https://www.nichd.nih.gov/Pages/index.aspx), JTR NS077079-01A1 (National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Chan KYY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036977; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Choo-Wing R, 2007, AM J PHYSIOL-LUNG C, V293, pL142, DOI 10.1152/ajplung.00434.2006; Ding QM, 1998, LIFE SCI, V64, P175, DOI 10.1016/S0024-3205(98)00549-9; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Ganguli K, 2013, AM J PHYSIOL-GASTR L, V304, pG132, DOI 10.1152/ajpgi.00142.2012; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Gomard T, 2010, PLOS ONE, V5, pA178, DOI 10.1371/journal.pone.0009585; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; Hackam DJ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475415; HARRIS MC, 1994, J PEDIATR-US, V124, P105, DOI 10.1016/S0022-3476(94)70264-0; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lu C, 2009, GENE, V433, P56, DOI 10.1016/j.gene.2008.11.015; Luther J, 2011, J CELL SCI, V124, P1465, DOI 10.1242/jcs.079855; Marden JJ, 2008, J BIOL CHEM, V283, P6687, DOI 10.1074/jbc.M705606200; Meng D, 2015, PEDIATR RES, V77, P416, DOI 10.1038/pr.2014.207; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2012, JPEN-PARENTER ENTER, V36, p30S, DOI 10.1177/0148607111422068; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; Pflegerl P, 2009, P NATL ACAD SCI USA, V106, P20423, DOI 10.1073/pnas.0910371106; Rautava S, J PEDIAT GASTROENTER, V54, P630, DOI [10.1097/MPG.0b013e31823e7c29, DOI 10.1097/MPG.0B013E31823E7E29]; Rautava S, 2011, NEONATOLOGY, V99, P192, DOI 10.1159/000314109; SANDERSON IR, 1995, INT ARCH ALLERGY IMM, V107, P396, DOI 10.1159/000237051; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Savidge TC, 2001, PEDIATR RES, V50, P196, DOI 10.1203/00006450-200108000-00006; SAVIDGE TC, 1995, DIFFERENTIATION, V58, P361, DOI 10.1046/j.1432-0436.1995.5850361.x; Smart DE, 2001, J BIOL CHEM, V276, P24414, DOI 10.1074/jbc.M101840200; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; WILKINSON DG, 1989, DEVELOPMENT, V106, P465; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145184	10.1371/journal.pone.0145184	http://dx.doi.org/10.1371/journal.pone.0145184			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799482	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300003
J	Gao, SS; Li, FM; Li, HM; Huang, YB; Liu, Y; Chen, YX				Gao, Shanshan; Li, Fangmin; Li, Huimin; Huang, Yibing; Liu, Yu; Chen, Yuxin			Effects and Molecular Mechanism of GST-Irisin on Lipolysis and Autocrine Function in 3T3-L1 Adipocytes	PLOS ONE			English	Article							ADIPOSE-TISSUE; MYOKINE IRISIN; FAT; METABOLISM; EXPRESSION; OBESITY; GENES; ATGL; HSL	Irisin, which was recently identified as a myokine and an adipokine, transforms white adipose tissue to brown adipose tissue and has increasingly caught the attention of the medical and scientific community. However, the signaling pathway of irisin and the molecular mechanisms responsible for the lipolysis effect remain unclear. In this study, we established an efficient system for the expression and purification of GST-irisin in Escherichia coli. The biological activity of GST-irisin was verified using the cell counting kit-8 assay and by detecting the mRNA expression of uncoupling protein 1. Our data showed that GST-irisin regulates mRNA levels of lipolysis-related genes such as adipose triglyceride lipase and hormone-sensitive lipase and proteins such as the fatty acid-binding protein 4, leading to increased secretion of glycerol and decreased lipid accumulation in 3T3-L1 adipocytes. In addition, exogenous GST-irisin can increase its autocrine function in vitro by regulating the expression of fibronectin type III domain-containing protein 5. GST-irisin could regulate glucose uptake in 3T3-L1 adipocytes. Hence, we believe that recombinant GST-irisin could promote lipolysis and its secretion in vitro and can potentially prevent obesity and related metabolic diseases.	[Gao, Shanshan; Li, Fangmin; Huang, Yibing; Chen, Yuxin] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, 2699 Qianjin St, Changchun 130012, Peoples R China; [Gao, Shanshan; Li, Fangmin; Li, Huimin; Huang, Yibing; Chen, Yuxin] Jilin Univ, Sch Life Sci, Changchun 130012, Peoples R China; [Huang, Yibing; Chen, Yuxin] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China; [Liu, Yu] Jilin Univ, Hosp 2, Dept Endocrinol, Changchun 130041, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University	Chen, YX (corresponding author), Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, 2699 Qianjin St, Changchun 130012, Peoples R China.; Chen, YX (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130012, Peoples R China.; Chen, YX (corresponding author), Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China.; Liu, Y (corresponding author), Jilin Univ, Hosp 2, Dept Endocrinol, Changchun 130041, Peoples R China.	drliuyu@jlu.edu.cn; chen_yuxin@jlu.edu.cn	Huang, Yibing/M-9462-2018	Huang, Yibing/0000-0002-2655-535X	National Natural Science Foundation of China [81373445, 21442001, 30971398, 81170746]; Natural Science Foundation of Jilin Province [20150101189JC, 20140101042JC]; Norman Bethune Program of Jilin University [2012214]; Science and Technology Development Program of Jilin Province [20140101183JC, 20150519013JH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province; Norman Bethune Program of Jilin University; Science and Technology Development Program of Jilin Province	This work was supported by the National Natural Science Foundation of China (no. 81373445, YXC, no. 21442001, YBH, no. 30971398, YL, and no. 81170746, YL), the Natural Science Foundation of Jilin Province (no. 20150101189JC, YXC and no. 20140101042JC, YBH), Norman Bethune Program of Jilin University (no. 2012214, YL), and Science and Technology Development Program of Jilin Province (no. 20140101183JC, YL and no. 20150519013JH, YL).	Aguirre L, 2014, MOLECULES, V19, P18632, DOI 10.3390/molecules191118632; Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Arbabi-Ghahroudi M, 2005, CANCER METAST REV, V24, P501, DOI 10.1007/s10555-005-6193-1; Bag S, 2015, J THEOR BIOL, V364, P344, DOI 10.1016/j.jtbi.2014.09.034; Birsoy K, 2008, P NATL ACAD SCI USA, V105, P12985, DOI 10.1073/pnas.0805621105; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Busiello RA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00036; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Catalan V, 2012, HISTOL HISTOPATHOL, V27, P1515, DOI 10.14670/HH-27.1515; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; Furuhashi M, 2014, CLIN MED INSIGHTS-CA, V8, P23, DOI 10.4137/CMC.S17067; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Gannon NP, 2015, INT J CANCER, V136, pE197, DOI 10.1002/ijc.29142; Hofmann T, 2014, PEPTIDES, V54, P89, DOI 10.1016/j.peptides.2014.01.016; Huh JY, 2014, INT J OBESITY, V38, P1538, DOI 10.1038/ijo.2014.42; Langfort J, 2010, BIOCHEM BIOPH RES CO, V399, P670, DOI 10.1016/j.bbrc.2010.07.140; Lo KA, 2013, BIOSCIENCE REP, V33, P711, DOI 10.1042/BSR20130046; Mahajan RD, 2013, INDIAN J CLIN BIOCHE, V28, P102, DOI 10.1007/s12291-012-0255-2; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Morak M, 2012, MOL CELL PROTEOMICS, V11, P1777, DOI 10.1074/mcp.M111.015743; Poher AL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00004; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Rodriguez A, 2015, INT J OBESITY, V39, P397, DOI 10.1038/ijo.2014.166; Sanchis-Gomar F, 2012, J DIABETES, V4, P196, DOI 10.1111/j.1753-0407.2012.00194.x; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Song HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110273; Unger RE, 2014, BIOMATERIALS, V35, P3180, DOI 10.1016/j.biomaterials.2013.12.059; Vaughan RA, 2014, DIABETES OBES METAB, V16, P711, DOI 10.1111/dom.12268; Villarroya F, 2012, CELL METAB, V15, P277, DOI 10.1016/j.cmet.2012.02.010; Wang C, 2015, ENDOCRINE, V49, P90, DOI 10.1007/s12020-014-0458-9; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Zhang HJ, 2013, J HEPATOL, V59, P557, DOI 10.1016/j.jhep.2013.04.030; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zhang YY, 2014, J BIOL CHEM, V289, P22063, DOI 10.1074/jbc.M114.559104; Zhao XY, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/581093; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	38	28	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147480	10.1371/journal.pone.0147480	http://dx.doi.org/10.1371/journal.pone.0147480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799325	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300113
J	Pereira, AL; Malcher, SM; Nagamachi, CY; O'Brien, PCM; Ferguson-Smith, MA; Mendes-Oliveira, AC; Pieczarka, JC				Pereira, Adenilson Leao; Malcher, Stella Miranda; Nagamachi, Cleusa Yoshiko; Mary O'Brien, Patricia Caroline; Ferguson-Smith, Malcolm Andrew; Mendes-Oliveira, Ana Cristina; Pieczarka, Julio Cesar			Extensive Chromosomal Reorganization in the Evolution of New World Muroid Rodents (Cricetidae, Sigmodontinae): Searching for Ancestral Phylogenetic Traits	PLOS ONE			English	Article							ARVICOLINAE CRICETIDAE; WHOLE CHROMOSOME; LABORATORY MOUSE; GENOME HOMOLOGY; MUS-MUSCULUS; FIELD VOLE; MURIDAE; FISH; RAT; KARYOTYPE	Sigmodontinae rodents show great diversity and complexity in morphology and ecology. This diversity is accompanied by extensive chromosome variation challenging attempts to reconstruct their ancestral genome. The species Hylaeamys megacephalus-HME (Oryzomyini, 2n = 54), Necromys lasiurus-NLA (Akodontini, 2n = 34) and Akodon sp.-ASP (Akodontini, 2n = 10) have extreme diploid numbers that make it difficult to understand the rearrangements that are responsible for such differences. In this study we analyzed these changes using whole chromosome probes of HME in cross-species painting of NLA and ASP to construct chromosome homology maps that reveal the rearrangements between species. We include data from the literature for other Sigmodontinae previously studied with probes from HME and Mus musculus (MMU) probes. We also use the HME probes on MMU chromosomes for the comparative analysis of NLA with other species already mapped by MMU probes. Our results show that NLA and ASP have highly rearranged karyotypes when compared to HME. Eleven HME syntenic blocks are shared among the species studied here. Four syntenies may be ancestral to Akodontini (HME2/18, 3/25, 18/25 and 4/11/16) and eight to Sigmodontinae (HME26, 1/12, 6/21, 7/9, 5/17, 11/16, 20/13 and 19/14/19). Using MMU data we identified six associations shared among rodents from seven subfamilies, where MMU3/18 and MMU8/13 are phylogenetic signatures of Sigmodontinae. We suggest that the associations MMU2entire, MMU6proximal/12entire, MMU3/18, MMU8/13, MMU1/17, MMU10/17, MMU12/17, MMU5/16, MMU5/6 and MMU7/19 are part of the ancestral Sigmodontinae genome.	[Pereira, Adenilson Leao; Malcher, Stella Miranda; Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] Fed Univ Para, ICB, Ctr Estudos Avancados Biodiversidade, Lab Citogenet, BR-66059 Belem, Para, Brazil; [Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] CNPq, Brasilia, DF, Brazil; [Mary O'Brien, Patricia Caroline; Ferguson-Smith, Malcolm Andrew] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Mendes-Oliveira, Ana Cristina] Fed Univ Para, ICB, Lab Zool & Ecol Vertebrados, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; University of Cambridge; Universidade Federal do Para	Pieczarka, JC (corresponding author), Fed Univ Para, ICB, Ctr Estudos Avancados Biodiversidade, Lab Citogenet, BR-66059 Belem, Para, Brazil.; Pieczarka, JC (corresponding author), CNPq, Brasilia, DF, Brazil.	juliopieczarka@gmail.com	Pereira, Adenilson Leão/C-9820-2018; Pieczarka, Julio C/E-7585-2016; de Oliveira, Ana Cristina Mendes/I-2680-2012; Nagamachi, Cleusa/AAV-8985-2021	Pereira, Adenilson Leão/0000-0003-2687-5297; Pieczarka, Julio C/0000-0003-2951-8877; Nagamachi, Cleusa Yoshiko/0000-0003-1516-2734; Mendes Oliveira, Ana Cristina/0000-0002-7863-9678	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [552032/2010-7]; Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA) [2010/110447]; Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA); CAPES Doctor Scholarship inNeuroscience and Cell Biology; CAPES Doctor Scholarship in Genetics and Molecular Biology	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES Doctor Scholarship inNeuroscience and Cell Biology(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES Doctor Scholarship in Genetics and Molecular Biology(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Proc 552032/2010-7, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://www.cnpq.br; ICAAF 007/2011); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA) (http://www.fapespa.pa.gov.br); Proc 2010/110447, Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA) (http://www.fapespa.pa.gov.br). S. M. Malcher is the recipient of a CAPES Doctor Scholarship inNeuroscience and Cell Biology, and A. L. Pereira is the recipient of a CAPES Doctor Scholarship in Genetics and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros MC, 2009, IHERINGIA SER ZOOL, V99, P373, DOI 10.1590/S0073-47212009000400006; Basheva EA, 2014, CHROMOSOME RES, V22, P351, DOI 10.1007/s10577-014-9429-5; Cavagna P, 2002, MAMM GENOME, V13, P157, DOI [10.1007/BF02684021, 10.1007/s0033501-1020-7]; Chaves R, 2012, CHROMOSOME RES, V20, P673, DOI 10.1007/s10577-012-9304-1; Cursino MS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-40; D'Elía Guillermo, 2007, Gayana (Concepc.), V71, P187; de Silva MJ, 1998, CYTOGENET CELL GENET, V81, P46; DELIA G, 2015, MAMMALS S AM, V2, P63; Di-Nizo CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117579; EISENBERG JF, 1999, MAMMALS NEOTROPICS, V3, P527; Engelbrecht A, 2006, CYTOGENET GENOME RES, V112, P126, DOI 10.1159/000087524; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; FORD CE, 1956, STAIN TECHNOL, V31, P247, DOI 10.3109/10520295609113814; Graphodatsky AS, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-22; Guilly MN, 1999, CHROMOSOME RES, V7, P213, DOI 10.1023/A:1009251416856; Hass I, 2011, CYTOGENET GENOME RES, V135, P42, DOI 10.1159/000330259; Hass I, 2008, CHROMOSOME RES, V16, P75, DOI 10.1007/s10577-007-1211-5; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; King M., 1995, SPECIES EVOLUTION RO; Leite RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100687; Lessa EP, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00039; Matsubara K, 2004, CHROMOSOME RES, V12, P383, DOI 10.1023/B:CHRO.0000034103.05528.83; Matsubara K, 2003, CHROMOSOME RES, V11, P57, DOI 10.1023/A:1022010116287; Mlynarski EE, 2010, MAMM GENOME, V21, P77, DOI 10.1007/s00335-009-9242-1; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nagamachi CY, 2013, CHROMOSOME RES, V21, P107, DOI 10.1007/s10577-013-9341-4; Nakamura T, 2007, CHROMOSOME RES, V15, P1023, DOI 10.1007/s10577-007-1177-3; Nakamura T, 2007, CHROMOSOME RES, V15, P799, DOI 10.1007/s10577-007-1163-9; Parada A, 2013, MOL PHYLOGENET EVOL, V66, P960, DOI 10.1016/j.ympev.2012.12.001; Pardiñas Ulyses F. J, 2015, Mastozool. neotrop., V22, P171; Percequillo AR, 2011, ZOOL J LINN SOC-LOND, V161, P357, DOI 10.1111/j.1096-3642.2010.00643.x; Percequillo AR, 2005, J MAMMAL, V86, P873, DOI 10.1644/1545-1542(2005)86[873:ANSONI]2.0.CO;2; Rambau RV, 2003, CHROMOSOME RES, V11, P91, DOI 10.1023/A:1022887629707; Robinson TJ, 2008, P NATL ACAD SCI USA, V105, P14477, DOI 10.1073/pnas.0807433105; Romanenko SA, 2012, HEREDITY, V108, P4, DOI 10.1038/hdy.2011.110; Romanenko SA, 2007, CHROMOSOME RES, V15, P891, DOI 10.1007/s10577-007-1171-9; Romanenko SA, 2007, CHROMOSOME RES, V15, P283, DOI 10.1007/s10577-007-1124-3; Romanenko SA, 2006, MAMM GENOME, V17, P1183, DOI 10.1007/s00335-006-0081-z; SCHMID M, 1988, CYTOGENET CELL GENET, V49, P305, DOI 10.1159/000132683; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sitnikova NA, 2007, CHROMOSOME RES, V15, P447, DOI 10.1007/s10577-007-1137-y; Stanyon R, 1999, CYTOGENET CELL GENET, V84, P150, DOI 10.1159/000015244; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Suarez P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143482; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Swier VJ, 2009, CYTOGENET GENOME RES, V125, P54, DOI 10.1159/000218747; Ventura K, 2009, CHROMOSOME RES, V17, P1063, DOI 10.1007/s10577-009-9083-5; Verma RS., 1995, HUMAN CHROMOSOMES PR, V2; Veyrunes F, 2006, P ROY SOC B-BIOL SCI, V273, P2925, DOI 10.1098/rspb.2006.3670; Vieira-da-Silva A, 2015, CYTOGENET GENOME RES, V145, P59, DOI 10.1159/000381840; Weksler M, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3537[1:TNGOOR]2.0.CO;2; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Yang F, 2000, CHROMOSOME RES, V8, P219, DOI 10.1023/A:1009200912436	53	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146179	10.1371/journal.pone.0146179	http://dx.doi.org/10.1371/journal.pone.0146179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800516	Green Published, gold, Green Submitted			2022-12-26	WOS:000368655300014
J	Biju, SD; Senevirathne, G; Garg, S; Mahony, S; Kamei, RG; Thomas, A; Shouche, Y; Raxworthy, CJ; Meegaskumbura, M; Van Bocxlaer, I				Biju, S. D.; Senevirathne, Gayani; Garg, Sonali; Mahony, Stephen; Kamei, Rachunliu G.; Thomas, Ashish; Shouche, Yogesh; Raxworthy, Christopher J.; Meegaskumbura, Madhava; Van Bocxlaer, Ines			Frankixalus, a New Rhacophorid Genus of Tree Hole Breeding Frogs with Oophagous Tadpoles	PLOS ONE			English	Article							CHIRIXALUS-EIFFINGERI-RHACOPHORIDAE; VAMPYRUS ANURA RHACOPHORIDAE; WESTERN-GHATS; REPRODUCTIVE MODES; ACRIS-CREPITANS; SYSTEMATICS; PHYLOGENY; EVOLUTION; AMPHIBIA; FAMILY	Despite renewed interest in the biogeography and evolutionary history of Old World tree frogs (Rhacophoridae), this family still includes enigmatic frogs with ambiguous phylogenetic placement. During fieldwork in four northeastern states of India, we discovered several populations of tree hole breeding frogs with oophagous tadpoles. We used molecular data, consisting of two nuclear and three mitochondrial gene fragments for all known rhacophorid genera, to investigate the phylogenetic position of these new frogs. Our analyses identify a previously overlooked, yet distinct evolutionary lineage of frogs that warrants recognition as a new genus and is here described as Frankixalus gen. nov. This genus, which contains the enigmatic 'Polypedates' jerdonii described by Gunther in 1876, forms the sister group of a clade containing Kurixalus, Pseudophilautus, Raorchestes, Mercurana and Beddomixalus. The distinctiveness of this evolutionary lineage is also corroborated by the external morphology of adults and tadpoles, adult osteology, breeding ecology, and life history features.	[Biju, S. D.; Garg, Sonali; Mahony, Stephen; Kamei, Rachunliu G.; Thomas, Ashish] Univ Delhi, Systemat Lab, Dept Environm Studies, Delhi 110007, India; [Senevirathne, Gayani; Meegaskumbura, Madhava] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka; [Mahony, Stephen] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland; [Kamei, Rachunliu G.] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England; [Thomas, Ashish] Univ Delhi, Hindu Coll, Dept Environm Studies, Delhi 110007, India; [Shouche, Yogesh] Natl Ctr Cell Sci, Microbial Culture Collect, NCCS Complex,Pune Univ Campus, Pune 411007, Maharashtra, India; [Raxworthy, Christopher J.] Amer Museum Nat Hist, Herpetol Dept, Cent Pk West & 79th St, New York, NY 10024 USA; [Van Bocxlaer, Ines] VUB, Amphibian Evolut Lab, Dept Biol, Pl Laan 2, B-1050 Brussels, Belgium	University of Delhi; University of Peradeniya; University College Dublin; Natural History Museum London; University of Delhi; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); American Museum of Natural History (AMNH); Vrije Universiteit Brussel	Biju, SD (corresponding author), Univ Delhi, Systemat Lab, Dept Environm Studies, Delhi 110007, India.; Meegaskumbura, M (corresponding author), Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka.; Van Bocxlaer, I (corresponding author), VUB, Amphibian Evolut Lab, Dept Biol, Pl Laan 2, B-1050 Brussels, Belgium.	sdbiju@es.du.ac.in; madhava88m@gmail.com; ivbocxla@vub.ac.be	Senevirathne, Gayani/ABD-5713-2021; Van Bocxlaer, Ines/L-4852-2015; Meegaskumbura, Madhava/F-8782-2013; Mahony, Stephen/N-9061-2015	Meegaskumbura, Madhava/0000-0002-4599-6724; Mahony, Stephen/0000-0002-8263-6832; Senevirathne, Gayani/0000-0001-6704-9691; Kamei, Rachunliu/0000-0003-3054-9785; THOMAS, ASHISH/0000-0002-0189-7580	DU/DST Purse Grant, Department of Science and Technology, Ministry of Science and Technology, Government of India [2009/868]; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR7833/NDB/51/153/2006]; University of Delhi Research and Development [2007/130, 2007/858, 2008/302, 2014/110]; FWO-Vlaanderen; National Research Council of Sri Lanka [NRC 11-124]; Council for Scientific and Industrial Research, India (CSIR) [9/45(1381)/2015-EMR-I]; Marie Sklodowska-Curie Fellowship [PIIF-GA-2013-625870]	DU/DST Purse Grant, Department of Science and Technology, Ministry of Science and Technology, Government of India; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); University of Delhi Research and Development; FWO-Vlaanderen(FWO); National Research Council of Sri Lanka; Council for Scientific and Industrial Research, India (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Marie Sklodowska-Curie Fellowship	This study was supported by the following grants to SDB: DU/DST Purse Grant '2009/868', Department of Science and Technology, Ministry of Science and Technology, Government of India; 'BT/PR7833/NDB/51/153/2006', Department of Biotechnology, Ministry of Science and Technology, Government of India; University of Delhi Research and Development Grants '2007/130', '2007/858', '2008/302', '2014/110'. IVB is supported by a post-doctoral fellowship from FWO-Vlaanderen. MM is supported by the National Research Council of Sri Lanka (# NRC 11-124); SG is supported by a research fellowship from the Council for Scientific and Industrial Research, India (CSIR No. 9/45(1381)/2015-EMR-I); RGK is supported by Marie Sklodowska-Curie Fellowship (PIIF-GA-2013-625870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RK, 2013, ZOOTAXA, V3640, P177, DOI 10.11646/zootaxa.3640.2.3; Ahl E., 1931, TIERREICH, V55; AmphibiaWeb, 2015, INF AMPH BIOL CONS W; [Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Biju SD, 2014, CONTRIB ZOOL, V83, P269, DOI 10.1163/18759866-08304004; Biju SD, 2010, CURR SCI INDIA, V98, P1119; Biju SD, 2009, ZOOL J LINN SOC-LOND, V155, P374, DOI 10.1111/j.1096-3642.2008.00466.x; Biju SD, 2008, ORG DIVERS EVOL, V8, P267, DOI 10.1016/j.ode.2007.11.004; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bossuyt F., 2001, ZEYLANICA, V6, P1; Boulenger GA, 1882, CATALOGUE BATRACHIA; Bowatte Gayan, 2011, Ceylon Journal of Science Biological Sciences, V40, P109; Chen YH, 2001, HERPETOLOGICA, V57, P438; Chiu CT, 2006, BEHAVIOUR, V143, P123, DOI 10.1163/156853906775133605; Das Indraneil, 1998, Hamadryad, V23, P63; Delorme Magali, 2005, Bulletin Mensuel de la Societe Linneenne de Lyon, V74, P165; Dubois A., 1987, ALYTES, V5, P7; Duellman W., 1986, BIOL AMPHIBIANS; Dutta S.K., 1997, AMPHIBIANS INDIA SRI; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gomez-Mestre I, 2012, EVOLUTION, V66, P3687, DOI 10.1111/j.1558-5646.2012.01715.x; Gosner K. L., 1960, Herpetologica, V16, P183; Grosjean S, 2008, J ZOOL SYST EVOL RES, V46, P169, DOI 10.1111/j.1439-0469.2007.00451.x; GUNTHER A., 1876, P ZOOLOGICAL SOC LON, V1875, P567; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Hertwig ST, 2012, ZOOL SCR, V41, P29, DOI 10.1111/j.1463-6409.2011.00499.x; Kam YC, 1996, J HERPETOL, V30, P52, DOI 10.2307/1564706; Kamei RG, 2013, ZOOTAXA, V3666, P401, DOI 10.11646/zootaxa.3666.4.1; Kamei RG, 2012, P ROY SOC B-BIOL SCI, V279, P2396, DOI 10.1098/rspb.2012.0150; KURAMOTO M, 1987, COPEIA, P931; Li JT, 2008, MOL PHYLOGENET EVOL, V48, P302, DOI 10.1016/j.ympev.2008.03.023; Li JT, 2013, P NATL ACAD SCI USA, V110, P3441, DOI 10.1073/pnas.1300881110; Li JT, 2012, ZOOL SCR, V41, P557, DOI 10.1111/j.1463-6409.2012.00557.x; Li JT, 2009, MOL PHYLOGENET EVOL, V53, P509, DOI 10.1016/j.ympev.2009.06.023; LIEM S S, 1970, Fieldiana Zoology, V57, P1; Maddison D. R., 2000, MACCLADE ANAL PHYLOG; Maglia AM, 2007, J MORPHOL, V268, P194, DOI 10.1002/jmor.10508; Matsui M, 2004, ZOOL SCI, V21, P671, DOI 10.2108/zsj.21.671; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; Meegaskumbura M, 2015, ZOOL SCR, V44, P509, DOI 10.1111/zsc.12121; Meegaskumbura Madhava, 2010, Ceylon Journal of Science Biological Sciences, V39, P75; Miller M.A., 2010, P GAT COMP ENV WORKS; Mittermeier Russell A., 2004, P1; MYERS C W, 1982, American Museum Novitates, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pugener LA, 2009, J MORPHOL, V270, P52, DOI 10.1002/jmor.10665; Richards CM, 1996, MOL PHYLOGENET EVOL, V5, P522, DOI 10.1006/mpev.1996.0047; Rowley JJL, 2012, J NAT HIST, V46, P2969, DOI 10.1080/00222933.2012.732622; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarkar A, 2006, STATE FAUNA SERIES 1, V13, P285; Savage J. M., 1967, BEITR NEOTROP FAUNA, V5, P111, DOI DOI 10.1080/01650526709360400; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Nguyen TT, 2015, MOL PHYLOGENET EVOL, V85, P59, DOI 10.1016/j.ympev.2015.02.003; Tao Thien Nguyen, 2014, Current Herpetology, V33, P101, DOI 10.5358/hsj.33.101; TAYLOR EDWARD H., 1962, UNIV KANSAS SCI BULL, V43, P265; TAYLOR W R, 1985, Cybium, V9, P107; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trueb L., 1973, P65; Vassilieva AB, 2013, J HERPETOL, V47, P607, DOI 10.1670/12-180; Vijayakumar SP, 2014, ZOOTAXA, V3893, P451, DOI 10.11646/zootaxa.3893.4.1; WASSERSUG RJ, 1981, J HERPETOL, V15, P41, DOI 10.2307/1563645; Wells KD., 2007, ECOLOGY BEHAV AMPHIB; Wolf S., 1936, Bulletin of the Raffles Museum Singapore, V12, P137; Yu GH, 2013, BIOCHEM SYST ECOL, V47, P31, DOI 10.1016/j.bse.2012.09.023; Yu GH, 2010, MOL PHYLOGENET EVOL, V56, P942, DOI 10.1016/j.ympev.2010.05.008	69	35	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145727	10.1371/journal.pone.0145727	http://dx.doi.org/10.1371/journal.pone.0145727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790105	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100016
J	Liu, SC; Jin, JQ; Ma, JQ; Yao, MZ; Ma, CL; Li, CF; Ding, ZT; Chen, L				Liu, Sheng-Chuan; Jin, Ji-Qiang; Ma, Jian-Qiang; Yao, Ming-Zhe; Ma, Chun-Lei; Li, Chun-Fang; Ding, Zhao-Tang; Chen, Liang			Transcriptomic Analysis of Tea Plant Responding to Drought Stress and Recovery	PLOS ONE			English	Article							GENE-EXPRESSION; SALICYLIC-ACID; DEHYDRATION; ACTIVATION; TOLERANCE; RESPONSES	Tea plant (Camellia sinensis) is an economically important beverage crop. Drought stress (DS) seriously limits the growth and development of tea plant, thus affecting crop yield and quality. To elucidate the molecular mechanisms of tea plant responding to DS, we performed transcriptomic analysis of tea plant during the three stages [control (CK) and during DS, and recovery (RC) after DS] using RNA sequencing (RNA-Seq). Totally 378.08 million high-quality trimmed reads were obtained and assembled into 59,674 unigenes, which were extensively annotated. There were 5,955 differentially expressed genes (DEGs) among the three stages. Among them, 3,948 and 1,673 DEGs were up-regulated under DS and RC, respectively. RNA-Seq data were further confirmed by qRT-PCR analysis. Genes involved in abscisic acid (ABA), ethylene, and jasmonic acid biosynthesis and signaling were generally up-regulated under DS and down-regulated during RC. Tea plant potentially used an exchange pathway for biosynthesis of indole-3-acetic acid (IAA) and salicylic acid under DS. IAA signaling was possibly decreased under DS but increased after RC. Genes encoding enzymes involved in cytokinin synthesis were up-regulated under DS, but down-regulated during RC. It seemed probable that cytokinin signaling was slightly enhanced under DS. In total, 762 and 950 protein kinases belonging to 26 families were differentially expressed during DS and RC, respectively. Overall, 547 and 604 transcription factor (TF) genes belonging to 58 families were induced in the DS vs. CK and RC vs. DS libraries, respectively. Most members of the 12 TF families were up-regulated under DS. Under DS, genes related to starch synthesis were down-regulated, while those related to starch decomposition were up-regulated. Mannitol, trehalose and sucrose synthesis-related genes were up-regulated under DS. Proline was probably mainly biosynthesized from glutamate under DS and RC. The mechanism by which ABA regulated stomatal movement under DS and RC was partly clarified. These results document the global and novel responses of tea plant during DS and RC. These data will serve as a valuable resource for drought-tolerance research and will be useful for breeding drought-resistant tea cultivars.	[Liu, Sheng-Chuan; Jin, Ji-Qiang; Ma, Jian-Qiang; Yao, Ming-Zhe; Ma, Chun-Lei; Li, Chun-Fang; Chen, Liang] Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Plant Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China; [Liu, Sheng-Chuan] Guizhou Tea Res Inst, Guiyang, Guizhou, Peoples R China; [Ding, Zhao-Tang] Qingdao Agr Univ, Tea Res Inst, Qingdao, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Guizhou Academy of Agricultural Sciences; Qingdao Agricultural University	Chen, L (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Plant Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China.	liangchen@tricaas.com	Chen, Liang/R-4438-2019; MINGZHE, YAO/AAH-7748-2021	Chen, Liang/0000-0002-7507-3947; 	Earmarked Fund for China Agriculture Research System [CARS-023]; Chinese Academy of Agricultural Sciences through the Agricultural Science and Technology Innovation Program [CAAS-ASTIP-2014-TRICAAS]; National Natural Science Foundation of China [31170624, 31100504, 31400581]; Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province [2012C12905]	Earmarked Fund for China Agriculture Research System; Chinese Academy of Agricultural Sciences through the Agricultural Science and Technology Innovation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province	This work was supported by the Earmarked Fund for China Agriculture Research System (CARS-023), the Chinese Academy of Agricultural Sciences through the Agricultural Science and Technology Innovation Program (CAAS-ASTIP-2014-TRICAAS) to LC, the National Natural Science Foundation of China (nos. 31170624, 31100504 and 31400581) and the Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province (2012C12905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Chen LM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-687; Cheruiyot EK, 2010, J PLANT NUTR, V33, P115, DOI 10.1080/01904160903392659; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Das A, 2015, J ENVIRON BIOL, V36, P875; Das A, 2012, PLANT MOL BIOL REP, V30, P1088, DOI 10.1007/s11105-012-0422-x; Daszkowska-Golec A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00138; Djilianov DL, 2013, J PLANT GROWTH REGUL, V32, P564, DOI 10.1007/s00344-013-9323-y; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farre G, 2014, ANNU REV PLANT BIOL, V65, P187, DOI 10.1146/annurev-arplant-050213-035825; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Gao F, 2015, PLOS ONE, V4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Granot D, 2014, J EXP BOT, V65, P809, DOI 10.1093/jxb/ert400; Gupta S, 2013, MOL BIOTECHNOL, V53, P237, DOI 10.1007/s12033-012-9517-8; Gupta S, 2012, FUNCT INTEGR GENOMIC, V12, P543, DOI 10.1007/s10142-012-0277-0; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iyer NJ, 2013, PLANT CELL ENVIRON, V36, P706, DOI 10.1111/pce.12008; Jimenez S, 2013, TREE PHYSIOL, V33, P1061, DOI 10.1093/treephys/tpt074; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Johnson SM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-456; Kang NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079248; Kang Y, 2013, PLANT CELL ENVIRON, V36, P706; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Klein T, 2014, TREE PHYSIOL, V34, P981, DOI 10.1093/treephys/tpu071; Komatsu K, 2013, NATURE, V4, P3219, DOI DOI 10.1038/NC0M; Kumar D, 2014, PLANT SCI, V228, P127, DOI 10.1016/j.plantsci.2014.04.014; Kumar V, 2013, TRANSGENIC RES, V22, P359, DOI 10.1007/s11248-012-9652-9; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Li M. R., 2013, ELECT J DIFFERENTIAL, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0059582; Li YG, 2012, PLANT SCI, V188, P10, DOI 10.1016/j.plantsci.2012.02.005; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Liu JY, 2014, PLOS ONE, V5; Liu SC, 2015, SCI HORTIC-AMSTERDAM, V184, P129, DOI 10.1016/j.scienta.2014.12.036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma HS, 2010, J EXP BOT, V61, P4011, DOI 10.1093/jxb/erq217; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahouachi J, 2007, PLANT GROWTH REGUL, V53, P43, DOI 10.1007/s10725-007-9202-2; Malnoy M, 2007, MOL PLANT MICROBE IN, V20, P1568, DOI 10.1094/MPMI-20-12-1568; Manavella PA, 2006, PLANT J, V48, P125, DOI 10.1111/j.1365-313X.2006.02865.x; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Maritim TK, 2015, J HORTIC SCI BIOTECH, V90, P395, DOI 10.1080/14620316.2015.11513200; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Pareek A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song SS, 2014, CURR OPIN PLANT BIOL, V21, P112, DOI 10.1016/j.pbi.2014.07.005; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Wan LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025216; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weijers D, 2009, CELL, V136, P1172, DOI 10.1016/j.cell.2009.03.009; Wu J, 2014, PLOS ONE, V10; Xia ST, 2013, PLANT PHYSIOL, V162, P1694, DOI 10.1104/pp.113.214551; Yang YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087283; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang YW, 2014, NEUROSCI LETT, V562, P1, DOI 10.1016/j.neulet.2014.01.006	69	149	158	18	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147306	10.1371/journal.pone.0147306	http://dx.doi.org/10.1371/journal.pone.0147306			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788738	Green Published, gold, Green Submitted			2022-12-26	WOS:000368529100074
J	Teixeira, C; Barbault, F; Couesnon, T; Gomes, JRB; Gomes, P; Maurel, F				Teixeira, Catia; Barbault, Florent; Couesnon, Thierry; Gomes, Jose R. B.; Gomes, Paula; Maurel, Francois			Striking HIV-1 Entry by Targeting HIV-1 gp41. But, Where Should We Target?	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; CONFORMATIONAL TRANSITION; ENVELOPE GLYCOPROTEIN; ATOMIC-STRUCTURE; SIMULATION; PROTEIN; FUSION; STATE; CORE	HIV-1 gp41 facilitates the viral fusion through a conformational switch involving the association of three C-terminal helices along the conserved hydrophobic grooves of three N-terminal helices coiled-coil. The control of these structural rearrangements is thought to be central to HIV-1 entry and, therefore, different strategies of intervention are being developed. Herewith, we describe a procedure to simulate the folding of an HIV-1 gp41 simplified model. This procedure is based on the construction of plausible conformational pathways, which describe protein transition between non-fusogenic and fusogenic conformations. The calculation of the paths started with 100 molecular dynamics simulations of the non-fusogenic conformation, which were found to converge to different intermediate states. Those presenting defined criteria were selected for separate targeted molecular dynamics simulations, subjected to a force constant imposing a movement towards the gp41 fusogenic conformation. Despite significant diversity, a preferred sequence of events emerged when the simulations were analyzed in terms of the formation, breakage and evolution of the contacts. We pointed out 29 residues as the most relevant for the movement of gp41; also, 2696 possible interactions were reduced to only 48 major interactions, which reveals the efficiency of the method. The analysis of the evolution of the main interactions lead to the detection of four main behaviors for those contacts: stable, increasing, decreasing and repulsive interactions. Altogether, these results suggest a specific small cavity of the HIV-1 gp41 hydrophobic groove as the preferred target to small molecules.	[Teixeira, Catia; Barbault, Florent; Couesnon, Thierry; Maurel, Francois] Univ Paris 07, Lab Interfaces Traitements Org & Dynam Syst ITODY, CNRS, UMR 7086, 15 Rue Jean Antoine Baif, F-75205 Paris 13, France; [Teixeira, Catia; Gomes, Paula] Univ Aveiro, Dept Quim, CICECO, Inst Mat Aveiro, Campus Univ Santiago, P-3810193 Aveiro, Portugal; [Teixeira, Catia; Gomes, Paula] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, UCIBIO,REQUIMTE, Rua Campo Alegre 687, P-4169007 Oporto, Portugal	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universidade de Aveiro; Universidade do Porto	Teixeira, C (corresponding author), Univ Paris 07, Lab Interfaces Traitements Org & Dynam Syst ITODY, CNRS, UMR 7086, 15 Rue Jean Antoine Baif, F-75205 Paris 13, France.; Teixeira, C (corresponding author), Univ Aveiro, Dept Quim, CICECO, Inst Mat Aveiro, Campus Univ Santiago, P-3810193 Aveiro, Portugal.; Teixeira, C (corresponding author), Univ Porto, Fac Ciencias, Dept Quim & Bioquim, UCIBIO,REQUIMTE, Rua Campo Alegre 687, P-4169007 Oporto, Portugal.	ca.teixeira@ua.pt	Barbault, Florent/F-6779-2010; Teixeira, Cátia/AEG-3309-2022; Teixeira, Cátia AS/B-5680-2011; Barbault, Florent/X-8525-2019; Gomes, José R. B./D-5442-2009; Gomes, Paula A. C./C-6698-2008	Teixeira, Cátia/0000-0001-9506-3781; Teixeira, Cátia AS/0000-0001-9506-3781; Barbault, Florent/0000-0002-6082-3194; Gomes, José R. B./0000-0001-5993-1385; Gomes, Paula A. C./0000-0002-6018-4724	FCT/MEC [POCI-01-0145-FEDER-007679, UID/CTM/50011/2013, UID/MULTI/04378/2013]; FEDER [FCOMP-01-0124-FEDER-041066]; Portuguese National Funds through FCT/MEC [EXPL/QEQ-COM/0927/2013]; FCT [SFRH/BPD/62967/2009]; European Union [SFRH/BPD/62967/2009]	FCT/MEC; FEDER(European Commission); Portuguese National Funds through FCT/MEC; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union(European Commission)	This work was developed within the scope of the projects CICECO-Aveiro Institute of Materials, POCI-01-0145-FEDER-007679 (FCT Ref. UID/CTM/50011/2013), and UCIBIO-Research Unit on Applied Molecular Biosciences, (FCT Ref. UID/MULTI/04378/2013), financed by national funds through the FCT/MEC and when appropriate co-financed by FEDER under the PT2020 Partnership Agreement. This research work was mainly supported by FEDER funds through "Programa Operacional Factores de Competitividade" - COMPETE (ref FCOMP-01-0124-FEDER-041066 and PT2020 Partnership Agreement) and by Portuguese National Funds through FCT/MEC (ref EXPL/QEQ-COM/0927/2013). CT and JRBG thank the FCT for the post-doctoral grant (SFRH/BPD/62967/2009) and the "Investigador FCT" program, respectively. SFRH/BPD/62967/2009 is part of the European & Developing Countries Clinical Trials Partnership (EDCTP2) program supported by the European Union.; .	[Anonymous], SYBYL 7 3; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Elber R, 2005, CURR OPIN STRUC BIOL, V15, P151, DOI 10.1016/j.sbi.2005.02.004; Ferrara P, 2000, PROTEINS, V39, P252, DOI 10.1002/(SICI)1097-0134(20000515)39:3<252::AID-PROT80>3.0.CO;2-3; Follis KE, 2002, J VIROL, V76, P7356, DOI 10.1128/JVI.76.14.7356-7362.2002; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; Kohn JE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000911; Kruger P, 2001, PROTEIN SCI, V10, P798, DOI 10.1110/ps.40401; Li CQ, 2014, INT J MOL SCI, V15, P5553, DOI 10.3390/ijms15045553; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Markwick PRL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000168; Milne JLS, 2013, FEBS J, V280, P28, DOI 10.1111/febs.12078; Sanders RW, 2002, HIV SEQUENCE COMPEND; Sen J, 2010, BIOCHEMISTRY-US, V49, P5057, DOI 10.1021/bi1005267; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Teixeira C, 2011, EUR J MED CHEM, V46, P979, DOI 10.1016/j.ejmech.2011.01.046; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0	24	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146743	10.1371/journal.pone.0146743	http://dx.doi.org/10.1371/journal.pone.0146743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785380	Green Submitted, Green Published, gold			2022-12-26	WOS:000368528400063
J	Marques, ARA; Gabriel, TL; Aten, J; van Roomen, CPAA; Ottenhoff, R; Claessen, N; Alfonso, P; Irun, P; Giraldo, P; Aerts, JMFG; van Eijk, M				Marques, Andre R. A.; Gabriel, Tanit L.; Aten, Jan; van Roomen, Cindy P. A. A.; Ottenhoff, Roelof; Claessen, Nike; Alfonso, Pilar; Irun, Pilar; Giraldo, Pilar; Aerts, Johannes M. F. G.; van Eijk, Marco			Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease	PLOS ONE			English	Article							LIPID STORAGE DISORDER; GAUCHER-DISEASE; CHOLESTEROL; MOUSE; MACROPHAGES; EXPRESSION; LIVER; TRAFFICKING; METABOLISM; INHIBITORS	Impaired function of NPC1 or NPC2 lysosomal proteins leads to the intracellular accumulation of unesterified cholesterol, the primary defect underlying Niemann-Pick type C (NPC) disease. In addition, glycosphingolipids (GSLs) accumulate in lysosomes as well. Intralysosomal lipid accumulation triggers the activation of a set of genes, including potential biomarkers. Transcript levels of Gpnmb have been shown to be elevated in various tissues of an NPC mouse model. We speculated that Gpnmb could serve as a marker for visceral lipid accumulation in NPC disease. We report that Gpnmb expression is increased at protein level in macrophages in the viscera of Npc1(nih/nih) mice. Interestingly, soluble Gpnmb was also found to be increased in murine and NPC patient plasma. Exposure of RAW264.7 macrophages to the NPC-phenotype-inducing drug U18666A also upregulated Gpnmb expression. Inhibition of GSL synthesis with the glucosylceramide synthase (GCS) inhibitor N-butyl-1-deoxynojirimycin prevented U18666A-induced Gpnmb induction and secretion. In summary, we show that Gpnmb is upregulated in NPC mice and patients, most likely due to GSL accumulation.	[Marques, Andre R. A.; Gabriel, Tanit L.; van Roomen, Cindy P. A. A.; Ottenhoff, Roelof; Aerts, Johannes M. F. G.; van Eijk, Marco] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Aten, Jan; Claessen, Nike] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Alfonso, Pilar; Irun, Pilar; Giraldo, Pilar] Ctr Invest Biomed Red Enfermedades Raras, Unidad Invest Traslac, Zaragoza, Spain; [Aerts, Johannes M. F. G.; van Eijk, Marco] Leiden Univ, Dept Biochem, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Leiden University; Leiden University - Excl LUMC	van Eijk, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; van Eijk, M (corresponding author), Leiden Univ, Dept Biochem, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands.	m.c.van.eijk@lic.leidenuniv.nl	Marques, André R. A./Q-3892-2018; Aerts, Johannes/A-1028-2009; Irun, Pilar/ABG-9652-2020	Marques, André R. A./0000-0001-9674-3017; Aerts, Johannes/0000-0001-8168-2565; Irun, Pilar/0000-0003-3392-7200; Aten, Jan/0000-0002-0997-6777; van Eijk, Marco/0000-0001-7751-4112	ERC-advanced program of the EU [290836]	ERC-advanced program of the EU	Johannes Aerts was supported by the ERC-advanced (290836) program of the EU.	Alam MS, 2014, J BIOL CHEM, V289, P8051, DOI 10.1074/jbc.M113.526392; Alam MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048273; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; BESLEY GTN, 1983, BIOCHIM BIOPHYS ACTA, V752, P54, DOI 10.1016/0005-2760(83)90232-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boot RG, 2006, J INHERIT METAB DIS, V29, P564, DOI 10.1007/s10545-006-0318-8; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Cologna SM, 2014, J INHERIT METAB DIS, V37, P83, DOI 10.1007/s10545-013-9610-6; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Gabriel TL, 2014, DIABETES, V63, P3310, DOI 10.2337/db13-1720; German DC, 2001, NEUROSCIENCE, V105, P999, DOI 10.1016/S0306-4522(01)00230-5; Giese AK, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0274-1; Gold H, 2013, CLIN CHEM, V59, P547, DOI 10.1373/clinchem.2012.192138; HARMALA AS, 1994, BBA-LIPID LIPID MET, V1211, P317, DOI 10.1016/0005-2760(94)90156-2; HEIDER JG, 1978, J LIPID RES, V19, P514; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lombardo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038520; Lopez ME, 2012, HUM MOL GENET, V21, P2946, DOI 10.1093/hmg/dds126; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; MORRIS MD, 1982, AM J PATHOL, V108, P140; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; PLATT FM, 1994, J BIOL CHEM, V269, P27108; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Ries M, 2006, J INHERIT METAB DIS, V29, P647, DOI 10.1007/s10545-006-0363-3; Rimkunas VM, 2009, J LIPID RES, V50, P327, DOI 10.1194/jlr.M800415-JLR200; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Sagiv Y, 2006, J IMMUNOL, V177, P26, DOI 10.4049/jimmunol.177.1.26; Salvioli R, 2004, J BIOL CHEM, V279, P17674, DOI 10.1074/jbc.M313517200; Sayre NL, 2010, J LIPID RES, V51, P2372, DOI 10.1194/jlr.M007211; Sillence DJ, 2013, MOL GENET METAB, V109, P194, DOI 10.1016/j.ymgme.2013.03.015; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Welford RWD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114669; Wennekes T, 2007, J ORG CHEM, V72, P1088, DOI 10.1021/jo061280p; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Zigdon H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120194	52	30	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147208	10.1371/journal.pone.0147208	http://dx.doi.org/10.1371/journal.pone.0147208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771826	Green Published, gold, Green Submitted			2022-12-26	WOS:000368628300072
J	Naidu, VV; Ismail, K; Amiel, S; Kohli, R; Crosby-Nwaobi, R; Sivaprasad, S; Stewart, R				Naidu, Vasanth Venkat; Ismail, Khalida; Amiel, Stephanie; Kohli, Reena; Crosby-Nwaobi, Roxanne; Sivaprasad, Sobha; Stewart, Robert			Associations between Retinal Markers of Microvascular Disease and Cognitive Impairment in Newly Diagnosed Type 2 Diabetes Mellitus: A Case Control Study	PLOS ONE			English	Article							VASCULAR TORTUOSITY; TELEPHONE INTERVIEW; STATUS TICS; RETINOPATHY; DEMENTIA; RISK; ABNORMALITIES; HYPERTENSION; DECLINE; ANGIOGENESIS	Objective To investigate associations between retinal microvascular changes and cognitive impairment in newly diagnosed type 2 diabetes mellitus. Design Case control study. Setting A primary care cohort with newly diagnosed type 2 diabetes mellitus. Methods For this analysis, we compared 69 cases with lowest decile scores (for the cohort) on the Modified Telephone Interview for Cognitive Status and 68 controls randomly selected from the remainder of the cohort. Retinal images were rated and the following measures compared between cases and controls: retinal vessel calibre, arterio-venous ratio, retinal fractal dimension, and simple and curvature retinal vessel tortuosity. Results Total and venular (but not arteriolar) simple retinal vessel tortuosity levels were significantly higher in cases than controls (t = 2.45, p = 0.015; t = 2.53, p = 0.013 respectively). The associations persisted after adjustment for demographic factors, retinopathy, neuropathy, obesity and blood pressure. There were no other significant differences between cases and controls in retinal measures. Conclusions A novel association was found between higher venular tortuosity and cognitive impairment in newly diagnosed type 2 diabetes mellitus. This might be accounted for by factors such as hypoxia, thrombus formation, increased vasoendothelial growth factor release and inflammation affecting both the visible retinal and the unobserved cerebral microvasculature.	[Naidu, Vasanth Venkat; Ismail, Khalida; Amiel, Stephanie; Crosby-Nwaobi, Roxanne; Sivaprasad, Sobha; Stewart, Robert] Kings Coll London, London WC2R 2LS, England; [Kohli, Reena] Kent & Medway NHS & Social Care Partnership Trust, Maidstone, Kent, England; [Crosby-Nwaobi, Roxanne; Sivaprasad, Sobha] NIHR Moorfields Biomed Res Ctr, London, England	University of London; King's College London	Naidu, VV (corresponding author), Kings Coll London, London WC2R 2LS, England.	vasanth.naidu@kcl.ac.uk	Stewart, Robert/B-1667-2010; Sivaprasad, S./D-6876-2015	Stewart, Robert/0000-0002-4435-6397; Sivaprasad, S./0000-0001-8952-0659; Ismail, Khalida/0000-0001-6084-449X	King's College Hospital R&D research initiative grant [KCH1039]; National Institute of Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London; National Institute for Health Research [RP-PG-0606-1142] Funding Source: researchfish	King's College Hospital R&D research initiative grant; National Institute of Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by grant KCH1039, King's College Hospital R&D research initiative grant. The funding was received by Sobha Sivaprasad (SS). Robert Stewart (RS) is part-funded by the National Institute of Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London.	Arden GB, 2011, CURR DIABETES REV, V7, P291, DOI 10.2174/157339911797415620; Ba-Tin L, 2011, CARDIOVASCULAR PSYCH, V2011; Barber M, 2004, INT J GERIATR PSYCH, V19, P75, DOI 10.1002/gps.1041; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chesnutt JKW, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005478; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Cines DB, 1998, BLOOD, V91, P3527; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Crosby-Nwaobi R, 2012, DIABETES RES CLIN PR, V96, P101, DOI 10.1016/j.diabres.2011.11.010; Crosby-Nwaobi R, 2012, OPHTHALMOLOGICA, V228, P84, DOI 10.1159/000337252; Crosby-Nwaobi RR, 2013, DIABETES CARE, V36, P3177, DOI 10.2337/dc12-2141; de Bresser J, 2010, DEMENT GERIATR COGN, V30, P381, DOI 10.1159/000321354; Ding J, 2010, DIABETES, V59, P2883, DOI 10.2337/db10-0752; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Exalto LG, 2012, EXP GERONTOL, V47, P858, DOI 10.1016/j.exger.2012.07.014; Gasecki D, 2013, CURR HYPERTENS REP, V15, P547, DOI 10.1007/s11906-013-0398-4; Hart WE, 1999, INT J MED INFORM, V53, P239, DOI 10.1016/S1386-5056(98)00163-4; Heng LZ, 2013, DIABETIC MED, V30, P640, DOI 10.1111/dme.12089; Heringa SM, 2013, J CEREBR BLOOD F MET, V33, P983, DOI 10.1038/jcbfm.2013.58; Hughes AD, 2006, J HYPERTENS, V24, P889, DOI 10.1097/01.hjh.0000222759.61735.98; Nguyen J, 2011, J CEREBR BLOOD F MET, V31, P2243, DOI 10.1038/jcbfm.2011.95; Kadoi Y, 2005, J THORAC CARDIOV SUR, V129, P576, DOI 10.1016/j.jtcvs.2004.07.012; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; MacCormick IJC, 2012, HIGH ALT MED BIOL, V13, P263, DOI 10.1089/ham.2011.1097; Mariani E, 2007, J ALZHEIMERS DIS, V12, P23; Mohsin F, 2005, DIABETES CARE, V28, P1974, DOI 10.2337/diacare.28.8.1974; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408; RENNIE D, 1975, ARCH OPHTHALMOL-CHIC, V93, P395; Saaristo A, 2002, FASEB J, V16, P1041, DOI 10.1096/fj.01-1042com; Sasongko MB, 2011, DIABETOLOGIA, V54, P2409, DOI 10.1007/s00125-011-2200-y; Sasongko MB, 2010, DIABETES CARE, V33, P1331, DOI 10.2337/dc10-0055; Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265; Seo EH, 2011, ARCH GERONTOL GERIAT, V52, pE26, DOI 10.1016/j.archger.2010.04.008; Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; Winkley K, 2013, DIABETOLOGIA, V56, P1272, DOI 10.1007/s00125-013-2873-5; Witt N, 2006, HYPERTENSION, V47, P975, DOI 10.1161/01.HYP.0000216717.72048.6c; Wong TY, 2002, STROKE, V33, P1487, DOI 10.1161/01.STR.0000016789.56668.43; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yau JWY, 2010, DIABETOLOGIA, V53, P2042, DOI 10.1007/s00125-010-1811-z	43	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147160	10.1371/journal.pone.0147160	http://dx.doi.org/10.1371/journal.pone.0147160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771382	Green Submitted, Green Published, gold			2022-12-26	WOS:000368628300068
J	Semlali, A; Parine, NR; Arafah, M; Mansour, L; Azzi, A; Al Shahrani, O; Al Amri, A; Shaik, JP; Aljebreen, AM; Alharbi, O; Almadi, MA; Azzam, NA; Kohailan, M; Rouabhia, M; Alanazi, MS				Semlali, Abdelhabib; Parine, Narasimha Reddy; Arafah, Maha; Mansour, Lamjed; Azzi, Arezki; Al Shahrani, Omair; Al Amri, Abdullah; Shaik, Jilani P.; Aljebreen, Abdulrahman M.; Alharbi, Othman; Almadi, Majid A.; Azzam, Nahla Ali; Kohailan, Muhammad; Rouabhia, Mahmoud; Alanazi, Mohammad Saud			Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-kappa B Mediated Inflammation in Colon Cancer Patients	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PATTERN-RECOGNITION RECEPTORS; DOUBLE-EDGED-SWORD; COLORECTAL-CANCER; PROSTATE-CANCER; GASTRIC-CANCER; THR399ILE POLYMORPHISMS; SIGNAL-TRANSDUCTION; INNATE IMMUNITY; BREAST-CANCER	Our aim was to evaluate the association between the expression and the polymorphism of TLR4/NF-kappa B pathways and colon cancer. TLR4 (rs4986790, rs10759932, rs10759931 and rs2770150) were genotyped in blood samples from Colorectal patients and healthy controls. TLR4 and cytokines inflammatory expression were evaluated by real time PCR on 40 matching normal and colon tissues and the protein level by Immunohistochemistry. The high level of TLR4 expression in colon cancer tissues is mainly due to infections by bacteria in the human colon and leads to induction of an acute secretion of inflammatory cytokines mediated by NF-kappa B. Also, we report here a clear evidence for an association between TLR4 rs10759931 polymorphism (OR = 0.086, CI: 0.04-0.18, P = <0.00001). This polymorphism affects the entire population without being specific to either gender or to any age group. In contrast, the rs2770150 is associated with colon cancer in women aged over 50 years and is closely linked with the decreased levels of female sex hormones during the post-menopausal period (OR = 0.188, CI: 0.074-0.48, P = <0.00084). rs10759932 and rs4986790 appear to have any association with colon cancer. Our data suggest that TLR4 SNPs could possibly serve as biomarkers for decision making in colon cancer treatment.	[Semlali, Abdelhabib; Parine, Narasimha Reddy; Al Shahrani, Omair; Al Amri, Abdullah; Shaik, Jilani P.; Kohailan, Muhammad; Alanazi, Mohammad Saud] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia; [Arafah, Maha; Aljebreen, Abdulrahman M.; Alharbi, Othman; Azzam, Nahla Ali] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Aljebreen, Abdulrahman M.; Alharbi, Othman; Almadi, Majid A.; Azzam, Nahla Ali] King Saud Univ, King Khalid Univ Hosp, Div Gastroenterol, Riyadh, Saudi Arabia; [Almadi, Majid A.] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Div Gastroenterol, Montreal, PQ H3G 1A4, Canada; [Rouabhia, Mahmoud] Univ Laval, Fac Med Dent, Dept Stomatol, Grp Rech Ecol Buccale, Quebec City, PQ, Canada; [Mansour, Lamjed] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Azzi, Arezki] Al Imam Muhammad Ibn Saud Islamic Univ IMSIU, Coll Med, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Saud University; King Khalid University Hospital; McGill University; Laval University; King Saud University; Imam Mohammad Ibn Saud Islamic University (IMSIU)	Semlali, A (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia.	asemlali@ksu.edu.sa	MANSOUR, Lamjed/AAO-6201-2020; Parine, Narasimha Reddy/B-7975-2011; Mansour, Lamjed/AAD-8613-2019; Alamri, Abdullah M/C-3108-2012; Mansour, Lamjed/U-3028-2017; Arafah, Maha/GZM-4328-2022; Almadi, Majid A/K-7819-2017; Semlali, Abdelhabib/AAP-7043-2020	MANSOUR, Lamjed/0000-0002-9415-9383; Parine, Narasimha Reddy/0000-0002-0765-9022; Alamri, Abdullah M/0000-0002-3045-1350; Mansour, Lamjed/0000-0002-9415-9383; Arafah, Maha/0000-0003-4966-2358; Almadi, Majid A/0000-0001-9917-2758; Semlali, Abdelhabib/0000-0002-1643-0377; Rouabhia, Mahmoud/0000-0003-2205-8281	Kingdom of Saudi Arabia [RGP-VPP-260]	Kingdom of Saudi Arabia	This work was supported by Grant number RGP-VPP-260, http://dsrs.ksu.edu.sa/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the research group program (number RGP-VPP-260) in the Kingdom of Saudi Arabia.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ahmed A, 2013, ANN SURG ONCOL, V20, pS389, DOI 10.1245/s10434-012-2595-9; Al-Azzawi F, 2002, CLIMACTERIC, V5, P3, DOI 10.1080/713605194; Alanazi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085541; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Barzi A, 2013, CLIN CANCER RES, V19, P5842, DOI 10.1158/1078-0432.CCR-13-0325; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bergmann C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-139; Bhatelia K, 2014, CELL SIGNAL, V26, P2350, DOI 10.1016/j.cellsig.2014.07.035; Bhide MR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-21; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Castano-Rodriguez N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00336; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Culig Z, 2005, J UROLOGY, V174, P417, DOI 10.1097/01.ju.0000171014.31670.a8; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; Davoodi H, 2011, IRAN J ALLERGY ASTHM, V10, P91, DOI 010.02/ijaai.9199; de Oliveira JG, 2012, WORLD J GASTROENTERO, V18, P1235, DOI 10.3748/wjg.v18.i11.1235; Debelec-Butuner B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109868; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gambara G, 2013, J CELL MOL MED, V17, P713, DOI 10.1111/jcmm.12055; Garcia-Tunon I, 2005, HISTOPATHOLOGY, V47, P82, DOI 10.1111/j.1365-2559.2005.02178.x; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; HENDRICKSE CW, 1993, BRIT J SURG, V80, P636, DOI 10.1002/bjs.1800800531; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Jeon JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105212; Jing JJ, 2012, GENE, V499, P237, DOI 10.1016/j.gene.2012.03.045; Kastritis E, 2009, TARGET ONCOL, V4, P23, DOI 10.1007/s11523-008-0102-9; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Lavole A, 2014, REV MAL RESPIR, V31, P133, DOI 10.1016/j.rmr.2013.07.009; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marino M, 2014, WORLD J GASTRO ONCOL, V6, P67, DOI 10.4251/wjgo.v6.i3.67; Medvedev A, 2012, J IMMUNOL, P188; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Mukherjee S, 2014, CELL SIGNAL, V26, P2674, DOI 10.1016/j.cellsig.2014.08.009; Niedzielska I, 2009, J PHYSIOL PHARMACOL, V60, P65; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2012, J BIOL CHEM, V287, P40611, DOI 10.1074/jbc.M112.404608; Okamoto M, 2001, INT IMMUNOPHARMACOL, V1, P1789, DOI 10.1016/S1567-5769(01)00103-5; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Priyadarshini Anjali, 2013, Indian J Urol, V29, P37, DOI 10.4103/0970-1591.109982; Rajput S, 2013, MOL CANCER THER, V12, P1676, DOI 10.1158/1535-7163.MCT-12-1019; Rizzo A, 2011, WORLD J GASTROENTERO, V17, P3092, DOI 10.3748/wjg.v17.i26.3092; Santini D, 2008, CLIN EXP IMMUNOL, V154, P360, DOI 10.1111/j.1365-2249.2008.03776.x; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Semiali A, 2008, AM J RESP CELL MOL, V38, P202, DOI 10.1165/rcmb.2007-0031OC; Semlali A, 2011, PEPTIDES, V32, P859, DOI 10.1016/j.peptides.2011.01.020; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; Simiantonaki N, 2007, INT J MOL MED, V20, P21; Slattery ML, 2012, INT J CANCER, V130, P2974, DOI 10.1002/ijc.26314; Smith Sinead M, 2014, World J Gastrointest Pathophysiol, V5, P133, DOI 10.4291/wjgp.v5.i3.133; Starkhammar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104114; Stevens VL, 2008, INT J CANCER, V123, P2644, DOI 10.1002/ijc.23826; Tahara T, 2008, DIGEST DIS SCI, V53, P919, DOI 10.1007/s10620-007-9950-x; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tang XY, 2012, ONCOL RES, V20, P15, DOI 10.3727/096504012X13425470196092; Vogel SN, 2003, BIOCHEM SOC T, V31, P664, DOI 10.1042/bst0310664; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang HA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-92; Yuan X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.334; Zhao S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00352	71	43	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146333	10.1371/journal.pone.0146333	http://dx.doi.org/10.1371/journal.pone.0146333			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771524	gold, Green Published, Green Submitted			2022-12-26	WOS:000368628300014
J	Ying, M; Zhang, L; Zhou, Q; Shao, X; Cao, J; Zhang, N; Li, W; Zhu, H; Yang, B; He, Q				Ying, M.; Zhang, L.; Zhou, Q.; Shao, X.; Cao, J.; Zhang, N.; Li, W.; Zhu, H.; Yang, B.; He, Q.			The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid-induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RAR alpha	ONCOGENE			English	Article							MESENCHYMAL STEM-CELLS; MYELOID-LEUKEMIA CELLS; GENE AMPLIFICATION; RECEPTOR-ALPHA; CANCER-THERAPY; HUMAN SARCOMAS; P53; PHOSPHORYLATION; STABILIZATION; ACTIVATION	Retinoic acid receptor alpha (RAR alpha) has a critical role in the differentiation process of osteosarcoma cells induced by all-trans retinoic acid (ATRA). However, degradation of RAR alpha through ubiquitin proteasome pathway weakens the differentiation efficiency of osteosarcoma cells. In this study, we discover that murine double minute-2 (MDM2) acts as an E3 ubiquitin ligase to target RAR alpha for degradation. We observe that MDM2 is required for RAR alpha polyubiquitination and proteasomal degradation because downregulation of MDM2 by short hairpin RNA results in the accumulation of RAR alpha, and MDM2 overexpression promotes the degradation of RAR alpha. We also demonstrate that the N-terminal domain of MDM2 (amino acids 1-109) is the major RAR alpha-binding site. Importantly, endogenous MDM2 levels are not only upregulated in human primary osteosarcoma blasts but are also inversely correlated with the level of osteopontin, which is a marker of bone differentiation. Moreover, MDM2 impairs the ATRA-induced osteoblastic differentiation of osteosarcoma cells, whereas an inhibitor of the MDM2 ubiquitin ligase synergizes with ATRA to enhance the differentiation of osteosarcoma cells and primary osteosarcoma blasts. Therefore, our study indicates that MDM2 serves as an E3 ubiquitin ligase to regulate the degradation of RARa and suggests that MDM2 is a novel therapeutic target for ATRA-based differentiation therapeutic approaches in osteosarcoma.	[Ying, M.; Zhang, L.; Zhou, Q.; Shao, X.; Cao, J.; Zhu, H.; Yang, B.; He, Q.] Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou, Zhejiang, Peoples R China; [Zhang, N.; Li, W.] Zhejiang Univ, Affiliated Hosp 2, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, B; He, Q (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Room 113,866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	yang924@zju.edu.cn; qiaojunhe@zju.edu.cn		Zhou, Qiong/0000-0002-8240-0440; Zhu, Hong/0000-0002-2575-4031	National Natural Science Foundation of China [81473227, 91029745, 81273536]; Zhejiang Provincial Program for Qianjiang Talents [2013R10025]; Zhejiang Provincial Natural Science Foundation of China [Y14H160124]; Fundamental Research Funds for Central Universities; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA047135] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for Qianjiang Talents; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81473227, 91029745 and 81273536), Zhejiang Provincial Program for Qianjiang Talents (2013R10025), Zhejiang Provincial Natural Science Foundation of China (No. Y14H160124) and the Fundamental Research Funds for the Central Universities.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Berner JM, 1996, GENE CHROMOSOME CANC, V17, P254, DOI 10.1002/(SICI)1098-2264(199612)17:4<254::AID-GCC7>3.0.CO;2-2; Chai Z, 2009, IUBMB LIFE, V61, P670, DOI 10.1002/iub.212; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Dingwall M, 2011, DIFFERENTIATION, V82, P57, DOI 10.1016/j.diff.2011.05.003; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Gianni M, 2009, CANCER RES, V69, P1016, DOI 10.1158/0008-5472.CAN-08-2603; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; Haydon RC, 2007, CLIN ORTHOP RELAT R, P237, DOI 10.1097/BLO.0b013e31802b683c; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; Hisada K, 2013, J BONE MINER METAB, V31, P53, DOI 10.1007/s00774-012-0385-x; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; LADANYI M, 1993, CANCER RES, V53, P16; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Luo P, 2010, ONCOGENE, V29, P2772, DOI 10.1038/onc.2010.50; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Moumen A, 2007, DEVELOPMENT, V134, P1443, DOI 10.1242/dev.02820; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Steinman HA, 2004, J BIOL CHEM, V279, P4877, DOI 10.1074/jbc.M305966200; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang WS, 2012, MED RES REV, V32, P1159, DOI 10.1002/med.20236; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Xiong L, 2007, J CELL BIOL, V178, P995, DOI 10.1083/jcb.200703044; Ying MD, 2013, MOL CANCER THER, V12, P195, DOI 10.1158/1535-7163.MCT-12-0433; Zhan CY, 2012, J AM CHEM SOC, V134, P6855, DOI 10.1021/ja301255n; Zhang L, 2014, CELL CYCLE, V13, P1277, DOI 10.4161/cc.28190; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618; Zhou Q, 2014, FEBS J, V281, P3032, DOI 10.1111/febs.12840; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807	39	44	45	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	33					4358	4367		10.1038/onc.2015.503	http://dx.doi.org/10.1038/onc.2015.503			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3ZU	26776160				2022-12-26	WOS:000382152100007
